Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" BET1L "GOLIM3, GS15" ENSG00000177951 "Bet1 golgi vesicular membrane trafficking protein like" Q9NYM9 11 167784-207428 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 142.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039819 Approved Supported "Nucleoplasm,Golgi apparatus" No No "Cluster 52: Eosinophils - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" Nucleoplasm "HPA039819: AB_10673020" "unprognostic (1.68e-1)" "unprognostic (2.07e-1)" "unprognostic (2.14e-3)" "unprognostic (2.56e-3)" "prognostic unfavorable (9.80e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.82e-1)" "unprognostic (1.52e-1)" "unprognostic (3.08e-2)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "unprognostic (9.10e-2)" "unprognostic (1.69e-1)" "unprognostic (3.75e-2)" "unprognostic (8.49e-2)" 36.2 38.2 26.8 29.4 28.2 18.0 35.5 26.5 27.6 43.2 33.2 37.0 29.1 37.0 37.3 30.1 38.8 27.5 34.3 25.6 27.1 40.4 53.5 35.4 32.9 31.0 28.5 53.6 79.9 39.9 56.0 29.8 28.0 43.4 29.8 17.1 52.9 41.6 22.5 36.1 39.4 31.3 27.5 39.4 43.1 33.0 27.5 28.2 37.5 23.4 35.7 37.4 33.2 30.1 46.2 37.6 22.0 27.3 66.5 58.3 31.8 48.1 62.8 50.6 51.5 47.3 43.4 40.5 22.9 87.7 36.4 42.1 25.6 44.0 38.3 31.6 27.7 37.5 21.5 48.2 61.4 43.2 70.2 66.2 58.1 29.8 79.6 58.7 34.7 28.2 55.7 41.3 32.7 25.0 31.7 27.3 33.6 66.8 42.3 32.6 32.6 27.7 41.8 20.3 23.9 29.0 42.9 68.5 47.7 31.5 35.2 33.6 38.6 39.0 18.0 16.0 24.0 72.2 35.9 35.6 52.7 35.6 36.4 58.5 19.0 66.0 28.4 27.5 34.1 31.9 32.5 29.1 19.0 25.0 37.4 29.6 43.5 27.9 25.8 22.1 27.4 32.5 26.8 28.2 26.5 27.6 25.6 27.1 31.0 28.5 28.0 27.5 27.5 30.1 9.8 12.8 17.0 3.9 23.0 9.3 16.8 12.8 16.5 6.8 21.3 19.0 14.5 15.7 10.7 14.7 8.4 15.8 16.9 24.4 21.5 12.8 58.8 8.6 13.2 10.6 7.8 12.0 3.6 23.4 28.2 19.4 20.9 10.1 38.0 10.2 18.2 39.3 22.7 3.3 4.4 23.1 14.2 16.4 12.7 142.9 22.1 18.4 7.2 2.8 14.8 9.1 10.3 4.0 4.7 18.6 26.1 18.8 68.3 29.2 39.2 28.7 12.6 10.4 6.6 12.8 15.9 47.2 21.8 11.9 11.6 26.3 19.4 8.9 17.1 29.3 SCGB1C1 RYD5 ENSG00000188076 "Secretoglobin family 1C member 1" Q8TD33 11 193078-194575 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.3;pancreas: 1.4;retina: 3.4;salivary gland: 1.0" "Cell type enriched" "Detected in single" 5 "Macrophages: 2.7" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.6" "Region enhanced" "Detected in single" "pons: 1.3" "Group enriched" "Detected in some" 32 "basophil: 5.0;neutrophil: 1.3" "Lineage enriched" "Detected in single" 50 "granulocytes: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted - unknown location" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 51: Myeloid cells - Hemostasis" "unprognostic (5.09e-3)" 0.0 0.1 0.1 0.1 0.1 0.7 0.1 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.0 3.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.3 0.1 0.1 0.7 0.3 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ODF3 "CT135, hSHIPPO, SHIPPO1" ENSG00000177947 "Outer dense fiber of sperm tails 3" Q96PU9 11 196761-200261 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "testis: 9.4" "Cell type enriched" "Detected in some" 4 "Early spermatids: 95.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA038919, HPA039241" Enhanced NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA038919: AB_2676270, HPA039241: AB_10673417" "unprognostic (4.17e-1)" "unprognostic (2.41e-1)" "unprognostic (1.24e-2)" "unprognostic (1.99e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RIC8A "synembryn, synembryn-A" ENSG00000177963 "RIC8 guanine nucleotide exchange factor A" Q9NPQ8 11 207511-215113 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041491, CAB046012" Approved Approved "Plasma membrane,Cytosol" NA NA 10000 "Cluster 44: Non-specific - Transcription" "Cluster 57: Non-specific - Angiogenesis" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "Plasma membrane" "CAB046012: AB_11129402, HPA041491: AB_2677510" "unprognostic (3.93e-2)" "unprognostic (8.69e-2)" "unprognostic (1.62e-1)" "prognostic favorable (8.60e-4)" "unprognostic (1.61e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.11e-6)" "unprognostic (2.13e-3)" "unprognostic (8.70e-2)" "unprognostic (7.68e-2)" "unprognostic (1.56e-1)" "unprognostic (8.35e-2)" "unprognostic (2.63e-3)" "unprognostic (5.35e-2)" "unprognostic (2.57e-1)" "unprognostic (2.14e-1)" "unprognostic (1.60e-1)" 39.2 39.6 43.0 34.8 43.6 40.6 37.4 42.1 48.5 41.2 46.6 46.3 29.5 44.2 41.8 43.1 41.1 30.6 42.9 45.4 43.7 36.5 37.8 37.6 37.6 43.5 44.4 39.7 39.3 34.2 38.1 34.1 44.2 39.0 30.8 24.8 34.4 40.3 32.8 39.5 38.1 49.4 43.4 41.6 38.1 44.0 44.0 41.6 33.7 28.3 41.8 45.9 36.6 45.0 176.3 83.9 66.8 66.7 89.7 73.4 46.3 124.1 99.2 166.0 114.2 72.6 121.1 69.6 50.5 189.0 125.7 93.4 76.4 131.4 92.0 84.5 76.7 39.4 59.5 67.8 72.3 66.5 125.8 80.6 114.3 103.2 92.6 85.2 82.8 72.8 68.7 66.0 129.3 71.1 79.6 52.6 61.1 74.0 103.0 74.0 66.0 47.5 96.9 45.6 69.2 62.2 96.3 107.1 67.1 63.9 76.1 52.8 93.4 109.2 96.5 40.4 117.3 72.6 117.6 67.8 107.7 59.5 83.5 72.9 41.1 88.3 79.0 49.7 78.2 64.4 70.1 69.0 43.7 55.1 59.9 60.6 59.9 73.0 61.0 35.8 65.0 86.6 43.0 43.6 42.1 48.5 45.4 43.7 43.5 44.4 44.2 43.4 44.0 45.0 30.9 16.0 21.1 10.7 28.7 17.7 20.5 38.6 17.1 28.1 22.5 27.2 23.5 28.6 25.5 25.8 10.4 41.4 46.5 26.3 27.4 53.1 20.2 15.9 24.3 27.2 20.3 27.4 9.4 44.2 60.0 30.4 23.0 19.7 17.7 28.8 27.8 17.1 46.8 32.0 8.4 19.2 30.5 27.4 11.5 17.3 30.7 27.5 28.4 11.2 38.9 43.4 30.9 5.0 7.8 71.6 25.5 39.9 35.2 26.5 29.9 23.0 20.8 33.1 19.7 20.7 35.4 93.2 62.5 20.9 19.5 32.4 34.8 30.2 25.0 17.0 SIRT3 SIR2L3 ENSG00000142082 "Sirtuin 3" Q9NTG7 11 215030-236931 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026809, CAB037142" Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 59: Non-specific - Transcription" "CAB037142: AB_1079982, HPA026809: AB_10601160" "unprognostic (1.76e-2)" "unprognostic (2.69e-1)" "unprognostic (2.04e-1)" "prognostic favorable (8.51e-5)" "unprognostic (1.52e-3)" "unprognostic (2.65e-1)" "unprognostic (3.45e-2)" "unprognostic (5.52e-2)" "unprognostic (8.64e-2)" "unprognostic (1.31e-1)" "prognostic favorable (4.45e-4)" "unprognostic (2.06e-1)" "prognostic favorable (4.85e-9)" "unprognostic (1.04e-1)" "unprognostic (5.53e-2)" "unprognostic (3.45e-1)" "unprognostic (3.75e-2)" 11.1 13.8 24.5 10.4 28.8 11.8 18.6 19.7 28.8 14.3 26.1 13.9 13.3 12.6 40.1 9.9 14.4 7.6 24.4 25.1 20.8 17.2 25.8 10.3 13.8 19.0 20.4 18.3 18.0 11.2 28.0 5.8 18.4 16.7 14.2 26.8 12.6 12.4 27.3 20.2 14.6 9.7 19.0 14.7 13.5 25.2 21.6 6.8 15.7 19.9 14.9 11.5 11.1 24.0 9.7 11.1 16.7 17.7 19.1 24.1 8.0 13.6 11.0 10.1 7.9 11.5 22.8 5.9 6.2 8.5 9.8 18.6 8.2 7.4 9.8 11.2 12.7 7.4 15.7 12.6 8.4 9.7 17.3 17.8 14.1 10.2 10.9 17.3 6.7 11.1 15.3 11.0 4.6 10.8 4.0 15.0 7.5 8.5 13.2 10.8 13.2 9.8 10.2 6.6 9.3 7.5 11.5 16.7 6.4 10.8 11.9 2.2 9.3 11.4 5.4 3.2 4.1 19.4 17.3 8.4 12.4 7.7 5.9 0.1 3.1 3.1 3.6 2.5 3.8 5.3 3.3 4.1 2.8 4.3 6.0 4.9 3.1 8.1 6.6 4.8 4.0 2.7 24.5 28.8 19.7 28.8 25.1 20.8 19.0 20.4 18.4 19.0 21.6 24.0 6.0 3.2 6.5 17.0 10.4 5.0 7.0 13.1 12.5 7.4 16.0 15.5 23.4 14.3 7.4 5.5 8.4 12.6 7.2 7.2 33.2 7.5 22.0 7.4 5.8 6.7 6.0 14.3 19.2 5.8 10.3 8.6 11.7 4.6 10.2 8.4 7.5 18.3 8.8 10.1 18.3 8.1 10.2 5.5 3.3 21.0 9.0 6.4 10.6 8.4 3.5 13.5 5.2 9.0 11.6 5.1 9.3 9.1 14.6 5.5 14.3 18.9 9.0 9.5 0.0 7.3 6.5 25.5 9.6 9.9 4.1 6.8 8.4 14.2 11.2 4.0 PSMD13 "p40.5, Rpn9" ENSG00000185627 "Proteasome 26S subunit, non-ATPase 13" Q9UNM6 11 236966-252984 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038691, HPA038692" Approved Approved "Nuclear speckles,Cytosol" NA NA 81000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 52: Non-specific - Ribosome" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 55: Plasma cells - Humoral immune response" "Nuclear speckles" Cytosol "HPA038691: AB_2676153, HPA038692: AB_10671749" "unprognostic (1.32e-2)" "unprognostic (7.98e-2)" "unprognostic (9.19e-2)" "prognostic favorable (5.74e-4)" "unprognostic (2.24e-2)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.76e-5)" "unprognostic (7.54e-3)" "unprognostic (2.94e-1)" "unprognostic (1.90e-1)" "unprognostic (1.98e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (1.52e-13)" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (1.73e-1)" "unprognostic (2.11e-1)" 56.6 41.3 48.2 65.2 49.1 69.4 74.9 50.0 51.5 57.8 49.5 64.1 57.0 50.7 62.6 63.6 51.8 42.9 76.1 50.3 52.6 53.6 71.8 56.2 79.5 50.3 50.2 40.0 48.9 45.6 18.0 64.9 54.0 67.1 66.7 30.8 46.3 52.0 122.4 62.4 55.7 68.1 51.1 54.3 45.9 44.2 49.5 91.6 48.3 124.3 86.9 65.5 20.1 52.3 240.7 163.7 155.2 163.7 135.3 114.0 102.3 151.8 186.1 277.7 210.6 156.1 352.4 193.0 178.2 172.7 145.5 179.4 154.6 200.2 251.0 202.7 148.7 109.9 52.4 131.7 160.9 203.8 207.7 116.3 149.7 138.4 121.2 114.0 241.7 186.3 249.1 158.1 189.9 126.3 197.4 185.0 243.1 195.0 184.0 168.6 145.3 156.3 190.2 59.2 141.7 111.5 106.5 166.7 111.0 103.6 97.7 123.7 192.6 115.2 96.8 60.3 160.6 161.2 192.4 271.8 185.2 193.0 176.3 198.6 171.3 133.6 145.8 173.0 143.0 125.0 133.1 141.1 176.1 128.6 121.3 130.3 127.8 168.7 194.7 122.1 169.2 286.0 48.2 49.1 50.0 51.5 50.3 52.6 50.3 50.2 54.0 51.1 49.5 52.3 80.8 48.1 41.4 17.0 64.7 35.8 54.1 124.8 26.2 43.2 43.8 41.7 45.7 52.9 68.8 31.3 31.3 162.3 79.9 76.5 82.2 114.8 39.2 41.6 47.1 75.1 48.0 35.7 16.8 130.8 138.6 55.9 34.1 45.2 67.2 59.9 54.7 59.0 100.5 37.0 15.5 75.2 71.2 47.5 43.5 57.8 68.6 64.4 46.2 11.2 91.9 65.0 71.1 8.5 17.2 123.4 65.5 59.8 73.9 58.7 80.8 76.2 61.3 44.2 85.5 40.8 66.9 94.0 86.4 34.4 38.8 205.8 71.6 73.8 74.2 51.4 NLRP6 "CLR11.4, NALP6, PAN3, PYPAF5" ENSG00000174885 "NLR family pyrin domain containing 6" P59044 11 278407-285388 "Plasma proteins, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 39.9" "Group enriched" "Detected in some" 4 "Proximal enterocytes: 9.9;T-cells: 2.6" "Group enriched" "Detected in some" 4 "colorectal cancer: 0.9;liver cancer: 1.2;renal cancer: 1.5;stomach cancer: 1.8" "Region enhanced" "Detected in single" "cerebral cortex: 3.6" "Group enriched" "Detected in many" 4 "neutrophil: 15.4;non-classical monocyte: 4.6" "Group enriched" "Detected in many" 4 "granulocytes: 15.4;monocytes: 4.6" "Cell line enhanced" "Detected in some" "REH: 2.0;U-266/70: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043681, HPA048500" Supported NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 56: Intestine - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "HPA043681: AB_2678614, HPA048500: AB_2680422" "unprognostic (6.37e-3)" "unprognostic (4.69e-2)" "unprognostic (4.26e-2)" "unprognostic (3.42e-2)" "unprognostic (6.40e-2)" "unprognostic (1.18e-2)" "prognostic favorable (4.23e-5)" "unprognostic (8.82e-2)" "unprognostic (2.40e-1)" "unprognostic (1.66e-1)" "unprognostic (5.16e-3)" "unprognostic (2.19e-1)" "unprognostic (3.11e-3)" "unprognostic (4.96e-2)" "unprognostic (2.14e-2)" "unprognostic (6.90e-3)" "unprognostic (3.69e-2)" 0.7 0.0 0.1 2.2 0.2 0.5 0.2 0.1 3.6 0.1 0.2 0.6 39.9 0.2 0.1 0.1 0.6 0.3 0.1 0.1 0.5 1.3 2.6 0.9 1.2 0.9 0.3 0.0 0.5 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.1 0.1 0.0 0.1 38.0 0.1 0.3 3.6 0.3 0.2 0.3 0.3 0.1 0.1 0.3 0.3 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.6 0.0 0.2 0.2 0.4 0.1 0.0 0.0 2.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.8 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.3 1.4 0.3 1.6 1.1 0.1 0.1 1.8 2.3 15.4 1.0 4.6 0.0 0.0 0.7 0.1 0.2 0.1 3.6 0.1 0.5 0.9 0.3 0.6 0.3 0.3 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.7 0.0 PGGHG "ATHL1, FLJ22635" ENSG00000142102 "Protein-glucosylgalactosylhydroxylysine glucosidase" Q32M88 11 289126-296107 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "pancreas: 657.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 160.3;Alveolar cells type 2: 81.8;Breast glandular cells: 35.1;Club cells: 31.6;Collecting duct cells: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 132.8;U-266/70: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA039383, HPA058829" Uncertain Enhanced Cytosol NA Yes "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 25: Pancreas - Digestion" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 11: Alveolar cells - Smell perception" Cytosol "HPA039383: AB_10796225, HPA058829: AB_2683830" "unprognostic (1.40e-3)" "unprognostic (2.18e-1)" "unprognostic (4.22e-2)" "unprognostic (2.37e-1)" "unprognostic (1.36e-2)" "unprognostic (5.83e-2)" "unprognostic (7.95e-3)" "unprognostic (2.77e-2)" "unprognostic (2.16e-2)" "unprognostic (2.14e-2)" "unprognostic (2.71e-2)" "unprognostic (3.45e-1)" "unprognostic (1.92e-3)" "unprognostic (2.85e-3)" "unprognostic (1.09e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.12e-4)" 25.3 5.6 5.8 41.6 5.8 16.3 41.9 5.5 25.6 56.0 6.8 25.2 50.5 21.6 32.7 14.1 34.6 18.9 18.8 5.4 5.8 116.4 77.8 67.0 63.5 6.9 6.4 8.7 657.7 2.9 12.5 7.3 8.2 34.6 6.3 0.6 36.2 46.1 4.5 8.6 103.0 3.0 5.7 101.9 18.5 6.3 7.1 37.4 74.4 3.2 17.6 21.5 22.6 6.3 5.4 5.8 10.5 11.7 4.2 3.7 8.2 4.2 3.4 2.4 2.1 5.0 15.0 0.0 5.3 5.1 5.1 3.3 0.9 1.9 0.3 13.3 4.0 2.5 4.2 6.8 5.3 0.3 22.8 13.8 1.5 0.9 0.7 8.9 8.1 132.8 10.5 15.9 1.3 7.7 24.0 12.1 8.3 1.8 1.0 21.5 2.1 7.8 5.6 1.8 0.1 2.4 1.5 7.8 7.2 4.6 5.7 2.9 7.5 4.9 7.0 1.5 0.5 34.8 1.0 6.0 0.8 4.3 5.8 1.2 0.7 1.0 6.1 3.2 5.1 1.5 1.0 3.3 0.5 1.5 2.1 4.5 3.7 5.6 2.5 2.0 0.1 2.2 5.8 5.8 5.5 25.6 5.4 5.8 6.9 6.4 8.2 5.7 7.1 6.3 17.8 160.3 81.8 0.0 9.1 0.0 0.0 0.0 0.0 0.0 35.1 26.8 0.0 0.0 31.6 33.1 0.0 0.3 29.8 0.0 0.0 4.9 0.0 12.5 12.0 4.5 0.0 0.0 0.0 8.3 3.3 4.2 0.0 17.6 6.3 1.5 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 16.1 0.0 0.0 2.9 10.2 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.3 14.4 0.9 0.0 0.0 IFITM5 "BRIL, DSPA1, fragilis4, Hrmp1" ENSG00000206013 "Interferon induced transmembrane protein 5" A6NNB3 11 298200-299526 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Mineral balance" "Developmental protein" "Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 4.9;pancreas: 7.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 8 "cerebral cortex: 4.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA039258 Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" "Plasma membrane" "Vesicles, Cytosol" "HPA039258: AB_10673608" "unprognostic (9.84e-2)" "unprognostic (2.15e-1)" "unprognostic (1.38e-1)" "unprognostic (5.80e-2)" "unprognostic (7.46e-2)" "unprognostic (4.20e-2)" "unprognostic (4.42e-2)" "unprognostic (8.31e-2)" "unprognostic (7.99e-3)" "unprognostic (1.94e-3)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (4.90e-2)" 0.1 0.0 0.0 0.1 0.0 0.7 0.2 0.0 4.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.2 0.4 0.1 0.1 0.1 0.0 7.3 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.1 0.1 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFITM2 "1-8D, DSPA2c" ENSG00000185201 "Interferon induced transmembrane protein 2" Q01629 11 303655-309397 "Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 920.0;NK-cells: 1350.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 6 "neutrophil: 23410.9" "Lineage enriched" "Detected in all" 11 "granulocytes: 23410.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 424.6;HHSteC: 547.7;HMC-1: 494.9;HSkMC: 710.9;NB-4: 603.3;U-937: 485.2" "HPA004337, HPA044731" Uncertain Approved "Nucleoplasm,Cell Junctions" NA NA 450000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 72: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 59: Non-specific - Transcription" "Cell Junctions" Nucleoplasm "HPA004337: AB_1851427, HPA044731: " "unprognostic (2.39e-2)" "unprognostic (2.69e-2)" "unprognostic (4.54e-1)" "unprognostic (1.65e-2)" "unprognostic (3.41e-2)" "unprognostic (1.86e-1)" "unprognostic (3.56e-2)" "unprognostic (3.87e-2)" "unprognostic (3.87e-1)" "unprognostic (2.36e-1)" "unprognostic (2.46e-3)" "unprognostic (1.64e-2)" "prognostic unfavorable (2.37e-9)" "unprognostic (2.79e-1)" "unprognostic (3.28e-2)" "unprognostic (1.51e-1)" "unprognostic (1.16e-2)" 1086.2 307.0 90.3 258.0 90.2 177.0 681.0 89.6 116.6 785.6 101.4 358.6 40.9 702.8 52.1 237.2 903.8 97.4 619.6 92.0 97.9 703.1 1288.5 1069.9 99.9 94.4 89.4 650.1 211.1 112.0 200.6 145.3 94.9 406.1 41.8 27.0 228.9 102.5 195.9 236.7 305.6 200.4 92.8 1402.1 304.3 123.0 95.4 29.8 437.7 132.8 105.8 493.1 496.6 95.1 32.2 65.4 313.1 2.9 137.2 358.3 0.9 106.8 65.1 27.0 63.3 1.7 206.9 2.7 126.6 424.6 0.4 68.5 1.1 9.3 9.0 1.8 41.1 75.1 102.6 117.6 547.7 124.1 494.9 710.9 2.3 5.2 3.3 64.4 51.2 22.5 5.2 210.5 11.6 129.9 2.5 603.3 36.4 5.3 229.4 101.0 29.9 1.1 181.6 0.4 0.8 7.0 65.4 74.9 34.5 5.3 86.7 69.8 338.3 5.7 26.8 36.1 1.4 4.5 5.0 3.3 14.5 485.2 18.1 2706.4 537.4 3789.5 666.6 1421.9 480.8 846.9 590.1 639.5 612.5 799.2 511.7 510.3 23410.9 1225.0 2199.0 279.0 411.7 1376.6 90.3 90.2 89.6 116.6 92.0 97.9 94.4 89.4 94.9 92.8 95.4 95.1 920.0 307.7 540.0 5.9 301.1 104.4 251.1 161.4 215.1 0.3 59.7 66.5 51.8 154.4 209.2 248.3 0.0 8.3 814.7 22.5 487.2 433.0 7.8 67.1 468.6 828.4 9.6 100.7 0.0 256.7 16.9 515.8 30.5 78.5 530.5 68.8 752.1 684.1 223.4 0.0 0.0 39.4 24.4 372.8 255.9 31.5 507.6 645.9 209.9 12.2 177.3 80.5 1350.1 0.0 0.1 161.9 149.2 223.8 123.0 126.3 4.7 45.3 104.8 1.5 315.5 442.5 568.4 8.4 10.4 22.8 83.0 23.4 667.2 61.8 44.3 102.4 AC136475.9 ENSG00000288681 "Novel protein" 11 308408-315272 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "brain: 4.1" "Cell type enhanced" "Detected in single" "dendritic cells: 1.1" "Group enriched" "Detected in some" 6 "cerebral cortex: 4.1;hippocampal formation: 1.7" "Immune cell enhanced" "Detected in all" "neutrophil: 473.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 473.0" "Cell line enhanced" "Detected in some" "Hep G2: 3.1;MCF7: 1.2;NB-4: 1.0;U-698: 2.7" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 7: Non-specific - Mitochondria" 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 4.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.0 2.7 0.0 0.0 0.0 151.8 6.4 206.0 16.5 41.9 20.0 12.0 24.2 8.8 6.0 13.3 10.6 29.8 473.0 87.7 53.0 2.8 6.4 170.9 0.1 0.0 0.3 4.1 1.7 0.0 0.1 0.1 0.1 0.1 0.1 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 IFITM1 "9-27, CD225, DSPA2a, IFI17" ENSG00000185885 "Interferon induced transmembrane protein 1" P13164 11 310041-315272 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity, Osteogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 673.8;Endothelial cells: 364.4;Leydig cells: 300.8;Sertoli cells: 276.1;T-cells: 595.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 1494.7;gdT-cell: 2906.3;MAIT T-cell: 2003.4;memory CD4 T-cell: 3120.6;memory CD8 T-cell: 3000.3;naive CD4 T-cell: 2939.3;naive CD8 T-cell: 2996.4;neutrophil: 2741.6;NK-cell: 4679.9;T-reg: 1944.8" "Group enriched" "Detected in all" 7 "granulocytes: 2741.6;NK-cells: 4679.9;T-cells: 3120.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 1038.8;BJ hTERT+ SV40 Large T+: 2266.3;BJ hTERT+ SV40 Large T+ RasG12V: 4016.8;HMC-1: 1138.9" "HPA004810, CAB017615" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 58: T-cells - T-cell receptor" "Golgi apparatus" "Plasma membrane, Cytosol" "CAB017615: AB_2264496, HPA004810: AB_1851419" "unprognostic (1.03e-3)" "unprognostic (6.79e-2)" "unprognostic (1.03e-1)" "unprognostic (2.98e-1)" "unprognostic (2.57e-1)" "unprognostic (9.06e-2)" "unprognostic (7.58e-2)" "unprognostic (3.03e-1)" "unprognostic (6.21e-2)" "unprognostic (5.53e-2)" "unprognostic (6.64e-3)" "unprognostic (1.48e-2)" "prognostic unfavorable (5.77e-9)" "unprognostic (7.29e-2)" "unprognostic (6.29e-2)" "unprognostic (3.15e-2)" "unprognostic (3.82e-2)" 477.7 102.3 291.8 282.0 303.4 367.1 401.7 293.8 402.1 563.3 321.5 249.0 128.4 314.6 1152.4 147.4 537.4 247.9 368.4 292.6 305.4 317.5 191.4 246.5 417.2 324.8 295.6 607.5 78.8 154.0 145.1 278.5 322.5 190.6 172.0 14.9 199.8 324.3 134.2 164.6 252.4 367.4 308.6 679.7 141.6 56.3 317.5 296.5 263.4 259.3 295.9 307.4 364.7 304.3 125.7 5.5 1011.4 74.5 79.1 279.8 7.4 250.1 1038.8 2266.3 4016.8 3.7 782.2 3.0 157.9 257.1 23.5 269.0 36.5 26.2 52.0 255.3 51.8 125.9 77.5 11.8 668.2 182.8 1138.9 496.3 0.2 26.6 2.6 27.0 4.2 41.1 450.0 880.7 1.7 23.9 85.1 318.2 264.5 0.5 33.5 27.1 3.1 24.5 654.9 0.0 1.0 2.2 122.7 11.9 196.9 138.5 42.1 17.0 8.8 3.8 4.7 1.5 1.1 61.6 44.8 6.8 3.4 253.8 3.1 544.4 62.1 1494.7 2906.3 312.7 2003.4 364.9 3120.6 3000.3 114.2 323.6 2939.3 2996.4 2741.6 4679.9 539.0 33.7 1944.8 4673.8 291.8 303.4 293.8 402.1 292.6 305.4 324.8 295.6 322.5 308.6 317.5 304.3 240.7 35.3 119.4 2.6 88.2 27.9 17.1 70.2 673.8 0.0 13.0 12.6 8.4 2.8 115.3 33.1 0.0 3.3 258.6 13.7 5.9 1.7 1.4 14.6 96.5 364.4 1.2 27.8 0.0 1.4 30.7 236.0 33.6 20.8 18.9 5.6 164.6 24.6 11.8 0.0 0.0 17.3 10.2 10.1 26.8 3.8 300.8 45.4 78.2 42.2 2.1 0.0 126.7 0.0 0.2 0.7 15.0 124.5 141.2 2.3 15.0 1.0 26.0 0.0 276.1 16.4 213.4 0.6 1.5 50.4 14.3 4.0 595.8 2.1 29.2 5.7 IFITM3 "1-8U, DSPA2b" ENSG00000142089 "Interferon induced transmembrane protein 3" Q01628 11 319676-329475 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 2128.0;Endothelial cells: 2064.8;Hepatocytes: 2268.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 2907.6;non-classical monocyte: 3344.3" "Group enriched" "Detected in all" 6 "granulocytes: 2907.6;monocytes: 3344.3;NK-cells: 926.2" "Cell line enhanced" "Detected in all" "BJ hTERT+ SV40 Large T+: 3222.7;BJ hTERT+ SV40 Large T+ RasG12V: 4076.3;HHSteC: 3609.8;HSkMC: 3476.2" HPA004337 Uncertain NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 33: Fibroblasts - ECM organization" "HPA004337: AB_1851427" "unprognostic (4.17e-2)" "unprognostic (4.19e-1)" "unprognostic (1.67e-1)" "unprognostic (2.25e-1)" "unprognostic (1.55e-3)" "unprognostic (6.00e-2)" "unprognostic (3.36e-2)" "unprognostic (6.44e-2)" "unprognostic (8.90e-2)" "unprognostic (9.42e-2)" "unprognostic (7.45e-2)" "unprognostic (1.95e-2)" "prognostic unfavorable (5.78e-7)" "unprognostic (7.81e-2)" "unprognostic (3.34e-2)" "unprognostic (8.28e-2)" "unprognostic (1.19e-1)" 1850.7 745.9 639.0 597.4 667.4 237.0 1281.1 644.9 909.9 1683.7 730.9 1212.1 235.2 1545.6 840.1 484.5 1933.7 702.4 1199.6 643.2 732.4 1299.5 2506.4 1573.4 272.7 745.4 671.4 1262.3 576.3 637.2 493.2 829.2 697.9 885.6 238.9 92.6 555.3 631.7 364.5 511.2 599.9 1121.8 666.2 1241.8 736.0 266.7 728.7 229.3 935.7 426.0 154.9 1203.7 1038.2 649.0 554.1 49.6 1930.0 508.9 952.4 1538.6 44.2 842.4 1638.0 3222.7 4076.3 65.4 1818.6 1.3 873.1 1276.4 826.0 872.0 1.1 619.9 176.8 19.2 57.1 8.1 578.4 570.2 3609.8 5.7 5.2 3476.2 136.1 257.3 561.7 418.1 610.5 5.2 3.1 5.0 290.3 1095.0 2.7 26.3 243.0 2.2 425.3 74.2 185.3 4.8 1741.5 50.1 1.5 3.5 1007.5 170.0 891.9 259.0 41.3 39.7 1130.9 192.1 131.9 180.6 34.8 2.5 3.4 10.3 89.6 7.6 315.3 520.4 740.1 563.7 115.7 2745.9 69.0 82.2 82.6 118.9 396.9 55.6 77.8 109.0 2907.6 926.2 3344.3 31.1 52.9 921.0 639.0 667.4 644.9 909.9 643.2 732.4 745.4 671.4 697.9 666.2 728.7 649.0 1971.3 532.0 709.5 32.0 35.5 317.2 684.3 856.2 1237.9 1.2 207.9 253.1 157.4 539.1 562.1 527.8 2.1 122.2 68.6 94.4 559.6 2128.0 27.3 164.2 1197.8 2064.8 54.1 92.0 0.0 1898.5 635.5 1572.4 103.5 207.0 242.7 223.5 2002.5 2268.4 539.7 0.0 0.1 228.2 132.2 491.4 463.2 102.3 1861.8 713.0 361.1 39.4 130.7 162.4 62.8 0.0 0.5 1135.8 198.3 1060.7 18.7 416.9 54.1 563.8 260.3 7.8 959.8 953.3 1483.2 26.9 12.5 222.4 209.1 125.7 96.6 303.3 263.4 270.6 B4GALNT4 "FLJ25045, NGalNAc-T1" ENSG00000182272 "Beta-1,4-N-acetyl-galactosaminyltransferase 4" Q76KP1 11 369499-382117 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3;ovary: 27.8" "Cell type enhanced" "Detected in many" "Astrocytes: 133.2;Bipolar cells: 23.8;Excitatory neurons: 31.2;Horizontal cells: 33.7;Inhibitory neurons: 32.3;Muller glia cells: 45.6;Oligodendrocyte precursor cells: 28.1;Oligodendrocytes: 32.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 35.4;NTERA-2: 32.0;SCLC-21H: 39.5;SH-SY5Y: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043276, HPA053126" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" NA No "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Cytosol" Vesicles "HPA043276: , HPA053126: AB_2682049" "unprognostic (6.11e-2)" "unprognostic (7.82e-2)" "unprognostic (1.79e-1)" "unprognostic (6.92e-3)" "unprognostic (5.36e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.69e-3)" "unprognostic (4.99e-3)" "unprognostic (1.52e-10)" "unprognostic (9.01e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-4)" "unprognostic (1.25e-1)" 0.9 0.6 23.1 0.9 17.2 0.0 3.3 5.1 33.3 17.2 0.0 5.9 0.6 14.1 0.6 2.3 11.9 0.5 1.6 23.8 12.9 1.0 0.3 0.5 0.3 19.3 20.7 27.8 1.1 2.6 17.9 0.0 14.9 6.3 0.2 5.3 2.0 1.2 0.0 2.1 2.9 1.0 8.4 0.3 2.1 1.5 15.1 0.3 0.5 0.0 0.3 1.8 6.3 13.4 0.0 4.8 35.4 20.4 0.0 0.1 8.4 6.5 1.7 2.9 0.8 3.7 0.0 0.0 4.8 0.7 5.6 1.4 4.8 8.5 0.8 0.0 12.3 0.0 13.4 11.4 0.4 0.0 8.7 0.6 5.0 0.2 3.8 12.7 0.4 1.9 11.5 0.0 0.0 10.8 0.4 0.0 32.0 0.6 14.0 0.0 0.0 4.9 0.4 0.0 39.5 47.6 2.4 1.7 0.5 3.7 14.0 0.0 9.0 2.0 11.1 3.5 0.4 0.1 1.7 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 17.2 5.1 33.3 23.8 12.9 19.3 20.7 14.9 8.4 15.1 13.4 0.1 0.0 0.0 133.2 0.2 0.8 1.5 1.4 0.6 23.8 6.5 8.9 12.5 0.0 0.1 1.8 4.2 0.1 0.3 0.1 0.0 1.3 0.0 0.6 7.1 0.6 1.8 0.0 31.2 0.0 0.0 2.4 0.0 1.1 0.0 6.9 0.0 0.0 0.2 33.7 32.3 0.1 2.0 0.0 0.0 0.0 3.1 0.1 3.6 2.8 0.2 45.6 0.0 28.1 32.5 0.2 0.0 1.2 0.0 2.6 0.0 0.0 0.1 8.6 0.0 0.0 3.3 0.1 0.2 0.1 0.3 0.3 0.1 0.6 0.5 0.4 PKP3 ENSG00000184363 "Plakophilin 3" Q9Y446 11 392614-404908 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 294.4;skin 1: 223.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 345.0;Extravillous trophoblasts: 176.8;Paneth cells: 248.9;Proximal enterocytes: 195.6;Undifferentiated cells: 142.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 151.3;CAPAN-2: 102.6;HaCaT: 199.1;hTCEpi: 126.9;MCF7: 94.9;SK-BR-3: 148.0" "Region enriched" "Detected in single" 37 "cerebellum: 8.9" "Low region specificity" "Detected in all" "CAB012993, HPA062937" Enhanced Enhanced "Nucleoplasm,Cell Junctions" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Cell Junctions" Nucleoplasm "CAB012993: AB_2533221, HPA062937: AB_2684908" "unprognostic (4.74e-2)" "unprognostic (5.28e-2)" "unprognostic (4.45e-2)" "unprognostic (2.25e-2)" "unprognostic (1.58e-2)" "unprognostic (1.57e-1)" "unprognostic (8.88e-3)" "prognostic unfavorable (2.89e-5)" "unprognostic (1.25e-1)" "unprognostic (6.73e-3)" "prognostic unfavorable (3.93e-4)" "unprognostic (3.55e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.16e-2)" "unprognostic (3.41e-1)" "unprognostic (2.60e-1)" "unprognostic (3.15e-2)" 1.1 0.1 0.3 3.7 0.2 0.0 9.1 0.2 0.6 50.2 0.1 34.3 31.1 1.4 4.7 294.4 7.5 4.9 0.8 0.3 0.3 4.2 0.8 9.7 0.1 0.6 0.2 0.3 27.4 9.1 15.8 10.9 0.6 19.8 10.2 0.0 52.8 5.0 1.0 223.0 28.6 0.5 0.2 0.2 29.1 0.7 0.3 2.5 12.8 0.1 8.8 9.2 104.3 0.3 151.3 28.8 0.0 0.6 0.1 0.2 60.3 1.2 1.0 3.1 1.6 59.2 102.6 0.1 6.0 1.1 6.4 199.1 0.0 75.1 0.5 0.1 36.9 0.1 18.0 41.7 0.6 0.0 0.3 0.5 126.9 0.5 30.8 0.5 0.5 0.0 45.3 0.9 0.4 94.9 0.5 0.2 0.3 75.6 49.1 0.8 0.3 0.6 1.6 29.9 41.1 0.7 42.7 148.0 0.2 1.8 53.8 0.4 5.4 1.0 5.2 2.7 0.8 0.2 0.4 0.1 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.6 0.3 0.3 0.6 0.2 0.6 0.2 0.3 0.3 0.2 16.0 13.0 0.0 1.1 72.1 52.0 56.1 54.7 0.2 27.7 26.5 1.1 11.5 36.8 12.9 0.0 133.8 0.4 345.0 0.0 83.8 0.0 16.1 1.8 1.8 21.7 0.0 0.2 62.9 176.8 2.3 91.3 27.4 13.4 0.4 0.0 0.3 13.2 0.0 0.0 95.1 36.7 0.3 6.5 0.4 0.9 0.9 1.8 0.0 2.0 0.6 0.0 0.0 0.0 140.2 248.9 0.0 0.2 63.5 195.6 0.9 17.9 0.2 0.0 0.0 2.8 0.2 1.7 114.1 88.7 109.7 1.6 0.0 142.9 60.4 SIGIRR "IL-1R8, TIR8" ENSG00000185187 "Single Ig and TIR domain containing" Q6IA17 11 405716-417455 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 401.9;Proximal tubular cells: 627.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 136.0;MCF7: 74.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA023188 Approved Approved "Nucleoli fibrillar center,Cytosol" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoli fibrillar center, Cytosol" "HPA023188: AB_1856856" "unprognostic (6.21e-3)" "prognostic favorable (7.44e-5)" "unprognostic (7.30e-2)" "prognostic favorable (1.34e-5)" "unprognostic (6.85e-2)" "prognostic favorable (9.08e-4)" "unprognostic (4.03e-1)" "unprognostic (1.39e-2)" "unprognostic (8.44e-2)" "unprognostic (1.67e-1)" "unprognostic (2.32e-2)" "unprognostic (1.31e-1)" "prognostic favorable (7.61e-6)" "unprognostic (1.00e-3)" "unprognostic (1.76e-1)" "unprognostic (7.63e-2)" "prognostic favorable (1.54e-5)" 21.3 6.8 47.5 32.4 46.6 33.2 22.3 47.3 58.7 21.5 42.5 45.0 28.9 20.5 19.1 19.1 29.9 19.9 36.0 46.1 47.4 68.4 87.7 33.9 45.8 52.4 47.6 12.9 47.6 16.3 15.8 9.5 51.8 32.8 13.7 5.6 33.4 17.4 6.7 9.7 46.4 10.3 48.0 68.3 42.0 7.8 48.9 18.5 31.0 10.0 18.0 23.1 17.9 49.9 22.2 59.6 3.7 20.7 3.2 16.9 42.7 3.3 5.1 10.0 8.8 27.7 136.0 6.2 16.2 19.1 1.1 31.4 9.7 11.2 1.6 19.0 35.9 12.7 11.8 0.7 10.6 11.0 20.4 9.2 2.3 1.6 1.3 5.6 29.0 24.0 12.7 0.4 2.8 74.4 31.4 35.6 21.3 44.9 32.6 38.3 0.0 21.6 7.1 14.8 35.9 17.6 0.4 20.1 26.4 9.0 25.4 8.6 34.4 3.0 3.9 5.0 0.0 7.4 13.5 16.2 13.3 24.0 11.6 77.8 42.3 39.0 123.6 48.4 98.7 37.6 101.8 108.3 43.0 28.7 91.7 90.1 22.0 102.4 61.8 16.3 106.1 82.6 47.5 46.6 47.3 58.7 46.1 47.4 52.4 47.6 51.8 48.0 48.9 49.9 83.1 28.9 34.4 16.6 46.5 16.3 34.1 33.2 43.9 8.6 44.3 40.0 21.3 72.9 35.0 55.2 12.5 17.7 105.6 163.9 62.6 54.1 1.0 47.9 15.0 62.7 78.9 14.7 2.6 73.3 11.4 37.0 80.0 40.7 40.6 15.4 79.6 401.9 51.2 26.9 2.5 106.1 63.1 52.7 31.9 5.1 31.4 61.7 85.4 4.7 46.9 109.2 218.3 1.5 10.4 79.6 153.7 29.7 37.9 24.6 105.3 627.4 75.8 19.2 26.3 21.2 34.7 6.0 69.8 21.1 12.8 10.1 117.3 10.2 93.6 43.6 ANO9 "PIG5, TMEM16J, TP53I5" ENSG00000185101 "Anoctamin 9" A1A5B4 11 417933-442011 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.2;skin 1: 27.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 81.0;Intestinal goblet cells: 50.5;Paneth cells: 50.5;Proximal enterocytes: 87.7;Undifferentiated cells: 45.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 26.1" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 48 "B-cells: 2.1;NK-cells: 4.1;T-cells: 8.2" "Cell line enhanced" "Detected in some" "BEWO: 9.2;CAPAN-2: 29.5;HaCaT: 16.8;RPMI-8226: 20.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039948, HPA040112" Approved Uncertain "Golgi apparatus" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA039948: AB_2676765, HPA040112: " "unprognostic (3.62e-3)" "unprognostic (2.83e-2)" "unprognostic (4.68e-2)" "unprognostic (1.62e-1)" "unprognostic (1.41e-2)" "unprognostic (8.93e-2)" "unprognostic (6.98e-2)" "unprognostic (8.94e-3)" "unprognostic (1.39e-1)" "unprognostic (2.28e-3)" "unprognostic (1.54e-1)" "unprognostic (7.94e-2)" "unprognostic (1.91e-2)" "unprognostic (1.18e-2)" "unprognostic (2.08e-1)" "unprognostic (3.92e-1)" "prognostic favorable (8.81e-4)" 0.7 0.1 0.0 7.0 0.0 2.2 1.7 0.0 0.0 1.1 0.2 16.0 34.2 0.5 7.0 6.3 1.2 2.0 0.1 0.0 0.0 3.7 0.3 2.9 12.0 0.0 0.0 0.1 6.5 0.7 1.3 0.1 0.0 2.9 9.1 0.0 3.0 0.7 0.0 27.8 30.0 0.8 0.0 4.7 7.0 0.2 0.0 9.0 2.4 0.1 8.7 2.4 3.4 0.0 2.7 0.6 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 3.1 29.5 1.9 1.4 0.0 0.1 16.8 0.0 7.0 0.0 2.1 0.0 0.0 0.6 5.1 0.0 0.4 0.0 0.0 5.6 0.0 1.2 0.1 0.0 4.5 0.1 1.9 0.0 3.8 0.5 0.1 0.0 6.0 0.0 0.1 0.0 20.6 5.1 4.4 1.6 0.0 0.3 7.3 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 5.5 2.1 6.5 3.3 0.0 0.8 3.7 2.8 0.0 4.1 0.0 0.0 8.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.7 0.3 9.1 5.2 4.6 15.3 6.2 0.0 5.5 3.9 2.4 8.6 9.1 3.7 0.0 0.3 3.0 81.0 0.0 10.5 0.8 4.9 1.0 0.8 15.5 0.0 0.3 6.5 3.7 0.6 29.0 11.0 0.0 0.0 0.7 0.3 0.4 0.0 0.2 50.5 14.2 0.3 1.9 0.1 0.0 1.2 3.6 0.0 1.3 0.0 0.0 0.0 0.0 9.0 50.5 0.0 5.0 2.7 87.7 3.7 9.2 0.0 0.0 0.1 1.0 0.2 0.2 7.0 6.3 0.1 12.8 0.0 45.2 5.7 PTDSS2 PSS2 ENSG00000174915 "Phosphatidylserine synthase 2" Q9BVG9 11 448268-491399 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 144.6;Late spermatids: 347.6;Spermatocytes: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HEK 293: 67.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038928, HPA038929" Approved NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" "HPA038928: AB_10672832, HPA038929: AB_2676274" "unprognostic (3.41e-1)" "unprognostic (2.52e-1)" "unprognostic (2.07e-1)" "unprognostic (5.75e-3)" "unprognostic (3.19e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (5.12e-9)" "unprognostic (6.18e-2)" "unprognostic (1.09e-1)" "unprognostic (1.89e-2)" "unprognostic (1.41e-3)" "unprognostic (6.41e-2)" "unprognostic (1.11e-2)" "unprognostic (3.39e-2)" "unprognostic (2.48e-1)" "unprognostic (2.25e-1)" "unprognostic (1.09e-1)" 13.8 21.3 6.2 2.2 9.6 2.2 12.5 8.6 8.6 16.3 8.4 15.4 1.5 15.4 3.7 12.0 14.7 3.9 25.2 6.3 6.1 21.0 13.5 12.8 2.3 10.6 9.1 21.9 18.9 13.6 13.7 5.8 8.1 17.0 2.2 3.1 11.4 5.2 17.7 11.9 10.4 4.9 6.7 12.6 15.5 47.2 8.4 3.3 17.4 5.5 2.0 14.2 12.0 12.6 15.7 15.6 12.8 18.5 11.0 18.2 15.9 13.1 15.5 16.7 14.7 4.1 10.5 8.3 11.0 17.0 15.1 25.4 15.7 20.8 8.0 13.9 67.2 10.5 11.9 9.6 21.3 13.9 8.8 20.8 15.2 5.8 10.1 14.6 13.2 9.8 30.9 2.5 13.3 2.2 13.9 13.3 18.1 12.4 36.8 14.7 14.4 4.1 11.9 3.1 19.3 10.6 18.4 11.9 15.2 13.9 4.3 8.1 16.1 7.7 5.1 3.9 8.5 10.3 4.8 3.6 13.5 6.4 5.6 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.0 6.2 9.6 8.6 8.6 6.3 6.1 10.6 9.1 8.1 6.7 8.4 12.6 10.3 0.0 6.1 18.6 6.2 4.8 8.3 6.1 6.2 36.9 11.1 11.0 20.1 5.7 6.7 7.3 29.2 19.6 3.0 12.5 5.9 13.3 144.6 7.1 11.1 11.4 16.1 8.2 21.1 13.1 21.3 12.9 9.7 7.5 0.0 30.1 9.3 6.0 17.2 21.9 17.8 7.6 8.2 4.7 4.2 347.6 17.1 6.9 5.4 5.6 5.8 22.7 2.1 18.6 26.8 11.7 6.9 15.4 9.5 10.5 7.0 17.7 4.9 29.8 6.6 11.3 12.9 98.2 24.7 8.2 5.1 17.4 4.9 34.1 9.0 6.1 RNH1 "RAI, RNH" ENSG00000023191 "Ribonuclease/angiogenin inhibitor 1" P13489 11 494512-507300 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 262.3;monocytes: 299.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039223, HPA040781" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 22000000 "Cluster 7: Monocytes - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 4: Macrophages - Innate immune response" "Nucleoplasm, Cytosol" "HPA039223: AB_10795581, HPA040781: AB_10796227" "unprognostic (1.87e-1)" "unprognostic (2.44e-1)" "unprognostic (1.38e-1)" "unprognostic (1.59e-3)" "unprognostic (2.48e-3)" "unprognostic (6.09e-2)" "unprognostic (4.82e-3)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (2.20e-1)" "unprognostic (1.55e-1)" "unprognostic (2.44e-1)" "prognostic favorable (2.14e-5)" "unprognostic (3.35e-1)" "unprognostic (1.66e-1)" "unprognostic (4.78e-2)" "unprognostic (4.35e-2)" 163.5 137.2 27.3 29.0 41.8 46.3 133.7 42.4 33.9 156.4 28.9 123.0 27.1 140.8 10.0 215.0 119.5 29.7 198.0 26.3 32.5 118.6 111.9 146.7 30.8 48.6 39.7 119.1 89.5 25.6 80.6 27.3 38.2 100.9 8.8 5.6 112.5 31.0 145.9 257.4 91.1 25.3 35.3 113.3 101.1 90.1 38.3 15.6 106.6 21.8 13.9 144.5 160.3 49.4 86.5 123.9 13.2 39.8 66.3 93.8 43.9 70.6 51.3 68.9 58.3 61.9 92.9 41.8 54.3 175.1 41.9 72.7 20.6 76.5 10.4 51.3 104.9 28.2 28.5 65.7 243.3 39.8 90.0 77.1 108.2 40.2 46.7 29.2 47.9 27.7 36.2 71.3 37.7 86.6 30.5 78.4 19.8 45.3 112.6 37.7 22.3 55.8 40.7 34.6 35.7 23.2 41.8 59.1 73.7 7.4 44.6 122.2 77.3 109.3 32.8 39.8 49.5 44.9 53.0 32.2 117.5 81.9 74.3 37.6 246.2 57.3 51.1 298.9 59.9 63.0 55.3 51.1 262.3 48.4 49.8 45.1 17.1 54.2 299.1 71.7 58.4 236.5 27.3 41.8 42.4 33.9 26.3 32.5 48.6 39.7 38.2 35.3 38.3 49.4 156.0 112.2 83.5 18.9 92.3 202.1 239.0 265.0 89.4 102.4 82.0 105.5 83.3 88.6 138.6 79.1 110.5 222.2 85.3 126.6 225.0 188.8 105.1 72.8 132.4 136.1 57.4 59.7 10.9 164.4 217.4 194.9 64.2 82.8 140.2 93.8 101.7 68.6 374.0 168.2 14.5 115.6 148.5 191.8 323.0 42.7 211.6 230.3 193.9 12.2 334.2 144.6 79.3 10.1 70.8 171.6 120.5 179.8 101.7 161.0 139.4 242.3 97.9 146.4 177.5 99.1 178.0 153.4 157.8 140.0 260.0 305.5 96.5 199.7 114.4 217.4 HRAS HRAS1 ENSG00000174775 "HRas proto-oncogene, GTPase" P01112 11 532242-537287 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 145.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 4.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002015, HPA049830, HPA070222" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Cytosol" "CAB002015: , HPA049830: AB_2680903, HPA070222: " "unprognostic (3.06e-2)" "unprognostic (2.98e-2)" "unprognostic (7.01e-2)" "unprognostic (3.08e-3)" "unprognostic (3.49e-3)" "unprognostic (3.87e-1)" "prognostic unfavorable (2.32e-4)" "unprognostic (1.07e-1)" "unprognostic (2.25e-1)" "unprognostic (1.50e-1)" "unprognostic (2.88e-3)" "unprognostic (9.85e-2)" "unprognostic (2.81e-1)" "unprognostic (1.85e-1)" "unprognostic (1.80e-1)" "unprognostic (1.58e-2)" "unprognostic (1.38e-1)" 28.1 24.6 64.6 3.5 67.2 2.9 27.0 62.1 86.8 30.4 58.3 34.3 2.8 23.6 12.5 80.1 18.9 3.6 56.8 64.4 64.6 33.8 21.8 27.1 4.3 65.6 65.3 20.0 20.5 13.1 38.2 9.0 66.9 38.3 6.9 10.2 27.3 12.3 59.0 69.9 19.5 8.9 64.2 20.6 24.2 16.5 64.8 9.2 20.5 25.2 10.2 34.5 44.2 65.4 59.0 105.6 44.2 25.6 22.2 17.5 39.6 49.9 25.1 64.5 29.5 62.4 29.7 20.4 10.9 63.2 60.7 43.7 46.0 114.1 19.3 19.5 108.4 6.6 43.7 56.1 38.5 13.9 12.0 28.3 118.0 42.0 51.5 19.6 31.5 34.3 29.7 32.3 40.9 110.6 34.0 50.5 26.5 39.9 94.5 31.6 40.7 18.2 47.0 33.2 87.6 43.7 25.5 55.4 17.9 31.5 43.3 14.8 35.4 47.3 44.7 16.4 39.7 20.3 17.7 15.4 39.1 17.0 38.3 0.0 0.5 0.6 0.8 0.7 0.4 0.3 0.9 0.8 0.7 2.0 0.9 0.3 0.0 0.1 4.0 0.9 1.5 0.2 64.6 67.2 62.1 86.8 64.4 64.6 65.6 65.3 66.9 64.2 64.8 65.4 51.3 12.8 10.7 9.1 18.0 131.2 101.7 25.4 82.0 46.0 38.8 75.7 25.2 22.8 11.2 35.0 18.8 78.8 21.5 72.2 74.3 35.2 1.6 36.1 28.6 32.0 29.3 11.2 9.8 37.4 63.4 25.9 33.6 34.1 2.5 26.8 22.9 17.4 39.9 48.8 10.6 26.5 4.1 11.7 38.4 7.9 17.1 21.3 64.0 10.3 12.8 50.8 11.3 4.0 12.3 48.2 30.9 23.0 26.5 61.2 30.8 54.6 20.0 37.6 32.9 20.3 40.3 5.4 21.4 118.1 145.9 78.1 22.0 18.8 26.2 106.4 LRRC56 "DKFZp761L1518, FLJ00101" ENSG00000161328 "Leucine rich repeat containing 56" Q8IYG6 11 537527-554912 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 12.3;testis: 22.3" "Group enriched" "Detected in many" 6 "Early spermatids: 68.0;Late spermatids: 141.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.8;Daudi: 1.3;Karpas-707: 2.4;SK-BR-3: 1.6;T-47d: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA038728 Approved NA NA "Cluster 71: Testis - DNA repair" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" "HPA038728: AB_10671864" "unprognostic (2.77e-2)" "unprognostic (9.54e-3)" "unprognostic (1.28e-2)" "prognostic favorable (7.39e-4)" "unprognostic (3.18e-2)" "unprognostic (4.65e-3)" "unprognostic (2.29e-2)" "prognostic favorable (6.19e-4)" "unprognostic (2.65e-3)" "unprognostic (1.86e-1)" "prognostic favorable (6.32e-4)" "unprognostic (1.17e-1)" "unprognostic (7.89e-2)" "unprognostic (1.33e-1)" "unprognostic (1.22e-1)" "unprognostic (4.56e-1)" "unprognostic (1.52e-3)" 0.8 0.8 0.5 0.1 1.9 0.2 1.6 0.3 0.5 2.4 0.6 1.7 0.1 0.9 1.3 2.7 6.4 0.0 0.5 0.8 0.3 3.2 1.6 2.9 0.0 0.5 0.3 1.8 2.4 0.0 12.3 0.0 0.1 3.7 0.0 0.1 2.0 0.3 1.2 2.5 2.2 0.0 0.4 2.2 2.1 22.3 0.6 0.1 2.7 0.0 0.2 1.2 2.0 0.3 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.4 1.1 0.4 0.8 0.0 0.2 0.0 0.0 0.5 0.0 2.4 0.0 0.0 0.1 0.7 0.0 0.7 0.7 0.0 0.0 0.5 0.2 0.0 0.3 0.2 0.0 1.6 0.0 0.0 2.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 1.9 0.3 0.5 0.8 0.3 0.5 0.3 0.1 0.4 0.6 0.3 0.5 0.0 3.4 3.3 3.0 1.7 1.5 1.5 0.0 1.1 2.1 0.9 0.6 1.5 2.4 3.7 16.7 0.3 0.6 4.9 0.0 1.1 68.0 11.6 0.6 0.5 12.5 0.4 5.2 0.4 0.2 1.1 1.5 1.3 0.0 0.5 1.1 0.3 0.3 6.7 3.8 2.1 6.1 0.6 0.3 141.2 1.2 0.3 1.8 1.0 0.0 2.7 1.0 1.5 2.8 0.5 1.4 1.2 0.1 1.2 0.2 0.8 14.4 7.0 0.0 0.2 0.6 6.6 2.2 0.6 0.9 0.5 1.4 0.7 0.6 0.8 LMNTD2 "C11orf35, MGC35138" ENSG00000185522 "Lamin tail domain containing 2" Q8IXW0 11 554850-560738 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 24.0;testis: 28.2" "Group enriched" "Detected in many" 7 "Early spermatids: 59.7;Late spermatids: 96.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 5.6;hTERT-RPE1: 21.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058474, HPA073912" Uncertain Approved "Cytoplasmic bodies" NA NA "Cluster 71: Testis - DNA repair" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 31: Spermatids - Spermatogenesis" "Cytoplasmic bodies" "HPA058474: AB_2683727, HPA073912: AB_2686642" "unprognostic (2.20e-3)" "unprognostic (7.80e-2)" "prognostic unfavorable (3.75e-4)" "unprognostic (1.33e-3)" "unprognostic (7.05e-4)" "unprognostic (6.06e-2)" "unprognostic (2.30e-1)" "unprognostic (8.85e-2)" "unprognostic (3.51e-1)" "unprognostic (2.42e-2)" "unprognostic (3.01e-3)" "unprognostic (2.04e-3)" "unprognostic (1.10e-2)" "unprognostic (5.02e-3)" "unprognostic (5.02e-2)" "unprognostic (3.72e-3)" "unprognostic (1.48e-3)" 2.1 2.9 0.3 0.6 1.5 1.6 3.1 2.8 1.6 1.7 0.4 4.6 5.1 1.3 0.0 5.2 4.7 0.2 0.6 0.4 0.3 8.7 24.0 3.2 0.4 0.9 0.5 1.2 8.5 0.0 5.9 0.3 0.7 5.7 0.2 0.4 3.9 0.8 0.4 7.0 5.7 0.2 0.4 5.4 6.5 28.2 0.7 1.3 8.6 0.0 1.1 2.3 2.8 0.1 0.0 2.6 0.6 4.5 0.0 0.0 0.0 0.6 0.3 0.2 0.4 3.8 0.0 2.5 0.0 0.1 1.2 3.4 0.7 1.0 0.1 0.0 0.3 0.6 5.6 2.3 0.4 0.1 1.8 0.4 0.0 0.1 0.1 21.4 0.3 0.6 0.0 2.9 0.0 0.0 0.6 0.0 0.5 2.4 1.2 0.0 0.0 1.5 1.5 0.0 0.3 0.8 0.0 2.5 0.0 4.2 4.9 1.2 0.1 0.4 0.3 0.4 0.4 4.2 1.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 2.8 1.6 0.4 0.3 0.9 0.5 0.7 0.4 0.7 0.1 1.3 0.0 0.0 0.0 4.3 0.0 2.5 0.0 1.8 0.8 4.3 3.4 0.9 10.0 0.0 3.7 0.0 1.8 1.2 2.9 7.9 3.4 59.7 5.0 0.4 0.7 0.0 3.2 0.1 2.2 1.4 0.2 9.2 4.2 0.0 6.1 0.7 5.4 1.2 0.0 0.1 2.5 0.0 1.2 0.0 96.4 2.1 1.1 0.0 2.8 0.9 3.6 2.1 0.0 0.0 3.6 2.7 0.0 0.7 2.0 4.3 2.8 0.0 1.0 0.0 0.1 0.5 1.7 6.3 2.8 0.0 1.0 1.4 4.2 2.8 3.2 RASSF7 "C11orf13, CFAP88, FAP88, HRAS1, HRC1" ENSG00000099849 "Ras association domain family member 7" Q02833 11 560404-564025 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 127.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 224.6;Intestinal goblet cells: 179.2;Paneth cells: 194.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 85.5;HaCaT: 86.4;SK-BR-3: 75.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078015 Supported "Centriolar satellite" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Centriolar satellite" "HPA078015: AB_2686875" "unprognostic (1.11e-2)" "unprognostic (5.10e-2)" "unprognostic (1.75e-2)" "unprognostic (2.24e-2)" "prognostic unfavorable (6.09e-4)" "unprognostic (1.13e-1)" "unprognostic (2.46e-3)" "unprognostic (1.01e-1)" "unprognostic (1.70e-1)" "unprognostic (1.60e-1)" "unprognostic (2.55e-1)" "unprognostic (5.05e-2)" "unprognostic (3.49e-2)" "unprognostic (2.30e-1)" "unprognostic (1.99e-1)" "unprognostic (2.83e-1)" "unprognostic (3.58e-3)" 15.6 5.0 7.1 8.5 9.4 6.5 13.8 10.1 10.4 23.4 6.8 50.5 33.6 6.3 15.8 49.2 50.9 10.8 4.9 7.3 7.1 127.5 92.8 44.6 10.7 9.3 6.5 6.6 67.5 6.4 27.4 5.0 9.9 42.6 8.5 1.6 42.5 11.5 1.6 53.5 43.5 1.0 6.4 17.7 63.5 13.2 7.1 8.7 23.3 0.6 5.6 18.6 23.7 6.3 51.7 49.9 2.3 12.8 0.0 0.0 35.2 7.7 5.9 8.0 5.9 52.6 85.5 6.6 34.6 4.2 14.0 86.4 7.3 26.5 1.2 8.9 25.6 4.6 28.0 25.9 5.3 10.8 7.4 0.1 25.5 2.7 2.4 11.0 4.8 13.4 11.7 2.5 0.7 51.7 12.2 23.1 7.1 58.2 28.1 19.2 3.7 14.8 39.2 24.8 10.9 8.4 5.4 75.7 6.6 4.0 34.0 6.9 6.6 1.6 23.5 3.1 15.0 8.6 9.9 5.3 12.8 15.1 6.9 5.2 6.0 23.0 17.7 5.2 16.1 13.6 18.3 15.9 10.5 14.8 14.8 13.2 7.3 8.3 5.7 18.7 21.9 8.9 7.1 9.4 10.1 10.4 7.3 7.1 9.3 6.5 9.9 6.4 7.1 6.3 6.5 86.6 70.0 3.3 19.1 25.4 23.4 118.1 14.2 2.7 39.2 30.6 4.7 92.9 90.4 86.5 0.0 38.9 20.9 224.6 52.8 90.7 17.2 28.8 3.9 8.5 51.0 14.5 5.5 90.5 111.7 5.9 124.4 35.2 15.2 15.5 7.9 73.3 19.9 11.8 2.6 179.2 46.8 11.2 15.7 23.0 2.5 11.5 5.4 1.0 28.7 7.9 21.6 1.5 0.6 148.1 194.4 0.4 12.3 61.8 110.0 44.7 73.4 3.2 0.0 0.3 6.7 4.6 9.7 21.2 25.7 40.5 29.7 4.3 113.1 60.3 PHRF1 "KIAA1542, PPP1R125, RNF221" ENSG00000070047 "PHD and ring finger domains 1" Q9P1Y6 11 576470-612222 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 24.2;MOLT-4: 39.0;U-138 MG: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019867, HPA062933" Uncertain NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" "HPA019867: AB_1852416, HPA062933: AB_2684907" "unprognostic (5.67e-2)" "unprognostic (1.00e-2)" "unprognostic (3.94e-2)" "unprognostic (9.65e-2)" "unprognostic (1.79e-3)" "unprognostic (1.25e-2)" "prognostic unfavorable (6.00e-5)" "unprognostic (6.28e-2)" "unprognostic (2.57e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-1)" "unprognostic (3.50e-2)" "unprognostic (2.33e-1)" "unprognostic (3.47e-2)" "unprognostic (1.94e-1)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" 14.3 17.5 1.2 1.0 2.6 3.1 13.9 1.4 3.6 14.4 0.9 14.2 0.0 13.2 1.3 18.7 13.5 1.1 14.0 1.1 1.1 12.5 26.5 14.5 0.0 1.5 1.1 14.6 14.4 0.0 13.9 0.0 1.5 14.5 0.0 0.2 13.8 1.2 18.7 22.2 16.3 1.0 0.5 17.6 14.3 17.9 1.7 0.1 13.5 0.0 2.1 12.6 14.4 1.7 2.6 1.6 0.4 7.9 0.0 0.4 1.5 6.2 0.5 0.6 0.0 0.0 0.2 14.8 14.7 0.3 0.3 3.1 0.2 0.0 0.0 4.6 10.5 0.9 0.0 24.2 0.0 1.7 1.6 3.6 0.0 0.0 3.9 0.0 0.3 13.1 3.5 0.0 0.0 0.8 39.0 0.5 1.9 0.2 7.2 1.4 1.5 0.0 0.0 0.3 11.4 1.8 4.3 12.9 0.1 8.9 0.4 5.1 1.2 21.2 7.4 0.5 1.5 2.7 3.7 1.5 0.5 1.2 0.0 0.0 0.3 0.0 0.3 0.2 0.3 0.1 0.4 0.5 0.3 0.4 0.4 0.2 0.5 0.3 0.1 0.4 0.3 0.2 1.2 2.6 1.4 3.6 1.1 1.1 1.5 1.1 1.5 0.5 1.7 1.7 11.5 6.4 11.1 10.1 14.9 17.6 10.1 7.4 18.2 12.2 11.6 7.9 7.8 11.5 8.2 14.7 8.4 8.0 17.1 24.1 0.0 11.6 2.1 14.0 12.9 11.9 11.4 16.0 5.9 10.6 8.0 11.3 23.4 17.7 5.1 14.7 4.6 17.5 9.5 20.2 6.6 14.2 2.0 10.6 11.7 2.8 11.8 13.1 3.6 10.3 11.3 8.2 23.7 4.5 8.4 18.0 12.2 10.5 17.5 12.4 21.8 7.0 12.5 16.0 13.1 14.1 12.2 26.4 28.0 17.4 17.8 8.9 17.2 13.0 14.9 13.6 IRF7 ENSG00000185507 "Interferon regulatory factor 7" Q92985 11 612553-615983 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 38.2;lymphoid tissue: 33.2" "Cell type enriched" "Detected in many" 7 "dendritic cells: 576.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 12 "plasmacytoid DC: 596.9" "Lineage enriched" "Detected in all" 12 "dendritic cells: 596.9" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 15.5;BJ hTERT+ SV40 Large T+ RasG12V: 9.6;Karpas-707: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017694, HPA052757" Approved Supported Nucleoplasm,Cytosol No NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm Cytosol "CAB017694: AB_2280489, HPA052757: AB_2681937" "unprognostic (1.39e-2)" "unprognostic (3.26e-2)" "unprognostic (1.08e-3)" "unprognostic (2.45e-1)" "unprognostic (4.52e-2)" "unprognostic (2.73e-1)" "unprognostic (1.04e-2)" "unprognostic (2.52e-2)" "unprognostic (1.39e-1)" "unprognostic (1.16e-1)" "unprognostic (7.08e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (1.71e-10)" "unprognostic (2.50e-1)" "unprognostic (1.07e-1)" "unprognostic (2.58e-1)" "unprognostic (4.71e-2)" 10.4 2.6 1.3 1.6 1.6 1.6 7.5 1.5 2.1 11.2 2.2 8.8 0.0 3.4 0.0 12.7 4.7 2.2 7.9 1.2 1.6 15.6 38.2 14.4 0.9 2.7 1.6 4.7 5.9 0.2 6.2 0.7 2.4 9.2 0.3 0.3 8.8 0.8 11.3 7.8 15.3 0.9 1.3 33.2 8.6 1.9 1.6 1.4 10.7 1.3 2.2 5.1 7.3 1.6 0.0 0.0 0.7 0.1 0.0 0.6 0.0 0.4 3.9 15.5 9.6 2.2 0.1 0.0 3.7 0.6 3.7 0.5 0.2 0.1 1.0 0.2 0.0 0.1 0.0 0.2 0.8 0.0 0.0 1.6 0.6 0.0 0.6 0.7 0.1 1.9 0.0 6.5 0.1 0.0 0.7 0.0 0.0 3.1 1.3 0.1 0.2 0.0 0.2 0.1 3.1 0.0 0.6 1.8 0.4 0.3 0.0 1.5 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 12.7 20.4 30.6 8.1 46.1 7.8 16.5 6.7 7.0 24.3 20.8 7.5 8.5 12.9 18.7 49.5 596.9 13.5 19.7 1.3 1.6 1.5 2.1 1.2 1.6 2.7 1.6 2.4 1.3 1.6 1.6 65.0 16.0 19.0 2.9 59.2 34.4 32.3 19.6 18.8 0.4 27.7 20.2 4.3 18.6 18.2 20.2 0.0 6.1 576.1 70.1 9.8 29.9 5.9 20.1 6.3 33.0 26.3 4.8 0.0 16.9 39.0 19.3 40.8 21.2 31.7 20.1 17.9 31.7 37.3 0.0 0.1 42.5 22.4 23.2 65.4 28.9 12.2 67.4 37.4 3.7 65.2 2.7 40.2 1.0 1.3 29.9 73.8 4.9 65.1 24.8 37.6 6.3 25.5 4.6 13.1 8.8 19.8 0.4 5.9 8.0 28.4 24.1 42.7 4.6 18.9 34.6 CDHR5 "FLJ20219, MU-PCDH, MUCDHL, MUPCDH" ENSG00000099834 "Cadherin related family member 5" Q9HBB8 11 616577-626078 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 296.8;liver: 129.8" "Group enriched" "Detected in some" 7 "Distal enterocytes: 811.5;Paneth cells: 732.4;Proximal enterocytes: 2545.8" "Cancer enhanced" "Detected in many" "liver cancer: 61.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009081, HPA009173, CAB025004" Enhanced "Intracellular and membrane" NA NA 190000000 "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 45: Enterocytes - Digestion" "CAB025004: , HPA009081: AB_1079428, HPA009173: AB_1079429" "unprognostic (7.65e-2)" "unprognostic (1.42e-1)" "unprognostic (9.85e-2)" "unprognostic (1.21e-1)" "unprognostic (1.05e-1)" "unprognostic (5.56e-3)" "unprognostic (4.89e-2)" "unprognostic (3.85e-2)" "unprognostic (5.75e-2)" "unprognostic (6.36e-2)" "unprognostic (7.95e-2)" "unprognostic (5.07e-2)" "unprognostic (5.01e-2)" "unprognostic (3.90e-1)" "unprognostic (8.85e-2)" "unprognostic (2.29e-1)" "unprognostic (2.14e-2)" 0.1 0.9 0.2 4.0 0.6 0.1 0.4 0.5 0.4 0.1 2.2 102.2 241.2 0.2 0.0 0.3 0.3 3.9 0.0 0.2 0.0 44.9 129.8 0.2 0.2 0.2 0.1 0.2 1.8 0.0 0.6 0.0 0.3 0.1 51.9 0.1 0.0 0.1 0.1 0.1 296.8 2.7 0.0 0.1 4.3 0.3 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.0 0.3 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 3.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.3 13.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.5 0.4 0.2 0.0 0.2 0.1 0.3 0.0 0.3 0.8 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 11.5 0.0 1.8 0.0 0.0 1.4 811.5 13.7 0.3 2.8 0.1 0.2 0.1 92.8 0.0 0.0 1.3 0.0 0.0 33.6 0.4 13.4 0.0 4.6 126.1 0.1 0.0 0.1 193.2 0.0 4.3 0.0 18.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 732.4 0.0 0.0 0.0 2545.8 107.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 154.6 0.0 SCT ENSG00000070031 Secretin P09683 11 626309-627181 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 44.2" "Cell type enhanced" "Detected in some" "dendritic cells: 92.8;Enteroendocrine cells: 267.8;Intestinal goblet cells: 46.4;Proximal enterocytes: 39.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 138 "plasmacytoid DC: 126.7" "Lineage enriched" "Detected in single" 138 "dendritic cells: 126.7" "Cell line enhanced" "Detected in single" "HSkMC: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA050961 Enhanced "Secreted to blood" NA NA 571000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 56: Intestine - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "HPA050961: AB_2681291" "unprognostic (5.28e-2)" "unprognostic (6.18e-2)" "prognostic unfavorable (3.70e-4)" "unprognostic (2.72e-1)" "unprognostic (7.91e-2)" "unprognostic (1.73e-1)" "unprognostic (2.43e-3)" "unprognostic (4.19e-2)" "unprognostic (1.07e-1)" "unprognostic (3.54e-2)" "unprognostic (1.88e-1)" "unprognostic (1.33e-1)" "unprognostic (4.01e-2)" "unprognostic (8.37e-2)" "unprognostic (5.45e-1)" "unprognostic (6.09e-2)" "unprognostic (1.13e-1)" 0.1 0.2 0.7 0.1 1.8 0.6 0.0 1.9 1.9 0.3 0.0 0.9 44.2 0.1 0.3 0.3 0.2 0.0 1.8 0.7 0.3 0.4 0.4 2.2 1.3 1.3 0.7 0.4 0.2 0.0 2.0 0.7 1.5 0.6 0.1 0.2 0.2 0.0 10.3 0.1 8.6 0.0 0.1 3.3 0.7 3.0 1.4 0.4 0.5 1.3 0.7 0.3 0.1 4.1 0.1 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.9 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.9 0.0 126.7 0.0 0.4 0.7 1.8 1.9 1.9 0.7 0.3 1.3 0.7 1.5 0.1 1.4 4.1 0.1 0.0 0.0 0.7 4.1 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.4 1.5 0.0 0.0 0.0 0.1 92.8 1.6 1.9 0.0 1.7 0.3 0.3 0.1 267.8 0.0 0.0 0.0 0.0 1.9 1.1 0.4 0.0 3.5 0.4 0.0 0.2 0.0 0.1 46.4 0.0 0.0 1.2 1.1 1.5 3.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 13.6 0.0 0.0 0.2 39.2 0.2 0.0 0.0 0.0 1.6 0.2 0.8 10.2 0.0 0.1 0.0 0.1 0.1 3.2 0.2 DRD4 ENSG00000069696 "Dopamine receptor D4" P21917 11 637269-640706 "FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "Biological rhythms" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Bipolar cells: 168.8;Cone photoreceptor cells: 87.6;Rod photoreceptor cells: 206.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 3.9" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062682 Uncertain "Plasma membrane,Centrosome" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 56: Bipolar cells - Visual perception" "Plasma membrane" Centrosome "HPA062682: " "unprognostic (8.83e-2)" "unprognostic (2.99e-2)" "unprognostic (4.98e-4)" "unprognostic (3.81e-2)" "unprognostic (7.52e-2)" "unprognostic (7.89e-3)" "unprognostic (3.14e-2)" "unprognostic (2.96e-1)" "unprognostic (8.45e-2)" "unprognostic (5.07e-2)" "unprognostic (3.28e-1)" "unprognostic (8.59e-2)" "unprognostic (1.05e-4)" "unprognostic (1.26e-2)" "unprognostic (8.21e-2)" "unprognostic (2.36e-2)" "unprognostic (1.85e-1)" 0.9 0.8 0.5 0.0 0.6 0.0 0.8 1.3 0.6 2.5 0.1 1.9 0.0 1.6 0.0 1.1 2.5 0.0 1.1 0.4 0.0 1.3 1.5 1.3 0.0 0.6 0.2 3.5 1.5 0.0 4.2 0.0 0.5 2.3 0.0 0.0 0.5 0.0 1.0 1.5 1.1 0.0 0.1 0.6 0.8 2.5 0.3 0.0 1.8 0.0 0.0 1.7 1.7 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.6 1.3 0.6 0.4 0.0 0.6 0.2 0.5 0.1 0.3 0.6 0.5 0.0 0.5 4.2 0.2 0.0 0.3 0.2 0.0 168.8 0.3 0.4 1.7 0.0 0.1 1.8 87.6 0.6 8.6 0.8 0.0 0.1 0.7 0.3 0.4 1.5 0.0 0.0 0.8 0.4 0.3 0.5 2.0 0.7 0.0 1.5 0.0 0.1 0.2 6.7 1.2 1.3 0.0 0.3 0.3 0.2 0.6 0.9 0.0 0.0 0.1 26.0 0.0 0.0 2.6 0.4 0.2 0.7 0.1 1.1 8.3 1.9 0.1 206.9 0.0 0.8 0.6 1.2 2.6 0.8 0.4 0.1 0.1 0.5 1.3 0.3 DEAF1 "NUDR, SPN, ZMYND5" ENSG00000177030 "DEAF1 transcription factor" O75398 11 644233-706715 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 108.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030302 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" "Intracellular and membrane" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 10: Brain - Neuronal signaling" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 30: Mammary glandular cells - Lactation" Nucleoplasm "Nucleoli fibrillar center" "HPA030302: AB_2673421" "unprognostic (1.32e-2)" "unprognostic (3.32e-2)" "unprognostic (3.58e-3)" "unprognostic (5.90e-2)" "prognostic unfavorable (9.70e-4)" "unprognostic (1.54e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (2.42e-2)" "unprognostic (2.65e-1)" "unprognostic (2.48e-1)" "unprognostic (2.61e-3)" "unprognostic (2.43e-1)" "unprognostic (2.39e-2)" "unprognostic (2.79e-1)" "unprognostic (3.03e-1)" "unprognostic (1.20e-1)" "unprognostic (5.15e-2)" 10.9 19.7 51.5 6.5 50.6 9.2 12.5 30.6 67.1 13.2 15.3 12.1 7.8 13.3 10.0 19.8 14.6 9.4 11.0 60.8 32.5 15.4 8.0 9.1 8.7 32.4 36.0 12.4 16.2 11.3 16.9 6.9 32.9 14.6 4.1 4.5 21.4 7.2 16.6 17.5 10.1 8.0 24.5 11.1 20.0 15.0 40.2 9.7 25.3 13.9 6.3 10.7 12.8 45.9 14.1 13.6 22.9 13.1 18.4 22.8 13.5 14.1 18.2 28.3 20.6 9.7 18.6 5.4 14.8 14.0 9.0 14.4 18.1 12.9 4.3 24.2 108.1 13.5 8.5 13.0 32.8 28.0 22.3 20.4 18.1 5.1 15.4 20.1 22.4 15.5 29.0 28.8 11.3 10.9 11.7 31.9 49.9 20.3 24.0 28.1 6.8 24.2 21.9 3.0 27.3 31.8 10.4 18.2 12.9 5.8 8.4 9.7 26.6 10.5 4.7 4.5 13.7 24.5 9.3 10.2 13.4 21.2 22.9 0.0 2.0 2.3 1.6 1.3 1.7 0.6 3.4 1.7 2.8 0.4 3.9 2.0 0.8 2.0 1.2 0.1 1.4 1.1 51.5 50.6 30.6 67.1 60.8 32.5 32.4 36.0 32.9 24.5 40.2 45.9 20.1 0.0 3.9 12.7 8.7 13.3 27.1 11.8 11.4 20.0 35.8 25.7 8.2 18.6 8.0 35.0 10.4 14.9 12.3 10.0 52.8 19.5 3.6 19.6 15.0 19.3 10.9 25.0 33.8 11.1 6.4 20.1 10.7 26.2 0.0 40.1 10.8 12.4 10.0 60.6 35.2 9.3 12.2 12.9 10.2 6.5 19.9 11.2 17.8 17.8 13.7 39.9 7.2 19.1 17.4 15.4 10.6 30.1 9.0 36.0 16.9 34.2 10.0 19.9 13.1 11.4 16.8 7.5 22.1 17.3 15.5 15.5 12.4 42.2 9.1 32.4 EPS8L2 "FLJ21935, FLJ22171, MGC3088" ENSG00000177106 "EPS8 like 2" Q9H6S3 11 694438-727727 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 188.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 211.4;Paneth cells: 175.3;Proximal enterocytes: 235.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "plasmacytoid DC: 3.1" "Lineage enriched" "Detected in single" 8 "dendritic cells: 3.1" "Cell line enhanced" "Detected in many" "A-431: 234.3;BEWO: 220.8;CAPAN-2: 206.6;SK-BR-3: 257.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 10 "cerebellum: 9.2" HPA041143 Approved Supported Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "HPA041143: AB_10794985" "unprognostic (1.39e-2)" "unprognostic (1.07e-1)" "unprognostic (7.58e-2)" "unprognostic (3.40e-2)" "prognostic unfavorable (2.31e-4)" "unprognostic (6.87e-2)" "unprognostic (3.27e-2)" "unprognostic (1.33e-1)" "unprognostic (4.82e-2)" "unprognostic (4.26e-2)" "unprognostic (2.54e-1)" "unprognostic (1.92e-1)" "unprognostic (3.25e-2)" "unprognostic (2.51e-2)" "unprognostic (4.19e-1)" "unprognostic (2.79e-1)" "unprognostic (5.03e-2)" 7.8 11.2 5.2 5.7 4.8 0.0 27.0 8.9 5.5 49.4 4.9 42.7 100.8 11.4 3.5 188.5 19.2 13.3 4.3 4.5 6.8 98.4 101.7 32.4 0.7 10.9 9.2 11.8 43.7 3.8 11.5 17.7 6.2 29.3 15.5 1.0 94.6 15.2 1.3 76.3 105.0 2.9 7.1 1.4 48.1 3.2 7.1 2.0 70.2 0.4 10.9 17.5 80.1 6.5 234.3 68.6 0.2 1.6 2.7 14.4 220.8 20.1 20.3 29.2 12.5 51.4 206.6 0.4 81.6 21.4 5.4 122.4 0.6 117.8 6.4 0.6 5.4 0.0 27.7 94.7 16.3 0.3 0.4 8.1 77.8 8.0 18.7 12.3 0.2 0.1 1.8 1.1 3.2 72.1 0.5 1.3 2.7 71.5 24.0 0.5 0.8 1.8 103.8 55.2 0.8 0.8 75.9 257.5 0.5 14.3 94.9 0.2 1.5 11.2 27.3 7.2 1.6 0.9 1.0 0.8 6.1 0.6 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.1 0.0 0.1 5.2 4.8 8.9 5.5 4.5 6.8 10.9 9.2 6.2 7.1 7.1 6.5 1.8 141.1 51.8 3.9 11.2 19.8 26.2 48.8 51.8 0.6 39.1 37.0 4.5 57.2 62.4 90.1 0.0 47.9 21.6 211.4 27.4 55.2 1.0 47.3 7.1 4.7 43.8 1.3 3.1 80.0 33.4 11.5 131.0 60.8 7.0 0.4 0.7 59.4 4.7 0.0 3.8 76.8 32.6 2.1 7.8 2.3 18.0 2.7 14.2 2.8 3.1 10.0 16.5 2.0 0.7 83.2 175.3 11.7 7.6 33.6 235.9 108.2 60.9 1.5 0.0 0.9 7.5 1.1 4.8 74.9 24.4 92.5 18.6 0.9 77.2 32.1 TMEM80 FLJ38216 ENSG00000177042 "Transmembrane protein 80" Q96HE8 11 695428-705028 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 82.2;Spermatogonia: 87.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059592, HPA067046" Uncertain Approved "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Golgi apparatus" "HPA059592: AB_2684076, HPA067046: AB_2685769" "unprognostic (1.48e-1)" "unprognostic (6.55e-3)" "unprognostic (1.70e-2)" "unprognostic (2.64e-2)" "unprognostic (2.71e-3)" "unprognostic (1.68e-3)" "unprognostic (4.36e-2)" "unprognostic (5.39e-3)" "unprognostic (3.85e-2)" "unprognostic (2.04e-1)" "unprognostic (1.41e-3)" "unprognostic (1.03e-1)" "prognostic favorable (2.47e-4)" "unprognostic (1.51e-1)" "unprognostic (2.78e-1)" "unprognostic (3.27e-1)" "unprognostic (4.23e-3)" 21.0 23.0 18.4 14.7 18.2 6.5 23.8 19.5 22.0 30.5 17.3 30.2 23.7 27.8 24.8 42.5 30.1 8.4 15.3 19.3 16.5 36.0 20.2 17.5 21.2 21.2 18.1 29.7 29.7 17.8 34.3 8.7 19.0 29.9 17.5 9.1 31.5 19.4 19.7 31.0 31.1 12.7 18.9 34.3 30.8 24.8 19.0 19.7 47.6 11.8 21.3 27.8 30.6 19.9 37.8 17.5 11.0 14.3 23.6 11.1 19.0 8.5 4.7 8.9 9.6 23.9 42.0 16.0 7.3 13.2 15.8 26.8 16.2 9.7 6.3 11.0 41.7 9.7 19.0 14.5 13.9 12.8 16.8 25.7 19.9 4.0 6.2 17.5 10.5 18.9 12.1 17.7 11.4 12.2 16.8 8.7 10.4 29.9 8.4 12.2 7.6 31.5 12.7 5.7 31.1 9.8 12.8 23.5 12.3 7.3 18.2 11.9 15.0 14.9 7.8 3.4 6.4 8.4 3.2 14.8 15.6 15.9 6.5 8.3 26.5 35.4 21.0 25.9 18.4 26.7 15.7 16.0 21.8 30.1 22.3 20.0 12.8 21.4 32.0 22.0 21.4 20.7 18.4 18.2 19.5 22.0 19.3 16.5 21.2 18.1 19.0 18.9 19.0 19.9 15.1 6.4 20.7 13.7 24.0 15.3 15.9 25.6 17.6 22.7 31.7 36.8 19.3 15.7 20.2 20.2 8.4 33.9 19.4 15.4 11.7 13.0 9.2 17.1 15.8 14.4 12.1 8.6 13.9 17.1 9.8 20.8 9.7 19.9 7.0 15.9 12.8 6.2 17.6 55.5 13.1 22.7 28.5 13.2 13.6 9.5 42.6 12.7 12.4 11.2 19.7 23.2 26.8 16.6 16.7 10.6 10.3 28.6 11.5 12.3 22.1 8.1 19.4 9.1 32.9 23.4 21.2 82.2 87.2 13.7 17.2 15.2 16.7 21.6 19.5 12.3 TALDO1 ENSG00000177156 "Transaldolase 1" P37837 11 747415-765012 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pentose shunt" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 820.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 2870.4;neutrophil: 3726.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048089 Approved Nucleoplasm,Cytosol NA NA 29000000 "Cluster 5: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 3: Monocytes - Immune response regulation" Nucleoplasm Cytosol "HPA048089: AB_2680260" "unprognostic (5.29e-2)" "unprognostic (1.78e-2)" "unprognostic (3.47e-1)" "unprognostic (9.65e-3)" "unprognostic (2.97e-2)" "unprognostic (4.15e-2)" "prognostic unfavorable (2.29e-4)" "unprognostic (9.78e-2)" "unprognostic (4.27e-2)" "unprognostic (1.74e-1)" "unprognostic (7.97e-3)" "unprognostic (2.94e-1)" "unprognostic (1.59e-1)" "unprognostic (9.99e-2)" "unprognostic (1.20e-1)" "unprognostic (2.37e-1)" "unprognostic (1.16e-3)" 139.5 80.7 108.0 121.8 128.8 464.8 121.0 129.3 119.3 101.9 105.2 99.6 116.0 68.4 66.4 330.6 79.1 100.0 95.5 108.0 113.8 111.6 136.2 109.1 107.8 135.8 119.3 77.0 107.5 49.3 53.0 88.0 130.0 91.9 78.4 34.2 132.8 60.1 120.7 132.7 101.0 60.8 124.0 152.6 132.5 40.4 120.1 109.9 140.3 107.1 115.8 160.8 142.1 148.2 331.0 405.5 115.4 218.1 235.8 136.5 338.0 242.2 313.8 238.2 194.5 176.6 694.8 179.5 323.1 324.7 181.9 345.5 185.6 263.5 122.8 238.9 372.5 310.9 146.0 616.4 250.3 498.4 449.0 112.0 210.6 159.6 129.0 170.4 331.6 224.0 413.5 294.3 224.5 318.0 296.4 601.2 183.9 478.9 326.0 243.5 131.5 656.4 437.9 185.4 284.2 100.1 224.9 466.1 243.3 102.4 220.0 383.9 434.1 107.9 99.5 86.0 232.9 122.9 132.1 223.5 238.5 440.5 444.7 1456.7 1203.5 2870.4 94.1 432.7 102.3 145.5 125.7 115.5 654.2 127.2 100.9 94.9 3726.6 112.2 457.8 267.0 192.7 1066.0 108.0 128.8 129.3 119.3 108.0 113.8 135.8 119.3 130.0 124.0 120.1 148.2 90.2 141.1 117.2 10.7 91.1 73.5 199.8 354.0 61.5 50.3 113.0 122.2 46.4 100.1 253.4 150.8 14.6 419.8 83.8 151.0 250.5 230.4 82.1 156.5 85.4 85.6 101.5 507.0 13.1 272.1 427.6 97.3 144.3 216.7 161.4 86.0 93.5 149.7 418.3 50.5 11.6 186.0 268.5 271.8 169.4 21.2 117.8 352.8 140.5 7.5 820.0 142.1 84.5 10.6 54.8 257.6 200.3 104.2 129.4 361.9 197.7 309.1 232.6 61.7 72.3 59.6 115.0 143.2 140.6 257.6 83.1 526.6 86.8 77.5 215.1 342.6 GATD1 "FLJ34283, PDDC1" ENSG00000177225 "Glutamine amidotransferase like class 1 domain containing 1" Q8NB37 11 767220-777488 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 44.8;Alveolar cells type 2: 22.1;Collecting duct cells: 22.0;Theca cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 120.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008812 Uncertain Supported Nucleoplasm "Secreted to blood" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA008812: AB_10962724" "unprognostic (3.39e-1)" "unprognostic (2.48e-2)" "unprognostic (1.31e-1)" "unprognostic (3.58e-2)" "unprognostic (2.82e-2)" "unprognostic (3.03e-2)" "prognostic unfavorable (3.98e-4)" "unprognostic (3.50e-2)" "unprognostic (2.19e-1)" "unprognostic (5.67e-2)" "unprognostic (5.23e-3)" "unprognostic (4.89e-3)" "prognostic favorable (3.79e-5)" "unprognostic (2.84e-2)" "unprognostic (8.40e-2)" "unprognostic (6.11e-2)" "unprognostic (6.61e-3)" 15.9 37.5 37.7 11.3 35.8 7.9 16.7 35.1 37.8 22.7 36.6 23.3 15.4 24.9 12.6 23.7 22.7 7.3 16.3 37.4 36.5 24.0 19.3 15.4 11.2 46.4 41.8 25.9 15.9 10.5 30.1 9.2 35.8 23.0 6.5 9.7 17.5 12.2 14.4 21.0 18.2 7.9 38.4 19.6 17.8 18.6 45.3 8.8 22.0 6.5 6.8 19.7 20.4 37.5 41.3 22.3 22.2 23.9 10.2 15.6 20.9 24.2 10.5 22.0 19.3 15.8 62.5 22.1 8.6 16.0 23.2 42.7 16.7 21.6 11.0 28.1 120.5 13.0 38.8 36.0 17.5 25.4 27.8 22.4 23.2 9.3 14.2 19.9 17.1 25.8 34.2 20.0 12.4 11.0 29.3 27.5 21.3 13.4 42.8 31.4 15.1 28.0 19.2 9.1 56.9 22.3 22.9 32.0 16.6 5.7 28.5 16.8 31.3 23.2 17.5 12.7 18.8 23.4 12.9 28.4 35.4 33.9 19.6 1.0 5.2 0.9 2.9 6.6 2.1 2.7 3.0 2.9 6.9 2.3 2.4 1.7 0.5 1.2 2.6 4.0 1.4 2.0 37.7 35.8 35.1 37.8 37.4 36.5 46.4 41.8 35.8 38.4 45.3 37.5 8.7 44.8 22.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 11.9 10.4 0.0 0.0 7.4 22.0 0.0 13.8 5.2 0.0 5.9 10.3 0.0 11.8 15.2 3.8 0.0 0.0 0.0 7.6 7.9 8.5 0.0 9.6 6.3 19.2 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 4.6 0.0 0.0 0.0 0.0 16.6 0.0 0.0 1.3 0.0 0.0 14.7 7.3 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 9.6 3.9 25.8 0.0 0.0 CEND1 "BM88, FLJ90066" ENSG00000184524 "Cell cycle exit and neuronal differentiation 1" Q8N111 11 787115-790113 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 234.7" "Cell type enhanced" "Detected in some" "Bipolar cells: 94.2;Excitatory neurons: 42.9;Horizontal cells: 75.7;Inhibitory neurons: 45.6;Rod photoreceptor cells: 25.5" "Cancer enriched" "Detected in many" 13 "glioma: 24.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 13.6;Karpas-707: 31.0;SCLC-21H: 54.1;SH-SY5Y: 20.4;U-266/70: 21.1;U-87 MG: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042527 Enhanced Supported Approved Mitochondria NA NA "Cluster 35: T-regs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 56: Bipolar cells - Visual perception" Mitochondria "HPA042527: AB_2678038" "unprognostic (4.62e-3)" "unprognostic (1.34e-4)" "unprognostic (9.66e-3)" "unprognostic (1.27e-2)" "prognostic unfavorable (4.38e-5)" "unprognostic (2.20e-3)" "unprognostic (4.11e-2)" "unprognostic (6.72e-2)" "unprognostic (2.60e-2)" "unprognostic (2.26e-1)" "unprognostic (2.00e-3)" "unprognostic (4.24e-3)" "unprognostic (1.94e-3)" "unprognostic (4.43e-2)" "unprognostic (1.71e-1)" "unprognostic (1.40e-1)" "unprognostic (1.03e-1)" 0.1 5.5 55.0 1.0 78.8 0.0 0.1 56.9 234.7 0.2 20.0 4.0 0.6 0.9 0.2 0.4 0.1 0.0 1.1 67.4 79.3 1.2 0.3 0.2 0.3 103.8 57.9 0.2 0.2 0.3 26.0 0.0 93.4 3.2 0.1 7.6 0.2 1.5 0.2 0.2 1.4 0.5 21.6 0.3 0.9 0.3 106.3 0.0 0.2 0.0 0.1 0.8 1.1 116.6 0.0 0.7 0.7 1.4 0.2 0.3 0.2 1.3 0.4 0.4 0.6 0.0 0.0 0.0 0.0 0.5 13.6 0.5 0.0 0.0 0.0 8.5 0.3 0.0 0.1 0.0 0.1 0.0 5.3 0.6 0.0 0.8 0.0 0.0 0.2 0.0 0.0 31.0 0.5 0.1 0.3 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 54.1 20.4 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.1 0.0 1.2 0.9 21.1 6.2 1.3 28.6 0.2 0.4 0.0 0.0 0.0 0.2 0.2 0.0 0.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 55.0 78.8 56.9 234.7 67.4 79.3 103.8 57.9 93.4 21.6 106.3 116.6 0.1 0.0 0.0 17.6 0.5 0.1 0.1 0.0 0.0 94.2 0.0 0.0 0.5 0.0 0.0 0.0 10.4 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.4 0.6 0.0 0.0 42.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 75.7 45.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 6.5 0.0 6.7 0.0 15.1 10.0 0.0 0.0 0.0 1.0 0.1 0.0 0.1 0.0 25.5 0.0 0.1 1.7 0.0 0.7 0.0 0.0 0.0 0.3 0.2 0.1 0.0 SLC25A22 "EIEE3, FLJ13044, GC1, NET44" ENSG00000177542 "Solute carrier family 25 member 22" Q9H936 11 790475-798281 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 83.1;pancreas: 83.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 143.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014662 Approved Uncertain Nucleoplasm,Mitochondria NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 22: Non-specific - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 56: Bipolar cells - Visual perception" Mitochondria Nucleoplasm "HPA014662: AB_10600808" "unprognostic (1.01e-2)" "unprognostic (2.12e-1)" "unprognostic (7.28e-2)" "unprognostic (4.68e-2)" "unprognostic (2.09e-3)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (8.67e-3)" "unprognostic (4.19e-2)" "unprognostic (3.70e-1)" "unprognostic (2.46e-2)" "unprognostic (1.16e-1)" "unprognostic (8.97e-3)" "unprognostic (2.61e-2)" "unprognostic (8.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" 15.8 13.6 49.1 11.0 59.8 7.5 11.2 17.9 83.1 9.0 0.0 10.0 12.9 9.6 2.1 15.2 10.4 4.1 7.7 74.2 7.9 15.1 40.2 15.1 10.1 24.5 11.1 12.7 83.4 4.0 48.7 5.0 25.4 13.9 3.0 16.1 14.4 4.3 2.0 14.2 12.2 3.7 2.4 13.9 13.5 19.1 19.1 6.3 9.4 0.5 6.2 10.3 10.3 40.2 56.2 35.7 20.4 18.6 8.3 14.8 19.4 26.3 21.3 28.0 17.7 34.9 37.1 16.8 19.2 21.6 31.9 48.8 22.4 31.1 6.3 31.9 41.4 15.4 18.2 21.9 35.8 24.7 25.0 14.9 18.6 21.4 22.6 8.8 13.0 19.3 31.8 25.3 12.7 33.9 26.3 23.5 44.8 33.9 53.7 30.9 11.2 38.9 16.8 9.2 100.3 45.3 15.0 35.9 18.7 3.1 17.4 12.5 13.0 32.1 21.5 14.8 25.0 22.1 14.3 21.5 37.8 22.2 19.3 0.0 1.6 2.5 3.7 3.3 2.2 1.3 2.3 3.9 1.8 1.0 1.3 2.3 0.9 2.0 3.4 0.5 1.3 1.6 49.1 59.8 17.9 83.1 74.2 7.9 24.5 11.1 25.4 2.4 19.1 40.2 5.7 6.4 8.6 7.8 8.4 12.6 8.7 9.5 9.1 143.2 9.1 7.5 2.5 8.6 5.0 9.2 33.3 7.1 8.8 3.9 3.9 22.0 12.4 9.5 9.0 7.0 13.1 2.5 11.8 19.3 10.3 5.1 12.8 11.2 2.5 7.2 3.3 17.6 4.3 43.7 10.0 7.6 2.0 2.8 4.6 7.7 4.7 4.1 3.6 3.7 6.6 16.0 13.4 2.5 1.4 14.1 7.8 4.9 13.7 23.8 13.0 7.1 5.8 32.0 0.0 2.8 6.7 1.8 10.4 7.4 13.4 3.1 8.2 13.7 5.9 8.8 AP006621.6 ENSG00000288675 "Proapoptotic nucleolar protein 1" I0J062 11 797511-799190 "Predicted intracellular proteins" Apoptosis "Tumor suppressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.3;pancreas: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 5.5;SCLC-21H: 4.2" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 28: BEWO - Transcription regulation" 0.3 0.6 0.9 0.4 1.0 1.0 0.0 3.3 1.6 0.1 0.5 0.2 0.3 0.3 0.6 0.3 0.2 0.3 0.2 1.1 0.9 0.2 0.2 0.2 0.6 0.6 0.5 0.3 2.4 0.1 0.2 0.7 0.3 0.0 1.2 0.7 0.1 0.1 1.1 0.2 0.1 0.4 0.7 0.4 0.6 0.8 0.1 0.2 0.0 0.1 0.1 0.9 1.0 0.8 1.4 2.5 0.3 0.6 5.5 1.7 0.2 0.3 0.1 0.6 1.1 1.3 0.6 0.6 0.6 2.5 0.3 0.1 0.1 2.5 2.1 0.9 0.8 0.6 0.3 0.8 2.6 0.9 0.3 0.2 0.2 0.5 0.1 1.3 0.5 1.3 0.4 1.2 1.3 1.6 1.8 1.1 0.5 1.6 0.4 0.1 0.7 0.3 4.2 1.9 0.6 1.1 0.7 0.3 0.8 0.4 0.7 1.0 0.7 0.5 0.8 1.3 0.8 1.0 1.0 1.0 1.0 0.8 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.9 0.5 0.1 0.1 0.0 0.0 0.9 1.0 3.3 1.6 1.1 0.9 0.6 0.5 0.7 0.4 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PIDD1 "DKFZp434D229, LRDD, MGC16925, PIDD" ENSG00000177595 "P53-induced death domain protein 1" Q9HB75 11 799179-809753 "Predicted intracellular proteins" Apoptosis Hydrolase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 26.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB012647, HPA055473, HPA066948" Supported Approved "Golgi apparatus,Cytosol" NA Yes "Cluster 39: Non-specific - mRNA processing" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 28: BEWO - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus, Cytosol" "CAB012647: , HPA055473: AB_2682827, HPA066948: " "unprognostic (1.38e-1)" "prognostic favorable (8.19e-5)" "unprognostic (5.07e-3)" "prognostic favorable (3.32e-5)" "unprognostic (7.25e-2)" "prognostic favorable (3.91e-4)" "unprognostic (8.17e-3)" "unprognostic (5.97e-2)" "unprognostic (3.10e-1)" "unprognostic (1.03e-1)" "unprognostic (3.37e-3)" "unprognostic (2.17e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (2.84e-3)" "unprognostic (8.46e-2)" "unprognostic (2.24e-1)" "unprognostic (2.22e-2)" 3.3 3.1 2.3 2.3 2.8 7.4 3.3 2.5 4.1 3.6 2.8 3.9 3.0 3.0 0.1 4.0 3.3 1.1 2.9 2.1 2.2 3.1 5.5 2.7 3.2 3.6 2.6 2.8 3.7 0.9 2.8 1.9 3.5 4.3 0.6 0.2 3.2 1.0 6.5 5.5 4.5 0.7 2.5 5.0 4.0 2.4 3.0 3.2 3.8 0.8 1.0 3.2 3.1 4.6 5.4 6.2 2.9 6.2 0.6 2.2 26.6 7.5 2.0 2.7 3.6 5.7 10.2 4.4 2.3 1.1 2.5 7.9 2.1 3.0 0.5 9.0 12.3 3.8 5.0 12.0 6.8 4.3 9.4 8.4 5.3 1.4 0.3 0.5 5.0 10.3 4.5 3.3 1.1 2.6 12.0 7.2 4.0 5.8 4.3 19.4 4.2 8.6 1.1 1.9 5.1 6.8 3.1 8.2 2.0 1.6 6.0 7.3 2.7 3.4 7.6 2.5 4.9 10.5 6.4 8.5 4.4 3.5 5.6 0.0 0.5 0.0 0.4 0.4 0.4 0.3 0.3 0.4 0.8 0.4 0.4 0.4 0.0 0.1 0.4 0.2 0.9 0.4 2.3 2.8 2.5 4.1 2.1 2.2 3.6 2.6 3.5 2.5 3.0 4.6 4.9 3.2 8.8 25.8 7.2 0.0 3.6 0.0 6.2 14.9 7.3 8.1 4.2 5.7 5.6 3.7 10.4 29.2 8.9 12.0 1.9 2.5 1.4 6.7 4.2 3.7 9.0 5.7 12.8 4.6 7.5 4.4 10.7 4.2 1.3 14.0 2.2 10.3 5.5 1.7 14.2 8.1 0.0 3.5 0.0 1.9 7.2 3.8 0.0 7.5 4.1 7.0 2.1 6.6 26.9 3.5 9.9 4.1 6.0 4.4 10.0 3.8 0.0 15.4 0.0 5.7 3.5 25.2 20.8 6.7 0.0 9.7 6.3 7.5 10.5 3.6 RPLP2 "D11S2243E, LP2, MGC71408, P2, RPP2" ENSG00000177600 "Ribosomal protein lateral stalk subunit P2" P05387 11 809965-812880 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053635, HPA075365" Approved Approved "Nuclear speckles,Mitotic spindle,Cytosol" "Intracellular and membrane" Yes NA 2900000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 32: Non-specific - Translation" "Nuclear speckles, Cytosol" "Mitotic spindle" "HPA053635: AB_2682212, HPA075365: " "unprognostic (6.98e-3)" "unprognostic (2.21e-1)" "unprognostic (4.57e-2)" "unprognostic (8.63e-2)" "unprognostic (2.30e-2)" "unprognostic (2.39e-1)" "prognostic unfavorable (9.14e-4)" "unprognostic (1.63e-1)" "unprognostic (2.98e-1)" "unprognostic (1.93e-1)" "unprognostic (2.08e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (2.19e-6)" "unprognostic (6.52e-2)" "unprognostic (1.67e-1)" "unprognostic (1.16e-1)" "unprognostic (3.31e-2)" 2013.7 831.3 1119.2 993.1 1162.5 2166.9 1656.6 1099.7 1368.9 1256.2 1084.1 1277.1 1016.8 930.2 701.6 1241.3 1240.4 564.0 869.3 1057.5 1116.3 885.0 657.0 851.0 1924.7 1138.0 1095.8 2092.8 2087.8 545.7 595.5 830.9 1154.3 925.8 887.8 180.9 1908.3 775.7 1802.7 1760.4 1191.7 624.4 1204.8 1543.8 1006.0 377.6 1167.5 1545.7 785.0 936.1 1715.4 1075.5 1137.9 1217.7 2773.5 2229.6 1070.4 1864.1 2343.2 2458.2 2389.5 1728.2 1285.0 2090.8 1638.4 3307.6 2218.5 3851.6 1225.0 1629.9 1107.9 2546.7 1786.2 2778.3 836.3 1713.6 8117.9 1901.7 1416.9 3996.4 2837.3 3540.8 1905.4 3393.9 4684.6 764.1 2182.7 1860.8 2111.9 2798.2 3432.2 2040.5 1317.9 2656.6 2969.5 6002.3 3188.8 3394.5 6045.3 3345.1 1465.6 4369.9 1759.0 1281.0 2222.2 3142.1 1118.5 2825.8 3582.4 885.1 1198.9 3577.2 1881.2 1142.3 1393.9 964.1 1981.6 3838.4 3778.8 3419.3 1790.5 2952.3 1340.6 1565.3 3908.1 1299.1 4402.2 3129.1 6208.3 10718.3 8296.0 6323.4 4273.6 9867.1 10158.6 8083.9 529.9 4310.4 2525.7 5882.9 5140.5 13330.7 1119.2 1162.5 1099.7 1368.9 1057.5 1116.3 1138.0 1095.8 1154.3 1204.8 1167.5 1217.7 1311.8 1067.3 1685.0 16.3 5889.9 6113.3 6658.4 2808.0 2619.1 206.2 5955.7 4736.9 638.4 2505.0 1972.2 1601.9 79.2 5046.4 3469.2 2296.4 2592.4 3688.3 1403.0 1105.9 2434.1 2724.8 2370.2 3482.2 18.6 7413.9 8045.8 2074.3 1401.2 1787.6 1721.9 1543.2 4028.6 3068.9 4514.0 146.4 17.8 5925.5 870.8 5458.4 6404.8 3133.4 6393.4 3169.4 2986.4 27.2 5854.8 1052.2 5787.9 6.0 19.0 5201.1 4547.7 2821.7 2403.4 6640.3 4473.8 4234.1 900.4 235.5 1991.9 3688.9 2346.3 1123.1 2093.1 4264.4 7887.4 5841.1 4889.3 1629.7 6189.1 7014.0 PNPLA2 "ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2" ENSG00000177666 "Patatin like phospholipase domain containing 2" Q96AD5 11 818914-825573 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 508.1;breast: 361.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 194.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055173, HPA062602, HPA075175" Approved Enhanced "Nucleoplasm,Lipid droplets" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "Lipid droplets" Nucleoplasm "HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: " "unprognostic (2.11e-2)" "unprognostic (3.37e-2)" "unprognostic (5.87e-3)" "unprognostic (2.51e-2)" "unprognostic (8.97e-3)" "unprognostic (1.68e-2)" "unprognostic (6.39e-2)" "unprognostic (3.28e-2)" "unprognostic (3.00e-1)" "unprognostic (5.61e-2)" "unprognostic (7.93e-2)" "unprognostic (2.09e-2)" "unprognostic (1.10e-1)" "unprognostic (1.68e-1)" "unprognostic (5.46e-1)" "unprognostic (4.09e-1)" "unprognostic (2.07e-2)" 508.1 75.3 11.9 9.2 14.0 43.1 361.4 13.6 18.8 42.2 13.4 58.1 19.3 49.2 2.8 39.9 50.8 9.5 171.3 11.9 14.0 61.9 58.4 57.3 8.1 17.5 11.8 50.5 75.4 9.6 46.3 8.4 16.8 46.6 4.8 1.3 81.1 16.7 194.6 71.8 74.7 6.4 12.6 51.2 71.3 32.1 12.8 10.9 55.3 64.3 4.1 64.8 44.5 15.3 33.9 26.0 5.3 14.0 194.4 17.2 34.1 35.3 28.1 21.6 19.1 22.3 33.3 19.9 20.4 26.7 13.6 30.0 8.1 14.6 6.6 25.9 71.5 27.6 11.2 36.3 63.3 19.2 33.4 33.9 18.7 14.5 16.7 22.3 17.7 14.5 23.8 19.9 19.5 20.0 25.8 42.3 15.2 34.3 55.1 24.6 11.5 45.7 21.4 7.7 19.6 26.0 65.3 55.0 21.9 3.4 23.7 22.0 32.5 19.3 15.0 12.7 16.3 75.2 49.8 16.7 48.4 27.0 13.8 11.5 9.5 22.1 3.7 6.1 3.6 4.7 4.8 5.4 6.1 4.1 5.4 4.4 8.2 4.0 7.1 7.0 4.2 4.7 11.9 14.0 13.6 18.8 11.9 14.0 17.5 11.8 16.8 12.6 12.8 15.3 78.1 6.4 11.8 12.7 63.5 44.2 69.2 34.2 42.1 14.0 79.5 67.1 45.5 61.5 65.2 51.5 8.4 70.2 50.8 151.8 33.2 65.1 22.1 58.0 31.8 51.8 51.5 52.6 8.9 65.3 32.0 37.4 204.4 114.3 11.4 42.2 100.6 50.6 29.2 11.8 7.5 96.1 20.3 27.6 29.0 6.2 48.4 46.6 42.7 16.9 29.6 32.2 21.6 5.5 13.8 142.2 170.7 39.1 92.0 78.5 166.8 45.0 31.3 9.0 65.7 64.4 50.7 33.5 23.9 53.7 41.2 169.4 53.3 182.2 43.6 195.5 CRACR2B "EFCAB4A, MGC45840" ENSG00000177685 "Calcium release activated channel regulator 2B" Q8N4Y2 11 826144-831991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 208.7;salivary gland: 223.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 180.4;Breast myoepithelial cells: 116.3;Gastric mucus-secreting cells: 178.9;Hepatic stellate cells: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 3.4;eosinophil: 3.7;memory B-cell: 3.9;naive B-cell: 3.0;NK-cell: 1.7" "Group enriched" "Detected in many" 6 "B-cells: 3.9;granulocytes: 3.7;NK-cells: 1.7" "Cell line enhanced" "Detected in many" "NB-4: 35.2;OE19: 29.6;SK-BR-3: 111.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046217 Approved NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 25: Pancreas - Digestion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 35: Glandular cells - Unknown function" "HPA046217: AB_10960833" "unprognostic (8.87e-2)" "unprognostic (4.89e-2)" "prognostic unfavorable (1.81e-5)" "unprognostic (4.47e-3)" "unprognostic (8.20e-3)" "unprognostic (5.27e-3)" "unprognostic (7.31e-2)" "unprognostic (1.90e-2)" "unprognostic (1.63e-1)" "unprognostic (5.61e-3)" "unprognostic (3.49e-3)" "unprognostic (9.25e-3)" "unprognostic (5.28e-2)" "unprognostic (4.29e-3)" "unprognostic (3.03e-1)" "unprognostic (3.65e-1)" "unprognostic (5.15e-3)" 11.9 8.4 1.5 3.3 1.6 13.3 65.8 3.1 2.1 8.3 3.5 43.6 22.4 4.6 1.0 6.7 6.4 6.8 22.4 1.3 1.5 27.0 3.4 14.9 2.4 1.8 1.5 1.3 208.7 6.8 23.3 2.7 1.8 44.9 13.6 1.0 223.6 5.2 4.3 21.9 28.5 1.2 1.1 13.9 81.0 2.4 1.9 0.6 6.4 1.7 2.0 19.6 3.9 1.0 3.6 3.1 0.6 1.5 0.2 0.0 11.5 0.3 0.0 0.1 0.0 3.8 12.0 0.0 4.7 0.0 0.3 3.2 2.1 0.1 0.0 26.2 1.1 13.3 3.1 8.8 0.0 10.9 0.5 0.2 0.5 0.0 0.0 2.2 0.5 1.4 17.3 10.7 0.0 8.0 0.3 35.2 0.9 29.6 0.4 2.4 0.6 22.5 8.7 2.8 2.8 1.5 0.4 111.6 0.0 0.6 17.5 9.0 0.3 1.7 0.6 0.4 0.2 26.3 2.4 3.8 5.5 14.4 0.1 3.4 0.5 3.7 0.1 0.0 0.0 3.9 0.0 0.3 0.0 3.0 0.0 0.0 0.1 1.7 0.3 0.5 0.0 0.2 1.5 1.6 3.1 2.1 1.3 1.5 1.8 1.5 1.8 1.1 1.9 1.0 61.5 6.4 19.8 3.3 16.8 0.0 6.6 0.0 1.8 2.4 180.4 116.3 8.8 22.8 27.2 12.9 0.0 3.8 6.4 18.8 15.6 15.0 2.6 11.6 1.9 34.8 12.2 6.1 0.1 37.1 1.7 2.5 178.9 16.2 1.3 0.6 85.3 2.0 3.5 0.0 0.1 71.9 0.0 5.0 0.0 5.0 2.5 3.8 0.0 3.7 1.2 11.4 0.0 0.0 0.0 25.8 40.5 1.9 24.2 29.6 46.2 4.3 13.1 7.2 13.1 2.4 4.4 2.1 6.5 4.2 0.0 1.8 5.0 1.8 43.6 66.5 CD151 "PETA-3, RAPH, SFA-1, TSPAN24" ENSG00000177697 "CD151 molecule (Raph blood group)" P48509 11 832887-839831 "Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Blood group antigen" "Deafness, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 716.2;Exocrine glandular cells: 636.7;Pancreatic endocrine cells: 736.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002428, HPA011906" Supported NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "CAB002428: AB_564129, HPA011906: AB_1846245" "unprognostic (1.50e-1)" "unprognostic (1.12e-2)" "unprognostic (5.47e-2)" "unprognostic (5.45e-3)" "unprognostic (4.10e-3)" "unprognostic (2.45e-2)" "prognostic unfavorable (5.58e-4)" "prognostic unfavorable (9.46e-4)" "unprognostic (5.47e-2)" "unprognostic (2.41e-1)" "unprognostic (1.02e-3)" "unprognostic (3.31e-1)" "unprognostic (4.39e-2)" "unprognostic (6.23e-3)" "unprognostic (3.24e-1)" "prognostic favorable (6.92e-4)" "unprognostic (7.83e-2)" 332.4 159.5 54.0 79.7 53.5 25.0 277.8 52.5 67.6 181.6 66.1 219.7 140.6 264.6 103.0 97.5 184.3 132.4 345.8 54.2 65.3 194.3 145.3 240.1 35.4 64.5 57.4 116.2 278.3 85.9 81.1 110.1 60.5 182.9 99.8 9.6 243.5 194.2 113.1 107.0 149.4 255.2 58.3 94.8 187.3 44.8 58.6 15.0 133.5 77.0 30.6 203.1 151.3 58.0 380.0 475.3 71.8 256.3 1088.7 422.8 110.4 587.1 400.4 285.0 241.2 252.6 677.2 0.2 224.0 943.5 388.4 358.4 71.1 498.4 96.1 135.0 236.6 112.8 139.1 193.4 366.7 90.2 157.4 388.6 328.2 164.5 367.8 1089.2 348.8 16.4 135.1 56.3 485.9 196.1 1.9 99.5 48.0 232.9 569.4 20.0 173.7 106.4 642.8 102.1 99.5 111.8 578.9 371.5 121.5 81.6 145.8 102.4 600.0 462.6 209.3 147.5 352.9 62.0 66.5 4.5 437.5 89.7 265.8 24.6 19.1 15.2 5.7 19.3 6.8 3.0 4.7 5.0 11.9 2.0 1.9 3.0 7.3 8.2 24.1 1.8 2.9 10.8 54.0 53.5 52.5 67.6 54.2 65.3 64.5 57.4 60.5 58.3 58.6 58.0 294.4 208.3 79.1 13.1 12.8 70.6 143.2 328.2 60.9 16.6 180.9 203.7 180.0 133.0 159.8 248.3 4.2 222.6 15.6 542.3 19.6 716.2 2.6 60.8 114.6 214.8 127.6 28.6 10.0 636.7 423.8 173.8 236.5 143.7 81.3 103.7 265.2 54.0 130.0 37.0 5.5 388.5 138.4 59.3 70.4 11.3 123.6 81.8 128.1 15.9 75.6 94.8 23.7 3.5 0.7 736.6 477.9 283.2 26.6 307.1 440.6 124.6 52.2 17.0 210.4 96.6 310.3 5.6 13.6 73.4 54.4 185.7 29.7 61.1 289.8 199.6 POLR2L "hRPB7.6, hsRPB10b, RBP10, RPABC5, RPB10beta, RPB7.6" ENSG00000177700 "RNA polymerase II, I and III subunit L" P62875 11 837356-842529 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 1813.6;Proximal tubular cells: 1989.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 569.0;PC-3: 706.8" "Low region specificity" "Detected in all" HPA073614 Supported Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA073614: " "unprognostic (2.65e-2)" "unprognostic (6.56e-3)" "unprognostic (1.40e-1)" "unprognostic (5.71e-2)" "unprognostic (3.49e-2)" "unprognostic (3.46e-2)" "prognostic unfavorable (2.37e-4)" "unprognostic (6.17e-3)" "unprognostic (1.34e-1)" "unprognostic (7.51e-3)" "unprognostic (2.37e-2)" "unprognostic (6.77e-2)" "prognostic favorable (5.56e-4)" "unprognostic (3.60e-2)" "unprognostic (1.32e-1)" "unprognostic (4.03e-3)" "unprognostic (1.73e-1)" 112.1 101.2 68.2 21.5 69.9 27.2 91.0 69.0 98.3 48.0 90.5 63.5 26.1 48.9 16.5 87.1 43.3 16.4 161.8 72.9 75.3 112.7 107.6 68.3 20.4 68.3 71.0 37.3 111.5 30.4 71.7 21.1 70.1 67.9 15.4 11.9 62.6 31.3 101.0 65.3 46.2 24.9 67.9 68.4 63.3 34.3 70.1 21.0 72.5 43.1 17.6 63.3 54.1 69.7 106.4 569.0 52.9 66.5 150.1 107.8 45.6 134.5 94.1 129.6 86.5 166.2 97.6 64.4 35.6 166.6 110.4 69.5 79.7 160.8 39.9 59.9 381.6 63.4 160.7 216.6 88.3 62.3 49.3 178.9 71.6 74.2 36.6 79.2 101.7 63.9 67.0 71.3 156.1 268.4 59.7 63.1 82.6 124.7 706.8 58.8 41.9 99.3 160.7 81.1 104.1 32.1 133.3 135.2 107.3 28.2 81.2 36.7 117.9 87.5 69.1 48.3 83.8 40.0 50.0 62.3 130.8 58.3 78.2 93.3 119.5 121.7 92.9 109.0 100.1 75.5 86.0 92.0 114.0 73.6 71.8 89.3 32.1 123.7 76.6 141.1 92.5 134.7 68.2 69.9 69.0 98.3 72.9 75.3 68.3 71.0 70.1 67.9 70.1 69.7 364.4 410.3 390.2 9.8 265.9 611.8 245.0 767.6 279.4 68.1 491.1 412.0 500.6 584.8 415.4 526.0 25.0 625.4 305.0 669.3 1287.4 444.0 84.2 388.4 377.2 400.3 501.7 363.4 5.0 684.1 467.7 392.3 283.4 301.7 266.2 194.4 649.6 1813.6 700.2 50.5 5.3 641.6 323.5 434.5 582.0 235.7 305.7 307.3 658.1 11.2 493.6 368.5 389.3 3.5 9.0 751.1 589.2 255.1 382.8 300.0 813.6 1989.1 329.9 82.5 157.8 195.2 340.8 182.6 268.6 459.8 696.6 449.6 286.1 284.9 553.1 289.7 TSPAN4 "NAG-2, TETRASPAN, TM4SF7, TSPAN-4" ENSG00000214063 "Tetraspanin 4" O14817 11 842812-867116 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 194.2;Fibroblasts: 168.7;Hofbauer cells: 240.6;Leydig cells: 172.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 146.4;intermediate monocyte: 143.5;myeloid DC: 101.2;NK-cell: 95.6;non-classical monocyte: 39.9" "Group enriched" "Detected in all" 10 "dendritic cells: 101.2;monocytes: 146.4;NK-cells: 95.6" "Low cell line specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 142.8" "Low region specificity" "Detected in all" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 33: Fibroblasts - ECM organization" "unprognostic (1.49e-1)" "unprognostic (2.85e-1)" "unprognostic (6.39e-2)" "unprognostic (2.53e-1)" "prognostic unfavorable (2.91e-4)" "unprognostic (1.88e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (1.24e-1)" "unprognostic (6.13e-2)" "unprognostic (1.18e-1)" "unprognostic (1.23e-1)" "unprognostic (9.49e-2)" "unprognostic (2.41e-2)" "unprognostic (1.29e-2)" "unprognostic (2.61e-2)" "unprognostic (2.41e-2)" "unprognostic (1.18e-1)" 129.1 37.1 15.8 29.6 14.7 11.8 102.0 17.9 18.7 90.9 44.1 60.3 13.7 84.2 9.2 26.1 85.8 54.1 57.6 15.6 17.4 60.8 37.6 101.4 46.3 17.1 16.7 91.3 32.5 17.6 24.2 61.6 15.6 52.9 10.5 2.5 34.2 33.7 25.7 56.3 43.3 27.5 15.5 85.0 37.0 16.8 18.2 13.2 79.9 22.9 12.7 66.8 71.8 12.9 30.7 238.7 40.8 73.6 61.2 121.4 27.5 153.0 182.5 118.4 81.3 49.5 37.5 2.3 60.4 221.3 68.2 11.3 14.5 145.6 22.2 20.4 17.4 32.5 75.7 71.6 201.4 10.4 38.9 211.5 26.1 42.8 129.0 116.1 78.5 12.5 13.5 184.5 115.8 64.6 7.0 13.0 52.3 39.2 172.7 24.2 29.1 55.4 138.3 2.0 48.0 28.6 75.8 83.6 162.1 17.4 118.5 7.7 116.0 134.2 53.4 27.3 52.2 10.2 1.5 4.5 138.5 11.1 121.8 0.1 146.4 0.1 7.4 143.5 4.6 6.9 3.7 7.2 101.2 5.4 6.2 11.7 3.4 95.6 39.9 7.0 3.6 65.2 15.8 14.7 17.9 18.7 15.6 17.4 17.1 16.7 15.6 15.5 18.2 12.9 194.2 105.8 68.5 6.5 5.6 47.5 22.2 78.8 13.6 9.5 19.4 38.6 9.5 74.4 24.6 31.3 4.2 39.5 8.1 1.7 7.9 82.6 2.1 5.9 43.2 117.3 0.0 12.0 0.6 16.7 31.9 168.7 5.6 10.8 37.2 62.8 97.5 28.2 240.6 13.5 2.9 2.6 4.1 109.9 71.5 7.3 172.7 70.3 147.7 11.2 19.2 43.8 8.2 2.5 0.3 61.3 0.3 95.2 9.3 15.7 0.3 34.7 5.8 6.7 59.2 23.9 67.5 4.7 31.5 6.1 32.8 16.8 10.2 44.7 1.1 6.1 CHID1 "FLJ42707, MGC3234, SI-CLP" ENSG00000177830 "Chitinase domain containing 1" Q9BWS9 11 867859-915058 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 404.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039374 Uncertain Uncertain "Nucleoplasm,Intermediate filaments" "Intracellular and membrane" No No 1500000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Intermediate filaments" "HPA039374: AB_10673609" "unprognostic (1.85e-1)" "unprognostic (2.19e-1)" "unprognostic (8.96e-2)" "prognostic favorable (6.76e-4)" "unprognostic (4.82e-2)" "unprognostic (3.22e-1)" "unprognostic (1.97e-2)" "unprognostic (3.62e-2)" "unprognostic (7.88e-2)" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" "unprognostic (5.21e-2)" "unprognostic (1.74e-3)" "unprognostic (1.15e-1)" "unprognostic (7.53e-2)" "unprognostic (3.29e-2)" "unprognostic (2.89e-2)" 43.9 63.3 43.1 22.7 44.1 46.2 40.2 41.0 51.7 44.5 60.0 34.2 30.9 38.0 89.5 34.8 63.5 41.3 54.4 44.1 47.2 52.5 85.8 30.9 27.2 42.9 42.9 58.0 149.9 46.1 62.8 42.7 42.5 42.3 29.7 25.2 82.2 41.3 37.0 34.9 27.7 35.7 42.6 71.6 47.1 74.1 45.7 20.1 47.3 31.1 20.2 34.3 35.3 47.0 75.6 71.7 53.2 131.6 203.3 107.5 90.1 83.2 97.0 78.8 76.7 78.7 214.6 61.1 75.1 121.7 78.4 145.2 53.1 95.9 57.3 53.7 131.9 44.1 25.9 75.1 92.6 102.9 37.4 104.1 59.2 53.9 77.2 130.3 67.2 76.6 81.2 152.6 55.8 52.9 58.4 134.0 47.2 141.6 107.3 49.0 50.9 111.8 57.5 21.5 101.8 84.5 90.3 124.0 78.4 53.0 50.4 156.8 66.6 89.6 38.9 25.3 68.3 88.9 81.4 36.0 100.2 88.6 71.7 21.1 50.4 19.2 34.7 45.0 37.1 45.7 33.2 36.8 74.0 32.1 34.9 35.3 6.2 43.4 45.6 69.6 32.4 46.0 43.1 44.1 41.0 51.7 44.1 47.2 42.9 42.9 42.5 42.6 45.7 47.0 33.0 41.7 36.7 4.2 28.6 22.8 62.2 78.9 22.2 38.5 69.9 75.7 25.6 51.5 49.0 53.3 18.8 121.3 34.4 25.2 72.4 62.3 120.9 44.0 44.4 31.5 53.3 56.4 7.8 58.3 79.7 69.6 20.9 36.8 29.2 107.6 50.0 91.2 81.1 30.3 7.8 42.8 57.0 66.6 24.7 404.8 62.7 34.0 55.2 1.9 35.2 60.6 20.6 6.0 6.8 38.0 43.2 58.3 123.7 86.5 71.5 85.1 45.7 53.2 52.6 45.9 41.7 208.3 139.9 37.2 23.3 91.5 19.2 85.4 59.9 62.6 AP2A2 "ADTAB, CLAPA2, DKFZP564D1864, HIP9, HYPJ, KIAA0899" ENSG00000183020 "Adaptor related protein complex 2 subunit alpha 2" O94973 11 924894-1012245 "Plasma proteins, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017514, HPA043040" Supported Supported Nucleoplasm,Vesicles NA NA 10000000 "Cluster 41: Basophils - Cellular respiration" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 4: Macrophages - Innate immune response" Vesicles Nucleoplasm "CAB017514: AB_2056344, HPA043040: AB_2678283" "unprognostic (1.90e-1)" "unprognostic (1.54e-1)" "unprognostic (2.20e-1)" "unprognostic (2.09e-2)" "unprognostic (1.28e-2)" "unprognostic (5.72e-2)" "prognostic unfavorable (9.27e-5)" "unprognostic (1.34e-2)" "unprognostic (4.09e-1)" "unprognostic (1.70e-1)" "prognostic favorable (4.57e-4)" "unprognostic (2.41e-1)" "unprognostic (2.86e-3)" "unprognostic (1.05e-1)" "unprognostic (1.58e-1)" "unprognostic (1.40e-1)" "unprognostic (2.08e-2)" 20.1 18.0 3.5 1.3 5.1 4.5 16.6 10.8 9.9 20.3 1.4 23.0 5.4 17.9 1.5 12.7 18.1 2.0 19.1 5.5 3.5 34.4 29.9 18.9 3.2 0.9 2.1 17.5 25.3 3.7 25.6 5.2 3.0 20.3 4.9 5.8 14.6 4.0 14.1 14.5 19.6 5.6 0.0 57.6 20.6 15.5 3.3 3.8 13.9 1.6 2.5 19.0 15.7 1.4 7.5 2.9 3.7 10.7 13.8 14.2 9.1 10.2 3.3 6.0 4.9 1.3 7.3 7.4 8.7 12.3 5.7 8.9 8.9 5.6 3.9 5.5 23.2 2.1 10.4 3.9 5.3 2.8 4.9 16.8 6.1 3.1 6.1 14.8 8.5 5.0 5.9 4.7 6.3 0.4 2.6 3.2 2.0 9.1 17.9 4.2 2.6 8.1 9.2 6.2 12.3 10.0 11.4 9.2 1.7 6.3 5.4 0.8 13.3 1.9 2.3 2.8 5.2 4.3 3.9 5.3 4.0 3.7 3.1 1.5 1.7 1.5 1.1 1.7 0.5 0.5 1.1 0.6 1.4 1.0 1.1 1.2 2.1 1.1 1.4 1.3 2.1 0.6 3.5 5.1 10.8 9.9 5.5 3.5 0.9 2.1 3.0 0.0 3.3 1.4 38.1 38.5 21.8 29.4 14.3 14.3 12.4 13.3 7.4 50.9 27.2 23.0 12.9 21.5 15.9 62.5 60.5 42.1 17.3 45.3 39.2 37.5 46.7 64.0 44.6 36.6 35.2 27.1 37.2 18.0 45.2 28.7 16.3 86.7 27.3 31.0 80.3 59.8 82.8 101.0 36.4 32.3 18.3 104.7 26.9 28.3 34.5 51.8 8.8 41.2 31.2 30.4 39.1 23.1 21.9 25.8 24.2 27.8 13.6 16.9 43.5 70.4 23.5 69.2 26.3 20.7 22.6 72.7 28.0 11.2 11.4 28.5 19.7 30.5 37.0 11.5 MUC6 ENSG00000184956 "Mucin 6, oligomeric mucus/gel-forming" Q6W4X9 11 1012823-1036718 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "pancreas: 171.2;stomach 1: 409.9" "Cell type enriched" "Detected in some" 4 "Gastric mucus-secreting cells: 278.8" "Group enriched" "Detected in many" 4 "pancreatic cancer: 42.9;stomach cancer: 58.0" "Region enhanced" "Detected in single" "amygdala: 1.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "OE19: 1.7" "Not detected" "Not detected" CAB002165 Enhanced "Secreted to digestive system" NA NA 75000 "Cluster 25: Pancreas - Digestion" "Cluster 21: OE19 - Mitochondria" "Cluster 16: Pancreatic endocrine cells - Mixed function" "CAB002165: AB_442114" "unprognostic (1.90e-2)" "unprognostic (1.00e-1)" "unprognostic (5.21e-3)" "unprognostic (1.56e-3)" "unprognostic (1.04e-1)" "unprognostic (5.17e-3)" "unprognostic (2.17e-1)" "unprognostic (1.48e-1)" "unprognostic (1.65e-2)" "unprognostic (2.63e-1)" "unprognostic (9.46e-2)" "unprognostic (8.62e-2)" "unprognostic (3.17e-3)" "unprognostic (1.95e-1)" "unprognostic (2.39e-1)" "unprognostic (4.72e-2)" "unprognostic (5.23e-2)" 0.5 0.2 1.2 0.0 0.6 0.0 0.9 0.3 0.5 26.3 0.0 3.0 15.6 2.1 0.9 5.2 2.5 0.3 0.2 0.8 0.0 2.6 5.4 0.2 0.0 0.0 0.0 0.2 171.2 0.0 0.2 0.0 0.0 4.3 0.0 0.0 0.1 28.0 0.1 0.1 0.1 0.0 0.0 0.3 409.9 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.3 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 11.3 2.8 1.7 54.3 0.0 9.2 0.0 0.0 0.2 0.1 0.0 12.2 0.1 0.5 0.1 0.1 0.0 0.0 1.2 19.1 0.0 0.1 278.8 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 59.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MUC2 ENSG00000198788 "Mucin 2, oligomeric mucus/gel-forming" 11 1074875-1110511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "intestine: 133.8" "Cell type enriched" "Detected in some" 12 "Intestinal goblet cells: 745.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 93.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB016275 Enhanced "Intracellular and membrane" NA NA "Cluster 27: Mucus-secreting cells - Mucin production" "CAB016275: AB_627970" "unprognostic (6.37e-2)" "unprognostic (8.32e-2)" "unprognostic (5.76e-3)" "unprognostic (5.09e-2)" "unprognostic (6.18e-3)" "unprognostic (3.39e-2)" "unprognostic (1.71e-2)" "unprognostic (5.76e-3)" "unprognostic (7.87e-2)" "unprognostic (2.04e-1)" "unprognostic (7.37e-3)" "unprognostic (4.20e-2)" "unprognostic (3.64e-5)" "unprognostic (1.38e-1)" "unprognostic (1.22e-1)" "unprognostic (3.10e-2)" 0.6 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 133.8 31.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.7 0.0 0.0 0.5 0.0 0.0 79.9 4.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 18.0 0.0 0.4 0.0 0.0 0.0 0.0 60.3 0.0 0.3 0.0 0.1 0.0 0.6 14.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 8.9 0.0 0.0 0.0 0.0 0.0 0.0 745.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 31.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 34.3 0.0 MUC5AC MUC5 ENSG00000215182 "Mucin 5AC, oligomeric mucus/gel-forming" P98088 11 1157953-1201138 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 101 "stomach 1: 185.1" "Cell type enriched" "Detected in some" 248 "Gastric mucus-secreting cells: 10434.9" "Group enriched" "Detected in many" 4 "pancreatic cancer: 25.3;stomach cancer: 61.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "A549: 19.9;OE19: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002774, CAB009395, HPA040615" Enhanced "Secreted to digestive system" NA NA "Cluster 4: Stomach - Digestion" "Cluster 21: OE19 - Mitochondria" "Cluster 16: Pancreatic endocrine cells - Mixed function" "CAB002774: , CAB009395: AB_2146854, HPA040615: AB_2677042" "unprognostic (2.10e-2)" "unprognostic (1.11e-1)" "unprognostic (1.27e-1)" "unprognostic (3.14e-2)" "unprognostic (1.72e-2)" "unprognostic (2.51e-2)" "unprognostic (4.56e-2)" "unprognostic (6.49e-2)" "unprognostic (2.44e-2)" "unprognostic (1.30e-3)" "unprognostic (8.46e-2)" "unprognostic (5.83e-4)" "unprognostic (1.84e-1)" "unprognostic (9.21e-3)" "unprognostic (4.07e-1)" "unprognostic (1.37e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 13.5 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 17.4 0.0 0.1 5.4 0.0 0.0 0.1 0.0 2.7 0.0 42.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.8 0.0 2.8 10434.9 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 4.1 0.0 0.0 0.2 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.1 0.0 30.0 8.9 0.0 0.0 10.0 0.0 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.1 7.9 0.0 0.0 28.1 MUC5B "MG1, MUC5" ENSG00000117983 "Mucin 5B, oligomeric mucus/gel-forming" Q9HC84 11 1223066-1262172 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "salivary gland: 2621.9" "Cell type enhanced" "Detected in many" "Cholangiocytes: 443.2;Distal enterocytes: 158.4;Intestinal goblet cells: 210.1;Undifferentiated cells: 183.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "OE19: 113.9;PC-3: 120.0" "Not detected" "Not detected" "HPA008246, CAB009396" Enhanced Supported Vesicles "Secreted in other tissues" NA NA 1300000 "Cluster 24: Salivary gland - Salivary secretion" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "CAB009396: AB_2282256, HPA008246: AB_1854203" "unprognostic (2.01e-2)" "unprognostic (1.46e-1)" "unprognostic (9.39e-2)" "unprognostic (2.76e-3)" "unprognostic (5.46e-2)" "unprognostic (1.22e-1)" "unprognostic (4.89e-2)" "unprognostic (7.80e-3)" "unprognostic (3.75e-1)" "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (8.95e-2)" "unprognostic (2.57e-7)" "unprognostic (2.71e-1)" "unprognostic (1.61e-1)" "unprognostic (1.07e-1)" "unprognostic (8.13e-2)" 0.1 0.7 0.2 2.0 0.1 0.0 1.3 0.0 0.4 229.4 0.0 58.0 0.1 0.3 0.0 101.0 1.1 221.3 0.1 0.0 0.0 0.1 2.4 7.5 0.0 0.1 0.0 0.1 9.8 0.0 0.4 0.0 0.0 0.6 17.1 0.0 2621.9 0.0 0.3 0.4 2.6 0.6 0.0 0.0 6.9 0.3 0.0 0.0 0.2 0.0 0.4 0.2 0.1 0.0 0.0 17.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.1 0.2 0.0 113.9 120.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.0 2.3 0.0 0.0 6.7 0.6 0.0 6.4 4.3 12.4 443.2 64.0 0.0 0.0 0.1 0.0 158.4 0.0 0.9 0.0 1.4 0.8 0.9 24.5 0.0 0.1 0.0 0.1 1.1 12.8 7.2 4.5 0.0 0.0 1.2 0.2 0.0 0.0 210.1 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 53.4 0.0 1.4 1.3 0.1 0.2 24.5 0.0 0.0 0.0 3.0 0.0 0.5 1.6 0.0 0.1 0.7 0.1 183.1 1.1 TOLLIP IL-1RAcPIP ENSG00000078902 "Toll interacting protein" Q9H0E2 11 1274371-1309654 "Plasma proteins, Predicted intracellular proteins" "Autophagy, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 498.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038621, HPA038622" Enhanced Approved Cytosol NA NA 140000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 15: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "HPA038621: AB_10673177, HPA038622: AB_10675946" "unprognostic (8.39e-2)" "unprognostic (1.89e-1)" "unprognostic (2.18e-2)" "unprognostic (6.08e-2)" "prognostic unfavorable (5.45e-4)" "unprognostic (8.89e-2)" "unprognostic (2.51e-1)" "unprognostic (8.53e-2)" "unprognostic (2.17e-1)" "unprognostic (1.55e-2)" "unprognostic (1.90e-2)" "unprognostic (2.74e-1)" "prognostic favorable (1.11e-16)" "unprognostic (2.72e-1)" "unprognostic (1.46e-1)" "unprognostic (3.21e-2)" "unprognostic (1.29e-2)" 26.8 35.4 58.2 12.4 73.5 13.6 25.8 27.5 80.9 35.9 17.6 26.3 25.5 23.5 11.5 93.4 22.4 18.4 31.3 85.0 39.4 43.1 113.3 26.6 14.2 39.9 39.1 24.6 58.2 18.9 54.2 12.1 39.8 31.4 8.2 11.4 31.6 20.5 76.2 75.9 23.4 11.1 32.9 28.8 31.9 73.4 42.7 13.2 24.7 22.7 14.2 33.5 48.8 56.5 31.4 32.6 16.3 18.6 34.0 21.2 14.2 27.2 24.5 31.3 27.7 35.4 19.5 14.6 25.6 25.3 47.9 27.7 14.7 33.4 8.5 30.1 30.1 11.9 6.9 54.2 48.4 22.8 29.0 32.1 38.5 18.6 17.9 17.1 19.7 21.7 19.9 38.5 26.1 26.3 29.1 27.9 20.0 33.9 42.1 21.8 16.6 14.6 20.9 41.3 43.5 25.5 24.4 29.4 30.7 8.3 23.3 25.7 36.0 33.8 14.4 14.4 16.0 38.8 37.8 18.3 53.2 14.9 27.0 45.4 126.6 139.6 33.4 114.0 27.8 38.8 35.3 31.5 99.9 50.0 27.4 26.1 179.1 44.5 108.8 52.4 48.8 77.3 58.2 73.5 27.5 80.9 85.0 39.4 39.9 39.1 39.8 32.9 42.7 56.5 19.5 9.6 19.3 15.0 27.8 66.9 43.9 71.7 23.3 42.6 30.3 24.6 22.8 58.6 30.9 23.9 8.4 49.2 28.0 50.8 70.5 66.3 173.6 11.7 14.8 24.9 51.6 45.0 35.1 69.2 41.1 27.6 19.4 15.8 38.1 20.7 37.9 112.2 92.1 74.0 17.0 30.8 48.8 38.4 33.1 498.2 21.8 48.3 71.2 16.9 50.6 38.1 19.6 10.6 15.0 76.3 53.7 30.9 33.4 55.7 66.6 110.1 15.4 20.6 6.6 18.5 24.5 100.7 39.6 76.3 98.9 104.4 22.0 27.4 29.3 74.0 BRSK2 "C11orf7, PEN11B, STK29" ENSG00000174672 "BR serine/threonine kinase 2" Q8IWQ3 11 1389899-1462689 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, Exocytosis, Mitosis, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 37.8;pancreas: 104.2" "Cell type enhanced" "Detected in some" "Astrocytes: 22.9;Bipolar cells: 87.9;Cone photoreceptor cells: 35.5;Excitatory neurons: 35.5;Horizontal cells: 69.0;Inhibitory neurons: 23.5;Rod photoreceptor cells: 28.6" "Cancer enhanced" "Detected in many" "glioma: 3.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 15.8;AN3-CA: 17.3;CACO-2: 14.4;HAP1: 13.3;NTERA-2: 27.2;SCLC-21H: 62.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073690 Approved "Golgi apparatus" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 56: Bipolar cells - Visual perception" "Golgi apparatus" "HPA073690: " "unprognostic (5.47e-2)" "unprognostic (4.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.85e-2)" "unprognostic (1.18e-1)" "unprognostic (1.40e-2)" "unprognostic (1.05e-2)" "unprognostic (3.63e-1)" "unprognostic (6.42e-2)" "unprognostic (3.86e-2)" "unprognostic (2.22e-2)" "unprognostic (2.31e-1)" "unprognostic (3.17e-7)" "unprognostic (3.24e-2)" "unprognostic (1.57e-1)" "unprognostic (1.49e-3)" "unprognostic (1.86e-1)" 1.1 2.4 11.5 0.2 16.0 0.1 0.7 29.2 37.8 2.1 0.0 2.8 0.5 1.0 0.0 0.8 2.0 0.7 1.0 20.5 2.1 0.5 0.2 0.4 0.1 7.9 3.6 0.9 104.2 2.2 15.6 0.6 8.6 1.4 0.1 17.4 0.4 0.2 0.4 0.3 1.5 0.1 0.5 0.6 1.9 9.0 5.0 0.1 1.0 0.2 0.0 0.8 1.1 17.6 0.1 7.2 15.8 17.3 0.3 0.5 0.0 0.2 0.2 1.3 0.5 14.4 0.9 0.0 2.4 0.2 0.2 0.0 13.3 0.1 1.0 1.7 6.2 0.0 0.0 0.2 0.7 0.0 0.6 0.2 0.0 0.0 1.6 0.3 0.0 0.5 0.2 0.1 0.3 1.7 0.0 0.0 27.2 5.1 2.2 0.0 0.0 0.0 0.2 0.2 62.0 9.0 3.3 0.2 4.7 0.3 0.3 0.8 0.3 1.4 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 16.0 29.2 37.8 20.5 2.1 7.9 3.6 8.6 0.5 5.0 17.6 0.4 0.0 0.0 22.9 0.1 0.3 0.1 0.0 0.0 87.9 0.1 0.1 2.1 0.0 0.0 0.0 35.5 0.0 0.2 0.1 0.0 0.1 0.5 0.2 0.4 0.6 0.0 0.0 35.5 1.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.2 69.0 23.5 0.2 0.0 0.0 0.0 0.7 0.9 0.1 0.0 6.5 0.0 20.7 0.0 20.1 20.6 0.3 0.0 1.2 0.0 0.2 0.0 0.1 0.0 28.6 6.6 0.9 6.0 0.9 1.7 0.1 0.0 0.0 0.6 0.1 0.1 0.0 MOB2 HCCA2 ENSG00000182208 "MOB kinase activator 2" Q70IA6 11 1469457-1501247 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046313 Uncertain Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 80: Striated muscle - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoli "Nucleoplasm, Cytosol" "HPA046313: AB_10959882" "unprognostic (5.02e-1)" "unprognostic (5.71e-2)" "unprognostic (6.24e-3)" "unprognostic (4.42e-3)" "prognostic unfavorable (4.64e-4)" "unprognostic (8.30e-2)" "unprognostic (1.06e-3)" "unprognostic (3.06e-2)" "unprognostic (1.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.30e-2)" "unprognostic (2.87e-1)" "prognostic favorable (2.02e-4)" "unprognostic (2.67e-1)" "unprognostic (8.56e-2)" "unprognostic (9.78e-2)" "unprognostic (1.15e-1)" 32.3 19.6 34.7 19.2 36.3 24.2 28.3 37.8 39.7 27.4 36.2 61.1 18.0 30.7 36.5 51.9 34.4 27.8 43.5 35.3 36.5 18.6 20.0 24.7 26.8 36.1 36.8 28.1 32.8 34.9 11.2 25.7 36.5 32.5 34.8 14.6 35.2 42.3 50.9 50.0 28.6 49.0 36.1 25.1 27.9 14.2 37.1 34.1 24.2 70.4 27.0 39.9 31.6 37.8 29.3 31.2 18.3 15.7 44.2 30.8 17.1 22.5 30.9 40.4 31.8 20.1 39.0 20.9 16.7 50.6 26.0 34.8 28.1 48.6 24.3 28.8 44.3 16.0 11.7 26.2 30.2 21.2 24.2 25.1 57.9 21.9 25.3 32.7 43.6 27.0 26.3 21.2 20.7 20.6 27.4 37.7 23.0 54.3 29.4 19.9 19.0 22.2 34.4 26.9 34.6 37.3 27.3 34.0 27.9 23.0 15.9 21.3 37.7 25.6 13.1 8.3 14.5 21.6 22.3 21.8 17.9 20.3 19.8 9.7 8.7 11.9 16.2 9.2 13.6 8.1 14.1 13.7 10.6 11.0 11.6 10.2 7.1 12.1 13.4 7.5 15.3 10.6 34.7 36.3 37.8 39.7 35.3 36.5 36.1 36.8 36.5 36.1 37.1 37.8 84.8 6.4 10.0 6.5 20.2 82.2 30.1 39.4 12.0 18.4 27.8 33.3 14.8 12.8 18.4 7.3 12.5 31.1 64.5 58.6 27.4 33.5 24.3 18.9 17.7 58.2 20.9 36.2 15.2 38.5 31.0 23.3 16.8 29.2 24.8 20.3 33.9 9.0 26.4 43.7 10.9 32.8 32.6 18.2 39.3 12.1 23.9 28.1 56.9 11.2 29.4 21.5 81.4 6.6 14.8 39.6 63.2 51.1 17.0 48.6 54.3 23.9 12.9 21.4 85.5 20.8 68.3 29.8 41.1 13.7 82.0 59.4 36.4 20.2 27.7 37.6 DUSP8 "C11orf81, FLJ42958, HB5, HVH-5" ENSG00000184545 "Dual specificity phosphatase 8" Q13202 11 1554051-1572271 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 25.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 113.6;Distal enterocytes: 57.8;Glandular and luminal cells: 65.6;Horizontal cells: 90.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.5;SCLC-21H: 1.4;SH-SY5Y: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020071 Approved Approved Cytosol NA NA "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 56: Bipolar cells - Visual perception" Cytosol "HPA020071: AB_1847903" "unprognostic (2.29e-1)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "unprognostic (4.00e-2)" "unprognostic (1.35e-1)" "unprognostic (7.58e-3)" "unprognostic (6.08e-2)" "unprognostic (1.11e-1)" "unprognostic (1.44e-3)" "unprognostic (1.81e-1)" "unprognostic (4.04e-3)" "unprognostic (1.82e-1)" "prognostic favorable (2.75e-6)" "unprognostic (1.51e-1)" "unprognostic (1.57e-1)" "unprognostic (8.65e-2)" "unprognostic (6.30e-2)" 6.6 2.1 3.5 0.2 3.0 1.0 6.0 0.3 8.1 5.1 0.0 11.3 0.0 8.4 0.6 1.4 8.7 0.5 17.0 5.0 0.1 5.4 3.6 9.5 0.3 1.9 0.4 2.4 15.7 0.2 25.5 0.1 0.1 5.1 0.3 1.6 6.1 0.2 13.3 4.3 6.8 1.2 0.3 3.1 8.3 3.1 0.7 0.2 3.7 0.0 0.1 3.6 4.2 2.0 0.6 0.3 0.4 0.0 0.0 0.0 1.1 0.1 0.4 0.1 0.6 0.6 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.1 0.3 1.1 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 2.5 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 1.4 1.7 0.1 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.8 0.3 0.8 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.0 0.3 8.1 5.0 0.1 1.9 0.4 0.1 0.3 0.7 2.0 14.9 3.2 1.1 0.0 6.3 9.8 8.1 2.7 2.8 113.6 32.1 24.3 6.0 14.3 3.2 12.9 47.9 0.3 11.1 57.8 1.9 7.7 0.3 31.5 24.7 6.5 42.3 0.0 11.1 11.3 0.5 4.3 8.6 65.6 0.0 0.4 1.4 0.6 0.5 90.9 11.3 32.6 6.1 0.0 3.4 0.2 0.6 4.7 5.4 2.8 1.0 22.3 1.0 3.0 5.2 11.0 22.4 0.4 4.7 17.4 19.1 1.6 2.8 35.5 6.6 8.0 15.1 0.8 0.6 2.2 4.8 5.9 10.5 0.7 25.0 14.2 KRTAP5-1 "KRN1L, KRTAP5.1" ENSG00000205869 "Keratin associated protein 5-1" Q6L8H4 11 1584342-1585283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 4.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 6 "cerebellum: 2.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.3" NA NA "Cluster 50: Non-specific - Ribosome" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 56: Bipolar cells - Visual perception" "unprognostic (2.68e-1)" "unprognostic (2.97e-1)" "prognostic unfavorable (2.37e-4)" "unprognostic (1.04e-1)" "unprognostic (8.08e-2)" "unprognostic (3.36e-3)" "unprognostic (2.41e-1)" "unprognostic (7.87e-2)" "unprognostic (1.43e-1)" "unprognostic (6.71e-2)" "unprognostic (9.66e-2)" "unprognostic (2.75e-2)" "unprognostic (6.32e-3)" "unprognostic (3.88e-2)" "unprognostic (1.25e-1)" "unprognostic (2.71e-2)" "unprognostic (3.10e-1)" 0.3 0.1 0.3 0.0 0.0 0.0 0.5 2.4 0.4 0.5 0.0 1.5 0.0 0.6 0.0 0.1 0.9 0.0 2.1 0.1 0.0 1.3 0.4 1.3 0.0 0.0 0.0 0.1 2.2 0.0 4.6 0.0 0.0 0.7 0.0 0.4 1.9 0.0 0.6 2.9 0.8 0.0 0.0 0.6 0.8 0.4 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 KRTAP5-2 "KRTAP5-8, KRTAP5.2" ENSG00000205867 "Keratin associated protein 5-2" Q701N4 11 1597177-1598294 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.6;SCLC-21H: 2.8;SH-SY5Y: 1.2" NA NA "Cluster 61: Skin - Cornification" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (6.31e-2)" 0.0 0.3 0.2 0.1 0.1 0.0 0.0 1.9 0.8 0.0 0.0 0.2 0.5 0.1 0.3 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.1 0.0 0.6 0.6 0.0 0.1 9.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.2 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.9 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.1 KRTAP5-3 "KRTAP5-9, KRTAP5.3" ENSG00000196224 "Keratin associated protein 5-3" Q6L8H2 11 1607565-1608463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 82 "skin 1: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 61: Skin - Cornification" "Cluster 54: Cardiomyocytes - Muscle contraction" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-4 KRTAP5.4 ENSG00000241598 "Keratin associated protein 5-4" 11 1620958-1622138 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "skin 1: 4.6" "Cell type enriched" "Detected in single" 10 "Cardiomyocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 61: Skin - Cornification" "Cluster 43: Cardiomyocytes - Nuclear processes" "unprognostic (6.52e-2)" "unprognostic (4.04e-4)" "unprognostic (1.80e-1)" "unprognostic (7.83e-2)" "unprognostic (2.00e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-5 "KRTAP5-11, KRTAP5.5" ENSG00000185940 "Keratin associated protein 5-5" Q701N2 11 1629775-1630707 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 36 "skin 1: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 61: Skin - Cornification" "unprognostic (5.45e-2)" "unprognostic (1.00e-2)" "unprognostic (7.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-6 KRTAP5.6 ENSG00000205864 "Keratin associated protein 5-6" Q6L8G9 11 1697195-1697755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "liver: 3.0;skin 1: 1.2" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 21 "liver cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "Cluster 85: Liver - Metabolism" "prognostic favorable (6.04e-5)" "unprognostic (3.70e-1)" "unprognostic (2.93e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFITM10 DSPA3 ENSG00000244242 "Interferon induced transmembrane protein 10" A6NMD0 11 1732406-1750595 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 2.6;bone marrow: 1.5;brain: 3.2;choroid plexus: 1.8;retina: 1.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 46.0;Bipolar cells: 30.5;granulocytes: 28.5;Hepatic stellate cells: 40.0;Oligodendrocyte precursor cells: 39.7;Respiratory ciliated cells: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.9;hTERT-RPE1: 4.7;MCF7: 4.4;SH-SY5Y: 11.2;SK-MEL-30: 4.0;U-87 MG: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "unprognostic (1.89e-3)" "unprognostic (2.10e-2)" "unprognostic (1.22e-6)" "unprognostic (6.49e-3)" "unprognostic (4.66e-2)" "unprognostic (2.20e-1)" "unprognostic (1.72e-1)" "unprognostic (2.20e-1)" "unprognostic (3.66e-1)" "unprognostic (4.09e-1)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.68e-3)" "unprognostic (2.49e-2)" "unprognostic (2.17e-1)" "unprognostic (2.44e-2)" "unprognostic (3.76e-2)" 0.1 2.6 2.1 0.1 2.1 1.5 0.0 3.2 3.0 0.1 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.2 2.4 0.1 0.3 0.2 0.0 2.3 2.2 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.0 1.5 0.3 0.5 0.2 0.4 0.1 0.0 2.1 0.1 0.0 0.3 2.3 0.0 0.0 0.0 0.1 0.3 0.1 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 11.2 0.0 0.0 4.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.6 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.1 3.2 3.0 2.2 2.4 2.3 2.2 2.4 2.1 2.3 2.2 0.3 3.2 0.6 1.0 1.3 2.2 9.3 46.0 14.2 30.5 0.8 1.7 1.9 1.5 16.4 0.0 0.0 1.8 0.4 8.1 1.9 3.9 0.4 1.2 0.5 1.0 0.0 0.0 10.5 2.6 0.6 5.4 1.1 2.7 28.5 0.0 40.0 1.6 20.6 1.7 11.4 0.9 18.3 5.0 1.1 0.6 0.9 9.3 0.0 1.9 2.6 2.1 3.1 39.7 1.0 2.3 4.2 1.5 1.3 1.3 3.3 0.1 49.4 2.3 0.0 2.4 4.0 0.5 1.3 3.2 0.9 2.6 2.5 0.1 1.9 12.7 AC068580.4 ENSG00000250644 "Novel protein" 11 1734821-1763954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "adrenal gland: 202.9;liver: 54.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.7;granulocytes: 1.3;Macrophages: 1.7;Respiratory ciliated cells: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 241.6;hTERT-RPE1: 212.9;U-87 MG: 63.6" HPA003001 Uncertain NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 11: Alveolar cells - Smell perception" "HPA003001: AB_1078404" "unprognostic (5.71e-2)" "unprognostic (1.79e-1)" "unprognostic (1.91e-6)" "unprognostic (1.77e-2)" "unprognostic (5.21e-2)" "unprognostic (6.20e-2)" "unprognostic (4.05e-3)" "unprognostic (1.45e-2)" "unprognostic (3.04e-1)" "unprognostic (1.14e-1)" "unprognostic (2.45e-2)" "unprognostic (1.96e-1)" "unprognostic (3.17e-3)" "unprognostic (8.30e-4)" "unprognostic (7.35e-2)" "unprognostic (5.79e-5)" "unprognostic (7.47e-2)" 9.3 202.9 14.8 2.2 17.0 13.3 7.7 16.4 24.0 4.6 4.5 4.3 2.8 3.9 6.7 6.9 3.2 9.9 3.7 12.8 15.3 20.7 54.0 11.5 1.9 20.7 13.2 2.5 3.2 0.8 2.4 7.0 19.9 7.6 2.2 2.2 14.1 15.1 20.6 15.3 6.6 1.3 12.3 30.1 4.5 8.5 14.4 1.1 1.6 3.2 2.9 15.9 11.1 22.7 1.2 9.0 0.5 1.8 4.2 2.3 2.5 3.2 4.2 0.9 1.1 2.2 241.6 0.5 4.1 13.4 8.3 18.5 0.4 0.3 0.3 1.1 4.6 1.7 1.3 0.9 4.2 2.5 5.0 9.6 2.7 1.1 1.7 212.9 0.6 0.9 0.3 4.0 22.9 23.1 0.0 3.2 1.1 10.9 1.6 0.5 3.6 2.1 10.0 11.3 0.9 49.2 1.6 18.8 32.6 0.6 41.4 1.1 5.9 12.2 1.8 2.8 4.3 10.9 25.8 0.5 63.6 2.2 10.2 1.3 5.9 1.7 1.5 2.5 1.1 0.3 0.7 1.0 1.6 0.1 1.1 1.6 5.8 7.0 3.4 3.0 0.9 5.0 14.8 17.0 16.4 24.0 12.8 15.3 20.7 13.2 19.9 12.3 14.4 22.7 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 1.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 CTSD "CLN10, CPSD" ENSG00000117984 "Cathepsin D" P07339 11 1752752-1764573 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Aspartyl protease, Hydrolase, Protease" "Alzheimer disease, Cancer-related genes, Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 1475.9;Hofbauer cells: 3763.5;Macrophages: 1512.6;Proximal enterocytes: 1699.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 2596.6;hTERT-RPE1: 2780.1;SK-BR-3: 2488.5" "CAB000109, HPA003001" Supported "Secreted to blood" NA NA 370000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 4: Macrophages - Innate immune response" "CAB000109: , HPA003001: AB_1078404" "unprognostic (9.95e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (2.46e-4)" "unprognostic (1.09e-1)" "unprognostic (1.71e-3)" "unprognostic (2.65e-2)" "unprognostic (9.40e-3)" "unprognostic (1.11e-1)" "unprognostic (1.52e-1)" "unprognostic (1.12e-3)" "unprognostic (1.59e-1)" "unprognostic (1.86e-2)" "prognostic favorable (4.93e-5)" "unprognostic (8.98e-2)" "unprognostic (3.39e-2)" "unprognostic (2.13e-2)" "unprognostic (1.60e-1)" 318.6 734.6 147.0 204.9 181.9 499.0 244.0 186.0 156.5 270.8 672.7 298.0 387.6 170.7 82.8 319.4 171.6 438.4 444.1 187.8 223.6 691.6 464.8 539.6 241.0 247.6 206.6 130.7 284.8 137.3 131.5 180.7 228.6 138.2 153.4 48.3 422.1 231.7 590.3 340.9 398.3 105.0 188.9 442.0 287.2 88.9 334.4 78.1 182.1 178.2 123.1 296.4 307.5 367.1 204.6 578.9 51.4 246.2 586.5 206.3 112.1 149.4 362.2 161.8 182.8 147.5 2596.6 49.2 376.8 285.8 1265.6 1072.2 63.7 142.6 35.8 206.7 222.9 70.4 92.5 196.5 736.2 171.4 787.7 350.9 621.6 82.5 136.9 2780.1 128.2 62.1 89.2 267.6 263.3 832.6 47.0 110.9 153.1 719.7 247.9 62.5 72.5 191.2 586.6 610.8 84.2 94.8 173.3 2488.5 535.0 68.6 1022.8 232.6 170.3 556.8 92.9 79.0 216.7 432.0 382.3 26.8 867.7 468.6 509.6 211.2 578.7 170.1 156.5 309.9 90.6 28.8 72.1 110.3 144.5 18.8 82.5 107.4 319.5 192.3 265.2 120.3 89.2 489.1 147.0 181.9 186.0 156.5 187.8 223.6 247.6 206.6 228.6 188.9 334.4 367.1 139.3 112.2 228.6 48.3 62.8 72.0 223.5 473.2 71.7 168.6 108.9 113.8 251.9 314.5 459.5 548.1 110.5 211.7 156.1 1475.9 109.5 911.4 3.3 118.1 67.4 128.3 159.6 132.6 18.3 370.1 165.0 157.0 237.5 203.4 474.3 119.4 695.7 678.9 3763.5 264.2 25.2 418.2 498.5 1187.8 67.5 14.6 108.4 1512.6 227.7 20.6 382.6 179.0 256.4 27.2 42.2 392.3 832.5 128.2 122.5 111.7 1699.4 311.8 270.3 102.1 111.7 70.7 135.2 26.6 63.5 141.2 82.1 471.3 155.0 96.0 399.1 357.8 SYT8 DKFZp434K0322 ENSG00000149043 "Synaptotagmin 8" Q8NBV8 11 1828307-1837521 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 29.2;skin 1: 65.5;urinary bladder: 40.5" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 184.7;Basal squamous epithelial cells: 520.2;Breast myoepithelial cells: 192.9;Cholangiocytes: 183.0;Extravillous trophoblasts: 201.8;Respiratory ciliated cells: 163.8;Squamous epithelial cells: 132.5" "Group enriched" "Detected in many" 5 "cervical cancer: 10.5;pancreatic cancer: 21.7;urothelial cancer: 33.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CAPAN-2: 32.2;hTCEpi: 50.2;T-47d: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047239, HPA052700" Uncertain Approved "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA047239: , HPA052700: AB_2681920" "unprognostic (1.66e-3)" "unprognostic (2.42e-1)" "unprognostic (1.12e-2)" "unprognostic (2.14e-1)" "unprognostic (6.31e-2)" "unprognostic (2.06e-1)" "unprognostic (3.10e-2)" "unprognostic (1.36e-2)" "unprognostic (1.02e-1)" "unprognostic (8.25e-2)" "unprognostic (7.09e-2)" "unprognostic (2.48e-1)" "unprognostic (2.33e-6)" "unprognostic (2.87e-2)" "unprognostic (1.75e-1)" "unprognostic (5.52e-2)" "unprognostic (2.77e-2)" 0.1 0.2 0.0 0.0 0.0 0.0 5.1 0.0 0.0 1.3 0.1 0.4 0.5 0.0 0.5 29.2 1.0 8.6 0.0 0.0 0.0 0.3 0.6 4.7 0.0 0.0 0.0 0.0 14.9 0.0 0.2 1.6 0.0 2.5 0.0 0.0 20.9 2.9 0.0 65.5 2.5 0.0 0.0 0.1 2.3 0.2 0.0 0.0 0.0 0.0 0.1 40.5 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 32.2 0.0 0.0 0.0 0.6 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 50.2 0.0 5.8 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.7 0.0 0.0 0.3 0.0 0.1 1.0 0.0 0.3 0.0 2.7 0.0 0.0 13.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 16.0 3.9 0.0 0.3 184.7 5.6 24.9 520.2 0.0 3.2 192.9 0.6 183.0 39.1 5.5 0.0 28.7 0.7 3.4 0.0 31.1 0.0 15.6 0.1 1.7 0.0 0.0 0.0 9.7 201.8 1.6 12.2 0.6 1.3 0.0 0.0 0.1 7.1 0.0 0.0 1.3 16.2 0.0 14.7 0.0 0.0 1.3 10.6 0.0 0.0 0.0 0.0 0.0 0.0 28.3 3.5 0.0 6.2 1.3 18.3 0.0 163.8 0.0 0.0 0.0 7.0 0.0 0.0 132.5 47.2 36.8 0.6 0.1 1.7 31.5 TNNI2 "AMCD2B, DA2B, FSSV" ENSG00000130598 "Troponin I2, fast skeletal type" P48788 11 1838981-1841680 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 25 "skeletal muscle: 7969.8;tongue: 2622.3" "Group enriched" "Detected in many" 6 "Extravillous trophoblasts: 449.4;Skeletal myocytes: 598.7" "Group enriched" "Detected in many" 10 "cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 86.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "CAPAN-2: 35.7;hTCEpi: 101.2" "Region enriched" "Detected in single" 6 "olfactory bulb: 5.1" "Not detected" "Not detected" "CAB018697, HPA055938" Enhanced Approved "Plasma membrane,Intermediate filaments" NA NA 110000 "Cluster 52: Eosinophils - Transcription" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 37: Myocytes - Muscle contraction" "Plasma membrane" "Intermediate filaments" "CAB018697: AB_628400, HPA055938: AB_2682976" "unprognostic (2.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-2)" "unprognostic (3.70e-1)" "unprognostic (1.85e-1)" "unprognostic (1.02e-2)" "unprognostic (9.99e-3)" "unprognostic (1.01e-1)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "unprognostic (1.23e-3)" "unprognostic (5.92e-3)" "unprognostic (5.62e-2)" "unprognostic (1.77e-1)" "unprognostic (2.79e-2)" 3.0 1.8 0.3 1.1 0.3 6.1 7.9 0.3 0.6 1.0 0.4 1.2 0.3 0.8 0.3 66.9 0.9 5.6 1.7 0.3 0.4 0.7 1.6 7.8 1.6 0.4 0.4 0.7 8.8 0.0 0.9 3.0 0.4 14.0 0.2 0.0 216.1 3.2 7969.8 55.2 2.7 0.2 0.4 5.8 1.1 0.7 0.5 1.9 2.8 2622.3 1.0 27.4 3.2 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 35.7 1.0 0.2 0.0 0.0 1.7 0.0 1.3 0.0 0.0 0.0 0.1 0.0 2.1 0.2 0.0 0.1 8.1 101.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 3.1 0.0 0.1 1.2 2.4 0.0 1.0 0.0 1.0 0.0 0.7 0.0 0.0 12.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 13.8 5.8 53.3 0.1 12.5 0.1 3.8 0.0 0.0 8.0 4.8 0.0 0.0 39.7 0.4 17.6 86.4 0.0 2.5 0.3 0.3 0.3 0.6 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.6 1.2 3.2 4.4 0.0 9.1 25.1 2.6 1.8 15.4 0.0 0.5 23.7 5.6 21.5 3.0 0.0 0.0 33.8 15.7 0.1 0.0 1.4 0.0 1.4 0.2 2.0 0.0 0.0 0.0 0.6 449.4 2.4 1.1 0.1 10.8 0.4 0.4 0.3 39.6 0.0 0.0 0.0 2.0 18.8 10.7 0.0 0.3 25.9 0.0 0.0 16.0 0.0 1.0 0.0 0.0 1.4 0.0 0.0 4.2 0.1 0.0 0.2 13.2 0.0 0.0 598.7 2.4 0.0 0.6 2.7 6.5 87.2 1.9 4.3 0.0 0.9 LSP1 WP34 ENSG00000130592 "Lymphocyte specific protein 1" P33241 11 1850904-1892267 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 224.7;lymphoid tissue: 245.0" "Cell type enhanced" "Detected in many" "Hofbauer cells: 492.2;Langerhans cells: 553.6;monocytes: 1505.6;NK-cells: 352.2;Plasma cells: 338.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 278.5;HDLM-2: 978.9;Karpas-707: 215.4;RPMI-8226: 500.2;U-937: 173.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017781, HPA019693" Enhanced NA NA 1600000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 3: Monocytes - Immune response regulation" "CAB017781: , HPA019693: AB_1853387" "unprognostic (7.53e-3)" "prognostic favorable (3.56e-4)" "unprognostic (4.35e-2)" "prognostic favorable (2.54e-4)" "prognostic unfavorable (5.35e-4)" "unprognostic (1.43e-3)" "unprognostic (3.82e-2)" "unprognostic (3.22e-1)" "unprognostic (1.13e-1)" "unprognostic (1.14e-1)" "unprognostic (6.10e-2)" "unprognostic (1.72e-1)" "unprognostic (1.03e-3)" "unprognostic (3.29e-1)" "unprognostic (6.33e-2)" "unprognostic (1.40e-1)" "unprognostic (6.20e-2)" 75.6 224.7 2.1 148.8 2.6 167.3 51.2 2.4 6.4 63.8 5.3 39.2 33.6 36.8 3.8 42.5 41.7 32.6 48.2 3.8 3.4 6.4 12.1 49.8 154.8 6.0 2.6 5.3 10.7 3.8 7.4 21.8 4.5 13.4 22.3 1.0 52.8 8.1 28.4 98.0 76.6 12.5 4.3 245.0 52.1 8.1 6.0 65.5 24.7 29.4 85.0 83.7 51.4 11.6 0.3 1.2 0.0 0.0 41.0 125.2 0.4 0.0 0.0 0.0 0.0 0.1 0.2 278.5 1.5 0.2 0.3 0.4 0.0 0.0 0.0 978.9 0.0 0.5 0.2 0.4 7.9 1.0 0.9 32.0 0.5 0.1 1.3 0.4 0.1 2.2 0.9 215.4 24.7 0.1 19.6 28.2 0.5 0.0 0.0 1.1 13.6 500.2 0.0 0.0 0.4 3.3 0.2 0.0 0.3 0.0 0.3 0.9 0.5 0.7 4.6 0.3 0.8 1.0 0.7 38.4 0.4 173.0 0.3 365.1 803.6 785.5 384.3 863.3 222.6 452.1 249.1 346.8 896.6 298.8 161.3 260.8 1574.3 279.6 888.2 669.7 491.4 1293.0 2.1 2.6 2.4 6.4 3.8 3.4 6.0 2.6 4.5 4.3 6.0 11.6 18.3 16.0 7.9 0.0 312.8 118.3 14.0 43.0 76.8 0.8 3.9 4.3 2.7 8.6 37.6 3.7 0.0 3.6 295.4 0.4 1.9 1.3 3.4 1.2 13.3 11.4 1.2 40.6 0.2 8.9 4.4 160.4 15.3 1.4 12.6 0.9 11.0 2.3 492.2 1.7 0.2 0.8 16.2 118.4 553.6 7.8 89.8 310.9 65.8 0.0 1505.6 0.2 352.2 0.5 0.1 1.4 1.4 30.1 338.4 1.1 1.2 12.9 36.6 1.0 0.0 182.1 15.9 0.4 1.3 16.7 114.7 6.4 310.1 92.7 3.2 67.3 PRR33 "C11orf89, LOC728008" ENSG00000283787 "Proline rich 33" 11 1888078-1891895 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 23.4;lymphoid tissue: 28.3;skeletal muscle: 35.2" "Cell type enriched" "Detected in single" 14 "Cardiomyocytes: 2.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.4" "Group enriched" "Detected in some" 5 "Daudi: 3.0;HDLM-2: 8.6;Karpas-707: 6.1;U-937: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 59: Non-specific - Translation" "Cluster 2: Karpas-707 - Immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" 4.8 23.4 0.0 6.1 0.0 9.7 3.0 0.0 0.2 6.1 0.1 3.0 1.3 2.8 0.0 3.1 3.1 1.5 7.2 0.0 0.1 0.5 1.1 2.7 6.3 0.2 0.1 0.5 0.6 0.0 0.6 1.4 0.2 1.3 0.0 0.0 3.3 0.0 35.2 11.0 6.1 0.0 0.2 28.3 2.9 1.2 0.2 0.0 1.7 4.0 0.0 6.9 4.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.1 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.2 0.2 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 TNNT3 "AMCD2B, DA2B, DKFZp779M2348, FSSV" ENSG00000130595 "Troponin T3, fast skeletal type" P45378 11 1919703-1938706 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Muscle protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 43 "skeletal muscle: 13906.8;tongue: 4507.7" "Cell type enriched" "Detected in many" 4 "Skeletal myocytes: 542.6" "Group enriched" "Detected in many" 9 "head and neck cancer: 28.8;urothelial cancer: 19.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 17 "basophil: 5.3" "Lineage enriched" "Detected in single" 17 "granulocytes: 5.3" "Cell line enriched" "Detected in some" 21 "HSkMC: 24.0" "Region enhanced" "Detected in some" "olfactory bulb: 5.1" "Low region specificity" "Detected in single" "CAB002451, HPA037810, HPA056909" Enhanced NA NA 470000 "Cluster 34: Basophils - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 37: Myocytes - Muscle contraction" "CAB002451: AB_564151, HPA037810: AB_10966217, HPA056909: AB_2683273" "unprognostic (1.01e-2)" "prognostic favorable (7.37e-4)" "unprognostic (2.17e-2)" "unprognostic (2.30e-3)" "unprognostic (1.23e-2)" "unprognostic (1.29e-2)" "unprognostic (4.53e-3)" "unprognostic (1.20e-1)" "unprognostic (5.88e-2)" "unprognostic (4.29e-3)" "unprognostic (3.53e-2)" "unprognostic (4.34e-1)" "unprognostic (1.42e-5)" "unprognostic (2.99e-2)" "unprognostic (1.61e-1)" "unprognostic (1.79e-2)" "unprognostic (2.90e-2)" 31.2 2.4 0.2 1.4 0.4 1.5 20.0 0.1 0.4 16.3 0.1 5.8 0.2 6.6 2.8 62.5 14.4 1.9 185.3 0.2 0.1 0.8 1.4 3.7 1.4 0.1 0.1 1.7 2.2 0.3 2.5 41.3 0.1 20.7 0.5 0.0 216.0 3.1 13906.8 8.8 3.0 1.3 0.1 2.8 3.3 5.2 0.1 5.4 7.6 4507.7 2.0 20.3 12.0 0.2 0.0 0.0 0.0 0.0 0.5 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.4 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 33.1 0.0 1.9 0.0 0.8 2.9 3.9 5.9 2.2 0.0 0.4 0.3 17.8 0.0 10.1 0.0 0.0 24.5 1.5 0.0 0.0 0.1 0.3 2.4 0.3 33.9 0.0 0.0 0.1 0.0 6.7 42.0 0.0 0.1 0.0 3.0 0.0 0.0 2.7 0.0 0.0 0.0 6.1 0.0 2.3 2.5 110.9 2.2 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 94.8 0.3 0.2 0.0 0.0 42.5 0.0 0.0 542.6 11.2 0.1 0.6 2.9 3.4 18.3 2.0 0.7 0.0 17.1 MRPL23 "L23MRP, RPL23L" ENSG00000214026 "Mitochondrial ribosomal protein L23" Q16540 11 1947278-1984522 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 342.1" HPA050406 Approved Supported "Nucleoli fibrillar center,Mitochondria" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Mitochondria "Nucleoli fibrillar center" "HPA050406: AB_2681116" "unprognostic (5.74e-2)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "prognostic favorable (3.97e-4)" "unprognostic (3.45e-2)" "unprognostic (2.08e-1)" "unprognostic (2.40e-1)" "unprognostic (2.56e-1)" "unprognostic (2.34e-2)" "unprognostic (8.32e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-1)" "unprognostic (8.43e-2)" "unprognostic (1.82e-1)" "unprognostic (6.33e-2)" "unprognostic (7.23e-3)" "unprognostic (4.08e-2)" 67.5 123.1 18.3 16.4 19.2 42.4 66.3 19.4 26.0 64.2 20.3 74.8 27.1 54.0 14.3 125.9 57.8 10.9 128.4 18.8 20.1 96.6 140.1 67.4 26.7 19.7 18.7 90.8 118.0 23.5 92.3 8.5 19.6 71.8 19.1 7.0 90.4 14.6 159.5 124.0 67.1 13.1 19.3 81.7 94.3 27.1 19.0 17.7 71.5 39.6 23.9 59.7 70.9 20.5 69.3 74.9 39.7 49.2 15.9 44.0 67.4 20.9 28.0 31.8 23.4 4.8 79.2 72.9 43.6 44.4 44.5 70.6 64.5 88.8 15.0 75.4 342.1 28.1 24.5 98.2 41.7 65.2 40.8 34.9 34.0 22.0 6.4 37.3 23.0 38.3 24.9 34.6 46.5 71.4 57.9 55.8 64.1 58.5 71.9 77.7 27.2 92.0 28.4 25.0 86.5 81.6 25.0 56.2 45.6 22.0 1.4 78.1 30.8 43.6 32.4 11.0 44.0 58.4 47.7 68.7 68.2 56.0 0.1 2.7 18.5 16.8 8.0 14.5 6.4 36.4 11.8 9.4 23.9 34.6 25.7 8.1 1.0 8.3 10.4 10.6 20.0 5.2 18.3 19.2 19.4 26.0 18.8 20.1 19.7 18.7 19.6 19.3 19.0 20.5 33.9 12.8 6.3 17.0 79.1 186.3 69.9 154.6 19.4 7.0 105.4 111.6 69.7 95.8 88.7 38.6 0.0 125.3 43.6 298.1 123.3 126.6 10.2 57.9 29.1 37.5 136.2 117.8 9.4 232.6 224.4 43.3 54.6 40.2 96.6 54.7 57.8 178.9 178.5 5.0 9.9 258.7 99.7 163.9 214.3 18.5 23.0 78.4 200.9 3.7 133.6 30.6 63.8 7.5 12.2 171.1 273.6 36.5 76.8 61.9 175.4 245.0 98.7 11.7 39.5 33.5 69.2 24.4 39.8 47.5 258.7 90.6 50.2 67.0 256.1 82.8 IGF2 "C11orf43, FLJ44734, IGF-II" ENSG00000167244 "Insulin like growth factor 2" P01344 11 2129112-2141238 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Carbohydrate metabolism, Glucose metabolism, Osteogenesis" "Growth factor, Hormone, Mitogen" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "placenta: 2749.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1104.3;Extravillous trophoblasts: 3196.3;Leydig cells: 3007.5;Peritubular cells: 643.9;Syncytiotrophoblasts: 1612.9" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebral cortex: 86.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 862.0;Hep G2: 600.5;LHCN-M2: 333.7;RH-30: 408.5;SH-SY5Y: 495.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007556, HPA007993" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 609000000 1200000000 "Cluster 28: Placenta - Pregnancy" "Cluster 39: CACO-2 - Unknown function" "Cluster 33: Fibroblasts - ECM organization" Vesicles "Nucleoplasm, Cytosol" "HPA007556: AB_2667860, HPA007993: AB_1851474" "unprognostic (1.54e-1)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" "unprognostic (7.08e-2)" "unprognostic (2.30e-3)" "unprognostic (2.59e-1)" "prognostic favorable (7.12e-4)" "unprognostic (7.92e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (3.69e-2)" "unprognostic (1.85e-1)" "unprognostic (1.79e-3)" "unprognostic (2.00e-2)" "unprognostic (8.98e-2)" "unprognostic (8.93e-3)" "unprognostic (5.78e-2)" 99.7 58.4 5.5 9.2 32.6 0.9 41.8 12.6 86.0 75.5 236.8 22.3 4.7 75.2 52.7 18.8 128.4 34.8 91.7 6.5 7.1 31.8 305.9 9.8 3.4 20.2 6.6 117.8 37.5 5.2 25.4 2749.2 10.1 14.5 4.8 0.5 11.6 15.2 82.1 8.4 10.9 14.7 13.0 14.4 11.9 23.7 10.9 3.4 12.4 114.0 4.7 24.2 23.6 9.0 0.0 2.8 0.3 0.6 0.2 0.3 1.8 112.8 1.3 3.6 0.4 862.0 0.4 0.1 8.4 0.0 2.1 0.1 0.9 7.0 7.9 0.1 0.5 0.2 0.2 600.5 143.4 0.7 0.0 174.7 0.5 0.7 0.2 0.1 1.4 0.0 0.3 0.0 333.7 2.2 0.1 0.8 1.2 0.2 1.5 0.1 408.5 0.9 0.0 0.9 32.7 495.6 0.7 0.1 0.0 83.0 4.2 0.0 0.4 0.2 20.1 0.2 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 32.6 12.6 86.0 6.5 7.1 20.2 6.6 10.1 13.0 10.9 9.0 40.6 3.2 3.1 0.0 2.6 5.4 0.5 0.5 0.6 0.4 0.0 0.0 6.5 8.6 0.9 3.7 0.0 1104.3 0.0 0.0 0.0 0.0 13.1 0.0 0.0 498.4 0.0 16.0 0.0 0.0 3196.3 334.2 0.0 0.0 0.0 0.0 171.4 494.9 218.2 0.0 0.0 0.0 0.0 11.6 5.5 91.1 3007.5 3.4 3.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 643.9 0.0 1.1 0.0 0.0 0.9 0.5 65.7 33.5 37.5 3.8 6.3 1.5 4.1 1612.9 1.8 0.0 0.0 0.4 AC132217.2 ENSG00000284779 "Novel protein" 11 2129112-2158391 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 24 "liver: 37.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 1.0" "Not detected" "Not detected" "Intracellular and membrane" NA NA "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 37.6 0.0 0.0 0.3 0.3 0.0 0.0 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.1 0.2 0.3 0.3 0.4 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 INS-IGF2 ENSG00000129965 "INS-IGF2 readthrough" F8WCM5 11 2132538-2161209 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 48 "pancreas: 9.1" "Cell type enriched" "Detected in single" 11 "Hepatocytes: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB019430 Enhanced "Secreted to digestive system" NA NA "Cluster 25: Pancreas - Digestion" "Cluster 2: Hepatocytes - Metabolism" "CAB019430: AB_10691857" "unprognostic (1.33e-1)" "unprognostic (2.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 INS "IDDM1, IDDM2" ENSG00000254647 Insulin P01308 11 2159779-2161221 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Carbohydrate metabolism, Glucose metabolism" Hormone "Cancer-related genes, Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 135 "pancreas: 12983.6" "Cell type enriched" "Detected in some" 21 "Pancreatic endocrine cells: 1475.2" "Cancer enriched" "Detected in single" 7165 "pancreatic cancer: 1751.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "EFO-21: 268.3;U-2 OS: 376.2;U-698: 132.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 13 "midbrain: 1.3" "CAB000048, HPA004932, CAB012098, CAB053843" Enhanced "Secreted to blood" NA NA 437000 "Cluster 25: Pancreas - Digestion" "Cluster 9: U-2 OS - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "CAB000048: , CAB012098: AB_300968, CAB053843: AB_620123, HPA004932: AB_1851816" "unprognostic (7.61e-2)" 19.2 4.0 0.1 0.2 0.1 49.8 0.6 0.0 0.0 0.7 0.0 12.8 1.5 1.4 0.0 1.8 0.3 3.7 5.6 0.1 0.1 40.7 1.4 1.7 5.4 0.2 0.4 2.6 12983.6 0.0 0.3 1.4 0.8 0.5 0.0 0.0 3.1 0.0 0.3 96.4 0.7 0.0 0.0 1.4 42.2 0.3 0.0 0.0 1.3 0.0 0.0 5.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 268.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 376.2 0.0 31.8 0.0 15.9 132.4 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 67.2 0.0 0.0 0.0 0.0 1475.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TH DYT5b ENSG00000180176 "Tyrosine hydroxylase" P07101 11 2163929-2171815 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Catecholamine biosynthesis, Neurotransmitter biosynthesis" "Monooxygenase, Oxidoreductase" "Disease variant, Dystonia, FDA approved drug targets, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 69 "adrenal gland: 196.6;brain: 270.9" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 9.0;Extravillous trophoblasts: 12.4;Leydig cells: 3.4;Syncytiotrophoblasts: 2.2" "Cancer enriched" "Detected in some" 5 "urothelial cancer: 4.0" "Group enriched" "Detected in many" 5 "midbrain: 192.4;pons: 270.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 30 "PC-3: 60.8;SK-BR-3: 21.0" "Region enhanced" "Detected in many" "olfactory bulb: 178.8" "Region enriched" "Detected in many" 20 "midbrain: 594.4" "CAB002522, HPA013768, HPA014010, HPA061003, CAB072340" Enhanced Supported Approved Cytosol NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" Cytosol "CAB002522: AB_564047, CAB072340: , HPA013768: , HPA014010: , HPA061003: AB_2630374" "unprognostic (1.31e-1)" "unprognostic (1.30e-1)" "unprognostic (9.08e-2)" "unprognostic (1.75e-4)" "unprognostic (8.82e-3)" "unprognostic (5.88e-2)" "unprognostic (1.93e-1)" "unprognostic (1.74e-3)" "unprognostic (3.83e-2)" "unprognostic (4.39e-4)" "unprognostic (4.97e-1)" "unprognostic (3.61e-2)" "unprognostic (1.92e-1)" "unprognostic (1.60e-1)" "unprognostic (2.43e-1)" "unprognostic (2.70e-2)" "unprognostic (2.18e-2)" 3.3 196.6 1.9 0.1 3.0 0.0 0.0 0.2 1.3 0.6 0.2 0.1 0.0 0.5 0.1 0.7 0.2 0.4 0.1 1.3 46.5 0.4 0.4 0.0 0.0 13.9 192.4 0.7 0.2 0.0 1.7 0.1 270.9 0.3 0.0 0.1 0.1 0.0 0.0 0.8 0.5 0.0 0.8 0.2 0.3 0.5 14.6 0.0 0.0 0.0 0.0 1.4 1.5 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.6 60.8 0.0 0.0 0.0 0.1 0.1 1.1 0.2 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 3.0 0.2 1.3 1.3 46.5 13.9 192.4 270.9 0.8 14.6 1.6 0.3 0.0 0.0 0.0 0.5 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.9 0.0 0.2 1.8 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.4 9.0 0.4 0.0 0.0 0.1 0.0 12.4 0.4 0.0 0.3 0.0 0.0 1.1 0.2 0.5 0.0 0.3 0.1 0.0 0.0 0.3 0.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 2.2 0.1 0.3 0.2 0.2 ASCL2 "ASH2, bHLHa45, HASH2" ENSG00000183734 "Achaete-scute family bHLH transcription factor 2" Q99929 11 2268498-2270588 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 6.9;salivary gland: 8.0;skin 1: 7.3" "Cell type enriched" "Detected in many" 9 "Extravillous trophoblasts: 1042.9" "Group enriched" "Detected in many" 5 "colorectal cancer: 76.1;stomach cancer: 23.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 7.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "BEWO: 25.1;NB-4: 8.1;OE19: 14.2;SCLC-21H: 20.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 31: Skin - Epidermis development" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "unprognostic (2.71e-3)" "prognostic favorable (5.11e-4)" "unprognostic (2.03e-1)" "unprognostic (2.33e-2)" "unprognostic (1.72e-1)" "unprognostic (2.69e-2)" "unprognostic (2.93e-2)" "unprognostic (7.88e-2)" "unprognostic (3.79e-2)" "unprognostic (1.22e-2)" "prognostic favorable (4.73e-4)" "unprognostic (5.85e-2)" "unprognostic (1.45e-6)" "unprognostic (8.86e-3)" "unprognostic (5.48e-2)" "unprognostic (6.12e-4)" "unprognostic (1.07e-3)" 0.3 0.2 1.0 1.2 0.6 0.8 0.7 0.5 0.9 2.4 0.4 3.9 6.9 2.2 0.5 1.6 0.4 0.1 0.1 0.9 0.5 1.7 0.8 0.6 0.7 1.7 2.0 0.1 0.7 0.1 0.1 5.5 1.0 2.3 2.5 0.0 8.0 1.6 0.2 7.3 5.5 0.1 1.1 2.3 2.1 0.8 1.4 0.5 0.5 0.0 0.6 1.5 1.9 2.3 0.0 0.0 0.4 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 2.7 0.0 8.1 0.6 14.2 0.0 0.0 0.0 0.0 0.0 0.6 20.5 0.1 0.0 0.5 0.0 0.0 2.5 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.9 1.2 7.9 2.2 1.7 0.1 0.0 0.5 1.3 0.8 0.0 0.1 1.3 0.9 0.0 1.4 0.0 0.0 0.4 1.0 0.6 0.5 0.9 0.9 0.5 1.7 2.0 1.0 1.1 1.4 2.3 1.2 0.0 0.0 0.0 1.4 13.6 14.1 3.3 23.3 0.0 7.2 3.3 0.9 1.5 0.7 20.2 0.0 18.7 29.2 14.4 7.9 0.2 0.1 1.4 4.7 2.6 78.2 4.4 0.0 0.0 1042.9 1.5 10.2 3.5 0.0 0.0 23.2 0.5 31.1 0.0 0.0 31.4 2.0 22.0 7.0 0.2 1.8 14.3 1.8 3.7 22.6 0.0 110.2 0.0 0.0 0.0 3.6 1.5 1.3 6.5 9.1 0.4 1.0 0.1 0.0 0.1 0.3 0.3 13.7 9.1 4.7 23.3 8.9 0.1 112.1 9.4 C11orf21 ENSG00000110665 "Chromosome 11 open reading frame 21" Q9P2W6 11 2295628-2303049 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "bone marrow: 50.4;heart muscle: 20.0;lymphoid tissue: 14.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 68.1;dendritic cells: 29.4;Macrophages: 20.3;monocytes: 28.4;NK-cells: 47.4;T-cells: 16.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 51.7;HL-60: 19.7;NB-4: 18.4;THP-1: 12.7;U-937: 22.2" HPA037607 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 51: Myeloid cells - Hemostasis" Nucleoplasm Cytosol "HPA037607: AB_10672909" "unprognostic (5.25e-3)" "unprognostic (2.65e-4)" "unprognostic (1.35e-1)" "unprognostic (4.61e-3)" "unprognostic (4.32e-2)" "unprognostic (3.58e-4)" "unprognostic (8.98e-4)" "unprognostic (2.37e-3)" "unprognostic (1.87e-1)" "unprognostic (1.15e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (8.84e-4)" "unprognostic (8.50e-2)" "unprognostic (9.54e-2)" "unprognostic (3.55e-1)" "unprognostic (4.07e-2)" 1.4 0.6 0.3 7.1 0.4 50.4 0.6 0.4 0.4 1.6 0.2 0.9 0.6 0.6 0.3 0.6 0.7 2.1 20.0 0.3 0.3 0.7 1.3 4.7 14.0 1.1 0.5 0.2 0.4 0.1 0.3 0.6 0.8 0.6 1.3 0.0 1.5 0.4 1.0 1.3 3.5 1.0 0.6 14.9 2.6 0.3 0.4 3.6 0.9 0.2 7.3 1.1 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 51.7 0.1 0.1 0.5 19.7 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.4 22.2 0.0 80.3 14.9 45.8 23.8 31.4 16.1 4.7 7.8 18.8 17.1 5.8 11.6 16.3 12.6 23.9 58.4 1.7 6.1 16.5 0.3 0.4 0.4 0.4 0.3 0.3 1.1 0.5 0.8 0.6 0.4 1.0 0.2 0.0 4.2 0.0 6.9 0.4 0.0 0.0 0.0 0.0 0.1 0.3 68.1 2.8 0.0 0.0 0.0 0.1 29.4 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.0 13.9 0.0 0.0 0.2 1.7 0.5 0.0 15.8 0.0 2.5 0.0 3.7 0.0 0.0 0.0 0.0 12.5 15.5 0.0 0.0 20.3 1.8 0.0 28.4 0.0 47.4 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.2 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.4 0.0 16.0 0.0 0.0 0.0 TSPAN32 "PHEMX, TSSC6" ENSG00000064201 "Tetraspanin 32" Q96QS1 11 2301997-2318204 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 19.9;heart muscle: 11.4;lymphoid tissue: 5.5" "Cell type enhanced" "Detected in some" "dendritic cells: 44.6;Erythroid cells: 20.6;granulocytes: 30.4;Langerhans cells: 19.6;NK-cells: 87.6;T-cells: 21.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 7 "HEL: 15.0;HL-60: 6.6;NB-4: 5.3;THP-1: 5.6;U-937: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA024135 Uncertain Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "HPA024135: AB_1858409" "unprognostic (7.50e-3)" "unprognostic (4.88e-4)" "unprognostic (1.58e-2)" "unprognostic (1.74e-1)" "unprognostic (4.45e-3)" "unprognostic (2.10e-4)" "unprognostic (7.72e-3)" "unprognostic (8.25e-3)" "unprognostic (9.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.02e-1)" "unprognostic (2.28e-7)" "unprognostic (1.07e-1)" "unprognostic (4.20e-1)" "unprognostic (4.35e-1)" "unprognostic (8.13e-2)" 0.5 0.5 0.2 1.6 0.2 19.9 0.3 0.5 0.2 1.1 0.0 0.5 0.3 0.7 0.2 0.4 0.5 1.4 11.4 0.2 0.3 0.2 0.4 2.0 5.5 0.5 0.3 0.5 0.0 0.0 0.0 0.3 0.3 0.2 0.3 0.2 0.9 0.5 0.3 0.6 0.5 0.0 0.1 3.5 0.9 0.2 0.2 0.9 0.2 0.2 2.4 0.7 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 15.0 0.0 0.1 0.6 6.6 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 8.9 0.0 40.5 31.8 4.2 25.8 40.9 16.5 2.4 9.1 22.7 32.2 1.1 7.2 27.1 17.3 58.6 46.0 1.6 13.2 21.7 0.2 0.2 0.5 0.2 0.2 0.3 0.5 0.3 0.3 0.1 0.2 0.5 0.5 0.0 6.7 0.0 4.5 0.9 0.0 0.0 0.0 0.0 0.2 0.1 15.9 0.0 0.6 0.0 0.0 0.1 44.6 0.0 0.0 0.0 0.8 0.1 0.3 0.8 0.0 20.6 0.0 0.0 0.3 1.3 0.5 0.0 30.4 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 6.5 19.6 4.1 0.9 13.6 1.8 1.0 14.4 0.2 87.6 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.2 1.5 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.6 0.0 21.9 0.0 0.0 0.1 CD81 "TAPA-1, TAPA1, TSPAN28" ENSG00000110651 "CD81 molecule" P60033 11 2376177-2397397 "CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 1003.1;Endometrial stromal cells: 1050.9;Muller glia cells: 809.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 148.9;naive B-cell: 137.2" "Lineage enriched" "Detected in all" 4 "B-cells: 148.9" "Cell line enhanced" "Detected in many" "ASC diff: 2960.6;fHDF/TERT166: 1752.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002507, HPA007234" Supported Supported "Plasma membrane,Cytosol" NA NA 400000 "Cluster 43: B-cells - Humoral immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" Cytosol "CAB002507: AB_563639, HPA007234: AB_1846333" "unprognostic (2.96e-1)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.56e-4)" "unprognostic (1.84e-2)" "prognostic unfavorable (8.21e-5)" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "prognostic favorable (3.86e-4)" "unprognostic (3.07e-3)" "unprognostic (2.08e-1)" "unprognostic (3.55e-2)" "unprognostic (1.67e-1)" "unprognostic (2.06e-1)" "unprognostic (2.06e-1)" 892.1 299.1 560.6 270.7 598.4 77.8 773.6 614.8 590.2 952.7 498.9 992.0 150.7 1384.0 960.5 364.3 853.1 534.5 937.9 511.1 615.8 636.6 1175.7 768.4 429.0 665.7 640.8 656.8 449.5 258.3 409.1 441.0 651.1 634.0 234.4 75.9 531.1 1602.0 214.3 511.1 423.1 978.5 694.1 631.3 494.3 316.9 655.1 158.9 564.6 227.6 278.6 749.2 763.4 734.4 337.0 342.0 268.5 413.4 2960.6 1668.4 224.8 621.0 1361.6 490.3 492.2 322.8 1.8 285.4 218.3 1752.6 312.5 430.5 167.3 442.2 199.9 135.6 517.8 43.7 117.1 0.3 976.4 188.2 359.8 1222.3 619.9 201.1 302.1 757.9 476.6 204.0 198.7 484.9 696.4 257.2 160.7 239.1 324.4 304.7 274.2 324.7 135.5 183.3 529.1 223.3 288.8 319.2 198.4 514.4 383.8 214.3 171.0 337.8 641.3 249.0 181.6 471.2 216.6 356.9 88.1 529.1 361.3 111.0 435.0 0.9 3.3 22.9 21.1 5.8 34.4 148.9 14.9 33.0 2.6 137.2 9.2 16.9 1.0 14.7 7.3 7.7 12.0 10.7 560.6 598.4 614.8 590.2 511.1 615.8 665.7 640.8 651.1 694.1 655.1 734.4 1003.1 243.6 270.0 95.0 88.2 179.8 391.8 89.7 26.2 82.7 325.6 452.0 277.4 167.3 102.3 207.8 27.1 21.8 267.1 20.0 35.2 105.7 15.9 365.4 1050.9 344.5 71.9 30.7 19.0 55.1 31.7 560.4 21.4 462.7 81.7 204.0 293.4 603.9 251.5 148.0 32.4 48.2 50.8 232.7 179.7 50.2 389.2 277.6 151.2 60.0 23.0 809.2 45.3 145.8 93.6 61.3 14.7 251.3 50.7 147.6 5.0 29.9 85.8 76.1 118.3 356.9 423.6 15.6 19.4 30.6 164.9 20.1 136.8 379.0 41.5 298.1 TSSC4 ENSG00000184281 "Tumor suppressing subtransferable candidate 4" Q9Y5U2 11 2400488-2403878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 178.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041801, HPA058763" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA041801: AB_10793934, HPA058763: AB_2683811" "unprognostic (1.98e-1)" "unprognostic (9.22e-2)" "unprognostic (8.66e-2)" "unprognostic (1.57e-1)" "unprognostic (3.42e-3)" "unprognostic (8.13e-2)" "prognostic unfavorable (9.91e-4)" "unprognostic (1.06e-1)" "unprognostic (1.97e-1)" "unprognostic (1.13e-1)" "unprognostic (3.29e-2)" "unprognostic (2.80e-1)" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (6.50e-2)" "unprognostic (1.32e-2)" "unprognostic (7.38e-2)" 34.9 26.0 25.2 16.5 27.1 42.5 30.9 26.5 32.5 33.5 22.4 44.4 17.6 43.1 6.4 33.5 36.7 16.0 38.7 24.8 25.1 35.0 46.8 31.8 21.2 26.8 26.5 31.1 28.4 9.6 31.3 11.9 25.6 39.6 6.0 5.9 25.1 19.3 62.3 39.3 29.2 13.1 25.7 39.1 31.5 72.7 27.6 17.1 29.7 16.6 10.5 39.6 29.4 28.0 48.1 62.4 18.9 29.8 15.4 11.1 35.8 31.9 21.8 38.0 26.1 46.8 60.2 34.9 27.6 24.8 42.6 46.6 21.5 37.5 7.1 40.7 66.7 20.3 34.7 47.3 43.0 35.9 40.5 27.3 51.9 24.2 22.7 16.2 27.2 33.7 47.0 37.5 18.0 64.7 41.9 61.9 54.4 35.7 74.3 46.6 17.2 30.6 19.0 42.0 48.7 49.2 28.3 59.8 38.5 9.7 31.4 40.8 36.1 49.4 26.0 47.3 37.2 73.8 70.3 29.1 42.9 35.4 53.1 105.4 64.9 69.6 64.2 58.7 68.9 64.1 63.6 66.6 67.3 87.2 56.6 53.3 64.0 70.5 65.5 65.0 74.9 57.6 25.2 27.1 26.5 32.5 24.8 25.1 26.8 26.5 25.6 25.7 27.6 28.0 56.4 19.2 17.8 8.1 33.8 67.3 56.3 59.0 18.2 35.3 36.0 36.2 20.5 31.5 34.0 12.9 12.5 50.9 44.3 72.7 50.9 55.0 88.1 31.6 31.9 42.4 57.3 52.8 4.0 50.5 45.9 32.4 29.6 31.6 17.2 33.4 37.5 32.0 39.0 28.6 4.1 44.9 63.1 29.8 34.9 178.8 44.4 32.3 32.0 6.5 53.4 43.7 57.7 5.5 6.8 62.3 53.9 33.8 27.9 71.9 58.2 46.7 20.9 40.6 39.5 43.3 45.6 129.3 73.1 27.9 82.3 82.1 38.2 38.9 46.9 55.8 TRPM5 "LTRPC5, MTR1" ENSG00000070985 "Transient receptor potential cation channel subfamily M member 5" Q9NZQ8 11 2404515-2423045 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 1.8;intestine: 3.3;pancreas: 2.4;seminal vesicle: 1.7" "Cell type enriched" "Detected in some" 4 "Gastric mucus-secreting cells: 9.7" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 16: Pancreatic endocrine cells - Mixed function" "unprognostic (1.82e-1)" "unprognostic (1.98e-1)" "unprognostic (6.47e-5)" "unprognostic (6.81e-4)" "unprognostic (7.90e-3)" "unprognostic (1.18e-1)" "unprognostic (1.13e-2)" "unprognostic (2.24e-2)" "unprognostic (4.75e-1)" "unprognostic (1.53e-1)" "unprognostic (2.36e-1)" "unprognostic (3.19e-1)" "unprognostic (5.07e-3)" "unprognostic (2.40e-1)" "unprognostic (5.21e-1)" "unprognostic (5.72e-2)" "unprognostic (4.91e-2)" 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 2.0 2.9 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.0 1.7 0.0 0.0 3.3 0.0 0.0 0.1 0.3 0.6 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.1 KCNQ1 "JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1" ENSG00000053918 "Potassium voltage-gated channel subfamily Q member 1" P51787 11 2444684-2849105 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Atrial fibrillation, Deafness, Diabetes mellitus, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 197.1;stomach 1: 98.9" "Cell type enhanced" "Detected in many" "Granulosa cells: 47.6;Microglial cells: 71.2;Undifferentiated cells: 57.8" "Cancer enhanced" "Detected in all" "colorectal cancer: 42.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 33.4;OE19: 41.4;RPMI-8226: 23.2;U-266/70: 11.5;U-937: 13.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB018656, HPA048553, HPA071107" Enhanced Supported "Endoplasmic reticulum,Plasma membrane" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" "Endoplasmic reticulum" "Plasma membrane" "CAB018656: AB_2131551, HPA048553: AB_2680438, HPA071107: " "unprognostic (6.02e-2)" "unprognostic (2.48e-1)" "unprognostic (6.39e-3)" "unprognostic (4.38e-1)" "unprognostic (1.86e-1)" "unprognostic (1.83e-1)" "unprognostic (3.46e-2)" "unprognostic (7.36e-2)" "unprognostic (8.07e-2)" "unprognostic (8.81e-2)" "unprognostic (1.58e-1)" "unprognostic (5.39e-2)" "unprognostic (2.46e-3)" "prognostic favorable (9.85e-4)" "unprognostic (3.99e-2)" "unprognostic (4.19e-2)" "unprognostic (5.27e-2)" 5.4 197.1 2.1 9.0 2.4 14.2 3.0 2.4 2.6 16.5 5.7 22.6 47.8 2.9 14.1 2.9 8.9 19.5 28.4 2.6 2.6 25.3 1.8 15.9 5.0 4.1 3.1 1.4 61.2 21.4 5.5 7.6 3.9 6.1 15.2 0.7 20.0 50.2 1.0 1.2 39.7 3.1 4.0 8.2 98.9 1.6 4.2 3.6 71.6 1.6 2.9 14.7 1.6 4.4 0.0 0.1 0.0 5.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 2.6 1.9 5.2 0.0 0.4 0.1 0.7 0.0 0.0 0.4 1.3 0.0 3.7 0.4 0.3 0.0 33.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.7 0.0 0.7 1.3 41.4 0.2 0.1 0.0 23.2 8.0 2.7 0.7 5.6 0.7 0.0 0.0 0.5 0.2 10.3 0.0 0.0 0.3 0.2 0.0 11.5 0.0 0.0 0.0 13.4 0.0 0.7 3.1 3.1 0.0 1.8 0.0 0.8 0.4 0.1 3.8 0.3 1.0 1.2 3.3 0.0 2.8 1.3 0.3 1.0 2.1 2.4 2.4 2.6 2.6 2.6 4.1 3.1 3.9 4.0 4.2 4.4 7.1 3.2 12.9 0.3 8.4 0.6 8.0 4.2 0.0 1.7 6.1 1.8 18.6 14.3 7.1 29.5 0.0 1.1 0.3 34.0 15.6 23.2 2.0 3.3 0.4 6.3 6.6 0.4 13.7 21.7 1.4 1.0 23.4 4.9 19.7 47.6 9.3 1.1 17.3 0.0 20.0 26.1 8.2 25.4 15.9 0.9 0.3 19.6 1.8 71.2 11.0 0.5 1.0 43.7 34.9 15.3 20.2 0.0 6.4 5.2 30.9 2.0 4.4 0.5 6.6 0.4 1.7 0.2 0.2 0.1 1.0 2.1 4.0 16.6 57.8 20.4 CDKN1C "BWCR, BWS, KIP2, P57" ENSG00000129757 "Cyclin dependent kinase inhibitor 1C" P49918 11 2883213-2885775 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 206.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 575.3;Extravillous trophoblasts: 1531.7;Syncytiotrophoblasts: 2241.2;Theca cells: 781.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "intermediate monocyte: 155.1;non-classical monocyte: 376.4" "Lineage enriched" "Detected in many" 14 "monocytes: 376.4" "Cell line enhanced" "Detected in many" "EFO-21: 12.0;HeLa: 12.8;RPMI-8226: 18.7;SH-SY5Y: 33.0;SiHa: 25.2;SK-MEL-30: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002924 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Nucleoplasm, Nuclear bodies" Cytosol "HPA002924: AB_1079548" "unprognostic (5.49e-3)" "unprognostic (2.62e-1)" "unprognostic (9.82e-3)" "unprognostic (5.79e-3)" "unprognostic (4.15e-1)" "unprognostic (2.84e-2)" "unprognostic (1.95e-2)" "unprognostic (1.85e-1)" "unprognostic (3.13e-1)" "unprognostic (3.15e-1)" "unprognostic (2.95e-1)" "unprognostic (3.39e-2)" "unprognostic (2.15e-1)" "unprognostic (3.31e-2)" "unprognostic (8.53e-2)" "unprognostic (1.93e-1)" "unprognostic (2.94e-1)" 127.4 182.9 8.2 3.3 38.0 1.7 92.5 43.3 18.7 73.7 6.5 48.1 1.4 70.6 0.2 29.9 70.7 0.8 82.6 11.7 18.8 149.5 8.3 34.5 0.2 55.1 33.5 206.4 28.5 0.2 27.8 28.1 45.0 33.1 0.2 0.5 21.7 1.5 60.3 26.6 25.0 0.4 31.8 20.6 54.1 8.6 34.3 0.2 17.0 0.9 0.4 75.0 49.4 95.3 0.1 0.1 1.6 0.0 0.4 0.5 1.8 0.3 0.6 0.3 0.0 3.3 0.4 0.0 12.0 0.2 0.1 0.5 0.3 0.3 0.1 5.6 1.2 0.1 12.8 0.0 3.3 0.0 1.4 2.4 1.6 0.0 0.2 0.1 0.3 0.1 2.7 0.8 0.5 0.1 0.0 6.0 10.6 0.5 4.0 2.2 0.0 18.7 0.7 0.0 3.5 33.0 25.2 0.3 15.2 0.9 0.2 2.8 0.4 0.0 2.2 0.0 0.1 7.3 0.0 0.1 0.0 1.8 6.8 9.1 1.2 0.9 0.4 155.1 1.8 0.0 0.4 0.6 26.9 0.3 1.0 0.3 2.2 0.0 376.4 0.2 0.7 14.7 8.2 38.0 43.3 18.7 11.7 18.8 55.1 33.5 45.0 31.8 34.3 95.3 357.3 3.2 5.8 1.0 11.6 10.7 81.7 4.9 30.7 11.9 81.0 150.5 45.3 61.5 10.8 31.3 6.2 575.3 46.9 20.3 15.6 9.8 176.5 38.8 101.5 100.8 106.5 0.8 0.6 0.6 1531.7 141.0 17.9 56.2 0.0 31.2 74.6 4.0 91.0 8.4 1.2 25.0 12.2 23.5 23.2 276.4 74.3 54.9 35.6 4.7 14.1 68.3 0.0 3.5 65.7 4.3 4.2 44.4 12.9 64.6 4.0 78.5 7.5 27.4 32.9 238.3 71.4 2.1 3.5 17.3 11.8 2241.2 25.1 781.8 15.2 71.8 SLC22A18AS "BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS" ENSG00000254827 "Solute carrier family 22 member 18 antisense" Q8N1D0 11 2887344-2903575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 17.7;kidney: 11.1;liver: 14.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 163.3;Paneth cells: 124.4;Proximal enterocytes: 75.7;Proximal tubular cells: 104.0;Syncytiotrophoblasts: 80.7;Undifferentiated cells: 48.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "classical monocyte: 7.0" "Group enriched" "Detected in many" 8 "dendritic cells: 3.9;granulocytes: 4.0;monocytes: 7.0" "Cell line enhanced" "Detected in some" "A549: 9.4;CAPAN-2: 9.4;MCF7: 18.8;OE19: 8.4;SK-MEL-30: 35.8;WM-115: 14.8" HPA068288 Enhanced Approved Nucleoplasm No NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA068288: AB_2685969" "unprognostic (1.43e-1)" "unprognostic (9.21e-2)" "unprognostic (3.36e-1)" "unprognostic (8.05e-2)" "unprognostic (1.33e-3)" "unprognostic (3.16e-2)" "unprognostic (5.14e-3)" "unprognostic (9.76e-2)" "unprognostic (1.45e-1)" "unprognostic (2.73e-1)" "unprognostic (1.10e-2)" "unprognostic (1.48e-2)" "unprognostic (9.52e-2)" "unprognostic (1.77e-1)" "unprognostic (2.39e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" 3.2 0.6 0.5 2.2 0.6 0.2 0.7 0.5 1.7 0.7 0.5 17.7 13.4 0.8 0.4 1.2 0.4 1.7 0.3 0.6 1.0 11.1 14.9 0.6 0.4 0.9 0.9 0.4 0.3 0.0 0.3 2.3 1.1 0.8 10.2 0.3 1.8 0.1 0.1 1.1 9.7 0.7 0.8 0.7 1.6 0.5 0.8 0.1 0.3 0.0 0.1 0.7 0.9 1.1 1.2 9.4 0.3 0.5 0.0 0.0 0.9 0.5 0.4 0.0 0.2 2.2 9.4 0.0 0.8 0.0 0.6 0.5 0.0 0.3 0.0 0.4 0.1 0.0 0.8 5.8 0.7 0.0 0.1 0.1 0.3 0.0 0.6 0.4 0.3 0.5 0.0 0.9 0.0 18.8 0.0 0.4 0.2 8.4 0.3 0.3 0.0 1.0 0.8 0.0 0.1 0.3 0.9 0.4 35.8 0.2 0.0 0.9 1.9 0.0 0.7 0.3 0.2 0.0 0.0 0.2 0.2 2.6 14.8 4.0 7.0 1.2 0.2 3.9 0.1 0.0 0.1 0.2 3.9 0.0 0.0 0.1 1.6 0.4 2.9 0.0 0.6 2.4 0.5 0.6 0.5 1.7 0.6 1.0 0.9 0.9 1.1 0.8 0.8 1.1 0.6 0.0 0.5 0.0 1.3 0.5 1.1 6.3 1.2 0.0 1.2 0.9 0.4 1.5 2.7 7.3 0.0 19.5 0.4 163.3 9.8 1.7 0.1 0.1 0.3 0.7 9.1 3.2 0.4 0.8 9.8 1.4 2.6 0.5 1.3 0.0 2.9 22.7 17.7 0.0 0.1 26.2 6.1 6.3 5.5 0.2 0.3 6.4 3.6 0.0 4.6 0.0 0.0 0.0 0.1 2.4 124.4 0.0 0.0 1.0 75.7 104.0 1.0 0.0 0.0 0.0 0.6 0.1 0.4 2.1 1.1 80.7 0.9 0.8 48.5 2.5 SLC22A18 "BWR1A, BWSCR1A, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5" ENSG00000110628 "Solute carrier family 22 member 18" Q96BI1 11 2899721-2925246 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 42.3;liver: 45.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 368.4;Late spermatids: 499.1;Paneth cells: 385.7;Proximal enterocytes: 730.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 33.4;Karpas-707: 29.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA067812, HPA071461" Enhanced NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 45: Enterocytes - Digestion" "HPA067812: AB_2685902, HPA071461: AB_2686401" "unprognostic (1.10e-1)" "unprognostic (1.14e-1)" "unprognostic (4.80e-1)" "unprognostic (7.75e-2)" "unprognostic (7.92e-3)" "unprognostic (2.67e-1)" "unprognostic (8.25e-2)" "unprognostic (4.21e-1)" "unprognostic (2.56e-2)" "unprognostic (3.48e-2)" "unprognostic (9.35e-2)" "unprognostic (8.60e-2)" "unprognostic (8.36e-2)" "unprognostic (9.51e-2)" "unprognostic (5.97e-3)" "unprognostic (1.55e-1)" "unprognostic (2.82e-1)" 6.9 3.0 0.1 2.1 0.1 1.5 6.7 0.0 1.2 6.5 0.8 27.8 42.3 6.8 0.2 13.3 8.2 4.0 16.7 0.1 1.0 16.7 45.2 6.8 2.3 0.6 0.5 4.8 6.4 1.7 3.2 5.4 0.4 8.0 4.2 0.0 10.3 2.8 1.7 16.1 28.0 0.9 0.2 9.1 11.3 2.1 1.0 0.7 12.0 0.0 1.1 6.5 9.7 0.8 2.3 14.1 0.0 7.2 1.3 2.0 5.8 4.4 7.4 2.5 4.2 8.0 33.4 1.0 14.1 5.8 5.6 7.3 0.4 0.7 0.5 6.8 1.3 0.3 3.3 7.4 13.5 0.1 6.2 5.7 1.3 2.1 0.4 2.2 0.0 4.5 0.3 29.1 1.4 6.8 0.2 0.8 0.7 10.6 3.3 2.6 0.0 4.7 1.1 4.2 0.3 2.5 1.8 17.6 15.7 0.1 3.6 3.8 0.5 1.9 4.2 6.1 0.3 5.5 1.4 0.3 7.7 3.9 7.5 32.1 28.7 27.4 6.8 28.2 3.7 4.2 5.1 4.8 17.9 3.0 2.7 4.0 42.3 6.3 22.9 13.2 9.4 13.5 0.1 0.1 0.0 1.2 0.1 1.0 0.6 0.5 0.4 0.2 1.0 0.8 1.6 6.4 9.6 1.6 5.6 7.4 22.5 48.8 14.2 1.2 16.8 11.0 11.2 54.3 29.0 27.6 0.0 102.6 9.0 368.4 7.9 31.4 161.7 9.3 5.3 2.7 19.8 1.3 3.0 8.7 20.9 9.4 47.9 14.1 15.9 7.6 6.4 158.6 46.3 0.0 0.6 93.2 52.9 33.0 16.7 499.1 10.5 23.5 19.6 4.7 18.8 6.9 10.3 0.5 1.6 22.5 385.7 7.5 3.1 10.2 730.9 122.1 26.6 1.1 0.0 2.7 11.2 5.8 4.1 19.2 8.8 181.3 13.7 7.3 121.3 20.3 PHLDA2 "BWR1C, HLDA2, IPL, TSSC3" ENSG00000181649 "Pleckstrin homology like domain family A member 2" Q53GA4 11 2928273-2929420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.6;placenta: 79.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 4600.4;Extravillous trophoblasts: 2222.5;Syncytiotrophoblasts: 9959.7;Urothelial cells: 2892.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 17 "dendritic cells: 1.9;monocytes: 1.2;T-cells: 1.8" "Cell line enhanced" "Detected in many" "HDLM-2: 395.9;PC-3: 326.0;SK-MEL-30: 289.9;WM-115: 358.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA003994 Uncertain Nucleoli NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 17: WM-115 - Nervous system development" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoli "HPA003994: AB_1855311" "unprognostic (1.90e-1)" "unprognostic (3.13e-2)" "unprognostic (9.93e-3)" "unprognostic (6.16e-2)" "unprognostic (4.28e-2)" "unprognostic (8.01e-3)" "prognostic unfavorable (4.22e-5)" "unprognostic (1.24e-3)" "unprognostic (3.84e-2)" "unprognostic (8.35e-2)" "unprognostic (1.67e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (2.63e-6)" "unprognostic (2.83e-1)" "unprognostic (6.13e-2)" "unprognostic (2.16e-2)" "unprognostic (1.59e-1)" 9.3 2.8 1.6 3.6 1.7 1.2 5.3 2.2 2.6 12.6 1.5 14.7 7.3 4.7 0.7 42.6 4.7 3.0 2.9 1.6 2.7 21.8 5.9 7.8 0.3 5.1 3.4 2.4 4.1 0.4 2.8 79.7 4.7 15.4 1.7 0.0 10.2 0.9 0.9 21.4 6.4 0.8 1.9 2.7 17.8 0.8 2.4 0.1 5.6 0.4 1.3 12.7 18.7 2.4 42.2 31.1 1.9 0.5 0.4 9.8 43.4 72.4 21.4 12.9 11.8 15.4 91.8 0.0 41.9 12.1 32.2 51.8 0.1 42.8 2.4 395.9 14.1 0.0 13.9 10.4 32.7 0.1 23.5 13.9 20.2 11.1 12.1 8.8 10.9 0.0 9.2 0.7 6.5 148.9 0.1 6.1 16.5 26.8 326.0 0.0 0.0 29.6 32.2 13.7 4.1 0.3 31.6 25.0 289.9 2.0 7.4 3.3 51.9 31.2 13.6 45.7 32.1 0.6 0.8 0.3 28.2 5.4 358.2 0.0 1.2 0.0 0.3 1.1 0.4 0.0 1.8 0.3 1.9 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.8 0.5 1.6 1.7 2.2 2.6 1.6 2.7 5.1 3.4 4.7 1.9 2.4 2.4 27.1 19.2 28.9 1.0 13.0 394.7 1494.1 518.9 116.1 0.0 274.4 221.4 6.0 64.3 328.3 44.1 0.0 4600.4 9.2 506.0 9.8 164.7 2.4 84.9 28.6 37.8 197.3 2.7 2.1 143.7 2222.5 92.0 278.8 175.6 82.6 0.4 15.7 6.2 405.9 0.0 1.0 384.5 258.4 12.9 303.6 0.8 3.7 79.6 103.2 1.9 10.5 0.1 0.0 0.0 0.4 502.3 871.7 3.0 13.2 1318.1 201.9 1.7 133.0 0.4 52.6 10.5 293.5 0.4 3.8 545.6 685.5 9959.7 50.5 0.2 292.8 2892.3 NAP1L4 NAP2 ENSG00000205531 "Nucleosome assembly protein 1 like 4" Q99733 11 2944431-2992377 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011567 Approved Supported Nucleoplasm NA NA 3100000 "Cluster 46: Basophils - DNA binding" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "CAB011567: AB_776638" "unprognostic (1.61e-1)" "prognostic favorable (9.77e-4)" "unprognostic (8.99e-2)" "unprognostic (9.64e-3)" "unprognostic (2.96e-3)" "unprognostic (2.24e-2)" "prognostic unfavorable (1.68e-7)" "unprognostic (1.80e-1)" "unprognostic (6.44e-2)" "unprognostic (1.77e-1)" "unprognostic (6.73e-2)" "unprognostic (2.31e-1)" "unprognostic (6.10e-3)" "unprognostic (1.19e-1)" "unprognostic (1.29e-1)" "prognostic favorable (1.55e-4)" "unprognostic (1.54e-1)" 39.6 43.5 44.3 36.1 59.2 50.3 41.3 53.0 178.1 46.7 70.3 60.3 20.1 45.4 17.3 79.6 41.2 32.5 111.4 41.3 52.1 63.7 56.2 40.5 65.7 57.2 53.8 42.9 38.0 63.5 61.4 36.8 60.2 51.9 34.2 38.6 66.4 32.1 146.1 49.0 53.8 39.1 52.2 59.0 56.6 87.4 56.4 78.8 44.6 110.7 75.8 61.9 52.1 72.2 82.8 59.9 81.7 65.7 83.9 92.4 37.7 159.8 104.1 145.4 132.5 129.7 208.4 149.5 95.3 98.0 15.1 140.0 21.9 136.3 166.8 159.2 57.5 106.7 151.4 168.2 57.7 93.0 110.5 77.8 65.1 78.6 59.1 12.0 88.9 77.6 139.3 150.7 128.0 74.5 206.4 4.2 199.8 98.9 75.2 101.4 98.1 117.0 12.2 131.7 121.4 104.3 80.5 118.1 78.3 82.5 7.3 7.4 67.8 112.5 104.4 152.4 13.8 79.3 136.5 201.5 8.4 66.0 75.3 67.5 22.9 32.6 42.3 24.0 39.9 24.7 51.9 53.0 27.2 28.4 45.7 52.1 14.5 57.6 30.4 25.0 70.5 48.0 44.3 59.2 53.0 178.1 41.3 52.1 57.2 53.8 60.2 52.2 56.4 72.2 53.6 44.8 49.8 56.2 64.3 70.1 67.4 76.9 83.1 80.4 54.6 48.3 200.4 42.9 69.0 75.4 45.9 103.8 99.4 37.2 97.8 78.7 97.0 107.7 65.9 55.4 45.4 168.7 36.9 50.4 109.2 56.6 54.0 91.1 74.6 100.6 43.5 50.0 47.3 65.6 56.6 41.4 67.1 30.8 44.7 142.6 48.1 49.7 35.6 38.4 65.3 67.5 95.8 60.8 125.3 74.1 26.8 50.0 100.7 76.1 39.8 76.9 92.6 68.1 46.0 58.8 64.7 166.1 129.0 102.3 66.9 91.3 123.8 79.7 55.1 83.7 CARS1 CARS ENSG00000110619 "Cysteinyl-tRNA synthetase 1" P49589 11 3000922-3057613 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Cancer-related genes, Disease variant, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 10.3;Cardiomyocytes: 8.8;Cytotrophoblasts: 22.2;Extravillous trophoblasts: 40.7;Hofbauer cells: 22.0;Syncytiotrophoblasts: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002383, HPA002384, CAB075734, CAB075735, CAB075736, CAB075737" Enhanced Enhanced Cytosol NA NA 200000 "Cluster 14: Monocytes - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" Cytosol "CAB075734: AB_2665740, CAB075735: AB_2665741, CAB075736: AB_2665742, CAB075737: AB_2665743, HPA002383: AB_1078399, HPA002384: AB_1846033" "unprognostic (9.10e-3)" "unprognostic (1.83e-1)" "unprognostic (4.16e-3)" "unprognostic (1.43e-1)" "unprognostic (1.00e-2)" "unprognostic (7.97e-2)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.41e-2)" "unprognostic (1.05e-1)" "unprognostic (8.00e-2)" "unprognostic (5.51e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.37e-2)" "unprognostic (1.71e-1)" "unprognostic (1.48e-1)" "unprognostic (3.46e-1)" 22.1 17.4 8.1 12.0 8.5 7.3 19.9 8.7 21.6 13.6 8.4 21.8 12.0 15.9 7.5 19.2 12.8 10.3 13.3 8.2 9.8 13.7 21.1 17.5 12.7 9.6 9.9 8.9 32.8 9.6 18.6 10.3 10.6 12.7 12.8 5.3 20.6 6.8 31.7 23.8 17.4 16.0 9.7 17.2 23.5 16.8 9.9 14.6 17.3 14.7 17.8 18.1 14.9 11.5 29.2 14.0 17.8 55.6 67.3 61.4 16.2 70.0 78.6 46.7 84.1 34.2 64.7 43.1 20.1 88.2 0.0 68.7 58.3 78.6 64.0 123.7 13.5 24.4 23.7 25.8 161.1 50.9 50.2 102.2 64.1 40.1 46.8 0.0 62.3 103.6 42.2 147.0 47.1 41.9 35.7 0.0 65.2 97.9 25.0 17.2 29.7 54.9 0.0 46.1 39.0 49.7 17.1 48.1 80.1 13.3 0.0 0.1 21.8 19.5 18.2 48.2 0.2 107.8 106.8 27.2 0.1 26.6 40.3 16.3 18.6 13.5 20.9 15.4 17.4 10.9 18.3 18.6 19.4 8.5 9.9 16.0 25.4 23.7 37.9 7.5 27.0 19.2 8.1 8.5 8.7 21.6 8.2 9.8 9.6 9.9 10.6 9.7 9.9 11.5 10.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 22.2 8.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 40.7 3.7 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 32.3 1.4 0.0 0.0 0.0 OSBPL5 "KIAA1534, OBPH1, ORP5" ENSG00000021762 "Oxysterol binding protein like 5" Q9H0X9 11 3087107-3166739 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 34.6;Horizontal cells: 62.2;NK-cells: 56.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 3.6;gdT-cell: 9.0;intermediate monocyte: 4.7;memory CD8 T-cell: 3.3;myeloid DC: 3.0;naive CD8 T-cell: 3.4;NK-cell: 11.0;non-classical monocyte: 11.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 75.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038335, HPA038712, HPA058727" Approved Enhanced Vesicles NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "HPA038335: AB_2675963, HPA038712: AB_10675949, HPA058727: AB_2683799" "unprognostic (6.02e-2)" "unprognostic (1.16e-1)" "unprognostic (1.68e-1)" "unprognostic (3.69e-2)" "unprognostic (8.22e-3)" "unprognostic (1.71e-1)" "unprognostic (1.25e-1)" "unprognostic (4.03e-3)" "unprognostic (1.29e-1)" "unprognostic (3.49e-3)" "unprognostic (2.16e-3)" "unprognostic (9.44e-2)" "unprognostic (2.78e-2)" "unprognostic (1.22e-1)" "unprognostic (6.50e-2)" "unprognostic (7.67e-2)" "unprognostic (2.60e-1)" 22.0 8.0 7.1 7.2 7.7 13.6 19.2 7.8 11.5 42.2 2.1 28.2 5.9 26.6 2.9 12.5 22.3 5.0 14.9 5.2 6.4 13.5 3.1 17.5 2.4 50.3 13.3 14.5 10.4 2.3 10.3 5.0 56.0 25.6 3.2 1.8 16.4 9.9 9.9 25.9 16.6 7.6 5.4 24.9 15.5 3.3 19.8 22.0 14.9 5.9 1.4 24.6 28.3 10.5 3.7 5.6 6.6 7.6 18.9 8.8 0.1 17.9 8.8 7.1 5.0 0.0 10.4 0.0 5.3 10.1 4.9 13.3 1.3 5.0 1.1 3.5 6.0 15.1 19.2 0.0 15.9 13.6 2.3 13.9 5.7 2.5 2.6 5.2 4.8 26.7 5.5 0.0 3.5 10.3 30.7 75.5 4.8 2.4 11.5 15.9 9.0 2.2 3.0 3.3 10.8 1.3 7.6 26.1 7.0 3.7 10.8 35.9 16.4 8.8 12.1 21.2 3.1 3.8 0.0 0.5 9.5 25.3 11.5 0.2 3.6 1.2 9.0 4.7 1.2 0.0 0.9 3.3 3.0 0.0 0.6 3.4 0.4 11.0 11.5 1.3 0.1 5.2 7.1 7.7 7.8 11.5 5.2 6.4 50.3 13.3 56.0 5.4 19.8 10.5 19.5 0.0 5.5 8.1 0.5 4.8 2.6 4.2 5.2 11.5 7.7 5.2 6.9 2.8 4.8 3.7 8.4 0.4 34.6 8.3 1.9 3.0 0.1 2.2 22.1 12.1 0.0 5.7 25.6 2.0 0.6 12.3 5.1 2.5 1.3 3.5 3.9 0.5 1.7 62.2 20.6 8.0 2.0 8.7 3.1 1.2 9.0 3.9 3.6 17.8 2.3 4.1 56.7 20.1 28.2 2.2 8.5 17.0 4.9 3.2 6.1 3.2 5.5 1.2 13.1 7.4 11.4 0.1 0.6 3.8 6.8 0.0 9.1 2.5 8.2 2.5 MRGPRG "GPR169, mrgG" ENSG00000182170 "MAS related GPR family member G" Q86SM5 11 3217944-3218813 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058909 Uncertain NA NA "HPA058909: AB_2683852" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRGPRE "GPR167, mrgE" ENSG00000184350 "MAS related GPR family member E" Q86SM8 11 3225030-3232417 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 37 "brain: 27.9" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 5 "thyroid cancer: 0.9" "Group enriched" "Detected in many" 4 "medulla oblongata: 27.9;pons: 26.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NB-4: 1.0;RPMI-8226: 2.7;SCLC-21H: 3.9" "Low region specificity" "Detected in all" HPA046556 Uncertain NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA046556: AB_10961404" "unprognostic (1.18e-1)" "unprognostic (7.52e-4)" "unprognostic (1.04e-1)" "unprognostic (9.09e-2)" "unprognostic (6.65e-2)" "unprognostic (1.77e-2)" "unprognostic (1.27e-1)" "unprognostic (1.83e-1)" "unprognostic (2.22e-2)" "unprognostic (1.19e-1)" 0.0 0.3 0.4 0.0 0.2 0.6 0.1 4.0 0.7 0.7 0.1 0.2 0.0 0.5 0.3 0.1 0.6 0.1 0.4 0.3 6.5 0.0 0.0 0.0 0.0 27.9 2.6 0.0 0.1 0.0 0.1 0.1 26.2 0.2 0.0 0.6 0.2 0.3 0.0 0.1 0.1 0.2 3.2 0.4 0.0 0.0 1.2 0.0 0.2 0.1 0.0 0.1 0.4 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 3.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 4.0 0.7 0.3 6.5 27.9 2.6 26.2 3.2 1.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF195 ENSG00000005801 "Zinc finger protein 195" O14628 11 3339261-3379222 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA030605 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA030605: AB_10602686" "unprognostic (2.30e-2)" "unprognostic (5.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.67e-1)" "unprognostic (5.40e-2)" "unprognostic (4.02e-2)" "prognostic unfavorable (3.53e-5)" "unprognostic (3.10e-2)" "unprognostic (1.39e-2)" "unprognostic (5.94e-2)" "unprognostic (3.14e-1)" "prognostic unfavorable (4.24e-4)" "prognostic unfavorable (7.89e-5)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.54e-2)" "prognostic favorable (4.79e-7)" 9.3 10.1 12.1 6.6 12.0 10.8 13.7 13.1 16.0 12.3 11.8 11.1 9.4 8.5 15.6 9.1 8.5 7.1 7.7 12.1 13.7 13.0 13.1 8.7 11.3 13.9 12.5 6.8 13.1 6.2 10.2 6.4 13.7 13.7 12.1 14.1 10.3 6.2 11.8 8.3 12.4 7.5 11.9 16.5 10.3 4.9 12.8 17.1 10.2 9.5 11.0 10.3 9.2 13.4 15.8 18.6 32.0 38.2 9.9 11.8 37.7 16.7 14.1 16.4 22.6 19.4 24.3 26.7 11.1 10.8 24.2 21.1 34.5 20.0 24.6 14.2 28.4 18.3 15.6 19.1 12.5 32.3 28.7 14.7 17.9 13.4 21.7 12.1 21.7 35.0 32.8 17.3 17.9 12.7 37.6 25.1 66.4 18.4 19.1 35.8 20.4 14.2 27.4 38.3 47.8 49.5 18.5 21.2 15.9 27.8 10.7 29.0 17.2 9.1 14.2 11.6 14.0 14.9 25.5 43.8 7.7 23.6 13.8 2.4 11.6 14.7 15.4 13.0 20.0 18.8 19.0 19.5 17.3 17.8 17.9 20.3 1.8 18.7 11.6 14.5 28.4 11.3 12.1 12.0 13.1 16.0 12.1 13.7 13.9 12.5 13.7 11.9 12.8 13.4 13.8 16.0 21.9 15.0 16.6 12.1 16.9 18.6 14.2 15.3 9.7 12.8 18.3 11.5 20.8 7.3 10.4 9.7 17.3 9.0 9.8 25.1 3.3 10.3 18.7 12.7 20.4 12.0 19.8 18.9 10.5 12.0 23.4 13.3 6.3 33.9 8.2 7.5 10.9 18.5 24.3 14.0 14.2 12.3 8.4 0.8 5.9 8.8 7.2 6.5 9.8 17.9 15.5 20.1 27.9 25.3 13.5 5.7 16.9 13.6 10.0 12.5 15.6 13.7 0.0 12.6 12.3 12.3 9.6 12.4 6.8 4.0 15.9 15.2 15.8 17.5 ART5 ARTC5 ENSG00000167311 "ADP-ribosyltransferase 5" Q96L15 11 3638512-3642316 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 13.4;testis: 29.4" "Group enriched" "Detected in some" 8 "Early spermatids: 18.3;Late spermatids: 18.5;Spermatocytes: 64.9" "Cancer enriched" "Detected in some" 4 "testis cancer: 4.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SuSa: 13.9" "Not detected" "Not detected" "HPA041637, HPA044099" Uncertain "Secreted in other tissues" NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 12: NES - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA041637: AB_2677589, HPA044099: AB_2678808" "unprognostic (6.32e-2)" "unprognostic (3.26e-5)" "unprognostic (4.09e-3)" "unprognostic (2.06e-4)" "unprognostic (1.53e-2)" "unprognostic (1.47e-2)" "unprognostic (2.22e-2)" "unprognostic (1.21e-2)" "unprognostic (5.65e-2)" "unprognostic (2.59e-2)" "unprognostic (1.17e-1)" "unprognostic (1.67e-1)" "prognostic favorable (1.85e-4)" "unprognostic (3.10e-3)" "unprognostic (3.46e-2)" "unprognostic (1.96e-1)" "unprognostic (3.18e-1)" 0.7 0.2 0.3 0.0 0.3 0.0 1.0 0.3 0.5 4.1 0.6 0.3 0.0 3.6 0.7 0.5 1.5 1.4 1.8 0.3 0.8 0.8 0.9 0.9 0.1 0.4 0.4 8.3 0.4 2.9 0.7 0.1 0.6 1.1 0.0 0.6 1.6 0.9 13.4 0.5 0.2 1.1 0.3 0.0 0.5 29.4 0.4 0.3 2.8 10.5 0.0 0.7 2.2 0.3 0.0 0.1 1.6 2.0 0.0 0.0 3.2 0.2 1.6 0.7 1.8 0.0 0.0 0.0 0.8 0.2 0.0 0.0 1.5 0.0 0.4 0.0 2.2 0.0 0.3 0.1 0.0 0.0 1.4 0.5 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.2 0.3 0.0 0.0 1.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.5 0.0 13.9 0.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.3 0.8 0.4 0.4 0.6 0.3 0.4 0.3 0.1 0.0 1.8 0.0 0.0 0.3 2.2 0.0 2.8 0.8 0.3 1.3 2.5 0.0 0.6 0.0 0.0 0.6 0.0 0.1 0.0 0.6 18.3 0.1 0.2 0.4 0.0 0.0 0.0 0.2 0.5 1.3 0.0 0.2 0.0 3.3 0.0 1.8 0.1 0.0 0.0 0.2 0.0 0.3 0.0 18.5 3.4 0.1 0.0 1.0 0.0 3.6 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.8 0.0 0.6 0.0 0.9 0.0 1.3 0.2 64.9 3.9 0.1 0.3 2.9 0.0 1.2 0.0 0.3 ART1 "ART2, ARTC1, CD296" ENSG00000129744 "ADP-ribosyltransferase 1" P52961 11 3645128-3664416 "CD markers, Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 57 "skeletal muscle: 47.4;tongue: 36.8" "Cell type enhanced" "Detected in single" "Microglial cells: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051148 Uncertain NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 64: Astrocytes - Nervous system maintenance" "HPA051148: AB_2681363" "unprognostic (3.73e-1)" "unprognostic (4.58e-2)" "unprognostic (3.12e-2)" "unprognostic (1.35e-1)" "unprognostic (3.01e-1)" "unprognostic (1.19e-1)" "unprognostic (1.06e-1)" "unprognostic (1.73e-1)" 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.1 47.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 36.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.4 0.5 0.3 0.2 0.3 0.3 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRNA10 ENSG00000129749 "Cholinergic receptor nicotinic alpha 10 subunit" Q9GZZ6 11 3665587-3671384 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "skeletal muscle: 47.8" "Cell type enhanced" "Detected in some" "Glandular and luminal cells: 4.4;Ionocytes: 4.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Region enriched" "Detected in some" 6 "olfactory bulb: 7.2" "Not detected" "Not detected" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 44: Endometrium - Transcription" "unprognostic (3.04e-1)" "unprognostic (2.23e-1)" "unprognostic (4.04e-2)" "unprognostic (1.11e-4)" "unprognostic (1.50e-1)" "unprognostic (1.71e-2)" "unprognostic (8.22e-2)" "unprognostic (1.50e-1)" "unprognostic (3.79e-2)" "unprognostic (2.74e-1)" "unprognostic (6.90e-5)" "unprognostic (4.35e-2)" "unprognostic (1.06e-5)" "unprognostic (5.60e-2)" "unprognostic (1.70e-2)" "unprognostic (2.32e-1)" "unprognostic (4.39e-3)" 0.8 0.7 1.1 0.5 0.9 0.3 0.4 1.3 1.4 0.9 1.1 0.8 0.5 0.6 0.3 0.7 0.8 0.1 1.1 1.0 1.0 2.1 1.5 0.8 0.4 1.0 0.9 0.8 0.7 0.1 1.4 0.2 1.0 1.5 0.1 0.7 0.8 0.1 47.8 0.5 0.9 0.1 0.7 1.9 0.8 1.1 0.9 0.4 1.1 0.1 0.2 0.6 0.4 0.8 0.5 0.5 0.7 1.0 0.3 0.1 0.5 0.6 0.1 0.4 0.4 0.4 0.9 0.9 0.3 0.3 0.3 1.1 0.5 0.3 0.3 0.6 1.8 0.2 1.7 0.1 0.4 0.2 0.9 0.3 0.3 0.3 0.1 0.2 0.2 1.1 0.7 0.2 0.3 0.1 0.5 1.5 1.0 0.9 0.7 1.0 0.3 0.1 0.3 0.7 0.6 0.3 0.3 0.3 0.5 0.6 0.2 1.1 0.2 0.6 0.8 0.4 0.7 0.2 0.6 0.5 0.3 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.1 0.9 1.3 1.4 1.0 1.0 1.0 0.9 1.0 0.7 0.9 0.8 1.5 0.0 0.5 1.3 0.5 1.8 0.6 0.5 0.0 1.6 2.2 3.6 1.3 0.0 0.4 0.0 0.0 0.4 0.4 0.9 0.0 0.2 1.4 2.1 0.9 0.9 0.0 0.0 1.3 0.4 0.3 0.4 2.0 4.4 0.0 0.8 1.1 1.2 0.6 1.7 1.3 0.9 4.1 0.6 0.7 0.8 0.3 1.1 1.8 2.8 0.6 1.2 0.0 1.0 0.6 0.4 0.2 0.4 0.4 0.8 0.6 0.0 2.1 0.8 0.0 3.1 0.9 0.4 0.5 0.1 1.1 0.3 0.6 0.7 0.8 0.7 NUP98 "NUP96, Nup98-96, Nup98-Nup96" ENSG00000110713 "Nucleoporin 98 and 96 precursor" P52948 11 3671083-3797792 "Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 118.7;Late spermatids: 158.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (7.41e-2)" "unprognostic (2.13e-1)" "unprognostic (7.71e-3)" "unprognostic (3.40e-1)" "unprognostic (4.08e-3)" "unprognostic (6.47e-2)" "unprognostic (1.04e-2)" "unprognostic (1.83e-2)" "unprognostic (7.76e-3)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (5.09e-1)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" 22.9 14.7 7.2 25.1 8.4 76.0 25.3 15.1 12.4 21.8 13.8 21.1 17.8 22.2 20.7 23.1 20.8 21.6 20.8 7.2 8.8 19.3 31.9 23.4 27.6 9.8 10.5 28.4 24.0 25.7 16.7 25.6 8.3 21.9 23.6 23.2 23.3 22.3 41.9 21.2 17.7 23.4 7.1 21.9 17.6 78.4 9.1 34.4 29.1 31.0 30.6 32.7 18.6 12.7 81.2 63.7 51.7 54.5 54.7 46.1 44.5 57.9 67.7 78.3 69.9 69.4 97.4 80.6 26.0 68.6 77.1 85.5 90.0 56.1 105.6 56.7 67.0 86.4 51.7 48.1 46.1 111.1 67.5 51.9 37.6 41.8 75.2 33.7 61.9 88.3 109.3 60.6 82.5 33.2 110.2 36.3 64.5 87.8 48.4 65.9 62.6 37.8 43.4 63.4 46.8 31.5 83.4 64.9 38.1 52.0 40.5 43.4 45.9 59.9 51.1 67.5 53.0 37.0 67.0 83.5 41.0 46.5 64.4 40.5 11.7 23.3 15.0 15.0 15.1 12.8 14.7 13.5 14.3 10.8 16.1 14.4 35.2 9.7 9.5 3.9 20.1 13.3 7.2 8.4 15.1 12.4 7.2 8.8 9.8 10.5 8.3 7.1 9.1 12.7 24.7 28.9 25.2 32.7 37.4 49.8 36.3 12.6 34.7 14.9 28.2 24.5 19.5 22.8 20.1 7.3 16.7 22.2 41.6 18.8 3.9 12.2 118.7 32.1 30.4 22.5 21.5 42.5 43.6 11.8 17.5 22.7 42.3 62.0 18.3 16.3 15.7 23.6 16.8 15.2 43.7 15.1 6.1 19.8 51.1 158.6 17.1 29.3 16.0 25.3 24.9 11.1 12.3 31.7 44.4 13.2 16.1 14.3 36.3 25.1 11.8 9.0 16.6 14.1 32.9 36.9 23.2 56.2 31.0 30.3 50.4 46.5 44.5 13.7 19.5 32.5 PGAP2 "CWH43-N, FRAG1, MRT17, MRT21" ENSG00000148985 "Post-GPI attachment to proteins 2" Q9UHJ9 11 3797724-3826371 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "GPI-anchor biosynthesis" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "epididymis: 216.2" "Group enriched" "Detected in all" 4 "Cytotrophoblasts: 74.9;Early spermatids: 147.6;Late spermatids: 296.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063099 Approved Approved Microtubules NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" Microtubules "HPA063099: AB_2684940" "unprognostic (1.94e-1)" "unprognostic (1.14e-1)" "unprognostic (2.19e-1)" "unprognostic (3.18e-2)" "unprognostic (5.13e-2)" "unprognostic (6.06e-2)" "prognostic unfavorable (7.49e-4)" "unprognostic (1.74e-1)" "unprognostic (2.51e-2)" "unprognostic (3.07e-1)" "unprognostic (1.11e-1)" "unprognostic (6.44e-2)" "unprognostic (3.85e-2)" "unprognostic (4.66e-3)" "unprognostic (4.13e-2)" "unprognostic (2.17e-2)" "unprognostic (2.67e-2)" 8.9 14.9 16.4 6.4 17.5 9.5 11.5 15.9 18.2 13.7 17.0 13.9 18.4 8.3 216.2 34.9 19.2 7.6 21.7 16.6 16.3 13.9 30.9 16.2 10.4 17.8 16.6 11.2 28.9 17.6 15.1 14.2 17.2 16.7 13.3 9.2 18.4 33.4 11.4 48.0 16.0 7.6 16.3 11.3 14.1 28.5 17.3 13.1 19.4 9.5 13.5 10.9 18.8 20.9 27.1 36.3 17.2 15.8 15.2 28.9 27.3 10.9 9.4 15.6 14.2 31.1 46.6 29.0 12.3 8.0 9.4 44.1 27.6 30.2 15.5 35.5 30.9 17.7 14.7 38.4 10.7 23.0 22.0 22.8 41.9 11.6 39.3 10.2 18.0 38.4 38.4 41.8 16.6 39.9 28.0 19.3 32.4 56.7 21.5 44.0 2.0 27.8 30.0 31.6 22.7 22.5 19.7 52.0 12.3 20.1 43.2 9.6 16.5 9.9 9.2 23.8 6.8 26.2 31.3 21.6 12.9 15.3 19.1 3.0 6.4 5.9 9.1 9.2 11.0 11.4 13.2 11.3 9.7 12.7 17.3 11.8 18.2 10.7 9.2 6.6 13.3 8.8 16.4 17.5 15.9 18.2 16.6 16.3 17.8 16.6 17.2 16.3 17.3 20.9 8.4 12.8 10.6 7.5 10.6 31.7 15.1 23.3 33.6 14.1 19.2 18.0 13.7 11.5 13.0 12.9 22.9 74.9 5.2 11.4 1.9 15.6 147.6 11.7 6.6 9.0 3.0 13.2 15.4 21.3 18.4 7.6 10.2 14.7 8.8 13.4 3.6 14.6 16.0 3.3 19.1 10.5 10.2 5.0 8.0 296.8 8.7 5.5 5.4 4.7 8.9 9.3 8.2 10.6 23.0 14.2 9.3 6.8 12.2 9.1 39.8 10.2 15.2 9.5 6.6 11.0 7.2 17.7 21.6 31.1 28.6 29.3 9.4 11.8 20.1 13.0 RHOG "ARHG, MGC125835, MGC125836" ENSG00000177105 "Ras homolog family member G" P84095 11 3826978-3840959 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 273.1" "Cell type enhanced" "Detected in many" "Kupffer cells: 365.2;Langerhans cells: 356.6;monocytes: 391.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 625.4" "Low region specificity" "Detected in all" HPA039871 Enhanced NA NA 86000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 3: Monocytes - Immune response regulation" "HPA039871: AB_10673428" "unprognostic (2.39e-2)" "unprognostic (1.02e-2)" "prognostic unfavorable (1.81e-4)" "unprognostic (2.26e-2)" "unprognostic (1.35e-1)" "unprognostic (4.21e-2)" "unprognostic (4.27e-3)" "unprognostic (7.28e-2)" "unprognostic (1.71e-2)" "unprognostic (3.28e-1)" "unprognostic (1.96e-1)" "unprognostic (3.53e-1)" "prognostic unfavorable (9.49e-8)" "unprognostic (9.38e-2)" "unprognostic (8.98e-2)" "unprognostic (1.11e-1)" "unprognostic (2.48e-1)" 61.2 39.5 62.6 82.5 90.0 273.1 45.7 84.0 70.5 46.2 56.0 50.1 44.7 46.7 19.5 82.6 44.6 34.4 47.0 60.4 71.2 35.6 39.3 87.5 85.2 91.1 83.6 38.0 30.5 18.3 25.4 43.5 91.7 36.8 28.3 4.3 39.1 28.4 53.0 50.1 64.2 39.2 76.5 168.4 42.2 15.3 81.7 68.0 29.0 27.0 67.3 56.5 48.6 107.2 74.1 99.0 19.8 34.1 74.8 84.1 21.4 48.1 59.6 73.7 77.8 61.0 78.7 74.9 24.9 89.2 74.9 85.3 31.2 68.0 47.6 66.6 75.3 170.3 44.7 57.9 75.3 150.0 625.4 82.0 61.1 46.1 44.4 42.6 85.8 99.5 101.3 80.8 61.0 86.5 126.5 206.8 31.5 53.4 78.8 63.7 21.4 44.4 53.1 50.9 10.6 26.7 34.0 77.7 39.4 22.5 41.0 111.6 67.2 88.8 44.5 95.3 57.2 44.8 66.4 42.5 81.0 135.8 50.6 441.3 351.1 739.9 114.8 468.1 101.8 79.8 125.6 128.7 310.8 78.1 87.4 101.6 981.2 97.9 561.9 77.2 206.6 346.7 62.6 90.0 84.0 70.5 60.4 71.2 91.1 83.6 91.7 76.5 81.7 107.2 38.4 19.2 21.5 2.9 109.0 68.7 62.4 35.3 22.8 0.9 24.0 26.3 6.6 20.0 26.9 20.2 0.0 100.4 105.2 99.1 15.6 67.2 1.6 10.2 20.6 58.5 16.2 71.9 1.9 56.6 82.1 38.2 22.4 19.1 200.0 62.8 43.5 19.5 247.7 3.3 1.9 26.7 14.2 365.2 356.6 3.6 38.5 250.6 53.4 8.4 391.7 18.0 166.9 3.0 45.9 86.6 143.6 36.1 45.1 70.4 135.4 24.8 9.7 3.0 19.7 21.6 34.0 10.2 23.9 45.1 59.5 124.2 124.8 11.2 28.9 95.7 STIM1 "D11S4896E, GOK" ENSG00000167323 "Stromal interaction molecule 1" Q13586 11 3854527-4093210 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011088, HPA012123, CAB037128, CAB037288" Enhanced Enhanced "Endoplasmic reticulum" NA NA 1900000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Endoplasmic reticulum" "CAB037128: AB_1079007, CAB037288: AB_1079008, HPA011088: AB_1849884, HPA012123: AB_1849882" "unprognostic (2.06e-1)" "unprognostic (9.75e-2)" "unprognostic (1.34e-1)" "unprognostic (3.85e-3)" "unprognostic (3.13e-2)" "unprognostic (4.12e-1)" "unprognostic (3.43e-1)" "unprognostic (1.59e-1)" "unprognostic (2.25e-1)" "unprognostic (7.41e-2)" "unprognostic (1.86e-1)" "unprognostic (2.88e-2)" "unprognostic (9.35e-2)" "unprognostic (1.40e-1)" "unprognostic (2.73e-1)" "unprognostic (3.48e-2)" "unprognostic (1.39e-2)" 40.6 18.4 32.9 22.3 31.5 46.4 33.1 18.1 34.5 40.4 30.5 33.7 18.1 39.3 18.2 65.6 39.0 25.1 24.0 30.5 23.1 20.0 38.0 26.8 29.8 17.4 22.9 41.2 30.1 43.7 18.0 17.5 18.9 26.0 24.6 11.4 61.1 24.3 111.9 47.1 31.3 34.3 18.6 31.5 32.2 25.4 26.9 68.6 40.9 49.7 29.7 32.2 40.4 22.4 42.4 48.5 14.1 23.5 60.9 55.4 22.2 31.1 31.0 22.6 28.5 24.3 13.8 44.7 35.4 46.2 50.9 74.3 20.1 21.5 19.3 36.7 30.5 70.1 19.2 36.0 53.0 58.9 40.1 56.8 53.2 32.0 90.7 28.2 31.7 59.6 44.2 80.1 24.7 9.8 55.8 20.7 5.4 23.3 18.1 13.8 22.1 41.7 38.2 23.7 3.4 14.2 51.2 33.5 19.2 22.5 12.7 32.4 34.0 40.2 13.8 42.2 25.1 88.0 71.9 22.5 33.4 24.0 26.0 16.6 11.2 20.0 17.8 14.8 14.5 7.9 13.1 19.5 9.6 11.4 14.8 13.3 16.7 20.8 25.5 8.3 14.7 17.1 32.9 31.5 18.1 34.5 30.5 23.1 17.4 22.9 18.9 18.6 26.9 22.4 20.1 16.0 8.2 53.8 22.2 16.4 7.4 9.5 17.6 5.3 16.5 13.2 4.6 18.6 10.5 5.5 14.6 27.3 35.2 27.9 1.9 12.4 4.9 17.5 35.5 12.6 9.1 18.1 63.5 14.5 13.5 20.2 10.7 24.0 29.8 4.7 20.3 32.6 15.7 16.8 56.3 13.0 12.2 22.2 15.2 9.2 27.4 18.7 17.8 57.1 11.0 16.5 36.0 77.4 5.1 12.3 6.7 11.3 14.8 11.2 7.9 3.6 14.2 3.9 26.3 17.1 18.4 21.4 13.5 50.6 22.3 17.4 28.5 1.6 11.8 11.9 RRM1 ENSG00000167325 "Ribonucleotide reductase catalytic subunit M1" P23921 11 4094707-4138932 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA replication" "Allosteric enzyme, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 102.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022093, HPA057265, HPA064297" Enhanced Supported Cytosol NA Yes 140000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "CAB022093: , HPA057265: AB_2683386, HPA064297: AB_2685236" "unprognostic (4.47e-2)" "unprognostic (1.73e-2)" "unprognostic (1.99e-3)" "unprognostic (3.65e-1)" "unprognostic (2.83e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (1.31e-2)" "unprognostic (3.43e-2)" "unprognostic (6.90e-2)" "unprognostic (1.06e-3)" "unprognostic (4.21e-2)" "unprognostic (6.88e-3)" "unprognostic (9.20e-3)" "unprognostic (6.16e-2)" "unprognostic (8.41e-2)" "unprognostic (9.93e-3)" 16.6 21.2 5.1 24.8 5.3 32.8 22.7 7.1 6.1 16.9 4.7 25.7 19.3 16.2 10.1 26.5 15.5 11.8 16.4 5.1 5.7 13.4 18.4 12.8 34.4 6.1 5.5 16.4 14.6 24.7 7.1 20.4 6.6 18.5 29.4 23.6 14.7 16.0 30.3 36.1 20.2 20.1 6.2 13.0 17.6 17.9 5.1 56.7 15.6 30.0 45.2 15.6 18.9 6.2 221.6 117.8 188.4 110.0 28.4 56.2 73.0 198.0 98.2 220.7 225.9 106.8 163.8 237.4 47.0 100.1 95.9 173.0 176.9 143.2 259.3 117.3 187.9 121.0 159.8 83.1 11.2 208.9 84.6 26.6 37.8 121.7 86.4 48.3 107.8 140.1 161.1 107.3 186.8 99.6 246.7 41.9 118.2 152.2 119.2 196.1 147.0 84.3 59.4 61.8 159.8 88.1 175.1 104.8 30.0 75.8 102.8 71.4 62.3 203.4 106.0 206.9 147.4 70.3 103.5 252.5 114.1 137.6 130.3 8.3 4.0 4.5 11.3 11.2 21.1 9.2 22.3 16.6 7.3 5.2 17.2 15.0 0.0 10.5 15.6 4.4 41.7 10.3 5.1 5.3 7.1 6.1 5.1 5.7 6.1 5.5 6.6 6.2 5.1 6.2 12.4 19.2 14.4 4.9 17.0 33.4 26.8 31.0 17.6 15.6 15.1 14.4 33.5 14.3 24.7 18.4 6.2 62.8 14.9 13.3 7.9 25.6 69.9 11.5 14.5 15.7 18.0 81.2 11.2 22.2 62.5 22.0 20.4 13.9 7.0 27.3 10.8 15.0 28.3 18.5 12.0 25.0 16.2 11.7 10.3 83.9 13.1 13.9 10.6 6.5 10.7 24.0 5.2 12.1 11.9 15.8 10.4 16.6 31.3 10.1 12.5 8.4 15.5 22.7 13.1 19.5 27.1 102.8 63.1 36.5 29.0 39.7 23.2 18.1 34.3 20.6 SSU72P5 ENSG00000284018 "SSU72 pseudogene 5" 11 4233288-4233872 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSU72P2 ENSG00000284306 "SSU72 pseudogene 2" 11 4242056-4242640 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSU72P4 ENSG00000283873 "SSU72 pseudogene 4" 11 4287499-4288083 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSU72P3 ENSG00000284546 "SSU72 pseudogene 3" 11 4329865-4330449 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSU72P7 ENSG00000284438 "SSU72 pseudogene 7" 11 4338660-4339244 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52B4 ENSG00000221996 "Olfactory receptor family 52 subfamily B member 4" Q8NGK2 11 4367263-4368386 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM21 "RNF81, RO52, SSA1" ENSG00000132109 "Tripartite motif containing 21" P19474 11 4384897-4393702 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" "DNA-binding, Ribonucleoprotein, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004566, HPA005673" Enhanced Approved Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "CAB004566: AB_628286, HPA005673: AB_1080090" "prognostic favorable (4.83e-5)" "unprognostic (4.55e-2)" "unprognostic (3.64e-2)" "unprognostic (3.01e-2)" "unprognostic (1.50e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.20e-1)" "unprognostic (5.04e-2)" "unprognostic (1.27e-1)" "unprognostic (2.49e-2)" "unprognostic (3.31e-1)" "unprognostic (1.82e-2)" "unprognostic (6.27e-2)" "unprognostic (4.69e-2)" "prognostic favorable (2.26e-6)" "unprognostic (9.12e-3)" 14.1 13.0 6.1 21.6 6.0 27.7 11.9 5.9 8.0 11.9 7.2 17.1 20.3 12.5 13.0 12.0 14.6 12.9 13.1 5.5 6.8 16.3 17.6 23.5 23.8 8.2 6.3 20.6 11.7 6.8 7.1 14.4 7.0 11.3 18.4 2.4 19.5 12.9 5.5 11.4 19.2 17.9 7.8 32.5 15.5 3.5 7.8 21.8 10.0 8.2 23.2 16.7 10.9 7.2 13.5 15.5 7.7 7.3 15.5 23.1 10.7 16.8 31.7 64.6 71.4 7.2 37.6 20.5 7.5 25.0 66.5 18.4 13.6 25.7 20.1 34.5 14.6 31.6 8.5 6.5 34.3 37.3 29.6 22.7 14.9 13.0 9.2 23.3 40.3 17.3 10.1 21.6 21.9 11.9 19.8 26.5 6.6 14.9 8.0 13.8 10.0 10.9 25.6 12.0 0.1 3.3 13.8 14.9 19.1 12.0 5.3 24.5 36.7 15.6 12.3 8.3 6.1 11.4 9.5 13.0 14.0 29.2 11.5 105.2 132.4 311.9 89.3 139.6 78.6 50.2 76.6 81.1 109.5 57.9 67.6 71.7 354.0 78.0 130.9 36.7 100.1 175.2 6.1 6.0 5.9 8.0 5.5 6.8 8.2 6.3 7.0 7.8 7.8 7.2 8.9 9.6 6.3 0.0 6.4 2.0 6.1 7.5 11.4 0.4 2.7 3.2 2.3 12.8 9.8 5.5 0.0 6.8 11.0 12.8 7.9 11.3 0.1 3.7 4.5 7.8 2.4 8.2 0.2 8.5 9.6 5.7 10.2 5.7 12.6 8.1 9.7 8.7 9.6 1.7 0.1 7.3 0.0 11.9 2.2 1.3 4.4 9.6 1.8 1.9 20.7 2.6 22.6 1.0 0.1 9.7 4.7 7.2 4.0 4.3 10.0 4.9 7.9 0.0 13.1 4.7 5.3 0.3 0.8 4.7 1.7 9.0 10.5 4.5 6.0 3.8 OR52K2 ENSG00000181963 "Olfactory receptor family 52 subfamily K member 2" Q8NGK3 11 4449295-4450361 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 3.3" "Lineage enhanced" "Detected in single" "granulocytes: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.2 0.3 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52K1 ENSG00000196778 "Olfactory receptor family 52 subfamily K member 1" Q8NGK4 11 4482646-4493497 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "bone marrow: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.1;RT4: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 6: Brain - Smell perception" "Cluster 15: RT4 - Unknown function" "Cluster 43: Cardiomyocytes - Nuclear processes" 0.1 0.0 0.4 0.2 0.2 1.0 0.1 0.7 0.6 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.3 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.2 0.1 0.1 0.6 0.1 0.0 0.2 0.3 0.2 0.0 0.1 0.3 0.0 0.3 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.7 0.2 0.3 0.2 0.3 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.4 0.3 0.3 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.2 0.1 0.3 1.1 0.5 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.2 0.6 0.3 0.1 0.0 0.3 0.2 0.0 0.2 0.4 0.2 0.2 0.1 1.3 0.4 0.2 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.5 0.1 0.1 0.5 0.3 0.2 0.2 0.1 0.4 0.3 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.7 0.6 0.2 0.0 0.1 0.0 0.2 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52M1 OR52M1P ENSG00000197790 "Olfactory receptor family 52 subfamily M member 1" Q8NGK5 11 4545191-4546144 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 43: Cardiomyocytes - Nuclear processes" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52I2 ENSG00000226288 "Olfactory receptor family 52 subfamily I member 2" Q8NH67 11 4581743-4593340 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049343 Uncertain NA NA "HPA049343: AB_2680721" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52I1 ENSG00000232268 "Olfactory receptor family 52 subfamily I member 1" Q8NGK6 11 4593614-4596574 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "brain: 2.7" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 9.6;Alveolar cells type 2: 6.5;Club cells: 8.6;granulocytes: 8.8;Respiratory ciliated cells: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 6: Brain - Smell perception" "Cluster 11: Alveolar cells - Smell perception" "unprognostic (2.95e-1)" 0.1 0.1 1.9 0.2 1.8 0.6 0.2 2.7 2.7 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 1.6 1.8 0.1 0.1 0.1 0.2 1.3 1.2 0.1 0.1 0.1 0.0 0.1 1.6 0.2 0.1 0.5 0.1 0.0 0.1 0.6 0.2 0.1 0.3 0.3 0.2 0.3 2.0 0.0 0.1 0.0 0.1 0.0 0.0 2.5 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.1 0.4 0.1 0.1 0.2 0.4 0.3 0.3 0.0 0.1 0.2 0.2 0.3 0.1 0.0 0.0 0.2 0.3 0.0 0.3 0.2 0.3 0.1 0.2 0.3 0.2 0.2 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 1.8 2.7 2.7 1.6 1.8 1.3 1.2 1.6 0.3 2.0 2.5 0.2 9.6 6.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.3 1.8 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.2 8.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 TRIM68 "FLJ10369, RNF137, SS-56" ENSG00000167333 "Tripartite motif containing 68" Q6AZZ1 11 4598672-4608231 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023455 Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nucleoplasm, Cytosol" "HPA023455: AB_1858319" "unprognostic (4.77e-2)" "unprognostic (5.15e-2)" "unprognostic (1.18e-1)" "unprognostic (4.10e-2)" "unprognostic (4.13e-2)" "unprognostic (8.63e-2)" "unprognostic (2.01e-2)" "unprognostic (1.28e-1)" "unprognostic (2.01e-1)" "unprognostic (6.70e-2)" "unprognostic (2.75e-2)" "unprognostic (7.78e-2)" "prognostic favorable (4.14e-6)" "unprognostic (4.23e-2)" "unprognostic (2.98e-1)" "unprognostic (1.61e-1)" "unprognostic (1.37e-1)" 5.1 6.5 6.6 3.7 7.0 2.1 6.4 7.2 7.2 9.6 6.3 7.1 6.6 6.5 7.2 5.0 7.6 5.1 7.2 6.6 7.0 9.7 7.4 6.6 5.2 6.6 6.9 10.1 6.2 8.9 6.3 6.2 6.8 10.7 6.2 5.8 8.3 8.1 5.9 4.8 6.0 6.0 6.8 6.8 8.0 6.5 7.3 6.5 9.6 6.6 5.8 7.0 5.3 7.2 10.2 11.2 4.5 8.2 7.2 11.6 0.0 10.9 8.0 9.9 8.9 1.4 10.3 6.9 6.5 5.6 9.3 11.6 4.5 7.7 8.4 17.2 8.8 8.4 2.9 0.0 8.3 13.7 11.4 9.1 11.1 5.7 8.6 10.2 12.6 6.3 8.0 3.7 8.9 2.4 11.3 3.7 5.4 7.1 9.2 9.0 6.4 0.3 6.3 4.4 2.4 4.3 0.0 11.0 7.1 9.0 4.8 6.8 10.3 13.1 8.8 13.3 5.0 13.7 15.9 9.9 8.9 6.0 12.5 8.6 2.5 8.9 7.9 4.8 8.8 8.5 8.8 8.9 5.6 7.6 11.1 9.0 0.3 5.7 5.5 3.8 8.7 7.4 6.6 7.0 7.2 7.2 6.6 7.0 6.6 6.9 6.8 6.8 7.3 7.2 3.2 0.0 3.6 2.9 2.8 0.8 1.4 2.7 3.4 3.3 2.6 2.4 5.4 2.8 5.9 5.5 2.1 6.1 2.7 5.3 5.9 3.2 0.9 2.6 2.2 3.4 6.7 1.3 1.7 3.3 2.7 2.9 4.6 2.8 3.8 5.9 3.6 6.0 2.2 0.0 1.6 5.2 6.1 2.1 0.6 0.4 1.8 2.0 0.0 1.9 2.7 4.1 5.2 3.5 3.0 3.3 1.9 1.9 1.8 2.0 2.4 2.5 2.4 2.8 6.6 2.0 2.6 2.9 6.6 2.0 1.0 4.4 2.8 3.9 4.7 0.6 OR51D1 OR51D1Q ENSG00000197428 "Olfactory receptor family 51 subfamily D member 1" Q8NGF3 11 4637477-4643060 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA061240 Uncertain NA NA "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA061240: AB_2684457" "unprognostic (1.90e-1)" 0.1 0.0 0.4 0.0 0.5 0.0 0.0 0.4 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.4 0.6 0.4 0.3 0.5 0.4 0.5 0.4 0.4 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51E1 "GPR136, GPR164, OR51E1P, OR52A3P" ENSG00000180785 "Olfactory receptor family 51 subfamily E member 1" Q8TCB6 11 4643420-4655488 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 5.7;placenta: 7.4;prostate: 6.6" "Group enriched" "Detected in some" 7 "Adipocytes: 44.1;Enteroendocrine cells: 21.3;Sertoli cells: 26.3;Smooth muscle cells: 31.8" "Cancer enriched" "Detected in many" 21 "prostate cancer: 34.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 107 "SCLC-21H: 10.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB019995, HPA051439" Approved NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 48: Smooth muscle cells - ECM organization" "CAB019995: AB_10283600, HPA051439: AB_2681487" "unprognostic (6.67e-3)" "unprognostic (2.34e-3)" "unprognostic (9.71e-2)" "unprognostic (4.87e-5)" "unprognostic (3.55e-2)" "unprognostic (9.80e-3)" "unprognostic (1.76e-1)" "unprognostic (2.30e-3)" "unprognostic (2.00e-2)" "unprognostic (3.94e-3)" "unprognostic (7.36e-2)" "unprognostic (6.15e-2)" "prognostic unfavorable (1.23e-6)" "unprognostic (2.72e-3)" "unprognostic (1.12e-1)" "unprognostic (1.61e-1)" "unprognostic (2.86e-1)" 5.7 0.0 0.2 0.7 0.2 0.0 2.4 0.2 0.4 0.5 0.2 1.7 0.4 0.9 0.3 0.1 0.6 0.5 4.6 0.2 0.2 0.7 0.0 0.0 0.1 0.3 0.2 0.5 0.1 0.1 0.5 7.4 0.2 6.6 0.8 0.0 0.2 0.5 2.1 0.2 1.3 1.0 0.2 0.1 0.7 0.2 0.2 0.0 0.5 3.9 0.2 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.4 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 44.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.3 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.3 4.1 21.3 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 1.7 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.5 0.0 0.3 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 3.4 0.1 0.0 0.0 0.0 26.3 0.7 31.8 0.0 0.2 0.1 0.3 0.0 0.1 0.8 0.1 0.2 OR51E2 PSGR ENSG00000167332 "Olfactory receptor family 51 subfamily E member 2" Q9H255 11 4680171-4697854 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 9.6;prostate: 28.9" "Cell type enriched" "Detected in some" 6 "Enteroendocrine cells: 77.4" "Cancer enriched" "Detected in some" 274 "prostate cancer: 217.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.9;BJ hTERT+: 1.1;hTERT-RPE1: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "unprognostic (1.98e-3)" "unprognostic (1.91e-1)" "unprognostic (6.09e-3)" "unprognostic (1.57e-2)" "unprognostic (8.00e-4)" "unprognostic (3.61e-2)" "unprognostic (6.27e-2)" "unprognostic (1.66e-1)" "unprognostic (3.05e-2)" "unprognostic (3.46e-2)" "unprognostic (2.97e-1)" "unprognostic (3.61e-1)" "unprognostic (5.04e-5)" "unprognostic (3.34e-2)" "unprognostic (4.66e-2)" "unprognostic (5.76e-2)" "unprognostic (3.29e-1)" 0.6 0.2 0.3 1.0 0.4 0.1 0.5 0.4 0.5 0.7 0.6 9.6 0.2 1.3 0.3 0.0 0.5 0.3 0.2 0.4 0.2 0.4 0.0 0.0 0.0 0.3 0.3 0.6 0.1 0.0 0.0 4.0 0.4 28.9 2.2 0.1 0.0 2.3 0.4 0.2 0.8 2.1 0.1 0.0 0.4 0.3 0.5 0.0 0.1 0.4 0.0 0.4 0.2 0.7 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.5 0.4 0.2 0.3 0.3 0.4 0.1 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 77.4 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 OR51C1P "OR51C2P, OR51C3P, OST734" ENSG00000197674 "Olfactory receptor family 51 subfamily C member 1 pseudogene" 11 4690423-4697831 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "Enteroendocrine cells: 1.8" "Cancer enriched" "Detected in single" 65 "prostate cancer: 3.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 17: Intestinal endocrine cells - Hormone signaling" "unprognostic (1.82e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MMP26 "endometase, MGC126590, MGC126592" ENSG00000167346 "Matrix metallopeptidase 26" Q9NRE1 11 4704927-4992429 "Enzymes, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 24 "endometrium 1: 13.1" "Group enriched" "Detected in some" 7 "Endometrial ciliated cells: 44.8;Glandular and luminal cells: 171.1" "Cancer enriched" "Detected in some" 4 "endometrial cancer: 8.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 44: Endometrium - Transcription" "unprognostic (4.21e-3)" "unprognostic (2.63e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 44.8 14.6 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 171.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 OR51F1 OR51F1P ENSG00000280021 "Olfactory receptor family 51 subfamily F member 1" A6NGY5 11 4768979-4769938 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52R1 ENSG00000279270 "Olfactory receptor family 52 subfamily R member 1" Q8NGF1 11 4803433-4804380 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51F2 ENSG00000176925 "Olfactory receptor family 51 subfamily F member 2" Q8NH61 11 4821321-4822456 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51S1 ENSG00000176922 "Olfactory receptor family 51 subfamily S member 1" Q8NGJ8 11 4847489-4849238 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51T1 ENSG00000176900 "Olfactory receptor family 51 subfamily T member 1" Q8NGJ9 11 4881819-4882883 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046877 Uncertain NA NA "HPA046877: AB_2679853" "unprognostic (2.59e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51A7 ENSG00000176895 "Olfactory receptor family 51 subfamily A member 7" Q8NH64 11 4903783-4909462 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA061356 Uncertain NA NA "HPA061356: AB_2684488" "unprognostic (4.57e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51G2 ENSG00000176893 "Olfactory receptor family 51 subfamily G member 2" Q8NGK0 11 4912588-4919350 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51G1 OR51G3P ENSG00000278870 "Olfactory receptor family 51 subfamily G member 1" Q8NGK1 11 4923374-4924339 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51A4 ENSG00000205497 "Olfactory receptor family 51 subfamily A member 4" Q8NGJ6 11 4942831-4947605 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51A2 ENSG00000205496 "Olfactory receptor family 51 subfamily A member 2" Q8NGJ7 11 4954772-4955713 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51L1 ENSG00000176798 "Olfactory receptor family 51 subfamily L member 1" Q8NGJ5 11 4994851-5005536 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 44: Endometrium - Transcription" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52J3 ENSG00000205495 "Olfactory receptor family 52 subfamily J member 3" Q8NH60 11 5046526-5047461 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52E2 ENSG00000176787 "Olfactory receptor family 52 subfamily E member 2" Q8NGJ4 11 5058650-5059627 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045748 Uncertain NA NA "HPA045748: AB_10959665" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52A5 ENSG00000171944 "Olfactory receptor family 52 subfamily A member 5" Q9H2C5 11 5128776-5138356 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52A1 HPFH1OR ENSG00000182070 "Olfactory receptor family 52 subfamily A member 1" Q9UKL2 11 5146824-5154757 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Club cells: 9.9;Respiratory ciliated cells: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 11: Alveolar cells - Smell perception" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51V1 OR51A12 ENSG00000176742 "Olfactory receptor family 51 subfamily V member 1" 11 5199735-5200682 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HBB "beta-globin, CD113t-C" ENSG00000244734 "Hemoglobin subunit beta" P68871 11 5225464-5229395 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Hypotensive agent, Vasoactive" "Congenital dyserythropoietic anemia, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "bone marrow: 133301.6" "Cell type enriched" "Detected in many" 24 "Erythroid cells: 672352.3" "Group enriched" "Detected in all" 4 "cervical cancer: 66.4;glioma: 244.6;renal cancer: 65.1" "Region enriched" "Detected in all" 11 "cerebral cortex: 3368.5" "Group enriched" "Detected in all" 5 "neutrophil: 658.1;plasmacytoid DC: 379.7" "Group enriched" "Detected in all" 11 "dendritic cells: 379.7;granulocytes: 658.1" "Cell line enhanced" "Detected in some" "HEL: 6.0;SCLC-21H: 5.0;SH-SY5Y: 6.4;U-266/70: 23.1;U-266/84: 4.2" "CAB009526, HPA043234" Enhanced NA NA 10000000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" "CAB009526: AB_2143058, HPA043234: AB_2678378" "unprognostic (2.41e-1)" "unprognostic (8.55e-2)" "unprognostic (2.40e-1)" "unprognostic (4.40e-2)" "unprognostic (1.14e-1)" "unprognostic (3.22e-1)" "unprognostic (4.88e-2)" "unprognostic (7.46e-2)" "unprognostic (2.91e-2)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (8.11e-3)" "unprognostic (2.40e-2)" "unprognostic (5.81e-2)" "unprognostic (1.42e-1)" "unprognostic (8.87e-3)" "unprognostic (6.41e-2)" 1641.5 481.4 155.7 217.3 219.2 133301.6 637.4 235.7 3368.5 546.2 384.6 278.2 28.8 78.8 45.6 505.7 829.6 792.7 2658.8 108.9 154.4 2333.1 1907.3 4039.6 26.8 209.6 243.5 289.0 158.5 50.5 808.2 6345.0 303.0 312.0 148.9 31.0 548.1 290.6 578.8 135.3 169.8 66.3 316.2 9225.9 269.1 170.6 171.4 196.8 1152.0 12902.5 40.3 320.1 633.5 180.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.2 0.0 0.0 0.0 0.8 0.2 0.4 0.0 0.0 0.4 0.3 0.0 0.0 5.0 6.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 23.1 4.2 0.0 0.0 0.0 0.0 99.5 25.3 73.7 37.8 1.3 4.0 21.5 6.8 1.1 35.2 13.8 13.7 39.9 658.1 47.9 5.0 379.7 1.4 22388.9 155.7 219.2 235.7 3368.5 108.9 154.4 209.6 243.5 303.0 316.2 171.4 180.7 441.7 3.2 8.4 0.0 280.5 157.0 2.3 5.1 0.0 4.0 54.7 72.0 3.4 217.3 4.5 7.3 4.2 2.2 369.9 5.2 50.9 0.0 0.0 6.8 6.6 151.7 3.6 672352.3 0.0 0.0 11.3 276.1 0.0 5.1 0.0 4.6 443.4 420.5 7.3 3.3 0.0 7.2 6.1 1452.1 702.6 0.0 0.0 1091.0 27383.1 0.0 72.7 9.7 38.1 0.0 0.0 0.1 3.5 0.0 1.9 0.0 0.1 272.4 84.9 117.8 0.0 126.0 396.8 0.0 0.0 0.0 252.5 2.2 769.8 0.3 3.0 0.1 HBD ENSG00000223609 "Hemoglobin subunit delta" P02042 11 5232678-5243657 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 57 "bone marrow: 2797.6" "Cell type enriched" "Detected in some" 318 "Erythroid cells: 22112.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "eosinophil: 2.1;neutrophil: 2.3;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 8 "dendritic cells: 1.6;granulocytes: 2.3" "Cell line enhanced" "Detected in some" "HEL: 74.5;HMC-1: 22.3;U-266/70: 127.4;U-266/84: 25.5" "CAB037087, HPA043234" Supported NA NA 6600000000 "Cluster 49: Eosinophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" "CAB037087: AB_260051, HPA043234: AB_2678378" "unprognostic (1.32e-2)" "unprognostic (4.87e-2)" "unprognostic (4.14e-2)" "unprognostic (2.26e-3)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "unprognostic (1.04e-1)" "unprognostic (8.67e-2)" "unprognostic (2.83e-2)" "unprognostic (3.17e-1)" "unprognostic (6.24e-2)" "unprognostic (3.17e-1)" 2.2 0.3 0.5 0.6 0.6 2797.6 0.7 0.8 2.7 0.1 0.7 0.5 0.0 0.1 0.0 0.3 2.8 0.1 2.5 0.5 0.4 3.2 7.5 6.2 0.5 0.6 0.5 0.3 0.2 4.5 2.2 19.5 0.7 0.2 0.3 0.1 2.2 0.3 0.5 0.6 0.2 0.0 0.6 49.1 0.3 0.1 0.5 4.3 1.0 11.5 0.2 0.2 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 74.5 0.0 0.0 0.0 0.3 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.4 25.5 0.0 0.0 0.1 0.0 0.4 0.2 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.2 0.0 1.6 0.0 105.0 0.5 0.6 0.8 2.7 0.5 0.4 0.6 0.5 0.7 0.6 0.5 1.0 0.0 0.0 0.0 0.0 11.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.3 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 22112.3 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.1 13.6 13.4 0.1 0.0 0.0 0.0 0.0 16.9 1.9 0.1 0.0 6.2 69.4 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.1 0.0 5.8 0.0 0.0 0.0 HBG1 HBG-T2 ENSG00000213934 "Hemoglobin subunit gamma 1" P69891 11 5248269-5249857 "Human disease related genes, Predicted intracellular proteins" "Oxygen transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "placenta: 367.3" "Cell type enriched" "Detected in single" 76 "Macrophages: 22.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 48 "K-562: 3611.8" HPA043234 Approved NA NA "Cluster 28: Placenta - Pregnancy" "Cluster 1: K-562 - Erythropoiesis" "Cluster 51: Myeloid cells - Hemostasis" "HPA043234: AB_2678378" "unprognostic (3.17e-2)" 1.5 0.5 0.1 0.0 0.2 0.3 0.5 0.1 0.7 1.0 0.1 0.4 0.2 0.4 0.0 0.4 0.3 0.0 2.1 0.1 0.2 1.3 1.3 3.0 0.0 0.3 0.2 0.4 0.4 0.0 0.6 367.3 0.3 0.4 0.0 0.0 0.2 0.0 0.9 0.3 0.3 0.0 0.1 5.5 0.4 0.2 0.1 0.9 1.0 2.3 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3611.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.1 0.2 0.1 0.7 0.1 0.2 0.3 0.2 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC104389.6 ENSG00000284931 "Novel protein" 11 5248270-5254783 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 24 "placenta: 4358.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HEL: 7590.9" HPA043234 Uncertain NA NA "Cluster 36: HEL - Hemostasis" "HPA043234: AB_2678378" 0.7 2.9 0.4 0.0 0.4 184.3 3.3 0.4 2.0 0.0 0.5 0.1 0.1 0.1 0.4 0.8 1.1 6.7 0.0 0.4 0.5 0.3 2.3 0.7 0.0 0.7 0.4 0.3 2.9 0.6 4358.4 0.9 0.5 0.2 0.0 0.7 0.1 5.1 0.0 0.2 1.8 0.7 0.0 0.0 0.2 0.5 3.9 0.4 5.3 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7590.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1682.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.4 0.4 0.4 2.0 0.4 0.5 0.7 0.4 0.9 0.7 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HBG2 HBG-T1 ENSG00000196565 "Hemoglobin subunit gamma 2" P69892 11 5253188-5505605 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Oxygen transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 132 "placenta: 10310.3" "Group enriched" "Detected in some" 17 "Erythroid cells: 66.1;Macrophages: 74.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 192 "HEL: 8197.4;K-562: 8088.4" "CAB016143, HPA043234" Approved NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 28: Placenta - Pregnancy" "Cluster 1: K-562 - Erythropoiesis" "Cluster 51: Myeloid cells - Hemostasis" "CAB016143: AB_2295004, HPA043234: AB_2678378" "unprognostic (4.48e-3)" "unprognostic (2.42e-1)" "unprognostic (6.24e-2)" "unprognostic (1.41e-1)" "unprognostic (8.94e-2)" "unprognostic (4.22e-1)" "unprognostic (5.29e-1)" "unprognostic (3.95e-2)" "unprognostic (2.99e-1)" "unprognostic (3.52e-2)" "unprognostic (4.27e-1)" "unprognostic (3.75e-2)" "unprognostic (7.70e-5)" "unprognostic (1.64e-1)" "unprognostic (2.65e-1)" "unprognostic (1.02e-1)" "unprognostic (1.20e-1)" 6.8 1.6 1.6 0.5 2.0 78.2 2.5 1.5 4.7 4.2 2.0 2.8 1.4 1.1 0.5 2.0 2.0 5.3 8.2 1.8 1.1 5.9 6.1 16.4 0.3 1.1 1.2 2.2 9.3 0.8 3.1 10310.3 1.1 1.5 0.1 0.4 3.7 0.2 4.2 1.2 0.9 4.4 0.7 27.3 3.3 0.8 1.2 2.4 4.8 0.6 0.4 0.4 3.1 2.0 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 1.4 0.0 0.2 23.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8197.4 0.5 0.4 0.0 1.5 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 8088.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 8.0 8.9 1.9 0.1 0.3 0.2 0.0 0.0 42.3 0.1 0.6 3.0 0.1 0.6 1.9 1.9 0.0 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 6.5 1.6 2.0 1.5 4.7 1.8 1.1 1.1 1.2 1.1 0.7 1.2 2.0 2.2 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 1.5 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 1.8 0.0 0.0 1.0 0.0 66.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 1.4 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.6 0.3 74.6 0.0 0.0 1.5 0.0 1.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.3 0.2 1.5 0.9 0.0 0.0 0.0 0.6 0.3 0.0 0.1 HBE1 HBE ENSG00000213931 "Hemoglobin subunit epsilon 1" P02100 11 5268345-5505652 "Plasma proteins, Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "Hofbauer cells: 174.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "K-562: 10059.8" "Not detected" "Not detected" HPA043234 Approved NA NA 510000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 15: Liver - Metabolism" "Cluster 1: K-562 - Erythropoiesis" "Cluster 4: Macrophages - Innate immune response" "HPA043234: AB_2678378" "unprognostic (7.59e-2)" "unprognostic (6.70e-2)" "unprognostic (3.76e-2)" "unprognostic (4.25e-1)" "unprognostic (1.64e-1)" "unprognostic (9.03e-2)" "unprognostic (2.28e-1)" "unprognostic (1.26e-1)" "unprognostic (7.32e-2)" "unprognostic (1.02e-3)" "unprognostic (2.14e-1)" "unprognostic (5.80e-2)" "unprognostic (7.34e-2)" 0.5 0.3 0.4 0.0 0.7 0.3 0.2 0.0 1.1 0.5 0.0 0.2 0.0 0.3 0.4 0.1 0.4 0.0 0.3 0.5 0.8 0.3 1.3 0.3 0.0 0.7 0.2 0.6 0.2 0.0 0.3 0.8 0.5 0.4 0.0 0.2 0.1 0.1 0.4 0.2 0.2 0.2 0.0 0.4 0.2 0.5 0.4 0.2 0.3 0.0 0.0 0.2 0.3 1.1 1.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 12.5 0.3 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.1 649.4 0.0 5.8 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10059.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.4 0.7 0.7 0.0 0.0 31.9 0.1 0.9 19.4 0.1 0.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.7 0.0 1.1 0.5 0.8 0.7 0.2 0.5 0.0 0.4 1.1 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.2 0.0 0.2 0.0 0.0 0.9 0.0 0.3 4.3 0.0 16.0 0.5 0.0 31.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 174.7 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.3 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.6 0.2 0.0 0.0 14.8 0.1 0.0 0.9 0.1 OR51B4 ENSG00000183251 "Olfactory receptor family 51 subfamily B member 4" Q9Y5P0 11 5301014-5301946 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "K-562: 3.8;U-2197: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 1: K-562 - Erythropoiesis" "unprognostic (6.16e-2)" "unprognostic (5.01e-1)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 4.6 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51B5 ENSG00000167355 "Olfactory receptor family 51 subfamily B member 5" Q9H339 11 5303444-5505652 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Astrocytes: 10.1;Excitatory neurons: 5.7;Microglial cells: 21.5;Oligodendrocyte precursor cells: 6.6" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "K-562: 4.1;U-2197: 1.1" "Low region specificity" "Detected in many" HPA063124 Uncertain NA NA "Cluster 1: K-562 - Erythropoiesis" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA063124: AB_2684943" "unprognostic (9.22e-3)" "unprognostic (1.80e-1)" "unprognostic (2.01e-1)" "unprognostic (3.76e-2)" "unprognostic (4.75e-1)" "unprognostic (1.36e-1)" "unprognostic (7.37e-5)" "unprognostic (2.94e-1)" "unprognostic (2.43e-1)" "unprognostic (4.20e-2)" "unprognostic (2.71e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 5.7 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.5 0.0 0.0 0.0 6.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 OR51B2 OR51B1P ENSG00000279012 "Olfactory receptor family 51 subfamily B member 2" Q9Y5P1 11 5323359-5324297 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51B6 ENSG00000176239 "Olfactory receptor family 51 subfamily B member 6" Q9H340 11 5351508-5352446 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51M1 ENSG00000184698 "Olfactory receptor family 51 subfamily M member 1" Q9H341 11 5383812-5393263 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056773 Uncertain NA NA "Cluster 11: Alveolar cells - Smell perception" "HPA056773: AB_2683233" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.3 3.2 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51Q1 ENSG00000167360 "Olfactory receptor family 51 subfamily Q member 1" Q8NH59 11 5422111-5423206 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "RT4: 2.8" "Not detected" "Not detected" HPA044998 Uncertain NA NA "Cluster 15: RT4 - Unknown function" "HPA044998: AB_10794780" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51I1 ENSG00000167359 "Olfactory receptor family 51 subfamily I member 1" Q9H343 11 5440570-5441514 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "olfactory bulb: 3.0" NA NA "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (2.36e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.3 0.2 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 OR51I2 ENSG00000187918 "Olfactory receptor family 51 subfamily I member 2" Q9H344 11 5449323-5456518 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52D1 ENSG00000181609 "Olfactory receptor family 52 subfamily D member 1" Q9H346 11 5488685-5489749 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "olfactory bulb: 3.1" HPA046965 Uncertain NA NA "Cluster 78: Testis - Spermatogenesis" "HPA046965: AB_2679878" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBQLN3 TUP-1 ENSG00000175520 "Ubiquilin 3" Q9H347 11 5507300-5509958 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 396 "testis: 158.8" "Group enriched" "Detected in some" 70 "Early spermatids: 709.6;Late spermatids: 1878.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020547, HPA062018" Enhanced NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 25: Spermatids - Spermatogenesis" "HPA020547: AB_1858577, HPA062018: AB_2684661" "unprognostic (3.79e-3)" 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 158.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.2 0.4 0.3 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 709.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1878.4 9.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 18.3 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBQLNL "MGC20470, MGC26958" ENSG00000175518 "Ubiquilin like" Q8IYU4 11 5514393-5518431 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 31.8" "Group enriched" "Detected in some" 76 "Early spermatids: 169.6;Late spermatids: 637.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (2.86e-1)" "unprognostic (1.79e-1)" "unprognostic (2.98e-4)" "unprognostic (1.43e-1)" "unprognostic (6.17e-2)" "unprognostic (7.60e-2)" "unprognostic (7.69e-2)" "unprognostic (2.22e-2)" "unprognostic (3.64e-1)" "unprognostic (1.17e-3)" "unprognostic (1.73e-1)" "unprognostic (1.54e-1)" "unprognostic (1.52e-8)" "unprognostic (1.17e-1)" "unprognostic (9.16e-2)" "unprognostic (1.17e-1)" "unprognostic (9.69e-5)" 0.7 0.7 0.5 0.1 0.4 0.3 0.5 0.3 0.5 1.5 0.6 0.7 0.1 0.9 1.2 0.4 1.2 0.2 0.6 0.4 0.6 1.3 0.9 0.8 0.3 0.6 0.6 2.4 0.7 0.1 0.6 0.2 0.6 1.5 0.1 0.0 0.4 0.1 0.1 0.5 0.8 0.3 0.5 1.5 0.5 31.8 0.4 0.4 1.1 0.0 0.1 0.7 0.8 0.5 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.3 0.5 0.4 0.6 0.6 0.6 0.6 0.5 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.2 0.3 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 169.6 0.5 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 1.5 1.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 637.7 5.3 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.2 2.6 0.1 0.3 0.0 0.4 0.5 0.0 0.0 0.3 0.2 4.0 2.6 0.0 0.1 0.3 0.1 0.3 0.2 0.2 OR52H1 ENSG00000181616 "Olfactory receptor family 52 subfamily H member 1" Q8NGJ2 11 5544489-5548533 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "Cluster 52: Non-specific - Transcription" "unprognostic (2.87e-1)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.4 0.5 0.3 0.4 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 OR52B6 ENSG00000187747 "Olfactory receptor family 52 subfamily B member 6" Q8NGF0 11 5580877-5581884 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.57e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM6 RNF89 ENSG00000121236 "Tripartite motif containing 6" Q9C030 11 5596109-5612958 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 20.9" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 74.4" "Cancer enhanced" "Detected in many" "testis cancer: 7.8" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NTERA-2: 22.2;SuSa: 36.7;TIME: 19.2;U-2 OS: 21.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA060514 Uncertain NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 5: NTERA-2 - Transcription" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA060514: AB_2684300" "unprognostic (9.00e-2)" "unprognostic (2.10e-3)" "unprognostic (9.16e-3)" "unprognostic (1.82e-1)" "unprognostic (3.25e-3)" "unprognostic (3.25e-3)" "unprognostic (2.35e-2)" "unprognostic (3.26e-3)" "unprognostic (8.59e-2)" "unprognostic (3.40e-2)" "unprognostic (8.61e-2)" "unprognostic (3.90e-1)" "unprognostic (5.68e-2)" "unprognostic (4.65e-4)" "unprognostic (4.77e-1)" "unprognostic (3.33e-2)" "unprognostic (4.36e-1)" 2.8 3.8 0.4 1.7 0.4 2.0 3.2 0.2 0.4 2.2 0.8 2.1 0.5 3.2 4.8 4.3 3.2 2.3 0.9 0.4 0.6 20.9 0.8 2.1 0.6 0.9 0.6 4.3 1.3 1.3 0.9 5.4 0.6 2.5 1.7 0.2 10.5 3.6 0.8 1.0 1.1 5.2 0.6 3.7 1.0 9.3 0.8 1.3 3.8 0.6 1.3 2.6 2.8 0.7 0.7 16.2 1.1 0.0 2.0 2.9 18.7 4.4 3.3 4.3 4.2 0.4 3.6 0.0 2.5 4.5 12.1 2.9 7.5 6.7 6.1 0.6 5.0 2.0 1.6 0.1 0.7 6.6 8.7 5.1 6.4 6.2 4.3 6.4 3.8 0.1 8.0 0.2 1.8 0.2 0.0 0.9 22.2 2.6 5.7 7.7 0.0 0.1 0.9 6.6 0.1 0.2 0.0 8.4 0.8 36.7 3.2 1.1 19.2 4.0 21.3 0.1 4.7 0.2 0.1 0.0 3.7 0.0 3.5 0.2 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 1.1 0.3 0.0 0.2 0.0 0.1 0.4 0.4 0.2 0.4 0.4 0.6 0.9 0.6 0.6 0.6 0.8 0.7 1.2 0.0 4.8 0.0 0.1 0.5 0.6 0.5 1.8 0.0 3.1 1.8 0.4 0.0 0.8 1.8 0.0 12.5 0.0 0.2 3.9 1.2 1.2 0.7 1.7 1.5 0.0 2.1 0.0 0.2 15.5 2.1 0.0 1.0 0.0 4.1 0.0 0.5 3.1 0.0 0.0 0.3 2.0 3.5 0.3 0.8 0.9 1.1 1.8 0.0 2.2 0.0 0.0 0.0 0.0 0.6 0.1 1.9 0.0 0.4 0.3 74.4 1.1 0.0 0.0 0.5 0.7 10.8 3.3 1.8 0.4 5.7 0.4 4.1 0.2 0.3 TRIM6-TRIM34 ENSG00000258588 "TRIM6-TRIM34 readthrough" 11 5596725-5644398 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "A549: 4.8" HPA077996 Uncertain Nucleoli,Centrosome NA NA "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" Centrosome Nucleoli "HPA077996: AB_2686873" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.1 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRIM34 RNF21 ENSG00000258659 "Tripartite motif containing 34" Q9BYJ4 11 5619764-5644398 "Predicted intracellular proteins" "Antiviral defense" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "B-cells: 6.2;Basal squamous epithelial cells: 1.8;Gastric mucus-secreting cells: 4.6;Macrophages: 1.8;Squamous epithelial cells: 4.3;T-cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 22.9;SK-BR-3: 24.6" "Low region specificity" "Detected in all" HPA077996 Approved Nucleoli,Centrosome NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 59: Non-specific - Transcription" Centrosome Nucleoli "HPA077996: AB_2686873" "unprognostic (8.66e-3)" "unprognostic (9.94e-2)" "unprognostic (1.53e-3)" "unprognostic (1.25e-1)" "unprognostic (2.71e-1)" "unprognostic (5.88e-2)" "unprognostic (9.68e-2)" "unprognostic (1.37e-1)" "unprognostic (1.70e-1)" "unprognostic (2.74e-1)" "unprognostic (9.16e-3)" "unprognostic (8.16e-2)" "unprognostic (1.79e-1)" "unprognostic (1.69e-1)" "unprognostic (3.91e-2)" "unprognostic (3.40e-1)" "unprognostic (6.76e-2)" 5.2 8.7 1.3 9.2 1.4 2.1 6.3 1.2 1.8 5.5 1.6 6.9 7.4 5.2 6.7 4.6 5.6 6.3 2.9 1.3 1.8 5.0 5.1 8.4 12.1 2.1 1.7 8.1 3.1 3.2 2.3 9.6 1.7 4.9 7.3 0.5 7.4 4.7 1.0 6.0 7.6 6.3 1.9 13.6 6.9 2.5 1.6 6.2 4.4 2.2 12.2 6.1 4.9 2.1 3.3 1.7 0.7 0.1 7.3 11.3 22.9 5.0 14.5 12.7 12.3 1.5 11.6 11.8 2.2 6.8 9.5 5.3 0.4 10.8 6.4 15.7 0.5 6.3 0.5 0.7 3.3 7.0 4.3 11.9 9.1 6.4 2.1 9.9 16.6 10.3 0.3 0.8 6.1 1.4 6.3 3.9 0.0 4.7 1.0 9.3 0.4 0.7 7.7 9.1 0.0 0.0 0.1 24.6 3.7 2.1 4.3 3.3 13.4 3.3 0.5 1.3 1.8 1.2 1.5 4.5 9.4 0.9 1.6 11.7 18.7 4.7 6.6 20.5 7.3 15.0 6.3 8.3 20.2 16.0 7.7 6.8 19.0 8.0 18.1 10.1 12.2 10.5 1.3 1.4 1.2 1.8 1.3 1.8 2.1 1.7 1.7 1.9 1.6 2.1 0.2 0.0 0.5 0.0 6.2 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.1 0.0 0.3 0.2 1.0 0.0 1.3 0.0 0.0 0.5 1.3 4.6 0.1 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.2 0.0 0.0 4.3 0.0 0.4 2.1 0.2 0.3 0.1 TRIM5 "RNF88, TRIM5alpha" ENSG00000132256 "Tripartite motif containing 5" Q9C035 11 5663195-5938619 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Antiviral defense, Autophagy, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB013497, HPA023420, HPA023422" Approved Supported Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "CAB013497: , HPA023420: AB_1856378, HPA023422: AB_1856379" "unprognostic (2.60e-1)" "unprognostic (9.62e-2)" "unprognostic (2.04e-2)" "unprognostic (1.41e-2)" "unprognostic (6.88e-2)" "unprognostic (4.74e-3)" "unprognostic (5.48e-3)" "unprognostic (5.82e-2)" "unprognostic (1.49e-1)" "unprognostic (6.76e-3)" "unprognostic (8.54e-3)" "unprognostic (1.64e-1)" "unprognostic (2.20e-2)" "unprognostic (1.90e-1)" "unprognostic (1.09e-1)" "unprognostic (1.07e-2)" "unprognostic (6.12e-2)" 8.8 10.9 2.1 8.1 2.3 3.8 8.0 2.0 2.4 11.8 7.2 7.2 7.4 11.7 18.4 7.7 9.4 6.9 5.7 2.0 3.3 9.0 12.8 11.8 8.4 4.0 3.5 11.4 13.3 4.2 3.8 9.6 3.4 8.5 7.7 1.9 14.0 9.1 1.9 5.5 8.5 11.3 3.0 10.4 7.8 8.3 3.5 9.4 9.6 4.0 8.9 8.2 8.6 2.9 7.7 15.4 19.2 12.4 24.0 22.5 5.4 18.0 35.0 37.3 50.0 13.8 13.5 5.5 13.3 18.8 27.6 13.0 18.4 25.8 14.9 9.6 5.1 15.2 10.4 9.5 20.2 11.5 15.3 15.4 22.7 10.5 31.3 22.9 52.8 8.9 16.9 12.2 32.1 4.2 7.7 5.3 7.7 11.7 8.1 14.3 4.7 1.5 23.7 14.4 0.5 1.1 11.8 18.4 6.8 20.7 9.3 6.6 43.3 13.9 20.2 3.6 4.2 9.4 7.9 1.9 10.9 6.8 15.4 10.7 7.6 11.6 3.6 7.8 3.0 3.1 2.8 2.8 9.4 2.6 1.8 3.7 7.7 4.1 8.0 7.0 2.2 4.1 2.1 2.3 2.0 2.4 2.0 3.3 4.0 3.5 3.4 3.0 3.5 2.9 14.2 6.4 14.0 4.9 8.7 5.2 9.5 9.7 9.6 0.2 8.3 6.5 4.9 2.8 13.4 11.0 0.0 7.8 16.4 5.5 5.9 10.6 5.0 8.6 12.6 14.8 1.2 8.4 3.0 8.8 10.5 12.4 6.1 12.5 0.0 11.9 15.4 13.9 6.4 0.0 1.4 9.7 4.1 12.2 7.1 3.8 7.8 10.8 3.6 19.7 10.8 7.0 14.4 3.0 1.0 8.1 4.9 7.5 6.7 10.1 7.4 6.3 3.7 0.1 19.7 6.5 10.9 5.2 3.3 7.0 5.4 7.8 7.5 20.6 7.5 9.9 TRIM22 "GPSTAF50, RNF94, STAF50" ENSG00000132274 "Tripartite motif containing 22" Q8IYM9 11 5689697-5737089 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 135.9;dendritic cells: 113.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 174.6;BJ hTERT+ SV40 Large T+ RasG12V: 209.9;HSkMC: 190.6;TIME: 153.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003307, HPA003575" Approved Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 57: B-cells - Immune response" "Nucleoplasm, Nuclear bodies" "Golgi apparatus" "HPA003307: AB_1080381, HPA003575: AB_1080378" "unprognostic (1.47e-2)" "unprognostic (5.27e-3)" "unprognostic (4.00e-2)" "unprognostic (4.21e-3)" "unprognostic (2.21e-1)" "unprognostic (1.21e-2)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (1.19e-1)" "unprognostic (1.86e-3)" "unprognostic (2.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.98e-2)" "unprognostic (1.30e-1)" "unprognostic (2.50e-2)" "unprognostic (1.15e-1)" "unprognostic (9.16e-2)" 54.0 21.3 13.1 101.3 18.8 90.3 50.7 16.3 23.7 42.7 25.5 36.0 25.2 50.6 70.2 37.1 49.3 78.6 22.6 14.7 16.5 21.2 72.5 83.4 139.0 17.9 16.7 60.3 17.2 8.0 12.6 21.5 16.7 43.3 53.4 11.0 65.4 52.6 13.4 18.1 53.4 52.1 17.7 143.1 39.5 15.4 12.8 101.2 21.7 40.6 120.7 61.6 22.6 29.3 2.8 1.2 13.9 2.4 88.6 174.6 5.0 53.3 93.9 89.8 209.9 1.7 8.6 111.9 13.0 80.2 20.6 10.5 34.0 56.4 10.7 2.0 0.0 6.4 5.6 1.4 107.8 18.2 11.4 190.6 54.3 18.7 9.6 124.5 128.7 1.0 2.3 4.7 111.6 1.5 54.1 16.9 40.3 0.5 4.9 62.6 3.4 2.3 51.1 14.9 1.4 2.7 4.5 4.5 2.1 56.8 4.5 17.9 153.6 56.4 29.8 2.5 2.4 4.9 4.4 11.2 67.7 28.9 7.2 108.7 118.5 79.6 109.0 143.3 145.9 149.4 118.4 117.2 138.7 158.2 106.5 102.7 103.1 61.3 181.1 177.0 197.9 181.9 13.1 18.8 16.3 23.7 14.7 16.5 17.9 16.7 16.7 17.7 12.8 29.3 54.4 67.3 57.7 2.0 135.9 12.6 17.0 42.5 56.3 0.5 17.7 14.0 6.0 7.2 60.5 29.5 0.0 1.5 113.9 4.7 5.9 11.2 0.3 16.1 27.0 40.5 4.2 16.8 4.9 8.0 4.7 36.2 20.9 23.8 17.7 5.4 33.5 4.3 18.7 1.7 0.3 9.0 30.5 87.1 46.6 2.0 36.1 67.8 5.4 52.5 59.0 6.4 83.4 1.0 0.5 5.4 6.3 30.1 18.8 9.9 4.4 3.3 52.5 1.0 13.1 35.1 24.4 0.6 0.3 14.1 8.7 2.3 89.3 13.0 5.0 18.8 OR56B1 OR56B1P ENSG00000181023 "Olfactory receptor family 56 subfamily B member 1" Q8NGI3 11 5736448-5738523 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045043 Uncertain NA NA "Cluster 32: Non-specific - Translation" "HPA045043: AB_10794296" 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 OR52N4 ENSG00000181074 "Olfactory receptor family 52 subfamily N member 4" Q8NGI2 11 5754243-5755905 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.7" "Cell type enhanced" "Detected in single" "Excitatory neurons: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 64: Macrophages - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (3.44e-2)" "unprognostic (2.59e-3)" "unprognostic (4.06e-2)" "unprognostic (1.32e-1)" "unprognostic (2.86e-4)" "unprognostic (1.75e-1)" "unprognostic (1.95e-1)" "unprognostic (3.03e-1)" "unprognostic (5.08e-2)" "unprognostic (2.62e-1)" "unprognostic (5.62e-2)" "unprognostic (1.41e-3)" "unprognostic (1.41e-1)" "unprognostic (3.80e-2)" "unprognostic (3.18e-2)" "unprognostic (4.41e-2)" 0.7 0.2 0.2 0.5 0.2 0.5 0.7 0.0 0.3 0.6 0.1 0.4 0.1 0.6 1.3 0.3 0.9 0.3 0.4 0.2 0.4 0.5 0.2 0.8 1.3 0.4 0.2 1.6 0.1 0.0 0.5 0.0 0.3 0.7 0.3 0.7 0.4 0.7 0.2 0.3 1.8 0.1 0.2 2.7 0.2 0.4 0.1 0.5 0.4 0.1 1.2 0.4 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.2 0.2 0.0 0.3 0.2 0.4 0.4 0.2 0.3 0.2 0.1 0.2 0.1 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56B2P OR56B2 ENSG00000181017 "Olfactory receptor family 56 subfamily B member 2 pseudogene" 11 5761153-5767465 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52N5 OR52N5Q ENSG00000181009 "Olfactory receptor family 52 subfamily N member 5" Q8NH56 11 5776165-5783355 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "Adipocytes: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52N1 ENSG00000181001 "Olfactory receptor family 52 subfamily N member 1" Q8NH53 11 5786471-5791265 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;granulocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA054028 Uncertain NA NA "Cluster 60: Granulocytes - Receptor signaling" "HPA054028: AB_2682348" 0.2 0.0 0.2 0.0 0.3 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.3 0.2 0.4 0.2 0.1 0.4 0.1 0.2 0.4 0.7 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OR52N2 ENSG00000180988 "Olfactory receptor family 52 subfamily N member 2" Q8NGI0 11 5820314-5821348 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 30 "Early spermatids: 2.2;Late spermatids: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 40 "basophil: 4.9" "Lineage enriched" "Detected in single" 40 "granulocytes: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (3.45e-1)" "unprognostic (2.81e-1)" "unprognostic (3.44e-1)" "unprognostic (7.82e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 OR52E6 ENSG00000205409 "Olfactory receptor family 52 subfamily E member 6" Q96RD3 11 5840928-5841952 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52E8 ENSG00000183269 "Olfactory receptor family 52 subfamily E member 8" Q6IFG1 11 5856674-5857734 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52E4 ENSG00000180974 "Olfactory receptor family 52 subfamily E member 4" Q8NGH9 11 5880629-5887079 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Cell type enhanced" "Detected in single" "Early spermatids: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 6: Brain - Smell perception" "Cluster 34: Spermatids - Unknown function" 0.0 0.1 0.3 0.1 0.4 0.2 0.1 1.0 0.7 0.0 0.0 0.0 0.1 0.1 0.5 0.1 0.0 0.2 0.1 0.4 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.6 0.1 0.0 0.2 0.5 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.9 0.6 0.0 0.1 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.1 0.1 0.5 0.3 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.7 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52E5 ENSG00000277932 "Olfactory receptor family 52 subfamily E member 5" Q8NH55 11 5893208-5902730 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56A3 "OR56A3P, OR56A6" ENSG00000184478 "Olfactory receptor family 56 subfamily A member 3" Q8NH54 11 5938751-5951347 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56A5 OR56A5P ENSG00000188691 "Olfactory receptor family 56 subfamily A member 5" P0C7T3 11 5967177-5968494 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.82e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52L1 ENSG00000183313 "Olfactory receptor family 52 subfamily L member 1" Q8NGH7 11 5985892-5986985 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56A4 ENSG00000183389 "Olfactory receptor family 56 subfamily A member 4" Q8NGH8 11 5999445-6006946 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "granulocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 60: Granulocytes - Receptor signaling" 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56A1 ENSG00000180934 "Olfactory receptor family 56 subfamily A member 1" 11 6019336-6034338 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 OR56B4 ENSG00000180919 "Olfactory receptor family 56 subfamily B member 4" Q8NH76 11 6107684-6108835 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 29: U-266 - Adaptive immune response" "unprognostic (2.04e-3)" "unprognostic (8.28e-2)" "unprognostic (6.02e-2)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (3.83e-1)" "unprognostic (3.01e-1)" "unprognostic (3.48e-2)" "unprognostic (9.71e-2)" "unprognostic (1.05e-1)" "unprognostic (1.70e-1)" "unprognostic (1.27e-1)" "unprognostic (2.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52B2 ENSG00000255307 "Olfactory receptor family 52 subfamily B member 2" Q96RD2 11 6169330-6170408 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.53e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52W1 OR52W1P ENSG00000175485 "Olfactory receptor family 52 subfamily W member 1" Q6IF63 11 6199146-6200259 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.33e-1)" "unprognostic (1.91e-1)" 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C11orf42 MGC34805 ENSG00000180878 "Chromosome 11 open reading frame 42" Q8N5U0 11 6205557-6211135 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "testis: 25.4" "Cell type enriched" "Detected in some" 5 "Late spermatids: 818.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;HeLa: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063404 Enhanced Approved "Nuclear membrane,Vesicles,Plasma membrane" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 20: HeLa - Mitochondria" "Cluster 31: Spermatids - Spermatogenesis" "Plasma membrane" "Nuclear membrane, Vesicles" "HPA063404: AB_2685006" "unprognostic (4.79e-2)" "unprognostic (1.83e-1)" "unprognostic (3.18e-1)" "unprognostic (2.56e-1)" "unprognostic (1.39e-3)" "unprognostic (3.49e-3)" "unprognostic (2.05e-1)" "unprognostic (5.39e-2)" "unprognostic (1.26e-1)" "unprognostic (3.50e-2)" "unprognostic (9.30e-2)" "unprognostic (6.47e-3)" "unprognostic (7.02e-2)" "unprognostic (1.09e-1)" "unprognostic (1.56e-1)" "unprognostic (2.07e-2)" "unprognostic (4.74e-2)" 0.0 0.1 0.5 0.2 0.5 0.1 0.1 1.4 0.7 0.1 0.0 0.3 0.9 0.3 0.0 0.1 0.1 0.1 0.1 0.4 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.4 0.2 0.0 0.1 1.5 0.7 0.0 0.0 0.2 0.3 25.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.1 0.8 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.2 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.2 1.3 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.3 0.1 0.0 0.2 0.3 0.1 0.4 0.1 0.4 0.2 0.3 0.0 0.0 0.1 0.4 0.1 0.0 0.3 0.1 0.1 0.1 0.3 0.1 0.3 0.1 0.6 0.1 0.1 0.3 0.1 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 1.4 0.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 146.5 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 818.5 1.5 0.2 0.0 1.0 0.0 0.0 0.0 2.0 2.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM160A2 "C11orf56, DKFZP566M1046, FHIP, FLJ22665, KIAA1759" ENSG00000051009 "Family with sequence similarity 160 member A2" Q8N612 11 6211345-6234711 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 76.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055994, HPA063987" Approved Approved Mitochondria NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Mitochondria "HPA055994: AB_2682999, HPA063987: AB_2685166" "unprognostic (1.40e-1)" "unprognostic (1.58e-1)" "unprognostic (3.44e-2)" "unprognostic (9.59e-3)" "unprognostic (2.20e-2)" "unprognostic (1.51e-1)" "unprognostic (4.16e-2)" "unprognostic (2.64e-1)" "unprognostic (2.19e-1)" "unprognostic (5.02e-2)" "unprognostic (2.16e-1)" "unprognostic (8.04e-2)" "unprognostic (6.65e-2)" "unprognostic (1.93e-1)" "unprognostic (1.64e-1)" "unprognostic (9.58e-2)" "unprognostic (1.85e-1)" 16.5 14.5 6.2 14.2 6.5 42.3 18.1 6.8 7.2 20.1 9.5 29.8 34.1 21.6 9.5 13.2 20.2 17.8 12.4 6.4 3.8 13.8 20.8 16.0 13.3 4.0 4.4 21.3 24.7 16.3 14.9 12.1 3.5 15.7 27.7 9.6 18.6 14.7 14.0 23.5 33.8 15.8 2.9 14.2 18.9 27.2 4.4 11.3 22.7 10.5 8.9 16.5 16.5 4.4 13.5 13.1 9.0 13.4 11.9 12.8 19.5 7.6 9.1 11.1 10.6 11.2 24.4 10.5 8.2 8.9 18.3 17.4 9.2 13.8 6.7 11.6 13.1 3.6 24.1 6.0 9.8 8.9 11.6 11.7 17.0 10.0 17.7 14.5 11.4 16.2 11.5 12.7 7.0 10.7 8.5 17.0 13.4 17.5 12.2 9.3 4.7 8.6 10.4 9.6 12.0 7.9 10.9 12.7 6.9 9.3 8.7 12.4 9.8 13.6 10.4 20.4 8.1 17.0 15.7 8.1 15.0 7.0 12.3 1.3 3.1 3.4 3.0 1.3 1.8 1.3 1.2 2.2 2.0 1.3 0.9 1.6 3.3 1.1 1.0 0.6 0.2 2.0 6.2 6.5 6.8 7.2 6.4 3.8 4.0 4.4 3.5 2.9 4.4 4.4 19.0 19.2 16.2 28.1 10.1 12.5 11.1 12.5 10.8 12.6 17.8 12.3 4.5 14.3 12.2 12.9 16.7 13.5 15.9 76.8 7.9 11.4 24.2 15.6 10.1 15.2 25.0 18.5 21.3 11.3 10.1 12.9 33.6 11.2 7.0 27.6 9.3 23.7 9.6 6.7 15.8 37.9 16.2 17.6 28.5 6.5 9.9 12.3 14.2 11.2 16.9 7.6 37.0 14.1 15.6 17.6 47.8 7.5 8.3 10.8 65.0 8.8 18.6 24.4 13.1 10.6 11.6 38.5 21.7 8.5 14.9 11.5 14.7 21.9 39.5 10.4 CNGA4 "CNCA2, CNG5, CNGB2, OCNC2, OCNCb" ENSG00000132259 "Cyclic nucleotide gated channel subunit alpha 4" Q8IV77 11 6234765-6244479 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Olfaction, Sensory transduction, Transport" "Ion channel, Ligand-gated ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 17.3;testis: 6.1" "Cell type enhanced" "Detected in some" "Astrocytes: 9.1;Early spermatids: 5.0;Endometrial ciliated cells: 2.7;Excitatory neurons: 3.0;Inhibitory neurons: 2.5;Late spermatids: 3.6;Oligodendrocytes: 3.1;Respiratory ciliated cells: 3.5" "Cancer enriched" "Detected in single" 6 "endometrial cancer: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA074128 Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Plasma membrane" "HPA074128: " "unprognostic (1.11e-2)" "unprognostic (4.32e-2)" "unprognostic (2.69e-3)" "prognostic favorable (1.48e-4)" "unprognostic (4.96e-2)" "unprognostic (1.09e-1)" "unprognostic (2.01e-3)" "unprognostic (1.89e-1)" "unprognostic (8.51e-2)" "unprognostic (5.51e-2)" "unprognostic (1.83e-2)" "unprognostic (8.70e-2)" "unprognostic (1.03e-3)" "unprognostic (3.84e-2)" "unprognostic (3.47e-2)" "unprognostic (8.11e-2)" "unprognostic (3.55e-3)" 0.1 0.2 1.2 0.2 1.3 0.4 0.2 1.3 1.2 0.7 0.7 0.2 0.3 0.6 0.2 0.2 17.3 0.2 0.1 1.4 1.4 0.4 0.2 1.4 0.2 2.8 3.8 0.4 0.4 0.0 0.7 0.0 2.5 0.2 0.1 1.1 0.1 0.5 0.0 0.3 0.2 0.1 1.8 0.3 0.2 6.1 1.2 0.3 0.2 0.0 0.2 0.2 0.2 1.9 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 1.3 1.2 1.4 1.4 2.8 3.8 2.5 1.8 1.2 1.9 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 2.7 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CCKBR ENSG00000110148 "Cholecystokinin B receptor" P32239 11 6259806-6272127 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 29 "brain: 14.1;pancreas: 27.1;stomach 1: 42.0" "Group enriched" "Detected in some" 4 "Excitatory neurons: 14.6;Gastric mucus-secreting cells: 14.3;Granulosa cells: 23.3" "Cancer enriched" "Detected in some" 8 "testis cancer: 9.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "NTERA-2: 73.4" "Low region specificity" "Detected in many" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (2.82e-1)" "unprognostic (4.62e-2)" "unprognostic (1.79e-3)" "unprognostic (2.19e-1)" "unprognostic (1.95e-1)" "unprognostic (6.34e-4)" "unprognostic (8.01e-2)" "unprognostic (3.01e-2)" "unprognostic (9.00e-2)" "unprognostic (3.30e-2)" "unprognostic (2.06e-1)" "unprognostic (2.92e-1)" "unprognostic (1.30e-2)" 0.1 0.2 8.2 0.0 11.7 0.0 0.0 6.3 14.1 0.0 0.3 0.2 0.3 0.3 0.0 0.0 0.3 0.0 0.0 11.9 1.7 0.0 0.0 0.0 0.0 3.7 1.8 0.1 27.1 0.0 0.9 0.0 3.8 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 42.0 0.5 2.6 0.0 0.2 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 73.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 11.7 6.3 14.1 11.9 1.7 3.7 1.8 3.8 1.3 2.6 6.6 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 14.6 1.3 0.0 0.2 14.3 0.1 0.0 23.3 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.7 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 CAVIN3 "cavin-3, HSRBC, MGC20400, PRKCDBP, SRBC" ENSG00000170955 "Caveolae associated protein 3" Q969G5 11 6318946-6320532 "Predicted intracellular proteins" "Biological rhythms" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 140.5;Exocrine glandular cells: 252.2;Extravillous trophoblasts: 88.9;Fibroblasts: 88.7;Pancreatic endocrine cells: 219.0;Smooth muscle cells: 146.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 16.2;myeloid DC: 42.8" "Group enriched" "Detected in many" 5 "dendritic cells: 42.8;monocytes: 16.2" "Cell line enhanced" "Detected in many" "A-431: 120.7;BJ: 111.6;HaCaT: 91.7;TIME: 133.6;U-87 MG: 125.9;WM-115: 137.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055136, HPA073327" Supported Approved "Plasma membrane" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 33: Fibroblasts - ECM organization" "Plasma membrane" "HPA055136: AB_2682711, HPA073327: AB_2686595" "unprognostic (7.92e-2)" "prognostic unfavorable (3.75e-5)" "unprognostic (3.12e-2)" "unprognostic (2.30e-1)" "unprognostic (4.69e-2)" "unprognostic (2.69e-1)" "unprognostic (2.24e-2)" "unprognostic (1.19e-3)" "unprognostic (2.49e-2)" "unprognostic (6.03e-3)" "unprognostic (3.37e-1)" "unprognostic (6.66e-2)" "prognostic unfavorable (5.21e-6)" "unprognostic (3.85e-2)" "unprognostic (1.70e-1)" "unprognostic (1.62e-1)" "unprognostic (1.96e-2)" 69.3 20.3 5.0 16.4 5.3 0.5 51.7 4.9 7.3 73.5 10.3 69.8 5.8 106.5 1.3 19.2 48.8 1.3 57.9 4.3 4.3 24.9 8.3 37.8 2.5 5.1 4.3 37.0 21.4 1.3 8.1 11.7 5.4 43.6 4.0 0.0 20.3 13.1 17.1 28.3 29.6 22.9 4.9 25.0 37.3 12.1 5.7 1.1 22.6 5.6 1.4 79.3 58.2 4.1 120.7 12.1 0.1 0.4 5.4 24.7 0.0 111.6 45.1 18.5 20.5 0.0 0.1 0.0 36.6 26.1 1.9 91.7 0.0 9.0 3.4 30.1 0.0 0.0 14.0 0.0 14.6 0.0 0.5 16.6 12.4 6.9 9.0 0.0 35.7 0.0 0.0 0.7 19.8 0.0 0.0 0.1 74.6 0.9 2.0 0.0 0.0 0.2 25.6 0.0 0.0 0.1 40.9 0.2 27.0 0.7 0.2 0.5 133.6 0.0 0.4 46.0 0.4 0.2 1.0 0.2 125.9 0.0 137.7 0.0 16.2 0.0 0.0 1.1 0.0 0.0 0.8 0.0 42.8 0.0 0.0 0.0 0.2 0.4 0.0 0.0 6.1 5.9 5.0 5.3 4.9 7.3 4.3 4.3 5.1 4.3 5.4 4.9 5.7 4.1 140.5 12.8 6.9 0.0 2.4 0.0 0.0 0.0 0.0 0.0 7.7 36.2 0.0 0.0 8.1 16.5 0.0 3.6 1.0 0.0 39.2 6.0 0.0 6.9 59.7 70.3 0.0 0.0 0.0 252.2 88.9 88.7 0.0 8.0 0.0 2.6 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 30.5 0.0 0.0 0.0 0.0 219.0 0.0 0.0 0.5 0.0 0.0 47.6 10.2 0.0 0.0 0.0 146.0 0.0 0.0 0.0 0.0 8.5 1.6 45.7 0.0 0.0 SMPD1 ASM ENSG00000166311 "Sphingomyelin phosphodiesterase 1" P17405 11 6390440-6394998 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Disease variant, Neurodegeneration, Niemann-Pick disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 131.3;Late spermatids: 200.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 139.1;fHDF/TERT166: 144.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 2700000 "Cluster 15: NK-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (8.76e-2)" "unprognostic (2.66e-1)" "unprognostic (6.99e-2)" "unprognostic (2.28e-3)" "prognostic unfavorable (7.72e-5)" "unprognostic (9.46e-2)" "unprognostic (1.46e-1)" "unprognostic (4.90e-2)" "unprognostic (8.06e-2)" "unprognostic (1.72e-1)" "prognostic favorable (7.47e-4)" "unprognostic (4.35e-2)" "prognostic favorable (4.57e-6)" "unprognostic (4.27e-2)" "unprognostic (2.00e-1)" "unprognostic (1.12e-2)" "unprognostic (1.71e-1)" 21.8 36.5 38.8 13.9 44.7 7.3 20.1 45.1 43.0 21.2 33.9 25.3 16.8 20.9 14.4 20.6 14.6 21.5 55.8 39.1 43.0 73.7 95.3 31.3 14.6 42.7 42.6 17.9 32.8 34.2 41.9 21.6 43.3 29.4 14.9 8.5 29.0 20.0 37.9 37.9 23.8 17.6 40.9 21.1 25.4 14.0 47.5 17.8 34.0 29.4 11.0 23.6 21.0 46.8 16.4 13.1 10.1 26.5 139.1 72.2 17.1 60.4 95.0 27.7 33.0 22.0 11.9 4.7 27.4 144.0 59.3 7.4 8.4 12.7 13.0 21.0 9.6 5.1 19.5 6.0 62.3 3.7 37.4 96.0 23.4 25.9 17.7 100.9 61.6 1.7 9.1 30.5 58.9 17.0 0.1 6.5 3.9 23.2 22.3 1.2 5.5 7.0 23.9 6.2 17.0 9.7 27.6 19.5 38.5 12.9 7.3 7.0 53.9 103.0 10.9 59.1 15.4 37.6 44.0 3.5 93.7 10.8 47.1 1.9 2.5 3.4 6.4 2.1 5.0 1.5 5.5 5.0 1.3 3.1 10.0 10.1 2.5 6.6 0.6 1.7 4.7 3.2 38.8 44.7 45.1 43.0 39.1 43.0 42.7 42.6 43.3 40.9 47.5 46.8 14.1 25.6 14.4 10.7 12.2 7.9 22.8 15.3 6.8 12.6 13.7 9.0 37.7 24.3 12.8 25.8 25.0 38.8 11.5 131.3 11.7 53.4 50.0 6.2 13.0 18.6 23.8 9.9 5.8 38.2 14.4 31.4 15.8 21.0 10.8 9.4 26.7 88.5 34.1 20.2 5.5 20.3 24.4 15.5 6.2 200.7 11.5 15.8 55.2 4.7 7.8 16.4 36.0 6.6 15.5 24.7 83.1 13.5 23.1 26.0 51.7 75.1 2.4 5.2 0.0 8.9 17.1 1.4 3.1 7.5 8.0 34.3 23.3 10.2 18.0 15.4 APBB1 "Fe65, RIR" ENSG00000166313 "Amyloid beta precursor protein binding family B member 1" O00213 11 6395124-6419414 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, DNA damage, Transcription, Transcription regulation" "Activator, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 152.9" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 85.6" "Lineage enriched" "Detected in all" 5 "T-cells: 85.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 68.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038521, HPA038522" Approved Supported "Plasma membrane" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 58: T-cells - T-cell receptor" "Plasma membrane" "HPA038521: AB_2676058, HPA038522: AB_2676059" "unprognostic (4.76e-2)" "unprognostic (1.98e-1)" "unprognostic (4.46e-3)" "unprognostic (1.97e-2)" "unprognostic (6.84e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (7.30e-2)" "unprognostic (3.22e-3)" "unprognostic (2.36e-1)" "prognostic favorable (1.86e-5)" "unprognostic (2.21e-1)" "prognostic favorable (7.44e-13)" "unprognostic (1.32e-2)" "unprognostic (2.71e-2)" "unprognostic (1.91e-1)" "unprognostic (1.09e-2)" 18.1 23.8 101.7 11.9 119.4 2.7 18.0 116.6 121.1 39.5 65.1 43.3 7.0 43.5 4.3 14.9 38.3 11.4 42.0 123.3 105.3 21.5 3.8 22.5 13.9 123.9 106.0 39.2 16.3 21.4 61.3 8.6 135.0 23.7 4.7 23.3 13.4 25.9 42.3 12.2 19.2 33.2 109.4 13.8 19.4 12.7 112.1 28.9 19.1 54.0 11.1 31.2 23.5 152.9 0.0 14.9 50.6 22.8 26.7 27.4 0.2 24.6 41.7 41.2 51.4 26.4 10.3 0.0 3.6 44.3 36.9 0.5 44.4 7.5 19.4 27.8 33.7 0.3 9.3 0.9 19.3 0.2 9.9 24.8 1.9 19.4 2.9 35.3 51.7 1.2 1.1 0.7 15.3 0.5 0.5 0.1 18.3 0.8 15.5 0.2 2.0 0.2 1.7 0.2 68.1 37.6 3.6 3.0 15.9 15.2 2.1 3.4 22.8 4.2 24.8 27.5 5.0 13.8 6.8 2.0 21.1 0.0 14.3 8.4 1.7 0.3 23.2 1.5 25.2 6.7 32.5 30.2 1.7 16.2 85.6 51.7 1.6 16.5 0.6 0.3 48.7 29.9 101.7 119.4 116.6 121.1 123.3 105.3 123.9 106.0 135.0 109.4 112.1 152.9 9.6 19.2 5.4 22.9 7.5 5.0 12.1 3.6 12.0 45.8 6.6 5.7 50.5 11.5 5.4 5.5 22.9 0.4 4.6 1.1 25.4 18.2 5.6 7.6 9.5 13.9 19.3 4.0 47.1 4.2 0.7 15.2 4.6 2.3 1.3 10.8 15.7 3.3 1.2 40.4 44.8 1.2 0.0 1.9 4.0 13.1 9.6 1.8 8.8 7.5 3.2 24.7 9.2 49.3 102.3 8.0 1.7 19.2 1.4 8.3 0.4 21.6 17.3 20.1 6.6 10.0 17.3 6.9 13.7 3.2 2.8 0.8 20.1 7.0 1.3 5.4 HPX ENSG00000110169 Hemopexin P02790 11 6431049-6442617 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Host-virus interaction, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 908 "liver: 5440.6" "Cell type enriched" "Detected in some" 38 "Hepatocytes: 6095.8" "Cancer enriched" "Detected in many" 79 "liver cancer: 571.1" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "Hep G2: 21.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB016725, HPA065318, HPA068847" Approved "Secreted to blood" NA NA 425000000000 190000000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" "CAB016725: , HPA065318: , HPA068847: " "unprognostic (3.39e-2)" "unprognostic (9.26e-2)" "unprognostic (3.88e-1)" "unprognostic (6.19e-4)" "unprognostic (2.05e-2)" "unprognostic (2.41e-1)" "prognostic favorable (2.26e-4)" "unprognostic (6.33e-2)" "unprognostic (5.67e-3)" "unprognostic (3.88e-1)" "unprognostic (5.08e-3)" "unprognostic (2.78e-2)" "unprognostic (5.82e-12)" "unprognostic (2.01e-1)" "unprognostic (4.48e-1)" "unprognostic (1.84e-2)" "unprognostic (2.14e-2)" 1.1 0.8 0.8 0.1 0.7 0.1 5.9 1.0 1.0 1.6 0.6 1.2 0.4 1.0 0.2 0.5 1.6 0.3 0.9 0.7 0.7 1.4 5440.6 1.2 0.3 0.7 0.7 1.6 5.5 0.1 1.2 0.3 0.7 2.4 0.6 1.7 1.1 0.6 0.3 1.6 1.1 0.3 0.6 3.8 0.9 1.1 0.8 0.1 0.9 0.0 0.1 1.1 1.2 0.7 0.2 0.1 0.4 0.2 0.0 0.6 0.0 0.0 0.1 0.1 0.3 1.3 0.0 0.8 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.2 0.2 0.6 0.2 21.3 0.0 3.0 0.0 0.8 0.6 0.1 0.0 0.5 0.1 0.2 0.4 0.1 0.1 0.4 0.0 0.0 0.3 0.9 0.0 0.1 1.3 0.2 0.0 0.1 0.2 0.0 1.0 3.0 0.2 0.2 1.1 0.0 0.5 0.3 0.2 1.0 0.1 0.4 0.2 0.9 0.2 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 1.0 1.0 0.7 0.7 0.7 0.7 0.7 0.6 0.8 0.7 0.5 3.2 0.5 0.3 15.1 0.6 0.2 0.2 0.0 1.5 19.1 7.7 0.7 80.1 0.2 0.0 2.1 0.1 0.1 0.6 0.0 0.1 2.3 0.2 0.3 6.2 0.0 157.7 0.7 0.6 0.1 0.4 0.0 1.2 0.0 1.1 132.8 6095.8 0.2 0.0 0.8 0.7 0.0 155.3 0.2 2.9 0.3 0.2 0.0 1.0 0.0 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 1.7 0.2 0.0 1.0 2.1 0.0 0.4 0.5 0.6 0.5 0.0 0.3 0.0 11.3 0.2 0.5 0.3 TRIM3 "BERP, HAC1, RNF22, RNF97" ENSG00000110171 "Tripartite motif containing 3" O75382 11 6448613-6474459 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043396, HPA048233" Enhanced Approved Mitochondria NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 45: Enterocytes - Digestion" Mitochondria "HPA043396: AB_2678460, HPA048233: AB_2680321" "unprognostic (1.24e-1)" "unprognostic (1.98e-1)" "unprognostic (2.31e-1)" "prognostic favorable (2.20e-4)" "unprognostic (4.01e-2)" "unprognostic (3.88e-2)" "unprognostic (1.61e-3)" "unprognostic (2.84e-1)" "unprognostic (2.24e-1)" "unprognostic (3.91e-1)" "prognostic favorable (5.49e-5)" "unprognostic (2.01e-1)" "prognostic unfavorable (1.07e-5)" "unprognostic (2.51e-1)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "unprognostic (1.93e-1)" 9.5 4.6 6.4 4.6 6.2 1.3 10.3 11.6 7.5 11.2 0.0 13.0 17.8 13.5 1.8 4.8 10.1 4.1 8.0 5.8 3.4 6.3 6.3 9.7 2.4 8.5 3.1 8.7 6.4 2.7 5.9 3.9 9.4 9.5 4.8 4.8 9.0 5.4 11.5 8.4 15.7 5.6 2.2 5.7 10.1 3.8 5.9 1.5 6.8 4.8 1.6 11.2 9.3 6.1 7.2 12.4 4.9 8.3 8.1 7.8 6.7 10.3 6.1 7.8 8.6 7.6 5.0 3.9 3.6 7.9 9.1 5.0 5.1 7.7 3.0 4.8 7.6 1.2 13.5 5.3 5.2 0.4 4.1 6.7 3.7 6.1 3.2 3.3 8.0 2.9 1.7 4.7 7.8 15.2 0.3 1.0 3.5 15.2 10.7 2.4 4.2 4.9 1.9 3.8 5.1 7.8 5.7 54.9 6.6 2.5 20.8 1.3 13.4 20.3 9.5 15.0 6.9 5.5 3.6 0.8 11.0 1.7 7.6 0.0 1.0 0.6 0.5 1.0 0.4 0.1 0.4 0.4 1.2 0.1 0.1 0.6 0.0 0.6 0.2 0.2 0.5 0.5 6.4 6.2 11.6 7.5 5.8 3.4 8.5 3.1 9.4 2.2 5.9 6.1 8.5 6.4 0.0 9.8 2.4 4.8 2.8 2.8 3.4 8.8 8.5 6.0 2.2 2.8 2.7 0.0 10.4 1.8 3.5 16.0 0.0 3.1 3.9 2.8 4.4 6.5 4.8 0.4 13.2 3.5 2.2 6.9 5.6 7.3 1.3 3.6 4.6 2.5 4.7 8.4 12.2 11.4 4.1 0.8 6.5 5.6 5.9 3.5 7.2 11.2 3.4 2.2 3.1 5.0 10.2 3.1 5.4 5.3 2.5 3.2 28.7 3.1 8.4 9.6 13.1 5.0 11.3 3.1 6.0 3.7 5.4 0.8 3.4 3.3 6.6 2.3 ARFIP2 POR1 ENSG00000132254 "ADP ribosylation factor interacting protein 2" P53365 11 6474683-6481479 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032985, HPA038156" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 4: Stomach - Digestion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" "Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus" "CAB032985: AB_2058811, HPA038156: AB_10697243" "unprognostic (2.32e-1)" "unprognostic (2.75e-1)" "unprognostic (2.97e-2)" "prognostic favorable (2.00e-5)" "unprognostic (8.44e-2)" "unprognostic (1.25e-1)" "unprognostic (4.05e-3)" "unprognostic (2.50e-1)" "unprognostic (2.96e-1)" "unprognostic (1.76e-1)" "unprognostic (5.70e-3)" "unprognostic (3.11e-1)" "prognostic favorable (9.53e-4)" "unprognostic (2.05e-1)" "unprognostic (2.41e-1)" "unprognostic (2.32e-2)" "unprognostic (9.48e-3)" 19.8 29.3 31.7 18.6 32.3 22.8 50.7 32.5 35.2 36.3 36.2 36.8 32.9 27.2 34.0 31.4 39.3 23.9 17.9 32.1 31.4 27.0 34.6 24.4 22.4 31.2 31.4 29.4 49.4 46.4 40.7 29.7 31.9 46.6 48.1 28.3 57.7 28.2 15.2 32.8 30.7 27.4 30.9 20.7 50.4 18.3 31.8 25.7 36.9 16.1 32.0 29.2 24.4 33.1 50.4 64.8 38.9 38.5 59.1 53.9 56.1 40.3 107.0 86.2 101.8 62.1 80.3 39.9 16.5 79.3 49.8 68.0 49.4 84.1 70.0 30.9 86.5 22.3 87.7 60.4 71.3 36.2 42.8 60.0 65.7 43.0 98.3 64.2 55.9 38.3 35.3 45.0 55.8 98.9 41.9 41.6 67.2 119.0 71.9 31.7 22.6 37.1 61.9 50.4 50.8 63.2 48.7 204.9 25.9 36.3 86.9 33.0 36.8 35.4 35.7 39.1 30.3 67.3 32.5 24.3 65.4 22.0 43.9 13.0 15.6 9.9 17.9 10.9 17.8 12.1 16.7 14.5 21.3 13.8 16.7 17.1 6.1 21.1 6.7 16.6 18.9 13.9 31.7 32.3 32.5 35.2 32.1 31.4 31.2 31.4 31.9 30.9 31.8 33.1 14.8 6.4 6.4 4.6 20.7 28.0 49.3 48.9 16.5 32.6 59.8 45.1 4.3 40.0 30.5 12.9 29.2 80.1 24.3 56.0 58.7 62.7 31.7 28.1 20.1 19.6 63.0 21.8 8.4 85.4 65.8 23.1 62.2 37.2 31.8 30.3 20.3 21.1 28.1 21.9 7.8 126.6 32.6 10.1 16.4 43.3 20.5 14.4 24.9 5.6 25.2 35.4 18.6 6.6 7.6 59.9 63.4 24.5 28.0 73.3 65.2 34.4 34.7 32.3 26.3 21.6 23.3 41.0 26.2 26.2 32.1 112.5 16.9 40.9 52.6 64.7 TIMM10B "FXC1, TIM10B, Tim9b" ENSG00000132286 "Translocase of inner mitochondrial membrane 10B" Q9Y5J6 11 6481501-6484681 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA052265 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 1: Thyroid gland - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" "HPA052265: AB_2681778" "unprognostic (1.70e-1)" "unprognostic (2.00e-1)" "unprognostic (1.96e-2)" "unprognostic (3.06e-2)" "unprognostic (1.13e-1)" "unprognostic (1.02e-1)" "unprognostic (2.15e-3)" "unprognostic (1.10e-3)" "unprognostic (8.72e-2)" "unprognostic (2.86e-1)" "unprognostic (6.78e-2)" "unprognostic (1.65e-1)" "prognostic favorable (3.19e-10)" "unprognostic (9.92e-2)" "unprognostic (3.84e-1)" "unprognostic (3.61e-1)" "unprognostic (2.42e-1)" 16.5 24.0 12.1 14.2 13.3 16.9 18.1 14.4 16.8 18.5 11.4 22.6 17.0 21.6 21.9 17.0 19.4 14.8 16.1 11.5 15.6 27.5 20.3 17.7 17.2 18.7 18.2 21.6 24.5 28.9 19.2 17.3 18.4 21.9 18.6 18.2 18.2 20.1 12.4 15.5 17.6 18.8 13.3 18.4 22.7 12.9 14.6 13.9 26.6 11.3 16.8 20.6 15.8 16.9 21.7 11.8 25.6 24.4 30.6 31.1 17.8 21.2 29.4 26.3 30.1 21.7 43.5 21.8 14.8 24.7 32.7 28.5 23.8 32.3 25.4 22.0 23.3 28.6 23.8 25.0 34.3 39.6 31.1 30.9 36.0 16.8 26.4 16.9 19.7 29.1 51.5 40.2 25.3 17.2 38.7 20.9 39.5 33.8 21.1 28.8 17.2 21.4 32.8 30.4 27.2 29.5 25.0 36.1 35.9 16.7 23.1 28.4 20.7 28.4 20.2 22.9 14.8 36.3 39.9 33.3 27.4 29.2 31.0 17.2 28.9 25.8 36.5 29.8 38.5 36.0 32.6 34.8 26.7 37.9 45.2 39.6 6.5 36.0 25.2 32.9 28.6 39.6 12.1 13.3 14.4 16.8 11.5 15.6 18.7 18.2 18.4 13.3 14.6 16.9 18.7 19.2 24.1 3.9 28.5 29.1 44.8 32.2 19.4 26.2 24.1 19.3 21.0 0.0 28.2 18.4 25.0 29.5 28.0 23.3 58.7 24.4 19.8 17.1 17.7 16.9 31.0 12.6 8.6 29.7 29.5 22.6 10.2 20.6 31.1 21.1 0.0 0.0 29.3 11.8 9.9 34.5 30.5 0.0 18.9 10.9 18.3 19.1 23.2 5.6 28.7 21.8 44.3 7.5 11.7 29.3 26.9 21.1 21.6 41.7 25.0 34.0 35.8 31.2 26.3 14.9 24.1 49.0 35.2 24.0 31.1 40.2 22.5 33.3 27.2 63.7 DNHD1 "C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184" ENSG00000179532 "Dynein heavy chain domain 1" Q96M86 11 6497260-6593758 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 69.5;Erythroid cells: 35.6;Excitatory neurons: 41.4;Inhibitory neurons: 32.8;Oligodendrocyte precursor cells: 36.2;Oligodendrocytes: 67.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039698, HPA040267, HPA057639" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Yes No "Cluster 45: Eosinophils - Innate immune response" "Cluster 43: Testis - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Cytokinetic bridge" "HPA039698: AB_10795111, HPA040267: AB_2676913, HPA057639: AB_2683486" "unprognostic (1.01e-2)" "unprognostic (2.31e-1)" "unprognostic (5.87e-2)" "unprognostic (2.18e-2)" "unprognostic (9.96e-2)" "unprognostic (2.00e-3)" "unprognostic (1.43e-1)" "unprognostic (3.11e-1)" "unprognostic (5.38e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-2)" "unprognostic (9.25e-3)" "unprognostic (5.45e-9)" "unprognostic (2.33e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-4)" "unprognostic (8.15e-2)" 2.2 1.7 2.6 1.5 3.3 4.5 2.2 2.1 4.3 2.9 2.3 3.3 1.6 2.5 2.1 1.6 2.6 1.4 2.0 2.1 3.2 2.5 2.8 3.3 2.5 4.7 2.8 3.3 1.7 0.4 2.2 0.8 5.0 2.4 1.4 4.0 1.8 1.3 2.0 2.3 3.3 1.4 2.4 2.8 2.0 10.3 3.5 2.1 2.4 0.8 2.0 2.4 2.5 6.2 2.1 2.0 2.4 1.9 2.0 2.9 2.6 1.0 1.2 0.7 0.9 1.3 2.3 2.4 0.4 1.0 1.8 3.7 1.1 1.1 0.9 1.5 2.3 1.8 3.7 1.5 1.3 2.1 0.8 2.0 1.8 2.2 3.6 1.2 0.6 3.1 2.0 2.3 1.0 0.6 0.9 3.0 2.6 0.7 2.0 1.4 0.9 1.5 1.3 1.6 1.1 2.2 0.8 2.2 1.9 1.8 1.3 2.5 1.2 1.3 1.4 1.8 1.4 6.6 5.0 3.0 1.3 2.6 1.7 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.3 0.3 0.4 0.1 0.0 0.0 0.2 0.2 0.1 2.6 3.3 2.1 4.3 2.1 3.2 4.7 2.8 5.0 2.4 3.5 6.2 2.3 0.0 3.4 69.5 3.8 0.9 1.2 1.9 0.6 9.9 2.7 3.0 3.8 0.0 4.3 0.0 4.2 0.3 4.0 2.2 0.0 0.3 12.7 4.0 1.5 2.8 0.0 35.6 41.4 0.4 0.2 2.2 2.6 3.6 1.3 4.7 3.3 4.8 0.8 10.1 32.8 1.7 0.0 2.5 1.5 13.9 0.9 4.0 0.0 19.7 2.2 3.4 3.1 36.2 67.4 0.4 1.6 1.2 1.7 1.8 2.2 0.6 7.3 9.5 0.0 2.1 1.7 19.5 2.0 1.5 3.8 0.7 2.4 1.8 2.1 1.8 RRP8 "KIAA0409, NML" ENSG00000132275 "Ribosomal RNA processing 8" O43159 11 6595072-6603616 "Metabolic proteins, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038487, HPA057562" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Nucleoli, Cytosol" "HPA038487: AB_10672518, HPA057562: AB_2683468" "unprognostic (9.01e-2)" "unprognostic (5.84e-2)" "unprognostic (2.53e-1)" "unprognostic (1.10e-2)" "unprognostic (1.92e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (3.10e-7)" "unprognostic (4.64e-2)" "unprognostic (2.48e-1)" "unprognostic (2.79e-1)" "unprognostic (1.41e-1)" "unprognostic (6.23e-2)" "unprognostic (3.81e-3)" "unprognostic (2.71e-1)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.87e-2)" 10.8 10.2 10.9 5.8 10.6 18.4 10.5 10.6 14.9 12.7 9.3 21.8 6.7 11.0 9.8 11.4 10.5 3.4 15.4 10.0 9.9 13.3 21.5 9.2 8.6 10.3 10.7 9.3 10.0 5.3 8.2 6.1 10.4 15.8 6.5 7.6 7.4 8.8 9.5 12.6 10.3 6.2 10.9 14.2 12.1 10.7 10.6 6.8 10.6 4.1 8.4 16.8 11.1 12.1 12.3 12.0 4.7 6.1 9.6 8.3 6.7 6.2 7.7 14.0 13.1 12.4 14.1 17.1 6.0 5.9 10.3 12.1 13.6 10.9 14.7 8.3 19.5 8.1 14.0 14.3 11.0 14.8 10.8 7.1 14.0 6.7 12.1 9.2 14.7 8.0 16.3 9.7 11.2 15.2 14.5 22.0 11.6 21.4 10.7 12.8 3.8 3.9 13.4 9.7 7.2 8.4 8.9 18.0 10.7 7.7 9.8 12.9 7.6 13.2 6.1 13.0 12.2 10.8 10.5 16.7 11.2 14.8 8.7 26.3 10.0 10.4 11.5 10.7 11.2 9.1 11.3 10.7 13.0 11.9 11.0 11.7 3.9 13.6 11.8 9.9 11.9 9.0 10.9 10.6 10.6 14.9 10.0 9.9 10.3 10.7 10.4 10.9 10.6 12.1 17.0 22.4 15.0 37.2 19.6 23.2 18.5 13.3 14.2 17.3 14.1 11.7 20.7 8.6 14.7 9.2 14.6 23.5 20.7 12.2 11.7 19.0 7.4 13.7 22.8 16.4 7.2 37.7 45.0 15.9 21.2 15.5 21.4 14.0 17.7 14.7 12.5 23.5 18.9 3.3 32.6 16.2 12.2 9.4 13.4 13.6 13.1 13.1 8.8 21.5 18.4 14.2 22.6 27.2 34.6 22.7 18.2 9.8 15.2 15.8 13.7 29.8 10.3 30.5 0.0 15.3 20.0 23.7 18.0 18.3 27.1 20.0 17.7 25.2 17.3 15.0 ILK ENSG00000166333 "Integrin linked kinase" Q13418 11 6603708-6610874 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004041, HPA048437" Enhanced Supported "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA 30000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 51: Myeloid cells - Hemostasis" "Plasma membrane, Focal adhesion sites" Nucleoplasm "CAB004041: AB_2127050, HPA048437: AB_2680391" "unprognostic (1.78e-1)" "unprognostic (2.26e-2)" "unprognostic (5.26e-2)" "unprognostic (2.12e-2)" "unprognostic (7.57e-2)" "unprognostic (1.01e-1)" "unprognostic (6.19e-3)" "unprognostic (5.25e-3)" "unprognostic (1.49e-2)" "unprognostic (9.65e-2)" "unprognostic (2.64e-1)" "unprognostic (8.12e-2)" "prognostic favorable (2.44e-4)" "unprognostic (4.01e-3)" "unprognostic (9.27e-2)" "unprognostic (2.42e-1)" "unprognostic (6.36e-3)" 108.0 77.2 49.8 85.1 52.4 43.7 91.8 51.7 50.6 151.6 55.0 398.2 66.4 359.1 81.8 115.5 164.2 88.0 175.9 47.4 50.7 78.8 65.9 107.9 72.4 51.8 50.6 101.0 89.3 73.2 47.1 98.8 50.9 182.7 116.8 28.3 69.5 412.2 90.8 61.5 117.4 364.7 51.1 95.5 149.7 26.5 53.7 45.8 72.0 92.0 70.5 226.7 118.8 51.9 127.8 94.4 148.9 51.8 224.8 159.4 67.2 182.2 360.0 211.9 256.0 102.7 145.7 47.0 47.0 304.1 206.9 99.5 84.4 155.6 213.0 83.5 74.3 69.1 84.9 82.8 150.8 55.9 74.7 153.2 72.8 143.8 108.9 217.7 206.9 40.5 63.7 55.0 282.8 97.1 49.4 97.4 94.3 107.5 110.8 51.0 77.8 50.5 160.3 100.8 25.6 57.4 86.0 118.4 103.6 144.0 82.2 62.2 238.8 263.9 118.0 111.1 90.7 38.9 25.9 67.1 195.6 82.8 125.3 314.9 260.0 417.6 127.3 258.1 124.9 96.9 114.4 122.3 242.7 92.9 70.2 88.5 165.5 257.8 254.8 98.5 142.8 402.8 49.8 52.4 51.7 50.6 47.4 50.7 51.8 50.6 50.9 51.1 53.7 51.9 79.5 44.8 17.9 24.2 33.6 50.5 73.7 100.6 24.5 21.5 43.1 68.2 0.5 70.1 49.7 57.0 8.4 119.8 46.0 71.9 58.7 136.1 64.6 33.2 78.1 69.4 37.9 53.7 14.6 125.0 177.7 83.2 50.4 52.5 30.4 41.6 76.4 31.4 127.4 8.4 17.1 50.1 69.2 51.5 97.7 143.7 71.4 115.9 85.4 30.9 143.0 54.3 77.2 15.6 15.3 117.1 60.0 147.4 35.1 42.0 74.5 98.6 31.0 32.9 157.8 53.3 165.8 31.7 17.1 32.3 43.2 110.0 49.3 65.0 50.1 43.9 TAF10 "TAF2A, TAF2H, TAFII30" ENSG00000166337 "TATA-box binding protein associated factor 10" Q12962 11 6606294-6612539 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 361.8;Late spermatids: 1039.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004148, CAB022405" Supported Supported Nucleoplasm NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 43: Testis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB022405: , HPA004148: AB_1857736" "unprognostic (1.69e-3)" "unprognostic (2.32e-1)" "unprognostic (3.19e-2)" "unprognostic (6.21e-3)" "unprognostic (9.10e-2)" "unprognostic (6.99e-2)" "unprognostic (5.24e-3)" "unprognostic (9.03e-3)" "unprognostic (1.12e-1)" "unprognostic (1.24e-2)" "unprognostic (3.46e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.38e-1)" "unprognostic (2.55e-1)" "unprognostic (9.64e-3)" "unprognostic (3.80e-3)" 78.9 140.7 147.5 53.3 150.3 93.0 69.2 149.2 204.1 59.3 142.6 66.2 44.3 63.6 97.5 103.1 61.7 28.3 130.0 147.7 156.2 100.9 151.6 76.7 56.8 157.1 153.2 50.0 152.8 53.2 96.2 31.0 155.9 79.8 54.1 30.8 69.6 42.9 107.5 61.2 68.1 38.7 147.7 125.4 100.1 190.7 149.9 82.0 74.6 50.0 76.3 72.1 58.3 150.9 82.4 138.2 88.7 77.7 140.6 135.1 67.5 61.4 134.6 98.9 98.6 102.0 145.0 45.4 77.2 111.4 137.4 68.6 66.0 99.7 97.3 92.2 95.3 64.2 95.6 122.2 227.7 85.4 98.9 157.8 125.1 77.5 163.0 168.0 110.6 139.5 67.0 80.7 157.4 159.5 122.2 78.5 62.6 130.9 107.6 72.2 46.8 78.5 163.5 108.1 62.2 84.4 82.9 95.0 107.6 129.8 67.1 100.6 64.6 67.2 78.9 97.6 87.9 94.6 70.7 73.4 110.4 44.5 108.2 12.7 9.9 11.8 9.7 15.7 8.8 9.8 9.4 11.1 10.8 11.6 8.8 7.8 27.9 8.7 16.2 23.7 11.4 5.1 147.5 150.3 149.2 204.1 147.7 156.2 157.1 153.2 155.9 147.7 149.9 150.9 106.4 3.2 23.3 6.2 60.1 21.4 56.8 9.4 32.5 23.0 116.3 148.0 51.5 47.1 13.1 36.8 20.9 48.5 130.7 79.7 19.6 18.2 361.8 93.8 90.0 39.3 34.7 45.4 4.4 33.3 55.2 43.0 56.6 86.3 5.1 70.5 26.7 53.8 65.9 23.5 4.4 50.8 2.0 78.4 44.4 1039.1 24.5 91.2 26.6 9.4 36.3 84.7 53.5 2.5 9.9 30.7 68.5 19.2 89.6 85.8 55.5 43.1 14.0 27.1 0.0 36.3 50.0 108.8 33.2 75.0 29.1 53.6 65.0 124.1 44.2 88.7 TPP1 "CLN2, LPIC, SCAR7, TPP-1" ENSG00000166340 "Tripeptidyl peptidase 1" O14773 11 6612768-6619448 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Disease variant, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 261.6;Kupffer cells: 376.5;Macrophages: 219.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037709, HPA044868" Enhanced "Intracellular and membrane" NA NA 9500000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 3: HMC-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "HPA037709: AB_10672913, HPA044868: AB_2679122" "unprognostic (8.27e-3)" "unprognostic (5.85e-2)" "unprognostic (7.12e-3)" "unprognostic (3.34e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (4.31e-4)" "prognostic unfavorable (1.11e-4)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (2.39e-2)" "unprognostic (1.31e-1)" "unprognostic (6.54e-2)" "unprognostic (6.23e-2)" "prognostic unfavorable (4.46e-4)" "unprognostic (3.87e-2)" "unprognostic (2.59e-1)" "unprognostic (1.12e-2)" 74.7 145.9 71.0 74.6 81.0 111.7 44.3 80.3 81.4 53.8 120.1 59.1 59.9 74.0 43.1 39.5 47.1 65.1 56.3 70.6 78.4 71.6 92.7 81.5 77.7 85.2 82.6 49.7 36.2 54.2 63.6 94.2 81.0 38.9 59.7 48.5 42.5 57.5 31.4 39.5 73.3 92.0 74.7 135.0 48.4 20.0 83.3 47.4 45.7 39.0 60.9 68.4 42.8 90.4 26.1 48.1 25.9 50.5 309.9 160.1 21.8 50.9 220.7 36.9 62.0 20.1 122.5 37.4 32.6 136.6 220.2 85.8 48.3 68.7 57.9 37.3 27.6 32.2 23.8 54.9 210.9 45.8 182.6 231.8 104.5 45.9 102.6 240.4 158.8 32.9 59.8 124.6 110.4 30.2 16.6 52.4 18.0 61.5 57.1 36.1 21.6 77.0 62.8 38.2 4.5 20.4 52.6 44.6 91.0 76.5 30.8 79.7 188.0 119.7 33.1 101.1 19.8 92.3 95.3 14.0 139.8 101.7 64.5 67.0 167.1 38.2 39.9 171.2 30.0 35.1 31.4 41.0 185.9 37.0 20.1 27.2 27.5 29.1 125.1 93.1 60.3 138.8 71.0 81.0 80.3 81.4 70.6 78.4 85.2 82.6 81.0 74.7 83.3 90.4 32.0 25.6 37.3 31.6 53.0 23.7 28.4 29.8 13.1 24.8 21.1 23.9 41.8 50.1 26.8 16.5 12.5 35.4 71.0 55.2 5.9 42.2 11.8 13.3 30.2 40.7 16.7 37.5 12.5 13.4 45.3 40.3 16.3 24.8 62.2 25.6 75.7 81.0 261.6 15.2 12.4 31.3 26.4 376.5 126.5 11.2 27.1 219.8 90.7 15.9 156.0 37.9 49.4 8.0 21.9 17.4 44.1 26.4 26.4 23.5 99.7 51.6 14.5 23.8 6.6 19.0 20.3 0.8 1.1 27.6 20.0 88.0 42.2 24.6 32.5 26.5 DCHS1 "CDH25, CDHR6, FIB1, FLJ11790, KIAA1773, PCDH16" ENSG00000166341 "Dachsous cadherin-related 1" Q96JQ0 11 6621330-6655809 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Deafness, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 34.8;Endometrial stromal cells: 17.3;Endothelial cells: 29.0;Fibroblasts: 17.0;Granulosa cells: 19.3;Hepatic stellate cells: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 33.5;HUVEC TERT2: 47.1;REH: 23.5;SH-SY5Y: 32.4;TIME: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017970, HPA050246" Approved Approved "Plasma membrane" NA NA 4000000 "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 12: NES - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane" "HPA017970: AB_2669718, HPA050246: AB_2681062" "unprognostic (2.42e-1)" "unprognostic (1.13e-1)" "unprognostic (8.93e-2)" "unprognostic (3.52e-2)" "unprognostic (1.83e-1)" "unprognostic (1.38e-3)" "unprognostic (2.52e-2)" "unprognostic (4.55e-3)" "unprognostic (2.63e-2)" "unprognostic (2.93e-2)" "unprognostic (5.96e-2)" "unprognostic (6.87e-2)" "prognostic unfavorable (9.32e-4)" "unprognostic (5.62e-2)" "unprognostic (2.28e-1)" "unprognostic (1.60e-2)" "unprognostic (1.24e-3)" 9.4 2.5 7.4 8.4 6.8 0.7 9.3 6.1 6.3 19.5 0.9 19.0 4.1 28.9 2.4 5.0 13.2 8.3 9.2 6.6 10.1 4.6 2.0 10.1 4.0 7.6 6.3 11.6 3.3 2.0 3.2 10.1 5.7 9.3 3.4 0.6 3.5 11.5 4.2 3.7 8.3 16.2 4.7 12.9 8.2 3.0 8.7 3.8 4.1 4.6 2.2 14.8 9.3 3.8 0.0 0.1 33.5 0.1 0.0 0.1 0.3 1.2 8.7 5.4 6.0 0.3 0.0 0.1 5.1 9.9 0.4 0.0 2.7 0.1 3.7 0.1 0.9 0.7 0.0 0.0 0.3 0.2 0.0 1.0 0.1 2.5 0.0 0.0 47.1 0.1 0.2 0.0 2.0 0.0 1.2 0.6 5.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 2.4 32.4 0.0 0.3 0.2 3.5 0.0 1.3 20.4 0.1 10.0 0.1 0.0 0.1 0.0 0.1 0.3 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 7.4 6.8 6.1 6.3 6.6 10.1 7.6 6.3 5.7 4.7 8.7 3.8 34.8 0.0 0.5 12.1 0.2 2.9 0.3 0.0 0.0 1.5 1.7 3.0 3.8 4.3 0.0 0.0 0.0 0.2 1.4 0.2 0.0 1.0 3.1 0.8 17.3 29.0 0.0 2.7 2.0 0.4 0.3 17.0 1.1 0.7 0.0 19.3 61.1 0.2 2.2 0.0 7.4 0.7 0.0 4.7 4.2 3.4 1.2 2.4 16.0 4.7 0.2 0.9 0.0 10.1 1.4 0.1 0.1 1.9 0.2 0.3 0.1 0.1 0.0 0.5 0.0 7.4 4.9 4.9 0.6 0.5 1.7 0.3 1.2 4.6 1.1 0.1 MRPL17 "MRP-L26, RPML26" ENSG00000158042 "Mitochondrial ribosomal protein L17" Q9NRX2 11 6680385-6683340 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043666, HPA050552" Uncertain NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 39: Non-specific - Basic cellular processes" "HPA043666: AB_2678607, HPA050552: AB_2681172" "unprognostic (1.12e-1)" "unprognostic (2.10e-1)" "unprognostic (1.33e-2)" "unprognostic (8.26e-2)" "unprognostic (3.70e-3)" "unprognostic (5.93e-3)" "prognostic unfavorable (2.59e-5)" "unprognostic (4.12e-2)" "unprognostic (2.83e-1)" "unprognostic (2.77e-3)" "unprognostic (1.66e-1)" "unprognostic (4.09e-2)" "prognostic unfavorable (3.15e-7)" "unprognostic (2.61e-1)" "unprognostic (2.14e-1)" "unprognostic (6.36e-3)" "unprognostic (2.71e-1)" 19.8 32.0 9.1 16.3 9.4 9.3 15.5 8.4 10.7 11.8 9.2 14.3 15.0 12.8 4.8 29.0 11.0 17.2 29.2 8.7 10.1 22.3 14.7 15.6 22.4 9.3 9.3 10.6 20.2 9.0 26.7 14.9 8.9 12.4 6.4 7.4 19.6 7.8 25.3 14.8 12.0 7.7 9.1 18.7 16.5 12.0 9.8 8.2 20.7 10.3 8.4 15.7 13.8 9.3 108.9 77.6 20.0 11.3 18.8 21.8 45.4 107.0 35.7 43.5 58.3 56.2 70.9 46.5 59.7 21.1 21.7 54.4 17.9 41.6 22.2 75.6 57.7 40.5 45.2 51.8 13.4 41.3 36.3 14.1 18.3 29.9 23.5 17.1 38.3 27.4 20.7 25.1 32.5 79.8 60.4 41.6 41.0 20.6 69.0 43.7 26.6 31.2 29.2 50.5 39.7 30.9 59.3 49.7 65.5 6.4 41.3 35.0 84.7 50.6 49.4 106.8 77.8 33.7 72.9 55.8 89.8 73.9 43.3 6.5 26.8 15.7 25.0 36.3 32.2 39.0 41.5 30.5 35.6 34.1 40.8 28.6 3.6 28.2 24.7 63.5 42.3 30.3 9.1 9.4 8.4 10.7 8.7 10.1 9.3 9.3 8.9 9.1 9.8 9.3 66.8 16.0 17.2 4.6 26.7 52.9 44.2 75.4 38.7 18.0 35.3 46.9 57.1 30.0 42.9 33.1 8.4 101.0 28.4 20.3 121.3 64.8 54.3 38.0 50.5 62.6 21.0 27.3 5.1 72.5 141.5 39.5 30.5 30.8 8.2 34.7 75.7 30.3 89.4 33.7 6.1 44.9 59.0 28.5 23.6 29.5 39.1 27.8 42.7 5.6 39.0 35.1 32.0 5.0 5.8 61.6 27.6 27.1 42.8 53.9 31.1 155.2 38.6 26.7 13.1 23.0 40.9 82.7 35.9 63.7 54.7 36.7 20.4 118.7 49.4 37.4 OR2AG2 OR2AG2P ENSG00000188124 "Olfactory receptor family 2 subfamily AG member 2" A6NM03 11 6765626-6771976 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Excitatory neurons: 119.0;Inhibitory neurons: 63.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (6.24e-3)" "unprognostic (7.69e-2)" "unprognostic (1.21e-2)" "unprognostic (1.56e-1)" "unprognostic (7.30e-2)" 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.3 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 119.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 63.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 13.6 2.7 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 OR2AG1 OR2AG3 ENSG00000279486 "Olfactory receptor family 2 subfamily AG member 1" Q9H205 11 6783020-6791558 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 50: Fibroblasts - ECM organization" 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 OR6A2 "OR11-55, OR6A1, OR6A2P" ENSG00000184933 "Olfactory receptor family 6 subfamily A member 2" O95222 11 6791736-6799689 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 OR10A5 "JCG6, OR10A1, OR11-403" ENSG00000166363 "Olfactory receptor family 10 subfamily A member 5" Q9H207 11 6845652-6846705 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.14e-5)" 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A2 "OR10A2P, OST363" ENSG00000170790 "Olfactory receptor family 10 subfamily A member 2" Q9H208 11 6863057-6874717 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 11: Alveolar cells - Smell perception" "unprognostic (5.04e-2)" 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A4 OR10A4P ENSG00000170782 "Olfactory receptor family 10 subfamily A member 4" Q9H209 11 6876625-6877619 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (1.16e-1)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 OR2D2 "hg27, OR11-610, OR2D1" ENSG00000166368 "Olfactory receptor family 2 subfamily D member 2" Q9H210 11 6891490-6892599 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.4 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 OR2D3 ENSG00000178358 "Olfactory receptor family 2 subfamily D member 3" Q8NGH3 11 6920974-6922043 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052551 Uncertain NA NA "Cluster 55: Plasma cells - Humoral immune response" "HPA052551: AB_2681867" "unprognostic (4.52e-1)" 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.7 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF215 "ZKSCAN11, ZSCAN43" ENSG00000149054 "Zinc finger protein 215" Q9UL58 11 6926404-7001004 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 4.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 13.7;Inhibitory neurons: 8.5;Plasma cells: 27.5;Spermatogonia: 9.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-698: 19.8" "Low region specificity" "Detected in many" "HPA047243, HPA051010" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 11: Basophils - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Nucleoplasm, Vesicles" "HPA047243: , HPA051010: AB_2681308" "unprognostic (2.18e-2)" "unprognostic (1.52e-1)" "unprognostic (2.29e-2)" "unprognostic (1.08e-1)" "unprognostic (8.18e-2)" "unprognostic (4.76e-2)" "unprognostic (1.01e-4)" "unprognostic (2.02e-1)" "unprognostic (1.50e-2)" "unprognostic (1.05e-1)" "unprognostic (3.44e-1)" "unprognostic (1.45e-2)" "unprognostic (9.01e-3)" "unprognostic (4.29e-3)" "unprognostic (7.89e-2)" "unprognostic (1.21e-1)" "unprognostic (1.90e-1)" 0.4 0.4 0.4 1.3 0.4 0.7 1.3 0.2 0.5 0.8 0.1 2.0 2.2 0.7 0.6 0.9 0.4 0.5 0.4 0.4 0.5 1.0 0.3 0.5 3.4 0.5 0.4 0.8 2.2 0.0 0.2 0.2 0.4 0.8 2.6 0.4 1.4 0.4 0.2 0.5 1.9 0.5 0.2 1.6 0.8 1.5 0.6 1.2 0.8 0.1 4.2 1.1 0.7 0.3 2.9 1.1 1.8 0.2 1.2 1.7 6.4 7.0 5.7 3.6 6.5 0.2 0.0 10.1 2.1 3.2 4.3 3.1 4.8 6.4 6.3 0.0 7.5 0.0 0.3 0.0 1.2 6.5 0.0 3.2 3.1 0.1 7.0 1.4 5.3 0.1 11.5 3.1 1.3 0.0 0.1 0.0 8.9 0.0 1.6 0.0 0.0 1.3 0.1 5.3 0.0 0.2 0.0 2.4 0.0 4.4 0.1 2.4 2.8 2.0 5.8 2.4 0.0 0.3 0.1 19.8 4.8 0.0 1.9 1.5 0.4 0.1 0.1 0.2 0.0 0.6 0.1 0.3 0.4 0.5 0.3 0.1 0.6 0.2 0.1 0.7 0.2 0.3 0.4 0.4 0.2 0.5 0.4 0.5 0.5 0.4 0.4 0.2 0.6 0.3 0.2 0.0 0.0 0.3 2.5 0.4 1.7 1.0 1.8 0.6 0.7 0.3 0.2 0.0 0.9 7.3 6.2 0.4 0.1 0.9 1.9 0.1 0.3 0.8 1.8 0.6 1.2 2.5 13.7 1.8 2.6 1.1 0.0 0.9 1.3 0.6 0.0 0.9 0.4 3.3 8.5 3.5 0.0 0.3 0.0 0.3 0.0 0.8 1.8 3.7 0.0 0.1 0.0 1.5 0.4 0.3 0.8 0.0 27.5 0.6 2.0 1.1 0.4 0.0 0.0 0.2 0.7 5.6 9.1 2.3 0.3 0.0 0.8 2.2 2.2 0.8 ZNF214 ENSG00000149050 "Zinc finger protein 214" Q9UL59 11 6997085-7020346 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 6.6;Endometrial ciliated cells: 6.6;Excitatory neurons: 10.5;Respiratory ciliated cells: 10.4;Spermatocytes: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 3.5" HPA055391 Uncertain Approved Nucleoplasm,Midbody Yes NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 12: NES - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm Midbody "HPA055391: AB_2682804" "unprognostic (3.01e-2)" "unprognostic (3.04e-1)" "unprognostic (1.56e-2)" "unprognostic (2.33e-1)" "unprognostic (8.77e-2)" "unprognostic (2.43e-2)" "unprognostic (3.28e-3)" "unprognostic (7.53e-4)" "unprognostic (1.71e-1)" "unprognostic (1.39e-2)" "unprognostic (3.21e-1)" "unprognostic (1.29e-1)" "unprognostic (3.67e-3)" "unprognostic (3.00e-2)" "unprognostic (3.21e-2)" "unprognostic (1.16e-1)" "unprognostic (6.22e-2)" 0.6 1.0 1.0 0.2 1.2 0.0 2.1 0.8 1.5 2.3 1.8 1.2 0.5 2.3 2.7 0.5 3.9 0.8 0.8 0.9 1.1 2.4 1.2 1.2 0.2 1.8 1.7 4.2 1.0 2.5 1.3 0.1 1.1 2.0 1.1 5.3 0.9 2.1 0.4 0.4 0.6 1.7 1.2 0.2 0.7 3.1 1.0 0.2 3.4 0.5 0.2 1.4 1.3 1.4 0.4 0.8 3.3 0.0 0.6 2.2 0.8 1.3 3.5 1.7 1.9 0.0 2.4 0.1 0.4 0.9 1.1 0.5 0.3 0.9 1.9 0.0 0.9 0.0 0.5 0.2 1.2 0.0 0.1 0.6 2.2 0.0 1.9 2.3 1.5 0.0 0.2 0.0 0.6 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.2 0.5 0.0 2.6 1.3 0.1 0.1 1.3 0.5 0.0 0.2 1.1 1.4 3.0 0.0 0.0 0.0 0.0 1.9 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.8 1.5 0.9 1.1 1.8 1.7 1.1 1.2 1.0 1.4 0.5 0.0 1.5 4.6 0.1 0.0 2.0 1.6 0.6 2.5 1.1 1.5 0.9 1.5 2.7 0.0 0.0 0.1 0.0 0.4 1.9 2.1 6.6 6.6 2.0 0.6 2.4 0.0 10.5 0.9 0.4 1.5 0.0 0.9 0.0 1.2 0.0 0.4 0.1 3.3 5.5 1.7 0.0 0.0 0.5 1.0 0.6 0.2 0.0 2.8 0.0 3.0 0.0 4.0 2.9 1.1 0.1 0.4 0.0 0.6 0.8 3.3 10.4 3.6 0.0 0.8 0.9 10.4 3.3 0.9 0.1 0.0 0.2 0.8 0.9 0.4 NLRP14 "CLR11.2, GC-LRR, Nalp-iota, NALP14, NOD5, PAN8" ENSG00000158077 "NLR family pyrin domain containing 14" Q86W24 11 7020479-7071526 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Astrocytes: 2.3;Bipolar cells: 2.2;Cone photoreceptor cells: 2.1;Distal tubular cells: 1.9;Early spermatids: 2.2;Excitatory neurons: 2.2;Rod photoreceptor cells: 3.2;Spermatocytes: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039477 Approved Uncertain Cytosol NA NA "Cluster 46: Photoreceptor cells - Phototransduction" Cytosol "HPA039477: AB_10794748" "unprognostic (6.46e-3)" "unprognostic (5.76e-3)" "unprognostic (1.44e-4)" "unprognostic (7.20e-4)" "unprognostic (5.57e-2)" "unprognostic (8.02e-3)" "unprognostic (6.57e-2)" "unprognostic (2.65e-1)" "unprognostic (2.68e-1)" "unprognostic (1.44e-1)" "unprognostic (2.68e-1)" "unprognostic (2.65e-2)" "unprognostic (3.17e-3)" "unprognostic (6.69e-2)" "unprognostic (3.22e-1)" "unprognostic (3.85e-2)" "unprognostic (1.25e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.5 0.1 0.1 0.2 0.2 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.2 0.0 0.4 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.9 0.1 2.2 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.2 0.0 0.0 0.0 2.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMXL2 "HNRNPG-T, HNRPGT" ENSG00000170748 "RBMX like 2" O75526 11 7088998-7091148 "Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 189 "testis: 35.9" "Group enriched" "Detected in some" 8 "Early spermatids: 157.6;Late spermatids: 160.6;Spermatocytes: 205.3" "Cancer enriched" "Detected in single" 133 "testis cancer: 6.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038912, HPA051842" Enhanced NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA038912: AB_10670913, HPA051842: AB_2681634" "unprognostic (3.73e-1)" "unprognostic (2.24e-1)" "unprognostic (5.47e-2)" "unprognostic (1.51e-2)" "unprognostic (3.24e-1)" "unprognostic (8.28e-2)" "unprognostic (3.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 35.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 160.6 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 205.3 20.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 SYT9 ENSG00000170743 "Synaptotagmin 9" Q86SS6 11 7238778-7469043 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.9;retina: 7.6" "Cell type enhanced" "Detected in some" "Astrocytes: 48.6;Late spermatids: 23.5;Oligodendrocyte precursor cells: 55.3;Oligodendrocytes: 139.2" "Cancer enhanced" "Detected in some" "breast cancer: 2.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEK 293: 10.3;RT4: 17.9;SH-SY5Y: 13.2;TIME: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 77: Retina - Visual perception" "Cluster 15: RT4 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "unprognostic (1.47e-1)" "unprognostic (9.41e-2)" "unprognostic (1.39e-5)" "unprognostic (1.63e-1)" "unprognostic (1.12e-1)" "unprognostic (5.50e-2)" "unprognostic (4.62e-2)" "unprognostic (1.19e-1)" "unprognostic (1.69e-1)" "unprognostic (1.67e-2)" "unprognostic (1.64e-2)" "unprognostic (1.81e-1)" "unprognostic (3.31e-3)" "unprognostic (4.35e-2)" "unprognostic (1.92e-4)" "unprognostic (1.22e-4)" 0.0 2.0 9.1 0.0 9.2 0.0 0.8 11.7 5.9 0.4 1.4 0.1 0.0 1.2 0.0 0.0 0.1 0.1 0.3 4.7 7.6 2.0 3.6 0.0 0.0 9.9 11.8 0.1 1.3 0.9 1.5 0.0 9.6 1.0 0.0 7.6 0.0 3.6 0.0 0.1 0.1 0.1 8.1 0.0 0.1 0.9 15.9 0.0 1.1 0.0 0.0 0.2 0.3 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 3.5 0.0 0.0 0.0 0.0 17.9 3.2 13.2 0.0 0.0 0.0 0.4 0.0 0.0 20.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 9.2 11.7 5.9 4.7 7.6 9.9 11.8 9.6 8.1 15.9 11.7 0.0 0.0 0.0 48.6 0.5 0.0 0.1 0.0 0.0 13.6 0.7 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 13.9 0.0 0.2 0.0 0.0 0.0 15.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 6.2 0.0 3.3 9.8 0.0 0.0 0.3 0.0 23.5 0.0 0.0 0.0 5.6 0.0 2.0 0.0 55.3 139.2 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 3.5 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OLFML1 UNQ564 ENSG00000183801 "Olfactomedin like 1" Q6UWY5 11 7485388-7511377 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Fibroblasts: 52.3;Leydig cells: 39.7;Peritubular cells: 39.5;Sertoli cells: 26.3;Smooth muscle cells: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 31.2;U-2197: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058824 Approved "Secreted - unknown location" NA NA 260000 "Cluster 14: Monocytes - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 50: Fibroblasts - ECM organization" "HPA058824: " "unprognostic (3.05e-1)" "unprognostic (5.35e-2)" "unprognostic (1.52e-1)" "unprognostic (3.80e-2)" "unprognostic (5.32e-1)" "unprognostic (1.82e-3)" "unprognostic (1.36e-1)" "unprognostic (1.16e-1)" "unprognostic (7.33e-2)" "unprognostic (1.37e-2)" "unprognostic (2.30e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.28e-8)" "unprognostic (3.13e-3)" "unprognostic (2.00e-2)" "unprognostic (3.34e-2)" "unprognostic (8.72e-3)" 21.6 6.2 1.4 5.2 1.8 0.3 12.5 2.2 1.9 27.2 7.5 8.4 5.0 19.0 21.3 8.2 17.5 23.8 14.8 1.8 1.9 6.4 10.8 18.9 9.3 2.0 1.5 48.6 2.8 2.3 3.1 7.3 1.7 14.1 10.2 0.2 5.6 18.3 5.2 8.3 7.2 18.0 1.2 14.7 5.4 4.1 2.1 3.2 8.2 12.1 5.6 14.9 17.7 2.0 0.0 0.0 0.4 0.0 1.9 1.9 31.2 0.3 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.2 0.1 0.1 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 6.4 0.0 0.0 0.1 0.2 0.1 20.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.6 0.1 0.1 0.2 0.0 0.8 0.1 0.0 0.0 1.4 1.8 2.2 1.9 1.8 1.9 2.0 1.5 1.7 1.2 2.1 2.0 6.1 0.0 0.0 1.0 0.4 5.2 0.0 0.0 1.2 0.1 0.2 0.3 1.0 0.0 0.6 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.3 13.3 2.9 0.0 0.0 0.1 0.0 2.0 52.3 0.0 0.4 0.0 0.0 5.0 0.9 0.6 0.0 0.1 0.0 0.0 0.0 6.1 0.7 39.7 0.4 7.2 2.8 0.0 0.0 0.0 0.5 1.4 0.1 0.0 39.5 0.2 0.1 0.0 0.3 0.0 0.0 26.3 9.4 16.3 0.3 0.1 0.2 3.7 0.3 0.7 5.0 0.0 0.1 PPFIBP2 Cclp1 ENSG00000166387 "PPFIA binding protein 2" Q8ND30 11 7513298-7657127 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 53.4;Extravillous trophoblasts: 56.2;Oligodendrocytes: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 80.5;OE19: 100.4;RT4: 105.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001935, HPA003911" Enhanced Approved Mitochondria NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 21: OE19 - Mitochondria" "Cluster 44: Endometrium - Transcription" Mitochondria "HPA001935: AB_1079667, HPA003911: AB_1079666" "unprognostic (4.14e-2)" "unprognostic (7.04e-3)" "unprognostic (7.20e-3)" "unprognostic (5.79e-2)" "unprognostic (2.08e-1)" "prognostic favorable (2.32e-4)" "unprognostic (1.33e-1)" "prognostic favorable (2.26e-5)" "unprognostic (6.66e-3)" "unprognostic (2.90e-1)" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "prognostic favorable (5.39e-8)" "unprognostic (1.78e-1)" "unprognostic (3.38e-1)" "unprognostic (2.52e-2)" "prognostic favorable (1.34e-5)" 10.8 11.7 21.5 12.0 34.2 7.6 16.6 24.9 24.4 14.7 51.3 22.4 26.4 6.7 33.5 27.3 17.2 15.7 13.0 21.8 26.2 19.0 35.4 11.6 15.2 27.4 29.8 14.3 9.4 66.5 4.8 21.0 29.0 18.2 26.5 2.8 54.8 32.8 33.4 33.2 26.0 5.4 20.6 11.1 44.1 31.5 31.7 4.5 37.5 21.4 25.0 29.5 21.8 43.8 2.0 32.7 5.3 3.1 6.1 0.4 80.5 7.1 16.1 4.1 4.0 26.7 4.6 9.7 3.7 4.1 15.1 14.2 21.0 2.1 3.7 3.9 2.4 0.0 0.3 17.1 8.4 19.6 9.3 10.7 7.6 0.0 4.5 0.4 1.5 2.0 0.9 26.5 4.0 15.9 0.0 19.0 37.8 100.4 0.1 3.3 0.1 17.4 0.1 105.0 1.5 12.4 1.1 28.9 21.9 14.6 4.0 14.7 0.5 1.9 2.8 6.4 0.7 14.1 11.1 8.3 2.3 4.5 13.0 3.4 9.1 6.5 3.1 11.2 2.3 12.7 5.0 2.1 8.3 7.2 6.6 5.2 4.2 2.6 14.4 0.6 1.1 5.2 21.5 34.2 24.9 24.4 21.8 26.2 27.4 29.8 29.0 20.6 31.7 43.8 1.7 16.0 13.6 3.9 21.2 5.5 18.7 4.5 10.2 1.5 10.1 7.7 5.2 11.5 13.7 14.7 18.8 9.1 1.6 29.8 9.8 5.8 53.4 6.7 4.8 3.2 3.6 0.0 3.8 9.6 56.2 7.7 40.2 35.7 7.0 0.6 1.1 17.3 7.1 0.0 6.0 23.2 8.2 10.4 7.2 47.2 4.7 11.3 16.0 17.8 15.7 1.7 3.1 49.8 70.5 6.9 22.8 7.2 9.0 13.4 26.8 19.7 7.5 3.3 0.0 5.7 10.2 22.2 2.6 10.7 9.9 4.8 2.0 1.2 18.0 18.6 CYB5R2 ENSG00000166394 "Cytochrome b5 reductase 2" Q6BCY4 11 7665100-7677222 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 139.2;testis: 133.6" "Cell type enhanced" "Detected in many" "Early spermatids: 268.0;Late spermatids: 601.1;Spermatocytes: 115.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "eosinophil: 6.1;memory B-cell: 10.6;naive B-cell: 2.8" "Group enriched" "Detected in many" 9 "B-cells: 10.6;granulocytes: 6.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 125.1;BJ hTERT+ SV40 Large T+: 65.9;BJ hTERT+ SV40 Large T+ RasG12V: 59.4;HBF TERT88: 52.0;NTERA-2: 69.8;WM-115: 96.3" "Low region specificity" "Detected in single" "HPA038962, HPA061707" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 77: Retina - Visual perception" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" Nucleoplasm "HPA038962: AB_10675954, HPA061707: AB_2732668" "unprognostic (1.47e-1)" "unprognostic (2.56e-2)" "unprognostic (8.90e-3)" "unprognostic (4.41e-2)" "unprognostic (4.13e-3)" "unprognostic (1.60e-2)" "unprognostic (4.02e-2)" "unprognostic (2.48e-1)" "unprognostic (3.41e-2)" "unprognostic (1.30e-2)" "unprognostic (2.64e-3)" "unprognostic (1.10e-1)" "unprognostic (4.78e-2)" "unprognostic (1.40e-1)" "unprognostic (8.16e-2)" "unprognostic (1.70e-1)" "unprognostic (7.01e-2)" 8.8 3.6 17.2 5.7 23.1 4.1 15.6 18.7 25.3 15.6 13.2 4.6 2.4 22.8 25.5 19.6 10.1 6.8 4.7 18.2 19.7 5.9 5.1 11.5 2.7 19.5 22.5 29.3 4.3 29.0 1.3 13.8 19.2 19.5 5.3 139.2 35.7 22.3 1.7 51.1 4.3 13.2 16.9 3.0 5.6 133.6 21.8 0.9 5.1 1.7 10.5 13.3 17.7 28.0 7.1 3.6 1.5 0.0 0.3 1.7 22.8 43.9 125.1 65.9 59.4 0.7 9.4 0.2 10.3 22.7 20.2 0.8 0.1 0.3 52.0 0.1 0.2 0.0 3.8 0.9 35.0 0.4 6.6 17.7 1.4 0.3 3.7 0.1 5.6 0.0 6.9 0.1 0.5 0.0 0.0 0.1 69.8 7.4 3.4 34.1 0.1 0.0 0.0 4.4 0.0 0.7 0.3 28.0 1.9 11.1 4.8 9.4 0.0 6.1 0.1 0.3 3.4 0.2 0.0 10.7 0.5 0.0 96.3 0.0 0.9 6.1 0.0 0.5 0.0 10.6 0.1 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 17.2 23.1 18.7 25.3 18.2 19.7 19.5 22.5 19.2 16.9 21.8 28.0 0.6 22.4 5.1 0.0 2.3 7.0 8.4 12.3 8.6 1.3 8.8 12.8 3.0 1.5 6.3 3.7 20.9 5.3 0.1 0.6 0.0 1.4 268.0 5.5 11.2 1.7 0.0 0.0 0.0 4.7 20.0 8.1 1.5 14.3 2.5 0.5 0.4 1.8 2.5 0.0 0.1 1.8 6.1 0.0 0.5 601.1 4.7 1.5 5.4 1.9 0.5 0.8 0.0 0.5 8.5 6.0 1.4 6.0 2.9 11.2 0.3 0.4 10.2 35.2 13.1 2.3 7.5 115.6 9.8 12.8 10.1 4.5 0.2 1.8 1.8 11.4 OVCH2 OVTN ENSG00000183378 "Ovochymase 2" 11 7689437-7706421 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 15 "epididymis: 189.0;retina: 92.2" "Group enriched" "Detected in some" 7 "Collecting duct cells: 7.3;Rod photoreceptor cells: 16.6" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.5" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "REH: 25.2" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 46: Photoreceptor cells - Phototransduction" "unprognostic (1.59e-2)" "unprognostic (3.74e-1)" "unprognostic (8.03e-2)" "unprognostic (9.77e-2)" "unprognostic (1.85e-1)" "unprognostic (1.70e-2)" "unprognostic (2.02e-1)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (2.84e-2)" "unprognostic (3.06e-1)" "unprognostic (9.27e-2)" "unprognostic (7.65e-2)" "unprognostic (1.22e-2)" 0.0 0.0 0.1 0.0 0.3 0.4 3.4 0.8 0.2 0.1 0.1 0.0 0.0 0.2 189.0 0.1 0.3 0.0 0.0 0.0 0.1 5.3 0.0 2.4 0.0 0.7 0.4 0.0 0.0 0.0 0.0 1.4 1.0 1.1 0.0 92.2 0.8 5.8 0.4 9.1 0.1 0.0 0.1 0.0 0.5 0.5 0.8 0.0 0.0 0.0 0.1 0.9 0.2 0.7 3.4 0.0 0.3 0.0 0.0 0.0 0.5 0.8 0.6 0.1 0.3 0.2 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 25.2 0.0 0.2 0.2 2.7 0.0 0.2 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.2 0.0 0.1 0.7 0.4 1.0 0.1 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.1 1.3 0.1 0.0 0.0 7.3 0.0 1.4 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.1 0.0 0.7 0.0 16.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 OR5P2 JCG3 ENSG00000183303 "Olfactory receptor family 5 subfamily P member 2" Q8WZ92 11 7795905-7796973 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "Rod photoreceptor cells: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 46: Photoreceptor cells - Phototransduction" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 3.7 4.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5P3 JCG1 ENSG00000182334 "Olfactory receptor family 5 subfamily P member 3" Q8WZ94 11 7824818-7830840 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "Cone photoreceptor cells: 4.2;Rod photoreceptor cells: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060787 Uncertain NA NA "Cluster 46: Photoreceptor cells - Phototransduction" "HPA060787: AB_2684364" "unprognostic (1.54e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 OR10A6 ENSG00000279000 "Olfactory receptor family 10 subfamily A member 6 (gene/pseudogene)" Q8NH74 11 7924592-7931268 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A3 "HSHTPCRX12, HTPCRX12" ENSG00000170683 "Olfactory receptor family 10 subfamily A member 3" P58181 11 7937171-7941708 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.53e-2)" "unprognostic (3.24e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLRP10 "CLR11.1, NALP10, NOD8, PAN5, Pynod" ENSG00000182261 "NLR family pyrin domain containing 10" Q86W26 11 7957537-7965426 "Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skin 1: 6.3" "Cell type enriched" "Detected in single" 5 "Microglial cells: 1.0" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 22.3;BJ: 5.9;HBF TERT88: 7.7;LHCN-M2: 3.7" "Region enhanced" "Detected in some" "olfactory bulb: 2.1" "HPA039498, HPA040101" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 61: Skin - Cornification" "Cluster 10: BJ & FHDF - ECM organization" Nucleoplasm "Nuclear membrane" "HPA039498: AB_10795679, HPA040101: AB_10795519" "unprognostic (4.06e-1)" "unprognostic (4.34e-1)" "unprognostic (9.78e-3)" "unprognostic (2.87e-2)" 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.1 6.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.3 0.0 0.0 0.1 0.0 0.3 0.1 5.9 2.8 1.3 2.8 0.1 0.0 0.0 0.1 1.8 0.0 0.0 0.0 1.0 7.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.3 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.9 2.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 EIF3F "eIF3-epsilon, eIF3-p47, EIF3S5" ENSG00000175390 "Eukaryotic translation initiation factor 3 subunit F" O00303 11 7970251-8001862 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis, Ubl conjugation pathway" "Hydrolase, Initiation factor, Protease, Thiol protease" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049250 Approved NA NA 83000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 50: Non-specific - Ribosome" "Cluster 24: NB-4 - Immune response" "Cluster 32: Non-specific - Translation" "HPA049250: AB_2680692" "unprognostic (1.11e-2)" "unprognostic (1.42e-1)" "unprognostic (8.46e-2)" "unprognostic (1.15e-2)" "unprognostic (8.50e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (1.16e-1)" "unprognostic (1.97e-1)" "unprognostic (1.74e-1)" "unprognostic (3.11e-1)" "unprognostic (2.04e-1)" "unprognostic (1.57e-1)" "unprognostic (5.66e-2)" "unprognostic (2.61e-1)" "unprognostic (8.36e-2)" "unprognostic (8.78e-2)" 225.1 160.8 7.8 10.2 7.4 21.7 216.8 8.6 7.6 249.1 5.1 248.9 10.5 206.8 10.1 227.3 213.3 16.7 186.2 7.6 6.6 165.8 160.3 157.0 24.7 7.9 6.8 353.9 361.3 8.0 126.6 11.7 7.7 170.0 12.6 15.5 175.5 12.9 374.0 333.1 188.6 21.2 6.7 201.6 238.9 132.7 7.3 11.8 153.7 12.8 25.4 218.7 212.9 8.2 23.6 9.3 12.7 11.3 23.5 52.6 39.9 16.1 28.1 20.3 19.4 9.6 23.0 70.4 6.7 15.7 9.1 12.5 9.9 27.7 20.4 23.1 32.4 24.8 9.5 11.1 38.7 26.9 10.0 32.2 32.7 7.9 18.7 18.6 20.7 12.6 21.5 16.1 22.2 9.6 15.8 25.5 13.1 9.5 22.6 17.7 17.3 22.4 11.0 15.8 29.2 50.6 15.2 6.7 19.3 7.7 11.9 18.6 19.3 9.5 11.0 6.9 11.7 11.8 21.1 29.0 6.4 16.8 12.6 37.5 92.4 41.7 81.5 99.7 112.1 174.6 130.5 96.4 130.9 161.6 155.4 114.5 11.7 95.8 93.6 87.7 177.6 246.5 7.8 7.4 8.6 7.6 7.6 6.6 7.9 6.8 7.7 6.7 7.3 8.2 179.9 109.0 145.4 11.1 355.2 349.1 364.1 411.0 266.9 72.2 271.6 285.6 96.8 264.5 197.2 79.1 52.1 631.3 283.7 121.1 293.5 277.0 424.5 113.8 204.9 218.3 210.2 221.7 11.5 442.8 670.6 216.3 139.7 112.1 164.8 335.7 256.6 170.6 344.2 45.4 10.9 262.0 140.4 423.1 398.1 913.3 246.0 263.4 247.3 8.4 471.1 141.5 362.5 7.5 18.8 322.2 242.2 196.7 237.6 247.4 312.9 286.9 115.1 87.1 98.6 222.4 374.3 197.0 124.8 358.3 440.4 563.4 319.3 264.8 392.2 426.0 TUB rd5 ENSG00000166402 "TUB bipartite transcription factor" P50607 11 8019244-8106243 "Disease related genes, Predicted intracellular proteins" "Phagocytosis, Sensory transduction" Obesity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 79.1;retina: 82.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 41.7;Excitatory neurons: 34.6;Horizontal cells: 30.3;Inhibitory neurons: 23.2;Oligodendrocyte precursor cells: 23.1;Rod photoreceptor cells: 55.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 26.8;HEK 293: 33.7;HeLa: 54.3;SCLC-21H: 51.0;SH-SY5Y: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017997, HPA049019" Enhanced Approved "Nucleoli,Centriolar satellite" "Intracellular and membrane" NA NA "Cluster 77: Retina - Visual perception" "Cluster 20: HeLa - Mitochondria" "Cluster 46: Photoreceptor cells - Phototransduction" "Centriolar satellite" Nucleoli "HPA017997: AB_1858449, HPA049019: AB_2680601" "unprognostic (2.53e-1)" "unprognostic (7.23e-2)" "unprognostic (1.80e-2)" "unprognostic (4.06e-2)" "unprognostic (9.62e-2)" "unprognostic (1.47e-2)" "unprognostic (1.53e-2)" "unprognostic (2.53e-1)" "unprognostic (9.71e-2)" "unprognostic (5.08e-2)" "prognostic favorable (2.85e-4)" "unprognostic (4.18e-1)" "prognostic favorable (2.35e-5)" "unprognostic (8.37e-3)" "unprognostic (1.61e-1)" "unprognostic (1.41e-1)" "unprognostic (1.39e-2)" 7.1 17.3 25.5 2.5 26.2 0.2 6.6 14.4 25.1 26.5 2.5 8.1 2.0 24.4 10.3 3.2 19.8 4.7 12.6 35.9 31.4 11.4 0.9 3.9 1.9 18.6 79.1 18.2 4.6 13.7 31.7 4.3 30.8 8.6 2.3 82.6 5.3 8.1 2.9 6.4 3.9 11.3 18.0 1.7 3.7 5.0 27.5 2.5 10.8 8.2 0.9 11.0 13.9 16.4 0.0 9.8 14.2 16.7 13.2 4.3 0.0 9.4 2.5 9.9 13.2 0.0 0.1 0.0 0.8 13.2 4.6 0.1 26.8 2.0 9.2 0.0 33.7 0.0 54.3 6.1 2.2 0.0 0.4 6.8 2.4 4.7 0.0 0.8 0.9 15.7 0.0 0.1 4.8 1.4 0.1 0.1 9.4 0.0 0.1 12.6 0.2 0.0 0.0 0.5 51.0 38.1 6.9 0.1 2.6 6.3 1.4 0.2 0.0 5.4 12.5 0.9 3.9 0.1 0.0 0.0 4.9 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.5 26.2 14.4 25.1 35.9 31.4 18.6 79.1 30.8 18.0 27.5 16.4 0.5 0.0 0.0 15.0 0.0 0.8 2.0 0.1 1.2 15.5 0.8 1.9 3.5 1.5 0.7 0.0 41.7 0.2 0.1 0.0 5.9 0.1 4.2 4.4 14.1 0.5 1.8 0.0 34.6 0.0 0.4 6.8 0.0 0.4 1.3 10.1 1.4 0.2 0.2 30.3 23.2 0.0 0.0 0.0 0.7 4.9 14.6 0.2 1.8 8.4 0.0 12.6 0.0 23.1 1.9 0.0 0.0 14.7 0.1 1.5 0.0 10.2 5.1 55.6 0.0 6.8 1.5 1.6 1.4 0.2 0.9 0.0 0.5 0.5 0.0 0.4 RIC3 "AYST720, FLJ11608, PRO1385" ENSG00000166405 "RIC3 acetylcholine receptor chaperone" Q7Z5B4 11 8106056-8169055 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 175.2;Cone photoreceptor cells: 143.9;Rod photoreceptor cells: 204.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 4 "B-cells: 12.8;granulocytes: 4.5;T-cells: 6.7" "Cell line enhanced" "Detected in some" "GAMG: 2.3;HMC-1: 2.6;NTERA-2: 5.0;SCLC-21H: 8.3;SH-SY5Y: 5.8;SuSa: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065016 Approved "Intracellular and membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 77: Retina - Visual perception" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 52: Non-specific - Transcription" "HPA065016: AB_2685404" "unprognostic (2.51e-3)" "unprognostic (2.32e-1)" "unprognostic (1.21e-1)" "unprognostic (6.98e-4)" "unprognostic (3.22e-2)" "unprognostic (1.04e-2)" "unprognostic (1.29e-1)" "unprognostic (2.43e-2)" "unprognostic (1.59e-2)" "unprognostic (1.48e-2)" "unprognostic (4.45e-4)" "unprognostic (1.28e-1)" "unprognostic (2.23e-9)" "unprognostic (4.37e-2)" "unprognostic (5.53e-2)" "unprognostic (1.35e-1)" "unprognostic (2.52e-2)" 3.1 13.5 17.9 5.2 17.8 1.9 6.4 24.6 21.7 8.9 14.8 11.3 1.9 10.9 21.5 5.7 10.1 3.5 9.8 17.0 20.3 10.5 3.5 3.7 7.7 15.5 15.5 19.7 18.0 11.7 31.3 0.3 16.0 16.9 2.1 42.2 16.0 10.3 5.9 14.2 8.2 6.1 14.1 7.3 8.5 7.4 16.2 2.1 22.9 2.4 7.1 10.5 5.9 17.3 0.0 0.9 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 2.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 8.3 5.8 0.1 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.9 0.1 1.2 0.5 0.0 0.0 0.1 0.0 0.1 4.5 0.6 1.3 2.2 0.8 1.4 11.9 4.6 2.4 0.6 12.8 6.7 5.9 1.9 1.8 1.7 1.6 2.6 0.8 17.9 17.8 24.6 21.7 17.0 20.3 15.5 15.5 16.0 14.1 16.2 17.3 1.5 6.4 15.5 56.2 79.1 36.3 55.9 8.2 58.6 175.2 34.8 47.0 14.0 42.9 20.7 23.9 143.9 0.5 7.2 0.1 0.0 33.5 2.9 0.2 1.6 4.2 7.7 4.4 95.3 28.5 0.3 10.8 2.0 0.2 24.6 9.5 6.4 4.9 0.2 95.9 90.1 4.4 8.2 1.0 2.2 4.5 33.5 2.2 12.4 17.8 3.3 52.3 4.1 101.0 50.4 14.6 1.4 46.6 18.6 38.6 3.1 6.6 19.4 204.9 0.0 9.0 7.0 51.0 39.5 15.9 39.6 0.5 19.8 1.1 1.5 38.2 LMO1 "RBTN1, RHOM1, TTG1" ENSG00000166407 "LIM domain only 1" P25800 11 8224309-8268716 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.8;skeletal muscle: 29.3;tongue: 12.4" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 18.5;Distal tubular cells: 27.4;Early spermatids: 60.7;Horizontal cells: 40.4" "Cancer enriched" "Detected in many" 6 "glioma: 6.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 33.8;SCLC-21H: 12.5;SH-SY5Y: 38.5;SiHa: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 29: Early spermatids - Spermatogenesis" "unprognostic (3.74e-3)" "unprognostic (1.45e-1)" "unprognostic (4.75e-6)" "unprognostic (9.34e-2)" "unprognostic (2.37e-1)" "unprognostic (1.98e-1)" "unprognostic (7.06e-3)" "unprognostic (8.09e-2)" "unprognostic (2.24e-1)" "unprognostic (9.05e-2)" "unprognostic (4.36e-12)" "unprognostic (1.76e-2)" "unprognostic (8.88e-2)" "unprognostic (2.58e-2)" "unprognostic (3.13e-2)" 0.1 1.2 2.4 0.1 2.3 0.0 0.3 4.1 3.4 0.0 1.1 0.2 0.2 0.1 1.6 0.3 0.1 0.0 1.1 3.2 3.2 3.5 0.0 0.0 0.0 5.3 9.8 0.1 0.8 0.0 2.3 0.1 5.2 0.1 0.0 2.0 0.3 0.0 29.3 7.3 0.0 0.2 1.9 0.5 0.7 2.2 5.3 0.0 0.1 12.4 0.0 0.3 0.1 2.4 0.1 0.9 1.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.1 0.1 0.5 0.0 0.0 0.0 1.5 0.0 33.8 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.3 0.0 4.3 0.0 0.0 0.0 0.6 1.4 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 38.5 7.9 4.4 0.2 1.5 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.1 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.3 4.1 3.4 3.2 3.2 5.3 9.8 5.2 1.9 5.3 2.4 0.1 0.0 0.0 3.3 0.0 18.5 0.1 0.3 1.8 7.1 0.0 0.0 3.0 0.0 0.2 0.0 0.0 0.2 0.0 0.4 27.4 0.1 60.7 0.1 0.1 0.4 0.0 0.0 1.1 1.2 8.4 0.1 0.0 0.5 1.3 0.2 0.0 0.0 0.2 40.4 0.6 0.0 0.0 0.0 0.4 6.8 0.0 0.2 0.0 11.2 0.0 0.5 0.0 3.0 0.3 2.0 1.1 0.4 0.1 0.1 0.0 0.2 2.3 4.0 0.0 0.5 0.7 0.6 1.3 0.3 3.4 0.3 0.0 0.0 0.0 0.0 STK33 ENSG00000130413 "Serine/threonine kinase 33" Q9BYT3 11 8391868-8594289 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 49.3;testis: 51.8" "Cell type enhanced" "Detected in many" "Astrocytes: 213.8;Early spermatids: 98.8;Endometrial ciliated cells: 220.9;Late spermatids: 157.0;Oligodendrocyte precursor cells: 117.6;Respiratory ciliated cells: 155.3;Spermatocytes: 148.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 4.1;naive B-cell: 2.2" "Lineage enriched" "Detected in single" 5 "B-cells: 4.1" "Cell line enhanced" "Detected in many" "Daudi: 23.0;hTERT-RPE1: 22.0;Karpas-707: 21.2;SCLC-21H: 22.9;U-251 MG: 24.3;U-266/84: 21.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015742, HPA056855" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Nucleoli, Cytosol" "HPA015742: AB_1857592, HPA056855: AB_2683257" "unprognostic (2.57e-2)" "unprognostic (2.80e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (3.57e-1)" "unprognostic (1.40e-1)" "unprognostic (7.28e-2)" "unprognostic (3.85e-4)" "unprognostic (1.23e-1)" "unprognostic (8.06e-2)" "unprognostic (1.33e-3)" "unprognostic (9.46e-2)" "prognostic favorable (4.89e-6)" "unprognostic (2.39e-2)" "unprognostic (1.37e-1)" "unprognostic (3.49e-2)" "unprognostic (2.90e-2)" 1.3 8.1 6.7 2.0 6.6 1.3 0.5 8.5 4.9 5.6 49.3 8.3 3.3 12.0 11.3 2.7 42.3 5.1 16.2 6.1 10.1 10.2 0.4 7.1 2.0 14.7 15.6 13.4 6.5 23.1 24.1 0.1 13.3 6.4 1.5 15.6 2.1 11.5 3.9 0.2 3.4 9.3 12.0 1.5 6.0 51.8 12.8 3.8 20.0 6.0 2.2 3.4 1.7 8.3 0.0 3.4 15.4 0.0 0.0 0.0 0.0 3.0 3.1 7.0 6.2 2.2 0.0 23.0 11.5 0.6 8.7 0.0 6.9 2.5 6.0 0.0 18.9 0.0 4.2 5.6 2.5 13.4 0.0 1.1 0.0 0.2 0.0 22.0 0.5 11.2 0.0 21.2 0.3 0.0 0.4 0.0 11.2 0.0 0.0 8.8 2.2 14.3 6.1 0.0 22.9 6.2 0.0 0.0 0.1 4.3 0.0 1.3 0.0 0.0 10.6 0.2 24.3 5.1 21.2 0.3 6.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.1 0.0 0.7 0.0 2.2 0.0 0.6 0.0 0.1 0.0 0.4 0.1 0.2 6.7 6.6 8.5 4.9 6.1 10.1 14.7 15.6 13.3 12.0 12.8 8.3 0.1 19.2 14.5 213.8 6.2 0.0 1.3 1.9 0.0 20.7 0.1 0.3 37.8 8.6 27.5 20.2 70.9 0.1 1.4 0.2 3.9 9.5 98.8 220.9 5.5 1.8 9.1 1.7 12.0 4.9 3.3 5.0 6.1 17.8 1.3 29.3 0.4 0.0 0.3 1.7 15.4 1.6 6.1 0.0 0.0 157.0 4.4 0.6 0.0 23.4 0.0 31.0 0.0 117.6 19.7 4.4 0.4 17.0 5.2 0.5 3.6 13.5 155.3 77.4 0.0 0.2 2.7 148.3 26.8 0.2 0.0 0.0 1.3 6.3 3.5 0.0 TRIM66 "C11orf29, KIAA0298, TIF1D" ENSG00000166436 "Tripartite motif containing 66" O15016 11 8612037-8682694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 47.7;Early spermatids: 46.0;Late spermatids: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027420 Approved Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 20: HeLa - Mitochondria" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm "HPA027420: AB_1858316" "unprognostic (1.26e-1)" "unprognostic (1.97e-1)" "unprognostic (2.43e-1)" "unprognostic (7.54e-2)" "unprognostic (3.99e-2)" "unprognostic (1.37e-3)" "unprognostic (8.01e-2)" "unprognostic (1.18e-1)" "unprognostic (8.49e-2)" "unprognostic (6.79e-2)" "prognostic favorable (8.89e-4)" "unprognostic (1.42e-1)" "prognostic unfavorable (3.96e-4)" "unprognostic (1.67e-1)" "unprognostic (4.26e-1)" "unprognostic (4.67e-2)" "unprognostic (4.31e-1)" 4.4 5.9 4.5 4.0 5.6 2.8 4.6 2.8 4.6 3.9 5.2 4.4 3.5 3.8 8.2 5.2 4.2 3.0 2.4 3.0 5.1 4.9 10.9 3.6 5.3 4.1 5.4 3.6 8.9 3.1 9.5 1.5 4.0 4.2 4.6 3.6 4.3 3.3 3.6 11.9 5.5 3.5 3.3 5.7 5.4 17.3 5.4 4.5 6.2 3.1 5.2 4.2 4.2 3.6 5.3 4.9 2.9 10.2 6.0 4.5 3.6 3.2 3.7 2.2 2.9 6.5 9.9 5.2 2.2 2.9 2.1 7.2 3.1 2.8 2.7 6.1 2.4 5.0 9.2 3.6 2.5 4.5 3.9 7.1 2.8 1.9 6.6 2.4 2.9 13.1 2.7 5.5 2.9 5.8 2.1 3.4 1.8 2.7 4.6 3.0 2.2 2.1 3.1 6.7 2.1 2.0 4.6 3.2 2.2 2.8 4.2 1.0 2.3 4.2 3.8 2.5 2.8 2.3 3.7 6.4 2.8 4.6 2.4 0.0 0.5 0.6 0.7 0.1 0.4 0.6 0.7 0.9 0.7 0.8 0.7 1.1 0.3 0.8 1.3 1.3 0.6 0.3 4.5 5.6 2.8 4.6 3.0 5.1 4.1 5.4 4.0 3.3 5.4 3.6 3.0 3.2 5.6 47.7 4.0 1.8 2.3 3.6 2.2 8.0 5.1 5.6 1.9 4.3 5.1 5.5 12.5 3.6 3.1 4.5 0.0 3.4 46.0 5.0 4.0 3.2 6.0 5.7 14.2 3.2 1.8 2.6 5.1 3.7 1.3 6.7 5.0 9.8 2.6 11.8 17.1 4.2 0.0 5.2 2.2 27.3 1.8 3.8 0.0 13.1 5.9 4.3 3.1 9.5 22.6 3.9 3.9 2.2 3.1 1.6 8.3 2.4 5.4 9.0 13.1 6.5 2.5 14.6 7.2 3.8 1.1 1.4 3.3 8.0 4.4 1.0 RPL27A L27A ENSG00000166441 "Ribosomal protein L27a" P46776 11 8682788-8714759 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060776, HPA063379" Supported Enhanced "Endoplasmic reticulum,Cytosol" NA NA 89000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" "HPA060776: AB_2684359, HPA063379: AB_2684997" "prognostic favorable (7.84e-5)" "unprognostic (1.29e-1)" "unprognostic (1.60e-1)" "unprognostic (9.94e-3)" "unprognostic (3.16e-1)" "unprognostic (1.25e-1)" "unprognostic (1.90e-3)" "unprognostic (2.85e-1)" "unprognostic (2.30e-1)" "unprognostic (1.17e-1)" "unprognostic (1.69e-1)" "unprognostic (2.95e-1)" "prognostic unfavorable (2.83e-10)" "unprognostic (2.28e-2)" "unprognostic (6.87e-2)" "unprognostic (3.37e-2)" "unprognostic (7.68e-2)" 1867.4 1586.5 1112.4 1138.4 1139.6 3242.1 2016.3 1103.5 1682.4 2307.6 1117.4 1835.7 1119.4 1509.5 1253.5 2532.6 1777.9 901.6 1434.4 1090.3 1137.3 1438.8 1513.7 1440.4 2469.0 1140.1 1117.4 3180.8 3079.8 550.4 1329.2 1034.8 1141.6 1798.9 1352.8 562.4 1872.7 559.2 2167.5 2731.4 1875.3 912.5 1148.6 2263.5 1881.1 397.9 1138.3 1569.0 1606.9 1159.8 2278.0 1816.8 2187.8 1161.9 3374.8 2282.4 1427.2 1723.1 1917.9 3636.8 2160.5 2131.4 2659.7 2386.0 1819.2 2904.7 3041.6 4726.7 1635.8 1877.3 1019.4 2400.8 1914.2 2976.5 1781.2 1742.6 4109.6 2101.8 2068.1 3642.3 3180.6 3846.3 2350.4 4015.9 5180.1 380.2 3959.2 3267.2 2398.7 2766.7 2203.9 1446.0 2043.8 2521.0 2863.4 5717.8 2332.9 2478.6 2375.5 2469.8 1504.9 2920.6 2292.2 3298.8 1631.2 2917.9 797.7 2987.9 3547.0 1494.5 1322.2 4282.8 2203.9 778.3 2093.9 2005.3 2746.5 1629.9 3909.0 3975.9 1772.1 2585.6 1433.3 3535.7 5105.6 1567.8 7665.6 4887.2 9888.7 13013.7 10807.7 9082.0 7409.3 11343.1 12593.4 10685.9 1149.1 6890.0 4553.8 7100.8 8081.2 27172.4 1112.4 1139.6 1103.5 1682.4 1090.3 1137.3 1140.1 1117.4 1141.6 1148.6 1138.3 1161.9 715.7 1121.8 1863.9 8.8 3163.6 4858.0 6358.1 4908.5 492.3 215.3 3316.7 1895.8 934.4 2174.7 2795.5 987.7 114.7 5885.0 2461.3 1680.5 2856.5 2520.9 861.4 1138.4 2272.9 2077.8 2118.2 1701.9 7.1 5396.5 7518.8 1703.8 407.8 1787.8 2132.2 1410.6 3162.6 2776.8 4393.9 80.8 8.6 5111.4 1617.4 4642.2 6081.0 1902.1 3623.5 2177.5 2833.5 7.5 4730.9 1006.9 4985.7 8.0 11.0 3962.9 4511.8 1957.0 678.2 5412.4 4146.2 3282.9 1236.0 352.8 1558.1 2338.6 2218.2 503.8 482.7 1064.4 6060.7 6015.7 2992.7 1341.3 5098.3 7041.0 DENND2B "HTS1, p126, ST5" ENSG00000166444 "DENN domain containing 2B" P78524 11 8693351-8910951 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Adipocytes: 3.2;Cardiomyocytes: 6.2;Cytotrophoblasts: 3.7;Extravillous trophoblasts: 1.8;Fibroblasts: 7.1;Hofbauer cells: 5.8;Smooth muscle cells: 5.7;Syncytiotrophoblasts: 2.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "non-classical monocyte: 2.9" "Lineage enriched" "Detected in single" 4 "monocytes: 2.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 95.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046796 Approved Approved Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "HPA046796: AB_2679812" "unprognostic (1.88e-3)" "unprognostic (2.18e-2)" "unprognostic (2.19e-1)" "unprognostic (1.88e-2)" "unprognostic (4.17e-2)" "unprognostic (2.46e-1)" "unprognostic (6.42e-2)" "unprognostic (1.17e-1)" "unprognostic (1.72e-1)" "unprognostic (5.56e-2)" "unprognostic (3.67e-2)" "unprognostic (1.28e-1)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" "unprognostic (8.77e-2)" "unprognostic (1.60e-1)" "unprognostic (1.54e-1)" 26.3 60.0 22.0 19.2 20.4 3.4 26.6 26.6 23.2 72.7 38.2 85.4 28.8 130.3 33.2 62.7 104.6 34.6 35.0 19.1 22.3 29.4 27.4 28.8 12.1 29.7 32.6 69.2 27.5 15.4 21.5 26.4 18.3 45.4 26.7 36.5 37.5 62.9 21.9 22.2 30.3 117.2 21.3 59.7 56.9 41.0 28.0 17.5 36.6 11.1 15.1 65.0 50.4 17.1 32.6 4.9 51.8 9.0 16.8 17.6 2.5 28.9 95.8 27.5 25.4 6.8 34.0 1.0 17.2 52.7 12.1 32.2 10.0 41.7 10.8 4.4 12.7 0.0 16.7 22.8 26.9 0.2 0.2 60.8 11.6 15.6 20.1 56.0 5.5 5.0 6.7 2.8 45.4 3.5 1.8 1.5 7.9 32.2 7.7 1.1 31.5 2.0 37.5 23.4 9.8 31.7 25.7 32.1 19.8 17.7 5.4 1.1 14.9 15.8 24.7 50.6 22.8 8.0 15.5 0.2 24.1 0.2 30.4 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.6 0.4 0.0 0.0 0.4 0.0 2.9 0.0 0.1 0.4 22.0 20.4 26.6 23.2 19.1 22.3 29.7 32.6 18.3 21.3 28.0 17.1 3.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.8 7.1 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 AKIP1 "BCA3, C11orf17" ENSG00000166452 "A-kinase interacting protein 1" Q9NQ31 11 8911139-8920084 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061391 Supported Nucleoplasm NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 39: Non-specific - Mitochondria" "Cluster 18: U-2197 - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "HPA061391: AB_2684499" "unprognostic (7.79e-3)" "unprognostic (5.65e-2)" "unprognostic (1.60e-1)" "prognostic favorable (5.15e-4)" "unprognostic (6.58e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (6.24e-9)" "unprognostic (1.03e-1)" "unprognostic (5.97e-2)" "unprognostic (5.77e-2)" "unprognostic (6.63e-2)" "unprognostic (8.88e-2)" "unprognostic (6.74e-3)" "unprognostic (1.15e-2)" "unprognostic (1.64e-1)" "unprognostic (1.71e-3)" "unprognostic (1.19e-1)" 16.0 33.0 21.3 12.4 21.6 11.0 14.9 20.8 21.9 22.1 21.4 22.2 13.7 22.7 17.3 22.4 19.2 13.5 27.1 21.2 22.8 22.7 15.5 17.2 11.3 21.8 24.6 19.6 13.0 13.9 18.7 16.0 21.9 17.3 11.3 16.4 14.6 14.9 37.7 10.3 14.2 14.9 22.4 25.5 16.7 17.6 22.2 16.0 18.6 22.1 9.1 18.8 17.3 22.7 81.5 73.2 31.1 30.4 29.2 37.0 25.0 58.6 45.6 35.0 33.4 39.2 48.1 14.7 45.2 42.5 36.9 53.4 15.6 28.3 24.2 72.4 40.3 25.1 39.7 34.9 34.3 33.6 29.1 31.7 37.8 17.2 62.9 26.8 32.2 29.0 52.2 15.3 65.3 26.6 27.3 31.2 26.3 39.3 54.6 28.5 22.9 18.7 35.7 33.4 22.0 21.6 67.2 29.3 31.7 20.1 33.7 27.6 53.1 49.0 44.5 84.2 56.7 23.0 63.0 3.6 51.0 40.5 52.6 3.1 31.5 1.4 15.3 29.0 16.1 9.2 17.8 17.4 41.1 8.5 11.9 21.0 1.9 13.1 14.5 43.7 58.8 18.1 21.3 21.6 20.8 21.9 21.2 22.8 21.8 24.6 21.9 22.4 22.2 22.7 16.1 19.2 9.9 6.8 7.8 10.7 15.1 54.0 16.5 15.9 13.2 17.0 11.7 20.0 22.2 20.2 10.4 40.9 12.5 7.0 25.4 41.4 54.6 7.6 20.6 24.5 2.4 15.3 8.3 36.0 41.5 22.0 9.2 10.7 49.4 25.9 22.9 15.2 65.9 25.2 10.3 9.8 75.3 25.5 17.3 28.0 22.1 25.6 16.0 8.4 33.4 32.3 7.2 9.5 5.2 33.1 18.6 48.2 9.0 8.3 11.5 21.0 15.7 15.5 19.7 15.4 22.2 39.8 35.1 18.5 7.1 11.8 14.7 48.9 13.7 11.8 C11orf16 ENSG00000176029 "Chromosome 11 open reading frame 16" Q9NQ32 11 8920076-8933006 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 6.2;fallopian tube: 12.9;lymphoid tissue: 6.2" "Group enriched" "Detected in some" 8 "Endometrial ciliated cells: 40.8;Ionocytes: 28.5;Respiratory ciliated cells: 110.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA040644 Uncertain "Endoplasmic reticulum,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" "Endoplasmic reticulum" Vesicles "HPA040644: " "unprognostic (5.32e-3)" "unprognostic (1.03e-2)" "unprognostic (4.09e-3)" "prognostic favorable (3.32e-4)" "unprognostic (1.73e-1)" "unprognostic (1.35e-2)" "unprognostic (1.94e-5)" "unprognostic (6.40e-4)" "unprognostic (1.58e-2)" "unprognostic (9.99e-2)" "unprognostic (4.87e-2)" "unprognostic (1.05e-1)" "unprognostic (1.84e-1)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" "unprognostic (1.71e-1)" "unprognostic (1.13e-3)" 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.3 0.1 1.0 6.2 0.0 0.0 0.3 0.0 0.0 12.9 0.0 0.0 0.3 0.7 0.3 0.0 2.6 0.0 1.3 2.3 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 2.2 0.6 6.2 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.3 0.1 0.3 0.7 1.3 2.3 0.8 1.0 0.6 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.3 0.1 0.0 0.0 7.1 5.5 0.0 0.1 0.0 0.0 0.0 0.0 1.6 40.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 28.5 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 110.8 0.0 0.0 0.0 1.5 1.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ASCL3 "bHLHa42, HASH3, Sgn1" ENSG00000176009 "Achaete-scute family bHLH transcription factor 3" Q9NQ33 11 8937579-8938211 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "salivary gland: 8.7" "Cell type enriched" "Detected in single" 923 "Ionocytes: 461.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA027032 Uncertain NA NA "Cluster 24: Salivary gland - Salivary secretion" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA027032: AB_10602434" "unprognostic (8.91e-2)" "unprognostic (1.32e-1)" "unprognostic (3.53e-1)" 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 8.7 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 461.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM9B C11orf15 ENSG00000175348 "TMEM9 domain family member B" Q9NQ34 11 8947202-8965011 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037784 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA037784: AB_10671886" "unprognostic (3.18e-1)" "unprognostic (4.68e-2)" "unprognostic (2.58e-1)" "unprognostic (1.84e-3)" "unprognostic (1.13e-1)" "unprognostic (8.48e-3)" "unprognostic (2.56e-2)" "unprognostic (6.34e-2)" "unprognostic (1.52e-1)" "unprognostic (3.78e-2)" "unprognostic (1.89e-2)" "unprognostic (5.06e-1)" "prognostic favorable (4.26e-5)" "unprognostic (1.83e-1)" "unprognostic (1.82e-1)" "unprognostic (5.51e-3)" "unprognostic (9.56e-2)" 34.2 40.0 67.6 33.8 70.5 78.0 47.9 70.1 80.8 37.0 62.3 63.6 54.6 22.2 59.0 62.4 31.4 39.5 53.3 65.1 69.3 60.2 39.8 50.7 40.5 70.6 69.5 24.1 41.4 63.9 38.5 45.2 71.5 34.2 67.0 42.3 51.4 26.0 47.4 45.5 54.8 22.2 70.8 41.7 59.3 27.5 72.0 35.6 75.0 42.9 43.3 47.3 35.9 75.2 63.0 42.4 23.7 46.0 117.1 65.9 41.1 78.4 69.3 45.2 46.3 32.4 96.7 39.1 40.3 81.6 53.2 81.9 22.3 57.5 47.3 72.7 45.0 26.2 36.8 31.0 66.3 53.2 79.5 61.1 94.6 27.9 56.0 61.7 54.5 26.4 21.0 58.0 87.2 43.9 16.6 33.9 7.4 90.1 49.5 18.8 30.4 31.6 67.7 72.4 26.4 22.5 44.8 92.3 40.6 29.7 55.7 35.1 59.4 55.0 24.9 93.7 48.6 24.1 44.7 27.8 69.0 35.0 47.5 178.7 104.5 151.8 98.5 134.7 101.7 103.2 94.3 109.8 112.6 89.3 77.7 109.0 50.5 93.3 150.2 80.7 136.8 159.8 67.6 70.5 70.1 80.8 65.1 69.3 70.6 69.5 71.5 70.8 72.0 75.2 61.5 41.7 52.0 17.9 65.7 65.0 65.5 155.5 58.6 61.0 67.5 35.9 28.6 70.1 104.1 95.6 20.9 104.8 69.6 124.0 70.5 84.5 16.4 29.2 28.0 49.3 31.2 111.6 21.9 80.7 112.9 48.0 34.7 43.8 88.1 21.1 55.0 30.5 109.3 43.7 23.2 78.8 213.6 79.0 109.8 13.4 38.2 70.1 60.5 15.9 58.1 82.6 77.2 24.1 33.8 70.9 103.9 28.6 53.6 59.2 114.7 45.7 53.2 49.2 19.7 41.6 26.2 56.4 58.2 83.7 87.4 160.8 66.8 40.3 82.8 80.6 NRIP3 C11orf14 ENSG00000175352 "Nuclear receptor interacting protein 3" Q9NQ35 11 8980576-9004049 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 72.9;retina: 24.5;testis: 43.5" "Cell type enhanced" "Detected in many" "Early spermatids: 545.3;Horizontal cells: 242.3;Late spermatids: 478.6;Spermatocytes: 189.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "basophil: 13.1" "Lineage enriched" "Detected in many" 12 "granulocytes: 13.1" "Cell line enhanced" "Detected in many" "HMC-1: 51.4;SiHa: 34.3;U-87 MG: 47.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058827, HPA072961" Approved Approved Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "HPA058827: AB_2683829, HPA072961: " "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "unprognostic (8.84e-3)" "unprognostic (5.43e-3)" "unprognostic (1.66e-1)" "unprognostic (2.68e-1)" "unprognostic (2.03e-4)" "unprognostic (1.25e-1)" "unprognostic (1.88e-1)" "unprognostic (3.63e-2)" "unprognostic (1.04e-2)" "unprognostic (1.11e-1)" "unprognostic (1.33e-1)" "unprognostic (1.13e-1)" "unprognostic (1.41e-1)" "unprognostic (5.88e-3)" "unprognostic (1.30e-1)" 1.1 10.2 16.7 1.6 13.4 13.8 3.9 23.2 42.1 3.4 0.0 1.5 0.5 3.2 3.1 0.8 2.2 1.6 1.2 72.9 20.8 1.4 0.2 0.8 0.8 20.5 18.4 0.5 0.4 5.4 1.5 0.8 23.6 0.7 0.6 24.5 0.6 0.9 0.3 0.6 0.6 2.3 25.1 0.5 2.5 43.5 31.6 0.9 0.9 0.2 0.6 1.3 0.7 17.2 0.0 0.9 1.9 0.3 0.7 2.7 0.1 20.3 8.0 16.2 16.9 3.1 1.8 0.1 3.0 5.9 9.6 0.2 5.5 0.5 28.0 1.7 8.5 2.2 1.2 0.2 1.4 26.5 51.4 3.7 0.3 16.7 0.1 17.1 13.3 4.4 4.2 0.2 15.0 0.0 1.3 8.6 6.6 0.1 0.0 0.0 2.8 0.0 0.3 1.2 5.4 1.7 34.3 0.9 5.3 1.4 3.5 2.5 16.6 24.7 11.8 1.4 0.1 0.1 0.0 0.0 47.9 3.1 12.3 13.1 0.1 2.0 0.1 0.3 0.2 0.1 0.5 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.1 0.3 16.7 13.4 23.2 42.1 72.9 20.8 20.5 18.4 23.6 25.1 31.6 17.2 4.0 0.0 1.3 1.0 1.7 2.2 5.7 0.5 0.0 19.6 12.1 8.9 1.6 0.0 0.4 0.0 10.4 0.4 7.4 0.6 5.9 0.4 545.3 3.7 4.1 2.5 5.3 2.7 11.5 1.1 0.5 2.5 7.1 6.6 15.8 2.4 0.0 0.0 12.1 242.3 96.3 0.5 8.2 3.1 17.2 478.6 6.8 12.8 3.6 0.0 0.6 4.4 0.0 4.5 1.6 8.2 0.1 5.7 1.2 3.5 0.1 0.0 0.1 10.6 0.0 6.0 3.6 189.8 44.0 0.9 1.0 1.0 5.5 5.6 0.2 4.2 SCUBE2 "Cegb1, Cegf1, FLJ16792" ENSG00000175356 "Signal peptide, CUB domain and EGF like domain containing 2" Q9NQ36 11 9019476-9138114 "Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 48.8" "Cell type enhanced" "Detected in many" "Adipocytes: 30.3;Basal prostatic cells: 51.4;Breast glandular cells: 45.0;Breast myoepithelial cells: 31.5;Prostatic glandular cells: 39.8" "Cancer enhanced" "Detected in all" "breast cancer: 54.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "non-classical monocyte: 1.0" "Lineage enriched" "Detected in single" 6 "monocytes: 1.0" "Cell line enhanced" "Detected in some" "HAP1: 5.7;SK-MEL-30: 8.1;T-47d: 28.4" "Group enriched" "Detected in some" 4 "olfactory bulb: 4.6;thalamus: 2.7" "Low region specificity" "Detected in all" "HPA006353, HPA029871" Uncertain "Secreted to blood" NA NA 1100000 "Cluster 7: Monocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 35: Glandular cells - Unknown function" "HPA006353: AB_1856642, HPA029871: AB_10602299" "prognostic favorable (2.41e-4)" "unprognostic (5.72e-3)" "unprognostic (2.91e-1)" "unprognostic (1.76e-2)" "unprognostic (2.73e-1)" "unprognostic (6.12e-4)" "unprognostic (3.11e-1)" "unprognostic (6.39e-2)" "unprognostic (2.08e-1)" "unprognostic (9.39e-2)" "unprognostic (1.54e-2)" "unprognostic (3.04e-1)" "unprognostic (1.94e-2)" "unprognostic (9.12e-4)" "unprognostic (4.35e-1)" "unprognostic (5.94e-2)" "unprognostic (2.88e-1)" 14.8 2.0 3.5 3.7 3.5 0.0 32.2 13.7 3.1 17.6 0.2 11.1 3.6 13.4 48.8 4.5 18.2 7.9 4.3 4.0 4.9 1.3 0.9 4.6 3.9 3.0 3.6 0.9 22.0 19.5 9.6 22.5 3.7 33.3 4.5 1.9 2.3 8.7 9.0 12.3 16.3 13.0 5.4 5.0 21.4 2.2 4.7 2.4 5.2 6.2 7.6 28.6 6.9 5.1 0.0 0.1 1.5 0.9 0.5 0.6 0.2 1.6 0.8 0.9 0.6 0.3 0.0 0.0 0.6 3.9 0.1 0.0 5.7 0.0 1.4 0.1 0.3 0.0 0.0 0.0 0.6 0.0 0.1 1.3 0.0 0.4 0.0 0.3 0.6 0.0 0.0 0.0 1.1 0.0 0.0 1.3 0.9 0.0 0.0 0.1 0.0 0.2 0.4 3.1 0.7 1.0 1.1 0.1 8.1 1.3 28.4 0.0 0.0 0.6 0.4 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 3.5 3.5 13.7 3.1 4.0 4.9 3.0 3.6 3.7 5.4 4.7 5.1 30.3 16.0 9.2 1.6 0.0 7.4 51.4 0.3 1.2 0.4 45.0 31.5 0.6 0.0 5.6 1.8 0.0 0.2 0.1 1.0 0.0 0.1 3.4 2.2 8.8 3.3 1.2 0.0 3.1 1.8 0.2 9.4 0.0 6.4 0.0 0.3 1.1 0.1 0.8 13.5 14.9 5.2 6.1 0.3 1.5 2.5 0.3 0.7 19.6 5.6 0.1 0.0 0.0 13.6 4.6 0.1 4.3 0.7 0.0 39.8 0.6 0.0 1.5 0.3 0.0 5.2 1.5 0.6 0.7 0.1 1.8 0.4 0.3 6.6 9.6 15.6 DENND5A "FLJ22354, FLJ33829, FLJ43455, KIAA1091, RAB6IP1" ENSG00000184014 "DENN domain containing 5A" Q6IQ26 11 9138825-9265959 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 287.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052923, HPA055009" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 44: Endometrium - Transcription" "Golgi apparatus, Vesicles" "HPA052923: AB_2681989, HPA055009: AB_2682669" "unprognostic (5.28e-3)" "unprognostic (1.42e-1)" "unprognostic (1.17e-1)" "unprognostic (1.28e-2)" "unprognostic (4.03e-1)" "unprognostic (3.48e-1)" "prognostic unfavorable (5.05e-6)" "unprognostic (1.84e-1)" "unprognostic (2.96e-1)" "unprognostic (1.02e-1)" "unprognostic (5.15e-2)" "unprognostic (3.10e-1)" "prognostic unfavorable (1.14e-6)" "unprognostic (9.86e-3)" "unprognostic (1.03e-1)" "unprognostic (4.32e-1)" "unprognostic (1.40e-2)" 45.8 23.5 72.4 23.2 90.5 21.7 36.3 85.0 80.7 36.1 45.5 44.2 5.8 38.5 14.1 17.4 37.5 23.3 58.0 65.1 85.4 25.5 15.7 46.1 16.8 81.5 86.6 30.2 23.2 18.5 20.5 28.8 77.0 24.5 12.9 34.7 19.5 40.0 26.7 17.3 20.2 47.5 74.9 31.4 23.7 15.8 87.3 28.0 22.0 33.7 15.9 40.4 25.1 81.3 18.8 23.3 63.7 56.1 113.0 92.0 61.7 69.2 99.8 85.7 104.5 16.4 13.6 0.0 30.5 129.0 82.4 12.7 64.3 22.5 111.4 73.0 30.9 6.2 32.2 34.5 61.0 34.4 13.9 76.8 11.5 51.1 74.6 59.7 83.8 21.9 33.6 0.3 101.9 11.0 19.4 15.1 19.7 3.2 28.6 34.2 46.1 0.3 41.6 13.4 15.9 32.1 65.8 29.7 27.2 70.4 15.7 24.6 59.2 63.0 41.0 78.7 47.3 1.4 0.4 18.7 63.4 14.1 51.9 4.4 5.0 5.7 0.1 6.3 0.6 1.8 1.3 1.3 4.6 0.2 3.8 1.9 10.8 1.0 9.2 1.1 0.0 1.9 72.4 90.5 85.0 80.7 65.1 85.4 81.5 86.6 77.0 74.9 87.3 81.3 34.1 19.2 14.5 43.8 7.4 21.7 19.3 10.3 10.2 9.7 15.3 13.8 33.2 14.3 8.0 14.7 60.5 15.9 6.4 0.3 0.0 7.3 1.1 26.3 31.8 31.3 6.6 7.8 47.7 6.7 20.1 27.1 3.1 57.8 2.5 11.6 21.4 10.9 21.8 13.5 74.2 2.2 4.1 36.3 63.4 2.0 21.5 48.9 19.6 68.4 41.1 11.6 3.1 136.2 287.1 8.4 1.4 20.7 0.9 32.5 0.1 10.3 4.8 10.5 26.3 34.4 31.6 7.9 12.3 6.3 8.2 11.2 6.3 16.0 0.8 15.0 TMEM41B KIAA0033 ENSG00000166471 "Transmembrane protein 41B" Q5BJD5 11 9280654-9314636 "Predicted membrane proteins, Transporters" "Autophagy, Host-virus interaction, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 108.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014946 Uncertain Approved Peroxisomes NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 45: Intestine - Brush border" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 44: Endometrium - Transcription" Peroxisomes "HPA014946: AB_2205037" "unprognostic (1.21e-1)" "unprognostic (2.19e-1)" "unprognostic (1.35e-1)" "unprognostic (2.75e-3)" "unprognostic (5.78e-3)" "unprognostic (1.94e-1)" "prognostic unfavorable (9.18e-6)" "unprognostic (6.18e-2)" "unprognostic (9.37e-3)" "unprognostic (4.90e-3)" "unprognostic (1.36e-2)" "unprognostic (4.02e-2)" "unprognostic (1.29e-1)" "unprognostic (1.40e-1)" "unprognostic (2.20e-1)" "unprognostic (3.55e-2)" "unprognostic (8.18e-2)" 6.0 7.6 9.9 7.2 11.0 11.1 8.8 12.5 15.1 5.3 8.9 11.6 17.6 5.4 9.9 8.0 4.9 7.4 8.8 9.5 11.5 11.6 18.8 14.7 8.9 12.8 12.2 4.7 9.6 10.2 3.0 11.4 12.0 11.7 9.5 8.3 9.7 6.1 5.1 9.7 17.1 3.3 12.8 6.8 12.1 8.1 11.6 9.2 15.7 5.0 7.9 7.8 3.4 15.9 34.1 25.5 17.3 18.4 17.8 25.0 47.6 31.5 24.6 14.3 26.3 17.9 108.8 13.2 26.2 18.8 28.5 42.0 19.8 16.4 18.4 20.9 19.4 12.0 21.3 21.1 24.5 11.5 14.2 20.1 23.5 14.5 17.5 18.0 13.0 16.2 25.5 32.8 29.3 11.2 16.0 12.6 50.1 18.8 17.3 12.1 23.9 18.7 25.6 32.2 5.6 20.7 26.1 23.7 26.4 22.5 20.4 15.8 17.9 16.7 21.1 28.9 17.3 9.3 17.6 22.5 18.4 8.0 14.6 9.9 1.4 5.5 5.5 1.7 6.7 7.0 4.1 6.9 1.7 5.3 8.2 10.4 3.5 9.5 1.7 8.5 4.1 3.4 9.9 11.0 12.5 15.1 9.5 11.5 12.8 12.2 12.0 12.8 11.6 15.9 21.6 48.1 77.1 32.3 27.9 76.0 57.8 48.5 42.7 36.7 36.4 21.0 21.3 34.3 44.3 31.3 66.7 44.6 34.8 58.0 7.9 30.6 1.3 48.5 31.5 20.1 39.8 29.0 47.3 39.4 60.5 29.0 22.4 89.2 17.1 24.8 21.4 55.4 22.7 20.2 52.1 42.3 36.7 18.9 44.6 2.0 18.0 24.7 19.6 26.2 23.4 24.0 22.6 37.2 69.3 57.9 40.3 13.9 26.6 58.4 56.0 17.2 34.2 38.4 19.7 37.9 25.4 50.9 44.6 47.0 63.6 56.1 28.3 31.3 33.8 77.0 IPO7 "Imp7, RANBP7" ENSG00000205339 "Importin 7" O95373 11 9384652-9448127 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019002, HPA056590" Approved Approved Supported Nucleoplasm,Cytosol NA NA 220000 "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "HPA019002: AB_1856059, HPA056590: AB_2683180" "unprognostic (1.92e-1)" "prognostic unfavorable (4.98e-4)" "unprognostic (9.50e-2)" "unprognostic (1.27e-1)" "unprognostic (3.68e-1)" "unprognostic (1.60e-2)" "prognostic unfavorable (6.57e-4)" "unprognostic (1.19e-2)" "unprognostic (7.60e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (8.38e-6)" "unprognostic (3.06e-1)" "unprognostic (1.55e-1)" "unprognostic (1.13e-1)" "unprognostic (8.08e-2)" "unprognostic (2.17e-1)" "unprognostic (3.90e-3)" 37.9 29.1 24.1 31.3 25.7 22.7 40.4 27.3 30.7 35.7 27.5 34.6 27.2 33.9 29.2 37.9 31.3 31.8 50.4 23.2 28.0 41.4 38.5 28.9 30.1 27.6 27.4 33.1 33.8 38.9 13.0 41.1 27.3 32.1 34.1 47.8 33.3 33.2 110.3 25.3 26.0 43.4 26.8 22.9 25.6 12.7 27.4 31.8 54.0 93.4 34.8 51.8 22.8 29.9 148.7 110.8 130.6 104.4 129.4 165.7 104.4 176.0 112.4 127.1 136.4 99.1 132.6 138.1 62.5 136.3 115.5 113.5 187.5 136.7 210.7 66.3 154.5 114.3 118.8 100.1 80.7 177.0 83.3 106.7 144.8 84.0 195.6 129.5 152.8 46.7 174.7 80.5 167.9 60.3 107.5 86.3 129.0 136.3 130.2 111.4 205.5 63.0 105.3 137.5 51.7 101.5 78.6 153.5 129.1 103.2 70.7 87.6 120.9 155.6 107.4 162.0 190.9 23.2 95.3 93.6 102.0 93.6 86.4 0.1 1.5 0.3 1.4 2.6 2.7 1.9 1.5 2.0 3.2 1.4 1.9 1.7 0.7 3.5 3.8 1.4 1.5 1.0 24.1 25.7 27.3 30.7 23.2 28.0 27.6 27.4 27.3 26.8 27.4 29.9 41.3 67.3 71.5 19.6 46.4 144.0 103.3 44.8 68.9 40.1 65.5 42.4 131.9 25.8 59.7 35.0 58.4 52.8 39.7 27.2 33.2 34.2 4.6 55.9 92.5 55.7 31.1 50.9 43.9 42.2 63.8 58.0 47.4 99.5 37.9 56.5 25.0 46.8 35.3 35.3 49.7 38.8 32.6 48.0 92.2 7.1 28.0 56.6 39.2 17.8 39.2 31.8 13.4 28.1 44.9 45.5 32.9 35.7 47.6 150.6 26.5 45.7 48.4 39.8 13.1 96.2 71.0 21.6 19.8 82.2 147.9 36.7 37.7 49.0 50.9 127.4 ZNF143 "pHZ-1, SBF, STAF" ENSG00000166478 "Zinc finger protein 143" P52747 11 9460319-9528524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Sertoli cells: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003263, HPA003264, HPA074818" Supported Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus,Vesicles" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Nuclear bodies, Golgi apparatus, Vesicles" "HPA003263: AB_1080672, HPA003264: , HPA074818: AB_2686715" "unprognostic (2.30e-2)" "unprognostic (2.12e-2)" "unprognostic (5.51e-2)" "unprognostic (9.72e-2)" "unprognostic (5.09e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.76e-5)" "unprognostic (4.87e-3)" "unprognostic (2.57e-3)" "unprognostic (9.56e-2)" "unprognostic (1.26e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (1.20e-3)" "unprognostic (1.92e-2)" "unprognostic (1.06e-2)" "unprognostic (7.55e-2)" 9.0 6.1 8.6 11.4 10.1 18.6 9.6 17.3 9.9 10.0 10.8 9.7 9.5 10.5 14.4 9.8 10.1 8.4 9.3 7.9 9.3 8.6 9.6 9.1 15.7 9.9 8.8 13.7 7.7 7.9 7.1 10.4 11.2 8.7 9.9 16.1 8.9 8.0 17.3 10.2 8.2 9.5 9.8 11.1 7.7 16.9 9.0 18.9 14.6 11.5 14.1 11.2 8.4 14.9 20.0 18.8 23.4 15.2 18.9 17.4 21.5 21.8 17.3 16.4 17.9 26.7 24.3 19.6 9.7 17.7 14.0 22.5 23.1 17.3 24.5 20.0 27.7 18.5 27.7 18.7 15.6 25.9 17.8 15.3 20.4 22.2 19.4 21.4 16.3 17.9 20.5 23.3 18.3 17.1 24.1 10.6 26.3 23.0 19.9 21.4 21.2 12.3 14.7 24.0 16.1 15.8 24.0 16.0 14.3 20.6 14.9 14.6 15.6 21.4 15.3 15.1 19.6 11.5 21.6 33.4 13.8 14.8 12.5 39.1 24.6 57.3 28.0 24.9 25.0 23.0 24.6 22.9 20.9 18.2 22.8 19.6 45.1 19.4 28.2 10.1 29.7 19.6 8.6 10.1 17.3 9.9 7.9 9.3 9.9 8.8 11.2 9.8 9.0 14.9 17.9 6.4 12.1 6.2 14.7 26.6 34.1 12.1 17.6 9.3 8.7 13.2 15.5 7.2 10.3 5.5 8.4 10.0 17.1 10.1 3.9 12.5 20.3 18.7 14.9 13.0 6.6 25.4 8.1 11.5 16.2 14.5 9.7 16.3 14.0 7.7 6.8 7.6 9.9 5.0 7.4 6.9 14.2 8.3 22.0 10.0 11.8 15.8 10.6 12.2 16.3 15.5 17.5 7.5 9.8 14.1 7.7 6.8 15.4 20.1 6.3 7.7 15.0 14.3 59.2 18.3 16.7 50.5 21.3 12.8 23.4 18.3 18.1 7.3 7.9 26.9 WEE1 WEE1A ENSG00000166483 "WEE1 G2 checkpoint kinase" P30291 11 9573670-9593457 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 213.9;Glandular and luminal cells: 262.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB004619, HPA068845" Approved Approved Nucleoli No No "Cluster 43: B-cells - Humoral immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 44: Endometrium - Transcription" Nucleoli "CAB004619: AB_628447, HPA068845: AB_2686048" "unprognostic (6.04e-2)" "unprognostic (1.90e-3)" "unprognostic (1.09e-2)" "unprognostic (9.29e-2)" "unprognostic (1.26e-1)" "unprognostic (1.39e-2)" "unprognostic (3.79e-3)" "unprognostic (2.48e-2)" "unprognostic (1.22e-1)" "unprognostic (1.79e-2)" "unprognostic (3.21e-3)" "unprognostic (3.73e-1)" "prognostic unfavorable (5.19e-4)" "unprognostic (1.07e-1)" "unprognostic (3.06e-1)" "unprognostic (2.08e-1)" "unprognostic (3.80e-1)" 12.7 5.6 1.5 14.1 1.3 23.0 46.1 2.4 2.3 21.5 2.8 18.4 10.6 62.6 24.5 46.3 18.6 49.0 43.0 1.2 2.3 16.8 57.8 11.6 24.8 2.8 4.0 10.9 10.1 17.8 8.4 34.6 3.6 21.2 14.4 4.5 17.4 12.7 10.4 57.1 13.5 35.0 2.2 8.1 17.2 31.5 2.0 23.7 26.6 7.2 30.2 53.0 15.4 1.9 43.1 16.4 69.1 38.8 65.2 29.8 125.9 48.8 44.8 29.3 29.8 33.8 53.3 100.7 18.0 27.6 30.8 48.8 49.0 23.3 41.1 33.3 30.7 43.1 30.1 26.2 7.0 66.6 39.7 12.0 25.3 13.8 53.8 34.9 21.6 43.6 64.0 75.8 55.7 13.2 63.5 39.4 97.6 36.9 18.5 57.6 54.5 24.6 28.1 100.0 25.0 31.8 39.9 48.6 29.2 89.3 27.1 32.9 21.7 51.1 35.2 23.0 42.2 14.4 51.1 140.1 23.3 36.5 41.0 0.0 0.0 6.0 1.7 0.0 0.2 8.0 1.7 3.0 0.1 4.7 0.1 1.3 0.1 1.9 0.0 0.1 7.1 0.6 1.5 1.3 2.4 2.3 1.2 2.3 2.8 4.0 3.6 2.2 2.0 1.9 17.2 51.3 33.9 0.0 36.8 176.4 170.4 38.5 213.9 1.8 168.5 67.2 61.1 65.8 53.5 42.3 0.0 94.8 11.2 54.7 13.7 24.9 25.0 160.1 86.2 18.7 61.1 40.4 0.1 13.6 200.1 39.2 52.5 262.4 7.0 28.5 9.7 85.0 17.0 1.7 0.4 65.6 18.3 2.5 21.9 41.7 11.8 10.0 17.8 1.0 2.4 9.9 8.2 2.0 0.1 24.8 38.5 10.9 17.2 82.7 35.9 8.3 62.6 7.1 6.6 180.7 23.7 61.4 44.4 181.4 191.1 137.2 19.0 11.8 55.5 85.5 SWAP70 "KIAA0640, SWAP-70" ENSG00000133789 "Switching B cell complex subunit SWAP70" Q9UH65 11 9664077-9752993 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 183.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 80.6;naive B-cell: 84.8" "Group enriched" "Detected in all" 7 "B-cells: 84.8;granulocytes: 48.6;monocytes: 29.6" "Cell line enhanced" "Detected in many" "Daudi: 161.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006810, HPA006929" Supported Supported "Plasma membrane,Actin filaments" NA NA 21000 "Cluster 19: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 57: B-cells - Immune response" "Plasma membrane" "Actin filaments" "HPA006810: AB_1857683, HPA006929: " "unprognostic (4.16e-2)" "unprognostic (7.06e-2)" "unprognostic (2.35e-1)" "unprognostic (3.68e-2)" "unprognostic (1.67e-1)" "unprognostic (3.38e-2)" "unprognostic (3.16e-3)" "unprognostic (1.26e-1)" "unprognostic (4.04e-1)" "unprognostic (3.33e-1)" "unprognostic (1.75e-1)" "unprognostic (3.85e-2)" "unprognostic (2.79e-3)" "unprognostic (5.00e-2)" "unprognostic (1.14e-1)" "unprognostic (3.61e-1)" "unprognostic (1.44e-1)" 39.3 10.4 12.8 37.5 13.7 20.9 31.9 13.6 15.9 22.6 17.2 15.0 15.4 17.8 10.4 17.8 16.3 22.0 16.2 12.2 14.1 17.2 10.0 24.9 66.1 16.7 13.6 10.2 15.0 19.4 5.7 39.0 16.7 14.1 12.8 3.9 18.0 15.3 9.8 26.4 20.3 19.7 16.5 59.5 15.9 4.8 14.3 17.3 22.3 14.7 75.3 31.2 17.6 16.5 40.6 22.2 30.8 0.1 62.9 54.6 54.0 43.4 52.6 40.3 44.1 24.7 31.3 161.0 41.6 83.5 57.9 47.7 37.9 24.2 51.6 14.8 15.2 42.6 25.7 12.1 35.2 33.3 76.2 38.4 29.6 29.5 52.3 32.6 124.4 20.2 3.9 0.6 42.4 6.4 10.0 16.1 28.4 10.7 11.3 23.6 28.9 4.7 33.6 106.1 1.5 15.5 41.3 52.6 35.2 42.9 20.9 25.1 143.6 70.3 25.1 59.4 41.2 4.2 12.4 111.5 27.9 36.6 29.3 19.7 5.7 48.6 1.2 13.5 0.5 80.6 1.4 1.1 8.2 84.8 1.2 1.3 1.1 7.9 29.6 2.3 4.2 5.4 12.8 13.7 13.6 15.9 12.2 14.1 16.7 13.6 16.7 16.5 14.3 16.5 154.0 67.3 60.8 33.0 183.7 35.6 68.1 40.1 36.5 3.4 35.1 28.3 17.6 22.8 57.7 20.2 0.0 82.6 9.9 11.3 13.7 47.4 1.6 66.5 18.6 136.0 13.1 9.7 9.0 21.6 128.0 39.1 15.8 71.6 137.8 10.3 53.2 7.2 65.0 26.9 14.5 8.7 18.3 61.9 50.8 2.9 29.8 58.5 28.4 77.8 88.8 9.2 6.2 22.1 22.4 37.0 15.1 34.6 20.7 63.0 22.4 11.7 50.9 2.3 19.7 46.2 35.5 5.5 10.8 17.4 31.3 140.1 15.5 33.4 9.0 78.8 SBF2 "CMT4B2, DENND7B, KIAA1766, MTMR13" ENSG00000133812 "SET binding factor 2" Q86WG5 11 9778667-10294219 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Autophagy "Guanine-nucleotide releasing factor" "Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 224.6;Excitatory neurons: 244.9;Inhibitory neurons: 367.4;Microglial cells: 273.6;Oligodendrocyte precursor cells: 290.5;Oligodendrocytes: 228.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 1.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 105.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050933 Uncertain Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Intermediate filaments, Cytosol" "HPA050933: AB_2681280" "unprognostic (2.26e-1)" "unprognostic (1.45e-2)" "unprognostic (1.91e-2)" "unprognostic (1.00e-1)" "unprognostic (2.28e-1)" "unprognostic (5.36e-2)" "unprognostic (5.55e-2)" "unprognostic (6.44e-3)" "unprognostic (2.84e-2)" "unprognostic (1.87e-1)" "unprognostic (3.62e-3)" "unprognostic (2.43e-1)" "prognostic favorable (3.66e-5)" "unprognostic (3.72e-2)" "unprognostic (8.77e-2)" "unprognostic (3.43e-1)" "unprognostic (4.11e-2)" 13.3 7.6 8.6 6.2 9.2 4.0 9.2 6.4 7.7 15.2 5.1 9.3 6.8 11.3 9.1 11.6 10.2 10.4 8.9 6.7 7.7 13.8 9.5 7.4 3.9 6.9 8.1 18.0 5.1 17.1 4.6 14.2 7.2 10.6 10.5 14.9 9.3 11.4 4.7 7.4 6.6 10.9 7.1 7.8 9.5 10.8 7.1 6.1 16.7 8.9 4.2 11.2 8.2 8.2 15.1 12.1 20.8 15.0 27.1 35.4 105.4 11.6 20.9 13.1 18.2 9.1 18.1 5.8 6.2 20.6 19.1 9.8 12.5 9.8 22.9 6.2 8.6 2.5 9.1 11.9 10.6 5.6 8.0 17.5 12.3 6.6 25.8 20.2 21.8 12.1 5.1 5.2 15.8 4.3 8.1 1.5 9.1 13.5 13.3 7.5 14.5 7.6 11.9 13.4 6.9 15.4 15.7 22.4 10.0 10.6 6.7 4.0 24.4 23.1 11.5 24.3 9.5 1.7 4.6 8.0 17.4 2.7 17.0 0.0 0.7 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.3 0.2 0.1 0.0 1.1 0.3 1.6 0.1 0.1 0.2 8.6 9.2 6.4 7.7 6.7 7.7 6.9 8.1 7.2 7.1 7.1 8.2 50.2 44.8 83.9 224.6 16.4 25.5 43.4 24.1 27.3 35.1 16.4 14.5 31.4 22.8 30.8 16.5 75.0 13.8 14.6 20.3 3.9 13.9 18.3 17.8 31.1 40.9 43.8 11.4 244.9 8.8 12.9 40.0 40.8 30.1 21.5 41.7 49.6 16.6 18.6 37.0 367.4 16.2 24.4 55.0 34.1 9.2 51.0 44.8 30.2 273.6 37.6 12.0 29.9 290.5 228.4 13.5 21.2 27.1 9.5 56.5 14.5 13.1 38.3 71.6 26.3 44.0 34.8 24.5 17.4 30.6 30.7 13.8 20.6 25.9 20.1 47.4 ADM AM ENSG00000148926 Adrenomedullin P35318 11 10305073-10307397 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 340.2" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 590.8;Extravillous trophoblasts: 1217.1;Syncytiotrophoblasts: 1084.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 18 "neutrophil: 242.2" "Lineage enriched" "Detected in many" 18 "granulocytes: 242.2" "Cell line enhanced" "Detected in many" "ASC diff: 684.6;fHDF/TERT166: 357.4;HSkMC: 410.9;U-138 MG: 390.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB016075, HPA068955" Approved "Secreted to blood" NA NA 31000 340000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 38: Extravillous trophoblasts - Unknown function" "CAB016075: AB_628693, HPA068955: " "unprognostic (1.67e-1)" "unprognostic (2.89e-2)" "unprognostic (1.78e-1)" "unprognostic (5.22e-2)" "unprognostic (1.55e-2)" "unprognostic (5.27e-3)" "prognostic unfavorable (7.56e-4)" "unprognostic (1.78e-3)" "unprognostic (1.06e-1)" "unprognostic (2.83e-1)" "unprognostic (8.13e-3)" "unprognostic (3.12e-1)" "prognostic unfavorable (6.33e-4)" "unprognostic (9.70e-3)" "unprognostic (2.01e-1)" "unprognostic (2.02e-2)" "unprognostic (1.62e-2)" 340.2 29.9 12.9 32.2 18.3 43.9 195.9 28.1 15.2 162.1 17.9 60.6 8.0 20.3 3.1 84.6 71.0 30.0 153.3 10.6 15.5 123.8 90.5 157.6 17.1 19.7 18.0 33.1 24.6 23.5 43.3 102.8 16.5 26.8 11.4 16.7 52.7 1.6 79.3 169.8 49.5 7.6 16.8 34.5 55.5 4.9 21.6 4.1 52.7 14.3 3.5 85.1 224.3 18.6 35.4 29.2 33.8 9.8 684.6 306.7 51.8 263.6 263.9 260.5 175.7 142.4 43.9 0.1 11.7 357.4 136.9 51.0 9.5 40.6 191.9 0.7 13.9 1.1 16.1 18.0 88.0 1.6 1.1 410.9 34.7 30.8 44.6 89.9 60.4 0.5 0.4 0.7 64.3 1.2 0.2 10.6 65.7 8.4 13.6 1.0 1.1 54.5 16.7 48.6 1.1 3.2 101.0 23.7 0.6 36.4 31.4 0.3 17.9 390.0 5.5 233.2 37.9 2.7 29.5 10.5 112.0 0.2 117.0 0.0 7.0 0.0 0.0 7.7 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.1 242.2 0.0 13.6 0.0 0.3 1.9 12.9 18.3 28.1 15.2 10.6 15.5 19.7 18.0 16.5 16.8 21.6 18.6 347.7 9.6 12.3 17.0 14.2 192.1 590.8 194.4 182.1 2.7 28.0 46.9 104.6 18.6 136.2 3.7 8.4 134.6 9.1 266.7 15.6 135.7 0.5 80.8 58.1 99.1 67.5 4.0 0.4 30.5 1217.1 202.8 55.0 210.9 9.5 30.1 95.7 18.6 71.4 3.3 3.0 127.6 181.0 69.6 57.7 2.6 132.7 107.9 40.9 6.5 8.1 4.9 1.0 1.5 0.1 61.7 298.3 19.2 20.0 218.9 14.0 60.1 38.7 15.3 0.0 73.3 76.5 5.1 4.9 182.3 125.6 1084.8 14.7 8.1 55.5 224.5 AMPD3 ENSG00000133805 "Adenosine monophosphate deaminase 3" Q01432 11 10308313-10507579 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 62.9;skeletal muscle: 73.3" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 111.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 44.2;CAPAN-2: 34.6;HMC-1: 36.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038662, HPA047408" Uncertain Approved "Nuclear membrane" NA NA 77000 "Cluster 49: Eosinophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nuclear membrane" "HPA038662: AB_2676136, HPA047408: AB_2680034" "unprognostic (2.24e-1)" "unprognostic (3.88e-3)" "unprognostic (1.44e-2)" "prognostic favorable (2.37e-4)" "unprognostic (1.89e-2)" "unprognostic (1.71e-3)" "unprognostic (2.91e-3)" "unprognostic (1.25e-1)" "unprognostic (7.83e-2)" "unprognostic (2.26e-1)" "unprognostic (1.84e-2)" "unprognostic (4.68e-1)" "unprognostic (3.06e-2)" "unprognostic (7.07e-2)" "unprognostic (4.42e-2)" "unprognostic (2.98e-1)" "unprognostic (2.12e-2)" 4.2 19.6 10.8 20.7 22.5 62.9 3.0 19.1 15.3 6.0 10.8 4.9 6.5 4.2 4.0 7.6 11.1 6.4 2.9 10.4 15.9 7.8 1.8 6.9 17.6 21.1 20.5 2.6 3.3 24.1 18.2 4.1 20.5 7.4 6.6 7.5 6.4 3.5 73.3 15.6 7.8 4.4 14.0 12.1 6.7 1.8 21.4 13.9 3.6 9.3 20.3 9.7 7.9 30.2 14.1 2.0 0.5 0.2 7.1 5.0 0.8 12.4 44.2 3.0 3.1 6.9 34.6 5.1 1.2 5.7 11.9 8.6 0.2 11.8 8.8 12.7 0.5 12.5 1.8 1.0 2.4 17.2 36.0 18.5 17.9 6.0 7.7 7.5 1.4 8.3 19.4 5.3 10.1 0.5 10.2 22.3 1.6 1.1 12.2 3.7 15.9 18.2 0.6 11.5 5.1 2.6 2.7 0.4 0.8 1.0 0.4 5.8 3.4 13.7 0.2 9.6 0.5 4.8 2.9 5.5 15.7 16.9 0.3 9.5 6.4 19.4 2.2 3.9 5.4 7.7 3.3 2.6 4.2 5.3 3.6 2.5 8.4 3.8 1.7 2.7 2.1 2.8 10.8 22.5 19.1 15.3 10.4 15.9 21.1 20.5 20.5 14.0 21.4 30.2 0.5 0.0 3.9 5.2 14.3 12.5 10.6 8.1 4.0 23.6 1.6 1.8 6.3 5.7 9.8 14.7 2.1 0.9 1.6 1.9 17.6 2.9 7.3 14.0 1.7 1.6 10.2 20.2 11.9 1.6 1.5 8.1 3.1 2.9 12.0 0.9 1.1 0.7 14.5 0.0 7.0 3.9 20.3 15.2 7.6 20.6 0.9 18.3 3.6 28.1 14.0 6.5 1.0 5.0 111.8 6.3 3.0 0.0 1.7 26.5 4.9 0.8 24.2 1.3 0.0 12.3 1.9 0.4 0.6 2.2 12.5 1.2 6.6 0.3 2.2 16.8 MTRNR2L8 ENSG00000255823 "MT-RNR2 like 8" P0CJ75 11 10507894-10509186 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 20406.5;choroid plexus: 8122.9;skeletal muscle: 7550.7" "Cell type enriched" "Detected in many" 11 "Cardiomyocytes: 32407.2" "Cancer enhanced" "Detected in many" "stomach cancer: 6.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 3689.6;eosinophil: 2784.3;neutrophil: 9219.1" "Lineage enriched" "Detected in all" 7 "granulocytes: 9219.1" "Cell line enhanced" "Detected in all" "HeLa: 3532.5;Hep G2: 1873.3" "Secreted to blood" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (6.19e-2)" "unprognostic (1.43e-1)" "unprognostic (6.66e-2)" "unprognostic (3.26e-2)" "unprognostic (3.71e-2)" "unprognostic (3.52e-2)" "unprognostic (2.81e-2)" "unprognostic (3.45e-2)" "unprognostic (5.28e-2)" "unprognostic (1.41e-1)" "unprognostic (4.87e-2)" "unprognostic (1.90e-1)" "unprognostic (4.59e-2)" "unprognostic (4.59e-2)" "unprognostic (3.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.96e-2)" 1000.1 1776.9 8126.4 330.8 8126.2 480.5 249.4 8126.3 20406.5 105.8 8122.9 906.3 612.7 222.9 263.8 642.6 200.9 300.7 3864.2 8509.5 8134.6 1780.1 1280.5 190.2 198.6 8655.4 8131.2 239.2 613.2 509.7 1.3 236.5 8396.6 342.3 741.4 864.6 742.7 271.9 7550.7 621.6 723.9 285.9 8194.3 375.6 681.5 599.0 8130.7 96.8 149.4 1897.1 267.0 201.6 0.6 8143.9 527.3 715.6 334.3 1521.1 294.0 151.4 438.7 562.6 61.4 61.1 75.9 427.1 742.2 698.2 544.0 91.4 54.0 1407.6 10.0 103.2 66.3 307.0 613.3 685.6 3532.5 1873.3 109.4 143.3 625.4 277.5 137.1 58.0 141.0 578.3 54.0 412.8 543.6 353.2 180.7 260.8 202.2 910.4 124.0 222.2 194.5 333.0 287.7 352.4 328.7 447.0 186.5 418.8 248.4 399.0 703.2 282.9 418.6 836.4 416.2 433.8 414.5 508.2 189.6 213.6 116.4 414.1 313.4 1053.0 125.3 3689.6 1275.5 2784.3 319.4 577.0 409.2 944.6 407.8 353.4 445.8 957.8 509.9 480.1 9219.1 466.8 613.2 688.5 439.4 1155.3 8126.4 8126.2 8126.3 20406.5 8509.5 8134.6 8655.4 8131.2 8396.6 8194.3 8130.7 8143.9 649.6 830.1 866.0 0.0 131.5 471.7 1069.8 27.1 1.2 0.0 599.2 1010.1 32407.2 124.4 492.7 57.0 0.0 6.9 118.0 2.1 72.4 0.0 23.1 785.5 473.5 1034.0 0.0 139.8 0.0 0.0 6.9 1450.7 3.1 916.4 543.7 140.3 119.2 384.5 12.8 0.0 0.0 0.5 4.1 129.6 1091.1 52.7 65.6 420.6 723.9 0.0 14.5 0.0 8.2 0.0 0.3 0.1 0.3 44.8 92.0 618.5 0.3 770.4 481.4 0.0 65.7 2750.1 1533.4 30.9 38.2 0.8 488.9 11.2 370.6 42.0 0.5 1232.9 RNF141 "ZFP26, ZNF230" ENSG00000110315 "Ring finger protein 141" Q8WVD5 11 10511673-10541230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Early spermatids: 1045.8;Late spermatids: 666.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 176.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018133 Approved Approved Nucleoplasm,Microtubules NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 78: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 34: Spermatids - Unknown function" Microtubules Nucleoplasm "HPA018133: AB_1859142" "unprognostic (7.41e-2)" "unprognostic (1.16e-1)" "unprognostic (7.88e-3)" "unprognostic (8.42e-2)" "unprognostic (2.12e-1)" "unprognostic (3.09e-2)" "unprognostic (1.08e-3)" "unprognostic (1.48e-1)" "unprognostic (1.44e-1)" "unprognostic (5.50e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (4.57e-2)" "prognostic favorable (2.60e-4)" "unprognostic (6.11e-2)" "unprognostic (1.30e-1)" "unprognostic (1.71e-2)" "unprognostic (1.61e-2)" 24.0 28.3 41.2 26.8 61.9 19.8 26.9 56.4 61.6 17.6 22.9 17.3 21.7 13.7 19.7 56.3 16.3 14.5 22.7 34.0 51.6 23.5 21.8 21.7 17.9 61.3 52.7 10.9 14.5 30.6 10.0 14.9 63.4 22.6 16.8 18.6 38.3 14.2 43.4 42.9 30.0 13.3 52.1 27.7 21.6 82.7 48.4 18.8 22.9 35.7 25.6 21.0 22.9 79.7 48.3 24.6 34.5 21.1 51.7 50.2 24.6 32.2 26.1 12.6 15.1 38.3 176.3 19.9 28.3 25.0 22.3 34.8 15.3 38.4 19.0 21.7 20.1 13.3 15.8 19.9 20.0 22.2 15.2 33.0 44.0 6.7 41.1 45.8 33.9 25.2 38.4 18.7 31.6 20.6 21.2 8.3 17.5 32.3 14.0 27.3 14.8 22.9 20.4 52.9 11.0 21.5 31.1 36.8 20.6 29.5 23.4 11.3 36.3 30.1 18.5 24.6 10.4 8.2 16.5 22.7 37.7 31.3 37.3 34.2 52.3 92.7 8.3 106.8 13.9 67.6 9.6 8.1 28.9 69.9 10.5 7.3 152.4 9.2 103.9 26.6 12.8 33.9 41.2 61.9 56.4 61.6 34.0 51.6 61.3 52.7 63.4 52.1 48.4 79.7 15.1 19.2 49.2 14.4 39.4 40.8 39.7 47.7 37.0 20.3 31.7 22.0 46.7 18.6 36.9 20.2 12.5 14.4 18.8 16.6 41.1 21.2 1045.8 18.5 14.0 18.4 21.0 15.4 10.7 24.7 15.1 15.9 16.8 23.0 13.3 18.8 21.0 28.0 41.6 37.0 11.8 28.2 16.2 107.4 10.5 666.5 19.6 52.6 19.6 4.7 41.7 27.8 4.1 12.1 67.9 41.6 11.2 19.5 15.2 53.3 58.8 33.5 48.0 11.0 6.6 19.1 18.6 83.4 39.4 49.1 40.1 17.9 11.7 23.3 21.1 74.8 LYVE1 "LYVE-1, XLKD1" ENSG00000133800 "Lymphatic vessel endothelial hyaluronan receptor 1" Q9Y5Y7 11 10556966-10611689 "Plasma proteins, Predicted membrane proteins, Transporters" Transport Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 126.4;placenta: 149.3" "Group enriched" "Detected in many" 4 "Hepatic stellate cells: 238.8;Hofbauer cells: 807.4;Kupffer cells: 338.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "HUVEC TERT2: 81.6" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "spinal cord: 1.8" "CAB025860, HPA042953" Supported NA NA 3300000000 "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 4: Macrophages - Innate immune response" "CAB025860: , HPA042953: AB_2678238" "unprognostic (9.83e-2)" "unprognostic (1.52e-1)" "unprognostic (1.87e-1)" "unprognostic (3.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" "unprognostic (1.94e-1)" "unprognostic (7.80e-2)" "prognostic unfavorable (1.07e-4)" "unprognostic (7.53e-2)" "unprognostic (4.09e-2)" "prognostic unfavorable (6.98e-5)" "unprognostic (1.67e-2)" "unprognostic (2.51e-1)" "unprognostic (1.07e-1)" "unprognostic (2.43e-3)" 126.4 68.9 2.7 19.3 3.5 0.9 37.3 2.0 5.1 17.6 8.9 19.9 13.3 8.1 5.7 26.2 23.0 20.2 13.5 2.9 2.4 8.1 44.2 23.8 8.4 3.0 2.2 11.8 4.9 2.3 2.7 149.3 3.1 4.0 20.0 0.3 5.4 11.2 5.0 7.1 17.6 67.1 2.1 61.6 10.5 4.3 3.3 1.7 13.5 27.4 3.0 35.1 6.8 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 81.6 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.7 3.5 2.0 5.1 2.9 2.4 3.0 2.2 3.1 2.1 3.3 3.2 5.7 0.0 2.8 8.1 2.1 3.7 0.1 0.0 0.0 0.0 0.5 0.3 4.6 8.6 0.0 0.0 0.0 5.3 0.3 0.0 0.0 0.0 1.0 0.0 0.2 102.7 0.0 5.3 0.8 0.0 5.7 3.4 0.0 0.0 1.3 0.0 238.8 4.5 807.4 0.0 0.4 0.0 0.0 338.1 10.7 2.3 3.7 86.0 7.2 12.2 0.1 0.0 0.0 0.5 0.6 0.0 0.0 0.4 2.7 0.2 0.0 0.0 1.5 0.0 13.1 3.4 6.8 0.0 0.0 1.4 3.3 11.1 1.4 0.7 0.0 0.2 IRAG1 "IRAG, JAW1L, MRVI1" ENSG00000072952 "Inositol 1,4,5-triphosphate receptor associated 1" Q9Y6F6 11 10573091-10693988 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 9 "Cardiomyocytes: 7.4;Hofbauer cells: 11.1;Smooth muscle cells: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "neutrophil: 24.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 24.0" "Cell line enhanced" "Detected in some" "ASC diff: 20.8;BJ: 15.3;BJ hTERT+: 17.6;fHDF/TERT166: 6.9;REH: 6.8" "Region enriched" "Detected in many" 5 "thalamus: 7.6" "Low region specificity" "Detected in all" HPA008704 Uncertain Approved "Nuclear bodies,Cytosol" NA NA 220000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 43: Cardiomyocytes - Nuclear processes" Cytosol "Nuclear bodies" "HPA008704: AB_1079413" "unprognostic (2.18e-1)" "unprognostic (3.40e-2)" "unprognostic (2.86e-3)" "prognostic favorable (5.78e-4)" "unprognostic (5.30e-1)" "unprognostic (3.37e-3)" "unprognostic (1.04e-2)" "unprognostic (1.87e-1)" "unprognostic (5.63e-3)" "unprognostic (1.04e-2)" "unprognostic (1.48e-1)" "unprognostic (6.98e-2)" "prognostic unfavorable (9.70e-4)" "unprognostic (3.72e-2)" "unprognostic (3.28e-2)" "unprognostic (1.97e-1)" "unprognostic (9.97e-3)" 29.7 8.0 64.6 18.2 85.8 1.5 16.1 50.4 53.4 55.4 17.7 67.6 8.5 60.8 16.1 37.5 45.6 33.2 10.1 54.5 54.3 9.3 2.1 13.3 3.7 65.8 71.4 20.2 2.9 2.7 3.8 11.8 54.4 37.9 17.3 1.7 4.1 39.5 6.7 9.3 22.0 69.1 55.2 7.1 33.7 8.2 89.8 2.3 10.2 8.1 1.8 43.8 21.9 48.8 0.1 0.0 4.2 0.0 20.8 4.1 0.2 15.3 17.6 0.0 0.0 0.4 1.7 0.0 0.1 6.9 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.7 0.0 0.1 0.2 0.0 0.2 4.8 0.4 0.0 0.1 0.0 1.2 0.0 0.6 0.1 0.3 0.0 0.1 0.3 0.5 0.0 0.1 6.8 0.0 0.3 0.0 0.0 0.0 3.1 0.0 2.6 0.0 4.4 0.0 0.5 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.3 6.0 0.0 0.7 2.2 1.7 0.0 3.9 0.0 0.8 0.0 0.0 0.6 0.9 0.0 0.0 24.0 0.0 5.7 0.1 0.0 0.7 64.6 85.8 50.4 53.4 54.5 54.3 65.8 71.4 54.4 55.2 89.8 48.8 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 CTR9 "KIAA0155, p150TSP, SH2BP1, TSBP" ENSG00000198730 "CTR9 homolog, Paf1/RNA polymerase II complex component" Q6PD62 11 10751246-10801625 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 186.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061027, HPA068122" Supported Enhanced Nucleoplasm No No "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 60: Granulocytes - Receptor signaling" Nucleoplasm "HPA061027: AB_2684418, HPA068122: AB_2685959" "unprognostic (1.92e-1)" "unprognostic (1.82e-1)" "unprognostic (2.89e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-2)" "unprognostic (1.58e-1)" "unprognostic (6.27e-2)" "unprognostic (2.42e-1)" "unprognostic (5.26e-2)" "unprognostic (2.80e-1)" "unprognostic (2.63e-1)" "unprognostic (7.27e-2)" "prognostic favorable (3.65e-6)" "unprognostic (6.88e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-1)" 15.4 20.6 10.0 21.0 10.2 23.7 18.8 9.9 11.3 19.9 13.4 16.9 16.2 22.2 48.0 17.5 16.8 15.3 17.2 10.4 10.8 22.5 25.2 17.2 26.3 10.0 12.0 22.0 13.3 30.0 12.5 20.3 10.5 17.6 18.1 29.2 18.3 16.1 17.9 19.2 16.8 16.4 9.7 22.5 17.2 27.0 10.4 30.3 23.2 15.1 26.0 21.8 11.8 11.0 40.5 30.9 43.5 41.4 93.1 37.0 21.2 43.9 29.2 34.8 36.5 51.1 83.9 36.7 23.6 36.6 42.3 40.9 54.0 36.2 56.7 56.7 64.6 186.6 31.0 29.2 29.7 74.1 98.8 34.6 28.8 22.5 30.1 32.1 40.6 34.5 77.0 43.2 42.6 18.3 47.5 28.9 36.0 48.7 38.2 43.6 52.9 25.1 29.9 54.8 19.9 47.4 39.6 38.9 31.3 41.5 34.6 32.3 40.2 29.2 30.0 51.7 24.0 23.6 59.8 39.5 31.2 49.5 30.5 54.4 15.4 31.3 20.0 17.7 26.3 16.7 21.4 19.7 18.1 17.0 20.1 19.6 11.3 26.7 18.3 9.0 19.4 15.8 10.0 10.2 9.9 11.3 10.4 10.8 10.0 12.0 10.5 9.7 10.4 11.0 51.5 57.7 48.8 14.7 49.0 87.2 46.2 29.7 64.3 34.0 30.2 31.6 49.2 31.5 41.7 25.8 56.3 37.9 42.7 30.7 19.6 26.9 28.5 34.0 38.0 37.7 26.9 25.5 16.5 24.5 24.8 36.4 15.8 52.4 85.9 33.2 28.5 38.6 29.1 63.9 21.4 45.1 32.6 32.3 23.6 13.1 33.5 36.1 12.4 15.0 31.8 31.1 29.9 20.6 18.6 26.9 17.5 31.2 37.2 26.1 22.8 18.3 33.7 45.9 26.3 47.8 33.1 100.3 71.3 51.1 81.1 45.7 48.0 56.4 25.3 31.5 EIF4G2 "DAP5, NAT1, p97" ENSG00000110321 "Eukaryotic translation initiation factor 4 gamma 2" P78344 11 10797050-10808940 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005163, HPA006773, HPA016965" Approved Enhanced Cytosol NA NA 48000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Cytosol "CAB005163: AB_638994, HPA006773: AB_1848099, HPA016965: AB_1848100" "unprognostic (1.10e-2)" "unprognostic (1.57e-1)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (9.92e-2)" "unprognostic (2.52e-1)" "prognostic unfavorable (6.18e-5)" "unprognostic (1.25e-1)" "unprognostic (7.84e-3)" "unprognostic (5.42e-2)" "unprognostic (7.07e-2)" "unprognostic (2.63e-1)" "prognostic favorable (1.67e-4)" "unprognostic (1.02e-2)" "unprognostic (2.08e-1)" "unprognostic (6.16e-2)" "unprognostic (2.74e-1)" 307.1 259.9 177.4 278.4 178.0 516.4 213.7 182.9 197.9 281.1 260.2 329.2 217.0 310.5 310.1 372.0 265.0 290.0 377.9 165.0 195.9 321.8 288.7 312.8 286.6 190.0 226.5 247.1 259.6 368.6 160.2 406.4 196.9 276.2 318.6 258.5 231.1 305.5 456.4 299.5 216.3 395.9 186.5 249.5 245.4 226.4 193.0 384.8 349.7 372.4 369.3 430.0 203.0 191.1 933.5 715.1 958.4 527.9 668.2 712.0 668.4 848.9 841.7 713.1 483.6 790.1 1064.3 525.7 474.1 1029.4 545.2 537.8 1048.1 781.0 970.8 820.1 489.0 676.3 427.7 607.2 580.2 1041.8 545.9 582.3 601.0 444.6 577.3 657.1 830.2 483.5 527.8 570.5 935.1 481.8 691.7 377.9 702.1 646.8 756.0 690.3 563.8 336.1 630.7 1328.3 357.9 584.6 966.5 658.7 516.7 640.7 561.1 474.5 805.5 916.1 614.8 793.4 711.4 281.5 841.5 766.9 531.5 600.2 998.7 343.1 331.3 498.6 212.1 382.2 277.0 251.3 237.3 250.1 304.6 212.9 205.8 212.9 244.6 262.4 422.3 162.3 295.9 767.1 177.4 178.0 182.9 197.9 165.0 195.9 190.0 226.5 196.9 186.5 193.0 191.1 306.7 323.7 284.4 48.6 273.6 633.2 372.0 213.4 285.1 128.1 236.0 196.0 382.6 198.8 243.4 147.1 123.0 321.8 289.0 422.3 244.6 325.2 163.7 213.4 247.1 302.9 247.8 169.1 48.1 368.1 373.7 250.1 263.5 269.3 199.5 271.3 209.9 209.0 272.2 164.9 53.8 279.7 191.2 240.1 417.9 152.0 208.8 312.7 250.8 54.4 279.7 197.3 224.6 36.7 53.3 582.5 260.6 240.7 262.0 307.1 205.6 329.5 225.3 142.8 131.5 328.1 363.1 203.6 197.6 320.3 630.1 1056.1 267.7 281.2 289.0 518.3 ZBED5 Buster1 ENSG00000236287 "Zinc finger BED-type containing 5" Q49AG3 11 10812074-10858796 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048472, HPA050994" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 57: B-cells - Immune response" "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA048472: AB_2680408, HPA050994: AB_2681300" "unprognostic (7.74e-2)" "unprognostic (1.36e-1)" "unprognostic (2.37e-1)" "unprognostic (4.72e-2)" "unprognostic (3.40e-1)" "unprognostic (9.05e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (5.69e-2)" "unprognostic (4.61e-2)" "unprognostic (2.23e-2)" "unprognostic (2.25e-2)" "unprognostic (3.27e-2)" "unprognostic (8.77e-3)" "unprognostic (1.47e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "prognostic favorable (3.87e-4)" 26.4 22.0 16.9 36.6 22.5 34.1 32.7 35.3 20.0 39.4 23.3 33.1 25.6 45.6 35.7 26.4 38.5 25.8 32.5 16.8 18.0 33.1 15.7 31.5 57.1 20.1 18.5 45.1 28.8 35.0 30.5 27.9 21.1 36.3 29.9 50.8 29.6 21.9 33.3 51.4 36.5 28.9 19.5 42.9 28.5 21.3 18.7 49.7 40.1 29.1 45.4 30.7 31.7 32.7 46.8 36.7 63.1 41.2 33.8 52.0 32.7 37.4 38.2 24.8 24.5 27.0 99.6 50.7 27.5 28.0 34.5 56.8 39.8 39.3 33.1 49.8 35.5 13.4 89.3 15.6 27.5 42.3 17.1 36.0 55.3 18.8 41.0 44.3 31.0 25.3 35.0 56.0 36.0 23.6 41.9 46.2 34.1 33.3 47.8 62.8 34.3 27.4 29.2 64.6 30.9 54.4 38.4 49.1 30.6 35.3 46.8 23.1 31.1 53.2 38.4 35.9 26.6 27.9 36.8 39.8 46.0 29.5 41.2 1.1 8.7 8.0 11.0 9.6 14.3 20.6 13.1 14.1 12.2 21.2 17.0 17.2 7.3 17.8 11.6 15.8 12.3 8.5 16.9 22.5 35.3 20.0 16.8 18.0 20.1 18.5 21.1 19.5 18.7 32.7 17.1 57.7 33.0 32.0 44.6 34.7 46.1 25.0 34.7 32.8 15.9 11.8 38.8 20.0 39.4 22.0 29.2 17.1 13.6 12.3 23.5 22.2 6.9 13.9 29.4 22.7 27.6 8.8 18.1 16.2 8.5 27.3 15.3 14.0 8.8 25.8 20.7 6.2 12.1 28.6 22.3 15.6 26.4 15.7 19.8 7.9 27.4 19.3 16.0 16.9 18.1 21.6 14.4 25.6 40.9 18.3 13.1 27.4 26.6 25.3 12.5 14.5 42.7 35.8 19.7 41.2 25.2 43.4 22.2 25.9 35.7 12.4 22.6 18.7 16.7 28.5 GALNT18 "GalNAc-T18, GALNT15, GALNTL4, MGC71806" ENSG00000110328 "Polypeptide N-acetylgalactosaminyltransferase 18" Q6P9A2 11 11270877-11622005 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 149.5;Excitatory neurons: 104.4;Inhibitory neurons: 156.3;Microglial cells: 79.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 42.1;HaCaT: 52.4;HBEC3-KT: 36.5;PC-3: 36.4;RPMI-8226: 39.3;SK-BR-3: 47.2;U-87 MG: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012955, HPA070681" Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA 300000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "Vesicles, Cytosol" "HPA012955: AB_1849460, HPA070681: " "unprognostic (1.26e-1)" "unprognostic (2.80e-1)" "unprognostic (3.69e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (7.37e-2)" "unprognostic (1.22e-1)" "unprognostic (6.42e-3)" "unprognostic (6.68e-2)" "unprognostic (6.04e-2)" "unprognostic (2.05e-1)" "unprognostic (5.24e-2)" "unprognostic (1.70e-1)" "unprognostic (2.66e-3)" "unprognostic (3.54e-2)" "unprognostic (1.63e-1)" "unprognostic (2.10e-1)" "unprognostic (1.81e-2)" 18.0 4.7 19.1 4.1 17.7 0.0 15.6 17.1 20.8 13.0 10.7 24.8 3.0 24.0 2.4 7.7 12.0 11.2 26.9 29.5 12.9 26.5 10.5 51.2 5.4 12.2 17.2 4.9 8.2 9.8 6.4 24.4 13.9 13.0 3.2 3.6 17.0 9.3 10.7 13.0 8.8 13.3 12.3 3.6 6.8 14.7 19.7 6.3 42.8 6.2 3.3 11.7 11.5 12.9 42.1 15.0 2.0 9.1 0.0 0.0 0.3 4.5 11.2 0.6 0.0 1.7 5.4 0.1 3.1 0.1 5.6 52.4 9.9 36.5 0.1 0.0 14.6 0.0 0.1 0.1 0.5 0.0 0.0 0.2 14.9 0.0 13.5 0.0 0.0 18.5 0.0 0.1 1.9 10.2 0.5 0.1 1.5 0.1 36.4 0.0 0.0 39.3 27.5 5.1 0.6 4.1 7.6 47.2 0.3 1.4 9.9 0.1 0.0 0.7 8.1 0.4 0.2 0.0 0.0 0.0 33.6 0.0 10.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 17.7 17.1 20.8 29.5 12.9 12.2 17.2 13.9 12.3 19.7 12.9 40.5 44.8 6.9 149.5 0.1 5.6 6.6 18.3 12.0 1.6 1.6 2.5 8.5 30.0 13.7 20.2 2.1 49.2 0.4 0.8 15.6 19.9 2.2 1.9 0.4 40.6 0.0 0.0 104.4 4.0 3.5 5.4 0.0 1.3 1.3 16.7 18.5 2.6 2.6 0.0 156.3 0.4 8.2 0.8 1.1 1.4 1.5 0.4 1.8 79.6 0.0 43.1 0.0 8.5 10.5 7.3 0.2 3.0 0.2 13.4 0.0 40.8 14.3 2.1 13.1 15.1 7.4 0.6 1.1 1.8 5.4 15.5 0.3 46.7 1.1 1.9 CSNK2A3 CSNK2A1P ENSG00000254598 "Casein kinase 2 alpha 3" Q8NEV1 11 11351942-11353250 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in single" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 12.4;Cholangiocytes: 4.3;Smooth muscle cells: 6.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.1;SK-BR-3: 1.3" "HPA059206, HPA061698" Uncertain Approved Nucleoplasm NA NA "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA059206: AB_2683948, HPA061698: AB_2732667" "unprognostic (3.10e-2)" "unprognostic (3.39e-1)" "unprognostic (4.65e-2)" "unprognostic (1.55e-3)" "unprognostic (1.82e-2)" "unprognostic (1.60e-1)" "unprognostic (6.25e-4)" "unprognostic (4.36e-2)" "unprognostic (5.42e-2)" "unprognostic (1.88e-1)" "unprognostic (5.46e-3)" "unprognostic (1.07e-1)" "unprognostic (1.50e-1)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (1.42e-1)" "unprognostic (3.38e-2)" 0.5 0.5 0.7 0.2 0.1 0.0 0.5 0.4 0.6 0.4 0.0 0.5 0.3 0.6 0.0 0.7 0.4 0.0 0.8 0.9 0.0 0.4 0.3 0.6 0.0 0.0 0.0 0.5 0.5 0.0 0.3 0.2 0.0 0.3 0.0 0.1 0.6 0.0 1.8 0.7 0.4 0.2 0.0 0.2 0.5 0.9 0.1 0.0 0.5 0.0 0.0 0.4 0.5 0.0 2.1 0.4 0.1 0.6 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.7 0.4 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.3 0.2 0.3 0.2 0.2 0.5 0.3 0.6 0.1 0.9 0.4 0.1 0.3 0.2 0.3 0.1 0.5 0.6 1.3 0.3 0.0 0.4 0.1 0.3 0.3 0.4 0.1 0.2 0.2 0.3 0.3 0.9 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.4 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 3.2 0.5 0.0 0.5 1.8 1.0 0.7 0.0 1.2 0.6 0.9 12.4 4.3 1.0 3.7 0.0 0.7 0.5 0.4 0.0 0.7 2.5 0.1 0.3 2.0 1.2 0.0 0.0 0.8 0.5 0.9 0.0 0.4 1.3 0.6 1.8 0.3 0.3 3.3 0.0 0.3 0.0 1.6 0.8 1.9 0.6 0.2 0.0 0.0 0.6 0.9 1.0 0.0 0.0 0.5 1.2 0.0 0.1 1.2 0.6 0.7 0.9 0.5 0.0 2.3 6.9 0.9 0.9 0.0 1.0 1.0 0.6 1.1 0.6 0.6 USP47 ENSG00000170242 "Ubiquitin specific peptidase 47" Q96K76 11 11841423-11961887 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 315.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029286, HPA029289" Supported Approved "Vesicles,Intermediate filaments" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 54: Cardiomyocytes - Muscle contraction" "Intermediate filaments" Vesicles "HPA029286: AB_10599852, HPA029289: AB_10601675" "unprognostic (2.02e-1)" "unprognostic (2.72e-1)" "unprognostic (3.05e-1)" "unprognostic (1.84e-1)" "unprognostic (2.99e-2)" "unprognostic (2.65e-2)" "unprognostic (2.27e-2)" "unprognostic (7.39e-2)" "unprognostic (1.54e-2)" "unprognostic (7.05e-2)" "unprognostic (2.83e-2)" "unprognostic (2.35e-1)" "unprognostic (1.51e-1)" "unprognostic (9.96e-3)" "unprognostic (1.90e-1)" "unprognostic (1.49e-1)" "unprognostic (2.85e-1)" 15.7 14.3 11.9 11.4 15.8 19.0 15.1 17.3 12.8 14.3 10.2 19.8 10.3 17.2 15.6 16.1 13.5 12.3 23.5 12.5 14.1 13.2 23.3 16.2 13.3 14.1 12.8 15.9 16.9 22.2 13.8 16.7 15.0 16.6 12.3 25.7 14.1 15.4 59.8 18.0 14.1 17.8 14.1 11.8 16.6 15.0 12.7 19.1 14.9 33.6 13.8 16.7 14.2 20.6 26.8 15.7 30.3 13.1 21.8 23.2 12.6 31.6 22.3 20.1 22.1 16.5 22.2 29.6 13.3 28.0 23.7 17.8 23.7 15.3 30.3 27.5 20.4 18.6 30.3 12.6 21.5 25.0 23.9 22.3 22.5 12.3 29.0 26.1 21.8 21.7 35.8 23.7 25.4 10.6 21.7 14.3 7.9 28.1 12.7 21.4 30.3 9.4 24.6 29.1 9.8 21.0 25.8 19.6 19.3 18.4 14.4 20.6 24.9 27.8 16.2 22.3 19.6 7.9 18.1 25.9 19.9 15.2 20.3 14.7 5.9 11.9 11.0 7.4 14.5 7.4 10.3 11.4 7.9 6.7 13.1 11.4 2.8 18.5 11.5 4.8 8.3 7.9 11.9 15.8 17.3 12.8 12.5 14.1 14.1 12.8 15.0 14.1 12.7 20.6 41.1 70.5 63.1 116.5 46.9 71.0 68.8 28.8 45.5 67.5 41.1 30.9 222.5 40.0 56.0 23.9 47.9 69.6 57.2 30.4 25.4 39.5 40.1 49.8 63.0 44.8 59.3 34.3 122.7 38.9 33.2 69.7 44.4 134.5 54.3 52.6 32.5 53.9 28.0 63.9 136.5 32.9 24.4 27.7 39.7 30.0 44.1 41.8 24.9 96.5 40.5 79.7 68.0 171.4 315.9 44.8 31.5 50.0 55.2 65.5 29.7 21.9 48.2 52.4 52.6 85.0 68.2 92.8 55.1 46.6 87.9 125.7 65.0 41.8 35.0 58.9 DKK3 "REIC, RIG" ENSG00000050165 "Dickkopf WNT signaling pathway inhibitor 3" Q9UBP4 11 11956207-12009769 "Plasma proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 1224.0" "Group enriched" "Detected in many" 7 "Cardiomyocytes: 884.3;Muller glia cells: 1960.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 6.2;memory CD8 T-cell: 3.8" "Lineage enriched" "Detected in single" 62 "T-cells: 6.2" "Cell line enhanced" "Detected in many" "BJ: 418.9;BJ hTERT+: 643.0;fHDF/TERT166: 614.4;hTERT-RPE1: 370.2;TIME: 349.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011868, CAB024949" Approved Supported "Nuclear bodies,Vesicles,Cytosol" "Secreted in other tissues" No No 18000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 5: Muller glia cells - Visual perception" Vesicles "Nuclear bodies, Cytosol" "CAB024949: , HPA011868: AB_1847716" "unprognostic (4.24e-2)" "unprognostic (6.40e-2)" "unprognostic (1.96e-1)" "unprognostic (7.84e-2)" "unprognostic (3.06e-3)" "unprognostic (6.58e-3)" "unprognostic (1.14e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-3)" "unprognostic (5.28e-2)" "unprognostic (4.51e-2)" "unprognostic (3.87e-2)" "prognostic unfavorable (6.31e-5)" "unprognostic (7.41e-3)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.02e-3)" 31.2 79.1 110.7 10.0 183.6 0.2 26.0 12.6 135.2 89.7 104.8 53.2 14.6 47.0 16.7 29.7 23.0 67.0 1224.0 147.7 80.2 17.0 5.6 123.7 8.5 95.1 54.3 38.1 18.2 34.2 38.2 25.0 46.8 59.4 13.0 204.1 30.9 78.1 7.8 29.7 24.6 43.1 83.9 33.2 31.7 30.9 99.9 4.7 16.4 18.8 5.4 40.9 48.3 121.6 1.5 13.1 18.1 0.1 15.3 29.7 0.6 418.9 643.0 182.4 205.5 9.6 3.2 0.0 44.8 614.4 96.8 64.4 1.5 181.9 69.5 0.1 0.5 0.0 1.7 0.0 113.6 0.0 0.3 45.3 60.0 61.9 151.3 370.2 195.3 0.0 0.2 0.4 256.4 0.0 0.1 0.4 8.6 0.0 0.5 0.1 1.2 0.1 62.5 0.6 0.5 53.2 2.0 0.0 0.2 47.9 0.2 0.5 349.7 107.5 82.8 11.2 110.3 0.1 0.0 0.3 18.1 0.0 103.5 0.0 0.0 0.0 0.5 0.0 6.2 0.0 0.6 3.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 110.7 183.6 12.6 135.2 147.7 80.2 95.1 54.3 46.8 83.9 99.9 121.6 5.8 3.2 3.0 94.3 0.1 45.6 59.5 70.3 93.4 31.6 3.2 103.2 884.3 0.0 12.8 0.0 12.5 0.5 0.4 0.0 0.0 0.8 104.3 0.7 8.4 32.9 1.8 0.0 90.4 0.2 0.8 106.1 7.1 0.6 1.3 17.0 66.8 0.4 20.4 13.5 83.7 0.1 0.0 1.3 12.5 88.5 20.5 1.4 64.0 38.4 0.0 1960.4 0.0 27.6 14.7 1.1 0.1 57.6 1.7 32.8 0.0 0.2 2.9 67.5 190.7 12.7 83.4 1.2 3.2 5.8 14.8 0.8 4.1 0.5 0.3 3.0 MICAL2 KIAA0750 ENSG00000133816 "Microtubule associated monooxygenase, calponin and LIM domain containing 2" O94851 11 12094008-12359144 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 61.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 193.5;Inhibitory neurons: 108.8;Late spermatids: 192.7;Peritubular cells: 112.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 8.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-138 MG: 109.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030437, HPA039895, HPA040438" Approved Uncertain "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 58: Brain - Synaptic function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus, Cytosol" "Nucleoplasm, Plasma membrane" "HPA030437: AB_10601873, HPA039895: AB_2676731, HPA040438: AB_10672896" "unprognostic (2.68e-2)" "unprognostic (1.77e-2)" "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (6.88e-4)" "unprognostic (2.20e-2)" "unprognostic (3.60e-2)" "unprognostic (9.32e-2)" "unprognostic (2.86e-1)" "unprognostic (1.36e-1)" "unprognostic (1.15e-2)" "unprognostic (6.47e-2)" "prognostic unfavorable (3.63e-5)" "unprognostic (4.61e-2)" "unprognostic (1.97e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-1)" 4.7 3.8 13.9 12.2 13.6 11.6 2.5 61.6 38.1 6.9 42.6 18.8 9.8 12.3 7.2 18.6 7.4 10.0 42.2 37.8 0.0 2.3 2.9 17.5 3.3 0.0 0.0 3.9 4.1 1.0 0.2 7.3 0.0 2.9 16.3 4.0 0.8 9.6 16.8 14.0 10.8 30.8 0.0 3.3 6.7 32.5 0.0 1.9 6.1 4.1 2.5 12.4 0.3 19.9 29.1 9.7 0.4 2.7 2.3 6.8 14.2 32.1 53.7 16.2 28.3 24.3 23.3 0.2 8.4 25.3 47.7 25.0 4.0 65.1 41.6 35.9 4.8 27.5 4.1 0.9 12.8 5.3 2.7 12.7 11.1 76.0 54.6 25.3 46.9 1.6 43.5 0.8 22.9 1.2 0.3 1.6 1.2 13.6 9.8 0.3 15.2 14.2 2.1 35.5 14.3 0.8 8.6 38.6 2.9 9.9 4.5 2.3 42.6 109.6 35.0 17.4 39.6 0.9 2.6 1.5 64.3 5.2 1.4 0.1 4.2 0.5 1.3 0.7 1.5 0.1 0.8 0.4 3.4 0.2 0.0 0.4 8.9 2.2 0.4 0.9 0.7 1.5 13.9 13.6 61.6 38.1 37.8 0.0 0.0 0.0 0.0 0.0 0.0 19.9 3.2 41.7 37.1 7.2 1.2 10.1 11.8 4.5 4.0 5.7 4.2 5.3 32.2 7.2 8.5 3.7 0.0 2.6 11.2 66.5 0.0 10.2 74.4 7.8 8.9 9.2 22.6 35.6 193.5 14.3 12.6 9.0 12.2 11.4 1.3 1.4 12.8 19.6 3.4 0.0 108.8 10.6 6.1 10.1 5.6 192.7 21.1 11.1 5.4 4.7 21.6 0.5 8.2 6.6 17.5 42.5 24.0 112.8 2.1 8.9 18.3 0.9 5.5 1.6 13.1 1.9 29.4 1.2 1.3 1.7 9.5 2.3 10.8 0.7 14.5 11.9 PARVA "FLJ10793, FLJ12254, MXRA2" ENSG00000197702 "Parvin alpha" Q9NVD7 11 12377563-12535356 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion, Cell shape, Chemotaxis, Cilium biogenesis/degradation" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 229.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005964 Approved Supported "Actin filaments,Focal adhesion sites,Cytosol" NA NA 7300000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Actin filaments, Focal adhesion sites" Cytosol "HPA005964: AB_1079569" "unprognostic (3.87e-2)" "unprognostic (7.38e-2)" "unprognostic (3.30e-2)" "prognostic favorable (1.76e-4)" "unprognostic (7.37e-3)" "unprognostic (1.38e-2)" "unprognostic (6.78e-2)" "prognostic unfavorable (8.19e-4)" "unprognostic (1.76e-2)" "unprognostic (2.80e-2)" "unprognostic (1.70e-2)" "unprognostic (9.82e-2)" "unprognostic (6.73e-2)" "unprognostic (6.58e-3)" "unprognostic (1.35e-1)" "unprognostic (1.50e-1)" "unprognostic (3.82e-2)" 61.8 17.6 9.3 22.7 9.0 0.1 40.9 7.2 10.1 53.9 16.5 92.4 17.5 71.8 16.7 42.8 38.8 31.9 34.3 9.8 11.6 23.0 16.9 28.8 6.4 11.0 7.3 31.9 36.0 16.9 11.7 35.9 8.4 50.6 38.4 8.9 20.9 68.9 8.1 14.0 26.1 95.5 11.3 11.3 42.5 6.8 8.6 4.6 17.9 11.7 9.1 55.0 28.2 11.0 34.0 33.1 30.2 39.4 147.8 110.6 69.1 126.5 130.1 87.7 81.6 24.7 51.8 0.0 41.1 229.5 9.9 20.7 0.4 66.4 104.0 0.6 14.9 0.1 42.4 18.7 114.7 0.1 0.9 91.3 22.3 37.1 57.4 107.5 110.9 0.0 0.1 0.3 131.8 20.4 0.0 0.2 14.2 20.2 26.4 0.0 75.2 0.2 44.9 32.8 4.8 0.1 97.6 39.1 65.5 66.9 18.4 0.9 138.2 105.1 43.8 57.2 35.4 0.1 0.1 0.2 58.5 0.1 118.3 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 9.0 7.2 10.1 9.8 11.6 11.0 7.3 8.4 11.3 8.6 11.0 37.0 99.3 33.0 47.3 1.1 13.8 25.0 29.3 20.5 4.3 24.4 24.8 45.1 18.6 27.0 27.6 0.0 39.9 0.7 39.6 39.2 56.1 0.9 26.9 62.5 33.3 27.1 0.0 31.4 67.1 92.2 59.1 24.5 35.9 5.1 34.8 39.7 19.1 6.5 0.0 34.9 26.2 18.3 1.8 8.8 2.5 41.0 2.0 46.2 36.5 1.0 25.3 0.0 30.7 1.0 51.7 25.4 51.9 0.2 33.5 23.1 38.1 54.8 2.5 52.6 32.6 60.6 1.1 3.4 20.2 8.9 19.0 2.3 25.1 32.4 25.1 TEAD1 "AA, TCF13, TEF-1" ENSG00000187079 "TEA domain transcription factor 1" P28347 11 12674421-12944737 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 230.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057339, HPA062471" Enhanced Nucleoplasm NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA057339: AB_2683413, HPA062471: AB_2684773" "unprognostic (1.00e-1)" "unprognostic (2.53e-2)" "unprognostic (8.84e-2)" "unprognostic (9.93e-3)" "unprognostic (2.05e-2)" "unprognostic (4.50e-1)" "unprognostic (1.50e-1)" "unprognostic (1.75e-1)" "unprognostic (1.43e-1)" "unprognostic (4.40e-3)" "unprognostic (8.39e-2)" "unprognostic (4.76e-2)" "unprognostic (1.41e-2)" "unprognostic (7.08e-3)" "unprognostic (2.52e-1)" "unprognostic (3.14e-1)" "unprognostic (2.18e-2)" 29.5 12.1 11.1 8.2 11.6 0.0 17.8 8.6 8.5 23.4 30.6 36.1 7.7 26.4 7.1 29.8 19.2 18.5 31.3 14.5 14.8 17.2 13.6 15.9 4.2 15.1 12.3 21.9 15.2 27.1 14.4 33.3 10.5 18.8 13.0 10.5 10.2 20.1 67.5 13.2 11.9 27.2 13.3 7.3 16.4 8.6 15.6 4.2 17.8 72.6 5.6 33.9 14.7 12.9 62.8 52.1 43.9 58.7 59.9 62.1 65.4 89.2 76.2 71.6 69.7 53.8 54.5 0.4 23.0 120.9 32.3 37.0 53.7 35.9 115.5 0.2 17.6 0.0 107.3 18.1 55.8 0.0 4.7 51.8 18.3 50.4 68.2 58.6 15.2 3.9 26.0 0.2 111.2 13.1 0.1 0.6 17.2 14.5 23.5 0.3 64.8 33.2 48.2 37.2 26.9 31.2 90.9 43.1 59.0 63.8 20.0 4.4 32.0 107.8 76.2 84.9 59.5 8.6 17.3 12.0 41.6 0.2 69.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 11.6 8.6 8.5 14.5 14.8 15.1 12.3 10.5 13.3 15.6 12.9 37.9 89.8 21.7 230.8 0.4 99.3 32.2 19.3 39.9 12.9 16.4 20.2 75.0 31.5 33.1 49.7 12.5 24.1 0.2 11.0 1.9 16.6 6.5 80.8 97.4 33.3 46.7 0.0 101.8 12.8 52.4 46.5 18.8 142.9 0.0 57.7 25.7 39.8 3.7 1.7 108.4 13.5 10.2 1.9 16.0 7.2 23.6 1.9 24.9 91.8 0.0 31.2 0.0 121.2 69.7 34.8 8.1 24.0 1.4 69.4 6.7 29.8 53.8 17.5 6.6 73.5 46.7 3.0 22.3 29.9 54.8 12.3 2.0 45.5 10.4 54.6 RASSF10 ENSG00000189431 "Ras association domain family member 10" A6NK89 11 13009316-13012119 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 6.0;skin 1: 6.6" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 64.3;Distal tubular cells: 25.4;Gastric mucus-secreting cells: 17.9;Squamous epithelial cells: 60.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A549: 8.9;CAPAN-2: 7.8;HaCaT: 12.6;HMC-1: 6.2;RPTEC TERT1: 11.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA040406 Approved Vesicles,Cytosol NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" Vesicles Cytosol "HPA040406: AB_2732485" "unprognostic (6.71e-2)" "unprognostic (5.12e-2)" "unprognostic (5.06e-2)" "unprognostic (2.41e-3)" "unprognostic (6.25e-3)" "prognostic favorable (2.76e-4)" "unprognostic (3.43e-3)" "unprognostic (8.04e-2)" "unprognostic (5.89e-2)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "prognostic favorable (4.12e-5)" "unprognostic (4.45e-2)" "unprognostic (1.73e-1)" "unprognostic (2.88e-1)" "unprognostic (1.65e-2)" 0.3 0.0 0.4 0.0 0.8 0.0 1.3 0.2 0.5 0.6 0.3 0.4 1.2 0.1 0.1 6.0 3.0 0.3 0.3 0.2 0.3 3.4 0.0 1.2 0.0 0.7 1.0 0.0 0.0 2.1 0.1 0.0 0.7 0.6 0.4 0.0 4.6 0.2 0.7 6.6 0.5 0.0 1.0 0.0 3.6 0.5 0.1 0.5 0.1 0.2 0.5 1.1 1.5 0.5 0.4 8.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.8 0.0 0.5 0.0 0.3 12.6 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 2.2 0.0 1.3 0.0 0.0 11.9 1.3 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.2 0.5 0.2 0.3 0.7 1.0 0.7 1.0 0.1 0.5 2.0 0.0 5.1 0.7 0.1 0.0 6.3 0.0 64.3 0.0 5.8 8.0 0.9 0.0 2.5 1.8 0.0 0.2 0.0 0.9 25.4 0.6 0.0 6.0 1.1 1.4 2.4 0.0 0.0 0.2 0.0 0.2 17.9 11.1 1.3 0.0 3.9 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.3 0.5 0.0 1.9 0.0 0.9 0.0 0.0 0.0 11.5 1.2 0.0 0.0 1.9 0.0 4.5 7.3 0.0 0.0 0.5 0.3 0.0 0.8 60.0 0.0 0.0 0.2 0.0 5.5 3.5 ARNTL "bHLHe5, BMAL1, JAP3, MOP3, PASD3" ENSG00000133794 "Aryl hydrocarbon receptor nuclear translocator like" O00327 11 13276652-13387266 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 63.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 11.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045962, HPA050938" Supported Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Vesicles "CAB045962: AB_11124144, HPA050938: AB_2681282" "unprognostic (1.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (9.00e-2)" "unprognostic (1.77e-1)" "unprognostic (3.72e-1)" "unprognostic (3.76e-2)" "unprognostic (8.92e-2)" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "unprognostic (7.80e-2)" "unprognostic (1.34e-2)" "unprognostic (2.10e-1)" "unprognostic (2.77e-2)" "unprognostic (3.11e-2)" "unprognostic (7.08e-2)" 15.0 13.3 3.2 5.1 4.8 7.4 14.1 4.8 8.3 10.5 3.2 12.4 5.2 11.6 1.6 10.5 11.5 4.0 9.5 5.5 1.9 7.2 19.4 15.0 5.8 1.6 2.6 19.7 10.3 1.5 12.3 4.4 2.2 8.5 4.1 23.4 12.7 3.4 27.0 17.6 12.4 5.6 1.9 11.6 10.9 10.9 4.4 14.1 18.9 8.2 6.4 9.3 11.5 7.4 8.2 9.0 7.5 4.0 15.0 9.0 5.7 9.5 8.1 8.6 9.7 3.7 10.9 0.1 2.6 5.2 10.4 3.4 5.3 10.3 7.7 13.6 6.3 3.9 6.6 1.8 23.7 1.8 16.2 10.1 21.3 3.7 14.1 5.9 6.2 12.6 2.5 14.9 6.9 4.7 4.7 0.9 1.6 5.4 4.3 5.1 11.4 3.4 5.7 1.8 1.2 12.2 6.1 0.7 7.6 7.1 5.7 7.0 11.5 6.2 6.8 20.3 5.5 4.1 12.0 0.0 6.4 4.1 8.3 4.3 8.3 17.9 18.1 9.0 25.2 2.6 16.8 15.6 8.4 3.1 9.4 11.1 24.5 14.1 8.9 1.1 11.1 10.7 3.2 4.8 4.8 8.3 5.5 1.9 1.6 2.6 2.2 1.9 4.4 7.4 4.9 25.6 21.0 49.9 9.0 30.8 13.4 7.3 10.2 28.3 6.1 5.0 8.8 10.0 11.1 1.8 16.7 17.6 34.8 8.6 17.6 6.8 1.5 6.1 14.2 6.6 1.2 3.0 63.6 6.4 2.2 10.3 11.7 12.9 2.5 6.9 10.8 22.9 8.2 30.3 30.5 4.6 4.1 14.0 12.3 4.2 12.8 11.9 3.6 18.7 13.1 18.8 32.0 34.2 11.9 8.3 9.3 19.9 11.5 8.0 13.5 11.3 5.3 30.9 13.1 6.6 10.7 4.7 5.4 9.4 32.4 6.3 33.0 4.7 4.5 12.0 BTBD10 "GMRP-1, GMRP1, MGC13007" ENSG00000148925 "BTB domain containing 10" Q9BSF8 11 13388008-13463297 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 116.5;Spermatocytes: 121.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046777 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Cluster 8: Neutrophils - Inflammatory response" "Cluster 78: Testis - Spermatogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Nucleoli fibrillar center" "HPA046777: AB_2679801" "unprognostic (2.38e-1)" "unprognostic (4.25e-1)" "unprognostic (1.75e-1)" "unprognostic (9.76e-2)" "unprognostic (1.59e-1)" "unprognostic (1.84e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (1.07e-1)" "unprognostic (2.52e-1)" "unprognostic (3.00e-1)" "unprognostic (1.29e-3)" "unprognostic (1.15e-2)" "unprognostic (1.43e-1)" "unprognostic (1.32e-1)" "unprognostic (2.02e-1)" "unprognostic (6.98e-2)" "unprognostic (1.27e-1)" 13.8 12.2 19.8 13.6 30.9 13.4 13.3 18.8 27.9 15.0 3.2 18.1 13.1 16.5 12.0 28.6 11.8 15.2 17.7 25.9 18.6 11.4 9.8 13.0 15.7 12.0 15.7 14.1 8.7 13.2 14.1 17.4 16.2 15.0 20.3 18.8 10.8 17.4 14.6 13.1 11.7 21.1 10.0 12.6 17.7 38.3 14.5 18.5 13.6 18.4 17.4 27.1 17.8 22.2 55.9 40.2 34.3 23.2 30.4 29.5 43.5 57.5 33.3 43.5 39.4 37.7 64.0 38.1 27.1 42.2 43.9 44.0 26.3 61.4 50.8 38.7 27.1 20.7 13.9 22.5 46.9 27.6 45.4 25.3 68.0 25.2 57.3 33.0 89.1 26.8 11.8 38.2 46.0 33.7 28.3 15.2 14.9 50.0 34.9 24.8 29.4 23.8 69.7 44.3 14.8 20.9 34.4 27.5 20.5 38.9 19.7 14.7 81.7 44.7 37.2 43.4 33.6 14.2 52.6 25.5 30.6 23.6 38.9 41.1 24.8 38.2 18.1 39.7 21.7 18.4 17.1 20.1 29.2 17.2 19.1 19.3 64.9 25.7 50.5 12.7 23.6 18.3 19.8 30.9 18.8 27.9 25.9 18.6 12.0 15.7 16.2 10.0 14.5 22.2 20.5 16.0 7.0 35.9 16.9 28.2 40.7 27.0 15.9 13.9 9.6 8.6 14.0 12.8 19.7 5.5 4.2 24.3 18.1 15.7 5.9 31.8 95.7 14.3 12.5 22.6 16.3 9.0 116.5 25.2 54.3 15.3 27.5 19.1 22.8 11.1 11.7 5.9 22.9 8.4 74.2 14.2 28.5 16.4 13.0 26.3 9.9 13.0 17.8 38.4 22.2 9.9 18.6 61.9 62.4 50.2 14.2 18.4 12.0 30.1 8.7 10.5 19.9 14.1 6.6 13.4 20.6 121.3 59.7 27.8 35.8 62.1 17.8 9.2 13.3 64.6 PTH PTH1 ENSG00000152266 "Parathyroid hormone" P01270 11 13492054-13496181 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" Hormone "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 245 "parathyroid gland: 50184.7" "Group enriched" "Detected in some" 4 "Inhibitory neurons: 1.0;Oligodendrocyte precursor cells: 1.0;Oligodendrocytes: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000072, CAB023409, CAB026363, HPA048540" Enhanced "Secreted to blood" NA NA 28000 "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "CAB000072: , CAB023409: AB_619175, CAB026363: , HPA048540: AB_2680435" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 50184.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.2 205.2 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAR1 "FLJ22728, MLSTD2, SDR10E1" ENSG00000197601 "Fatty acyl-CoA reductase 1" Q8WVX9 11 13668668-13732346 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Cataract, Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 437.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017322 Approved Supported Peroxisomes NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 15: RT4 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" Peroxisomes "HPA017322: AB_1848424" "unprognostic (3.96e-2)" "unprognostic (1.92e-1)" "prognostic favorable (2.27e-4)" "unprognostic (1.38e-1)" "unprognostic (1.34e-1)" "unprognostic (4.62e-2)" "unprognostic (3.66e-1)" "unprognostic (3.30e-1)" "unprognostic (2.79e-1)" "unprognostic (3.60e-2)" "unprognostic (2.59e-2)" "unprognostic (1.84e-2)" "unprognostic (2.97e-2)" "unprognostic (2.52e-1)" "unprognostic (2.22e-1)" "unprognostic (2.22e-1)" "unprognostic (2.37e-3)" 21.1 16.2 19.3 23.0 36.0 74.9 20.6 34.3 31.5 23.8 24.5 32.9 38.7 24.7 24.9 50.9 17.7 13.7 20.0 22.6 29.7 14.0 5.0 20.2 20.5 48.4 29.9 19.9 21.3 29.1 15.6 24.6 44.1 20.5 37.6 32.6 18.2 15.4 15.2 12.2 21.1 30.7 37.3 20.5 62.0 20.8 32.1 16.5 19.8 18.6 23.9 28.4 30.0 94.8 79.5 50.6 49.1 38.4 45.9 52.6 26.7 69.2 27.6 50.0 52.7 53.5 66.4 100.9 30.2 55.5 74.3 84.3 73.2 69.9 76.1 30.0 59.4 43.4 44.8 0.2 44.1 87.9 33.7 40.2 70.3 36.2 107.7 36.9 49.6 50.2 68.9 29.3 41.5 39.9 65.5 26.3 25.8 100.1 72.6 56.9 62.6 28.4 48.4 126.4 37.7 27.3 65.5 61.6 34.4 56.2 37.8 54.1 62.1 68.5 58.2 63.7 58.4 16.4 59.6 84.7 43.4 26.4 42.4 10.4 24.9 28.0 7.7 21.3 5.4 3.5 3.7 6.6 28.5 5.5 3.3 5.5 38.9 9.1 18.2 4.4 5.3 7.7 19.3 36.0 34.3 31.5 22.6 29.7 48.4 29.9 44.1 37.3 32.1 94.8 38.6 35.3 21.1 80.0 24.2 32.2 24.2 21.5 41.5 46.0 27.6 20.3 24.1 5.7 26.2 22.0 41.7 25.7 40.2 59.8 5.9 12.8 100.8 21.1 36.5 31.4 36.0 38.5 146.0 25.9 18.5 26.8 114.7 26.2 38.7 23.3 29.6 2.5 33.9 47.1 113.5 28.8 26.4 53.5 57.0 181.3 26.8 48.8 35.6 71.2 54.8 20.6 20.6 93.5 437.2 29.3 43.4 25.6 36.1 30.8 23.3 8.7 18.7 50.4 26.3 29.3 29.3 41.6 32.3 116.9 19.9 9.9 25.8 17.0 47.7 42.0 SPON1 "f-spondin, KIAA0762" ENSG00000262655 "Spondin 1" Q9HCB6 11 13962723-14268133 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 101.4" "Cell type enhanced" "Detected in many" "Astrocytes: 399.9;Endometrial stromal cells: 78.9;Muller glia cells: 141.9" "Cancer enriched" "Detected in all" 5 "ovarian cancer: 199.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "MAIT T-cell: 3.3" "Lineage enriched" "Detected in single" 33 "T-cells: 3.3" "Group enriched" "Detected in some" 36 "EFO-21: 213.7;RPTEC TERT1: 604.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038584, HPA077546" Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge" "Secreted to blood" Yes No 11500000 28000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoli, Microtubule ends" "Nucleoplasm, Actin filaments, Cytokinetic bridge" "HPA038584: AB_10697394, HPA077546: AB_2732351" "unprognostic (1.66e-1)" "unprognostic (1.03e-2)" "unprognostic (8.36e-2)" "unprognostic (8.72e-2)" "unprognostic (1.52e-1)" "unprognostic (3.76e-2)" "unprognostic (1.82e-1)" "unprognostic (8.20e-2)" "unprognostic (1.05e-1)" "unprognostic (5.93e-2)" "unprognostic (6.45e-2)" "unprognostic (1.07e-1)" "prognostic favorable (3.12e-4)" "unprognostic (7.22e-3)" "unprognostic (7.89e-2)" "unprognostic (4.65e-2)" "prognostic unfavorable (1.88e-4)" 54.2 16.9 25.8 18.6 33.7 0.1 19.5 26.3 22.3 43.8 7.8 31.8 31.6 36.5 15.2 17.3 63.1 101.4 30.6 28.2 28.3 12.2 2.0 49.2 1.6 25.6 33.6 23.9 4.6 0.8 10.0 41.3 26.4 16.9 46.6 63.8 7.0 8.8 0.8 8.8 28.4 46.9 14.9 8.3 28.8 2.5 34.0 1.7 5.2 1.6 1.2 51.5 12.5 21.8 0.1 0.1 0.4 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 9.8 0.2 0.2 213.7 0.0 0.2 0.4 0.0 0.0 0.0 0.3 1.9 0.0 0.1 0.1 0.0 0.0 0.1 11.4 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.7 0.0 0.1 1.7 0.0 0.1 604.1 0.1 0.1 0.2 0.0 0.0 0.0 4.1 0.0 0.1 2.6 0.2 0.7 0.5 0.3 0.3 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.3 0.0 0.6 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 25.8 33.7 26.3 22.3 28.2 28.3 25.6 33.6 26.4 14.9 34.0 21.8 0.2 0.0 2.3 399.9 13.5 0.0 17.3 0.0 1.2 13.5 2.0 5.5 1.9 5.7 0.0 0.0 2.1 3.4 4.8 38.9 3.9 4.3 1.5 36.1 78.9 2.5 16.7 0.0 17.0 2.0 4.2 41.2 0.5 61.5 2.5 1.8 2.5 0.2 1.9 1.7 16.8 24.0 0.0 0.3 0.0 1.3 4.4 1.0 0.0 11.2 0.5 141.9 20.6 62.4 1.6 6.8 20.6 30.1 0.9 9.0 18.4 2.1 0.7 26.8 6.6 5.8 7.0 0.4 0.8 0.6 0.0 4.9 7.8 1.1 40.9 9.4 RRAS2 TC21 ENSG00000133818 "RAS related 2" P62070 11 14277922-14364506 "Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Prostatic glandular cells: 120.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 11.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010420, HPA050942" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Cytosol" "CAB010420: AB_2253855, HPA050942: AB_2681285" "unprognostic (6.13e-2)" "unprognostic (1.85e-1)" "unprognostic (1.92e-1)" "unprognostic (1.47e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (7.80e-4)" "prognostic unfavorable (3.31e-4)" "unprognostic (4.15e-2)" "unprognostic (1.59e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (4.50e-2)" "unprognostic (4.15e-1)" "unprognostic (9.02e-2)" "unprognostic (1.05e-1)" "unprognostic (6.80e-2)" "unprognostic (1.63e-1)" 30.8 14.1 8.0 16.1 8.0 5.2 21.2 9.7 10.7 21.7 14.9 22.3 20.8 19.7 9.2 15.4 14.2 11.9 44.4 12.0 10.5 39.3 39.1 22.9 28.3 7.0 8.1 18.3 18.2 17.2 8.5 29.4 8.0 20.1 18.7 12.1 18.0 19.3 40.8 12.1 39.5 18.0 6.3 16.3 17.7 25.1 10.4 14.4 29.0 34.0 37.7 23.4 14.0 6.3 89.3 38.2 35.7 30.8 122.0 121.1 52.8 309.1 160.7 260.5 328.1 78.0 108.7 102.2 46.8 209.0 84.3 97.1 61.0 110.8 260.5 88.7 49.6 6.8 21.5 62.4 133.6 0.3 0.7 129.5 205.0 104.2 331.2 106.5 131.7 24.8 45.9 0.2 229.3 43.5 21.5 5.6 98.3 18.2 31.4 19.0 118.5 1.9 133.7 48.8 9.7 18.4 74.7 46.0 42.5 119.9 30.6 6.2 303.1 139.6 74.0 272.1 85.1 0.2 0.2 48.4 56.0 0.1 29.0 2.1 0.0 0.0 5.5 0.0 2.4 11.8 1.0 2.8 0.0 6.6 0.5 2.1 0.4 3.8 0.0 0.2 0.0 0.9 8.0 8.0 9.7 10.7 12.0 10.5 7.0 8.1 8.0 6.3 10.4 6.3 6.6 19.2 18.9 14.4 57.8 69.3 76.2 17.7 23.9 5.5 22.6 13.7 31.5 40.0 20.6 18.4 0.0 36.5 31.2 30.5 23.5 46.5 55.2 25.8 16.0 15.2 19.1 3.2 32.8 18.4 58.0 29.7 12.8 34.7 8.9 15.6 13.6 33.4 8.2 13.5 35.4 16.0 14.2 2.4 12.0 45.2 16.4 2.3 26.6 9.4 2.0 21.7 56.7 28.6 4.9 57.1 30.1 11.3 22.0 120.3 89.9 112.9 15.0 10.1 19.7 20.7 21.4 39.5 42.1 20.3 49.9 29.0 29.5 13.3 20.8 96.5 COPB1 COPB ENSG00000129083 "COPI coat complex subunit beta 1" P53618 11 14443440-14500027 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012338, HPA043954, HPA064403" Supported Enhanced "Golgi apparatus,Vesicles,Cytosol" NA NA 330000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus, Vesicles, Cytosol" "CAB012338: AB_726922, HPA043954: AB_2678746, HPA064403: AB_2685258" "unprognostic (2.35e-1)" "unprognostic (1.02e-3)" "unprognostic (1.36e-2)" "unprognostic (4.76e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (6.91e-4)" "prognostic unfavorable (5.63e-7)" "unprognostic (4.69e-3)" "unprognostic (3.42e-2)" "unprognostic (3.60e-1)" "prognostic unfavorable (8.04e-4)" "unprognostic (8.94e-2)" "unprognostic (1.78e-2)" "unprognostic (3.02e-2)" "unprognostic (8.00e-2)" "unprognostic (3.87e-1)" "unprognostic (1.69e-2)" 48.1 47.1 19.9 55.0 21.8 79.8 62.6 26.2 25.3 64.9 44.7 59.8 57.7 52.6 69.3 46.7 49.2 54.9 43.7 20.1 23.6 65.3 73.6 49.9 59.1 24.2 21.8 49.1 59.2 67.6 48.4 69.2 23.7 66.9 67.1 39.3 67.5 53.8 33.1 36.6 58.8 61.1 23.5 46.3 59.7 46.8 23.0 68.1 81.0 38.1 64.5 60.4 40.0 27.6 134.9 113.6 118.6 89.4 193.1 221.3 95.9 199.2 206.5 173.1 202.0 89.1 203.5 130.1 87.1 252.9 164.6 144.7 134.6 133.3 212.1 122.7 114.0 138.3 74.3 135.8 171.3 128.9 134.4 156.3 172.4 116.0 217.8 158.9 183.7 71.6 104.5 103.8 221.1 101.6 117.2 78.7 61.7 163.3 123.1 94.9 163.1 89.0 156.1 123.3 75.6 81.2 154.2 123.2 104.8 135.5 112.3 110.1 189.5 166.2 85.4 181.3 110.1 55.2 100.5 143.8 125.1 79.2 158.6 52.8 38.7 43.5 45.7 47.8 55.7 38.4 38.1 47.6 52.3 32.0 37.8 39.8 31.2 44.6 49.8 31.1 44.8 43.2 19.9 21.8 26.2 25.3 20.1 23.6 24.2 21.8 23.7 23.5 23.0 27.6 55.6 109.0 63.2 29.0 64.3 38.9 59.7 82.6 52.3 28.4 43.0 27.9 31.3 35.8 107.8 44.1 27.1 65.4 71.2 55.9 41.1 77.1 17.2 72.6 81.4 55.5 43.8 50.9 36.9 81.7 69.6 70.5 63.2 72.5 65.2 50.7 51.4 58.1 60.9 18.5 39.1 87.5 61.1 50.7 43.5 10.7 51.0 61.5 21.4 35.6 70.1 34.0 44.3 32.6 49.6 93.6 37.5 55.3 107.4 54.3 60.6 57.3 131.9 29.5 52.6 60.8 78.7 87.5 64.3 48.7 35.8 117.0 77.0 49.3 51.5 60.7 PSMA1 "HC2, MGC14542, MGC14575, MGC14751, MGC1667, MGC21459, MGC22853, MGC23915, NU, PROS30" ENSG00000129084 "Proteasome 20S subunit alpha 1" P25786 11 14504874-14643635 "Enzymes, Predicted intracellular proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 627.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033765, HPA037646, HPA043891, CAB079995" Supported Supported "Nucleoplasm,Nuclear bodies,Centrosome" NA NA 20000000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm "Nuclear bodies, Centrosome" "CAB033765: AB_2253026, CAB079995: , HPA037646: AB_10670386, HPA043891: AB_2678718" "unprognostic (1.72e-2)" "unprognostic (4.97e-2)" "unprognostic (7.33e-2)" "unprognostic (4.74e-2)" "unprognostic (7.52e-2)" "unprognostic (6.66e-3)" "prognostic unfavorable (3.79e-5)" "unprognostic (3.28e-3)" "unprognostic (7.44e-2)" "unprognostic (3.43e-3)" "unprognostic (8.27e-3)" "unprognostic (8.77e-2)" "prognostic unfavorable (4.03e-11)" "unprognostic (1.93e-1)" "unprognostic (1.69e-1)" "unprognostic (4.66e-2)" "unprognostic (1.23e-2)" 87.2 85.5 55.1 94.9 57.8 135.8 96.2 55.4 68.2 76.8 58.7 92.5 96.4 80.7 108.0 94.7 79.4 79.6 140.5 59.4 64.4 98.4 139.2 77.5 114.9 55.8 56.6 79.4 54.6 78.5 50.4 113.0 58.8 81.7 101.9 63.2 74.4 85.8 168.7 80.5 86.1 96.1 56.6 75.6 75.7 56.2 60.2 122.2 88.4 152.6 109.9 111.2 56.0 58.6 408.8 279.8 227.8 275.7 223.7 225.5 193.3 232.9 305.2 348.3 283.9 244.2 500.1 349.5 262.1 248.6 315.4 303.1 259.3 290.1 328.3 344.0 389.6 220.4 190.5 326.1 291.0 355.3 277.5 217.8 171.6 188.9 390.7 252.7 347.0 271.6 398.9 283.4 315.2 277.8 334.0 319.5 191.6 340.5 414.1 223.3 336.1 217.5 313.0 304.7 188.2 119.3 246.6 273.9 229.0 233.8 164.4 222.9 272.0 226.2 222.9 402.7 295.4 123.3 366.1 319.9 334.8 291.1 296.6 115.5 191.2 47.5 97.7 139.8 128.0 104.1 110.8 109.7 243.3 95.3 98.5 94.4 36.3 145.1 137.5 138.7 154.9 235.8 55.1 57.8 55.4 68.2 59.4 64.4 55.8 56.6 58.8 56.6 60.2 58.6 119.0 83.3 90.2 64.3 101.7 142.9 231.2 365.7 76.2 50.3 105.7 125.9 0.0 82.9 176.1 88.3 18.8 469.5 135.3 49.2 256.3 228.5 75.5 84.0 94.0 135.5 40.1 163.9 56.8 233.1 370.6 128.5 66.8 79.8 78.2 134.7 95.3 127.9 292.9 57.2 66.3 63.6 231.9 161.8 170.5 36.3 116.5 153.6 144.1 122.7 263.7 111.6 168.9 64.8 35.3 223.2 88.6 127.5 112.1 209.1 135.0 257.1 115.1 54.8 85.5 99.2 129.8 174.9 80.1 114.3 151.9 627.3 130.7 137.2 97.1 248.1 PDE3B HcGIP1 ENSG00000152270 "Phosphodiesterase 3B" Q13370 11 14643804-14872044 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins" Angiogenesis Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 64.5" "Cell type enhanced" "Detected in many" "Astrocytes: 171.7;Excitatory neurons: 140.5;Inhibitory neurons: 158.0;Microglial cells: 192.0;Oligodendrocyte precursor cells: 118.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 13.5" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 3.8;T-cells: 6.3" "Cell line enhanced" "Detected in many" "HL-60: 23.5;Karpas-707: 25.7;THP-1: 28.4;U-266/70: 28.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056111 Approved "Endoplasmic reticulum" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Endoplasmic reticulum" "HPA056111: AB_2683041" "unprognostic (1.05e-1)" "unprognostic (2.86e-2)" "unprognostic (4.12e-2)" "unprognostic (2.76e-3)" "unprognostic (4.25e-1)" "unprognostic (1.84e-3)" "unprognostic (3.40e-2)" "unprognostic (3.24e-2)" "unprognostic (5.39e-2)" "unprognostic (1.20e-1)" "prognostic favorable (7.91e-4)" "unprognostic (1.77e-1)" "unprognostic (2.33e-2)" "unprognostic (1.39e-2)" "unprognostic (3.42e-1)" "unprognostic (2.47e-1)" "unprognostic (9.03e-3)" 64.5 1.1 1.3 12.4 2.1 10.1 12.2 13.5 2.6 3.4 0.0 25.2 2.9 0.7 0.5 2.9 0.5 3.7 4.7 1.9 2.6 3.0 25.8 10.2 14.9 2.8 1.7 0.5 8.3 0.2 4.4 7.6 1.9 8.7 10.7 0.5 14.0 1.6 0.4 0.5 6.0 1.7 2.3 8.9 2.6 9.6 2.0 7.3 0.8 2.4 7.9 8.5 1.9 2.6 0.0 2.5 5.6 9.2 10.9 0.1 2.2 0.6 0.1 0.0 0.0 8.5 0.0 0.0 0.1 0.0 2.6 0.0 8.5 0.0 0.0 0.2 18.7 0.3 13.1 17.5 3.9 23.5 0.1 0.8 0.0 0.0 0.5 0.0 0.1 6.6 20.6 25.7 0.0 0.3 4.7 11.4 7.6 3.1 4.1 11.0 2.5 17.7 0.0 1.9 8.5 15.8 2.3 14.6 5.1 2.5 0.0 28.4 0.0 0.0 1.3 0.0 0.0 28.8 9.4 0.7 0.2 4.0 1.7 0.0 0.5 2.5 1.0 0.6 2.1 0.2 3.1 2.4 0.3 0.1 6.3 5.7 3.8 0.1 1.0 0.1 3.5 1.5 1.3 2.1 13.5 2.6 1.9 2.6 2.8 1.7 1.9 2.3 2.0 2.6 1.5 16.0 8.9 171.7 6.4 0.3 0.9 0.0 0.6 1.0 0.3 0.3 11.1 0.0 6.2 1.8 0.0 1.4 26.7 11.5 1.9 0.0 19.0 0.3 5.1 4.0 1.2 12.8 140.5 5.0 2.8 9.7 7.7 0.3 36.1 0.5 4.2 64.1 7.6 0.0 158.0 13.7 0.0 13.1 3.7 13.4 1.5 15.6 0.0 192.0 10.8 6.3 8.2 118.6 5.4 1.8 22.3 9.1 28.9 3.3 0.7 2.0 3.6 0.5 0.0 3.4 3.0 48.8 19.5 0.1 0.1 2.5 60.9 0.0 9.4 1.1 CYP2R1 ENSG00000186104 "Cytochrome P450 family 2 subfamily R member 1" Q6VVX0 11 14877440-14892231 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Early spermatids: 176.3;Late spermatids: 106.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 26.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042949 Approved "Intracellular and membrane" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 2: Karpas-707 - Immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA042949: AB_2678237" "unprognostic (1.62e-2)" "unprognostic (1.82e-2)" "unprognostic (5.90e-2)" "unprognostic (1.63e-3)" "unprognostic (2.67e-1)" "unprognostic (2.19e-1)" "unprognostic (3.23e-2)" "unprognostic (7.73e-2)" "unprognostic (1.70e-1)" "unprognostic (3.90e-2)" "unprognostic (2.25e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (2.86e-4)" "unprognostic (1.01e-1)" "unprognostic (1.81e-1)" "unprognostic (1.46e-1)" "unprognostic (1.44e-2)" 2.5 1.8 1.6 3.1 1.9 3.0 4.1 4.9 2.4 2.6 0.5 3.7 4.6 2.2 3.2 4.6 1.8 1.6 2.2 1.6 2.1 1.8 2.2 2.5 3.0 1.7 1.5 2.0 5.2 1.5 2.6 1.0 1.8 2.8 3.3 3.3 4.5 1.4 2.8 6.9 4.4 1.5 1.5 3.0 5.0 4.3 1.6 2.4 1.9 1.6 2.9 3.0 3.3 2.3 6.1 3.7 3.6 1.5 1.5 2.5 0.0 2.1 1.1 1.2 1.3 4.3 6.8 7.6 1.6 0.4 4.7 0.0 1.2 2.8 0.5 6.3 5.8 3.4 4.7 0.3 5.4 5.9 3.4 2.4 10.6 0.0 4.4 1.1 1.4 9.3 5.1 26.0 0.8 1.6 6.5 11.9 3.4 4.4 3.5 4.6 2.6 11.6 1.4 0.7 3.0 4.7 4.5 5.4 5.2 2.3 4.0 2.2 3.8 3.6 4.4 2.2 2.7 12.8 16.1 9.0 5.0 7.6 3.3 2.4 2.0 1.6 3.0 1.9 4.7 1.6 2.5 1.9 1.7 2.8 3.5 3.0 0.3 2.1 2.3 2.0 3.6 1.2 1.6 1.9 4.9 2.4 1.6 2.1 1.7 1.5 1.8 1.5 1.6 2.3 4.4 12.8 4.8 8.5 15.4 5.9 13.9 9.3 12.5 1.9 7.0 5.8 4.3 8.6 7.4 5.5 6.2 0.3 9.8 10.1 5.9 8.1 176.3 1.9 3.3 6.7 6.7 4.6 13.1 16.9 0.2 4.4 14.8 3.9 3.8 7.8 5.0 6.0 5.9 1.7 18.4 5.5 0.0 7.6 12.6 106.7 2.1 7.7 14.2 13.1 6.1 5.0 13.4 14.6 13.3 11.3 2.9 4.1 11.9 6.4 12.6 6.2 2.8 5.0 13.1 3.2 4.9 23.8 20.2 20.4 6.7 0.0 16.4 6.7 8.8 6.1 CALCB "CALC2, CGRP-II, FLJ30166" ENSG00000175868 "Calcitonin related polypeptide beta" P10092 11 14904997-15082342 "FDA approved drug targets, Plasma proteins, Predicted secreted proteins" Hormone "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 18.9;thyroid gland: 20.7" "Group enriched" "Detected in some" 4 "Melanocytes: 5.4;Spermatogonia: 5.1" "Group enriched" "Detected in some" 5 "colorectal cancer: 1.2;endometrial cancer: 2.4;thyroid cancer: 0.9" "Group enriched" "Detected in many" 4 "hypothalamus: 6.8;medulla oblongata: 8.9;midbrain: 11.6;pons: 18.9;white matter: 4.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 5.8;Karpas-707: 10.4;SH-SY5Y: 3.5;U-266/70: 16.0" "Region enriched" "Detected in some" 7 "pons and medulla: 9.6" "Group enriched" "Detected in many" 5 "amygdala: 30.4;basal ganglia: 74.3;hypothalamus: 50.1;midbrain: 33.9;pons: 41.7" HPA059886 Supported "Secreted to blood" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 29: U-266 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "HPA059886: " "unprognostic (7.84e-2)" "unprognostic (4.07e-1)" "unprognostic (3.92e-1)" "prognostic unfavorable (3.42e-5)" "unprognostic (2.02e-1)" "unprognostic (8.40e-2)" "unprognostic (1.75e-1)" "unprognostic (7.21e-2)" "unprognostic (2.07e-1)" "unprognostic (3.32e-2)" "unprognostic (4.87e-2)" "unprognostic (1.16e-1)" "unprognostic (1.02e-2)" "unprognostic (2.33e-2)" "unprognostic (2.66e-1)" "unprognostic (1.99e-1)" "unprognostic (2.33e-1)" 0.3 0.0 0.1 0.3 0.2 0.0 0.2 0.5 0.6 0.2 0.1 1.4 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.3 6.8 1.0 0.8 0.1 0.1 8.9 11.6 0.1 1.5 0.3 2.2 0.1 18.9 0.1 0.2 0.1 0.3 0.0 0.8 0.1 0.4 0.1 2.3 0.1 0.1 0.3 1.0 0.0 20.7 0.1 0.1 0.0 0.1 4.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.2 5.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 1.9 0.0 0.4 0.1 0.0 10.4 0.0 0.0 0.0 0.6 2.9 0.1 0.1 0.4 0.0 0.2 0.0 0.0 1.1 3.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 16.0 0.6 0.4 2.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.6 0.3 6.8 8.9 11.6 18.9 2.3 1.0 4.7 0.0 0.0 0.0 0.3 0.2 1.3 0.1 0.0 0.0 0.0 0.6 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.4 0.2 0.9 0.5 0.2 0.5 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.3 0.0 0.0 5.4 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.9 5.1 0.0 0.0 0.1 1.2 0.0 0.0 0.1 CALCA "CALC1, CGRP, CGRP-alpha" ENSG00000110680 "Calcitonin related polypeptide alpha" "P01258, P06881" 11 14966668-14972351 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, Transporters" Hormone "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "parathyroid gland: 178.3;thyroid gland: 154.2" "Cell type enriched" "Detected in some" 64 "Ionocytes: 2368.1" "Cancer enriched" "Detected in many" 7 "lung cancer: 64.7" "Region enhanced" "Detected in many" "pons: 34.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in all" 5 "pons and medulla: 57.9" "HPA059886, HPA064453" Enhanced Supported "Secreted to blood" NA NA 51500 "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA059886: , HPA064453: " "unprognostic (1.97e-1)" "prognostic unfavorable (4.49e-5)" "unprognostic (5.99e-2)" "unprognostic (2.42e-1)" "unprognostic (1.17e-1)" "unprognostic (6.45e-2)" "unprognostic (1.28e-1)" "unprognostic (7.66e-2)" "unprognostic (3.33e-2)" "unprognostic (7.49e-2)" "unprognostic (6.74e-2)" "unprognostic (2.53e-3)" "unprognostic (1.02e-2)" 0.7 0.2 0.6 1.5 0.6 0.0 0.2 0.6 0.5 0.2 0.0 0.6 0.0 0.2 0.0 0.1 0.3 0.2 1.1 0.3 0.8 46.4 37.5 2.4 0.1 20.9 7.0 0.1 0.4 178.3 0.8 0.0 34.4 2.5 0.1 0.0 0.1 0.0 0.5 0.0 0.1 1.5 1.5 3.0 0.2 0.2 0.6 0.3 154.2 0.0 0.0 4.3 0.4 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.6 0.5 0.3 0.8 20.9 7.0 34.4 1.5 0.6 10.4 0.1 0.0 0.0 0.0 0.2 0.3 0.4 35.4 0.0 0.0 0.0 0.1 0.4 0.0 0.3 36.8 0.0 0.0 0.0 0.0 5.9 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 1.9 0.0 0.6 0.0 0.3 0.0 0.0 0.7 4.4 0.3 0.0 0.0 0.0 2368.1 0.0 4.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.2 0.0 0.0 0.4 5.5 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 INSC ENSG00000188487 "INSC spindle orientation adaptor protein" Q1MX18 11 15112424-15247208 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "parathyroid gland: 25.3" "Cell type enhanced" "Detected in some" "Distal tubular cells: 3.9;Early spermatids: 4.6;Exocrine glandular cells: 3.1;Oligodendrocyte precursor cells: 8.0;Pancreatic endocrine cells: 10.9;Proximal tubular cells: 8.9" "Cancer enhanced" "Detected in some" "melanoma: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 11.7;hTERT-HME1: 6.0;Karpas-707: 3.3;LHCN-M2: 3.6;TIME: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA039769 Uncertain NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA039769: AB_10697556" "unprognostic (1.64e-2)" "unprognostic (6.54e-2)" "unprognostic (1.45e-3)" "unprognostic (1.59e-1)" "unprognostic (6.00e-2)" "unprognostic (4.59e-3)" "unprognostic (6.88e-2)" "unprognostic (3.44e-3)" "unprognostic (3.69e-1)" "unprognostic (3.59e-2)" "unprognostic (2.63e-1)" "unprognostic (2.31e-1)" "unprognostic (3.30e-3)" "unprognostic (2.31e-1)" "unprognostic (1.35e-1)" "unprognostic (2.50e-2)" "unprognostic (5.00e-2)" 0.2 0.8 0.2 1.0 0.1 0.6 0.2 0.1 0.2 1.1 0.1 4.7 2.1 0.1 0.1 0.5 0.3 0.6 1.2 0.1 0.2 0.3 0.2 0.9 0.0 0.3 0.2 0.1 0.9 25.3 0.2 0.0 0.2 1.0 1.8 0.0 0.5 1.0 0.0 0.1 3.0 0.5 0.2 0.1 2.4 0.7 0.1 0.2 0.3 0.1 0.0 0.8 0.8 0.2 0.0 0.0 0.0 0.0 0.3 11.7 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.1 0.1 0.4 0.0 0.0 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.6 6.0 0.0 0.0 0.0 0.0 3.3 3.6 0.0 0.0 0.2 0.0 0.1 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 1.0 0.0 0.0 1.5 0.2 0.0 0.5 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.2 0.3 0.2 0.2 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.9 0.1 4.6 0.2 0.0 0.1 1.8 0.0 0.5 3.1 0.0 0.9 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.0 0.0 10.9 0.0 0.0 0.1 0.2 0.0 8.9 0.0 0.0 0.0 0.0 1.1 1.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.6 SOX6 ENSG00000110693 "SRY-box transcription factor 6" P35712 11 15966449-16739591 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.9" "Cell type enhanced" "Detected in many" "Astrocytes: 308.9;Early spermatids: 256.8;Inhibitory neurons: 481.0;Oligodendrocyte precursor cells: 1687.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 20 "neutrophil: 2.0" "Lineage enriched" "Detected in single" 20 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "CACO-2: 5.7;HAP1: 4.4;hTCEpi: 5.0;SK-MEL-30: 4.9;WM-115: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001923, HPA003908" Enhanced Supported Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "HPA001923: AB_1080065, HPA003908: AB_1080063" "unprognostic (3.40e-2)" "unprognostic (1.70e-1)" "unprognostic (1.20e-1)" "unprognostic (1.68e-1)" "unprognostic (4.17e-3)" "unprognostic (1.05e-2)" "unprognostic (6.47e-3)" "unprognostic (1.25e-2)" "unprognostic (1.31e-1)" "unprognostic (7.89e-4)" "unprognostic (9.08e-2)" "unprognostic (7.37e-3)" "prognostic favorable (6.47e-12)" "unprognostic (9.90e-2)" "unprognostic (5.02e-2)" "unprognostic (1.15e-1)" "unprognostic (3.04e-2)" 1.8 1.3 5.4 0.4 5.9 26.9 0.7 2.6 4.7 1.7 5.5 1.2 6.5 0.6 2.0 2.1 4.0 2.6 3.0 4.0 7.2 11.1 4.8 0.8 0.1 7.2 7.8 0.7 6.8 0.1 2.9 2.5 6.0 0.4 1.3 3.2 0.5 0.6 9.3 5.8 11.0 0.5 7.7 0.5 1.0 14.4 4.1 1.6 3.4 5.9 0.2 0.8 0.8 6.8 0.0 0.7 3.9 3.7 0.0 0.0 0.0 0.3 1.3 0.1 0.1 5.7 0.0 0.0 3.6 0.0 0.0 0.1 4.4 1.1 0.0 0.0 0.5 0.0 0.0 0.3 0.6 0.0 0.0 0.0 5.0 0.0 0.1 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.8 0.0 1.8 0.0 0.0 0.1 0.4 0.0 4.9 0.5 0.0 0.0 0.0 2.6 2.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 5.4 5.9 2.6 4.7 4.0 7.2 7.2 7.8 6.0 7.7 4.1 6.8 2.7 3.2 6.3 308.9 1.0 40.1 5.8 6.8 66.6 26.3 3.7 2.5 21.6 54.3 3.8 36.8 10.4 1.3 0.1 1.4 9.8 19.8 256.8 29.4 5.3 4.8 7.8 126.7 2.8 3.7 0.6 14.5 2.0 27.8 0.0 1.6 2.2 7.5 1.1 0.0 481.0 6.6 0.0 2.9 3.2 70.1 3.4 1.4 35.6 21.5 0.0 48.4 0.0 1687.9 8.9 5.5 20.3 2.2 0.1 3.2 99.8 27.1 8.3 4.3 0.0 26.2 14.6 22.1 4.5 32.7 16.1 0.5 1.1 3.0 11.8 3.7 C11orf58 SMAP ENSG00000110696 "Chromosome 11 open reading frame 58" O00193 11 16613132-16758340 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036591, HPA076406" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum" NA NA 100000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Endoplasmic reticulum" Nucleoplasm "HPA036591: AB_10669909, HPA076406: AB_2686798" "unprognostic (8.09e-2)" "unprognostic (1.19e-1)" "unprognostic (1.20e-1)" "unprognostic (4.31e-2)" "unprognostic (2.88e-1)" "unprognostic (9.19e-2)" "prognostic unfavorable (5.84e-5)" "unprognostic (1.30e-1)" "unprognostic (7.84e-2)" "unprognostic (9.45e-3)" "unprognostic (1.76e-1)" "unprognostic (2.06e-1)" "unprognostic (4.41e-2)" "unprognostic (7.30e-2)" "unprognostic (9.77e-2)" "unprognostic (1.39e-1)" "unprognostic (1.50e-1)" 142.2 135.1 52.2 129.5 57.8 128.3 94.5 55.3 79.7 91.5 66.5 101.8 89.9 136.1 73.8 172.3 128.0 115.6 159.9 52.0 62.7 114.9 132.9 102.9 162.9 57.6 56.0 172.0 127.8 115.1 78.7 123.9 61.3 111.7 71.7 94.2 128.6 85.3 212.2 99.8 96.5 113.8 56.8 125.8 111.7 89.6 55.4 138.2 162.1 109.6 127.9 125.1 81.3 69.1 416.1 362.9 390.3 197.0 199.5 162.3 272.8 419.2 213.0 276.2 245.5 348.0 397.7 383.1 315.2 253.7 311.4 242.3 275.0 206.9 232.8 485.8 289.9 342.7 286.8 310.1 243.4 492.8 276.2 182.3 230.6 168.9 336.6 209.7 178.4 232.6 435.2 246.5 191.1 247.8 506.5 211.7 291.1 212.7 197.6 404.3 413.6 196.0 158.6 248.7 269.8 267.4 372.4 273.4 501.4 225.0 244.4 315.7 359.5 336.7 268.2 407.1 388.0 164.0 648.6 525.2 297.2 275.3 326.1 587.6 390.4 552.8 407.8 451.9 482.3 621.9 451.4 435.0 429.7 578.9 506.9 440.6 186.9 433.9 490.1 544.7 522.0 896.2 52.2 57.8 55.3 79.7 52.0 62.7 57.6 56.0 61.3 56.8 55.4 69.1 188.3 246.8 222.5 41.8 219.8 257.1 275.3 379.8 167.9 169.5 170.9 168.4 206.4 178.7 259.1 200.5 150.1 312.2 242.8 65.6 428.4 249.7 65.6 204.2 202.0 217.3 159.2 213.7 72.5 228.1 346.8 258.2 73.4 139.8 237.3 151.3 175.6 163.8 227.0 143.0 68.6 133.2 299.1 164.3 261.0 34.3 205.9 180.1 229.5 45.0 249.9 230.5 248.2 61.3 63.5 232.3 104.3 204.2 183.0 324.1 103.4 364.6 237.0 215.7 157.8 164.9 246.8 331.6 245.7 142.5 276.6 453.5 217.3 188.2 118.7 296.6 PLEKHA7 DKFZp686M22243 ENSG00000166689 "Pleckstrin homology domain containing A7" Q6IQ23 11 16777297-17014414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 111.0;Gastric mucus-secreting cells: 40.8;Microglial cells: 48.7;Oligodendrocytes: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "eosinophil: 3.7;MAIT T-cell: 2.0" "Group enriched" "Detected in many" 6 "granulocytes: 3.7;T-cells: 2.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 116.4;HaCaT: 75.2;OE19: 58.6;RT4: 109.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038610, HPA066103" Approved Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Cell Junctions" Cytosol "HPA038610: AB_10671746, HPA066103: AB_2732738" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (3.81e-2)" "unprognostic (4.30e-2)" "unprognostic (2.51e-2)" "unprognostic (6.95e-3)" "unprognostic (2.81e-2)" "unprognostic (1.85e-2)" "unprognostic (2.65e-1)" "unprognostic (1.73e-1)" "unprognostic (2.65e-3)" "unprognostic (3.13e-2)" "prognostic favorable (1.89e-15)" "unprognostic (9.74e-2)" "unprognostic (1.17e-2)" "unprognostic (4.81e-1)" "unprognostic (2.65e-2)" 10.3 1.7 10.0 5.5 11.9 0.6 13.3 9.6 7.0 11.2 26.5 18.3 27.3 4.1 3.8 46.0 9.1 7.3 24.0 7.5 14.3 26.4 16.7 8.0 2.3 11.5 17.9 12.7 15.2 17.6 4.2 9.0 11.8 7.0 16.9 27.4 21.5 5.3 2.2 14.1 25.4 3.6 7.3 1.8 23.7 10.1 21.2 4.0 10.9 2.2 6.6 14.0 18.3 10.3 14.2 12.7 11.9 5.5 0.7 0.0 20.7 0.1 0.4 4.9 9.0 22.6 116.4 0.2 5.4 1.9 0.7 75.2 16.9 0.2 3.5 4.2 16.2 39.7 11.2 13.5 0.3 0.1 0.5 0.6 6.4 0.0 0.4 10.7 0.0 14.3 1.7 0.4 2.0 8.7 8.8 0.3 6.1 58.6 12.4 11.5 0.0 3.0 10.9 109.9 8.3 0.9 16.7 44.3 0.6 22.3 11.3 4.1 3.3 0.2 4.1 3.2 2.8 7.6 2.4 16.2 0.1 0.8 0.1 0.1 0.1 3.7 0.3 0.0 2.0 0.1 0.3 0.2 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.4 0.0 0.2 10.0 11.9 9.6 7.0 7.5 14.3 11.5 17.9 11.8 7.3 21.2 10.3 8.2 3.2 17.0 111.0 0.6 0.6 1.1 1.4 0.6 2.3 6.9 6.1 8.7 7.2 8.6 11.0 25.0 6.7 0.2 12.0 3.9 6.1 16.3 20.5 2.3 4.7 0.0 1.3 19.3 6.0 0.9 1.0 40.8 22.9 2.5 16.1 2.2 2.9 1.8 0.0 26.2 6.5 0.0 1.0 1.4 6.1 0.6 2.7 0.0 48.7 0.8 4.3 1.0 15.6 37.9 10.7 4.1 0.4 1.8 0.8 9.2 10.6 8.0 9.7 0.0 1.0 1.2 0.5 0.5 12.3 0.4 6.0 1.2 2.1 3.1 6.4 RPS13 S13 ENSG00000110700 "Ribosomal protein S13" P62277 11 17074388-17077715 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005985 Uncertain Approved "Endoplasmic reticulum" NA NA 190000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum" "HPA005985: AB_10960703" "unprognostic (7.74e-3)" "unprognostic (2.73e-1)" "unprognostic (2.03e-1)" "unprognostic (3.21e-3)" "unprognostic (2.88e-1)" "unprognostic (4.85e-2)" "unprognostic (8.68e-3)" "unprognostic (3.81e-1)" "unprognostic (1.41e-1)" "unprognostic (3.74e-2)" "unprognostic (8.20e-3)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (5.71e-2)" "unprognostic (3.85e-2)" "unprognostic (2.62e-1)" "unprognostic (1.03e-1)" 1087.7 732.8 827.4 821.7 866.8 2404.4 2065.5 844.9 1205.2 1301.5 834.4 1135.5 854.6 1115.2 1152.5 1160.4 1285.2 950.2 1064.7 797.8 862.5 845.3 1101.5 696.5 2031.2 867.4 824.3 2669.7 1736.0 646.3 520.4 981.3 878.5 814.1 1136.1 660.8 1368.0 829.6 1934.5 1450.1 817.7 947.1 897.4 1102.7 962.6 356.6 856.5 1737.4 997.0 1525.9 1845.3 1318.5 1070.0 910.6 2115.6 1619.7 1524.1 1279.1 2680.1 4138.4 1660.6 1430.9 1991.9 2194.7 1774.8 2580.3 2640.4 3164.1 975.4 1710.4 1405.0 1546.0 2213.2 2387.6 2309.0 1326.2 4617.5 1347.9 1531.6 2761.0 3226.4 2821.8 1400.8 3174.0 3942.6 917.4 3647.4 2486.7 2632.2 2073.1 2128.5 1736.5 2173.6 2173.4 2377.2 3920.5 1727.0 2853.9 3099.3 2189.8 2064.2 2008.3 2147.5 2483.2 1249.0 2080.7 682.1 2723.3 3495.9 1527.1 1238.1 4255.9 1550.7 997.4 1660.5 2271.0 1835.2 1186.2 2726.3 2444.2 1143.1 2407.0 1352.5 582.6 2489.7 362.9 1356.0 1807.4 2715.0 3719.8 2904.9 2027.9 3004.4 3245.9 4371.9 3365.9 232.1 1880.4 1483.8 3192.8 2173.3 6018.5 827.4 866.8 844.9 1205.2 797.8 862.5 867.4 824.3 878.5 897.4 856.5 910.6 2429.5 926.3 1565.1 24.8 4390.9 4567.0 4447.1 4666.4 4408.4 271.6 5079.9 8516.0 778.1 1998.8 2361.4 665.8 104.3 3971.3 2743.0 912.1 2915.1 2434.7 1352.5 1075.0 2375.9 2226.1 1369.9 2311.8 19.4 4554.7 5434.6 2170.0 1711.1 1305.6 1506.6 2246.3 2328.4 2036.1 2923.8 90.9 24.7 2896.7 1501.4 4367.6 4707.0 1820.3 3551.8 2950.1 2180.6 30.9 4862.5 1677.2 2326.5 18.6 33.1 2988.2 2321.6 1774.6 2669.5 4100.7 1793.2 3790.7 1206.8 482.6 874.4 3314.3 2545.4 616.6 352.4 5638.8 5447.9 4488.7 3426.6 2642.9 3153.8 4835.4 PIK3C2A PI3K-C2alpha ENSG00000011405 "Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha" O00443 11 17077730-17207983 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Endocytosis, Exocytosis" "Kinase, Transferase" "Cataract, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 217.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037641, HPA037642" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "Vesicles, Cytosol" "HPA037641: AB_10671878, HPA037642: AB_10697081" "unprognostic (2.35e-1)" "unprognostic (2.16e-2)" "unprognostic (3.71e-2)" "unprognostic (1.06e-1)" "unprognostic (1.63e-1)" "unprognostic (6.63e-2)" "unprognostic (2.47e-2)" "unprognostic (1.39e-1)" "unprognostic (2.29e-2)" "unprognostic (1.86e-2)" "unprognostic (4.74e-2)" "unprognostic (1.84e-1)" "prognostic favorable (1.66e-4)" "unprognostic (3.20e-2)" "unprognostic (1.51e-1)" "unprognostic (1.18e-1)" "unprognostic (1.37e-1)" 22.5 13.7 16.3 12.3 25.9 9.4 15.9 22.5 14.6 16.1 17.4 13.2 14.9 18.0 15.7 15.4 14.5 19.0 12.4 10.5 14.0 23.5 15.5 16.6 11.3 16.6 16.1 14.1 12.3 43.6 10.3 23.1 17.0 16.4 13.0 22.4 11.8 14.8 6.4 12.3 11.8 18.3 13.8 13.0 18.0 19.3 19.6 9.4 30.7 12.1 10.9 14.9 12.0 15.8 53.8 24.1 39.6 24.8 28.0 28.3 35.3 33.2 35.7 23.9 33.2 58.9 6.0 15.6 16.2 28.6 39.1 34.8 31.9 25.4 42.1 13.5 27.6 9.8 28.4 23.3 30.6 12.3 14.9 22.2 17.5 23.6 45.8 22.2 57.7 9.9 23.4 14.7 18.6 16.6 6.6 7.7 22.6 30.1 18.5 6.9 41.1 11.0 29.6 47.0 23.2 20.5 50.6 21.4 23.2 33.0 12.7 12.3 72.5 19.1 27.4 50.1 20.4 5.9 14.1 12.8 22.8 11.3 22.6 1.7 1.5 1.1 1.7 1.0 1.1 1.4 1.3 1.3 2.1 1.5 1.7 1.0 2.3 1.8 3.2 1.4 0.9 0.6 16.3 25.9 22.5 14.6 10.5 14.0 16.6 16.1 17.0 13.8 19.6 15.8 93.2 76.9 62.0 217.4 25.0 35.3 26.1 18.7 24.5 49.1 34.7 25.0 29.7 25.8 33.1 36.8 70.9 29.6 29.5 22.6 19.6 19.8 35.9 51.8 35.1 87.6 28.7 11.2 57.0 25.1 17.9 28.6 45.3 72.4 32.2 22.8 106.7 32.4 19.2 35.3 81.1 23.5 18.3 46.3 33.1 18.6 25.7 27.0 19.6 69.3 19.6 73.0 17.5 62.8 79.4 26.1 13.1 31.2 29.9 42.7 15.2 22.4 26.4 40.4 39.5 33.7 35.1 52.6 26.8 23.5 34.0 143.5 25.3 25.1 20.7 37.3 NUCB2 NEFA ENSG00000070081 "Nucleobindin 2" P80303 11 17208153-17349980 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "DNA-binding, Guanine-nucleotide releasing factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 758.3;salivary gland: 771.4" "Cell type enhanced" "Detected in all" "Early spermatids: 690.6;Late spermatids: 508.5;Respiratory ciliated cells: 618.8;Syncytiotrophoblasts: 1158.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 1867.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008395, CAB015931, CAB079781" Enhanced Supported Enhanced "Golgi apparatus" "Secreted to blood" NA NA 1250000 690000 "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 32: U-937 - Innate immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Golgi apparatus" "CAB015931: , CAB079781: AB_2313672, HPA008395: AB_1854683" "unprognostic (2.49e-1)" "unprognostic (1.75e-2)" "unprognostic (1.39e-1)" "prognostic favorable (8.27e-6)" "unprognostic (5.24e-3)" "unprognostic (2.51e-1)" "unprognostic (3.96e-3)" "unprognostic (3.66e-3)" "unprognostic (1.81e-1)" "prognostic favorable (1.98e-4)" "unprognostic (1.46e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (3.94e-5)" "unprognostic (2.39e-1)" "unprognostic (1.61e-1)" "unprognostic (4.78e-2)" "unprognostic (8.02e-3)" 56.2 75.7 23.9 62.1 27.8 619.9 141.1 28.8 32.1 137.2 58.0 68.3 57.3 60.8 458.2 146.3 107.2 60.8 95.7 22.8 34.7 43.2 102.2 49.8 60.2 25.7 28.2 56.0 758.3 479.1 113.0 90.9 26.8 70.9 68.4 64.5 771.4 190.9 38.5 21.1 40.7 78.5 26.2 42.2 92.9 119.2 28.4 334.2 153.9 30.4 78.5 61.8 44.9 26.6 119.9 49.0 53.7 163.4 118.9 162.3 65.0 260.5 381.0 115.1 203.0 48.7 26.8 182.9 63.5 250.7 107.1 50.1 34.4 66.8 178.7 126.7 76.3 135.8 57.8 85.2 340.5 1867.0 238.6 71.1 86.8 82.9 200.9 284.9 143.3 672.1 120.1 361.1 114.9 105.9 656.2 670.3 12.9 194.0 50.5 239.8 130.4 15.1 51.9 37.5 63.5 35.4 114.6 114.2 61.4 78.0 93.5 498.1 128.1 120.9 110.9 369.1 112.1 70.3 41.3 101.1 140.5 646.1 106.4 210.5 43.5 168.2 94.1 30.5 122.9 22.7 88.5 173.7 40.6 14.5 246.7 271.2 39.3 277.9 25.6 426.0 42.7 119.8 23.9 27.8 28.8 32.1 22.8 34.7 25.7 28.2 26.8 26.2 28.4 26.6 118.7 44.8 70.4 16.3 54.8 27.5 60.2 156.3 14.8 71.0 152.8 87.0 193.8 55.8 176.5 42.3 54.2 127.1 136.5 17.6 27.4 91.1 690.6 112.4 92.9 94.7 42.4 137.8 21.9 132.6 319.1 148.8 40.2 97.0 67.6 80.0 108.5 141.8 70.7 35.3 23.5 189.0 189.2 29.4 40.0 508.5 149.8 37.6 69.4 18.7 24.1 111.2 95.8 13.6 10.8 75.2 13.2 114.3 256.5 108.7 3.9 28.5 618.8 99.3 46.0 50.8 75.4 174.9 61.3 87.7 30.1 1158.2 92.3 88.3 45.3 61.2 NCR3LG1 "B7-H6, DKFZp686O24166" ENSG00000188211 "Natural killer cell cytotoxicity receptor 3 ligand 1" Q68D85 11 17351800-17377341 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 7.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 32.2;Inhibitory neurons: 29.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 7 "cerebellum: 4.7;cerebral cortex: 4.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HL-60: 53.8;K-562: 30.8" HPA024137 Uncertain NA NA 21000 "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA024137: AB_1859534" "unprognostic (1.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.52e-2)" "unprognostic (1.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.05e-1)" "unprognostic (7.03e-5)" "unprognostic (6.24e-2)" "unprognostic (1.09e-1)" "unprognostic (3.59e-1)" "unprognostic (2.62e-1)" "unprognostic (2.36e-1)" "prognostic favorable (4.21e-12)" "unprognostic (7.88e-3)" "unprognostic (1.72e-1)" "unprognostic (3.52e-3)" "unprognostic (1.36e-1)" 1.1 0.5 0.3 1.1 0.5 1.9 0.5 4.7 4.7 0.6 3.7 3.4 4.5 1.0 0.4 0.7 1.4 0.9 1.0 0.3 0.6 2.5 0.4 1.1 0.5 0.1 0.0 1.2 0.8 7.5 1.7 0.4 0.1 0.6 5.1 1.9 0.8 0.6 0.4 0.8 3.3 1.0 0.0 0.6 1.3 2.3 0.0 1.3 2.6 0.1 0.7 1.1 0.5 0.7 3.9 1.3 8.8 1.2 3.0 8.1 0.6 2.8 5.2 3.8 9.0 7.3 1.5 22.4 0.4 3.1 1.2 4.0 14.4 3.6 3.1 3.9 23.8 20.6 10.0 7.2 12.5 53.8 0.9 6.7 1.8 5.3 12.8 1.6 4.2 8.1 30.8 0.1 1.2 0.4 5.2 4.7 0.5 14.4 2.1 1.7 4.6 0.3 3.1 1.4 9.3 3.5 3.1 0.7 2.5 0.1 2.1 11.9 6.1 0.7 1.2 2.3 1.6 2.4 4.5 25.1 3.9 17.6 1.8 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 4.7 4.7 0.3 0.6 0.1 0.0 0.1 0.0 0.0 0.7 0.8 0.0 2.0 8.1 1.4 2.5 2.1 2.1 5.2 7.2 1.9 0.4 0.8 2.8 1.7 1.8 2.1 0.1 3.1 6.8 0.0 2.3 13.6 2.3 3.2 1.6 1.8 1.3 32.2 0.9 0.0 4.0 5.6 3.2 0.0 1.5 3.6 0.5 0.9 5.0 29.3 6.6 0.0 1.6 13.6 2.5 0.6 4.4 3.6 4.7 0.4 1.4 2.1 8.5 1.7 1.2 5.4 0.4 0.8 1.8 4.1 1.1 5.3 1.1 0.0 3.1 1.9 0.7 1.1 4.1 3.7 1.5 1.6 5.6 7.5 0.9 KCNJ11 "BIR, Kir6.2" ENSG00000187486 "Potassium inwardly rectifying channel subfamily J member 11" Q14654 11 17385248-17389331 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Diabetes mellitus, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "skeletal muscle: 134.7;tongue: 40.7" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 14.1;Collecting duct cells: 5.5;Enteroendocrine cells: 4.2;Excitatory neurons: 5.5;Inhibitory neurons: 5.9;Oligodendrocyte precursor cells: 4.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 6.6;HEK 293: 12.3;MCF7: 10.0;SCLC-21H: 8.5;U-266/84: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048891 Approved NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA048891: AB_2680547" "unprognostic (1.95e-2)" "unprognostic (6.18e-3)" "unprognostic (7.79e-2)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.25e-1)" "unprognostic (4.81e-5)" "unprognostic (1.83e-3)" "unprognostic (5.45e-2)" "unprognostic (8.09e-3)" "unprognostic (3.72e-3)" "unprognostic (9.23e-3)" "prognostic favorable (1.56e-4)" "unprognostic (4.05e-2)" "unprognostic (2.10e-2)" "unprognostic (1.67e-1)" "unprognostic (4.75e-2)" 2.7 0.6 5.1 0.4 8.3 0.2 3.0 12.4 11.9 0.6 0.0 1.1 1.0 0.9 1.6 1.5 0.7 0.5 13.8 5.3 4.2 4.7 1.5 2.5 0.8 8.0 3.4 0.3 11.3 5.0 7.4 0.1 8.2 2.2 0.4 1.3 2.2 2.4 134.7 1.5 1.3 0.1 2.6 1.6 13.1 0.6 6.4 0.3 5.1 40.7 0.5 0.9 0.4 5.9 1.5 2.1 0.2 4.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 2.0 0.2 6.6 0.2 0.0 0.3 0.3 4.1 0.1 0.2 1.6 12.3 3.4 0.9 0.5 0.1 0.5 0.3 0.1 0.2 0.0 0.1 0.1 0.0 5.6 3.5 3.6 0.0 10.0 0.7 0.1 1.1 4.0 0.3 1.3 1.6 2.0 0.3 0.9 8.5 0.7 0.0 3.4 0.0 0.0 4.2 0.2 0.0 0.0 1.1 0.0 0.0 0.2 6.5 0.8 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.1 8.3 12.4 11.9 5.3 4.2 8.0 3.4 8.2 2.6 6.4 5.9 1.5 0.0 2.7 3.3 0.1 0.0 0.1 0.0 0.0 2.1 2.6 0.9 14.1 0.0 0.6 5.5 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.3 0.3 0.3 4.2 0.0 5.5 0.4 0.0 0.9 0.0 0.6 0.0 0.2 0.4 1.3 0.1 0.0 5.9 0.9 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 4.0 0.8 0.1 0.0 0.0 0.0 0.8 0.1 0.2 0.0 0.7 0.0 1.3 0.2 0.2 0.3 1.0 0.0 0.0 0.0 0.1 0.4 0.2 ABCC8 "ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2" ENSG00000006071 "ATP binding cassette subfamily C member 8" Q09428 11 17392498-17476879 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" Transport Receptor "Diabetes mellitus, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "pancreas: 20.1;pituitary gland: 34.4" "Group enriched" "Detected in some" 4 "Astrocytes: 19.6;Bipolar cells: 39.0;Endometrial stromal cells: 17.9;Enteroendocrine cells: 22.0;Excitatory neurons: 48.2;Inhibitory neurons: 39.3;Oligodendrocyte precursor cells: 39.2" "Cancer enriched" "Detected in some" 9 "pancreatic cancer: 16.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A549: 1.8;AN3-CA: 1.4;SCLC-21H: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011451, HPA042318" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" No NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 56: Bipolar cells - Visual perception" Nucleoli "Golgi apparatus, Cytosol" "CAB011451: , HPA042318: AB_2677947" "unprognostic (4.30e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (4.73e-2)" "unprognostic (9.48e-3)" "unprognostic (2.23e-1)" "unprognostic (4.46e-3)" "unprognostic (2.53e-3)" "unprognostic (6.04e-2)" "unprognostic (2.34e-2)" "unprognostic (8.72e-3)" "unprognostic (1.13e-1)" "unprognostic (2.22e-2)" "unprognostic (1.96e-2)" "unprognostic (6.88e-5)" "unprognostic (2.72e-2)" "unprognostic (1.85e-1)" 0.4 2.8 2.6 0.0 3.7 0.0 1.8 3.9 5.2 3.5 0.0 0.7 0.5 2.6 1.4 0.1 0.6 0.0 1.6 3.1 1.4 0.5 0.1 5.0 0.0 3.3 2.7 0.4 20.1 0.2 34.4 0.4 3.3 2.1 0.3 2.2 0.0 1.5 1.5 0.2 1.0 0.2 0.6 0.1 6.1 0.4 1.2 0.0 3.4 0.6 0.0 0.4 1.3 3.5 0.0 1.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.7 3.9 5.2 3.1 1.4 3.3 2.7 3.3 0.6 1.2 3.5 0.3 0.0 0.0 19.6 0.3 0.0 0.1 0.0 0.0 39.0 5.3 3.7 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.5 17.9 0.3 22.0 0.0 48.2 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.3 0.1 0.0 39.3 0.7 0.0 0.3 0.5 0.0 0.0 0.1 0.0 3.7 0.0 1.9 0.0 39.2 7.6 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.3 0.0 0.7 2.0 0.1 0.8 0.0 0.1 0.0 0.1 2.6 0.1 0.2 USH1C "AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C" ENSG00000006611 "USH1 protein network component harmonin" Q9Y6N9 11 17493895-17544416 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Hearing" "Cancer-related genes, Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 97.8;kidney: 54.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 190.0;Muller glia cells: 163.6;Paneth cells: 203.0;Proximal enterocytes: 430.7;Proximal tubular cells: 190.3;Undifferentiated cells: 115.7" "Group enriched" "Detected in many" 7 "colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 60.6;HeLa: 21.8;OE19: 57.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB013690, HPA027398, HPA027492, HPA028033" Enhanced Enhanced Cytosol No NA "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 45: Enterocytes - Digestion" Cytosol "CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782" "unprognostic (3.60e-2)" "unprognostic (6.19e-2)" "unprognostic (2.36e-1)" "unprognostic (3.83e-2)" "unprognostic (1.98e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (2.22e-1)" "unprognostic (2.78e-1)" "unprognostic (1.51e-2)" "unprognostic (9.65e-2)" "prognostic favorable (9.41e-4)" "unprognostic (1.29e-2)" "unprognostic (1.88e-1)" "unprognostic (1.62e-1)" "unprognostic (2.61e-1)" 0.4 0.3 2.8 5.9 6.8 0.0 0.2 2.8 3.9 0.1 1.5 51.5 97.8 0.1 0.3 0.0 2.9 25.9 0.1 9.0 4.7 54.0 0.6 0.1 0.1 6.1 5.7 0.0 3.9 0.0 6.7 0.0 7.0 0.0 48.3 19.0 0.0 0.3 0.0 0.0 96.5 2.1 4.1 0.0 26.7 0.2 5.9 0.1 1.1 0.0 0.0 0.6 0.1 8.3 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 60.6 8.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 21.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 6.8 2.8 3.9 9.0 4.7 6.1 5.7 7.0 4.1 5.9 8.3 0.0 0.0 0.0 18.3 1.6 0.0 0.1 0.0 0.0 0.7 0.0 1.3 0.6 52.9 0.7 5.5 2.1 0.0 0.0 190.0 21.5 20.5 1.0 1.7 0.0 0.4 64.0 0.0 0.6 27.5 0.0 0.3 53.5 0.0 4.5 0.0 0.0 0.0 0.0 1.7 0.2 92.9 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 163.6 0.0 0.5 36.4 56.0 203.0 0.0 0.2 0.0 430.7 190.3 1.0 4.9 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.8 0.1 115.7 0.1 OTOG "FLJ46346, mlemp, OTGN" ENSG00000188162 Otogelin Q6ZRI0 11 17547259-17647150 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "pituitary gland: 1.4" "Group enriched" "Detected in some" 5 "Early spermatids: 11.9;Late spermatids: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "CACO-2: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "Cluster 77: Retina - Visual perception" "Cluster 39: CACO-2 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (1.25e-2)" "unprognostic (1.19e-1)" "unprognostic (6.95e-3)" "unprognostic (1.85e-6)" "unprognostic (1.89e-1)" "unprognostic (3.60e-1)" "unprognostic (5.14e-5)" "unprognostic (1.78e-1)" "unprognostic (8.97e-2)" "unprognostic (1.57e-2)" "unprognostic (4.72e-5)" "unprognostic (5.55e-2)" "unprognostic (1.48e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 MYOD1 "bHLHc1, MYF3, MYOD, PUM" ENSG00000129152 "Myogenic differentiation 1" P15172 11 17719571-17722136 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skeletal muscle: 36.1" "Group enriched" "Detected in some" 9 "Skeletal myocytes: 10.0;Spermatogonia: 3.8" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "RH-30: 461.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA055436, HPA078647" Enhanced Nucleoplasm NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" Nucleoplasm "HPA055436: , HPA078647: " "unprognostic (1.07e-3)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.5 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 31.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 461.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.3 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNC1 Kv3.1 ENSG00000129159 "Potassium voltage-gated channel subfamily C member 1" P48547 11 17734774-17856804 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 47.3" "Group enriched" "Detected in some" 5 "Bipolar cells: 79.6;Excitatory neurons: 48.2;Inhibitory neurons: 120.2" "Group enriched" "Detected in some" 5 "glioma: 1.1;testis cancer: 0.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 3.2;neutrophil: 1.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.2" "Cell line enhanced" "Detected in some" "HeLa: 1.6;RH-30: 3.7;SCLC-21H: 3.5;SH-SY5Y: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047634, HPA048249" Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 6: Brain - Smell perception" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA047634: AB_2680109, HPA048249: " "unprognostic (1.79e-2)" "unprognostic (2.68e-1)" "unprognostic (1.33e-1)" "unprognostic (4.09e-3)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-1)" "unprognostic (7.04e-5)" "unprognostic (5.89e-2)" "unprognostic (7.32e-4)" "unprognostic (1.29e-1)" "unprognostic (5.44e-2)" "unprognostic (1.05e-2)" "unprognostic (7.83e-2)" 0.1 0.8 1.1 0.1 3.3 0.9 0.2 41.0 47.3 0.9 0.0 0.3 0.3 0.3 0.0 0.2 0.1 0.2 0.1 4.5 8.0 0.1 0.2 0.1 0.2 8.8 3.0 0.2 0.4 0.0 2.2 0.0 9.3 0.2 0.0 7.0 0.3 0.0 0.5 0.5 0.3 0.0 1.0 0.2 0.3 1.4 12.3 0.1 0.3 1.2 0.0 0.3 0.5 18.8 0.1 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.4 0.9 0.0 0.1 0.2 1.1 0.3 1.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.7 0.0 0.2 0.2 0.4 0.7 0.0 0.0 0.4 3.7 0.4 0.0 0.2 3.5 2.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 1.0 0.1 0.0 0.2 0.3 0.4 0.2 0.2 0.4 3.2 0.3 0.4 0.3 0.2 0.2 0.2 0.3 0.2 0.0 0.5 0.2 0.2 1.4 0.2 0.3 0.3 0.1 0.1 1.1 3.3 41.0 47.3 4.5 8.0 8.8 3.0 9.3 1.0 12.3 18.8 0.2 0.0 0.0 5.5 1.1 0.0 0.2 0.0 0.0 79.6 0.3 0.4 2.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 9.5 0.2 0.5 0.4 7.7 0.0 48.2 0.2 0.0 0.3 0.0 0.3 0.0 2.8 0.0 0.0 0.0 1.7 120.2 0.0 0.0 0.0 0.0 10.2 0.3 0.2 0.0 7.5 0.6 1.5 0.0 16.1 5.6 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.7 0.0 0.2 0.5 6.1 5.0 0.0 0.0 0.0 0.6 1.8 0.0 0.0 SERGEF "DelGEF, Gnefr" ENSG00000129158 "Secretion regulating guanine nucleotide exchange factor" Q9UGK8 11 17788048-18013047 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 155.4;Excitatory neurons: 114.9;Inhibitory neurons: 123.9;Late spermatids: 258.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037811, HPA037812, HPA074086" Supported Enhanced Nucleoplasm,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 34: Spermatids - Unknown function" Nucleoplasm Cytosol "HPA037811: AB_10672726, HPA037812: AB_2675680, HPA074086: AB_2686658" "unprognostic (2.67e-2)" "unprognostic (7.15e-2)" "unprognostic (7.00e-2)" "unprognostic (9.04e-3)" "prognostic unfavorable (5.67e-4)" "unprognostic (6.94e-2)" "unprognostic (1.30e-3)" "unprognostic (1.87e-1)" "unprognostic (3.69e-2)" "unprognostic (1.70e-1)" "unprognostic (3.74e-3)" "unprognostic (5.56e-2)" "unprognostic (4.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.43e-1)" "unprognostic (1.24e-2)" "unprognostic (5.82e-2)" 16.1 17.5 35.9 9.4 37.4 6.4 16.4 49.6 42.8 19.5 32.2 25.4 7.4 16.8 18.4 12.5 16.5 9.9 18.9 39.0 39.1 19.6 14.0 14.0 10.7 37.4 53.9 27.5 23.1 17.1 36.8 5.7 43.8 21.3 12.3 22.5 15.1 18.0 22.7 20.2 13.8 16.4 34.8 12.8 19.7 5.0 37.3 12.3 27.7 21.7 13.5 21.5 17.7 39.1 10.8 13.2 10.6 22.3 19.1 18.6 7.2 9.0 18.3 9.5 12.0 8.5 3.7 9.5 11.0 12.2 26.1 14.5 37.3 27.6 7.5 21.0 37.7 15.3 10.6 36.3 21.5 13.5 16.6 17.7 27.4 4.8 20.4 28.6 10.5 20.8 9.2 17.6 15.2 16.0 14.0 30.0 8.9 33.7 16.2 18.3 13.0 10.0 21.2 16.1 27.1 5.9 15.8 16.1 17.1 21.1 7.2 12.1 6.2 8.9 12.1 13.1 10.2 12.3 16.1 12.9 15.5 15.4 10.2 15.6 21.3 17.1 34.5 17.6 28.6 25.5 35.5 25.8 26.1 18.7 34.8 30.5 2.3 22.4 17.5 10.5 41.4 25.9 35.9 37.4 49.6 42.8 39.0 39.1 37.4 53.9 43.8 34.8 37.3 39.1 12.7 6.4 6.8 58.4 14.3 26.5 25.3 30.5 15.9 14.1 18.5 20.8 11.6 10.0 13.6 11.0 2.1 6.4 14.4 7.8 39.2 17.1 155.4 3.3 5.1 9.0 48.5 7.4 114.9 24.5 12.5 14.4 4.6 5.2 14.5 26.7 12.5 14.7 14.3 11.8 123.9 14.7 34.6 17.8 14.9 258.3 19.6 9.3 21.4 44.0 12.9 31.7 17.5 82.9 46.5 14.0 9.8 21.4 11.6 18.7 12.3 46.0 7.6 10.9 6.6 13.3 16.9 9.0 7.6 8.7 20.2 3.1 18.2 15.6 13.0 20.0 TPH1 "TPH, TPRH" ENSG00000129167 "Tryptophan hydroxylase 1" P17752 11 18017564-18042426 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Serotonin biosynthesis" "Monooxygenase, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.0;intestine: 19.3;stomach 1: 15.0" "Cell type enriched" "Detected in many" 30 "Enteroendocrine cells: 1466.7" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.4" "Group enriched" "Detected in some" 5 "hypothalamus: 3.4;midbrain: 9.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.5" "Low region specificity" "Detected in some" "CAB010767, HPA022483" Uncertain Uncertain Cytosol NA NA "Cluster 9: Intestine - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 17: Intestinal endocrine cells - Hormone signaling" Cytosol "CAB010767: AB_261587, HPA022483: AB_1858378" "unprognostic (2.14e-4)" "unprognostic (9.97e-2)" "unprognostic (6.92e-2)" "unprognostic (6.78e-2)" "unprognostic (1.55e-1)" "unprognostic (6.26e-5)" "unprognostic (1.73e-1)" "unprognostic (5.33e-2)" "unprognostic (1.60e-1)" "unprognostic (2.12e-2)" "unprognostic (1.19e-4)" "unprognostic (6.72e-2)" "unprognostic (5.40e-8)" "unprognostic (3.76e-2)" "unprognostic (7.42e-2)" "unprognostic (3.10e-1)" "unprognostic (2.46e-5)" 0.6 0.1 0.2 1.2 0.3 1.1 1.3 0.3 0.3 0.6 4.7 9.0 10.2 0.9 0.9 0.2 0.9 0.1 0.3 0.4 3.4 0.5 0.2 0.8 0.5 0.2 9.0 0.7 0.5 0.1 3.0 0.2 1.1 1.4 19.3 1.8 0.5 0.1 0.4 1.4 11.2 0.2 0.2 0.7 15.0 0.9 0.4 0.3 0.5 0.1 0.7 0.4 0.4 0.3 0.1 0.0 0.5 0.4 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.6 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.5 0.2 0.4 1.0 0.7 0.3 1.1 0.0 1.5 0.3 0.0 0.6 0.0 0.2 0.1 0.2 0.8 0.3 0.2 0.0 0.1 0.3 0.2 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.4 0.3 0.0 0.1 0.2 0.0 0.0 0.9 0.0 0.1 0.4 0.1 0.5 0.0 0.1 0.3 0.0 0.3 0.4 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.3 0.3 0.3 0.4 3.4 0.2 9.0 1.1 0.2 0.4 0.3 1.4 0.0 0.0 1.0 1.1 0.4 0.4 0.5 0.0 14.9 1.9 1.0 0.8 0.0 0.1 5.5 2.1 0.2 0.6 1.7 0.0 0.2 0.8 0.1 0.6 0.7 1466.7 0.4 0.5 0.6 0.0 1.2 2.0 0.2 0.0 5.6 0.4 0.2 0.2 1.7 0.4 48.2 0.0 0.3 1.4 0.8 0.9 0.5 0.0 0.0 0.1 1.4 1.0 0.0 0.6 0.4 13.4 1.2 0.3 2.3 1.5 0.3 0.9 5.6 6.6 1.3 1.3 2.8 3.7 0.0 1.4 0.0 1.2 0.0 2.7 0.4 SAAL1 FLJ41463 ENSG00000166788 "Serum amyloid A like 1" Q96ER3 11 18069935-18106087 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039003, HPA039004" Approved Supported Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA039003: AB_2676303, HPA039004: AB_10673602" "unprognostic (1.13e-1)" "unprognostic (3.00e-1)" "unprognostic (4.35e-1)" "unprognostic (2.37e-2)" "unprognostic (1.88e-1)" "unprognostic (5.76e-2)" "unprognostic (4.10e-3)" "unprognostic (1.53e-2)" "unprognostic (4.75e-2)" "unprognostic (7.26e-2)" "unprognostic (3.36e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.78e-5)" "unprognostic (2.86e-1)" "unprognostic (1.39e-1)" "unprognostic (3.72e-1)" "unprognostic (1.87e-1)" 6.0 5.3 4.9 8.2 4.8 19.1 10.0 5.6 6.1 6.2 4.3 9.6 8.0 7.5 7.7 6.6 5.6 4.8 6.5 4.6 5.0 5.4 8.3 4.9 14.6 4.8 5.3 8.2 8.1 5.4 5.2 7.0 4.9 6.0 11.9 8.2 5.6 5.8 5.8 5.7 6.7 9.6 4.8 7.5 6.7 12.8 5.1 13.7 6.1 7.2 15.6 7.8 6.1 5.7 27.1 41.5 29.5 40.5 19.5 21.8 24.6 29.9 20.4 44.8 52.8 57.8 10.1 73.0 15.5 16.9 62.3 34.9 56.9 48.5 62.6 32.5 57.4 33.6 24.9 35.0 15.9 57.1 28.6 15.2 22.2 28.7 42.9 16.8 38.5 62.8 50.5 23.9 37.2 36.2 66.7 54.2 38.5 41.7 39.0 65.7 51.8 25.4 25.7 31.4 36.4 34.3 26.9 28.4 36.4 37.1 18.2 25.9 15.8 51.0 35.0 29.4 43.2 11.6 37.7 80.6 21.2 45.2 47.5 11.1 12.9 4.3 14.0 15.4 13.5 16.5 16.2 12.3 22.3 11.7 12.3 13.3 0.6 10.4 14.6 11.4 20.9 10.8 4.9 4.8 5.6 6.1 4.6 5.0 4.8 5.3 4.9 4.8 5.1 5.7 7.6 0.0 10.8 7.5 15.9 4.6 7.8 16.0 9.6 9.0 7.2 6.9 8.5 2.8 7.4 1.8 2.1 22.0 13.6 6.3 5.9 9.6 21.9 4.4 8.0 8.7 28.1 11.1 8.5 10.2 23.1 8.0 4.6 4.2 14.0 15.3 5.7 4.6 16.1 0.0 9.5 10.7 8.2 10.9 7.3 3.5 8.1 7.7 5.4 6.5 10.7 6.5 4.1 15.1 11.7 6.6 7.5 7.9 17.3 3.8 6.9 7.7 6.0 8.5 6.6 6.1 10.5 41.5 24.9 8.3 5.4 10.4 9.9 10.1 15.1 6.1 MRGPRX3 MRGX3 ENSG00000179826 "MAS related GPR family member X3" Q96LB0 11 18120955-18138488 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "salivary gland: 2.6" "Cell type enriched" "Detected in some" 24 "Basal respiratory cells: 53.8" "Group enriched" "Detected in some" 4 "head and neck cancer: 1.3;melanoma: 2.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HBEC3-KT: 13.8" NA NA "Cluster 24: Salivary gland - Salivary secretion" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "unprognostic (1.54e-3)" "unprognostic (5.07e-2)" "unprognostic (1.61e-1)" "unprognostic (1.50e-1)" "unprognostic (7.65e-2)" "unprognostic (1.74e-1)" "unprognostic (4.75e-2)" "unprognostic (2.09e-1)" 0.0 0.0 0.5 0.3 0.4 0.2 0.6 0.5 0.7 0.0 0.2 0.0 0.1 0.1 0.0 0.9 0.0 0.1 0.0 0.5 0.5 0.0 0.0 0.1 0.1 0.5 0.4 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.1 2.6 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.8 0.3 0.0 13.8 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.5 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.0 0.5 0.2 0.2 0.3 0.3 0.1 0.1 1.4 0.9 0.3 0.1 0.5 0.1 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.5 0.7 0.5 0.5 0.5 0.4 0.4 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 53.8 0.0 0.0 0.0 0.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRGPRX4 MRGX4 ENSG00000179817 "MAS related GPR family member X4" Q96LA9 11 18172837-18174280 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 10 "melanoma: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SK-MEL-30: 1.4;WM-115: 1.8" NA NA "Cluster 17: WM-115 - Nervous system development" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "unprognostic (2.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SAA4 "C-SAA, CSAA" ENSG00000148965 "Serum amyloid A4, constitutive" P35542 11 18231355-18236802 "Plasma proteins, Predicted secreted proteins" "Acute phase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 124 "liver: 1943.5" "Group enriched" "Detected in some" 7 "Hepatocytes: 2132.8;Respiratory ciliated cells: 706.8" "Cancer enriched" "Detected in many" 141 "liver cancer: 118.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "Hep G2: 28.8" "Not detected" "Not detected" "CAB026061, HPA060139" Supported "Secreted to blood" NA NA 65000000000 33000000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "CAB026061: , HPA060139: AB_2684210" "unprognostic (4.70e-4)" "unprognostic (1.17e-1)" "unprognostic (1.17e-1)" "unprognostic (4.83e-1)" "unprognostic (4.15e-2)" "unprognostic (6.05e-2)" "unprognostic (3.63e-3)" "unprognostic (5.94e-2)" "unprognostic (2.40e-2)" "unprognostic (1.41e-1)" "unprognostic (7.35e-2)" "unprognostic (2.54e-8)" "unprognostic (2.49e-1)" "unprognostic (6.46e-2)" 7.4 0.5 0.3 0.4 0.3 0.0 6.7 0.3 0.6 15.6 0.3 0.2 0.0 0.0 0.2 0.5 0.5 1.0 0.1 0.3 0.3 0.4 1943.5 0.7 0.0 0.4 0.4 0.0 0.1 0.0 0.8 0.0 0.3 1.2 0.0 0.1 11.4 0.1 3.4 0.5 0.1 0.1 0.3 1.2 0.1 1.3 0.4 0.9 0.0 0.0 0.2 0.1 0.1 0.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.3 0.1 28.8 0.3 0.2 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.6 0.3 0.3 0.4 0.4 0.3 0.3 0.4 0.5 0.1 0.0 0.0 0.0 2.5 0.0 0.0 184.7 0.0 0.0 2.1 1.4 0.0 18.6 172.6 0.0 0.0 0.0 0.0 3.5 0.0 4.0 0.6 0.4 0.0 1.6 0.0 21.5 0.0 1.2 0.1 0.0 0.0 0.3 0.0 0.0 27.5 2132.8 0.1 0.0 0.0 0.0 71.2 38.0 0.0 0.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 706.8 0.0 0.0 0.0 23.6 0.1 0.0 0.0 0.1 0.0 1.9 0.0 0.2 0.5 SAA2-SAA4 ENSG00000255071 "SAA2-SAA4 readthrough" 11 18231423-18248635 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "liver: 127.0" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 20.7" "Cancer enriched" "Detected in many" 13 "liver cancer: 39.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.6;EFO-21: 1.5;GAMG: 1.1;HaCaT: 1.0" HPA060139 Uncertain NA NA "Cluster 62: Liver - Hemostasis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 15: Hepatocytes - Hemostasis" "HPA060139: AB_2684210" "prognostic favorable (4.56e-4)" "unprognostic (1.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.44e-1)" "unprognostic (1.23e-3)" "unprognostic (9.41e-3)" "unprognostic (1.96e-2)" "unprognostic (1.96e-1)" "unprognostic (8.27e-3)" "unprognostic (3.17e-2)" "unprognostic (7.30e-2)" "prognostic unfavorable (2.92e-8)" "unprognostic (1.92e-1)" "unprognostic (2.72e-1)" 23.7 1.5 0.0 1.5 0.0 0.0 5.1 0.0 0.3 15.2 0.0 0.1 0.0 0.0 0.1 0.5 0.3 0.6 0.0 0.0 0.0 0.2 127.0 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.5 0.0 0.0 18.8 0.2 5.2 0.4 0.2 0.1 0.0 0.1 0.2 0.2 0.0 0.6 0.0 0.0 0.6 0.3 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.5 0.0 1.1 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 20.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SAA2 ENSG00000134339 "Serum amyloid A2" P0DJI9 11 18239223-18248668 "Disease related genes, Predicted secreted proteins" "Acute phase" Amyloidosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 20 "liver: 36265.6" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 55342.6" "Cancer enriched" "Detected in many" 22 "liver cancer: 150.5" "Group enriched" "Detected in some" 9 "midbrain: 6.3;pons: 4.8;thalamus: 7.7" "Immune cell enhanced" "Detected in some" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 27.8;EFO-21: 20.2;GAMG: 19.6;HaCaT: 25.0;HBEC3-KT: 55.4;HSkMC: 17.6" "Secreted to blood" NA NA 9200000000 "Cluster 17: Basophils - Unknown function" "Cluster 62: Liver - Hemostasis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 15: Hepatocytes - Hemostasis" "unprognostic (1.73e-3)" "unprognostic (4.42e-2)" "unprognostic (2.63e-1)" "unprognostic (5.03e-2)" "unprognostic (1.40e-3)" "unprognostic (7.12e-2)" "unprognostic (7.45e-2)" "unprognostic (2.15e-2)" "unprognostic (1.57e-1)" "unprognostic (2.86e-2)" "unprognostic (2.78e-2)" "unprognostic (6.13e-2)" "prognostic unfavorable (1.30e-8)" "unprognostic (1.53e-1)" "unprognostic (9.72e-2)" "unprognostic (7.62e-3)" "unprognostic (1.28e-1)" 562.3 16.9 0.0 137.9 0.1 0.4 321.5 0.5 0.7 277.0 0.6 11.5 0.9 1.0 0.2 22.1 21.1 14.0 8.3 0.1 0.1 12.8 36265.6 35.7 0.6 0.2 6.3 1.7 13.9 0.2 31.1 1.7 4.8 38.5 1.3 0.6 1796.2 1.6 221.2 25.7 21.0 6.5 0.0 20.1 18.1 2.1 7.7 16.3 6.6 0.2 6.8 22.4 7.8 0.7 27.8 0.1 0.2 0.2 1.0 0.0 3.6 0.1 0.8 0.1 0.3 0.0 12.1 0.1 20.2 0.2 19.6 25.0 0.0 55.4 0.1 1.2 0.0 1.0 0.5 0.0 7.8 0.8 0.1 17.6 7.4 0.0 8.9 0.6 0.2 0.0 0.0 0.9 1.5 0.0 0.2 0.0 0.5 0.4 0.0 0.2 0.7 0.0 12.4 1.3 0.3 0.0 1.7 8.5 0.1 0.5 0.4 0.5 0.2 0.2 1.2 0.5 1.2 0.5 0.3 1.7 0.1 1.1 0.3 1.0 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.1 0.1 1.1 0.1 0.2 0.2 0.2 0.1 0.0 0.1 0.5 0.7 0.1 0.1 0.2 6.3 4.8 0.0 7.7 0.7 7.6 0.0 1.5 0.0 184.4 1.0 5.6 4629.9 0.6 0.0 56.8 68.5 0.2 1052.3 4596.4 3.7 0.0 0.4 0.8 21.9 0.0 70.3 1.6 12.3 0.9 68.2 0.0 2356.0 0.0 34.4 2.3 2.0 0.0 13.5 0.0 0.0 1442.8 55342.6 0.4 0.0 0.0 1.1 1204.4 1502.7 0.0 0.5 0.0 0.6 8.8 0.0 1.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.1 34.5 2.9 0.1 11449.8 0.0 0.0 3.1 400.9 0.3 0.0 5.6 0.1 0.5 144.2 0.0 5.3 65.4 SAA1 "PIG4, SAA, TP53I4" ENSG00000173432 "Serum amyloid A1" P0DJI8 11 18266260-18269977 "Disease related genes, Predicted secreted proteins" "Acute phase" Heparin-binding Amyloidosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 20 "liver: 48144.3" "Cell type enriched" "Detected in many" 6 "Hepatocytes: 99298.7" "Cancer enriched" "Detected in many" 16 "liver cancer: 1249.6" "Group enriched" "Detected in some" 5 "midbrain: 3.8;pons: 2.6;thalamus: 6.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "HBEC3-KT: 716.4" "Secreted to blood" NA NA 300000000 11000000000 "Cluster 7: Monocytes - Unknown function" "Cluster 62: Liver - Hemostasis" "Cluster 30: Epithelial cell lines - Translation" "Cluster 15: Hepatocytes - Hemostasis" "unprognostic (2.86e-3)" "unprognostic (1.41e-1)" "unprognostic (2.82e-1)" "unprognostic (1.50e-1)" "unprognostic (4.54e-3)" "unprognostic (1.79e-2)" "unprognostic (1.63e-2)" "unprognostic (7.04e-2)" "unprognostic (1.54e-1)" "unprognostic (1.08e-2)" "unprognostic (8.95e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (4.57e-12)" "unprognostic (5.15e-2)" "unprognostic (9.78e-2)" "unprognostic (9.23e-3)" "unprognostic (1.64e-1)" 2040.4 54.4 0.1 161.7 0.2 0.0 1382.7 0.1 0.6 258.0 1.8 40.3 1.4 2.2 0.2 51.1 56.6 33.6 23.2 0.3 0.3 29.5 48144.3 98.5 1.1 0.8 3.8 3.3 46.7 0.5 66.6 7.2 2.6 66.5 6.4 0.0 2368.1 4.4 511.6 88.6 75.0 18.8 0.1 38.8 42.0 1.7 6.0 52.1 18.1 0.2 15.7 63.9 29.0 0.1 49.2 0.3 0.0 0.3 34.4 0.2 18.9 1.3 1.1 0.2 0.3 0.1 17.2 0.0 38.3 0.0 11.7 45.5 0.0 716.4 0.3 0.6 0.0 0.8 0.0 0.1 148.4 1.1 0.0 60.9 66.7 0.2 76.7 0.1 0.0 0.0 0.1 0.0 9.3 0.1 0.0 0.1 0.0 0.0 0.0 0.2 1.7 0.0 28.5 0.9 0.0 0.1 4.2 5.5 0.2 0.0 0.5 0.0 0.0 0.2 5.5 0.0 1.3 0.0 1.3 1.3 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.6 0.3 0.3 0.8 3.8 2.6 0.1 6.0 0.1 107.2 6.4 2.8 0.0 259.8 9.3 64.9 10039.5 10.2 0.0 210.6 1010.4 0.1 1701.5 7604.7 55.2 0.0 1.3 3.0 44.5 0.0 250.4 0.0 12.6 1.6 114.9 1.8 3543.7 0.1 81.1 34.4 8.3 0.0 14.3 2.5 0.0 2568.6 99298.7 1.0 0.0 0.1 5.2 2012.1 2454.9 0.3 0.0 0.0 2.6 51.6 0.0 2.6 0.0 1.0 0.0 0.1 68.8 5.5 0.0 0.1 185.5 3.1 0.2 15716.2 0.0 0.0 31.5 736.1 0.0 0.0 34.1 0.1 2.1 214.7 0.0 36.7 178.8 HPS5 "AIBP63, BLOC2S2, RU2" ENSG00000110756 "HPS5 biogenesis of lysosomal organelles complex 2 subunit 2" Q9UPZ3 11 18278668-18322198 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Albinism, Disease variant, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 35.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 96.1" "Cancer enhanced" "Detected in all" "melanoma: 19.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077851 Approved Supported Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 17: WM-115 - Nervous system development" "Cluster 41: Macrophages - Immune response" Cytosol "HPA077851: " "unprognostic (2.25e-2)" "unprognostic (1.97e-1)" "unprognostic (1.07e-1)" "unprognostic (2.59e-1)" "unprognostic (9.85e-3)" "unprognostic (5.89e-1)" "unprognostic (1.47e-2)" "unprognostic (1.55e-1)" "unprognostic (1.61e-1)" "unprognostic (5.20e-2)" "unprognostic (1.51e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (2.06e-1)" "unprognostic (1.18e-1)" "unprognostic (8.67e-2)" "unprognostic (2.72e-1)" 7.4 8.4 4.4 5.8 5.5 3.7 10.5 4.7 4.5 5.1 5.9 4.8 6.1 5.0 2.8 7.3 5.1 3.9 5.9 4.0 4.6 5.4 35.7 8.6 9.2 5.6 5.0 7.1 6.8 3.6 8.5 7.1 5.9 4.8 3.3 8.9 16.3 3.5 5.5 6.3 8.1 3.9 5.2 9.0 4.6 14.8 5.4 5.9 6.0 3.1 8.3 4.9 5.5 7.4 5.9 8.5 9.0 9.1 11.9 6.6 9.8 15.3 12.6 9.9 10.4 5.3 1.8 14.1 5.8 13.3 12.4 8.3 10.6 10.1 12.1 11.8 7.7 6.9 7.1 6.7 11.2 15.2 12.4 10.6 9.9 6.1 12.9 10.0 8.0 9.0 9.1 8.0 16.1 4.8 8.1 11.0 4.5 6.8 9.3 11.8 12.9 6.0 9.6 5.3 3.0 5.9 19.2 6.8 22.8 8.9 5.1 8.8 5.9 11.3 6.1 14.8 7.1 3.4 12.0 16.1 6.2 7.8 32.4 12.3 3.6 2.9 2.1 5.4 2.6 5.3 2.6 2.2 8.3 4.4 2.5 2.6 1.0 2.8 6.0 3.2 2.6 2.5 4.4 5.5 4.7 4.5 4.0 4.6 5.6 5.0 5.9 5.2 5.4 7.4 17.2 96.1 14.6 13.1 30.8 15.6 14.2 16.2 12.5 17.5 17.4 23.0 18.2 17.2 14.7 7.3 31.3 22.2 16.0 4.7 5.9 5.2 50.9 20.7 11.2 13.4 10.7 11.6 16.7 8.4 10.6 11.8 18.3 30.0 14.5 17.8 7.9 45.1 18.1 10.1 21.0 5.0 12.2 22.7 45.0 18.6 8.4 35.8 28.4 11.2 32.3 16.1 0.0 21.1 24.0 6.2 8.5 13.2 17.4 15.2 27.1 6.5 21.1 26.1 6.6 17.1 13.1 16.2 12.6 19.6 15.3 17.4 17.8 10.5 6.0 21.8 GTF2H1 "BTF2, P62, TFIIH" ENSG00000110768 "General transcription factor IIH subunit 1" P32780 11 18322295-18367045 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004637, HPA046660" Enhanced Enhanced Nucleoplasm NA NA "Cluster 10: Basophils - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 30: Epithelial cell lines - Translation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "CAB004637: AB_425470, HPA046660: AB_2679743" "unprognostic (2.25e-1)" "unprognostic (2.33e-1)" "unprognostic (9.78e-2)" "unprognostic (2.38e-1)" "unprognostic (2.63e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (5.98e-9)" "unprognostic (7.71e-2)" "unprognostic (4.24e-2)" "unprognostic (2.81e-1)" "unprognostic (1.33e-1)" "unprognostic (2.26e-2)" "unprognostic (7.42e-3)" "unprognostic (8.31e-2)" "unprognostic (1.24e-1)" "unprognostic (7.90e-2)" "unprognostic (2.94e-1)" 19.0 18.2 6.0 7.6 6.4 4.7 18.2 7.6 7.2 16.5 10.0 17.9 7.5 15.6 8.2 19.4 14.6 9.4 14.9 6.7 6.0 16.2 17.2 13.9 10.9 5.5 5.8 19.2 17.9 8.2 13.8 10.0 5.6 15.8 8.2 13.1 18.7 10.0 16.6 20.0 14.7 8.4 5.8 17.2 15.2 26.5 6.1 8.8 16.0 8.3 11.1 17.7 16.9 7.6 14.7 13.3 11.0 15.5 25.1 20.1 13.7 21.8 23.6 19.0 21.9 13.9 5.6 24.9 8.4 22.4 27.2 19.8 19.1 20.1 24.1 11.0 18.5 15.9 13.4 14.1 35.8 30.7 16.5 22.4 23.8 11.7 37.3 15.7 17.3 12.8 25.2 12.6 27.7 13.6 15.6 23.3 9.8 24.7 19.8 16.1 23.4 11.3 15.3 19.6 12.5 13.5 17.8 17.1 27.0 9.4 8.8 17.5 12.6 24.9 12.2 45.3 17.8 6.3 16.0 17.7 21.5 24.0 24.4 11.0 5.0 5.4 3.8 5.0 4.2 5.4 4.8 4.3 5.4 5.7 5.8 4.7 3.5 7.5 6.0 2.9 5.2 4.2 6.0 6.4 7.6 7.2 6.7 6.0 5.5 5.8 5.6 5.8 6.1 7.6 27.8 16.0 18.2 19.2 26.1 48.3 22.7 22.2 39.9 17.3 23.4 20.6 28.3 22.8 21.9 11.0 20.9 26.1 26.8 14.7 7.9 25.2 50.2 19.0 17.7 21.6 7.7 26.1 32.1 30.5 27.5 27.1 21.4 20.2 18.3 20.0 22.1 13.9 25.2 21.9 29.9 12.9 14.2 20.8 27.2 46.1 17.1 28.8 23.2 20.6 25.9 23.4 25.7 24.1 29.4 28.8 10.5 16.1 25.7 23.4 18.6 25.1 23.6 21.2 6.6 23.4 23.2 84.8 30.1 37.6 51.7 28.2 20.4 29.2 16.8 26.8 LDHA ENSG00000134333 "Lactate dehydrogenase A" P00338 11 18394560-18408425 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes, Disease variant, FDA approved drug targets, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 2198.1;Basal respiratory cells: 2133.0;Extravillous trophoblasts: 2086.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015336, CAB069404" Uncertain Supported Vesicles,Cytosol NA NA 170000000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 16: Pancreatic endocrine cells - Mixed function" Cytosol Vesicles "CAB015336: AB_2134947, CAB069404: " "unprognostic (8.83e-2)" "prognostic unfavorable (2.78e-5)" "unprognostic (3.81e-2)" "unprognostic (1.73e-1)" "unprognostic (3.43e-3)" "unprognostic (4.66e-3)" "prognostic unfavorable (3.26e-8)" "prognostic unfavorable (2.27e-6)" "unprognostic (1.08e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (8.09e-6)" "unprognostic (1.76e-2)" "prognostic unfavorable (9.69e-9)" "unprognostic (4.15e-2)" "unprognostic (1.89e-1)" "unprognostic (3.07e-1)" "unprognostic (1.05e-2)" 444.5 358.1 64.3 139.5 68.4 184.6 330.4 54.0 72.1 203.1 58.4 278.5 158.1 151.1 43.8 450.6 189.2 75.5 361.2 68.4 73.7 440.2 729.2 242.0 97.2 73.6 74.9 149.7 171.5 26.6 95.9 113.9 94.9 170.1 117.4 443.8 267.5 81.8 947.5 468.6 296.6 124.2 58.5 185.3 181.1 95.2 67.4 115.3 180.8 500.3 146.5 266.2 314.4 65.9 1261.4 730.9 28.4 415.2 599.8 399.3 400.6 1186.1 1148.5 936.9 1366.4 324.5 196.6 909.3 380.3 1110.8 727.1 979.2 716.1 1715.1 2082.2 331.3 422.6 329.6 629.4 588.5 148.9 811.2 235.8 411.1 760.3 380.3 373.7 1670.8 550.8 292.3 462.8 431.7 1127.7 319.4 674.8 509.3 182.7 413.2 849.4 432.0 298.0 768.0 1546.6 284.5 220.5 279.3 642.7 518.6 230.8 431.4 241.7 192.9 546.9 1228.3 455.3 1094.7 14.3 348.0 545.1 899.4 1767.1 415.0 434.1 98.4 147.1 79.7 93.8 165.0 105.2 70.4 122.1 99.6 202.1 54.4 78.1 81.0 47.1 91.3 169.3 68.0 140.8 237.6 64.3 68.4 54.0 72.1 68.4 73.7 73.6 74.9 94.9 58.5 67.4 65.9 421.7 73.7 201.6 21.5 220.8 2198.1 475.6 2133.0 523.0 464.2 213.6 229.5 241.8 175.8 837.3 309.0 146.0 509.8 427.2 696.1 434.3 1293.9 204.4 180.0 317.4 492.8 45.6 123.2 38.7 1532.3 2086.2 544.4 163.6 485.8 262.9 205.3 205.6 514.4 659.3 514.8 33.5 285.1 649.0 224.4 1155.1 129.6 287.7 373.9 1177.5 20.6 973.4 444.2 170.0 9.5 12.6 1771.4 590.3 205.0 376.0 546.8 1765.0 682.5 178.1 481.4 190.7 251.6 706.3 195.5 44.0 422.9 1723.2 501.7 410.9 196.2 362.1 530.8 LDHC CT32 ENSG00000166796 "Lactate dehydrogenase C" P07864 11 18412318-18452063 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 177 "testis: 265.2" "Group enriched" "Detected in many" 7 "Early spermatids: 1441.7;Spermatocytes: 1584.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SK-BR-3: 2.1;U-2197: 5.1;U-266/70: 4.5;U-266/84: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA045442 Enhanced NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 36: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA045442: AB_10966720" "unprognostic (2.32e-2)" "unprognostic (3.42e-3)" "unprognostic (1.87e-1)" "unprognostic (2.83e-2)" "unprognostic (2.19e-1)" "unprognostic (8.56e-4)" "unprognostic (1.35e-1)" "unprognostic (5.74e-2)" "unprognostic (6.65e-2)" "unprognostic (1.73e-1)" "unprognostic (2.04e-1)" "unprognostic (1.18e-2)" "unprognostic (1.08e-1)" "unprognostic (9.30e-2)" "unprognostic (3.00e-1)" "unprognostic (4.25e-1)" "unprognostic (1.93e-1)" 0.1 0.2 0.6 0.0 0.6 0.4 0.4 1.2 0.9 0.1 0.4 0.3 0.3 0.0 0.6 0.3 0.6 0.0 0.3 0.7 0.3 0.6 1.4 0.2 0.4 0.3 0.3 0.4 1.4 0.0 0.2 0.1 0.4 0.3 0.0 0.6 0.5 0.0 0.7 0.4 0.7 0.1 0.1 0.1 0.1 265.2 0.5 0.3 0.6 0.2 0.7 0.2 0.0 0.4 0.0 0.0 0.1 1.2 0.9 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.6 0.1 0.1 0.3 0.0 0.2 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.3 2.1 0.3 0.0 0.1 0.0 0.5 0.2 1.6 5.1 0.0 4.5 4.2 0.2 0.1 0.0 0.0 0.6 0.2 0.3 0.1 0.3 0.6 0.2 0.5 0.6 0.0 0.7 1.0 0.7 1.1 0.0 0.3 0.9 0.6 0.3 0.6 0.6 1.2 0.9 0.7 0.3 0.3 0.3 0.4 0.1 0.5 0.4 1.9 0.0 0.0 1.3 1.3 0.1 0.8 0.4 1.2 0.1 2.5 3.2 0.9 0.0 1.0 1.8 0.0 0.0 0.1 0.4 3.9 1.6 1441.7 3.7 0.8 2.0 0.0 0.4 1.0 6.3 0.1 1.3 0.5 1.9 0.0 0.3 0.4 0.2 0.2 0.0 0.9 0.2 0.0 0.0 0.4 209.5 23.3 2.7 0.0 1.9 0.0 1.5 0.0 1.0 2.0 2.0 0.0 18.0 0.9 0.3 0.0 3.5 1.2 0.6 19.7 1.2 1.2 1584.7 30.7 1.0 0.6 0.0 1.4 0.1 0.0 0.3 LDHAL6A "LDH6A, MGC23940" ENSG00000166800 "Lactate dehydrogenase A like 6A" Q6ZMR3 11 18455824-18479601 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 9.8" "Cell type enhanced" "Detected in some" "Early spermatids: 13.3;Excitatory neurons: 3.5;Late spermatids: 7.4;Spermatocytes: 19.3;Spermatogonia: 3.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HL-60: 11.0" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 78: Testis - Spermatogenesis" "Cluster 32: U-937 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (1.41e-1)" "unprognostic (4.84e-2)" "unprognostic (8.95e-2)" "unprognostic (5.35e-2)" "unprognostic (1.03e-1)" "unprognostic (3.31e-2)" "unprognostic (7.34e-2)" "unprognostic (1.75e-1)" "unprognostic (1.23e-1)" "unprognostic (1.60e-1)" "unprognostic (2.35e-2)" "unprognostic (3.58e-1)" "unprognostic (2.22e-2)" "unprognostic (2.51e-1)" "unprognostic (1.81e-1)" "unprognostic (8.31e-3)" "unprognostic (1.48e-1)" 0.1 0.5 0.2 0.3 0.3 1.0 0.1 1.6 0.4 0.0 0.0 0.1 0.6 0.2 0.2 0.2 0.1 0.2 0.1 0.2 0.1 0.1 0.0 0.1 0.4 0.2 0.0 0.3 0.3 0.0 0.1 0.2 0.3 0.1 0.1 1.1 0.2 0.2 0.1 0.9 0.5 0.0 0.0 0.3 0.3 9.8 0.1 0.1 0.5 0.0 0.2 0.0 0.0 0.2 0.1 0.3 0.7 0.5 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.3 0.6 0.1 0.0 0.1 0.3 0.0 0.2 0.3 0.5 0.5 0.4 0.7 0.3 0.0 11.0 0.5 0.1 0.2 0.0 0.1 0.1 0.0 0.7 0.3 0.7 0.0 0.2 0.3 0.8 0.2 0.1 0.4 0.5 0.3 0.2 0.1 0.7 0.3 0.3 0.3 0.2 0.1 0.3 0.2 1.5 0.5 0.4 0.1 0.6 0.2 0.2 0.2 0.1 0.2 0.4 0.2 0.6 0.0 0.1 0.4 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.2 0.2 0.7 0.3 0.1 0.0 0.3 0.1 0.2 0.3 1.6 0.4 0.2 0.1 0.2 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 13.3 0.1 0.1 0.1 0.0 0.0 3.5 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 7.4 0.9 0.1 0.0 0.0 0.0 0.9 1.0 1.5 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.2 0.0 19.3 3.5 0.0 0.0 0.3 0.0 0.3 0.0 0.0 TSG101 "TSG10, VPS23" ENSG00000074319 "Tumor susceptibility 101" Q99816 11 18468336-18526951 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 296.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004283, HPA006161" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 8: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 10: Non-specific - Unknown function" Cytosol "Nucleoli, Plasma membrane" "CAB004283: AB_671392, HPA006161: AB_1080408" "unprognostic (1.42e-1)" "unprognostic (7.91e-2)" "unprognostic (2.11e-1)" "unprognostic (6.77e-2)" "unprognostic (1.82e-1)" "unprognostic (2.72e-3)" "prognostic unfavorable (3.74e-6)" "unprognostic (5.67e-2)" "unprognostic (2.08e-1)" "unprognostic (2.00e-2)" "unprognostic (4.15e-3)" "unprognostic (4.27e-2)" "prognostic favorable (5.52e-6)" "unprognostic (1.92e-2)" "unprognostic (1.02e-1)" "unprognostic (4.02e-3)" "unprognostic (1.06e-1)" 40.4 55.6 41.1 32.2 42.2 60.8 56.6 43.1 50.8 44.8 45.7 49.5 42.8 40.2 56.3 56.7 49.3 36.5 68.2 42.1 44.5 70.1 62.3 43.9 42.9 42.4 42.3 44.6 45.4 61.5 36.5 61.4 42.4 43.1 59.0 43.6 46.4 41.1 77.1 47.2 43.4 42.9 43.9 34.0 45.4 55.5 41.8 45.9 52.4 83.0 57.4 46.9 42.2 46.5 51.3 79.1 73.7 51.1 82.2 85.4 63.7 77.1 103.0 92.2 90.3 54.3 27.5 65.5 49.2 86.4 103.7 77.0 74.0 70.3 102.0 95.4 87.7 41.1 38.6 79.7 106.3 64.6 69.8 75.0 139.9 48.6 131.6 102.2 76.8 68.4 66.9 55.2 112.7 85.7 45.7 66.8 45.1 115.6 81.5 37.0 72.5 54.7 63.6 68.8 52.2 88.6 75.7 61.6 101.1 77.1 59.7 64.8 43.1 63.0 38.0 126.4 59.4 37.2 76.0 56.9 64.5 34.2 80.5 187.8 69.8 155.7 50.4 81.6 52.4 78.5 48.0 54.0 66.1 69.2 51.5 54.9 123.6 57.9 114.3 54.5 84.4 91.1 41.1 42.2 43.1 50.8 42.1 44.5 42.4 42.3 42.4 43.9 41.8 46.5 63.0 64.1 57.5 22.9 44.4 42.6 81.5 159.2 26.7 41.0 39.2 42.2 68.0 42.9 90.4 44.1 25.0 191.9 34.2 85.5 125.2 112.4 48.0 58.4 36.0 54.4 61.6 74.5 29.1 101.3 107.7 48.6 32.6 48.9 44.9 46.2 47.2 36.0 79.6 37.0 28.4 65.0 156.6 45.2 33.6 21.2 56.2 51.6 56.9 26.2 82.3 86.1 54.6 32.2 32.8 132.7 76.2 43.2 47.0 103.0 72.2 126.8 113.4 43.3 46.0 44.7 81.2 177.6 153.7 32.8 48.4 296.1 38.1 91.5 47.8 97.4 UEVLD "Attp, UEV3" ENSG00000151116 "UEV and lactate/malate dehyrogenase domains" Q8IX04 11 18529609-18588747 "Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047134 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 18: U-2197 - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Cytosol "HPA047134: AB_10960698" "unprognostic (1.05e-1)" "unprognostic (6.76e-2)" "prognostic favorable (7.07e-4)" "unprognostic (5.94e-3)" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (1.38e-3)" "unprognostic (9.08e-3)" "unprognostic (9.81e-2)" "unprognostic (2.87e-2)" "unprognostic (1.26e-3)" "unprognostic (1.71e-2)" "unprognostic (1.61e-3)" "unprognostic (2.65e-1)" "unprognostic (3.22e-1)" "unprognostic (8.23e-2)" "unprognostic (3.39e-1)" 10.1 8.4 5.3 8.8 7.9 4.5 11.8 6.5 6.7 11.5 6.3 13.4 11.1 8.8 8.7 10.7 8.8 9.4 9.2 5.7 6.4 12.3 9.0 9.0 7.0 8.1 7.1 8.0 7.2 9.9 4.2 9.4 8.5 10.4 14.1 9.7 7.5 9.5 11.0 14.8 10.0 11.0 6.6 6.9 9.8 5.3 7.0 7.6 10.9 10.5 8.6 10.2 6.9 11.1 16.2 19.6 8.9 8.6 28.2 25.1 8.3 17.5 24.3 22.7 21.6 8.1 4.6 5.0 9.4 20.7 19.8 24.8 8.2 18.1 25.8 14.6 10.7 7.5 8.8 9.1 12.7 11.5 10.4 17.4 18.3 11.2 15.5 15.9 21.2 0.4 5.7 4.7 29.3 12.3 0.3 3.7 2.4 24.9 19.8 1.8 20.7 6.2 26.9 25.4 3.7 7.9 19.1 23.8 15.1 11.0 19.1 6.8 16.2 20.7 11.1 34.0 17.2 0.9 11.3 1.1 17.7 8.7 21.3 4.6 4.9 3.1 4.2 5.1 4.0 2.6 3.1 3.5 3.4 2.7 1.8 2.6 6.5 5.2 4.2 4.2 2.3 2.4 5.3 7.9 6.5 6.7 5.7 6.4 8.1 7.1 8.5 6.6 7.0 11.1 10.3 16.0 19.3 18.9 4.5 6.2 6.3 9.9 8.6 9.3 11.2 6.3 10.1 5.7 12.4 23.9 10.4 8.4 9.4 27.3 3.9 10.8 3.3 13.6 12.4 11.6 9.1 4.8 14.7 13.3 7.4 8.7 10.7 12.9 6.3 11.6 13.6 13.5 12.5 15.2 14.4 15.4 18.3 18.6 10.3 2.0 8.1 11.0 7.2 20.6 11.9 13.3 11.3 25.1 34.3 14.5 10.3 18.4 3.4 8.3 12.8 12.8 23.9 11.1 13.1 10.2 8.7 7.1 7.2 10.1 9.2 7.7 6.6 11.7 15.7 7.6 SPTY2D1OS SPTY2D1-AS1 ENSG00000247595 "SPTY2D1 opposite strand" A0A0U1RRN3 11 18588781-18610255 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 34 "testis: 487.5" "Cell type enhanced" "Detected in many" "Breast glandular cells: 7.5;Distal tubular cells: 23.5;Endometrial stromal cells: 6.9;Granulosa cells: 18.4;Proximal tubular cells: 14.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 4.4;HeLa: 7.6;Hep G2: 4.5" "Low region specificity" "Detected in many" "Secreted in male reproductive system" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 83: Testis - Spermatogenesis" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.07e-1)" "unprognostic (1.24e-1)" "unprognostic (8.60e-3)" "unprognostic (5.14e-2)" "unprognostic (6.61e-2)" "unprognostic (9.32e-2)" "unprognostic (4.44e-7)" "unprognostic (1.75e-1)" "unprognostic (1.39e-2)" "unprognostic (7.83e-2)" "unprognostic (5.36e-2)" "unprognostic (6.50e-3)" "unprognostic (5.41e-4)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (1.48e-2)" 0.9 1.8 1.4 1.4 1.5 0.9 2.7 3.2 2.9 1.7 3.8 1.5 0.2 2.0 3.7 1.3 1.6 1.2 1.5 1.4 2.6 2.0 0.7 0.8 0.7 2.2 1.7 2.4 1.1 0.9 1.6 1.2 1.9 2.0 2.3 3.5 1.7 1.4 1.5 14.1 1.0 1.3 0.9 1.2 0.9 487.5 1.8 0.4 1.7 0.3 0.8 0.9 1.3 2.7 0.5 4.4 1.7 2.3 1.5 2.3 2.1 0.3 0.5 0.9 1.0 3.4 1.2 0.8 0.2 0.4 0.9 0.9 0.0 0.0 0.0 1.3 1.6 0.5 7.6 4.5 0.2 0.6 1.3 0.9 0.3 0.2 1.0 1.1 0.9 0.0 1.2 0.3 0.3 1.6 0.1 1.6 1.2 1.1 2.7 0.1 0.5 0.3 1.8 1.8 0.4 0.2 1.6 0.1 0.0 0.6 0.9 0.0 0.9 1.6 1.3 0.8 0.1 0.0 0.2 0.0 0.6 0.9 1.1 0.2 0.3 0.6 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.5 0.2 0.1 0.1 0.3 0.2 1.4 1.5 3.2 2.9 1.4 2.6 2.2 1.7 1.9 0.9 1.8 2.7 2.8 3.2 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.5 6.0 0.0 0.0 1.3 5.5 0.0 1.0 1.5 0.0 23.5 3.2 0.0 4.9 6.9 1.1 0.0 0.0 0.0 5.0 1.1 1.8 0.0 3.9 0.0 18.4 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 14.3 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.8 2.1 0.0 0.0 SPTY2D1 "DKFZp686I068, FLJ39441, Spt2" ENSG00000179119 "SPT2 chromatin protein domain containing 1" Q68D10 11 18606403-18634791 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 34.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039372, HPA040177, HPA047957" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 46: Basophils - DNA binding" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nucleoli" "HPA039372: AB_2676472, HPA040177: , HPA047957: AB_2680224" "unprognostic (8.43e-2)" "unprognostic (1.50e-1)" "unprognostic (8.62e-2)" "unprognostic (2.16e-1)" "unprognostic (1.73e-2)" "unprognostic (1.03e-1)" "unprognostic (1.51e-2)" "unprognostic (5.42e-2)" "unprognostic (1.74e-1)" "unprognostic (2.48e-1)" "prognostic unfavorable (2.59e-4)" "unprognostic (2.03e-1)" "prognostic favorable (2.07e-4)" "unprognostic (1.33e-2)" "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (3.33e-1)" 7.5 8.7 2.3 8.6 2.4 34.3 10.0 3.6 5.9 10.6 4.3 7.8 7.0 7.6 5.6 8.1 6.6 10.1 4.9 3.0 2.7 8.9 10.3 7.3 8.2 2.3 2.9 9.7 7.8 8.1 4.0 8.7 2.4 8.7 8.2 4.5 9.4 5.6 7.9 7.4 6.5 7.8 2.4 7.3 7.5 4.2 2.7 8.5 10.0 7.5 9.6 9.4 5.3 3.1 11.8 11.2 9.0 12.7 14.3 15.1 13.5 17.3 18.9 14.2 16.8 10.4 5.2 27.0 9.3 16.3 11.0 12.1 15.3 13.4 20.5 14.1 14.0 10.6 6.4 9.5 14.1 22.6 20.4 12.7 13.6 9.3 17.8 10.1 15.3 15.8 15.3 41.7 15.9 12.2 15.5 9.3 8.5 22.8 12.6 14.2 25.1 11.4 14.9 16.9 8.8 12.3 15.1 17.8 12.3 11.7 11.0 9.6 13.7 13.7 11.7 27.1 10.8 14.3 19.0 21.0 16.4 12.6 11.8 4.7 1.9 2.9 2.7 2.9 4.1 1.2 2.6 2.8 1.7 1.1 2.4 2.6 2.2 3.7 2.8 1.4 3.1 1.8 2.3 2.4 3.6 5.9 3.0 2.7 2.3 2.9 2.4 2.4 2.7 3.1 42.3 25.6 47.7 5.2 38.0 55.8 19.6 17.1 32.5 13.7 55.0 39.5 21.6 18.6 29.9 27.6 10.4 14.3 75.3 31.7 17.6 25.3 2.4 47.4 53.8 29.1 44.3 15.4 9.9 24.9 26.5 35.3 40.2 74.1 57.7 20.5 22.9 28.5 16.3 11.8 9.6 39.4 24.4 33.4 49.6 3.2 19.0 44.3 16.0 15.0 24.4 12.4 49.4 9.0 8.9 27.7 29.8 13.9 83.6 28.0 21.0 17.4 47.5 11.4 32.9 42.9 28.2 14.2 17.3 41.6 66.3 27.5 69.7 27.1 24.4 29.2 TMEM86A FLJ90119 ENSG00000151117 "Transmembrane protein 86A" Q8N2M4 11 18693122-18704785 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 17.6" "Cell type enhanced" "Detected in many" "Hofbauer cells: 40.6;Theca cells: 17.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057119 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 61: Skin - Cornification" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 4: Macrophages - Innate immune response" "Nucleoplasm, Golgi apparatus" "HPA057119: AB_2683342" "unprognostic (1.25e-1)" "unprognostic (1.09e-3)" "unprognostic (8.08e-3)" "unprognostic (1.89e-1)" "unprognostic (2.53e-1)" "unprognostic (1.10e-1)" "unprognostic (4.05e-2)" "unprognostic (2.94e-1)" "unprognostic (3.73e-1)" "unprognostic (1.74e-1)" "unprognostic (8.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.36e-1)" "unprognostic (1.50e-2)" "unprognostic (7.92e-2)" "unprognostic (4.20e-1)" "unprognostic (3.24e-1)" 2.8 2.7 2.6 2.2 2.2 0.3 3.2 2.1 2.8 2.3 3.8 1.5 1.4 2.2 1.0 2.3 2.6 4.0 2.9 2.1 2.6 9.5 2.6 3.5 4.7 3.1 2.7 7.1 3.4 5.4 2.2 4.3 2.5 1.6 1.8 5.7 2.7 1.4 2.9 17.6 2.0 1.9 2.7 4.9 2.1 2.3 4.0 1.6 2.1 2.5 2.5 2.3 3.6 4.5 0.0 0.2 0.6 3.1 2.7 0.0 0.1 0.6 0.5 0.5 0.5 0.0 0.4 0.0 1.2 0.6 3.0 0.3 0.2 0.1 0.3 0.2 1.9 0.2 0.1 0.0 2.1 0.0 2.8 3.8 1.2 0.1 0.2 0.7 1.7 1.8 0.6 0.0 1.3 1.7 0.0 0.0 0.2 0.5 1.6 0.0 5.1 0.0 17.5 3.8 1.0 1.3 1.0 3.2 1.4 1.1 3.9 0.4 1.9 0.5 0.2 0.1 0.1 3.2 2.7 0.0 1.1 0.0 1.1 0.0 1.9 0.1 0.2 1.4 0.5 0.0 0.2 0.4 3.4 0.1 0.4 0.8 0.0 0.1 0.5 2.0 0.5 0.8 2.6 2.2 2.1 2.8 2.1 2.6 3.1 2.7 2.5 2.7 4.0 4.5 1.9 0.0 0.0 0.3 0.0 0.1 0.8 0.4 0.0 5.2 3.5 1.8 2.2 0.0 0.7 11.0 8.4 0.5 1.4 0.6 7.9 7.8 12.2 1.1 1.9 2.1 3.5 0.0 0.5 8.0 0.3 1.7 1.1 1.0 0.0 3.0 3.9 1.6 40.6 0.0 0.8 0.8 0.0 12.7 0.8 12.1 2.1 8.3 0.0 3.7 2.3 2.6 0.0 2.0 0.1 7.4 0.1 1.9 0.4 0.6 0.0 8.3 0.4 4.8 6.6 0.4 1.2 7.8 2.6 0.2 0.3 2.3 0.7 17.4 0.2 0.4 IGSF22 "FLJ37794, IGFN2" ENSG00000179057 "Immunoglobulin superfamily member 22" Q8N9C0 11 18704312-18726230 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "skin 1: 1.0" "Cell type enhanced" "Detected in many" "Collecting duct cells: 23.9;Distal tubular cells: 21.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026459, HPA037851" Uncertain Approved Mitochondria NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "CAB026459: , HPA037851: " "unprognostic (4.05e-2)" "unprognostic (3.65e-2)" "unprognostic (2.34e-2)" "unprognostic (1.84e-1)" "unprognostic (1.23e-1)" "unprognostic (8.93e-2)" "unprognostic (1.02e-1)" "unprognostic (8.38e-2)" "unprognostic (8.70e-2)" "unprognostic (4.24e-2)" "unprognostic (1.99e-4)" "unprognostic (9.35e-2)" "unprognostic (3.72e-4)" "unprognostic (2.87e-1)" "unprognostic (2.18e-1)" "unprognostic (3.43e-1)" "unprognostic (7.94e-3)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 1.0 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.3 0.2 0.3 0.1 0.1 0.1 0.0 0.3 0.2 0.6 0.0 0.5 0.3 2.9 2.4 4.7 1.4 0.6 1.3 7.5 5.3 1.7 0.0 3.1 23.9 0.0 0.0 1.0 1.5 21.5 3.3 1.4 5.3 1.2 0.9 3.6 0.0 3.2 4.3 0.0 0.7 2.0 5.8 2.5 0.7 0.4 0.4 1.5 1.7 1.7 5.8 8.2 0.3 1.0 4.6 1.5 0.6 0.0 0.0 0.7 0.5 2.1 1.5 0.3 9.5 2.6 0.7 0.3 4.0 0.3 2.2 6.1 0.9 0.0 0.5 1.0 0.0 0.4 0.7 1.7 0.0 2.9 3.1 2.8 8.4 PTPN5 "PTPSTEP, STEP, STEP61" ENSG00000110786 "Protein tyrosine phosphatase non-receptor type 5" P54829 11 18727928-18792721 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 161.0" "Group enriched" "Detected in some" 4 "Excitatory neurons: 59.0;Inhibitory neurons: 51.9" "Group enriched" "Detected in some" 6 "glioma: 1.6;testis cancer: 2.0" "Region enhanced" "Detected in many" "basal ganglia: 161.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.1;NTERA-2: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031014, HPA072091" Supported Approved "Endoplasmic reticulum" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 5: NTERA-2 - Transcription" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Endoplasmic reticulum" "HPA031014: AB_10669550, HPA072091: AB_2686487" "unprognostic (1.23e-1)" "unprognostic (2.91e-2)" "unprognostic (8.93e-3)" "unprognostic (1.09e-2)" "unprognostic (3.27e-2)" "unprognostic (2.13e-2)" "unprognostic (5.83e-3)" "unprognostic (3.59e-1)" "unprognostic (4.91e-2)" "unprognostic (2.59e-1)" "unprognostic (2.00e-1)" "unprognostic (3.58e-1)" "unprognostic (8.44e-4)" "unprognostic (4.21e-3)" "unprognostic (3.90e-2)" "unprognostic (9.39e-2)" "unprognostic (8.49e-2)" 1.5 0.5 37.2 0.2 161.0 0.1 1.1 0.0 55.2 0.7 0.0 1.0 0.1 0.8 0.0 0.5 1.1 0.3 11.9 32.1 25.5 1.7 0.0 1.5 0.1 11.3 6.4 2.1 0.4 0.2 2.1 0.0 6.7 1.0 0.3 2.0 1.2 0.6 0.7 0.6 0.6 0.4 4.7 0.4 0.9 2.9 19.9 0.0 0.7 3.3 0.0 1.0 1.1 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.2 161.0 0.0 55.2 32.1 25.5 11.3 6.4 6.7 4.7 19.9 29.5 0.1 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.2 6.9 0.0 0.0 59.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 51.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.3 0.0 12.5 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 2.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 MRGPRX1 MRGX1 ENSG00000170255 "MAS related GPR family member X1" Q96LB2 11 18933813-18939507 "G-protein coupled receptors, Predicted membrane proteins" "Acute phase" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "SuSa: 2.8" NA NA "Cluster 12: NES - Nervous system development" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 MRGPRX2 MRGX2 ENSG00000183695 "MAS related GPR family member X2" Q96LB1 11 19054455-19060717 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "skin 1: 1.0" "Cell type enhanced" "Detected in single" "Melanocytes: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055220 Approved NA NA "Cluster 31: Skin - Epidermis development" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA055220: AB_2682743" "unprognostic (1.56e-2)" "unprognostic (1.79e-1)" 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZDHHC13 "FLJ10852, FLJ10941, HIP14L" ENSG00000177054 "Zinc finger DHHC-type palmitoyltransferase 13" Q8IUH4 11 19117099-19176422 "Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 120.5;Urothelial cells: 103.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 136.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016759, HPA018791" Uncertain Supported "Golgi apparatus,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 37: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 22: Epithelial cell types - Mixed function" Vesicles "Golgi apparatus" "HPA016759: AB_1858993, HPA018791: AB_1858992" "unprognostic (1.43e-2)" "unprognostic (4.00e-3)" "unprognostic (1.08e-1)" "unprognostic (1.11e-3)" "unprognostic (2.95e-2)" "unprognostic (1.34e-2)" "unprognostic (1.55e-2)" "unprognostic (1.57e-1)" "unprognostic (3.57e-3)" "unprognostic (3.03e-2)" "unprognostic (1.63e-1)" "unprognostic (2.16e-1)" "unprognostic (6.95e-3)" "unprognostic (1.15e-1)" "unprognostic (7.93e-2)" "unprognostic (2.17e-1)" "unprognostic (2.76e-2)" 4.8 5.7 5.2 7.8 5.2 9.7 8.9 6.6 7.1 9.3 6.6 16.9 11.2 6.7 5.1 37.2 12.9 8.7 9.1 5.4 5.7 9.2 2.2 6.1 9.6 5.5 5.0 5.3 11.2 14.9 11.7 6.2 5.8 8.2 18.2 16.1 10.2 5.4 1.6 18.8 11.3 6.1 5.3 5.7 18.5 14.4 5.0 11.7 8.7 2.9 22.4 22.4 15.4 5.2 41.6 19.3 18.0 15.5 6.3 7.2 17.3 19.4 17.8 21.3 24.4 11.7 9.7 21.1 13.1 16.3 47.9 61.3 26.0 12.8 23.3 26.4 22.6 11.1 12.6 9.7 14.6 15.2 18.5 8.3 14.7 9.0 12.5 19.9 136.8 28.9 10.7 10.3 22.1 13.5 19.6 12.2 15.1 38.7 17.6 21.3 25.0 5.0 21.9 27.0 31.3 23.0 23.2 28.0 10.7 17.3 13.2 17.6 39.6 18.9 13.2 29.2 15.8 8.7 28.5 19.2 22.6 15.5 33.6 11.6 4.7 32.7 8.5 7.9 7.8 8.7 6.6 9.6 5.9 5.5 6.2 8.3 6.0 6.3 6.4 5.6 9.4 4.6 5.2 5.2 6.6 7.1 5.4 5.7 5.5 5.0 5.8 5.3 5.0 5.2 8.1 9.6 10.7 28.7 9.6 24.2 22.3 27.2 14.2 12.0 7.5 4.8 34.1 12.8 41.3 16.5 10.4 8.7 10.6 20.1 5.9 25.1 120.5 21.5 6.6 11.3 15.6 11.6 27.2 19.2 18.8 9.2 24.5 30.8 12.0 16.2 12.8 0.9 6.1 16.8 34.9 24.7 36.7 6.8 8.3 46.6 7.8 6.2 3.6 9.4 20.8 52.8 18.6 19.6 20.9 20.4 16.4 2.2 10.4 47.4 15.5 3.5 57.0 8.8 0.0 5.4 7.4 58.1 31.7 21.3 36.2 6.3 11.4 7.7 21.4 103.0 CSRP3 "CLP, CMD1M, MLP" ENSG00000129170 "Cysteine and glycine rich protein 3" P50461 11 19182030-19210571 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Actin-binding, Developmental protein" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 2613.3;skeletal muscle: 1649.3;tongue: 579.0" "Cell type enriched" "Detected in some" 35 "Cardiomyocytes: 3433.6" "Cancer enriched" "Detected in some" 6 "head and neck cancer: 18.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HSkMC: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA042581 Enhanced Uncertain Nucleoplasm,Cytosol NA NA 250000 "Cluster 38: Heart - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" Cytosol Nucleoplasm "HPA042581: AB_2678061" "unprognostic (1.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.55e-2)" "unprognostic (4.72e-2)" "unprognostic (5.99e-2)" "unprognostic (1.08e-1)" 0.3 0.2 0.3 0.0 0.1 0.1 2.8 0.5 0.3 0.0 0.0 0.2 0.0 0.1 0.0 39.6 0.0 0.5 2613.3 0.1 0.2 0.2 0.2 1.2 1.2 0.2 0.1 0.5 2.6 0.0 0.1 0.1 0.2 32.8 0.0 0.0 24.8 0.0 1649.3 0.4 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.1 0.7 579.0 0.2 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.2 0.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.3 0.1 0.2 0.2 0.1 0.2 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3433.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 28.8 0.0 0.0 0.3 6.0 0.0 79.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 95.5 32.7 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 E2F8 FLJ23311 ENSG00000129173 "E2F transcription factor 8" A0AVK6 11 19224063-19241620 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.2;lymphoid tissue: 11.8;skeletal muscle: 12.6" "Cell type enhanced" "Detected in some" "Erythroid cells: 34.1;Gastric mucus-secreting cells: 10.2;Plasma cells: 9.7;Squamous epithelial cells: 10.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA064882, HPA076614" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol No No "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoli "Nucleoplasm, Cytosol" "HPA064882: AB_2685381, HPA076614: " "unprognostic (5.62e-2)" "unprognostic (5.24e-2)" "unprognostic (3.17e-2)" "unprognostic (6.99e-3)" "unprognostic (2.86e-2)" "unprognostic (1.66e-2)" "unprognostic (1.29e-5)" "unprognostic (1.94e-2)" "unprognostic (3.90e-3)" "unprognostic (2.41e-1)" "unprognostic (7.29e-4)" "unprognostic (1.16e-2)" "unprognostic (9.13e-8)" "unprognostic (1.02e-3)" "unprognostic (1.37e-1)" "unprognostic (3.81e-1)" "unprognostic (4.28e-3)" 0.3 0.1 0.0 2.8 0.0 14.2 0.5 0.1 0.1 1.0 0.0 4.0 3.8 0.4 0.0 4.9 0.9 0.4 2.1 0.0 0.0 0.1 0.3 0.3 7.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.4 5.1 0.0 0.9 0.2 12.6 3.0 3.0 0.6 0.0 1.3 5.6 1.7 0.0 11.8 0.1 0.4 7.3 1.8 1.3 0.1 23.3 7.2 7.1 9.8 0.4 1.1 31.7 13.0 3.7 15.3 16.4 25.4 7.8 23.5 5.5 4.3 9.0 20.2 17.2 1.6 13.5 15.9 14.9 8.0 4.1 7.1 0.0 12.7 19.2 0.3 0.1 3.1 1.0 0.9 21.0 17.2 17.6 22.1 6.3 11.6 25.8 16.6 6.9 26.3 10.1 26.9 12.8 16.0 6.6 16.8 6.0 7.0 5.5 11.3 1.3 4.0 7.7 13.7 4.2 7.3 9.0 18.3 11.8 7.7 16.2 30.6 9.0 24.4 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 1.1 0.1 1.3 0.0 0.0 0.3 0.1 3.8 0.0 0.5 0.0 0.0 0.9 0.8 2.5 0.0 0.0 0.4 3.3 0.8 0.8 1.2 34.1 0.1 0.0 1.7 1.0 10.2 3.3 0.0 3.1 0.0 0.0 2.4 0.0 0.0 3.9 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 1.2 0.0 9.7 0.1 0.4 0.2 5.6 0.0 0.0 1.5 0.9 4.0 3.1 10.0 0.3 0.3 2.2 0.5 6.3 0.9 NAV2 "FLJ10633, FLJ11030, FLJ23707, HELAD1, KIAA1419, POMFIL2, RAINB1" ENSG00000166833 "Neuron navigator 2" Q8IVL1 11 19350724-20121601 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.7;heart muscle: 61.2" "Cell type enhanced" "Detected in many" "Astrocytes: 466.8;Excitatory neurons: 333.8;Inhibitory neurons: 525.7;Oligodendrocyte precursor cells: 863.6;Oligodendrocytes: 354.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 89.9;SH-SY5Y: 81.9;TIME: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011755, HPA011891" Approved Supported Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "HPA011755: AB_1854319, HPA011891: AB_1854318" "unprognostic (7.71e-2)" "unprognostic (2.37e-1)" "unprognostic (1.29e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (1.76e-3)" "unprognostic (3.01e-2)" "unprognostic (3.86e-2)" "unprognostic (1.54e-1)" "unprognostic (1.00e-1)" "unprognostic (3.53e-3)" "unprognostic (1.84e-1)" "unprognostic (2.83e-2)" "unprognostic (3.85e-2)" "unprognostic (1.08e-1)" "unprognostic (6.43e-2)" "unprognostic (3.28e-2)" 7.4 1.6 11.6 3.3 18.8 1.8 12.0 16.1 10.8 6.3 3.5 16.2 4.4 7.6 11.1 6.5 4.4 1.8 61.2 9.6 13.8 9.5 14.9 9.5 1.8 55.7 43.7 3.1 8.8 6.0 5.1 14.8 36.5 6.2 4.9 8.7 15.0 9.3 2.6 6.7 4.1 8.5 39.3 1.4 7.2 0.9 27.7 2.5 16.9 9.4 3.9 5.7 7.4 35.6 16.2 4.7 10.2 1.4 33.7 21.6 11.0 13.3 22.6 17.2 13.0 18.2 2.1 0.1 0.6 20.1 28.0 1.9 0.6 10.4 20.1 3.8 1.2 0.4 25.1 20.9 6.1 0.0 0.5 14.1 26.5 8.3 89.9 12.7 23.2 0.1 1.9 8.0 50.2 17.2 0.0 0.1 26.4 5.3 13.1 0.1 47.1 2.6 14.8 4.6 18.2 81.9 10.3 7.9 14.8 54.2 0.3 0.0 65.2 39.6 6.3 47.7 12.7 2.7 2.0 0.1 13.5 0.8 12.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.6 18.8 16.1 10.8 9.6 13.8 55.7 43.7 36.5 39.3 27.7 35.6 5.5 64.1 22.6 466.8 1.4 4.2 23.6 13.8 14.2 4.6 33.6 31.0 14.3 8.6 18.3 20.2 0.0 31.8 0.8 2.8 13.7 20.3 2.6 34.4 4.6 14.5 10.8 0.0 333.8 21.3 23.3 16.5 11.2 62.1 1.3 152.4 11.7 47.0 10.7 26.9 525.7 10.1 18.3 1.4 5.0 7.9 0.9 3.2 16.0 194.9 1.0 28.9 0.0 863.6 354.4 37.5 0.8 4.1 0.4 33.7 1.8 0.4 24.0 2.4 0.0 30.7 17.8 1.5 0.6 23.1 3.7 14.6 1.7 54.7 9.2 17.8 DBX1 ENSG00000109851 "Developing brain homeobox 1" A6NMT0 11 20156155-20160475 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "NTERA-2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA039802 Uncertain NA NA "Cluster 5: NTERA-2 - Transcription" "HPA039802: AB_10795256" "unprognostic (3.76e-1)" "unprognostic (5.64e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTATIP2 "CC3, FLJ26963, SDR44U1, TIP30" ENSG00000109854 "HIV-1 Tat interactive protein 2" Q9BUP3 11 20363685-20383782 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis, Differentiation, Host-virus interaction" "Developmental protein, Oxidoreductase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 269.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 283.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006417, HPA024321" Approved Supported Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 44: HDLM-2 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "HPA006417: AB_1079091, HPA024321: AB_1851288" "unprognostic (8.05e-3)" "unprognostic (2.13e-1)" "unprognostic (9.31e-2)" "unprognostic (3.01e-1)" "unprognostic (1.36e-2)" "unprognostic (3.79e-3)" "prognostic unfavorable (2.86e-4)" "unprognostic (1.20e-3)" "unprognostic (1.05e-1)" "unprognostic (4.93e-2)" "prognostic unfavorable (6.18e-4)" "unprognostic (1.75e-1)" "prognostic unfavorable (8.01e-4)" "unprognostic (1.20e-1)" "unprognostic (9.42e-2)" "unprognostic (1.71e-1)" "unprognostic (2.03e-1)" 30.0 57.5 29.6 32.3 35.9 18.6 29.6 33.2 46.1 24.2 34.7 88.4 135.9 13.8 31.4 50.0 13.5 44.8 21.2 29.2 31.3 32.6 97.8 39.1 28.5 34.1 31.7 16.2 26.7 27.8 39.9 28.5 34.6 22.4 80.7 1.9 35.0 20.6 46.2 36.0 121.4 14.4 32.3 38.6 75.4 21.4 32.3 20.2 51.3 21.3 27.4 37.7 35.4 45.8 109.6 177.5 3.9 0.2 52.5 39.4 38.7 46.4 45.8 35.3 41.8 103.2 93.8 24.8 93.1 58.3 136.6 149.7 0.0 28.2 33.9 283.9 21.4 30.8 170.1 0.2 125.3 11.3 139.6 57.3 196.0 28.7 44.5 0.0 102.2 0.0 76.8 31.6 66.3 102.0 0.4 7.0 56.5 193.2 87.1 23.2 0.3 89.8 48.1 60.1 47.2 0.5 150.9 59.1 73.6 18.0 123.7 57.0 125.4 25.1 54.8 51.0 1.2 33.5 44.7 0.6 0.4 76.9 111.4 233.4 133.3 171.1 64.3 126.4 73.4 65.9 74.1 69.2 76.9 76.4 63.9 62.7 304.1 64.5 135.2 23.2 140.9 116.7 29.6 35.9 33.2 46.1 29.2 31.3 34.1 31.7 34.6 32.3 32.3 45.8 49.2 25.6 9.6 3.9 28.0 36.3 60.0 74.2 67.2 1.0 32.9 26.7 11.6 102.9 43.7 47.8 0.0 53.7 16.7 175.6 31.3 91.4 51.1 19.3 6.1 29.5 24.1 28.8 12.9 72.3 118.0 23.8 49.5 34.5 22.9 22.7 33.2 77.5 82.8 3.3 9.1 100.3 105.8 54.0 27.6 59.5 19.9 61.3 44.4 8.4 114.6 9.5 39.1 3.5 40.2 94.7 157.3 9.4 21.4 65.2 269.7 69.0 37.4 1.7 13.1 19.2 28.5 45.5 21.5 87.2 42.1 61.6 33.4 13.2 87.8 62.7 PRMT3 HRMT1L3 ENSG00000185238 "Protein arginine methyltransferase 3" O60678 11 20387558-20509338 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 54.2;Excitatory neurons: 55.5;Inhibitory neurons: 66.9;Oligodendrocytes: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007832, CAB022083" Uncertain NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "CAB022083: , HPA007832: AB_1855721" "unprognostic (2.08e-2)" "unprognostic (4.43e-2)" "unprognostic (1.08e-2)" "unprognostic (5.98e-2)" "unprognostic (2.57e-2)" "unprognostic (8.97e-2)" "prognostic unfavorable (2.81e-5)" "unprognostic (2.01e-1)" "unprognostic (9.92e-2)" "unprognostic (9.78e-2)" "prognostic unfavorable (3.17e-5)" "unprognostic (9.15e-2)" "unprognostic (7.22e-2)" "unprognostic (8.86e-2)" "unprognostic (2.09e-1)" "unprognostic (1.40e-2)" "unprognostic (4.11e-2)" 5.0 7.4 4.5 8.1 5.4 8.6 9.6 5.0 8.3 5.1 3.7 6.5 7.6 7.7 3.8 8.2 8.5 5.4 9.7 5.2 5.3 6.9 5.4 4.7 7.8 5.4 5.0 8.1 6.7 11.1 2.6 6.9 5.5 6.1 7.7 7.7 6.5 5.7 10.2 6.2 5.9 7.3 5.0 5.5 6.6 4.3 4.8 9.9 19.8 7.7 8.8 8.0 4.6 7.9 26.5 31.4 18.9 17.4 11.8 19.5 36.1 17.9 15.5 24.5 18.5 25.9 7.2 55.8 12.8 14.1 22.4 34.0 27.2 25.6 37.7 26.1 26.4 26.9 25.5 23.3 24.0 48.8 11.4 16.3 26.3 16.1 54.6 10.3 19.7 19.8 61.1 15.3 15.6 26.7 38.6 16.6 26.7 45.1 27.8 27.9 42.3 46.3 23.8 20.2 18.9 24.8 31.0 28.5 23.2 20.3 30.1 14.1 13.3 19.8 17.3 32.7 34.2 9.1 9.7 58.3 15.7 34.1 39.0 3.8 5.1 4.4 4.4 6.1 7.7 5.3 5.5 4.9 9.8 4.9 6.0 5.2 1.3 10.7 5.2 2.0 3.6 3.9 4.5 5.4 5.0 8.3 5.2 5.3 5.4 5.0 5.5 5.0 4.8 7.9 5.5 9.6 5.1 54.2 11.8 6.0 7.7 6.7 15.9 3.8 6.5 4.2 11.8 4.3 5.7 0.0 2.1 11.4 5.0 3.2 9.8 6.9 3.1 6.0 8.2 5.5 7.8 29.2 55.5 5.1 11.0 8.9 11.2 5.5 5.7 8.0 2.9 4.3 6.5 6.7 66.9 7.3 14.2 5.3 3.6 1.0 6.5 10.9 3.6 35.6 6.7 5.6 2.1 41.7 63.2 5.1 2.2 6.4 8.9 9.5 3.5 5.9 5.8 6.6 0.0 7.8 6.7 13.7 9.6 18.7 5.8 7.3 7.0 12.5 7.6 5.7 SLC6A5 "GLYT2, NET1" ENSG00000165970 "Solute carrier family 6 member 5" Q9Y345 11 20599594-20659285 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 23 "brain: 22.2" "Group enriched" "Detected in some" 39 "Early spermatids: 20.6;Late spermatids: 66.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "medulla oblongata: 22.2;pons: 20.0;spinal cord: 7.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 9 "pons and medulla: 49.3" "Group enriched" "Detected in many" 8 "medulla oblongata: 30.5;spinal cord: 18.3" CAB079052 Supported NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 31: Spermatids - Spermatogenesis" "CAB079052: " "unprognostic (6.94e-2)" "unprognostic (2.28e-1)" "unprognostic (4.75e-2)" 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 22.2 1.3 0.0 0.0 0.0 0.6 0.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.3 0.2 0.2 0.0 22.2 1.3 20.0 7.6 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 66.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NELL1 "FLJ45906, IDH3GL" ENSG00000165973 "Neural EGFL like 1" Q92832 11 20669551-21575686 "Predicted secreted proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.2;kidney: 16.6" "Group enriched" "Detected in some" 9 "Excitatory neurons: 279.0;Inhibitory neurons: 175.8;Oligodendrocyte precursor cells: 323.2" "Cancer enhanced" "Detected in many" "melanoma: 5.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051535 Approved "Secreted in other tissues" NA NA 160000 "Cluster 7: Kidney - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA051535: AB_2681524" "unprognostic (1.73e-1)" "unprognostic (1.31e-1)" "unprognostic (7.29e-2)" "unprognostic (5.35e-4)" "unprognostic (3.78e-4)" "unprognostic (1.67e-2)" "unprognostic (3.91e-1)" "unprognostic (4.38e-2)" "unprognostic (4.65e-2)" "unprognostic (1.57e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-1)" "unprognostic (7.27e-3)" "unprognostic (4.23e-2)" "unprognostic (1.83e-1)" "unprognostic (2.29e-1)" 0.3 0.1 4.5 0.1 5.5 0.0 0.0 0.0 8.2 0.3 0.0 0.2 0.0 0.3 1.6 0.6 0.1 0.4 0.0 10.2 2.0 16.6 0.0 0.4 0.0 2.4 1.9 0.1 0.0 0.0 3.5 0.0 2.5 5.1 0.3 0.8 0.4 2.5 0.0 0.6 0.1 0.1 0.0 0.1 0.6 1.0 1.5 1.2 0.0 0.3 0.7 0.1 0.6 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 28.6 0.0 0.0 0.7 0.0 0.0 0.1 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 5.5 0.0 8.2 10.2 2.0 2.4 1.9 2.5 0.0 1.5 4.2 0.1 0.0 0.0 7.2 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.8 0.7 0.0 0.0 1.8 0.0 0.8 0.0 0.0 5.9 0.0 28.8 0.8 0.1 0.0 0.0 0.0 279.0 0.0 0.0 0.2 0.0 0.0 3.8 0.0 0.0 0.0 0.1 0.0 175.8 0.0 0.0 0.0 0.0 22.3 0.3 0.0 0.0 13.1 0.0 0.0 0.0 323.2 7.6 0.0 0.0 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.0 0.0 0.1 2.2 0.5 0.0 0.0 0.7 0.1 0.0 0.0 0.2 ANO5 "GDD1, LGMD2L, TMEM16E" ENSG00000171714 "Anoctamin 5" Q75V66 11 21799934-22283357 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease variant, Limb-girdle muscular dystrophy, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 24.9;parathyroid gland: 17.0;skeletal muscle: 65.5;tongue: 50.4" "Group enriched" "Detected in many" 7 "Astrocytes: 67.9;Cardiomyocytes: 86.2;Excitatory neurons: 166.6;Inhibitory neurons: 136.4;Oligodendrocyte precursor cells: 81.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.9;HAP1: 5.0;HEK 293: 6.6;NTERA-2: 3.5;RPTEC TERT1: 3.2;U-266/84: 3.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA058857 Uncertain NA NA "Cluster 8: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA058857: AB_2683835" "unprognostic (5.25e-3)" "unprognostic (1.36e-3)" "unprognostic (2.43e-1)" "unprognostic (7.67e-3)" "unprognostic (3.50e-2)" "unprognostic (5.85e-2)" "unprognostic (8.17e-3)" "unprognostic (2.30e-2)" "unprognostic (1.68e-1)" "unprognostic (3.89e-2)" "unprognostic (2.54e-4)" "unprognostic (8.55e-2)" "prognostic favorable (2.50e-7)" "unprognostic (3.65e-3)" "unprognostic (2.84e-1)" "unprognostic (2.77e-4)" "unprognostic (7.94e-2)" 0.9 4.5 1.9 0.8 3.0 0.0 0.7 0.1 8.9 1.6 3.0 2.6 3.3 1.5 1.3 2.0 0.8 1.7 24.9 4.0 2.2 3.6 2.1 1.2 0.2 2.7 2.1 0.5 3.9 17.0 3.4 0.0 2.2 4.2 3.3 2.1 2.6 4.1 65.5 0.1 2.5 2.7 0.4 0.7 3.0 1.8 2.4 0.2 4.7 50.4 0.3 2.0 0.3 3.4 0.0 4.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.3 1.4 2.5 0.0 0.0 0.0 0.0 3.5 2.6 0.0 0.0 0.0 0.0 3.2 0.1 2.7 2.6 0.0 0.0 0.0 2.1 2.1 1.9 0.0 0.0 1.9 0.0 0.0 2.0 3.7 0.0 2.8 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 3.0 0.1 8.9 4.0 2.2 2.7 2.1 2.2 0.4 2.4 3.4 0.4 0.0 5.9 67.9 0.6 0.3 0.3 0.0 0.0 6.7 2.2 0.6 86.2 1.5 0.0 1.8 0.0 0.1 0.0 7.8 1.9 1.3 5.8 0.4 0.2 3.2 5.4 0.4 166.6 2.7 0.0 3.0 1.5 0.3 0.0 3.0 2.5 5.1 0.5 1.7 136.4 7.1 0.0 0.6 1.4 2.9 0.0 1.6 1.8 14.0 1.9 2.8 0.0 81.4 4.2 1.0 4.4 1.2 0.0 1.4 2.7 3.3 0.7 0.8 0.0 8.1 2.4 11.0 0.9 0.1 0.1 0.0 0.2 1.6 4.6 0.2 SLC17A6 "DNPI, VGLUT2" ENSG00000091664 "Solute carrier family 17 member 6" Q9P2U8 11 22338381-22379503 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 39.6" "Group enriched" "Detected in some" 4 "Excitatory neurons: 14.4;Rod photoreceptor cells: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 229 "SCLC-21H: 30.3" "Group enriched" "Detected in all" 5 "basal ganglia: 51.9;hypothalamus: 139.9;midbrain: 172.4;pons and medulla: 86.4;thalamus: 164.9" "Low region specificity" "Detected in many" "CAB037130, HPA039226, CAB078204" Supported Supported NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "CAB037130: AB_477611, CAB078204: AB_2665794, HPA039226: AB_2676400" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" 0.0 0.0 6.6 0.0 1.5 0.0 0.0 13.4 11.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 16.6 0.0 0.0 0.0 0.0 38.3 16.1 0.0 0.2 0.0 3.6 0.0 35.6 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 39.6 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 1.5 13.4 11.0 3.8 16.6 38.3 16.1 35.6 7.1 39.6 4.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FANCF FAF ENSG00000183161 "FA complementation group F" Q9NPI8 11 22622533-22625823 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Distal tubular cells: 45.0;Early spermatids: 168.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008899 Supported Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "HPA008899: " "unprognostic (1.16e-2)" "unprognostic (4.10e-2)" "unprognostic (2.33e-2)" "unprognostic (1.37e-2)" "unprognostic (4.55e-2)" "unprognostic (8.84e-2)" "prognostic unfavorable (2.27e-4)" "unprognostic (4.29e-2)" "unprognostic (1.11e-1)" "unprognostic (2.74e-3)" "unprognostic (3.95e-1)" "unprognostic (1.67e-1)" "unprognostic (2.29e-1)" "unprognostic (3.73e-2)" "unprognostic (1.81e-1)" "unprognostic (9.14e-2)" "unprognostic (7.64e-3)" 2.1 3.8 3.8 5.6 3.8 2.8 5.2 4.1 3.9 4.9 6.1 5.6 7.9 3.9 8.5 2.8 8.9 3.2 3.6 3.5 4.2 5.0 4.2 3.4 8.2 4.2 4.3 6.1 8.1 4.9 3.7 3.0 3.9 4.6 5.9 5.1 6.1 4.8 1.2 5.1 7.6 2.5 4.1 6.3 7.1 4.9 4.6 9.3 5.6 1.1 7.7 3.5 2.1 4.5 2.3 6.7 8.6 9.5 4.5 5.4 3.5 4.3 5.3 5.0 5.5 4.3 3.5 11.3 1.2 4.5 8.9 9.6 7.2 7.5 2.5 18.5 3.3 4.3 2.7 7.0 5.2 8.0 4.6 5.2 14.1 1.7 7.7 8.5 8.1 15.9 10.9 13.8 3.2 7.0 20.4 7.5 9.8 19.2 8.4 17.0 4.1 12.8 9.7 8.7 32.0 15.1 2.4 7.7 7.8 9.2 15.5 7.1 5.7 5.0 5.1 9.3 6.4 8.0 11.0 3.4 8.1 3.2 11.8 12.3 7.6 16.8 15.3 8.1 18.0 16.1 14.3 14.9 9.2 20.9 19.3 16.2 1.1 15.0 8.7 13.5 10.7 10.6 3.8 3.8 4.1 3.9 3.5 4.2 4.2 4.3 3.9 4.1 4.6 4.5 4.7 3.2 2.2 2.3 13.9 3.3 6.2 8.8 6.8 15.2 7.1 6.0 5.7 18.6 6.3 3.7 10.4 11.6 15.3 10.2 45.0 18.8 168.1 14.1 6.8 6.3 3.5 8.0 2.6 18.7 7.5 5.4 10.7 6.8 2.5 9.6 6.4 10.7 6.9 16.8 3.3 16.5 10.2 6.9 2.6 25.5 9.6 6.7 5.4 5.6 11.3 13.1 22.6 0.5 6.2 10.7 10.3 9.8 7.1 5.6 13.2 22.5 24.4 18.0 6.6 3.2 5.3 23.1 16.7 10.1 2.3 2.3 11.2 11.1 15.8 2.4 GAS2 ENSG00000148935 "Growth arrest specific 2" O43903 11 22625509-22813055 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell shape, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 39.7" "Group enriched" "Detected in some" 4 "Astrocytes: 39.8;Excitatory neurons: 114.9;Inhibitory neurons: 141.9;Oligodendrocytes: 83.9" "Cancer enhanced" "Detected in many" "liver cancer: 4.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "Hep G2: 43.2;JURKAT: 24.0;Karpas-707: 85.2;SCLC-21H: 24.8;U-266/84: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058904 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" Yes NA "Cluster 30: Non-specific - Translation" "Cluster 85: Liver - Metabolism" "Cluster 2: Karpas-707 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "HPA058904: AB_2683850" "unprognostic (5.48e-3)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (1.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.08e-2)" "unprognostic (1.08e-1)" "unprognostic (1.49e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-2)" "unprognostic (3.30e-5)" "prognostic favorable (6.13e-4)" "unprognostic (5.85e-2)" "unprognostic (4.22e-2)" "unprognostic (7.94e-2)" "unprognostic (3.58e-2)" 0.4 0.8 2.1 0.3 1.9 0.1 0.8 4.5 5.4 0.9 0.0 0.7 1.8 0.8 0.0 0.7 1.2 1.6 3.5 0.7 2.2 5.4 39.7 1.0 1.0 6.2 7.5 2.0 9.6 0.1 2.5 0.4 6.3 1.0 0.4 2.2 1.5 0.6 4.6 0.8 1.6 0.3 3.3 1.3 2.6 0.8 6.1 8.2 0.8 1.8 0.7 1.0 0.7 6.1 0.0 0.1 1.7 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.1 1.7 0.4 0.2 0.0 43.2 0.5 0.1 0.3 0.1 0.1 0.0 0.2 0.3 0.0 24.0 1.6 85.2 0.0 0.4 0.3 0.1 0.3 2.4 0.0 0.9 0.5 4.4 0.0 1.1 24.8 1.3 0.0 0.0 0.5 0.2 0.1 0.0 1.8 0.0 0.4 1.1 0.0 1.1 30.7 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 1.9 4.5 5.4 0.7 2.2 6.2 7.5 6.3 3.3 6.1 6.1 0.1 0.0 0.0 39.8 0.4 0.1 0.4 0.1 0.6 1.9 0.4 0.1 12.7 10.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.4 2.3 1.3 0.1 0.4 0.0 0.0 114.9 3.3 0.0 1.0 3.1 0.7 0.0 0.2 0.7 22.9 0.0 0.0 141.9 0.6 0.0 0.0 0.0 5.4 0.6 0.0 0.0 9.4 0.2 0.2 0.0 18.6 83.9 1.6 1.4 0.0 0.5 0.1 0.1 3.2 4.0 1.2 0.0 0.3 0.8 0.4 1.1 0.6 0.0 0.0 0.4 0.1 0.9 0.3 SVIP DKFZp313A2432 ENSG00000198168 "Small VCP interacting protein" Q8NHG7 11 22813799-22830299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 406.9;Early spermatids: 945.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 50.2" "Low region specificity" "Detected in all" HPA039807 Approved NA NA "Cluster 6: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 29: Early spermatids - Spermatogenesis" "HPA039807: AB_10795232" "unprognostic (1.18e-2)" "unprognostic (2.05e-1)" "unprognostic (2.21e-1)" "unprognostic (2.72e-2)" "unprognostic (1.66e-1)" "unprognostic (1.77e-2)" "unprognostic (2.34e-2)" "unprognostic (1.73e-1)" "unprognostic (8.80e-2)" "unprognostic (2.02e-2)" "unprognostic (9.31e-2)" "unprognostic (2.44e-1)" "prognostic favorable (1.77e-8)" "unprognostic (2.18e-2)" "unprognostic (1.24e-1)" "unprognostic (5.21e-2)" "unprognostic (1.16e-2)" 3.3 8.4 11.6 5.6 14.4 17.5 10.7 13.3 18.5 6.9 9.4 7.7 10.4 7.2 18.2 5.6 8.2 7.2 5.6 12.1 14.7 15.5 4.0 6.7 7.8 15.1 13.1 8.2 13.3 14.0 11.9 2.7 14.9 12.8 8.2 9.2 11.8 8.0 5.5 5.4 11.1 3.6 16.2 8.2 18.6 4.8 15.2 6.2 23.7 4.2 7.2 6.3 3.3 19.0 0.1 4.5 10.0 0.3 1.2 0.4 5.9 4.1 3.0 5.6 4.5 2.9 3.8 0.1 6.3 3.1 6.0 2.6 14.6 4.1 7.3 28.9 11.3 14.5 4.2 7.2 2.9 24.3 20.3 0.6 5.5 0.0 3.6 6.9 21.3 26.3 29.9 31.2 5.6 7.2 26.4 3.2 5.7 24.8 11.5 22.7 10.0 21.8 10.4 12.8 50.2 11.2 0.0 12.3 13.9 2.5 20.8 4.6 14.9 2.4 8.7 34.9 7.0 7.8 0.0 8.4 16.2 0.0 10.4 9.6 1.3 23.3 8.0 0.7 10.6 12.4 12.8 9.1 1.7 12.5 15.8 11.3 4.4 6.6 0.9 24.0 9.6 6.3 11.6 14.4 13.3 18.5 12.1 14.7 15.1 13.1 14.9 16.2 15.2 19.0 68.8 80.1 66.9 4.9 80.1 26.8 69.0 61.6 12.5 48.9 141.2 110.4 157.7 82.9 71.4 161.8 22.9 34.8 89.6 63.8 406.9 89.9 945.7 64.2 9.3 79.4 112.5 187.8 4.8 143.5 7.4 24.9 57.6 80.2 125.4 36.4 79.9 100.7 24.2 26.9 3.8 105.9 111.9 22.1 64.8 319.1 34.8 55.6 55.2 7.5 62.0 67.0 65.9 6.0 62.0 156.5 63.4 47.0 67.1 77.3 100.8 224.4 59.2 79.3 13.1 23.7 32.5 201.7 87.6 28.6 77.4 32.8 89.2 23.2 84.6 92.8 CCDC179 ENSG00000255359 "Coiled-coil domain containing 179" H3BU77 11 22846922-22860474 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 88 "testis: 23.5" "Group enriched" "Detected in some" 161 "Early spermatids: 1079.5;Late spermatids: 2024.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 34: Spermatids - Unknown function" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1079.5 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2024.9 4.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LUZP2 ENSG00000187398 "Leucine zipper protein 2" Q86TE4 11 24496970-25082638 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 30.6" "Cell type enriched" "Detected in some" 5 "Oligodendrocyte precursor cells: 1890.0" "Group enriched" "Detected in some" 7 "glioma: 3.5;prostate cancer: 4.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 10.9;HAP1: 4.4;HeLa: 1.9;hTERT-RPE1: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039007, HPA046161" Enhanced Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted in brain" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039007: AB_2676307, HPA046161: AB_2679564" "unprognostic (4.49e-2)" "unprognostic (2.74e-2)" "unprognostic (8.63e-2)" "unprognostic (3.50e-1)" "unprognostic (5.22e-3)" "unprognostic (3.38e-1)" "unprognostic (4.88e-2)" "unprognostic (5.67e-4)" "unprognostic (2.40e-1)" "unprognostic (5.66e-2)" "unprognostic (6.16e-3)" "unprognostic (4.09e-2)" "unprognostic (5.18e-3)" "unprognostic (9.41e-3)" "unprognostic (4.18e-2)" "unprognostic (2.17e-1)" "unprognostic (9.64e-2)" 0.3 6.5 8.6 0.1 8.5 0.1 0.5 11.8 8.0 0.1 1.1 0.8 0.1 0.2 0.0 0.1 0.0 0.1 0.1 6.3 15.1 0.2 0.9 0.2 0.0 10.8 30.6 0.0 0.0 0.0 0.6 0.0 17.2 2.4 0.6 1.1 0.1 0.1 0.0 0.1 0.2 0.3 17.6 0.1 0.1 0.5 15.3 0.0 0.0 0.6 0.0 0.3 0.1 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.9 4.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.2 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.6 8.5 11.8 8.0 6.3 15.1 10.8 30.6 17.2 17.6 15.3 16.5 0.3 0.0 0.0 11.4 0.0 0.6 0.1 0.0 1.8 6.9 0.3 1.7 0.6 0.0 0.0 3.7 0.0 0.0 0.1 1.2 0.0 0.0 33.7 0.6 0.7 0.1 0.0 0.0 149.4 0.0 0.1 2.6 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 371.4 1.7 0.0 0.0 0.0 6.4 0.9 0.1 0.0 4.7 0.0 0.3 0.0 1890.0 9.1 0.2 23.9 0.0 0.0 4.5 0.0 0.7 0.0 0.8 0.0 0.4 0.3 0.3 0.6 0.9 0.3 0.1 0.0 2.4 1.5 1.6 ANO3 "C11orf25, DYT23, GENX-3947, TMEM16C" ENSG00000134343 "Anoctamin 3" Q9BYT9 11 26188842-26663289 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Disease variant, Dystonia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "brain: 59.2;epididymis: 57.4" "Cell type enriched" "Detected in some" 5 "Excitatory neurons: 201.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "basal ganglia: 59.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.9;HDLM-2: 6.8;U-2 OS: 1.6;U-2197: 4.3" "Region enhanced" "Detected in all" "basal ganglia: 158.9" "Region enriched" "Detected in all" 7 "basal ganglia: 180.1" HPA041629 Uncertain NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA041629: AB_10793969" "unprognostic (7.01e-3)" "unprognostic (4.31e-1)" "unprognostic (2.94e-1)" "unprognostic (9.29e-2)" "unprognostic (9.28e-2)" "unprognostic (1.25e-1)" "unprognostic (1.35e-1)" "unprognostic (2.75e-2)" "unprognostic (1.66e-1)" "unprognostic (2.45e-2)" "unprognostic (7.02e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-4)" "unprognostic (9.48e-3)" "unprognostic (3.50e-2)" "unprognostic (4.33e-1)" "unprognostic (4.01e-1)" 3.0 0.8 4.3 0.1 59.2 0.0 0.5 0.0 11.8 0.5 0.0 0.2 0.1 0.1 57.4 0.0 0.2 1.8 0.3 7.7 0.0 1.0 1.1 0.4 0.0 1.1 0.1 0.1 0.3 0.1 0.3 0.0 1.9 0.0 0.1 0.4 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.4 0.0 1.9 0.3 0.1 1.0 0.1 0.0 0.0 0.1 1.7 0.0 0.0 0.4 0.0 1.1 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 4.3 0.0 0.4 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 59.2 0.0 11.8 7.7 0.0 1.1 0.1 1.9 0.0 0.3 1.7 1.0 0.0 2.0 3.3 0.0 0.0 0.0 0.1 0.0 1.7 0.2 0.0 0.9 0.0 0.2 0.0 14.6 0.2 0.0 0.0 0.0 0.1 12.0 0.5 0.0 0.4 0.0 0.0 201.9 0.0 0.3 0.5 0.0 0.3 0.0 0.0 1.8 0.7 0.0 8.4 4.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 8.4 0.0 0.0 0.0 38.2 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 2.3 0.0 0.0 4.7 3.8 2.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 MUC15 ENSG00000169550 "Mucin 15, cell surface associated" Q8N387 11 26559032-26572263 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "epididymis: 1949.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 109.0;Respiratory ciliated cells: 168.3;Syncytiotrophoblasts: 665.9" "Cancer enriched" "Detected in many" 11 "thyroid cancer: 56.7" "Region enriched" "Detected in single" 7 "basal ganglia: 4.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.9;K-562: 11.7;SK-BR-3: 18.0;SuSa: 12.0;U-266/70: 7.8;U-266/84: 21.1" "Group enriched" "Detected in some" 4 "cerebellum: 1.2;thalamus: 1.4" "Low region specificity" "Detected in many" "HPA026110, HPA073304" Enhanced "Intracellular and membrane" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 16: U-266 - Nucleosome" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "HPA026110: AB_1854200, HPA073304: " "unprognostic (1.49e-1)" "unprognostic (2.08e-3)" "unprognostic (7.71e-5)" "unprognostic (5.09e-3)" "unprognostic (2.77e-2)" "unprognostic (3.04e-2)" "unprognostic (6.58e-2)" "unprognostic (1.12e-1)" "unprognostic (9.44e-3)" "unprognostic (1.98e-1)" "unprognostic (7.27e-3)" "unprognostic (4.96e-3)" "unprognostic (1.09e-1)" "unprognostic (5.70e-2)" "unprognostic (4.54e-3)" 0.1 0.3 0.4 0.0 4.5 0.0 15.4 0.0 0.6 6.5 1.1 0.0 0.0 0.4 1949.7 17.4 6.7 0.1 0.0 0.3 0.0 24.1 0.1 12.3 0.1 0.0 0.0 0.0 7.8 0.0 1.4 14.8 0.1 0.9 0.0 0.0 52.2 6.8 0.0 29.4 0.0 0.0 0.0 0.0 1.0 0.2 0.0 3.6 75.7 0.0 7.7 2.5 11.6 0.1 0.6 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 11.7 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.1 0.2 0.6 0.0 18.0 0.0 12.0 0.2 0.0 0.0 0.0 3.1 0.0 0.0 7.8 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.5 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 109.0 32.5 0.0 0.1 3.4 12.5 7.5 4.6 0.0 43.0 6.9 0.0 0.0 55.1 49.7 0.0 68.7 0.0 0.0 31.3 4.6 0.6 39.8 5.4 0.7 0.0 0.0 0.2 0.0 19.2 1.3 0.0 53.1 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 8.2 0.0 0.6 0.2 0.0 0.6 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 168.3 0.0 0.0 0.0 2.2 0.2 0.2 26.5 29.7 665.9 0.4 0.0 0.0 12.6 SLC5A12 "MGC52019, SMCT2" ENSG00000148942 "Solute carrier family 5 member 12" Q1EHB4 11 26667020-26723427 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 47.7;intestine: 30.1;kidney: 171.7" "Group enriched" "Detected in some" 23 "Proximal enterocytes: 286.0;Proximal tubular cells: 181.0" "Cancer enriched" "Detected in single" 26 "renal cancer: 9.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.3;NTERA-2: 1.7;SuSa: 3.3;T-47d: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA060904 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 5: NTERA-2 - Transcription" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Plasma membrane" Nucleoplasm "HPA060904: AB_2684385" "unprognostic (3.69e-3)" "unprognostic (6.92e-2)" "unprognostic (1.79e-1)" "unprognostic (2.86e-1)" "unprognostic (2.01e-2)" "unprognostic (9.35e-3)" "unprognostic (4.21e-3)" "unprognostic (4.49e-2)" "unprognostic (2.36e-3)" "unprognostic (1.71e-1)" "unprognostic (2.03e-2)" "unprognostic (3.43e-1)" "unprognostic (2.91e-3)" "unprognostic (1.34e-1)" "unprognostic (8.53e-2)" "unprognostic (1.42e-2)" "unprognostic (9.40e-3)" 0.1 0.1 0.3 0.0 0.5 0.9 0.1 0.9 0.4 0.0 0.3 0.2 4.9 0.1 47.7 0.0 0.1 0.1 4.3 0.3 0.4 171.7 1.7 0.1 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.6 0.2 0.1 0.2 1.0 0.1 0.1 0.1 0.3 30.1 0.0 0.0 0.6 0.3 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.5 0.2 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.3 0.0 0.0 0.1 0.2 1.7 0.3 0.0 0.0 0.0 0.3 0.0 0.5 0.8 0.1 0.7 0.1 0.0 3.3 1.2 0.2 0.2 0.2 0.1 0.2 0.1 1.0 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.5 0.9 0.4 0.3 0.4 0.2 0.1 0.2 0.0 0.2 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.1 3.7 0.0 0.1 0.0 2.4 9.8 0.0 1.4 0.2 0.0 0.2 0.0 0.0 0.7 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 6.7 0.0 0.0 0.0 0.2 0.0 0.7 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 286.0 181.0 0.1 0.3 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.6 4.5 3.5 0.1 FIBIN MGC24932 ENSG00000176971 "Fin bud initiation factor homolog" Q8TAL6 11 26994112-26997087 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 33.0;Fibroblasts: 80.8;Granulosa cells: 42.4;Leydig cells: 37.9;Oligodendrocyte precursor cells: 32.2;Peritubular cells: 35.0" "Cancer enhanced" "Detected in all" "glioma: 48.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 65.2;ASC TERT1: 41.8;fHDF/TERT166: 22.1;HHSteC: 88.2;HSkMC: 89.5;hTCEpi: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040120 Uncertain "Intracellular and membrane" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "HPA040120: AB_10795243" "unprognostic (1.72e-1)" "unprognostic (2.61e-1)" "unprognostic (1.29e-1)" "unprognostic (9.04e-2)" "unprognostic (1.62e-2)" "unprognostic (5.42e-2)" "unprognostic (7.28e-2)" "unprognostic (1.03e-1)" "unprognostic (4.32e-2)" "unprognostic (5.08e-3)" "unprognostic (3.16e-2)" "unprognostic (2.20e-1)" "prognostic favorable (1.93e-5)" "prognostic unfavorable (6.72e-4)" "unprognostic (8.48e-2)" "prognostic unfavorable (1.85e-6)" "unprognostic (1.02e-2)" 32.3 4.9 11.0 7.7 10.6 0.0 25.1 11.4 10.8 35.6 6.1 27.8 2.2 26.1 8.0 11.3 35.7 7.9 32.6 10.8 10.7 15.2 2.0 27.2 2.8 10.6 12.7 18.5 3.8 0.3 2.6 12.6 11.7 17.0 2.6 0.6 17.6 61.3 17.1 16.7 12.0 17.1 11.4 14.1 21.1 1.3 11.6 2.1 13.4 14.5 0.9 16.3 58.3 11.7 0.0 0.0 1.0 0.0 65.2 41.8 0.1 2.1 5.7 0.2 0.9 0.0 0.0 0.0 0.0 22.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 88.2 0.0 0.0 89.5 24.0 1.1 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 4.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.6 11.4 10.8 10.8 10.7 10.6 12.7 11.7 11.4 11.6 11.7 2.5 0.0 0.0 17.9 0.0 6.6 1.6 33.0 1.8 0.3 1.9 0.9 1.2 11.5 4.0 11.0 0.0 1.2 0.0 0.1 11.7 0.6 0.1 0.0 0.1 1.0 0.0 0.0 0.5 0.0 0.9 80.8 0.0 0.0 0.0 42.4 6.1 0.5 1.8 0.0 0.1 0.0 12.2 0.0 10.3 0.3 37.9 0.8 7.2 0.0 0.0 19.8 0.0 32.2 0.1 0.1 0.0 35.0 0.1 0.2 0.0 4.3 0.9 0.6 0.0 3.7 7.4 0.1 0.3 0.8 5.1 1.9 0.5 3.9 0.0 0.0 BBOX1 "BBH, BBOX, G-BBH, gamma-BBH" ENSG00000129151 "Gamma-butyrobetaine hydroxylase 1" O75936 11 27040725-27127809 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carnitine biosynthesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 467.9;liver: 131.9" "Cell type enriched" "Detected in many" 7 "Proximal tubular cells: 1623.0" "Group enriched" "Detected in many" 6 "glioma: 23.7;renal cancer: 59.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "hTCEpi: 13.7;RPTEC TERT1: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA007600, HPA027823" Enhanced Approved Uncertain "Vesicles,Actin filaments" NA NA 35000 "Cluster 7: Kidney - Transmembrane transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "Actin filaments" "HPA007600: AB_1845284, HPA027823: AB_10602394" "unprognostic (9.96e-3)" "unprognostic (1.80e-2)" "unprognostic (8.17e-2)" "prognostic unfavorable (6.65e-4)" "unprognostic (7.03e-2)" "unprognostic (6.66e-2)" "unprognostic (7.05e-3)" "unprognostic (1.13e-2)" "unprognostic (3.03e-1)" "unprognostic (6.89e-2)" "unprognostic (2.03e-2)" "unprognostic (1.60e-1)" "prognostic favorable (1.45e-5)" "unprognostic (1.71e-2)" "unprognostic (2.70e-1)" "unprognostic (3.22e-1)" "unprognostic (1.73e-3)" 1.4 0.0 24.3 0.0 23.4 0.0 25.1 28.8 34.0 5.1 17.3 0.2 0.0 0.1 8.1 17.5 9.0 9.6 0.0 22.8 25.6 467.9 131.9 0.3 0.1 27.2 33.1 0.0 0.8 0.0 6.9 0.3 35.0 0.5 0.0 0.4 6.1 4.1 0.9 51.8 0.0 0.0 28.8 0.0 0.2 0.1 25.2 1.1 9.6 0.0 0.6 0.1 11.3 27.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 13.7 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.2 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 23.4 28.8 34.0 22.8 25.6 27.2 33.1 35.0 28.8 25.2 27.0 0.1 0.0 0.6 66.3 5.3 8.2 9.0 80.9 0.6 0.0 16.3 11.0 0.0 15.7 18.1 46.0 0.0 0.3 0.2 0.0 223.0 0.7 1.1 10.3 0.1 0.3 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.9 0.0 0.1 0.4 27.9 0.0 0.0 0.8 0.0 12.2 0.6 1.1 1.1 0.0 7.1 1.8 4.7 0.0 13.8 0.0 2.0 0.3 0.1 0.0 0.4 0.0 0.2 0.0 1623.0 9.4 0.4 0.0 0.0 1.4 0.0 0.6 16.9 35.8 0.3 5.0 0.0 0.0 2.6 CCDC34 "L15, NY-REN-41, RAMA3" ENSG00000109881 "Coiled-coil domain containing 34" Q96HJ3 11 27330827-27363234 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.8" "Cell type enhanced" "Detected in many" "Early spermatids: 383.4;Endometrial ciliated cells: 156.1;Spermatocytes: 336.8;Spermatogonia: 218.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-266/84: 159.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037574 Uncertain Approved "Nuclear membrane,Nucleoli fibrillar center" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear membrane, Nucleoli fibrillar center" "HPA037574: AB_10795136" "unprognostic (8.23e-3)" "unprognostic (1.09e-3)" "unprognostic (7.47e-2)" "unprognostic (1.65e-1)" "unprognostic (1.46e-2)" "unprognostic (6.40e-2)" "prognostic unfavorable (1.32e-7)" "unprognostic (9.09e-2)" "unprognostic (1.34e-3)" "prognostic favorable (8.52e-4)" "unprognostic (1.16e-1)" "unprognostic (4.06e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (4.97e-2)" "unprognostic (4.14e-2)" "unprognostic (1.64e-2)" "unprognostic (6.11e-2)" 3.8 5.3 16.1 5.6 15.9 13.7 11.2 13.8 32.8 4.4 16.7 8.8 10.7 4.9 11.3 5.5 12.5 3.4 3.4 15.9 15.4 5.0 4.6 2.3 6.5 15.2 14.9 9.7 4.3 8.1 5.5 5.1 15.4 5.4 10.1 6.2 4.1 4.3 3.1 6.5 8.9 3.5 14.3 4.4 9.3 48.8 15.9 15.8 5.6 3.4 8.8 3.3 3.5 14.8 46.1 50.4 41.6 44.7 7.5 17.6 30.8 29.5 11.1 29.8 28.8 28.2 8.3 49.4 20.2 15.8 42.7 40.2 41.9 18.2 54.3 19.5 58.2 39.4 62.6 74.1 3.8 40.6 15.4 5.7 13.4 26.0 12.5 13.2 23.3 70.1 39.0 15.9 32.1 32.6 79.3 63.1 42.9 31.4 44.1 74.8 152.8 7.4 12.8 15.2 32.2 42.2 44.0 19.5 20.8 23.4 52.8 21.4 11.1 47.8 45.2 91.3 69.4 153.2 159.4 34.8 44.5 2.0 42.7 0.0 0.2 0.4 3.1 1.0 3.7 3.4 3.9 4.2 1.0 4.0 4.5 2.8 0.0 3.7 3.8 2.3 6.7 1.1 16.1 15.9 13.8 32.8 15.9 15.4 15.2 14.9 15.4 14.3 15.9 14.8 5.1 0.0 1.7 4.9 10.1 22.8 22.9 33.2 13.1 10.3 71.4 73.3 9.2 27.1 20.6 23.9 12.5 45.5 3.4 41.0 19.6 14.1 383.4 156.1 12.5 11.1 21.6 91.3 11.5 12.3 25.1 17.2 31.1 15.3 7.0 30.9 10.0 16.0 22.0 3.3 7.5 40.5 18.3 8.9 8.4 82.4 21.5 5.7 14.2 0.0 4.7 26.6 7.2 1.0 1.2 5.5 12.1 20.7 13.9 10.3 6.2 17.6 101.5 20.6 6.6 11.6 18.3 336.8 218.8 33.2 20.6 16.1 9.1 10.3 71.2 15.5 LGR4 GPR48 ENSG00000205213 "Leucine rich repeat containing G protein-coupled receptor 4" Q9BXB1 11 27365961-27472790 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Differentiation, Immunity, Innate immunity, Spermatogenesis, Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 204.4;Distal enterocytes: 123.3;Glandular and luminal cells: 137.7;Syncytiotrophoblasts: 128.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 83.5;RPTEC TERT1: 100.4;U-2197: 82.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030267, HPA054350" Uncertain Approved "Centriolar satellite" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" "Centriolar satellite" "HPA030267: AB_10610004, HPA054350: " "unprognostic (5.27e-3)" "unprognostic (5.18e-2)" "unprognostic (4.64e-3)" "unprognostic (1.59e-1)" "unprognostic (4.92e-2)" "unprognostic (2.31e-1)" "unprognostic (1.98e-1)" "unprognostic (2.02e-2)" "unprognostic (2.00e-2)" "unprognostic (4.63e-2)" "unprognostic (5.84e-3)" "unprognostic (2.10e-1)" "prognostic favorable (2.00e-7)" "unprognostic (5.01e-1)" "unprognostic (3.59e-1)" "unprognostic (3.54e-2)" "unprognostic (1.76e-1)" 16.4 16.8 10.2 8.1 10.2 2.4 16.1 13.0 9.2 7.5 10.2 36.8 22.6 10.2 13.3 13.7 10.2 9.0 19.4 7.8 10.5 51.5 55.7 3.2 1.5 14.1 10.4 22.9 59.7 6.4 6.8 34.4 12.8 15.4 36.8 44.4 18.1 16.1 14.4 18.3 24.7 13.2 13.4 11.7 31.0 13.9 10.1 4.4 15.2 8.2 3.0 10.1 11.7 18.0 28.3 50.7 49.5 5.7 4.5 3.1 56.0 15.7 14.8 13.8 11.8 7.6 0.5 0.1 10.1 21.2 23.2 45.8 83.5 31.1 23.5 0.2 37.0 15.3 28.4 36.1 1.4 1.6 0.1 4.1 19.5 9.5 21.0 57.0 7.0 0.0 4.5 0.1 5.7 9.0 0.1 2.7 47.9 76.3 20.4 0.2 33.8 3.3 100.4 12.1 0.7 6.0 7.7 45.7 4.6 37.6 15.1 23.4 22.6 10.2 8.2 82.6 14.6 18.9 15.2 0.0 17.3 0.0 6.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 10.2 13.0 9.2 7.8 10.5 14.1 10.4 12.8 13.4 10.1 18.0 1.7 3.2 0.5 204.4 1.4 30.3 13.5 33.1 38.7 18.6 17.2 14.1 26.6 24.3 15.4 44.1 25.0 55.1 0.4 123.3 3.9 21.4 7.1 75.4 11.5 3.9 16.8 3.4 35.6 50.7 29.2 14.5 43.3 137.7 0.0 78.6 3.6 60.7 8.1 25.2 51.6 47.1 20.3 5.3 5.7 2.2 5.0 1.6 7.2 15.0 2.1 109.8 0.0 36.7 62.1 31.4 48.8 17.0 0.6 11.7 37.9 19.4 14.5 14.8 6.6 6.9 13.0 1.3 1.4 36.8 21.9 128.6 1.8 6.3 55.5 19.7 LIN7C "FLJ11215, LIN-7-C, LIN-7C, MALS-3, VELI3" ENSG00000148943 "Lin-7 homolog C, crumbs cell polarity complex component" Q9NUP9 11 27494418-27506769 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051118 Approved NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" "HPA051118: AB_2681347" "unprognostic (1.46e-3)" "unprognostic (1.54e-2)" "unprognostic (3.65e-1)" "unprognostic (7.57e-3)" "unprognostic (9.65e-2)" "unprognostic (1.68e-1)" "unprognostic (7.04e-2)" "unprognostic (1.33e-1)" "unprognostic (1.04e-1)" "unprognostic (4.26e-2)" "unprognostic (3.14e-2)" "unprognostic (1.59e-1)" "prognostic favorable (1.09e-4)" "unprognostic (5.45e-2)" "unprognostic (1.50e-1)" "unprognostic (3.59e-1)" "unprognostic (1.51e-2)" 9.1 10.7 8.9 7.8 8.9 15.8 8.7 29.7 12.0 7.5 9.1 9.4 11.3 7.9 10.5 10.6 6.4 6.1 5.8 9.7 10.4 12.2 24.1 7.4 7.4 7.5 10.1 8.1 10.2 9.0 6.8 8.2 8.0 9.6 9.6 10.5 9.0 5.8 6.1 11.5 8.9 8.5 9.3 9.2 10.0 4.1 11.5 6.3 14.1 7.3 9.3 7.5 8.0 9.4 9.1 14.0 8.5 15.0 11.6 11.1 12.8 13.5 12.4 12.0 12.7 12.1 5.4 18.6 9.6 17.0 11.4 17.0 12.0 19.3 21.9 15.1 9.9 10.3 27.7 18.8 14.9 21.1 13.3 11.8 18.0 8.2 29.1 15.6 10.7 6.2 16.0 25.1 16.1 9.8 13.5 14.0 12.3 18.5 9.3 7.6 37.2 9.3 16.6 22.3 14.5 11.5 25.9 22.4 11.3 9.4 21.9 11.3 14.7 25.3 19.7 29.7 20.3 14.5 10.2 11.8 20.2 13.6 26.3 17.4 8.1 9.7 5.9 8.6 9.0 6.3 7.0 5.6 7.4 5.7 9.4 7.7 3.3 6.6 9.9 4.3 5.3 7.9 8.9 8.9 29.7 12.0 9.7 10.4 7.5 10.1 8.0 9.3 11.5 9.4 23.8 28.9 13.1 10.7 14.7 41.2 31.5 20.9 21.1 33.1 21.5 16.5 13.4 25.8 21.3 27.6 35.5 16.3 21.8 35.2 33.2 14.1 53.8 21.9 19.2 22.9 48.5 19.3 17.0 20.0 16.1 21.0 25.0 27.3 10.8 23.0 18.2 59.4 18.4 33.7 16.7 38.6 22.4 20.1 24.4 12.9 16.1 17.2 14.2 10.3 16.9 44.6 12.3 10.6 12.6 26.1 25.1 18.4 21.4 44.6 33.7 32.7 15.7 49.0 0.0 27.3 25.7 10.1 10.7 41.5 44.8 19.0 16.6 18.4 33.9 43.7 BDNF ENSG00000176697 "Brain derived neurotrophic factor" P23560 11 27654893-27722058 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 38.5;Bipolar cells: 13.8;Cardiomyocytes: 9.1;Excitatory neurons: 22.3;Smooth muscle cells: 25.8;Theca cells: 9.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 36.6;BJ hTERT+ SV40 Large T+: 28.0;BJ hTERT+ SV40 Large T+ RasG12V: 20.9;HBF TERT88: 26.5;U-138 MG: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009564, HPA031440, HPA056104" Enhanced Supported "Nuclear speckles,Mitochondria" "Secreted to blood" NA Yes 16000000 24000 "Cluster 10: Brain - Neuronal signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 10: Non-specific - Unknown function" "Nuclear speckles, Mitochondria" "CAB009564: AB_2064213, HPA031440: AB_2673883, HPA056104: AB_2683038" "unprognostic (1.25e-2)" "unprognostic (2.84e-1)" "unprognostic (4.35e-2)" "unprognostic (2.54e-2)" "unprognostic (1.01e-2)" "unprognostic (6.82e-2)" "unprognostic (2.39e-2)" "unprognostic (2.21e-1)" "unprognostic (3.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.22e-2)" "unprognostic (2.65e-1)" "unprognostic (3.22e-2)" "unprognostic (3.88e-2)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (2.84e-3)" 0.4 0.5 1.9 0.2 2.4 0.2 0.2 3.3 5.3 0.6 0.1 0.4 0.3 0.2 3.3 0.6 0.1 0.7 3.6 8.2 1.9 0.6 0.1 2.0 0.1 3.3 2.1 0.5 0.4 0.0 1.2 1.6 2.5 2.0 0.1 0.7 0.3 1.8 0.4 0.9 0.1 0.1 0.4 0.1 0.3 0.6 1.6 0.3 1.0 0.0 0.1 2.1 0.6 0.8 2.9 12.2 0.3 0.0 3.7 2.2 0.0 36.6 7.9 28.0 20.9 0.1 4.0 0.0 3.7 11.8 0.5 1.4 0.1 0.2 26.5 0.2 0.1 0.0 3.5 0.0 17.4 0.2 0.2 9.2 4.2 6.8 3.7 18.1 1.3 0.1 0.0 0.1 4.8 0.0 0.0 0.0 4.0 0.1 2.9 0.0 2.0 0.0 4.5 0.0 0.2 1.1 7.8 0.1 0.1 1.7 0.2 0.0 11.0 37.6 6.9 14.4 9.2 0.5 0.1 0.0 14.1 1.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.4 3.3 5.3 8.2 1.9 3.3 2.1 2.5 0.4 1.6 0.8 0.2 38.5 0.5 1.6 0.0 0.6 0.4 0.5 1.8 13.8 0.5 0.9 9.1 0.0 0.4 1.8 4.2 0.4 0.0 0.1 0.0 0.8 1.8 0.3 0.3 0.2 0.0 0.0 22.3 0.0 0.5 6.1 0.0 0.1 1.3 1.9 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.4 1.5 0.3 0.9 1.8 0.0 0.0 0.2 0.0 2.0 2.2 0.2 0.0 0.0 0.0 0.8 0.0 1.5 0.1 1.8 0.0 1.8 25.8 3.7 0.8 2.3 0.0 0.7 0.0 9.3 0.1 0.1 KIF18A "DKFZP434G2226, PPP1R99" ENSG00000121621 "Kinesin family member 18A" Q8NI77 11 28020619-28108156 "Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 8.2;lymphoid tissue: 9.6;testis: 13.7" "Cell type enhanced" "Detected in many" "Early spermatids: 43.1;Spermatocytes: 78.7;Spermatogonia: 28.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 4.1;memory B-cell: 1.0;NK-cell: 1.4;T-reg: 1.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA039312, HPA039484" Approved Supported "Microtubules,Cytokinetic bridge" Yes Yes "Cluster 41: Basophils - Cellular respiration" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Microtubules, Cytokinetic bridge" "HPA039312: AB_10794087, HPA039484: AB_10795252" "unprognostic (3.79e-1)" "unprognostic (2.63e-1)" "unprognostic (7.09e-3)" "unprognostic (3.80e-2)" "unprognostic (6.56e-2)" "unprognostic (1.39e-1)" "unprognostic (1.34e-7)" "unprognostic (2.43e-3)" "unprognostic (2.04e-3)" "unprognostic (1.23e-2)" "unprognostic (1.72e-4)" "unprognostic (4.41e-2)" "unprognostic (0.00e+0)" "unprognostic (7.88e-3)" "unprognostic (1.67e-1)" "unprognostic (1.43e-1)" "unprognostic (2.50e-1)" 0.2 0.1 0.0 1.9 0.1 8.2 0.7 0.0 0.1 0.7 0.1 1.6 1.5 0.5 0.3 1.4 0.3 0.5 0.0 0.1 0.1 0.3 0.3 1.0 4.7 0.1 0.1 0.1 0.1 0.1 0.1 1.5 0.1 0.3 2.0 0.6 0.3 0.4 0.2 1.2 1.4 0.8 0.1 0.7 0.6 13.7 0.2 9.6 1.1 0.1 4.6 0.7 0.5 0.1 27.9 27.4 27.2 19.0 0.9 3.7 9.1 28.3 13.2 44.2 46.0 9.2 11.0 23.3 10.0 14.7 24.1 27.2 23.4 11.1 61.4 23.4 14.2 15.2 17.8 11.8 2.1 22.6 13.4 6.8 1.4 15.5 18.1 7.8 17.2 19.0 24.6 20.0 25.2 14.8 23.1 16.7 13.4 18.0 11.1 17.8 65.0 11.6 12.5 8.0 16.3 12.6 23.7 11.1 7.8 16.5 23.8 6.9 10.1 35.0 27.2 33.2 37.4 7.9 19.8 23.4 21.0 16.5 25.2 4.1 0.0 0.3 0.1 0.2 0.3 1.0 0.4 0.2 0.3 0.4 0.3 0.1 0.0 1.4 0.0 0.3 1.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 1.2 3.2 0.0 0.0 4.7 2.3 1.3 1.4 1.2 0.3 1.3 2.9 0.5 0.0 2.2 0.0 6.2 4.6 2.8 1.9 0.0 0.6 43.1 3.4 2.5 1.1 1.8 15.4 0.2 0.9 7.1 5.4 1.5 3.4 4.5 9.7 1.4 0.0 2.2 0.0 0.1 1.9 0.0 1.6 1.4 8.7 0.6 1.4 0.0 1.0 1.1 0.7 1.0 0.5 0.9 0.5 0.1 0.4 5.1 0.2 0.2 0.6 1.7 1.9 0.0 2.5 1.9 78.7 28.3 4.3 1.0 1.6 3.9 2.7 3.6 0.5 METTL15 "FLJ33979, METT5D1" ENSG00000169519 "Methyltransferase like 15" A6NJ78 11 28108248-28527041 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 130.2;Oligodendrocyte precursor cells: 132.7;Oligodendrocytes: 146.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039885 Approved "Golgi apparatus,Plasma membrane,Actin filaments" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 44: Endometrium - Transcription" "Golgi apparatus, Plasma membrane" "Actin filaments" "HPA039885: AB_2676725" "unprognostic (2.57e-1)" "unprognostic (2.64e-1)" "unprognostic (1.00e-2)" "unprognostic (3.21e-2)" "unprognostic (2.66e-2)" "unprognostic (1.83e-1)" "unprognostic (4.17e-2)" "unprognostic (1.95e-1)" "unprognostic (2.94e-2)" "unprognostic (7.93e-2)" "unprognostic (6.31e-3)" "unprognostic (2.28e-1)" "prognostic favorable (7.95e-5)" "unprognostic (7.77e-2)" "unprognostic (1.38e-1)" "unprognostic (6.58e-2)" "unprognostic (6.84e-3)" 4.3 8.1 4.8 4.1 4.5 2.3 6.2 5.5 5.4 6.1 6.1 7.0 5.1 5.0 5.7 4.6 5.7 4.5 7.7 4.9 5.4 7.7 9.3 4.3 5.3 4.9 4.8 5.9 4.4 7.0 4.2 5.1 5.2 6.3 6.9 7.0 4.5 5.6 8.7 5.1 5.1 4.5 4.5 4.3 5.4 3.3 5.2 5.2 7.6 11.2 5.3 4.4 3.3 6.2 8.8 9.2 9.3 7.1 11.3 18.0 6.5 10.6 8.1 10.6 10.9 6.3 5.9 20.2 6.2 8.8 6.7 7.3 12.3 10.9 20.2 12.5 10.8 6.4 6.5 7.3 12.6 12.1 5.6 10.2 16.0 5.9 15.1 11.5 10.3 6.7 13.7 8.9 12.6 6.0 8.4 7.4 7.2 9.2 6.8 4.5 20.2 7.4 15.8 5.0 8.2 6.7 8.8 7.8 12.7 8.9 15.4 7.4 7.8 9.6 7.4 12.3 9.4 6.0 7.6 11.7 13.5 12.0 10.6 2.1 1.4 3.7 2.2 1.0 2.7 3.6 2.6 2.9 1.7 1.8 2.8 3.6 0.6 4.4 1.2 1.8 3.1 1.5 4.8 4.5 5.5 5.4 4.9 5.4 4.9 4.8 5.2 4.5 5.2 6.2 16.5 12.8 24.3 130.2 21.3 44.0 38.1 37.1 23.9 13.6 21.6 15.0 14.3 14.3 20.3 11.0 18.8 11.3 28.7 18.2 11.7 10.6 34.5 19.6 24.7 15.7 9.6 17.0 96.8 11.8 14.1 23.5 16.3 28.2 5.1 18.1 12.8 15.0 10.4 13.5 93.9 17.6 10.2 14.2 50.7 12.6 10.8 17.9 14.2 105.9 6.1 8.7 19.6 132.7 146.1 9.9 13.3 8.2 21.0 57.2 13.0 14.9 18.9 16.1 6.6 60.7 23.2 17.9 10.0 17.4 35.7 8.5 35.5 21.3 16.2 53.1 KCNA4 "HK1, HPCN2, KCNA4L, Kv1.4" ENSG00000182255 "Potassium voltage-gated channel subfamily A member 4" P22459 11 30009730-30017030 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Cataract, Disease variant, Dystonia, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "adrenal gland: 6.1;brain: 20.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 11.7;Excitatory neurons: 8.2;Horizontal cells: 13.5;Muller glia cells: 6.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 20.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB001977, HPA016422" Approved NA NA "Cluster 65: Brain - Ion transport" "Cluster 62: Horizontal cells - Visual perception" "CAB001977: , HPA016422: AB_1855574" "unprognostic (1.12e-2)" "unprognostic (1.80e-2)" "unprognostic (1.31e-2)" "unprognostic (2.73e-2)" "unprognostic (1.00e-1)" "unprognostic (4.09e-3)" "unprognostic (2.24e-1)" "unprognostic (1.15e-2)" "unprognostic (6.71e-2)" "unprognostic (1.17e-1)" 1.5 6.1 4.7 0.0 20.0 0.0 0.1 0.0 6.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 2.2 4.7 4.4 0.2 0.0 0.7 0.0 1.6 1.7 0.0 0.0 0.0 1.3 0.2 1.3 0.0 0.0 1.9 0.0 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 6.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 20.0 0.0 6.5 4.7 4.4 1.6 1.7 1.3 0.1 6.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 8.2 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 13.5 2.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.4 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FSHB ENSG00000131808 "Follicle stimulating hormone subunit beta" P01225 11 30231014-30235261 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" Hormone "Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 436 "pituitary gland: 239.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB023410, HPA069703" Enhanced "Secreted to blood" NA NA 78000 "Cluster 26: Pituitary gland - Hormone signaling" "CAB023410: AB_324983, HPA069703: AB_2686176" "unprognostic (1.04e-1)" 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 239.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARL14EP "ARF7EP, C11orf46, FLJ38968" ENSG00000152219 "ADP ribosylation factor like GTPase 14 effector protein" Q8N8R7 11 30323104-30338223 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 130.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039634, HPA048127" Approved Supported "Nucleoplasm,Vesicles,Focal adhesion sites,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 66: Spermatocytes - Spermatogenesis" "Vesicles, Focal adhesion sites, Cytosol" Nucleoplasm "HPA039634: AB_2676606, HPA048127: AB_2680277" "prognostic favorable (2.50e-5)" "unprognostic (8.93e-2)" "unprognostic (6.19e-3)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (3.09e-1)" "prognostic unfavorable (5.26e-4)" "unprognostic (2.50e-2)" "unprognostic (6.50e-3)" "unprognostic (5.76e-2)" "unprognostic (8.86e-2)" "unprognostic (1.04e-1)" "unprognostic (8.57e-3)" "unprognostic (1.60e-1)" "unprognostic (3.47e-1)" "unprognostic (4.50e-2)" "prognostic favorable (7.49e-4)" 13.9 22.5 13.5 13.2 15.6 8.0 20.0 15.9 17.3 17.0 14.9 11.8 9.5 18.9 23.2 11.6 16.4 13.1 22.9 15.7 14.2 17.4 19.7 10.9 22.5 12.4 13.3 20.5 12.9 26.1 12.0 11.5 12.1 19.7 10.8 15.9 19.1 19.9 20.6 12.6 9.7 14.5 13.9 20.8 15.7 14.6 13.3 15.6 24.7 20.8 21.4 14.5 8.1 13.8 10.8 15.4 16.9 14.8 27.1 29.2 8.5 20.8 26.0 18.4 20.2 8.5 4.1 43.8 13.9 15.0 20.5 17.8 24.8 17.5 25.9 35.2 30.7 13.3 12.0 15.0 42.6 24.0 14.7 30.5 34.7 8.7 32.8 26.7 20.6 17.9 21.4 23.2 32.5 10.4 21.9 19.6 19.6 24.1 21.3 18.8 41.2 18.0 24.7 14.8 19.2 20.4 16.2 21.4 25.8 15.0 22.8 13.4 18.1 20.8 11.2 41.7 20.1 36.0 21.9 28.5 20.0 14.8 20.4 12.7 19.2 6.4 23.3 20.0 55.5 35.9 28.2 25.9 26.3 28.9 25.7 25.0 3.5 52.9 15.5 18.9 20.3 23.1 13.5 15.6 15.9 17.3 15.7 14.2 12.4 13.3 12.1 13.9 13.3 13.8 27.3 28.9 33.6 14.4 39.7 12.4 46.6 35.1 8.0 34.0 19.9 30.4 68.1 24.3 23.8 25.8 14.6 19.1 29.2 5.9 76.3 27.3 130.1 25.8 41.0 29.2 14.5 13.2 31.1 22.5 12.7 33.4 12.8 19.0 27.8 33.5 15.4 29.8 25.7 32.0 26.4 11.7 32.6 27.1 29.3 66.3 27.4 28.4 26.6 18.7 45.4 36.1 38.1 27.6 19.9 21.9 8.4 25.2 25.4 46.0 9.4 42.1 27.5 32.4 13.1 33.1 29.8 111.4 37.6 13.8 11.1 11.1 29.6 33.0 12.6 28.4 MPPED2 "239FB, C11orf8, D11S302E, dJ1024C24.1, dJ873F21.1, FAM1B, Hs.46638" ENSG00000066382 "Metallophosphoesterase domain containing 2" Q15777 11 30384493-30586872 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 24.5;thyroid gland: 24.6" "Cell type enhanced" "Detected in many" "Astrocytes: 155.7;Cone photoreceptor cells: 285.7;Excitatory neurons: 108.1;Horizontal cells: 82.4;Oligodendrocyte precursor cells: 345.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 21.6;HAP1: 12.2;JURKAT: 10.9;RT4: 9.0;SH-SY5Y: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062575 Approved Nucleoli,Vesicles,Mitochondria NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoli "Vesicles, Mitochondria" "HPA062575: AB_2684797" "unprognostic (9.60e-3)" "unprognostic (6.12e-3)" "unprognostic (3.70e-3)" "unprognostic (4.56e-2)" "unprognostic (5.46e-2)" "unprognostic (5.04e-2)" "unprognostic (1.46e-1)" "unprognostic (2.32e-1)" "unprognostic (1.57e-2)" "unprognostic (1.13e-1)" "unprognostic (7.98e-4)" "unprognostic (6.82e-2)" "unprognostic (2.47e-7)" "unprognostic (3.64e-3)" "unprognostic (2.50e-1)" "unprognostic (2.22e-2)" "unprognostic (2.57e-2)" 2.0 5.2 6.3 0.5 13.3 0.3 4.1 4.7 10.5 24.5 0.9 4.9 0.7 6.4 5.6 0.9 8.9 1.0 3.7 11.9 13.0 9.6 0.4 0.4 0.2 19.6 10.3 0.5 1.6 3.2 11.0 1.6 11.7 12.6 0.6 16.0 10.3 7.4 5.1 0.7 1.0 3.6 4.9 2.3 1.7 1.7 9.5 3.6 24.6 1.5 0.3 3.3 5.1 6.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 12.2 0.0 0.0 0.0 2.6 0.0 0.2 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.9 0.0 0.3 3.5 0.1 0.1 0.0 3.4 0.2 0.0 9.0 0.1 6.5 0.0 0.0 3.6 1.3 1.8 0.0 0.1 0.0 1.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.8 0.0 0.0 0.2 0.1 0.4 0.5 0.0 0.0 0.7 0.0 0.2 0.0 0.1 6.3 13.3 4.7 10.5 11.9 13.0 19.6 10.3 11.7 4.9 9.5 6.8 3.1 0.0 2.2 155.7 1.8 1.0 51.7 2.6 2.8 26.7 3.6 5.2 5.2 0.0 1.0 46.0 285.7 0.3 0.5 0.1 25.4 4.2 2.1 35.6 1.5 6.3 0.0 1.3 108.1 0.0 0.2 2.6 0.0 13.8 5.1 12.1 0.7 0.2 4.1 82.4 56.0 0.3 2.0 22.5 3.6 1.6 0.3 2.7 5.4 13.1 0.5 44.0 0.0 345.8 7.9 0.1 0.1 3.4 0.5 19.3 0.0 3.1 3.0 18.5 0.0 1.2 7.1 0.1 2.1 1.5 1.1 0.5 0.8 0.4 0.0 28.4 DCDC1 "DCDC5, FLJ46154" ENSG00000170959 "Doublecortin domain containing 1" M0R2J8 11 30830369-31369810 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.5;choroid plexus: 10.6" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 20.9;Early spermatids: 39.0;Endometrial ciliated cells: 47.7;Late spermatids: 18.0;Respiratory ciliated cells: 61.6;Rod photoreceptor cells: 19.0;Spermatocytes: 15.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.5" "Low region specificity" "Detected in all" NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.01e-2)" "unprognostic (1.57e-1)" "unprognostic (8.72e-2)" "unprognostic (1.55e-2)" "unprognostic (9.78e-2)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (5.68e-2)" "unprognostic (4.73e-1)" "unprognostic (3.17e-1)" "unprognostic (4.47e-3)" "unprognostic (6.84e-2)" "unprognostic (1.28e-1)" "unprognostic (1.31e-2)" "unprognostic (1.81e-1)" "unprognostic (2.09e-3)" "unprognostic (2.61e-1)" 0.0 0.1 0.9 0.0 1.0 0.0 0.3 0.3 0.4 0.4 10.6 0.0 0.0 0.2 1.7 0.0 4.1 1.8 0.0 2.4 1.3 0.9 2.7 0.4 0.0 4.5 4.5 0.2 1.0 1.1 1.8 0.0 2.7 0.0 0.0 3.6 0.1 0.1 0.0 0.2 0.0 0.0 3.4 0.0 0.0 2.4 1.7 0.0 0.7 0.1 0.0 0.0 0.0 1.3 0.0 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.3 0.4 2.4 1.3 4.5 4.5 2.7 3.4 1.7 1.3 0.2 0.0 1.5 3.3 0.1 0.3 0.3 0.9 0.0 6.0 0.8 0.9 1.0 2.8 4.8 0.0 20.9 0.0 0.0 0.0 0.0 0.9 39.0 47.7 0.8 0.2 0.0 0.0 5.3 0.0 0.0 0.7 0.0 1.7 0.0 0.3 0.0 3.4 0.1 0.0 1.9 0.0 2.0 0.6 0.3 18.0 1.5 0.1 0.0 1.0 0.0 4.6 0.0 1.5 1.4 0.0 0.0 0.4 0.0 0.2 0.0 1.2 61.6 19.0 0.0 0.1 0.7 15.4 4.4 0.0 0.0 0.0 0.1 0.4 0.0 0.1 DNAJC24 "DPH4, JJJ3, ZCSL3" ENSG00000170946 "DnaJ heat shock protein family (Hsp40) member C24" Q6P3W2 11 31369840-31432835 "Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 204.8;Late spermatids: 223.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020025, HPA025237" Approved Approved Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 18: U-2197 - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "HPA020025: AB_1847801, HPA025237: AB_1847802" "unprognostic (2.07e-1)" "unprognostic (3.73e-2)" "unprognostic (2.27e-2)" "unprognostic (9.74e-2)" "unprognostic (3.58e-2)" "unprognostic (1.76e-1)" "unprognostic (1.32e-2)" "unprognostic (3.40e-1)" "unprognostic (2.21e-2)" "unprognostic (1.49e-1)" "unprognostic (3.50e-1)" "unprognostic (1.28e-1)" "unprognostic (3.56e-1)" "unprognostic (2.74e-1)" "unprognostic (9.86e-2)" "unprognostic (1.54e-1)" "unprognostic (1.67e-1)" 7.2 6.3 6.7 5.4 6.7 1.9 6.8 8.5 8.9 4.8 5.8 4.8 4.4 5.9 6.4 5.3 3.1 4.9 11.8 7.0 7.4 6.4 6.0 4.3 6.8 6.7 7.0 4.6 7.3 4.7 4.6 5.0 6.7 5.7 4.4 8.3 5.8 5.9 17.0 8.8 4.5 6.3 6.5 5.8 5.0 4.4 6.9 5.2 6.6 11.3 5.7 5.6 3.4 7.1 4.8 6.4 11.2 8.2 8.7 10.9 4.9 12.7 8.0 7.0 7.3 5.2 4.5 6.3 6.7 8.6 10.4 6.2 6.4 8.2 12.2 14.8 11.9 6.9 10.2 5.3 11.1 14.0 10.9 10.3 10.4 4.3 13.8 10.2 9.5 10.7 13.3 10.9 14.0 5.0 10.8 9.4 5.7 7.0 6.7 6.7 18.8 6.5 10.3 4.5 4.9 6.9 11.0 7.5 11.0 6.3 10.5 9.1 10.0 13.1 8.9 16.3 15.8 13.3 11.3 7.6 19.3 6.6 14.9 4.5 1.0 0.9 2.2 1.8 3.1 1.5 2.2 1.9 0.8 1.6 2.8 2.9 0.7 1.3 1.1 1.6 1.5 1.3 6.7 6.7 8.5 8.9 7.0 7.4 6.7 7.0 6.7 6.5 6.9 7.1 7.5 3.2 7.4 14.0 14.4 12.1 7.0 9.2 6.8 11.9 9.1 7.2 20.3 1.5 9.3 3.7 10.4 8.6 15.5 5.6 3.9 9.1 204.8 6.4 11.0 7.7 7.2 5.2 40.7 9.1 9.4 10.4 7.1 6.3 5.1 5.3 9.3 10.5 8.2 23.5 28.9 5.1 4.1 6.9 10.3 223.9 9.0 8.5 12.4 25.3 7.1 26.2 9.2 41.2 29.9 11.7 6.2 9.4 18.5 7.2 5.2 11.4 4.4 14.6 0.0 9.6 8.3 28.2 18.2 9.5 8.2 6.3 13.5 7.1 5.9 9.1 IMMP1L "FLJ25059, IMMP1" ENSG00000148950 "Inner mitochondrial membrane peptidase subunit 1" Q96LU5 11 31432401-31509645 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038372, HPA058308" Approved Enhanced Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 10: Non-specific - Unknown function" Mitochondria "HPA038372: AB_10669643, HPA058308: AB_2732620" "unprognostic (2.39e-1)" "unprognostic (1.20e-2)" "unprognostic (1.12e-1)" "unprognostic (6.17e-2)" "unprognostic (9.67e-2)" "unprognostic (2.08e-2)" "prognostic unfavorable (7.97e-4)" "unprognostic (7.59e-2)" "unprognostic (4.66e-3)" "unprognostic (5.15e-3)" "prognostic favorable (6.72e-4)" "unprognostic (1.97e-1)" "unprognostic (1.07e-2)" "unprognostic (4.66e-1)" "unprognostic (4.52e-2)" "unprognostic (1.37e-2)" "unprognostic (1.04e-3)" 11.7 15.6 42.8 6.4 43.7 11.1 19.3 45.5 66.4 13.5 41.8 12.7 8.6 11.5 29.8 11.7 10.4 5.1 26.2 42.8 42.3 27.2 18.6 8.9 9.5 42.4 42.0 17.5 16.4 17.9 23.3 6.9 42.3 14.3 10.0 37.7 11.8 14.1 50.0 12.5 9.5 10.7 42.9 10.8 15.1 16.7 43.0 24.8 13.2 42.1 13.1 10.9 12.6 43.5 22.9 26.9 95.6 21.0 14.9 9.9 15.3 19.9 8.7 16.2 11.7 21.0 17.5 20.7 18.7 15.9 32.5 25.8 37.6 28.8 23.8 24.9 52.6 29.4 45.5 32.3 15.8 29.6 19.9 8.0 27.1 8.7 19.2 29.5 17.5 48.8 38.0 23.2 15.9 28.2 48.5 48.9 15.8 114.6 26.3 41.1 72.2 20.6 54.6 26.2 22.5 27.0 32.5 11.6 32.5 61.9 37.1 35.1 2.6 15.3 27.2 16.2 42.2 17.2 58.2 47.5 24.9 24.9 18.5 21.9 3.0 32.2 28.9 3.4 26.3 34.1 25.3 29.5 8.1 32.1 32.0 39.8 0.8 37.3 3.0 40.2 35.4 13.6 42.8 43.7 45.5 66.4 42.8 42.3 42.4 42.0 42.3 42.9 43.0 43.5 29.2 35.3 14.6 30.7 22.4 18.2 26.8 60.5 12.0 30.6 44.6 55.1 56.8 18.6 26.8 60.7 33.3 36.3 17.6 21.7 119.3 17.0 39.8 30.2 16.9 19.4 56.5 47.4 40.6 24.5 32.5 19.7 20.9 33.8 22.7 22.7 18.2 45.0 21.3 43.7 48.0 30.6 52.9 7.7 11.4 10.5 13.4 9.4 8.8 24.4 10.3 85.3 30.9 51.3 60.7 15.8 26.7 20.7 22.0 26.0 18.6 98.4 28.9 38.5 32.9 19.1 51.0 61.6 23.0 19.6 27.3 23.7 24.2 16.2 34.7 26.2 ELP4 "C11orf19, PAXNEB" ENSG00000109911 "Elongator acetyltransferase complex subunit 4" Q96EB1 11 31509755-31790324 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.9" "Cell type enhanced" "Detected in all" "Astrocytes: 153.5;Excitatory neurons: 93.6;Inhibitory neurons: 90.2;Microglial cells: 91.8;Oligodendrocyte precursor cells: 129.2;Oligodendrocytes: 123.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038572, HPA038573" Approved Supported Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm "HPA038572: AB_2676090, HPA038573: AB_2676091" "unprognostic (7.25e-2)" "unprognostic (5.40e-2)" "unprognostic (7.81e-2)" "unprognostic (1.61e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-3)" "unprognostic (1.67e-2)" "unprognostic (1.87e-1)" "unprognostic (6.73e-2)" "unprognostic (8.13e-2)" "unprognostic (1.01e-1)" "unprognostic (5.33e-2)" "unprognostic (1.09e-2)" "unprognostic (2.15e-1)" "unprognostic (1.48e-1)" "unprognostic (8.38e-2)" "unprognostic (3.63e-2)" 7.1 7.2 14.6 7.4 16.4 8.6 6.8 37.9 19.0 7.4 13.3 9.0 4.6 6.8 8.3 9.7 7.3 7.2 10.2 14.0 13.3 10.2 9.6 7.3 9.7 13.6 14.3 7.5 9.4 8.1 5.4 7.8 14.7 6.7 7.7 12.7 6.9 7.4 8.3 9.6 6.5 7.6 13.6 6.4 6.5 8.3 15.2 15.1 6.6 8.3 8.4 7.8 7.3 18.2 13.2 11.2 12.0 14.4 10.9 14.9 4.6 11.5 12.3 16.7 18.4 10.4 11.5 18.0 9.7 10.3 20.9 23.3 16.5 14.4 18.3 15.1 18.3 5.9 13.2 16.0 11.2 12.6 11.2 14.9 8.7 7.2 19.5 13.2 20.4 22.9 27.4 15.7 10.7 20.3 21.4 14.9 6.9 38.9 13.7 12.8 25.7 12.0 25.6 13.0 13.8 6.4 22.3 13.4 10.0 11.7 25.4 18.2 8.2 15.3 13.5 25.3 15.2 6.1 12.9 22.0 10.8 17.6 13.4 5.9 8.0 8.1 6.7 9.2 8.3 9.1 7.6 7.9 9.3 5.9 8.5 7.4 2.1 7.5 9.5 8.3 10.1 6.6 14.6 16.4 37.9 19.0 14.0 13.3 13.6 14.3 14.7 13.6 15.2 18.2 13.9 12.8 10.5 153.5 11.4 8.3 11.0 20.2 6.8 4.9 7.7 8.5 7.7 5.7 14.5 7.3 4.2 20.2 11.4 4.3 29.4 9.1 18.0 11.0 14.0 7.5 6.7 4.6 93.6 11.3 15.6 10.5 4.1 8.3 10.8 12.8 3.9 5.5 11.5 15.2 90.2 6.0 12.2 5.7 2.4 3.6 5.0 8.5 3.6 91.8 7.7 16.5 8.2 129.2 123.4 6.1 3.9 6.4 14.3 2.9 4.0 33.1 8.6 6.1 6.6 8.3 12.9 23.5 10.2 9.4 8.2 18.9 11.4 11.6 6.4 6.9 PAX6 "AN, AN1, AN2, D11S812E, WAGR" ENSG00000007372 "Paired box 6" P26367 11 31784779-31817961 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease variant, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 61.6;retina: 68.9" "Group enriched" "Detected in some" 4 "Horizontal cells: 264.2;Muller glia cells: 462.6" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.1;AN3-CA: 20.1;HEK 293: 18.0;HeLa: 14.9;hTERT-RPE1: 50.6;U-251 MG: 16.5" "Region enhanced" "Detected in all" "cerebellum: 54.3" "Low region specificity" "Detected in all" "HPA030775, CAB034143" Enhanced Supported Enhanced Nucleoplasm NA NA "Cluster 77: Retina - Visual perception" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 5: Muller glia cells - Visual perception" Nucleoplasm "CAB034143: AB_1127044, HPA030775: AB_10601243" "unprognostic (2.89e-1)" "unprognostic (2.98e-2)" "unprognostic (8.34e-2)" "unprognostic (3.85e-2)" "unprognostic (4.42e-2)" "unprognostic (7.82e-2)" "unprognostic (2.76e-1)" "unprognostic (1.91e-1)" "unprognostic (4.24e-3)" "unprognostic (1.68e-1)" "unprognostic (1.20e-2)" "unprognostic (3.91e-1)" "unprognostic (8.96e-2)" "unprognostic (1.32e-1)" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "unprognostic (3.42e-3)" 0.0 0.6 21.7 0.0 22.9 0.2 0.1 61.6 34.1 0.0 16.5 0.2 1.7 0.0 0.6 0.0 0.0 0.0 0.0 23.6 20.7 0.8 0.1 0.0 0.0 22.0 18.1 0.0 9.2 0.0 4.3 0.0 21.7 0.0 0.3 68.9 0.1 0.0 0.8 0.5 0.9 0.0 21.4 0.0 9.4 1.6 19.6 0.4 0.0 0.0 0.1 0.1 0.1 25.8 0.0 0.2 15.1 20.1 4.6 6.6 5.9 0.0 0.0 0.2 0.0 1.3 3.7 0.1 6.3 2.3 9.0 0.4 1.8 0.0 0.3 0.0 18.0 8.9 14.9 8.4 0.0 0.5 0.0 0.1 0.7 0.1 0.5 50.6 0.0 5.2 7.6 0.0 0.2 0.0 3.7 0.6 0.3 0.0 10.1 0.0 7.3 0.1 0.8 0.6 0.7 0.0 0.4 0.1 0.0 0.0 4.7 0.0 0.0 5.3 0.4 0.0 16.5 0.1 0.2 0.1 8.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.7 22.9 61.6 34.1 23.6 20.7 22.0 18.1 21.7 21.4 19.6 25.8 0.2 0.0 0.0 76.7 0.1 0.5 0.0 0.0 0.0 78.8 0.5 0.0 3.8 0.0 0.0 0.0 12.5 0.1 0.1 0.2 0.0 0.0 0.7 0.2 0.5 1.0 74.6 0.0 3.6 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.1 264.2 1.6 3.1 0.0 0.0 0.4 0.6 0.0 0.2 0.0 3.7 0.6 462.6 0.0 3.5 0.6 2.5 1.3 0.0 0.0 0.0 0.1 0.2 0.0 30.6 0.0 0.9 0.5 21.4 7.5 0.0 0.0 0.0 0.1 0.1 0.2 0.0 AL035078.4 ENSG00000285283 "Novel protein" 11 31812391-32104665 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 8.8;lymphoid tissue: 5.7;retina: 7.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 224.4;RH-30: 110.7;RT4: 139.0;TIME: 116.0" HPA038474 Uncertain Supported "Endoplasmic reticulum" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" "Endoplasmic reticulum" "HPA038474: AB_10672595" 1.3 0.0 0.4 5.7 0.7 0.5 0.0 2.5 1.4 0.3 0.0 8.8 0.0 2.3 0.1 2.2 0.7 0.0 0.0 0.4 1.3 0.3 1.6 1.0 0.0 1.5 1.2 1.1 0.0 0.0 0.4 1.1 0.2 0.2 7.4 0.0 0.0 4.1 0.0 1.5 0.2 1.0 0.2 2.1 0.5 0.8 0.3 0.0 0.0 0.5 0.1 1.6 14.7 33.3 4.9 22.6 2.8 0.0 0.6 224.4 40.6 18.6 9.5 11.2 25.0 0.0 46.0 12.7 14.3 7.1 21.8 12.1 14.7 13.1 0.8 13.4 24.1 0.0 0.0 11.3 1.8 0.0 0.0 23.7 6.4 3.8 4.4 0.1 3.7 13.5 0.0 0.2 13.8 0.0 2.6 0.0 0.3 8.7 110.7 2.7 0.0 139.0 12.9 3.7 36.6 1.4 16.3 0.0 13.9 0.5 116.0 62.2 27.3 30.4 64.6 0.0 0.1 0.6 74.6 2.9 24.7 0.0 0.8 0.0 0.3 0.4 0.4 0.2 0.0 0.2 1.0 0.0 0.0 0.1 0.1 0.8 0.3 0.1 0.0 0.4 0.4 0.7 2.5 1.4 0.4 1.3 1.5 1.2 1.1 1.0 0.8 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RCN1 "FLJ37041, PIG20, Rcal, RCN" ENSG00000049449 "Reticulocalbin 1" Q15293 11 32091074-32105722 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "epididymis: 660.2" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 288.2;Muller glia cells: 327.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038474, HPA062104" Approved Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 9400000 "Cluster 39: Non-specific - mRNA processing" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Endoplasmic reticulum" "HPA038474: AB_10672595, HPA062104: AB_2684683" "unprognostic (1.65e-1)" "unprognostic (7.69e-3)" "unprognostic (1.24e-1)" "unprognostic (2.03e-2)" "unprognostic (7.20e-3)" "unprognostic (1.70e-2)" "unprognostic (6.92e-3)" "prognostic unfavorable (7.13e-6)" "unprognostic (8.85e-2)" "unprognostic (1.30e-2)" "unprognostic (2.12e-1)" "unprognostic (9.32e-2)" "prognostic unfavorable (2.70e-13)" "unprognostic (1.78e-2)" "unprognostic (2.04e-1)" "unprognostic (1.14e-1)" "unprognostic (6.93e-3)" 81.8 54.4 26.7 58.3 39.6 8.1 64.6 24.0 28.2 73.9 37.2 54.7 43.4 79.7 660.2 25.7 69.5 50.1 46.0 26.4 37.2 39.2 100.7 50.6 29.2 29.9 27.6 83.6 21.9 62.2 67.3 129.0 29.0 85.6 53.7 48.7 89.9 82.5 32.7 26.8 41.5 79.5 31.8 35.9 40.7 22.5 36.7 19.0 63.4 28.8 23.1 113.1 41.1 31.3 130.0 143.7 335.9 217.4 720.2 548.1 340.4 425.5 501.5 286.6 515.6 123.6 157.2 0.4 293.3 718.4 380.4 157.6 118.0 135.2 450.2 63.9 231.9 28.2 104.7 58.4 519.7 21.7 42.0 780.1 154.8 197.1 215.4 333.7 647.7 60.6 17.4 25.8 342.1 116.0 61.4 50.2 137.2 2.7 143.9 45.1 393.5 39.2 270.1 355.8 82.1 42.6 117.1 26.2 333.1 227.2 171.0 77.5 350.8 417.0 215.8 338.5 364.6 1.0 0.9 1.7 514.2 28.3 224.9 0.3 13.6 0.5 14.9 16.2 11.8 6.2 6.9 12.3 15.2 4.8 5.1 9.5 0.6 10.9 10.3 8.2 2.7 9.3 26.7 39.6 24.0 28.2 26.4 37.2 29.9 27.6 29.0 31.8 36.7 31.3 131.3 54.5 34.8 9.8 11.8 41.6 80.8 78.2 34.1 40.4 47.9 37.5 9.0 42.9 55.1 47.8 12.5 172.6 10.5 14.3 7.9 143.4 210.4 60.7 154.9 112.1 53.2 16.4 8.0 45.7 288.2 152.1 23.0 110.2 12.7 100.3 85.3 61.7 44.2 15.2 5.9 80.9 38.7 17.8 33.9 173.8 80.5 19.9 32.0 8.4 50.3 327.4 19.6 16.6 1.3 39.7 30.8 73.0 38.6 184.9 6.7 14.1 30.4 17.0 26.3 80.8 91.7 17.0 7.2 33.2 28.3 217.0 13.6 55.8 75.3 99.8 WT1 "AWT1, GUD, NPHS4, WAGR, WIT-2" ENSG00000184937 "WT1 transcription factor" P19544 11 32387775-32435564 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 67.6;fallopian tube: 52.3;ovary: 45.8" "Cell type enhanced" "Detected in some" "Collecting duct cells: 20.2;Endometrial stromal cells: 70.1;Endothelial cells: 16.3;Granulosa cells: 9.3;Late spermatids: 9.3" "Cancer enriched" "Detected in many" 14 "ovarian cancer: 55.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 20.7;HMC-1: 29.9;K-562: 19.6;NB-4: 37.2;THP-1: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000327, HPA035717, HPA053848" Enhanced Enhanced Nucleoplasm NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 36: Stromal cells - Cell proliferation" Nucleoplasm "CAB000327: AB_2304486, HPA035717: AB_2674748, HPA053848: AB_2682279" "unprognostic (3.09e-3)" "unprognostic (9.97e-4)" "unprognostic (3.32e-1)" "unprognostic (8.24e-3)" "unprognostic (5.20e-2)" "unprognostic (1.98e-3)" "unprognostic (2.94e-2)" "unprognostic (1.59e-2)" "unprognostic (1.23e-2)" "unprognostic (4.15e-2)" "unprognostic (1.86e-2)" "unprognostic (1.36e-1)" "unprognostic (1.31e-10)" "unprognostic (2.65e-3)" "unprognostic (1.87e-1)" "unprognostic (1.96e-3)" "unprognostic (1.30e-2)" 26.5 0.2 0.0 0.5 0.1 0.0 0.1 0.0 0.1 18.4 0.0 0.7 0.0 67.6 5.3 0.0 52.3 1.3 4.5 0.1 0.0 16.3 0.1 0.8 0.0 0.2 0.1 45.8 0.1 0.0 0.0 1.3 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.1 33.1 0.0 19.0 0.2 24.2 0.0 0.0 0.0 0.0 0.0 0.2 8.4 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 8.4 20.7 0.0 1.2 4.7 10.8 29.9 0.0 0.0 3.4 0.0 0.0 0.0 0.7 19.6 0.0 2.0 0.0 11.2 37.2 0.8 0.0 6.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.9 2.1 19.6 0.2 0.0 3.3 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 20.2 0.0 1.0 0.0 0.0 0.0 0.0 3.6 2.2 70.1 16.3 0.0 0.0 0.1 0.0 0.5 7.3 0.0 1.4 0.0 9.3 1.4 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 9.3 8.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.1 0.0 2.3 0.0 0.0 6.6 0.0 2.0 4.5 1.0 0.0 0.0 0.8 0.5 0.4 0.0 0.1 EIF3M "FLJ29030, GA17, hfl-B5, PCID1, TANGO7" ENSG00000149100 "Eukaryotic translation initiation factor 3 subunit M" Q7L2H7 11 32583798-32606264 "Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031063 Approved Approved Cytosol NA NA 130000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 50: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Cytosol "HPA031063: AB_10602128" "unprognostic (4.40e-2)" "unprognostic (1.47e-1)" "unprognostic (2.64e-2)" "unprognostic (7.16e-2)" "unprognostic (3.18e-1)" "unprognostic (4.10e-2)" "prognostic unfavorable (1.28e-9)" "unprognostic (5.79e-3)" "unprognostic (2.27e-2)" "unprognostic (1.83e-2)" "unprognostic (4.14e-3)" "unprognostic (1.91e-1)" "unprognostic (5.89e-2)" "unprognostic (2.12e-1)" "unprognostic (1.12e-1)" "unprognostic (1.10e-2)" "unprognostic (6.42e-2)" 96.9 105.0 49.5 72.4 53.0 141.4 135.1 51.9 71.6 89.6 51.1 80.6 77.1 96.5 106.6 95.0 146.4 70.8 86.1 52.0 56.1 112.7 108.4 60.1 122.7 52.3 49.5 162.9 131.6 64.7 49.4 79.8 51.5 71.3 98.4 43.3 78.6 82.3 103.1 102.5 60.2 98.3 52.7 71.1 88.0 74.3 51.7 131.2 107.6 82.4 146.6 113.6 79.5 55.9 173.6 219.0 171.0 218.8 222.7 318.2 251.5 176.1 242.7 264.5 255.6 284.5 124.1 445.6 118.1 201.6 226.7 214.1 301.1 319.4 328.2 151.4 372.3 201.2 164.5 303.4 322.1 473.9 276.4 287.4 355.1 178.8 434.6 221.5 301.3 234.6 403.8 151.2 293.8 204.1 238.3 494.4 188.4 230.8 334.2 192.0 430.7 209.9 291.4 321.4 131.3 203.0 125.2 233.5 279.9 187.0 259.3 279.6 142.1 164.6 188.0 353.0 540.2 183.5 248.8 324.0 148.2 284.3 166.1 71.9 211.7 65.7 99.7 189.3 137.6 144.9 136.9 127.3 258.4 117.9 141.1 129.9 24.8 142.3 142.8 154.8 156.5 186.0 49.5 53.0 51.9 71.6 52.0 56.1 52.3 49.5 51.5 52.7 51.7 55.9 82.7 83.3 66.4 19.2 147.5 212.9 256.2 372.8 189.0 44.7 112.9 132.3 41.1 81.5 168.0 60.7 20.9 261.8 127.8 47.1 131.0 187.3 154.9 76.4 168.8 106.3 72.4 148.5 23.8 250.7 284.0 121.9 103.0 104.3 158.4 123.6 98.6 73.3 197.1 10.1 23.5 132.3 156.6 250.6 209.6 55.2 133.9 153.6 110.3 12.2 283.6 70.0 131.8 20.1 21.6 171.8 87.4 120.4 132.4 212.0 86.3 220.6 87.6 42.5 72.3 140.1 254.9 109.4 72.6 159.5 225.0 243.0 154.1 228.3 169.9 252.9 CCDC73 NY-SAR-79 ENSG00000186714 "Coiled-coil domain containing 73" Q6ZRK6 11 32602246-32794658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 3.7" "Group enriched" "Detected in some" 16 "Spermatocytes: 160.3;Spermatogonia: 84.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MOLT-4: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038668, HPA038669" Uncertain NA NA "Cluster 24: B-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA038668: AB_10673292, HPA038669: AB_2676142" "unprognostic (9.41e-3)" "unprognostic (2.46e-2)" "unprognostic (2.36e-1)" "unprognostic (8.65e-2)" "unprognostic (5.79e-2)" "unprognostic (1.14e-2)" "unprognostic (1.89e-1)" "unprognostic (1.73e-4)" "unprognostic (1.74e-1)" "unprognostic (2.02e-2)" "unprognostic (2.10e-2)" "unprognostic (3.27e-2)" "unprognostic (1.62e-5)" "unprognostic (3.87e-1)" "unprognostic (1.02e-1)" "unprognostic (1.68e-1)" "unprognostic (1.20e-3)" 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 3.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 1.8 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 3.2 0.6 2.3 0.1 0.0 0.3 0.2 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.9 0.0 4.8 1.8 0.5 0.6 0.0 0.0 4.5 0.2 0.1 0.2 0.0 0.6 0.0 0.2 0.0 1.1 0.2 0.0 3.9 0.1 0.0 0.0 0.0 4.3 0.6 0.1 0.0 7.5 0.1 0.0 0.0 3.5 1.7 0.3 1.2 0.7 0.3 0.3 0.0 0.9 1.0 0.6 6.6 0.0 0.2 160.3 84.2 0.0 0.0 0.1 0.2 4.3 0.0 0.5 PRRG4 TMG4 ENSG00000135378 "Proline rich and Gla domain 4" Q9BZD6 11 32829927-32858120 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 124.3;Basal squamous epithelial cells: 145.1;Prostatic glandular cells: 153.9;Squamous epithelial cells: 141.8;Suprabasal keratinocytes: 141.5;Urothelial cells: 167.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 5 "neutrophil: 11.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.9" "Cell line enhanced" "Detected in many" "HaCaT: 52.7;hTCEpi: 28.0;SK-BR-3: 22.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA009040, HPA024566" Uncertain Approved "Golgi apparatus" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA009040: AB_1079694, HPA024566: AB_2237712" "unprognostic (3.30e-1)" "unprognostic (3.68e-2)" "unprognostic (1.14e-1)" "unprognostic (6.51e-2)" "unprognostic (2.80e-1)" "unprognostic (1.13e-1)" "unprognostic (3.45e-2)" "unprognostic (2.06e-1)" "unprognostic (4.13e-1)" "unprognostic (3.24e-2)" "unprognostic (2.22e-3)" "unprognostic (3.22e-1)" "unprognostic (2.26e-3)" "unprognostic (3.16e-2)" "unprognostic (1.99e-1)" "unprognostic (2.41e-1)" "unprognostic (1.26e-2)" 1.1 1.6 0.7 2.0 0.9 4.6 7.2 0.7 0.8 7.5 2.1 6.9 7.5 1.4 6.1 23.4 5.4 3.4 1.3 0.7 1.5 13.3 22.6 6.4 1.1 1.1 0.9 0.3 3.9 2.9 2.8 5.8 1.1 6.3 6.3 0.2 10.0 6.0 1.1 20.8 7.4 0.9 0.7 3.0 5.4 0.5 1.0 3.6 5.5 1.4 6.6 6.8 13.7 1.3 13.2 0.4 0.1 0.1 0.3 0.0 5.4 0.1 6.5 1.5 2.6 6.2 12.7 0.1 0.4 0.0 3.3 52.7 1.3 3.2 0.4 0.4 8.7 2.7 1.8 0.4 0.0 0.9 2.4 0.4 28.0 0.5 0.1 2.2 0.0 0.0 0.0 0.7 0.5 5.9 1.1 6.0 0.6 10.7 1.5 0.1 0.0 1.6 9.6 16.5 1.8 0.1 8.8 22.0 2.8 1.6 16.0 12.8 0.1 0.6 0.8 2.9 1.3 5.8 4.3 0.1 1.6 7.5 2.5 0.8 2.3 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.1 11.9 0.2 0.8 0.2 0.1 0.5 0.7 0.9 0.7 0.8 0.7 1.5 1.1 0.9 1.1 0.7 1.0 1.3 4.2 28.9 23.0 1.0 2.8 124.3 92.5 53.6 145.1 0.1 43.0 21.1 1.0 95.8 33.9 47.8 0.0 24.4 1.7 46.8 7.9 31.5 0.7 75.5 7.4 10.2 13.8 2.5 0.3 36.3 16.8 3.6 25.0 81.9 0.0 6.0 8.9 57.1 8.1 1.7 0.3 34.7 24.4 50.0 15.4 0.3 0.3 12.6 12.4 4.7 40.2 0.1 0.0 1.0 0.1 26.4 19.5 1.5 6.9 153.9 48.3 21.4 51.1 0.2 6.6 2.5 8.8 2.4 4.1 141.8 141.5 82.0 2.6 0.2 47.0 167.4 QSER1 FLJ21924 ENSG00000060749 "Glutamine and serine rich 1" Q2KHR3 11 32892811-32993316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005682 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 18: U-2197 - ECM organization" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "HPA005682: AB_1855985" "unprognostic (2.94e-1)" "unprognostic (6.55e-2)" "unprognostic (1.36e-1)" "unprognostic (2.76e-1)" "unprognostic (6.78e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (7.94e-5)" "unprognostic (1.14e-1)" "unprognostic (4.75e-2)" "unprognostic (6.71e-2)" "prognostic unfavorable (5.27e-5)" "unprognostic (6.77e-2)" "prognostic unfavorable (6.87e-4)" "unprognostic (1.80e-2)" "unprognostic (7.20e-2)" "unprognostic (8.12e-2)" "unprognostic (7.96e-2)" 5.4 4.5 5.3 5.5 6.5 4.1 8.9 15.1 5.3 7.5 10.0 5.1 3.5 8.3 6.7 7.6 6.1 5.9 5.9 5.1 5.8 5.5 5.8 4.4 5.5 5.6 5.7 12.7 6.9 6.5 3.9 5.7 5.6 4.6 5.5 7.1 10.0 5.1 4.6 11.8 4.1 6.4 5.7 6.1 5.5 9.0 5.4 8.6 8.8 7.0 6.5 6.3 6.1 6.6 23.4 28.7 32.4 30.5 12.2 23.2 15.7 20.0 17.9 14.0 17.3 24.5 10.8 24.2 12.5 23.9 23.5 29.4 30.9 17.6 30.3 10.7 19.5 22.9 26.7 21.0 9.8 27.7 11.9 11.6 18.9 17.7 29.5 16.8 19.9 14.2 35.2 10.6 22.2 20.5 14.3 10.8 34.1 14.4 17.9 22.5 64.6 10.1 14.5 24.6 16.7 23.9 37.8 19.4 12.3 23.7 20.2 14.3 20.3 34.0 34.2 62.9 44.0 6.8 10.3 22.5 21.9 12.7 22.6 0.0 0.2 0.0 0.2 0.4 0.1 0.5 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.4 0.1 0.4 0.0 0.1 5.3 6.5 15.1 5.3 5.1 5.8 5.6 5.7 5.6 5.7 5.4 6.6 22.0 19.2 13.4 35.6 10.6 27.9 12.0 14.2 35.9 17.7 21.6 18.7 31.0 14.3 15.9 7.3 14.6 12.9 7.7 5.9 3.9 10.6 14.0 9.9 37.0 19.5 0.0 17.7 51.6 12.1 12.2 27.2 15.8 17.1 3.8 39.3 15.7 10.5 14.5 10.1 50.6 11.7 14.2 16.0 16.1 11.0 24.5 19.1 16.0 54.4 15.9 12.9 5.2 50.3 48.6 10.7 9.3 21.1 23.1 15.0 5.3 8.9 12.2 15.0 6.6 37.9 17.8 21.3 20.5 43.1 27.6 4.2 8.4 21.5 13.6 14.3 DEPDC7 ENSG00000121690 "DEP domain containing 7" Q96QD5 11 33015876-33033582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "intestine: 29.0;kidney: 19.6;liver: 74.0;testis: 28.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 34.8;Early spermatids: 153.3;Extravillous trophoblasts: 47.0;Proximal enterocytes: 33.2;Spermatocytes: 42.3" "Cancer enhanced" "Detected in many" "liver cancer: 6.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 6.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 53.7;RH-30: 40.1;SiHa: 37.3;SK-MEL-30: 34.4;U-2197: 34.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA015800 Approved Nucleoplasm,Nucleoli,Cytosol Yes No "Cluster 2: Granulocytes - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoli "Nucleoplasm, Cytosol" "HPA015800: AB_1847610" "unprognostic (2.34e-1)" "unprognostic (5.57e-2)" "unprognostic (1.27e-1)" "unprognostic (2.27e-1)" "unprognostic (2.66e-2)" "unprognostic (7.26e-2)" "prognostic favorable (7.26e-4)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.17e-3)" "unprognostic (8.99e-2)" "unprognostic (1.89e-2)" "unprognostic (9.30e-2)" "unprognostic (8.09e-3)" "unprognostic (2.64e-1)" "unprognostic (2.94e-2)" 0.6 0.8 2.5 1.9 3.2 1.8 0.9 2.9 3.7 2.8 2.7 4.6 24.6 1.0 2.2 4.4 0.9 4.4 1.1 2.6 2.7 19.6 74.0 0.9 0.7 3.2 2.7 1.6 3.8 2.3 0.8 1.5 3.0 1.9 5.1 0.1 2.0 1.5 4.9 6.0 29.0 1.7 2.8 0.3 3.0 28.2 2.7 2.9 0.5 0.9 1.5 1.2 3.4 4.9 9.4 5.2 7.3 3.3 3.8 3.6 4.9 16.2 5.4 9.8 13.0 13.5 0.9 0.0 3.7 16.2 4.5 9.4 10.8 3.8 11.5 0.0 14.9 2.5 16.1 19.3 3.2 9.1 10.9 4.6 5.7 5.7 4.2 5.3 0.0 0.0 6.2 0.0 53.7 1.0 0.0 14.6 4.8 7.7 0.0 0.0 40.1 0.1 3.2 1.3 1.6 4.2 37.3 6.6 34.4 5.1 1.7 4.7 0.0 6.3 10.4 34.1 10.6 0.0 0.0 0.1 2.3 0.0 31.5 4.1 0.5 6.7 0.2 0.1 0.0 0.0 0.4 0.2 3.2 0.0 1.9 2.1 0.0 2.4 0.0 1.2 0.0 0.4 2.5 3.2 2.9 3.7 2.6 2.7 3.2 2.7 3.0 2.8 2.7 4.9 0.2 0.0 0.0 1.0 0.0 34.8 12.8 4.5 12.5 0.0 0.2 0.6 0.1 1.5 0.9 0.0 0.0 0.5 0.5 6.0 3.9 0.9 153.3 0.2 0.2 0.3 3.5 3.2 0.1 0.6 47.0 1.6 0.0 0.1 2.5 0.1 1.4 22.6 3.1 0.0 0.4 2.4 0.0 0.6 9.5 16.3 1.5 1.7 1.8 3.7 1.2 0.0 0.0 3.5 10.4 0.8 0.6 1.2 0.1 2.4 33.2 18.4 0.9 0.0 0.0 4.5 1.4 42.3 6.5 6.6 7.4 1.5 0.7 0.2 2.4 1.6 TCP11L1 FLJ11336 ENSG00000176148 "T-complex 11 like 1" Q9NUJ3 11 33039417-33105943 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005769 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Cluster 41: Basophils - Cellular respiration" "Cluster 10: Brain - Neuronal signaling" "Cluster 20: HeLa - Mitochondria" "Cluster 3: Monocytes - Immune response regulation" Cytosol "Golgi apparatus" "HPA005769: AB_2202398" "unprognostic (5.22e-2)" "unprognostic (1.40e-1)" "unprognostic (3.51e-2)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (3.73e-2)" "unprognostic (4.16e-2)" "unprognostic (1.83e-2)" "unprognostic (6.99e-2)" "unprognostic (9.10e-2)" "unprognostic (1.42e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.39e-5)" "unprognostic (1.36e-1)" "unprognostic (2.01e-1)" "unprognostic (1.39e-1)" "unprognostic (9.50e-3)" 6.3 5.0 5.6 5.5 7.9 7.4 4.5 0.7 7.3 4.8 0.0 6.9 6.1 5.0 3.3 4.9 4.0 8.1 4.7 9.6 7.4 5.9 4.0 4.6 4.9 4.9 8.9 5.3 5.7 4.0 5.0 7.0 8.3 5.0 7.2 6.0 4.9 7.0 3.0 5.4 8.9 8.7 1.0 5.4 4.2 5.6 3.1 7.6 3.2 4.1 5.7 5.8 4.5 7.5 11.9 21.3 10.7 10.2 18.3 20.3 7.2 16.9 14.4 12.8 17.3 11.0 5.6 12.3 4.6 33.1 19.0 18.7 14.5 13.2 18.2 16.1 13.0 8.3 23.1 8.1 12.0 8.2 10.8 16.4 16.2 13.2 25.0 14.6 12.8 17.4 5.2 14.3 32.4 17.6 8.1 3.2 8.0 8.8 8.2 9.4 22.4 2.2 11.6 4.6 9.1 18.3 43.3 27.5 7.9 13.5 7.0 3.4 20.0 22.7 32.5 25.7 18.1 17.5 19.7 13.9 16.5 4.0 18.1 18.6 6.1 8.8 3.4 3.9 3.4 2.1 1.8 3.8 5.9 2.8 1.8 2.4 3.6 4.8 1.1 11.1 5.9 3.5 5.6 7.9 0.7 7.3 9.6 7.4 4.9 8.9 8.3 1.0 3.1 7.5 4.9 9.6 1.1 12.7 5.0 2.3 10.7 4.2 12.0 5.6 1.7 2.0 3.1 2.8 1.8 0.0 4.2 3.8 4.6 3.5 1.9 4.6 11.6 1.8 4.4 4.5 1.8 2.1 22.5 4.0 19.2 6.3 3.1 2.3 4.5 2.4 4.2 1.6 6.8 8.4 23.7 1.2 2.0 5.7 5.2 6.3 1.8 6.9 0.0 18.7 20.2 1.6 8.2 23.1 29.6 5.7 1.6 2.6 11.6 8.9 13.3 5.0 0.7 5.7 0.0 7.0 6.4 10.4 5.4 6.1 2.6 4.7 6.7 2.8 1.4 3.9 CSTF3 CstF-77 ENSG00000176102 "Cleavage stimulation factor subunit 3" Q12996 11 33077188-33162371 "Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039743, HPA040168" Enhanced Enhanced Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA039743: AB_10795682, HPA040168: AB_10794025" "unprognostic (2.38e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.63e-4)" "unprognostic (3.77e-1)" "unprognostic (4.04e-2)" "unprognostic (4.35e-2)" "prognostic unfavorable (8.20e-6)" "unprognostic (1.47e-1)" "unprognostic (1.67e-2)" "unprognostic (6.42e-3)" "unprognostic (9.73e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (4.64e-2)" "unprognostic (1.86e-2)" "unprognostic (1.15e-2)" "unprognostic (1.01e-3)" 13.8 21.2 28.5 20.8 30.9 12.7 19.5 34.7 39.8 24.2 30.5 20.3 19.1 19.8 61.1 26.7 21.2 14.9 17.1 30.0 32.4 28.9 34.6 21.3 26.6 26.3 26.8 25.9 21.1 18.2 57.6 19.1 27.4 30.4 20.0 31.9 20.6 15.0 16.9 26.1 20.2 13.7 26.1 25.5 18.6 32.9 31.1 23.8 29.8 11.8 21.5 22.0 24.7 32.9 45.8 43.3 82.8 56.4 22.0 38.7 59.8 44.2 28.5 48.5 66.2 31.7 34.9 49.3 31.2 28.5 32.4 58.5 73.8 42.9 77.5 52.7 128.3 50.6 109.1 58.2 24.9 66.5 30.9 28.2 30.6 37.6 36.7 39.1 64.4 39.2 67.9 34.2 66.4 32.3 66.8 35.7 40.3 34.6 54.0 52.2 80.5 39.7 54.6 58.2 61.4 34.9 50.9 29.9 37.6 52.7 54.4 44.1 39.5 40.3 49.7 64.5 59.7 32.3 46.8 41.9 47.4 68.9 40.2 4.6 4.8 7.0 5.8 6.9 6.8 6.5 7.2 5.8 7.7 5.0 7.5 7.9 1.9 6.9 8.3 5.7 9.1 3.7 28.5 30.9 34.7 39.8 30.0 32.4 26.3 26.8 27.4 26.1 31.1 32.9 12.8 19.2 18.7 38.5 19.0 18.9 50.6 50.1 10.2 33.3 22.3 19.9 21.8 17.2 43.5 58.8 6.2 63.0 12.7 15.1 62.6 24.3 37.6 31.4 20.7 21.2 31.8 34.9 75.2 16.9 32.0 23.1 15.3 18.9 14.5 29.0 11.0 57.3 28.4 13.5 59.1 30.0 77.3 22.0 21.1 10.3 29.8 17.0 28.4 42.2 28.1 35.7 14.4 62.4 56.9 20.8 18.6 29.7 14.0 33.0 20.6 47.0 68.0 25.2 26.3 26.1 25.4 77.3 57.6 19.1 19.5 33.8 18.3 25.3 29.6 55.6 HIPK3 "DYRK6, FIST3, PKY, YAK1" ENSG00000110422 "Homeodomain interacting protein kinase 3" Q9H422 11 33256672-33357023 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028069 Approved Supported "Nuclear bodies,Cytosol" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "Nuclear bodies" "HPA028069: AB_10601815" "unprognostic (2.41e-3)" "unprognostic (1.02e-1)" "unprognostic (4.61e-1)" "unprognostic (5.74e-2)" "unprognostic (2.09e-1)" "unprognostic (1.78e-2)" "unprognostic (1.63e-1)" "unprognostic (7.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.78e-1)" "unprognostic (2.18e-1)" "unprognostic (2.68e-1)" "unprognostic (3.29e-3)" "unprognostic (7.89e-3)" "unprognostic (1.80e-1)" "unprognostic (1.87e-1)" "unprognostic (2.48e-2)" 57.8 21.5 29.5 25.3 31.5 23.3 35.1 32.9 23.4 27.6 75.9 30.7 16.7 33.1 24.2 30.9 31.7 30.6 53.7 19.9 42.1 38.2 29.8 26.9 22.8 35.5 36.2 27.2 25.8 46.7 12.8 34.7 27.8 23.3 20.6 22.4 22.9 26.1 69.0 22.3 20.2 39.3 34.2 30.6 22.1 18.9 43.1 25.5 33.7 85.3 24.7 32.3 22.4 33.0 19.3 18.0 13.4 15.1 60.5 37.9 12.9 20.0 23.1 15.9 13.3 19.9 13.8 20.7 16.3 24.4 8.0 24.3 10.2 22.2 22.1 30.8 15.8 21.0 20.3 15.2 25.0 22.9 12.8 35.8 42.8 6.1 17.7 16.5 19.4 14.8 6.4 40.4 26.0 10.1 19.2 15.8 3.4 17.3 11.1 25.4 47.3 19.9 26.4 29.4 2.0 11.3 27.1 30.7 18.7 14.2 34.6 41.2 25.8 24.8 16.9 28.9 14.6 21.7 37.2 21.4 11.9 23.5 23.7 10.6 12.7 6.1 4.0 9.4 5.0 2.8 3.6 4.3 14.0 3.3 3.2 4.0 21.1 4.4 11.1 1.7 4.0 5.0 29.5 31.5 32.9 23.4 19.9 42.1 35.5 36.2 27.8 34.2 43.1 33.0 122.2 12.8 44.7 46.0 29.6 66.5 42.8 21.3 39.3 16.2 35.8 25.8 159.9 37.1 32.9 33.1 18.8 18.6 31.2 32.7 5.9 13.0 21.8 76.5 80.5 96.5 37.1 20.6 44.9 24.9 13.4 59.2 23.0 49.0 14.5 24.3 57.5 53.2 30.7 32.0 48.0 28.4 12.2 102.0 76.0 26.1 42.9 68.1 58.7 73.1 69.1 16.2 25.7 45.8 69.1 21.5 21.1 37.6 24.9 52.6 40.7 35.0 65.4 24.9 52.6 83.4 56.4 10.7 8.1 33.4 75.0 15.5 29.8 12.5 25.2 51.2 KIAA1549L "C11orf41, C11orf69, G2, MGC34830" ENSG00000110427 "KIAA1549 like" Q6ZVL6 11 33376108-33674102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "brain: 26.4;parathyroid gland: 33.5" "Group enriched" "Detected in some" 6 "Excitatory neurons: 366.9;Inhibitory neurons: 193.5" "Cancer enhanced" "Detected in many" "melanoma: 4.4" "Group enriched" "Detected in many" 141 "amygdala: 8.6;basal ganglia: 14.9;cerebral cortex: 26.4;hippocampal formation: 12.3;white matter: 7.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "TIME: 42.4;U-138 MG: 53.8;WM-115: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010132, HPA051594" Approved Nucleoplasm,Vesicles NA NA 160000 "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 17: WM-115 - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm Vesicles "HPA010132: AB_1078313, HPA051594: " "unprognostic (3.02e-1)" "unprognostic (1.18e-1)" "unprognostic (2.70e-2)" "unprognostic (1.34e-5)" "unprognostic (2.63e-1)" "unprognostic (7.92e-2)" "unprognostic (2.89e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-2)" "unprognostic (2.59e-4)" "unprognostic (8.88e-2)" "unprognostic (1.44e-1)" "unprognostic (3.62e-3)" "unprognostic (1.08e-3)" "unprognostic (8.46e-2)" "unprognostic (4.04e-1)" "unprognostic (1.09e-1)" 0.2 0.4 8.6 0.2 14.9 0.0 0.7 0.0 26.4 0.1 0.0 0.3 0.0 0.1 0.0 0.7 0.0 0.3 0.1 12.3 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.2 0.3 33.5 0.7 1.1 0.0 0.0 0.1 0.9 0.3 0.0 0.1 1.8 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.1 0.7 0.3 0.2 7.9 0.1 1.9 6.1 0.2 1.0 6.5 0.0 24.7 14.4 3.8 2.1 0.0 0.6 18.7 0.3 21.9 19.2 1.4 0.9 7.3 5.7 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.1 6.4 11.0 13.4 16.9 0.5 0.2 20.5 15.1 0.0 0.2 0.0 1.4 0.0 9.1 0.0 1.6 0.0 0.0 9.6 2.2 2.2 0.3 0.0 6.2 0.2 0.0 0.0 42.4 53.8 11.8 1.3 19.6 0.0 0.0 0.0 14.7 0.0 37.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 14.9 0.0 26.4 12.3 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.2 0.0 0.0 18.3 0.1 2.0 0.6 0.6 0.0 5.6 2.2 2.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 0.8 1.1 0.2 0.1 0.7 0.0 0.0 366.9 0.0 0.2 1.0 0.0 0.6 0.0 0.2 5.0 0.2 0.3 3.3 193.5 0.0 0.0 0.0 0.9 1.2 0.0 0.1 17.8 18.7 0.0 0.1 0.0 40.2 7.2 1.2 0.0 0.4 0.0 1.2 0.0 0.1 0.1 0.4 0.0 0.1 1.8 0.0 1.8 0.6 0.3 0.0 0.0 0.1 0.0 0.7 C11orf91 ENSG00000205177 "Chromosome 11 open reading frame 91" Q3C1V1 11 33698261-33700801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 9.5" "Cell type enhanced" "Detected in some" "Early spermatids: 16.6;Late spermatids: 4.0;Sertoli cells: 6.6;Spermatocytes: 12.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 16.2;hTERT-HME1: 10.0;HUVEC TERT2: 8.2;TIME: 12.6;U-2197: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047064, HPA050487" Uncertain Supported Vesicles NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 66: Spermatocytes - Spermatogenesis" Vesicles "HPA047064: AB_2679920, HPA050487: AB_2681142" "unprognostic (9.22e-3)" "unprognostic (1.51e-2)" "unprognostic (1.76e-1)" "unprognostic (6.60e-2)" "unprognostic (1.62e-2)" "unprognostic (3.63e-2)" "unprognostic (2.31e-1)" "unprognostic (5.68e-3)" "unprognostic (7.41e-2)" "unprognostic (2.97e-2)" "unprognostic (1.99e-2)" "unprognostic (3.01e-1)" "unprognostic (8.33e-2)" "unprognostic (4.06e-2)" "unprognostic (3.95e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" 4.8 0.2 0.3 0.6 0.3 1.0 1.5 1.2 2.0 0.1 0.0 0.4 0.0 0.2 0.1 2.9 0.3 4.7 0.8 0.2 0.5 1.4 0.2 1.1 0.2 0.3 0.5 0.2 1.5 0.0 0.1 0.5 0.6 0.2 0.0 0.2 0.5 0.2 0.5 1.0 0.3 0.8 0.4 0.0 2.1 9.5 0.3 0.2 0.4 0.0 0.4 1.4 0.3 0.6 0.2 0.0 0.2 1.5 0.0 0.0 0.0 1.8 0.0 0.9 0.4 0.3 0.6 0.0 0.1 1.9 0.2 0.7 0.5 16.2 1.3 0.5 0.0 0.0 4.0 0.9 0.3 0.0 0.0 0.0 0.1 1.2 10.0 0.5 8.2 0.2 0.0 2.5 3.9 0.0 0.0 0.3 0.0 0.1 5.0 0.0 0.0 0.0 1.1 2.1 0.0 0.3 0.0 1.6 0.1 0.5 0.0 0.0 12.6 1.2 0.3 10.3 0.3 0.7 0.6 0.0 2.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.2 2.0 0.2 0.5 0.3 0.5 0.6 0.4 0.3 0.6 1.2 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 16.6 0.4 0.2 0.6 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.3 0.1 0.0 6.6 0.1 0.3 12.3 0.4 0.3 0.0 0.1 0.0 0.0 0.0 1.5 AL049629.2 ENSG00000284969 "Novel protein" 11 33698261-33722467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Ductal cells: 9.1;Exocrine glandular cells: 14.4;Pancreatic endocrine cells: 44.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 42.8;HUVEC TERT2: 55.1;TIME: 66.2;U-2197: 57.6" HPA026494 Uncertain Uncertain "Golgi apparatus,Vesicles" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Golgi apparatus, Vesicles" "HPA026494: AB_1846321" 2.5 0.7 1.5 2.3 1.4 1.5 1.1 1.5 1.6 0.5 2.5 0.7 1.4 1.3 1.8 1.2 0.6 2.1 1.1 1.4 1.7 1.6 0.8 1.7 0.3 1.8 2.0 0.6 0.7 1.0 1.5 1.8 0.5 0.7 0.6 2.4 0.7 3.5 0.3 0.3 0.6 1.8 0.5 2.9 1.1 1.8 0.2 0.8 1.1 1.4 2.3 2.1 1.3 3.3 0.2 2.4 3.4 7.9 0.1 18.5 8.4 2.3 2.2 0.1 9.6 0.0 2.3 12.5 1.1 2.2 0.3 42.8 4.0 2.0 0.4 0.3 7.1 0.8 0.8 0.4 1.2 3.0 2.7 1.0 14.7 1.9 55.1 0.3 0.5 7.4 15.4 1.0 1.8 0.8 0.5 1.3 24.8 0.4 1.5 1.3 4.9 2.2 0.0 0.3 2.0 3.4 7.3 0.2 1.0 0.0 66.2 7.0 2.7 57.6 7.4 3.8 3.7 0.3 16.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.5 1.4 1.5 1.6 1.4 1.7 1.8 2.0 1.8 1.8 1.8 2.1 0.5 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.7 0.2 2.1 0.0 0.0 0.0 14.4 0.0 0.2 0.0 1.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.8 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CD59 "16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20" ENSG00000085063 "CD59 molecule (CD59 blood group)" P13987 11 33703010-33736479 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ductal cells: 1445.2;Prostatic glandular cells: 1678.0;Urothelial cells: 1531.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 3747.5;U-2197: 3049.9" "CAB001448, HPA026494" Supported Uncertain "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 58000000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus, Vesicles" "CAB001448: AB_563604, HPA026494: AB_1846321" "unprognostic (2.07e-2)" "prognostic unfavorable (3.81e-5)" "unprognostic (7.40e-2)" "unprognostic (1.14e-2)" "unprognostic (2.11e-2)" "prognostic unfavorable (3.10e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (4.47e-2)" "unprognostic (2.98e-1)" "prognostic unfavorable (2.92e-5)" "unprognostic (1.66e-2)" "prognostic favorable (1.39e-10)" "prognostic unfavorable (9.03e-4)" "unprognostic (1.31e-1)" "unprognostic (1.03e-2)" "unprognostic (3.09e-1)" 517.4 248.3 284.5 209.6 310.8 198.8 555.9 329.0 365.1 305.5 542.2 255.1 120.7 290.7 971.7 478.9 368.1 475.3 608.3 288.2 359.7 577.4 339.8 553.5 148.8 327.9 340.2 228.5 353.6 706.1 250.3 485.6 340.9 256.8 271.4 130.7 693.6 443.2 529.3 282.8 167.9 380.0 330.5 131.8 422.7 127.7 337.0 167.7 308.1 915.0 288.6 550.5 325.5 315.6 297.2 278.4 77.6 212.0 1697.1 1314.9 46.8 1765.7 1778.5 408.9 451.9 129.7 822.1 23.9 291.5 1802.5 475.5 314.0 141.0 1589.9 561.1 475.5 218.2 31.3 846.7 193.1 483.2 183.4 94.8 631.8 387.2 343.3 1550.6 1104.9 2475.5 109.3 207.9 585.9 2575.4 282.7 79.9 70.3 43.5 541.8 1421.8 30.1 232.1 227.8 1304.4 510.0 54.3 79.5 576.2 243.7 298.2 218.0 187.5 18.1 3747.5 838.6 235.5 3049.9 595.9 273.8 558.8 30.4 734.2 1.3 1556.9 164.9 22.3 209.6 50.9 7.9 64.8 63.9 104.9 56.6 95.4 59.6 68.2 41.4 134.3 92.5 4.8 49.9 298.2 53.5 284.5 310.8 329.0 365.1 288.2 359.7 327.9 340.2 340.9 330.5 337.0 315.6 728.0 272.4 247.2 32.3 39.1 286.0 1103.2 951.4 82.0 51.3 434.9 270.0 315.5 444.7 569.7 242.8 33.3 553.5 29.2 344.6 164.4 1445.2 129.4 94.3 91.6 792.6 166.6 206.0 25.1 618.3 407.2 303.5 109.6 115.6 139.4 88.2 585.0 185.7 486.7 47.1 29.9 112.8 722.2 139.4 374.2 61.6 237.3 88.2 1270.0 54.4 161.7 198.3 26.8 32.6 22.2 1195.7 392.2 204.7 149.7 1678.0 41.7 208.2 1042.5 56.2 276.1 159.1 410.7 130.6 31.2 83.7 284.4 836.6 52.4 139.5 104.9 1531.0 FBXO3 "FBA, FBX3" ENSG00000110429 "F-box protein 3" Q9UK99 11 33740939-33774543 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002467 Approved Nucleoplasm,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 18: U-2197 - ECM organization" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA002467: AB_2666602" "unprognostic (1.87e-1)" "unprognostic (2.81e-1)" "unprognostic (6.07e-2)" "unprognostic (1.25e-1)" "unprognostic (3.71e-1)" "unprognostic (1.34e-1)" "unprognostic (2.61e-1)" "unprognostic (8.53e-2)" "unprognostic (5.21e-2)" "unprognostic (2.42e-1)" "unprognostic (1.47e-1)" "unprognostic (7.36e-2)" "prognostic favorable (2.46e-9)" "unprognostic (6.96e-2)" "unprognostic (1.92e-1)" "unprognostic (1.27e-1)" "unprognostic (3.19e-2)" 21.2 24.2 18.1 14.8 21.6 26.9 27.5 20.7 24.6 21.4 19.0 21.4 18.1 24.8 24.2 33.6 23.3 21.5 46.3 20.3 19.8 47.0 42.0 19.7 18.3 16.5 16.8 28.9 27.1 56.8 17.7 16.5 17.5 25.6 23.7 33.9 23.0 25.5 124.1 28.9 20.5 24.5 17.2 19.1 23.5 25.2 19.0 20.4 34.3 98.8 21.4 20.8 22.5 19.0 22.1 19.2 25.8 27.6 30.4 23.8 15.6 25.7 25.6 20.4 25.3 22.1 21.6 14.6 17.7 28.2 25.1 37.2 34.8 33.9 34.1 14.7 48.2 7.5 28.4 18.3 19.4 17.4 16.9 24.2 33.8 14.1 22.3 29.7 27.3 10.6 25.9 28.4 23.2 14.9 13.0 10.2 13.1 49.4 29.5 9.9 57.5 20.8 29.5 27.5 36.3 20.0 36.4 24.8 19.6 24.6 35.8 13.2 25.2 25.2 22.0 35.9 22.0 15.7 22.1 24.5 22.5 13.4 25.4 25.9 11.9 18.0 21.6 11.8 24.4 16.2 25.5 24.6 12.8 20.0 32.1 22.4 12.8 25.1 15.5 6.6 34.3 15.8 18.1 21.6 20.7 24.6 20.3 19.8 16.5 16.8 17.5 17.2 19.0 19.0 33.3 35.3 17.2 31.3 28.9 48.8 64.2 32.0 35.3 56.8 24.5 14.7 42.4 21.5 31.0 25.8 27.1 22.7 28.9 22.6 56.7 49.6 130.8 17.3 19.2 31.7 23.9 32.8 45.1 25.3 28.7 30.7 17.3 21.8 16.5 25.8 32.5 41.0 12.3 57.2 37.9 18.8 54.9 15.0 20.1 51.3 29.8 11.9 28.4 22.5 15.2 46.7 40.2 30.7 40.1 34.9 25.2 27.1 28.3 33.3 23.2 63.6 34.4 52.4 59.2 26.2 37.1 64.2 27.3 43.6 67.5 36.5 32.9 19.4 16.7 50.4 LMO2 "RBTN2, RBTNL1, RHOM2, TTG2" ENSG00000135363 "LIM domain only 2" P25791 11 33858576-33892076 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 109.2;Endothelial cells: 144.6;Erythroid cells: 103.7;Hepatic stellate cells: 167.4;Kupffer cells: 65.0;Microglial cells: 64.6" "Cancer enhanced" "Detected in all" "glioma: 30.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 6 "dendritic cells: 1.9;granulocytes: 1.5;monocytes: 1.7" "Cell line enhanced" "Detected in some" "HEL: 71.8;HL-60: 72.7;K-562: 60.9;NB-4: 27.3;THP-1: 81.6;U-937: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016258, HPA029285, HPA070901, HPA070910" Approved Enhanced Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 32: U-937 - Innate immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "CAB016258: AB_2136572, HPA029285: AB_2672978, HPA070901: , HPA070910: " "unprognostic (1.60e-1)" "unprognostic (1.47e-2)" "unprognostic (6.03e-2)" "unprognostic (1.71e-3)" "unprognostic (1.89e-1)" "unprognostic (1.14e-3)" "prognostic favorable (3.12e-4)" "unprognostic (1.73e-3)" "unprognostic (8.95e-2)" "unprognostic (5.76e-2)" "unprognostic (7.86e-3)" "unprognostic (3.69e-1)" "unprognostic (7.10e-2)" "unprognostic (9.65e-2)" "unprognostic (3.90e-1)" "unprognostic (1.45e-1)" "unprognostic (4.46e-2)" 15.0 5.9 14.9 11.4 13.0 27.7 12.5 14.2 16.6 8.4 13.4 5.0 4.6 6.5 0.7 6.8 8.3 5.4 4.4 14.7 16.0 13.1 2.3 18.2 19.4 19.9 16.3 3.5 2.6 2.3 8.6 6.5 18.5 5.7 1.5 0.6 5.3 2.4 23.4 4.9 6.6 4.8 18.7 19.0 3.9 1.7 19.0 1.8 12.3 4.6 8.4 5.8 7.3 13.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 2.2 1.3 12.8 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.4 71.8 0.0 0.0 0.3 72.7 18.5 0.0 0.0 0.0 0.0 0.0 10.2 0.0 60.9 0.0 0.0 0.3 5.1 27.3 0.9 0.0 0.0 15.3 0.8 0.2 0.0 0.8 4.3 0.0 0.3 0.5 0.1 0.2 0.0 81.6 0.9 0.0 0.2 1.7 0.0 0.0 0.2 0.6 4.7 29.2 0.3 0.6 0.5 1.5 0.0 1.4 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.7 0.0 1.7 0.1 0.0 0.2 14.9 13.0 14.2 16.6 14.7 16.0 19.9 16.3 18.5 18.7 19.0 13.3 109.2 3.2 7.1 8.5 6.6 8.4 7.9 8.0 0.6 1.6 2.8 9.5 2.8 8.6 1.7 5.5 2.1 0.4 1.0 0.8 0.0 3.0 0.5 40.5 11.0 144.6 0.0 103.7 1.3 2.0 3.2 9.8 0.0 39.6 7.6 0.9 167.4 1.7 39.1 0.0 3.8 0.2 2.0 65.0 56.8 1.2 4.1 54.1 10.6 64.6 47.5 1.1 4.1 5.0 1.0 1.0 1.9 0.0 3.0 5.4 0.0 8.8 5.0 2.6 0.0 17.3 3.6 0.3 7.9 0.8 6.0 21.5 1.9 12.4 0.5 25.1 CAPRIN1 "caprin-1, GPIAP1, M11S1, RNG105" ENSG00000135387 "Cell cycle associated protein 1" Q14444 11 34051731-34102610 "Predicted intracellular proteins" Differentiation "Protein synthesis inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 483.0;Late spermatids: 289.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018126, HPA063617" Approved Enhanced Cytosol NA NA 43000 "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" Cytosol "HPA018126: AB_1849929, HPA063617: AB_2685062" "unprognostic (3.79e-1)" "unprognostic (3.85e-2)" "unprognostic (3.51e-3)" "unprognostic (1.12e-1)" "unprognostic (2.28e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (8.67e-8)" "unprognostic (3.79e-1)" "unprognostic (3.12e-2)" "unprognostic (1.13e-1)" "unprognostic (1.93e-3)" "unprognostic (2.90e-1)" "unprognostic (2.87e-2)" "unprognostic (2.55e-1)" "unprognostic (1.37e-2)" "unprognostic (1.22e-1)" "unprognostic (1.22e-1)" 45.2 30.6 26.1 42.2 28.6 70.3 56.8 25.0 30.9 56.8 21.8 48.8 46.0 52.7 30.5 47.1 61.8 41.7 44.9 28.7 28.3 49.9 39.9 43.3 42.9 26.1 26.7 60.5 47.5 59.9 21.6 53.8 27.3 45.7 60.5 58.7 38.6 53.5 45.3 30.3 41.1 66.2 32.3 40.1 42.1 123.0 26.9 77.6 53.3 54.0 62.6 58.9 31.8 36.7 134.7 168.8 245.6 137.2 180.9 182.5 117.5 168.0 175.8 202.4 188.2 154.9 80.8 211.1 104.9 213.9 169.4 173.1 311.9 204.3 244.9 134.7 155.5 174.1 153.3 131.9 109.4 282.0 122.8 164.0 109.2 129.1 236.3 174.7 204.2 153.7 228.1 103.6 211.3 114.5 243.7 55.8 114.8 155.3 150.6 191.8 339.2 93.7 120.4 263.1 155.5 147.7 202.6 101.1 88.8 150.5 183.5 104.4 205.3 172.7 116.4 167.9 190.8 110.9 175.5 238.7 117.2 116.3 191.7 25.0 33.3 13.9 18.8 39.7 27.3 19.4 20.9 23.2 39.0 17.8 21.6 21.1 13.5 30.7 43.4 18.2 28.1 31.0 26.1 28.6 25.0 30.9 28.7 28.3 26.1 26.7 27.3 32.3 26.9 36.7 42.1 35.3 43.5 37.9 46.0 77.8 45.5 51.5 68.9 38.1 63.7 43.9 55.4 24.3 37.2 64.4 18.8 46.7 47.2 46.0 31.3 56.6 483.0 90.0 116.5 52.1 71.8 79.0 37.4 60.1 60.2 54.6 65.7 132.2 17.1 63.1 39.7 46.1 57.2 25.2 38.8 51.1 54.9 75.8 72.3 289.3 47.8 57.9 39.2 37.5 57.0 36.7 35.0 44.2 53.1 71.3 40.4 72.6 83.0 72.7 42.9 47.4 49.5 32.3 39.5 40.4 64.3 201.7 74.8 93.2 72.9 45.8 46.5 53.9 65.5 77.7 NAT10 "FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43" ENSG00000135372 "N-acetyltransferase 10" Q9H0A0 11 34105617-34147670 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035546, HPA057576, HPA071628" Approved Enhanced Nucleoli,Midbody Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoli Midbody "CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426" "unprognostic (3.04e-1)" "unprognostic (9.24e-2)" "unprognostic (2.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (1.07e-4)" "prognostic unfavorable (9.61e-8)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.12e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.83e-5)" "unprognostic (1.24e-1)" "unprognostic (7.18e-2)" "unprognostic (9.55e-2)" "unprognostic (8.69e-2)" 20.6 24.2 16.0 17.3 15.4 20.4 19.6 14.7 17.4 20.1 14.0 17.0 10.2 20.0 13.7 25.7 19.2 9.4 18.4 15.1 15.4 19.5 22.3 14.9 23.4 14.3 13.6 23.1 25.3 16.8 17.5 15.1 14.7 19.4 15.5 16.3 16.7 12.2 24.8 28.9 17.5 15.5 12.6 22.8 18.7 22.0 15.6 19.4 17.2 12.5 27.5 20.3 20.5 16.9 40.0 55.5 29.3 62.0 34.2 30.2 33.6 38.8 28.5 48.4 38.4 62.6 22.6 127.6 28.3 33.0 41.8 59.5 110.5 59.4 59.5 35.9 70.2 58.0 44.5 58.9 31.0 147.3 40.7 31.1 40.0 31.5 88.3 22.8 37.4 60.6 128.6 43.5 40.8 76.0 120.5 65.7 41.9 69.3 65.7 89.3 98.0 53.7 27.8 68.5 43.1 32.6 52.3 54.9 23.6 28.2 55.0 41.0 30.5 42.8 34.0 63.7 72.8 47.0 61.0 120.3 43.3 60.0 43.4 0.7 8.3 2.8 11.7 13.7 15.5 12.2 12.6 13.4 15.5 10.6 12.7 13.2 0.9 15.0 12.9 11.6 12.0 9.1 16.0 15.4 14.7 17.4 15.1 15.4 14.3 13.6 14.7 12.6 15.6 16.9 8.5 6.4 20.7 10.4 12.7 12.2 11.3 6.9 12.5 12.2 8.8 10.2 12.6 7.2 15.1 14.7 12.5 18.1 8.0 5.8 5.9 9.2 6.1 10.1 18.3 10.9 7.2 21.0 22.8 9.6 13.4 14.5 5.6 12.2 5.1 17.3 5.7 7.5 12.0 11.8 21.7 8.9 4.1 5.5 4.4 3.4 9.3 8.5 1.8 6.5 12.9 5.3 7.2 11.6 16.0 8.7 3.5 13.2 9.8 14.8 3.7 5.8 10.6 11.0 13.1 19.6 8.4 20.5 21.6 13.1 13.8 14.4 11.0 19.7 14.3 7.6 ABTB2 "ABTB2A, BTBD22, DKFZP586C1619" ENSG00000166016 "Ankyrin repeat and BTB domain containing 2" Q8N961 11 34150987-34358010 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 126.2;Syncytiotrophoblasts: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "eosinophil: 5.0;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 14 "dendritic cells: 1.6;granulocytes: 5.0" "Cell line enhanced" "Detected in many" "SK-BR-3: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020065, HPA030699" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 70: Brain - Nervous system development" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm Vesicles "HPA020065: AB_1844459, HPA030699: AB_2673576" "unprognostic (3.00e-1)" "prognostic unfavorable (5.70e-5)" "unprognostic (2.61e-1)" "unprognostic (9.09e-2)" "unprognostic (3.17e-2)" "unprognostic (2.40e-2)" "unprognostic (1.34e-1)" "unprognostic (1.23e-2)" "unprognostic (2.04e-1)" "unprognostic (2.09e-1)" "unprognostic (1.24e-3)" "unprognostic (2.86e-1)" "prognostic favorable (3.51e-5)" "unprognostic (1.50e-1)" "unprognostic (1.42e-1)" "unprognostic (3.81e-2)" "unprognostic (6.58e-2)" 2.3 13.0 7.9 2.0 12.6 2.5 2.0 18.1 6.7 8.1 1.2 3.4 8.8 6.1 4.4 4.1 4.6 2.1 12.8 5.3 8.5 9.4 11.6 2.9 2.1 24.1 16.3 2.5 2.3 0.5 3.5 3.2 16.7 4.9 2.5 2.6 6.7 4.3 16.9 6.8 7.0 2.5 12.7 0.9 2.5 2.7 15.9 2.4 2.0 7.2 2.0 3.6 5.6 20.3 5.6 16.2 6.4 1.8 1.7 0.1 6.4 3.2 2.5 2.8 5.3 4.0 4.0 0.2 5.3 4.1 16.5 10.5 3.6 3.7 2.3 0.2 8.8 0.1 9.8 17.4 1.0 8.9 1.2 0.9 2.0 5.6 2.4 10.1 0.0 0.7 1.9 0.5 1.8 13.8 0.3 10.7 8.0 8.1 8.8 1.7 3.8 6.3 10.0 13.0 8.1 6.6 8.1 24.6 6.5 4.2 5.3 3.8 0.9 3.1 0.5 9.8 5.8 0.9 0.4 0.1 7.1 2.5 9.7 0.0 0.1 5.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 7.9 12.6 18.1 6.7 5.3 8.5 24.1 16.3 16.7 12.7 15.9 20.3 0.7 0.0 2.3 18.9 1.1 4.7 3.2 1.3 1.2 2.1 3.0 3.3 10.0 2.8 1.1 12.9 0.0 2.7 2.5 12.2 5.9 4.6 1.2 3.4 4.5 0.9 7.2 0.0 4.0 4.5 1.1 5.8 4.6 10.7 1.3 0.3 0.0 6.8 0.8 0.0 8.9 2.3 4.1 0.8 6.1 0.3 1.2 1.2 1.8 6.5 9.3 7.5 0.0 50.3 126.2 10.5 9.1 6.0 2.1 9.3 15.5 2.0 0.3 0.6 0.0 4.3 2.4 0.5 1.1 1.0 4.8 28.3 2.9 0.4 2.9 7.5 CAT ENSG00000121691 Catalase P04040 11 34438934-34472060 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrogen peroxide" "Mitogen, Oxidoreductase, Peroxidase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 1217.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 722.4;Hepatocytes: 443.4;Proximal tubular cells: 333.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 13 "eosinophil: 4736.8" "Lineage enriched" "Detected in all" 13 "granulocytes: 4736.8" "Cell line enhanced" "Detected in many" "HL-60: 391.4;THP-1: 321.2;U-937: 265.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001515, HPA051282, HPA055838" Enhanced Enhanced Vesicles NA NA 760000000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 32: U-937 - Innate immune response" "Cluster 6: Erythroid cells - Oxygen transport" Vesicles "CAB001515: AB_384710, HPA051282: AB_2681419, HPA055838: AB_2682937" "unprognostic (3.62e-2)" "unprognostic (2.72e-1)" "unprognostic (3.59e-3)" "unprognostic (5.43e-2)" "unprognostic (4.44e-2)" "unprognostic (5.80e-3)" "prognostic favorable (9.67e-4)" "unprognostic (9.95e-3)" "unprognostic (3.22e-1)" "unprognostic (7.23e-2)" "unprognostic (3.34e-2)" "unprognostic (9.77e-2)" "prognostic favorable (1.96e-8)" "unprognostic (1.01e-1)" "unprognostic (7.31e-2)" "unprognostic (4.77e-2)" "unprognostic (6.59e-3)" 281.3 115.1 27.1 52.1 29.6 407.7 123.6 27.9 35.5 82.0 39.4 82.6 145.1 53.1 34.8 40.1 86.8 59.8 58.1 26.6 29.4 296.6 1217.3 163.2 58.4 35.2 29.4 46.7 86.3 43.2 13.6 78.0 34.3 66.8 71.3 9.8 83.7 64.0 103.8 70.6 136.3 59.4 29.6 78.6 74.1 11.4 29.5 74.9 122.6 136.6 56.7 105.8 39.9 40.8 31.7 34.3 24.5 38.9 233.2 100.6 52.3 39.3 49.8 43.3 47.1 19.7 30.9 78.3 37.5 79.2 63.9 73.9 42.3 42.9 47.3 68.8 38.8 65.6 34.0 113.7 27.6 391.4 31.1 54.5 29.3 13.2 5.1 59.9 53.2 46.2 139.3 31.3 55.1 30.2 81.1 77.4 0.1 148.7 82.6 56.5 117.9 64.9 120.2 117.2 13.1 19.8 44.5 70.6 60.0 0.0 101.4 321.2 38.3 25.9 24.9 65.4 23.8 25.0 15.2 16.8 51.3 265.6 19.3 256.5 324.7 4736.8 54.4 265.1 64.6 133.9 63.7 61.0 353.5 124.1 61.7 66.7 290.2 105.7 298.5 235.8 92.7 397.9 27.1 29.6 27.9 35.5 26.6 29.4 35.2 29.4 34.3 29.6 29.5 40.8 196.9 227.6 275.9 41.1 53.8 28.9 93.7 44.9 27.9 13.5 42.6 36.1 44.9 82.9 66.9 73.5 27.1 96.8 92.0 59.4 225.0 36.0 2.7 72.2 41.4 43.8 48.0 722.4 12.6 26.2 30.0 53.1 54.6 29.3 24.0 38.7 57.1 443.4 138.5 0.0 1.2 56.9 91.6 125.5 95.8 6.2 78.3 93.9 26.6 16.9 253.4 19.5 28.8 22.6 45.6 15.3 44.8 77.5 25.4 37.0 151.6 333.2 96.9 19.4 78.9 46.6 68.0 6.3 11.3 24.4 27.1 40.5 37.7 57.7 95.6 97.5 ELF5 ENSG00000135374 "E74 like ETS transcription factor 5" Q9UKW6 11 34478791-34525193 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 151.2;salivary gland: 147.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 40.3;Breast glandular cells: 143.2;Breast myoepithelial cells: 57.1;Collecting duct cells: 101.2;Cytotrophoblasts: 26.9" "Cancer enhanced" "Detected in many" "breast cancer: 8.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "RT4: 30.2;T-47d: 56.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA062706 Approved Nucleoplasm NA NA "Cluster 24: Salivary gland - Salivary secretion" "Cluster 6: T47d - Mammary gland" "Cluster 30: Mammary glandular cells - Lactation" Nucleoplasm "HPA062706: AB_2684841" "unprognostic (1.13e-1)" "unprognostic (1.48e-1)" "unprognostic (7.55e-2)" "unprognostic (3.31e-2)" "unprognostic (2.41e-4)" "unprognostic (6.90e-2)" "unprognostic (3.93e-1)" "prognostic favorable (3.64e-4)" "unprognostic (1.12e-1)" "unprognostic (3.40e-2)" "unprognostic (8.15e-2)" "unprognostic (3.15e-2)" "unprognostic (1.78e-3)" "unprognostic (3.09e-1)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (2.86e-1)" 0.2 0.0 0.1 0.0 0.1 0.2 151.2 0.2 0.2 0.9 0.4 0.0 2.1 0.0 0.0 1.3 0.1 0.2 0.0 0.1 0.0 17.0 0.2 7.5 0.0 0.0 0.1 0.0 0.5 0.0 0.0 1.4 0.0 2.5 0.0 0.0 147.6 30.4 0.0 6.2 0.0 0.0 0.0 1.1 0.6 0.2 0.1 0.5 0.0 0.0 2.5 5.7 2.3 0.2 0.1 0.0 0.0 0.1 0.0 0.5 3.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 30.2 0.0 0.0 0.0 5.1 0.0 0.1 56.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 1.0 3.2 40.3 0.0 1.1 0.3 1.9 0.9 0.0 0.0 143.2 57.1 0.4 0.0 9.7 101.2 0.0 26.9 1.4 0.0 0.0 0.0 0.2 0.1 0.1 0.8 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.0 1.9 0.4 0.1 0.0 0.5 17.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.4 4.8 0.0 0.0 0.2 0.9 2.5 0.2 0.0 0.1 11.5 0.6 0.0 0.0 6.5 EHF "ESE3, ESEJ" ENSG00000135373 "ETS homologous factor" Q9NZC4 11 34621093-34663288 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 287.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 400.8;Basal respiratory cells: 271.6;Club cells: 323.3;Endometrial ciliated cells: 229.6;Glandular and luminal cells: 281.8;Squamous epithelial cells: 251.1;Urothelial cells: 397.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 11 "myeloid DC: 1.7" "Lineage enriched" "Detected in single" 11 "dendritic cells: 1.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 138.4;HaCaT: 95.7;HBEC3-KT: 107.6;OE19: 132.9;RT4: 214.8;T-47d: 213.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA050923, HPA060734" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" No NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "Golgi apparatus" "HPA050923: AB_2681275, HPA060734: AB_2684351" "unprognostic (1.06e-2)" "unprognostic (1.06e-1)" "prognostic favorable (5.81e-4)" "unprognostic (2.82e-1)" "unprognostic (5.62e-2)" "unprognostic (1.22e-3)" "unprognostic (2.44e-1)" "unprognostic (2.04e-1)" "unprognostic (1.38e-1)" "unprognostic (6.79e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (1.29e-1)" "unprognostic (6.26e-2)" "unprognostic (3.47e-3)" "unprognostic (2.24e-1)" "unprognostic (2.89e-1)" "unprognostic (7.08e-2)" 0.9 1.1 0.9 14.7 1.7 0.2 199.5 0.9 0.6 120.8 1.3 99.3 42.2 13.9 95.0 200.7 129.6 32.2 0.3 1.1 0.8 25.7 1.3 23.4 1.5 2.6 4.0 0.2 41.1 18.5 0.7 0.1 2.8 82.7 126.3 0.8 287.7 153.4 0.2 53.6 34.1 3.5 2.5 1.2 59.5 0.7 1.3 1.3 2.5 0.0 67.3 50.7 79.2 4.7 46.5 26.8 0.0 0.3 0.0 0.0 0.8 0.0 3.9 0.0 0.2 0.4 138.4 0.1 17.1 0.0 0.2 95.7 0.0 107.6 0.5 0.1 0.2 0.0 1.5 0.2 0.0 0.2 0.0 0.0 41.7 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.1 2.6 0.1 0.8 0.2 132.9 1.0 0.0 0.1 1.0 20.2 214.8 0.0 0.2 0.5 14.8 0.2 0.0 213.5 0.5 0.0 0.2 1.2 5.1 0.4 0.5 0.2 0.3 0.3 0.2 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 0.9 0.6 1.1 0.8 2.6 4.0 2.8 2.5 1.3 4.7 0.8 48.1 97.2 1.3 0.6 109.6 400.8 271.6 133.1 0.0 123.0 51.9 0.9 60.1 323.3 55.2 0.0 0.1 1.1 62.7 15.6 77.8 14.2 229.6 17.7 4.0 23.3 0.0 0.7 86.5 0.0 3.2 53.5 281.8 1.3 0.0 0.0 0.4 0.1 0.0 0.0 82.8 116.0 0.0 17.7 1.0 0.0 5.1 12.4 0.0 5.6 3.8 0.0 0.0 2.4 104.8 30.2 0.0 1.2 173.1 14.1 0.3 204.6 0.0 0.0 0.0 9.6 0.4 0.1 251.1 170.1 1.4 4.9 0.0 74.5 397.3 APIP "APIP2, CGI-29, Mmrp19" ENSG00000149089 "APAF1 interacting protein" Q96GX9 11 34853094-34916379 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Apoptosis, Methionine biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 187.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021188, HPA024131" Approved Approved Nucleoplasm,Cytosol NA NA 52000 "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 30: Mammary glandular cells - Lactation" Nucleoplasm Cytosol "HPA021188: AB_10610977, HPA024131: AB_10602171" "unprognostic (2.80e-1)" "unprognostic (7.68e-2)" "unprognostic (5.30e-2)" "unprognostic (3.68e-3)" "unprognostic (4.22e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (2.74e-2)" "unprognostic (3.84e-2)" "unprognostic (9.16e-2)" "unprognostic (2.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-1)" "unprognostic (3.23e-1)" "unprognostic (5.48e-2)" "unprognostic (7.44e-2)" "unprognostic (1.58e-2)" 30.4 25.4 14.7 20.7 17.1 14.4 20.7 17.3 17.1 18.0 14.2 19.9 13.6 15.0 15.0 13.8 17.2 18.5 20.0 13.9 16.3 27.0 19.4 21.2 20.2 18.7 16.4 12.3 17.2 15.8 9.1 13.3 18.4 16.8 19.5 16.8 31.7 23.6 65.6 10.0 16.3 12.3 17.1 15.5 18.8 10.7 16.0 31.3 24.6 38.3 16.3 19.1 9.6 20.9 25.1 27.3 33.5 8.3 27.7 26.8 14.5 36.8 38.0 38.9 44.4 15.6 21.3 77.1 21.7 15.5 40.3 28.8 56.1 24.9 53.3 49.9 56.3 39.5 27.8 42.6 41.2 111.3 28.9 23.6 20.6 22.1 40.7 19.1 29.8 49.8 94.2 45.2 27.6 24.2 59.7 57.7 25.1 39.6 61.7 36.4 89.1 29.6 46.8 36.3 28.5 13.6 45.0 37.2 50.2 17.4 38.9 34.3 24.1 29.2 26.9 68.1 9.0 43.9 36.1 89.4 32.2 27.3 37.2 11.3 27.3 25.4 17.2 30.0 21.3 24.5 21.1 18.8 42.7 24.3 21.4 18.3 6.7 31.4 36.8 27.2 27.2 18.4 14.7 17.1 17.3 17.1 13.9 16.3 18.7 16.4 18.4 17.1 16.0 20.9 24.7 35.3 30.1 42.4 27.9 25.0 37.5 62.7 19.4 28.8 73.8 36.2 23.1 37.1 63.0 18.4 4.2 37.2 25.5 49.5 187.9 30.2 8.0 33.4 23.9 22.8 35.5 42.5 28.4 32.4 23.4 24.4 29.6 24.8 20.3 22.0 21.0 26.0 76.5 18.5 35.2 41.3 87.5 47.1 31.8 8.3 23.9 47.6 21.4 17.8 59.4 23.1 25.7 51.3 108.8 25.4 28.4 24.8 44.2 33.0 35.0 101.7 56.8 21.6 39.5 37.8 30.1 32.4 22.3 31.4 26.3 26.4 25.8 27.1 50.1 50.4 PDHX "DLDBP, E3BP, OPDX, PDX1, proX" ENSG00000110435 "Pyruvate dehydrogenase complex component X" O00330 11 34915829-35020591 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 138.6;tongue: 125.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 115.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038484, HPA038485" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Plasma membrane" Mitochondria "HPA038484: AB_10669645, HPA038485: AB_10669540" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (1.42e-2)" "unprognostic (1.06e-1)" "unprognostic (2.03e-1)" "unprognostic (8.34e-3)" "unprognostic (3.56e-3)" "unprognostic (1.94e-1)" "unprognostic (2.14e-1)" "unprognostic (5.41e-2)" "unprognostic (2.60e-2)" "unprognostic (2.08e-1)" "prognostic favorable (1.83e-5)" "unprognostic (2.24e-1)" "unprognostic (8.28e-2)" "unprognostic (9.53e-2)" "unprognostic (2.82e-1)" 23.5 21.6 16.5 12.2 19.9 7.4 16.6 21.6 21.9 13.3 9.4 22.8 20.1 14.2 13.3 17.2 10.0 12.3 77.8 21.1 14.5 21.5 31.0 12.7 11.9 16.6 17.2 11.7 21.5 21.0 15.4 24.4 16.5 18.9 20.6 27.1 20.4 16.0 138.6 14.6 15.0 17.8 13.4 11.1 23.1 27.8 19.7 13.2 14.3 125.2 14.8 15.0 11.7 21.1 20.4 54.3 29.9 11.9 20.7 25.5 28.5 38.9 30.1 40.3 38.9 69.3 18.8 27.2 24.7 31.4 49.1 39.4 58.9 31.9 41.1 25.8 47.2 26.9 54.6 82.3 45.0 50.7 30.7 25.6 37.9 23.2 31.5 23.8 31.1 23.9 57.9 25.4 33.1 35.7 32.2 29.9 25.2 54.2 30.5 27.0 53.5 23.8 62.1 54.7 32.0 23.3 33.8 48.1 52.2 29.3 54.8 29.9 21.0 30.4 35.5 32.3 42.7 24.4 53.3 35.7 23.9 24.2 32.5 14.0 19.4 17.5 15.4 21.4 14.3 18.8 14.4 12.7 27.5 16.0 17.2 12.6 3.9 22.1 34.6 7.4 22.1 14.7 16.5 19.9 21.6 21.9 21.1 14.5 16.6 17.2 16.5 13.4 19.7 21.1 9.0 35.3 24.6 34.3 14.5 26.0 21.4 26.7 15.4 25.8 15.1 11.4 115.3 20.0 26.0 5.5 29.2 62.9 9.0 14.4 64.6 21.4 52.6 15.1 12.2 13.0 9.0 13.5 85.4 14.3 34.9 20.6 16.3 16.6 5.7 16.5 11.7 23.6 26.4 20.2 80.3 17.2 42.7 18.6 13.6 54.0 10.8 14.7 21.4 24.4 23.2 21.0 9.2 40.2 53.4 16.7 15.9 13.5 14.1 22.4 15.0 30.7 19.8 26.7 0.0 14.5 18.8 57.2 36.1 17.9 25.4 83.0 13.4 27.5 20.0 19.7 CD44 "CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1" ENSG00000026508 "CD44 molecule (Indian blood group)" P16070 11 35138882-35232402 "Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Blood group antigen, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 504.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 999.7;Ductal cells: 992.1;Exocrine glandular cells: 869.6;Langerhans cells: 1934.2;Suprabasal keratinocytes: 1024.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 1650.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000112, CAB000316, HPA005785" Enhanced Supported "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA 1200000000 "Cluster 39: Non-specific - mRNA processing" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 1: Pancreatic cells - Digestion" "Plasma membrane" "Golgi apparatus" "CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467" "unprognostic (5.33e-2)" "unprognostic (1.85e-1)" "unprognostic (4.97e-2)" "unprognostic (9.90e-3)" "unprognostic (3.50e-3)" "unprognostic (1.46e-2)" "unprognostic (1.56e-2)" "unprognostic (8.12e-2)" "unprognostic (1.57e-1)" "unprognostic (4.18e-2)" "unprognostic (1.51e-3)" "unprognostic (4.63e-2)" "prognostic unfavorable (1.78e-8)" "unprognostic (6.41e-2)" "unprognostic (4.14e-2)" "unprognostic (3.93e-2)" "unprognostic (7.98e-2)" 143.7 42.4 29.2 218.0 33.9 308.1 164.7 63.0 25.1 146.0 16.8 91.1 53.0 200.4 20.1 227.8 69.0 129.7 30.4 33.0 116.5 31.3 31.0 214.1 108.8 114.9 102.3 11.7 263.2 6.0 8.1 74.1 118.3 87.3 111.5 38.0 504.2 57.0 17.1 433.3 60.8 175.8 114.3 83.8 61.5 6.6 62.8 64.2 76.2 27.7 188.7 235.2 193.4 114.9 493.0 448.6 4.3 1.2 252.6 691.5 1.6 962.2 740.3 521.3 288.2 30.4 150.4 0.7 126.5 1350.2 1065.4 820.1 9.9 1013.9 716.4 110.3 6.2 18.9 198.3 0.3 262.3 254.6 1124.3 315.4 778.3 693.2 552.7 1650.0 184.3 0.1 4.0 157.9 518.9 3.0 25.6 166.9 9.8 8.7 136.4 1.4 89.3 7.5 777.4 138.1 2.0 1.4 185.2 5.5 462.8 38.6 25.7 15.1 547.3 646.6 120.0 815.8 1006.0 281.6 327.7 3.7 980.4 145.1 969.8 127.4 403.0 35.4 140.6 257.8 196.5 122.5 210.1 186.5 229.0 90.0 179.7 153.6 92.6 322.3 356.1 79.9 309.7 437.3 29.2 33.9 63.0 25.1 33.0 116.5 114.9 102.3 118.3 114.3 62.8 114.9 41.0 96.1 361.8 54.5 250.1 999.7 297.7 335.3 228.2 0.6 139.6 71.2 8.6 27.1 125.6 20.2 2.1 4.5 257.0 14.0 1.9 992.1 41.3 43.6 395.4 50.9 100.1 94.4 0.4 869.6 3.6 282.2 39.8 196.9 763.2 25.2 13.2 3.6 226.6 0.0 0.4 93.3 30.5 474.3 1934.2 24.3 22.4 523.9 604.7 8.4 594.2 29.6 62.8 0.5 11.2 813.1 10.9 0.4 216.3 386.7 6.0 1.6 18.8 2.0 157.8 197.2 227.9 0.4 0.4 279.3 1024.9 17.9 430.8 1.0 79.1 330.7 SLC1A2 "EAAT2, GLT-1" ENSG00000110436 "Solute carrier family 1 member 2" P43004 11 35251205-35420063 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 782.3;choroid plexus: 202.7" "Cell type enriched" "Detected in many" 7 "Astrocytes: 4607.2" "Cancer enriched" "Detected in some" 5 "glioma: 28.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.1;BJ hTERT+: 2.4;fHDF/TERT166: 1.7;Hep G2: 2.9;NTERA-2: 3.1;SCLC-21H: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002574, HPA009172, HPA067499" Enhanced NA NA "Cluster 17: Basophils - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 64: Astrocytes - Nervous system maintenance" "CAB002574: AB_564087, HPA009172: AB_1849764, HPA067499: " "unprognostic (8.00e-2)" "unprognostic (5.71e-3)" "unprognostic (1.39e-1)" "unprognostic (2.77e-2)" "unprognostic (1.33e-1)" "unprognostic (5.65e-3)" "unprognostic (1.39e-2)" "unprognostic (9.27e-3)" "unprognostic (1.55e-1)" "unprognostic (1.65e-2)" "unprognostic (1.79e-3)" "unprognostic (2.35e-1)" "unprognostic (8.33e-4)" "unprognostic (6.34e-2)" "unprognostic (8.06e-2)" "unprognostic (5.24e-2)" "unprognostic (3.49e-2)" 0.6 4.6 546.9 0.6 731.2 0.4 3.8 388.1 782.3 1.2 202.7 0.2 0.5 1.0 0.3 0.2 0.3 0.2 0.9 631.1 432.5 0.2 34.9 0.6 1.9 450.6 533.6 0.1 9.5 0.1 2.6 1.1 384.2 0.3 0.1 60.1 4.6 0.1 0.3 1.3 0.2 0.3 409.7 0.5 2.1 1.7 498.7 0.2 0.3 0.5 1.6 0.3 0.6 453.4 0.0 0.1 0.5 0.0 0.2 2.1 0.0 0.5 2.4 0.1 0.1 0.0 0.0 0.0 0.0 1.7 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.3 2.9 0.1 0.3 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.2 0.0 1.1 0.0 0.1 0.5 0.0 0.3 0.1 0.1 0.2 0.0 0.3 0.0 0.0 0.5 0.0 0.1 1.3 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.5 0.2 0.1 0.1 0.1 0.1 546.9 731.2 388.1 782.3 631.1 432.5 450.6 533.6 384.2 409.7 498.7 453.4 0.4 3.2 4.8 4607.2 0.4 2.9 0.0 0.0 0.0 109.9 8.1 2.4 3.1 0.0 0.0 0.0 148.0 25.6 0.3 0.1 0.0 0.1 96.6 1.8 11.7 1.6 0.0 0.0 83.7 3.4 1.0 3.1 1.1 1.5 0.0 0.7 0.0 6.7 3.3 6.7 81.5 0.0 0.0 0.0 3.0 97.9 0.0 0.6 1.8 194.9 31.6 10.1 0.0 634.9 12.3 0.4 0.0 0.0 0.1 0.3 0.0 0.1 0.8 161.2 0.0 0.3 1.8 0.5 1.3 0.0 1.1 269.4 0.2 0.0 0.0 0.1 PAMR1 "DKFZP586H2123, RAMP" ENSG00000149090 "Peptidase domain containing associated with muscle regeneration 1" Q6UXH9 11 35431823-35530300 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Serine protease homolog" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 7 "Astrocytes: 380.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 86.9;ASC TERT1: 354.7;BJ hTERT+: 357.7;fHDF/TERT166: 86.7;HSkMC: 123.1;U-87 MG: 82.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA 5600000 "Cluster 57: Non-specific - Angiogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 64: Astrocytes - Nervous system maintenance" "unprognostic (3.38e-1)" "unprognostic (1.07e-2)" "unprognostic (1.67e-1)" "unprognostic (1.00e-3)" "unprognostic (6.50e-3)" "unprognostic (1.01e-1)" "unprognostic (2.07e-2)" "unprognostic (6.92e-2)" "unprognostic (3.32e-2)" "unprognostic (4.07e-2)" "unprognostic (1.91e-2)" "unprognostic (1.36e-2)" "prognostic unfavorable (5.08e-5)" "prognostic unfavorable (6.29e-4)" "unprognostic (2.08e-1)" "unprognostic (9.98e-2)" "unprognostic (8.25e-2)" 32.8 14.9 25.1 0.6 27.4 0.0 15.4 22.0 23.2 59.9 13.9 14.9 4.5 58.2 18.3 10.0 22.6 20.3 23.2 22.5 26.2 7.1 12.6 5.9 1.3 37.9 35.9 3.4 5.3 1.7 6.4 55.9 32.4 21.2 6.6 0.9 5.7 17.9 2.7 19.8 9.9 14.9 46.1 5.7 5.4 0.2 34.1 2.8 7.0 9.0 1.7 28.0 41.3 38.8 0.0 0.0 0.1 0.0 86.9 354.7 0.1 42.8 357.7 4.9 8.3 32.7 0.0 0.0 0.0 86.7 0.1 0.1 0.0 0.0 3.3 0.0 0.8 0.0 0.0 0.0 50.1 0.0 0.0 123.1 1.8 9.7 1.3 0.1 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.7 0.0 0.2 0.0 0.2 0.2 0.0 8.4 0.1 0.0 0.0 0.0 0.0 14.3 2.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.1 0.0 82.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.1 27.4 22.0 23.2 22.5 26.2 37.9 35.9 32.4 46.1 34.1 38.8 2.5 0.0 0.0 380.3 0.0 19.1 1.4 14.8 1.2 0.1 0.7 19.7 1.3 0.0 2.4 1.8 0.0 2.2 0.0 0.0 0.0 1.4 0.1 4.5 26.2 1.1 0.0 0.0 13.1 0.0 1.4 50.2 1.1 0.8 0.0 0.6 0.0 0.0 2.0 0.0 8.2 0.2 0.0 0.0 5.5 0.1 0.3 0.5 1.8 28.1 0.6 0.0 0.0 9.5 1.4 0.1 0.0 0.0 0.0 0.4 0.2 0.0 1.8 0.2 0.0 1.6 5.8 0.0 0.2 0.1 9.2 3.4 0.6 0.2 0.0 0.2 FJX1 "FLJ22416, FLJ25593" ENSG00000179431 "Four-jointed box kinase 1" Q86VR8 11 35618460-35620865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 29.0;Cytotrophoblasts: 25.6;Endometrial ciliated cells: 30.6;Endometrial stromal cells: 35.4;Granulosa cells: 31.2" "Cancer enhanced" "Detected in all" "glioma: 34.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-251 MG: 60.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059220 Uncertain Approved Vesicles "Intracellular and membrane" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 36: Stromal cells - Cell proliferation" Vesicles "HPA059220: AB_2683950" "unprognostic (8.99e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-3)" "unprognostic (5.20e-2)" "unprognostic (5.72e-2)" "unprognostic (9.56e-3)" "unprognostic (5.16e-2)" "unprognostic (1.06e-2)" "unprognostic (1.74e-1)" "unprognostic (4.39e-3)" "unprognostic (5.28e-2)" "unprognostic (2.02e-1)" "prognostic unfavorable (9.24e-9)" "unprognostic (1.64e-2)" "unprognostic (9.64e-2)" "unprognostic (8.35e-2)" "prognostic unfavorable (6.56e-4)" 8.9 5.9 8.4 1.7 10.4 0.1 3.5 6.8 9.2 7.8 4.4 2.1 0.3 5.2 1.5 3.8 4.9 2.3 2.5 10.2 7.1 9.5 2.2 2.8 1.1 8.2 13.1 9.2 3.5 0.6 2.3 3.4 6.6 5.2 0.2 0.7 2.5 2.2 1.1 6.0 1.3 1.6 9.6 5.0 1.6 0.7 12.0 1.0 2.9 0.3 1.7 3.8 3.3 10.1 23.3 11.4 12.0 3.8 4.1 12.6 3.7 25.4 17.3 24.1 17.2 14.5 7.1 0.0 5.7 10.2 49.6 24.3 4.2 42.6 20.4 0.3 33.0 2.1 4.4 0.6 9.7 2.7 0.1 4.8 31.8 12.7 38.1 3.9 11.1 1.2 12.5 0.1 23.6 5.4 0.8 0.0 16.4 0.1 33.6 1.4 26.6 5.4 18.6 28.5 11.2 6.4 2.7 2.1 7.5 8.7 48.2 0.5 21.7 19.0 35.5 3.7 60.9 0.0 0.0 0.0 33.9 1.1 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 10.4 6.8 9.2 10.2 7.1 8.2 13.1 6.6 9.6 12.0 10.1 7.8 0.0 0.0 9.4 0.2 17.5 15.8 14.0 29.0 1.8 5.3 13.3 1.2 0.0 3.9 0.0 12.5 25.6 0.0 0.1 1.9 7.6 0.3 30.6 35.4 11.8 0.0 0.0 6.6 0.2 13.9 7.2 0.0 6.5 0.0 31.2 17.9 0.4 3.6 0.0 3.9 0.0 2.0 0.6 1.7 0.1 0.6 1.1 0.0 1.0 0.0 12.5 0.0 6.6 1.7 1.4 0.0 0.7 0.0 22.9 0.0 8.0 4.3 0.5 0.0 6.0 22.3 0.6 1.0 5.6 9.5 11.9 0.4 3.1 0.0 2.5 TRIM44 "DIPB, MC7" ENSG00000166326 "Tripartite motif containing 44" Q96DX7 11 35662775-35818007 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049053, HPA057633" Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 77: Retina - Visual perception" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 9: Photoreceptor cells - Phototransduction" Vesicles "Plasma membrane" "HPA049053: AB_2680613, HPA057633: AB_2683484" "unprognostic (2.73e-1)" "unprognostic (2.74e-1)" "unprognostic (1.37e-1)" "unprognostic (5.53e-2)" "unprognostic (3.91e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (5.24e-5)" "unprognostic (9.06e-2)" "unprognostic (5.29e-2)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (8.57e-2)" "unprognostic (1.49e-3)" "unprognostic (2.15e-2)" "unprognostic (1.59e-1)" "unprognostic (1.52e-1)" "unprognostic (3.00e-1)" 12.6 10.7 16.9 12.3 16.4 6.0 11.1 18.5 21.9 10.9 8.3 13.5 10.6 10.9 10.2 9.1 11.1 11.6 11.6 16.6 17.0 18.0 14.4 11.9 12.8 16.0 16.7 10.3 15.5 11.1 7.9 13.3 16.1 10.4 11.1 27.0 9.4 11.4 11.5 8.3 12.0 12.2 17.8 14.1 11.3 6.7 17.3 12.1 14.9 9.8 13.2 11.1 8.6 19.0 20.1 16.9 26.4 12.3 19.6 29.6 0.1 18.5 21.9 22.7 20.6 19.7 13.3 26.7 17.1 24.3 25.7 15.4 9.1 21.1 25.4 17.6 17.4 28.7 23.0 11.4 26.0 22.7 23.7 22.4 23.2 13.3 36.0 25.1 24.3 9.2 45.4 9.3 24.1 12.1 24.1 11.1 14.9 4.2 14.5 16.6 68.4 14.5 21.0 26.9 18.1 15.5 27.7 19.6 21.0 14.3 29.5 19.0 27.4 28.9 23.8 16.6 21.2 15.7 15.0 0.1 23.9 23.7 22.2 0.2 0.9 0.3 0.9 1.2 0.8 1.1 0.9 0.9 0.8 1.5 1.1 1.2 0.0 1.2 1.5 1.8 0.3 0.5 16.9 16.4 18.5 21.9 16.6 17.0 16.0 16.7 16.1 17.8 17.3 19.0 67.5 60.9 72.6 78.4 68.5 26.8 57.9 19.8 74.0 221.5 45.3 38.2 58.9 55.8 45.6 25.8 204.3 55.4 72.1 70.3 33.2 62.8 18.8 78.0 74.0 62.4 51.4 39.3 151.7 71.1 25.9 49.4 74.9 54.4 58.9 107.1 49.2 53.3 42.7 84.1 134.5 57.6 16.2 65.7 37.8 13.4 36.1 70.3 19.6 84.3 76.9 72.2 72.1 121.7 171.0 53.3 50.4 37.2 59.6 90.3 50.9 75.6 48.4 173.4 98.6 71.9 52.1 88.2 81.5 46.1 26.7 52.1 47.0 58.5 54.5 59.9 LDLRAD3 LRAD3 ENSG00000179241 "Low density lipoprotein receptor class A domain containing 3" Q86YD5 11 35943981-36232136 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 92.4;Excitatory neurons: 68.6;Microglial cells: 104.9;Oligodendrocyte precursor cells: 308.6;Oligodendrocytes: 215.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 4.8;non-classical monocyte: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 63.7;RH-30: 60.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038251 Approved Approved "Cell Junctions" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 68: Oligodendrocytes - Mixed function" "Cell Junctions" "HPA038251: AB_10675790" "unprognostic (1.59e-3)" "prognostic unfavorable (2.24e-4)" "unprognostic (3.25e-2)" "unprognostic (4.08e-3)" "unprognostic (1.81e-1)" "unprognostic (1.93e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (9.34e-6)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (1.68e-2)" "unprognostic (6.93e-2)" "prognostic unfavorable (5.05e-8)" "unprognostic (3.32e-2)" "unprognostic (9.21e-3)" "unprognostic (9.33e-2)" "prognostic unfavorable (2.14e-5)" 10.9 4.5 9.9 4.7 13.9 1.4 18.6 20.8 10.6 7.7 6.3 3.4 2.0 8.5 3.2 6.7 5.8 4.8 4.0 9.7 12.4 4.4 1.6 3.8 3.6 22.0 16.8 11.2 3.8 1.3 5.1 2.3 18.5 11.2 2.1 1.1 20.6 4.1 5.6 13.7 3.5 5.4 15.8 2.1 3.7 3.5 14.8 3.5 3.3 3.0 3.6 5.8 6.8 19.3 11.5 10.7 32.3 19.7 25.2 27.5 24.7 6.5 5.8 14.3 12.7 8.0 7.0 0.0 4.8 7.1 21.4 5.7 10.0 14.6 19.9 1.0 21.1 36.5 6.6 2.3 33.2 8.0 4.0 33.1 63.7 6.5 56.0 5.8 24.3 0.0 9.6 1.3 26.7 6.4 0.0 1.8 13.3 1.2 18.4 0.0 60.3 3.5 2.5 1.6 11.0 24.8 11.3 12.2 36.6 12.5 16.9 10.6 24.7 17.0 15.3 1.4 21.8 0.7 0.0 0.0 8.6 9.6 31.3 1.4 4.8 0.5 0.0 4.5 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.1 0.0 6.4 0.2 0.0 1.8 9.9 13.9 20.8 10.6 9.7 12.4 22.0 16.8 18.5 15.8 14.8 19.3 3.5 0.0 3.2 92.4 0.5 15.4 7.4 3.6 10.8 0.4 31.1 12.1 0.6 0.0 1.7 0.0 0.0 2.6 0.7 0.2 0.0 3.8 13.0 1.2 10.8 15.4 0.0 2.5 68.6 1.1 13.1 9.1 0.5 0.9 0.0 11.4 25.4 0.6 4.0 0.0 8.4 0.0 0.0 15.4 4.9 22.6 9.6 9.5 7.2 104.9 6.2 0.9 0.0 308.6 215.5 1.2 0.1 24.8 0.1 20.3 0.0 1.8 0.8 0.1 13.1 21.3 9.9 0.4 3.0 19.3 26.0 1.4 1.1 9.8 0.5 3.4 COMMD9 "FLJ31106, HSPC166" ENSG00000110442 "COMM domain containing 9" Q9P000 11 36269284-36289449 "Predicted intracellular proteins" "Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 105.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009142 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 18: U-2197 - ECM organization" "Cluster 4: Macrophages - Innate immune response" Nucleoplasm "Golgi apparatus, Cytosol" "HPA009142: AB_1847105" "unprognostic (1.56e-2)" "unprognostic (4.75e-3)" "unprognostic (7.57e-2)" "unprognostic (4.40e-3)" "unprognostic (1.91e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-3)" "unprognostic (2.62e-1)" "unprognostic (6.15e-2)" "prognostic favorable (8.54e-4)" "unprognostic (4.94e-2)" "unprognostic (2.40e-1)" "unprognostic (6.08e-3)" "unprognostic (7.24e-2)" "unprognostic (1.71e-1)" "unprognostic (7.31e-3)" "unprognostic (1.88e-1)" 26.8 32.1 33.8 21.8 34.1 50.8 24.3 35.1 36.7 17.2 29.6 19.6 21.1 14.1 25.1 24.9 20.3 20.5 31.1 33.8 33.8 38.7 36.6 26.8 26.0 34.2 34.4 19.4 26.4 27.4 23.2 24.8 33.9 14.0 24.2 20.3 21.9 13.3 64.2 27.1 20.2 21.9 36.9 26.8 19.7 14.9 36.0 30.6 25.1 61.7 32.0 20.6 16.6 39.1 28.8 33.4 36.1 38.2 54.5 37.8 20.0 33.6 42.6 74.7 69.8 27.3 23.9 33.0 32.5 67.1 57.5 41.4 64.0 45.2 69.6 39.9 75.2 18.2 57.6 48.0 51.0 71.6 52.3 48.0 49.5 40.9 25.0 38.5 62.2 43.3 45.7 34.7 59.4 36.9 47.9 49.6 38.5 55.6 70.3 52.1 81.7 38.9 78.6 26.6 44.1 49.2 47.9 47.1 43.6 29.2 102.7 27.0 41.9 45.0 34.4 107.9 49.8 24.3 53.2 37.2 51.8 66.4 44.0 85.6 376.6 173.7 91.4 359.0 86.8 130.7 87.5 88.4 383.6 138.3 99.8 83.4 42.7 94.8 300.9 145.8 114.5 315.2 33.8 34.1 35.1 36.7 33.8 33.8 34.2 34.4 33.9 36.9 36.0 39.1 26.9 22.4 29.4 2.6 27.0 15.3 12.7 37.4 13.1 16.6 25.6 38.7 29.9 12.8 20.2 18.4 10.4 43.2 28.3 16.9 78.2 70.1 9.5 13.2 20.3 22.8 25.7 23.1 9.4 46.4 52.9 21.2 11.7 17.0 19.0 25.6 15.4 17.1 105.1 5.0 8.7 20.4 34.6 59.5 35.6 28.9 17.7 57.5 24.9 1.9 61.3 36.3 33.0 4.5 8.8 46.5 17.7 11.7 10.4 4.9 30.3 62.5 8.5 22.9 13.1 12.3 22.8 32.8 33.3 19.6 21.6 24.9 19.2 28.4 24.6 12.0 PRR5L "FLJ14213, PROTOR-2" ENSG00000135362 "Proline rich 5 like" Q6MZQ0 11 36296288-36465204 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.9;intestine: 34.7;lymphoid tissue: 36.4" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 302.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 35.5;HMC-1: 55.7;hTERT-HME1: 57.9;SiHa: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070174 Approved "Cytokinetic bridge,Cytosol" Yes No "Cluster 38: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 3: HMC-1 - Innate immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Cytokinetic bridge, Cytosol" "HPA070174: AB_2686231" "unprognostic (6.76e-2)" "unprognostic (1.61e-1)" "unprognostic (3.48e-2)" "prognostic favorable (7.30e-5)" "unprognostic (2.34e-2)" "unprognostic (1.21e-1)" "unprognostic (1.63e-1)" "unprognostic (7.45e-2)" "unprognostic (3.61e-1)" "unprognostic (1.46e-2)" "unprognostic (3.03e-3)" "unprognostic (2.12e-1)" "prognostic unfavorable (7.71e-8)" "prognostic unfavorable (4.86e-4)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (2.98e-2)" 3.6 1.5 10.1 8.9 27.8 4.7 2.7 21.7 16.7 11.4 2.2 34.7 3.3 2.8 2.0 1.4 6.3 7.1 2.0 9.6 21.1 7.7 2.9 13.6 9.3 36.6 23.8 12.8 1.2 0.9 2.7 3.6 33.9 2.4 27.8 0.7 7.8 2.0 0.9 1.7 12.2 5.9 24.1 36.4 3.4 1.5 23.9 3.4 3.2 0.7 3.3 4.3 3.8 46.9 0.0 5.5 10.3 0.2 1.4 0.0 0.1 13.2 8.9 25.7 27.2 0.0 0.2 0.1 4.4 15.7 5.9 0.5 2.1 5.9 12.9 5.0 3.7 1.5 35.5 0.0 3.5 0.0 55.7 3.8 9.0 2.3 57.9 25.2 9.4 0.0 0.0 0.1 13.6 3.3 0.7 0.1 0.8 0.1 2.3 4.1 1.1 1.1 27.0 6.9 0.0 0.4 40.1 0.0 2.2 6.5 0.0 0.6 7.8 22.3 6.8 0.0 16.4 0.2 0.0 0.0 9.7 1.5 6.7 36.1 2.0 24.9 34.6 21.4 8.2 0.0 12.2 29.7 2.5 1.6 2.6 18.0 11.8 9.6 24.6 7.7 0.0 15.4 10.1 27.8 21.7 16.7 9.6 21.1 36.6 23.8 33.9 24.1 23.9 46.9 2.1 19.2 4.2 17.6 0.7 0.4 0.2 5.0 0.0 0.1 1.9 0.9 0.9 1.5 6.8 7.3 0.0 0.2 25.9 44.3 1.9 1.3 17.6 1.5 0.8 7.7 1.8 7.0 1.8 2.2 0.1 2.1 1.1 2.5 5.1 0.5 22.5 0.4 8.8 0.0 1.1 22.7 10.2 11.7 0.7 54.9 0.6 5.4 0.0 16.9 4.7 1.2 58.7 31.7 302.0 3.9 37.0 0.4 4.2 0.7 13.2 0.5 9.0 0.2 6.6 1.8 2.6 0.3 0.6 0.4 0.6 0.3 14.5 0.9 17.5 0.5 TRAF6 RNF85 ENSG00000175104 "TNF receptor associated factor 6" Q9Y4K3 11 36483769-36510272 "Enzymes, Predicted intracellular proteins" "DNA damage, Immunity, Osteogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004605, HPA019805, HPA020599" Approved Uncertain Nucleoli,Mitochondria NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 59: Non-specific - Transcription" Mitochondria Nucleoli "CAB004605: AB_628391, HPA019805: AB_1858231, HPA020599: AB_1858232" "unprognostic (2.48e-2)" "unprognostic (1.38e-1)" "unprognostic (2.83e-1)" "unprognostic (8.73e-2)" "unprognostic (1.71e-1)" "unprognostic (1.55e-1)" "unprognostic (2.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.21e-1)" "unprognostic (1.16e-2)" "unprognostic (9.22e-2)" "prognostic favorable (1.36e-4)" "unprognostic (2.82e-2)" "unprognostic (1.20e-1)" "unprognostic (3.92e-2)" "unprognostic (1.07e-1)" 6.5 5.1 4.3 5.3 5.2 23.3 5.8 4.6 5.8 6.1 4.7 5.7 6.0 6.4 5.7 6.4 6.2 5.7 7.5 4.8 4.4 6.7 7.9 7.9 6.3 4.7 4.5 7.9 7.2 6.0 4.0 6.2 4.5 5.0 6.3 5.4 5.9 5.4 7.0 6.4 7.6 7.5 3.7 8.4 5.7 7.8 4.8 9.5 9.6 8.0 7.1 5.5 6.2 6.5 5.1 6.3 12.0 6.8 11.0 7.9 5.1 7.5 8.0 6.8 8.8 5.6 3.3 6.7 4.5 8.0 7.8 9.4 9.6 7.6 11.2 11.0 11.1 6.4 5.0 5.0 7.1 7.2 7.5 7.5 10.5 3.6 11.1 6.6 9.7 8.7 9.7 7.1 8.7 6.2 11.6 4.0 6.5 5.8 5.7 7.5 16.2 3.8 8.2 10.4 1.9 10.4 7.5 7.1 5.3 8.0 8.3 6.9 7.7 9.6 8.5 8.9 9.2 8.2 7.4 7.1 5.4 5.0 7.3 59.5 12.4 34.6 17.8 17.9 17.4 17.1 15.0 17.5 12.3 13.6 14.5 19.0 17.5 16.2 13.7 7.2 13.2 14.5 4.3 5.2 4.6 5.8 4.8 4.4 4.7 4.5 4.5 3.7 4.8 6.5 9.1 9.6 5.1 13.1 12.1 12.7 13.8 6.5 6.8 2.7 5.3 3.6 7.0 7.2 4.0 3.7 6.2 6.6 12.3 8.1 5.9 8.7 7.3 6.3 6.3 12.1 4.2 7.4 29.0 7.2 6.2 6.5 6.6 10.4 19.0 5.5 19.2 6.0 7.2 8.4 24.0 5.8 8.2 8.5 13.6 3.4 2.5 7.8 7.2 17.8 9.1 4.6 8.2 11.1 29.1 7.9 8.2 4.1 10.8 10.4 10.0 5.5 3.1 2.9 13.1 6.6 9.5 15.2 9.3 8.0 12.5 6.4 10.9 4.4 3.9 11.6 RAG1 "MGC43321, RNF74" ENSG00000166349 "Recombination activating 1" P15918 11 36510709-36593156 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA recombination, Ubl conjugation pathway" "Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Multifunctional enzyme, Nuclease, Transferase" "Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 92 "lymphoid tissue: 395.0" "Cell type enhanced" "Detected in some" "Distal tubular cells: 3.9;Hepatic stellate cells: 8.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "MOLT-4: 283.5;REH: 266.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA043939 Supported Nucleoplasm NA NA "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA043939: AB_2732512" "unprognostic (7.35e-2)" "unprognostic (1.57e-3)" "unprognostic (8.75e-2)" "unprognostic (3.44e-1)" "unprognostic (2.14e-1)" "unprognostic (1.46e-2)" "unprognostic (2.30e-1)" "unprognostic (1.70e-2)" "unprognostic (1.43e-1)" "unprognostic (1.54e-2)" "unprognostic (5.98e-3)" "unprognostic (1.28e-1)" "unprognostic (1.16e-9)" "unprognostic (2.16e-2)" "unprognostic (1.04e-1)" "unprognostic (2.53e-4)" "unprognostic (1.53e-1)" 0.4 0.5 0.1 0.2 0.1 4.3 0.2 0.1 0.2 0.4 0.2 0.4 0.8 0.2 0.8 0.1 0.3 0.4 0.3 0.1 0.1 1.3 0.8 0.6 0.1 0.1 0.1 0.3 0.3 0.6 0.1 0.6 0.1 0.3 0.3 0.6 0.4 0.3 0.1 0.1 1.0 0.1 0.1 2.6 0.5 0.3 0.1 395.0 2.4 0.3 0.6 0.3 0.1 0.1 0.4 0.0 0.5 0.1 0.2 0.6 0.0 0.3 0.3 0.1 0.5 0.0 0.4 0.5 0.0 0.0 0.1 0.2 0.0 0.4 0.4 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.3 0.4 0.0 0.3 0.2 0.5 54.0 0.2 0.0 0.5 0.0 283.5 0.0 2.2 0.2 0.0 266.4 0.0 1.3 0.9 0.0 0.1 0.3 0.1 0.7 0.1 1.2 1.0 0.1 1.0 0.2 0.2 0.2 0.1 2.3 1.9 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.5 0.0 0.0 0.0 0.1 0.1 1.4 0.7 0.0 1.0 1.0 0.8 0.9 0.0 0.4 1.8 0.0 0.2 0.5 1.3 3.9 0.8 2.3 0.3 0.3 1.6 0.0 0.4 1.8 0.5 0.1 0.7 0.0 0.4 0.0 0.3 8.2 2.1 0.4 0.0 1.7 0.8 0.0 0.6 0.7 1.7 0.0 0.1 0.0 1.0 1.1 0.5 2.1 1.0 1.3 1.1 0.4 0.0 0.0 0.5 3.0 2.9 0.4 0.9 0.0 0.2 0.7 1.0 1.0 0.2 0.4 0.4 0.4 0.5 0.6 0.6 RAG2 ENSG00000175097 "Recombination activating 2" P55895 11 36575574-36598279 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA recombination" "Chromatin regulator" "Disease variant, SCID" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 152.3" "Group enriched" "Detected in some" 19 "Astrocytes: 1.3;Early spermatids: 2.3;Excitatory neurons: 2.9;Inhibitory neurons: 1.5;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 1.3;Spermatocytes: 1.5" "Cancer enriched" "Detected in single" 21 "thyroid cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 40.0;MOLT-4: 46.8;REH: 183.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065704 Approved Nucleoplasm NA NA "Cluster 63: T-cells - Adaptive immune response" "Cluster 14: REH - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "HPA065704: AB_2732737" "unprognostic (4.30e-2)" "unprognostic (9.09e-2)" "unprognostic (1.21e-1)" "unprognostic (1.77e-1)" "unprognostic (4.58e-2)" "unprognostic (2.17e-1)" "unprognostic (8.11e-2)" "unprognostic (1.68e-3)" 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 152.3 23.9 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.0 0.0 0.0 0.0 0.0 46.8 0.0 0.1 0.0 0.0 183.8 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFTAP "C11orf74, FLJ38678, HEPIS, NWC" ENSG00000166352 "Intraflagellar transport associated protein" Q86VG3 11 36594369-36675695 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 10.0;Cardiomyocytes: 60.7;Cytotrophoblasts: 19.3;Extravillous trophoblasts: 19.0;Fibroblasts: 8.5;Hofbauer cells: 26.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044880 Uncertain Approved Aggresome,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 24: Non-specific - Transcription regulation" "Aggresome, Cytosol" "HPA044880: AB_10796908" "unprognostic (9.22e-3)" "unprognostic (6.79e-2)" "unprognostic (3.23e-2)" "unprognostic (7.47e-2)" "unprognostic (5.00e-3)" "unprognostic (1.13e-2)" "unprognostic (1.13e-2)" "unprognostic (9.86e-2)" "unprognostic (2.36e-1)" "unprognostic (3.65e-2)" "unprognostic (8.52e-2)" "unprognostic (1.92e-1)" "unprognostic (1.95e-2)" "unprognostic (1.37e-2)" "unprognostic (1.17e-2)" "unprognostic (1.24e-1)" "unprognostic (3.24e-1)" 17.1 20.0 19.5 5.3 20.0 13.3 15.3 19.7 31.0 17.0 33.0 30.7 7.5 16.2 23.7 9.5 31.7 12.7 45.3 19.7 19.1 25.3 18.7 11.8 5.4 19.3 20.0 21.8 18.0 16.5 25.9 10.3 19.4 12.8 10.4 19.5 12.2 10.3 41.0 7.2 10.1 16.5 18.9 8.3 17.5 52.4 19.8 10.5 82.2 42.3 5.0 17.5 12.9 20.1 11.4 19.7 41.4 31.3 39.0 56.2 16.4 24.5 26.8 23.6 43.3 0.7 18.8 0.2 18.1 25.0 32.4 4.5 28.3 33.9 48.8 0.2 47.8 19.9 9.2 20.0 30.0 27.4 4.5 36.4 24.4 15.7 22.4 40.5 40.4 15.2 25.4 0.3 25.6 18.8 4.9 22.7 24.8 7.0 31.0 19.5 51.4 11.3 34.1 3.6 0.6 46.6 28.0 5.4 42.6 37.4 38.3 14.7 24.7 32.3 22.3 43.4 21.8 6.2 12.3 0.0 29.4 33.2 17.0 10.5 18.3 1.2 1.6 15.4 5.1 0.0 4.8 3.9 20.9 0.3 11.6 2.9 1.0 14.1 15.3 28.5 0.7 8.3 19.5 20.0 19.7 31.0 19.7 19.1 19.3 20.0 19.4 18.9 19.8 20.1 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 0.0 0.0 0.0 0.0 19.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 19.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 LRRC4C "KIAA1580, NGL-1" ENSG00000148948 "Leucine rich repeat containing 4C" Q9HCJ2 11 40114203-41459773 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.4;retina: 17.1" "Cell type enriched" "Detected in many" 4 "Oligodendrocyte precursor cells: 5497.5" "Cancer enhanced" "Detected in some" "glioma: 3.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 19.1;U-2 OS: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054800, HPA075816" Supported Approved Cytosol NA NA "Cluster 24: B-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Cytosol "HPA054800: AB_2682603, HPA075816: " "unprognostic (4.86e-3)" "unprognostic (3.43e-2)" "unprognostic (7.62e-3)" "unprognostic (4.87e-3)" "unprognostic (6.48e-2)" "unprognostic (1.42e-1)" "unprognostic (2.84e-1)" "unprognostic (4.64e-2)" "unprognostic (1.93e-1)" "unprognostic (2.22e-1)" "unprognostic (2.44e-1)" "unprognostic (1.49e-1)" "unprognostic (4.90e-13)" "unprognostic (5.05e-4)" "unprognostic (5.21e-1)" "unprognostic (1.12e-1)" "unprognostic (6.45e-3)" 0.7 3.4 11.4 0.8 14.1 0.0 1.4 0.5 15.4 3.0 0.0 2.5 0.4 1.2 0.3 0.4 0.5 0.8 2.1 14.4 9.6 0.3 1.1 0.8 0.7 7.8 10.7 0.6 0.3 1.7 4.0 0.0 5.7 0.6 0.7 17.1 0.6 1.6 0.3 0.2 0.8 1.3 4.6 0.6 0.5 0.2 8.1 0.6 2.3 0.7 0.7 0.7 2.0 9.2 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 20.9 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 14.1 0.5 15.4 14.4 9.6 7.8 10.7 5.7 4.6 8.1 9.2 0.2 0.0 1.3 498.2 0.2 0.1 0.0 1.4 0.0 35.5 4.2 3.0 1.2 0.0 1.4 0.0 6.2 0.0 0.0 0.0 1.9 0.0 0.9 0.3 10.5 1.4 0.0 0.0 1171.8 0.0 0.0 5.6 0.0 0.9 0.0 0.1 0.0 0.0 0.1 8.4 1274.6 0.0 0.0 0.0 1.9 0.2 2.1 0.4 1.8 49.6 0.0 93.6 0.0 5497.5 221.3 0.3 0.0 1.5 0.1 0.1 0.0 0.7 0.0 99.7 0.0 2.0 0.7 0.3 0.5 0.0 0.0 0.0 0.0 2.3 0.0 0.0 API5 "AAC-11, AAC11, API5L1" ENSG00000166181 "Apoptosis inhibitor 5" Q9BZZ5 11 43311963-43344529 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026598 Approved Enhanced "Nuclear speckles" NA NA 31000 "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nuclear speckles" "HPA026598: AB_1844927" "unprognostic (4.05e-2)" "unprognostic (1.57e-1)" "unprognostic (2.58e-3)" "unprognostic (6.08e-2)" "unprognostic (5.88e-2)" "unprognostic (3.46e-2)" "unprognostic (1.24e-2)" "unprognostic (1.73e-1)" "unprognostic (8.69e-3)" "unprognostic (1.45e-3)" "unprognostic (2.87e-2)" "unprognostic (1.35e-1)" "prognostic favorable (1.06e-4)" "unprognostic (5.03e-2)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (3.05e-2)" 37.6 33.1 29.2 43.4 31.1 35.3 45.7 38.5 37.4 39.3 25.9 44.3 42.8 42.1 34.5 44.6 36.6 32.4 28.2 32.0 30.6 49.1 57.7 34.8 53.5 29.2 28.5 35.1 45.9 46.6 19.0 29.9 30.8 40.4 46.6 44.1 39.0 39.5 37.1 40.0 45.5 46.6 32.8 40.3 41.1 26.8 29.9 62.1 51.4 35.9 57.2 44.2 27.6 38.6 90.2 93.0 119.4 75.2 82.7 82.4 82.9 83.8 89.4 116.3 110.2 69.4 38.8 106.4 67.2 90.2 86.9 107.7 143.2 99.7 160.6 122.4 134.9 96.5 53.0 60.8 74.8 165.6 88.9 64.2 104.6 59.0 102.9 72.4 98.9 65.8 160.3 93.9 82.1 57.0 141.2 71.1 214.6 111.1 86.0 145.2 126.3 85.3 89.5 103.8 95.5 64.2 100.7 88.7 81.4 88.4 109.1 76.6 86.5 102.0 78.3 139.8 144.5 77.5 122.7 172.1 88.8 95.0 62.3 61.3 47.3 51.5 66.5 64.5 75.1 61.7 64.8 69.3 62.1 60.4 66.3 68.7 9.9 116.3 67.3 40.0 61.4 88.4 29.2 31.1 38.5 37.4 32.0 30.6 29.2 28.5 30.8 32.8 29.9 38.6 26.4 16.0 27.3 30.0 35.9 43.8 16.6 21.6 47.3 23.8 27.8 17.8 14.4 31.5 28.0 20.2 10.4 30.4 31.8 20.1 31.3 21.3 13.6 23.5 25.8 26.2 24.0 48.0 40.2 19.7 30.4 28.3 35.2 28.2 32.3 25.9 22.1 48.0 26.3 28.6 33.5 27.5 12.2 33.6 28.8 6.5 18.6 30.0 32.0 27.2 41.7 21.1 17.5 25.1 45.4 24.9 19.8 20.3 44.2 24.0 29.4 37.3 20.8 19.0 6.6 28.9 31.1 28.4 26.6 43.1 51.9 38.9 33.8 26.6 31.4 19.2 TTC17 FLJ10890 ENSG00000052841 "Tetratricopeptide repeat domain 17" Q96AE7 11 43358920-43494933 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038508 Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" "Plasma membrane" Cytosol "HPA038508: AB_10671744" "unprognostic (2.71e-1)" "unprognostic (4.04e-3)" "unprognostic (6.48e-2)" "unprognostic (2.64e-1)" "unprognostic (1.17e-1)" "unprognostic (5.66e-2)" "unprognostic (1.74e-1)" "unprognostic (9.03e-2)" "unprognostic (5.01e-3)" "unprognostic (2.62e-1)" "unprognostic (1.34e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (4.75e-6)" "unprognostic (1.04e-2)" "unprognostic (4.40e-1)" "unprognostic (1.18e-1)" "unprognostic (1.54e-2)" 20.7 18.7 11.0 16.1 11.3 15.5 28.6 16.7 12.2 22.0 22.0 21.2 21.6 26.9 25.0 14.2 28.4 22.3 13.5 11.1 12.2 19.4 38.6 24.2 20.2 11.9 12.5 40.9 49.5 27.7 12.3 29.2 11.7 25.4 22.9 25.1 40.7 21.4 16.4 19.5 25.5 23.0 11.0 23.4 27.4 24.8 12.4 24.6 36.9 20.0 22.4 18.8 15.6 13.0 15.0 30.4 31.3 49.3 77.2 63.6 22.1 35.6 47.6 29.3 35.1 21.1 21.7 31.6 34.9 35.9 33.7 31.1 22.3 23.5 35.2 24.5 29.0 24.2 19.5 20.8 95.3 36.6 29.9 59.5 69.8 21.3 68.4 66.2 29.5 22.7 35.5 26.2 29.8 18.1 27.1 20.3 46.8 58.0 25.0 25.1 33.3 36.9 37.2 21.4 16.7 39.7 27.7 73.1 44.6 31.4 68.6 40.8 39.6 41.7 18.4 47.1 52.1 51.1 44.5 29.8 26.9 21.6 45.3 20.0 21.7 19.0 14.9 22.4 15.9 16.4 16.2 14.5 16.9 14.8 16.3 15.1 18.5 16.5 20.8 17.6 16.1 18.0 11.0 11.3 16.7 12.2 11.1 12.2 11.9 12.5 11.7 11.0 12.4 13.0 43.0 64.1 62.7 159.6 53.3 42.1 35.0 36.4 30.7 44.1 40.3 35.7 20.5 31.5 51.9 22.0 60.5 32.6 43.8 30.7 3.9 23.1 52.6 35.8 44.5 40.9 22.3 44.0 204.6 43.4 28.8 44.4 40.2 48.6 36.6 56.2 40.0 57.5 26.2 47.1 203.2 42.1 34.6 48.0 32.3 18.4 57.2 37.1 28.4 181.8 47.8 24.8 37.0 192.0 200.6 29.7 31.5 36.5 48.9 50.1 47.7 15.5 54.3 47.3 52.6 45.5 36.2 51.8 35.0 34.6 43.2 30.8 45.6 33.5 35.8 42.7 HSD17B12 "KAR, SDR12C1" ENSG00000149084 "Hydroxysteroid 17-beta dehydrogenase 12" Q53GQ0 11 43680680-43856617 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016427 Approved NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 15: Hepatocytes - Hemostasis" "HPA016427: AB_1844347" "unprognostic (1.93e-1)" "unprognostic (1.92e-2)" "unprognostic (1.53e-1)" "unprognostic (1.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.14e-3)" "prognostic unfavorable (2.76e-4)" "unprognostic (2.99e-1)" "unprognostic (3.31e-2)" "unprognostic (9.16e-3)" "unprognostic (5.16e-2)" "unprognostic (7.54e-2)" "prognostic favorable (2.10e-8)" "unprognostic (6.87e-2)" "unprognostic (1.49e-1)" "unprognostic (2.43e-1)" "unprognostic (2.28e-2)" 60.9 65.4 42.0 31.4 50.4 25.1 48.8 58.1 63.0 51.3 71.5 65.8 67.3 37.4 50.6 36.3 41.3 35.6 69.5 42.0 54.3 91.3 122.9 51.4 28.5 58.8 52.1 45.3 43.5 134.3 28.5 41.6 58.9 52.8 59.5 47.0 46.9 41.5 27.8 30.0 41.7 48.6 52.8 34.8 56.1 33.5 48.9 22.3 66.8 51.6 32.3 31.4 26.8 61.9 40.2 64.3 68.4 69.6 226.8 211.5 45.0 96.7 97.8 67.3 73.0 75.7 80.7 97.4 69.4 91.5 111.7 151.6 48.7 125.5 82.6 19.0 89.2 46.4 28.3 66.2 114.6 132.3 125.4 131.1 93.6 68.1 193.6 85.9 96.1 60.4 43.9 157.9 59.4 22.9 38.6 63.1 126.0 49.9 45.3 63.9 102.3 110.8 129.5 95.9 24.5 56.5 132.0 110.7 100.2 64.6 80.2 112.5 92.4 73.9 28.3 189.3 117.6 81.6 110.3 58.3 78.5 25.0 55.4 8.8 13.4 7.0 12.1 14.8 13.5 12.7 9.6 10.5 21.3 15.2 15.6 13.9 11.2 16.4 8.2 18.4 6.2 11.6 42.0 50.4 58.1 63.0 42.0 54.3 58.8 52.1 58.9 52.8 48.9 61.9 73.6 64.1 111.1 96.6 45.4 31.7 47.1 92.8 57.5 77.1 46.1 36.4 80.7 74.4 81.4 51.5 77.2 60.4 30.6 82.2 27.4 100.2 61.8 36.9 47.5 70.9 138.2 40.8 126.9 82.3 42.1 59.7 60.6 37.0 155.9 37.3 76.1 214.0 63.5 121.1 155.6 75.5 87.5 50.9 43.7 24.1 34.2 45.3 39.2 59.0 37.2 128.2 30.9 128.7 97.5 71.4 62.5 56.8 61.4 61.3 54.2 50.1 75.8 67.8 78.9 45.4 60.2 17.5 14.5 66.0 45.7 74.8 29.4 95.5 115.5 48.6 ALKBH3 DEPC-1 ENSG00000166199 "AlkB homolog 3, alpha-ketoglutarate dependent dioxygenase" Q96Q83 11 43880811-43920274 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 90.9;Late spermatids: 103.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA009674, HPA046489" Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm Mitochondria "HPA009674: AB_1850460, HPA046489: AB_2679671" "unprognostic (3.53e-1)" "unprognostic (2.41e-1)" "unprognostic (7.43e-3)" "unprognostic (4.70e-2)" "unprognostic (6.94e-3)" "unprognostic (1.89e-1)" "unprognostic (7.71e-2)" "unprognostic (5.42e-2)" "unprognostic (8.56e-2)" "unprognostic (4.62e-1)" "unprognostic (5.87e-2)" "unprognostic (7.02e-2)" "unprognostic (2.09e-2)" "unprognostic (1.22e-1)" "unprognostic (2.31e-1)" "unprognostic (2.76e-1)" "unprognostic (1.35e-2)" 20.6 15.7 14.6 9.1 16.0 7.9 20.6 18.3 20.9 21.3 15.7 18.3 10.9 20.5 24.7 18.5 19.5 9.2 15.3 15.3 15.4 16.7 18.5 13.2 13.8 15.5 15.2 22.9 23.6 16.9 18.2 7.3 15.3 21.9 12.8 17.0 19.3 13.5 35.2 23.4 15.9 13.6 15.3 19.6 20.0 20.4 15.2 15.9 15.3 25.8 14.6 19.2 19.9 17.6 15.8 26.0 10.7 0.0 20.3 26.1 0.0 19.5 42.0 36.9 34.7 10.7 12.0 2.6 12.2 28.7 20.5 21.3 14.6 32.3 33.1 0.0 49.6 23.7 17.1 27.4 51.9 44.5 30.5 27.8 55.7 17.0 81.4 15.2 26.5 44.7 33.9 25.9 18.3 18.4 38.6 21.9 20.6 16.2 38.5 11.6 23.8 30.3 21.3 23.2 20.3 16.1 15.7 22.6 37.1 9.7 32.9 26.3 20.6 21.6 12.5 35.7 28.0 23.1 25.1 26.3 31.3 18.3 17.6 34.4 16.4 9.4 19.8 18.4 19.3 18.6 20.9 18.2 23.5 21.8 24.8 22.9 2.9 24.6 29.4 20.9 21.3 17.4 14.6 16.0 18.3 20.9 15.3 15.4 15.5 15.2 15.3 15.3 15.2 17.6 12.0 16.0 10.9 15.0 12.6 10.3 8.8 16.5 10.8 11.5 10.9 12.8 6.8 14.3 13.3 16.5 4.2 3.4 13.7 9.8 31.3 24.6 90.9 6.3 7.3 14.6 9.5 9.9 15.8 32.6 4.6 14.0 10.2 4.8 7.6 12.5 13.2 12.9 19.0 10.1 15.8 11.3 6.1 11.2 7.0 103.3 16.1 13.1 17.8 3.7 14.1 20.4 22.6 13.0 16.1 27.7 8.6 10.5 12.4 9.3 15.5 17.1 14.0 13.0 6.6 9.9 15.3 29.3 12.6 20.6 7.1 2.2 12.7 15.7 12.5 8.3 C11orf96 AG2 ENSG00000187479 "Chromosome 11 open reading frame 96" Q7Z7L8 11 43925342-43943878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 750.2;ovary: 721.3" "Cell type enhanced" "Detected in many" "Adipocytes: 796.5;Endometrial stromal cells: 906.3;Fibroblasts: 801.3;Granulosa cells: 982.4;Peritubular cells: 474.3;Smooth muscle cells: 1942.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 9 "SH-SY5Y: 197.7" "Low region specificity" "Detected in all" HPA038843 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" No NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Focal adhesion sites, Cytosol" "HPA038843: AB_10673296" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.28e-2)" "unprognostic (8.15e-3)" "unprognostic (5.49e-2)" "unprognostic (3.42e-3)" "unprognostic (8.11e-3)" "unprognostic (1.15e-2)" "unprognostic (2.46e-2)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (5.98e-2)" "prognostic unfavorable (2.34e-5)" "unprognostic (2.65e-2)" "unprognostic (2.07e-1)" "unprognostic (1.18e-2)" "unprognostic (3.19e-2)" 478.3 199.0 28.7 39.2 24.3 4.9 203.5 26.1 34.2 305.0 18.4 151.0 19.7 283.4 8.7 44.8 750.2 61.1 269.3 24.8 44.4 226.8 179.2 377.9 6.8 93.8 42.4 721.3 60.7 3.2 126.5 15.4 38.5 157.3 8.4 1.3 22.2 14.3 110.8 97.2 130.3 28.4 35.1 54.4 240.2 67.8 44.5 5.0 119.4 10.3 0.7 176.3 148.1 21.0 0.0 0.0 0.0 0.0 4.0 2.0 1.1 0.3 1.3 0.0 0.1 0.1 0.0 0.0 0.5 0.5 2.1 0.1 0.4 0.0 0.0 0.0 2.9 6.2 0.1 0.0 0.8 0.5 0.6 0.3 0.1 1.4 0.0 0.0 1.2 2.1 2.3 0.0 0.0 0.0 2.4 2.7 1.7 0.0 0.9 10.3 0.7 4.7 0.0 0.0 2.2 197.7 0.0 0.0 19.4 5.5 0.0 2.3 2.7 9.2 3.8 2.3 0.2 22.5 0.2 3.2 7.1 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 24.3 26.1 34.2 24.8 44.4 93.8 42.4 38.5 35.1 44.5 21.0 796.5 6.4 139.9 0.0 1.9 92.9 15.2 1.6 5.2 15.4 8.2 13.7 6.0 0.0 1.9 0.0 2.1 1.5 13.7 0.3 0.0 4.5 4.3 34.1 906.3 260.3 0.0 2.7 0.0 0.6 4.4 801.3 4.1 183.3 13.9 982.4 172.7 6.4 3.8 1.7 0.0 0.2 0.0 8.4 171.8 13.9 215.6 27.1 174.3 0.0 0.1 2.7 0.0 0.0 0.0 1.9 0.0 474.3 9.4 73.6 0.0 0.0 0.9 9.3 302.4 173.2 1942.9 2.1 1.5 6.5 88.5 3.1 14.2 243.9 0.1 50.5 ACCSL ENSG00000205126 "1-aminocyclopropane-1-carboxylate synthase homolog (inactive) like" Q4AC99 11 44047981-44059977 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Astrocytes: 2.0;Excitatory neurons: 2.6;Inhibitory neurons: 2.7;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 1.8" "Cancer enriched" "Detected in single" 22 "melanoma: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA065042 Approved Cytosol NA NA "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "HPA065042: " "unprognostic (2.37e-2)" "unprognostic (2.91e-1)" "unprognostic (9.76e-5)" "unprognostic (7.42e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACCS "ACS, PHACS" ENSG00000110455 "1-aminocyclopropane-1-carboxylate synthase homolog (inactive)" Q96QU6 11 44065925-44084237 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018873, HPA021654" Approved Approved "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 6: T47d - Mammary gland" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA018873: AB_1855273, HPA021654: AB_1855274" "unprognostic (3.96e-2)" "unprognostic (1.90e-1)" "unprognostic (1.98e-1)" "unprognostic (1.86e-1)" "unprognostic (7.86e-3)" "unprognostic (2.01e-2)" "unprognostic (1.40e-1)" "unprognostic (7.57e-3)" "unprognostic (1.41e-1)" "unprognostic (3.38e-2)" "prognostic favorable (4.25e-4)" "unprognostic (6.51e-2)" "unprognostic (3.07e-2)" "unprognostic (2.29e-1)" "unprognostic (2.14e-1)" "unprognostic (5.63e-3)" "unprognostic (1.92e-2)" 11.4 17.0 1.8 3.7 1.5 10.0 11.2 1.5 2.0 11.1 7.2 8.3 5.4 14.2 8.1 5.5 15.4 10.1 5.8 1.9 2.2 10.4 18.9 9.7 5.5 2.0 1.8 9.8 11.0 2.8 11.0 2.6 1.8 10.9 6.9 1.0 10.3 6.3 3.1 7.8 10.3 6.3 1.5 14.0 10.4 6.5 2.3 4.1 12.7 2.4 6.4 9.1 8.3 2.0 4.0 8.8 0.0 1.0 2.3 4.1 0.0 2.1 2.7 1.9 2.0 0.7 5.6 1.5 1.6 4.7 0.0 6.7 2.4 0.5 1.0 0.5 2.6 6.3 3.3 0.1 4.4 0.0 0.0 4.6 8.2 2.4 1.1 2.6 3.5 0.0 5.0 0.0 5.8 3.0 0.0 2.5 3.4 5.1 1.3 5.5 0.0 0.0 4.8 2.6 1.1 3.5 2.1 1.1 2.5 2.2 8.6 3.8 3.8 2.2 2.3 3.5 1.1 0.0 0.0 0.2 5.3 0.0 2.3 0.9 3.1 5.6 0.8 3.1 0.7 1.1 0.7 1.3 4.4 1.4 1.1 0.7 0.0 0.9 2.5 3.3 1.2 2.0 1.8 1.5 1.5 2.0 1.9 2.2 2.0 1.8 1.8 1.5 2.3 2.0 12.2 12.8 22.7 11.8 4.6 2.7 2.7 4.0 6.8 1.9 8.6 10.2 4.0 7.2 8.9 9.2 0.0 3.1 4.0 6.4 0.0 2.3 2.1 8.6 3.9 7.0 7.2 3.4 3.4 4.2 0.4 6.9 13.7 5.0 9.5 11.0 8.2 9.7 6.1 0.0 3.3 8.2 4.1 7.0 5.5 4.4 9.6 9.0 0.0 5.6 9.4 2.6 7.2 4.5 6.6 2.9 8.0 7.5 2.5 2.1 16.6 6.5 7.4 1.0 0.0 3.7 4.7 0.7 2.4 2.4 2.3 1.9 3.3 9.2 6.4 2.1 EXT2 SOTV ENSG00000151348 "Exostosin glycosyltransferase 2" Q93063 11 44095673-44251962 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Disease variant, Epilepsy, Hereditary multiple exostoses, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078409 Supported "Golgi apparatus" NA NA 39000000 "Cluster 27: Non-specific - Gene expression" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA078409: AB_2686884" "unprognostic (5.87e-2)" "unprognostic (3.05e-3)" "unprognostic (3.48e-2)" "unprognostic (3.94e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.77e-3)" "unprognostic (2.22e-2)" "unprognostic (1.97e-1)" "unprognostic (2.05e-1)" "unprognostic (1.74e-3)" "unprognostic (3.70e-2)" "prognostic unfavorable (5.36e-6)" "unprognostic (7.07e-3)" "unprognostic (2.97e-1)" "unprognostic (3.85e-1)" "unprognostic (1.36e-2)" 33.5 22.8 14.4 22.1 15.4 11.2 29.3 15.4 16.3 36.1 17.5 29.1 26.5 43.1 33.3 20.1 33.7 28.1 27.3 15.6 18.1 26.5 26.9 27.9 16.0 15.5 16.0 33.5 26.5 28.9 20.1 61.9 15.5 29.8 28.7 20.9 26.7 30.2 16.2 25.8 31.0 49.3 14.7 21.6 23.8 21.6 19.4 15.2 27.6 18.4 17.3 29.7 28.5 16.1 57.9 71.6 38.3 121.5 170.4 124.2 60.8 181.1 198.0 93.1 125.1 51.2 36.5 40.4 82.1 188.8 98.5 90.0 41.0 114.0 110.0 83.2 71.5 38.4 33.7 39.7 67.5 37.5 76.6 97.7 73.4 56.3 86.6 108.8 132.7 34.8 50.0 63.9 68.4 40.3 25.9 22.3 43.8 67.1 70.9 32.3 116.1 21.1 53.9 49.1 30.9 35.5 118.1 41.4 28.1 67.0 69.8 37.2 137.8 127.4 90.6 133.1 111.4 33.4 46.0 30.4 84.7 27.9 140.0 15.2 17.5 19.4 20.9 17.7 23.5 9.0 16.5 19.3 21.3 8.8 15.4 15.2 3.4 26.3 12.8 7.4 14.2 15.5 14.4 15.4 15.4 16.3 15.6 18.1 15.5 16.0 15.5 14.7 19.4 16.1 24.5 16.0 10.6 41.4 8.7 15.2 17.3 22.0 10.8 11.5 11.0 11.4 10.2 8.6 13.5 12.9 14.6 34.3 10.6 21.1 5.9 33.5 43.2 7.9 17.1 19.2 1.8 6.7 64.3 23.7 37.0 32.3 7.7 11.5 6.3 22.7 22.9 18.3 18.3 13.5 63.3 12.9 12.2 10.8 7.2 23.0 27.4 10.4 5.4 28.1 10.2 17.4 7.2 50.3 51.8 24.0 14.9 28.6 7.0 23.6 31.6 8.2 8.1 15.0 19.7 15.8 20.7 51.2 24.4 10.2 12.6 35.3 9.2 12.2 15.0 15.3 ALX4 "FPP, KIAA1788, PFM, PFM2" ENSG00000052850 "ALX homeobox 4" Q9H161 11 44260440-44310139 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 1.8;choroid plexus: 1.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 20.4;Fibroblasts: 4.3;Leydig cells: 4.7;Microglial cells: 6.5;Skeletal myocytes: 5.5" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.0;BJ: 3.4;HAP1: 4.7;HEK 293: 4.8;HEL: 6.8;K-562: 3.2;SiHa: 7.0" "Region enriched" "Detected in some" 8 "olfactory bulb: 9.0" "Region enriched" "Detected in single" 31 "olfactory bulb: 9.0" HPA001903 Supported Nucleoplasm NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 36: HEL - Hemostasis" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "HPA001903: AB_2666495" "unprognostic (7.56e-5)" "unprognostic (1.69e-1)" "unprognostic (5.40e-2)" "unprognostic (2.74e-1)" "unprognostic (7.24e-3)" "unprognostic (2.63e-4)" "unprognostic (1.95e-1)" "unprognostic (2.89e-2)" "unprognostic (2.33e-4)" "unprognostic (5.13e-2)" "unprognostic (1.25e-1)" "unprognostic (1.55e-1)" "unprognostic (1.34e-6)" "unprognostic (3.62e-2)" "unprognostic (2.85e-1)" "unprognostic (2.02e-3)" "unprognostic (2.03e-1)" 0.4 0.0 0.1 0.0 0.1 0.0 1.8 0.1 0.4 0.4 1.9 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.7 0.0 1.0 0.9 0.0 0.3 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.5 0.0 4.0 0.0 0.0 0.0 3.4 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.7 0.0 0.0 1.0 4.8 6.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.2 0.0 0.2 0.3 0.1 0.1 0.0 0.1 0.4 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 1.1 1.3 20.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.6 4.7 0.1 0.0 6.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CD82 "IA4, KAI1, R2, ST6, TSPAN27" ENSG00000085117 "CD82 molecule" P27701 11 44564427-44620358 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 280.3;Proximal enterocytes: 220.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 536.4" "Group enriched" "Detected in all" 6 "B-cells: 310.1;granulocytes: 536.4;T-cells: 173.1" "Cell line enhanced" "Detected in many" "HMC-1: 463.8;U-87 MG: 323.3" "Region enhanced" "Detected in all" "white matter: 210.9" "Low region specificity" "Detected in all" "CAB002508, HPA028900, HPA061418" Supported Approved Vesicles NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Vesicles "CAB002508: AB_563640, HPA028900: AB_10603558, HPA061418: AB_2684510" "unprognostic (5.31e-2)" "unprognostic (4.62e-1)" "unprognostic (2.38e-2)" "unprognostic (1.33e-1)" "unprognostic (2.79e-1)" "unprognostic (1.37e-2)" "unprognostic (1.78e-1)" "unprognostic (7.29e-2)" "unprognostic (3.48e-1)" "unprognostic (2.97e-1)" "unprognostic (2.58e-2)" "unprognostic (1.58e-1)" "unprognostic (3.48e-3)" "unprognostic (1.86e-3)" "unprognostic (2.33e-2)" "unprognostic (2.88e-2)" "unprognostic (6.30e-2)" 39.2 9.1 47.7 57.3 80.5 140.9 36.6 45.2 48.8 38.8 48.5 24.7 74.1 9.1 31.9 130.9 54.0 39.6 25.6 41.9 51.7 26.1 36.9 87.3 68.5 58.5 74.3 14.9 31.3 7.8 7.5 41.0 49.8 27.5 17.2 4.2 81.1 72.1 23.1 84.2 81.6 16.6 39.6 47.3 62.8 4.5 79.0 45.0 22.4 20.0 82.6 47.6 66.1 67.2 30.0 5.2 35.1 7.2 24.0 98.4 1.2 16.9 132.9 29.4 78.5 2.0 19.6 30.9 20.8 8.1 61.1 118.8 4.6 88.4 59.6 145.4 2.7 220.9 9.3 0.6 21.3 58.8 463.8 142.1 99.2 128.3 62.1 68.4 49.7 26.9 1.6 9.4 247.3 25.0 46.7 97.7 1.1 103.2 2.4 1.5 190.0 43.9 16.8 36.1 1.2 2.0 13.0 162.6 23.0 4.2 161.2 51.3 33.9 94.4 12.5 1.8 179.0 3.6 0.4 0.9 323.3 32.5 56.0 369.9 59.3 110.7 29.9 33.0 51.4 310.1 150.7 70.3 14.9 211.9 51.1 23.1 536.4 50.1 25.0 44.5 173.1 65.9 47.7 80.5 45.2 48.8 41.9 51.7 58.5 74.3 49.8 39.6 79.0 67.2 43.6 48.1 38.8 9.4 112.8 55.1 108.1 149.0 107.6 2.4 68.1 54.7 7.7 58.6 143.8 158.2 2.1 1.3 14.9 17.4 11.7 79.7 2.0 23.1 5.0 41.0 13.2 92.9 0.3 66.7 1.1 29.1 58.6 25.2 280.3 0.7 59.6 32.5 64.3 1.7 0.6 36.8 63.1 26.6 18.2 2.0 40.4 52.3 64.0 3.7 11.0 35.7 0.0 54.3 22.4 86.7 50.3 8.2 16.0 59.1 220.6 2.5 73.0 2.7 13.1 109.0 46.0 2.1 5.9 161.3 67.2 1.4 46.3 0.6 43.1 142.8 TSPAN18 TSPAN ENSG00000157570 "Tetraspanin 18" Q96SJ8 11 44726465-44932423 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 83.5" "Group enriched" "Detected in many" 6 "Adipocytes: 72.2;Cardiomyocytes: 22.3;Early spermatids: 29.7;Endothelial cells: 51.8;Hepatic stellate cells: 70.3;Proximal tubular cells: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 36.7;CAPAN-2: 61.5;GAMG: 35.2;HDLM-2: 48.7;NTERA-2: 33.0;RH-30: 38.4;SCLC-21H: 31.9;SH-SY5Y: 36.2;SuSa: 99.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 12: NES - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "unprognostic (1.09e-1)" "unprognostic (1.97e-1)" "unprognostic (8.53e-3)" "unprognostic (3.48e-2)" "unprognostic (6.30e-2)" "unprognostic (8.64e-2)" "unprognostic (7.17e-2)" "unprognostic (2.91e-2)" "unprognostic (8.75e-2)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (2.29e-1)" "unprognostic (1.04e-3)" "unprognostic (6.78e-3)" "unprognostic (3.22e-1)" "unprognostic (2.19e-1)" "unprognostic (5.59e-2)" 22.2 46.1 5.8 10.4 4.3 1.2 10.0 30.5 8.2 14.4 3.6 47.9 6.7 46.7 3.6 21.0 20.8 13.3 83.5 26.1 4.6 14.5 4.9 22.4 7.7 5.1 10.4 7.4 1.6 3.9 5.4 30.2 4.9 15.8 9.9 1.0 3.3 41.4 14.7 6.3 16.4 46.6 8.9 14.1 16.6 4.0 10.8 4.0 14.8 19.9 4.2 23.1 10.2 2.3 0.0 0.6 36.7 0.5 0.0 0.0 0.0 0.6 0.5 2.3 0.1 7.3 61.5 0.0 16.4 1.0 35.2 0.0 6.6 0.2 0.6 48.7 2.4 0.2 5.0 0.0 0.0 0.2 0.1 0.7 0.0 0.1 0.0 0.0 14.3 0.2 1.1 0.0 0.1 0.0 0.0 0.1 33.0 0.1 1.0 0.1 38.4 0.2 0.0 0.0 31.9 36.2 0.4 0.1 0.1 99.8 0.2 0.1 1.4 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 1.6 1.0 0.0 0.0 1.6 0.1 0.0 0.8 0.2 1.1 0.5 0.0 0.0 1.3 0.2 0.3 0.5 0.0 0.0 0.3 1.7 5.8 4.3 30.5 8.2 26.1 4.6 5.1 10.4 4.9 8.9 10.8 2.3 72.2 0.0 3.7 5.5 1.5 1.7 0.1 0.0 0.6 1.8 1.0 0.3 22.3 0.0 0.0 7.3 0.0 0.1 1.1 0.0 0.0 0.4 29.7 0.7 0.9 51.8 0.0 3.6 2.7 0.2 0.2 6.8 0.5 1.4 1.3 0.0 70.3 1.0 0.4 1.7 4.1 0.0 0.0 2.5 2.6 5.6 2.8 3.4 7.2 2.8 0.2 0.1 0.0 4.0 1.3 0.7 0.0 1.5 0.6 0.2 0.0 20.2 0.0 0.5 0.0 4.9 2.0 0.6 1.0 0.0 1.1 0.3 3.0 3.2 0.0 0.1 TP53I11 PIG11 ENSG00000175274 "Tumor protein p53 inducible protein 11" O14683 11 44885903-44951306 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 461.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 41.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 133.9;SCLC-21H: 357.9;T-47d: 209.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059727, HPA061276" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 25: Spermatids - Spermatogenesis" "Endoplasmic reticulum, Golgi apparatus" "HPA059727: AB_2684113, HPA061276: AB_2684461" "prognostic unfavorable (7.33e-5)" "unprognostic (1.87e-1)" "unprognostic (4.03e-2)" "unprognostic (3.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.66e-1)" "unprognostic (1.26e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (6.12e-4)" "unprognostic (6.55e-2)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (4.65e-4)" "unprognostic (2.14e-2)" "unprognostic (1.64e-1)" "unprognostic (2.09e-1)" "unprognostic (1.10e-1)" 77.8 18.6 41.1 20.4 17.8 29.6 63.7 40.5 27.5 32.8 19.7 43.4 20.2 36.0 4.9 24.5 45.5 24.7 71.7 24.7 27.6 27.9 10.5 45.7 12.7 16.9 30.2 20.0 37.7 5.6 20.3 23.9 24.1 47.8 27.5 2.2 42.7 11.7 15.0 30.3 38.8 32.8 19.5 61.2 29.9 16.2 18.3 9.1 41.0 10.3 12.3 29.2 32.0 13.4 0.0 82.0 27.3 38.2 28.0 2.2 0.5 23.9 46.3 8.5 10.7 5.1 0.5 14.3 20.5 6.9 21.7 14.5 14.6 0.5 2.8 28.0 12.3 1.3 0.8 0.0 52.5 0.8 101.1 118.0 1.9 11.5 4.9 2.0 29.6 31.6 2.2 0.1 11.3 73.0 1.4 133.9 48.9 53.4 26.9 60.3 16.1 7.2 0.0 5.2 357.9 13.0 44.2 96.8 0.1 33.9 209.9 7.5 6.8 55.8 39.3 87.3 0.1 0.5 0.5 0.3 0.1 7.8 16.1 0.0 5.9 0.0 5.2 5.8 7.0 8.0 1.0 5.1 4.7 8.4 0.0 1.7 41.2 8.1 21.2 25.3 0.9 4.8 41.1 17.8 40.5 27.5 24.7 27.6 16.9 30.2 24.1 19.5 18.3 13.4 52.2 22.4 30.9 0.3 13.2 10.8 36.9 12.9 13.6 1.7 29.5 22.7 10.3 24.3 23.7 42.3 0.0 57.8 8.7 31.0 1.9 32.0 96.5 9.0 6.3 45.1 36.0 3.2 2.7 21.3 22.0 15.0 23.0 9.7 0.0 7.8 76.8 1.6 35.7 0.0 10.2 30.1 38.7 7.5 20.3 461.2 12.2 9.3 10.6 5.6 11.5 0.8 0.0 0.0 0.5 28.5 16.0 7.5 2.1 28.6 17.7 0.1 14.5 0.8 13.1 1.4 22.4 3.4 6.3 4.4 4.4 68.3 8.7 5.1 54.0 45.7 PRDM11 PFM8 ENSG00000019485 "PR/SET domain 11" Q9NQV5 11 45095806-45235110 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 60.0;Sertoli cells: 19.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057072 Approved NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 50: Fibroblasts - ECM organization" "HPA057072: AB_2683328" "unprognostic (3.32e-4)" "unprognostic (3.94e-2)" "unprognostic (3.01e-1)" "unprognostic (1.71e-3)" "unprognostic (4.27e-2)" "unprognostic (2.23e-2)" "unprognostic (7.10e-4)" "unprognostic (7.06e-2)" "unprognostic (1.41e-1)" "unprognostic (2.23e-1)" "unprognostic (9.57e-5)" "unprognostic (1.60e-1)" "unprognostic (4.93e-6)" "unprognostic (9.25e-2)" "unprognostic (2.88e-1)" "unprognostic (1.39e-3)" "unprognostic (2.21e-1)" 5.5 4.3 8.8 2.6 8.2 2.5 4.5 7.1 10.6 11.0 5.1 11.2 2.1 13.0 3.0 6.6 10.1 3.3 10.8 8.2 8.2 5.3 2.6 5.5 2.5 6.8 7.6 10.3 5.2 2.8 8.6 4.1 6.6 8.9 2.3 2.5 4.2 7.8 6.8 3.8 5.5 9.2 5.7 5.4 6.5 1.9 8.5 2.4 9.0 8.2 2.6 8.7 9.0 7.7 4.6 12.7 3.1 1.6 5.1 4.3 0.7 2.3 5.1 7.7 5.0 11.7 1.7 5.1 5.2 3.3 9.9 5.5 6.2 2.8 2.5 1.6 4.8 3.8 18.3 2.2 8.1 4.5 4.9 5.5 10.2 0.4 8.1 5.4 7.7 0.9 1.7 0.0 3.8 2.3 0.0 6.0 3.7 4.1 8.3 5.8 11.6 0.1 4.2 4.2 4.0 4.9 5.3 0.8 5.8 1.9 19.3 2.4 4.1 16.5 7.8 4.0 5.2 3.9 4.7 4.7 0.7 1.0 4.7 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 8.8 8.2 7.1 10.6 8.2 8.2 6.8 7.6 6.6 5.7 8.5 7.7 3.1 6.4 6.2 11.4 2.9 2.2 5.4 0.9 2.8 5.7 3.1 3.7 8.2 0.0 6.0 5.5 2.1 0.8 2.8 1.1 0.0 1.4 1.3 4.8 4.3 4.3 0.0 2.1 11.4 1.1 0.3 4.4 3.6 2.7 0.0 3.2 6.8 1.4 0.8 10.1 10.3 1.9 2.0 0.8 0.3 7.8 5.3 1.3 0.0 60.0 1.6 3.6 1.0 9.5 8.2 0.5 0.6 7.2 0.6 3.5 0.5 1.4 3.0 1.6 19.7 6.5 5.5 0.4 0.7 1.8 0.9 0.3 2.9 3.9 2.9 2.4 SYT13 KIAA1427 ENSG00000019505 "Synaptotagmin 13" Q7L8C5 11 45240302-45286341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.1;gallbladder: 20.8;pituitary gland: 16.8" "Cell type enriched" "Detected in many" 7 "Enteroendocrine cells: 336.8" "Group enriched" "Detected in many" 5 "breast cancer: 13.5;colorectal cancer: 7.4;pancreatic cancer: 19.9;renal cancer: 16.9;stomach cancer: 11.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 19.1;NTERA-2: 8.8;RPTEC TERT1: 56.8;SCLC-21H: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046224, HPA056602" Uncertain Supported Vesicles NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 17: Intestinal endocrine cells - Hormone signaling" Vesicles "HPA046224: AB_10961288, HPA056602: AB_2683185" "unprognostic (4.96e-2)" "unprognostic (1.06e-2)" "unprognostic (9.92e-2)" "prognostic unfavorable (7.79e-5)" "unprognostic (1.00e-2)" "unprognostic (4.17e-2)" "unprognostic (3.75e-2)" "unprognostic (9.83e-3)" "unprognostic (2.19e-1)" "unprognostic (7.58e-2)" "unprognostic (1.21e-1)" "unprognostic (2.47e-1)" "unprognostic (5.66e-3)" "unprognostic (2.94e-2)" "unprognostic (1.76e-1)" "unprognostic (8.70e-2)" "unprognostic (5.13e-2)" 0.1 4.7 7.0 1.5 12.7 0.0 0.2 1.7 30.1 0.0 0.0 12.2 12.5 0.2 0.0 0.0 0.2 20.8 5.2 18.0 11.5 8.9 0.3 0.5 0.0 5.7 1.2 0.0 7.1 0.4 16.8 0.0 5.4 1.8 12.6 11.3 1.9 0.0 0.1 0.2 12.8 0.8 0.0 0.1 11.0 1.7 9.0 0.3 1.6 0.1 0.0 0.0 0.0 5.2 0.0 19.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.2 0.0 1.1 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 8.8 0.0 0.2 0.0 0.0 0.0 56.8 0.0 15.0 0.7 0.0 0.0 0.1 0.7 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 12.7 1.7 30.1 18.0 11.5 5.7 1.2 5.4 0.0 9.0 5.2 0.0 0.0 0.0 4.6 0.1 0.0 0.2 0.0 0.0 3.3 0.1 0.3 15.3 17.2 0.0 3.7 25.0 0.0 0.0 10.2 5.9 1.2 3.1 0.4 0.2 0.1 336.8 0.0 41.6 0.6 0.0 1.7 3.6 2.0 0.0 2.5 0.0 0.0 0.0 1.7 43.8 37.3 4.1 0.0 0.0 9.7 0.3 0.0 0.0 5.6 0.0 0.7 0.0 1.5 3.5 8.2 14.3 0.0 0.0 2.3 13.9 0.5 0.0 2.7 0.0 0.0 0.2 2.0 0.2 0.0 0.0 0.0 0.0 0.0 32.8 0.2 CHST1 "C6ST, KSGal6ST" ENSG00000175264 "Carbohydrate sulfotransferase 1" O43916 11 45647689-45665622 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.6;thyroid gland: 20.5" "Cell type enhanced" "Detected in many" "Astrocytes: 38.5;Early spermatids: 75.9;Granulosa cells: 138.1;Spermatocytes: 96.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 9.3;TIME: 9.2;WM-115: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 10000 "Cluster 10: Brain - Neuronal signaling" "Cluster 17: WM-115 - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (1.77e-2)" "unprognostic (1.67e-1)" "unprognostic (6.37e-3)" "unprognostic (1.32e-1)" "unprognostic (2.18e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (3.95e-4)" "unprognostic (6.22e-2)" "unprognostic (1.64e-1)" "unprognostic (1.39e-1)" "unprognostic (1.09e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (4.64e-7)" "unprognostic (5.37e-3)" "unprognostic (1.06e-1)" "unprognostic (1.30e-1)" "unprognostic (9.11e-3)" 2.3 3.7 31.4 0.5 34.2 0.3 1.9 0.4 35.6 2.7 0.0 1.8 0.5 2.3 0.1 1.0 5.5 0.6 5.7 32.6 13.4 8.7 2.1 4.5 0.7 6.9 12.7 5.3 1.3 3.3 11.9 0.4 6.8 2.0 0.1 1.0 6.4 0.3 8.7 1.1 1.6 0.5 2.4 7.6 1.5 4.0 24.2 0.5 20.5 1.0 0.4 2.0 2.1 16.4 0.0 0.3 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 2.0 0.0 0.0 0.2 0.3 9.3 0.1 0.0 0.1 0.8 0.2 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.5 0.7 0.2 0.0 9.2 1.8 2.6 0.0 0.0 0.0 0.0 0.0 3.8 0.0 24.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 31.4 34.2 0.4 35.6 32.6 13.4 6.9 12.7 6.8 2.4 24.2 16.4 4.4 0.0 0.0 38.5 0.0 0.1 2.9 0.4 0.0 10.0 1.4 0.4 2.1 0.0 0.3 1.8 0.0 0.0 0.2 0.0 0.0 2.6 75.9 0.7 1.1 21.1 0.0 0.0 23.9 0.2 0.1 2.3 0.5 2.5 0.0 138.1 10.4 0.3 0.2 0.0 10.2 0.0 0.0 0.9 1.7 15.0 5.6 0.9 0.0 4.7 0.0 4.5 0.0 3.0 3.9 0.3 0.0 4.9 0.0 2.4 0.0 0.1 0.2 0.5 26.3 0.7 2.6 96.8 1.4 0.2 0.0 0.0 0.5 2.3 0.0 0.9 SLC35C1 "FLJ11320, FUCT1" ENSG00000181830 "Solute carrier family 35 member C1" Q96A29 11 45804072-45813016 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 84.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 50.6;Distal enterocytes: 54.6;Pancreatic endocrine cells: 50.6;Paneth cells: 54.0;Proximal enterocytes: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064001 Enhanced Supported "Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "HPA064001: AB_2685171" "unprognostic (2.62e-2)" "unprognostic (5.16e-2)" "unprognostic (7.82e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (8.22e-2)" "unprognostic (9.40e-2)" "unprognostic (1.56e-2)" "unprognostic (2.83e-2)" "unprognostic (1.28e-1)" "unprognostic (4.09e-2)" "unprognostic (2.73e-1)" "unprognostic (7.68e-2)" "unprognostic (1.83e-3)" "unprognostic (2.18e-1)" "prognostic favorable (3.64e-4)" "unprognostic (2.30e-2)" 28.2 7.3 6.6 10.7 6.3 2.4 19.8 7.0 7.0 9.6 6.1 19.8 24.4 8.8 2.3 41.5 7.3 12.2 9.0 6.2 7.2 7.0 84.5 10.2 6.6 8.2 7.9 6.3 13.4 5.6 10.4 15.0 7.7 9.9 14.3 1.6 26.1 5.9 6.8 5.1 24.1 9.9 6.5 8.4 18.5 5.2 8.8 4.5 6.6 6.9 10.0 13.8 14.9 6.3 10.3 25.8 6.3 16.3 19.9 19.8 19.5 22.1 20.1 13.3 14.4 10.7 15.2 10.4 9.9 27.3 19.4 26.0 13.4 13.6 6.5 24.8 14.5 5.9 20.4 20.6 42.6 11.4 16.2 23.8 16.3 9.2 11.1 16.2 17.6 10.3 13.3 13.8 14.4 21.8 5.9 9.0 27.5 39.9 34.6 7.2 10.5 21.5 15.1 25.4 6.0 8.6 16.6 16.3 9.5 6.6 13.7 6.0 25.7 25.0 14.7 46.1 15.6 9.8 26.9 4.9 18.5 14.4 14.2 9.7 11.6 12.5 11.0 11.9 12.3 5.0 18.0 14.7 9.6 3.7 9.3 8.0 1.8 5.6 8.7 8.2 13.0 10.1 6.6 6.3 7.0 7.0 6.2 7.2 8.2 7.9 7.7 6.5 8.8 6.3 5.5 0.0 11.2 2.6 6.2 3.6 8.9 12.7 3.4 1.9 11.1 3.0 50.6 22.8 26.7 5.5 2.1 13.8 6.4 54.6 0.0 18.4 4.9 7.3 6.7 10.6 9.6 3.6 2.0 41.9 14.0 10.5 23.4 11.4 2.5 5.2 6.8 42.2 14.7 3.3 2.1 40.6 4.1 9.3 4.8 6.0 6.5 6.3 1.8 2.8 9.5 2.8 7.2 1.0 2.1 50.6 54.0 5.7 13.6 11.8 58.0 4.7 11.4 1.1 0.0 3.6 9.7 4.0 4.3 12.7 2.4 15.3 6.5 5.7 26.4 20.1 CRY2 ENSG00000121671 "Cryptochrome circadian regulator 2" Q49AN0 11 45847118-45883248 "Predicted intracellular proteins" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation" "Photoreceptor protein, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Bipolar cells: 141.9;Horizontal cells: 101.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037577 Supported Supported "Nuclear speckles,Cytosol" "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 62: Horizontal cells - Visual perception" "Nuclear speckles" Cytosol "HPA037577: AB_10672497" "unprognostic (1.67e-1)" "unprognostic (9.35e-2)" "prognostic unfavorable (1.67e-4)" "unprognostic (1.31e-2)" "unprognostic (9.16e-2)" "unprognostic (3.09e-2)" "prognostic favorable (6.82e-5)" "unprognostic (1.48e-3)" "unprognostic (1.67e-1)" "unprognostic (5.07e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.01e-1)" "prognostic favorable (6.44e-15)" "unprognostic (8.13e-3)" "unprognostic (1.89e-1)" "unprognostic (4.24e-2)" "unprognostic (2.24e-1)" 31.8 22.3 33.3 8.9 35.3 29.4 27.1 36.4 36.9 24.4 22.8 26.5 10.8 23.3 16.9 15.9 29.1 17.4 60.0 36.6 29.3 22.5 62.7 22.9 10.4 27.4 31.5 38.7 34.7 22.4 30.8 13.5 28.5 25.3 9.9 52.8 21.7 22.1 96.7 50.4 16.7 17.1 28.8 14.0 24.6 34.4 35.2 12.6 34.0 64.8 10.3 26.0 18.4 31.4 1.4 4.2 6.3 7.5 16.7 8.4 13.8 5.0 8.9 6.2 4.5 6.8 3.3 9.8 3.8 10.5 5.9 8.5 6.0 5.2 4.3 9.8 5.5 6.4 8.2 9.4 6.4 8.0 8.5 9.9 7.5 4.8 7.6 7.0 4.4 7.5 12.7 16.2 5.6 5.3 6.8 9.4 17.1 17.8 5.0 11.5 9.1 4.6 4.5 7.8 10.1 3.8 8.3 7.5 4.5 8.0 10.0 5.5 5.5 8.7 5.3 13.5 3.6 15.0 10.8 7.9 5.3 3.5 5.3 4.1 3.5 5.4 5.7 4.8 4.7 5.0 5.5 6.1 3.6 4.6 6.6 6.9 1.8 7.5 8.0 2.6 4.9 5.3 33.3 35.3 36.4 36.9 36.6 29.3 27.4 31.5 28.5 28.8 35.2 31.4 11.7 12.8 18.2 48.0 12.6 17.0 9.7 5.1 8.0 141.9 10.6 8.6 34.7 14.3 11.6 7.3 27.1 8.0 10.0 17.2 29.4 5.4 24.2 28.1 7.5 9.2 7.1 3.0 30.3 4.7 5.6 19.8 12.8 15.4 14.7 10.8 8.6 47.3 3.6 101.0 26.0 7.4 6.1 8.5 12.5 8.7 31.4 7.2 16.0 10.3 6.2 34.4 10.3 13.0 13.6 6.0 6.0 39.9 8.5 11.6 10.5 11.6 23.8 27.5 19.7 14.5 14.6 29.1 15.0 4.4 17.5 9.3 9.1 8.4 6.0 9.8 MAPK8IP1 "IB1, JIP-1, JIP1, PRKM8IP" ENSG00000121653 "Mitogen-activated protein kinase 8 interacting protein 1" Q9UQF2 11 45885651-45906465 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 166.8;pituitary gland: 118.2" "Cell type enhanced" "Detected in many" "Early spermatids: 43.8;Enteroendocrine cells: 40.2;Horizontal cells: 67.3;Late spermatids: 39.2;Muller glia cells: 41.3;Oligodendrocytes: 48.7" "Cancer enhanced" "Detected in all" "glioma: 51.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 76.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058921, HPA070332, HPA079657" Approved Enhanced "Plasma membrane" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 62: Horizontal cells - Visual perception" "Plasma membrane" "HPA058921: AB_2683854, HPA070332: AB_2686254, HPA079657: " "unprognostic (3.96e-2)" "unprognostic (8.73e-2)" "unprognostic (1.08e-1)" "unprognostic (6.88e-2)" "unprognostic (5.59e-2)" "unprognostic (2.82e-1)" "unprognostic (8.25e-3)" "unprognostic (3.42e-3)" "unprognostic (1.27e-2)" "unprognostic (9.54e-2)" "unprognostic (3.22e-3)" "unprognostic (2.20e-2)" "prognostic favorable (1.23e-11)" "unprognostic (7.19e-2)" "unprognostic (4.01e-2)" "unprognostic (4.46e-2)" "unprognostic (1.80e-3)" 4.8 23.3 127.9 2.3 131.0 1.3 4.8 122.0 147.7 8.2 29.6 8.3 1.4 10.9 3.5 2.2 11.3 3.5 5.5 166.8 120.6 11.5 5.6 4.0 0.6 154.9 130.9 9.1 43.1 19.2 118.2 1.4 142.6 11.6 1.2 11.5 11.4 6.1 2.4 4.0 3.7 5.7 124.6 2.3 9.0 27.7 139.3 1.0 7.0 2.5 0.4 6.7 4.8 164.4 0.0 7.1 9.4 26.2 3.4 1.8 0.3 5.1 4.6 9.9 7.2 6.3 1.1 0.4 2.5 5.9 16.8 5.8 10.2 4.8 4.4 4.0 13.1 0.1 8.6 4.1 3.1 0.6 4.4 2.4 1.0 6.4 1.3 6.6 2.2 0.9 11.5 1.6 2.8 3.9 0.4 0.6 24.9 3.3 10.5 0.6 15.4 0.3 4.6 0.2 76.4 28.5 8.4 6.8 10.0 3.6 11.0 0.4 2.1 12.5 19.1 19.0 9.3 1.1 1.3 0.5 7.9 0.2 3.8 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.0 127.9 131.0 122.0 147.7 166.8 120.6 154.9 130.9 142.6 124.6 139.3 164.4 1.7 6.4 4.1 7.2 0.9 2.4 5.8 2.0 2.8 34.4 6.1 5.3 1.1 5.7 3.3 11.0 22.9 1.6 0.4 2.2 13.7 6.9 43.8 23.9 15.9 2.9 40.2 0.0 10.3 28.9 0.6 6.5 4.1 19.9 0.0 2.8 0.4 4.6 0.5 67.3 11.6 1.6 4.1 0.8 3.5 39.2 6.2 1.1 3.6 1.0 1.6 41.3 0.0 3.5 48.7 11.6 0.5 6.4 0.1 6.3 1.4 8.9 10.9 18.3 0.0 14.2 6.0 10.6 8.2 0.9 1.0 5.7 1.3 7.7 0.9 5.5 C11orf94 ENSG00000234776 "Chromosome 11 open reading frame 94" C9JXX5 11 45906513-45907272 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 148 "testis: 54.7" "Group enriched" "Detected in some" 82 "Early spermatids: 390.0;Late spermatids: 189.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (1.55e-1)" "unprognostic (2.71e-1)" "unprognostic (2.28e-1)" "unprognostic (2.36e-1)" "unprognostic (7.28e-2)" "unprognostic (5.99e-2)" "unprognostic (6.21e-3)" "unprognostic (1.97e-1)" "unprognostic (1.43e-1)" "unprognostic (7.11e-2)" "unprognostic (3.33e-2)" "unprognostic (4.24e-2)" "unprognostic (9.05e-4)" "unprognostic (1.90e-1)" "unprognostic (1.10e-1)" "unprognostic (3.28e-1)" "unprognostic (1.47e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 390.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 189.9 1.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 3.5 1.6 0.0 0.0 0.0 0.0 0.1 0.2 0.1 PEX16 ENSG00000121680 "Peroxisomal biogenesis factor 16" Q9Y5Y5 11 45909663-45918812 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043286 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 22: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 1: Pancreatic cells - Digestion" "HPA043286: AB_10794179" "unprognostic (2.48e-1)" "unprognostic (1.95e-2)" "unprognostic (8.14e-2)" "unprognostic (3.15e-2)" "unprognostic (1.76e-1)" "unprognostic (1.53e-1)" "unprognostic (9.06e-3)" "unprognostic (9.06e-3)" "unprognostic (2.11e-1)" "unprognostic (1.10e-1)" "unprognostic (3.48e-3)" "unprognostic (1.51e-1)" "unprognostic (6.75e-3)" "unprognostic (5.72e-3)" "unprognostic (2.71e-1)" "unprognostic (1.00e-1)" "prognostic favorable (9.06e-4)" 23.4 27.1 22.3 10.9 23.8 20.3 22.2 23.4 24.4 18.2 16.6 20.6 21.3 18.7 6.3 21.3 18.9 10.1 17.0 23.0 22.7 26.7 50.2 16.2 16.6 26.2 23.6 18.3 40.0 10.1 32.0 6.7 23.2 21.7 5.1 4.4 21.6 9.7 18.1 27.2 25.3 6.0 21.9 24.5 27.6 25.8 23.6 11.8 21.8 7.5 8.6 20.1 18.0 26.0 15.0 19.9 6.7 16.8 11.0 13.2 19.4 11.6 15.2 15.5 12.0 22.6 10.7 25.6 15.0 10.9 14.7 27.2 6.9 23.0 3.7 22.4 23.6 16.7 28.8 20.1 34.8 24.9 33.8 21.3 20.1 9.4 15.1 9.1 17.0 21.9 13.4 29.6 10.7 42.0 21.3 32.5 15.1 28.7 20.0 18.4 16.8 29.4 10.0 26.5 17.0 22.7 13.3 27.1 24.5 4.2 40.4 21.1 13.6 14.8 19.0 36.9 21.5 47.1 33.1 16.2 16.2 14.7 16.2 35.3 44.1 36.8 47.9 51.0 44.9 57.0 48.9 49.6 47.8 50.5 44.4 46.7 32.2 44.9 38.6 44.7 61.1 46.1 22.3 23.8 23.4 24.4 23.0 22.7 26.2 23.6 23.2 21.9 23.6 26.0 25.1 3.2 5.4 3.9 35.7 16.6 24.4 47.6 19.4 15.7 25.9 22.4 3.8 22.8 25.1 14.7 10.4 39.9 31.9 45.8 50.9 37.3 25.9 19.7 13.8 21.5 28.1 25.9 4.8 88.7 22.2 15.7 17.9 20.3 21.0 16.2 21.8 68.6 34.2 15.2 5.1 26.5 30.5 37.7 19.7 32.6 19.3 20.0 21.4 3.7 46.6 28.8 26.8 5.0 10.6 55.9 49.2 14.3 27.1 26.1 90.5 68.1 26.4 18.0 32.9 16.8 24.4 27.2 15.4 21.6 21.0 64.0 33.0 19.9 29.6 28.2 LARGE2 "FLJ35207, GYLTL1B, PP5656" ENSG00000165905 "LARGE xylosyl- and glucuronyltransferase 2" Q8N3Y3 11 45921621-45929096 "Predicted intracellular proteins" "Glycosyltransferase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 36.6" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 189.8;Syncytiotrophoblasts: 116.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.4;naive B-cell: 2.1" "Lineage enriched" "Detected in single" 4 "B-cells: 2.1" "Cell line enhanced" "Detected in many" "BEWO: 34.3;NTERA-2: 32.5;SK-BR-3: 23.5;T-47d: 71.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA056621 Approved "Intracellular and membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 6: T47d - Mammary gland" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA056621: AB_2683194" "unprognostic (9.82e-2)" "unprognostic (3.63e-2)" "unprognostic (3.65e-2)" "unprognostic (2.43e-2)" "unprognostic (6.20e-2)" "unprognostic (4.46e-3)" "unprognostic (1.36e-1)" "unprognostic (3.93e-2)" "unprognostic (1.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.30e-2)" "unprognostic (6.94e-2)" "prognostic favorable (3.04e-12)" "unprognostic (2.31e-1)" "unprognostic (9.77e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-2)" 0.2 2.4 0.0 2.3 0.0 0.5 4.4 0.3 0.1 5.1 12.2 1.0 1.3 2.0 4.9 17.1 3.9 0.6 0.2 0.8 0.0 15.9 3.3 1.9 4.7 0.1 0.1 2.0 27.1 12.5 11.5 36.6 0.0 9.9 0.7 3.5 17.7 8.3 0.6 19.7 3.7 0.1 0.0 2.5 11.2 1.6 0.2 4.1 11.3 0.0 2.3 2.2 6.8 0.1 1.2 1.6 0.1 0.0 0.0 0.0 34.3 0.0 0.0 0.0 0.0 8.5 0.6 0.0 0.9 0.0 0.8 8.0 0.1 15.2 0.0 0.0 4.7 0.0 1.2 9.3 0.2 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 2.0 9.7 0.0 0.0 2.7 0.2 0.0 32.5 12.2 1.1 0.9 0.0 3.1 0.5 0.6 9.6 1.1 0.3 23.5 0.1 1.9 71.4 0.0 0.0 0.2 10.4 0.0 0.0 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.4 0.1 0.4 0.0 2.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.8 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.2 3.2 2.2 0.0 4.0 0.0 0.0 0.0 0.0 0.0 13.5 8.3 0.0 0.0 0.6 7.3 0.0 189.8 0.4 0.0 3.9 4.6 0.0 10.9 3.4 0.9 0.0 0.0 0.0 6.4 11.3 0.9 0.0 28.0 0.0 9.4 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.1 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 116.2 0.8 0.1 0.0 0.0 PHF21A "BHC80, BM-006, KIAA1696" ENSG00000135365 "PHD finger protein 21A" Q96BD5 11 45929319-46121454 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 172.4;Excitatory neurons: 171.0;Inhibitory neurons: 140.0;Microglial cells: 138.7;Oligodendrocyte precursor cells: 250.3;Oligodendrocytes: 231.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 34.9;neutrophil: 31.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 34.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023253, HPA023580" Uncertain Approved Nucleoplasm NA NA "Cluster 38: Basophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "HPA023253: , HPA023580: AB_10962727" "unprognostic (5.30e-3)" "unprognostic (8.93e-2)" "prognostic unfavorable (6.15e-4)" "unprognostic (1.93e-2)" "unprognostic (1.05e-1)" "unprognostic (2.44e-2)" "prognostic unfavorable (1.66e-6)" "unprognostic (2.20e-2)" "unprognostic (3.10e-1)" "unprognostic (5.35e-2)" "unprognostic (1.25e-3)" "unprognostic (3.84e-1)" "prognostic unfavorable (2.59e-8)" "unprognostic (1.89e-1)" "unprognostic (1.97e-1)" "unprognostic (9.53e-2)" "unprognostic (1.21e-1)" 13.1 17.4 18.5 20.5 25.1 28.8 11.0 39.1 23.8 12.9 5.4 18.5 7.0 17.2 10.7 11.4 12.9 12.6 17.4 13.2 20.7 7.9 8.0 17.3 16.8 17.0 17.9 24.1 8.6 16.5 12.8 13.1 15.8 12.1 9.5 16.7 9.9 11.3 15.3 13.5 10.4 16.7 12.0 17.4 10.0 23.7 26.8 17.8 12.8 12.8 14.8 14.0 11.6 27.3 7.3 19.1 36.8 35.6 14.8 22.5 4.9 14.6 25.4 12.3 20.5 3.7 11.2 30.4 10.3 14.2 19.3 8.2 22.0 9.4 12.4 34.0 15.3 17.2 19.9 7.7 17.6 12.5 25.9 20.6 21.3 7.1 20.2 30.2 18.4 21.1 21.0 48.2 14.5 6.9 13.6 20.6 31.9 9.3 11.3 22.8 18.2 10.4 12.6 12.2 24.1 31.7 21.6 10.9 16.0 23.6 19.7 23.5 18.8 20.2 16.3 16.9 12.0 52.5 46.2 20.8 16.1 13.6 16.3 34.9 7.8 4.1 6.1 3.9 5.1 5.0 4.7 5.4 4.3 4.2 2.8 4.8 31.3 5.6 7.2 2.9 6.0 4.1 18.5 25.1 39.1 23.8 13.2 20.7 17.0 17.9 15.8 12.0 26.8 27.3 13.9 12.8 17.7 172.4 25.2 10.3 8.8 11.2 22.2 25.5 11.8 12.1 25.7 10.0 10.5 3.7 27.1 4.3 26.1 4.8 1.9 10.0 9.0 10.3 26.8 15.0 23.4 18.7 171.0 6.3 3.4 18.3 12.8 11.1 16.5 30.1 12.5 5.5 10.0 15.2 140.0 6.8 4.1 25.4 12.4 8.2 26.1 23.9 10.6 138.7 35.6 7.9 37.0 250.3 231.3 5.5 6.5 14.7 21.8 7.6 5.6 3.9 15.4 23.3 13.1 18.6 18.8 16.9 16.9 19.0 8.8 4.2 19.5 19.2 6.2 5.7 CREB3L1 OASIS ENSG00000157613 "CAMP responsive element binding protein 3 like 1" Q96BA8 11 46277662-46321409 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation, Unfolded protein response" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 133.9;salivary gland: 83.0" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 89.2;Gastric mucus-secreting cells: 105.0;Glandular and luminal cells: 120.5;Intestinal goblet cells: 280.5" "Cancer enhanced" "Detected in all" "prostate cancer: 87.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 134.3;BJ hTERT+: 130.7;BJ hTERT+ SV40 Large T+: 120.6;fHDF/TERT166: 321.8;OE19: 129.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA024069, CAB026151" Enhanced NA NA "Cluster 4: Stomach - Digestion" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 27: Mucus-secreting cells - Mucin production" "CAB026151: , HPA024069: AB_1854750" "unprognostic (2.46e-2)" "unprognostic (2.80e-1)" "unprognostic (1.34e-1)" "prognostic favorable (3.92e-4)" "unprognostic (1.66e-3)" "unprognostic (2.93e-1)" "unprognostic (5.41e-2)" "unprognostic (2.75e-2)" "unprognostic (3.21e-2)" "unprognostic (3.13e-1)" "unprognostic (1.54e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (2.97e-4)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (8.59e-4)" "unprognostic (1.12e-2)" 8.6 15.1 4.3 8.0 3.3 0.1 10.7 0.9 4.2 43.2 2.1 41.2 27.7 20.4 2.4 3.2 5.2 25.0 15.6 7.2 3.4 2.8 1.1 14.8 0.7 1.9 5.1 9.3 133.9 2.3 10.7 26.7 4.1 42.3 43.3 0.1 83.0 26.8 4.4 5.6 30.6 13.3 1.1 3.2 68.0 3.9 8.4 1.0 4.5 4.2 4.7 21.4 15.3 2.4 0.9 0.8 1.3 26.1 81.9 77.9 0.6 134.3 130.7 120.6 83.3 13.7 0.3 0.0 0.7 321.8 8.3 0.0 1.6 0.4 66.6 0.1 1.5 2.0 0.8 0.0 113.5 0.0 1.9 75.2 0.0 68.6 2.5 109.0 1.0 0.5 11.2 0.0 102.5 0.0 0.1 0.4 17.0 129.0 13.7 0.1 18.0 0.2 0.2 0.0 0.0 0.2 0.9 3.4 0.2 23.3 0.1 4.9 0.0 62.7 18.3 48.6 83.4 0.1 0.1 0.0 75.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 3.3 0.9 4.2 7.2 3.4 1.9 5.1 4.1 1.1 8.4 2.4 10.3 0.0 46.4 0.3 0.6 1.5 44.4 2.6 0.0 0.0 52.0 5.1 15.9 25.8 10.0 29.5 0.0 1.2 0.1 56.8 3.9 42.0 2.1 37.2 24.1 9.0 9.1 0.0 2.1 89.2 2.3 49.4 105.0 120.5 4.5 1.9 3.3 0.0 1.9 0.0 1.0 280.5 6.1 0.0 3.5 6.6 83.6 1.0 10.6 2.8 2.0 0.0 0.0 19.6 0.1 49.2 59.8 44.4 0.2 40.4 9.5 0.7 3.6 0.0 0.0 0.7 29.3 1.0 1.5 0.6 2.3 3.4 1.8 10.7 57.7 51.3 DGKZ "DAGK5, DAGK6, DGK-ZETA, hDGKzeta" ENSG00000149091 "Diacylglycerol kinase zeta" Q13574 11 46332905-46380554 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 146.2" "Cell type enhanced" "Detected in all" "NK-cells: 129.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 27 "amygdala: 46.5;basal ganglia: 75.1;cerebral cortex: 146.2;hippocampal formation: 133.8;white matter: 51.0" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051336 Enhanced Supported Supported "Nuclear speckles" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 10: Brain - Neuronal signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 63: NK-cells & T-cells - Immune response" "Nuclear speckles" "HPA051336: AB_2681448" "unprognostic (2.85e-2)" "unprognostic (3.90e-2)" "unprognostic (2.39e-1)" "unprognostic (1.65e-1)" "unprognostic (1.40e-1)" "unprognostic (4.12e-2)" "unprognostic (3.08e-3)" "unprognostic (1.31e-1)" "unprognostic (1.03e-2)" "unprognostic (2.49e-2)" "unprognostic (3.66e-3)" "unprognostic (8.18e-2)" "prognostic unfavorable (4.74e-5)" "unprognostic (1.48e-3)" "unprognostic (7.75e-2)" "unprognostic (3.61e-2)" "unprognostic (7.84e-3)" 20.7 14.2 46.5 21.6 75.1 54.6 19.4 3.3 146.2 16.5 0.0 20.3 36.4 16.8 4.0 19.5 15.3 11.1 46.5 133.8 0.0 18.3 10.5 18.3 39.9 0.0 0.0 12.4 31.5 10.0 58.7 14.1 0.0 18.6 6.6 2.5 43.4 10.7 95.7 22.3 41.2 9.1 0.0 36.1 22.2 15.4 1.4 34.0 12.5 25.1 17.1 18.2 15.3 51.0 38.1 33.2 22.1 33.2 11.5 12.8 102.1 29.0 21.5 30.0 26.3 39.8 17.1 48.4 20.5 30.1 33.0 43.3 26.7 42.0 10.6 48.8 62.5 31.7 25.2 29.5 20.5 60.5 61.2 17.3 19.3 16.5 22.2 15.3 33.4 39.3 45.1 29.1 21.5 99.8 58.6 94.3 64.3 54.5 50.3 69.0 38.2 20.6 9.1 36.6 150.3 25.6 33.2 109.6 23.0 13.8 78.8 75.2 37.9 39.2 42.4 62.6 52.9 19.1 23.4 40.3 53.8 54.0 37.2 12.4 13.5 6.0 6.8 5.6 4.1 0.3 4.3 5.9 12.0 0.8 4.3 4.6 9.5 7.6 6.4 5.7 4.4 10.5 46.5 75.1 3.3 146.2 133.8 0.0 0.0 0.0 0.0 0.0 1.4 51.0 46.0 3.2 6.6 44.7 16.4 13.3 22.3 16.3 14.2 27.6 24.6 19.8 24.4 8.6 8.7 9.2 20.9 14.6 95.8 37.7 9.8 13.2 6.1 9.9 15.2 34.2 51.5 23.4 114.0 47.8 105.1 12.4 34.1 14.1 21.0 25.7 56.7 7.1 51.2 16.8 45.0 26.3 22.4 46.1 26.9 11.4 13.1 34.0 12.4 31.9 50.6 6.4 129.8 8.5 24.7 33.5 41.0 8.2 25.3 16.6 97.0 20.2 8.2 9.9 32.9 17.8 16.8 7.0 12.2 12.3 9.2 27.4 71.8 19.4 29.9 17.2 MDK "FLJ27379, MK, NEGF2" ENSG00000110492 Midkine P21741 11 46380756-46383837 "Cancer-related genes, Predicted secreted proteins" Differentiation "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 529.1" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 1010.4;Granulosa cells: 726.2;Paneth cells: 1272.7;Proximal enterocytes: 883.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.8;neutrophil: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 888.4;REH: 1343.8;SH-SY5Y: 1093.6" "CAB010055, HPA057126" Uncertain Approved Vesicles "Secreted to blood" NA NA 158000 960000 "Cluster 35: T-regs - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 5: NTERA-2 - Transcription" "Cluster 33: Fibroblasts - ECM organization" Vesicles "CAB010055: AB_627949, HPA057126: AB_2683344" "unprognostic (8.87e-3)" "unprognostic (6.65e-2)" "unprognostic (4.02e-2)" "unprognostic (7.24e-2)" "prognostic unfavorable (5.48e-4)" "unprognostic (1.90e-1)" "unprognostic (5.67e-3)" "unprognostic (1.02e-1)" "unprognostic (3.66e-2)" "unprognostic (1.11e-2)" "unprognostic (4.01e-2)" "unprognostic (4.15e-1)" "prognostic unfavorable (3.06e-6)" "unprognostic (8.78e-2)" "unprognostic (1.31e-1)" "unprognostic (3.48e-1)" "unprognostic (1.12e-2)" 41.1 98.0 23.3 22.9 23.3 11.7 82.2 27.0 37.0 379.4 16.3 78.0 263.3 208.2 60.3 38.1 170.3 140.0 36.1 21.6 40.7 35.9 8.5 48.5 20.3 31.8 27.5 529.1 30.5 103.9 370.4 32.0 22.6 128.7 38.0 5.9 137.4 84.1 7.6 26.9 211.3 49.5 24.6 78.1 108.3 16.8 31.5 92.9 26.8 9.8 15.9 84.1 129.3 24.6 51.1 66.5 758.4 2.5 5.2 62.2 18.6 39.2 77.0 145.6 128.8 505.2 219.5 3.4 528.6 58.5 6.3 429.6 431.8 0.7 13.3 157.0 91.6 22.5 5.6 703.6 336.2 1.7 3.5 100.0 13.2 89.2 0.5 31.0 214.3 28.9 385.2 3.5 83.3 348.6 19.8 9.4 888.4 275.9 388.0 1343.8 28.8 4.4 1.8 1.6 418.1 1093.6 128.9 11.3 11.0 665.8 347.3 349.5 59.0 221.1 526.2 3.1 27.2 2.9 11.0 5.1 6.5 13.7 197.3 0.0 0.0 0.0 0.1 0.2 0.0 1.8 0.1 0.2 0.0 0.4 0.0 0.0 2.1 0.1 0.2 0.1 0.9 0.4 23.3 23.3 27.0 37.0 21.6 40.7 31.8 27.5 22.6 24.6 31.5 24.6 108.2 0.0 5.4 5.5 9.6 11.1 162.1 392.4 12.5 1.3 245.2 218.7 7.0 34.3 393.6 47.8 0.0 162.3 5.4 499.0 1.9 286.0 26.4 134.6 490.2 115.0 1010.4 2.5 2.1 104.5 123.5 275.2 162.1 228.2 4.5 726.2 102.4 4.6 48.3 0.0 1.9 368.8 286.8 4.2 12.0 126.3 109.6 10.0 37.4 7.5 9.4 47.1 0.0 4.5 1.3 221.1 1272.7 18.8 18.6 163.6 883.4 19.6 109.5 1.1 85.5 26.1 197.0 31.8 34.3 26.2 8.1 153.1 11.4 8.9 187.6 511.1 CHRM4 ENSG00000180720 "Cholinergic receptor muscarinic 4" P08173 11 46385098-46386608 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 18.5;intestine: 6.8;lymphoid tissue: 15.9;testis: 5.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in many" 6 "basal ganglia: 18.5;cerebral cortex: 4.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 3.4;SCLC-21H: 10.0;U-2 OS: 2.8" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 16.8" "CAB022444, HPA072083" Enhanced Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Nucleoplasm "CAB022444: , HPA072083: " "unprognostic (7.11e-2)" "unprognostic (3.79e-1)" "unprognostic (5.31e-2)" "unprognostic (7.38e-2)" "unprognostic (8.63e-3)" "unprognostic (1.38e-1)" "unprognostic (6.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (2.96e-3)" "unprognostic (4.08e-3)" "unprognostic (5.02e-2)" "unprognostic (3.83e-2)" "unprognostic (3.64e-1)" "unprognostic (1.71e-1)" "unprognostic (3.56e-1)" "unprognostic (5.08e-2)" 0.1 0.5 1.6 0.2 18.5 1.7 0.1 0.0 4.6 0.1 0.0 1.5 3.2 0.1 0.0 0.0 0.1 0.0 0.1 1.8 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.2 0.2 1.2 0.0 0.0 0.0 0.1 2.4 0.1 0.0 0.0 2.0 6.8 0.1 0.0 15.9 0.6 5.0 1.7 2.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.5 0.2 0.0 0.1 0.0 2.1 0.0 0.1 0.1 0.1 1.0 0.1 0.2 0.2 0.0 1.8 0.1 1.3 0.1 0.0 1.6 0.2 0.4 0.1 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.1 0.0 0.7 0.2 0.1 0.4 0.1 0.1 0.0 3.4 0.0 0.0 0.1 10.0 0.2 0.2 0.0 0.1 0.2 0.1 1.7 0.0 0.3 2.8 0.0 0.0 0.5 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 18.5 0.0 4.6 1.8 0.1 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AMBRA1 "DCAF3, FLJ20294, KIAA1736, WDR94" ENSG00000110497 "Autophagy and beclin 1 regulator 1" Q9C0C7 11 46396414-46594125 "Predicted intracellular proteins" "Autophagy, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Astrocytes: 65.6;Excitatory neurons: 101.4;Inhibitory neurons: 101.9;Microglial cells: 84.3;Oligodendrocyte precursor cells: 84.9;Oligodendrocytes: 136.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 11.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017825, HPA038535" Approved Approved Vesicles,Mitochondria NA NA "Cluster 38: Basophils - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles Mitochondria "CAB017825: , HPA038535: AB_2676068" "unprognostic (1.76e-3)" "unprognostic (1.51e-1)" "unprognostic (1.95e-1)" "unprognostic (1.56e-1)" "unprognostic (6.00e-2)" "unprognostic (1.87e-1)" "unprognostic (1.46e-3)" "unprognostic (7.78e-2)" "unprognostic (1.32e-1)" "unprognostic (1.98e-2)" "unprognostic (5.53e-3)" "unprognostic (2.32e-1)" "prognostic favorable (1.61e-4)" "unprognostic (2.90e-1)" "unprognostic (8.17e-2)" "unprognostic (1.61e-2)" "unprognostic (7.98e-2)" 10.2 16.4 7.5 6.7 9.1 11.6 10.5 7.8 9.1 10.4 7.4 10.1 10.0 11.7 5.8 10.6 10.1 6.4 8.4 7.9 6.4 8.2 9.1 8.6 8.2 6.6 6.1 11.6 8.3 12.3 9.2 7.6 7.3 9.8 7.0 7.8 10.6 7.6 13.0 17.4 9.8 8.8 5.4 10.3 9.7 12.6 8.4 13.5 9.4 8.3 8.1 9.4 10.0 10.8 8.7 23.0 15.5 16.8 16.1 12.0 9.6 8.5 16.1 13.6 14.1 17.4 14.8 17.5 8.5 15.1 16.1 15.4 7.9 15.0 10.0 15.3 25.5 11.9 14.6 22.5 10.5 17.3 14.6 16.7 11.6 8.6 16.3 14.8 14.3 14.9 20.8 11.7 10.2 21.4 22.2 12.2 26.1 19.6 12.4 21.5 21.3 9.7 13.1 15.4 12.5 13.9 14.7 16.6 15.6 10.1 17.2 11.6 15.2 12.5 11.1 14.6 12.8 13.2 11.3 18.1 11.1 9.6 11.3 11.8 2.2 1.7 2.6 1.1 2.2 2.4 1.9 2.0 2.0 2.1 1.9 1.7 2.5 1.4 1.9 2.1 3.2 1.9 7.5 9.1 7.8 9.1 7.9 6.4 6.6 6.1 7.3 5.4 8.4 10.8 5.1 3.2 5.6 65.6 7.2 4.1 2.5 3.4 4.0 6.6 5.1 5.2 8.2 4.3 4.3 0.0 2.1 4.0 5.9 16.0 0.0 6.9 13.8 5.2 5.3 4.7 9.6 10.3 101.4 9.3 2.1 6.7 13.7 8.3 4.5 8.8 3.6 4.1 5.2 5.0 101.9 9.7 2.0 3.5 2.3 6.7 5.3 4.8 5.4 84.3 3.1 3.2 6.2 84.9 136.4 8.4 7.5 7.9 6.6 3.5 8.2 3.2 4.4 5.7 13.1 4.2 5.8 2.1 2.1 7.4 4.5 6.8 6.4 7.9 6.4 4.2 HARBI1 "C11orf77, FLJ32675" ENSG00000180423 "Harbinger transposase derived 1" Q96MB7 11 46602861-46617909 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 70.9;Late spermatids: 73.0;Spermatocytes: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038671, HPA045457" Approved Enhanced "Plasma membrane,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 78: Testis - Spermatogenesis" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" "Plasma membrane, Cytosol" "HPA038671: AB_10675947, HPA045457: AB_2679332" "unprognostic (1.29e-1)" "unprognostic (6.82e-2)" "unprognostic (7.76e-2)" "unprognostic (2.65e-1)" "unprognostic (1.61e-1)" "unprognostic (3.95e-1)" "unprognostic (1.23e-5)" "unprognostic (2.10e-1)" "unprognostic (1.66e-2)" "unprognostic (9.58e-2)" "unprognostic (3.15e-1)" "unprognostic (6.34e-2)" "unprognostic (6.96e-2)" "unprognostic (1.47e-1)" "unprognostic (1.66e-1)" "unprognostic (5.01e-2)" "unprognostic (1.13e-1)" 2.0 2.6 2.6 2.4 4.5 5.6 2.4 3.3 4.2 2.3 2.3 3.0 2.6 1.7 3.4 2.3 2.1 2.0 2.5 2.7 3.1 2.9 3.3 2.2 3.4 3.5 3.5 1.4 2.4 2.2 2.5 2.8 3.6 2.2 3.4 2.7 2.8 1.9 2.6 3.2 2.8 3.0 2.8 2.4 4.0 12.1 4.0 4.2 2.7 2.0 3.4 2.6 1.5 7.3 3.3 5.3 4.3 4.1 8.4 5.1 5.1 4.7 4.5 6.3 8.0 3.7 3.7 5.8 2.9 3.9 7.1 6.3 4.6 4.1 5.9 6.7 5.5 5.9 3.9 4.2 9.8 5.5 7.6 6.5 10.7 4.2 8.2 2.4 4.0 6.2 9.4 7.0 5.3 7.1 6.8 2.3 11.8 10.8 6.4 4.5 6.1 10.3 4.8 3.9 4.1 3.4 5.6 5.9 6.8 5.7 9.9 4.7 3.8 6.3 4.9 8.4 4.3 6.6 7.7 6.3 4.8 3.2 6.6 21.9 7.6 10.9 9.6 10.3 6.7 4.7 7.6 7.0 6.4 6.6 7.2 8.0 11.2 6.9 9.8 8.3 10.2 4.4 2.6 4.5 3.3 4.2 2.7 3.1 3.5 3.5 3.6 2.8 4.0 7.3 1.0 0.0 1.3 1.3 2.2 1.0 2.7 4.0 1.8 3.5 2.5 1.8 2.3 1.5 4.4 0.0 2.1 4.9 1.5 2.1 5.9 4.1 70.9 4.7 2.2 1.4 1.2 13.5 1.5 2.2 3.4 1.7 2.0 4.7 0.0 1.6 1.8 2.8 3.3 3.3 1.5 2.2 8.2 3.3 0.8 73.0 3.1 1.7 1.8 0.0 4.2 2.9 1.0 0.5 4.6 3.0 0.8 1.9 3.4 1.6 3.4 3.5 6.1 3.7 0.0 2.1 2.0 25.2 13.5 1.7 2.7 9.3 2.2 2.2 1.7 2.3 ATG13 KIAA0652 ENSG00000175224 "Autophagy related 13" O75143 11 46617527-46674818 "Cancer-related genes, Predicted intracellular proteins, Transporters" Autophagy "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039350 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 44: Endometrium - Transcription" Cytosol "Nucleoplasm, Plasma membrane" "HPA039350: AB_10673142" "unprognostic (3.66e-1)" "unprognostic (1.14e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-1)" "unprognostic (5.36e-2)" "unprognostic (2.31e-1)" "prognostic unfavorable (8.59e-5)" "unprognostic (1.05e-1)" "unprognostic (1.10e-1)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (7.57e-2)" "unprognostic (2.44e-2)" "unprognostic (2.41e-1)" "unprognostic (2.14e-1)" "unprognostic (7.68e-2)" "unprognostic (3.47e-1)" 32.3 39.7 55.9 26.1 67.6 60.5 30.1 49.4 63.7 30.6 46.1 26.5 29.3 28.2 32.2 32.0 32.1 29.6 36.8 55.2 51.8 28.7 43.9 25.3 31.5 60.2 59.4 29.7 44.6 37.5 57.7 21.9 61.8 31.1 24.1 48.4 35.9 25.5 34.5 39.6 28.0 24.8 51.8 36.4 36.4 82.0 59.6 40.6 36.8 33.4 33.6 27.4 29.1 87.9 32.8 58.5 44.1 26.1 60.2 70.0 44.5 37.5 65.4 45.0 57.0 40.2 31.7 30.2 25.6 56.5 58.1 38.8 42.7 50.3 45.2 57.9 81.1 32.8 39.7 71.2 67.4 44.1 54.1 84.9 59.0 31.0 67.9 63.9 45.0 69.4 57.8 66.8 40.8 48.8 44.0 65.1 55.0 59.5 49.9 41.4 57.0 53.7 29.9 34.5 41.6 42.1 51.2 40.6 55.4 42.1 58.0 89.5 44.6 54.7 33.3 51.1 41.2 61.1 73.8 38.6 67.8 39.3 40.9 41.7 36.1 48.5 35.1 42.6 27.9 27.1 31.2 27.8 35.0 21.7 26.4 29.2 67.7 31.5 35.1 25.6 44.7 39.9 55.9 67.6 49.4 63.7 55.2 51.8 60.2 59.4 61.8 51.8 59.6 87.9 10.6 16.0 16.2 14.7 16.9 9.3 12.0 9.0 13.1 22.7 16.7 12.3 13.2 8.6 12.0 12.9 39.6 9.9 25.4 24.5 7.9 18.9 42.7 30.0 17.3 12.7 18.0 28.2 23.4 32.3 22.4 14.8 20.9 46.1 8.8 22.5 13.2 22.5 15.1 33.7 25.7 22.6 14.2 19.1 9.8 46.8 11.5 15.7 12.4 15.0 22.8 16.3 19.6 25.1 61.0 30.4 12.9 11.3 36.6 19.9 19.5 13.5 9.4 32.2 13.1 16.9 19.9 46.3 16.3 15.8 11.5 26.4 18.0 9.8 11.9 24.3 ARHGAP1 "CDC42GAP, p50rhoGAP, RhoGAP" ENSG00000175220 "Rho GTPase activating protein 1" Q07960 11 46677080-46700619 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004689, HPA008285" Approved Approved Approved Vesicles NA NA 11000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" Vesicles "HPA004689: AB_1078194, HPA008285: AB_1078195" "unprognostic (1.06e-1)" "unprognostic (2.73e-1)" "unprognostic (2.05e-3)" "unprognostic (5.19e-2)" "unprognostic (2.48e-2)" "unprognostic (9.07e-2)" "prognostic unfavorable (2.14e-4)" "unprognostic (1.34e-3)" "unprognostic (1.24e-1)" "unprognostic (7.96e-2)" "unprognostic (1.35e-2)" "unprognostic (4.94e-1)" "unprognostic (4.79e-2)" "unprognostic (4.13e-2)" "unprognostic (3.49e-2)" "unprognostic (2.55e-1)" "unprognostic (9.24e-2)" 84.5 49.2 40.9 38.0 48.3 33.4 61.8 33.4 46.1 71.3 31.2 62.8 25.7 93.7 21.5 75.0 68.4 50.7 112.3 39.1 41.0 41.5 46.2 38.4 30.7 45.7 43.2 46.4 36.5 24.7 36.8 39.0 39.0 64.9 32.6 9.6 46.1 62.6 30.0 65.3 46.7 80.6 38.0 58.4 49.0 15.8 49.8 23.2 44.6 20.5 34.6 107.9 63.4 57.4 23.0 56.7 27.9 39.8 135.4 99.6 32.9 50.3 50.7 45.3 41.2 34.2 29.5 33.1 26.7 102.3 40.7 55.8 22.4 76.0 33.5 23.3 24.6 36.8 27.7 40.4 44.5 31.3 52.3 131.9 46.7 34.5 42.9 46.8 39.1 27.1 24.3 30.3 55.9 82.6 21.2 30.9 72.1 78.5 29.4 25.0 39.9 49.3 42.3 85.2 10.0 31.6 45.8 69.8 19.1 40.1 88.0 35.4 49.1 82.1 25.5 98.7 51.0 32.0 38.2 24.8 77.4 52.0 39.3 27.6 33.0 33.1 26.7 56.9 19.3 14.3 20.8 22.8 32.3 14.7 17.9 20.8 37.3 23.7 72.0 34.1 27.4 24.9 40.9 48.3 33.4 46.1 39.1 41.0 45.7 43.2 39.0 38.0 49.8 57.4 25.2 19.2 18.7 16.6 18.3 8.5 13.4 24.6 10.8 11.9 22.3 24.6 50.2 10.0 18.1 29.5 27.1 25.1 35.2 35.2 3.9 22.2 0.4 17.9 26.9 19.6 19.4 15.3 13.0 27.9 31.0 29.2 31.6 27.6 19.6 21.3 25.7 32.1 30.4 16.8 15.3 36.0 14.2 30.7 8.4 1.7 23.6 19.1 8.8 11.2 28.2 11.0 36.0 23.1 92.3 27.3 19.2 35.3 10.1 11.4 22.4 13.3 10.9 14.2 59.2 28.0 55.9 3.1 3.5 24.7 13.1 16.6 19.9 9.4 21.5 18.7 ZNF408 FLJ12827 ENSG00000175213 "Zinc finger protein 408" Q9H9D4 11 46701030-46705912 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017892 Uncertain Approved "Centriolar satellite,Cytosol" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 44: Endometrium - Transcription" "Centriolar satellite, Cytosol" "HPA017892: AB_1859248" "unprognostic (7.54e-2)" "unprognostic (2.41e-1)" "unprognostic (3.02e-3)" "unprognostic (1.20e-1)" "unprognostic (6.87e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (6.59e-5)" "unprognostic (3.01e-2)" "unprognostic (6.89e-2)" "unprognostic (1.42e-1)" "unprognostic (7.13e-3)" "unprognostic (5.77e-2)" "unprognostic (3.38e-2)" "unprognostic (9.99e-3)" "unprognostic (9.24e-2)" "unprognostic (1.19e-1)" "unprognostic (2.09e-2)" 5.9 5.1 6.2 4.0 6.6 14.5 5.6 6.8 7.8 6.4 4.7 6.6 5.1 7.8 1.6 8.6 5.7 4.0 6.6 5.9 5.8 5.9 12.7 3.9 5.3 6.7 6.4 5.7 6.5 3.2 5.3 3.7 6.1 7.2 2.8 1.2 5.7 4.3 10.3 10.1 6.6 3.4 6.1 7.5 7.4 5.9 6.5 5.4 5.3 6.2 3.3 7.2 5.9 6.8 4.8 11.4 5.2 9.4 6.5 5.7 13.5 6.3 8.8 12.5 9.1 10.3 5.3 7.4 5.7 7.6 9.0 12.2 6.7 12.4 4.4 5.9 13.5 7.1 8.0 12.7 12.2 7.4 9.7 11.2 12.0 6.3 9.0 6.7 6.2 11.1 11.4 6.5 5.2 15.5 9.0 15.1 21.8 15.9 13.8 9.8 7.8 11.7 6.7 12.5 7.3 9.8 12.1 15.0 10.0 4.8 13.1 12.9 7.1 12.2 8.1 10.2 12.4 9.4 8.8 10.9 7.9 8.5 9.9 3.9 7.6 7.8 8.5 8.3 6.6 6.3 8.3 10.2 7.2 7.6 9.2 7.0 7.1 5.8 6.3 5.7 8.1 7.3 6.2 6.6 6.8 7.8 5.9 5.8 6.7 6.4 6.1 6.1 6.5 6.8 4.6 6.4 2.2 1.6 7.5 6.6 5.5 12.0 7.4 5.1 6.4 5.5 5.3 4.3 5.7 1.8 0.0 10.1 8.5 9.6 11.7 7.8 5.6 7.0 7.2 4.8 8.4 11.4 1.4 4.8 7.7 4.5 6.6 14.9 0.0 8.2 5.3 9.2 5.5 3.3 1.6 9.4 2.0 7.1 2.8 3.2 6.2 3.2 10.6 1.9 6.6 7.9 8.2 1.5 2.1 5.9 3.2 6.4 5.2 4.5 9.0 5.8 4.3 3.5 13.1 3.7 7.2 11.2 9.0 7.5 4.1 10.5 4.8 5.7 7.1 6.0 F2 ENSG00000180210 "Coagulation factor II, thrombin" P00734 11 46719196-46739506 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1518 "liver: 1217.3" "Cell type enriched" "Detected in some" 26 "Hepatocytes: 991.0" "Cancer enriched" "Detected in some" 110 "liver cancer: 508.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "Hep G2: 281.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB016780, HPA051476, HPA054698" Enhanced "Secreted to blood" NA NA 108000000000 41000000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" "CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578" "unprognostic (1.98e-1)" "unprognostic (2.52e-1)" "unprognostic (2.64e-2)" "unprognostic (1.85e-1)" "unprognostic (2.29e-1)" "unprognostic (2.81e-1)" "unprognostic (2.23e-2)" "unprognostic (3.94e-2)" "unprognostic (5.79e-2)" "unprognostic (8.29e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (6.75e-12)" "unprognostic (5.65e-3)" "unprognostic (5.80e-2)" "unprognostic (1.54e-3)" 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.2 1217.3 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.9 0.0 0.2 2.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.2 281.0 0.0 1.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 20.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.2 0.0 37.5 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.3 21.8 991.0 0.0 0.0 0.2 0.2 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 2.0 0.0 0.0 0.1 CKAP5 "ch-TOG, KIAA0097, TOG, TOGp" ENSG00000175216 "Cytoskeleton associated protein 5" Q14008 11 46743048-46846308 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 119.7;Spermatocytes: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039377, HPA040375" Supported Approved "Nucleoli,Nucleoli rim,Plasma membrane,Centrosome" NA Yes 360000 "Cluster 27: Non-specific - Gene expression" "Cluster 21: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Plasma membrane, Centrosome" "Nucleoli, Nucleoli rim" "HPA039377: AB_10805477, HPA040375: AB_10794739" "unprognostic (8.00e-2)" "unprognostic (7.35e-2)" "unprognostic (2.35e-1)" "unprognostic (4.12e-2)" "unprognostic (1.91e-1)" "unprognostic (2.08e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (6.09e-2)" "unprognostic (1.12e-2)" "unprognostic (2.21e-2)" "unprognostic (4.30e-3)" "unprognostic (3.77e-2)" "unprognostic (2.03e-1)" "unprognostic (2.71e-1)" "unprognostic (1.12e-1)" "unprognostic (3.48e-1)" "unprognostic (4.69e-2)" 12.8 30.7 15.9 15.1 19.5 25.9 14.9 30.8 24.3 11.7 5.2 18.5 12.6 15.7 12.2 13.0 11.5 12.2 21.3 21.4 18.0 11.5 45.5 10.4 18.4 21.0 17.4 27.8 9.0 21.2 12.5 17.3 22.9 15.9 17.2 57.0 9.1 13.2 37.8 13.7 12.3 19.3 17.5 11.9 16.1 33.0 20.2 36.4 9.6 28.8 18.5 13.5 10.8 24.6 104.7 95.8 212.6 90.8 48.7 73.0 48.3 117.1 69.4 107.8 114.6 76.8 33.3 104.5 41.0 76.0 117.0 116.2 144.0 62.7 134.3 102.0 107.6 176.6 80.2 78.4 35.0 139.6 76.7 37.0 34.0 60.3 125.6 56.1 79.3 97.9 129.5 103.8 89.2 71.2 127.9 39.2 114.7 78.8 73.0 131.2 210.0 98.3 34.7 63.3 96.8 83.9 149.8 56.9 57.3 88.9 103.9 39.1 64.0 106.2 92.9 180.8 176.2 59.2 137.3 158.6 66.5 64.9 105.9 4.6 4.2 4.6 6.1 6.2 5.9 6.5 4.5 6.9 6.1 6.2 5.4 5.8 0.7 8.6 6.2 3.9 5.6 3.1 15.9 19.5 30.8 24.3 21.4 18.0 21.0 17.4 22.9 17.5 20.2 24.6 13.4 25.6 23.6 32.3 17.4 8.5 11.0 17.9 16.5 19.3 11.6 12.3 65.2 12.8 18.8 9.2 37.5 19.4 11.2 13.3 9.8 12.2 119.7 19.7 21.0 16.5 12.1 32.6 61.9 7.8 15.0 27.8 29.0 18.8 37.9 55.5 11.7 8.1 18.7 13.5 63.1 16.9 16.2 17.6 5.6 50.7 19.6 19.6 7.2 30.9 16.5 16.2 16.5 32.6 51.7 13.7 15.2 29.0 26.4 14.2 9.1 9.3 30.7 25.6 19.7 18.0 21.4 107.4 59.3 24.3 11.6 11.5 16.1 83.3 19.8 9.7 LRP4 "CLSS, LRP-4, MEGF7, SOST2" ENSG00000134569 "LDL receptor related protein 4" O75096 11 46856717-46918642 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 46.7;skin 1: 31.6" "Cell type enhanced" "Detected in many" "Astrocytes: 123.1;Cone photoreceptor cells: 41.7;Distal enterocytes: 31.1;Oligodendrocyte precursor cells: 137.2;Oligodendrocytes: 31.3" "Group enriched" "Detected in all" 4 "colorectal cancer: 12.2;endometrial cancer: 8.6;glioma: 13.2;testis cancer: 15.6;thyroid cancer: 28.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 21.3;SuSa: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011934, HPA012300" Approved Uncertain Nucleoplasm,Nucleoli,Mitochondria NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Nucleoli, Mitochondria" "HPA011934: AB_1853286, HPA012300: AB_1853288" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-1)" "unprognostic (1.33e-2)" "unprognostic (4.39e-2)" "unprognostic (9.73e-3)" "unprognostic (5.29e-4)" "unprognostic (8.61e-2)" "unprognostic (2.29e-2)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (7.59e-2)" "unprognostic (7.95e-2)" "unprognostic (2.76e-2)" "unprognostic (9.90e-3)" "unprognostic (6.79e-2)" 0.7 1.4 23.3 0.9 30.5 0.0 1.5 19.1 21.3 2.3 0.0 4.8 3.4 1.6 0.9 1.8 1.4 2.0 6.9 24.2 16.0 0.7 0.2 2.9 0.1 46.7 23.0 4.6 2.2 5.6 2.6 2.6 19.8 2.1 3.4 7.9 1.7 2.3 4.4 31.6 4.9 1.5 21.3 3.9 7.8 1.1 30.9 1.5 2.4 7.7 0.3 0.9 1.4 25.6 0.1 9.6 21.3 6.5 13.4 3.7 4.9 1.0 1.9 2.8 3.2 2.8 0.0 0.0 1.4 11.4 3.1 3.9 12.0 7.5 2.2 0.0 10.3 1.0 3.8 6.8 2.8 0.1 1.9 4.5 4.2 4.4 1.1 2.5 2.5 2.6 0.9 0.0 1.6 0.8 0.2 0.3 11.9 0.0 0.9 1.6 7.3 0.0 0.3 2.8 0.1 14.2 1.2 0.0 3.4 16.2 0.3 0.5 0.2 5.7 3.5 6.5 2.1 0.0 0.0 0.4 4.3 0.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 30.5 19.1 21.3 24.2 16.0 46.7 23.0 19.8 21.3 30.9 25.6 0.2 0.0 1.9 123.1 0.0 8.2 2.7 2.4 10.8 0.5 0.3 1.9 6.2 0.0 1.9 1.8 41.7 2.6 0.0 31.1 1.9 0.0 0.5 1.0 4.7 1.0 0.0 0.0 19.7 0.4 0.4 5.0 3.1 4.4 5.1 1.6 1.8 0.4 0.2 0.0 18.6 2.8 0.0 0.0 0.4 0.0 1.8 0.2 1.8 15.0 0.6 9.3 0.0 137.2 31.3 0.3 3.0 1.2 0.0 1.0 8.0 0.3 1.1 2.7 0.0 12.4 0.9 0.2 0.8 2.3 10.9 1.4 0.2 8.4 3.3 0.8 C11orf49 "FLJ22210, MGC4707" ENSG00000149179 "Chromosome 11 open reading frame 49" Q9H6J7 11 46936689-47164385 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 140.0;Excitatory neurons: 140.8;Inhibitory neurons: 112.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040051, HPA040280" Uncertain Approved "Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear speckles" "HPA040051: AB_10795412, HPA040280: AB_10795363" "unprognostic (3.11e-2)" "unprognostic (3.01e-1)" "unprognostic (2.15e-1)" "unprognostic (1.06e-2)" "unprognostic (6.65e-2)" "unprognostic (7.76e-2)" "prognostic unfavorable (2.18e-5)" "unprognostic (1.27e-1)" "unprognostic (2.76e-1)" "unprognostic (1.72e-1)" "unprognostic (2.14e-2)" "unprognostic (1.55e-1)" "unprognostic (1.54e-2)" "unprognostic (1.36e-1)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "unprognostic (5.34e-3)" 8.1 13.4 52.4 6.2 51.6 3.3 10.0 45.9 54.7 15.6 46.1 14.3 11.2 16.8 14.1 9.7 32.5 9.6 12.3 52.4 53.3 15.7 3.9 12.1 6.3 47.0 53.9 14.9 12.7 22.6 30.3 6.8 49.2 12.4 11.4 21.8 11.0 13.2 7.3 31.6 11.9 12.8 46.2 7.0 15.4 20.2 53.7 13.7 16.1 6.4 7.2 11.9 11.4 45.5 10.9 30.6 37.9 27.9 17.8 25.7 9.5 11.7 26.9 24.6 29.9 6.9 17.0 9.1 12.3 24.4 29.7 14.8 18.8 28.7 20.9 18.1 27.2 12.2 36.6 12.6 30.5 14.6 16.2 17.5 19.1 11.2 16.4 47.0 27.6 22.1 10.3 11.7 18.2 22.8 23.0 16.2 14.3 26.5 16.4 8.2 9.5 10.1 43.3 11.7 25.5 36.5 13.4 14.9 14.7 19.7 25.0 8.5 6.5 13.8 11.0 22.0 17.7 10.4 9.2 7.5 33.7 3.0 17.5 12.7 10.2 9.0 19.2 13.7 23.0 24.1 18.1 22.7 24.6 17.6 19.1 20.3 0.3 25.2 10.3 21.8 19.0 18.3 52.4 51.6 45.9 54.7 52.4 53.3 47.0 53.9 49.2 46.2 53.7 45.5 6.6 9.6 26.7 140.0 9.9 13.0 16.4 30.6 12.0 22.9 12.0 13.0 9.4 12.8 24.0 23.9 18.8 19.4 5.6 18.3 46.9 30.2 53.2 42.8 20.4 10.2 19.2 8.0 140.8 20.4 13.4 18.0 25.5 14.1 16.4 23.3 8.6 2.4 9.9 37.0 112.7 12.8 22.4 3.3 7.0 35.8 12.8 6.2 12.4 41.2 10.9 45.0 7.2 93.0 71.9 16.2 21.2 20.3 5.8 8.1 22.1 33.4 66.7 53.1 6.6 12.2 13.5 63.3 7.6 10.5 18.0 10.0 10.8 32.6 13.7 12.1 ARFGAP2 "FLJ14576, IRZ, Zfp289, ZNF289" ENSG00000149182 "ADP ribosylation factor GTPase activating protein 2" Q8N6H7 11 47164299-47177125 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016649, HPA018152" Enhanced Supported "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA016649: AB_1844980, HPA018152: AB_1844979" "unprognostic (1.69e-2)" "unprognostic (9.11e-2)" "unprognostic (5.91e-2)" "unprognostic (3.75e-2)" "unprognostic (2.20e-2)" "unprognostic (1.12e-1)" "unprognostic (4.81e-3)" "unprognostic (1.23e-1)" "unprognostic (1.25e-1)" "unprognostic (2.41e-1)" "unprognostic (3.42e-2)" "unprognostic (7.00e-2)" "prognostic favorable (7.65e-7)" "unprognostic (2.05e-1)" "unprognostic (9.36e-2)" "unprognostic (1.06e-1)" "unprognostic (9.20e-2)" 38.0 51.4 62.1 36.3 63.9 82.2 41.7 63.2 68.3 42.3 57.2 49.4 40.0 43.3 35.5 60.8 49.3 32.1 58.7 62.5 60.1 47.6 76.8 40.7 51.9 65.1 61.8 44.6 69.7 48.2 38.7 39.9 61.8 51.4 39.4 38.9 56.1 41.7 115.9 78.7 43.8 38.8 60.6 51.2 55.7 30.7 63.1 49.8 47.4 81.4 50.5 44.7 43.3 70.3 55.7 36.4 54.9 43.3 45.9 37.3 51.6 51.2 48.1 64.1 48.4 41.3 45.3 91.3 32.4 58.7 40.8 82.3 47.2 74.6 40.3 45.0 46.1 77.6 85.5 50.8 53.7 107.0 84.4 56.7 82.3 33.3 71.1 46.1 60.4 65.6 111.8 67.8 58.5 102.5 50.8 87.8 43.6 98.3 48.4 78.8 94.8 116.8 60.3 79.3 53.0 47.0 58.7 81.7 38.8 26.1 126.8 78.8 48.7 55.2 43.3 50.5 68.6 58.6 60.7 78.3 38.6 81.2 56.4 108.5 69.1 92.8 74.0 77.3 66.6 59.0 57.1 66.2 65.9 63.1 63.0 63.4 41.8 69.2 98.4 35.4 71.8 108.1 62.1 63.9 63.2 68.3 62.5 60.1 65.1 61.8 61.8 60.6 63.1 70.3 23.8 35.3 45.9 25.1 46.5 22.2 31.4 22.1 29.6 73.6 30.9 25.8 13.0 20.0 41.2 31.3 114.7 64.3 40.7 38.6 25.4 38.7 2.7 20.3 26.4 29.8 45.4 47.1 16.2 36.6 47.1 29.7 34.1 27.0 60.8 44.9 31.1 44.0 36.8 74.0 15.1 35.0 38.7 33.6 25.4 6.6 34.2 28.6 28.4 15.9 58.1 51.1 71.1 13.0 23.7 39.2 45.0 26.4 31.7 26.4 41.0 26.3 34.1 115.4 39.5 33.0 28.0 24.7 35.9 30.3 26.7 91.8 43.7 40.3 36.3 34.0 PACSIN3 SDPIII ENSG00000165912 "Protein kinase C and casein kinase substrate in neurons 3" Q9UKS6 11 47177522-47186443 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 161.8;skeletal muscle: 480.9;tongue: 279.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 112.0;Extravillous trophoblasts: 60.6;Muller glia cells: 63.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 127.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039480, HPA043904" Approved Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 20: HeLa - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" Cytosol "Plasma membrane" "HPA039480: AB_2676531, HPA043904: AB_2678725" "unprognostic (1.75e-1)" "unprognostic (1.11e-1)" "unprognostic (1.73e-2)" "unprognostic (3.10e-2)" "unprognostic (1.21e-1)" "unprognostic (6.89e-2)" "unprognostic (4.66e-2)" "unprognostic (8.17e-2)" "unprognostic (2.85e-1)" "prognostic favorable (2.09e-4)" "unprognostic (3.86e-3)" "unprognostic (1.26e-1)" "unprognostic (2.75e-2)" "unprognostic (9.72e-2)" "unprognostic (1.92e-1)" "unprognostic (1.29e-1)" "unprognostic (4.76e-2)" 14.4 66.5 19.6 4.5 28.2 0.4 18.4 24.5 20.9 33.3 18.8 50.2 4.7 33.5 11.4 52.6 29.1 7.2 161.8 18.0 19.4 14.8 43.6 15.9 2.0 33.8 27.5 23.2 33.1 11.0 6.2 16.1 32.1 35.2 2.7 4.5 40.8 20.6 480.9 41.4 11.3 21.2 25.0 4.5 33.5 4.5 25.4 2.0 24.5 279.4 5.2 21.5 31.8 39.0 56.4 27.1 12.5 51.5 10.3 10.2 59.8 19.4 24.6 33.9 19.1 40.8 7.3 0.3 5.9 9.2 23.0 90.0 23.7 40.2 13.0 8.7 44.8 8.4 105.5 91.7 19.9 2.0 8.4 28.2 52.3 17.9 28.3 27.2 15.3 15.2 18.4 0.7 13.9 106.7 0.7 40.8 15.5 43.7 58.7 33.1 48.0 9.0 14.3 49.3 0.3 42.6 28.2 17.9 24.6 24.6 127.3 6.9 6.9 57.6 62.5 7.5 47.1 10.1 4.4 5.3 18.6 19.2 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 19.6 28.2 24.5 20.9 18.0 19.4 33.8 27.5 32.1 25.0 25.4 39.0 6.1 0.0 8.1 4.9 0.3 35.9 29.1 25.1 30.7 0.7 32.2 24.3 112.0 38.6 18.1 5.5 0.0 31.0 0.6 0.2 9.8 37.7 0.0 3.1 8.4 7.8 0.0 2.7 0.8 15.5 60.6 12.6 9.7 6.2 0.0 3.0 8.6 33.1 6.0 0.0 1.1 0.2 14.2 1.6 4.6 0.4 16.1 1.0 17.8 2.8 0.0 63.6 0.0 0.0 9.5 41.0 0.0 12.4 2.6 56.8 1.5 24.3 5.0 3.2 32.9 18.5 25.4 0.2 7.5 39.7 29.8 18.3 0.7 4.8 1.4 29.8 DDB2 "DDBB, FLJ34321, UV-DDB2, XPE" ENSG00000134574 "Damage specific DNA binding protein 2" Q92466 11 47214465-47239217 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" DNA-binding "Cancer-related genes, Disease variant, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 75.1;monocytes: 135.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025912, HPA058406" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 31: Skin - Epidermis development" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 3: Monocytes - Immune response regulation" "Nucleoplasm, Cell Junctions" "CAB025912: , HPA058406: AB_2683708" "prognostic favorable (7.29e-4)" "prognostic favorable (1.58e-4)" "unprognostic (1.49e-1)" "prognostic favorable (1.20e-4)" "unprognostic (4.29e-2)" "unprognostic (2.04e-2)" "unprognostic (2.96e-2)" "unprognostic (6.18e-2)" "unprognostic (2.25e-1)" "unprognostic (3.58e-3)" "unprognostic (3.53e-1)" "unprognostic (1.94e-1)" "unprognostic (4.57e-3)" "unprognostic (1.21e-2)" "unprognostic (4.25e-2)" "unprognostic (9.82e-3)" "unprognostic (1.07e-1)" 13.2 22.5 2.6 8.2 3.2 11.6 13.5 3.4 3.6 12.5 3.4 12.8 7.6 12.7 11.7 24.8 17.6 12.5 6.8 2.5 2.4 4.4 27.0 12.2 14.7 3.4 2.7 11.6 14.4 4.8 4.7 6.8 3.5 9.7 14.9 2.3 14.4 11.7 6.2 46.7 10.2 13.9 2.7 11.3 9.5 4.5 3.2 23.5 5.5 6.9 17.0 11.2 14.1 3.6 23.7 62.3 25.9 19.3 16.6 32.7 29.9 26.0 58.8 32.0 37.1 10.1 14.1 56.6 5.3 23.2 23.6 40.8 14.6 51.8 15.7 14.5 27.5 13.3 55.7 46.7 15.8 15.9 34.4 43.4 58.0 15.9 35.2 10.2 94.2 14.7 3.5 27.0 52.7 44.4 60.4 7.7 8.4 31.1 22.3 30.3 5.6 30.6 13.5 22.7 13.2 16.7 31.2 8.7 8.1 30.8 56.1 5.5 41.2 96.8 44.1 21.3 12.6 27.6 22.4 12.5 37.0 20.2 35.9 9.8 12.8 20.2 19.3 18.4 18.8 18.3 20.1 18.8 10.4 14.5 14.8 15.7 3.7 14.1 15.8 0.3 47.7 15.9 2.6 3.2 3.4 3.6 2.5 2.4 3.4 2.7 3.5 2.7 3.2 3.6 13.8 16.0 22.2 7.8 25.1 38.9 39.7 28.1 75.1 5.0 18.0 25.8 7.8 11.5 16.3 5.5 10.4 3.6 21.3 11.1 9.8 12.5 1.5 5.2 8.1 19.5 7.7 19.1 6.6 13.8 9.0 16.0 18.3 9.5 22.8 31.2 15.0 16.6 17.5 1.7 1.4 12.6 16.2 17.5 12.8 2.1 19.0 16.8 19.6 24.4 135.5 9.6 35.0 1.0 10.6 19.9 9.8 10.5 34.1 8.9 15.7 7.7 13.9 12.8 0.0 12.1 14.0 3.1 8.6 34.5 30.3 1.5 34.3 25.4 16.5 26.5 ACP2 LAP ENSG00000134575 "Acid phosphatase 2, lysosomal" P11117 11 47239302-47248906 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 89.3;Hofbauer cells: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 69.9" "Lineage enriched" "Detected in all" 5 "monocytes: 69.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 12000 "Cluster 51: Monocytes - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 44: HDLM-2 - Immune response" "Cluster 4: Macrophages - Innate immune response" "unprognostic (5.27e-3)" "unprognostic (1.56e-1)" "unprognostic (3.86e-2)" "prognostic favorable (1.04e-4)" "unprognostic (7.90e-3)" "unprognostic (2.93e-1)" "unprognostic (6.16e-3)" "unprognostic (1.09e-1)" "unprognostic (2.63e-1)" "unprognostic (3.28e-3)" "unprognostic (2.64e-3)" "unprognostic (5.42e-2)" "unprognostic (1.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.20e-1)" "unprognostic (8.68e-3)" "unprognostic (1.57e-1)" 25.2 36.6 17.3 22.9 17.1 6.4 21.8 17.0 18.5 16.5 22.1 23.3 42.9 15.8 29.8 14.3 14.1 19.6 21.7 19.8 26.0 27.4 80.5 21.4 29.4 20.8 19.6 11.1 45.9 21.3 21.3 28.7 23.1 25.4 18.1 11.9 50.3 18.3 14.0 11.4 31.9 16.9 16.9 29.1 24.8 12.2 22.0 13.7 19.3 14.8 15.3 22.0 13.1 17.2 16.5 33.5 31.9 28.2 28.1 13.6 24.4 26.6 47.1 47.5 49.4 23.3 26.3 4.3 21.9 34.2 14.3 23.7 16.9 24.6 22.5 85.5 29.1 11.1 48.1 24.6 38.4 16.4 27.1 34.1 15.2 24.6 14.5 28.3 34.9 14.1 20.3 33.9 31.5 26.8 13.4 14.2 21.5 24.8 20.0 10.8 43.1 36.2 34.9 37.6 16.7 26.0 36.8 80.1 19.2 16.3 49.0 14.0 21.0 23.9 19.8 31.4 38.4 28.1 40.0 3.6 35.0 8.2 37.6 12.5 16.9 7.2 12.3 69.9 9.4 2.5 7.6 11.1 15.1 1.5 6.6 5.7 2.8 9.7 48.2 0.6 8.3 10.9 17.3 17.1 17.0 18.5 19.8 26.0 20.8 19.6 23.1 16.9 22.0 17.2 13.3 19.2 18.6 6.2 5.6 4.1 9.3 42.2 10.2 14.4 13.5 9.1 9.2 21.5 29.4 18.4 6.2 41.3 2.6 37.6 9.8 50.6 1.8 7.7 15.6 18.3 15.0 13.5 6.9 60.1 33.3 15.3 17.3 12.1 12.0 10.7 45.7 89.3 113.5 11.8 8.9 26.7 22.4 80.0 3.9 3.5 5.0 33.8 24.9 3.7 29.8 20.6 7.2 8.5 4.3 33.5 29.5 10.5 21.1 10.9 55.3 33.4 19.2 11.9 19.7 8.1 14.5 11.8 19.1 9.5 2.4 29.3 5.8 25.2 14.3 8.6 NR1H3 "LXR-a, LXRa, RLD-1" ENSG00000025434 "Nuclear receptor subfamily 1 group H member 3" Q13133 11 47248300-47269033 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 66.6;Hofbauer cells: 54.4;Kupffer cells: 100.9;Proximal enterocytes: 69.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 13.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC TERT1: 45.3;HSkMC: 61.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036443, CAB037109" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 2: Hepatocytes - Metabolism" Nucleoplasm Cytosol "CAB037109: AB_1840991, HPA036443: AB_10966142" "unprognostic (2.95e-3)" "unprognostic (5.31e-3)" "unprognostic (5.19e-2)" "prognostic favorable (5.05e-4)" "unprognostic (1.19e-1)" "unprognostic (2.65e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.51e-1)" "unprognostic (1.76e-1)" "unprognostic (7.73e-2)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.40e-5)" "unprognostic (3.56e-1)" "unprognostic (4.42e-2)" "unprognostic (2.84e-1)" "prognostic favorable (3.40e-4)" 60.7 19.9 11.3 19.4 11.8 3.3 51.1 11.2 14.3 25.3 10.2 24.6 48.4 13.6 17.6 7.6 20.3 19.6 18.5 10.3 11.1 23.4 83.8 24.1 46.7 11.0 12.1 15.2 16.7 6.8 7.2 25.4 11.7 19.4 12.0 2.2 14.8 11.5 9.1 11.7 41.0 7.9 10.5 53.2 16.3 21.8 13.8 11.0 20.3 6.3 13.6 22.4 17.5 11.5 3.5 13.8 6.4 6.1 41.0 45.3 31.1 3.5 17.9 5.7 8.8 17.0 43.2 6.1 6.5 2.8 2.1 9.2 7.6 6.1 3.8 5.8 6.1 8.3 18.7 26.1 17.5 2.9 1.0 61.2 3.7 8.7 5.5 9.7 5.0 9.4 10.2 2.5 4.5 14.8 5.8 17.0 7.1 18.7 4.5 8.4 8.3 4.1 5.0 31.9 6.1 2.3 12.2 7.9 10.4 6.1 19.5 8.8 1.3 4.5 6.1 9.1 2.0 11.9 18.3 7.6 8.2 3.9 2.2 7.8 2.7 2.5 1.4 13.3 1.9 1.0 1.5 1.3 4.3 0.7 1.7 1.4 1.6 5.8 4.2 0.7 3.8 1.9 11.3 11.8 11.2 14.3 10.3 11.1 11.0 12.1 11.7 10.5 13.8 11.5 27.2 0.0 11.3 8.1 3.0 3.3 8.6 4.6 2.2 2.4 12.7 12.1 6.6 15.7 4.9 5.5 2.1 11.0 1.5 24.4 11.7 5.8 31.0 2.4 15.3 12.5 1.8 7.0 9.2 8.7 13.3 14.1 17.9 2.8 13.3 7.1 24.7 66.6 54.4 1.7 10.9 14.6 2.0 100.9 3.3 49.0 9.0 24.7 3.6 1.0 5.4 4.4 2.1 3.0 5.6 4.2 10.7 6.0 2.4 4.1 69.5 26.1 2.5 0.8 19.7 7.4 16.3 32.4 16.8 3.0 2.4 6.6 2.1 5.4 19.0 6.3 MADD "DENN, KIAA0358, RAB3GEP" ENSG00000110514 "MAP kinase activating death domain" Q8WXG6 11 47269161-47330031 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Guanine-nucleotide releasing factor" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 133.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 80.9;Cone photoreceptor cells: 125.1;Horizontal cells: 132.9;Rod photoreceptor cells: 106.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 33.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 33.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038568 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 15: RT4 - Unknown function" "Cluster 62: Horizontal cells - Visual perception" "Plasma membrane, Cytosol" "HPA038568: AB_10795030" "unprognostic (3.16e-1)" "unprognostic (1.81e-1)" "unprognostic (8.51e-3)" "prognostic favorable (6.62e-5)" "unprognostic (1.27e-1)" "unprognostic (6.36e-3)" "unprognostic (4.82e-3)" "unprognostic (1.16e-1)" "unprognostic (1.91e-1)" "unprognostic (3.78e-2)" "prognostic favorable (5.69e-5)" "unprognostic (1.53e-1)" "unprognostic (3.55e-1)" "unprognostic (8.07e-2)" "unprognostic (1.06e-1)" "unprognostic (2.76e-1)" "prognostic favorable (8.25e-4)" 15.1 24.6 32.4 17.7 32.2 28.4 14.8 46.7 44.5 16.1 0.3 17.9 12.4 15.1 12.0 11.1 14.0 12.2 24.6 40.5 21.2 17.1 13.0 19.0 20.9 18.2 18.8 18.8 17.5 18.4 65.7 16.0 22.1 20.7 16.6 133.2 16.6 17.1 30.1 22.8 19.0 14.6 7.0 22.0 18.8 28.5 16.7 23.6 14.4 23.4 17.9 18.7 15.0 32.1 14.0 28.7 30.8 27.6 20.6 14.3 6.9 19.3 25.8 24.2 25.9 21.0 12.9 29.6 6.0 21.3 31.1 27.2 25.2 13.6 20.8 33.1 25.6 52.7 55.0 18.3 14.8 36.1 69.4 13.9 14.3 12.7 15.9 16.4 22.4 18.7 34.5 21.1 21.5 19.7 17.2 38.6 18.4 32.8 19.6 23.2 49.5 19.7 12.4 66.0 48.4 31.5 24.9 29.0 17.6 18.1 22.8 27.0 19.2 22.4 14.1 32.3 13.2 24.9 27.9 16.6 20.9 25.1 21.5 33.3 3.4 6.5 5.6 5.6 5.0 4.0 3.9 4.6 5.2 4.2 4.5 3.6 0.9 5.7 7.9 2.7 7.5 6.2 32.4 32.2 46.7 44.5 40.5 21.2 18.2 18.8 22.1 7.0 16.7 32.1 10.6 12.8 9.2 21.5 11.7 10.7 4.1 6.1 6.8 80.9 11.3 10.2 23.4 7.2 5.8 7.3 125.1 4.6 29.0 21.2 0.0 7.5 14.6 5.3 7.0 11.5 16.3 8.6 37.4 4.9 2.3 7.8 23.4 8.3 26.6 13.9 14.6 7.0 11.5 132.9 33.7 17.7 4.1 19.4 14.9 4.9 7.2 14.9 10.6 21.5 11.1 14.4 23.7 14.1 22.4 12.0 12.2 12.8 17.7 8.0 12.2 5.1 6.2 106.8 6.6 8.7 7.7 14.9 23.2 6.7 8.2 4.4 15.4 16.2 13.7 5.9 MYBPC3 "CMH4, cMyBP-C, FHC" ENSG00000134571 "Myosin binding protein C3" Q14896 11 47331406-47352702 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 584 "heart muscle: 1725.4" "Cell type enriched" "Detected in some" 42 "Cardiomyocytes: 1876.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "U-937: 6.4" "Region enriched" "Detected in some" 33 "cerebellum: 34.4" "Low region specificity" "Detected in many" "HPA040147, HPA043898" Enhanced NA NA 21000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 32: U-937 - Innate immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA040147: AB_2676861, HPA043898: AB_2678720" "unprognostic (1.06e-1)" "unprognostic (1.47e-6)" "unprognostic (2.17e-1)" "unprognostic (6.16e-2)" "unprognostic (3.00e-3)" "unprognostic (1.40e-4)" "unprognostic (7.47e-2)" "unprognostic (2.72e-2)" "unprognostic (2.53e-1)" "unprognostic (1.62e-1)" "unprognostic (9.53e-2)" "unprognostic (4.22e-2)" "unprognostic (1.11e-3)" "unprognostic (2.11e-1)" "unprognostic (1.96e-1)" "unprognostic (4.15e-1)" "unprognostic (3.21e-2)" 0.4 2.9 0.0 0.7 0.0 1.5 0.7 0.2 0.4 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.4 1725.4 0.0 0.0 0.3 0.3 2.0 0.5 0.2 0.1 0.1 0.7 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.6 0.0 0.4 0.2 0.3 0.1 0.0 2.8 2.8 1.4 0.0 0.0 0.3 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.9 0.0 1.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1876.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 28.3 0.0 0.0 14.3 0.0 0.0 0.2 0.0 0.0 43.9 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.2 0.8 0.0 0.8 0.0 19.2 0.3 0.7 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.1 0.9 0.0 0.0 0.3 0.0 17.4 0.6 0.0 SPI1 "OF, PU.1, SFPI1, SPI-1, SPI-A" ENSG00000066336 "Spi-1 proto-oncogene" P17947 11 47354860-47378547 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, RNA-binding" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "bone marrow: 335.1;lung: 101.0;lymphoid tissue: 172.7" "Group enriched" "Detected in many" 6 "Hofbauer cells: 432.9;Kupffer cells: 411.9;Langerhans cells: 537.6;Macrophages: 453.3;monocytes: 357.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 179.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 179.7" "Cell line enhanced" "Detected in some" "HEL: 90.1;HL-60: 159.7;HMC-1: 282.2;NB-4: 267.8;THP-1: 206.7;U-698: 85.3;U-937: 117.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004079, HPA044653" Enhanced Supported Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" Nucleoplasm "CAB004079: AB_10692379, HPA044653: AB_2679036" "unprognostic (4.45e-2)" "unprognostic (3.31e-3)" "unprognostic (2.92e-2)" "unprognostic (1.66e-2)" "unprognostic (5.97e-2)" "unprognostic (3.33e-2)" "unprognostic (5.28e-2)" "unprognostic (1.07e-1)" "unprognostic (2.35e-2)" "unprognostic (2.79e-1)" "unprognostic (3.36e-1)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.07e-5)" "unprognostic (1.20e-1)" "unprognostic (4.95e-2)" "unprognostic (2.40e-1)" "unprognostic (4.92e-2)" 36.5 19.7 12.0 107.3 13.1 335.1 17.7 14.3 19.4 7.9 15.8 15.6 21.5 7.3 2.1 9.1 19.1 21.3 13.5 11.7 16.4 10.6 15.6 101.0 65.0 31.2 20.9 5.2 7.8 3.1 7.6 28.0 24.7 10.3 10.2 1.0 14.6 6.1 5.0 13.8 29.3 21.9 19.8 172.7 17.0 3.7 26.2 15.7 8.8 8.3 32.0 29.9 7.6 30.3 0.2 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.2 0.1 0.0 0.0 72.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 90.1 0.0 0.0 0.0 159.7 282.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.7 0.0 0.0 0.2 267.8 0.2 0.0 0.0 48.7 0.2 47.5 0.0 0.0 0.2 0.3 0.0 0.0 0.6 0.0 0.0 206.7 0.3 0.0 0.5 0.5 0.1 0.1 0.3 85.3 0.3 117.5 0.1 14.1 19.2 179.7 0.0 27.4 0.0 3.9 0.0 0.0 16.4 2.4 0.0 0.0 83.8 0.0 34.7 0.9 0.0 7.3 12.0 13.1 14.3 19.4 11.7 16.4 31.2 20.9 24.7 19.8 26.2 30.3 2.1 3.2 1.1 10.4 72.6 10.5 0.5 0.0 1.2 1.3 2.1 5.0 2.9 4.3 0.6 5.5 0.0 2.3 6.3 0.5 19.6 0.1 7.5 0.1 0.3 5.5 4.2 39.7 3.1 0.4 3.1 2.6 1.1 0.3 33.7 0.2 7.9 3.2 432.9 0.0 3.3 0.3 0.0 411.9 537.6 27.5 1.8 453.3 10.6 36.5 357.5 7.0 8.2 3.5 1.5 0.0 0.1 0.0 21.8 0.4 0.2 2.3 0.7 1.7 13.1 1.5 1.4 5.1 9.3 0.8 9.9 4.2 4.8 1.1 0.4 0.5 SLC39A13 FLJ25785 ENSG00000165915 "Solute carrier family 39 member 13" Q96H72 11 47407132-47416496 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 13 "Early spermatids: 298.2;Late spermatids: 905.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043971 Approved NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "HPA043971: AB_10959744" "unprognostic (7.84e-2)" "unprognostic (1.02e-2)" "prognostic unfavorable (2.60e-4)" "unprognostic (1.18e-1)" "unprognostic (8.56e-3)" "unprognostic (3.81e-2)" "unprognostic (7.44e-3)" "unprognostic (1.36e-1)" "unprognostic (5.40e-2)" "prognostic unfavorable (2.73e-5)" "unprognostic (1.39e-2)" "unprognostic (2.04e-2)" "prognostic favorable (1.96e-4)" "unprognostic (3.16e-1)" "unprognostic (1.73e-1)" "unprognostic (8.61e-2)" "unprognostic (4.12e-1)" 40.9 42.4 28.3 24.2 31.4 8.3 37.5 30.6 36.3 51.1 30.4 53.4 14.0 77.9 8.8 21.8 48.1 20.2 59.5 26.0 27.3 80.4 26.7 61.4 18.2 33.0 29.7 50.9 42.3 27.2 51.3 40.6 30.4 52.7 6.8 11.0 31.3 26.2 31.4 32.4 31.8 26.6 26.8 36.5 41.2 73.4 35.0 12.3 46.8 12.6 8.7 45.6 37.4 28.5 23.3 20.4 23.5 26.7 56.3 78.2 6.8 89.7 66.2 50.4 57.0 8.1 15.7 8.8 22.9 69.6 49.6 38.3 7.1 61.7 13.9 25.7 25.9 4.7 52.7 16.7 84.3 8.1 11.0 65.4 43.4 31.9 26.1 62.9 53.4 16.9 4.5 19.6 54.8 20.7 17.4 11.5 11.0 19.8 28.2 20.6 33.6 8.9 86.1 11.1 19.9 37.0 26.9 49.1 26.2 8.7 32.8 11.7 76.0 76.6 34.6 88.1 42.7 14.9 5.2 4.1 85.2 11.2 57.3 2.1 3.6 3.2 12.4 13.3 8.5 4.1 8.2 8.9 4.6 5.1 7.5 6.4 6.6 7.4 15.3 4.9 4.5 5.9 28.3 31.4 30.6 36.3 26.0 27.3 33.0 29.7 30.4 26.8 35.0 28.5 20.0 9.6 6.4 18.6 6.7 18.2 18.3 23.0 17.1 24.0 11.5 15.6 18.3 15.7 8.0 29.5 12.5 11.1 11.6 3.4 9.8 32.9 298.2 6.5 20.3 20.9 9.6 4.4 9.6 20.7 16.4 37.8 6.6 13.1 5.7 15.4 21.8 6.2 18.9 32.0 11.7 7.9 14.2 5.3 12.2 905.5 32.9 9.3 19.6 4.7 26.6 16.7 11.3 8.0 10.1 35.5 8.3 40.3 8.1 23.5 8.2 8.8 4.5 17.0 46.0 16.1 36.2 12.7 6.4 2.4 4.1 19.6 9.6 36.7 5.7 8.3 PSMC3 "TBP-1, TBP1" ENSG00000165916 "Proteasome 26S subunit, ATPase 3" P17980 11 47418769-47426473 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006065 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 290000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA006065: AB_1079706" "unprognostic (2.01e-2)" "unprognostic (5.08e-3)" "unprognostic (9.43e-2)" "unprognostic (8.12e-3)" "unprognostic (6.32e-2)" "unprognostic (5.71e-2)" "unprognostic (8.99e-3)" "unprognostic (1.63e-1)" "unprognostic (9.95e-2)" "unprognostic (1.27e-2)" "unprognostic (3.88e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (1.49e-1)" "unprognostic (2.25e-1)" "unprognostic (2.55e-2)" "unprognostic (1.84e-1)" 85.3 86.1 106.8 64.7 117.3 96.1 77.9 105.3 131.0 73.7 105.8 110.2 52.2 89.9 62.5 88.7 69.0 44.0 172.1 107.8 106.3 73.8 117.7 76.2 65.3 108.6 114.7 58.2 81.4 74.1 55.4 78.8 111.0 74.2 59.1 30.9 73.0 69.8 292.0 103.4 64.0 77.5 104.6 67.8 87.7 74.7 115.2 90.6 69.4 162.9 76.5 80.8 71.7 107.0 223.7 248.2 233.5 173.3 109.6 117.3 226.5 181.5 267.4 445.7 313.8 223.3 126.8 179.5 110.1 230.1 195.7 218.3 206.7 237.7 199.0 269.4 268.1 173.1 301.1 218.5 141.4 203.7 177.0 131.4 126.1 181.6 202.5 98.4 253.8 182.7 249.2 164.7 276.0 497.0 259.5 258.4 229.5 280.7 296.1 269.3 458.8 157.3 209.5 165.2 170.0 147.1 148.7 206.9 116.2 98.2 255.7 209.8 181.3 253.7 321.1 363.8 474.7 176.5 220.0 209.2 262.4 201.7 325.1 111.5 154.3 121.8 160.8 194.6 146.7 146.8 132.9 147.8 160.6 122.4 116.5 118.6 33.9 173.3 211.6 160.0 191.0 254.7 106.8 117.3 105.3 131.0 107.8 106.3 108.6 114.7 111.0 104.6 115.2 107.0 81.5 57.7 42.0 3.9 59.5 86.3 112.8 198.5 50.7 41.2 61.4 64.1 217.6 81.5 103.7 68.0 16.7 265.9 60.0 143.9 152.6 199.2 152.5 72.0 75.7 96.0 64.5 136.6 6.4 202.6 257.9 100.4 54.0 70.1 75.3 79.2 77.1 144.2 158.2 37.0 5.3 111.5 75.3 62.4 80.0 217.6 88.6 62.5 99.6 1.9 132.0 120.2 74.2 3.0 5.2 214.2 110.8 100.1 96.3 102.8 127.7 191.3 76.9 47.4 118.3 75.1 193.3 147.0 63.6 51.3 77.3 352.9 61.8 74.1 117.6 101.6 RAPSN "CMS1D, CMS1E, RNF205" ENSG00000165917 "Receptor associated protein of the synapse" Q13702 11 47437764-47449143 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 23 "skeletal muscle: 88.9;tongue: 33.1" "Cell type enriched" "Detected in some" 4 "Skeletal myocytes: 63.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RH-30: 238.7" "Low region specificity" "Detected in some" HPA039475 Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane, Centrosome, Cytosol" "HPA039475: AB_10794196" "unprognostic (5.37e-2)" "unprognostic (1.02e-1)" "unprognostic (7.34e-2)" "unprognostic (4.58e-2)" "unprognostic (2.95e-2)" "unprognostic (1.44e-1)" "unprognostic (2.62e-2)" "unprognostic (1.77e-3)" "unprognostic (1.35e-1)" "unprognostic (5.38e-2)" "unprognostic (4.81e-2)" "unprognostic (2.89e-2)" "unprognostic (1.08e-2)" "unprognostic (1.64e-4)" "unprognostic (3.83e-1)" "unprognostic (4.73e-3)" "unprognostic (4.48e-2)" 0.3 1.5 0.5 0.2 0.5 0.3 0.2 0.3 1.2 0.2 0.9 0.8 0.1 0.0 0.1 1.2 0.1 0.1 2.6 0.5 0.5 0.3 0.5 0.4 0.2 0.3 0.5 0.0 0.2 0.0 0.1 2.1 0.5 0.7 0.0 0.1 1.3 0.0 88.9 0.5 0.5 0.1 0.4 0.6 0.2 0.3 0.6 0.1 0.2 33.1 0.1 0.1 0.1 0.5 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.3 0.2 0.7 0.1 0.2 1.2 4.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 59.6 0.0 0.0 0.2 0.0 0.0 0.2 0.0 238.7 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.3 0.1 0.3 0.3 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 1.2 0.5 0.5 0.3 0.5 0.5 0.4 0.6 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.3 0.3 1.4 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.5 2.7 0.3 0.1 0.2 0.0 0.0 0.1 0.2 0.1 1.0 0.0 0.5 0.0 0.2 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.3 0.3 13.8 0.0 0.5 0.0 0.0 0.6 1.3 0.0 0.5 0.0 0.8 0.0 0.0 0.1 0.2 0.0 0.0 1.1 0.0 0.0 63.8 0.5 0.0 0.4 0.0 0.0 0.3 0.4 0.1 0.2 0.1 CELF1 "BRUNOL2, CUG-BP, CUGBP, CUGBP1, EDEN-BP, hNab50, NAB50, NAPOR" ENSG00000149187 "CUGBP Elav-like family member 1" Q92879 11 47465933-47565569 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016114, HPA044597, CAB069989" Supported Enhanced Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoplasm "CAB016114: AB_627319, CAB069989: AB_2086153, HPA044597: AB_2679012" "unprognostic (1.05e-1)" "unprognostic (7.54e-2)" "unprognostic (3.24e-2)" "unprognostic (7.64e-2)" "unprognostic (2.69e-1)" "unprognostic (4.08e-2)" "prognostic unfavorable (7.55e-4)" "unprognostic (3.84e-2)" "unprognostic (3.41e-2)" "unprognostic (1.59e-1)" "unprognostic (2.75e-1)" "unprognostic (4.24e-2)" "unprognostic (1.24e-1)" "unprognostic (4.81e-2)" "unprognostic (2.68e-1)" "unprognostic (9.58e-2)" "unprognostic (3.34e-2)" 27.3 32.2 36.5 31.9 44.8 46.0 25.8 59.0 37.3 29.7 35.4 34.5 22.4 31.7 23.9 32.0 28.4 24.4 30.1 34.7 31.5 26.9 56.1 32.1 39.4 24.1 26.0 26.0 28.0 48.0 23.4 27.6 20.7 23.6 25.8 29.2 26.1 22.6 74.3 30.7 30.6 29.0 20.2 34.6 26.6 29.8 30.3 28.9 28.8 58.0 38.5 29.4 29.4 24.9 48.6 84.4 68.8 71.0 52.9 55.8 58.5 51.0 52.5 62.9 65.4 72.3 56.0 127.6 34.6 55.2 75.6 70.6 107.5 72.3 104.9 53.5 46.9 39.2 117.3 52.2 51.3 62.2 41.4 43.0 43.7 68.5 82.5 44.4 58.0 54.2 75.0 50.5 40.6 64.8 64.5 49.3 96.5 60.0 49.3 65.5 54.8 49.9 54.3 85.4 64.3 54.3 67.9 62.0 41.1 70.0 87.8 40.5 67.0 71.3 69.7 69.1 70.0 42.9 42.2 99.7 57.6 29.2 59.3 13.9 11.6 22.8 12.5 10.2 15.8 14.4 13.3 14.6 13.1 15.0 14.0 11.9 14.9 7.9 17.7 8.0 10.1 9.5 36.5 44.8 59.0 37.3 34.7 31.5 24.1 26.0 20.7 20.2 30.3 24.9 56.2 54.5 41.9 90.8 74.6 107.7 78.0 82.1 79.6 82.4 78.8 59.3 51.1 72.9 56.2 79.1 95.9 52.6 84.1 51.6 21.5 57.3 16.3 76.5 68.4 73.2 85.6 81.0 134.4 56.1 48.8 48.8 57.1 94.4 21.5 92.6 92.4 233.5 72.4 127.9 108.5 62.3 52.9 123.2 98.2 12.4 52.8 81.3 42.7 91.8 106.2 52.2 98.9 76.4 65.8 86.5 53.7 55.3 55.3 103.5 46.2 43.5 106.1 42.9 52.6 52.3 72.0 50.1 69.7 70.2 109.1 36.0 68.8 50.2 70.0 101.1 NDUFS3 CI-30 ENSG00000213619 "NADH:ubiquinone oxidoreductase core subunit S3" O75489 11 47565336-47584562 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 292.3" "Cell type enhanced" "Detected in all" "Distal tubular cells: 405.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004484, CAB034894" Enhanced Supported "Nuclear bodies,Mitochondria" NA NA 14000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "Nuclear bodies" "CAB034894: AB_2151118, HPA004484: AB_1079464" "unprognostic (2.18e-1)" "unprognostic (7.42e-3)" "unprognostic (1.75e-1)" "unprognostic (5.01e-2)" "unprognostic (7.51e-2)" "unprognostic (3.13e-2)" "unprognostic (6.40e-2)" "unprognostic (6.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.41e-2)" "unprognostic (6.75e-3)" "unprognostic (7.73e-2)" "prognostic favorable (2.61e-6)" "unprognostic (2.77e-2)" "unprognostic (1.42e-1)" "unprognostic (1.88e-2)" "unprognostic (3.17e-3)" 52.4 91.3 47.4 16.5 52.6 44.1 50.7 55.6 50.2 43.5 59.4 97.5 53.8 49.7 26.2 78.7 42.6 18.1 210.3 49.3 51.9 94.2 96.2 40.5 25.5 48.8 49.3 37.3 56.7 53.6 67.5 17.6 49.4 44.0 52.7 23.5 60.9 27.5 292.3 66.2 69.4 26.6 50.3 55.5 81.4 48.2 54.7 33.8 49.7 194.2 33.3 51.4 52.0 47.7 37.7 68.7 59.8 62.9 48.8 52.3 48.2 35.0 60.3 84.6 80.4 103.6 65.1 81.8 34.8 49.7 63.0 64.9 81.7 61.8 69.4 44.2 137.2 49.5 90.6 106.5 49.7 121.5 62.1 50.1 46.6 32.0 52.2 37.5 55.3 69.2 73.7 57.1 57.7 118.6 87.0 164.9 83.6 109.6 97.7 100.7 81.8 68.7 76.4 60.2 63.9 47.1 43.4 76.9 83.5 35.2 84.4 118.2 37.0 49.3 56.4 57.0 80.4 61.2 93.5 91.8 50.1 94.9 51.3 38.3 69.3 48.9 43.2 79.8 46.4 60.6 45.2 47.5 83.3 59.2 42.4 46.0 18.4 45.6 66.7 89.3 61.3 90.3 47.4 52.6 55.6 50.2 49.3 51.9 48.8 49.3 49.4 50.3 54.7 47.7 54.7 54.5 42.6 23.5 54.6 65.6 67.4 217.5 62.6 45.6 60.2 72.5 176.9 81.5 108.5 69.9 41.7 122.0 70.8 183.1 405.0 113.0 132.3 56.8 58.6 60.0 84.7 73.8 12.7 111.3 116.5 60.8 81.1 40.5 57.7 67.1 58.5 126.3 195.9 60.6 14.5 162.8 173.0 66.9 59.3 63.2 67.4 62.8 119.2 7.5 83.9 117.9 58.7 12.5 13.1 91.7 109.3 69.2 69.8 53.0 257.8 297.0 109.7 59.5 105.2 55.5 154.8 85.5 74.7 115.3 75.9 89.1 55.5 128.3 210.7 85.3 PTPMT1 "DUSP23, MOSP, PLIP" ENSG00000110536 "Protein tyrosine phosphatase mitochondrial 1" Q8WUK0 11 47565430-47573461 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 235.1;Late spermatids: 640.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043932, HPA060060" Approved Enhanced Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 71: Testis - DNA repair" "Cluster 6: T47d - Mammary gland" "Cluster 25: Spermatids - Spermatogenesis" Mitochondria "HPA043932: AB_2678738, HPA060060: " "unprognostic (6.61e-2)" "unprognostic (2.09e-1)" "unprognostic (1.28e-1)" "unprognostic (2.37e-3)" "unprognostic (1.02e-1)" "unprognostic (1.26e-2)" "prognostic unfavorable (3.04e-5)" "unprognostic (3.29e-2)" "unprognostic (2.77e-2)" "unprognostic (1.93e-3)" "unprognostic (6.76e-2)" "unprognostic (1.72e-1)" "unprognostic (2.68e-3)" "unprognostic (1.21e-1)" "unprognostic (5.39e-1)" "unprognostic (2.17e-2)" "unprognostic (1.75e-1)" 38.8 56.5 15.0 5.3 16.1 9.0 37.4 15.8 17.4 31.1 16.6 31.0 7.6 32.8 7.8 34.8 29.5 4.2 27.7 14.4 16.5 37.6 40.6 36.5 6.1 15.6 16.3 28.0 44.7 9.6 41.9 6.7 15.8 32.7 3.9 4.2 37.1 5.9 41.0 28.1 23.4 4.7 16.0 28.9 39.2 105.4 17.0 4.3 30.6 5.8 4.9 27.5 28.1 16.0 34.5 19.4 2.3 17.8 17.5 11.4 7.0 20.1 17.1 19.4 16.8 27.9 17.6 27.9 22.1 14.7 16.8 30.6 16.9 20.4 16.6 31.4 57.3 12.9 43.8 43.4 25.7 25.2 17.1 12.7 21.9 8.8 24.0 11.2 13.7 26.2 32.6 19.5 14.2 65.4 21.4 41.0 18.8 3.9 37.7 38.6 16.7 22.3 22.5 23.3 15.5 21.4 33.8 11.1 23.2 7.2 53.1 32.7 16.6 13.6 23.3 28.6 33.1 27.1 22.6 18.6 13.6 23.3 10.0 11.2 38.0 38.2 24.8 36.8 23.0 33.7 22.7 26.2 44.9 30.3 22.3 21.0 3.1 26.1 34.6 64.6 28.5 28.8 15.0 16.1 15.8 17.4 14.4 16.5 15.6 16.3 15.8 16.0 17.0 16.0 26.8 22.4 35.0 14.4 31.8 17.8 15.8 58.5 34.1 14.4 64.9 78.4 5.8 45.8 38.6 40.5 4.2 72.2 34.7 19.9 72.4 95.3 235.1 48.0 23.9 24.6 31.3 30.1 8.2 85.8 66.3 23.9 28.1 25.6 17.1 16.5 29.6 39.8 62.4 5.0 10.8 45.7 48.8 32.6 21.2 640.8 46.6 45.6 46.2 6.5 56.2 74.9 41.2 9.5 14.6 106.2 38.8 46.6 61.0 26.0 37.9 72.8 57.2 15.7 19.7 17.3 28.1 179.8 28.6 55.0 17.3 76.8 25.9 21.3 62.7 22.0 KBTBD4 "BKLHD4, FLJ10450, HSPC252" ENSG00000123444 "Kelch repeat and BTB domain containing 4" Q9NVX7 11 47572197-47578976 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037792, HPA037793" Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "Vesicles, Cytosol" "HPA037792: AB_10671633, HPA037793: AB_2675671" "unprognostic (5.52e-2)" "unprognostic (2.23e-1)" "unprognostic (8.36e-3)" "unprognostic (1.15e-1)" "unprognostic (3.30e-2)" "unprognostic (7.32e-2)" "unprognostic (1.21e-1)" "unprognostic (2.09e-1)" "unprognostic (8.73e-3)" "unprognostic (2.78e-1)" "unprognostic (4.04e-2)" "unprognostic (7.22e-2)" "prognostic favorable (2.70e-7)" "unprognostic (4.18e-1)" "unprognostic (1.32e-1)" "unprognostic (2.07e-1)" "unprognostic (4.25e-2)" 10.2 13.9 5.8 4.6 6.2 8.7 10.0 7.2 6.2 10.0 6.4 12.8 4.2 13.2 8.8 9.2 10.6 4.6 10.6 5.9 5.8 9.9 8.3 8.3 6.4 5.5 5.7 10.9 8.4 12.4 13.0 4.3 5.6 8.5 6.2 7.4 10.3 6.7 24.3 13.1 10.5 6.7 5.7 10.9 10.4 14.5 5.7 7.9 9.3 11.0 8.4 11.3 8.3 6.0 5.0 11.8 13.0 10.2 7.8 10.6 3.7 9.0 11.8 12.8 11.2 4.0 9.8 9.6 4.8 11.6 9.2 8.5 7.5 13.3 10.9 12.6 10.7 7.2 15.9 5.7 5.8 15.3 14.5 9.6 9.1 5.4 6.9 8.8 13.4 6.7 5.4 7.6 10.2 13.1 11.2 4.6 6.4 14.0 7.6 10.2 17.0 5.4 13.8 11.9 17.2 11.0 7.7 10.4 6.5 4.3 17.4 4.8 10.7 7.9 8.4 12.1 9.0 10.3 20.3 14.2 11.5 4.2 8.8 11.6 4.6 11.7 12.5 3.8 13.8 11.6 9.8 11.4 5.9 10.9 10.6 11.4 8.3 13.5 4.1 2.5 12.8 10.4 5.8 6.2 7.2 6.2 5.9 5.8 5.5 5.7 5.6 5.7 5.7 6.0 6.2 6.4 3.6 3.3 9.6 4.8 6.2 16.4 7.4 14.0 6.9 4.4 0.1 8.6 11.3 11.0 8.4 12.3 9.7 6.9 23.5 13.9 14.5 10.2 5.2 9.0 7.2 9.5 5.7 13.7 7.3 5.8 1.5 4.6 10.8 6.8 7.5 8.8 8.1 13.5 6.6 4.0 20.3 4.1 2.9 18.3 5.0 4.3 1.8 3.7 11.4 24.9 10.3 2.5 4.6 9.0 2.9 9.4 5.8 4.1 6.3 10.9 18.8 12.1 13.1 6.9 6.0 23.7 20.1 4.0 4.5 14.1 10.2 7.6 5.4 4.6 FAM180B LOC399888 ENSG00000196666 "Family with sequence similarity 180 member B" Q6P0A1 11 47586678-47589194 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 6.5;brain: 5.9;breast: 5.2;choroid plexus: 5.1;skin 1: 6.3" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 7.4;Fibroblasts: 20.4;Langerhans cells: 11.9;Melanocytes: 5.4;Peritubular cells: 4.1;Suprabasal keratinocytes: 6.3" "Cancer enhanced" "Detected in some" "melanoma: 1.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA029408 Uncertain "Secreted in other tissues" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "HPA029408: AB_10601319" "unprognostic (1.28e-2)" "unprognostic (4.99e-3)" "unprognostic (7.48e-2)" "unprognostic (7.26e-2)" "unprognostic (1.24e-2)" "unprognostic (1.64e-2)" "unprognostic (1.21e-3)" "unprognostic (1.04e-1)" "unprognostic (2.69e-1)" "unprognostic (3.87e-2)" "unprognostic (3.16e-2)" "unprognostic (1.03e-5)" "unprognostic (5.65e-2)" "unprognostic (1.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" 6.5 0.1 0.8 0.0 2.0 0.1 5.2 5.9 1.7 0.4 5.1 0.6 0.0 0.2 0.0 0.1 0.4 0.4 0.7 0.6 0.8 0.0 0.0 0.2 0.0 1.9 1.3 0.1 0.1 0.0 0.2 0.0 1.5 0.0 0.0 0.1 1.1 0.0 1.0 6.3 0.2 0.1 1.3 0.1 0.5 0.5 1.6 0.7 4.3 2.9 0.1 0.4 0.2 2.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.0 5.9 1.7 0.6 0.8 1.9 1.3 1.5 1.3 1.6 2.6 0.8 0.0 0.0 1.0 0.0 7.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 20.4 0.5 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.6 11.9 0.3 2.5 0.3 5.4 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.7 0.0 0.0 0.0 6.3 0.1 0.3 0.0 0.0 0.0 C1QTNF4 "CTRP4, ZACRP4" ENSG00000172247 "C1q and TNF related 4" Q9BXJ3 11 47589667-47594411 "Predicted secreted proteins" Cytokine "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.0;pituitary gland: 17.1" "Cell type enhanced" "Detected in many" "Late spermatids: 51.7;Leydig cells: 46.0;Muller glia cells: 54.5;Peritubular cells: 38.4;Spermatogonia: 44.5;Theca cells: 39.0" "Group enriched" "Detected in some" 4 "glioma: 1.7;ovarian cancer: 2.5;testis cancer: 2.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "REH: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041032 Approved Uncertain "Golgi apparatus,Vesicles" "Secreted in brain" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 14: REH - Unknown function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus, Vesicles" "HPA041032: AB_10671170" "unprognostic (1.84e-3)" "unprognostic (1.58e-1)" "unprognostic (8.98e-4)" "unprognostic (8.19e-2)" "unprognostic (3.59e-2)" "unprognostic (2.26e-3)" "unprognostic (6.78e-2)" "unprognostic (6.11e-2)" "unprognostic (6.35e-2)" "unprognostic (4.00e-1)" "unprognostic (4.91e-4)" "unprognostic (1.22e-1)" "unprognostic (8.22e-6)" "unprognostic (6.02e-3)" "unprognostic (1.00e-1)" "unprognostic (2.80e-2)" "unprognostic (6.28e-2)" 1.7 1.5 7.9 0.0 33.0 1.1 2.2 13.2 17.6 5.3 0.0 3.9 0.1 5.8 0.0 0.5 4.2 0.0 1.0 7.5 1.1 1.4 0.9 0.7 0.0 6.0 4.9 12.0 0.4 0.7 17.1 0.0 2.1 2.8 0.0 0.1 1.1 0.1 0.9 1.8 1.5 0.1 1.0 1.0 1.5 5.8 6.7 0.0 1.5 0.0 0.0 1.3 2.0 3.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 33.0 13.2 17.6 7.5 1.1 6.0 4.9 2.1 1.0 6.7 3.4 2.4 0.0 0.0 18.9 0.0 2.4 6.5 0.2 0.0 15.8 1.3 25.8 0.7 1.5 0.3 3.7 16.7 1.3 0.1 0.2 3.9 0.1 11.3 0.8 21.2 4.5 0.0 2.5 15.5 0.2 2.7 20.7 0.5 0.6 0.0 31.3 2.5 0.2 3.3 5.0 17.8 0.1 0.0 0.3 3.0 51.7 46.0 0.7 10.6 4.7 0.0 54.5 0.0 5.0 8.0 0.1 0.1 38.4 0.0 4.3 0.1 0.6 0.6 24.7 26.3 12.8 8.5 13.5 44.5 0.3 1.8 3.6 0.6 39.0 0.2 2.4 MTCH2 SLC25A50 ENSG00000109919 "Mitochondrial carrier 2" Q9Y6C9 11 47617315-47642607 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 569.2;Proximal tubular cells: 508.1;Spermatocytes: 435.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038390 Approved Approved Mitochondria NA NA 14000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 18: U-2197 - ECM organization" "Cluster 10: Non-specific - Unknown function" Mitochondria "HPA038390: AB_10669723" "unprognostic (4.94e-2)" "unprognostic (3.29e-1)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (4.27e-1)" "unprognostic (7.63e-3)" "unprognostic (1.80e-1)" "unprognostic (7.03e-2)" "unprognostic (1.51e-1)" "unprognostic (1.53e-2)" "unprognostic (1.08e-1)" "unprognostic (1.14e-1)" "prognostic favorable (9.05e-6)" "unprognostic (1.12e-2)" "unprognostic (8.75e-2)" "unprognostic (2.25e-1)" "unprognostic (1.77e-1)" 28.8 40.3 13.2 14.1 14.1 12.6 25.3 14.3 15.7 20.5 12.7 41.7 38.9 26.8 19.4 50.3 18.9 11.9 41.0 13.8 15.1 57.3 115.3 20.0 14.7 13.3 14.0 13.6 22.6 21.2 18.5 9.9 13.7 18.3 32.7 16.2 29.8 11.9 81.8 28.7 37.6 21.4 12.8 19.6 22.6 69.8 14.7 14.6 21.6 47.5 23.0 23.2 26.1 14.9 47.8 51.2 42.9 57.9 49.7 45.8 31.6 50.5 46.1 66.7 62.6 40.9 47.2 65.4 26.8 62.3 71.7 58.5 77.7 66.4 80.9 33.0 73.4 37.5 69.3 82.5 68.2 79.1 36.1 52.1 51.5 44.3 65.8 38.6 61.1 55.1 70.9 38.0 82.9 69.3 61.1 59.5 46.4 92.4 77.0 56.1 65.4 47.0 78.5 60.6 51.0 35.7 69.1 68.8 37.1 40.3 99.2 36.4 51.2 60.9 52.9 102.4 65.8 40.5 49.3 73.2 50.4 67.7 55.7 13.3 33.8 14.1 20.3 37.6 19.6 25.1 17.7 19.2 44.0 19.5 15.1 17.6 3.2 22.2 31.5 28.9 24.0 34.1 13.2 14.1 14.3 15.7 13.8 15.1 13.3 14.0 13.7 12.8 14.7 14.9 28.4 22.4 35.9 54.9 39.2 47.0 56.0 169.3 44.9 0.0 50.7 41.3 67.8 71.4 84.0 53.3 0.0 82.8 41.2 98.1 181.9 153.3 569.2 48.8 37.5 31.6 79.8 74.6 47.0 109.4 119.1 40.0 46.4 40.1 37.3 29.3 33.2 289.4 164.2 0.0 50.9 97.0 150.5 65.7 40.3 166.5 28.9 67.5 81.8 22.5 103.9 0.0 30.9 58.8 58.6 93.0 69.7 58.3 70.9 84.9 213.3 508.1 79.0 0.0 32.9 30.0 141.3 435.4 104.4 129.8 54.1 127.8 34.5 74.4 165.5 65.2 AGBL2 "CCP2, FLJ23598" ENSG00000165923 "ATP/GTP binding protein like 2" Q5U5Z8 11 47659591-47715389 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 7.7;testis: 12.5" "Cell type enhanced" "Detected in many" "Early spermatids: 37.5;Endometrial ciliated cells: 25.7;Respiratory ciliated cells: 77.2;Spermatocytes: 19.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.3;T-47d: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007718 Uncertain NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "HPA007718: AB_1078110" "unprognostic (3.44e-5)" "unprognostic (1.16e-1)" "unprognostic (5.84e-2)" "unprognostic (5.33e-4)" "unprognostic (1.13e-1)" "unprognostic (3.00e-1)" "unprognostic (2.05e-1)" "unprognostic (1.38e-2)" "unprognostic (9.83e-3)" "unprognostic (4.11e-2)" "unprognostic (5.56e-2)" "unprognostic (1.79e-1)" "unprognostic (8.24e-6)" "unprognostic (1.01e-2)" "unprognostic (1.28e-1)" "unprognostic (9.62e-2)" "unprognostic (1.17e-3)" 0.3 1.3 0.3 0.4 0.2 0.2 0.5 0.7 0.3 1.4 2.6 0.8 0.3 0.6 1.1 0.4 7.7 0.2 0.2 0.3 0.4 1.6 3.0 1.6 0.5 1.2 1.8 1.3 0.8 0.3 1.7 0.2 0.8 1.2 0.2 0.3 0.5 0.4 0.0 0.4 1.2 0.1 1.0 0.9 0.6 12.5 0.2 0.7 1.5 0.0 0.4 1.1 0.6 0.4 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.3 0.2 0.6 0.2 2.3 0.0 0.1 0.1 0.2 0.6 0.0 0.0 0.3 0.7 0.1 0.1 1.1 0.8 0.3 0.0 0.3 0.6 0.2 0.3 0.2 0.2 0.0 0.8 0.1 0.5 0.3 0.9 0.5 0.2 0.0 0.1 0.0 0.6 0.0 0.2 0.3 1.0 0.8 0.1 0.2 0.0 0.2 0.0 1.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.2 0.3 0.3 0.0 0.5 0.4 0.4 0.1 0.3 0.0 0.3 0.5 0.1 0.3 0.2 0.7 0.3 0.3 0.4 1.2 1.8 0.8 1.0 0.2 0.4 0.1 0.0 2.7 2.6 1.3 0.1 1.3 2.6 2.2 0.1 0.9 0.6 0.6 0.0 6.5 7.3 0.0 0.4 0.5 0.7 0.0 0.4 37.5 25.7 1.3 0.1 1.2 0.8 0.6 0.0 0.3 1.2 1.5 0.9 0.0 0.8 0.4 0.8 0.1 0.0 0.6 0.5 2.0 0.6 0.0 8.2 0.3 0.3 0.0 1.0 1.0 0.7 0.0 1.0 0.5 0.3 0.6 1.5 0.4 0.4 2.4 0.2 77.2 0.5 0.0 0.3 1.1 19.3 1.8 0.6 0.0 0.4 1.3 1.3 0.9 0.5 FNBP4 KIAA1014 ENSG00000109920 "Formin binding protein 4" Q8N3X1 11 47716494-47767443 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039485, HPA040029" Supported Enhanced "Nuclear speckles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA039485: AB_2676536, HPA040029: AB_2676808" "unprognostic (2.49e-2)" "unprognostic (3.95e-1)" "unprognostic (5.50e-2)" "unprognostic (2.78e-1)" "unprognostic (1.19e-1)" "unprognostic (6.13e-3)" "prognostic unfavorable (7.33e-5)" "unprognostic (5.58e-3)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.60e-2)" "unprognostic (3.28e-1)" "prognostic unfavorable (6.35e-4)" "prognostic unfavorable (1.91e-8)" "unprognostic (3.54e-1)" "unprognostic (1.60e-1)" "unprognostic (3.58e-1)" "prognostic favorable (7.23e-5)" 38.0 34.4 5.8 12.1 6.1 19.6 36.6 9.9 7.4 46.7 8.4 35.4 8.9 38.9 9.4 33.8 40.6 8.2 29.9 5.7 6.8 29.5 31.3 39.1 15.9 5.9 6.2 48.8 39.2 7.5 29.2 9.6 5.8 36.3 8.8 14.9 32.7 8.2 51.0 40.5 42.8 9.0 5.3 50.6 31.6 16.5 6.4 14.0 42.8 7.0 14.2 34.2 40.2 7.8 10.6 8.5 17.7 12.5 10.0 11.6 12.0 12.3 12.7 11.1 12.9 8.4 14.0 23.2 6.0 14.0 9.3 21.2 15.8 10.0 16.4 18.2 24.1 17.5 28.1 14.3 14.1 19.5 16.6 14.2 16.4 9.7 22.0 16.2 13.1 14.1 19.2 19.2 10.7 9.7 30.0 22.6 16.7 9.4 7.8 21.2 16.8 12.9 10.9 12.8 7.9 13.1 18.5 15.2 10.5 13.2 12.3 9.1 14.4 13.1 13.8 19.0 17.3 18.6 13.4 26.1 9.5 11.9 9.1 3.8 2.1 3.4 3.7 1.5 2.9 5.1 2.6 2.6 1.3 5.4 2.7 2.9 2.0 1.8 2.2 5.6 3.9 0.9 5.8 6.1 9.9 7.4 5.7 6.8 5.9 6.2 5.8 5.3 6.4 7.8 65.0 51.3 71.7 82.6 114.7 70.9 112.5 45.9 112.7 95.1 57.0 49.0 38.2 27.1 63.6 25.8 108.4 48.9 122.0 46.1 5.9 39.9 5.5 94.3 121.9 59.7 36.5 59.1 86.7 37.8 37.4 70.6 89.2 165.4 57.6 95.5 48.2 27.0 28.4 67.3 93.6 46.5 34.6 37.2 58.3 8.0 89.5 59.2 39.2 71.2 62.1 28.1 83.4 100.5 108.3 50.8 39.4 62.1 102.4 120.8 36.6 11.3 60.5 103.2 46.0 70.5 61.6 37.3 28.1 96.0 69.9 82.9 105.7 93.4 42.6 168.0 NUP160 "FLJ22583, KIAA0197" ENSG00000030066 "Nucleoporin 160" Q12769 11 47778087-47848555 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 15000 "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "unprognostic (8.72e-2)" "unprognostic (1.11e-1)" "unprognostic (3.22e-2)" "unprognostic (2.87e-2)" "unprognostic (2.27e-1)" "unprognostic (3.23e-1)" "unprognostic (3.59e-3)" "unprognostic (1.55e-1)" "unprognostic (4.30e-3)" "unprognostic (1.94e-1)" "unprognostic (3.78e-2)" "unprognostic (3.14e-2)" "unprognostic (2.22e-2)" "unprognostic (1.93e-1)" "unprognostic (1.52e-1)" "unprognostic (1.82e-1)" "unprognostic (1.01e-1)" 13.3 9.5 5.1 17.3 6.6 20.0 16.5 9.4 6.5 13.5 8.6 12.1 11.8 17.6 11.4 11.0 15.5 10.9 8.7 5.1 6.2 14.2 14.5 14.0 20.6 6.4 6.2 19.6 14.7 16.3 9.9 20.7 6.1 12.7 14.9 15.2 11.7 11.5 11.1 12.6 11.5 16.5 5.8 15.1 10.8 14.5 5.9 30.9 16.9 9.3 21.6 14.6 11.7 9.2 24.4 31.7 52.2 36.6 30.3 34.8 67.3 30.7 22.7 40.8 46.8 40.3 36.2 33.2 20.3 28.0 41.0 52.1 96.5 30.4 45.3 29.1 66.7 36.6 131.3 44.1 20.2 108.1 24.0 27.4 18.7 29.0 56.5 16.6 32.5 52.9 103.7 45.5 22.0 41.9 72.9 47.6 78.4 53.7 33.1 86.2 78.3 29.8 20.9 42.2 43.0 49.0 72.8 35.6 27.6 45.7 44.6 41.1 22.1 44.6 38.4 75.2 41.7 19.7 19.9 83.8 22.0 45.2 45.2 8.6 7.5 13.3 9.9 9.5 13.6 15.3 11.7 10.8 12.3 14.8 15.4 11.5 4.3 9.7 6.8 16.3 9.8 7.1 5.1 6.6 9.4 6.5 5.1 6.2 6.4 6.2 6.1 5.8 5.9 9.2 15.0 22.4 18.8 39.5 31.0 22.9 35.7 18.6 20.5 24.8 14.8 11.2 7.8 12.8 19.4 20.2 43.8 33.1 31.4 10.3 15.6 17.7 27.6 17.9 16.3 17.9 19.2 19.6 35.2 16.7 30.4 19.2 15.3 20.3 19.7 23.3 19.2 12.0 15.2 6.7 50.1 14.6 20.3 10.1 19.8 11.5 24.2 14.4 10.6 44.0 15.7 19.7 24.7 61.9 53.8 16.4 8.6 21.8 21.8 32.9 10.9 10.5 15.0 48.4 19.7 19.6 17.2 18.2 22.0 16.4 27.7 30.8 25.3 20.5 15.7 34.8 PTPRJ "CD148, DEP1, HPTPeta" ENSG00000149177 "Protein tyrosine phosphatase receptor type J" Q12913 11 47980558-48170841 "CD markers, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 167.5;Microglial cells: 189.3;Oligodendrocyte precursor cells: 239.8;Oligodendrocytes: 167.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 9.5" "Group enriched" "Detected in many" 4 "granulocytes: 9.5;monocytes: 4.7" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 52.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006026 Approved "Intracellular and membrane" NA NA 670000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 68: Oligodendrocytes - Mixed function" "HPA006026: AB_1078446" "unprognostic (1.46e-1)" "unprognostic (2.21e-1)" "unprognostic (1.55e-1)" "unprognostic (3.83e-2)" "unprognostic (3.20e-2)" "unprognostic (2.99e-2)" "unprognostic (6.58e-2)" "unprognostic (2.15e-1)" "unprognostic (9.64e-3)" "unprognostic (3.79e-3)" "unprognostic (5.16e-2)" "unprognostic (1.89e-1)" "prognostic favorable (1.13e-5)" "unprognostic (1.09e-2)" "unprognostic (7.98e-2)" "unprognostic (9.18e-2)" "unprognostic (2.00e-1)" 6.0 3.2 10.2 20.5 13.8 29.5 6.1 6.9 14.9 6.2 18.5 10.2 9.4 2.4 7.8 1.9 4.1 7.1 2.7 10.0 12.7 13.9 11.9 10.0 15.5 9.7 11.7 1.6 6.1 15.8 10.1 7.6 12.4 7.9 8.7 8.1 10.1 7.0 2.4 4.2 14.5 5.9 6.0 23.3 14.6 2.3 18.5 7.0 19.6 2.7 11.0 6.9 2.1 14.7 7.6 28.3 12.1 7.0 1.9 4.1 4.2 7.5 5.5 12.9 9.2 2.0 40.8 6.9 51.8 19.1 19.6 6.0 19.0 2.0 14.9 46.6 5.4 1.9 34.9 2.8 12.1 2.7 41.5 3.2 0.6 3.8 1.0 31.7 7.8 0.5 2.6 4.4 4.7 17.0 0.1 17.3 9.7 25.7 4.4 1.6 1.6 4.0 52.6 11.1 7.9 2.5 20.2 12.0 19.4 8.9 13.0 20.3 25.7 9.9 10.8 20.5 23.4 1.1 1.7 11.4 11.7 8.0 37.3 0.7 1.1 2.8 1.6 2.0 1.0 0.8 0.9 1.2 0.8 0.5 0.7 0.9 9.5 1.0 4.7 1.5 1.0 0.8 10.2 13.8 6.9 14.9 10.0 12.7 9.7 11.7 12.4 6.0 18.5 14.7 1.5 9.6 16.7 43.1 11.3 0.3 9.8 0.8 0.6 13.6 8.3 4.1 3.7 17.2 13.0 38.6 6.2 1.9 32.7 35.5 0.0 7.4 5.5 13.5 2.2 4.5 12.6 3.2 81.0 5.0 0.6 4.0 22.4 22.9 13.9 2.5 5.0 15.6 30.0 10.1 167.5 10.1 2.0 74.2 5.7 8.2 0.3 40.2 1.8 189.3 36.0 10.3 21.6 239.8 167.7 11.8 28.0 0.4 12.9 25.3 37.6 13.5 4.9 1.3 0.0 3.3 4.9 0.2 4.8 0.5 0.3 1.9 22.0 2.3 7.6 8.2 OR4B1 OST208 ENSG00000175619 "Olfactory receptor family 4 subfamily B member 1" Q8NGF8 11 48216810-48217739 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059443 Uncertain NA NA "HPA059443: AB_2684019" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4X2 ENSG00000172208 "Olfactory receptor family 4 subfamily X member 2" Q8NGF9 11 48245056-48246080 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4X1 ENSG00000176567 "Olfactory receptor family 4 subfamily X member 1" Q8NH49 11 48263861-48264778 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4S1 ENSG00000176555 "Olfactory receptor family 4 subfamily S member 1" Q8NGB4 11 48306223-48307152 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C3 ENSG00000176547 "Olfactory receptor family 4 subfamily C member 3" Q8NH37 11 48324920-48328471 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C5 "OR4C5P, OR4C5Q" ENSG00000176540 "Olfactory receptor family 4 subfamily C member 5" Q8NGB2 11 48365485-48366465 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049516 Uncertain NA NA "HPA049516: AB_2680800" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4A47 ENSG00000237388 "Olfactory receptor family 4 subfamily A member 47" Q6IF82 11 48488717-48489780 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059763 Uncertain NA NA "HPA059763: AB_2684122" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM51GP ENSG00000220948 "Tripartite motif-containing 51G, pseudogene" 11 48975324-48983826 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-MEL-30: 1.1" "HPA044988, HPA077883" Uncertain Approved Nucleoli,Vesicles NA NA "Cluster 33: SK-MEL-30 - Melanocyte processes" Vesicles Nucleoli "HPA044988: AB_2679171, HPA077883: AB_2732362" "unprognostic (2.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49B ENSG00000182053 "Tripartite motif containing 49B" A6NDI0 11 49027501-49038451 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM64C ENSG00000214891 "Tripartite motif containing 64C" A6NLI5 11 49053714-49059112 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045370 Uncertain NA NA "HPA045370: AB_2679298" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOLH1 "FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA" ENSG00000086205 "Folate hydrolase 1" Q04609 11 49145092-49208638 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 266.4;prostate: 76.0" "Cell type enriched" "Detected in some" 8 "Oligodendrocytes: 367.6" "Cancer enriched" "Detected in many" 27 "prostate cancer: 142.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.3;RPMI-8226: 1.7;SK-BR-3: 1.8;TIME: 1.3;WM-115: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001451, HPA010593" Enhanced NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 17: WM-115 - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "CAB001451: AB_563979, HPA010593: AB_1079685" "unprognostic (1.33e-1)" "unprognostic (1.19e-1)" "unprognostic (1.24e-1)" "prognostic favorable (5.24e-5)" "unprognostic (2.55e-1)" "unprognostic (8.31e-2)" "prognostic favorable (4.25e-4)" "unprognostic (1.32e-1)" "unprognostic (2.09e-2)" "unprognostic (2.67e-3)" "unprognostic (2.13e-2)" "unprognostic (2.72e-1)" "prognostic unfavorable (1.30e-6)" "unprognostic (4.81e-2)" "unprognostic (7.27e-2)" "unprognostic (4.74e-3)" "unprognostic (4.04e-1)" 1.8 1.1 17.3 0.9 37.3 0.7 4.8 27.1 27.7 1.9 7.9 0.7 266.4 1.7 0.9 1.5 3.5 10.2 0.5 18.3 22.4 13.5 35.5 1.3 0.9 32.7 28.4 1.0 0.3 0.2 0.0 0.3 31.5 76.0 0.5 4.0 52.8 0.6 0.2 1.7 82.9 1.0 24.1 2.4 1.1 0.8 31.1 0.1 1.0 0.2 0.6 1.4 0.3 59.3 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.1 2.3 0.2 0.0 0.5 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.1 0.1 1.7 0.0 0.0 0.2 0.7 0.0 1.8 0.3 0.2 0.3 0.0 1.3 0.1 0.9 0.2 0.1 0.0 0.2 0.0 0.0 0.4 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 17.3 37.3 27.1 27.7 18.3 22.4 32.7 28.4 31.5 24.1 31.1 59.3 0.5 0.0 0.6 0.0 0.0 0.3 0.7 0.1 0.6 0.0 8.2 7.0 0.3 0.0 1.9 0.0 0.0 0.0 0.5 0.0 7.9 0.0 5.2 2.1 0.5 5.0 0.0 0.0 0.5 0.0 0.0 2.2 0.0 2.8 0.0 0.0 2.9 25.9 0.1 0.0 1.0 1.1 0.0 0.3 0.0 1.4 1.5 0.2 3.6 1.0 0.0 17.4 0.0 0.0 367.6 0.0 1.2 0.4 0.0 43.0 0.8 32.4 0.1 0.6 0.0 0.0 0.4 1.1 1.5 1.5 0.9 0.0 0.2 0.5 0.2 0.6 OR4C13 ENSG00000258817 "Olfactory receptor family 4 subfamily C member 13" Q8NGP0 11 49952391-49953419 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C12 ENSG00000221954 "Olfactory receptor family 4 subfamily C member 12" Q96R67 11 49981473-49982535 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C46 ENSG00000185926 "Olfactory receptor family 4 subfamily C member 46" A6NHA9 11 54603069-54603998 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4A5 ENSG00000221840 "Olfactory receptor family 4 subfamily A member 5" Q8NH83 11 54706832-54707902 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM48 RNF101 ENSG00000150244 "Tripartite motif containing 48" Q8IWZ4 11 55262155-55271114 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "melanoma: 1.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.04e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4A16 OR4A16Q ENSG00000181961 "Olfactory receptor family 4 subfamily A member 16" Q8NH70 11 55343151-55344231 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4A15 ENSG00000181958 "Olfactory receptor family 4 subfamily A member 15" 11 55367974-55368918 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C15 ENSG00000181939 "Olfactory receptor family 4 subfamily C member 15" Q8NGM1 11 55554307-55555419 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA061939 Uncertain NA NA "HPA061939: AB_2684643" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C16 ENSG00000279514 "Olfactory receptor family 4 subfamily C member 16" Q8NGL9 11 55572128-55573060 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C11 OR4C11P ENSG00000172188 "Olfactory receptor family 4 subfamily C member 11" Q6IEV9 11 55602360-55607645 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4P4 OR4P3P ENSG00000181927 "Olfactory receptor family 4 subfamily P member 4" Q8NGL7 11 55635113-55640309 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059458 Uncertain NA NA "HPA059458: AB_2684027" 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.3 0.2 0.1 0.2 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4S2 "OR4S2P, OST725" ENSG00000174982 "Olfactory receptor family 4 subfamily S member 2" Q8NH73 11 55648327-55652854 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C6 ENSG00000181903 "Olfactory receptor family 4 subfamily C member 6" Q8NH72 11 55662201-55666195 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 4.2;Karpas-707: 4.4" NA NA "Cluster 2: Karpas-707 - Immune response" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5D3P "OR11-8b, OR11-8c, OR5D3, OR5D4" ENSG00000186886 "Olfactory receptor family 5 subfamily D member 3 pseudogene" 11 55723776-55729621 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5D13 ENSG00000279761 "Olfactory receptor family 5 subfamily D member 13" Q8NGL4 11 55773438-55774382 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5D14 ENSG00000186113 "Olfactory receptor family 5 subfamily D member 14" Q8NGL3 11 55795556-55796500 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5L1 OST262 ENSG00000279395 "Olfactory receptor family 5 subfamily L member 1" Q8NGL2 11 55811367-55812476 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047524 Uncertain NA NA "HPA047524: AB_2680076" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5D18 ENSG00000186119 "Olfactory receptor family 5 subfamily D member 18" Q8NGL1 11 55819607-55820597 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5L2 "HSHTPCRX16, HTPCRX16" ENSG00000205030 "Olfactory receptor family 5 subfamily L member 2" Q8NGL0 11 55827219-55828154 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047524 Uncertain NA NA "HPA047524: AB_2680076" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5D16 ENSG00000205029 "Olfactory receptor family 5 subfamily D member 16" Q8NGK9 11 55838752-55839738 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046711 Uncertain NA NA "HPA046711: AB_2679766" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM51 "SPRYD5, TRIM51A" ENSG00000124900 "Tripartite motif-containing 51" Q9BSJ1 11 55883297-55891810 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 50 "melanoma: 4.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 112 "basophil: 11.2" "Lineage enriched" "Detected in single" 112 "granulocytes: 11.2" "Cell line enriched" "Detected in some" 4 "SK-MEL-30: 61.3" "HPA044988, HPA077883" Uncertain Approved Nucleoli,Vesicles NA NA "Cluster 38: Basophils - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 40: Granulosa cells - Unknown function" Vesicles Nucleoli "HPA044988: AB_2679171, HPA077883: AB_2732362" "unprognostic (9.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5W2 "OR5W2P, OR5W3P" ENSG00000187612 "Olfactory receptor family 5 subfamily W member 2" Q8NH69 11 55913650-55914582 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5I1 "HSOlf1, OLF1" ENSG00000167825 "Olfactory receptor family 5 subfamily I member 1" Q13606 11 55935456-55936400 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10AG1 ENSG00000174970 "Olfactory receptor family 10 subfamily AG member 1" Q8NH19 11 55965755-55969945 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5F1 OR11-10 ENSG00000149133 "Olfactory receptor family 5 subfamily F member 1" O95221 11 55993681-55994625 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059360 Uncertain NA NA "HPA059360: AB_2683990" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AS1 ENSG00000181785 "Olfactory receptor family 5 subfamily AS member 1" Q8N127 11 56027654-56038191 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.6" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 6.4;Alveolar cells type 2: 8.7;Club cells: 5.6;Respiratory ciliated cells: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 20: HeLa - Mitochondria" "Cluster 11: Alveolar cells - Smell perception" 0.5 0.4 1.9 0.6 3.0 1.9 0.5 6.6 6.4 0.2 0.3 0.4 0.4 0.4 0.8 0.3 0.2 0.4 0.7 2.6 0.0 0.3 1.1 0.5 0.6 0.6 0.0 0.7 0.5 0.2 0.0 0.8 1.3 0.6 0.4 3.1 0.6 0.5 0.7 1.5 0.5 0.3 0.3 0.6 0.5 1.0 1.3 0.4 0.4 0.2 0.3 0.2 0.0 6.1 0.7 0.3 0.7 0.7 0.2 0.3 0.7 0.5 0.1 0.1 0.2 0.6 0.6 1.1 0.6 0.3 0.7 0.7 0.2 0.2 0.4 1.1 0.3 0.7 1.8 0.5 0.1 0.8 0.9 0.3 0.4 0.6 0.3 0.4 0.3 0.6 0.9 1.6 0.1 0.5 1.1 0.7 1.1 0.4 0.3 0.6 0.8 0.4 0.3 0.8 0.5 0.6 0.4 0.4 0.3 0.8 0.8 0.4 1.1 1.0 0.8 0.7 0.6 1.2 1.0 0.3 0.6 0.7 1.4 1.5 0.4 0.2 0.4 0.3 0.3 0.2 0.3 0.3 0.2 0.6 0.3 0.3 1.0 0.4 0.4 0.3 0.1 0.0 1.9 3.0 6.6 6.4 2.6 0.0 0.6 0.0 1.3 0.3 1.3 6.1 0.0 6.4 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 OR8I2 ENSG00000172154 "Olfactory receptor family 8 subfamily I member 2" Q8N0Y5 11 56093277-56094286 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8H2 ENSG00000181767 "Olfactory receptor family 8 subfamily H member 2" Q8N162 11 56103687-56107658 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.0" "Not detected" "Not detected" NA NA "Cluster 17: Basophils - Unknown function" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8H3 ENSG00000181761 "Olfactory receptor family 8 subfamily H member 3" Q8N146 11 56122373-56123311 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8J3 ENSG00000167822 "Olfactory receptor family 8 subfamily J member 3" Q8NGG0 11 56134721-56140201 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8K5 ENSG00000181752 "Olfactory receptor family 8 subfamily K member 5" Q8NH50 11 56159394-56160317 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 10 "stomach cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5J2 ENSG00000174957 "Olfactory receptor family 5 subfamily J member 2" Q8NH18 11 56176618-56177556 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059466 Uncertain NA NA "HPA059466: AB_2684029" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5T2 ENSG00000181718 "Olfactory receptor family 5 subfamily T member 2" Q8NGG2 11 56231282-56234255 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.2 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5T3 OR5T3Q ENSG00000172489 "Olfactory receptor family 5 subfamily T member 3" 11 56252254-56253222 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5T1 OR5T1P ENSG00000181698 "Olfactory receptor family 5 subfamily T member 1" Q8NG75 11 56274154-56276819 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA050952 Uncertain NA NA "HPA050952: AB_2681287" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8H1 ENSG00000181693 "Olfactory receptor family 8 subfamily H member 1" Q8NGG4 11 56288462-56292254 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 67: Proximal tubular cells - Tubular reabsorption" 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8K3 ENSG00000280314 "Olfactory receptor family 8 subfamily K member 3 (gene/pseudogene)" Q8NH51 11 56315144-56320639 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8K1 ENSG00000150261 "Olfactory receptor family 8 subfamily K member 1" Q8NGG5 11 56345945-56347031 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA055233 Uncertain NA NA "HPA055233: AB_2682749" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8J1 ENSG00000172487 "Olfactory receptor family 8 subfamily J member 1" Q8NGP2 11 56354291-56361511 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8U1 ENSG00000172199 "Olfactory receptor family 8 subfamily U member 1" Q8NH10 11 56375624-56376553 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8U3 "OR5R1, OR5R1P" ENSG00000279961 "Olfactory receptor family 8 subfamily U member 3" Q8NH85 11 56417258-56418232 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP002512.3 ENSG00000284732 "Novel olfactory receptor" 11 56459221-56473352 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M9 ENSG00000150269 "Olfactory receptor family 5 subfamily M member 9" Q8NGP3 11 56462469-56463401 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M3 ENSG00000174937 "Olfactory receptor family 5 subfamily M member 3" Q8NGP4 11 56469274-56473352 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M8 ENSG00000181371 "Olfactory receptor family 5 subfamily M member 8" Q8NGP6 11 56490349-56491395 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M11 OR11-199 ENSG00000255223 "Olfactory receptor family 5 subfamily M member 11" Q96RB7 11 56542262-56543281 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "Late spermatids: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (2.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M10 ENSG00000254834 "Olfactory receptor family 5 subfamily M member 10" Q6IEU7 11 56576736-56577787 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M1 OST050 ENSG00000255012 "Olfactory receptor family 5 subfamily M member 1" Q8NGP8 11 56609236-56614874 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AP2 ENSG00000172464 "Olfactory receptor family 5 subfamily AP member 2" Q8NGF4 11 56641466-56642471 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AR1 ENSG00000172459 "Olfactory receptor family 5 subfamily AR member 1" Q8NGP9 11 56663662-56664687 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9G1 OR9G5 ENSG00000174914 "Olfactory receptor family 9 subfamily G member 1" Q8NH87 11 56699095-56703884 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9G4 ENSG00000172457 "Olfactory receptor family 9 subfamily G member 4" 11 56741223-56748697 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AK2 ENSG00000181273 "Olfactory receptor family 5 subfamily AK member 2" Q8NH90 11 56988872-56989867 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "white matter: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 64: Macrophages - Immune response" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.4 0.4 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC55 FLJ45686 ENSG00000183908 "Leucine rich repeat containing 55" Q6ZSA7 11 57181747-57191717 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 15.0" "Cell type enhanced" "Detected in some" "Endothelial cells: 2.1;Excitatory neurons: 1.9;Inhibitory neurons: 1.2" "Group enriched" "Detected in some" 9 "glioma: 9.0;ovarian cancer: 2.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AF22: 19.4" "Region enhanced" "Detected in all" "olfactory bulb: 105.4" "Low region specificity" "Detected in all" HPA014053 Uncertain NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 12: NES - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA014053: AB_2137630" "unprognostic (1.40e-2)" "unprognostic (1.48e-1)" "unprognostic (3.68e-2)" "unprognostic (3.03e-2)" "unprognostic (2.78e-3)" "unprognostic (2.29e-3)" "unprognostic (2.30e-1)" "unprognostic (1.43e-1)" "unprognostic (2.26e-2)" "unprognostic (3.39e-1)" "unprognostic (9.43e-2)" "unprognostic (2.11e-2)" "unprognostic (3.32e-2)" "unprognostic (7.17e-4)" "unprognostic (6.66e-2)" "unprognostic (3.59e-1)" "unprognostic (3.79e-2)" 0.4 0.5 4.7 1.0 2.8 0.0 0.1 0.8 3.5 0.1 0.0 0.5 0.3 1.8 0.0 0.0 0.3 0.2 0.3 4.1 6.7 0.3 1.2 0.2 2.1 15.0 11.7 0.0 0.2 0.0 0.0 0.9 3.7 0.0 0.5 0.1 0.6 0.0 0.3 0.1 0.4 1.0 8.4 1.3 0.1 0.2 5.9 0.9 0.1 0.3 0.5 0.0 0.0 6.8 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 2.8 0.8 3.5 4.1 6.7 15.0 11.7 3.7 8.4 5.9 6.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APLNR "AGTRL1, APJ, APJR, FLJ90771" ENSG00000134817 "Apelin receptor" P35414 11 57233577-57237235 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Angiogenesis, Gastrulation, Host-virus interaction" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 268.8;lymphoid tissue: 101.0;placenta: 88.1" "Group enriched" "Detected in some" 7 "Adipocytes: 67.6;Endothelial cells: 98.5" "Cancer enhanced" "Detected in all" "glioma: 50.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "AF22: 4.9;HEL: 4.3;K-562: 1.3;NTERA-2: 1.8;SuSa: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB025842 Approved NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 36: HEL - Hemostasis" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "CAB025842: " "unprognostic (5.06e-2)" "unprognostic (3.56e-1)" "unprognostic (2.70e-2)" "unprognostic (1.00e-1)" "unprognostic (2.79e-1)" "unprognostic (6.68e-3)" "unprognostic (1.32e-2)" "unprognostic (2.55e-1)" "unprognostic (1.11e-1)" "unprognostic (1.80e-1)" "unprognostic (1.26e-1)" "unprognostic (4.72e-1)" "unprognostic (1.77e-3)" "unprognostic (3.27e-2)" "unprognostic (8.13e-2)" "unprognostic (1.13e-1)" "unprognostic (7.13e-3)" 17.3 3.7 47.1 9.4 46.3 0.1 10.6 52.0 45.7 2.3 22.7 5.4 4.5 3.5 0.3 4.1 1.2 13.0 23.7 48.3 130.5 5.7 18.5 8.1 9.6 268.8 97.4 0.7 2.0 2.9 2.4 88.1 92.2 1.0 6.0 0.0 3.5 1.9 15.2 7.1 4.2 9.9 99.9 101.0 3.2 1.4 92.7 4.1 9.5 10.8 4.2 6.2 1.7 122.4 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.1 46.3 52.0 45.7 48.3 130.5 268.8 97.4 92.2 99.9 92.7 122.4 67.6 0.0 0.0 6.5 0.6 2.3 0.1 0.0 0.0 0.0 0.5 0.6 3.2 1.5 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.3 0.3 98.5 0.0 0.0 0.0 0.2 0.1 2.6 0.0 0.5 0.0 0.0 10.4 0.0 0.2 0.0 0.0 0.0 0.0 0.8 2.6 0.2 0.0 0.5 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 2.7 0.0 0.0 0.3 3.1 0.1 0.2 2.7 0.0 0.1 TNKS1BP1 "FLJ45975, KIAA1741, TAB182" ENSG00000149115 "Tankyrase 1 binding protein 1" Q9C0C2 11 57299638-57324952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Suprabasal keratinocytes: 88.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037929, HPA037930" Enhanced Uncertain "Plasma membrane" NA NA 180000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "Plasma membrane" "HPA037929: AB_10672613, HPA037930: AB_2675745" "unprognostic (7.31e-2)" "unprognostic (1.66e-2)" "unprognostic (5.38e-2)" "unprognostic (2.25e-1)" "unprognostic (3.13e-1)" "unprognostic (9.17e-2)" "unprognostic (2.47e-2)" "unprognostic (7.90e-2)" "unprognostic (4.27e-1)" "unprognostic (2.67e-2)" "unprognostic (4.22e-3)" "unprognostic (9.21e-2)" "prognostic unfavorable (2.11e-8)" "unprognostic (2.46e-1)" "unprognostic (2.31e-2)" "unprognostic (2.41e-1)" "unprognostic (3.07e-1)" 62.7 27.3 11.8 17.3 10.2 3.3 41.9 4.6 9.4 43.3 18.0 23.6 28.8 40.3 30.3 55.4 35.3 28.1 23.3 11.3 9.2 14.7 31.6 40.3 6.6 9.6 8.8 32.2 30.9 18.9 17.1 29.5 7.2 33.6 16.2 3.3 44.2 40.2 67.2 83.0 26.6 29.4 4.9 18.1 52.8 10.1 11.0 22.3 25.0 29.9 14.3 38.5 45.6 6.7 89.5 58.7 41.2 33.6 127.8 97.1 31.0 61.5 113.8 46.3 42.5 26.1 59.5 2.0 38.5 101.2 49.6 151.7 31.4 105.3 30.1 34.2 10.4 11.5 38.2 12.2 86.6 14.4 4.3 96.8 123.5 70.9 54.6 57.5 60.0 12.4 13.2 9.3 65.3 45.4 11.0 14.7 45.8 46.5 45.9 16.9 57.2 25.9 53.5 116.6 14.6 22.6 81.5 121.5 44.3 29.0 182.2 11.9 115.1 47.3 45.8 56.6 35.2 15.0 4.1 11.3 107.0 4.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 11.8 10.2 4.6 9.4 11.3 9.2 9.6 8.8 7.2 4.9 11.0 6.7 38.1 12.8 35.4 12.7 1.9 83.6 28.0 61.9 40.9 4.8 24.8 23.9 7.9 38.6 39.0 44.1 2.1 16.8 1.3 27.3 0.0 31.8 1.8 18.5 25.4 25.9 18.0 7.4 7.2 22.3 3.2 31.2 49.5 38.4 2.5 3.7 19.6 46.0 3.9 8.4 4.8 25.8 18.3 1.5 25.4 2.9 48.1 3.8 17.8 1.9 0.7 4.0 0.0 4.5 2.4 38.8 14.3 49.2 0.6 41.2 18.2 2.4 15.4 1.3 32.9 41.2 26.9 1.5 3.0 68.9 88.2 24.5 2.3 23.4 14.5 36.8 SSRP1 FACT80 ENSG00000149136 "Structure specific recognition protein 1" Q08945 11 57325986-57335892 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002697 Approved Approved Nucleoplasm,Cytosol NA NA 42000 "Cluster 26: Non-specific - Mitochondria" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol Nucleoplasm "HPA002697: AB_1857509" "unprognostic (1.67e-1)" "unprognostic (3.21e-1)" "unprognostic (2.96e-2)" "unprognostic (3.54e-1)" "unprognostic (2.84e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (4.03e-7)" "unprognostic (3.22e-2)" "unprognostic (1.96e-1)" "unprognostic (1.49e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.06e-1)" "prognostic unfavorable (5.63e-4)" "unprognostic (5.92e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.52e-2)" 52.3 42.7 37.6 62.9 39.1 78.9 53.7 37.9 46.4 61.0 37.2 64.7 48.3 64.9 47.7 67.7 68.3 37.0 47.0 39.3 41.2 48.8 43.3 51.7 76.1 38.2 38.9 74.1 74.0 60.9 57.4 57.5 37.1 46.6 66.1 36.0 55.0 49.6 140.6 67.0 55.1 58.4 38.5 52.6 59.8 45.8 42.4 87.8 54.0 63.9 91.9 58.6 56.4 40.2 353.0 332.0 308.3 226.9 95.1 105.1 150.7 188.9 181.1 321.8 229.2 230.0 255.2 424.4 196.7 166.7 204.5 264.8 493.7 293.9 402.2 297.7 276.9 271.5 233.1 250.5 149.3 455.4 195.3 106.7 175.7 331.8 456.8 149.1 213.3 320.7 376.0 207.9 222.6 237.1 463.3 400.3 406.1 186.1 201.7 386.1 520.4 412.0 151.7 249.3 321.4 271.6 267.6 226.2 286.7 157.0 275.3 177.0 162.7 218.2 287.1 298.3 328.9 240.9 259.9 431.9 185.0 251.6 294.6 0.8 4.1 4.6 8.6 5.1 8.2 8.4 7.4 9.5 6.0 10.5 8.2 11.0 1.0 7.2 5.2 10.0 9.9 5.0 37.6 39.1 37.9 46.4 39.3 41.2 38.2 38.9 37.1 38.5 42.4 40.2 31.2 76.9 91.2 4.6 51.0 74.9 78.1 52.0 55.8 27.3 38.3 39.8 26.4 44.3 78.1 29.5 25.0 115.6 31.7 29.9 13.7 92.5 83.0 40.8 47.2 52.0 28.8 106.8 10.5 99.4 116.9 45.3 32.1 33.2 41.0 55.6 33.2 39.7 57.5 25.2 9.1 45.2 32.6 37.9 45.5 158.0 42.6 34.9 28.4 8.4 42.5 26.3 40.2 6.0 8.4 69.0 32.9 44.4 72.2 80.0 32.3 25.7 101.0 18.9 19.7 53.1 66.1 58.4 108.0 75.3 76.3 67.6 43.5 46.7 78.4 70.7 P2RX3 P2X3 ENSG00000109991 "Purinergic receptor P2X 3" P56373 11 57338352-57372396 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 2.9;liver: 1.7;testis: 5.2" "Group enriched" "Detected in some" 28 "Early spermatids: 34.5;Late spermatids: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA057776 Uncertain NA NA "Cluster 43: Testis - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" "HPA057776: AB_2683526" "unprognostic (5.44e-2)" "unprognostic (9.43e-2)" "unprognostic (2.84e-1)" "unprognostic (1.33e-3)" "unprognostic (2.24e-2)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "unprognostic (3.33e-2)" "unprognostic (1.24e-1)" "unprognostic (3.49e-7)" "unprognostic (1.58e-1)" "unprognostic (2.88e-1)" "unprognostic (3.00e-2)" "unprognostic (1.29e-1)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 2.9 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.1 0.0 0.3 0.0 0.6 5.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.5 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRG3 "MBP2, MBPH" ENSG00000156575 "Proteoglycan 3, pro eosinophil major basic protein 2" Q9Y2Y8 11 57376769-57381150 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "bone marrow: 48.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 46 "HMC-1: 198.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory bulb: 3.5" HPA064183 Enhanced "Secreted in other tissues" NA NA 680000 "Cluster 67: Neutrophils - Humoral immune response" "Cluster 3: HMC-1 - Innate immune response" "HPA064183: AB_2685205" 0.0 0.0 0.0 0.0 0.0 48.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.4 198.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRG2 "BMPG, MBP, proMBP" ENSG00000186652 "Proteoglycan 2, pro eosinophil major basic protein" P13727 11 57386780-57390650 "FDA approved drug targets, Plasma proteins, Predicted secreted proteins" Immunity "Antibiotic, Antimicrobial, Heparin-binding" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "placenta: 2616.3" "Group enriched" "Detected in some" 10 "Erythroid cells: 44.3;Extravillous trophoblasts: 107.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 36 "basophil: 7.2" "Lineage enriched" "Detected in single" 73 "granulocytes: 7.2" "Group enriched" "Detected in some" 62 "HL-60: 3328.5;HMC-1: 5009.7;NB-4: 10560.9" "Not detected" "Not detected" HPA038515 Supported "Secreted in female reproductive system" NA NA 100000000 "Cluster 38: Basophils - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 24: NB-4 - Immune response" "Cluster 38: Extravillous trophoblasts - Unknown function" "HPA038515: AB_10675800" "unprognostic (7.32e-2)" "unprognostic (1.68e-1)" "unprognostic (3.39e-2)" "unprognostic (3.49e-1)" "unprognostic (8.62e-4)" "unprognostic (4.77e-3)" "unprognostic (3.20e-2)" "unprognostic (4.17e-2)" "unprognostic (2.26e-2)" "unprognostic (5.19e-3)" "unprognostic (2.17e-1)" "unprognostic (1.40e-11)" "unprognostic (4.26e-2)" "unprognostic (4.52e-3)" "unprognostic (6.47e-2)" "unprognostic (2.32e-1)" 0.7 0.0 0.0 0.1 0.0 215.8 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.1 2.5 1.1 1.4 0.0 0.0 0.3 3.8 0.0 0.2 2616.3 0.0 0.0 0.4 0.0 0.9 0.0 0.2 2.1 0.4 0.5 0.0 3.0 0.3 0.0 0.0 8.7 0.2 0.0 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 101.3 0.0 0.0 0.2 3328.5 5009.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 9.0 0.6 0.0 0.0 0.8 10560.9 0.0 0.0 0.0 0.3 0.8 1.0 0.0 0.0 1.6 4.2 0.4 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.3 0.8 0.0 0.5 0.0 0.4 0.2 0.4 0.3 7.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 44.3 0.0 0.0 107.2 0.5 0.0 0.0 6.3 0.0 0.0 0.1 7.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.7 0.0 0.0 0.0 0.0 AP000781.2 ENSG00000254979 "Novel protein" 11 57387365-57424059 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.3;liver: 7.2;placenta: 7.1" "Cell type enriched" "Detected in single" 10 "granulocytes: 6.3" "Cancer enhanced" "Detected in single" "melanoma: 0.5" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 9 "basophil: 3.5" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.5" "Cell line enriched" "Detected in some" 7 "HMC-1: 186.9" HPA038515 Supported NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "HPA038515: AB_10675800" "unprognostic (1.12e-1)" "unprognostic (1.19e-1)" "unprognostic (5.10e-2)" "unprognostic (1.55e-4)" "unprognostic (2.16e-1)" "unprognostic (4.01e-1)" "unprognostic (4.83e-2)" "unprognostic (2.05e-2)" "unprognostic (2.20e-1)" "unprognostic (3.08e-2)" "unprognostic (1.33e-2)" "unprognostic (1.79e-1)" "unprognostic (1.51e-10)" "unprognostic (4.86e-2)" "unprognostic (1.54e-1)" "unprognostic (5.59e-2)" "unprognostic (3.10e-1)" 6.1 0.2 0.0 0.6 0.0 13.3 2.6 0.0 0.3 0.6 0.0 0.5 0.7 0.4 0.0 1.1 0.2 1.1 0.6 0.0 0.0 0.5 7.2 1.0 1.0 0.0 0.0 0.3 2.9 0.0 0.2 7.1 0.0 0.3 0.4 0.0 1.4 0.0 1.0 5.4 0.5 0.3 0.0 0.5 0.3 0.1 0.0 0.4 1.2 0.1 0.9 1.0 0.6 0.0 0.7 0.0 0.1 0.0 0.0 0.9 0.8 0.0 0.3 0.2 0.6 0.0 0.2 0.8 0.0 0.1 0.0 1.3 0.0 0.0 0.6 0.0 0.0 4.2 0.0 0.0 0.8 28.6 186.9 1.7 0.0 0.6 0.0 0.0 0.4 0.7 0.4 1.6 0.0 0.0 1.1 9.1 0.3 0.0 0.0 4.0 0.0 8.7 0.2 0.0 1.0 0.3 0.2 0.4 2.9 0.0 0.0 0.9 0.1 0.2 0.5 3.3 0.0 0.3 0.0 1.0 0.9 1.1 1.3 3.5 0.2 0.2 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC43A3 "DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1" ENSG00000134802 "Solute carrier family 43 member 3" Q8NBI5 11 57406954-57427580 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 146.9" "Cell type enhanced" "Detected in many" "Ductal cells: 75.5;granulocytes: 67.0;Hofbauer cells: 73.7;Langerhans cells: 74.6;Sertoli cells: 65.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 105.7;intermediate monocyte: 127.0;myeloid DC: 85.8;non-classical monocyte: 146.3;plasmacytoid DC: 85.7" "Group enriched" "Detected in all" 4 "dendritic cells: 85.8;monocytes: 146.3" "Cell line enhanced" "Detected in many" "HL-60: 513.8;HMC-1: 428.4;RPMI-8226: 570.9;WM-115: 532.1" "Region enhanced" "Detected in many" "olfactory bulb: 10.3" "Low region specificity" "Detected in all" "HPA030551, HPA077244" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA Yes "Cluster 51: Monocytes - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 25: RPMI-8226 - Immune response" "Cluster 4: Macrophages - Innate immune response" Vesicles "Nucleoplasm, Plasma membrane" "HPA030551: AB_10604094, HPA077244: AB_2732335" "unprognostic (2.64e-1)" "unprognostic (7.63e-2)" "unprognostic (9.67e-3)" "unprognostic (7.41e-3)" "unprognostic (6.59e-3)" "unprognostic (5.30e-3)" "unprognostic (1.29e-1)" "unprognostic (4.91e-2)" "unprognostic (1.36e-1)" "unprognostic (2.26e-1)" "unprognostic (5.73e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (3.97e-13)" "unprognostic (8.16e-2)" "unprognostic (1.77e-1)" "unprognostic (8.34e-2)" "unprognostic (1.00e-1)" 61.4 16.8 5.2 34.8 5.9 58.0 50.3 5.9 7.3 40.2 6.8 23.7 8.3 28.1 4.5 34.8 30.0 28.5 34.8 5.5 7.1 15.9 146.9 46.9 26.5 6.7 6.4 24.3 13.7 3.9 4.9 14.3 7.3 14.4 11.8 0.9 35.2 7.5 15.6 34.6 20.6 25.5 6.3 20.8 20.1 4.7 11.1 23.2 76.3 13.3 28.9 30.7 28.2 8.5 289.2 0.0 16.0 0.4 52.9 76.9 0.7 22.0 93.0 31.6 54.1 0.0 61.4 165.0 9.8 52.0 16.3 161.8 47.0 28.8 63.3 1.0 0.2 257.3 93.0 0.0 106.6 513.8 428.4 231.7 0.9 306.5 3.5 22.9 89.7 75.0 299.8 154.4 123.7 0.6 108.6 328.2 24.3 0.0 5.3 221.8 3.3 570.9 76.1 0.0 38.0 0.0 62.2 1.4 263.5 1.5 24.1 77.3 48.1 1.5 81.4 209.2 62.5 0.3 0.9 41.3 187.3 183.2 532.1 15.2 105.7 23.4 19.6 127.0 22.2 9.6 13.5 26.8 85.8 7.1 10.4 10.5 9.0 3.9 146.3 85.7 26.5 60.7 5.2 5.9 5.9 7.3 5.5 7.1 6.7 6.4 7.3 6.3 11.1 8.5 19.8 16.0 49.1 1.6 6.1 46.8 7.4 30.8 48.3 0.5 8.0 14.2 3.7 28.6 26.1 1.8 0.0 0.6 11.9 0.3 0.0 75.5 1.0 1.0 3.1 33.0 0.0 38.3 0.1 6.4 5.0 33.4 2.0 3.0 67.0 2.9 14.3 61.7 73.7 0.0 0.2 0.6 16.2 21.0 74.6 1.7 9.9 47.0 30.2 8.4 10.2 0.6 3.1 8.5 0.8 9.4 0.5 12.4 22.5 14.5 0.0 0.1 4.9 0.1 65.7 15.5 22.0 0.7 1.1 13.6 17.6 0.8 11.8 12.3 1.2 3.0 RTN4RL2 "NgR2, NGRH1" ENSG00000186907 "Reticulon 4 receptor like 2" Q86UN3 11 57460528-57477534 "Plasma proteins, Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 39.1;liver: 40.7;thyroid gland: 30.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 19.9;Cholangiocytes: 12.8;Excitatory neurons: 16.7;Hepatocytes: 14.0;Oligodendrocyte precursor cells: 9.5;Spermatocytes: 10.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HMC-1: 44.1;Karpas-707: 67.5;REH: 42.3;RPMI-8226: 134.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "amygdala: 13.5;cerebral cortex: 23.8;hippocampal formation: 21.0" "Intracellular and membrane" NA NA 27000000 "Cluster 7: Monocytes - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 56: Bipolar cells - Visual perception" "unprognostic (6.27e-3)" "unprognostic (2.02e-2)" "unprognostic (4.57e-2)" "unprognostic (8.40e-2)" "unprognostic (8.51e-2)" "unprognostic (7.64e-2)" "unprognostic (6.83e-2)" "unprognostic (3.72e-2)" "unprognostic (7.27e-2)" "unprognostic (2.41e-1)" "unprognostic (1.09e-2)" "unprognostic (3.28e-1)" "prognostic unfavorable (3.05e-7)" "unprognostic (3.53e-2)" "unprognostic (1.40e-1)" "unprognostic (5.16e-3)" "unprognostic (2.18e-2)" 4.1 0.7 19.0 0.3 39.1 0.8 3.5 0.0 27.3 2.1 0.0 1.0 1.1 2.0 0.2 1.6 1.7 3.0 3.3 25.2 0.0 2.8 40.7 2.6 0.4 0.0 0.0 1.1 2.4 3.7 3.6 1.9 0.0 1.6 0.1 1.0 3.4 0.3 1.7 4.3 1.1 0.7 0.0 1.0 1.5 1.8 0.0 1.9 30.5 0.4 0.3 1.2 1.6 8.2 7.4 10.1 7.6 13.1 3.1 4.4 1.0 0.1 2.9 0.3 2.7 1.3 1.4 0.2 0.2 0.4 4.3 0.2 11.9 0.2 0.1 1.7 4.7 2.3 1.1 7.2 4.4 1.7 44.1 11.9 1.3 1.1 1.1 1.3 0.1 12.9 1.6 67.5 0.1 1.4 0.2 5.3 13.3 0.5 7.6 42.3 5.4 134.0 0.1 0.2 14.0 1.2 1.1 0.6 7.7 0.6 8.5 2.0 0.1 0.5 22.7 3.1 2.4 4.1 9.2 1.4 16.7 7.3 5.8 0.0 0.3 0.0 0.0 0.6 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 19.0 39.1 0.0 27.3 25.2 0.0 0.0 0.0 0.0 0.0 0.0 8.2 1.7 0.0 0.0 2.0 0.4 5.7 0.4 0.3 2.8 19.9 2.1 1.5 0.4 12.8 0.1 0.0 0.0 0.0 0.9 0.2 3.9 1.3 2.6 0.6 0.9 2.1 1.8 0.8 16.7 0.6 5.5 1.6 0.5 2.1 0.0 0.0 1.1 14.0 0.4 0.0 1.1 0.6 0.0 0.0 2.1 1.3 0.3 0.6 1.8 3.7 0.5 0.8 2.1 9.5 1.2 0.8 0.1 1.2 0.0 1.0 0.0 1.1 0.0 1.4 6.6 1.0 5.4 10.2 1.7 1.1 2.8 0.0 0.9 0.1 0.2 0.2 SLC43A1 "PB39, POV1, R00504" ENSG00000149150 "Solute carrier family 43 member 1" O75387 11 57484534-57515780 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "liver: 128.6;pancreas: 233.2" "Cell type enhanced" "Detected in many" "Cholangiocytes: 47.1;Erythroid cells: 82.9;Exocrine glandular cells: 35.4;Hepatocytes: 138.2" "Cancer enhanced" "Detected in all" "liver cancer: 45.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 62.7;NB-4: 74.3;U-937: 70.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018813, HPA018826" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus, Vesicles, Plasma membrane" "HPA018813: AB_1857164, HPA018826: AB_1857165" "unprognostic (3.04e-1)" "unprognostic (1.15e-1)" "unprognostic (9.19e-2)" "prognostic favorable (3.19e-4)" "unprognostic (2.51e-2)" "unprognostic (5.48e-2)" "unprognostic (2.32e-1)" "unprognostic (6.71e-3)" "unprognostic (1.63e-1)" "unprognostic (3.12e-2)" "unprognostic (6.06e-2)" "unprognostic (2.72e-1)" "prognostic unfavorable (2.97e-5)" "unprognostic (1.39e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (5.27e-4)" "unprognostic (7.30e-2)" 13.9 10.7 3.6 4.7 4.2 35.7 11.1 2.7 5.0 13.1 2.7 15.7 8.7 12.6 10.3 4.4 13.5 18.2 8.6 3.6 2.8 7.3 128.6 9.9 7.4 3.8 3.2 20.3 233.2 1.8 4.4 6.3 3.5 12.8 9.4 1.3 13.8 6.2 17.1 18.8 9.2 8.7 2.7 8.5 30.4 3.4 3.4 2.1 12.7 9.1 6.6 16.2 9.9 3.9 1.1 1.7 1.8 20.3 25.7 18.8 0.2 10.4 13.8 3.0 7.6 6.5 2.8 59.5 2.7 7.9 3.9 1.0 18.1 1.2 3.7 2.8 4.6 30.9 0.5 62.7 33.7 54.3 7.2 23.8 4.4 5.2 23.2 7.3 13.4 34.7 43.9 10.7 3.8 2.3 0.5 74.3 6.6 27.0 13.6 51.0 9.8 27.2 0.5 0.1 23.5 3.6 1.9 0.3 23.8 0.5 1.6 27.3 5.5 3.1 7.1 26.2 1.7 12.1 4.3 35.3 1.5 70.6 4.2 11.1 6.2 0.7 10.9 2.4 9.2 2.9 4.9 7.7 8.4 1.5 4.9 6.9 0.5 7.5 0.2 1.9 9.5 5.5 3.6 4.2 2.7 5.0 3.6 2.8 3.8 3.2 3.5 2.7 3.4 3.9 4.4 0.0 7.3 1.6 3.3 7.0 1.6 0.0 3.4 5.7 1.8 2.4 6.8 47.1 0.6 0.0 0.0 0.2 3.6 3.1 3.9 3.4 21.5 5.3 6.0 4.7 6.0 82.9 3.5 35.4 0.4 10.9 4.6 13.4 3.8 1.3 15.4 138.2 7.4 0.0 1.4 8.8 0.0 8.1 2.9 14.8 15.5 3.2 5.4 5.6 1.3 0.2 5.2 4.0 0.6 11.1 2.9 7.9 6.2 3.2 0.3 0.1 0.7 0.4 6.6 6.4 7.7 0.7 1.5 0.3 3.7 0.1 6.4 2.9 9.0 0.9 TIMM10 "TIM10, TIM10A, TIMM10A" ENSG00000134809 "Translocase of inner mitochondrial membrane 10" P62072 11 57528464-57530803 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 284.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039946 Supported Enhanced Mitochondria NA NA 16000 "Cluster 26: Non-specific - Mitochondria" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA039946: AB_10673023" "unprognostic (9.34e-3)" "unprognostic (1.16e-2)" "unprognostic (2.21e-1)" "unprognostic (2.01e-1)" "unprognostic (4.42e-2)" "unprognostic (1.25e-2)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "unprognostic (2.07e-1)" "unprognostic (3.40e-3)" "unprognostic (7.62e-2)" "unprognostic (1.18e-1)" "unprognostic (5.96e-2)" "unprognostic (9.87e-2)" "unprognostic (1.96e-1)" "unprognostic (1.62e-2)" "unprognostic (2.15e-2)" 40.5 41.6 55.1 28.5 56.9 34.8 42.5 56.3 68.3 24.8 53.2 35.5 27.0 27.2 43.8 44.1 25.1 20.3 60.9 56.7 57.4 50.7 77.6 27.9 45.8 55.8 55.6 25.5 33.6 45.1 29.2 21.7 56.1 31.0 35.9 15.1 28.0 30.2 77.8 33.7 27.8 27.5 58.5 37.9 35.3 35.6 56.1 38.5 29.7 67.7 50.1 33.7 27.2 58.0 115.6 171.9 79.1 76.0 67.6 57.2 99.7 96.6 77.0 151.1 85.9 127.6 97.9 218.1 108.0 86.5 131.4 86.3 114.0 112.6 136.4 74.8 84.9 139.4 67.0 167.5 71.3 183.3 148.0 54.2 89.6 146.1 101.4 40.0 95.2 142.8 157.1 96.7 112.7 241.1 99.4 243.5 83.4 99.9 184.4 163.5 167.0 190.3 77.6 78.2 64.0 82.2 101.5 198.6 128.6 77.7 150.1 69.3 60.2 86.0 160.5 150.6 188.1 133.2 192.6 176.1 79.2 91.3 146.2 30.9 88.3 20.9 71.5 84.2 81.6 187.6 86.4 79.0 146.4 179.0 118.0 103.6 4.9 67.3 81.3 146.6 84.0 145.1 55.1 56.9 56.3 68.3 56.7 57.4 55.8 55.6 56.1 58.5 56.1 58.0 53.2 12.8 11.0 3.9 66.4 122.9 42.9 94.5 54.1 16.9 103.1 142.2 124.1 78.6 45.6 44.1 4.2 68.0 52.5 78.2 211.3 84.1 134.7 36.7 28.1 55.8 27.0 56.8 3.2 125.6 88.2 42.0 24.5 39.1 52.6 30.1 40.4 212.3 125.9 8.4 3.9 61.0 48.8 71.7 100.3 284.7 46.3 52.9 81.8 3.7 103.2 55.0 56.7 3.0 5.6 85.3 63.5 51.1 51.5 102.4 120.3 227.3 23.2 15.5 13.1 50.5 71.3 85.9 52.8 78.1 129.7 39.5 42.2 37.7 92.6 52.4 SMTNL1 CHASM ENSG00000214872 "Smoothelin like 1" A8MU46 11 57542641-57550274 "Predicted intracellular proteins" "Calmodulin-binding, Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 51 "skeletal muscle: 711.3;tongue: 192.9" "Cell type enriched" "Detected in some" 5 "Skeletal myocytes: 5.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/70: 1.6;U-266/84: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 37: Myocytes - Muscle contraction" "unprognostic (1.35e-2)" "unprognostic (3.90e-1)" "unprognostic (1.10e-1)" "unprognostic (1.79e-3)" "unprognostic (3.09e-1)" "unprognostic (1.66e-1)" "unprognostic (2.22e-1)" "unprognostic (8.41e-2)" "unprognostic (1.41e-1)" "unprognostic (3.53e-3)" "unprognostic (4.04e-2)" "unprognostic (2.68e-2)" "unprognostic (1.04e-6)" "unprognostic (1.21e-1)" "unprognostic (1.10e-1)" "unprognostic (4.49e-1)" "unprognostic (1.44e-2)" 0.4 0.2 0.7 0.9 0.1 2.3 0.4 0.2 0.3 0.4 0.0 0.2 0.3 0.3 0.0 8.8 0.5 0.3 0.3 0.2 0.2 0.2 0.8 0.9 0.8 2.5 0.6 0.5 0.1 0.0 0.5 0.1 0.5 1.6 0.0 0.6 6.1 0.0 711.3 0.3 0.5 0.0 1.3 1.1 0.2 0.5 0.9 0.0 0.4 192.9 0.0 0.2 0.4 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.4 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.0 0.1 0.7 0.3 0.2 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.6 1.0 0.0 0.1 0.4 0.0 0.6 0.3 0.7 0.4 0.4 0.4 0.2 0.3 0.5 0.2 0.3 0.6 0.4 1.1 0.2 0.5 0.2 0.2 0.1 0.7 0.1 0.2 0.3 0.2 0.2 2.5 0.6 0.5 1.3 0.9 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBE2L6 UBCH8 ENSG00000156587 "Ubiquitin conjugating enzyme E2 L6" O14933 11 57551656-57568284 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 165.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003328, CAB073407" Enhanced Approved Cytosol NA NA 15000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "CAB073407: , HPA003328: AB_1858539" "prognostic favorable (6.75e-4)" "unprognostic (2.10e-2)" "unprognostic (1.09e-2)" "unprognostic (2.93e-2)" "unprognostic (1.72e-1)" "unprognostic (1.18e-1)" "unprognostic (3.13e-2)" "unprognostic (4.74e-2)" "unprognostic (1.36e-2)" "unprognostic (1.37e-3)" "prognostic unfavorable (4.88e-4)" "unprognostic (3.07e-2)" "unprognostic (1.02e-2)" "unprognostic (1.28e-1)" "unprognostic (4.17e-2)" "unprognostic (1.88e-2)" "unprognostic (6.42e-2)" 70.7 60.4 84.4 92.3 84.8 85.5 51.1 80.0 95.2 54.2 70.7 46.3 47.6 44.1 68.5 42.7 66.1 66.6 35.2 80.2 88.0 51.5 121.1 91.1 119.9 93.6 88.1 61.5 24.3 39.9 36.8 53.1 86.2 47.0 43.6 23.6 103.3 49.2 14.3 36.1 57.6 67.3 96.2 126.4 55.6 17.1 94.6 113.4 37.4 29.3 86.7 76.0 44.4 86.1 55.6 26.2 85.8 29.0 179.2 222.3 9.7 30.2 178.8 261.3 337.0 9.8 140.9 169.3 110.3 92.5 223.3 43.7 38.0 99.4 55.4 163.9 1.5 169.2 0.0 38.0 330.7 38.8 54.3 238.9 22.9 122.8 33.6 96.2 83.9 173.2 7.9 118.5 47.8 67.6 280.1 92.2 23.3 0.5 33.3 243.1 52.9 118.4 71.0 58.5 2.1 45.2 60.3 5.4 139.9 15.3 68.3 20.3 30.9 56.3 19.6 43.6 10.2 162.1 176.6 3.4 161.0 98.8 12.3 508.1 534.8 487.8 359.2 638.4 394.1 379.2 368.2 377.9 401.3 310.9 315.1 331.1 838.8 486.9 556.7 256.3 513.7 1060.5 84.4 84.8 80.0 95.2 80.2 88.0 93.6 88.1 86.2 96.2 94.6 86.1 94.6 28.9 22.2 2.9 53.5 23.3 26.2 75.7 26.2 12.4 31.9 38.7 6.0 24.3 38.2 12.9 4.2 4.2 59.3 16.4 64.6 95.4 4.9 16.6 83.4 65.5 23.9 53.0 2.0 65.2 38.1 43.8 23.0 16.4 53.9 41.3 53.2 35.3 165.3 13.5 4.8 38.6 48.8 77.4 36.9 10.9 48.1 73.1 8.8 9.4 79.0 54.0 97.9 3.5 2.0 37.3 48.1 33.4 51.4 52.8 47.7 32.3 33.3 4.4 26.3 15.4 33.8 2.4 9.8 25.6 27.7 3.4 68.8 26.9 22.7 33.3 SERPING1 "C1-INH, C1IN, C1INH, C1NH, HAE1, HAE2" ENSG00000149131 "Serpin family G member 1" P05155 11 57597387-57619171 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Complement pathway, Fibrinolysis, Hemostasis, Immunity, Innate immunity" "Protease inhibitor, Serine protease inhibitor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 2622.4" "Cell type enhanced" "Detected in many" "Cholangiocytes: 726.4;Ductal cells: 604.0;Fibroblasts: 793.6;Hepatocytes: 2530.0;Leydig cells: 735.3" "Cancer enhanced" "Detected in all" "liver cancer: 609.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 65.2;plasmacytoid DC: 60.6" "Group enriched" "Detected in many" 243 "dendritic cells: 60.6;granulocytes: 65.2;monocytes: 25.7" "Group enriched" "Detected in many" 6 "ASC diff: 1372.2;ASC TERT1: 694.9;HSkMC: 1159.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 194.1" "CAB026161, HPA048738" Supported "Secreted to blood" NA NA 28000000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 2: Hepatocytes - Metabolism" "CAB026161: , HPA048738: AB_2680505" "unprognostic (1.35e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (9.96e-4)" "unprognostic (4.26e-2)" "unprognostic (4.38e-2)" "unprognostic (2.32e-1)" "unprognostic (4.12e-3)" "unprognostic (2.13e-1)" "unprognostic (8.95e-2)" "prognostic favorable (8.03e-4)" "unprognostic (5.92e-3)" "unprognostic (3.76e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (2.60e-2)" "unprognostic (4.14e-2)" "unprognostic (2.56e-1)" "unprognostic (1.17e-1)" 971.5 144.2 27.4 90.0 27.5 10.9 733.0 27.1 36.0 629.4 53.4 358.7 52.0 616.7 163.3 162.0 793.2 533.0 547.1 26.2 34.8 337.3 2622.4 785.0 147.6 67.4 34.7 918.3 267.5 55.2 138.2 198.9 34.2 329.3 97.0 34.5 250.5 258.1 151.8 293.5 283.5 226.8 42.3 240.7 344.8 50.6 37.2 36.1 338.2 173.4 64.4 555.9 519.8 35.1 0.0 0.0 48.2 0.0 1372.2 694.9 7.3 74.2 57.0 16.8 30.7 2.5 0.0 0.0 96.7 42.1 0.0 0.0 0.4 4.7 9.4 0.0 0.1 33.7 0.0 1.7 170.3 0.9 5.4 1159.0 15.5 5.7 0.2 6.0 0.0 0.0 1.0 0.0 1.0 0.0 0.0 1.3 46.6 0.0 0.0 4.3 4.0 0.7 7.4 0.0 0.2 14.4 0.3 0.0 0.9 41.8 0.2 3.3 0.0 0.8 21.2 0.7 0.0 0.2 0.4 0.6 0.2 0.5 0.0 0.0 18.3 0.3 0.0 25.7 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 65.2 0.2 11.5 60.6 0.0 5.7 27.4 27.5 27.1 36.0 26.2 34.8 67.4 34.7 34.2 42.3 37.2 35.1 162.1 118.6 110.8 5.5 8.0 75.8 61.2 7.1 24.5 0.8 24.2 57.7 28.7 726.4 57.5 158.2 0.0 37.1 15.3 0.0 43.0 604.0 4.8 76.0 297.4 150.5 0.0 69.2 3.6 44.0 93.4 793.6 8.6 69.6 7.6 8.3 260.5 2530.0 43.6 0.0 6.2 0.1 2.0 118.9 94.2 25.6 735.3 46.9 90.7 15.9 10.4 57.2 0.0 3.5 0.5 41.4 0.0 228.7 4.5 32.4 0.0 53.5 23.1 4.5 269.5 143.6 259.6 2.5 10.4 9.0 59.5 25.2 16.8 3.4 0.0 37.4 YPEL4 FLJ30213 ENSG00000166793 "Yippee like 4" Q96NS1 11 57645087-57649944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 34.0;Early spermatids: 29.7;Erythroid cells: 92.4;Langerhans cells: 15.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.2;ASC diff: 2.1;SK-MEL-30: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045621 Uncertain NA NA "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 6: Erythroid cells - Oxygen transport" "HPA045621: " "unprognostic (6.91e-3)" "unprognostic (1.74e-1)" "unprognostic (2.51e-2)" "unprognostic (8.62e-3)" "unprognostic (2.40e-1)" "unprognostic (7.50e-2)" "unprognostic (2.11e-2)" "unprognostic (2.47e-1)" "unprognostic (4.28e-2)" "unprognostic (1.04e-1)" "unprognostic (2.14e-1)" "unprognostic (4.18e-1)" "unprognostic (1.34e-6)" "unprognostic (1.50e-4)" "unprognostic (9.56e-2)" "unprognostic (1.86e-3)" "unprognostic (2.92e-1)" 1.6 3.3 9.6 0.3 12.8 7.2 1.9 11.7 23.2 4.8 0.0 1.9 0.4 3.6 0.2 0.6 1.9 1.2 0.8 12.3 10.5 0.7 0.4 1.6 0.2 11.3 6.9 5.4 0.4 0.1 5.4 0.7 11.0 0.8 0.2 3.2 0.7 0.4 0.4 0.9 1.1 1.3 4.3 1.2 0.8 2.4 7.7 0.3 0.8 0.7 0.1 0.8 2.8 16.5 0.2 0.1 3.2 0.2 2.1 1.9 0.4 0.1 1.7 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.8 0.9 0.1 0.3 0.0 1.8 0.0 0.7 0.0 0.2 0.1 0.0 0.7 0.3 1.2 0.0 0.1 1.3 0.3 0.2 0.0 0.0 0.0 0.8 0.1 0.1 4.4 1.8 0.3 0.0 0.0 0.1 0.7 0.0 0.0 1.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.6 12.8 11.7 23.2 12.3 10.5 11.3 6.9 11.0 4.3 7.7 16.5 0.7 0.0 0.0 1.0 0.9 1.1 0.8 0.1 0.6 34.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.6 29.7 0.6 1.7 1.2 0.0 92.4 13.4 0.0 0.6 4.3 0.5 0.6 3.8 0.1 0.4 0.1 1.0 8.4 15.0 0.0 0.0 1.3 15.7 12.8 1.2 3.3 5.4 1.0 0.1 1.0 0.0 5.5 12.3 0.1 0.0 0.4 0.4 0.2 0.0 0.0 0.0 2.8 0.0 4.4 2.6 0.3 0.1 0.4 1.3 3.3 2.5 0.1 0.0 0.1 CLP1 "hClp1, HEAB" ENSG00000172409 "Cleavage factor polyribonucleotide kinase subunit 1" Q92989 11 57648188-57661865 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, tRNA processing" "Kinase, Transferase" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057770 Supported Supported Nucleoplasm NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "HPA057770: AB_2683523" "unprognostic (1.33e-1)" "unprognostic (7.90e-2)" "unprognostic (1.11e-3)" "unprognostic (2.13e-2)" "unprognostic (4.90e-2)" "unprognostic (3.58e-1)" "unprognostic (1.93e-3)" "unprognostic (1.16e-1)" "unprognostic (3.01e-1)" "unprognostic (1.66e-2)" "unprognostic (8.82e-2)" "unprognostic (7.58e-2)" "unprognostic (8.31e-3)" "unprognostic (3.71e-2)" "unprognostic (1.75e-1)" "unprognostic (8.78e-2)" "unprognostic (3.07e-1)" 8.9 7.4 3.1 10.1 3.6 26.1 9.2 3.9 4.4 7.1 4.4 9.0 8.7 7.7 7.6 9.2 7.3 5.9 6.5 3.3 3.3 8.0 10.1 7.3 10.8 3.3 3.1 6.8 7.4 6.8 4.4 9.2 3.7 5.6 8.6 3.2 6.7 7.1 8.2 9.0 8.4 8.9 3.4 10.0 8.1 8.4 3.3 11.2 7.2 9.3 13.1 8.6 5.0 3.7 21.2 22.2 21.0 21.6 22.3 14.4 19.7 21.4 23.2 30.1 25.8 21.4 18.4 35.1 24.3 18.9 24.2 25.9 29.2 34.5 34.2 24.3 18.0 19.4 13.5 21.7 17.7 28.5 22.2 17.4 24.0 26.9 18.6 11.9 27.7 17.4 30.4 11.9 24.9 14.8 21.8 32.9 31.8 24.3 22.2 21.7 32.1 37.5 16.5 15.0 11.1 22.3 19.1 17.2 28.7 21.7 32.7 23.2 20.0 16.0 21.7 27.7 15.9 18.6 26.4 39.3 17.3 16.3 17.3 31.2 19.0 20.0 15.9 16.4 18.9 15.6 14.1 16.4 19.0 14.3 16.4 14.9 21.7 13.6 15.9 10.8 16.2 12.3 3.1 3.6 3.9 4.4 3.3 3.3 3.3 3.1 3.7 3.4 3.3 3.7 6.1 9.6 5.1 1.0 8.5 19.4 10.7 13.4 16.5 4.3 6.0 6.2 2.4 7.2 10.5 0.0 6.2 16.5 12.7 4.8 9.8 12.9 32.5 6.7 5.7 7.3 2.4 12.2 1.9 11.7 13.9 7.4 3.1 7.1 8.2 4.9 4.2 3.5 11.0 5.0 1.8 3.2 8.2 6.0 6.9 4.1 5.6 5.8 8.8 1.0 15.0 3.3 7.2 2.5 1.4 9.8 4.7 8.6 5.9 4.7 6.2 10.1 6.4 3.1 6.6 10.4 6.9 9.4 12.0 9.3 14.5 13.5 9.7 6.5 4.6 7.8 ZDHHC5 "DHHC5, KIAA1748, ZNF375" ENSG00000156599 "Zinc finger DHHC-type palmitoyltransferase 5" Q9C0B5 11 57667747-57701182 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014670 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 15: RT4 - Unknown function" "Cluster 46: Photoreceptor cells - Phototransduction" "Plasma membrane" Nucleoplasm "HPA014670: AB_2257442" "unprognostic (1.34e-1)" "unprognostic (3.47e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (5.32e-2)" "unprognostic (1.70e-2)" "unprognostic (9.82e-3)" "unprognostic (1.74e-3)" "unprognostic (4.36e-2)" "unprognostic (9.78e-2)" "prognostic unfavorable (6.74e-5)" "unprognostic (1.76e-1)" "unprognostic (4.72e-3)" "unprognostic (2.16e-1)" "unprognostic (6.80e-2)" "unprognostic (2.06e-2)" "unprognostic (1.74e-3)" 29.0 21.7 8.3 27.2 7.8 29.2 25.8 8.3 9.5 27.0 11.0 36.4 29.6 22.3 24.1 60.9 25.0 27.9 27.9 7.5 9.2 28.2 36.7 29.0 24.4 8.5 8.9 20.7 31.6 45.3 12.6 36.7 8.7 28.0 34.4 35.9 35.0 26.7 40.9 45.2 31.0 29.0 6.9 25.5 30.2 36.2 10.9 30.6 36.9 45.5 35.0 42.3 28.7 8.9 80.3 86.2 33.7 34.7 74.9 57.4 64.9 72.8 89.8 61.8 46.3 52.3 97.0 53.4 91.9 89.5 53.1 110.1 53.6 88.9 55.4 66.5 24.4 45.8 40.1 49.3 81.5 85.9 73.7 81.3 79.3 88.8 92.9 51.1 71.0 45.6 61.5 66.2 79.7 48.4 49.1 29.3 41.1 61.0 52.2 47.8 66.6 67.1 74.8 115.2 25.3 30.7 67.6 77.0 78.5 45.4 81.9 52.6 80.7 76.5 40.7 82.9 52.2 48.2 63.0 45.9 59.1 44.4 68.0 11.6 5.2 7.1 6.9 6.8 8.3 5.8 6.7 6.0 5.4 5.7 6.7 6.9 6.9 5.0 8.1 9.0 7.0 6.8 8.3 7.8 8.3 9.5 7.5 9.2 8.5 8.9 8.7 6.9 10.9 8.9 28.8 16.0 10.5 14.7 13.4 16.2 12.7 13.7 16.5 21.4 20.4 15.2 21.6 12.8 19.8 12.9 37.5 10.1 20.3 41.3 3.9 14.4 21.3 19.9 22.1 17.1 11.5 10.8 16.4 18.2 9.9 15.5 15.8 35.5 19.7 24.9 16.1 15.1 13.0 13.5 17.9 17.5 18.3 16.3 10.2 9.8 11.8 18.4 1.8 14.0 16.0 14.0 17.5 17.6 14.7 26.0 20.8 7.5 12.4 15.1 22.9 11.4 17.4 47.7 0.0 18.4 18.5 13.3 7.1 31.5 19.9 18.6 15.9 16.8 19.7 20.5 MED19 LCMR1 ENSG00000156603 "Mediator complex subunit 19" A0JLT2 11 57703714-57712323 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039912, HPA040860" Uncertain Enhanced "Nuclear bodies" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 10: Non-specific - Unknown function" "Nuclear bodies" "HPA039912: AB_10795262, HPA040860: AB_10794153" "unprognostic (2.61e-1)" "unprognostic (1.62e-1)" "unprognostic (5.01e-2)" "unprognostic (2.23e-1)" "unprognostic (1.05e-1)" "unprognostic (2.64e-1)" "prognostic unfavorable (1.34e-6)" "unprognostic (1.40e-1)" "unprognostic (4.87e-3)" "prognostic favorable (1.76e-6)" "unprognostic (3.08e-1)" "unprognostic (1.97e-1)" "unprognostic (1.14e-2)" "unprognostic (6.71e-2)" "unprognostic (6.97e-2)" "unprognostic (4.91e-2)" "unprognostic (1.38e-2)" 11.3 18.1 22.7 6.2 23.7 6.8 11.6 20.7 41.5 11.0 21.0 10.0 9.6 11.6 13.4 15.5 9.2 6.1 11.3 23.4 22.6 14.7 13.2 8.9 7.5 21.4 22.9 9.6 11.6 9.8 16.0 10.2 22.2 12.5 7.8 12.0 12.1 8.9 10.6 15.5 9.7 8.1 22.2 10.8 11.1 22.8 26.0 8.2 13.6 9.2 9.4 10.1 11.9 23.7 30.3 19.1 22.7 21.0 23.6 21.4 27.0 25.4 19.7 23.9 24.0 13.6 23.0 16.6 38.5 24.4 21.0 22.6 17.1 16.1 21.0 21.8 18.6 14.3 11.3 12.7 35.5 15.7 16.4 17.5 28.9 23.8 46.6 16.7 31.1 13.3 15.9 16.1 29.1 14.5 22.3 29.2 19.8 21.4 37.7 21.1 32.2 20.2 15.9 12.6 17.6 24.7 20.5 20.7 47.2 19.1 43.8 16.0 25.7 20.7 24.8 49.2 22.6 19.9 20.5 15.7 28.3 11.5 22.1 27.9 25.8 31.3 29.2 37.2 31.6 45.0 32.8 31.4 25.6 39.4 34.0 32.0 16.4 24.6 39.2 36.9 33.9 26.0 22.7 23.7 20.7 41.5 23.4 22.6 21.4 22.9 22.2 22.2 26.0 23.7 40.7 9.6 27.1 4.6 32.5 87.6 60.9 72.0 62.0 38.6 37.4 39.8 14.7 30.0 40.2 51.5 35.5 58.2 32.2 36.2 39.2 44.1 12.2 33.3 37.8 39.3 23.3 21.4 9.2 45.4 48.6 38.1 20.9 34.0 22.2 39.2 36.0 26.3 29.3 37.0 8.3 38.3 54.9 17.6 31.4 15.4 28.3 18.6 37.4 2.8 26.3 37.4 24.7 5.5 7.2 40.6 33.2 29.7 22.9 53.6 32.9 47.2 42.1 59.7 19.7 31.3 50.5 111.7 97.9 42.7 82.3 73.1 35.8 37.5 31.8 52.8 TMX2 "PDIA12, TXNDC14" ENSG00000213593 "Thioredoxin related transmembrane protein 2" Q9Y320 11 57712593-57740973 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease variant, Lissencephaly, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040282, HPA063763" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Cytosol" "HPA040282: AB_10697715, HPA063763: AB_2685116" "unprognostic (3.66e-3)" "unprognostic (6.96e-2)" "unprognostic (6.69e-3)" "unprognostic (2.73e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (3.64e-4)" "prognostic unfavorable (4.11e-4)" "unprognostic (4.48e-2)" "unprognostic (2.98e-1)" "unprognostic (7.26e-3)" "unprognostic (1.90e-2)" "unprognostic (2.22e-1)" "prognostic favorable (1.55e-5)" "unprognostic (5.88e-3)" "unprognostic (4.19e-2)" "unprognostic (3.40e-1)" "prognostic unfavorable (3.37e-4)" 52.9 75.1 77.7 37.3 83.0 27.0 50.5 87.4 101.9 43.6 103.3 70.0 56.4 39.4 58.2 62.8 42.7 33.2 71.5 75.0 84.1 78.7 83.4 45.0 31.5 81.7 81.5 40.9 57.7 84.9 43.1 44.0 83.5 50.1 80.8 64.7 49.6 53.8 44.7 45.1 58.3 43.1 84.3 44.9 60.9 30.6 85.5 34.9 57.1 41.3 47.6 48.2 43.8 90.6 122.7 141.4 78.5 143.4 144.8 77.2 86.6 144.2 111.8 140.0 117.9 135.3 205.6 115.1 156.6 116.3 207.1 220.0 203.5 115.4 146.3 83.3 88.9 110.2 105.7 136.8 119.3 156.6 145.5 94.8 166.5 154.8 243.2 76.3 80.6 95.3 194.4 130.9 157.7 62.7 93.0 177.1 153.8 227.7 191.5 124.7 97.9 242.5 174.4 136.4 90.3 129.3 110.2 255.7 168.3 76.7 228.5 102.2 66.7 130.5 84.8 176.1 152.1 127.9 269.5 115.3 146.6 109.3 198.3 37.8 41.5 40.0 34.6 72.4 44.0 36.8 34.4 40.9 40.6 34.9 43.1 43.8 11.2 37.8 86.0 49.7 32.0 45.0 77.7 83.0 87.4 101.9 75.0 84.1 81.7 81.5 83.5 84.3 85.5 90.6 37.9 38.5 34.0 0.0 32.0 32.1 44.9 108.2 19.9 43.4 35.8 28.1 42.6 30.0 60.8 49.7 31.3 108.0 29.9 39.5 43.0 72.4 2.0 19.6 27.4 36.8 28.8 37.6 0.0 43.5 85.6 38.6 23.0 20.7 43.1 29.9 31.8 48.7 62.0 30.3 0.0 49.6 81.4 30.8 21.4 3.6 48.7 31.9 48.0 0.0 37.8 91.1 19.6 0.0 0.0 54.5 32.0 43.6 32.5 49.0 51.4 41.1 37.4 66.7 39.5 36.3 34.5 60.7 62.2 33.6 32.7 99.6 26.6 46.6 75.2 43.6 SELENOH "C11orf31, SELH" ENSG00000211450 "Selenoprotein H" Q8IZQ5 11 57741250-57743554 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 444.1;Exocrine glandular cells: 315.1;Hofbauer cells: 416.3;Proximal tubular cells: 588.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048362 Uncertain Approved Nucleoplasm,Nucleoli No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA048362: AB_2680370" "unprognostic (1.12e-2)" "unprognostic (3.05e-2)" "unprognostic (6.14e-2)" "unprognostic (1.18e-1)" "unprognostic (2.39e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (4.30e-4)" "unprognostic (3.61e-2)" "unprognostic (1.23e-2)" "prognostic favorable (1.80e-4)" "unprognostic (1.58e-1)" "unprognostic (7.56e-2)" "unprognostic (4.12e-3)" "unprognostic (1.43e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (2.60e-1)" 96.0 167.2 38.4 31.6 41.1 39.4 95.6 36.4 70.0 91.4 39.5 82.0 31.7 73.7 11.9 135.0 72.7 20.6 117.5 39.9 43.2 125.6 171.2 85.9 42.5 38.2 38.7 96.4 110.8 9.2 104.6 26.2 39.6 110.6 13.1 5.4 99.4 16.2 117.0 79.6 88.0 15.0 37.5 130.1 91.3 66.8 41.1 14.5 103.2 6.2 27.9 87.0 86.3 39.7 116.5 84.5 79.8 47.6 7.6 29.1 18.8 43.1 30.3 36.4 19.8 26.7 56.2 51.0 120.7 15.4 31.0 50.9 26.6 47.1 8.3 75.7 85.3 67.8 59.0 66.4 63.7 105.1 140.0 38.4 43.3 39.0 19.4 39.9 50.4 68.9 70.2 44.0 23.7 112.6 103.5 181.1 155.6 32.8 89.6 122.5 75.6 106.7 23.6 62.2 46.0 105.1 39.1 35.2 133.6 18.3 102.2 79.7 64.1 41.1 101.2 90.3 64.2 269.8 226.2 41.3 95.3 89.0 106.1 295.2 385.8 204.5 160.2 417.6 151.4 346.4 209.6 171.4 396.4 349.2 282.1 208.8 29.7 187.7 394.2 488.1 175.3 469.5 38.4 41.1 36.4 70.0 39.9 43.2 38.2 38.7 39.6 37.5 41.1 39.7 182.7 166.7 151.8 0.0 61.0 0.0 0.0 0.0 0.0 0.0 273.3 267.0 0.0 0.0 74.3 150.8 0.0 288.7 77.7 0.0 444.1 256.7 0.0 175.5 95.2 90.2 0.0 0.0 0.0 315.1 280.8 68.4 0.0 104.1 133.7 148.5 0.0 0.0 416.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 119.1 0.0 0.0 102.4 0.0 0.0 0.0 0.0 288.7 0.0 0.0 14.8 0.0 0.0 588.6 142.8 0.0 0.0 0.0 74.7 0.0 0.0 0.0 0.0 147.2 49.0 190.5 0.0 0.0 BTBD18 ENSG00000233436 "BTB domain containing 18" B2RXH4 11 57743514-57751781 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 3.1;testis: 2.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.7;Cone photoreceptor cells: 4.2;Rod photoreceptor cells: 1.6;Spermatocytes: 5.5;Spermatogonia: 3.9" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 3.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA049325 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 21: Non-specific - Transcription" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Plasma membrane" Vesicles "HPA049325: AB_2680713" "unprognostic (6.68e-2)" "unprognostic (3.13e-2)" "unprognostic (3.43e-1)" "unprognostic (4.81e-2)" "unprognostic (1.75e-1)" "unprognostic (2.47e-2)" "unprognostic (8.69e-3)" "unprognostic (4.84e-3)" "unprognostic (1.77e-1)" "unprognostic (2.96e-1)" "unprognostic (7.17e-3)" "unprognostic (5.95e-3)" "unprognostic (1.42e-2)" "unprognostic (2.34e-2)" "unprognostic (3.15e-1)" "unprognostic (3.34e-1)" "unprognostic (2.88e-1)" 0.0 0.0 0.1 0.0 0.3 0.4 0.0 3.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.4 0.4 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.3 3.1 0.9 0.2 0.0 0.2 0.1 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.0 0.2 0.7 0.4 0.1 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 5.5 3.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 CTNND1 "CTNND, KIAA0384, p120, p120cas, p120ctn" ENSG00000198561 "Catenin delta 1" O60716 11 57753243-57819546 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway" "Cancer-related genes, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 305.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 4.9;intermediate monocyte: 9.5;myeloid DC: 6.3;non-classical monocyte: 5.6" "Group enriched" "Detected in many" 19 "dendritic cells: 6.3;monocytes: 9.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB003837, HPA015954, HPA015955" Enhanced Enhanced "Plasma membrane" NA NA 200000 "Cluster 7: Monocytes - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "Plasma membrane" "CAB003837: AB_562066, HPA015954: AB_2669326, HPA015955: AB_1846068" "unprognostic (1.06e-2)" "unprognostic (1.60e-2)" "unprognostic (5.17e-3)" "unprognostic (4.87e-2)" "unprognostic (7.81e-2)" "unprognostic (2.30e-1)" "unprognostic (2.98e-2)" "unprognostic (3.52e-3)" "unprognostic (4.17e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (2.75e-1)" "prognostic favorable (3.54e-4)" "unprognostic (7.17e-2)" "unprognostic (4.09e-2)" "unprognostic (3.34e-1)" "unprognostic (7.33e-2)" 72.6 48.8 29.6 34.8 28.1 5.9 83.3 28.2 33.0 86.0 50.0 107.9 97.8 70.8 49.3 209.7 58.4 56.3 49.0 26.6 26.8 77.9 82.6 83.9 19.0 34.8 30.6 49.3 120.0 76.1 57.7 106.0 32.5 78.9 102.0 23.5 121.8 57.1 26.8 129.4 104.9 54.8 32.3 51.5 105.4 44.3 38.0 24.4 98.6 19.9 48.4 83.5 111.9 33.5 156.6 106.4 70.2 63.3 46.1 71.6 141.7 65.1 78.8 58.5 55.6 88.5 163.9 1.0 113.2 72.5 50.9 201.7 58.8 97.4 71.1 1.0 21.9 32.0 35.8 109.9 52.6 5.0 52.7 70.0 133.5 67.1 73.5 103.8 197.2 1.7 55.1 0.4 55.1 48.0 1.7 13.9 54.7 101.2 56.5 0.7 67.4 1.3 90.2 171.0 4.9 40.1 91.5 133.6 113.1 176.3 138.9 6.1 166.0 59.6 50.3 53.2 34.6 1.2 0.9 2.3 53.2 3.4 111.5 0.0 4.9 0.1 0.0 9.5 0.2 0.2 0.0 0.1 6.3 0.3 0.0 0.0 0.2 0.4 5.6 1.4 0.1 1.1 29.6 28.1 28.2 33.0 26.6 26.8 34.8 30.6 32.5 32.3 38.0 33.5 116.2 147.4 84.0 0.0 8.8 117.1 96.9 82.9 126.9 21.0 101.5 70.5 17.5 125.8 96.6 141.6 39.6 94.0 2.3 305.5 13.7 106.7 14.1 91.1 58.5 98.6 86.2 21.3 0.0 97.2 85.6 34.5 165.1 139.4 32.4 61.1 91.8 127.6 44.4 15.2 0.0 160.7 52.9 64.3 55.5 10.5 28.3 46.4 48.0 0.0 28.5 30.2 2.1 0.0 0.0 141.8 169.3 38.4 5.0 116.9 179.6 57.6 88.2 26.4 26.3 32.3 38.1 37.0 21.1 285.1 200.5 90.8 6.2 39.9 127.0 194.6 OR9Q1 ENSG00000186509 "Olfactory receptor family 9 subfamily Q member 1" Q8NGQ5 11 58023881-58181616 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Excitatory neurons: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (2.65e-3)" "unprognostic (2.27e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6Q1 ENSG00000279051 "Olfactory receptor family 6 subfamily Q member 1" Q8NGQ2 11 58030930-58031931 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9I1 ENSG00000172377 "Olfactory receptor family 9 subfamily I member 1" Q8NGQ6 11 58116742-58125530 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9Q2 OR9Q2P ENSG00000186513 "Olfactory receptor family 9 subfamily Q member 2" Q8NGE9 11 58189070-58194053 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 54: Cardiomyocytes - Muscle contraction" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1S2 ENSG00000197887 "Olfactory receptor family 1 subfamily S member 2" Q8NGQ3 11 58203202-58204181 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049304 Uncertain NA NA "HPA049304: AB_2680704" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1S1 OST034 ENSG00000280204 "Olfactory receptor family 1 subfamily S member 1" Q8NH92 11 58212720-58216084 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049304 Uncertain NA NA "HPA049304: AB_2680704" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10Q1 ENSG00000180475 "Olfactory receptor family 10 subfamily Q member 1" Q8NGQ4 11 58227882-58228918 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046968 Uncertain NA NA "HPA046968: AB_2679881" "unprognostic (4.82e-1)" "unprognostic (6.34e-2)" "unprognostic (4.37e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10W1 OR10W1P ENSG00000172772 "Olfactory receptor family 10 subfamily W member 1" Q8NGF6 11 58266792-58268260 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.61e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5B17 OR5B20P ENSG00000197786 "Olfactory receptor family 5 subfamily B member 17" Q8NGF7 11 58358124-58359069 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5B3 "OR5B13, OST129" ENSG00000172769 "Olfactory receptor family 5 subfamily B member 3" Q8NH48 11 58402464-58406874 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5B2 OST073 ENSG00000172365 "Olfactory receptor family 5 subfamily B member 2" Q96R09 11 58421238-58428121 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.9 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5B12 "OR5B12P, OR5B16, OST743" ENSG00000172362 "Olfactory receptor family 5 subfamily B member 12" Q96R08 11 58439077-58442758 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5B21 ENSG00000198283 "Olfactory receptor family 5 subfamily B member 21" A6NL26 11 58507175-58508105 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 65: Plasmacytoid DCs - Unknown function" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LPXN LDPL ENSG00000110031 Leupaxin O60711 11 58526871-58578220 "Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 118.5" "Cell type enhanced" "Detected in many" "B-cells: 75.9;dendritic cells: 80.7;Langerhans cells: 154.6;Macrophages: 81.7;Plasma cells: 82.2;T-cells: 90.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 200.7;HMC-1: 329.3;Karpas-707: 285.0;U-2197: 199.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043741, CAB046478, HPA061441" Enhanced Supported "Nuclear speckles,Focal adhesion sites,Cytosol" No No "Cluster 13: T-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 58: T-cells - T-cell receptor" "Focal adhesion sites" "Nuclear speckles, Cytosol" "CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518" "unprognostic (1.61e-3)" "unprognostic (6.91e-2)" "unprognostic (6.54e-2)" "prognostic favorable (8.81e-4)" "unprognostic (5.16e-2)" "unprognostic (2.07e-3)" "unprognostic (2.16e-2)" "unprognostic (8.87e-3)" "unprognostic (5.18e-2)" "unprognostic (3.96e-2)" "unprognostic (2.39e-2)" "unprognostic (3.05e-1)" "unprognostic (3.60e-3)" "unprognostic (1.91e-1)" "unprognostic (5.25e-2)" "unprognostic (2.55e-1)" "unprognostic (2.41e-3)" 10.4 8.3 7.5 48.3 8.2 10.2 10.2 7.8 11.8 7.9 4.5 14.5 10.9 7.4 11.9 5.2 7.6 15.1 5.3 7.1 7.8 10.6 14.0 33.5 87.1 9.1 8.8 9.5 8.6 6.5 7.2 5.2 10.2 9.4 19.6 7.0 11.0 7.1 3.8 5.9 26.2 9.7 8.6 44.1 13.0 10.2 10.0 103.3 10.2 5.1 118.5 32.4 6.0 10.9 1.7 2.1 2.0 3.9 7.4 9.3 1.4 50.5 200.7 12.4 22.0 0.4 5.1 149.8 2.0 61.9 9.2 2.0 1.7 137.7 51.4 65.4 0.9 6.8 1.3 1.0 12.8 41.1 329.3 7.2 3.2 170.8 22.0 12.0 80.9 90.0 1.9 285.0 101.5 1.1 144.8 51.6 1.6 2.3 45.8 2.1 2.5 129.2 8.3 71.2 1.0 1.6 2.2 3.2 20.1 2.8 2.7 11.7 79.8 30.8 9.5 199.5 45.9 18.4 18.9 146.5 71.6 36.8 71.6 6.3 74.3 12.2 101.3 41.8 148.9 71.9 102.9 117.6 137.5 46.2 79.6 95.9 14.1 79.2 22.2 124.4 152.1 98.8 7.5 8.2 7.8 11.8 7.1 7.8 9.1 8.8 10.2 8.6 10.0 10.9 4.1 0.0 6.7 22.9 75.9 9.7 6.6 7.2 3.4 4.1 4.0 4.7 2.3 4.3 2.8 0.0 4.2 2.8 80.7 4.2 3.9 2.5 23.0 2.8 1.9 5.9 6.1 13.3 18.2 5.6 1.3 6.6 13.3 2.3 51.5 5.4 2.5 7.6 44.0 1.7 19.8 3.1 6.1 63.7 154.6 8.7 1.8 81.7 19.6 30.0 52.9 2.8 49.4 11.6 27.3 4.1 5.2 3.8 82.2 3.6 6.9 5.7 4.3 4.4 6.6 3.6 3.8 9.2 4.2 2.6 9.7 2.5 90.3 2.9 5.2 27.6 ZFP91 "PZF, ZNF757" ENSG00000186660 "ZFP91 zinc finger protein, atypical E3 ubiquitin ligase" Q96JP5 11 58579063-58621550 "Enzymes, Predicted intracellular proteins, Transcription factors" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 243.7;Late spermatids: 179.3;Spermatocytes: 140.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA024037, CAB025417, HPA065325" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 18: U-2197 - ECM organization" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli" "CAB025417: , HPA024037: AB_1859051, HPA065325: AB_2685468" "unprognostic (6.10e-2)" "unprognostic (5.01e-2)" "unprognostic (3.33e-3)" "unprognostic (9.19e-2)" "unprognostic (1.24e-1)" "unprognostic (2.33e-1)" "unprognostic (2.33e-2)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (2.36e-2)" "prognostic unfavorable (3.74e-6)" "unprognostic (3.16e-1)" "unprognostic (1.75e-3)" "unprognostic (3.12e-2)" "unprognostic (2.61e-1)" "unprognostic (2.23e-1)" "unprognostic (2.00e-3)" 25.0 22.0 27.8 23.0 32.3 59.2 21.9 28.0 33.4 22.0 16.0 28.9 25.9 22.4 17.6 24.4 19.9 21.5 29.8 22.9 26.9 25.1 30.7 21.3 24.8 26.5 28.8 20.2 22.8 29.8 15.3 20.3 27.1 19.3 33.5 29.8 20.2 22.6 53.2 25.7 29.0 24.4 28.8 24.3 21.1 86.4 28.4 36.7 25.9 45.3 26.2 27.5 20.4 32.8 65.4 36.3 42.0 43.3 39.6 47.5 23.1 52.3 98.3 59.6 50.7 19.9 67.1 77.5 50.6 66.9 59.4 56.7 43.2 56.0 77.9 41.3 24.3 51.2 36.5 21.9 44.9 65.3 80.9 41.8 53.8 83.9 97.3 49.4 60.0 51.5 51.4 71.4 77.7 21.7 56.8 36.1 22.2 37.6 35.4 43.4 71.0 51.8 43.8 60.9 45.1 35.9 67.2 61.0 86.8 22.7 68.2 48.5 67.8 74.8 51.4 114.0 59.3 41.0 32.3 62.9 66.2 36.1 78.1 1.3 1.4 1.0 1.5 1.2 0.8 1.3 0.9 0.9 1.4 1.1 0.9 1.2 1.5 1.0 1.3 2.0 0.8 0.8 27.8 32.3 28.0 33.4 22.9 26.9 26.5 28.8 27.1 28.8 28.4 32.8 24.6 25.6 33.6 0.0 29.1 60.2 26.1 20.6 44.3 31.9 25.4 17.9 45.7 38.6 20.6 18.4 16.7 12.1 31.7 46.2 13.7 23.7 243.7 30.1 33.7 28.8 25.2 46.7 0.0 31.2 11.4 31.3 23.9 40.9 50.6 32.5 27.5 51.3 16.6 35.3 0.0 27.6 12.2 45.3 55.9 179.3 30.7 36.5 23.2 0.0 36.4 21.1 25.7 0.0 0.0 29.5 18.6 27.1 26.2 35.0 34.6 26.7 24.2 22.4 19.7 34.7 27.6 140.9 41.1 53.7 66.5 13.8 24.2 17.9 39.1 43.4 CNTF HCNTF ENSG00000242689 "Ciliary neurotrophic factor" P26441 11 58622665-58625733 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.9;brain: 7.7" "Cell type enhanced" "Detected in single" "Melanocytes: 1.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 7.9" "Low region specificity" "Detected in all" HPA019654 Approved Approved Vesicles NA NA 69200 "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 18: U-2197 - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA019654: AB_1859050" "unprognostic (1.88e-1)" "unprognostic (2.64e-3)" "unprognostic (1.01e-2)" "unprognostic (4.37e-2)" "unprognostic (1.52e-1)" "unprognostic (5.91e-2)" "unprognostic (1.63e-1)" "unprognostic (9.24e-2)" "unprognostic (5.87e-2)" "unprognostic (1.63e-1)" "unprognostic (8.25e-4)" "unprognostic (5.42e-2)" "unprognostic (8.50e-2)" "unprognostic (1.02e-1)" "unprognostic (1.91e-1)" "unprognostic (9.50e-2)" "unprognostic (9.67e-2)" 0.9 0.5 1.2 0.6 3.0 6.9 0.7 2.9 2.4 0.2 1.2 0.6 0.9 0.2 0.9 0.6 4.7 0.5 1.6 1.1 2.0 0.6 0.8 0.6 0.5 5.8 3.6 0.2 0.5 0.4 0.4 0.4 3.9 0.3 0.8 0.8 1.1 0.3 3.2 0.9 0.7 0.4 3.4 0.4 0.4 0.6 2.2 0.7 0.6 1.8 0.4 0.4 0.3 7.7 1.3 0.5 2.1 2.2 0.6 0.2 1.1 0.9 1.4 1.0 0.7 1.9 1.8 2.8 0.7 1.4 1.1 2.4 2.3 2.5 2.0 1.9 1.3 1.4 3.1 1.0 0.3 2.2 2.5 0.6 0.8 3.2 1.0 0.4 1.0 1.9 2.2 0.6 1.3 0.5 2.1 2.1 1.3 1.0 1.0 1.3 1.4 2.0 1.2 1.6 0.9 2.6 1.4 1.5 3.7 1.5 1.8 1.6 0.7 1.5 1.1 7.9 2.6 1.4 3.3 2.3 4.0 1.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 3.0 2.9 2.4 1.1 2.0 5.8 3.6 3.9 3.4 2.2 7.7 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.1 GLYAT "ACGNAT, GAT" ENSG00000149124 Glycine-N-acyltransferase Q6IB77 11 58640426-58731974 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Detoxification "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "kidney: 571.8;liver: 698.0" "Group enriched" "Detected in some" 6 "Hepatocytes: 346.7;Proximal tubular cells: 1261.0" "Group enriched" "Detected in some" 158 "liver cancer: 21.7;renal cancer: 25.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-937: 1.4" "Not detected" "Not detected" "HPA040251, HPA044094" Enhanced NA NA 21000 "Cluster 81: Kidney & Liver - Metabolism" "Cluster 32: U-937 - Innate immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA040251: AB_2676902, HPA044094: AB_2678807" "unprognostic (2.15e-2)" "unprognostic (9.38e-4)" "unprognostic (4.60e-2)" "unprognostic (1.65e-3)" "unprognostic (1.83e-1)" "unprognostic (1.60e-1)" "prognostic favorable (1.31e-6)" "unprognostic (2.69e-1)" 47.0 0.1 0.0 0.1 0.1 0.1 8.5 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.0 571.8 698.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 1.2 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.3 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.3 0.1 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 11.5 0.0 31.3 0.0 0.1 0.0 0.0 123.3 0.0 6.0 0.0 0.0 0.6 0.0 8.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 346.7 0.0 0.0 0.2 0.0 0.0 10.7 0.0 8.2 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1261.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 GLYATL2 "BXMAS2-10, MGC24009" ENSG00000156689 "Glycine-N-acyltransferase like 2" Q8WU03 11 58834065-58904215 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 12.0;cervix: 19.9;salivary gland: 33.4" "Cell type enhanced" "Detected in some" "Breast glandular cells: 14.8;Oligodendrocyte precursor cells: 3.0;Prostatic glandular cells: 3.6;Sertoli cells: 6.6" "Group enriched" "Detected in many" 4 "breast cancer: 16.7;endometrial cancer: 15.7" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.3;BJ hTERT+ SV40 Large T+ RasG12V: 3.7;HAP1: 6.0;SK-BR-3: 14.1;U-2197: 6.6" "Low region specificity" "Detected in many" "HPA060292, HPA065454" Uncertain Approved Mitochondria NA NA "Cluster 24: Salivary gland - Salivary secretion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 35: Glandular cells - Unknown function" Mitochondria "HPA060292: AB_2684245, HPA065454: " "unprognostic (1.02e-2)" "unprognostic (3.79e-3)" "unprognostic (8.11e-4)" "prognostic favorable (9.05e-7)" "unprognostic (1.05e-1)" "unprognostic (8.41e-2)" "unprognostic (2.66e-2)" "unprognostic (9.98e-3)" "unprognostic (1.27e-1)" "unprognostic (9.18e-3)" "unprognostic (1.64e-1)" "unprognostic (1.59e-1)" "unprognostic (7.42e-5)" "unprognostic (7.79e-3)" "unprognostic (8.28e-2)" "unprognostic (9.11e-3)" "unprognostic (2.31e-2)" 0.2 0.1 0.2 0.1 0.3 0.1 12.0 0.2 0.5 19.9 0.0 0.1 0.3 0.4 0.3 0.9 0.1 7.5 0.3 0.2 0.4 0.9 0.1 0.0 0.3 0.7 0.2 0.0 0.1 0.0 0.1 0.0 0.6 0.9 0.2 0.3 33.4 0.1 0.0 1.4 0.1 0.3 0.7 0.3 0.1 0.0 0.2 0.1 0.1 0.5 0.4 0.1 0.3 1.1 0.0 0.0 0.4 0.0 0.7 2.6 0.0 1.7 5.3 2.3 3.7 0.0 0.0 0.1 0.0 1.4 1.0 0.4 6.0 0.0 1.9 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.5 0.2 2.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.1 14.1 0.0 0.0 0.0 0.0 0.0 1.8 0.1 6.6 2.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.2 0.5 0.2 0.4 0.7 0.2 0.6 0.7 0.2 1.1 0.2 0.0 0.0 0.0 0.0 1.0 2.3 1.4 0.0 0.5 14.8 2.2 0.1 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 1.1 0.0 0.0 1.5 1.4 0.0 0.5 0.0 1.2 0.0 0.4 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.0 3.0 0.4 0.1 0.0 0.0 0.0 3.6 0.0 0.2 0.1 0.1 6.6 0.2 0.6 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 1.9 GLYATL1 "FLJ34646, MGC15397" ENSG00000166840 "Glycine-N-acyltransferase like 1" Q969I3 11 58905398-59043527 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 576.3" "Group enriched" "Detected in some" 4 "Hepatocytes: 234.3;Proximal tubular cells: 797.1" "Group enriched" "Detected in some" 8 "liver cancer: 14.1;prostate cancer: 13.3;renal cancer: 10.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.0;Daudi: 4.9;RPTEC TERT1: 1.5;U-2197: 1.2" HPA039501 Supported Uncertain "Golgi apparatus,Cytosol" NA NA "Cluster 85: Liver - Metabolism" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" Cytosol "HPA039501: AB_2676545" "unprognostic (9.46e-3)" "unprognostic (5.33e-2)" "unprognostic (3.90e-5)" "unprognostic (3.93e-3)" "unprognostic (3.54e-3)" "unprognostic (2.17e-1)" "prognostic favorable (3.69e-4)" "unprognostic (3.62e-1)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (2.08e-1)" "unprognostic (2.92e-1)" "prognostic favorable (3.03e-5)" "unprognostic (1.50e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-2)" "unprognostic (4.55e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 1.3 0.3 0.4 0.1 0.4 0.3 1.6 0.1 0.7 0.1 1.3 0.9 0.0 0.1 0.3 141.4 576.3 0.0 0.1 0.9 0.2 0.0 1.7 2.6 0.0 0.0 1.1 11.1 0.3 0.2 1.9 0.0 0.0 0.6 0.2 0.0 0.3 0.1 2.7 0.1 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.1 0.5 0.4 2.0 0.0 4.9 0.0 0.3 0.4 0.0 0.0 0.0 0.8 0.0 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.5 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.1 0.3 0.9 0.2 1.1 0.3 0.3 0.3 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.3 12.8 0.0 14.7 0.0 0.0 0.0 0.1 107.6 0.1 0.0 2.5 0.1 0.5 0.0 8.0 0.7 0.6 0.0 0.1 0.0 0.1 0.0 0.1 5.0 234.3 0.0 0.0 0.8 0.1 0.0 8.1 0.0 0.0 0.0 3.1 1.8 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.0 1.3 0.0 797.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 1.9 0.1 0.9 0.2 GLYATL1B GLYATL1P3 ENSG00000255151 "Glycine-N-acyltransferase like 1B" A0A0U1RQE8 11 59086307-59094786 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 7 "breast: 7.3;lymphoid tissue: 2.8" "Cell type enriched" "Detected in single" 57 "Proximal tubular cells: 5.8" "Cancer enhanced" "Detected in single" "prostate cancer: 0.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.5" "Lineage enriched" "Detected in single" 15 "B-cells: 1.5" "Cell line enhanced" "Detected in some" "Daudi: 1.8;T-47d: 1.2;U-266/70: 1.8" HPA039501 Uncertain Uncertain "Golgi apparatus,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" Cytosol "HPA039501: AB_2676545" "unprognostic (1.39e-1)" "unprognostic (3.46e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (5.20e-2)" "unprognostic (2.62e-1)" "unprognostic (2.11e-1)" "unprognostic (3.21e-4)" "unprognostic (3.45e-1)" 0.0 0.0 0.0 0.8 0.0 0.0 7.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.9 0.0 1.8 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM111B CANP ENSG00000189057 "Family with sequence similarity 111 member B" Q6SJ93 11 59107185-59127412 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Hydrolase, Protease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.0" "Cell type enhanced" "Detected in many" "B-cells: 12.8;Erythroid cells: 9.1;Plasma cells: 8.8;Squamous epithelial cells: 7.1;Undifferentiated cells: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "memory B-cell: 3.3;naive B-cell: 2.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038637 Uncertain Approved Nucleoplasm,Cytosol No Yes "Cluster 37: B-cells - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm Cytosol "HPA038637: AB_10672522" "unprognostic (2.31e-1)" "unprognostic (2.68e-2)" "unprognostic (1.80e-3)" "unprognostic (6.94e-2)" "unprognostic (1.89e-1)" "unprognostic (1.96e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (1.49e-3)" "unprognostic (1.40e-2)" "unprognostic (4.85e-2)" "prognostic unfavorable (1.17e-5)" "unprognostic (1.01e-2)" "unprognostic (1.24e-5)" "unprognostic (2.94e-2)" "unprognostic (1.80e-1)" "unprognostic (1.20e-3)" "unprognostic (1.24e-1)" 0.9 0.5 0.5 5.9 0.6 4.8 2.7 2.8 1.8 1.0 0.1 5.6 3.4 1.0 0.5 3.4 0.5 0.8 0.3 0.6 1.1 0.4 2.5 1.1 12.3 0.5 1.0 0.2 0.6 0.9 0.0 1.7 0.7 1.0 5.8 1.3 0.8 0.4 0.4 4.4 4.0 2.0 0.1 1.8 3.2 0.8 0.6 18.0 0.9 0.1 13.3 1.7 1.0 2.1 72.6 18.5 26.6 0.4 2.7 4.9 0.3 53.5 26.7 31.2 46.1 38.7 28.0 89.8 35.4 15.7 26.3 54.7 39.5 36.2 55.2 46.8 9.5 9.8 32.3 16.9 0.1 0.3 11.1 1.2 1.2 30.3 2.4 6.0 16.9 24.1 2.8 81.9 37.2 27.3 57.7 0.6 0.3 43.2 21.0 60.1 39.7 34.7 16.8 61.2 5.2 16.9 44.4 50.8 8.7 9.7 56.2 5.0 9.4 24.1 52.4 73.5 49.6 62.6 48.4 0.6 35.0 0.4 35.4 0.2 0.1 0.1 0.1 0.0 0.1 3.3 0.2 0.3 0.1 2.6 0.1 0.1 1.6 0.0 0.1 0.1 0.7 0.1 0.5 0.6 2.8 1.8 0.6 1.1 0.5 1.0 0.7 0.1 0.6 2.1 0.7 0.0 0.0 0.0 12.8 4.2 2.2 4.2 1.8 0.0 2.5 4.2 0.3 0.0 1.4 0.0 0.0 1.1 1.4 4.0 0.0 0.8 0.0 0.9 1.6 1.2 0.0 9.1 0.0 0.0 0.4 1.5 3.6 1.9 0.0 6.3 0.0 0.2 3.9 0.0 0.0 4.4 2.0 0.3 1.6 0.0 0.0 2.4 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.6 1.3 0.0 8.8 0.7 0.5 0.1 1.6 0.0 0.0 1.3 1.8 0.1 1.0 7.1 2.7 0.1 3.2 1.1 10.4 1.6 FAM111A "FLJ22794, KIAA1895" ENSG00000166801 "Family with sequence similarity 111 member A" Q96PZ2 11 59142748-59155039 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction" "DNA-binding, Hydrolase, Protease" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 83.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039529, HPA040176" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli fibrillar center" "HPA039529: AB_10795149, HPA040176: AB_10793958" "unprognostic (4.12e-3)" "unprognostic (8.47e-2)" "unprognostic (7.80e-3)" "unprognostic (1.00e-1)" "unprognostic (1.81e-1)" "unprognostic (2.41e-1)" "unprognostic (5.83e-3)" "unprognostic (1.81e-1)" "unprognostic (9.88e-2)" "unprognostic (5.96e-2)" "unprognostic (2.74e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (1.15e-5)" "unprognostic (2.66e-2)" "unprognostic (1.79e-1)" "unprognostic (1.76e-2)" "prognostic favorable (4.39e-4)" 14.8 18.9 7.0 23.1 7.0 20.3 16.0 6.7 9.6 20.8 12.9 17.1 22.5 13.8 17.3 12.8 16.5 18.7 11.6 6.6 7.6 23.7 17.9 25.2 36.1 9.0 7.7 14.6 15.0 16.9 14.3 19.5 8.1 33.2 19.3 9.1 19.0 10.7 5.5 18.8 27.6 10.9 7.8 42.5 22.5 7.1 8.2 42.3 26.6 4.1 30.1 14.8 17.4 8.4 66.0 16.2 7.9 7.5 16.9 21.4 5.1 91.6 50.8 38.5 56.3 24.9 59.0 94.3 37.1 29.7 51.2 21.9 26.9 40.4 47.4 86.0 1.2 36.3 22.7 7.6 17.8 58.7 45.7 14.5 9.6 36.2 11.1 22.0 37.7 57.2 4.8 76.7 42.2 18.0 85.6 36.9 3.5 19.5 17.5 59.9 28.7 22.8 25.4 57.6 0.2 2.3 48.6 38.5 17.5 4.1 80.1 24.7 37.0 61.9 55.5 42.5 42.7 39.0 43.4 15.3 34.3 39.5 75.9 6.0 5.0 4.8 4.2 3.4 5.3 2.6 2.7 3.2 4.6 2.6 2.4 2.5 5.4 5.0 1.9 1.2 3.1 2.2 7.0 7.0 6.7 9.6 6.6 7.6 9.0 7.7 8.1 7.8 8.2 8.4 38.9 64.1 43.7 14.4 27.4 8.5 10.7 21.3 26.2 1.7 24.2 24.3 5.5 14.3 24.7 16.5 0.0 11.1 40.5 20.8 9.8 13.8 0.2 31.5 26.0 25.9 6.0 42.5 0.2 7.7 1.4 22.7 30.5 20.7 27.8 83.9 30.0 8.1 28.2 0.0 0.2 24.8 22.4 31.3 19.5 1.8 13.1 39.2 7.2 21.5 40.2 25.2 47.4 12.1 3.9 7.5 17.6 6.8 29.7 14.2 19.4 10.3 36.9 7.3 0.0 17.0 14.3 0.4 2.1 24.3 8.8 4.4 41.3 48.8 18.6 14.0 DTX4 "KIAA0937, RNF155" ENSG00000110042 "Deltex E3 ubiquitin ligase 4" Q9Y2E6 11 59171430-59208588 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 50.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 33.6;Oligodendrocytes: 33.9" "Cancer enhanced" "Detected in all" "thyroid cancer: 63.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 62.8;CACO-2: 34.5;CAPAN-2: 37.7;OE19: 35.4;RT4: 95.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056760, HPA059294" Approved Approved Vesicles NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 15: RT4 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "HPA056760: AB_2683228, HPA059294: AB_2683969" "unprognostic (3.23e-2)" "unprognostic (1.57e-1)" "unprognostic (1.10e-2)" "unprognostic (4.98e-2)" "unprognostic (4.97e-2)" "unprognostic (5.03e-1)" "unprognostic (2.92e-1)" "unprognostic (1.06e-1)" "unprognostic (3.75e-1)" "unprognostic (1.14e-1)" "unprognostic (5.69e-2)" "unprognostic (3.04e-1)" "prognostic unfavorable (8.94e-4)" "unprognostic (5.51e-2)" "unprognostic (2.51e-1)" "prognostic favorable (5.81e-4)" "unprognostic (2.57e-3)" 10.4 1.9 13.9 5.5 21.2 9.3 9.5 21.4 20.0 8.0 8.2 17.5 16.4 3.8 1.9 4.7 5.8 4.9 3.2 13.2 21.2 8.5 32.5 18.1 5.3 30.2 22.4 15.0 7.9 1.0 4.1 14.8 27.0 7.5 17.2 10.4 21.7 3.1 1.4 3.9 14.4 2.5 33.5 6.7 11.6 1.7 25.6 1.5 10.2 1.7 6.5 15.0 3.9 50.5 4.8 5.7 30.5 0.6 8.5 0.5 62.8 0.4 2.7 0.3 0.4 34.5 37.7 11.6 2.1 0.7 1.2 16.5 9.5 11.8 0.1 0.8 0.5 0.1 6.6 11.2 2.4 0.9 2.3 1.4 19.3 0.1 0.5 2.1 0.0 2.1 0.1 1.1 1.4 2.7 0.5 0.1 16.1 35.4 1.5 4.1 27.1 1.3 2.6 95.2 0.0 0.1 24.3 6.4 0.8 7.7 4.9 0.5 0.3 0.1 4.9 0.1 0.0 0.4 0.1 1.1 0.2 2.8 2.6 0.7 0.4 0.4 0.0 0.4 0.0 1.0 0.0 0.0 0.6 1.3 0.0 0.0 1.5 0.0 0.2 2.8 0.0 0.1 13.9 21.2 21.4 20.0 13.2 21.2 30.2 22.4 27.0 33.5 25.6 50.5 8.9 19.2 16.8 9.4 3.1 1.7 3.2 7.9 2.2 2.0 2.9 3.9 1.4 28.6 21.8 7.3 0.0 15.0 6.9 33.6 0.0 10.2 0.4 1.5 8.1 3.6 4.9 0.0 12.0 4.9 19.2 7.2 12.2 3.0 1.3 4.9 5.7 23.1 3.7 0.0 8.4 10.5 2.0 2.5 2.5 0.4 4.1 2.7 5.4 3.7 0.9 30.3 0.0 7.5 33.9 10.8 16.3 3.4 0.0 3.1 19.8 9.1 14.9 2.0 0.0 22.1 3.6 0.4 1.7 1.8 1.3 5.5 1.2 5.9 18.5 22.5 MPEG1 MPG1 ENSG00000197629 "Macrophage expressed 1" Q2M385 11 59208510-59212927 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 207.4" "Group enriched" "Detected in some" 4 "dendritic cells: 156.0;Kupffer cells: 409.8;Macrophages: 174.6;monocytes: 218.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 290.5;intermediate monocyte: 209.9;myeloid DC: 144.7;non-classical monocyte: 245.2;plasmacytoid DC: 204.9" "Group enriched" "Detected in many" 6 "dendritic cells: 204.9;monocytes: 290.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA046801 Approved "Secreted to blood" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "HPA046801: AB_2679814" "unprognostic (1.24e-1)" "unprognostic (2.17e-3)" "unprognostic (1.05e-2)" "unprognostic (2.00e-2)" "unprognostic (3.38e-2)" "unprognostic (2.79e-3)" "unprognostic (7.82e-2)" "unprognostic (1.41e-2)" "unprognostic (6.23e-2)" "unprognostic (2.76e-1)" "unprognostic (5.48e-2)" "unprognostic (3.51e-1)" "unprognostic (1.48e-1)" "unprognostic (9.38e-2)" "unprognostic (2.48e-2)" "unprognostic (1.76e-1)" "unprognostic (5.86e-2)" 29.2 15.8 1.5 112.4 1.6 21.3 13.5 1.7 2.4 11.6 3.2 32.9 40.9 10.9 3.7 12.6 6.9 36.2 10.3 1.4 2.1 6.0 41.1 35.4 96.3 3.3 1.9 4.9 4.6 4.6 1.6 35.8 2.5 8.0 43.4 0.3 7.3 9.3 3.9 7.1 52.8 28.2 2.9 207.4 19.2 4.5 4.0 42.8 5.9 8.3 75.2 42.7 2.1 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 290.5 8.4 0.5 209.9 0.5 12.6 0.3 0.2 144.7 14.0 0.2 0.1 38.5 1.2 245.2 204.9 0.6 214.5 1.5 1.6 1.7 2.4 1.4 2.1 3.3 1.9 2.5 2.9 4.0 4.0 0.7 0.0 7.9 0.0 33.8 1.1 0.0 0.0 1.2 0.0 0.3 0.9 1.7 1.5 0.6 0.0 0.0 0.3 156.0 0.1 0.0 0.0 0.2 0.0 0.1 1.7 0.0 4.4 0.0 0.0 0.6 0.8 0.5 0.1 2.5 0.0 4.6 3.7 52.4 0.0 0.0 0.0 0.0 409.8 48.0 0.6 0.0 174.6 1.8 10.3 218.2 0.2 7.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.7 0.7 0.1 6.6 0.7 0.4 0.0 0.0 0.3 1.6 0.3 2.7 0.0 0.0 0.1 OR5AN1 ENSG00000176495 "Olfactory receptor family 5 subfamily AN member 1" Q8NGI8 11 59358895-59371714 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 4: Macrophages - Innate immune response" 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5A2 ENSG00000172324 "Olfactory receptor family 5 subfamily A member 2" Q8NGI9 11 59416969-59426413 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HDLM-2: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047135, HPA049575" Uncertain NA NA "Cluster 6: Brain - Smell perception" "Cluster 44: HDLM-2 - Immune response" "HPA047135: AB_2679948, HPA049575: AB_2680820" 0.2 0.2 0.8 0.3 0.6 0.8 0.2 1.7 1.1 0.1 0.0 0.2 0.3 0.4 0.4 0.1 0.2 0.2 0.2 0.7 1.2 0.2 0.3 0.2 0.4 0.6 0.2 0.2 0.3 0.1 0.0 0.1 0.7 0.2 0.2 1.1 0.3 0.2 0.4 0.5 0.4 0.1 0.1 0.5 0.2 0.5 0.7 0.2 0.3 0.1 0.2 0.1 0.0 1.2 0.2 0.2 0.4 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.2 0.3 0.1 0.1 0.2 0.3 0.4 0.0 0.2 1.4 0.2 0.3 0.7 0.3 0.0 0.2 0.6 0.1 0.1 0.0 0.1 0.2 0.0 0.5 0.3 0.7 0.0 0.2 0.2 0.3 0.5 0.1 0.1 0.5 0.3 0.2 0.1 0.3 0.3 0.1 0.2 0.1 0.4 0.4 0.2 0.2 0.3 0.1 0.3 0.4 0.1 0.6 0.4 0.2 0.2 0.6 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.0 0.8 0.6 1.7 1.1 0.7 1.2 0.6 0.2 0.7 0.1 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5A1 "OR5A1P, OST181" ENSG00000172320 "Olfactory receptor family 5 subfamily A member 1" Q8NGJ0 11 59436469-59451380 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 6: Brain - Smell perception" "unprognostic (1.73e-2)" 0.1 0.2 0.6 0.2 0.8 0.7 0.1 1.8 1.6 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.8 0.1 0.0 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.0 0.0 0.1 0.3 0.1 0.1 0.9 0.2 0.0 0.2 0.5 0.1 0.0 0.0 0.2 0.1 0.4 0.4 0.0 0.2 0.0 0.1 0.0 0.0 1.4 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.6 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.7 0.0 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.3 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.8 1.8 1.6 0.8 0.1 0.1 0.2 0.3 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 OR4D6 ENSG00000166884 "Olfactory receptor family 4 subfamily D member 6" Q8NGJ1 11 59456938-59457991 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.96e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D10 "OR4D10P, OST711" ENSG00000254466 "Olfactory receptor family 4 subfamily D member 10" Q8NGI6 11 59473315-59479361 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 11 "thyroid cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.59e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D11 OR4D11P ENSG00000176200 "Olfactory receptor family 4 subfamily D member 11" Q8NGI4 11 59503576-59504511 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D9 ENSG00000172742 "Olfactory receptor family 4 subfamily D member 9" Q8NGE8 11 59511368-59520703 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 2.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.7;Collecting duct cells: 1.8;granulocytes: 1.3" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 2.0" "Immune cell enhanced" "Detected in some" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 11: Alveolar cells - Smell perception" 0.0 0.1 0.4 0.2 0.4 0.9 0.1 2.0 0.7 0.0 0.3 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.3 0.2 0.0 0.2 0.4 0.2 0.0 0.0 0.2 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.7 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.5 0.0 0.2 0.1 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.1 0.2 0.1 0.2 0.2 1.4 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.2 0.2 1.2 0.4 0.1 0.2 0.1 0.2 0.4 0.4 2.0 0.7 0.4 0.1 0.1 0.0 0.2 0.0 0.2 0.7 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 OSBP OSBP1 ENSG00000110048 "Oxysterol binding protein" P22059 11 59574398-59615774 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039227, HPA043625" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 70000 "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039227: AB_2676401, HPA043625: AB_2678587" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "prognostic favorable (2.08e-5)" "unprognostic (7.80e-3)" "unprognostic (7.32e-2)" "unprognostic (2.79e-2)" "unprognostic (2.13e-1)" "unprognostic (1.49e-2)" "unprognostic (3.34e-1)" "unprognostic (7.42e-2)" "unprognostic (1.42e-3)" "unprognostic (1.22e-1)" "prognostic favorable (3.08e-7)" "unprognostic (1.25e-1)" "unprognostic (9.00e-2)" "unprognostic (1.93e-1)" "unprognostic (2.67e-1)" 19.6 41.7 14.1 15.5 15.2 27.2 27.4 15.3 18.9 24.7 18.4 26.8 29.4 20.0 31.6 19.6 22.4 19.5 25.5 15.0 15.6 42.8 57.6 18.5 17.8 15.4 16.7 22.4 37.3 44.9 16.1 22.9 16.7 25.9 28.3 15.9 30.1 27.0 57.7 26.6 25.5 21.2 14.0 15.6 27.8 18.0 15.7 24.0 32.3 43.8 23.7 19.6 17.1 15.1 40.9 33.6 24.7 33.2 56.5 52.4 26.8 32.9 42.3 38.4 34.4 38.1 40.2 41.1 42.7 37.9 47.2 41.4 45.4 43.5 43.0 40.0 20.9 28.1 25.1 25.8 60.2 36.2 52.9 40.4 52.8 36.2 94.4 40.0 41.7 38.3 48.6 37.3 34.5 19.0 34.0 26.2 28.0 59.5 32.7 32.5 39.8 28.6 45.6 47.0 28.5 20.3 38.6 47.7 46.0 33.6 66.9 22.7 45.8 32.7 22.8 49.5 22.3 51.9 45.2 41.4 37.0 25.6 26.8 1.7 1.6 1.5 2.8 1.4 2.6 2.2 2.9 2.3 1.6 1.6 2.6 2.1 1.5 2.2 1.3 4.0 1.3 1.1 14.1 15.2 15.3 18.9 15.0 15.6 15.4 16.7 16.7 14.0 15.7 15.1 29.2 25.6 9.0 14.7 18.9 39.6 16.4 13.7 29.6 23.8 38.0 27.1 34.1 32.9 19.0 27.6 22.9 14.2 31.1 34.0 7.9 14.0 8.8 37.9 52.7 21.8 30.0 10.5 25.6 18.6 14.7 21.1 22.4 43.8 27.9 21.8 15.4 67.1 16.0 26.9 22.9 40.0 8.2 12.9 16.9 14.5 15.8 17.9 14.2 12.2 9.6 15.7 18.6 18.1 23.3 20.2 20.5 19.9 32.2 31.2 34.6 21.0 27.8 21.7 6.6 28.4 19.3 25.1 14.5 27.0 47.3 30.8 20.0 43.5 28.4 26.4 PATL1 "FLJ36874, Pat1b" ENSG00000166889 "PAT1 homolog 1, processing body mRNA decay factor" Q86TB9 11 59636716-59669037 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039030, HPA074680" Approved Supported "Cytoplasmic bodies" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 44: Endometrium - Transcription" "Cytoplasmic bodies" "HPA039030: AB_10673232, HPA074680: " "unprognostic (3.00e-2)" "unprognostic (1.17e-1)" "prognostic favorable (4.56e-4)" "unprognostic (3.93e-3)" "unprognostic (3.03e-2)" "unprognostic (5.26e-2)" "unprognostic (6.37e-3)" "unprognostic (6.74e-3)" "unprognostic (2.16e-1)" "unprognostic (7.34e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (3.86e-2)" "unprognostic (4.54e-2)" "unprognostic (3.64e-2)" "unprognostic (3.04e-2)" "unprognostic (6.99e-2)" "unprognostic (2.18e-1)" 18.6 17.3 10.1 18.9 11.7 56.6 16.5 11.9 11.8 19.0 12.4 17.5 22.4 18.7 11.6 19.1 14.5 14.6 15.7 9.5 11.3 16.5 33.1 21.4 20.3 12.0 11.1 19.2 11.1 14.2 8.6 21.9 12.4 12.0 20.8 23.5 15.8 12.1 40.8 19.0 19.1 18.5 10.7 18.8 16.8 12.5 11.9 20.3 14.6 32.9 23.7 20.0 18.1 14.0 57.7 44.2 31.9 31.4 30.7 34.3 27.6 37.4 63.8 66.1 66.1 28.7 49.4 56.3 35.6 40.4 64.0 42.1 46.6 45.0 70.4 49.4 21.4 32.4 21.3 28.6 110.1 43.0 69.2 38.9 33.9 56.7 77.3 31.8 32.1 34.2 40.5 44.5 37.9 26.7 41.7 39.1 32.5 41.8 28.9 33.6 53.2 24.2 41.1 52.9 22.8 22.0 52.7 39.1 64.9 26.7 55.6 31.5 31.3 43.0 39.4 75.5 33.5 45.4 53.8 47.6 51.8 35.5 36.1 1.9 2.4 3.4 2.7 2.8 2.2 2.0 2.1 2.4 2.3 1.4 2.0 2.0 3.4 1.6 2.9 1.4 1.9 1.5 10.1 11.7 11.9 11.8 9.5 11.3 12.0 11.1 12.4 10.7 11.9 14.0 13.8 3.2 15.9 10.4 24.1 27.0 18.9 15.8 27.3 10.5 12.7 9.8 13.0 18.6 17.6 11.0 0.0 11.1 16.2 21.7 13.7 14.0 11.8 16.9 21.8 17.6 13.7 12.6 10.7 18.2 14.0 13.2 13.7 28.6 23.4 10.8 10.4 34.5 24.0 6.7 11.2 16.3 2.0 30.8 36.3 4.2 10.8 24.6 10.6 13.1 29.6 7.9 15.5 16.1 18.1 22.8 13.7 9.4 17.4 21.3 16.4 9.4 13.8 10.8 6.6 13.4 12.1 12.0 9.1 25.0 34.1 12.7 18.8 10.1 16.1 19.3 OR10V1 ENSG00000172289 "Olfactory receptor family 10 subfamily V member 1" Q8NGI7 11 59712916-59713845 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA060076 Uncertain NA NA "HPA060076: AB_2684198" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STX3 STX3A ENSG00000166900 "Syntaxin 3" Q13277 11 59713456-59805882 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "retina: 313.2" "Cell type enhanced" "Detected in all" "Bipolar cells: 373.0;Cone photoreceptor cells: 394.0;Rod photoreceptor cells: 400.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 42.5;eosinophil: 74.1;neutrophil: 60.7" "Lineage enriched" "Detected in many" 10 "granulocytes: 74.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 167.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002191, HPA069176" Approved Approved "Nuclear membrane,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 3: HMC-1 - Innate immune response" "Cluster 9: Photoreceptor cells - Phototransduction" Vesicles "Nuclear membrane" "HPA002191: AB_1080165, HPA069176: AB_2686098" "unprognostic (2.24e-2)" "unprognostic (1.97e-2)" "unprognostic (7.96e-3)" "unprognostic (1.02e-1)" "unprognostic (2.84e-2)" "unprognostic (2.36e-3)" "prognostic unfavorable (8.41e-7)" "unprognostic (1.64e-1)" "unprognostic (3.00e-1)" "unprognostic (7.71e-3)" "unprognostic (2.07e-2)" "unprognostic (5.55e-2)" "prognostic favorable (1.14e-6)" "unprognostic (1.06e-1)" "unprognostic (2.85e-1)" "unprognostic (4.02e-2)" "unprognostic (1.17e-2)" 16.4 24.1 10.1 23.7 11.8 59.2 20.1 18.3 14.6 21.1 11.8 51.0 59.5 29.7 36.7 21.4 15.1 39.1 16.4 10.8 11.2 58.6 15.4 40.7 9.7 11.7 11.9 18.7 24.0 34.1 19.4 50.3 13.4 20.2 56.3 313.2 21.6 24.6 10.9 26.2 44.1 26.4 9.7 23.4 47.5 22.1 12.4 7.4 27.8 17.9 13.8 28.3 18.3 13.1 40.1 23.8 0.9 11.0 20.5 11.5 33.1 21.1 37.7 49.4 61.0 109.4 38.2 11.2 38.9 16.1 85.6 44.0 63.5 22.0 59.4 9.6 12.0 12.7 16.4 34.0 51.1 41.7 116.4 21.0 46.6 38.3 46.2 30.5 39.7 16.6 110.5 23.0 21.5 23.8 0.4 28.9 60.1 63.1 18.2 14.5 40.8 18.6 92.7 94.5 27.0 41.4 9.0 48.0 167.2 79.9 52.1 29.0 54.0 20.8 44.0 28.6 19.3 25.8 49.4 22.8 27.8 27.0 29.0 42.5 6.3 74.1 2.4 1.9 2.5 1.0 3.3 1.6 7.1 3.1 3.0 0.9 60.7 0.5 1.2 1.0 0.0 2.7 10.1 11.8 18.3 14.6 10.8 11.2 11.7 11.9 13.4 9.7 12.4 13.1 17.0 67.3 30.6 2.6 9.5 50.7 69.5 12.8 30.1 373.0 43.5 15.2 10.2 31.5 18.9 11.0 394.0 10.1 5.9 124.6 17.6 40.2 4.8 37.8 9.6 30.2 26.3 4.4 40.4 25.6 15.9 12.8 29.6 68.5 58.2 14.9 20.7 5.6 16.0 72.3 33.0 36.5 18.3 18.9 49.7 7.5 3.7 26.4 37.4 24.4 28.7 48.4 11.3 3.5 25.3 48.9 64.1 7.5 5.8 87.2 34.0 69.5 13.3 400.3 6.6 10.0 15.9 4.6 20.6 29.4 60.1 40.5 17.9 5.6 26.5 87.7 MRPL16 "FLJ20484, PNAS-111" ENSG00000166902 "Mitochondrial ribosomal protein L16" Q9NX20 11 59806140-59810778 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 248.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054133 Supported NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 39: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 39: Non-specific - Basic cellular processes" "HPA054133: AB_2682394" "prognostic favorable (1.04e-4)" "unprognostic (1.13e-1)" "unprognostic (3.45e-3)" "unprognostic (5.88e-2)" "unprognostic (2.08e-1)" "unprognostic (5.40e-2)" "unprognostic (1.78e-1)" "unprognostic (1.59e-1)" "unprognostic (1.20e-1)" "unprognostic (2.40e-3)" "unprognostic (1.50e-3)" "unprognostic (2.67e-2)" "unprognostic (2.87e-3)" "unprognostic (3.01e-2)" "unprognostic (1.23e-1)" "unprognostic (6.38e-2)" "unprognostic (2.01e-2)" 35.2 61.4 44.1 29.6 44.7 57.0 34.6 45.6 54.7 30.4 45.4 49.7 42.1 32.7 23.1 33.7 29.0 20.6 85.7 44.2 45.3 51.2 78.3 25.6 44.3 43.4 44.0 31.5 38.6 56.1 23.0 29.8 43.8 25.3 48.3 21.4 43.2 28.8 85.8 24.6 34.7 36.3 44.5 41.6 44.3 34.1 45.3 50.7 20.7 103.5 46.0 29.4 25.7 44.8 76.3 75.4 53.4 50.1 74.9 59.1 48.0 52.1 68.9 93.9 80.1 75.1 79.5 174.0 87.0 68.2 50.3 72.8 178.0 96.9 84.0 58.9 89.5 92.7 69.9 89.5 57.8 139.4 55.1 71.1 52.4 78.8 56.4 54.5 92.4 112.6 278.4 51.2 70.9 150.6 97.8 224.1 84.1 89.8 124.2 85.4 78.6 91.1 137.2 103.3 50.2 34.9 83.4 83.8 134.3 49.4 100.1 132.0 46.3 36.9 50.7 77.4 63.7 57.9 69.8 240.7 44.9 88.1 40.8 80.8 95.1 72.9 87.4 118.1 91.0 118.7 96.5 91.5 116.1 121.2 102.8 91.4 18.1 116.8 94.5 166.9 108.2 149.7 44.1 44.7 45.6 54.7 44.2 45.3 43.4 44.0 43.8 44.5 45.3 44.8 44.3 48.1 31.4 10.4 43.6 31.9 19.7 87.9 34.1 9.9 29.4 47.0 146.1 31.5 42.6 42.3 12.5 94.2 45.9 35.5 248.4 47.9 18.0 28.5 41.5 41.0 34.1 64.8 9.0 53.4 74.1 46.7 46.9 28.5 61.4 104.6 35.7 73.6 75.3 8.4 10.9 67.7 46.8 45.6 24.4 11.8 39.7 34.5 44.4 10.3 54.4 45.4 42.2 9.5 8.0 43.0 42.2 37.6 66.0 19.4 65.6 125.2 44.0 17.0 72.3 34.1 53.1 54.8 46.5 64.4 36.8 28.5 34.9 120.3 82.2 22.3 CBLIF "GIF, IF, IFMH, INF, TCN3" ENSG00000134812 "Cobalamin binding intrinsic factor" P27352 11 59829273-59845499 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins" "Cobalt transport, Ion transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1859 "stomach 1: 1575.7" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 11 "stomach cancer: 10.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039908, HPA040774" Enhanced "Secreted to digestive system" NA NA "Cluster 4: Stomach - Digestion" "HPA039908: AB_10796335, HPA040774: AB_10795626" "unprognostic (2.78e-4)" "unprognostic (1.04e-1)" "unprognostic (2.45e-1)" "unprognostic (3.59e-1)" "unprognostic (1.66e-1)" 0.8 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.7 0.6 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1575.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCN1 "TC1, TCI" ENSG00000134827 "Transcobalamin 1" P20061 11 59852800-59866489 "Plasma proteins, Predicted secreted proteins" "Cobalt transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "salivary gland: 776.3" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 52.0;Cholangiocytes: 62.9;Club cells: 94.9;Exocrine glandular cells: 372.3;Glandular and luminal cells: 84.7;Urothelial cells: 61.0" "Cancer enriched" "Detected in many" 4 "pancreatic cancer: 124.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 149 "basophil: 2374.2" "Lineage enriched" "Detected in many" 1592 "granulocytes: 2374.2" "Cell line enriched" "Detected in some" 21 "OE19: 159.0" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 4000000 "Cluster 18: Basophils - Vesicular transport" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 21: OE19 - Mitochondria" "Cluster 1: Pancreatic cells - Digestion" "prognostic favorable (1.90e-4)" "unprognostic (1.17e-1)" "unprognostic (5.89e-2)" "unprognostic (3.61e-3)" "unprognostic (2.49e-2)" "unprognostic (5.28e-3)" "unprognostic (4.52e-3)" "unprognostic (3.11e-3)" "unprognostic (1.13e-1)" "unprognostic (7.56e-2)" "unprognostic (9.07e-3)" "unprognostic (3.88e-1)" "prognostic unfavorable (1.56e-8)" "unprognostic (2.50e-1)" "unprognostic (8.80e-2)" "unprognostic (1.40e-1)" "unprognostic (3.76e-2)" 0.1 0.2 0.0 0.7 0.0 190.7 5.4 0.0 0.2 31.7 0.0 0.2 9.6 3.1 0.0 23.0 1.4 173.8 0.1 0.0 0.0 0.1 0.4 1.4 0.3 0.0 0.0 0.0 5.3 108.5 0.2 0.5 0.0 1.2 0.8 0.0 776.3 0.0 0.1 0.9 1.0 0.0 0.0 4.5 76.3 0.3 0.0 1.3 0.0 0.0 0.9 15.5 10.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 2.2 0.0 0.8 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.0 159.0 7.5 0.0 0.2 0.0 1.5 0.0 0.0 0.0 7.3 0.0 1.6 0.0 0.0 3.0 0.1 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 2374.2 0.0 0.3 0.0 0.1 0.2 0.2 0.3 0.0 0.2 0.1 0.2 0.4 15.9 0.1 1.4 0.1 0.3 4.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 19.2 52.0 0.0 0.0 21.9 4.2 0.2 62.9 94.9 23.9 0.0 0.0 0.5 0.3 0.0 23.7 0.4 2.2 8.0 0.4 0.0 0.0 0.1 372.3 0.0 0.1 3.6 84.7 0.0 0.0 0.0 0.3 0.2 0.0 0.1 1.2 12.2 0.6 0.3 0.0 0.3 0.9 0.0 0.0 0.7 0.0 0.0 0.5 0.0 46.5 0.0 0.0 0.1 5.0 0.0 0.3 11.7 0.0 0.0 0.0 2.5 0.0 0.0 6.0 0.1 0.0 0.5 0.0 0.2 61.0 OOSP3 ENSG00000285231 "Oocyte secreted protein family member 3" A0A2R8YFM6 11 59878809-59896481 "Predicted secreted proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 33 "basophil: 5.5" "Lineage enriched" "Detected in single" 55 "granulocytes: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "Cluster 41: Basophils - Cellular respiration" 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 5.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OOSP1 ENSG00000284873 "Oocyte secreted protein 1" 11 59938432-59957480 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Excitatory neurons: 2.2;Inhibitory neurons: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "THP-1: 1.2" "Not detected" "Not detected" NA NA "Cluster 43: THP-1 - Innate immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OOSP4A ENSG00000285010 "Oocyte secreted protein family member 4A" A0A2R8YFL7 11 59964033-59970146 "Predicted secreted proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 12 "basophil: 4.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 4.1" "Group enriched" "Detected in some" 5 "HEL: 1.0;K-562: 2.6" "Secreted - unknown location" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 1: K-562 - Erythropoiesis" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.2 0.2 0.1 0.2 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OOSP4B ENSG00000255393 "Oocyte secreted protein family member 4B" A0A2R8Y4Y8 11 59978020-60031077 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted - unknown location" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OOSP2 "FLJ36198, OOSP2A, PLAC1L, TMEM122" ENSG00000149507 "Oocyte secreted protein 2" Q86WS3 11 60040409-60048044 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 180 "testis: 18.0" "Cell type enriched" "Detected in some" 5 "Late spermatids: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA050914 Enhanced "Secreted in male reproductive system" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 74: Testis - Spermatogenesis" "Cluster 31: Spermatids - Spermatogenesis" "HPA050914: AB_2681271" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A3 "CD20L, HTM4" ENSG00000149516 "Membrane spanning 4-domains A3" Q96HJ5 11 60056587-60071115 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 93 "bone marrow: 420.2" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 19.7" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 1478 "basophil: 2686.3" "Lineage enriched" "Detected in single" 4507 "granulocytes: 2686.3" "Cell line enhanced" "Detected in some" "HEL: 48.9;K-562: 94.2;NB-4: 109.8;THP-1: 319.0;U-937: 126.2" "Not detected" "Not detected" HPA019210 Supported Approved "Golgi apparatus" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA019210: AB_1854134" "unprognostic (6.37e-3)" "unprognostic (1.25e-1)" "unprognostic (2.67e-1)" "unprognostic (3.77e-1)" 0.1 0.0 0.0 0.3 0.0 420.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 4.5 0.0 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 48.9 0.0 0.0 0.0 17.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.2 0.0 0.0 0.0 0.0 109.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 319.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 126.2 0.0 2686.3 0.1 1.8 0.1 0.1 0.3 0.2 0.4 0.0 0.3 0.2 0.2 0.4 0.9 0.1 0.5 0.2 0.1 8.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 19.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.3 0.0 0.0 0.8 0.0 3.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 MS4A2 "APY, FCER1B, IGER, MS4A1" ENSG00000149534 "Membrane spanning 4-domains A2" Q01362 11 60088261-60098467 "FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "IgE-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 12.6" "Cell type enriched" "Detected in some" 20 "granulocytes: 967.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 908 "basophil: 275.5" "Lineage enriched" "Detected in single" 1467 "granulocytes: 275.5" "Cell line enhanced" "Detected in some" "HEL: 2.7;THP-1: 1.3" "Not detected" "Not detected" "Region enhanced" "Detected in all" "spinal cord: 15.3" HPA059967 Enhanced NA NA "Cluster 38: Basophils - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 36: HEL - Hemostasis" "Cluster 60: Granulocytes - Receptor signaling" "HPA059967: AB_2684183" "unprognostic (7.28e-2)" "unprognostic (9.21e-2)" "unprognostic (2.50e-4)" "unprognostic (4.97e-2)" "unprognostic (4.47e-1)" "unprognostic (2.40e-6)" "unprognostic (1.88e-2)" "unprognostic (6.21e-3)" "unprognostic (3.96e-1)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (6.63e-3)" "unprognostic (6.49e-3)" "unprognostic (9.95e-2)" "unprognostic (4.03e-2)" "unprognostic (1.57e-1)" "unprognostic (1.74e-1)" 2.6 0.2 0.3 2.4 0.3 0.9 2.7 0.5 0.5 6.3 0.6 4.9 5.5 4.2 3.7 4.8 0.9 8.2 0.6 0.3 0.3 0.5 0.4 12.6 1.1 0.4 0.3 0.1 0.5 0.3 0.1 0.3 0.4 3.0 5.4 0.0 1.8 2.4 2.9 2.5 6.7 4.1 0.3 0.2 5.3 1.0 0.3 1.2 0.1 1.2 1.8 3.8 2.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 275.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.4 0.3 0.3 0.5 0.5 0.3 0.3 0.4 0.3 0.4 0.3 0.3 0.5 0.1 0.0 30.9 0.0 0.3 0.0 0.9 0.0 0.0 0.3 0.1 0.1 0.5 0.0 6.8 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.4 0.1 0.1 0.3 0.0 46.7 0.1 0.0 0.1 1.1 0.0 0.1 967.4 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.0 0.0 0.7 0.4 0.0 0.7 0.2 0.1 0.1 0.0 0.0 0.0 12.2 0.0 0.0 0.2 MS4A6A "CD20L3, MS4A6" ENSG00000110077 "Membrane spanning 4-domains A6A" Q9H2W1 11 60172014-60184666 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 580.8;Hofbauer cells: 376.8;Kupffer cells: 1649.6;Langerhans cells: 470.0;Macrophages: 675.9;monocytes: 429.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "basophil: 406.4;classical monocyte: 1095.3;intermediate monocyte: 345.6;myeloid DC: 638.8;plasmacytoid DC: 454.4" "Group enriched" "Detected in all" 74 "dendritic cells: 638.8;granulocytes: 406.4;monocytes: 1095.3" "Cell line enriched" "Detected in some" 8 "THP-1: 47.9" "HPA011391, HPA076623" Approved Approved Vesicles NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" Vesicles "HPA011391: AB_10603876, HPA076623: AB_2686809" "unprognostic (1.17e-1)" "prognostic favorable (6.33e-4)" "unprognostic (2.35e-2)" "unprognostic (1.21e-2)" "unprognostic (1.00e-1)" "unprognostic (8.51e-2)" "unprognostic (2.33e-1)" "unprognostic (3.75e-2)" "unprognostic (3.61e-1)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (3.20e-1)" "unprognostic (4.75e-3)" "unprognostic (1.06e-1)" "unprognostic (4.66e-2)" "unprognostic (3.94e-2)" "unprognostic (2.97e-2)" 72.6 42.3 10.7 57.5 10.9 33.5 40.0 10.8 22.5 28.1 14.7 41.0 27.8 14.3 9.6 25.7 16.8 61.4 22.8 10.0 11.8 11.5 108.6 56.4 109.1 15.8 13.7 12.3 7.8 8.7 9.8 65.2 14.8 12.4 54.9 1.4 16.0 18.3 5.3 7.3 45.1 52.6 12.4 121.5 24.5 7.8 13.6 32.2 10.0 17.7 47.6 59.9 8.6 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 4.1 0.0 5.7 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 47.9 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 4.1 0.0 406.4 1095.3 8.2 1.6 345.6 3.4 9.6 2.2 1.4 638.8 1.5 1.0 1.0 72.8 2.1 24.4 454.4 1.9 752.8 10.7 10.9 10.8 22.5 10.0 11.8 15.8 13.7 14.8 12.4 13.6 17.6 5.3 6.4 22.9 0.0 16.1 9.3 0.6 0.0 1.2 0.3 2.2 8.0 3.3 17.2 2.5 3.7 0.0 2.0 220.6 0.3 0.0 0.0 2.2 0.4 0.2 12.8 0.0 43.9 0.1 0.0 2.7 4.3 2.6 0.2 13.9 0.1 580.8 20.5 376.8 0.0 0.1 0.1 0.0 1649.6 470.0 5.1 1.5 675.9 14.2 40.3 429.2 0.0 11.3 0.5 0.1 0.0 1.2 0.0 2.0 0.2 0.0 0.5 1.5 0.6 46.0 3.0 4.4 0.5 1.1 2.4 8.0 2.1 10.4 0.1 0.2 0.3 MS4A4A "CD20L1, MS4A4, MS4A7" ENSG00000110079 "Membrane spanning 4-domains A4A" Q96JQ5 11 60185657-60318080 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 63.1" "Group enriched" "Detected in many" 7 "Hofbauer cells: 376.8;Kupffer cells: 445.0;Macrophages: 264.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 61.2;myeloid DC: 27.6;non-classical monocyte: 82.9;plasmacytoid DC: 27.7" "Group enriched" "Detected in many" 30 "dendritic cells: 27.7;monocytes: 82.9" "Cell line enhanced" "Detected in some" "HEL: 35.6;HMC-1: 45.8;K-562: 154.9" HPA029323 Approved NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 1: K-562 - Erythropoiesis" "Cluster 4: Macrophages - Innate immune response" "HPA029323: AB_10601866" "unprognostic (7.93e-2)" "unprognostic (2.05e-2)" "unprognostic (1.37e-3)" "unprognostic (1.98e-1)" "unprognostic (4.46e-2)" "unprognostic (2.31e-1)" "unprognostic (9.66e-2)" "unprognostic (1.59e-1)" "unprognostic (4.56e-1)" "unprognostic (6.65e-2)" "unprognostic (8.10e-2)" "unprognostic (2.11e-1)" "unprognostic (5.02e-3)" "unprognostic (3.32e-2)" "unprognostic (4.66e-2)" "unprognostic (4.89e-2)" "unprognostic (4.21e-2)" 42.8 24.7 3.5 16.5 3.6 6.1 12.3 3.7 8.6 14.1 4.4 14.0 5.2 4.9 3.4 8.9 11.6 25.8 8.4 3.5 3.9 4.8 15.4 28.0 31.3 4.2 3.4 4.1 4.0 3.3 3.3 63.1 3.6 3.4 16.1 2.0 7.6 4.9 2.3 2.9 13.5 20.0 2.5 33.3 6.6 3.0 5.5 11.5 3.7 10.4 7.5 28.0 3.3 4.3 0.3 0.1 0.1 0.6 0.0 0.2 0.7 0.6 0.0 0.2 0.4 0.3 0.9 0.8 0.4 0.0 0.4 0.3 0.5 0.1 0.6 1.6 0.0 35.6 0.7 0.6 0.1 1.2 45.8 0.4 0.3 0.2 0.8 0.2 0.0 0.4 154.9 4.2 0.6 0.7 0.6 0.9 0.7 0.3 0.1 0.7 0.0 2.5 0.1 1.5 0.5 0.5 0.3 0.3 0.1 0.7 0.7 8.9 0.8 1.5 0.6 0.4 0.2 6.0 0.7 0.5 0.2 0.8 0.2 0.1 9.9 0.0 0.1 61.2 0.2 1.0 0.1 0.1 27.6 0.3 0.2 0.1 0.9 1.8 82.9 27.7 0.1 6.0 3.5 3.6 3.7 8.6 3.5 3.9 4.2 3.4 3.6 2.5 5.5 4.3 2.3 0.0 7.9 0.0 3.0 1.8 0.1 0.0 0.6 0.0 0.3 2.2 3.4 2.8 2.5 0.0 0.0 1.8 7.5 0.0 0.0 0.0 0.7 0.0 0.0 5.7 0.0 13.0 0.1 0.0 2.0 1.6 0.0 0.0 7.6 0.0 47.5 4.6 376.8 0.0 0.1 0.0 0.0 445.0 24.9 1.0 0.9 264.6 3.6 10.3 8.3 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 13.1 1.2 1.1 0.1 0.2 0.7 1.8 3.6 1.5 0.1 0.0 0.1 MS4A4E ENSG00000214787 "Membrane spanning 4-domains A4E" Q96PG1 11 60200270-60243137 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "dendritic cells: 1.4;Erythroid cells: 1.3;Kupffer cells: 3.4;Macrophages: 5.4;Microglial cells: 1.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "basophil: 17.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 17.8" "Cell line enhanced" "Detected in many" "HMC-1: 8.1" HPA040075 Uncertain NA NA "Cluster 38: Basophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "HPA040075: AB_10793915" "unprognostic (1.90e-1)" "unprognostic (2.64e-2)" "unprognostic (7.05e-2)" "unprognostic (9.42e-2)" "unprognostic (5.99e-2)" "unprognostic (1.45e-2)" "unprognostic (8.97e-2)" "unprognostic (1.23e-3)" "unprognostic (3.33e-2)" "unprognostic (1.74e-1)" "unprognostic (1.28e-3)" "unprognostic (4.16e-2)" "unprognostic (9.88e-3)" "unprognostic (4.97e-2)" "unprognostic (4.38e-2)" "unprognostic (1.07e-2)" "unprognostic (4.05e-2)" 5.9 4.0 5.4 3.5 5.1 7.7 3.7 8.1 6.7 1.1 6.5 2.8 3.3 1.8 2.8 1.6 1.5 3.0 1.3 6.0 4.7 1.8 5.5 2.9 2.8 5.4 4.1 1.6 1.5 1.3 0.0 1.8 4.6 2.0 2.7 4.5 1.7 1.2 4.4 4.2 4.5 2.9 2.6 4.7 2.7 2.9 5.3 1.1 1.2 0.8 1.9 1.5 0.0 5.8 4.2 1.7 0.9 2.2 0.7 0.4 3.2 1.7 0.2 0.2 0.3 1.2 1.8 1.3 1.7 0.1 1.2 3.4 0.3 0.2 0.3 5.0 1.1 2.3 3.5 2.0 0.6 1.3 8.1 0.5 1.5 0.5 0.7 0.9 0.2 1.8 2.4 4.2 0.2 1.6 1.9 2.6 1.8 2.0 1.3 1.6 1.7 1.8 0.5 2.1 1.3 2.2 4.9 1.8 2.4 2.0 2.4 2.4 1.1 1.7 7.8 4.8 1.6 5.6 4.7 1.9 0.9 2.8 1.5 17.8 1.4 0.2 0.4 1.6 0.3 0.5 0.3 0.2 2.5 0.7 0.3 0.4 2.7 0.9 1.4 1.4 0.2 0.3 5.4 5.1 8.1 6.7 6.0 4.7 5.4 4.1 4.6 2.6 5.3 5.8 0.1 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.0 5.4 0.0 1.9 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A6E ENSG00000166926 "Membrane spanning 4-domains A6E" Q96DS6 11 60334831-60396596 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 35.6" "Cell type enriched" "Detected in some" 10 "Early spermatids: 1211.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA076623 Approved Vesicles NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 29: Early spermatids - Spermatogenesis" Vesicles "HPA076623: AB_2686809" "unprognostic (2.58e-1)" "unprognostic (3.35e-1)" "unprognostic (3.47e-1)" "unprognostic (6.81e-3)" "unprognostic (4.55e-4)" "unprognostic (1.08e-1)" "unprognostic (1.71e-1)" "unprognostic (1.76e-1)" 2.1 0.0 0.0 1.1 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 35.6 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1211.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 114.8 6.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 MS4A7 "CD20L4, CFFM4, MS4A8" ENSG00000166927 "Membrane spanning 4-domains A7" Q9GZW8 11 60378485-60395951 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 196.6" "Cell type enhanced" "Detected in many" "Hofbauer cells: 311.4;Kupffer cells: 1060.3;Macrophages: 567.5;monocytes: 184.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "intermediate monocyte: 747.4;non-classical monocyte: 1486.0" "Lineage enriched" "Detected in many" 12 "monocytes: 1486.0" "Cell line enriched" "Detected in some" 25 "THP-1: 114.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA017418, CAB026387" Approved NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "CAB026387: , HPA017418: AB_1854137" "unprognostic (1.43e-1)" "unprognostic (2.60e-3)" "unprognostic (3.24e-2)" "unprognostic (9.67e-2)" "unprognostic (2.04e-1)" "unprognostic (1.81e-1)" "unprognostic (1.04e-1)" "unprognostic (9.51e-2)" "unprognostic (3.02e-2)" "unprognostic (4.85e-2)" "unprognostic (5.79e-2)" "unprognostic (1.90e-1)" "unprognostic (1.43e-2)" "unprognostic (4.59e-2)" "unprognostic (3.90e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" 46.9 37.6 6.3 50.9 5.0 10.7 30.7 4.5 13.7 18.2 13.9 21.4 17.6 7.6 4.1 12.7 6.6 46.8 9.9 4.2 8.7 8.0 66.5 75.7 23.2 12.8 10.4 6.0 6.0 9.0 4.7 43.9 11.4 4.9 23.3 1.2 6.7 9.0 1.9 2.3 25.1 15.9 7.4 196.6 14.8 4.7 17.1 18.2 7.3 4.1 18.6 41.2 3.9 18.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.5 0.1 0.0 0.1 1.1 0.1 0.1 0.0 2.8 0.0 0.1 0.1 0.8 0.5 0.0 0.0 114.2 0.0 0.1 0.1 0.1 0.1 0.2 0.2 3.0 0.0 3.1 0.0 8.3 188.0 2.5 0.8 747.4 1.1 22.3 0.6 0.5 120.9 19.7 0.8 0.4 9.3 0.8 1486.0 3.2 0.9 137.8 6.3 5.0 4.5 13.7 4.2 8.7 12.8 10.4 11.4 7.4 17.1 18.3 5.0 12.8 31.4 0.0 30.6 2.7 0.8 0.0 0.6 3.6 14.7 9.9 2.1 0.0 3.7 9.2 0.0 1.0 1.4 0.3 0.0 0.0 2.4 0.1 0.0 12.2 0.0 10.1 0.1 0.2 1.7 3.9 1.5 0.1 13.9 0.1 11.0 4.7 311.4 0.0 0.2 0.0 0.0 1060.3 93.4 1.2 1.2 567.5 1.8 59.0 184.8 0.4 4.1 0.0 0.3 0.1 1.1 0.0 1.8 1.1 0.0 0.7 7.3 0.5 19.7 2.2 1.2 0.0 0.4 0.9 1.8 1.9 5.3 0.3 0.1 1.0 MS4A14 "DKFZp434H092, FLJ32856, MS4A16, NYD-SP21" ENSG00000166928 "Membrane spanning 4-domains A14" Q96JA4 11 60378530-60417756 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 73.0" "Group enriched" "Detected in some" 44 "Early spermatids: 262.3;Late spermatids: 672.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 5.5;non-classical monocyte: 8.0" "Lineage enriched" "Detected in many" 5 "monocytes: 8.0" "Cell line enriched" "Detected in single" 23 "THP-1: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA058973 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 78: Testis - Spermatogenesis" "Cluster 43: THP-1 - Innate immune response" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "Plasma membrane" "HPA058973: " "unprognostic (1.78e-1)" "unprognostic (1.76e-1)" "unprognostic (5.75e-2)" "unprognostic (1.77e-1)" "unprognostic (1.27e-1)" "unprognostic (1.79e-2)" "unprognostic (1.24e-1)" "unprognostic (3.45e-2)" "unprognostic (4.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.77e-1)" "unprognostic (2.14e-1)" "unprognostic (4.50e-6)" "unprognostic (3.73e-2)" "unprognostic (7.16e-3)" "unprognostic (8.40e-2)" "unprognostic (7.11e-2)" 5.1 3.7 6.2 3.5 5.6 0.6 3.6 5.8 8.8 1.2 7.5 2.7 0.7 0.9 0.6 0.9 1.3 0.9 2.6 5.8 6.3 1.8 2.0 11.9 1.3 7.7 6.8 0.7 1.3 0.3 1.5 2.4 7.2 1.8 1.1 0.4 1.9 0.5 0.9 0.9 2.7 1.2 6.0 10.4 1.2 73.0 8.5 0.3 1.5 0.3 1.9 2.0 1.2 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 3.4 0.0 0.0 5.5 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.9 6.2 5.6 5.8 8.8 5.8 6.3 7.7 6.8 7.2 6.0 8.5 8.0 0.2 0.0 1.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 262.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 7.3 5.5 672.0 4.1 10.4 0.0 3.7 5.7 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.7 0.0 6.6 0.1 0.0 6.5 3.4 0.0 0.3 0.1 0.1 0.0 0.0 0.0 MS4A5 CD20L2 ENSG00000166930 "Membrane spanning 4-domains A5" Q9H3V2 11 60429572-60455214 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 167 "testis: 44.5" "Group enriched" "Detected in some" 66 "Early spermatids: 700.0;Late spermatids: 1017.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043732 Uncertain NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 34: Spermatids - Unknown function" "HPA043732: AB_10959759" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 700.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1017.8 5.6 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 5.3 0.0 0.0 0.0 0.1 0.0 0.0 6.6 0.0 0.0 13.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A1 "B1, Bp35, CD20, MS4A2" ENSG00000156738 "Membrane spanning 4-domains A1" P11836 11 60455846-60470752 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "B-cell activation" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 673.3" "Cell type enriched" "Detected in some" 35 "B-cells: 970.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 96 "memory B-cell: 625.4;naive B-cell: 627.0" "Lineage enriched" "Detected in many" 96 "B-cells: 627.0" "Group enriched" "Detected in some" 26 "Daudi: 731.3;U-698: 364.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000015, HPA014341, HPA014391" Enhanced Supported "Plasma membrane" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "Plasma membrane" "CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264" "prognostic favorable (4.34e-5)" "unprognostic (4.45e-4)" "unprognostic (1.19e-4)" "unprognostic (2.04e-3)" "unprognostic (1.06e-1)" "unprognostic (5.53e-7)" "unprognostic (2.46e-3)" "unprognostic (1.85e-3)" "unprognostic (3.06e-2)" "unprognostic (2.89e-4)" "unprognostic (6.96e-2)" "unprognostic (2.84e-2)" "unprognostic (3.96e-5)" "unprognostic (2.23e-1)" "unprognostic (8.04e-2)" "unprognostic (1.44e-1)" "unprognostic (1.30e-1)" 3.6 0.4 0.0 149.7 0.0 19.1 0.8 0.0 0.1 0.5 0.1 9.0 3.0 2.2 1.0 4.2 0.5 8.4 1.8 0.0 0.1 3.4 2.1 4.0 500.4 0.2 0.0 0.3 0.2 7.3 0.3 0.9 0.1 5.1 10.6 0.0 8.9 0.3 0.8 0.1 123.5 1.2 0.1 253.8 18.4 1.2 0.1 50.6 6.7 0.1 673.3 16.3 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 731.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.5 0.2 0.0 0.1 0.0 364.1 0.0 0.2 0.0 0.8 0.5 0.3 2.4 0.1 3.7 625.4 2.8 5.5 0.5 627.0 0.5 2.1 2.0 6.5 0.6 0.5 0.8 32.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.3 0.0 3.8 0.0 970.5 0.1 0.1 0.0 0.0 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.0 0.0 14.5 0.3 0.0 0.0 4.5 0.7 0.1 0.3 0.0 7.0 0.0 0.0 0.1 1.8 2.0 0.1 2.5 0.0 1.1 0.3 0.1 0.0 0.0 0.2 0.0 0.6 0.3 2.0 0.0 4.6 7.2 0.0 2.5 0.0 2.1 0.0 0.0 0.0 0.3 0.0 9.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.5 0.2 0.1 0.8 0.1 0.0 27.3 0.7 0.2 0.0 MS4A12 "FLJ20217, Ms4a10" ENSG00000071203 "Membrane spanning 4-domains A12" Q9NXJ0 11 60492778-60507430 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "intestine: 254.3" "Cell type enriched" "Detected in some" 4 "Distal enterocytes: 1139.3" "Cancer enriched" "Detected in some" 8 "colorectal cancer: 6.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048616, HPA057657" Enhanced Approved "Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Cytosol" "Nucleoli, Endoplasmic reticulum, Golgi apparatus" "HPA048616: , HPA057657: AB_2683491" "unprognostic (2.64e-2)" "unprognostic (2.33e-1)" "unprognostic (1.49e-1)" "unprognostic (3.26e-1)" "unprognostic (2.83e-1)" "unprognostic (9.20e-3)" 0.2 0.0 0.0 10.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 234.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 254.3 0.0 0.0 0.5 0.0 0.0 0.3 4.8 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1139.3 0.0 0.0 0.4 0.1 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 255.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.6 0.1 27.8 0.0 MS4A13 ENSG00000204979 "Membrane spanning 4-domains A13" Q5J8X5 11 60515392-60542721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 35 "testis: 3.5" "Cell type enhanced" "Detected in some" "Early spermatids: 25.0;Late spermatids: 47.0;Spermatocytes: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045017, HPA063626" Uncertain NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "HPA045017: AB_10962976, HPA063626: AB_2685065" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 1.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 47.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A8 "CD20L5, MS4A4, MS4A8B" ENSG00000166959 "Membrane spanning 4-domains A8" Q9BY19 11 60699585-60715807 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 129.7;intestine: 197.7" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 376.4;Enteroendocrine cells: 473.4;Ionocytes: 140.4;Proximal enterocytes: 694.6;Respiratory ciliated cells: 502.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 14.1" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 1.9;RPMI-8226: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA007319 Enhanced NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 45: Enterocytes - Digestion" "HPA007319: AB_1854138" "unprognostic (7.28e-3)" "unprognostic (2.11e-1)" "unprognostic (9.03e-2)" "unprognostic (1.91e-2)" "unprognostic (2.52e-2)" "unprognostic (9.41e-2)" "unprognostic (4.89e-3)" "unprognostic (9.33e-2)" "unprognostic (7.97e-3)" "unprognostic (2.40e-1)" "unprognostic (2.40e-9)" "unprognostic (2.46e-1)" "unprognostic (3.02e-2)" "unprognostic (1.59e-3)" 0.0 0.8 1.6 3.5 1.3 0.0 0.0 0.0 1.1 25.6 5.4 18.2 189.8 8.2 0.0 0.3 129.7 10.8 0.0 0.6 0.4 0.1 0.0 16.6 0.2 0.0 0.2 0.3 2.2 0.7 7.5 0.1 0.0 1.7 16.9 0.0 0.6 7.1 4.6 0.0 197.7 1.0 0.0 0.0 45.7 0.5 0.9 0.1 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.9 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.3 0.0 1.1 0.6 0.4 0.0 0.2 0.0 0.0 0.9 0.0 0.0 6.4 6.4 0.0 0.2 0.0 0.2 11.9 0.0 0.0 0.0 0.0 0.3 18.6 58.8 1.8 0.0 0.0 0.0 15.0 0.0 0.3 1.3 376.4 3.2 0.3 473.4 0.0 0.4 2.5 0.0 2.0 14.3 11.6 1.3 0.0 0.0 0.0 0.0 0.0 0.1 42.5 140.4 0.0 0.0 1.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 46.1 0.0 0.0 1.7 694.6 0.2 502.8 0.0 0.0 0.0 3.5 0.3 0.7 0.0 0.0 0.0 0.5 0.2 24.7 0.4 MS4A18 ENSG00000214782 "Membrane spanning 4-domains A18" Q3C1V0 11 60729304-60744212 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 24 "breast: 7.7;intestine: 23.6" "Group enriched" "Detected in some" 8 "Early spermatids: 5.1;Late spermatids: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045121 Approved NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 34: Spermatids - Unknown function" "HPA045121: AB_10969456" "unprognostic (1.02e-1)" "unprognostic (8.87e-2)" "unprognostic (2.51e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A15 ENSG00000166961 "Membrane spanning 4-domains A15" Q8N5U1 11 60756867-60776733 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "lung: 43.9" "Cell type enriched" "Detected in some" 15 "Alveolar cells type 1: 96.1" "Cancer enhanced" "Detected in many" "lung cancer: 6.3" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 3.2" "Lineage enriched" "Detected in single" 12 "T-cells: 3.2" "Cell line enhanced" "Detected in some" "EFO-21: 1.2;HEL: 3.6;JURKAT: 1.6;MOLT-4: 1.6;U-266/70: 4.0;U-266/84: 2.1" "Region enriched" "Detected in some" 28 "olfactory bulb: 166.8" "Region enriched" "Detected in single" 26 "olfactory bulb: 20.2" HPA054563 Approved "Plasma membrane,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 19: Lung - Lung function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 11: Alveolar cells - Smell perception" "Plasma membrane" Cytosol "HPA054563: " "unprognostic (1.85e-1)" "unprognostic (4.31e-3)" "unprognostic (8.59e-2)" "unprognostic (5.89e-4)" "unprognostic (4.49e-1)" "unprognostic (1.09e-3)" "unprognostic (3.92e-3)" "unprognostic (5.43e-3)" "unprognostic (1.20e-1)" "unprognostic (7.30e-2)" "unprognostic (3.14e-1)" "unprognostic (1.04e-9)" "unprognostic (7.02e-2)" "unprognostic (8.63e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-1)" 0.3 0.2 0.2 0.4 0.2 0.1 2.2 0.3 0.4 0.3 0.2 0.3 1.0 1.2 0.3 0.4 1.0 0.2 0.3 0.7 0.2 0.1 0.0 43.9 0.5 0.4 0.2 1.8 0.1 0.0 0.0 0.7 0.4 0.3 0.6 0.4 0.1 1.2 0.0 0.0 2.2 1.6 0.1 0.3 0.4 0.6 0.2 3.8 0.3 0.0 1.8 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 3.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.5 1.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.3 0.0 0.0 4.0 2.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.5 0.2 0.0 0.2 0.0 0.0 3.2 0.2 0.2 0.2 0.3 0.4 0.7 0.2 0.4 0.2 0.4 0.1 0.2 0.3 0.2 96.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.1 0.0 0.0 1.3 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 2.5 0.0 1.5 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 2.1 0.2 0.1 0.0 0.0 MS4A10 "CD20L7, MS4A9" ENSG00000172689 "Membrane spanning 4-domains A10" Q96PG2 11 60785333-60801305 "Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 96 "intestine: 85.8" "Cell type enriched" "Detected in some" 25 "Proximal enterocytes: 319.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA014778 Uncertain NA NA "Cluster 17: Basophils - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 45: Enterocytes - Digestion" "HPA014778: AB_2669089" "unprognostic (7.67e-3)" "unprognostic (1.28e-1)" "unprognostic (8.73e-3)" "unprognostic (1.27e-1)" "unprognostic (5.21e-2)" 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.3 0.2 0.0 0.2 0.3 72.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 85.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.2 319.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 3.3 0.3 CCDC86 MGC2574 ENSG00000110104 "Coiled-coil domain containing 86" Q9H6F5 11 60842113-60851081 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "parathyroid gland: 377.6" "Cell type enhanced" "Detected in many" "Spermatocytes: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041117, HPA041540" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Cluster 28: Myeloid DCs - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 25: RPMI-8226 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA041117: AB_10794984, HPA041540: AB_10794299" "unprognostic (2.93e-1)" "unprognostic (6.59e-2)" "unprognostic (2.38e-1)" "unprognostic (1.47e-3)" "unprognostic (3.64e-1)" "prognostic unfavorable (7.36e-5)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.65e-3)" "unprognostic (9.52e-2)" "unprognostic (1.25e-2)" "unprognostic (6.12e-2)" "unprognostic (4.47e-1)" "unprognostic (3.76e-2)" "unprognostic (7.54e-3)" "unprognostic (2.90e-1)" "unprognostic (2.16e-1)" "unprognostic (6.25e-2)" 25.6 26.7 12.0 14.3 13.3 10.2 20.8 13.1 14.2 12.9 11.2 14.1 11.4 16.7 3.5 19.4 15.2 6.9 16.0 12.7 13.5 19.2 13.7 11.8 11.6 13.2 13.5 13.8 23.9 377.6 24.9 11.6 13.7 23.9 5.8 8.2 12.2 8.6 34.7 22.7 12.3 10.4 12.3 12.7 16.4 48.9 12.7 8.8 12.9 13.7 8.5 20.2 14.5 14.1 83.4 110.2 26.5 76.1 21.8 35.7 36.3 54.3 42.4 98.1 52.4 95.0 53.7 98.9 100.7 31.0 69.7 73.3 94.2 65.7 48.2 35.7 101.3 51.0 45.8 133.2 70.7 80.7 82.6 39.5 48.7 90.2 61.8 14.3 75.8 53.5 166.0 46.9 50.3 97.3 125.2 122.6 107.0 48.6 156.3 81.4 39.6 253.5 37.2 33.8 59.9 38.9 34.7 79.5 64.6 17.6 80.8 30.3 45.9 93.6 59.6 131.6 118.2 41.0 66.5 109.2 78.2 86.0 118.6 1.7 13.5 4.2 9.1 29.4 9.7 9.4 9.6 8.3 29.8 9.0 11.5 10.2 1.0 6.9 9.3 16.6 9.7 10.1 12.0 13.3 13.1 14.2 12.7 13.5 13.2 13.5 13.7 12.3 12.7 14.1 9.3 0.0 2.2 2.0 8.9 37.0 22.2 5.7 28.5 12.1 9.9 10.3 0.6 4.3 4.0 1.8 8.4 17.2 5.7 5.3 7.9 18.6 25.6 6.8 9.4 12.7 7.2 8.8 2.0 12.2 20.4 10.2 9.7 7.7 5.1 7.9 3.6 3.1 18.4 3.3 1.7 5.7 6.1 2.5 16.5 15.0 11.5 7.3 16.0 1.0 5.3 3.9 4.1 1.0 1.3 19.2 3.6 6.0 8.6 24.0 4.4 7.3 1.3 8.3 19.7 10.7 19.1 74.6 18.8 21.2 31.0 8.2 7.0 12.5 11.3 18.8 PTGDR2 "CD294, CRTH2, DP2, GPR44" ENSG00000183134 "Prostaglandin D2 receptor 2" Q9Y5Y4 11 60850933-60855950 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.2;intestine: 8.2;stomach 1: 9.3" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 2.1;Endothelial cells: 2.2;Fibroblasts: 4.1;granulocytes: 4.5;Intestinal goblet cells: 2.0;Langerhans cells: 2.4;Smooth muscle cells: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 178.1;eosinophil: 234.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 234.1" "Cell line enhanced" "Detected in some" "HEL: 9.6;Hep G2: 4.8;HMC-1: 5.9;K-562: 4.0;MOLT-4: 3.1;NB-4: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA014259 Uncertain NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 3: HMC-1 - Innate immune response" "Cluster 48: Smooth muscle cells - ECM organization" "HPA014259: AB_1849304" "unprognostic (9.77e-2)" "unprognostic (1.35e-3)" "unprognostic (5.45e-3)" "unprognostic (1.69e-1)" "unprognostic (1.90e-1)" "unprognostic (1.85e-3)" "unprognostic (1.70e-1)" "unprognostic (2.30e-4)" "unprognostic (2.61e-1)" "unprognostic (7.92e-2)" "unprognostic (8.68e-3)" "unprognostic (1.52e-1)" "unprognostic (1.32e-2)" "unprognostic (1.52e-1)" "unprognostic (3.31e-1)" "unprognostic (1.49e-1)" "unprognostic (4.99e-2)" 0.6 0.0 4.3 0.6 4.2 0.0 0.6 3.3 11.2 0.4 2.3 8.2 4.4 0.4 0.2 0.8 0.6 0.5 6.7 3.4 3.6 0.1 0.5 0.6 0.1 3.7 4.2 0.1 0.5 3.4 0.3 1.0 3.9 0.5 4.1 0.1 0.1 0.1 7.3 0.4 6.9 0.3 3.0 0.5 9.3 0.3 4.2 5.0 0.1 3.9 0.1 0.5 0.2 3.4 0.0 0.0 0.1 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 9.6 0.0 4.8 1.0 0.0 5.9 1.9 0.1 0.0 0.0 0.0 0.0 0.3 4.0 0.0 0.0 0.1 3.1 14.0 0.0 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 178.1 0.1 234.1 0.0 10.9 0.0 0.0 1.5 1.1 5.2 0.0 0.0 0.0 0.7 0.1 35.8 1.1 1.6 2.3 4.3 4.2 3.3 11.2 3.4 3.6 3.7 4.2 3.9 3.0 4.2 3.4 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.1 0.1 0.6 0.0 0.0 0.0 2.1 0.0 0.4 0.1 0.0 0.0 0.1 0.1 0.0 2.2 1.2 0.0 0.2 0.0 0.0 4.1 0.5 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 2.4 0.0 0.3 0.5 0.0 1.9 0.6 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.9 6.8 0.1 0.0 0.0 0.3 0.0 1.8 0.0 0.1 0.0 ZP1 ENSG00000149506 "Zona pellucida glycoprotein 1" P60852 11 60867562-60875693 "Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "Early spermatids: 32.3;Late spermatids: 87.6" "Cancer enhanced" "Detected in single" "prostate cancer: 0.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 32 "plasmacytoid DC: 3.1" "Lineage enriched" "Detected in single" 32 "dendritic cells: 3.1" "Group enriched" "Detected in some" 40 "RPMI-8226: 12.4;SK-BR-3: 3.3" "Not detected" "Not detected" "Secreted in female reproductive system" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 25: RPMI-8226 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (6.40e-3)" "unprognostic (2.18e-4)" "unprognostic (1.63e-1)" "unprognostic (1.15e-2)" "unprognostic (1.14e-1)" "unprognostic (7.02e-2)" "unprognostic (8.27e-2)" "unprognostic (9.95e-2)" "unprognostic (1.94e-2)" "unprognostic (8.15e-3)" "unprognostic (2.52e-1)" "unprognostic (9.25e-4)" "unprognostic (5.31e-13)" "unprognostic (4.13e-2)" "unprognostic (2.38e-1)" "unprognostic (6.27e-2)" "unprognostic (5.61e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 1.3 0.3 0.0 0.1 0.0 0.0 0.0 1.3 0.1 0.1 0.7 0.0 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 32.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 87.6 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 6.6 0.1 5.0 1.9 0.0 0.0 0.1 0.3 0.8 0.0 0.0 0.1 PRPF19 "hPSO4, NMP200, PRP19, PSO4, SNEV, UBOX4" ENSG00000110107 "Pre-mRNA processing factor 19" Q9UMS4 11 60890547-60906585 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012448, HPA038051, HPA059070" Supported Enhanced "Nuclear speckles" NA NA 71000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear speckles" "CAB012448: AB_2170868, HPA038051: AB_2675807, HPA059070: AB_2683896" "unprognostic (5.73e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-1)" "unprognostic (2.68e-1)" "unprognostic (4.51e-2)" "unprognostic (1.18e-2)" "prognostic unfavorable (4.11e-8)" "unprognostic (1.03e-1)" "unprognostic (2.13e-1)" "unprognostic (9.37e-3)" "unprognostic (9.53e-2)" "unprognostic (1.54e-1)" "unprognostic (6.70e-2)" "unprognostic (9.62e-2)" "unprognostic (7.12e-2)" "unprognostic (9.04e-2)" "unprognostic (3.41e-3)" 46.1 70.6 89.8 49.8 87.9 67.0 48.8 73.7 100.2 57.4 60.2 54.5 42.9 55.4 34.2 81.7 57.3 29.4 47.9 91.3 94.1 50.4 77.2 34.6 64.1 92.0 80.7 66.6 69.4 79.8 79.3 42.9 92.9 62.1 51.8 46.1 56.5 48.2 75.2 80.3 49.5 47.9 75.6 54.3 54.3 30.5 81.1 78.5 43.4 38.9 73.7 58.7 55.9 84.5 197.5 147.0 161.8 116.2 92.7 80.8 155.6 102.4 137.5 200.2 149.0 162.7 141.1 280.5 145.2 98.2 120.2 179.0 229.2 184.6 153.4 207.0 153.4 232.4 111.3 184.9 134.2 308.6 161.1 86.3 137.0 154.4 171.9 58.7 158.7 167.4 248.2 155.3 99.5 270.6 328.9 249.5 292.6 150.5 197.7 285.8 165.5 227.5 101.7 127.5 142.3 172.9 126.6 208.3 178.0 73.1 225.8 170.2 101.9 89.6 147.2 161.8 171.2 147.2 223.3 287.9 111.6 208.6 138.6 4.2 7.8 2.0 2.4 3.8 1.7 0.9 1.8 1.7 3.6 2.4 2.2 2.0 0.5 1.8 2.3 3.9 1.7 1.0 89.8 87.9 73.7 100.2 91.3 94.1 92.0 80.7 92.9 75.6 81.1 84.5 15.8 19.2 23.7 10.1 26.7 42.1 35.2 40.2 33.0 32.0 24.6 19.4 17.6 20.0 28.6 27.6 10.4 94.7 16.2 20.4 27.4 48.5 21.6 21.4 19.7 27.3 39.0 45.2 19.8 51.6 90.2 24.9 23.4 28.4 22.8 25.4 20.0 46.1 46.3 62.2 22.2 40.0 32.6 23.0 21.6 3.6 37.0 19.3 26.6 11.2 41.2 25.4 21.6 10.1 11.8 33.4 27.7 38.7 31.9 40.4 27.8 27.9 17.8 25.3 46.0 22.4 22.6 25.2 38.0 37.4 41.6 40.6 24.8 24.8 55.1 26.3 TMEM109 MGC5508 ENSG00000110108 "Transmembrane protein 109" Q9BVC6 11 60914158-60923443 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011785 Approved Approved "Nuclear membrane,Cytosol" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 2: Karpas-707 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nuclear membrane, Cytosol" "HPA011785: AB_1858075" "unprognostic (5.23e-2)" "unprognostic (9.02e-2)" "unprognostic (2.46e-2)" "unprognostic (2.69e-2)" "unprognostic (1.23e-1)" "unprognostic (2.40e-2)" "unprognostic (5.29e-3)" "unprognostic (2.95e-1)" "unprognostic (2.70e-1)" "unprognostic (2.40e-2)" "unprognostic (2.52e-1)" "unprognostic (3.63e-2)" "unprognostic (1.83e-1)" "unprognostic (2.82e-1)" "unprognostic (1.51e-1)" "unprognostic (2.84e-2)" "prognostic unfavorable (2.68e-4)" 83.0 46.4 22.2 44.4 23.2 27.0 71.9 23.3 25.5 85.4 42.1 75.1 26.2 97.7 26.7 93.8 73.7 35.7 84.0 19.8 23.2 47.3 32.1 71.8 48.0 26.7 24.5 81.5 46.1 67.3 41.1 46.8 25.4 52.4 27.0 14.3 81.8 60.8 99.4 69.7 47.8 70.0 25.9 58.1 58.2 14.4 25.5 41.4 57.3 77.0 50.3 70.4 79.9 24.7 111.5 103.5 63.3 102.1 169.4 77.7 51.5 107.3 100.4 118.5 99.8 94.5 115.7 131.5 190.4 130.1 69.9 143.5 73.2 48.8 72.5 102.5 97.0 96.2 44.3 21.1 50.2 188.4 77.0 54.1 61.6 92.9 46.8 41.9 148.1 104.8 48.4 330.4 85.4 217.2 139.9 80.8 104.6 62.8 111.4 132.3 123.9 183.0 56.6 63.6 25.3 44.4 86.2 196.8 102.7 44.8 110.4 35.8 143.7 136.9 65.9 174.4 95.8 108.7 89.5 69.9 121.2 82.0 159.7 39.0 76.0 56.4 188.7 69.5 193.3 116.5 108.4 161.4 227.4 140.4 97.4 124.8 8.2 121.1 52.4 470.0 91.1 139.4 22.2 23.2 23.3 25.5 19.8 23.2 26.7 24.5 25.4 25.9 25.5 24.7 118.2 70.5 23.2 5.5 60.2 50.7 43.8 30.9 63.7 13.4 39.5 45.3 34.6 25.8 23.9 25.8 0.0 120.7 83.4 6.8 25.4 76.6 20.7 18.7 25.9 91.2 7.2 33.0 5.3 80.2 116.4 75.9 10.7 27.9 50.7 22.2 71.0 18.9 66.8 30.3 3.8 10.1 22.4 21.3 69.1 11.1 89.5 43.4 51.6 11.2 45.4 30.2 68.0 3.5 5.1 53.1 14.7 97.4 38.4 36.5 10.6 17.1 18.7 34.8 39.5 45.0 67.6 5.9 7.2 55.1 50.6 53.2 52.7 25.8 16.8 33.9 TMEM132A "FLJ20539, GBP, HSPA5BP1" ENSG00000006118 "Transmembrane protein 132A" Q24JP5 11 60924460-60937159 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 187.8;choroid plexus: 117.3" "Cell type enhanced" "Detected in many" "Astrocytes: 82.3;Ductal cells: 80.0;Horizontal cells: 254.1;Muller glia cells: 188.8;Rod photoreceptor cells: 165.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 174.1;MCF7: 177.8;SK-BR-3: 176.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051979, HPA060492" Enhanced Supported Approved Mitochondria No No 4100000 "Cluster 73: Brain - Neuropeptide signaling" "Cluster 38: EFO-21 - Unknown function" "Cluster 62: Horizontal cells - Visual perception" Mitochondria "HPA051979: AB_2681681, HPA060492: " "unprognostic (2.52e-2)" "unprognostic (2.01e-1)" "unprognostic (3.75e-2)" "prognostic favorable (1.98e-5)" "unprognostic (7.94e-3)" "unprognostic (3.74e-1)" "unprognostic (4.42e-3)" "unprognostic (2.39e-2)" "unprognostic (1.99e-1)" "unprognostic (1.30e-1)" "unprognostic (2.88e-1)" "unprognostic (5.98e-2)" "prognostic unfavorable (1.55e-9)" "unprognostic (3.31e-1)" "unprognostic (9.74e-2)" "unprognostic (1.50e-1)" "unprognostic (8.41e-3)" 7.7 21.0 137.9 8.6 134.3 0.3 7.7 119.4 187.8 12.0 117.3 5.5 2.5 13.6 1.2 19.5 4.8 5.5 13.7 134.1 136.9 13.9 2.1 10.1 1.7 154.5 131.2 18.8 6.8 12.4 23.6 16.6 126.4 9.4 1.0 28.1 25.9 1.8 3.9 6.1 6.0 3.7 123.0 5.7 32.4 6.7 144.6 1.3 4.8 3.1 5.4 4.2 9.2 114.7 37.0 50.7 44.1 88.0 3.6 1.7 78.1 27.0 84.5 24.6 20.3 18.0 33.3 0.3 174.1 7.8 79.9 67.6 10.3 46.0 9.5 0.5 14.8 1.1 33.3 32.7 30.8 0.5 1.3 7.7 8.6 45.8 7.1 38.7 42.1 7.0 2.3 2.3 7.8 177.8 0.9 0.2 58.5 1.2 26.9 0.4 18.6 4.2 36.4 18.7 43.7 104.1 19.3 176.4 16.7 22.3 123.7 0.6 49.4 9.5 43.2 2.7 52.3 0.4 0.3 2.1 78.5 0.1 46.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 137.9 134.3 119.4 187.8 134.1 136.9 154.5 131.2 126.4 123.0 144.6 114.7 11.8 0.0 0.0 82.3 0.6 1.3 2.7 56.2 5.7 62.8 17.1 11.7 0.8 4.3 22.2 5.5 18.8 31.4 0.1 0.7 1.9 80.0 0.5 12.4 7.0 11.9 15.6 0.0 22.6 13.3 28.7 7.7 9.2 27.7 0.0 57.5 11.4 0.0 3.3 254.1 29.1 2.7 20.3 0.3 1.0 1.0 1.8 0.7 0.0 7.5 3.1 188.8 0.0 12.1 3.3 63.2 1.6 3.4 0.0 9.7 0.0 0.4 4.0 165.3 6.6 4.4 15.2 1.2 4.0 5.7 0.9 27.1 0.3 19.2 2.3 7.2 SLC15A3 "hPTR3, PHT2" ENSG00000110446 "Solute carrier family 15 member 3" Q8IY34 11 60937060-60952653 "Metabolic proteins, Predicted membrane proteins, Transporters" "Immunity, Innate immunity, Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 90.6;Kupffer cells: 59.3;Macrophages: 65.5;monocytes: 70.9;Muller glia cells: 211.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 9.0;intermediate monocyte: 12.8;memory B-cell: 4.9;myeloid DC: 6.5;neutrophil: 13.4;non-classical monocyte: 6.4;plasmacytoid DC: 10.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 23.4;BJ hTERT+ SV40 Large T+: 58.0;BJ hTERT+ SV40 Large T+ RasG12V: 74.0;HHSteC: 34.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047880, HPA057642" Approved Supported Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 5: Muller glia cells - Visual perception" Vesicles "HPA047880: AB_10959455, HPA057642: AB_2683487" "unprognostic (5.61e-2)" "prognostic favorable (4.07e-5)" "unprognostic (8.79e-2)" "unprognostic (1.67e-2)" "unprognostic (8.48e-2)" "unprognostic (9.33e-3)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (9.78e-3)" "unprognostic (6.47e-2)" "unprognostic (4.42e-2)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" 27.5 12.8 11.6 30.7 10.3 35.3 18.2 10.7 15.1 19.7 13.0 34.9 12.0 13.9 3.9 9.3 18.2 19.1 27.1 9.7 13.1 14.9 15.1 52.2 40.1 14.5 10.9 29.2 6.5 4.4 8.4 27.5 13.8 16.7 9.4 17.5 10.0 8.5 6.4 7.9 28.7 15.1 13.5 63.9 18.5 5.5 14.3 12.9 10.5 10.1 15.7 15.6 17.6 15.5 4.3 0.0 2.2 0.0 12.6 9.9 23.4 1.2 21.8 58.0 74.0 0.1 1.9 9.7 0.3 8.8 14.2 1.7 0.0 0.7 3.4 9.4 0.0 0.1 0.1 0.6 34.9 0.0 0.9 6.6 0.0 15.3 0.0 0.1 2.8 0.0 0.0 0.5 3.6 0.5 0.0 1.8 9.8 0.0 0.1 3.9 0.0 3.3 0.0 1.3 0.0 0.1 2.8 9.6 0.4 0.4 4.2 5.7 0.3 0.3 1.2 1.0 0.1 0.0 0.0 3.8 3.9 0.0 13.7 0.0 9.0 1.2 0.1 12.8 0.0 4.9 0.0 0.0 6.5 1.9 0.9 0.9 13.4 0.0 6.4 10.7 0.0 2.4 11.6 10.3 10.7 15.1 9.7 13.1 14.5 10.9 13.8 13.5 14.3 15.5 19.3 9.6 13.2 0.0 7.7 1.7 0.2 4.5 2.2 1.6 0.7 1.4 2.5 1.5 3.7 0.0 0.0 3.6 9.6 1.1 0.0 0.3 7.9 0.1 2.0 12.6 0.0 0.4 0.1 2.2 15.1 5.6 1.1 0.3 15.2 3.7 20.3 3.1 90.6 5.0 0.0 1.2 2.0 59.3 35.5 3.8 8.1 65.5 1.8 4.7 70.9 211.7 1.0 0.0 0.1 2.2 2.8 4.9 2.0 0.1 0.3 0.1 3.1 5.5 13.1 3.1 3.0 4.2 0.7 0.6 1.4 2.6 1.9 4.5 1.1 0.3 CD6 Tp120 ENSG00000013725 "CD6 molecule" P30203 11 60971680-61020377 "CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 13.6;lymphoid tissue: 43.1" "Cell type enhanced" "Detected in many" "dendritic cells: 25.7;NK-cells: 49.4;Plasma cells: 18.5;T-cells: 107.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 33 "gdT-cell: 27.7;MAIT T-cell: 24.7;memory CD4 T-cell: 51.4;memory CD8 T-cell: 48.4;naive CD4 T-cell: 34.4;naive CD8 T-cell: 25.2;T-reg: 25.5" "Lineage enriched" "Detected in many" 51 "T-cells: 51.4" "Group enriched" "Detected in some" 12 "JURKAT: 10.2;MOLT-4: 39.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002489, CAB016252" Enhanced "Secreted to blood" NA NA 5270000 160000 "Cluster 32: T-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "CAB002489: AB_563605, CAB016252: AB_631163" "prognostic favorable (1.95e-4)" "prognostic favorable (1.57e-5)" "unprognostic (4.47e-2)" "prognostic favorable (2.41e-4)" "unprognostic (2.06e-2)" "prognostic favorable (5.10e-6)" "unprognostic (8.45e-3)" "unprognostic (8.21e-3)" "unprognostic (2.87e-3)" "unprognostic (5.32e-3)" "unprognostic (2.07e-1)" "unprognostic (5.35e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (1.77e-1)" "unprognostic (4.95e-2)" "unprognostic (6.19e-2)" "unprognostic (5.96e-2)" 1.4 0.9 1.5 21.9 0.9 11.3 1.2 0.5 1.1 1.3 0.7 3.2 4.0 0.9 0.7 1.8 1.4 3.9 0.5 0.6 1.7 1.0 1.4 6.6 43.1 1.5 2.0 0.9 0.6 0.2 0.4 0.3 1.7 1.1 3.1 0.2 3.2 0.4 0.8 1.3 13.6 0.7 0.9 18.0 6.6 0.7 2.5 39.6 1.4 0.3 29.0 4.8 1.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.2 0.0 0.0 0.0 39.2 0.1 0.2 0.2 0.1 0.1 0.0 0.8 0.0 0.1 0.1 0.2 0.0 0.4 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 27.7 0.0 24.7 1.0 51.4 48.4 0.3 0.9 34.4 25.2 0.7 0.2 0.0 0.0 25.5 13.8 1.5 0.9 0.5 1.1 0.6 1.7 1.5 2.0 1.7 0.9 2.5 0.9 3.2 0.0 2.5 0.3 10.8 2.0 0.2 0.1 0.0 1.4 0.9 0.8 2.6 1.5 0.1 0.0 0.0 0.2 25.7 0.2 0.0 0.2 0.9 0.4 0.3 1.2 0.0 0.0 0.8 0.6 0.2 1.5 8.2 0.3 0.0 0.1 2.5 0.8 2.0 1.7 0.9 0.0 0.0 1.9 4.4 0.4 0.3 3.4 3.6 1.0 2.4 0.0 49.4 0.0 0.2 0.7 0.2 0.0 18.5 0.0 0.1 0.2 0.1 0.2 0.0 1.0 0.9 0.4 0.9 1.0 1.4 0.3 107.3 0.7 0.5 0.4 CD5 "LEU1, T1" ENSG00000110448 "CD5 molecule" P06127 11 61102489-61127852 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 46.5" "Cell type enhanced" "Detected in some" "dendritic cells: 7.5;Langerhans cells: 9.3;Muller glia cells: 16.0;T-cells: 57.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 138.2" "Lineage enriched" "Detected in many" 33 "T-cells: 138.2" "Group enriched" "Detected in some" 66 "JURKAT: 21.0;MOLT-4: 70.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB015392, CAB020308, HPA043416, HPA060839" Enhanced NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "CAB015392: AB_2075324, CAB020308: , HPA043416: AB_2678472, HPA060839: AB_2684376" "prognostic favorable (4.05e-4)" "prognostic favorable (9.16e-5)" "unprognostic (2.33e-1)" "prognostic favorable (9.00e-5)" "unprognostic (1.02e-2)" "prognostic favorable (7.41e-6)" "unprognostic (2.45e-3)" "unprognostic (1.37e-2)" "prognostic favorable (3.93e-4)" "unprognostic (1.25e-2)" "unprognostic (5.00e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (8.94e-5)" "unprognostic (4.78e-2)" "unprognostic (1.02e-2)" "unprognostic (2.38e-1)" "unprognostic (1.06e-1)" 1.4 0.9 0.4 22.6 0.4 12.2 1.0 0.1 0.5 0.9 0.0 2.8 3.1 0.7 0.4 2.3 0.8 4.9 0.9 0.6 0.4 0.8 1.5 5.7 38.0 0.2 0.0 0.8 0.4 0.2 0.4 0.3 0.5 1.0 2.7 1.8 6.4 0.3 0.6 1.4 7.1 1.2 0.0 14.1 7.9 0.8 0.3 46.5 1.0 0.3 22.2 6.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.1 70.5 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.4 0.6 45.9 0.4 32.8 1.5 108.7 72.5 3.7 3.4 88.4 69.8 1.8 0.4 3.4 4.1 138.2 61.5 0.4 0.4 0.1 0.5 0.6 0.4 0.2 0.0 0.5 0.0 0.3 0.0 0.4 0.0 1.7 0.0 4.1 0.9 0.0 0.0 0.0 0.2 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 2.7 0.0 0.1 0.2 0.0 1.3 0.3 0.0 0.0 0.9 2.6 0.1 1.3 0.0 1.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 9.3 0.9 0.0 1.8 3.6 0.0 2.1 16.0 1.0 0.0 0.1 0.1 0.3 0.0 6.3 0.0 0.0 0.1 0.0 1.3 0.0 0.1 0.6 0.4 0.7 0.2 0.3 0.0 57.0 0.0 0.2 0.2 VPS37C FLJ20847 ENSG00000167987 "VPS37C subunit of ESCRT-I" A5D8V6 11 61130257-61161615 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 1.4;eosinophil: 1.7;intermediate monocyte: 2.6;myeloid DC: 1.0;neutrophil: 3.8;non-classical monocyte: 2.4" "Group enriched" "Detected in many" 5 "dendritic cells: 1.0;granulocytes: 3.8;monocytes: 2.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043348 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 46: Photoreceptor cells - Phototransduction" Vesicles Nucleoplasm "HPA043348: AB_10794658" "unprognostic (1.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.50e-1)" "unprognostic (7.95e-3)" "unprognostic (3.38e-1)" "unprognostic (9.01e-2)" "prognostic unfavorable (5.85e-5)" "unprognostic (7.42e-2)" "unprognostic (1.14e-1)" "unprognostic (3.00e-1)" "unprognostic (3.41e-2)" "unprognostic (3.17e-2)" "prognostic favorable (2.37e-7)" "unprognostic (1.99e-1)" "unprognostic (1.08e-1)" "unprognostic (3.85e-1)" "unprognostic (7.05e-2)" 14.1 13.8 11.5 13.2 10.9 10.3 14.0 10.0 12.2 14.3 11.9 17.7 17.1 15.9 5.2 22.0 12.5 11.2 15.8 12.6 9.9 16.8 10.7 14.5 8.1 11.9 11.6 14.1 24.1 11.9 20.1 14.1 10.5 20.9 10.5 22.7 23.3 14.6 23.6 22.2 15.5 14.5 9.6 13.3 27.7 15.3 12.0 6.2 12.1 11.8 10.0 18.3 15.9 11.4 33.8 13.1 16.7 16.1 8.0 16.6 37.2 16.4 44.0 23.9 16.2 15.7 15.6 8.8 22.5 22.5 19.7 18.5 15.2 17.3 12.3 19.2 11.4 11.2 9.0 17.8 25.7 9.0 13.7 15.0 26.3 20.6 25.7 14.3 15.8 6.0 29.6 14.6 16.4 41.1 2.0 13.7 20.6 14.7 18.8 3.1 7.2 21.4 18.9 17.2 10.3 25.1 16.4 52.2 28.8 14.0 49.5 22.2 12.1 23.9 17.2 24.4 20.8 6.9 10.0 7.2 21.6 11.1 16.5 0.4 1.4 1.7 0.3 2.6 0.4 0.5 0.2 0.4 1.0 0.5 0.3 0.1 3.8 0.2 2.4 0.1 0.2 0.7 11.5 10.9 10.0 12.2 12.6 9.9 11.9 11.6 10.5 9.6 12.0 11.4 6.3 16.0 6.0 5.9 4.1 12.5 14.3 9.4 10.2 5.8 14.9 9.3 7.5 12.8 10.0 12.9 10.4 30.6 1.2 15.6 11.7 17.4 8.9 5.0 4.0 11.2 16.3 4.2 8.9 19.8 20.9 10.6 13.7 6.8 0.0 5.1 7.1 6.7 17.3 25.2 7.1 18.3 8.2 13.7 11.4 6.5 7.8 13.9 7.2 13.1 12.3 11.5 2.1 4.5 8.3 21.7 11.3 13.5 2.2 17.7 19.0 7.2 12.2 41.7 0.0 6.7 9.2 12.9 16.7 8.4 19.9 35.2 2.9 7.4 10.6 14.5 PGA3 ENSG00000229859 "Pepsinogen A3" P0DJD8 11 61203307-61213098 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 613 "stomach 1: 89073.4" "Cell type enriched" "Detected in some" 526 "Gastric mucus-secreting cells: 3263.5" "Cancer enriched" "Detected in single" 498 "stomach cancer: 24.8" "Region enhanced" "Detected in single" "hippocampal formation: 2.9" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 2.8;THP-1: 1.1" "CAB026358, HPA046875" Enhanced "Secreted to digestive system" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 4: Stomach - Digestion" "Cluster 3: HMC-1 - Innate immune response" "Cluster 16: Pancreatic endocrine cells - Mixed function" "CAB026358: , HPA046875: AB_2679851" "unprognostic (6.39e-2)" "unprognostic (1.11e-1)" 80.5 10.0 0.5 0.2 0.2 0.2 18.2 0.7 0.9 11.1 0.0 145.3 1.3 3.8 0.0 96.4 4.5 0.1 11.4 2.9 0.0 5.4 16.2 6.2 0.0 0.0 0.0 5.4 13.0 0.0 13.4 0.5 0.1 5.5 0.1 0.9 6.8 0.7 4.4 6.0 5.7 0.4 0.0 6.3 89073.4 7.3 0.0 0.1 5.0 0.5 0.1 6.2 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.7 1.3 0.4 0.1 0.2 0.7 0.1 0.1 0.1 0.6 0.4 0.2 0.3 0.0 0.0 1.3 0.5 0.2 0.7 0.9 2.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 6.2 0.0 0.3 3263.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.1 0.0 0.1 0.0 3.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.1 PGA4 ENSG00000229183 "Pepsinogen A4" P0DJD7 11 61222349-61231694 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1281 "stomach 1: 66596.4" "Cell type enriched" "Detected in some" 8 "Exocrine glandular cells: 109.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "classical monocyte: 9.9;intermediate monocyte: 10.9;non-classical monocyte: 3.4" "Lineage enriched" "Detected in single" 26 "monocytes: 10.9" "Group enriched" "Detected in some" 6 "BJ hTERT+: 26.1;HMC-1: 9.5;THP-1: 15.7" HPA046875 Supported "Secreted to digestive system" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 4: Stomach - Digestion" "Cluster 3: HMC-1 - Innate immune response" "Cluster 1: Pancreatic cells - Digestion" "HPA046875: AB_2679851" "unprognostic (2.22e-1)" 9.6 8.3 0.1 2.1 0.1 0.0 9.0 0.1 0.2 7.5 0.1 52.0 2.5 4.6 0.0 9.1 19.1 0.3 6.2 0.1 0.1 30.3 11.7 37.9 0.0 0.1 0.1 4.1 18.8 0.0 3.5 3.8 0.1 16.2 0.4 0.3 4.5 0.7 2.5 4.1 2.9 0.8 0.1 5.2 66596.4 4.3 0.1 0.1 3.1 0.0 0.2 5.0 5.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.0 0.0 1.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 1.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.3 0.0 3.4 0.0 0.0 1.8 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 109.1 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PGA5 ENSG00000256713 "Pepsinogen A5" P0DJD9 11 61241175-61251444 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Aspartyl protease, Hydrolase, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 2014 "stomach 1: 39870.8" "Cell type enriched" "Detected in some" 77 "Exocrine glandular cells: 4383.1" "Cancer enriched" "Detected in some" 12 "stomach cancer: 15.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 29 "classical monocyte: 1.8;intermediate monocyte: 4.3;non-classical monocyte: 2.4" "Lineage enriched" "Detected in single" 44 "monocytes: 4.3" "Cell line enriched" "Detected in some" 19 "BJ hTERT+: 28.8" HPA046875 Supported "Secreted to digestive system" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 4: Stomach - Digestion" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "HPA046875: AB_2679851" "unprognostic (1.36e-3)" "unprognostic (2.98e-2)" "unprognostic (5.83e-3)" "unprognostic (2.11e-1)" "unprognostic (4.22e-1)" "unprognostic (4.36e-2)" "unprognostic (2.16e-2)" "unprognostic (1.05e-1)" "unprognostic (7.10e-2)" 19.7 4.4 0.3 1.1 0.3 0.0 4.5 0.1 0.6 4.0 0.0 6.2 0.6 1.9 0.0 7.0 5.1 0.1 3.5 0.7 0.0 2.4 7.0 5.4 0.0 0.1 0.0 2.6 8.2 0.0 3.8 0.5 0.1 1.8 0.1 1.5 2.5 0.5 1.9 2.1 2.1 0.9 0.0 3.9 39870.8 2.3 0.0 0.2 3.1 0.2 0.1 2.3 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 28.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.3 0.3 0.3 0.1 0.6 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 4383.1 0.0 0.1 56.6 0.0 0.0 0.2 0.0 0.0 6.7 0.0 0.0 0.0 0.0 5.1 0.0 1.6 0.9 1.3 0.0 0.0 1.0 25.1 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 VWCE "FLJ32009, URG11, VWC1" ENSG00000167992 "Von Willebrand factor C and EGF domains" Q96DN2 11 61258286-61295316 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 14.3;ovary: 7.9" "Cell type enhanced" "Detected in many" "Astrocytes: 19.2;Cone photoreceptor cells: 29.2;Hepatocytes: 16.4;Rod photoreceptor cells: 21.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 7.2;Hep G2: 26.3;HSkMC: 13.4;REH: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA040401, HPA043921" Uncertain Supported Nucleoplasm,Vesicles,Cytosol "Secreted - unknown location" NA NA 2200000 "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "Vesicles, Cytosol" "HPA040401: AB_2676963, HPA043921: AB_2678731" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (3.58e-2)" "unprognostic (1.15e-1)" "unprognostic (3.96e-3)" "unprognostic (9.27e-4)" "unprognostic (1.21e-2)" "unprognostic (4.01e-4)" "unprognostic (3.04e-2)" "unprognostic (3.42e-2)" "unprognostic (6.58e-4)" "unprognostic (7.20e-2)" "unprognostic (3.01e-1)" "unprognostic (1.25e-2)" "unprognostic (1.92e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-1)" 2.8 1.1 0.6 0.1 0.9 1.6 1.5 0.3 1.6 2.9 0.0 0.6 0.3 1.3 0.6 0.9 3.5 0.6 0.8 0.7 0.7 0.5 14.3 0.3 0.2 0.5 1.2 7.9 0.3 0.1 0.6 2.4 0.4 1.0 0.4 0.8 0.9 0.5 0.7 0.7 0.4 0.4 0.0 0.4 0.4 1.8 0.5 2.5 0.8 0.4 0.1 0.6 1.2 0.2 0.0 0.1 1.5 0.2 0.2 1.8 0.6 0.2 2.0 0.0 0.3 7.2 0.0 0.5 0.0 0.4 0.1 0.0 2.3 0.0 0.1 0.4 0.0 0.8 0.0 26.3 1.2 0.0 0.3 13.4 0.6 0.7 0.0 0.1 2.3 3.3 0.2 0.3 0.3 0.1 5.5 0.0 2.2 0.0 0.0 14.0 0.2 0.0 0.1 0.1 0.6 1.0 0.0 0.1 0.7 2.4 0.9 0.0 0.8 0.3 0.3 0.5 0.2 0.2 0.6 1.2 0.9 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.3 1.6 0.7 0.7 0.5 1.2 0.4 0.0 0.5 0.2 2.1 3.2 1.7 19.2 0.3 1.8 1.8 3.8 3.4 3.6 1.7 0.5 1.0 1.5 2.3 0.0 29.2 1.0 0.5 0.2 0.0 0.1 0.5 2.9 1.0 5.5 1.8 6.1 7.5 0.5 5.0 2.6 0.0 1.8 3.8 6.5 2.5 16.4 1.2 0.0 5.8 0.1 2.0 3.5 2.4 0.8 6.8 2.6 1.8 2.8 2.3 2.3 1.0 2.5 1.4 0.0 0.0 1.9 0.4 1.1 0.1 0.3 5.4 21.1 0.0 0.9 1.1 1.1 3.4 1.3 2.3 4.4 0.9 7.7 0.3 0.7 DDB1 ENSG00000167986 "Damage specific DNA binding protein 1" Q16531 11 61299451-61342596 "Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 352.3;Rod photoreceptor cells: 451.4;Syncytiotrophoblasts: 389.4;Theca cells: 303.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032821, HPA045174, HPA068456" Approved Enhanced Nucleoplasm NA NA 440000 "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "CAB032821: AB_639050, HPA045174: AB_2679242, HPA068456: AB_2685992" "unprognostic (3.45e-1)" "unprognostic (8.38e-2)" "prognostic favorable (7.09e-4)" "unprognostic (1.21e-1)" "unprognostic (6.56e-2)" "unprognostic (1.19e-2)" "unprognostic (1.11e-2)" "unprognostic (9.33e-2)" "unprognostic (9.74e-3)" "unprognostic (1.09e-1)" "unprognostic (7.42e-3)" "unprognostic (3.11e-1)" "prognostic favorable (1.51e-8)" "unprognostic (3.44e-1)" "unprognostic (1.58e-1)" "unprognostic (7.30e-2)" "unprognostic (1.25e-3)" 52.8 164.8 30.2 44.0 32.5 47.2 59.0 29.5 30.2 61.3 42.5 50.0 53.2 48.0 79.7 49.7 78.3 39.9 65.1 31.9 36.4 64.8 55.9 43.1 47.0 31.8 33.5 89.3 42.5 232.1 44.5 129.7 36.9 56.6 52.3 162.5 54.1 70.9 133.1 60.6 49.9 61.9 31.9 41.9 44.4 69.1 33.5 81.2 65.0 125.1 66.6 58.6 39.2 36.1 160.3 168.1 159.0 142.2 151.4 139.2 237.8 140.9 193.6 174.4 129.2 188.7 130.7 237.6 126.8 203.4 107.4 141.4 245.5 177.5 188.0 115.7 131.3 128.0 144.3 192.0 109.4 182.7 112.6 169.1 121.7 174.0 146.2 123.5 195.7 86.0 278.4 119.9 158.9 194.7 238.4 77.4 214.5 104.3 146.3 197.9 198.5 254.3 119.7 177.3 140.3 143.0 154.6 183.8 145.9 144.8 226.0 85.6 150.9 120.9 113.6 138.2 106.4 139.5 157.0 194.7 134.9 103.7 121.1 38.4 43.6 36.5 46.7 47.1 61.1 35.8 42.0 47.3 60.5 30.5 37.8 43.3 4.6 46.4 45.3 34.2 49.6 54.6 30.2 32.5 29.5 30.2 31.9 36.4 31.8 33.5 36.9 31.9 33.5 36.1 34.2 28.9 69.9 46.4 48.8 52.6 53.6 61.1 51.2 87.0 52.0 39.9 105.6 34.3 54.5 53.3 352.3 283.5 57.5 45.0 17.6 43.9 15.7 46.6 40.8 48.1 74.2 102.3 27.8 42.4 130.1 50.6 46.4 51.3 30.9 102.7 45.0 67.4 75.5 87.5 31.6 55.4 44.7 45.3 33.5 18.8 85.1 38.3 42.7 30.0 61.1 64.4 71.1 24.1 31.0 52.6 36.4 62.1 65.4 55.7 63.2 46.7 64.4 451.4 32.9 51.5 44.5 114.0 120.9 52.3 59.8 389.4 46.0 303.8 60.0 57.1 TKFC "DAK, DKFZP586B1621, NET45" ENSG00000149476 "Triokinase and FMN cyclase" Q3LXA3 11 61333220-61353295 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Lyase, Multifunctional enzyme, Transferase" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 192.8;liver: 115.8" "Cell type enhanced" "Detected in many" "Hepatocytes: 115.9;Proximal enterocytes: 415.8;Proximal tubular cells: 91.2;Theca cells: 93.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 133.2;RPMI-8226: 140.7;T-47d: 135.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039486, HPA048186" Enhanced Approved Nucleoplasm,Cytosol NA NA 6800000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 25: RPMI-8226 - Immune response" "Cluster 45: Enterocytes - Digestion" Cytosol Nucleoplasm "HPA039486: AB_10795402, HPA048186: AB_2680305" "unprognostic (4.00e-1)" "unprognostic (3.13e-1)" "unprognostic (7.42e-2)" "prognostic favorable (1.32e-5)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (3.02e-2)" "unprognostic (2.81e-3)" "unprognostic (1.49e-1)" "unprognostic (2.47e-1)" "unprognostic (1.51e-1)" "unprognostic (2.15e-1)" "prognostic favorable (8.38e-5)" "unprognostic (2.07e-2)" "unprognostic (8.96e-2)" "unprognostic (3.30e-1)" "unprognostic (4.02e-1)" 9.5 82.8 5.9 9.4 6.0 16.6 12.1 5.8 6.6 9.5 5.7 12.5 192.8 11.0 7.6 16.3 15.4 9.2 7.6 6.4 5.1 45.5 115.8 9.0 13.6 6.8 6.3 10.3 24.0 6.7 14.0 6.1 6.2 12.2 5.7 5.6 16.2 8.9 10.9 17.8 138.0 5.2 6.5 13.0 16.6 28.2 6.0 7.5 14.7 5.6 8.0 10.9 11.0 7.2 19.9 51.3 8.5 30.0 10.7 11.4 24.2 11.7 12.4 10.4 6.9 23.1 47.1 25.0 39.3 8.5 11.0 27.7 16.3 21.8 3.5 42.5 21.7 15.7 26.2 133.2 17.9 13.4 25.0 18.2 14.5 9.9 35.4 9.4 10.7 17.1 27.2 46.7 7.9 91.8 11.9 11.9 23.8 19.2 33.8 20.0 13.8 140.7 17.1 35.0 33.0 29.6 21.0 36.4 19.3 6.0 135.4 9.2 13.0 21.0 21.6 16.6 7.0 85.8 76.5 22.9 21.3 12.3 19.7 2.6 13.4 6.5 7.1 7.8 9.6 10.3 8.3 7.1 21.2 9.7 5.8 6.2 1.2 6.5 6.5 10.1 12.9 9.7 5.9 6.0 5.8 6.6 6.4 5.1 6.8 6.3 6.2 6.5 6.0 7.2 8.0 0.0 14.5 0.0 9.5 0.0 13.8 0.0 11.4 12.8 19.1 16.0 3.8 11.5 6.8 14.7 14.6 31.2 8.3 4.8 29.4 19.6 16.2 16.4 6.6 8.0 13.3 7.8 0.0 14.6 6.2 11.2 20.4 12.1 7.6 10.8 7.5 115.9 17.1 8.4 0.0 31.6 0.0 17.2 0.0 12.0 15.2 8.2 0.0 0.0 21.2 10.0 9.2 0.0 0.0 11.2 32.9 22.6 11.0 11.1 415.8 91.2 10.9 17.8 6.6 4.7 3.6 37.5 14.1 12.6 0.0 15.2 6.5 93.6 47.6 13.4 CYB561A3 CYBASC3 ENSG00000162144 "Cytochrome b561 family member A3" Q8NBI2 11 61348754-61362283 "Predicted membrane proteins" "Electron transport, Transport" "Oxidoreductase, Translocase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 251.4" "Cell type enhanced" "Detected in all" "dendritic cells: 145.1;Melanocytes: 320.2;Theca cells: 128.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "memory B-cell: 314.5;naive B-cell: 386.6;plasmacytoid DC: 841.4" "Group enriched" "Detected in all" 9 "B-cells: 386.6;dendritic cells: 841.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045674, HPA052548" Approved Approved Nucleoli,Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 65: Plasmacytoid DCs - Unknown function" Vesicles Nucleoli "HPA045674: , HPA052548: AB_2681866" "unprognostic (2.61e-1)" "unprognostic (8.78e-2)" "unprognostic (4.16e-1)" "unprognostic (3.62e-2)" "unprognostic (1.37e-1)" "unprognostic (9.41e-3)" "unprognostic (7.41e-3)" "unprognostic (2.48e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.73e-1)" "unprognostic (2.53e-1)" "unprognostic (2.83e-1)" "unprognostic (3.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.80e-3)" 19.5 251.4 10.2 32.6 11.5 26.0 17.3 10.5 10.7 17.1 17.4 33.3 19.2 24.1 18.7 19.6 30.4 27.5 12.3 11.0 10.1 15.3 31.0 21.3 70.3 13.0 13.7 27.1 24.4 21.5 13.8 17.3 12.6 20.9 27.8 11.4 21.8 19.8 26.1 76.0 27.8 18.8 12.3 49.7 20.8 13.6 12.1 28.1 18.5 17.7 70.4 22.9 16.2 14.0 50.2 80.6 13.4 40.6 67.8 41.9 11.3 26.0 37.3 29.8 28.9 22.6 54.3 98.1 42.1 46.2 24.0 67.5 13.6 72.2 20.1 64.5 28.5 18.3 53.6 16.5 32.0 24.9 42.3 63.4 95.7 65.3 30.0 25.0 44.1 46.1 55.5 57.3 51.2 53.3 45.7 11.4 24.5 44.7 51.9 52.2 14.0 72.6 35.2 48.1 16.2 26.1 54.7 71.5 60.5 9.6 58.6 29.3 31.7 34.2 17.8 34.2 35.6 34.3 49.9 56.8 50.6 44.2 46.4 19.4 66.4 35.5 31.0 53.8 28.6 314.5 22.1 29.2 63.5 386.6 23.5 24.6 21.8 31.5 64.0 841.4 23.6 84.8 10.2 11.5 10.5 10.7 11.0 10.1 13.0 13.7 12.6 12.3 12.1 14.0 13.0 6.4 22.8 6.8 96.2 28.3 18.3 86.6 19.9 15.9 19.6 18.7 1.9 10.0 30.0 12.9 31.3 49.9 145.1 53.6 11.7 26.2 53.6 15.4 12.0 13.5 19.2 14.1 4.3 38.8 39.5 16.4 21.4 7.5 8.8 13.0 15.4 21.0 51.4 18.5 4.1 28.9 22.4 23.8 21.2 14.2 20.8 47.9 320.2 8.4 57.1 23.7 28.8 5.5 7.2 26.6 48.9 20.7 10.5 15.9 55.6 13.7 72.0 56.2 13.1 14.8 15.8 7.2 11.5 18.4 24.0 39.5 18.7 128.9 30.7 16.2 TMEM138 "HSPC196, JBTS16" ENSG00000149483 "Transmembrane protein 138" Q9NPI0 11 61362344-61369509 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 194.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042373 Approved Approved Microtubules NA Yes "Cluster 12: Non-specific - Basic cellular processes" "Cluster 77: Retina - Visual perception" "Cluster 30: Epithelial cell lines - Translation" "Cluster 46: Photoreceptor cells - Phototransduction" Microtubules "HPA042373: AB_10793880" "unprognostic (1.30e-1)" "unprognostic (4.69e-3)" "unprognostic (1.28e-1)" "unprognostic (2.78e-2)" "unprognostic (2.15e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (7.90e-4)" "unprognostic (1.06e-2)" "unprognostic (1.58e-1)" "unprognostic (1.86e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (4.12e-6)" "unprognostic (2.28e-1)" "unprognostic (4.42e-2)" "unprognostic (3.49e-1)" "unprognostic (4.46e-1)" 13.8 40.6 8.4 11.5 8.5 18.1 14.3 10.3 9.7 16.3 10.0 13.4 10.8 17.5 25.9 10.8 17.3 11.6 9.1 8.7 9.1 17.9 22.2 15.3 18.0 9.0 11.0 23.7 13.9 18.4 12.6 14.9 8.6 17.1 18.7 50.7 11.1 13.8 6.8 18.6 15.9 18.6 9.0 18.4 13.5 12.5 8.9 14.0 13.5 8.5 22.8 17.8 13.3 9.5 16.3 35.5 14.0 20.3 48.9 20.1 16.5 24.9 30.7 36.2 32.8 17.7 24.6 14.0 21.0 29.7 56.5 30.2 26.0 31.0 39.8 18.0 14.4 10.1 28.7 21.0 35.0 21.8 26.3 32.4 47.7 60.5 39.4 13.5 31.4 16.7 29.8 23.0 60.1 45.4 17.3 21.6 22.8 28.2 34.5 11.9 10.3 30.4 32.3 39.6 14.9 11.1 31.7 30.4 34.2 12.8 47.3 19.0 18.7 45.2 18.7 31.5 24.7 24.0 24.6 13.6 23.7 26.5 24.0 41.7 26.0 26.5 23.1 26.6 25.3 26.1 21.7 22.3 15.9 24.1 24.0 21.4 5.3 27.8 18.2 28.0 30.2 24.1 8.4 8.5 10.3 9.7 8.7 9.1 9.0 11.0 8.6 9.0 8.9 9.5 12.6 16.0 23.2 16.0 23.1 19.9 16.1 49.8 25.0 28.9 15.7 17.1 4.2 4.3 26.2 20.2 81.3 54.8 27.3 13.9 15.6 17.1 21.7 22.0 16.6 18.7 9.6 22.1 12.5 16.0 39.9 20.5 9.2 7.0 37.3 17.8 13.6 16.3 45.7 15.2 12.1 11.6 16.2 15.6 10.7 7.6 31.7 35.6 37.4 3.7 25.5 25.9 36.0 10.1 8.1 18.6 11.5 28.6 18.1 22.1 26.7 20.8 59.6 194.1 0.0 15.3 14.3 24.9 16.2 16.3 20.5 27.5 23.3 56.9 14.3 12.9 TMEM216 "CORS2, HSPC244, JBTS2, MGC13379, MKS2" ENSG00000187049 "Transmembrane protein 216" Q9P0N5 11 61392360-61398863 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 192.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 84.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "unprognostic (7.75e-2)" "unprognostic (1.54e-1)" "unprognostic (6.20e-2)" "unprognostic (1.94e-1)" "unprognostic (1.06e-2)" "unprognostic (1.58e-1)" "unprognostic (9.02e-3)" "unprognostic (4.44e-2)" "unprognostic (1.97e-1)" "unprognostic (1.79e-1)" "unprognostic (1.90e-2)" "unprognostic (9.66e-2)" "unprognostic (2.59e-3)" "unprognostic (2.05e-1)" "unprognostic (2.54e-1)" "unprognostic (1.47e-2)" "unprognostic (8.03e-3)" 12.5 12.5 22.2 8.0 22.0 16.5 18.8 22.0 23.8 16.4 22.2 10.4 8.5 11.6 18.0 10.7 20.4 10.0 8.4 21.6 22.4 15.1 6.4 8.3 13.7 22.2 22.7 28.3 15.6 11.4 20.8 13.3 21.7 13.2 11.7 11.8 15.9 12.9 4.3 9.6 11.3 10.7 22.1 14.7 11.3 14.8 22.9 12.7 12.7 6.9 16.5 13.9 12.2 21.5 13.9 15.1 23.2 18.6 37.6 18.2 5.6 7.8 11.9 16.9 12.1 24.3 24.4 5.1 25.6 13.0 0.1 18.1 26.1 14.7 19.6 41.2 16.8 9.7 9.3 32.2 21.7 51.8 14.6 16.0 22.7 10.2 20.2 6.1 16.4 1.7 21.7 11.1 10.9 57.9 3.7 84.1 24.8 44.9 34.2 0.6 18.8 16.2 14.5 32.8 10.6 16.9 19.6 11.3 14.4 17.3 12.8 26.4 7.5 0.1 0.6 8.5 0.1 9.1 6.9 7.9 0.2 20.6 8.0 87.2 28.1 192.7 32.5 31.0 30.7 50.5 34.1 32.3 33.9 49.9 36.0 30.5 44.3 68.6 26.1 12.3 42.0 23.6 22.2 22.0 22.0 23.8 21.6 22.4 22.2 22.7 21.7 22.1 22.9 21.5 11.7 6.4 9.7 11.1 17.8 4.7 17.5 30.8 23.3 4.2 18.8 29.8 2.9 11.5 14.5 1.8 2.1 19.6 11.9 5.1 19.6 14.0 5.7 8.5 15.7 11.3 9.6 12.6 4.0 16.9 20.6 18.5 5.1 5.6 8.8 14.1 12.5 2.0 14.1 5.0 4.1 11.6 14.2 6.2 5.2 2.4 21.1 8.6 7.2 4.7 7.9 25.4 24.7 4.5 2.2 12.5 8.6 13.5 13.9 23.6 8.1 9.2 19.1 5.4 13.1 11.7 9.3 36.5 20.8 19.3 3.4 8.6 16.7 14.5 11.5 14.1 CPSF7 "CFIM59, FLJ12529" ENSG00000149532 "Cleavage and polyadenylation specific factor 7" Q8N684 11 61402641-61430031 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041094 Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm Cytosol "HPA041094: AB_10794187" "unprognostic (6.87e-3)" "unprognostic (8.31e-2)" "unprognostic (1.94e-1)" "unprognostic (4.79e-3)" "unprognostic (1.07e-1)" "unprognostic (9.41e-3)" "prognostic unfavorable (9.83e-4)" "unprognostic (5.35e-2)" "unprognostic (2.07e-3)" "unprognostic (7.95e-2)" "unprognostic (2.59e-1)" "unprognostic (3.74e-2)" "unprognostic (3.90e-2)" "unprognostic (2.16e-1)" "unprognostic (1.71e-1)" "unprognostic (2.38e-1)" "unprognostic (6.18e-2)" 43.2 44.1 39.1 36.0 40.7 55.0 44.2 40.0 48.4 55.2 39.8 48.9 32.0 54.8 44.1 46.6 55.1 27.3 39.5 37.9 41.3 44.2 62.8 38.0 43.3 38.1 41.0 55.6 49.2 35.0 79.1 37.8 39.1 47.3 34.3 40.7 41.4 34.7 68.0 52.3 49.0 43.7 33.9 57.4 47.3 42.0 39.3 57.8 58.9 48.1 43.7 47.4 45.7 44.3 72.5 71.0 98.0 78.2 52.0 45.8 68.7 58.9 56.2 76.7 58.4 83.7 60.6 107.7 61.4 63.6 65.0 87.4 94.7 67.4 93.1 71.8 48.4 90.9 95.8 68.0 52.5 111.4 77.9 48.7 54.3 81.3 118.4 46.7 52.8 69.1 111.2 67.1 56.2 87.7 110.5 90.9 96.2 50.5 55.6 102.8 77.1 88.9 57.8 87.9 66.3 67.6 78.2 68.4 74.3 59.7 94.4 47.6 53.2 84.4 71.6 79.0 61.4 92.0 116.5 122.4 49.3 53.2 63.0 15.1 5.6 7.1 8.1 6.0 8.7 6.9 6.4 8.4 7.6 6.5 7.0 7.2 9.8 6.7 4.6 6.4 4.8 5.7 39.1 40.7 40.0 48.4 37.9 41.3 38.1 41.0 39.1 33.9 39.3 44.3 23.3 35.3 21.2 56.8 29.0 23.2 18.4 15.5 26.7 21.4 26.1 24.9 11.4 11.5 16.0 16.5 39.6 26.7 29.4 22.6 17.6 15.7 41.8 17.1 21.7 22.6 22.2 20.0 29.8 13.8 17.5 20.7 22.4 21.3 23.5 26.6 22.9 27.2 19.6 32.0 31.0 21.9 16.2 31.0 19.0 29.1 27.4 23.4 3.6 37.5 39.7 24.2 22.6 31.7 39.8 19.5 13.6 25.2 28.6 25.0 22.3 14.3 19.9 21.7 39.5 28.8 22.6 37.5 27.1 25.0 26.3 27.5 22.1 17.7 23.0 23.0 AP003108.2 ENSG00000256591 "Novel transcript" 11 61429220-61485822 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Collecting duct cells: 3.7;dendritic cells: 1.4;Endometrial stromal cells: 1.5;Glandular and luminal cells: 1.4;Granulosa cells: 3.4;Respiratory ciliated cells: 1.5;Theca cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 28.0" "Low region specificity" "Detected in all" HPA039732 Approved NA NA "Cluster 35: T-regs - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 40: Granulosa cells - Unknown function" "HPA039732: AB_10962868" "unprognostic (1.23e-1)" "unprognostic (8.61e-2)" "unprognostic (9.60e-2)" "unprognostic (4.91e-2)" "unprognostic (5.69e-2)" "unprognostic (5.98e-2)" "unprognostic (4.41e-2)" "unprognostic (6.40e-2)" "unprognostic (3.53e-2)" "unprognostic (5.83e-2)" "unprognostic (4.98e-1)" "unprognostic (2.28e-1)" "unprognostic (2.36e-7)" "unprognostic (5.74e-2)" "unprognostic (9.69e-2)" "unprognostic (1.40e-1)" "unprognostic (4.66e-3)" 5.1 4.7 2.7 4.0 3.1 8.7 4.0 3.0 3.9 5.9 2.6 2.7 2.2 3.6 3.1 3.4 3.2 4.8 7.0 3.1 3.4 3.6 2.4 3.8 4.6 3.2 3.3 2.1 2.0 2.3 1.3 3.1 3.3 3.3 3.3 1.0 2.6 2.7 1.8 1.7 2.6 4.2 3.0 4.4 3.4 2.9 3.2 7.7 5.1 5.9 4.8 5.4 1.9 3.1 6.8 3.3 3.8 6.1 9.7 8.1 2.0 8.9 7.6 6.6 6.2 2.6 4.5 7.1 14.5 8.3 5.5 3.0 4.5 6.3 3.9 6.3 5.3 5.4 0.9 0.9 11.4 4.2 2.0 15.6 3.8 9.8 7.8 4.2 16.7 9.2 5.8 6.0 10.9 5.3 14.1 4.0 8.5 5.8 4.5 8.4 5.8 8.6 4.4 5.4 3.0 3.8 3.7 3.5 12.6 2.5 4.9 4.8 28.0 8.4 4.7 4.5 5.0 2.2 9.5 4.8 7.2 5.5 6.3 5.9 8.0 8.4 11.6 7.3 14.6 5.9 11.5 11.8 6.3 6.8 13.2 12.3 11.2 7.4 6.8 6.8 12.9 10.2 2.7 3.1 3.0 3.9 3.1 3.4 3.2 3.3 3.3 3.0 3.2 3.1 0.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.0 0.6 3.7 0.0 0.3 1.4 0.0 0.0 0.2 0.0 0.7 1.5 0.6 0.0 0.0 0.0 0.2 0.4 0.3 0.0 1.4 1.3 3.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.6 1.5 0.0 0.0 SDHAF2 "C11orf79, FLJ20487, PGL2, SDH5" ENSG00000167985 "Succinate dehydrogenase complex assembly factor 2" Q9NX18 11 61430042-61446733 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039464, HPA039732" Supported Approved Nucleoli,Mitochondria,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Mitochondria, Cytosol" Nucleoli "HPA039464: AB_10962146, HPA039732: AB_10962868" "unprognostic (5.31e-2)" "unprognostic (1.12e-2)" "unprognostic (3.13e-1)" "unprognostic (1.30e-2)" "unprognostic (1.40e-1)" "unprognostic (6.71e-2)" "unprognostic (1.98e-3)" "unprognostic (9.06e-2)" "unprognostic (2.17e-1)" "unprognostic (2.09e-3)" "unprognostic (4.21e-3)" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (3.61e-1)" "unprognostic (1.78e-1)" "unprognostic (1.45e-1)" "unprognostic (4.48e-2)" 27.5 37.1 36.2 26.4 37.4 45.6 28.9 37.9 38.2 23.8 37.4 27.2 24.7 23.8 34.8 28.8 28.7 25.5 40.4 35.9 40.2 36.5 46.4 23.8 39.9 37.9 37.6 26.9 24.0 32.9 41.0 24.9 37.9 29.0 29.1 23.4 26.3 20.9 38.9 26.3 27.0 26.9 37.7 34.7 27.6 22.1 38.0 38.0 28.6 44.7 41.6 32.8 21.7 39.2 45.0 58.4 36.5 25.1 57.2 52.2 27.0 33.3 58.0 48.9 41.8 52.8 46.8 42.3 58.4 55.6 62.8 45.4 45.4 51.4 56.6 60.4 39.7 33.2 35.5 71.9 52.8 41.4 48.1 55.6 58.7 50.2 45.8 35.3 80.8 43.5 42.2 50.9 63.5 86.0 49.2 89.3 56.1 47.0 78.6 45.9 45.9 76.6 63.7 57.9 36.9 40.6 46.9 53.5 99.0 38.5 83.0 40.2 53.3 45.0 32.7 54.3 37.5 31.2 51.2 54.7 43.4 37.3 46.0 125.3 68.8 126.6 82.5 64.5 103.1 89.7 93.0 91.7 55.9 84.8 101.5 97.5 97.9 97.9 53.3 63.3 126.7 78.6 36.2 37.4 37.9 38.2 35.9 40.2 37.9 37.6 37.9 37.7 38.0 39.2 32.8 35.3 33.2 11.1 28.9 20.6 34.6 53.7 10.2 14.0 27.9 35.1 22.3 14.3 33.5 29.5 6.2 77.0 41.9 29.5 54.8 55.3 15.8 19.3 21.7 36.5 34.2 30.3 13.2 60.3 51.4 28.4 16.8 19.0 32.3 22.2 42.5 42.3 52.7 15.2 13.3 31.4 59.0 36.5 22.8 17.8 31.4 29.7 44.4 8.4 66.4 49.4 69.0 16.6 18.1 62.9 34.9 30.9 16.3 30.8 34.0 51.9 31.5 19.7 32.9 17.3 27.2 23.1 25.8 10.9 22.4 99.6 41.5 45.1 27.6 38.8 PPP1R32 "C11orf66, FLJ32771, IIIG9" ENSG00000162148 "Protein phosphatase 1 regulatory subunit 32" Q7Z5V6 11 61481120-61490931 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 93.8" "Group enriched" "Detected in many" 4 "Early spermatids: 253.2;Late spermatids: 363.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039068 Enhanced NA NA "Cluster 10: Basophils - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 25: Spermatids - Spermatogenesis" "HPA039068: AB_10672840" "unprognostic (1.70e-1)" "unprognostic (3.18e-3)" "unprognostic (4.48e-4)" "prognostic favorable (4.13e-4)" "unprognostic (2.23e-1)" "unprognostic (1.07e-2)" "unprognostic (1.50e-3)" "unprognostic (4.52e-2)" "unprognostic (2.81e-1)" "unprognostic (1.60e-1)" "unprognostic (1.04e-2)" "unprognostic (3.03e-2)" "unprognostic (9.44e-9)" "unprognostic (2.64e-1)" "unprognostic (2.71e-1)" "unprognostic (2.32e-1)" "unprognostic (1.75e-2)" 5.3 3.4 18.1 3.8 18.3 5.5 5.7 14.9 20.5 8.8 32.7 6.4 3.6 6.2 12.7 2.9 40.6 3.7 4.4 18.6 20.9 6.5 7.7 10.9 7.3 28.0 36.7 6.6 3.6 1.9 14.0 4.2 25.7 6.0 2.7 2.6 4.1 4.5 4.6 11.5 5.0 4.8 24.6 7.4 4.2 93.8 19.4 6.4 4.4 2.0 4.3 4.4 5.6 21.8 0.7 1.4 8.4 3.5 3.7 5.5 1.1 1.7 1.3 1.1 0.9 0.4 7.4 1.6 2.3 0.8 0.4 0.9 1.2 0.6 2.1 2.7 1.7 2.1 0.4 0.2 3.6 1.4 1.6 5.8 2.1 0.4 6.2 6.7 0.8 6.0 0.8 5.0 0.5 1.9 2.1 3.0 0.6 1.4 0.8 4.1 0.2 0.5 1.1 0.3 0.9 2.0 0.3 3.7 0.6 0.7 4.3 4.6 3.1 0.4 1.7 1.3 0.3 8.0 2.3 1.0 0.9 6.0 0.7 1.5 1.1 0.7 1.0 1.3 1.0 0.4 0.6 0.2 0.5 0.4 0.4 1.3 2.0 0.8 0.4 0.4 0.8 0.9 18.1 18.3 14.9 20.5 18.6 20.9 28.0 36.7 25.7 24.6 19.4 21.8 1.5 3.2 1.1 6.8 0.5 0.1 0.8 2.5 0.0 0.5 4.2 4.1 1.3 0.0 6.1 5.5 0.0 1.0 2.2 0.7 31.3 0.5 253.2 27.9 0.9 1.5 3.5 0.0 2.2 1.6 0.3 1.1 0.0 0.8 0.0 1.7 0.4 10.8 0.8 0.0 1.1 1.0 4.1 1.8 1.2 363.8 3.7 0.8 0.0 1.9 1.3 3.0 2.1 1.5 2.7 0.6 1.1 4.1 0.9 1.8 2.1 20.3 72.1 0.2 0.0 0.7 2.6 8.1 1.9 0.1 0.3 0.4 0.7 0.6 0.9 0.8 LRRC10B ENSG00000204950 "Leucine rich repeat containing 10B" A6NIK2 11 61508749-61511018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 42.4;fallopian tube: 28.7;pituitary gland: 33.7" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 49.3;Muller glia cells: 9.5;Respiratory ciliated cells: 37.2;Sertoli cells: 19.7;Smooth muscle cells: 20.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.8" "Region enhanced" "Detected in many" "basal ganglia: 42.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 9.7;RH-30: 10.5;SCLC-21H: 5.4" "Region enriched" "Detected in many" 7 "basal ganglia: 222.5" "Group enriched" "Detected in many" 5 "basal ganglia: 30.9;hippocampal formation: 24.2" HPA047619 Uncertain Approved Nucleoplasm,Nucleoli No NA "Cluster 10: Brain - Neuronal signaling" "Cluster 12: NES - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm Nucleoli "HPA047619: AB_2680106" "unprognostic (9.95e-2)" "unprognostic (2.67e-2)" "unprognostic (4.92e-2)" "unprognostic (1.26e-2)" "unprognostic (2.11e-1)" "unprognostic (1.32e-1)" "unprognostic (6.10e-2)" "unprognostic (9.22e-2)" "unprognostic (4.88e-3)" "unprognostic (1.62e-1)" "unprognostic (9.21e-3)" "unprognostic (2.52e-2)" "unprognostic (5.27e-4)" "unprognostic (5.07e-2)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (6.63e-2)" 3.7 0.9 11.1 0.4 42.4 0.0 2.9 0.5 11.2 5.9 3.6 2.2 0.3 4.9 1.9 0.5 28.7 0.3 1.7 13.5 5.2 2.2 0.1 4.9 0.0 4.0 4.0 2.3 1.3 2.2 33.7 0.5 2.1 1.6 0.3 0.1 1.3 0.5 0.7 0.9 1.4 1.6 3.1 0.4 2.9 5.9 7.9 2.7 1.6 0.9 0.0 1.1 2.5 3.4 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.8 0.0 0.2 0.0 0.0 0.0 10.5 0.0 0.0 0.0 5.4 0.5 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 42.4 0.5 11.2 13.5 5.2 4.0 4.0 2.1 3.1 7.9 3.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.6 0.6 0.4 1.1 0.0 3.5 1.8 0.0 0.0 0.0 0.1 0.0 0.0 3.2 49.3 0.5 0.4 4.2 0.0 1.0 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.8 6.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 37.2 0.2 19.7 0.7 20.6 0.8 1.1 0.0 0.3 0.1 0.1 0.2 0.1 0.1 SYT7 "IPCA-7, MGC150517, PCANAP7, SYT-VII" ENSG00000011347 "Synaptotagmin 7" O43581 11 61513714-61581148 "Predicted intracellular proteins, Predicted membrane proteins" Exocytosis Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.4;liver: 86.7;salivary gland: 57.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 45.2;Enteroendocrine cells: 49.8;Excitatory neurons: 82.1;Hepatocytes: 70.7;Prostatic glandular cells: 36.8;Syncytiotrophoblasts: 66.4" "Cancer enhanced" "Detected in all" "prostate cancer: 54.4" "Region enhanced" "Detected in many" "cerebral cortex: 78.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 35.0;hTERT-HME1: 89.5;RT4: 37.8;SCLC-21H: 28.4;SK-BR-3: 40.7;T-47d: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012869 Enhanced NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA012869: AB_1857698" "unprognostic (7.09e-2)" "unprognostic (8.26e-2)" "unprognostic (2.43e-1)" "unprognostic (2.10e-2)" "unprognostic (5.42e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (4.37e-2)" "unprognostic (5.08e-2)" "unprognostic (2.74e-3)" "unprognostic (1.79e-2)" "unprognostic (1.02e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (2.08e-1)" "unprognostic (1.69e-1)" "unprognostic (2.23e-3)" "unprognostic (2.47e-1)" 3.8 4.3 17.7 1.2 33.8 0.1 9.2 0.0 78.4 3.1 0.0 5.0 2.3 2.6 1.8 3.5 3.4 1.2 19.0 30.7 1.9 24.7 86.7 1.9 0.3 0.0 1.9 1.3 16.7 5.7 51.6 18.4 0.0 50.8 5.3 8.0 57.0 0.9 3.6 4.2 5.2 1.8 0.0 2.1 3.7 4.0 13.9 0.4 8.0 1.8 0.3 1.9 3.3 38.5 13.4 1.9 0.5 0.2 1.0 14.1 10.4 0.2 35.0 0.6 0.5 3.5 6.9 0.0 0.6 0.2 1.3 6.9 0.9 0.2 0.2 0.2 1.7 0.0 1.7 2.1 0.9 0.1 0.1 0.4 7.8 4.2 89.5 0.2 0.2 0.8 0.1 0.2 0.5 21.6 0.1 0.3 2.4 24.8 14.1 0.0 0.7 1.7 0.0 37.8 28.4 5.2 1.9 40.7 0.3 5.6 39.8 0.0 0.0 8.6 3.1 10.1 0.2 0.0 0.0 0.1 0.9 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 33.8 0.0 78.4 30.7 1.9 0.0 1.9 0.0 0.0 13.9 38.5 10.6 0.0 0.5 4.2 0.2 0.3 0.4 5.1 0.0 22.6 23.2 16.3 22.3 1.5 5.0 5.5 0.0 45.2 0.6 1.9 5.9 1.2 8.4 0.3 4.3 4.9 49.8 2.7 82.1 1.6 3.4 3.0 0.0 0.5 0.0 5.9 4.6 70.7 4.0 21.9 17.8 30.2 6.1 1.0 0.0 7.6 3.4 0.1 1.8 7.5 0.0 0.6 0.0 6.0 2.5 1.0 4.6 2.2 0.0 36.8 3.5 0.1 1.3 3.5 0.0 2.8 1.4 0.8 3.9 0.9 0.1 66.4 0.2 0.6 2.4 1.7 DAGLA "C11orf11, DAGLALPHA, KIAA0659, NSDDR" ENSG00000134780 "Diacylglycerol lipase alpha" Q9Y4D2 11 61680391-61747001 "Disease related genes, Metabolic proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.5" "Cell type enhanced" "Detected in many" "Astrocytes: 12.7;Excitatory neurons: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.5;T-47d: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062497, CAB078793" Approved Supported NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 6: T47d - Mammary gland" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "CAB078793: , HPA062497: AB_2684784" "unprognostic (2.53e-3)" "unprognostic (1.85e-1)" "unprognostic (1.26e-2)" "prognostic unfavorable (1.13e-7)" "unprognostic (1.23e-1)" "unprognostic (1.70e-1)" "unprognostic (1.14e-4)" "unprognostic (2.22e-2)" "unprognostic (2.29e-3)" "unprognostic (3.99e-3)" "unprognostic (1.55e-1)" "unprognostic (1.09e-1)" "unprognostic (1.11e-3)" "unprognostic (1.53e-1)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" "unprognostic (1.14e-2)" 1.7 1.4 3.0 1.3 4.2 0.3 2.6 0.3 12.5 1.9 0.0 3.8 2.2 2.4 1.7 3.8 2.2 1.3 2.7 9.1 2.0 1.5 0.3 1.9 0.5 0.0 2.6 0.6 5.3 0.8 3.0 0.7 0.0 2.4 1.7 0.6 3.9 1.8 3.3 0.6 2.4 1.3 0.0 1.7 1.8 2.0 5.5 0.1 1.2 1.1 0.2 0.7 0.9 4.2 5.6 6.4 4.9 1.0 1.1 1.7 0.7 2.6 0.7 2.9 3.1 3.7 11.5 0.0 2.6 2.4 4.5 3.3 0.8 0.0 1.2 0.0 3.3 0.0 5.0 5.8 1.8 0.0 0.8 0.9 0.3 3.7 0.0 1.7 0.7 0.4 0.0 0.0 1.3 2.3 0.1 0.0 9.4 1.9 6.2 0.0 0.7 0.0 0.9 1.3 10.0 5.5 1.4 2.0 1.2 1.2 12.5 2.5 3.5 1.6 8.5 5.2 3.2 0.0 0.0 0.0 5.2 1.5 2.8 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.0 4.2 0.3 12.5 9.1 2.0 0.0 2.6 0.0 0.0 5.5 4.2 2.9 3.2 0.5 12.7 0.1 0.4 0.3 1.3 1.8 1.6 3.2 2.2 1.0 1.5 2.8 3.7 0.0 0.1 0.0 4.0 0.0 1.8 0.1 0.7 3.9 1.2 4.2 0.0 14.8 2.3 0.1 1.2 3.1 0.5 0.0 0.5 1.8 0.1 2.5 0.0 8.3 6.1 4.1 4.4 4.7 0.4 1.8 2.9 0.0 3.7 0.9 1.9 0.0 3.5 1.1 2.2 1.5 4.1 0.0 0.5 3.6 0.4 1.7 0.6 0.0 3.1 0.8 1.8 3.0 2.5 0.3 0.0 0.2 0.7 4.9 0.2 MYRF "C11orf9, MRF, Ndt80, pqn-47" ENSG00000124920 "Myelin regulatory factor" Q9Y2G1 11 61752636-61788518 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Hydrolase, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 168.0;stomach 1: 88.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 48.1;Cholangiocytes: 60.1;Gastric mucus-secreting cells: 130.0;Oligodendrocytes: 255.8;Pancreatic endocrine cells: 70.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 38.8;CACO-2: 63.6;CAPAN-2: 34.0;EFO-21: 48.6;Hep G2: 21.8;OE19: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018310 Approved Nucleoplasm,Cytosol NA NA 1400000 "Cluster 70: Brain - Nervous system development" "Cluster 39: CACO-2 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm Cytosol "HPA018310: AB_1845534" "unprognostic (3.51e-2)" "unprognostic (3.34e-1)" "unprognostic (1.56e-1)" "unprognostic (5.39e-2)" "unprognostic (1.54e-1)" "unprognostic (3.65e-2)" "unprognostic (1.34e-1)" "unprognostic (9.34e-3)" "unprognostic (2.44e-1)" "unprognostic (1.27e-1)" "unprognostic (1.01e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (2.01e-4)" "unprognostic (8.91e-3)" "unprognostic (1.11e-1)" "unprognostic (2.67e-1)" "unprognostic (6.73e-2)" 15.4 0.6 31.3 1.1 99.0 0.3 0.4 67.9 67.5 2.2 0.0 3.8 11.4 13.1 0.1 2.4 15.4 17.3 2.4 36.9 48.8 12.0 16.9 22.3 0.1 101.7 89.4 17.6 31.6 0.0 0.4 1.1 84.9 0.7 1.1 0.4 0.6 0.3 0.1 0.5 10.8 1.9 43.5 0.5 88.3 3.1 85.7 0.0 0.3 0.0 0.1 0.5 0.6 168.0 3.1 38.8 4.7 1.5 0.0 0.0 0.2 0.2 0.1 0.9 0.8 63.6 34.0 0.9 48.6 0.0 1.2 0.3 1.3 0.0 0.9 0.1 0.6 0.2 0.7 21.8 18.9 0.0 0.4 0.3 0.0 0.6 0.0 10.9 0.1 1.6 11.7 0.3 0.2 0.5 0.0 0.9 1.6 37.2 4.8 0.0 0.1 1.9 6.5 0.0 0.1 0.9 0.0 0.4 0.3 10.6 0.6 0.4 1.4 0.4 19.5 0.0 0.6 0.2 0.1 0.3 0.1 2.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.3 99.0 67.9 67.5 36.9 48.8 101.7 89.4 84.9 43.5 85.7 168.0 0.1 48.1 5.1 2.3 0.6 0.1 0.1 0.2 0.0 0.5 0.8 0.8 1.3 60.1 3.4 3.7 0.0 0.4 1.6 6.4 0.0 31.7 0.2 1.4 3.2 0.6 1.2 0.0 0.9 36.7 0.3 5.6 130.0 4.1 0.0 4.4 0.7 6.0 0.9 0.0 1.1 4.5 6.1 0.0 0.6 1.2 5.9 0.8 3.6 0.0 1.0 3.5 0.0 5.5 255.8 70.5 13.0 3.8 0.4 0.2 12.8 2.2 1.3 0.3 0.0 0.2 1.2 1.4 3.7 0.8 0.0 0.8 0.7 0.3 7.7 3.1 TMEM258 "C11orf10, Kud, Kuduk" ENSG00000134825 "Transmembrane protein 258" P61165 11 61768501-61792802 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044602 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "Plasma membrane" "HPA044602: AB_10961423" "unprognostic (6.35e-2)" "unprognostic (1.70e-1)" "unprognostic (7.49e-2)" "unprognostic (4.99e-3)" "unprognostic (9.95e-2)" "unprognostic (1.24e-2)" "unprognostic (3.18e-2)" "unprognostic (1.24e-1)" "unprognostic (8.48e-2)" "prognostic favorable (4.37e-4)" "unprognostic (1.34e-3)" "unprognostic (7.39e-2)" "unprognostic (4.75e-3)" "unprognostic (2.59e-2)" "unprognostic (1.02e-1)" "unprognostic (3.34e-2)" "unprognostic (2.58e-1)" 116.4 158.4 125.5 66.1 128.7 128.4 120.8 130.8 162.2 142.2 123.0 112.4 80.9 116.0 350.1 122.8 123.1 59.3 170.8 122.6 128.7 123.5 160.6 110.0 83.0 130.0 125.6 154.9 300.3 80.5 128.9 80.4 130.3 105.5 107.6 44.0 183.9 88.7 146.7 95.3 99.8 81.5 131.1 124.4 142.8 79.1 126.8 111.7 109.1 120.6 108.9 107.5 111.7 140.1 144.3 254.9 194.9 173.3 329.0 308.4 117.1 113.9 177.1 104.5 124.8 223.5 265.5 103.9 205.9 272.1 196.1 154.8 186.7 222.7 149.1 141.7 168.6 86.8 258.3 347.6 310.7 186.9 96.3 272.5 339.6 137.1 364.8 267.9 210.9 207.4 221.7 394.5 185.4 501.1 131.2 318.8 267.1 315.6 172.9 142.1 144.6 673.0 241.5 243.7 169.3 173.1 103.8 221.7 211.5 179.6 244.5 347.3 108.0 129.2 111.7 166.1 78.3 248.6 201.7 173.6 183.8 112.6 135.7 507.9 225.6 287.6 169.5 200.4 216.5 233.2 198.8 190.1 177.8 187.1 167.1 166.7 182.4 151.7 204.4 496.4 236.8 244.9 125.5 128.7 130.8 162.2 122.6 128.7 130.0 125.6 130.3 131.1 126.8 140.1 211.3 102.5 224.1 6.8 323.6 228.9 220.5 794.5 170.8 41.3 525.1 608.3 491.3 403.2 445.9 318.2 18.8 409.5 279.8 306.2 295.4 534.8 234.4 369.2 304.7 254.8 311.1 197.7 7.4 654.4 667.7 314.8 210.5 305.6 226.7 261.8 335.2 572.9 461.4 37.0 8.2 631.5 441.5 401.7 396.9 142.8 335.5 265.7 569.2 3.7 430.0 418.6 270.8 6.0 25.8 469.4 432.6 214.4 821.3 296.6 392.2 553.8 470.9 73.9 170.9 192.3 248.5 399.4 433.8 297.4 279.0 508.0 245.2 135.3 442.1 274.9 FEN1 "FEN-1, MF1, RAD2" ENSG00000168496 "Flap structure-specific endonuclease 1" P39748 11 61792911-61797238 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 46.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 87.5;Extravillous trophoblasts: 70.9;Spermatocytes: 61.0;Spermatogonia: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002262, HPA006748" Enhanced Enhanced Nucleoplasm,Nucleoli NA Yes 160000 "Cluster 44: Non-specific - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "CAB002262: AB_563729, HPA006748: AB_1848494" "unprognostic (1.82e-1)" "unprognostic (2.71e-2)" "unprognostic (3.76e-2)" "unprognostic (2.77e-1)" "unprognostic (1.26e-1)" "unprognostic (6.45e-2)" "prognostic unfavorable (3.39e-6)" "unprognostic (1.50e-2)" "unprognostic (9.82e-2)" "prognostic favorable (7.85e-4)" "unprognostic (2.82e-3)" "unprognostic (5.86e-2)" "prognostic unfavorable (5.73e-6)" "prognostic favorable (9.46e-4)" "unprognostic (1.10e-1)" "unprognostic (4.49e-3)" "unprognostic (4.04e-2)" 5.9 10.4 7.8 21.3 7.8 39.5 10.2 10.9 9.9 6.2 9.6 15.5 11.2 6.3 7.1 14.2 5.7 4.3 6.6 8.0 7.7 5.8 9.9 5.6 34.0 10.0 8.3 3.9 6.8 5.6 8.3 12.9 10.7 6.2 16.1 17.4 6.1 5.9 13.1 9.6 11.4 8.9 6.8 12.8 8.4 19.1 9.1 46.0 4.8 9.6 37.4 8.1 4.9 8.1 154.6 139.7 149.3 81.3 14.9 18.0 94.9 133.3 76.1 160.9 181.4 123.4 112.8 222.6 100.3 57.3 150.5 158.3 214.3 117.7 163.3 117.8 117.6 117.6 187.7 127.3 11.0 184.7 115.4 12.7 15.8 148.1 39.0 23.3 63.1 122.1 181.3 155.1 136.0 195.4 259.7 165.4 165.3 120.3 134.7 173.8 173.7 228.9 64.4 144.7 170.0 140.7 89.6 115.0 79.1 70.1 167.4 127.1 43.2 141.5 178.1 182.3 134.6 120.4 204.3 228.9 98.4 121.9 124.6 24.7 6.7 14.2 16.2 12.9 16.8 14.4 12.3 15.1 8.0 14.8 14.0 13.8 2.7 20.0 12.9 24.5 25.2 10.3 7.8 7.8 10.9 9.9 8.0 7.7 10.0 8.3 10.7 6.8 9.1 8.1 2.7 0.0 2.2 0.3 14.0 10.3 5.2 18.2 7.4 23.8 7.4 7.4 5.8 5.7 7.7 0.0 12.5 53.0 15.9 6.7 7.9 17.3 21.7 4.2 5.5 5.5 4.8 87.5 2.0 12.2 70.9 8.6 7.1 6.3 0.0 18.6 1.1 7.2 25.7 15.2 2.4 8.0 18.3 5.4 6.8 14.4 5.6 6.2 5.4 0.0 12.4 31.3 13.4 1.5 3.1 12.2 9.4 7.2 45.3 6.5 3.7 5.7 6.4 23.3 0.0 6.8 12.2 61.0 62.1 11.3 6.1 30.9 11.0 9.0 22.0 5.2 FADS2 "D6D, DES6, FADSD6, LLCDL2, SLL0262, TU13" ENSG00000134824 "Fatty acid desaturase 2" O95864 11 61792980-61867354 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 364.1" "Cell type enhanced" "Detected in many" "Astrocytes: 69.9;Endometrial stromal cells: 57.7;Hepatocytes: 55.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 1141.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006741 Approved NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "HPA006741: AB_1078796" "unprognostic (2.37e-2)" "unprognostic (1.02e-1)" "unprognostic (8.34e-2)" "unprognostic (4.33e-3)" "unprognostic (4.63e-2)" "unprognostic (2.42e-2)" "unprognostic (4.51e-2)" "unprognostic (4.35e-3)" "unprognostic (2.01e-1)" "unprognostic (4.21e-2)" "unprognostic (8.95e-3)" "unprognostic (7.80e-2)" "prognostic unfavorable (1.00e-7)" "unprognostic (6.19e-2)" "unprognostic (1.34e-1)" "unprognostic (1.41e-2)" "prognostic unfavorable (3.42e-4)" 23.7 364.1 140.2 34.7 126.7 28.0 59.6 128.5 135.0 68.0 157.0 24.2 31.9 86.3 27.7 10.6 34.6 20.2 27.7 131.8 164.8 20.3 126.7 33.4 16.5 175.1 186.2 29.1 9.8 80.0 50.8 40.6 155.1 97.7 13.2 41.5 24.3 188.7 12.3 131.6 15.9 125.3 152.0 11.5 14.1 27.8 222.9 34.1 10.4 8.8 31.2 24.6 27.9 134.2 14.6 492.6 655.8 345.0 551.3 1141.8 167.2 86.3 658.3 109.0 288.2 31.4 149.6 3.8 11.4 172.3 167.8 15.7 436.4 709.5 52.7 6.9 11.8 297.9 106.5 72.0 421.9 18.9 15.9 430.9 25.8 383.4 39.1 170.3 324.4 254.4 17.9 212.1 52.0 13.5 166.4 104.7 291.5 0.7 150.1 206.1 13.9 663.1 392.1 4.4 197.4 260.8 49.9 1.4 23.5 164.0 21.5 197.7 139.2 14.0 120.5 9.8 13.1 115.7 110.3 39.7 13.0 96.3 131.2 4.4 6.0 6.9 8.5 8.7 2.0 1.4 3.1 4.6 10.1 3.7 1.8 3.8 2.8 6.6 7.4 13.0 2.9 4.9 140.2 126.7 128.5 135.0 131.8 164.8 175.1 186.2 155.1 152.0 222.9 134.2 3.2 9.6 18.8 69.9 2.0 1.7 1.3 26.9 0.0 9.1 4.7 3.0 4.2 1.5 15.1 3.7 4.2 1.7 5.2 0.5 0.0 6.9 2.2 4.7 57.7 12.2 5.4 26.7 7.4 17.8 22.0 21.0 5.1 9.5 5.1 28.3 2.5 55.8 20.5 5.0 7.7 0.2 22.4 7.2 3.1 5.3 25.7 7.0 8.8 15.0 20.7 32.1 8.2 38.7 11.9 5.1 0.0 23.7 1.4 16.9 0.1 0.7 5.4 13.2 0.0 23.8 29.5 1.3 0.5 1.2 0.6 3.1 2.5 28.3 2.0 0.9 FADS1 "D5D, FADS6, FADSD5, LLCDL1, TU12" ENSG00000149485 "Fatty acid desaturase 1" O60427 11 61799627-61829318 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 91.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC TERT1: 521.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042705 Approved NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA042705: AB_10795709" "unprognostic (8.28e-2)" "unprognostic (3.54e-1)" "unprognostic (1.29e-1)" "unprognostic (1.99e-1)" "unprognostic (8.17e-3)" "unprognostic (1.40e-1)" "unprognostic (1.99e-2)" "unprognostic (3.23e-3)" "unprognostic (7.88e-2)" "unprognostic (1.94e-2)" "unprognostic (4.10e-2)" "unprognostic (2.00e-1)" "prognostic unfavorable (1.95e-9)" "unprognostic (2.29e-2)" "unprognostic (3.59e-2)" "prognostic unfavorable (2.79e-4)" "prognostic unfavorable (1.33e-4)" 26.2 67.7 43.1 19.8 39.2 9.7 13.6 38.4 40.7 19.6 70.7 9.5 5.5 21.3 6.6 5.2 17.4 14.5 22.6 39.3 58.5 9.7 52.8 20.3 9.8 57.9 62.1 27.5 10.0 27.2 21.3 21.1 52.2 19.6 4.9 35.1 6.4 15.8 17.5 15.5 6.7 20.5 46.4 8.0 9.4 11.9 68.7 8.1 6.0 7.8 9.2 12.7 10.2 56.0 66.3 170.1 159.1 41.1 313.2 521.2 46.4 42.0 204.5 69.9 118.9 53.3 143.2 2.3 43.4 60.5 177.2 84.7 130.8 114.1 51.7 12.2 18.4 107.9 191.2 98.9 169.1 23.4 10.4 238.1 38.3 154.7 74.7 73.8 64.1 104.7 59.9 118.6 70.1 18.6 78.6 23.6 94.2 5.5 63.0 85.4 162.5 231.2 81.5 29.0 80.7 89.6 106.7 1.7 90.0 58.4 38.6 98.6 62.1 71.8 70.8 74.2 50.6 112.9 111.3 55.4 42.6 108.9 61.4 7.5 33.2 6.2 12.1 40.4 2.6 2.5 4.0 4.9 28.0 8.7 2.3 5.4 2.6 6.9 17.4 23.6 2.9 15.7 43.1 39.2 38.4 40.7 39.3 58.5 57.9 62.1 52.2 46.4 68.7 56.0 10.3 6.4 77.9 28.7 3.2 2.7 2.5 48.5 1.2 78.9 2.6 3.7 30.4 8.6 25.3 12.9 27.1 9.5 12.4 0.9 0.0 15.2 8.7 4.9 30.7 16.6 9.7 46.3 9.4 33.4 50.0 34.9 6.1 7.8 37.9 65.3 9.3 74.5 37.2 69.0 14.7 0.6 16.2 21.7 21.0 16.4 29.8 27.6 32.0 12.2 32.0 70.5 6.2 13.6 27.4 7.6 0.0 21.4 2.1 6.4 0.1 1.1 8.0 91.9 0.0 40.3 31.9 6.5 17.5 2.3 1.4 9.3 5.5 75.2 1.4 1.6 FADS3 "CYB5RP, LLCDL3" ENSG00000221968 "Fatty acid desaturase 3" Q9Y5Q0 11 61873519-61892051 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 164.6;Extravillous trophoblasts: 138.4;Rod photoreceptor cells: 120.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 7.7;naive B-cell: 8.7" "Group enriched" "Detected in many" 4 "B-cells: 8.7;granulocytes: 5.7;T-cells: 2.1" "Cell line enhanced" "Detected in all" "ASC diff: 283.2;HHSteC: 243.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045224 Approved Approved "Nucleoli fibrillar center" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoli fibrillar center" "HPA045224: AB_10967570" "unprognostic (4.69e-3)" "unprognostic (1.31e-2)" "unprognostic (5.55e-3)" "unprognostic (1.20e-1)" "unprognostic (2.91e-2)" "prognostic unfavorable (9.54e-5)" "unprognostic (1.76e-3)" "unprognostic (3.46e-1)" "unprognostic (6.45e-2)" "unprognostic (1.49e-1)" "unprognostic (1.28e-3)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.50e-9)" "unprognostic (1.14e-1)" "unprognostic (3.92e-2)" "unprognostic (1.53e-1)" "unprognostic (2.37e-1)" 105.0 72.3 37.1 23.4 37.3 5.1 72.5 29.6 50.7 31.2 55.3 27.5 4.8 27.9 31.7 9.5 26.7 12.1 88.9 36.9 35.2 29.4 23.7 45.4 21.6 34.8 33.7 35.7 25.4 11.4 14.1 64.0 38.9 21.3 4.6 15.0 14.3 13.1 45.2 13.4 28.1 19.4 29.8 22.3 22.7 13.4 37.3 4.3 18.1 14.8 20.9 36.7 21.4 35.3 37.3 11.4 3.6 22.5 283.2 57.0 71.5 73.1 177.9 77.0 73.7 16.2 13.3 27.5 46.5 147.1 60.0 20.1 13.7 199.4 40.8 7.9 7.6 22.7 48.9 32.8 243.6 2.1 4.5 62.5 85.2 92.4 175.4 46.8 90.1 14.3 22.2 50.8 132.6 42.7 8.3 11.3 10.7 4.1 29.4 46.4 142.8 76.8 86.0 13.0 5.7 7.2 83.4 11.2 77.9 29.9 16.4 5.0 61.2 74.5 51.1 22.0 32.6 15.5 8.0 35.0 62.4 11.2 55.2 0.0 0.7 5.7 1.6 1.2 1.4 7.7 1.4 2.1 0.6 8.7 0.1 0.5 0.3 0.6 0.8 0.0 0.4 0.6 37.1 37.3 29.6 50.7 36.9 35.2 34.8 33.7 38.9 29.8 37.3 35.3 164.6 32.1 5.2 54.5 39.0 6.8 8.2 15.6 2.8 11.2 23.3 26.2 19.5 18.6 2.0 5.5 8.4 38.9 15.2 35.7 1.9 46.4 17.4 8.2 31.2 57.7 6.7 13.0 31.6 20.6 138.4 31.3 16.8 13.1 7.0 12.4 20.3 9.8 19.7 1.7 10.0 21.0 0.0 3.9 43.0 14.0 28.6 16.5 35.6 8.4 8.0 48.5 5.2 17.1 17.6 16.4 6.7 17.7 13.1 10.7 6.3 13.9 2.9 120.3 19.7 97.3 90.2 2.0 5.5 3.5 5.5 68.0 17.6 16.1 15.8 4.3 RAB3IL1 GRAB ENSG00000167994 "RAB3A interacting protein like 1" Q8TBN0 11 61897301-61920269 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 110.9;Hofbauer cells: 65.3;Late spermatids: 133.8;Leydig cells: 56.2;Peritubular cells: 45.1;Theca cells: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 36.9;HHSteC: 36.9;K-562: 34.4;RPMI-8226: 44.3;U-2197: 56.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039723 Uncertain Approved "Centriolar satellite,Cytosol" NA NA "Cluster 71: Testis - DNA repair" "Cluster 18: U-2197 - ECM organization" "Cluster 34: Spermatids - Unknown function" "Centriolar satellite, Cytosol" "HPA039723: AB_10795406" "unprognostic (1.62e-1)" "unprognostic (3.59e-2)" "prognostic unfavorable (6.08e-4)" "unprognostic (1.97e-2)" "unprognostic (8.95e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (1.61e-7)" "unprognostic (7.93e-2)" "unprognostic (2.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.86e-1)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (1.42e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.30e-4)" "unprognostic (1.59e-3)" 29.8 9.5 10.9 7.9 11.2 13.8 22.8 10.3 13.4 38.6 12.7 13.6 4.7 30.0 4.6 6.2 24.0 11.3 20.5 10.5 10.8 16.0 6.9 11.8 6.5 12.8 11.0 37.1 5.1 7.8 9.5 15.9 11.8 10.6 2.6 3.1 12.2 5.1 7.6 15.2 9.9 9.3 11.6 28.2 9.4 41.2 14.8 9.0 15.1 10.0 2.4 19.0 20.7 12.7 6.9 13.3 0.4 7.3 26.9 19.9 1.5 5.5 13.7 8.0 5.4 1.9 1.5 0.1 10.1 8.4 36.9 3.7 9.6 0.5 1.2 0.0 2.1 12.8 5.1 7.2 36.9 0.5 0.3 10.7 6.9 3.9 9.1 1.3 0.7 7.1 34.4 0.3 4.7 12.3 0.0 0.1 4.3 1.2 14.1 0.7 1.9 44.3 0.7 0.5 0.6 4.9 3.4 2.9 25.0 2.2 2.2 1.6 0.6 29.3 13.2 56.5 2.3 0.4 2.1 0.0 5.7 15.8 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 11.2 10.3 13.4 10.5 10.8 12.8 11.0 11.8 11.6 14.8 12.7 5.5 0.0 0.0 1.6 0.8 5.1 0.9 0.0 0.6 0.5 1.3 1.9 1.9 2.8 0.6 1.8 0.0 1.3 0.1 0.1 1.9 2.2 110.9 1.9 27.8 9.6 0.0 34.5 0.4 1.0 2.0 24.3 1.1 1.8 0.0 1.1 16.1 1.4 65.3 1.7 1.3 0.0 0.0 19.9 10.2 133.8 56.2 6.8 8.8 8.4 0.0 6.5 0.0 1.0 0.7 1.1 0.0 45.1 0.0 1.6 0.0 15.9 0.0 8.2 0.0 3.4 8.2 1.7 9.1 0.2 4.0 1.4 0.6 47.6 0.2 0.2 BEST1 "BEST, BMD, RP50, VMD2" ENSG00000167995 "Bestrophin 1" O76090 11 61950063-61965515 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Transport, Vision" "Chloride channel, Ion channel" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.3;brain: 41.7" "Cell type enhanced" "Detected in many" "Langerhans cells: 272.8" "Group enriched" "Detected in some" 6 "glioma: 2.0;melanoma: 6.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "neutrophil: 37.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 37.6" "Cell line enriched" "Detected in many" 4 "SK-MEL-30: 71.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057464 Enhanced NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 11: Alveolar cells - Smell perception" "HPA057464: AB_2683444" "unprognostic (2.41e-3)" "unprognostic (3.67e-2)" "unprognostic (5.91e-3)" "unprognostic (1.21e-1)" "unprognostic (1.25e-1)" "unprognostic (2.73e-1)" "unprognostic (1.53e-2)" "unprognostic (1.04e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (1.07e-3)" "unprognostic (2.06e-1)" "unprognostic (4.27e-10)" "unprognostic (1.38e-1)" "unprognostic (4.93e-2)" "unprognostic (3.59e-3)" "unprognostic (2.72e-3)" 9.1 3.7 16.3 8.3 30.5 26.3 5.3 24.9 23.2 5.3 10.2 3.8 1.7 4.1 10.0 2.8 5.9 5.1 5.7 16.5 20.2 3.7 2.6 10.3 2.3 27.9 27.3 4.6 2.5 0.3 3.4 2.4 26.7 4.0 1.0 6.7 2.2 2.0 1.6 2.7 3.9 1.8 19.2 11.0 3.3 5.4 28.6 0.4 2.7 1.4 0.4 5.3 4.7 41.7 0.8 0.8 0.4 0.7 17.7 3.8 1.4 1.0 1.8 0.4 1.3 0.5 0.5 0.1 1.7 1.1 2.0 1.1 0.0 0.0 0.3 0.3 0.2 0.0 6.7 0.9 4.9 0.2 0.5 5.6 1.6 1.9 4.1 1.8 0.0 0.8 0.8 7.6 1.9 0.6 0.1 0.6 0.0 0.8 2.1 0.0 0.1 0.3 0.0 2.0 1.0 0.9 1.6 0.1 71.6 0.8 0.7 2.3 0.2 0.9 0.5 0.7 0.3 10.3 0.8 0.7 4.8 0.6 1.2 2.6 3.9 3.9 0.2 4.6 0.2 0.7 0.2 0.1 2.6 0.2 0.1 0.1 37.6 0.1 5.1 0.4 0.3 1.9 16.3 30.5 24.9 23.2 16.5 20.2 27.9 27.3 26.7 19.2 28.6 41.7 2.7 25.6 59.3 9.1 11.4 36.3 6.3 54.8 18.8 2.0 22.0 7.4 3.3 14.3 57.2 1.8 0.0 14.5 5.6 22.5 0.0 3.8 8.3 5.3 9.0 16.4 10.3 29.0 0.3 3.3 23.4 32.4 9.2 9.0 76.4 1.9 21.0 13.8 37.1 0.0 0.7 10.7 22.4 75.4 272.8 2.9 15.2 49.0 55.2 1.0 14.1 6.0 3.1 17.1 43.0 3.1 21.0 6.8 5.9 11.8 28.0 5.6 37.7 9.6 6.6 16.1 20.8 3.2 4.1 6.2 32.7 20.4 24.5 0.9 11.9 13.2 FTH1 "FHC, FTH, FTHL6, PIG15, PLIF" ENSG00000167996 "Ferritin heavy chain 1" P02794 11 61959718-61967634 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Iron storage" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 49889.9;monocytes: 34409.9;Proximal enterocytes: 28837.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 23933.9;HHSteC: 24849.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB008623 Approved NA NA 5600000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 3: Monocytes - Immune response regulation" "CAB008623: " "unprognostic (7.15e-2)" "unprognostic (1.52e-2)" "unprognostic (2.27e-1)" "unprognostic (2.00e-2)" "unprognostic (2.53e-1)" "prognostic unfavorable (7.56e-5)" "prognostic unfavorable (6.18e-4)" "unprognostic (3.08e-2)" "unprognostic (2.48e-2)" "unprognostic (6.65e-2)" "unprognostic (2.44e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (5.20e-5)" "unprognostic (2.99e-1)" "unprognostic (4.89e-2)" "unprognostic (3.44e-1)" "unprognostic (5.83e-2)" 6767.7 5191.4 5741.8 3546.9 5464.0 4734.2 5696.1 5591.9 7973.3 3973.1 4801.2 4701.2 1819.9 3712.8 2421.8 4025.0 3195.6 1995.6 4779.5 5252.8 5737.2 6092.3 3500.8 6057.7 1460.4 6416.7 5812.4 3069.9 3883.8 1696.4 2105.4 1800.3 6188.9 2778.8 3357.4 3123.7 3533.1 1514.8 4695.5 2125.0 4331.6 2040.7 6506.2 3496.3 4044.1 769.5 6153.5 1109.8 3167.6 2766.8 1291.2 4718.0 3163.8 6630.2 3029.8 8290.2 1236.6 3293.8 23933.9 11490.1 6794.4 2684.1 11547.3 2694.6 2698.6 1011.0 4065.8 345.3 16669.6 7830.0 10259.7 5035.8 1118.8 2235.9 1733.9 1439.0 542.9 1720.3 10802.1 6692.1 24849.2 821.6 2626.6 15711.1 10758.7 5384.0 10038.1 8476.6 3427.6 1970.7 2622.1 3874.4 9546.5 4080.7 935.3 1361.8 2114.6 10461.4 13675.6 914.9 1508.5 2502.3 13877.6 8068.8 1044.8 1325.0 9113.3 1005.9 4645.6 4045.3 1790.3 1098.4 3791.5 8310.7 1978.7 3727.4 1732.0 662.7 2516.5 1088.1 11353.7 363.1 2030.4 29466.0 19068.5 15453.6 2306.3 22407.8 2274.9 4088.8 3267.1 2296.9 9762.5 4113.3 2710.5 2108.2 45110.1 1981.1 27515.2 7217.1 4321.5 22214.4 5741.8 5464.0 5591.9 7973.3 5252.8 5737.2 6416.7 5812.4 6188.9 6506.2 6153.5 6630.2 3864.7 1317.3 2890.3 319.3 3200.9 5157.7 7723.2 23426.3 3495.0 881.7 9884.9 10192.4 11.7 4466.7 11711.1 1918.2 573.4 4541.1 4513.5 13653.9 10888.0 10748.7 274.2 4921.8 2908.5 4303.3 2520.6 6318.6 252.8 11073.9 6803.9 5931.3 2059.7 8005.0 6736.0 1798.6 3266.1 5199.9 18411.3 738.6 153.7 3927.4 10379.8 13784.1 49889.9 527.7 4666.1 22792.0 7116.5 183.6 34409.9 12189.1 1699.3 153.3 1031.0 7813.2 7936.8 3818.1 1789.1 12995.8 28837.7 21355.6 5978.6 3311.6 2084.0 2686.9 6139.1 585.4 927.1 1983.6 3555.6 4622.6 5225.4 2496.8 4921.7 18650.3 INCENP FLJ31633 ENSG00000149503 "Inner centromere protein" Q9NQS7 11 62123998-62153169 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 20.9" "Cell type enhanced" "Detected in many" "Squamous epithelial cells: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "basophil: 1.2;NK-cell: 1.1" "Group enriched" "Detected in many" 7 "granulocytes: 1.2;NK-cells: 1.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013292, HPA051339, HPA070550" Enhanced Supported "Nucleoplasm,Nuclear bodies,Kinetochore,Midbody" Yes Yes "Cluster 15: NK-cells - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear bodies, Kinetochore" "Nucleoplasm, Midbody" "CAB013292: AB_2533405, HPA051339: AB_2732566, HPA070550: AB_2686279" "unprognostic (6.31e-2)" "unprognostic (7.29e-2)" "unprognostic (1.65e-3)" "unprognostic (7.35e-2)" "unprognostic (3.18e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.25e-4)" "prognostic unfavorable (8.58e-4)" "unprognostic (1.63e-2)" "unprognostic (4.37e-2)" "prognostic unfavorable (5.76e-5)" "unprognostic (1.74e-2)" "unprognostic (1.08e-3)" "unprognostic (1.17e-3)" "unprognostic (1.22e-1)" "unprognostic (1.36e-1)" "unprognostic (2.78e-3)" 3.1 2.5 2.7 7.5 1.1 20.9 2.8 6.2 3.0 4.6 0.0 4.8 6.8 3.0 8.1 14.0 3.5 2.2 2.8 2.9 0.5 2.4 1.9 3.0 11.6 1.6 0.8 3.8 3.1 3.1 1.5 4.1 1.3 2.5 3.6 3.4 6.1 2.9 4.2 7.9 5.7 3.4 0.1 5.5 4.5 6.4 0.5 17.8 5.1 3.4 8.2 2.8 5.5 1.2 74.3 69.4 51.6 45.5 6.8 8.4 28.1 47.6 21.2 44.4 28.3 37.0 50.7 70.0 36.2 16.0 46.2 72.6 52.2 28.4 31.8 60.5 36.6 45.7 68.0 29.6 2.7 53.5 62.1 4.3 6.5 41.3 23.6 6.8 25.8 50.2 48.8 57.6 25.3 59.7 85.0 43.3 56.2 28.0 34.4 79.3 66.4 53.4 12.0 35.8 40.1 42.2 46.8 30.8 27.9 19.8 48.2 19.4 28.5 41.8 51.9 59.8 50.0 29.7 48.3 75.8 23.5 34.7 50.6 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 2.7 1.1 6.2 3.0 2.9 0.5 1.6 0.8 1.3 0.1 0.5 1.2 1.2 3.2 2.3 1.3 3.4 5.6 0.8 1.0 2.8 2.4 1.1 0.6 1.3 0.0 3.7 0.0 0.0 4.2 4.2 5.4 0.0 1.9 1.0 2.0 2.1 1.5 0.0 10.9 3.3 2.5 7.1 1.9 9.2 2.7 3.8 5.7 0.0 0.7 4.2 0.0 2.5 3.4 0.0 0.9 1.6 0.5 2.8 3.3 3.6 1.0 5.0 1.5 3.1 2.0 1.5 2.2 1.6 1.5 10.9 1.2 1.3 0.3 2.6 2.3 0.0 1.9 4.3 6.5 7.8 15.1 3.3 2.2 3.7 1.9 4.8 1.1 SCGB1D1 "LIPA, LPHA, MGC71958" ENSG00000168515 "Secretoglobin family 1D member 1" O95968 11 62190216-62193539 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "cervix: 1.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 40 "endometrial cancer: 23.3;ovarian cancer: 16.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "SCLC-21H: 6.0" "Secreted in other tissues" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 7: SCLC-21H - Neuronal signaling" "unprognostic (6.95e-3)" "unprognostic (9.01e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 SCGB2A1 "LPHC, MGB2, MGC71973, UGB3" ENSG00000124939 "Secretoglobin family 2A member 1" O75556 11 62208673-62213943 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "cervix: 2021.0;epididymis: 1372.0" "Group enriched" "Detected in many" 6 "Endometrial ciliated cells: 2506.4;Glandular and luminal cells: 2597.0" "Cancer enriched" "Detected in many" 5 "endometrial cancer: 971.9" "Region enhanced" "Detected in some" "medulla oblongata: 3.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "EFO-21: 8.6" HPA034584 Enhanced Approved Vesicles "Secreted in other tissues" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" Vesicles "HPA034584: AB_10602221" "unprognostic (7.73e-2)" "unprognostic (3.77e-1)" "prognostic favorable (1.22e-4)" "prognostic favorable (1.54e-8)" "unprognostic (2.98e-2)" "unprognostic (1.86e-2)" "unprognostic (3.39e-1)" "unprognostic (1.95e-1)" "unprognostic (2.69e-1)" "unprognostic (6.87e-3)" "prognostic favorable (6.36e-4)" "unprognostic (5.67e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-3)" "unprognostic (3.35e-1)" 0.2 0.0 0.0 0.2 0.0 0.0 57.8 0.0 0.0 2021.0 0.1 12.7 1.3 118.8 1372.0 4.2 238.4 13.4 0.2 0.1 0.4 1.9 0.1 2.4 0.0 3.5 1.4 0.7 17.2 1.1 5.1 0.1 0.8 6.8 16.3 0.0 29.6 15.6 0.0 8.6 1.0 2.2 0.5 0.0 45.9 0.0 1.1 2.7 5.8 0.0 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.1 0.0 0.7 0.1 0.0 1.6 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 3.5 1.4 0.8 0.5 1.1 0.2 0.6 0.0 4.8 0.0 0.4 0.1 3.8 4.8 0.0 0.0 123.6 71.0 0.0 48.6 10.1 16.5 0.0 0.2 1.6 9.7 3.9 6.6 0.0 2506.4 397.7 7.6 37.1 0.0 0.0 5.3 0.0 3.8 26.5 2597.0 0.0 0.3 0.0 0.1 4.9 0.0 0.0 59.9 10.2 0.3 0.0 0.0 0.0 14.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 15.3 10.8 0.0 0.0 27.0 0.7 0.1 109.3 0.0 0.0 0.0 8.5 0.0 0.0 1.7 0.4 0.0 13.7 0.1 7.0 16.6 SCGB1D2 "LIPB, LPHB" ENSG00000124935 "Secretoglobin family 1D member 2" O95969 11 62242239-62244812 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "breast: 1227.2;cervix: 4002.8" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 3242.1;Glandular and luminal cells: 3417.9" "Group enriched" "Detected in many" 6 "breast cancer: 625.1;endometrial cancer: 226.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 10.4" HPA035318 Approved "Secreted in other tissues" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 44: Endometrium - Transcription" "HPA035318: AB_10610421" "unprognostic (8.76e-2)" "unprognostic (2.14e-1)" "prognostic favorable (3.46e-6)" "unprognostic (2.39e-2)" "unprognostic (5.89e-2)" "unprognostic (4.72e-2)" "unprognostic (1.99e-1)" "unprognostic (6.43e-2)" "prognostic favorable (8.03e-6)" "unprognostic (1.55e-1)" "unprognostic (1.15e-2)" 12.9 4.9 4.1 0.0 4.0 0.0 1227.2 3.2 5.4 4002.8 13.8 0.3 0.1 89.0 355.8 10.1 110.3 0.1 3.1 3.5 4.4 10.1 0.2 0.1 0.1 4.7 5.7 1.1 4.5 0.5 5.2 0.2 4.2 8.6 0.2 1.8 69.2 2.9 7.2 342.4 0.4 0.0 3.5 0.0 0.3 0.2 4.3 0.4 0.6 6.0 0.0 0.2 0.3 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.4 0.1 0.0 1.8 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 4.0 3.2 5.4 3.5 4.4 4.7 5.7 4.2 3.5 4.3 4.6 2.1 0.0 0.0 0.0 1.6 27.4 4.8 0.0 0.0 0.5 647.8 251.6 10.9 0.0 0.0 7.3 0.0 0.0 5.3 0.0 23.5 0.3 0.0 3242.1 409.9 12.0 0.0 0.0 0.0 0.2 0.0 3.6 0.0 3417.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 15.0 823.6 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.7 0.0 46.1 0.0 0.9 0.0 0.2 8.6 0.0 0.0 0.0 7.0 0.1 20.0 0.0 0.0 1.1 SCGB2A2 "MGB1, MGC71974, PSBP1, UGB2" ENSG00000110484 "Secretoglobin family 2A member 2" Q13296 11 62270158-62273160 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "breast: 2805.9;skin 1: 708.1" "Group enriched" "Detected in some" 11 "Breast glandular cells: 2119.6;Breast myoepithelial cells: 1028.8;Melanocytes: 1762.7" "Cancer enriched" "Detected in many" 23 "breast cancer: 823.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 124 "SK-BR-3: 18.0" CAB026270 Enhanced "Secreted in female reproductive system" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 35: Glandular cells - Unknown function" "CAB026270: AB_912980" "unprognostic (2.38e-1)" "unprognostic (7.28e-2)" "prognostic favorable (9.57e-8)" "unprognostic (4.17e-1)" "unprognostic (3.75e-1)" 34.4 0.2 0.0 0.0 0.0 0.0 2805.9 0.0 0.0 309.2 0.0 0.4 0.0 4.1 0.0 76.6 0.1 0.0 4.0 0.0 0.0 0.5 0.3 0.2 0.0 0.0 0.0 0.2 0.4 0.0 1.6 1.3 0.0 0.2 0.0 0.0 159.3 0.1 1.8 708.1 0.2 0.0 0.0 0.2 0.3 1.1 0.0 2.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 6.6 49.6 0.3 0.0 0.0 0.0 2119.6 1028.8 0.1 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 1.4 41.9 21.6 11.3 0.0 0.0 0.0 0.0 0.0 6.7 0.0 141.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 3.2 1762.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 10.9 0.0 9.2 0.0 0.0 0.0 SCGB1D4 IIS ENSG00000197745 "Secretoglobin family 1D member 4" Q6XE38 11 62296281-62299075 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "cervix: 52.3;endometrium 1: 15.6;epididymis: 43.7;fallopian tube: 53.7" "Cell type enriched" "Detected in some" 6 "Endometrial ciliated cells: 3089.4" "Cancer enriched" "Detected in some" 57 "endometrial cancer: 100.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in female reproductive system" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (2.26e-3)" "unprognostic (3.20e-1)" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 52.3 0.0 0.0 0.0 15.6 43.7 0.0 53.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 3089.4 111.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 457.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.6 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.2 0.0 0.0 0.0 3.9 0.0 0.0 0.0 ASRGL1 "ALP, ALP1, FLJ22316" ENSG00000162174 "Asparaginase and isoaspartyl peptidase 1" Q7L266 11 62337448-62393412 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 112.7;cervix: 121.7;testis: 100.5" "Cell type enhanced" "Detected in many" "Early spermatids: 372.5;Endometrial ciliated cells: 414.6;Glandular and luminal cells: 437.1;Late spermatids: 597.6;Proximal tubular cells: 214.1;Spermatocytes: 534.3" "Cancer enhanced" "Detected in all" "endometrial cancer: 53.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 277.9;eosinophil: 269.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 277.9" "Cell line enhanced" "Detected in many" "EFO-21: 85.2;HAP1: 83.9;SCLC-21H: 112.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029725, HPA055572, CAB070192" Enhanced Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes NA "Cluster 2: Granulocytes - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 44: Endometrium - Transcription" Microtubules "Nucleoplasm, Cytokinetic bridge" "CAB070192: AB_2665720, HPA029725: AB_10602328, HPA055572: AB_2682854" "unprognostic (1.14e-1)" "unprognostic (8.38e-3)" "prognostic favorable (6.14e-4)" "prognostic favorable (1.56e-5)" "unprognostic (5.35e-2)" "unprognostic (8.19e-2)" "prognostic unfavorable (9.46e-4)" "unprognostic (8.67e-2)" "unprognostic (1.85e-1)" "unprognostic (3.54e-2)" "unprognostic (2.71e-1)" "unprognostic (4.44e-1)" "prognostic favorable (4.32e-7)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (5.43e-3)" "unprognostic (1.40e-1)" 13.8 3.7 94.2 6.5 95.4 14.4 12.0 92.5 103.5 121.7 71.7 14.2 6.8 26.4 3.1 2.1 68.1 11.2 6.2 87.1 93.3 42.5 10.2 25.8 5.6 87.5 102.7 1.8 13.4 2.3 21.2 3.2 87.6 23.8 17.1 17.8 13.2 7.2 7.3 2.9 9.5 4.4 83.4 4.7 15.1 100.5 112.7 10.3 6.7 3.0 4.7 4.3 2.0 90.0 2.4 19.5 20.9 27.2 0.1 0.0 16.4 2.3 0.8 3.6 3.5 32.0 8.5 1.9 85.2 0.3 9.3 1.8 83.9 0.7 4.2 2.6 34.4 1.2 28.1 23.5 0.6 24.0 30.8 0.8 0.2 1.6 0.4 1.3 39.4 47.8 24.5 21.5 0.9 37.5 65.3 15.9 28.5 13.6 15.2 26.1 12.5 11.8 73.3 5.9 112.3 16.1 16.4 28.2 14.4 21.2 15.0 12.1 2.0 0.4 15.4 1.2 9.5 32.8 33.6 3.0 0.8 12.3 9.7 277.9 68.6 269.5 2.8 50.8 1.9 2.4 1.0 3.3 39.7 1.5 2.3 3.4 16.3 11.5 38.5 7.2 0.8 24.2 94.2 95.4 92.5 103.5 87.1 93.3 87.5 102.7 87.6 83.4 112.7 90.0 29.2 6.4 27.8 56.8 5.2 3.4 2.5 2.2 0.6 24.4 13.8 6.6 2.4 42.9 4.1 22.0 33.3 2.3 3.2 14.0 133.1 30.3 372.5 414.6 39.9 31.2 47.2 14.1 13.9 22.3 2.4 4.0 19.9 437.1 80.9 16.6 49.2 3.7 25.0 16.8 18.6 67.4 6.1 11.4 6.4 597.6 8.7 26.9 1.8 9.4 10.5 80.8 4.1 15.1 22.0 7.8 7.5 7.2 13.9 35.4 2.9 214.1 5.4 37.1 13.1 7.7 6.1 534.3 48.6 0.1 1.3 0.8 7.8 10.8 36.0 15.9 SCGB1A1 "CC10, CC16, CCSP, UGB" ENSG00000149021 "Secretoglobin family 1A member 1" P11684 11 62405103-62423195 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Phospholipase A2 inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lung: 3079.0" "Cell type enriched" "Detected in some" 4 "Club cells: 43564.7" "Cancer enriched" "Detected in many" 8 "lung cancer: 215.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 71 "HaCaT: 1977.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025686, HPA031828" Enhanced "Secreted in other tissues" NA NA 13000000 "Cluster 19: Lung - Lung function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "CAB025686: , HPA031828: AB_2674061" "unprognostic (2.40e-3)" "unprognostic (1.55e-2)" "unprognostic (5.46e-2)" "unprognostic (2.70e-2)" "unprognostic (4.69e-3)" "unprognostic (2.12e-2)" "unprognostic (1.23e-2)" "unprognostic (2.31e-2)" "unprognostic (2.63e-2)" "unprognostic (1.63e-1)" "unprognostic (2.40e-2)" 1.1 2.0 0.6 0.9 0.7 0.1 0.3 1.3 1.1 0.6 0.3 0.2 0.4 0.2 0.7 11.0 334.2 0.2 0.6 0.5 0.6 0.2 0.4 3079.0 0.2 0.6 0.9 2.0 1.9 0.0 2.4 1.7 0.5 85.1 0.0 0.2 0.5 0.9 0.3 0.3 1.6 0.0 0.5 7.2 4.3 0.2 1.0 2.8 0.4 0.0 5.9 0.2 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.3 1977.1 0.0 0.3 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.3 27.9 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 1.1 0.0 0.0 0.6 1.4 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.1 0.4 0.0 0.0 1.0 2.0 0.0 1.0 0.0 0.0 1.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 1.3 1.1 0.5 0.6 0.6 0.9 0.5 0.5 1.0 0.5 0.0 1125.0 2573.3 0.0 0.0 0.0 71.4 3938.5 0.0 0.0 0.0 0.0 0.0 0.0 43564.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 113.5 0.0 0.0 0.1 0.0 0.0 304.5 0.0 0.5 691.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4534.8 0.0 0.0 0.7 0.0 128.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 134.7 0.0 0.0 9997.0 0.0 0.0 0.0 850.3 0.0 0.0 3.9 0.0 0.0 83.7 0.0 0.0 800.2 AHNAK MGC5395 ENSG00000124942 "AHNAK nucleoprotein" Q09666 11 62433542-62556235 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 561.4;fHDF/TERT166: 554.5;TIME: 582.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 395.4" "HPA019010, HPA019070, HPA026643" Uncertain Enhanced "Plasma membrane,Cytosol" NA NA 10000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 31: Skin - Epidermis development" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane, Cytosol" "HPA019010: AB_1844657, HPA019070: AB_1844656, HPA026643: AB_10670426" "unprognostic (1.39e-1)" "unprognostic (7.84e-2)" "unprognostic (3.46e-1)" "unprognostic (3.19e-1)" "unprognostic (1.96e-2)" "unprognostic (5.99e-2)" "unprognostic (2.53e-1)" "unprognostic (1.63e-2)" "unprognostic (4.84e-2)" "unprognostic (1.98e-3)" "prognostic unfavorable (2.42e-4)" "unprognostic (4.30e-1)" "unprognostic (4.49e-3)" "unprognostic (5.42e-2)" "unprognostic (1.18e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (3.47e-6)" 243.1 27.9 62.6 43.4 50.2 44.1 190.3 33.7 45.4 183.3 61.0 276.2 49.0 183.3 51.7 248.2 145.5 74.8 115.1 65.0 98.0 59.7 60.1 144.1 36.7 76.2 48.3 125.8 30.3 26.3 16.9 97.3 62.9 88.5 96.6 10.1 127.5 105.7 188.5 334.7 136.6 113.1 60.8 59.5 133.5 18.0 49.0 27.9 64.9 172.2 63.7 142.0 213.3 78.4 188.2 107.9 9.8 44.1 421.8 561.4 70.3 166.0 201.4 103.0 57.4 93.7 64.9 0.2 61.7 554.5 79.8 244.1 41.2 203.7 130.7 154.2 7.3 22.6 173.4 27.9 80.8 31.5 142.2 204.2 233.0 202.4 183.6 131.5 215.4 2.7 21.8 138.8 211.7 72.1 0.4 60.7 3.0 59.6 171.7 0.4 45.1 113.9 227.1 120.2 0.3 9.2 167.5 69.3 69.0 198.8 133.7 28.4 582.1 182.4 119.8 229.8 74.4 25.0 5.4 0.6 138.2 10.1 60.9 44.1 75.6 0.3 38.7 45.0 25.8 20.0 24.8 31.7 73.8 16.1 3.2 17.3 1.1 31.5 37.8 20.2 21.5 36.8 62.6 50.2 33.7 45.4 65.0 98.0 76.2 48.3 62.9 60.8 49.0 78.4 413.1 439.1 106.3 49.3 171.4 479.4 133.8 285.0 253.2 1.4 173.0 226.8 199.9 195.9 224.1 193.1 0.0 110.8 194.3 400.8 13.7 99.6 10.6 188.5 195.0 282.5 47.6 43.7 0.9 64.1 145.6 312.9 538.2 351.2 238.9 4.3 201.4 88.5 79.4 1.7 0.8 164.8 138.4 329.8 458.3 33.2 451.4 292.3 318.4 43.1 284.8 30.7 138.0 0.5 0.4 262.5 195.5 466.0 329.0 202.4 262.3 6.8 149.3 1.2 177.5 349.5 244.4 3.1 8.1 596.4 610.3 102.2 256.5 3.0 101.8 198.0 EEF1G EF1G ENSG00000254772 "Eukaryotic translation elongation factor 1 gamma" P26641 11 62559596-62574086 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 1021.0;Plasma cells: 770.5;Squamous epithelial cells: 1166.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040688, HPA055316" Enhanced Approved "Golgi apparatus,Cytosol" NA NA 2500000 "Cluster 30: Non-specific - Translation" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" Cytosol "Golgi apparatus" "HPA040688: AB_10961632, HPA055316: AB_2732593" "unprognostic (2.12e-1)" "unprognostic (1.23e-1)" "unprognostic (2.44e-1)" "unprognostic (1.37e-2)" "unprognostic (2.28e-1)" "unprognostic (1.60e-1)" "unprognostic (9.22e-4)" "unprognostic (1.14e-1)" "unprognostic (5.14e-2)" "unprognostic (5.07e-3)" "unprognostic (1.86e-1)" "unprognostic (8.59e-2)" "unprognostic (8.99e-2)" "unprognostic (1.00e-1)" "unprognostic (1.08e-1)" "unprognostic (1.16e-1)" "unprognostic (6.04e-2)" 1237.6 883.6 646.7 951.1 663.7 1897.3 1890.9 640.9 722.0 1595.1 659.8 1229.0 1094.9 1078.6 1079.3 1634.9 1555.9 749.8 1089.3 616.4 690.9 1162.4 885.3 818.1 1532.7 678.1 661.0 2604.5 2191.5 835.7 708.1 780.5 675.9 1219.1 1272.4 416.0 1588.0 875.6 4810.2 2215.7 1098.5 991.5 690.1 1073.0 1090.2 441.9 677.4 1281.7 1050.2 3030.5 1951.7 1173.7 1440.6 676.7 1773.6 1824.3 1859.1 2656.2 2742.6 3529.1 1866.2 1505.0 2692.9 1830.1 1392.3 2045.9 2161.9 5161.2 2365.4 2392.2 1048.0 2018.3 2229.8 2200.1 1663.3 1693.2 2071.2 1348.7 2061.8 2120.7 2974.2 2810.2 1523.6 4060.8 3913.9 1812.1 4419.8 3014.9 2562.7 1777.2 2755.8 2451.2 2190.6 3611.0 3035.5 4895.3 2304.9 1546.3 1575.0 2545.1 2390.9 4978.7 2454.9 2276.4 1608.2 2002.3 901.7 3010.3 4214.5 1179.1 3496.3 3012.0 1759.8 1057.1 1476.4 2070.0 1338.6 1680.0 1783.1 2609.2 1210.8 2005.2 1517.1 883.9 2365.5 589.6 2182.3 2151.6 4333.1 5399.6 4153.2 2825.0 3623.0 5080.7 6117.7 4188.5 320.6 3285.2 1837.0 2869.7 3307.5 11090.3 646.7 663.7 640.9 722.0 616.4 690.9 678.1 661.0 675.9 690.1 677.4 676.7 2.8 150.6 366.9 14.4 403.6 7.9 2.5 8.8 1021.0 0.5 21.9 10.3 0.0 14.3 300.8 1.8 2.1 17.7 9.6 63.7 3.9 124.8 4.3 2.2 7.2 70.2 148.5 405.0 8.4 188.5 26.8 149.5 252.8 3.5 375.6 1.8 11.0 4.9 12.5 0.0 13.8 152.0 4.1 8.8 4.9 18.8 3.1 134.7 1.8 24.4 126.4 0.8 16.5 6.0 13.0 114.9 121.0 2.2 770.5 3.0 132.1 12.1 152.0 0.5 0.0 1.6 43.9 1.4 0.8 1166.7 6.1 21.1 235.3 1.1 223.8 2.3 TUT1 "FLJ21850, FLJ22267, FLJ22347, PAPD2, RBM21, TENT1, TUTase" ENSG00000149016 "Terminal uridylyl transferase 1, U6 snRNA-specific" Q9H6E5 11 62575045-62591637 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA processing" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 32.5;Early spermatids: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069055, HPA071838" Supported Nucleoplasm,Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 25: RPMI-8226 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm Cytosol "HPA069055: AB_2686075, HPA071838: AB_2686456" "unprognostic (3.81e-2)" "unprognostic (3.54e-2)" "prognostic unfavorable (9.51e-4)" "unprognostic (2.43e-1)" "unprognostic (1.01e-1)" "unprognostic (7.59e-2)" "unprognostic (1.83e-1)" "unprognostic (2.59e-2)" "unprognostic (1.83e-1)" "unprognostic (5.79e-3)" "unprognostic (1.59e-2)" "unprognostic (2.71e-1)" "unprognostic (7.20e-3)" "unprognostic (1.03e-2)" "unprognostic (4.41e-1)" "unprognostic (1.35e-1)" "unprognostic (3.97e-3)" 10.5 10.7 9.1 7.4 10.1 6.0 11.8 9.1 9.9 10.4 8.1 8.9 8.8 9.9 5.8 9.3 11.2 6.1 9.5 8.8 8.6 10.7 22.2 8.3 11.8 10.5 9.3 11.2 19.4 7.6 10.6 6.2 10.1 12.7 4.0 5.4 11.7 7.3 20.4 12.8 10.2 4.6 9.4 12.7 12.6 13.6 9.8 10.2 12.3 7.6 7.9 10.4 9.2 12.0 12.5 16.0 10.7 15.4 12.6 7.3 14.0 12.7 8.3 11.2 9.7 14.0 24.9 19.5 30.1 6.6 14.3 23.7 19.8 15.9 5.7 15.1 10.5 20.3 15.8 14.1 14.3 14.8 9.3 10.3 16.6 13.7 21.1 10.5 10.8 26.2 32.1 20.7 9.6 28.8 21.1 33.3 12.4 8.4 19.1 23.7 16.6 50.9 10.6 6.9 18.2 24.6 10.4 19.6 17.5 8.9 27.2 14.2 10.1 12.9 11.3 15.2 10.1 36.1 32.9 24.6 14.8 11.5 10.7 6.0 5.9 7.0 9.9 7.2 13.7 9.2 9.5 8.1 7.9 11.6 14.3 11.7 3.5 11.0 5.6 9.3 9.2 7.7 9.1 10.1 9.1 9.9 8.8 8.6 10.5 9.3 10.1 9.4 9.8 12.0 32.5 0.0 6.7 7.5 7.5 2.7 5.2 7.2 4.0 8.4 5.9 5.2 4.2 18.6 7.1 11.0 6.2 12.8 6.0 4.4 5.9 8.5 34.3 5.7 3.1 15.0 7.2 3.2 3.9 7.4 7.8 5.1 7.7 4.1 2.5 5.5 18.2 17.8 5.9 1.7 4.6 9.1 6.1 5.0 2.2 16.4 7.2 4.3 10.6 1.0 4.0 9.8 14.4 4.0 5.4 5.6 3.6 3.4 4.9 7.1 8.4 7.1 13.1 8.4 0.0 4.1 4.1 10.0 16.3 3.1 2.3 14.0 5.6 5.6 7.0 3.1 MTA2 "MTA1-L1, MTA1L1" ENSG00000149480 "Metastasis associated 1 family member 2" O94776 11 62593214-62601865 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005315, HPA006214, CAB017522, HPA072727" Supported Enhanced Nucleoplasm NA NA 10000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm "CAB005315: AB_2146965, CAB017522: AB_831564, HPA006214: AB_1079421, HPA072727: " "unprognostic (5.97e-3)" "unprognostic (1.63e-2)" "unprognostic (1.23e-1)" "unprognostic (3.04e-2)" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" "prognostic unfavorable (4.82e-5)" "unprognostic (3.32e-3)" "unprognostic (1.95e-1)" "unprognostic (5.38e-3)" "unprognostic (3.09e-2)" "unprognostic (1.59e-1)" "unprognostic (1.16e-3)" "unprognostic (3.16e-3)" "unprognostic (9.84e-2)" "unprognostic (2.23e-1)" "unprognostic (2.50e-2)" 41.6 34.4 44.4 46.2 46.7 60.7 35.7 45.7 45.3 40.2 38.2 40.0 31.0 37.2 28.7 79.3 33.4 32.6 29.7 44.3 44.1 31.9 30.3 37.8 70.1 49.0 46.1 37.8 23.0 30.2 31.8 39.1 49.4 37.0 47.4 119.8 37.3 36.7 21.2 74.7 40.1 43.8 46.1 60.7 33.9 30.4 45.8 90.2 26.8 24.1 91.8 51.7 47.2 52.7 97.1 83.4 129.8 171.1 57.0 53.2 88.8 80.0 112.3 157.5 114.7 79.7 82.7 137.0 84.0 106.3 84.3 127.2 177.2 222.1 132.8 136.4 87.9 146.4 91.2 81.0 88.3 167.2 180.0 59.6 122.6 111.3 164.1 74.8 148.3 140.4 164.2 106.1 114.6 189.0 213.9 212.1 112.3 91.7 95.1 201.5 92.4 160.6 112.1 143.4 102.9 94.2 83.5 118.2 67.6 102.4 138.9 113.2 104.5 87.9 80.4 100.4 94.0 78.3 109.4 191.8 64.4 120.4 86.9 7.3 7.2 9.9 18.6 12.6 15.6 13.9 15.2 13.5 11.8 10.0 14.0 14.3 3.1 12.1 16.4 13.8 13.5 6.7 44.4 46.7 45.7 45.3 44.3 44.1 49.0 46.1 49.4 46.1 45.8 52.7 22.9 3.2 3.9 2.3 16.9 13.4 4.2 4.2 34.1 0.0 11.3 7.9 3.7 1.5 4.9 1.8 0.0 15.3 16.5 12.1 5.9 5.1 0.8 5.2 10.0 12.0 12.0 20.8 1.5 9.5 8.3 8.6 15.3 9.5 10.8 7.5 13.2 8.2 8.9 0.0 1.6 11.9 4.1 12.8 7.6 0.7 5.0 8.9 1.8 2.8 8.9 0.0 9.2 2.0 2.7 9.7 8.2 4.1 24.1 4.2 6.6 2.7 0.9 0.0 0.0 8.2 11.7 5.9 5.2 32.5 11.2 18.9 18.1 13.6 12.2 4.5 EML3 "ELP95, FLJ35827" ENSG00000149499 "EMAP like 3" Q32P44 11 62602218-62612775 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Squamous epithelial cells: 74.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 64: Macrophages - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 61: Squamous epithelial cells - Keratinization" "unprognostic (1.08e-3)" "unprognostic (2.57e-2)" "unprognostic (1.03e-1)" "unprognostic (1.02e-3)" "unprognostic (2.11e-1)" "unprognostic (4.56e-2)" "unprognostic (2.12e-2)" "unprognostic (1.34e-2)" "unprognostic (1.07e-1)" "unprognostic (5.36e-2)" "unprognostic (9.46e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.13e-8)" "unprognostic (1.42e-1)" "unprognostic (2.68e-2)" "unprognostic (3.80e-1)" "unprognostic (2.52e-1)" 38.6 21.6 15.3 28.3 15.4 21.5 35.3 13.5 15.1 36.7 13.5 21.0 10.5 29.4 7.8 49.6 31.5 14.5 20.6 14.5 14.9 32.0 31.2 29.0 26.9 19.6 15.8 36.4 22.2 13.4 15.6 12.3 17.5 28.1 9.3 17.4 24.3 13.2 10.1 32.4 26.4 14.7 14.8 44.1 24.5 12.8 18.7 18.7 27.1 4.3 22.6 27.1 32.0 18.9 18.8 13.3 13.9 12.7 19.8 33.8 12.5 17.4 18.7 18.6 11.4 11.3 29.8 33.2 43.3 24.4 14.0 29.8 12.3 31.9 9.6 43.5 12.1 31.1 36.9 9.5 27.4 22.8 26.1 46.5 13.3 15.3 22.9 36.0 37.9 14.5 23.7 32.6 24.9 52.1 16.0 28.2 3.4 22.4 18.5 21.1 12.8 71.2 21.5 21.0 5.4 18.7 12.9 44.0 22.1 12.8 43.9 15.5 42.6 24.3 20.0 19.2 19.6 45.3 27.9 20.8 26.4 15.4 17.8 8.7 4.5 5.7 4.6 4.9 4.6 3.1 4.4 4.8 3.4 3.8 3.9 4.8 2.7 5.6 4.6 2.4 5.5 4.4 15.3 15.4 13.5 15.1 14.5 14.9 19.6 15.8 17.5 14.8 18.7 18.9 29.8 6.4 14.5 15.3 18.5 14.3 12.1 14.5 30.1 7.7 13.9 18.3 4.8 15.7 11.6 11.0 8.4 19.6 14.0 12.5 5.9 9.3 7.4 5.9 8.3 27.0 10.2 11.6 0.3 13.6 15.2 12.8 19.9 7.6 3.8 8.1 37.5 18.5 15.1 1.7 1.1 11.0 12.2 23.2 8.5 26.8 22.4 16.7 5.4 6.5 16.1 6.6 23.7 5.0 4.5 20.1 11.5 18.0 15.9 10.3 9.5 5.5 7.6 22.6 19.7 8.0 12.8 7.3 12.3 74.1 21.6 16.8 23.5 10.2 10.3 14.1 ROM1 "ROM, TSPAN23" ENSG00000149489 "Retinal outer segment membrane protein 1" Q03395 11 62611722-62615116 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 18 "retina: 1186.9" "Cell type enriched" "Detected in many" 5 "Rod photoreceptor cells: 3239.7" "Cancer enriched" "Detected in all" 6 "glioma: 14.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 2.7" "Group enriched" "Detected in many" 4 "NK-cells: 2.7;T-cells: 1.2" "Cell line enhanced" "Detected in many" "HSkMC: 25.2;U-266/84: 31.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA028910, HPA073279" Enhanced Approved "Plasma membrane,Cytosol" No No "Cluster 22: NK-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 16: U-266 - Nucleosome" "Cluster 46: Photoreceptor cells - Phototransduction" "Plasma membrane, Cytosol" "HPA028910: AB_2672824, HPA073279: " "unprognostic (1.54e-2)" "unprognostic (1.37e-2)" "unprognostic (4.24e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.02e-1)" "unprognostic (4.05e-1)" "prognostic favorable (2.20e-4)" "unprognostic (2.20e-1)" "unprognostic (9.87e-2)" "unprognostic (7.65e-3)" "unprognostic (3.50e-2)" "prognostic unfavorable (2.85e-6)" "unprognostic (2.61e-1)" "unprognostic (4.65e-1)" "unprognostic (1.02e-1)" "unprognostic (7.24e-2)" 12.8 7.9 57.9 2.2 60.5 1.2 9.3 56.8 67.4 9.1 48.1 9.8 1.8 7.7 4.7 7.6 10.7 4.6 8.1 54.5 59.0 7.0 7.1 6.0 2.5 67.4 61.0 13.5 3.6 5.2 7.0 1.4 62.1 8.2 2.6 1186.9 4.2 5.0 3.3 5.4 5.3 5.4 60.0 7.5 7.0 6.2 63.1 1.6 6.0 3.7 2.5 9.6 7.3 62.1 3.2 1.9 3.1 6.6 4.5 22.0 0.6 2.1 3.7 4.3 2.8 0.9 5.3 3.0 15.9 12.2 2.0 4.1 1.5 4.2 1.1 5.3 3.0 3.1 8.6 4.0 13.0 1.1 0.9 25.2 5.9 4.5 9.1 15.1 7.0 1.2 4.0 6.5 9.1 8.3 1.7 2.3 0.8 1.7 5.9 1.6 2.6 19.1 5.0 1.8 3.3 5.1 5.0 5.8 2.5 0.5 8.1 1.4 8.3 7.2 2.7 8.3 2.5 2.9 31.9 2.4 14.2 3.1 1.5 0.0 0.4 0.3 0.3 0.1 0.9 0.2 1.2 0.3 0.2 0.3 0.5 0.6 0.1 2.7 0.4 0.3 0.4 0.5 57.9 60.5 56.8 67.4 54.5 59.0 67.4 61.0 62.1 60.0 63.1 62.1 19.9 0.0 4.4 4.9 0.6 3.7 5.7 5.0 7.4 356.6 3.8 7.2 2.5 2.8 2.3 5.5 594.2 1.0 0.6 2.4 1.9 1.6 2.0 1.0 4.1 31.3 4.2 0.0 0.2 3.1 0.2 4.1 1.1 1.0 1.3 1.2 21.8 1.7 1.1 171.6 0.5 2.8 0.0 1.9 0.8 7.9 19.0 1.2 3.6 1.9 1.3 516.9 1.0 1.0 6.5 2.1 2.5 5.7 0.6 3.1 3.1 4.7 2.7 3239.7 0.0 2.5 4.3 1.6 5.1 5.3 1.0 0.7 1.5 4.0 2.9 3.1 B3GAT3 GlcAT-I ENSG00000149541 "Beta-1,3-glucuronyltransferase 3" O94766 11 62615296-62622154 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051328 Approved "Intracellular and membrane" NA NA 990000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 4: Macrophages - Innate immune response" "HPA051328: AB_2681444" "unprognostic (1.55e-1)" "unprognostic (3.93e-2)" "unprognostic (8.45e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (4.69e-4)" "unprognostic (3.80e-2)" "prognostic unfavorable (5.11e-6)" "unprognostic (4.94e-2)" "unprognostic (2.42e-1)" "unprognostic (3.66e-2)" "unprognostic (1.08e-3)" "unprognostic (1.40e-1)" "unprognostic (1.58e-3)" "unprognostic (1.46e-3)" "unprognostic (6.00e-2)" "unprognostic (4.48e-2)" "unprognostic (2.58e-2)" 28.2 30.0 63.4 17.0 63.8 18.2 27.4 67.0 81.8 33.7 65.9 27.8 17.2 30.0 11.5 21.0 30.0 15.3 23.1 64.0 66.7 52.1 48.7 29.0 26.2 72.3 64.3 32.3 30.7 19.1 55.7 19.1 76.5 37.1 6.9 16.0 25.9 18.2 14.3 33.9 27.8 14.0 63.3 40.0 28.9 23.9 67.1 18.5 30.1 6.8 10.8 30.5 25.7 69.7 36.0 57.3 32.0 55.0 40.0 38.7 23.4 28.3 38.9 26.7 29.4 25.4 52.3 33.4 91.1 29.5 70.6 24.5 30.8 28.7 6.2 71.5 61.3 17.0 25.9 32.8 96.8 21.4 34.8 69.1 47.6 35.0 15.3 42.4 25.3 37.9 51.5 76.7 33.9 89.1 38.1 76.7 47.5 18.9 55.1 36.7 22.5 175.4 55.0 7.2 33.6 53.1 32.6 38.2 134.6 10.6 52.9 41.6 18.6 28.6 20.8 75.2 54.4 79.3 28.7 37.6 82.3 41.0 56.0 32.0 29.3 27.4 21.6 31.8 14.0 18.5 14.9 17.7 25.8 15.3 14.8 17.2 8.6 41.0 33.8 15.5 19.9 16.4 63.4 63.8 67.0 81.8 64.0 66.7 72.3 64.3 76.5 63.3 67.1 69.7 33.2 6.4 13.2 22.2 36.8 19.8 39.0 53.3 51.2 52.3 33.1 44.4 4.2 31.5 26.1 40.5 33.3 77.0 45.3 26.5 15.6 33.8 0.4 20.0 36.3 22.8 25.2 24.4 19.1 46.3 61.3 34.8 25.5 24.1 1.3 45.3 23.2 28.4 67.8 48.8 25.3 23.9 57.0 35.2 17.5 3.2 36.1 34.4 44.4 8.4 45.3 52.5 49.4 14.6 19.5 36.4 31.2 22.6 51.0 30.6 27.3 16.2 15.2 49.6 26.3 22.3 33.7 6.8 25.8 21.9 19.5 43.5 41.7 31.9 28.3 21.0 GANAB "G2AN, GIIA, GluII, KIAA0088" ENSG00000089597 "Glucosidase II alpha subunit" Q14697 11 62624826-62646726 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026874, HPA061426" Enhanced Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA 23000000 "Cluster 39: Non-specific - mRNA processing" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA026874: AB_1849745, HPA061426: AB_2684516" "unprognostic (2.12e-1)" "unprognostic (5.95e-3)" "unprognostic (4.35e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-2)" "unprognostic (3.65e-2)" "prognostic unfavorable (1.27e-5)" "unprognostic (5.80e-3)" "unprognostic (1.09e-1)" "unprognostic (1.79e-1)" "unprognostic (1.68e-3)" "unprognostic (5.91e-2)" "unprognostic (1.01e-3)" "unprognostic (3.81e-2)" "unprognostic (1.82e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (9.54e-4)" 93.9 73.7 31.8 88.2 34.5 83.7 92.8 36.6 36.7 112.6 51.6 104.7 95.6 102.1 151.7 66.4 106.9 75.3 67.9 31.7 41.2 98.5 171.7 86.8 81.7 38.5 34.9 115.5 88.1 130.6 21.8 141.8 38.1 97.5 116.8 79.4 101.8 111.1 39.4 74.7 90.5 126.0 36.5 86.7 85.2 66.1 39.8 105.2 132.6 53.0 94.8 90.7 34.2 43.4 298.2 245.9 318.2 552.0 464.1 389.0 332.9 312.4 480.4 436.2 362.1 222.2 515.9 201.2 616.0 572.5 337.8 376.4 375.2 376.7 443.8 155.8 191.3 202.9 317.8 125.6 389.0 325.7 248.7 397.2 248.4 433.6 475.3 533.0 422.3 199.6 278.5 352.9 398.2 313.6 167.6 193.4 262.3 236.6 237.7 209.5 368.7 513.1 285.7 230.3 168.6 221.2 451.1 308.2 370.8 321.6 380.9 304.8 311.6 430.0 272.2 342.9 309.9 360.8 423.8 152.2 473.9 173.1 421.7 23.9 19.3 19.1 23.8 23.4 23.1 15.9 17.2 20.0 20.8 14.9 20.9 21.3 8.9 29.8 22.2 18.4 17.3 22.6 31.8 34.5 36.6 36.7 31.7 41.2 38.5 34.9 38.1 36.5 39.8 43.4 42.7 12.8 20.7 17.3 29.8 28.3 29.4 45.8 13.6 31.4 57.4 53.8 7.8 52.9 24.2 68.0 60.5 81.7 33.4 40.1 5.9 47.0 18.5 31.4 59.1 42.2 31.8 25.0 12.6 42.6 137.3 45.9 27.5 46.5 11.4 72.8 48.2 98.0 57.9 35.3 16.0 48.9 34.6 45.8 25.1 16.4 58.4 32.7 35.6 15.9 38.9 36.5 38.1 11.1 16.5 39.5 29.3 68.1 50.4 34.0 47.8 27.0 26.3 41.4 32.9 36.4 34.7 25.3 47.4 21.2 31.3 80.2 25.2 63.1 56.3 32.4 INTS5 "INT5, KIAA1698" ENSG00000185085 "Integrator complex subunit 5" Q6P9B9 11 62646848-62653302 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046181, HPA056915" Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Cytosol "HPA046181: , HPA056915: AB_2683276" "unprognostic (2.87e-1)" "unprognostic (9.51e-2)" "unprognostic (9.11e-2)" "unprognostic (9.70e-2)" "unprognostic (2.71e-1)" "unprognostic (6.41e-2)" "unprognostic (1.97e-2)" "unprognostic (5.52e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-2)" "unprognostic (2.33e-1)" "unprognostic (5.09e-2)" "prognostic favorable (8.44e-5)" "unprognostic (7.08e-3)" "unprognostic (2.97e-2)" "unprognostic (3.36e-1)" "unprognostic (1.35e-2)" 8.3 9.3 5.5 8.0 5.7 5.4 8.5 5.7 6.0 10.1 5.5 9.1 7.8 11.4 5.3 12.1 12.9 5.8 8.1 5.7 5.4 8.6 12.6 7.7 10.6 6.0 5.6 10.2 10.3 8.8 6.6 6.0 5.8 9.2 5.8 2.8 11.7 6.9 13.9 12.4 8.8 8.3 5.5 10.5 9.5 6.1 5.8 8.3 7.8 8.3 9.2 9.1 8.7 5.8 17.5 21.1 12.2 11.4 23.5 17.1 11.4 14.2 14.4 18.7 13.4 15.1 19.0 33.1 25.0 18.0 15.5 26.7 24.6 32.9 9.0 20.8 17.1 17.2 15.8 10.2 21.2 19.0 15.7 19.9 25.3 20.1 17.1 14.2 18.8 14.5 26.6 18.9 16.3 35.8 22.0 22.1 18.7 20.7 26.4 22.2 16.5 39.9 14.3 11.3 16.4 13.8 15.9 22.0 22.2 8.6 31.3 12.9 15.7 17.8 13.6 27.6 12.9 26.5 21.9 23.8 20.5 14.3 17.2 4.3 5.3 3.9 6.4 3.5 10.1 4.1 5.9 5.7 5.5 5.0 6.9 6.4 1.9 7.7 4.1 5.5 4.6 6.3 5.5 5.7 5.7 6.0 5.7 5.4 6.0 5.6 5.8 5.5 5.8 5.8 5.0 3.2 7.8 2.3 8.8 2.2 7.1 8.2 4.6 7.5 6.6 6.3 3.1 7.2 9.3 3.7 0.0 14.0 10.7 4.8 11.7 12.0 6.4 5.7 5.0 6.9 6.7 2.5 2.0 10.6 9.3 5.2 4.1 4.4 8.9 6.7 9.7 11.5 8.7 10.1 2.1 7.9 8.2 7.0 3.1 8.9 6.5 4.3 0.0 1.9 12.6 10.4 8.2 2.0 1.0 9.7 2.2 7.9 7.3 8.5 8.7 10.2 13.2 3.8 13.1 5.1 8.6 10.8 11.3 5.4 4.1 19.8 6.8 9.1 7.6 5.9 AP001458.2 ENSG00000255432 "Novel protein" 11 62649694-62665178 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" 0.3 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.7 0.2 0.0 0.0 0.9 0.9 0.3 0.6 0.2 0.5 0.4 0.6 0.4 0.4 0.5 0.7 0.3 0.5 0.1 0.6 0.3 0.3 0.8 0.2 0.1 0.3 0.1 0.3 0.1 0.3 0.2 0.3 0.2 0.1 0.2 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LBHD1 "C11orf48, MGC2477" ENSG00000162194 "LBH domain containing 1" Q9BQE6 11 62662817-62672255 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 65.9" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 4.2;Respiratory ciliated cells: 8.7;Rod photoreceptor cells: 7.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 30.8;JURKAT: 53.8" "Low region specificity" "Detected in all" "HPA012127, HPA023592" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 79: Retina - Phototransduction" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm Cytosol "HPA012127: AB_1845527, HPA023592: AB_1845528" "unprognostic (4.34e-4)" "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" "unprognostic (7.90e-3)" "unprognostic (1.02e-1)" "unprognostic (2.33e-1)" "unprognostic (2.18e-8)" "unprognostic (2.75e-1)" "unprognostic (1.03e-1)" "unprognostic (1.52e-2)" "unprognostic (2.81e-1)" "unprognostic (6.79e-2)" "unprognostic (2.78e-8)" "unprognostic (3.69e-2)" "unprognostic (1.62e-1)" "unprognostic (5.79e-2)" "unprognostic (4.72e-3)" 4.6 13.1 1.8 5.5 1.8 6.3 3.7 2.9 2.8 3.4 2.9 4.7 3.5 2.0 4.2 3.4 3.4 2.6 3.2 1.8 2.0 3.8 8.6 3.5 7.5 2.1 2.2 1.9 3.8 4.1 3.9 1.9 2.2 4.3 3.4 65.9 3.6 3.5 1.8 2.5 6.0 2.3 1.6 9.5 4.5 7.3 2.1 6.0 4.1 0.9 4.7 3.6 2.6 2.4 2.7 4.7 2.8 2.1 4.2 7.9 6.2 3.6 5.3 5.8 4.6 3.7 30.8 9.4 7.7 4.5 6.0 11.8 3.0 8.4 4.5 12.8 9.5 7.9 14.6 2.7 6.2 7.4 9.9 10.9 0.9 10.4 3.2 6.5 3.2 53.8 8.3 8.3 3.7 4.8 4.6 11.0 3.6 6.4 4.0 11.2 6.9 17.4 7.7 5.4 3.2 4.7 4.0 5.4 12.1 3.8 10.1 11.1 2.5 3.6 2.3 3.7 4.0 13.7 12.8 9.1 3.3 7.4 3.8 1.5 3.5 3.4 3.2 2.4 2.9 2.4 1.9 3.5 3.1 2.5 2.6 2.1 0.8 4.8 2.1 3.9 1.2 2.6 1.8 1.8 2.9 2.8 1.8 2.0 2.1 2.2 2.2 1.6 2.1 2.4 0.8 3.2 2.7 0.0 2.0 0.0 0.2 0.0 1.2 2.3 0.6 0.5 0.8 0.0 2.5 0.0 4.2 0.2 2.0 0.2 0.0 0.2 0.0 2.7 1.1 0.5 0.0 0.4 0.3 0.0 0.3 1.0 2.0 0.7 2.5 1.2 0.0 0.6 0.2 1.7 0.3 0.1 0.0 0.3 0.0 0.3 0.3 1.6 0.0 1.0 0.1 1.5 2.1 0.0 0.1 0.2 0.0 0.4 3.9 0.4 0.4 0.3 8.7 7.6 0.0 1.1 0.3 0.7 0.6 0.9 0.0 0.3 1.8 3.6 0.1 0.3 C11orf98 C11orf48 ENSG00000278615 "Chromosome 11 open reading frame 98" E9PRG8 11 62662817-62665210 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 33.6;Erythroid cells: 25.2;Gastric mucus-secreting cells: 50.0;Plasma cells: 58.3;Squamous epithelial cells: 57.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" "unprognostic (3.52e-2)" "unprognostic (2.63e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (7.62e-4)" "unprognostic (3.73e-1)" "unprognostic (4.37e-2)" "prognostic unfavorable (5.85e-5)" "unprognostic (3.30e-1)" "unprognostic (8.35e-2)" "unprognostic (3.02e-3)" "unprognostic (2.52e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (4.02e-6)" "unprognostic (2.14e-2)" "unprognostic (4.33e-2)" "unprognostic (1.29e-2)" "unprognostic (4.70e-3)" 48.9 63.4 71.5 57.3 73.8 38.0 45.9 75.1 109.4 41.9 70.7 56.9 45.5 37.7 31.6 66.8 41.0 27.2 65.9 70.5 73.8 77.3 74.0 44.3 72.5 74.3 75.6 35.1 47.6 29.8 35.7 29.8 74.9 55.6 50.6 80.2 43.3 29.2 67.6 52.3 57.1 30.2 72.0 68.7 62.1 65.9 74.6 63.7 41.3 35.9 69.3 50.3 41.2 75.3 265.0 162.8 115.3 140.6 66.5 74.8 63.6 129.6 89.1 145.8 100.2 172.8 144.2 164.3 191.8 81.2 100.6 173.8 115.0 130.5 104.5 178.3 69.2 162.7 101.3 174.9 96.0 254.9 143.0 78.6 150.6 151.7 150.5 87.0 117.1 137.3 202.9 76.1 124.0 337.9 185.1 230.6 188.8 194.6 140.8 139.3 106.1 206.2 163.5 135.0 98.4 110.4 102.5 283.2 182.2 89.4 304.4 91.0 99.4 109.3 147.1 278.7 234.1 74.8 123.9 153.7 141.9 101.4 140.1 340.2 187.3 388.7 202.5 206.3 223.2 352.0 224.4 252.2 166.0 313.6 202.5 250.1 201.9 273.2 217.0 279.3 331.4 288.3 71.5 73.8 75.1 109.4 70.5 73.8 74.3 75.6 74.9 72.0 74.6 75.3 3.0 9.6 5.1 0.0 20.0 0.0 0.3 0.0 33.6 0.1 2.9 2.2 0.1 2.8 5.6 1.8 0.0 1.6 3.6 0.8 1.9 4.2 1.6 5.2 4.8 4.0 0.0 25.2 0.0 2.3 2.1 6.5 50.0 4.3 11.4 0.7 2.9 12.0 1.5 0.0 0.0 0.9 0.0 5.0 0.0 1.3 1.2 11.3 0.0 0.0 8.2 0.2 2.1 0.0 0.0 4.7 1.7 0.7 58.3 0.3 3.1 7.1 13.1 0.7 6.6 0.2 3.7 1.2 0.8 57.1 0.0 1.8 19.6 1.0 0.8 0.6 CSKMT "CS-KMT, METTL12, U99HG" ENSG00000214756 "Citrate synthase lysine methyltransferase" A8MUP2 11 62665309-62668496 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "Adipocytes: 40.4;Alveolar cells type 2: 41.4;Breast glandular cells: 65.9;Breast myoepithelial cells: 68.5;dendritic cells: 46.3;Endometrial stromal cells: 37.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" HPA038533 Approved NA Yes "Cluster 30: Non-specific - Translation" "Cluster 6: T47d - Mammary gland" "Cluster 7: Non-specific - Mitochondria" "HPA038533: AB_10697392" "prognostic favorable (8.73e-4)" "unprognostic (2.59e-1)" "unprognostic (3.84e-1)" "unprognostic (1.15e-1)" "unprognostic (1.48e-2)" "unprognostic (3.17e-1)" "unprognostic (9.43e-5)" "unprognostic (1.55e-2)" "unprognostic (7.62e-2)" "unprognostic (2.88e-1)" "unprognostic (1.07e-1)" "unprognostic (2.54e-1)" "unprognostic (4.98e-3)" "unprognostic (2.72e-3)" "unprognostic (1.85e-1)" "unprognostic (1.57e-2)" "unprognostic (3.28e-1)" 0.3 0.3 0.4 0.1 0.3 0.1 0.4 0.3 0.7 0.5 0.3 0.4 0.5 0.4 0.1 0.5 0.5 0.1 0.3 0.3 0.4 0.3 0.3 0.2 0.2 0.4 0.3 0.6 0.7 0.1 0.2 0.5 0.4 0.4 0.4 0.1 0.3 0.4 0.9 0.3 0.2 0.1 0.3 0.2 0.4 0.0 0.4 0.2 0.2 0.2 0.3 0.4 0.5 0.4 0.9 0.9 0.3 0.4 2.6 1.0 0.4 0.3 0.6 0.7 0.9 0.7 0.9 1.6 0.4 1.2 0.2 1.7 1.6 0.8 1.4 0.5 0.0 0.6 0.0 1.0 0.0 0.0 0.6 0.9 2.7 0.2 1.0 0.7 0.2 0.2 0.7 0.0 1.0 0.8 0.5 0.7 1.6 0.0 0.8 0.8 0.4 0.2 0.3 0.1 0.0 0.0 0.8 1.0 0.9 0.4 2.0 0.2 0.0 0.2 0.9 2.4 0.0 0.3 0.0 0.0 0.2 0.4 0.4 0.7 1.1 0.1 0.8 1.8 1.7 2.9 2.4 1.1 1.1 1.5 2.9 2.5 0.0 0.5 1.3 1.3 1.3 1.4 0.4 0.3 0.3 0.7 0.3 0.4 0.4 0.3 0.4 0.3 0.4 0.4 40.4 12.8 41.4 0.0 25.0 0.0 0.0 0.0 0.0 0.0 65.9 68.5 0.0 0.0 21.1 18.4 0.0 27.7 46.3 0.0 5.9 7.4 0.0 17.5 37.7 10.1 0.0 0.0 0.0 5.6 20.0 13.2 0.0 23.0 27.8 15.3 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 8.8 0.0 0.0 9.8 6.6 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 26.5 24.4 13.5 0.0 0.0 UQCC3 "C11orf83, UNQ655" ENSG00000204922 "Ubiquinol-cytochrome c reductase complex assembly factor 3" Q6UW78 11 62670273-62673686 "Disease related genes, Human disease related genes, Predicted membrane proteins" "ATP synthesis" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 209.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 82.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046851 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Mitochondria" Cytosol "HPA046851: AB_2679839" "unprognostic (5.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "unprognostic (3.42e-2)" "unprognostic (3.91e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (2.18e-1)" "unprognostic (1.67e-1)" "unprognostic (8.70e-3)" "unprognostic (7.84e-2)" "unprognostic (8.96e-2)" "unprognostic (7.07e-2)" "unprognostic (7.21e-3)" "unprognostic (1.48e-1)" "unprognostic (3.20e-1)" "unprognostic (1.36e-1)" 7.5 12.2 7.4 3.7 7.5 5.7 7.5 8.2 9.7 7.6 9.3 9.9 8.1 6.5 1.7 12.3 6.1 1.2 10.2 7.1 7.1 10.7 11.9 4.7 4.2 7.6 7.3 6.5 9.0 3.5 6.7 2.2 7.7 9.4 1.9 3.9 11.5 3.3 15.7 9.0 8.3 1.5 7.0 7.4 9.6 3.4 7.4 2.4 6.3 5.0 1.6 6.3 8.1 8.1 26.9 52.9 7.7 12.0 4.7 4.6 6.5 10.4 3.5 7.7 7.6 31.4 22.8 17.4 21.1 3.6 10.4 26.1 7.4 12.3 2.4 8.8 27.4 9.8 28.7 20.3 6.3 16.0 7.6 4.4 10.3 6.8 7.6 4.8 6.0 8.1 21.3 12.2 4.3 82.4 15.7 39.2 8.6 10.6 29.8 17.9 11.7 31.1 6.1 13.2 15.5 15.7 11.5 41.7 16.2 2.4 39.7 14.9 7.9 16.8 19.7 17.6 23.6 18.7 11.0 18.3 13.8 13.7 12.3 14.6 25.0 20.1 21.3 19.1 20.4 30.8 21.1 19.0 20.0 29.9 19.2 15.3 11.0 19.6 17.2 26.7 25.8 20.0 7.4 7.5 8.2 9.7 7.1 7.1 7.6 7.3 7.7 7.0 7.4 8.1 49.0 44.8 25.0 3.6 32.3 0.0 42.2 0.0 47.3 21.8 77.5 86.4 35.8 70.1 16.1 64.4 16.7 53.1 22.9 65.2 140.8 56.6 1.7 50.3 40.6 32.9 35.2 32.2 2.4 78.4 53.1 32.4 54.6 41.1 5.1 28.0 44.6 125.4 54.8 18.5 4.2 75.2 0.0 39.7 0.0 3.7 48.4 29.2 0.0 7.5 47.2 59.7 66.9 5.0 5.2 67.4 66.9 36.1 38.4 85.1 209.3 170.6 12.4 37.0 39.5 28.3 31.8 4.2 32.0 91.0 0.0 29.0 25.3 35.1 79.0 57.0 UBXN1 "2B28, LOC51035, SAKS1, UBXD10" ENSG00000162191 "UBX domain protein 1" Q04323 11 62676498-62679117 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012669, HPA076932" Approved Supported Nucleoplasm,Cytosol NA NA 45000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" Cytosol Nucleoplasm "HPA012669: AB_1853149, HPA076932: " "unprognostic (1.76e-3)" "unprognostic (8.72e-3)" "unprognostic (3.67e-3)" "unprognostic (2.94e-2)" "unprognostic (9.39e-2)" "unprognostic (8.72e-2)" "unprognostic (2.96e-2)" "unprognostic (1.15e-1)" "unprognostic (1.15e-1)" "unprognostic (4.36e-2)" "unprognostic (1.73e-1)" "unprognostic (1.07e-1)" "unprognostic (3.81e-2)" "unprognostic (3.52e-2)" "unprognostic (1.43e-1)" "unprognostic (3.34e-3)" "unprognostic (2.42e-1)" 138.3 103.0 88.9 67.1 94.0 63.7 121.3 91.5 102.9 133.5 86.1 130.6 71.9 113.2 44.3 99.6 112.4 54.4 106.4 85.8 88.5 95.1 72.8 81.9 108.0 96.5 90.1 147.8 120.3 58.9 75.8 52.2 93.9 89.4 37.9 28.0 79.0 56.1 284.3 128.6 93.3 48.3 91.2 111.7 116.6 113.5 91.1 107.6 96.8 105.3 82.2 113.2 103.8 94.7 86.2 137.7 101.3 142.5 137.7 147.0 87.7 73.4 136.6 139.4 94.6 99.0 109.7 135.7 131.3 100.1 123.7 119.2 81.6 128.3 64.5 124.3 99.5 95.6 118.9 136.4 269.1 150.7 102.6 191.7 195.1 123.5 188.5 149.4 132.1 170.3 148.0 86.4 88.5 196.6 117.8 280.3 5.2 67.4 88.9 86.6 107.9 135.3 114.1 85.8 98.6 165.5 68.8 108.3 330.0 43.2 150.5 188.0 128.6 111.8 84.0 113.4 84.6 109.0 89.3 123.8 129.7 64.9 103.7 158.0 320.2 160.7 273.9 346.7 350.2 534.6 415.2 323.7 346.2 533.5 494.7 365.8 173.5 303.8 440.6 276.8 562.3 559.0 88.9 94.0 91.5 102.9 85.8 88.5 96.5 90.1 93.9 91.2 91.1 94.7 183.1 93.0 116.4 16.6 222.8 264.0 176.5 240.7 142.3 61.7 202.9 190.2 86.4 137.2 160.7 75.4 45.9 172.9 194.1 162.0 156.5 191.1 184.1 91.2 119.0 194.9 126.2 144.9 9.2 184.7 195.2 124.1 78.0 81.4 162.7 146.6 180.2 77.0 216.3 30.3 9.1 156.5 187.2 325.2 352.2 245.8 208.8 196.2 183.2 8.4 307.5 153.5 244.1 7.5 17.8 203.8 235.9 143.3 93.0 192.7 335.9 259.7 132.7 57.4 197.2 171.3 300.3 257.6 220.6 130.2 302.8 324.7 226.9 147.0 161.4 235.0 LRRN4CL ENSG00000177363 "LRRN4 C-terminal like" Q8ND94 11 62686406-62689530 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Fibroblasts: 62.1;Leydig cells: 27.1;Melanocytes: 33.8;Peritubular cells: 17.3;Skeletal myocytes: 33.0" "Cancer enriched" "Detected in many" 5 "melanoma: 26.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 7.7;ASC TERT1: 25.3;HHSteC: 19.8;HSkMC: 10.6;LHCN-M2: 13.4" "Low region specificity" "Detected in many" HPA050317 Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Nuclear bodies" "HPA050317: AB_2681084" "unprognostic (1.28e-1)" "unprognostic (2.74e-2)" "unprognostic (2.84e-1)" "unprognostic (9.95e-3)" "unprognostic (2.61e-2)" "unprognostic (4.03e-3)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" "unprognostic (3.04e-1)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.35e-7)" "unprognostic (2.73e-2)" "unprognostic (6.12e-2)" "unprognostic (4.53e-3)" "unprognostic (1.86e-2)" 23.3 6.6 0.4 2.5 0.4 0.5 16.0 1.5 1.3 22.4 2.6 15.1 1.8 29.7 3.7 4.5 18.2 3.6 7.2 0.6 0.6 1.0 0.1 3.5 0.5 0.5 0.3 21.0 1.1 0.3 1.7 0.7 0.4 6.1 2.1 0.4 5.5 5.8 4.8 10.6 7.2 9.1 0.2 0.2 8.2 1.5 0.5 0.4 4.2 5.6 0.3 9.7 16.1 0.7 0.0 0.1 0.2 0.3 7.7 25.3 0.3 2.8 4.0 0.3 1.4 0.2 0.1 0.2 0.3 4.6 0.1 0.3 0.1 0.0 0.4 0.2 0.2 0.5 0.2 0.2 19.8 0.2 0.2 10.6 0.1 0.6 0.0 0.2 0.1 0.4 0.3 0.1 13.4 0.1 0.3 0.6 0.6 0.1 0.1 0.1 1.7 0.3 0.0 0.2 0.8 0.3 0.4 0.3 0.8 0.1 0.2 0.3 0.3 2.4 0.2 2.7 0.1 0.2 0.2 0.3 1.5 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.1 0.0 0.1 0.0 0.0 0.4 0.4 1.5 1.3 0.6 0.6 0.5 0.3 0.4 0.2 0.5 0.7 4.0 0.0 1.8 0.0 0.1 6.6 2.1 0.0 0.0 2.1 0.5 0.8 1.5 0.0 0.6 0.0 2.1 0.1 0.2 0.0 0.0 0.0 1.0 0.5 11.0 3.7 1.2 0.0 0.1 0.0 0.2 62.1 0.5 0.4 1.3 0.2 1.4 0.1 0.4 1.7 0.3 0.3 0.0 0.6 8.3 0.5 27.1 1.1 33.8 1.9 0.1 0.2 1.0 0.0 0.1 0.0 0.1 17.3 0.4 1.4 0.1 0.3 0.0 1.0 0.0 33.0 2.8 0.4 0.3 0.5 7.0 0.1 1.1 1.2 0.1 1.3 BSCL2 "GNG3LG, seipin, SPG17" ENSG00000168000 "BSCL2 lipid droplet biogenesis associated, seipin" Q96G97 11 62690275-62709845 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid degradation, Lipid metabolism" "Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 292.1;pituitary gland: 237.0" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 35.9;Late spermatids: 53.1;Plasma cells: 86.3;Spermatocytes: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 242.1;RPMI-8226: 176.1;SCLC-21H: 181.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042394 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA042394: AB_10794047" "unprognostic (7.78e-2)" "unprognostic (8.74e-2)" "unprognostic (1.24e-1)" "unprognostic (8.17e-2)" "unprognostic (3.08e-2)" "unprognostic (2.01e-1)" "unprognostic (1.70e-1)" "unprognostic (1.13e-1)" "unprognostic (9.30e-2)" "unprognostic (4.44e-2)" "unprognostic (5.13e-3)" "unprognostic (2.41e-1)" "prognostic favorable (7.55e-5)" "unprognostic (3.56e-1)" "unprognostic (1.69e-1)" "unprognostic (1.70e-1)" "unprognostic (1.96e-1)" 24.9 88.1 126.6 7.4 133.2 12.0 26.2 75.0 155.6 38.2 85.4 24.3 10.8 28.4 156.7 24.1 63.7 21.5 18.7 134.9 292.1 50.8 39.3 26.7 15.3 138.1 139.0 32.7 79.4 61.7 237.0 10.0 203.4 35.4 13.3 52.6 66.1 30.3 30.9 25.1 17.2 13.7 83.1 16.2 37.1 190.3 169.3 14.4 37.9 15.5 8.9 17.5 26.1 89.9 18.0 61.7 49.6 83.8 130.8 41.5 7.2 7.2 34.4 13.6 14.5 9.6 26.3 11.9 16.5 25.2 11.8 62.1 5.2 21.8 7.0 30.7 5.0 10.9 33.4 7.8 27.7 9.7 13.5 27.8 16.6 26.9 10.9 19.7 10.8 33.0 7.8 242.1 19.8 44.0 11.4 21.8 132.4 13.9 13.0 21.3 4.2 176.1 65.0 2.4 181.2 29.4 28.2 13.9 25.3 5.7 41.3 15.3 6.5 16.5 3.7 24.5 4.2 32.2 72.5 16.6 82.4 3.2 14.5 26.6 59.2 34.6 24.7 46.2 27.4 27.5 25.5 26.1 42.4 29.7 25.7 27.0 14.2 41.0 40.3 54.3 33.1 43.3 126.6 133.2 75.0 155.6 134.9 292.1 138.1 139.0 203.4 83.1 169.3 89.9 0.8 16.0 5.6 0.0 7.1 1.7 1.0 1.4 35.9 2.5 3.6 2.2 0.2 1.5 1.6 3.7 0.0 2.4 0.9 1.7 3.9 2.0 25.5 4.8 1.5 2.9 0.0 8.8 0.0 1.1 1.9 9.2 20.4 1.5 2.5 0.7 1.4 2.1 1.9 3.3 0.0 1.6 6.1 2.5 3.1 53.1 2.5 6.2 12.4 0.0 0.7 0.8 1.0 0.0 0.0 0.5 1.6 3.0 86.3 0.9 2.5 6.0 23.9 1.2 6.6 1.2 4.1 32.6 18.1 24.7 4.0 1.5 6.5 0.7 1.2 0.5 GNG3 ENSG00000162188 "G protein subunit gamma 3" P63215 11 62707676-62709201 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 295.7" "Cell type enhanced" "Detected in some" "Bipolar cells: 39.8;Early spermatids: 27.6;Excitatory neurons: 23.3;Inhibitory neurons: 20.7;Late spermatids: 123.0" "Cancer enriched" "Detected in some" 14 "glioma: 12.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 30 "memory B-cell: 16.9;naive B-cell: 17.1" "Lineage enriched" "Detected in single" 31 "B-cells: 17.1" "Group enriched" "Detected in many" 7 "Karpas-707: 149.4;SCLC-21H: 292.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 65: Brain - Ion transport" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (2.43e-2)" "unprognostic (2.57e-2)" "unprognostic (1.78e-1)" "unprognostic (4.68e-4)" "unprognostic (2.73e-2)" "unprognostic (7.60e-2)" "unprognostic (1.77e-2)" "unprognostic (1.69e-1)" "unprognostic (6.03e-3)" "unprognostic (3.04e-1)" "unprognostic (2.33e-3)" "unprognostic (1.50e-1)" "unprognostic (5.37e-5)" "unprognostic (3.16e-1)" "unprognostic (1.63e-1)" "unprognostic (1.00e-1)" "unprognostic (1.00e-1)" 0.3 14.8 168.3 1.9 183.3 1.1 0.3 132.0 295.7 0.3 62.2 8.3 1.3 0.2 1.0 0.4 0.2 0.3 0.6 203.9 207.0 0.6 0.8 0.4 0.4 146.2 148.2 0.6 0.7 0.9 48.4 0.1 179.5 0.7 2.6 35.3 0.6 0.7 0.6 0.6 3.2 1.2 106.6 0.3 1.5 11.3 152.4 0.0 0.4 0.1 0.2 0.3 1.2 201.3 0.5 1.0 7.3 0.5 0.0 0.0 3.2 0.6 0.0 0.5 0.0 2.4 1.4 0.4 0.8 0.0 0.3 1.0 0.0 0.0 0.0 2.2 0.5 0.8 0.9 2.1 0.2 1.3 0.6 0.3 0.0 0.1 0.0 1.3 0.0 1.1 1.7 149.4 0.0 1.3 0.3 3.9 33.2 0.7 0.1 2.0 1.3 0.8 0.5 2.4 292.9 2.5 0.8 1.0 0.2 1.5 1.7 0.7 0.4 1.7 2.9 0.9 0.5 0.9 2.4 0.8 1.5 1.1 0.4 0.0 0.1 0.5 0.0 0.0 0.0 16.9 0.1 0.1 0.1 17.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 168.3 183.3 132.0 295.7 203.9 207.0 146.2 148.2 179.5 106.6 152.4 201.3 0.1 0.0 0.0 5.9 1.2 0.0 0.4 0.0 0.0 39.8 0.4 0.9 0.1 0.0 0.0 0.0 4.2 0.2 0.0 0.2 0.0 0.1 27.6 0.5 0.0 0.1 0.0 0.0 23.3 0.4 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.3 5.0 20.7 0.2 0.0 0.0 0.4 123.0 0.9 0.1 0.0 2.8 0.6 5.3 0.0 8.0 7.4 0.0 1.2 0.0 0.0 0.0 0.1 0.3 0.0 14.1 0.0 0.0 0.1 4.4 3.0 0.0 0.3 0.0 0.1 0.4 0.1 0.2 HNRNPUL2 "DKFZp762N1910, HNRPUL2" ENSG00000214753 "Heterogeneous nuclear ribonucleoprotein U like 2" Q1KMD3 11 62712630-62727457 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA041632, HPA056696, HPA067699" Supported Enhanced Nucleoplasm NA NA 88000 "Cluster 6: Non-specific - Transcription" "Cluster 70: Brain - Nervous system development" "Cluster 36: HEL - Hemostasis" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA041632: AB_10960896, HPA056696: AB_2683211, HPA067699: AB_2685891" "unprognostic (3.06e-3)" "unprognostic (2.31e-1)" "unprognostic (7.48e-2)" "unprognostic (9.27e-3)" "unprognostic (4.38e-2)" "unprognostic (1.95e-1)" "unprognostic (1.91e-2)" "unprognostic (2.21e-1)" "unprognostic (2.83e-1)" "unprognostic (4.99e-3)" "unprognostic (2.35e-1)" "unprognostic (6.43e-2)" "unprognostic (2.50e-1)" "unprognostic (3.92e-2)" "unprognostic (2.17e-1)" "unprognostic (2.33e-2)" "unprognostic (6.45e-2)" 30.4 20.9 44.3 28.6 45.4 27.3 26.2 47.3 52.3 28.7 37.2 40.5 29.0 32.5 36.3 37.2 29.1 17.1 33.1 45.0 43.1 26.8 21.1 25.8 35.1 42.3 43.8 26.5 32.5 24.7 20.9 25.1 43.0 26.6 28.0 37.5 30.6 30.2 48.6 39.8 35.2 28.3 42.4 34.1 31.3 16.7 45.5 47.4 24.3 35.9 37.6 34.2 28.2 44.2 110.9 49.8 83.5 50.3 45.1 55.3 14.4 70.2 41.5 52.1 40.2 34.4 37.5 129.1 36.5 57.9 45.0 62.2 51.2 66.3 69.1 59.1 27.8 123.0 64.9 39.1 41.2 127.8 78.1 43.8 50.7 50.2 61.4 41.0 64.8 33.5 46.6 47.8 61.0 63.5 128.1 114.1 39.8 41.4 42.9 88.6 77.0 62.3 65.4 65.2 48.4 56.3 71.7 57.8 75.3 39.3 43.5 55.6 72.8 61.0 28.2 77.4 74.4 60.8 54.3 124.6 55.3 62.1 57.5 1.1 0.8 1.3 1.4 0.6 1.0 1.0 1.0 1.2 0.5 1.3 0.8 0.9 1.0 0.8 1.4 1.4 1.0 0.5 44.3 45.4 47.3 52.3 45.0 43.1 42.3 43.8 43.0 42.4 45.5 44.2 21.1 28.9 12.1 0.0 19.0 29.4 15.0 20.2 13.6 31.3 25.0 18.7 43.8 30.0 17.5 53.3 10.4 27.9 32.4 68.8 5.9 27.4 9.9 20.8 26.3 30.6 38.4 23.5 0.0 36.0 26.9 23.0 19.4 29.7 15.2 28.0 37.5 40.7 37.9 42.1 0.0 48.3 22.4 54.1 29.4 6.9 42.0 27.6 14.2 0.0 38.0 18.2 24.7 0.0 0.0 35.0 42.7 45.9 12.5 24.1 59.6 25.6 16.1 19.7 32.9 22.8 27.5 15.6 20.1 19.6 32.1 25.2 19.8 20.6 58.6 17.4 TTC9C MGC29649 ENSG00000162222 "Tetratricopeptide repeat domain 9C" Q8N5M4 11 62728069-62740293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055169 Approved Approved Nucleoplasm NA Yes "Cluster 2: Granulocytes - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 3: Monocytes - Immune response regulation" Nucleoplasm "HPA055169: AB_2682724" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "unprognostic (2.71e-2)" "unprognostic (7.23e-3)" "unprognostic (2.17e-1)" "unprognostic (6.56e-3)" "unprognostic (1.86e-3)" "unprognostic (1.52e-1)" "unprognostic (5.66e-2)" "unprognostic (6.90e-3)" "unprognostic (1.33e-3)" "unprognostic (1.57e-1)" "prognostic unfavorable (4.67e-7)" "prognostic favorable (4.15e-5)" "unprognostic (7.49e-2)" "unprognostic (3.55e-2)" "unprognostic (1.53e-2)" 12.9 14.1 17.0 18.2 17.5 5.6 14.8 18.9 21.7 13.7 15.9 16.0 20.4 15.3 17.3 14.4 18.4 15.1 11.3 18.2 17.7 15.0 13.4 12.4 25.9 18.7 17.6 26.2 13.3 9.4 11.9 19.3 19.1 12.1 15.5 9.9 14.9 14.2 16.2 19.9 15.4 15.6 17.4 19.7 15.4 14.0 17.8 25.1 19.3 13.7 23.9 15.9 11.5 18.4 47.4 39.4 32.8 31.5 46.6 54.3 24.4 48.7 49.7 57.1 47.6 35.0 45.0 35.7 88.1 33.5 50.7 41.2 49.8 14.8 44.9 93.0 24.8 39.3 57.1 43.0 51.1 26.9 41.1 35.8 31.4 46.3 47.1 42.5 43.3 42.0 29.3 34.3 54.2 33.9 42.5 55.2 27.4 38.5 31.5 32.5 42.3 54.0 36.6 18.0 28.3 23.3 41.3 35.3 57.1 29.1 46.5 24.8 36.9 56.5 33.3 64.0 34.1 36.4 58.6 40.1 31.3 20.2 30.5 70.1 39.1 40.5 22.4 36.4 17.6 42.3 24.1 22.9 33.9 37.9 23.6 21.7 25.1 29.9 24.3 33.9 39.5 24.7 17.0 17.5 18.9 21.7 18.2 17.7 18.7 17.6 19.1 17.4 17.8 18.4 14.5 16.0 10.9 7.8 27.0 29.6 13.3 14.2 25.0 17.5 13.8 13.8 9.3 10.0 17.3 18.4 8.4 35.0 21.8 17.0 27.4 24.0 23.3 14.0 14.4 19.6 6.0 14.1 18.0 14.9 41.9 18.5 7.7 10.9 8.2 22.6 13.6 9.9 38.5 28.6 13.5 15.8 18.3 27.1 20.6 20.4 28.3 18.8 16.0 4.7 40.5 13.5 35.0 7.5 9.8 19.7 15.3 27.4 22.4 21.3 25.9 27.0 18.2 16.0 32.9 10.2 17.0 32.4 31.8 21.2 33.2 23.8 21.5 19.6 17.7 19.6 ZBTB3 FLJ23392 ENSG00000185670 "Zinc finger and BTB domain containing 3" Q9H5J0 11 62748319-62754184 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 12.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035321, HPA035322" Approved Approved Mitochondria NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 5: NTERA-2 - Transcription" "Cluster 29: Early spermatids - Spermatogenesis" Mitochondria "HPA035321: AB_2674569, HPA035322: AB_10610567" "unprognostic (1.39e-1)" "unprognostic (2.08e-2)" "unprognostic (3.48e-2)" "unprognostic (1.83e-3)" "unprognostic (2.93e-1)" "unprognostic (5.52e-3)" "unprognostic (7.85e-2)" "unprognostic (1.37e-1)" "unprognostic (4.56e-2)" "unprognostic (5.02e-2)" "unprognostic (1.23e-2)" "unprognostic (1.83e-1)" "prognostic favorable (1.65e-5)" "prognostic favorable (9.98e-4)" "unprognostic (3.37e-3)" "unprognostic (4.15e-2)" "unprognostic (2.43e-2)" 1.3 1.4 3.2 2.2 4.9 2.3 2.0 3.5 3.9 1.8 1.4 2.4 2.3 1.6 1.9 1.9 4.3 1.0 3.0 2.9 2.6 1.7 1.8 2.8 2.4 4.2 3.7 2.5 2.5 2.2 1.0 2.0 3.9 1.8 2.1 3.1 3.5 2.2 2.8 5.8 2.2 1.8 2.6 2.1 5.0 2.8 3.6 2.8 2.7 3.2 2.6 1.4 1.2 8.1 2.1 3.2 2.6 3.5 4.9 2.4 2.2 2.3 2.4 2.6 2.3 2.1 2.7 3.4 3.3 2.4 1.9 4.6 2.3 2.5 1.2 3.9 3.9 1.8 6.7 2.6 2.4 2.7 3.7 2.7 2.9 2.0 3.0 3.3 2.2 2.7 3.3 3.5 2.6 4.3 3.4 3.1 7.8 1.6 1.6 2.5 2.0 3.3 2.1 2.7 2.4 2.3 2.3 2.9 1.6 3.7 4.3 2.0 2.0 3.9 1.7 2.8 1.3 3.6 2.8 2.9 3.7 1.6 1.5 1.9 7.2 9.4 4.0 5.6 4.8 4.0 4.1 4.9 5.2 3.3 4.6 3.6 2.3 5.0 4.8 1.5 5.9 6.2 3.2 4.9 3.5 3.9 2.9 2.6 4.2 3.7 3.9 2.6 3.6 8.1 1.4 3.2 2.7 0.7 2.1 0.8 1.6 1.3 2.8 2.7 1.6 1.8 3.3 1.5 1.3 0.0 6.2 4.4 0.9 3.2 7.9 3.2 12.8 1.5 2.4 1.7 0.0 0.4 0.5 1.9 2.4 1.9 2.6 1.6 0.0 2.5 1.1 3.0 2.4 0.0 0.5 3.1 4.1 2.2 0.8 7.5 1.5 1.4 0.0 0.0 2.0 1.7 4.1 0.0 2.2 2.1 3.9 3.0 1.0 1.1 2.8 2.7 1.4 4.5 0.0 0.9 1.8 2.9 3.9 1.0 1.1 2.5 1.5 2.1 1.9 1.1 POLR2G "hRPB19, hsRPB7, RPB7" ENSG00000168002 "RNA polymerase II subunit G" P62487 11 62761565-62766710 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053000 Approved Supported Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "HPA053000: AB_2682010" "unprognostic (7.58e-3)" "unprognostic (2.75e-1)" "unprognostic (2.37e-2)" "prognostic favorable (8.23e-4)" "unprognostic (1.39e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (6.02e-5)" "unprognostic (8.50e-2)" "unprognostic (6.01e-2)" "unprognostic (6.26e-3)" "unprognostic (9.41e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (1.53e-1)" "unprognostic (1.64e-1)" "unprognostic (2.46e-1)" "unprognostic (2.21e-1)" 63.1 69.5 75.5 48.3 79.7 70.6 75.3 82.0 101.1 54.8 72.3 53.9 37.3 52.5 85.8 59.2 64.3 41.5 53.5 75.1 80.7 67.7 67.9 49.1 89.1 85.0 76.6 54.6 41.1 57.9 41.1 60.7 84.5 55.2 66.1 76.0 41.9 51.8 45.4 60.9 44.1 66.2 83.8 62.7 49.9 32.6 79.2 112.2 53.6 47.3 106.2 53.1 50.1 90.1 124.4 212.7 225.1 142.9 114.0 111.7 56.7 85.7 107.8 199.8 159.9 129.3 141.4 173.9 192.5 129.8 86.2 118.9 103.6 159.8 176.4 342.3 129.7 116.6 157.2 156.5 159.6 159.7 103.2 108.8 161.2 93.0 185.9 105.6 157.9 160.5 148.5 115.4 143.4 389.4 230.6 209.4 142.3 130.7 218.2 185.6 207.0 234.8 150.8 103.8 95.7 162.1 143.8 112.8 226.2 84.6 318.6 132.6 62.7 101.7 109.0 199.1 101.0 89.0 177.6 192.8 103.7 99.8 139.1 169.9 147.5 164.1 127.2 160.7 124.2 150.4 109.0 126.0 174.9 146.7 103.5 129.6 64.0 154.6 175.3 184.5 151.0 230.5 75.5 79.7 82.0 101.1 75.1 80.7 85.0 76.6 84.5 83.8 79.2 90.1 50.9 38.5 60.7 3.3 69.1 44.9 46.6 209.0 43.3 43.5 47.0 56.3 46.4 55.8 102.3 77.3 8.4 222.1 79.3 27.5 140.8 120.3 7.4 51.3 66.4 73.3 58.6 59.3 1.9 111.3 138.4 69.5 30.5 61.2 90.0 69.6 73.5 73.8 191.6 38.7 2.2 55.1 148.5 74.5 80.7 14.9 70.8 86.4 88.9 2.8 149.2 147.2 118.4 2.5 8.5 93.1 48.3 62.1 39.3 35.1 44.1 150.4 58.0 55.9 78.9 51.8 65.7 36.4 38.9 62.9 60.4 139.0 79.7 91.7 77.6 41.4 TAF6L PAF65A ENSG00000162227 "TATA-box binding protein associated factor 6 like" Q9Y6J9 11 62771357-62787342 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067239 Approved Supported Nucleoplasm NA NA "Cluster 10: Basophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA067239: AB_2685809" "unprognostic (5.41e-2)" "unprognostic (1.37e-1)" "unprognostic (3.23e-1)" "unprognostic (1.46e-2)" "unprognostic (1.35e-1)" "prognostic favorable (8.98e-5)" "unprognostic (1.03e-1)" "unprognostic (2.47e-1)" "unprognostic (9.37e-2)" "unprognostic (2.83e-3)" "unprognostic (5.45e-3)" "unprognostic (9.65e-2)" "unprognostic (4.38e-2)" "unprognostic (1.63e-3)" "unprognostic (1.04e-1)" "unprognostic (3.66e-1)" "unprognostic (2.61e-3)" 8.6 12.0 6.0 4.3 6.3 5.7 9.1 6.0 8.8 11.2 4.1 8.9 6.7 13.0 6.2 9.9 10.3 3.9 8.1 5.1 5.2 11.8 21.2 7.5 5.3 7.2 6.0 11.0 13.0 5.2 14.9 3.4 6.9 11.1 3.3 4.0 8.5 5.1 17.4 11.8 9.8 4.8 4.8 11.8 9.4 6.7 5.7 5.3 12.7 5.0 3.9 9.6 8.6 5.9 12.6 12.3 15.8 12.6 7.0 5.8 13.1 10.5 7.1 11.6 9.0 6.9 14.3 16.9 21.0 7.5 10.7 16.7 11.2 10.5 3.6 23.3 24.4 8.9 14.4 11.8 10.0 11.4 15.6 7.7 7.6 9.3 6.1 6.0 10.0 17.2 18.9 12.2 7.4 24.5 16.7 31.8 17.1 6.4 15.8 20.4 11.2 21.4 7.9 8.9 16.8 16.7 9.9 10.5 16.2 6.6 18.5 7.9 9.3 11.7 14.6 19.2 11.9 13.3 23.1 19.7 10.4 8.6 10.9 0.7 0.7 0.9 0.6 0.8 0.7 0.8 0.4 0.4 0.9 0.7 0.9 0.6 0.2 1.1 0.3 0.9 0.3 0.2 6.0 6.3 6.0 8.8 5.1 5.2 7.2 6.0 6.9 4.8 5.7 5.9 6.1 3.2 3.0 8.8 9.3 6.1 4.7 1.5 11.4 8.7 6.8 6.0 2.8 12.8 1.8 1.8 0.0 15.0 5.0 9.8 15.6 4.8 6.0 5.3 5.0 5.6 5.3 11.6 3.5 3.1 8.9 5.0 10.2 7.2 0.0 6.9 5.7 12.1 9.8 3.3 5.2 6.9 0.0 10.9 5.5 5.0 5.3 8.0 8.8 2.8 8.9 9.9 13.4 6.0 5.1 3.4 8.5 4.9 11.8 4.6 8.5 18.1 3.2 5.5 0.0 6.8 7.0 3.2 9.6 10.7 6.3 19.4 5.7 9.9 9.4 4.3 TMEM223 MGC3196 ENSG00000168569 "Transmembrane protein 223" A0PJW6 11 62771629-62792006 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014504 Approved Approved "Nucleoplasm,Nuclear membrane,Mitochondria" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nuclear membrane, Mitochondria" "HPA014504: AB_1853881" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.87e-1)" "unprognostic (3.15e-2)" "unprognostic (1.00e-1)" "unprognostic (2.21e-2)" "unprognostic (3.20e-3)" "unprognostic (1.97e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-3)" "unprognostic (1.29e-1)" "unprognostic (2.50e-1)" "unprognostic (5.20e-2)" "unprognostic (7.26e-2)" "unprognostic (1.66e-1)" "unprognostic (1.14e-3)" "unprognostic (9.75e-2)" 13.1 20.9 10.4 9.4 12.0 6.4 12.8 12.4 13.4 13.2 11.6 15.7 11.0 12.9 9.7 13.3 11.7 5.5 27.9 10.4 10.5 17.3 22.5 11.1 12.0 11.6 10.2 11.4 19.8 8.0 13.2 7.1 11.8 14.8 7.4 5.2 15.3 7.2 16.1 13.3 14.4 5.3 10.0 16.6 15.4 6.7 10.4 7.3 13.8 8.5 7.0 12.2 11.1 12.1 29.2 24.4 14.3 19.6 11.8 13.5 19.5 15.3 13.4 16.9 14.1 21.5 34.9 21.6 36.8 11.1 22.5 43.3 17.3 18.9 9.6 34.7 32.5 16.1 26.9 25.9 20.6 20.0 18.4 14.4 18.8 11.2 13.9 20.3 13.9 28.2 24.8 15.8 12.6 42.3 20.3 44.3 28.2 30.2 29.2 24.7 17.3 48.8 26.8 18.3 24.3 32.0 16.0 32.3 43.0 14.5 48.1 18.4 13.9 20.2 24.4 18.7 18.5 32.1 27.5 25.1 24.0 17.8 21.5 21.0 41.3 25.0 71.3 46.2 68.8 77.6 69.8 69.9 46.8 81.8 74.9 73.0 19.0 66.2 29.8 75.6 66.8 41.5 10.4 12.0 12.4 13.4 10.4 10.5 11.6 10.2 11.8 10.0 10.4 12.1 31.9 12.8 5.6 4.2 24.1 13.5 15.3 39.7 8.6 17.9 27.6 45.0 18.8 52.9 25.2 20.2 12.5 49.4 22.8 30.2 62.6 37.2 2.6 29.1 26.9 28.9 20.5 18.5 6.1 44.3 42.9 22.0 15.3 22.3 19.7 22.4 31.8 36.0 37.6 6.7 8.0 32.6 38.7 20.1 13.6 3.4 32.6 16.2 19.6 4.7 16.2 16.5 35.0 6.0 5.7 36.1 19.3 26.4 25.4 22.4 32.1 52.3 39.6 18.0 19.7 22.3 17.9 6.9 19.7 21.3 13.9 14.2 24.3 34.2 43.4 17.1 TMEM179B ENSG00000185475 "Transmembrane protein 179B" Q7Z7N9 11 62787402-62790400 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016585, HPA062068" Enhanced "Nuclear speckles" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear speckles" "HPA016585: AB_1844357, HPA062068: AB_2684676" "unprognostic (1.18e-2)" "unprognostic (2.83e-1)" "unprognostic (2.20e-1)" "unprognostic (1.78e-2)" "unprognostic (1.68e-1)" "unprognostic (6.11e-3)" "unprognostic (1.96e-2)" "unprognostic (2.35e-1)" "unprognostic (2.44e-1)" "unprognostic (1.25e-2)" "unprognostic (4.61e-3)" "unprognostic (2.76e-2)" "unprognostic (4.56e-1)" "unprognostic (1.64e-1)" "unprognostic (2.16e-1)" "unprognostic (5.74e-3)" "unprognostic (3.60e-2)" 52.1 60.3 32.4 22.0 34.7 21.5 55.0 33.7 36.4 50.5 41.8 48.7 34.7 44.4 71.2 47.9 46.7 28.4 34.0 30.8 32.9 54.3 64.3 51.0 26.9 35.3 33.3 39.6 58.7 34.1 31.0 30.0 35.6 45.8 40.1 10.4 59.1 26.4 27.2 58.2 49.8 26.3 33.7 48.1 53.9 41.6 33.0 33.0 55.4 21.6 29.8 43.3 46.0 36.9 35.6 68.8 17.7 35.7 136.3 34.3 22.6 38.2 47.5 29.8 34.2 39.3 82.9 16.5 53.1 78.0 44.2 64.8 33.4 35.4 23.2 48.6 44.9 24.1 29.2 36.3 90.8 30.9 32.2 65.8 55.8 57.1 70.0 60.0 30.3 46.9 33.2 46.3 34.5 81.1 40.2 59.5 26.5 76.8 74.6 26.5 28.8 86.1 57.7 42.6 24.4 26.7 49.3 65.3 70.4 35.8 76.2 37.8 42.2 39.6 29.4 73.3 32.2 51.2 32.5 22.6 57.0 19.0 47.3 302.9 300.4 332.7 149.4 305.0 147.9 169.2 135.5 144.9 198.2 140.6 118.2 117.3 224.3 140.2 305.9 366.1 146.6 282.5 32.4 34.7 33.7 36.4 30.8 32.9 35.3 33.3 35.6 33.7 33.0 36.9 119.6 60.9 59.2 15.3 52.7 68.7 73.9 175.6 86.0 12.4 108.0 122.2 1.3 65.8 121.1 60.7 0.0 174.5 71.7 91.2 37.2 138.1 5.8 75.2 54.5 83.7 65.2 40.4 9.9 149.0 160.5 76.8 54.6 66.5 54.6 43.8 69.9 81.9 133.2 8.4 9.0 103.5 128.1 63.7 83.0 11.0 75.8 76.5 106.7 12.2 98.3 74.4 91.6 16.1 28.1 124.0 137.1 45.9 93.9 97.1 179.4 87.5 122.9 14.7 65.7 50.5 57.8 120.8 100.5 93.2 76.0 185.1 60.0 90.4 94.8 97.5 NXF1 "DKFZp667O0311, Mex67, TAP" ENSG00000162231 "Nuclear RNA export factor 1" Q9UBU9 11 62792123-62806302 "Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016327, HPA061593" Supported Supported Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB016327: AB_627608, HPA061593: AB_2684565" "unprognostic (2.45e-2)" "unprognostic (1.15e-3)" "unprognostic (2.34e-1)" "unprognostic (1.68e-3)" "unprognostic (2.36e-1)" "unprognostic (1.45e-2)" "unprognostic (5.40e-3)" "unprognostic (7.21e-3)" "unprognostic (2.54e-2)" "unprognostic (2.64e-1)" "prognostic favorable (4.08e-4)" "unprognostic (4.33e-3)" "unprognostic (8.08e-2)" "unprognostic (1.18e-1)" "unprognostic (3.38e-1)" "unprognostic (3.66e-3)" "unprognostic (1.25e-2)" 90.2 103.4 57.2 47.9 56.8 204.6 81.8 61.6 71.9 100.1 66.8 106.0 39.4 94.6 55.2 80.2 86.8 51.8 78.0 57.3 59.0 100.3 130.0 82.0 69.9 56.6 57.2 97.3 98.3 63.8 136.7 58.9 56.1 107.2 45.6 49.9 77.3 57.8 75.7 110.6 96.1 66.6 55.2 143.8 97.1 59.5 58.2 75.5 123.1 41.5 56.1 83.1 78.8 59.9 44.6 48.5 82.8 56.5 69.6 50.2 50.2 67.5 60.5 89.0 52.6 66.8 35.1 70.0 39.1 54.4 35.7 54.1 89.9 42.3 80.2 55.5 61.3 52.9 82.1 56.4 52.8 66.3 73.6 74.5 59.9 65.6 31.5 66.5 58.9 60.7 69.3 50.7 64.4 61.1 81.3 85.1 50.4 54.8 41.6 77.5 46.0 74.6 61.7 51.7 43.6 36.5 66.4 52.8 49.8 59.9 60.3 57.9 60.3 51.2 41.5 64.6 61.3 61.4 56.8 70.2 39.6 55.2 52.1 7.6 21.3 23.5 18.9 26.0 20.5 16.0 18.4 18.5 23.6 12.8 19.6 18.4 16.1 20.2 23.6 18.3 24.0 17.1 57.2 56.8 61.6 71.9 57.3 59.0 56.6 57.2 56.1 55.2 58.2 59.9 53.2 38.5 45.3 14.7 40.2 83.4 27.0 29.4 42.7 13.2 45.9 74.7 24.6 21.5 23.4 22.0 31.3 50.4 44.1 42.2 9.8 17.6 32.6 30.4 36.8 36.8 31.6 17.7 11.0 12.3 25.9 35.1 43.3 51.7 49.9 19.8 26.0 18.6 28.6 5.0 13.0 35.9 22.4 33.8 43.2 12.3 36.7 62.5 32.0 11.2 21.8 12.7 21.6 7.1 10.1 14.7 28.6 25.9 29.7 22.0 24.0 10.2 18.6 17.2 26.3 48.6 40.4 28.2 19.9 53.4 70.0 99.2 42.3 15.4 30.4 15.2 STX5 "SED5, STX5A" ENSG00000162236 "Syntaxin 5" Q13190 11 62806860-62832051 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 177.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001358 Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" Nucleoplasm "HPA001358: AB_1080119" "unprognostic (3.51e-2)" "unprognostic (4.23e-2)" "unprognostic (1.79e-1)" "unprognostic (1.91e-3)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.71e-2)" "unprognostic (3.30e-1)" "unprognostic (1.13e-1)" "unprognostic (3.34e-2)" "unprognostic (1.01e-1)" "unprognostic (2.19e-1)" "unprognostic (1.67e-2)" "unprognostic (3.42e-2)" "unprognostic (2.79e-1)" "unprognostic (2.86e-2)" "unprognostic (8.22e-3)" 34.2 31.8 31.2 22.2 32.1 41.9 34.4 35.3 39.0 42.0 34.6 27.5 22.7 30.6 42.6 34.9 33.1 25.0 27.2 31.3 32.1 38.3 51.0 32.7 25.1 34.2 31.8 42.2 51.1 27.0 29.6 27.4 31.7 43.6 22.4 18.8 51.8 26.9 27.7 41.4 28.4 23.9 31.3 35.5 36.0 29.0 32.9 30.4 37.9 20.2 31.6 28.4 34.2 33.5 40.9 25.4 34.5 29.9 44.6 50.2 31.0 39.2 54.9 64.7 52.0 18.8 39.0 26.0 35.9 55.9 37.8 41.7 29.7 37.2 47.8 60.4 28.3 23.0 33.0 39.2 55.3 26.9 33.5 40.7 41.6 58.6 70.3 50.5 31.9 37.0 21.0 71.7 34.5 48.4 36.5 43.8 11.3 36.2 36.8 37.1 32.3 70.2 28.8 20.7 26.3 21.6 31.4 49.4 63.6 25.7 54.4 35.9 36.8 46.8 24.6 54.6 25.1 64.2 38.1 27.4 38.0 18.7 29.6 11.7 11.4 36.2 10.4 14.1 9.3 11.0 8.1 10.1 10.4 11.3 7.5 7.6 17.8 13.1 12.7 12.9 13.0 6.6 31.2 32.1 35.3 39.0 31.3 32.1 34.2 31.8 31.7 31.3 32.9 33.5 30.3 22.4 29.3 12.7 64.1 67.2 79.5 37.9 13.6 21.0 38.0 27.9 5.6 20.0 27.6 11.0 27.1 55.3 57.6 29.8 29.4 45.7 113.1 28.2 28.6 33.1 32.9 23.5 16.0 59.6 75.1 39.5 23.9 34.0 52.7 25.2 30.0 24.4 46.5 18.5 15.4 54.8 22.4 39.5 53.5 143.7 39.1 33.2 46.2 12.2 51.6 30.3 44.3 10.1 16.6 44.1 36.0 25.2 47.2 61.2 44.8 32.6 20.7 18.6 32.9 34.1 33.6 32.2 30.1 19.8 64.2 177.6 40.4 28.0 26.2 75.5 TEX54 ENSG00000283268 "Testis expressed 54" A0A1B0GVG6 11 62832319-62832803 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "testis: 76.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in all" 6 "neutrophil: 147.9" "Lineage enriched" "Detected in all" 17 "granulocytes: 147.9" "Cell line enhanced" "Detected in single" "HeLa: 1.0" "Not detected" "Not detected" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 74: Testis - Spermatogenesis" "Cluster 20: HeLa - Mitochondria" 0.2 0.3 0.2 0.3 0.2 0.6 0.2 1.0 0.5 0.2 0.6 0.2 0.2 0.2 0.2 0.1 0.3 0.2 0.3 0.3 0.1 0.5 0.4 0.2 0.3 0.3 0.4 0.3 0.5 0.0 1.1 0.2 0.1 0.6 0.0 0.1 2.1 0.0 0.2 0.9 0.4 0.0 0.1 0.4 0.6 76.8 0.2 0.0 0.7 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.7 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.2 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.8 0.2 0.0 1.0 0.3 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.5 0.0 0.0 0.4 0.4 0.1 0.0 0.5 0.3 0.0 0.9 0.0 0.1 0.3 0.0 0.0 0.6 0.1 0.1 0.2 0.0 0.5 0.2 0.2 0.6 0.0 0.7 0.2 0.3 0.0 0.0 0.6 25.1 8.9 20.3 5.0 6.2 8.4 6.4 5.2 4.5 2.8 6.7 8.8 6.4 147.9 5.2 2.9 7.5 3.9 0.9 0.2 0.2 1.0 0.5 0.3 0.1 0.3 0.4 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 WDR74 "FLJ10439, Nsa1" ENSG00000133316 "WD repeat domain 74" Q6RFH5 11 62832342-62841809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 565.6;choroid plexus: 711.0" "Cell type enriched" "Detected in all" 5 "Early spermatids: 616.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037795, HPA038419" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA037795: AB_10671380, HPA038419: AB_2676006" "unprognostic (5.52e-2)" "unprognostic (3.10e-1)" "unprognostic (1.06e-1)" "unprognostic (1.17e-2)" "unprognostic (4.35e-2)" "unprognostic (3.47e-2)" "unprognostic (3.97e-3)" "unprognostic (6.58e-2)" "unprognostic (1.67e-2)" "unprognostic (1.62e-2)" "unprognostic (2.46e-2)" "unprognostic (8.20e-3)" "unprognostic (1.29e-3)" "unprognostic (2.77e-2)" "unprognostic (6.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.35e-1)" 21.3 21.8 352.4 20.5 274.3 127.1 21.2 485.9 291.6 19.5 711.0 19.6 17.1 20.8 14.6 25.8 22.3 11.4 23.1 251.8 208.5 21.5 28.5 14.9 30.6 220.8 221.4 25.6 30.9 15.1 11.4 18.3 292.3 19.5 16.4 33.7 25.0 13.7 59.3 31.2 17.7 17.0 305.3 30.1 22.0 15.4 244.7 62.3 28.4 25.3 23.9 24.8 18.9 565.6 64.2 76.2 28.8 49.4 22.9 31.4 85.9 35.8 37.5 73.6 49.1 108.8 77.0 111.6 97.6 28.5 59.0 84.1 88.8 69.0 56.8 72.7 64.2 55.5 84.1 97.5 65.9 112.3 36.0 30.9 75.7 47.8 153.9 24.8 36.1 80.5 126.1 32.5 33.7 120.6 106.7 178.7 117.1 70.9 96.7 108.9 49.9 193.6 52.7 35.6 65.7 72.1 40.8 84.1 115.4 27.8 58.8 83.1 28.0 44.4 52.4 98.3 88.2 81.0 120.3 137.1 47.5 68.3 57.2 40.1 140.9 11.7 40.2 61.4 49.7 66.0 42.1 38.6 105.0 121.5 56.8 52.0 51.0 93.2 44.9 154.3 52.4 47.8 352.4 274.3 485.9 291.6 251.8 208.5 220.8 221.4 292.3 305.3 244.7 565.6 36.8 38.5 67.9 1.6 112.5 104.5 47.2 45.7 60.9 15.2 37.6 57.0 2.0 40.0 108.7 16.5 16.7 55.2 57.9 32.0 43.0 42.8 616.0 22.4 34.0 41.7 41.0 26.5 3.6 40.5 53.8 39.1 65.2 32.4 43.6 23.5 20.7 34.0 37.9 3.3 3.0 32.1 20.3 33.1 69.2 97.1 32.9 45.0 30.2 1.0 22.4 15.4 45.3 2.0 2.8 39.8 24.2 21.4 74.3 50.3 44.8 54.0 32.0 11.4 19.7 53.0 89.3 19.4 31.4 50.3 109.3 34.8 66.3 30.4 41.5 39.8 SLC3A2 "4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE" ENSG00000168003 "Solute carrier family 3 member 2" P08195 11 62856004-62888880 "Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 780.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 1441.0;SiHa: 1287.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010455, HPA017980" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 170000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Plasma membrane" "CAB010455: AB_638288, HPA017980: AB_2669723" "unprognostic (1.79e-1)" "unprognostic (9.61e-3)" "unprognostic (3.59e-1)" "unprognostic (7.87e-3)" "unprognostic (2.06e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (8.17e-4)" "unprognostic (2.09e-3)" "unprognostic (2.62e-1)" "unprognostic (4.16e-2)" "unprognostic (2.29e-2)" "unprognostic (3.71e-1)" "prognostic favorable (8.22e-4)" "unprognostic (2.92e-2)" "unprognostic (5.52e-3)" "unprognostic (3.49e-3)" "prognostic unfavorable (1.48e-4)" 103.3 105.6 130.5 46.7 138.0 122.0 108.9 140.1 160.4 101.6 115.6 60.6 51.5 97.2 65.3 112.9 94.0 35.8 52.0 123.1 133.3 171.2 71.9 117.8 34.9 138.4 132.6 93.0 109.7 189.7 65.3 55.4 134.0 100.8 23.1 22.8 110.6 41.9 122.3 127.1 79.7 33.8 135.8 77.4 90.2 65.1 154.5 30.1 110.2 26.0 28.8 77.7 95.1 130.6 155.5 675.7 60.2 213.2 89.7 69.7 596.7 267.5 106.2 154.0 126.3 643.3 293.0 173.9 290.5 185.4 284.5 540.0 123.1 588.9 84.3 319.3 114.0 117.5 422.4 299.2 825.7 136.0 169.4 144.9 1441.0 175.3 528.8 46.2 83.6 380.7 232.9 347.4 95.1 792.6 149.8 181.3 106.9 222.5 214.2 153.8 92.7 341.8 113.9 84.0 112.5 53.5 1287.0 499.6 948.5 121.2 161.5 182.6 146.2 138.3 200.0 204.4 195.5 436.0 556.1 561.2 135.0 225.1 418.0 37.8 149.0 49.7 117.9 147.4 157.7 58.3 107.3 122.1 88.6 72.1 90.1 97.2 31.2 90.3 123.9 304.7 112.5 186.3 130.5 138.0 140.1 160.4 123.1 133.3 138.4 132.6 134.0 135.8 154.5 130.6 97.8 48.1 37.3 91.1 78.8 218.1 244.2 321.7 399.5 58.4 124.2 120.8 13.4 30.0 141.1 49.7 66.7 222.5 136.2 109.6 33.2 161.9 31.5 122.0 96.3 149.2 84.3 117.7 16.9 151.1 143.7 102.9 71.4 179.7 84.3 43.2 99.2 27.0 202.9 53.8 25.1 60.4 223.8 54.1 140.9 28.9 30.4 141.5 224.1 29.0 104.7 188.4 40.2 21.1 11.3 130.6 58.7 30.5 140.9 156.9 120.7 227.4 63.4 61.2 6.6 71.8 114.6 21.3 31.9 160.7 150.6 780.7 118.1 52.4 60.7 194.9 CHRM1 ENSG00000168539 "Cholinergic receptor muscarinic 1" P11229 11 62908679-62921807 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 27.0;prostate: 29.6;salivary gland: 28.8" "Cell type enhanced" "Detected in some" "Astrocytes: 2.9;Breast myoepithelial cells: 3.6;Excitatory neurons: 8.7;Inhibitory neurons: 7.8;Intestinal goblet cells: 3.2;Melanocytes: 3.6;Oligodendrocyte precursor cells: 3.0;Prostatic glandular cells: 4.4" "Cancer enriched" "Detected in some" 16 "prostate cancer: 27.9" "Group enriched" "Detected in many" 178 "amygdala: 12.4;basal ganglia: 18.7;cerebral cortex: 27.0;hippocampal formation: 22.6;white matter: 8.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "MCF7: 3.7;OE19: 12.3" "Low region specificity" "Detected in many" HPA014101 Enhanced Supported NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 21: OE19 - Mitochondria" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA014101: AB_1854210" "unprognostic (3.19e-2)" "unprognostic (2.14e-1)" "unprognostic (2.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.94e-2)" "unprognostic (2.29e-1)" "unprognostic (1.16e-2)" "unprognostic (2.89e-2)" "unprognostic (1.91e-1)" "unprognostic (2.76e-1)" "unprognostic (2.08e-1)" "unprognostic (8.57e-4)" "unprognostic (4.88e-1)" "unprognostic (6.43e-2)" "unprognostic (1.75e-1)" 0.0 3.3 12.4 0.3 18.7 0.0 2.7 0.0 27.0 0.0 0.0 0.8 0.4 0.1 0.0 0.3 0.2 0.1 0.1 22.6 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.0 0.6 0.3 0.2 0.2 0.0 29.6 0.7 0.1 28.8 0.0 0.0 2.8 0.7 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.1 0.0 12.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.4 0.1 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 18.7 0.0 27.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.1 0.0 0.0 2.9 0.0 0.1 0.2 0.0 0.0 0.0 1.8 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.8 3.2 0.0 0.0 0.3 0.0 0.0 0.0 3.6 1.0 0.0 0.0 0.0 3.0 1.0 0.0 0.1 0.0 0.0 4.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.1 SLC22A6 "OAT1, PAHT, ROAT1" ENSG00000197901 "Solute carrier family 22 member 6" Q4U2R8 11 62936385-62984967 "FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "kidney: 196.5" "Cell type enriched" "Detected in some" 17 "Proximal tubular cells: 310.4" "Cancer enriched" "Detected in single" 102 "renal cancer: 18.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA074559, CAB075704" Enhanced NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "CAB075704: , HPA074559: AB_2732260" "unprognostic (2.42e-2)" "unprognostic (2.25e-3)" "unprognostic (4.43e-1)" 0.0 0.0 1.3 0.0 2.5 0.0 0.0 3.6 2.3 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.8 196.5 0.0 0.0 0.0 7.0 5.5 0.0 0.0 0.0 0.6 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.5 3.6 2.3 1.3 3.8 7.0 5.5 3.1 3.3 7.6 1.2 0.0 0.0 0.0 4.9 1.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 7.3 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 310.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 SLC22A8 OAT3 ENSG00000149452 "Solute carrier family 22 member 8" Q8TCC7 11 62989154-63015841 "FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters" "Detoxification, Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 61 "choroid plexus: 111.4;kidney: 335.0" "Cell type enriched" "Detected in some" 38 "Proximal tubular cells: 347.6" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Region enhanced" "Detected in some" "hippocampal formation: 3.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044174 Enhanced NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA044174: AB_10963058" "unprognostic (5.35e-4)" "unprognostic (4.66e-1)" "unprognostic (6.88e-3)" "unprognostic (1.72e-1)" "unprognostic (2.20e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.7 0.0 111.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 335.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.7 3.6 0.0 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 1.2 0.0 0.0 5.5 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 347.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 SLC22A24 "MGC34821, NET46" ENSG00000197658 "Solute carrier family 22 member 24" Q8N4F4 11 63079940-63144221 "Predicted membrane proteins" "Ion transport, Lipid metabolism, Steroid metabolism, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 1.1;kidney: 4.4" "Group enriched" "Detected in some" 5 "Excitatory neurons: 5.9;Proximal tubular cells: 11.8" "Cancer enriched" "Detected in single" 11 "renal cancer: 0.5" "Region enhanced" "Detected in single" "cerebral cortex: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045015 Uncertain NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA045015: AB_2679183" "unprognostic (5.72e-3)" "unprognostic (1.80e-7)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A10 "hOAT5, OAT5" ENSG00000184999 "Solute carrier family 22 member 10" Q63ZE4 11 63137867-63369718 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 160 "liver: 100.8" "Group enriched" "Detected in some" 10 "Excitatory neurons: 6.4;Hepatocytes: 21.0" "Cancer enriched" "Detected in single" 14 "liver cancer: 6.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 2: Hepatocytes - Metabolism" "unprognostic (1.17e-2)" "unprognostic (9.77e-2)" "unprognostic (7.07e-3)" "unprognostic (7.46e-4)" "unprognostic (7.62e-3)" "unprognostic (2.87e-1)" "unprognostic (1.56e-1)" "unprognostic (6.52e-2)" "unprognostic (4.25e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 100.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 21.0 0.0 0.0 0.7 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 SLC22A25 "HIMTP, MGC120420, UST6" ENSG00000196600 "Solute carrier family 22 member 25" Q6T423 11 63163776-63229652 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 18 "liver: 11.3" "Cell type enhanced" "Detected in some" "Excitatory neurons: 3.4;Hepatocytes: 6.4;Inhibitory neurons: 1.2;Oligodendrocyte precursor cells: 1.5;Oligodendrocytes: 1.2" "Cancer enriched" "Detected in single" 66 "liver cancer: 3.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039390 Uncertain NA NA "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 15: Hepatocytes - Hemostasis" "HPA039390: AB_10671996" "unprognostic (3.19e-2)" "unprognostic (2.38e-1)" "unprognostic (4.51e-1)" "prognostic favorable (7.04e-4)" "unprognostic (1.01e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.4 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A9 "FLJ23666, OAT4, OAT7, UST3" ENSG00000149742 "Solute carrier family 22 member 9" Q8IVM8 11 63369785-63410294 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "liver: 46.3" "Cell type enhanced" "Detected in some" "Erythroid cells: 2.7;Excitatory neurons: 5.0;granulocytes: 4.5;Hepatocytes: 15.4" "Cancer enriched" "Detected in single" 166 "liver cancer: 19.3" "Region enhanced" "Detected in some" "cerebral cortex: 1.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 62: Liver - Hemostasis" "Cluster 15: Hepatocytes - Hemostasis" "unprognostic (2.45e-1)" "unprognostic (7.24e-2)" "unprognostic (8.86e-2)" "unprognostic (2.10e-2)" "unprognostic (1.08e-2)" "unprognostic (2.26e-1)" "unprognostic (2.17e-1)" "unprognostic (2.71e-1)" "unprognostic (3.09e-2)" 0.1 0.0 0.5 0.0 0.5 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 1.4 0.0 0.2 46.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.1 0.5 0.5 0.0 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 2.7 5.0 0.2 0.0 0.1 0.0 0.0 4.5 0.1 0.0 15.4 0.0 0.0 0.3 0.0 0.0 0.6 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 PLAAT5 "HRASLS5, HRLP5, iNAT, PLAAT-5" ENSG00000168004 "Phospholipase A and acyltransferase 5" Q96KN8 11 63461404-63491194 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adipose tissue: 16.5;pancreas: 13.6;testis: 53.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.6;Syncytiotrophoblasts: 1.0" "Cancer enhanced" "Detected in many" "breast cancer: 3.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 64 "basophil: 5.4;eosinophil: 16.4" "Lineage enriched" "Detected in single" 97 "granulocytes: 16.4" "Group enriched" "Detected in some" 5 "HAP1: 11.4;NB-4: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042493 Uncertain "Plasma membrane" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "HPA042493: AB_10797499" "unprognostic (3.16e-1)" "unprognostic (3.45e-2)" "unprognostic (2.83e-3)" "unprognostic (4.24e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (7.11e-3)" "unprognostic (2.14e-1)" "unprognostic (6.66e-2)" "unprognostic (9.46e-2)" "unprognostic (8.89e-3)" "unprognostic (3.15e-2)" "unprognostic (7.33e-2)" "unprognostic (1.04e-5)" "unprognostic (1.52e-1)" "unprognostic (1.21e-2)" "unprognostic (2.57e-3)" "unprognostic (4.50e-4)" 16.5 0.2 1.2 0.3 0.9 0.1 3.3 0.7 0.8 0.1 0.0 0.7 0.2 0.5 0.2 0.8 0.9 0.6 0.6 1.0 1.3 0.1 0.0 0.6 0.1 1.5 0.5 0.6 13.6 0.0 0.0 0.0 1.0 0.4 0.2 0.5 0.8 1.3 0.1 0.2 0.3 1.4 1.1 0.1 0.5 53.4 0.8 0.0 0.1 0.1 0.0 0.5 0.1 3.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.9 0.7 0.8 1.0 1.3 1.5 0.5 1.0 1.1 0.8 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 LGALS12 GRIP1 ENSG00000133317 "Galectin 12" Q96DT0 11 63506052-63516774 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 78.3;breast: 41.3" "Cell type enhanced" "Detected in some" "granulocytes: 17.8;Macrophages: 13.3;monocytes: 2.5;Muller glia cells: 3.9" "Cancer enhanced" "Detected in some" "renal cancer: 1.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 20 "eosinophil: 554.9" "Lineage enriched" "Detected in many" 20 "granulocytes: 554.9" "Group enriched" "Detected in some" 14 "ASC diff: 28.9;HL-60: 53.0;NB-4: 109.4;U-937: 112.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA021124 Approved Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 24: NB-4 - Immune response" "Cluster 51: Myeloid cells - Hemostasis" Cytosol "HPA021124: " "unprognostic (3.89e-2)" "unprognostic (4.40e-2)" "unprognostic (5.17e-2)" "unprognostic (1.79e-1)" "unprognostic (6.26e-2)" "unprognostic (4.75e-2)" "unprognostic (1.51e-1)" "unprognostic (4.31e-2)" "unprognostic (1.01e-1)" "unprognostic (2.13e-3)" "unprognostic (4.69e-2)" "unprognostic (3.08e-1)" "prognostic unfavorable (4.60e-7)" "unprognostic (2.72e-3)" "unprognostic (1.19e-1)" "unprognostic (6.22e-2)" "unprognostic (8.60e-2)" 78.3 0.8 0.1 2.7 0.2 18.4 41.3 0.1 0.2 0.1 0.4 0.9 0.5 0.2 0.0 0.2 1.0 1.7 2.1 0.1 0.2 0.3 0.3 1.0 0.1 0.2 0.2 0.2 0.6 0.0 0.0 0.1 0.2 0.4 0.6 1.9 4.5 0.7 0.5 1.0 2.0 1.0 0.2 1.1 0.9 0.0 0.1 0.3 0.7 1.4 0.0 1.0 0.3 0.2 0.0 0.0 0.0 0.0 28.9 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.8 53.0 3.3 3.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 109.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 5.3 0.0 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 112.2 0.0 15.5 28.1 554.9 0.2 3.3 0.2 0.0 0.0 0.0 7.5 0.1 0.1 0.1 5.7 0.2 0.5 0.7 0.3 17.3 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 17.8 0.0 1.1 0.1 1.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 13.3 0.0 0.0 2.5 3.9 0.0 0.5 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 PLAAT4 "HRASLS4, PLAAT-4, RARRES3, RIG1, TIG3" ENSG00000133321 "Phospholipase A and acyltransferase 4" Q9UL19 11 63536808-63546462 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 20.0;dendritic cells: 75.8;Extravillous trophoblasts: 19.0;Hofbauer cells: 26.6;Syncytiotrophoblasts: 30.1;T-cells: 12.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 223.6;RPTEC TERT1: 114.4;SK-BR-3: 169.0;U-266/70: 81.7" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 24: Non-specific - Transcription regulation" "prognostic favorable (1.35e-5)" "prognostic favorable (4.00e-4)" "unprognostic (4.12e-2)" "unprognostic (1.37e-1)" "unprognostic (3.30e-1)" "unprognostic (2.45e-2)" "unprognostic (2.11e-1)" "unprognostic (6.91e-2)" "unprognostic (1.78e-1)" "unprognostic (2.92e-2)" "prognostic unfavorable (6.26e-6)" "unprognostic (8.50e-2)" "unprognostic (1.59e-1)" "unprognostic (3.42e-1)" "unprognostic (2.11e-1)" "unprognostic (9.36e-3)" "unprognostic (2.64e-1)" 47.7 18.8 84.1 52.9 83.8 20.7 102.5 78.4 121.9 46.5 78.3 56.2 87.7 28.5 62.3 19.2 99.1 52.3 19.0 83.3 90.1 202.7 111.1 107.9 98.2 97.8 83.6 58.5 14.0 2.4 24.2 16.9 85.5 57.2 57.0 12.5 83.7 73.7 14.2 9.0 101.9 43.5 84.1 73.1 64.7 7.7 86.8 79.4 46.3 16.1 56.1 55.5 25.7 89.8 22.2 14.0 0.0 0.6 19.8 68.5 5.0 2.0 37.2 28.1 25.2 0.4 223.6 3.5 18.7 3.9 22.9 5.2 5.2 4.1 5.9 37.8 0.0 1.4 1.3 0.0 78.4 0.7 0.9 79.0 0.5 10.5 0.2 60.1 3.4 7.8 0.0 27.5 4.1 0.0 55.3 4.7 0.3 4.0 1.9 24.2 0.1 1.7 114.4 4.8 0.3 0.1 4.8 169.0 9.5 1.2 20.3 1.6 6.5 2.0 0.2 4.1 0.8 81.7 1.2 0.9 8.5 13.6 1.5 258.1 80.6 53.6 426.8 114.5 328.6 81.5 323.4 454.2 48.9 61.4 282.7 370.3 57.1 256.5 96.5 5.8 278.2 563.0 84.1 83.8 78.4 121.9 83.3 90.1 97.8 83.6 85.5 84.1 86.8 89.8 12.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 20.0 75.8 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 19.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 30.1 12.6 0.0 0.0 0.0 PLAAT2 "FLJ20556, HRASLS2, PLAAT-2" ENSG00000133328 "Phospholipase A and acyltransferase 2" Q9NWW9 11 63552770-63563379 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 67.9" "Cell type enhanced" "Detected in single" "dendritic cells: 2.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 8 "memory B-cell: 17.3;naive B-cell: 8.2" "Lineage enriched" "Detected in many" 10 "B-cells: 17.3" "Cell line enriched" "Detected in some" 8 "U-266/70: 128.9" HPA058997 Approved Approved Mitochondria NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 56: Intestine - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Mitochondria "HPA058997: AB_2683874" "unprognostic (4.76e-2)" "prognostic favorable (6.87e-4)" "unprognostic (1.20e-1)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" "unprognostic (9.69e-2)" "unprognostic (3.91e-3)" "prognostic unfavorable (5.27e-5)" "unprognostic (1.56e-1)" "unprognostic (2.29e-1)" "unprognostic (1.38e-2)" "unprognostic (2.51e-1)" "unprognostic (2.43e-1)" "unprognostic (1.57e-2)" 0.3 0.0 0.6 0.8 0.6 0.1 9.1 0.5 0.9 0.9 0.3 11.2 67.9 0.3 1.2 1.5 4.7 0.6 0.2 0.5 0.5 8.6 4.6 3.6 0.3 0.7 0.6 0.2 0.0 0.0 0.2 0.2 0.6 0.4 13.7 0.0 0.9 0.5 0.0 0.3 42.5 0.3 0.5 0.7 12.4 0.5 0.6 0.3 0.9 0.0 0.3 1.3 0.2 1.1 0.4 1.7 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.4 0.1 0.3 15.6 0.0 0.9 0.0 0.4 1.0 0.6 0.2 0.1 0.2 0.0 0.1 1.0 0.1 0.2 0.0 0.1 0.1 1.2 0.3 0.0 0.7 0.0 0.0 0.0 6.7 0.0 0.0 0.2 0.3 0.1 8.7 1.9 0.0 0.0 1.5 0.6 0.0 0.0 0.2 0.1 4.0 0.0 0.1 2.2 0.1 0.0 0.0 0.0 0.1 0.0 128.9 16.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.9 17.3 0.2 1.0 0.1 8.2 0.2 0.7 0.1 1.6 0.0 0.9 0.0 3.9 0.6 0.6 0.5 0.9 0.5 0.5 0.7 0.6 0.6 0.5 0.6 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 PLAAT3 "AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-3, MGC118754., PLA2G16, PLAAT-3" ENSG00000176485 "Phospholipase A and acyltransferase 3" P53816 11 63573195-63616883 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Host-virus interaction, Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 318.7;brain: 394.8" "Cell type enhanced" "Detected in some" "Adipocytes: 80.5;Cardiomyocytes: 151.9;Cytotrophoblasts: 137.4;Extravillous trophoblasts: 365.5;Hofbauer cells: 71.0;Syncytiotrophoblasts: 290.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 187.8" "Group enriched" "Detected in all" 6 "dendritic cells: 187.8;T-cells: 55.0" "Cell line enhanced" "Detected in many" "A549: 135.1;ASC diff: 148.2;CAPAN-2: 247.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011749, HPA058997" Approved Supported Mitochondria NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 57: Non-specific - Angiogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 38: Extravillous trophoblasts - Unknown function" Mitochondria "HPA011749: , HPA058997: AB_2683874" "unprognostic (5.18e-2)" "unprognostic (3.67e-2)" "unprognostic (7.92e-2)" "unprognostic (3.89e-2)" "unprognostic (1.94e-1)" "unprognostic (1.78e-1)" "unprognostic (1.13e-1)" "unprognostic (3.06e-2)" "unprognostic (6.97e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (5.58e-6)" "unprognostic (6.38e-2)" "unprognostic (1.93e-3)" "unprognostic (1.62e-1)" "unprognostic (1.75e-1)" "prognostic favorable (2.54e-5)" "unprognostic (2.35e-1)" 318.7 36.2 208.5 10.2 287.0 3.1 166.8 234.7 261.6 13.3 142.8 32.8 8.7 17.6 26.6 13.2 33.0 29.1 103.0 197.7 215.3 65.0 76.5 37.6 11.6 283.0 250.7 73.4 32.4 28.6 33.4 40.3 279.8 16.4 7.6 26.6 28.9 29.9 108.9 10.7 21.8 15.8 241.2 15.9 31.9 54.7 237.1 7.1 41.2 118.7 4.4 26.7 9.6 394.8 87.7 135.1 3.7 0.2 148.2 25.1 24.1 3.2 26.9 22.3 11.2 30.8 247.1 0.0 55.3 6.9 72.4 4.4 127.4 6.8 16.9 108.0 5.0 1.3 33.3 5.4 87.8 0.0 1.3 15.2 0.7 55.4 2.2 88.1 35.4 0.0 1.6 9.6 24.0 15.3 0.2 0.6 10.8 55.0 43.0 0.0 0.0 8.7 71.2 12.3 1.7 9.7 18.0 51.5 28.7 54.6 111.6 4.5 52.2 10.0 0.7 34.0 7.7 39.6 28.0 0.3 40.1 0.0 1.0 0.1 21.1 0.1 55.0 9.1 30.3 7.4 12.1 40.5 6.4 1.2 3.9 30.0 1.3 21.0 0.6 187.8 9.3 27.2 208.5 287.0 234.7 261.6 197.7 215.3 283.0 250.7 279.8 241.2 237.1 394.8 80.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 151.9 0.0 0.0 0.0 0.0 137.4 18.6 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 365.5 14.7 0.0 0.0 0.0 0.0 0.0 0.0 71.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 290.6 2.0 0.0 0.0 0.0 ATL3 DKFZP564J0863 ENSG00000184743 "Atlastin GTPase 3" Q6DD88 11 63624087-63671921 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hydrolase "Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 264.4;Late spermatids: 728.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065702, HPA076616" Enhanced "Endoplasmic reticulum" NA NA 58000 "Cluster 39: Non-specific - mRNA processing" "Cluster 71: Testis - DNA repair" "Cluster 20: HeLa - Mitochondria" "Cluster 34: Spermatids - Unknown function" "Endoplasmic reticulum" "HPA065702: AB_2685536, HPA076616: AB_2732318" "unprognostic (4.19e-2)" "unprognostic (1.10e-1)" "unprognostic (8.32e-2)" "unprognostic (1.62e-1)" "unprognostic (6.89e-2)" "unprognostic (6.95e-2)" "unprognostic (1.91e-2)" "unprognostic (6.09e-3)" "unprognostic (3.38e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (4.52e-2)" "unprognostic (1.11e-3)" "unprognostic (7.41e-2)" "unprognostic (2.88e-1)" "unprognostic (1.04e-1)" "unprognostic (7.67e-3)" 30.6 18.1 11.6 17.9 16.6 13.2 22.1 14.9 12.6 23.0 22.0 26.0 9.9 24.3 16.5 24.5 20.1 15.9 11.5 9.8 13.9 12.6 17.7 18.8 12.6 19.8 16.4 16.9 15.4 13.3 6.6 14.9 18.9 16.7 16.6 4.0 15.4 20.4 6.3 25.2 13.7 33.2 16.8 16.9 17.4 36.9 15.5 10.8 20.9 9.6 15.4 27.1 19.4 20.6 44.2 39.4 11.7 28.4 59.2 82.5 0.2 53.2 60.0 51.9 35.0 32.9 69.7 26.3 53.8 93.6 40.0 28.3 21.8 34.8 69.8 40.4 5.8 27.9 41.8 0.2 40.7 53.2 39.2 54.0 55.6 69.1 42.8 34.7 56.3 28.5 30.6 70.2 59.6 46.6 19.2 30.7 14.9 14.1 33.7 40.7 29.3 37.8 41.2 29.7 6.3 17.0 174.3 37.6 50.5 14.5 65.7 19.1 79.1 109.0 51.9 105.3 38.3 19.0 29.6 51.4 57.7 33.6 67.1 7.1 8.3 3.7 8.9 11.4 9.8 5.3 7.4 7.3 8.6 4.2 5.9 8.2 3.5 6.9 13.4 4.3 9.3 7.8 11.6 16.6 14.9 12.6 9.8 13.9 19.8 16.4 18.9 16.8 15.5 20.6 56.7 44.8 27.2 16.6 18.8 43.7 45.7 36.4 30.1 4.8 31.9 18.4 8.5 30.0 29.9 33.1 0.0 6.7 28.5 45.2 1.9 41.2 264.4 23.8 46.4 48.2 10.7 29.5 13.5 50.2 20.1 46.2 19.4 63.8 17.1 20.3 49.6 51.3 37.6 5.0 12.1 21.0 28.5 55.3 43.0 728.4 54.3 35.7 42.7 16.9 49.5 12.6 24.7 16.6 35.6 72.7 24.7 67.4 21.0 55.3 27.7 24.7 21.5 8.5 72.3 35.9 55.2 36.0 29.0 32.9 40.6 4.0 28.2 25.6 19.8 50.9 RTN3 "ASYIP, HAP, NSPL2, NSPLII, RTN3-A1" ENSG00000133318 "Reticulon 3" O95197 11 63681446-63759891 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, ER-Golgi transport, Host-virus interaction, Stress response, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 514.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1074.7" "Group enriched" "Detected in all" 6 "granulocytes: 1074.7;monocytes: 400.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015649, HPA015650" Enhanced Supported "Endoplasmic reticulum" NA NA 130000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 65: Brain - Ion transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Endoplasmic reticulum" "HPA015649: AB_1856498, HPA015650: AB_1856499" "unprognostic (8.11e-3)" "unprognostic (8.51e-2)" "unprognostic (3.61e-2)" "unprognostic (7.88e-3)" "unprognostic (1.41e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (1.30e-6)" "unprognostic (5.49e-2)" "unprognostic (1.25e-1)" "unprognostic (1.07e-2)" "unprognostic (2.70e-2)" "unprognostic (1.07e-1)" "prognostic favorable (9.87e-4)" "unprognostic (1.60e-2)" "unprognostic (2.54e-1)" "unprognostic (2.73e-2)" "unprognostic (1.57e-2)" 207.5 81.8 361.4 54.1 412.2 108.5 93.3 338.4 514.5 87.6 190.7 88.1 54.0 62.5 81.2 55.7 88.5 56.3 57.4 428.4 378.9 92.8 87.5 77.8 36.0 404.5 309.1 48.1 91.1 109.9 81.0 62.2 417.2 53.3 79.9 194.4 138.8 76.1 70.2 103.7 65.2 80.1 329.2 51.7 57.0 46.6 334.0 53.7 175.5 43.7 48.5 55.7 54.2 384.0 157.5 113.8 134.0 128.4 242.3 170.9 53.4 139.3 147.5 120.5 128.4 99.6 338.1 184.2 231.7 210.0 115.7 157.2 194.0 68.7 157.5 149.5 103.5 236.5 151.3 70.4 201.1 212.8 182.4 113.5 199.2 146.7 162.3 200.7 165.2 158.9 136.2 290.1 107.4 129.2 113.4 235.2 156.7 127.3 127.3 148.4 93.8 342.9 239.7 87.5 282.7 164.0 226.2 245.3 271.5 95.4 271.1 172.7 155.2 71.3 95.6 251.1 108.4 183.4 169.9 145.6 274.7 173.8 77.2 441.0 400.1 487.7 41.4 187.6 44.8 28.6 41.6 41.3 130.8 19.4 30.1 32.7 1074.7 41.7 240.4 79.0 68.6 323.0 361.4 412.2 338.4 514.5 428.4 378.9 404.5 309.1 417.2 329.2 334.0 384.0 62.8 134.6 67.5 110.7 35.9 144.5 103.5 63.0 101.3 157.7 125.2 59.9 36.1 81.5 91.9 244.6 70.9 68.6 55.6 118.2 29.4 154.4 35.8 96.4 74.3 68.1 99.8 85.8 398.8 117.1 105.6 96.7 60.1 129.2 77.3 71.4 85.6 81.3 143.7 82.4 372.7 83.5 122.1 178.3 110.8 71.2 79.2 151.4 113.8 100.2 178.0 150.3 42.2 200.6 294.8 103.3 82.0 89.9 94.8 79.4 94.5 55.9 156.0 97.6 78.9 53.1 78.6 194.7 133.5 85.9 146.2 86.5 48.8 51.7 96.5 99.8 C11orf95 MGC3032 ENSG00000188070 "Chromosome 11 open reading frame 95" C9JLR9 11 63759892-63768775 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Leydig cells: 18.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045002 Approved "Intermediate filaments" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 36: Stromal cells - Cell proliferation" "Intermediate filaments" "HPA045002: AB_2679179" "unprognostic (4.23e-3)" "unprognostic (7.24e-3)" "unprognostic (6.47e-2)" "unprognostic (9.01e-3)" "unprognostic (7.54e-2)" "unprognostic (3.89e-1)" "unprognostic (8.94e-2)" "unprognostic (3.67e-1)" "unprognostic (1.03e-1)" "unprognostic (6.00e-2)" "unprognostic (8.01e-3)" "unprognostic (2.89e-1)" "unprognostic (1.52e-3)" "unprognostic (1.85e-2)" "unprognostic (6.60e-2)" "unprognostic (5.68e-2)" "unprognostic (1.31e-3)" 12.4 7.1 13.6 5.1 13.5 2.0 9.6 8.4 17.6 16.4 3.8 13.7 3.8 20.3 6.8 4.9 13.6 6.9 9.6 16.1 15.3 12.0 9.6 5.8 6.0 9.0 8.9 22.8 8.7 5.3 11.4 11.0 7.1 8.8 3.5 4.2 6.8 10.1 7.7 4.6 7.5 11.3 7.0 6.7 7.3 4.8 15.2 8.2 11.4 5.4 5.5 12.1 11.3 9.3 3.5 4.6 34.7 11.6 17.7 20.3 5.5 13.0 9.3 6.0 4.2 11.4 2.2 11.2 18.6 12.6 4.5 7.9 15.2 5.2 6.8 11.0 10.3 7.5 8.9 5.2 6.2 3.6 6.0 15.2 1.8 9.9 3.2 19.8 13.5 10.0 9.7 5.0 9.7 4.6 13.6 18.5 16.2 2.1 13.4 31.9 6.6 3.5 8.7 4.4 14.6 30.8 6.2 6.6 18.3 14.1 9.3 8.8 21.3 12.2 11.4 15.7 7.6 4.5 6.3 13.5 3.3 9.1 6.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.0 13.6 13.5 8.4 17.6 16.1 15.3 9.0 8.9 7.1 7.0 15.2 9.3 8.0 0.0 5.3 6.8 2.2 5.1 1.3 2.8 3.4 4.6 6.3 9.5 7.2 11.5 2.3 0.0 0.0 6.4 2.6 1.0 3.9 2.6 0.3 2.8 11.8 9.0 4.9 0.8 3.9 2.2 0.5 11.3 0.5 4.9 1.3 8.6 13.9 7.0 1.7 6.7 3.0 2.7 4.1 1.6 6.3 1.3 18.3 2.0 3.6 3.7 3.8 11.8 0.0 2.5 0.5 2.1 1.2 7.9 0.7 1.5 0.7 3.6 1.5 3.1 13.1 6.8 11.2 0.4 4.2 1.4 3.4 1.5 1.1 2.3 2.5 1.0 SPINDOC "C11orf84, SPIN-DOC" ENSG00000168005 "Spindlin interactor and repressor of chromatin binding" Q9BUA3 11 63813456-63827716 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 7.2;Breast glandular cells: 6.7;Breast myoepithelial cells: 8.6;Cytotrophoblasts: 13.3;dendritic cells: 9.4;Endometrial stromal cells: 8.0;Granulosa cells: 9.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040128, HPA050313" Uncertain Approved "Nuclear speckles" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" "HPA040128: AB_10673027, HPA050313: AB_2681083" "unprognostic (2.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.52e-2)" "unprognostic (2.82e-3)" "unprognostic (1.13e-1)" "unprognostic (1.75e-2)" "prognostic unfavorable (1.53e-5)" "unprognostic (2.20e-1)" "unprognostic (3.78e-3)" "unprognostic (1.44e-2)" "unprognostic (1.20e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (5.42e-5)" "unprognostic (2.54e-2)" "unprognostic (1.26e-1)" "unprognostic (7.23e-2)" "unprognostic (1.25e-1)" 11.9 10.4 25.8 12.1 26.3 6.2 8.9 27.9 38.1 16.3 20.7 19.2 5.4 19.1 5.1 10.1 15.3 9.3 15.8 26.0 31.5 13.8 5.2 16.4 15.0 25.4 26.4 16.6 8.0 3.3 17.3 26.4 27.9 18.2 3.6 9.8 9.0 10.4 8.0 6.0 11.3 8.2 22.9 13.9 11.4 38.8 31.4 12.3 13.4 7.2 9.8 18.0 12.3 25.8 34.9 45.7 65.7 57.6 12.5 12.3 24.7 26.6 22.7 47.4 32.9 48.7 23.4 58.1 60.6 15.5 60.8 44.9 60.3 13.7 17.1 55.6 26.4 64.2 46.4 42.0 20.1 36.4 53.6 14.2 14.1 37.2 13.6 24.9 28.5 54.8 36.1 27.6 20.2 48.0 75.7 98.2 112.9 10.0 42.1 100.3 45.5 19.7 16.5 20.2 50.0 63.2 40.6 25.6 55.3 39.7 35.3 43.0 32.2 52.9 60.8 64.0 47.3 40.1 61.9 58.2 27.3 31.8 38.1 0.5 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 25.8 26.3 27.9 38.1 26.0 31.5 25.4 26.4 27.9 22.9 31.4 25.8 7.2 3.2 1.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 6.7 8.6 0.0 0.0 0.6 0.0 0.0 13.3 9.4 0.0 0.0 2.2 0.0 5.6 8.0 3.1 0.0 0.0 0.0 1.8 3.0 2.7 0.0 6.5 0.0 9.6 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.4 0.0 0.0 0.7 0.7 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 3.8 2.8 4.0 0.0 0.0 MARK2 "EMK1, PAR-1, PAR-1B, Par1b" ENSG00000072518 "Microtubule affinity regulating kinase 2" Q7KZI7 11 63838928-63911020 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, Wnt signaling pathway" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038790, HPA074905" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" Nucleoplasm "HPA038790: AB_10674840, HPA074905: AB_2686722" "unprognostic (1.33e-2)" "unprognostic (2.45e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.21e-4)" "unprognostic (7.13e-2)" "unprognostic (3.82e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (2.73e-3)" "unprognostic (4.41e-1)" "unprognostic (5.79e-2)" "unprognostic (3.94e-3)" "unprognostic (3.77e-1)" "unprognostic (5.20e-3)" "unprognostic (5.15e-3)" "unprognostic (6.78e-2)" "unprognostic (1.03e-1)" "unprognostic (2.40e-1)" 11.3 13.8 12.6 21.1 16.1 24.0 16.8 8.1 16.3 18.5 10.8 25.9 26.1 14.6 7.7 51.8 16.6 14.1 20.9 14.9 9.3 13.9 13.1 17.0 21.5 11.8 9.3 12.0 22.4 19.4 19.8 14.9 11.5 20.5 22.4 8.8 27.0 13.1 20.8 40.9 25.1 16.3 7.3 24.1 20.9 10.6 9.5 23.2 19.5 13.7 24.0 19.3 25.0 17.9 52.0 34.1 26.6 28.6 14.6 18.6 35.2 20.8 20.0 29.5 22.3 34.1 49.5 37.8 35.6 20.8 32.0 57.5 26.9 28.7 24.6 26.7 20.9 40.7 23.9 20.3 17.0 45.9 51.4 10.9 36.8 27.0 21.4 13.5 24.7 33.6 35.7 36.5 19.5 64.4 49.3 29.9 31.7 36.0 24.2 39.9 20.4 39.7 19.1 39.8 37.9 25.4 34.7 90.2 24.3 28.9 65.1 26.4 22.7 30.3 19.1 39.6 23.4 24.5 28.8 36.7 20.1 23.2 25.3 1.4 0.7 2.1 1.3 0.7 2.1 0.9 1.0 1.3 1.0 1.6 0.8 0.9 3.6 1.6 1.1 0.9 0.6 0.7 12.6 16.1 8.1 16.3 14.9 9.3 11.8 9.3 11.5 7.3 9.5 17.9 17.3 6.4 6.8 29.7 18.5 25.2 21.1 9.1 19.4 26.8 30.0 18.2 12.8 27.1 11.9 20.2 8.4 26.0 33.4 90.3 1.9 20.2 0.6 29.5 15.8 14.7 29.9 14.7 43.6 21.4 20.6 11.7 27.0 41.0 17.2 21.1 13.6 13.0 17.9 20.2 30.3 39.9 10.2 26.7 18.5 0.9 12.8 25.0 3.6 29.0 17.0 18.8 36.0 31.7 51.8 27.3 39.4 10.9 15.6 30.4 33.4 8.1 14.5 18.1 19.7 19.6 13.1 9.1 18.4 39.9 34.4 65.0 23.6 16.0 33.6 44.3 RCOR2 ENSG00000167771 "REST corepressor 2" Q8IZ40 11 63911230-63917164 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 20.7;Excitatory neurons: 5.9;Extravillous trophoblasts: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 35.7;NTERA-2: 47.0;SCLC-21H: 72.6;SH-SY5Y: 48.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021638 Uncertain Approved Nucleoplasm,Vesicles,Midbody Yes NA "Cluster 58: Brain - Synaptic function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm "Vesicles, Midbody" "HPA021638: AB_10960885" "unprognostic (1.96e-2)" "unprognostic (1.15e-1)" "unprognostic (4.10e-2)" "unprognostic (1.98e-3)" "unprognostic (3.10e-2)" "unprognostic (5.86e-2)" "unprognostic (2.33e-4)" "unprognostic (8.64e-2)" "unprognostic (1.46e-1)" "unprognostic (4.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-3)" "unprognostic (2.62e-1)" "unprognostic (1.75e-1)" "unprognostic (3.51e-1)" "unprognostic (9.93e-2)" "unprognostic (6.06e-3)" 0.3 0.5 1.8 0.2 3.2 0.0 0.4 1.3 3.7 1.4 0.1 1.1 0.8 2.7 1.0 0.4 1.5 0.4 2.8 2.5 1.1 0.6 0.1 0.3 0.0 1.2 1.0 1.2 0.5 1.4 3.5 0.7 0.8 0.9 0.6 3.4 0.9 0.6 1.5 0.3 0.6 1.0 1.1 0.1 0.7 3.2 1.0 0.9 0.2 0.7 0.0 1.2 0.6 2.4 0.0 1.0 35.7 2.5 0.5 2.9 10.9 0.2 0.6 0.5 1.2 1.4 0.3 0.3 0.4 0.8 0.7 0.4 15.8 0.0 0.3 0.6 2.0 0.5 0.3 11.9 5.9 0.0 0.3 3.5 0.0 0.6 0.0 0.0 0.3 4.8 2.0 0.0 0.0 3.3 3.4 13.2 47.0 4.8 0.1 12.4 2.1 1.0 0.1 0.1 72.6 48.7 0.3 3.2 1.8 8.7 2.7 4.5 0.3 0.1 2.3 0.1 0.1 0.3 0.1 0.4 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 3.2 1.3 3.7 2.5 1.1 1.2 1.0 0.8 1.1 1.0 2.4 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 20.7 0.6 0.4 2.2 0.0 0.1 0.0 0.0 0.5 0.0 1.0 0.0 0.1 0.1 0.3 3.3 0.6 1.2 0.0 5.9 0.2 4.4 1.1 0.0 0.6 0.0 1.2 0.0 0.0 0.2 3.3 1.5 1.2 2.0 0.0 0.0 0.1 1.5 0.1 0.0 0.0 0.0 2.1 1.0 1.0 1.5 0.2 0.2 0.4 0.0 0.0 0.3 0.1 0.2 2.2 0.0 0.3 0.7 0.7 2.9 0.0 0.3 0.8 0.1 1.2 0.8 0.1 NAA40 "FLJ13848, NAT11" ENSG00000110583 "N-alpha-acetyltransferase 40, NatD catalytic subunit" Q86UY6 11 63938959-63957319 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 102.6;Late spermatids: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037816, HPA056142" Uncertain Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "Centriolar satellite, Cytosol" "HPA037816: AB_10672289, HPA056142: " "unprognostic (3.52e-1)" "unprognostic (4.12e-1)" "unprognostic (1.40e-1)" "unprognostic (6.88e-3)" "unprognostic (1.50e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (1.43e-7)" "unprognostic (1.45e-1)" "unprognostic (1.13e-2)" "unprognostic (1.58e-1)" "unprognostic (7.01e-3)" "unprognostic (6.29e-3)" "unprognostic (3.42e-2)" "unprognostic (6.43e-3)" "unprognostic (2.49e-1)" "unprognostic (1.55e-1)" "unprognostic (5.25e-2)" 3.3 8.9 5.1 3.9 5.1 2.5 4.4 4.5 5.7 4.0 5.7 5.2 5.7 3.0 3.3 6.7 6.8 3.6 9.5 5.3 4.9 9.1 3.8 3.6 7.5 5.6 5.3 2.7 6.5 15.1 10.4 6.7 5.2 4.2 4.7 7.2 6.6 4.0 4.7 2.7 5.7 3.1 5.0 8.8 4.8 15.3 5.2 10.0 6.1 8.5 7.3 4.2 3.6 5.0 15.5 17.3 21.7 11.8 6.0 5.9 13.8 11.3 12.0 27.3 19.1 14.8 19.3 9.5 13.6 10.2 18.9 13.7 18.3 8.2 20.1 12.5 11.2 13.0 11.1 16.9 7.9 20.9 10.8 6.0 7.4 17.0 4.6 10.6 18.0 16.1 22.4 6.9 12.9 11.8 22.3 16.3 20.2 14.3 11.8 21.9 19.5 12.1 18.5 11.8 28.7 15.1 17.7 15.2 9.2 15.8 25.1 9.2 11.6 15.1 18.3 8.9 9.3 8.3 5.6 16.5 9.2 8.9 11.9 2.3 0.5 2.7 6.9 0.4 2.4 2.7 1.8 3.3 2.7 2.4 1.1 2.6 0.1 5.2 0.2 3.5 0.5 2.3 5.1 5.1 4.5 5.7 5.3 4.9 5.6 5.3 5.2 5.0 5.2 5.0 4.3 3.2 4.8 12.1 8.1 2.8 2.0 4.5 10.8 30.9 11.5 7.0 14.8 5.7 9.4 18.4 33.3 9.6 12.1 13.6 0.0 5.7 46.3 20.0 7.4 7.6 17.5 7.4 14.3 5.4 12.8 4.8 6.1 8.5 1.3 14.3 9.7 5.2 9.5 102.6 15.6 6.1 10.2 10.3 5.3 130.5 4.7 7.3 1.8 15.0 4.4 8.6 17.5 11.6 10.1 5.9 3.5 7.2 12.2 2.1 10.6 4.1 22.5 23.9 0.0 4.3 4.4 27.4 16.5 6.5 2.8 4.1 8.9 10.4 7.3 1.8 COX8A "COX, COX8, COX8-2, COX8L, VIII, VIII-L" ENSG00000176340 "Cytochrome c oxidase subunit 8A" P10176 11 63974620-63976543 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 2341.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055942 Supported NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "HPA055942: AB_2682979" "unprognostic (6.93e-2)" "unprognostic (1.01e-3)" "unprognostic (2.96e-2)" "unprognostic (1.02e-2)" "unprognostic (2.24e-1)" "unprognostic (7.70e-3)" "unprognostic (2.01e-2)" "unprognostic (2.12e-1)" "unprognostic (3.46e-1)" "unprognostic (6.49e-3)" "unprognostic (1.00e-1)" "unprognostic (1.24e-1)" "prognostic favorable (2.51e-6)" "unprognostic (2.70e-2)" "unprognostic (5.41e-2)" "unprognostic (1.13e-1)" "unprognostic (8.44e-2)" 322.0 443.8 421.6 134.1 435.5 292.0 286.8 470.0 544.7 259.3 524.0 516.1 337.8 236.1 121.2 612.5 246.8 78.4 1287.8 415.9 469.2 771.1 449.9 265.4 119.9 421.5 420.4 248.0 275.7 366.3 373.9 105.7 414.7 316.0 250.2 149.5 362.1 223.8 1523.9 362.0 381.5 132.3 427.7 277.0 467.3 96.7 480.4 206.6 342.9 1005.3 175.8 307.1 331.2 427.9 613.9 803.9 505.6 505.2 213.8 260.8 365.3 317.0 355.2 621.2 480.1 543.1 489.1 290.1 680.8 447.1 581.6 597.7 395.7 550.9 212.5 427.6 687.8 423.2 621.8 650.3 341.4 431.0 527.7 336.7 412.4 497.3 398.6 274.1 391.9 676.2 503.9 613.3 397.7 1600.5 613.8 1461.1 460.7 726.4 1401.4 473.9 406.3 1234.3 512.9 512.7 457.8 645.0 377.1 541.2 816.1 215.0 796.1 459.8 240.7 356.1 481.0 769.2 374.2 760.8 662.4 461.7 462.0 420.9 436.9 764.9 743.9 692.9 407.0 848.8 301.5 398.5 441.6 403.5 867.0 347.3 337.1 369.6 530.6 418.3 794.1 851.2 589.5 723.9 421.6 435.5 470.0 544.7 415.9 469.2 421.5 420.4 414.7 427.7 480.4 427.9 236.7 224.4 259.8 13.7 255.3 294.6 392.2 640.4 385.3 196.8 394.3 458.2 1263.1 424.7 396.1 437.7 73.0 451.2 305.9 1382.7 2341.9 453.1 9.6 271.6 217.2 215.7 721.6 272.9 12.5 483.1 559.6 246.1 395.0 305.1 224.5 209.3 227.4 811.5 927.5 107.7 16.8 1011.7 592.0 535.2 427.0 25.6 239.6 455.4 627.9 11.2 508.9 429.3 416.1 7.5 15.2 562.9 1103.8 221.2 393.2 419.8 1417.0 1658.2 345.2 187.5 157.8 256.0 339.9 74.0 55.5 844.0 370.9 366.9 290.4 203.7 1088.7 593.4 AP000721.1 ENSG00000256100 "Novel transcript" 11 63974620-63988346 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 6.4;Alveolar cells type 2: 7.2;Club cells: 3.7;Respiratory ciliated cells: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055942 Uncertain NA NA "Cluster 11: Alveolar cells - Smell perception" "HPA055942: AB_2682979" "unprognostic (3.25e-1)" "unprognostic (1.20e-1)" "unprognostic (5.96e-2)" "unprognostic (3.95e-1)" "unprognostic (2.67e-1)" "unprognostic (7.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 6.4 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OTUB1 "FLJ20113, FLJ40710" ENSG00000167770 "OTU deubiquitinase, ubiquitin aldehyde binding 1" Q96FW1 11 63985853-64001811 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039176, CAB072836" Approved Supported Approved Nucleoplasm,Cytosol NA NA 500000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Cytosol" "CAB072836: , HPA039176: AB_10674980" "unprognostic (2.50e-1)" "unprognostic (5.70e-3)" "unprognostic (3.93e-2)" "unprognostic (1.63e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.85e-3)" "unprognostic (1.34e-2)" "unprognostic (2.45e-1)" "unprognostic (1.27e-2)" "unprognostic (3.04e-1)" "unprognostic (1.34e-1)" "unprognostic (1.33e-3)" "unprognostic (6.76e-2)" "unprognostic (1.42e-1)" "unprognostic (4.84e-2)" "unprognostic (1.82e-1)" 44.8 57.0 69.9 43.0 78.0 63.5 47.3 53.0 93.4 54.1 39.7 51.9 42.0 49.0 37.4 85.4 55.8 35.9 62.4 79.3 62.5 61.3 47.0 47.1 59.8 65.0 58.0 44.5 43.9 47.1 48.6 49.3 66.1 53.5 39.3 25.6 54.3 42.6 70.2 78.1 51.9 38.0 51.2 58.6 54.0 57.1 65.0 56.0 51.9 48.4 57.1 52.5 56.7 67.7 113.4 198.9 107.2 95.7 70.7 77.8 83.0 66.0 97.1 143.6 105.1 138.1 104.5 59.3 122.0 106.6 124.4 138.1 140.4 165.4 88.1 69.9 111.7 99.3 114.1 172.9 98.8 99.2 104.3 83.4 106.4 110.2 69.8 74.4 137.2 54.6 71.2 65.3 97.9 237.2 109.2 133.0 126.5 95.4 94.1 88.3 41.8 102.5 151.1 162.1 81.5 117.5 74.6 114.1 123.3 72.9 178.2 86.3 100.1 75.8 74.2 103.3 88.4 76.2 51.7 86.4 98.4 64.0 74.5 228.8 186.8 189.9 165.5 244.2 131.2 149.6 152.1 153.6 203.1 139.3 117.1 130.4 184.6 161.8 218.9 140.7 224.7 313.4 69.9 78.0 53.0 93.4 79.3 62.5 65.0 58.0 66.1 51.2 65.0 67.7 37.0 19.2 56.5 15.0 67.2 48.3 70.9 137.8 83.6 44.4 42.5 48.8 31.9 37.1 82.5 46.0 39.6 146.2 56.5 104.7 74.3 80.7 72.6 55.4 36.2 43.4 87.8 35.5 17.8 85.5 109.2 50.0 71.9 44.3 48.7 54.6 35.7 33.2 90.4 30.3 16.9 70.8 101.7 57.4 65.9 87.1 34.2 61.0 51.6 8.4 98.0 43.2 78.2 12.5 18.8 90.1 92.0 25.6 80.8 51.8 90.8 85.2 89.2 55.7 26.3 28.1 62.0 48.0 71.4 77.7 52.6 194.8 73.7 51.7 62.7 71.6 MACROD1 LRP16 ENSG00000133315 "Mono-ADP ribosylhydrolase 1" Q9BQ69 11 63998558-64166113 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 290.1" "Cell type enhanced" "Detected in many" "Distal tubular cells: 137.0;Proximal tubular cells: 333.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 73.8;RPMI-8226: 145.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041031, HPA071075" Uncertain Supported Nucleoplasm NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 59: Non-specific - Translation" "Cluster 25: RPMI-8226 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "HPA041031: AB_10794435, HPA071075: AB_2686341" "unprognostic (1.19e-2)" "unprognostic (2.15e-1)" "unprognostic (1.38e-1)" "unprognostic (3.14e-2)" "unprognostic (3.88e-2)" "unprognostic (6.03e-2)" "unprognostic (1.95e-2)" "unprognostic (2.82e-1)" "unprognostic (2.44e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.15e-1)" "prognostic favorable (4.68e-6)" "unprognostic (2.45e-2)" "unprognostic (9.92e-2)" "unprognostic (2.36e-1)" "unprognostic (2.86e-2)" 14.9 14.1 6.4 1.3 5.9 2.8 17.3 6.8 12.7 15.6 5.9 21.3 5.7 13.8 0.9 18.6 15.3 2.2 111.6 6.4 8.2 55.1 50.2 10.4 1.1 8.6 7.9 21.6 49.5 4.1 11.8 1.6 8.8 19.6 1.4 1.2 30.1 5.5 290.1 26.0 10.7 1.1 6.6 6.5 27.2 4.7 9.1 1.0 32.0 58.9 0.5 17.4 16.8 7.4 12.7 5.7 1.9 10.2 1.7 1.0 10.9 7.5 3.2 5.3 5.1 5.3 33.2 44.9 25.4 0.6 2.6 29.8 1.9 0.1 0.6 3.6 21.9 16.8 23.3 29.7 6.1 13.8 1.8 2.5 3.4 0.6 1.7 4.5 1.8 14.7 15.2 8.5 1.1 73.8 20.1 45.1 5.5 4.3 24.4 18.7 11.5 145.4 1.8 0.7 15.7 31.2 5.7 40.3 41.4 0.2 29.8 1.0 2.9 4.9 7.4 7.0 0.8 17.8 3.1 7.4 3.4 13.4 4.6 0.0 0.0 0.0 0.4 0.2 0.4 0.1 0.4 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 6.4 5.9 6.8 12.7 6.4 8.2 8.6 7.9 8.8 6.6 9.1 7.4 19.4 0.0 4.6 6.8 7.1 28.0 39.8 7.5 57.5 15.1 46.2 45.0 32.5 30.0 8.6 42.3 0.0 35.6 1.3 34.6 137.0 20.8 7.1 19.0 13.3 11.9 22.9 8.0 7.1 40.4 16.1 15.9 20.9 22.7 0.0 41.6 9.7 45.3 11.7 11.8 12.4 55.2 8.2 6.9 5.1 26.8 24.8 7.2 39.2 4.7 2.4 16.9 1.0 13.6 6.9 19.2 35.2 14.3 12.9 37.6 23.0 333.4 3.1 20.6 19.7 55.7 19.1 8.2 32.5 46.3 37.1 23.9 6.1 18.8 67.9 49.8 FLRT1 "MGC21624, SPG68" ENSG00000126500 "Fibronectin leucine rich transmembrane protein 1" 11 64103188-64119173 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 8.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 6.1;Excitatory neurons: 8.8;Inhibitory neurons: 16.1;Muller glia cells: 6.2;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 13.2" "Cancer enhanced" "Detected in some" "glioma: 2.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 4.0;SCLC-21H: 5.4;SH-SY5Y: 13.5;THP-1: 11.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054589 Uncertain NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA054589: AB_2682533" "unprognostic (5.13e-3)" "unprognostic (1.55e-1)" "unprognostic (1.63e-1)" "unprognostic (8.65e-2)" "unprognostic (2.89e-1)" "unprognostic (9.55e-2)" "unprognostic (2.61e-3)" "unprognostic (6.95e-2)" "unprognostic (1.41e-2)" "unprognostic (2.98e-1)" "unprognostic (4.64e-3)" "unprognostic (6.02e-2)" "unprognostic (1.79e-1)" "unprognostic (2.62e-2)" "unprognostic (5.62e-2)" "unprognostic (1.29e-3)" "unprognostic (4.37e-2)" 0.3 4.4 7.0 0.3 8.4 0.0 0.4 1.6 6.8 2.9 0.0 3.9 0.5 1.5 0.0 0.8 0.6 0.5 1.2 7.1 3.0 2.5 0.9 0.2 0.0 1.5 4.3 0.5 1.0 0.0 1.2 0.1 0.6 1.2 0.3 1.6 0.7 0.9 0.2 1.0 0.9 0.5 1.6 0.3 1.1 0.3 8.5 0.0 2.2 0.1 0.0 0.7 1.1 7.4 0.4 0.7 2.7 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.4 0.0 1.1 0.6 3.7 0.0 0.0 0.7 0.2 0.0 0.9 0.1 0.0 2.1 0.3 4.0 0.0 0.5 0.1 0.6 1.2 0.1 0.2 0.8 0.2 0.1 0.0 0.3 5.4 13.5 0.3 0.3 0.4 0.0 0.4 11.3 0.1 0.3 1.2 0.0 0.1 0.0 0.0 0.0 0.2 3.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 8.4 1.6 6.8 7.1 3.0 1.5 4.3 0.6 1.6 8.5 7.4 0.0 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.0 6.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 8.8 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 6.2 0.0 32.2 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STIP1 "HOP, STI1" ENSG00000168439 "Stress induced phosphoprotein 1" P31948 11 64185272-64204543 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 340.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017448, HPA039291, HPA044062" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3600000 "Cluster 27: Non-specific - Gene expression" "Cluster 47: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Plasma membrane" Cytosol "CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795" "unprognostic (2.49e-3)" "unprognostic (6.04e-2)" "unprognostic (1.57e-1)" "unprognostic (4.65e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.23e-4)" "prognostic unfavorable (6.18e-8)" "unprognostic (2.16e-3)" "unprognostic (4.56e-2)" "unprognostic (1.12e-2)" "unprognostic (3.56e-2)" "unprognostic (3.04e-3)" "unprognostic (1.70e-1)" "unprognostic (6.72e-2)" "unprognostic (8.23e-2)" "unprognostic (7.16e-2)" "unprognostic (2.99e-2)" 68.0 128.0 114.5 70.2 119.9 61.3 49.7 124.6 340.6 69.5 122.1 72.9 40.4 74.1 49.0 79.5 72.4 43.5 98.5 120.2 133.4 86.7 68.9 70.8 72.9 124.0 131.3 87.6 53.3 61.4 71.7 77.5 139.2 60.7 56.0 62.9 56.1 56.1 140.3 60.5 53.9 66.7 123.6 69.0 66.1 126.3 134.2 66.2 57.6 92.2 88.2 81.2 63.8 159.4 321.0 486.3 298.1 251.7 161.8 108.1 271.5 277.2 150.1 393.9 228.1 361.3 265.2 371.1 322.9 220.3 475.4 329.7 745.4 280.3 427.6 302.1 311.7 521.5 302.6 336.7 142.8 278.7 325.1 109.4 174.5 327.1 242.7 162.4 284.2 276.1 537.2 209.5 232.1 468.8 432.0 388.6 366.4 306.0 407.2 418.3 279.1 385.6 282.8 271.8 242.7 217.3 314.4 338.9 266.7 310.3 357.1 194.0 253.8 252.0 310.9 333.1 389.0 189.8 434.0 388.0 328.8 282.6 374.1 61.0 66.8 57.4 87.6 95.1 88.2 85.9 65.5 79.5 69.9 68.5 72.7 81.6 20.0 108.2 114.6 58.1 66.1 119.1 114.5 119.9 124.6 340.6 120.2 133.4 124.0 131.3 139.2 123.6 134.2 159.4 31.3 44.8 32.9 7.8 40.0 80.4 184.1 61.5 40.9 37.5 32.5 29.8 46.1 31.5 59.1 20.2 41.7 124.8 39.8 38.3 49.0 76.3 31.0 65.8 48.6 45.9 67.3 69.0 9.5 55.2 146.1 49.6 24.5 51.1 79.3 47.8 14.3 27.4 91.5 63.9 14.9 39.9 97.6 21.9 90.3 77.5 27.4 46.7 62.2 12.2 51.8 36.9 53.5 11.1 17.2 69.5 32.7 39.9 56.4 75.7 22.3 39.6 85.8 36.7 26.3 36.1 65.4 96.3 118.6 47.6 72.0 211.0 67.0 62.8 48.6 95.3 FERMT3 "KIND3, MGC10966, MIG-2, MIG2B, UNC112C, URP2" ENSG00000149781 "Fermitin family member 3" Q86UX7 11 64206678-64223891 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 180.6;lymphoid tissue: 130.1" "Cell type enhanced" "Detected in many" "dendritic cells: 118.3;granulocytes: 96.4;Hofbauer cells: 193.1;Kupffer cells: 95.8;Langerhans cells: 88.0;Macrophages: 232.9;monocytes: 142.9;NK-cells: 93.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 306.9;HL-60: 135.9;HMC-1: 314.2;Karpas-707: 127.6;MOLT-4: 121.8;NB-4: 174.1;U-937: 138.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA065231 Approved Vesicles NA NA 160000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 51: Myeloid cells - Hemostasis" Vesicles "HPA065231: AB_2685439" "unprognostic (1.96e-2)" "unprognostic (1.07e-2)" "unprognostic (3.38e-3)" "prognostic favorable (9.89e-4)" "unprognostic (8.77e-2)" "unprognostic (1.83e-2)" "unprognostic (3.56e-2)" "unprognostic (2.46e-1)" "unprognostic (4.20e-1)" "unprognostic (3.98e-1)" "unprognostic (2.70e-1)" "unprognostic (3.88e-1)" "prognostic unfavorable (2.12e-5)" "unprognostic (3.08e-3)" "unprognostic (5.25e-2)" "unprognostic (4.97e-2)" "unprognostic (1.75e-1)" 25.1 14.5 9.4 63.3 11.6 180.6 13.0 11.2 18.1 8.5 12.2 17.3 22.0 8.4 0.7 6.4 13.6 15.6 12.0 9.8 11.6 11.1 12.5 46.2 89.2 17.9 12.2 5.1 7.0 1.3 5.9 15.0 13.2 8.2 8.1 0.6 10.7 4.4 6.0 7.1 34.1 9.4 13.3 130.1 29.6 4.5 17.1 48.7 10.0 4.6 41.8 19.8 7.3 15.3 1.2 1.6 0.5 0.9 0.3 0.8 2.0 1.4 0.2 0.4 0.3 2.6 2.3 32.6 3.2 6.3 0.7 2.4 1.0 0.5 0.5 83.9 0.6 306.9 1.6 0.1 10.8 135.9 314.2 1.2 1.1 5.2 0.0 0.5 81.2 77.0 7.3 127.6 8.6 3.5 121.8 174.1 1.2 1.0 2.3 72.4 8.8 0.7 0.3 0.7 1.9 0.5 0.7 4.5 1.7 0.7 2.0 92.6 7.8 1.1 2.5 1.9 0.9 1.5 3.3 59.4 19.5 138.9 86.6 204.1 207.0 236.5 120.0 192.6 114.9 54.5 94.1 112.0 162.0 53.1 60.9 80.6 184.6 102.4 151.2 195.7 120.9 292.6 9.4 11.6 11.2 18.1 9.8 11.6 17.9 12.2 13.2 13.3 17.1 15.3 3.8 9.6 14.7 0.7 52.1 4.7 0.9 0.3 3.4 0.5 3.3 5.2 2.4 4.3 3.9 0.0 0.0 1.2 118.3 6.1 0.0 0.8 0.4 4.3 5.6 7.9 0.0 62.5 1.2 2.4 1.4 5.4 19.9 7.3 96.4 0.4 19.6 1.4 193.1 0.0 1.5 32.1 0.0 95.8 88.0 0.9 0.9 232.9 17.8 5.6 142.9 0.3 93.7 1.0 1.5 4.3 10.9 2.6 35.2 0.9 8.2 0.4 1.0 0.3 6.6 13.7 6.6 1.2 0.8 1.9 4.5 2.6 78.5 1.4 15.0 0.7 TRPT1 MGC11134 ENSG00000149743 "TRNA phosphotransferase 1" Q86TN4 11 64223799-64226254 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 173.8" "Cell type enhanced" "Detected in many" "Early spermatids: 147.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038705, HPA038706" Uncertain Approved Mitochondria NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 27: Mucus-secreting cells - Mucin production" Mitochondria "HPA038705: AB_2676161, HPA038706: AB_10671863" "unprognostic (2.50e-2)" "unprognostic (1.72e-1)" "unprognostic (1.33e-1)" "unprognostic (3.59e-2)" "unprognostic (7.20e-2)" "unprognostic (1.53e-1)" "unprognostic (5.84e-2)" "unprognostic (8.56e-2)" "unprognostic (1.18e-1)" "unprognostic (3.26e-3)" "unprognostic (1.12e-1)" "unprognostic (7.71e-2)" "unprognostic (7.38e-2)" "unprognostic (2.49e-1)" "unprognostic (3.28e-1)" "unprognostic (1.99e-1)" "unprognostic (4.58e-3)" 27.6 38.8 33.1 14.1 34.9 8.4 27.5 36.3 36.2 26.3 33.8 35.2 22.2 23.1 21.4 35.2 26.3 15.4 88.3 31.7 34.6 52.0 46.5 20.3 16.3 35.0 34.0 26.0 51.3 19.2 35.2 10.9 33.7 36.0 18.4 12.7 38.9 28.4 173.8 27.4 30.3 12.0 34.1 30.8 41.9 51.1 36.7 21.1 33.5 116.1 17.6 30.0 25.8 34.3 25.1 24.5 26.5 43.0 32.0 23.5 32.2 16.4 31.6 28.7 24.0 16.1 37.1 24.7 63.6 27.4 22.2 34.1 11.8 35.7 10.1 23.8 14.2 12.7 23.8 28.0 46.4 16.2 21.4 17.7 20.7 31.6 28.1 52.7 20.4 49.0 22.3 27.1 24.2 59.4 30.3 33.7 16.8 33.3 26.1 39.3 19.5 71.4 74.4 29.1 23.0 33.4 13.2 32.1 47.5 18.0 37.1 25.8 23.9 19.4 14.9 37.9 16.4 53.0 14.3 16.3 46.7 8.3 32.1 11.0 16.9 28.5 18.8 31.2 15.0 38.0 18.5 19.9 24.4 39.9 20.1 23.3 15.8 26.1 27.4 59.0 25.2 12.0 33.1 34.9 36.3 36.2 31.7 34.6 35.0 34.0 33.7 34.1 36.7 34.3 17.1 9.6 23.1 9.8 31.4 13.3 18.7 32.7 28.5 8.9 40.4 45.3 42.5 32.9 25.5 27.6 0.0 44.4 17.0 66.3 95.9 41.4 147.5 41.3 20.1 17.5 26.9 14.9 2.8 58.4 46.7 19.8 41.8 27.5 24.6 10.0 21.0 30.0 25.5 10.1 4.9 111.3 30.5 18.9 12.8 82.1 19.9 15.0 37.4 2.8 27.2 32.1 15.5 7.5 6.8 46.6 60.5 17.0 47.1 24.0 92.0 82.9 48.2 11.6 6.6 22.4 29.3 59.6 13.4 42.8 18.5 36.0 21.8 20.2 40.3 22.6 NUDT22 MGC13045 ENSG00000149761 "Nudix hydrolase 22" Q9BRQ3 11 64225941-64230686 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 164.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039334, HPA053464" Approved Enhanced Nucleoplasm No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA039334: AB_10795174, HPA053464: AB_2682160" "unprognostic (2.72e-1)" "unprognostic (3.77e-1)" "unprognostic (1.86e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-2)" "unprognostic (9.75e-2)" "unprognostic (1.73e-3)" "unprognostic (1.98e-1)" "unprognostic (1.15e-1)" "unprognostic (1.43e-1)" "unprognostic (7.65e-2)" "unprognostic (6.61e-2)" "prognostic favorable (2.18e-6)" "unprognostic (1.76e-2)" "unprognostic (1.50e-1)" "unprognostic (1.71e-1)" "unprognostic (8.54e-2)" 21.0 34.7 12.2 12.6 13.2 16.2 21.7 14.0 18.1 19.1 15.4 39.2 30.2 18.5 4.6 34.2 18.5 9.0 52.0 12.2 14.0 43.8 48.8 22.0 17.3 14.1 13.3 15.7 45.4 14.1 24.9 10.3 13.0 26.1 8.3 1.1 30.6 14.8 42.4 27.2 36.3 6.0 13.4 41.9 38.1 10.8 14.8 12.9 31.6 19.7 10.4 26.0 21.5 12.7 35.5 22.7 5.4 22.6 8.1 9.7 20.1 15.0 15.1 10.3 9.5 14.8 29.1 16.6 38.4 14.6 15.5 36.1 3.2 23.0 1.3 21.6 9.2 22.6 15.6 15.4 24.2 14.9 35.5 15.2 16.9 10.8 11.7 7.9 16.9 19.5 11.1 17.7 12.2 53.1 20.4 27.1 8.5 21.5 47.0 25.1 9.2 62.4 17.9 19.4 12.6 19.9 12.8 47.8 58.8 2.1 48.9 16.3 15.9 17.0 16.2 54.5 12.6 66.2 28.5 10.6 58.7 17.0 20.4 40.6 69.1 52.5 53.4 88.7 48.1 63.4 47.0 52.8 72.7 77.3 40.8 44.7 42.7 52.1 86.2 121.4 64.9 52.1 12.2 13.2 14.0 18.1 12.2 14.0 14.1 13.3 13.0 13.4 14.8 12.7 18.8 3.2 14.6 5.5 42.6 12.0 28.9 78.8 19.4 14.7 34.6 30.1 3.7 48.6 36.6 40.5 12.5 107.9 51.5 94.1 164.4 61.8 15.5 19.0 27.2 20.3 37.2 14.5 4.8 87.4 50.9 20.1 47.4 27.8 15.2 15.5 23.2 54.3 57.7 30.3 5.6 98.1 61.1 50.1 21.8 9.6 20.2 40.0 33.8 4.7 70.8 26.5 49.4 1.5 3.5 68.0 93.0 19.5 65.8 33.6 133.5 144.8 13.6 18.0 13.1 20.2 45.0 6.6 8.2 34.3 17.5 67.5 37.5 43.6 73.6 33.0 DNAJC4 "HSPF2, MCG18" ENSG00000110011 "DnaJ heat shock protein family (Hsp40) member C4" Q9NNZ3 11 64230278-64234286 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 240.9" "Cell type enriched" "Detected in all" 5 "Late spermatids: 3342.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011947 Uncertain NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" "HPA011947: AB_1847803" "unprognostic (8.99e-3)" "unprognostic (2.28e-2)" "prognostic unfavorable (3.12e-4)" "unprognostic (2.95e-2)" "unprognostic (1.15e-1)" "unprognostic (5.20e-2)" "unprognostic (8.99e-2)" "unprognostic (1.56e-2)" "unprognostic (7.69e-2)" "unprognostic (5.44e-3)" "unprognostic (1.73e-3)" "unprognostic (1.07e-1)" "prognostic favorable (6.21e-4)" "unprognostic (2.47e-1)" "unprognostic (2.87e-1)" "unprognostic (1.59e-1)" "unprognostic (2.69e-1)" 38.4 80.5 48.3 25.0 48.9 43.2 38.8 47.9 51.0 52.0 52.3 53.2 39.0 37.8 35.6 44.1 40.2 23.9 94.3 44.5 48.5 71.1 71.8 38.5 35.0 50.7 48.7 61.4 98.5 33.3 54.6 16.4 50.8 58.5 22.8 11.3 59.9 23.2 64.2 55.1 53.7 16.1 47.6 70.4 62.3 240.9 52.8 29.0 57.2 49.2 33.3 43.0 40.4 46.3 12.4 11.6 26.9 39.9 32.0 56.0 18.8 17.9 30.2 10.9 15.0 11.6 17.6 14.9 57.6 32.1 6.4 9.7 13.5 16.2 6.3 31.6 15.9 18.5 12.2 31.8 39.0 13.9 42.3 58.4 42.9 17.3 20.2 51.5 26.1 16.4 12.7 76.2 7.1 30.4 5.6 33.2 7.8 29.1 22.3 38.7 7.1 101.1 45.4 8.2 23.4 37.9 18.0 20.2 68.8 25.6 48.8 24.6 24.3 12.6 12.6 19.4 10.2 74.8 32.8 18.6 11.1 17.3 36.8 48.2 57.6 42.7 21.9 52.2 27.7 47.6 21.8 25.6 80.4 49.1 30.9 24.8 31.2 41.6 42.7 129.8 22.4 36.4 48.3 48.9 47.9 51.0 44.5 48.5 50.7 48.7 50.8 47.6 52.8 46.3 29.8 12.8 30.5 11.4 69.5 43.7 58.2 54.5 95.0 21.1 93.8 119.9 22.3 34.3 37.8 27.6 8.4 80.1 58.1 47.6 160.4 37.6 667.3 22.1 27.3 35.1 81.3 28.2 5.0 38.5 60.2 34.4 45.9 24.9 46.3 41.6 43.2 32.4 53.0 25.2 6.9 74.1 69.2 69.5 63.8 3342.9 62.7 66.0 48.0 4.7 112.4 35.0 55.6 3.0 5.5 28.7 55.6 46.6 96.3 43.4 115.0 101.7 15.1 14.5 19.7 29.0 30.3 28.4 28.8 60.1 51.1 54.5 46.6 61.9 68.9 64.9 VEGFB "VEGFL, VRF" ENSG00000173511 "Vascular endothelial growth factor B" P49765 11 64234584-64239264 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 204.9;Muller glia cells: 130.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "plasmacytoid DC: 30.5" "Lineage enriched" "Detected in many" 10 "dendritic cells: 30.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 186000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 50: Fibroblasts - ECM organization" "unprognostic (4.88e-2)" "unprognostic (6.04e-2)" "unprognostic (1.33e-2)" "unprognostic (3.55e-1)" "unprognostic (1.47e-1)" "unprognostic (1.27e-1)" "unprognostic (5.38e-2)" "unprognostic (2.45e-1)" "unprognostic (4.68e-1)" "unprognostic (5.01e-3)" "unprognostic (2.35e-3)" "unprognostic (1.08e-2)" "unprognostic (1.67e-2)" "unprognostic (8.08e-3)" "unprognostic (2.00e-1)" "unprognostic (4.15e-2)" "unprognostic (4.31e-3)" 209.8 82.0 45.7 12.0 51.3 3.9 151.3 41.8 53.1 103.6 48.2 151.5 12.1 99.9 7.2 50.8 72.5 19.2 253.3 38.7 45.1 84.6 44.0 82.5 14.4 54.8 47.4 82.6 84.9 18.3 104.2 9.8 45.0 92.7 4.7 12.7 57.7 28.5 143.8 77.3 59.5 10.2 44.2 55.9 89.2 17.5 50.6 6.6 83.7 51.5 9.1 118.0 77.5 37.3 15.4 25.9 9.9 28.1 49.7 36.8 12.7 14.7 27.8 13.1 16.0 13.8 31.7 19.8 28.6 14.0 28.8 20.8 15.8 11.5 2.3 20.6 15.1 16.7 33.9 13.3 45.4 4.8 20.1 39.6 12.0 19.6 12.2 33.9 18.4 20.6 20.2 32.5 22.2 31.8 27.4 12.6 7.0 10.9 22.3 32.1 20.5 46.5 11.0 19.5 14.0 46.4 12.4 38.1 57.4 7.6 25.1 5.6 13.0 50.8 30.2 23.1 8.7 90.5 45.5 15.4 41.6 5.3 25.1 0.3 0.2 0.6 0.9 0.0 0.8 3.0 0.8 0.9 0.4 2.4 0.9 1.6 0.0 0.4 0.0 30.5 0.5 0.4 45.7 51.3 41.8 53.1 38.7 45.1 54.8 47.4 45.0 44.2 50.6 37.3 54.1 19.2 32.6 43.8 27.6 12.7 6.7 10.1 2.2 47.9 32.8 65.7 204.9 10.0 7.6 14.7 33.3 9.6 68.3 11.9 39.2 14.8 1.1 24.2 47.7 21.9 53.3 4.4 7.3 12.9 16.8 68.6 5.1 31.6 18.4 62.7 19.6 9.8 51.4 65.6 26.6 12.2 20.3 31.5 21.5 3.5 60.9 50.0 35.6 19.7 17.7 130.6 12.3 29.1 11.8 14.5 7.3 109.1 12.3 11.5 20.3 31.6 8.9 39.6 6.6 47.4 53.7 0.5 1.2 6.4 13.9 8.9 19.0 34.3 12.8 7.5 FKBP2 "FKBP-13, FKBP13, PPIase" ENSG00000173486 "FKBP prolyl isomerase 2" P26885 11 64241003-64244132 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 929.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025561, HPA049405" Enhanced Approved "Plasma membrane" "Intracellular and membrane" No No 510000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Plasma membrane" "CAB025561: , HPA049405: AB_2680749" "unprognostic (4.94e-2)" "unprognostic (1.12e-1)" "unprognostic (5.77e-2)" "unprognostic (2.66e-3)" "unprognostic (7.40e-2)" "unprognostic (1.92e-2)" "unprognostic (8.64e-2)" "unprognostic (1.62e-1)" "unprognostic (3.23e-1)" "unprognostic (5.91e-3)" "unprognostic (5.86e-2)" "unprognostic (7.18e-2)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (5.23e-1)" "unprognostic (2.30e-1)" "unprognostic (3.57e-2)" 64.7 127.6 185.1 77.5 187.6 50.1 58.3 192.7 234.7 113.1 210.8 105.7 136.3 81.1 397.7 68.4 94.4 77.2 117.4 185.0 196.9 122.7 197.3 62.7 70.7 199.9 199.6 75.3 280.1 160.4 200.9 73.1 197.7 92.5 84.2 37.1 208.9 146.7 33.3 60.9 107.3 72.6 183.4 67.5 113.4 74.7 194.3 59.0 187.6 48.4 70.4 85.7 61.6 196.0 101.2 144.8 82.8 165.9 178.5 98.2 94.6 132.9 146.4 108.8 101.4 148.1 257.0 80.8 195.4 186.5 148.2 134.7 70.5 121.0 51.3 101.4 54.5 90.0 196.5 158.3 231.6 74.5 125.5 116.0 169.3 145.4 163.5 156.9 86.9 76.6 61.0 253.6 138.1 186.7 85.1 112.6 92.6 211.1 130.0 70.8 70.9 299.2 198.9 120.7 110.0 91.3 85.4 263.2 147.9 59.5 98.1 69.5 68.9 123.8 100.9 182.8 72.6 128.5 48.6 69.0 156.7 80.6 142.8 276.8 173.1 25.9 178.9 191.2 230.8 170.1 139.2 176.4 172.2 165.0 90.4 131.5 68.6 162.9 162.7 929.1 55.9 126.7 185.1 187.6 192.7 234.7 185.0 196.9 199.9 199.6 197.7 183.4 194.3 196.0 129.5 147.4 168.0 20.9 179.7 164.4 251.0 447.2 125.2 86.4 205.0 185.4 134.7 275.9 270.6 389.9 22.9 279.8 174.4 534.1 412.8 270.8 126.4 212.5 206.3 138.6 342.6 41.4 11.3 254.2 386.9 167.0 179.4 258.5 144.0 146.5 148.5 754.4 228.4 32.0 14.8 508.2 305.2 100.1 201.7 99.0 230.2 140.7 300.6 16.9 151.7 181.7 111.2 11.1 20.6 292.2 424.7 255.1 765.2 315.5 594.7 792.2 241.9 83.3 184.1 138.4 221.3 327.1 282.1 136.6 168.1 620.5 123.6 138.8 339.4 312.0 AP001453.3 ENSG00000286264 "Uncharacterized protein LOC114841035" 11 64241095-64244132 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" 3.4 2.7 4.3 3.1 4.7 2.6 0.8 4.0 6.5 2.1 3.8 3.0 6.8 2.3 0.7 1.6 1.4 1.4 1.9 4.0 4.0 2.1 1.8 1.9 2.1 4.2 4.6 1.8 3.3 1.3 2.5 4.1 2.5 1.6 0.4 6.0 3.2 3.4 5.4 5.1 1.0 3.2 3.6 3.7 1.1 5.6 1.5 1.7 0.5 1.5 1.2 4.1 4.6 5.0 1.7 2.4 2.2 2.5 7.3 3.4 2.0 0.8 1.0 3.3 7.5 2.8 5.9 2.0 2.0 5.6 0.6 2.4 0.2 4.0 2.7 4.4 8.4 4.9 3.5 1.3 4.1 2.3 4.5 1.7 2.3 3.5 2.1 2.2 3.2 2.4 1.5 4.0 2.6 6.6 1.9 1.4 6.7 4.4 4.9 8.5 3.3 2.7 1.4 3.7 2.6 6.6 4.8 0.4 4.6 1.5 5.6 2.5 4.6 8.6 1.6 11.1 2.1 2.6 7.0 2.4 3.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.1 1.6 0.0 0.0 4.3 4.7 4.0 6.5 4.0 4.0 4.2 4.6 4.1 3.2 5.6 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPP1R14B "PHI-1, PLCB3N, PNG, SOM172" ENSG00000173457 "Protein phosphatase 1 regulatory inhibitor subunit 14B" Q96C90 11 64244479-64246943 "Plasma proteins, Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 653.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 75 "plasmacytoid DC: 382.3" "Lineage enriched" "Detected in all" 75 "dendritic cells: 382.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053882 Approved NA NA 190000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA053882: AB_2682291" "unprognostic (1.36e-1)" "unprognostic (7.12e-3)" "unprognostic (1.74e-2)" "unprognostic (1.20e-2)" "unprognostic (3.74e-1)" "unprognostic (2.01e-3)" "prognostic unfavorable (1.75e-6)" "unprognostic (1.14e-1)" "unprognostic (9.87e-2)" "unprognostic (3.04e-3)" "prognostic unfavorable (6.77e-4)" "unprognostic (6.86e-2)" "unprognostic (1.44e-2)" "unprognostic (1.10e-1)" "unprognostic (1.25e-1)" "unprognostic (1.77e-3)" "unprognostic (3.43e-1)" 90.7 107.4 31.1 49.6 32.0 49.0 71.5 33.1 38.2 82.1 34.4 76.2 51.6 54.2 14.5 238.8 48.9 19.1 128.5 30.4 33.3 97.6 139.5 64.3 32.7 35.7 33.1 40.4 247.8 19.8 39.3 38.1 32.8 49.6 24.2 3.9 83.6 18.3 217.3 172.4 65.0 22.1 32.4 83.8 74.6 61.2 38.6 31.0 52.9 53.2 36.5 92.3 107.9 31.6 409.8 236.0 147.4 237.1 69.9 93.6 224.7 211.4 130.8 215.4 95.2 138.6 351.1 204.0 369.8 198.0 181.1 264.8 112.2 214.0 80.6 178.7 176.0 145.3 260.5 218.4 126.8 227.7 137.3 86.4 223.9 165.5 283.4 189.5 194.1 149.3 201.2 108.4 240.2 483.3 246.2 341.4 416.4 209.3 520.0 236.8 475.2 540.3 191.4 190.8 220.3 319.0 165.2 227.3 314.3 72.5 156.3 138.4 180.0 311.1 291.1 614.7 320.2 102.2 70.2 204.7 269.0 189.7 362.2 0.0 2.3 1.9 1.5 3.1 3.1 5.0 2.4 1.7 4.0 3.8 1.3 1.2 4.8 3.0 2.8 382.3 0.7 2.7 31.1 32.0 33.1 38.2 30.4 33.3 35.7 33.1 32.8 32.4 38.6 31.6 107.4 9.6 11.7 6.5 49.3 228.5 90.0 66.2 41.5 21.9 211.7 273.7 38.7 41.5 32.2 79.1 8.4 58.4 333.8 69.9 76.3 131.9 6.3 60.8 180.6 81.8 83.0 37.6 3.0 234.2 653.6 77.5 45.3 126.1 27.3 273.4 46.8 101.4 87.4 20.2 4.6 109.8 44.7 33.0 119.5 9.0 9.3 75.2 60.5 2.8 72.8 38.7 12.3 6.6 1.8 306.8 51.2 11.7 55.0 365.5 129.8 63.1 10.2 19.3 26.3 332.6 136.6 5.9 14.8 169.1 259.0 132.8 37.4 179.6 107.4 258.3 PLCB3 ENSG00000149782 "Phospholipase C beta 3" Q01970 11 64251530-64269150 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 113.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 52.3;Proximal enterocytes: 161.7;Undifferentiated cells: 65.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009257, HPA039279, HPA043907" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA 210000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 56: Intestine - Transmembrane transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 45: Enterocytes - Digestion" Nucleoplasm "Golgi apparatus" "CAB009257: AB_654079, HPA039279: AB_2676425, HPA043907: AB_2678726" "unprognostic (1.30e-1)" "unprognostic (1.21e-2)" "unprognostic (2.86e-1)" "unprognostic (2.35e-1)" "unprognostic (9.35e-2)" "unprognostic (6.23e-3)" "prognostic unfavorable (1.39e-4)" "unprognostic (2.44e-2)" "unprognostic (6.61e-2)" "unprognostic (1.26e-1)" "unprognostic (8.07e-3)" "unprognostic (1.00e-2)" "prognostic unfavorable (4.31e-5)" "unprognostic (5.04e-3)" "unprognostic (1.52e-1)" "unprognostic (1.20e-1)" "unprognostic (3.88e-2)" 12.8 19.1 6.8 9.7 7.3 7.4 11.2 8.2 8.0 19.7 7.0 22.8 113.8 17.8 3.6 35.3 16.5 7.1 11.5 6.5 7.3 11.7 6.4 15.6 4.4 9.2 7.6 15.8 8.6 10.0 5.8 10.3 8.1 13.1 12.5 1.4 13.5 10.4 6.7 20.3 101.6 11.4 7.7 14.5 14.7 9.5 9.2 3.9 10.3 4.2 5.3 13.8 18.8 7.7 45.2 24.9 24.0 36.0 24.6 18.9 23.8 35.3 26.4 29.5 17.9 22.1 33.5 3.2 20.8 44.4 25.4 75.9 27.2 33.0 10.1 21.8 15.1 35.1 54.9 16.7 17.0 8.6 22.3 16.0 21.5 32.1 23.6 32.2 43.5 13.4 17.6 3.8 37.9 54.5 10.9 17.9 38.8 56.9 26.9 23.5 54.0 13.3 18.2 46.8 6.4 26.4 52.0 64.4 25.2 14.8 33.9 16.4 76.4 27.1 32.0 62.7 23.2 4.6 2.4 3.6 44.8 19.9 25.5 0.0 0.4 0.0 0.2 0.4 0.2 0.0 0.2 0.1 0.4 0.0 0.1 0.1 0.2 0.1 0.4 1.2 0.0 0.1 6.8 7.3 8.2 8.0 6.5 7.3 9.2 7.6 8.1 7.7 9.2 7.7 11.2 3.2 7.9 7.5 1.8 13.0 6.0 6.4 6.2 1.2 6.1 4.6 3.3 8.6 6.3 16.5 0.0 9.2 8.3 52.3 1.9 7.8 1.3 3.5 8.7 13.2 2.4 7.8 0.6 7.7 19.1 7.6 28.5 7.1 5.7 20.2 18.2 3.4 9.8 3.3 0.9 46.2 12.2 10.1 13.5 1.4 9.9 8.8 8.8 8.4 22.1 4.7 2.1 1.5 0.6 17.3 23.8 12.4 2.6 7.4 161.7 4.0 2.8 1.1 26.3 6.0 9.8 3.1 8.3 19.4 11.8 14.6 2.7 6.8 65.5 8.3 BAD "BBC2, BCL2L8" ENSG00000002330 "BCL2 associated agonist of cell death" Q92934 11 64269830-64284704 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004205, HPA028185, HPA062105" Approved Enhanced Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Mitochondria "CAB004205: AB_626717, HPA028185: AB_10603445, HPA062105: AB_2684684" "unprognostic (1.47e-1)" "unprognostic (3.08e-2)" "unprognostic (1.17e-1)" "unprognostic (8.24e-3)" "unprognostic (2.60e-1)" "unprognostic (6.73e-2)" "unprognostic (1.24e-3)" "unprognostic (1.07e-1)" "unprognostic (1.99e-1)" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (1.14e-1)" "unprognostic (8.26e-2)" "unprognostic (9.04e-2)" "unprognostic (2.17e-1)" "unprognostic (1.48e-1)" "unprognostic (7.95e-2)" 60.8 85.1 94.0 13.2 91.1 23.3 58.8 89.0 133.1 64.9 86.6 81.7 26.5 64.8 12.7 72.9 58.8 15.5 118.0 93.1 87.8 87.6 96.1 58.7 14.7 93.4 92.7 55.2 53.7 35.6 55.3 21.7 89.4 79.7 15.1 17.2 57.7 27.6 50.7 70.6 44.7 14.0 89.9 45.0 87.1 55.1 98.9 17.2 75.8 15.1 12.4 65.9 57.7 92.7 95.0 85.1 25.2 38.3 30.0 36.4 36.9 38.2 45.9 60.0 47.5 54.8 53.1 19.5 67.7 37.4 46.9 49.9 16.8 62.7 11.9 77.6 58.7 24.9 81.4 26.1 45.9 20.7 45.0 35.3 53.7 45.8 28.3 45.9 37.5 44.1 10.1 42.9 26.6 94.7 49.8 49.7 9.8 27.7 109.6 46.7 13.8 57.9 36.8 44.3 51.2 67.1 39.2 46.8 49.9 9.6 70.5 32.0 30.3 72.8 48.1 112.8 43.8 79.6 64.0 21.3 59.2 15.6 40.6 88.0 69.7 102.3 52.9 56.7 54.7 58.6 55.4 51.9 50.5 57.5 39.8 40.9 92.4 59.5 55.3 94.0 71.8 51.4 94.0 91.1 89.0 133.1 93.1 87.8 93.4 92.7 89.4 89.9 98.9 92.7 56.3 32.1 45.1 7.8 32.9 103.1 54.1 170.2 51.2 67.7 76.7 74.8 51.6 70.1 66.4 53.3 18.8 162.5 32.4 214.4 137.0 101.2 43.5 71.5 64.8 56.8 104.1 69.2 10.4 109.9 197.8 75.3 53.0 45.4 24.1 58.2 62.4 51.0 73.8 47.1 7.5 141.8 89.5 24.1 72.6 93.3 74.3 32.9 110.3 2.8 52.4 95.9 36.0 4.0 8.9 120.7 210.0 85.4 33.2 62.1 138.1 152.8 83.2 52.0 59.2 36.2 72.6 69.5 25.0 57.7 119.1 255.0 36.0 57.8 117.1 63.4 GPR137 "C11orf4, GPR137A, TM7SF1L1" ENSG00000173264 "G protein-coupled receptor 137" Q96N19 11 64270062-64289500 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 203.8" "Cell type enhanced" "Detected in all" "Early spermatids: 193.1;Late spermatids: 573.0;Spermatocytes: 175.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 14.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062871 Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 43: Testis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Nucleoli" "Actin filaments" "HPA062871: AB_2684889" "unprognostic (2.25e-1)" "unprognostic (4.21e-2)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.29e-3)" "unprognostic (6.37e-2)" "prognostic unfavorable (5.34e-4)" "unprognostic (5.68e-2)" "unprognostic (1.83e-2)" "unprognostic (7.61e-3)" "prognostic favorable (6.18e-4)" "unprognostic (4.95e-2)" "unprognostic (8.66e-3)" "unprognostic (3.67e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (5.41e-1)" 20.6 32.6 54.4 16.4 50.9 13.7 19.6 49.4 63.8 24.5 42.5 22.6 12.2 23.6 12.6 28.9 22.3 15.0 29.1 52.8 44.3 34.0 33.9 19.4 14.9 55.3 50.5 18.7 16.2 23.2 26.5 15.6 56.2 29.1 7.5 11.8 23.7 14.8 16.8 22.5 19.5 10.4 45.9 24.5 27.4 203.8 56.2 10.6 30.8 15.9 12.8 26.7 21.4 48.2 22.0 50.2 18.6 49.5 34.9 19.9 69.6 25.5 24.3 31.0 18.4 38.0 31.6 22.7 42.4 24.1 51.9 44.3 28.8 17.1 9.7 73.0 27.9 22.7 53.7 22.5 21.6 15.0 40.9 24.8 25.0 27.5 19.0 20.8 16.3 28.4 20.6 56.2 19.1 56.9 16.8 40.5 22.5 20.4 49.9 31.0 18.0 37.5 20.0 30.3 27.2 32.6 30.0 44.6 30.6 21.4 46.0 6.3 23.1 69.1 46.8 53.3 18.7 41.9 84.9 20.5 50.0 12.3 44.9 1.9 2.8 5.1 2.3 2.5 2.9 2.7 2.0 1.7 3.0 3.8 2.1 1.8 14.0 1.9 2.1 3.0 1.6 1.4 54.4 50.9 49.4 63.8 52.8 44.3 55.3 50.5 56.2 45.9 56.2 48.2 13.0 3.2 11.2 12.7 15.0 14.4 18.5 21.8 19.4 14.1 16.2 13.3 5.3 20.0 13.7 12.9 12.5 49.6 9.5 26.2 15.6 39.0 193.1 14.4 14.8 15.8 16.2 14.7 9.3 26.6 69.7 13.4 15.3 10.0 2.5 10.3 11.4 10.8 23.2 20.2 9.0 16.8 14.2 15.4 14.5 573.0 19.3 11.5 14.2 6.5 16.4 38.9 11.3 4.5 11.2 30.8 14.6 16.1 13.4 26.7 31.5 19.6 18.6 9.1 26.3 8.7 14.1 175.0 55.9 16.9 15.2 119.6 10.8 16.6 15.1 23.3 KCNK4 "K2p4.1, TRAAK" ENSG00000182450 "Potassium two pore domain channel subfamily K member 4" Q9NYG8 11 64291302-64300031 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 28 "brain: 6.9" "Cell type enhanced" "Detected in some" "Astrocytes: 2.9;Endometrial stromal cells: 9.8;Excitatory neurons: 9.0;Extravillous trophoblasts: 3.6;Horizontal cells: 3.3;Muller glia cells: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 36: Stromal cells - Cell proliferation" "unprognostic (1.85e-1)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "unprognostic (2.84e-1)" 0.0 0.0 5.7 0.0 4.1 0.0 0.0 0.5 6.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.1 0.7 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.1 0.1 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 4.1 0.5 6.9 6.1 0.7 0.6 0.6 0.6 0.0 1.3 3.2 0.0 0.0 0.0 2.9 0.0 0.5 0.0 0.0 0.0 0.9 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 9.8 0.1 0.0 0.0 9.0 0.0 3.6 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.2 3.3 2.4 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.0 1.0 0.0 4.4 0.0 0.5 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.1 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 CATSPERZ "C11orf20, DKFZP566E164, TEX40" ENSG00000219435 "Catsper channel auxiliary subunit zeta" Q9NTU4 11 64300358-64304770 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 93 "testis: 586.3" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 4.1;Endometrial stromal cells: 12.7;Extravillous trophoblasts: 36.3;Syncytiotrophoblasts: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.8;CACO-2: 13.9;PC-3: 7.9;T-47d: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052822 Approved Nucleoplasm NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 39: CACO-2 - Unknown function" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "HPA052822: AB_2797245" "unprognostic (1.89e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (8.23e-2)" "unprognostic (2.18e-1)" "unprognostic (1.11e-1)" "unprognostic (5.66e-4)" "unprognostic (5.96e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" 0.4 0.2 4.0 0.1 4.1 0.0 0.6 5.9 6.3 1.0 2.1 0.3 0.1 0.5 0.0 0.4 0.2 0.6 0.1 4.5 3.1 0.5 0.3 0.5 0.1 3.5 3.1 0.1 0.6 0.6 0.1 0.8 3.1 0.8 0.3 0.4 0.2 0.0 0.2 1.2 0.2 0.0 2.6 0.1 0.3 586.3 3.5 0.0 1.0 0.1 0.0 0.3 0.3 4.0 0.0 3.5 0.3 0.1 0.4 0.8 4.8 0.0 0.3 0.0 0.0 13.9 2.8 0.1 0.2 0.1 0.1 3.1 2.6 0.4 0.1 0.0 0.0 1.3 0.1 0.9 0.1 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.1 0.0 1.4 0.6 0.2 0.6 0.0 0.6 0.9 4.0 7.9 1.5 0.0 1.8 3.9 1.2 0.1 0.8 1.4 0.4 0.2 0.2 6.6 0.3 0.2 0.2 0.0 1.8 0.0 0.4 0.1 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.1 5.9 6.3 4.5 3.1 3.5 3.1 3.1 2.6 3.5 4.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.5 12.7 0.2 0.0 0.0 0.0 0.5 36.3 0.3 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.3 0.0 0.1 0.0 0.0 ESRRA "ERR1, ERRa, ERRalpha, ESRL1, NR3B1" ENSG00000173153 "Estrogen related receptor alpha" P11474 11 64305497-64316743 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 195.3" "Cell type enhanced" "Detected in all" "Distal enterocytes: 159.2;Hepatocytes: 266.3;Proximal enterocytes: 199.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053785, HPA077297" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Microtubules,Cytokinetic bridge" Yes No "Cluster 8: Neutrophils - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 2: Hepatocytes - Metabolism" "Nucleoplasm, Nucleoli fibrillar center, Microtubules" "Cytokinetic bridge" "HPA053785: AB_2682260, HPA077297: " "unprognostic (7.63e-2)" "unprognostic (1.51e-1)" "unprognostic (1.04e-1)" "unprognostic (1.28e-2)" "unprognostic (3.08e-1)" "unprognostic (7.24e-2)" "unprognostic (1.07e-1)" "unprognostic (2.97e-1)" "unprognostic (2.98e-1)" "unprognostic (3.52e-2)" "unprognostic (2.50e-2)" "unprognostic (1.03e-1)" "prognostic favorable (1.34e-7)" "unprognostic (3.43e-3)" "unprognostic (3.19e-2)" "unprognostic (2.38e-2)" "unprognostic (7.20e-2)" 27.3 35.5 25.5 15.8 29.8 16.3 23.6 36.4 31.4 17.5 33.6 67.6 81.8 15.5 4.7 62.7 14.6 10.2 154.9 23.5 31.6 70.3 91.5 30.9 11.0 30.9 31.7 8.1 56.3 23.9 15.9 15.4 29.8 26.4 22.9 5.1 48.5 12.6 195.3 35.9 65.4 7.1 26.6 32.0 52.4 8.4 37.5 8.4 28.3 88.8 12.4 31.0 28.8 23.7 25.9 40.2 9.8 23.6 13.0 12.7 54.2 25.0 11.9 9.2 9.0 37.4 30.3 34.9 45.1 12.8 23.7 66.0 16.9 33.0 3.5 23.0 21.0 22.9 51.7 30.1 18.0 39.3 55.3 17.4 49.8 20.7 27.0 12.8 12.8 18.1 37.9 18.7 15.3 57.9 19.4 55.9 27.9 30.4 74.4 20.4 19.7 79.6 31.1 52.4 20.6 26.2 12.8 81.2 83.8 5.5 25.8 38.2 28.9 16.6 20.4 47.4 25.6 28.6 25.5 23.6 26.9 38.2 13.4 0.2 2.9 4.8 2.7 5.4 2.6 1.7 2.3 1.9 2.7 2.3 2.3 3.3 5.3 1.8 5.1 2.1 3.6 1.7 25.5 29.8 36.4 31.4 23.5 31.6 30.9 31.7 29.8 26.6 37.5 23.7 20.8 9.6 22.7 21.2 14.7 18.6 41.0 29.7 18.8 28.8 30.9 24.3 9.2 100.1 21.3 20.2 33.3 103.8 20.9 159.2 54.8 51.3 3.4 18.7 17.4 15.3 37.8 19.4 13.6 80.2 61.3 12.4 39.8 20.3 7.6 9.3 35.0 266.3 33.6 33.7 16.6 82.5 28.5 82.7 11.7 1.1 6.5 22.2 17.8 11.2 28.8 20.1 27.8 9.0 6.4 81.1 103.1 12.0 8.2 42.8 199.7 82.2 19.8 20.4 13.1 18.7 21.7 3.5 7.1 26.3 18.5 134.2 14.5 22.2 113.7 65.0 TRMT112 "HSPC152, HSPC170, hTrm112, TRM112, TRMT11-2" ENSG00000173113 "TRNA methyltransferase subunit 11-2" Q9UI30 11 64316460-64317559 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039901, HPA040006" Uncertain Approved Nucleoplasm,Microtubules NA NA 17000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Microtubules Nucleoplasm "HPA039901: AB_10796334, HPA040006: AB_10793859" "unprognostic (1.48e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-1)" "unprognostic (1.10e-1)" "unprognostic (2.44e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (6.08e-3)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (1.44e-3)" "unprognostic (6.28e-3)" "unprognostic (2.56e-1)" "prognostic unfavorable (2.78e-4)" "unprognostic (2.53e-1)" "unprognostic (1.73e-1)" "unprognostic (3.15e-3)" "unprognostic (1.32e-2)" 159.1 273.6 158.4 109.5 159.8 149.7 152.5 161.3 182.3 182.2 172.7 143.8 68.5 173.0 140.7 167.7 167.5 90.9 138.0 157.3 175.5 176.0 164.7 129.6 170.8 165.9 169.2 238.2 145.5 109.9 182.0 112.2 170.3 137.7 65.4 64.3 116.5 96.4 159.4 146.6 110.0 105.6 163.0 146.8 129.4 130.7 169.0 152.3 142.0 81.8 153.4 145.8 150.3 177.6 411.4 590.3 203.2 298.9 238.0 195.8 199.9 195.3 245.2 231.2 188.3 308.0 401.7 320.5 575.6 204.5 353.1 338.8 367.8 430.1 157.7 373.0 340.1 359.7 503.6 708.9 264.3 282.2 225.2 227.1 401.0 205.5 409.7 241.4 239.7 218.3 298.2 394.5 220.0 1070.4 414.0 527.9 543.0 279.2 511.0 249.6 233.0 451.3 270.6 416.8 133.3 599.3 278.1 322.8 571.4 178.1 503.8 249.7 197.0 241.7 297.2 408.7 365.7 338.7 591.5 512.8 330.2 276.3 255.4 780.9 377.7 573.3 428.7 331.8 444.1 956.3 559.0 481.0 404.8 808.8 617.8 534.8 459.0 392.8 303.5 671.5 551.1 883.6 158.4 159.8 161.3 182.3 157.3 175.5 165.9 169.2 170.3 163.0 169.0 177.6 234.8 160.3 164.3 8.1 269.6 349.9 421.7 465.9 299.9 89.4 219.5 323.8 137.4 135.8 255.8 274.0 22.9 561.1 239.3 96.1 491.0 232.1 71.3 270.9 200.4 236.0 154.4 251.8 10.0 224.4 469.8 249.8 96.8 257.8 217.4 251.8 189.5 196.0 395.2 52.2 10.9 160.6 205.4 174.6 312.3 63.1 299.5 179.1 336.2 12.2 321.2 177.2 247.2 9.0 24.5 221.2 126.4 218.6 296.7 304.4 111.0 610.2 305.0 88.1 216.9 196.2 246.6 230.6 531.2 276.6 396.4 412.1 261.6 258.2 155.3 386.8 PRDX5 "ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10" ENSG00000126432 "Peroxiredoxin 5" P30044 11 64318121-64321811 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 2430.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008661, HPA037915, HPA037916" Enhanced Supported Mitochondria NA NA 6900000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Mitochondria "CAB008661: AB_1620988, HPA037915: AB_2675735, HPA037916: AB_2675736" "unprognostic (2.75e-1)" "unprognostic (4.08e-1)" "unprognostic (1.33e-1)" "unprognostic (1.46e-1)" "unprognostic (9.43e-2)" "unprognostic (6.71e-3)" "unprognostic (1.08e-3)" "unprognostic (3.11e-1)" "unprognostic (9.30e-2)" "unprognostic (1.07e-3)" "unprognostic (1.57e-2)" "unprognostic (2.20e-1)" "prognostic favorable (1.24e-5)" "unprognostic (8.19e-2)" "unprognostic (2.30e-1)" "unprognostic (9.63e-2)" "unprognostic (5.03e-2)" 181.8 400.3 346.0 112.7 342.6 285.7 170.1 375.9 429.4 227.2 480.2 346.6 213.3 153.7 176.6 448.5 400.3 120.7 467.4 340.4 384.6 377.1 280.3 217.2 110.1 382.8 373.3 246.0 224.9 254.5 313.3 164.1 387.0 165.5 299.6 109.0 286.2 164.4 504.0 181.1 226.1 97.1 365.2 162.9 313.9 150.1 377.8 167.7 354.5 439.6 137.8 192.5 244.8 346.4 225.3 453.4 267.9 444.5 284.3 424.4 308.5 274.9 442.3 199.8 247.4 332.9 451.8 329.2 467.0 447.4 712.6 503.5 253.3 589.4 125.8 456.6 200.8 333.3 728.8 386.3 581.0 127.8 271.3 432.4 757.2 334.9 337.8 387.6 308.4 380.6 191.5 755.6 285.5 572.0 220.9 547.8 402.6 356.5 573.9 210.9 274.5 1178.8 760.1 442.9 224.7 424.9 230.8 506.8 818.8 254.3 370.5 283.3 298.3 281.8 258.6 326.7 123.1 383.1 490.8 392.4 340.7 253.7 223.6 703.9 465.4 630.7 251.0 432.9 218.3 393.5 229.0 205.1 369.8 409.0 224.5 225.9 802.3 368.5 399.0 487.9 297.1 639.6 346.0 342.6 375.9 429.4 340.4 384.6 382.8 373.3 387.0 365.2 377.8 346.4 213.7 266.0 463.4 17.6 182.1 326.5 760.2 1591.9 405.2 159.0 266.2 435.9 617.6 371.8 931.2 450.6 70.9 1122.2 185.8 846.1 1612.1 788.4 79.6 865.2 221.3 204.7 801.9 200.6 12.4 1039.2 1144.0 296.1 365.4 285.9 104.7 299.8 205.6 405.2 476.9 92.5 14.0 1041.6 1072.1 206.5 261.0 294.9 279.0 210.8 435.8 8.4 339.7 309.6 278.1 14.1 15.3 1487.3 641.3 226.8 288.9 401.3 922.4 1468.5 2430.7 150.3 197.2 176.2 433.1 150.2 333.9 482.8 257.7 978.9 165.2 713.3 1231.7 1077.1 CCDC88B "BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3" ENSG00000168071 "Coiled-coil domain containing 88B" A6NC98 11 64340204-64357534 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 47.6;lymphoid tissue: 86.1" "Cell type enhanced" "Detected in many" "NK-cells: 64.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 21.7;HMC-1: 83.3;Karpas-707: 22.0;THP-1: 34.5;U-937: 25.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA026652 Approved Supported Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Centrosome, Cytosol" Nucleoplasm "HPA026652: AB_1846168" "unprognostic (1.18e-2)" "unprognostic (3.33e-3)" "unprognostic (3.65e-1)" "unprognostic (1.58e-2)" "unprognostic (2.36e-1)" "prognostic favorable (1.48e-4)" "unprognostic (2.14e-2)" "unprognostic (1.55e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-1)" "unprognostic (2.94e-1)" "unprognostic (7.32e-2)" "prognostic unfavorable (7.65e-5)" "unprognostic (3.77e-2)" "unprognostic (7.38e-2)" "unprognostic (1.90e-1)" "unprognostic (2.83e-2)" 8.5 6.7 14.9 15.1 15.1 47.6 5.3 20.1 21.6 5.6 15.3 17.8 4.0 3.5 0.3 12.9 6.5 8.5 5.5 15.3 15.0 6.5 7.3 21.1 28.6 17.2 15.5 3.1 4.1 0.9 4.5 1.7 17.5 7.8 3.6 1.4 14.4 2.5 1.2 4.5 34.1 1.2 15.4 86.1 8.9 17.4 15.4 17.4 5.4 0.8 13.8 8.3 7.7 15.9 0.3 1.3 0.0 0.0 0.0 0.0 2.6 0.0 0.6 0.0 0.0 0.0 3.4 19.7 2.9 1.1 0.5 1.6 0.1 0.6 0.0 21.7 0.0 15.0 4.6 1.1 0.8 9.4 83.3 0.0 0.0 0.2 0.0 1.3 0.5 6.3 0.5 22.0 0.7 0.9 12.7 7.7 0.7 3.7 0.5 11.9 0.3 18.5 0.3 0.3 4.8 0.0 0.0 0.5 1.1 0.1 2.6 34.5 0.0 0.0 0.7 0.1 0.2 4.7 1.5 15.8 1.0 25.3 0.4 2.9 4.6 6.7 3.5 3.6 1.0 1.6 2.0 2.9 1.6 2.0 1.8 2.2 9.2 6.5 2.5 2.7 0.6 1.3 14.9 15.1 20.1 21.6 15.3 15.0 17.2 15.5 17.5 15.4 15.4 15.9 3.3 0.0 10.7 5.2 30.3 2.7 4.5 10.5 0.6 45.2 5.7 4.8 13.5 4.3 9.9 9.2 0.0 2.9 34.9 46.0 0.0 12.8 11.1 8.7 2.6 4.4 18.0 7.0 2.6 28.9 5.8 3.1 51.0 6.8 26.6 2.2 6.1 10.4 14.5 0.0 2.0 24.4 8.2 26.0 26.6 15.8 1.5 27.3 5.4 12.2 35.0 15.4 64.9 2.0 0.6 35.0 33.2 0.7 24.9 2.9 36.1 3.2 22.7 4.7 0.0 2.8 2.8 13.7 8.7 2.0 1.6 1.4 31.7 10.0 32.4 15.7 RPS6KA4 "MSK2, RSK-B" ENSG00000162302 "Ribosomal protein S6 kinase A4" O75676 11 64359148-64372215 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Inflammatory response, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 70.0;dendritic cells: 75.0;Pancreatic endocrine cells: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 10.5" "Group enriched" "Detected in many" 5 "dendritic cells: 10.5;monocytes: 2.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008649, HPA023225" Approved Supported Nucleoplasm,Cytosol No No "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 18: U-2197 - ECM organization" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm Cytosol "CAB008649: AB_1619460, HPA023225: AB_1854144" "unprognostic (2.30e-1)" "unprognostic (7.05e-2)" "unprognostic (2.03e-1)" "unprognostic (4.07e-2)" "unprognostic (2.40e-1)" "unprognostic (7.47e-2)" "prognostic unfavorable (8.17e-4)" "prognostic unfavorable (9.27e-4)" "unprognostic (2.45e-1)" "unprognostic (9.03e-2)" "unprognostic (1.41e-2)" "unprognostic (3.06e-3)" "unprognostic (1.98e-2)" "unprognostic (3.93e-3)" "unprognostic (5.25e-2)" "unprognostic (1.09e-1)" "unprognostic (2.85e-1)" 15.0 13.1 14.8 11.8 16.1 10.9 12.5 17.0 17.9 13.7 10.5 16.8 9.8 16.5 2.8 31.0 12.0 4.7 16.2 15.3 13.7 14.2 12.0 16.4 12.0 14.7 14.7 8.5 12.2 3.3 6.8 11.7 14.7 13.1 5.6 2.1 12.5 5.6 16.0 22.8 17.1 6.8 14.4 25.0 15.8 3.5 15.1 5.7 10.2 5.0 9.5 16.6 14.6 14.3 76.1 41.5 5.9 15.0 12.8 11.9 84.0 39.4 20.6 30.2 14.9 41.7 38.8 7.9 44.9 22.9 38.6 69.1 7.1 32.1 14.7 24.1 14.0 17.8 36.8 21.6 12.8 18.0 32.0 12.0 29.7 25.7 20.9 10.9 18.4 14.2 7.4 10.6 15.6 69.2 16.6 28.4 6.5 29.2 88.1 31.8 24.4 25.3 21.1 34.4 8.7 6.9 40.7 24.8 35.6 8.5 28.6 22.3 37.0 41.0 51.7 74.7 35.9 12.5 10.4 7.8 27.0 20.6 21.2 1.3 2.7 1.4 0.7 2.1 0.7 0.4 0.5 0.6 2.2 0.2 0.3 0.3 0.2 0.2 1.3 10.5 0.5 2.6 14.8 16.1 17.0 17.9 15.3 13.7 14.7 14.7 14.7 14.4 15.1 14.3 11.8 3.2 3.0 8.5 6.4 12.1 6.8 8.6 8.6 7.3 5.4 4.8 15.2 7.2 5.4 3.7 4.2 70.0 75.0 25.2 5.9 20.1 0.8 3.5 8.7 9.9 8.4 9.9 6.6 25.2 38.2 9.3 26.0 7.6 19.1 5.7 10.8 7.8 29.6 8.4 5.3 14.3 2.0 30.5 13.2 1.5 11.1 25.8 8.8 11.2 26.6 3.6 10.3 4.5 5.4 65.1 12.8 6.8 5.7 10.2 16.2 8.4 3.1 2.1 0.0 6.0 10.2 0.7 6.5 13.9 10.7 46.7 11.3 7.5 19.9 9.6 SLC22A11 OAT4 ENSG00000168065 "Solute carrier family 22 member 11" Q9NSA0 11 64555690-64572875 "FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 72 "epididymis: 10.6;kidney: 31.9;placenta: 33.4" "Group enriched" "Detected in some" 19 "Cytotrophoblasts: 654.0;Syncytiotrophoblasts: 1520.6" "Cancer enriched" "Detected in some" 4 "renal cancer: 15.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.3;Hep G2: 1.0" "Not detected" "Not detected" HPA026076 Enhanced NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "HPA026076: AB_1854756" "unprognostic (8.21e-5)" "unprognostic (3.29e-2)" "unprognostic (3.57e-1)" "unprognostic (1.57e-1)" "unprognostic (3.20e-2)" "unprognostic (4.57e-3)" "unprognostic (3.48e-1)" "unprognostic (1.93e-1)" "unprognostic (4.86e-2)" "unprognostic (4.51e-2)" "unprognostic (7.56e-2)" "unprognostic (1.13e-1)" "prognostic favorable (3.68e-5)" "unprognostic (4.62e-2)" "unprognostic (6.52e-2)" "unprognostic (3.50e-2)" "unprognostic (8.24e-3)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 31.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 33.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 654.0 0.0 0.0 5.9 0.0 1.2 0.0 0.2 1.7 0.0 0.0 0.0 0.4 22.5 3.4 0.0 0.0 0.0 0.0 0.4 0.2 50.3 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.3 0.3 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 1520.6 0.2 0.1 0.2 0.0 SLC22A12 "OAT4L, RST, URAT1" ENSG00000197891 "Solute carrier family 22 member 12" Q96S37 11 64590641-64602353 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 204 "kidney: 109.4" "Cell type enriched" "Detected in some" 17 "Proximal tubular cells: 173.1" "Cancer enriched" "Detected in some" 4 "renal cancer: 16.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA024575 Enhanced NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA024575: AB_1858650" "unprognostic (5.88e-2)" "unprognostic (2.33e-1)" "prognostic favorable (2.63e-4)" "unprognostic (6.19e-2)" "unprognostic (3.91e-2)" 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 109.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 173.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 NRXN2 ENSG00000110076 "Neurexin 2" "P58401, Q9P2S2" 11 64606174-64723197 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 73.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 72.4;Horizontal cells: 149.7;Inhibitory neurons: 47.8;Late spermatids: 49.7;Muller glia cells: 60.7;Oligodendrocyte precursor cells: 47.3;Peritubular cells: 59.0" "Cancer enhanced" "Detected in many" "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 47.8;SCLC-21H: 22.8;SH-SY5Y: 10.5;U-2 OS: 26.1;U-87 MG: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 1000000 "Cluster 7: Monocytes - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 14: REH - Unknown function" "Cluster 62: Horizontal cells - Visual perception" "unprognostic (3.87e-2)" "unprognostic (1.54e-4)" "unprognostic (2.60e-2)" "unprognostic (1.96e-1)" "unprognostic (8.07e-2)" "unprognostic (2.51e-2)" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (5.08e-2)" "unprognostic (3.23e-1)" "unprognostic (5.93e-3)" "unprognostic (3.40e-1)" "unprognostic (9.97e-3)" "unprognostic (2.39e-2)" "unprognostic (6.99e-2)" "unprognostic (4.27e-4)" "unprognostic (5.46e-3)" 3.8 4.7 61.0 2.0 51.6 0.5 2.6 73.6 65.9 27.0 0.0 17.1 1.0 19.0 1.1 0.4 14.6 2.2 3.7 61.9 21.8 5.8 1.0 1.5 1.0 16.0 18.2 15.5 3.0 0.1 4.3 0.7 11.6 4.9 0.6 13.0 1.6 2.9 1.1 0.9 2.7 2.4 4.6 1.5 2.4 15.3 24.8 0.8 4.0 0.3 0.4 5.9 7.4 18.3 0.0 0.0 2.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 2.1 0.0 0.3 0.3 2.5 2.0 0.1 3.3 0.0 0.0 0.3 0.4 6.5 0.0 0.0 0.0 0.0 0.5 1.2 0.0 4.5 0.0 0.0 0.0 0.1 0.0 9.0 3.1 0.0 0.7 0.3 7.6 0.0 0.0 47.8 1.4 1.9 0.0 0.0 22.8 10.5 0.1 0.0 0.0 0.1 0.0 0.0 0.3 1.1 26.1 0.5 0.0 0.0 0.0 0.0 18.6 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 61.0 51.6 73.6 65.9 61.9 21.8 16.0 18.2 11.6 4.6 24.8 18.3 0.5 0.0 0.0 13.1 0.0 0.5 0.1 0.0 0.0 72.4 0.2 0.6 3.2 0.0 0.0 1.8 6.2 0.1 0.6 6.3 3.9 0.0 23.6 0.9 23.5 2.5 6.7 2.1 36.0 2.7 0.2 7.3 0.0 0.6 0.0 0.7 2.9 8.6 0.2 149.7 47.8 1.1 0.0 1.2 0.7 49.7 42.6 1.2 0.0 7.5 0.7 60.7 6.2 47.3 26.0 0.4 2.5 59.0 0.0 0.1 5.1 40.9 0.0 21.7 0.0 27.3 4.0 37.5 15.2 0.0 0.1 0.3 0.7 4.9 0.9 0.0 RASGRP2 CALDAG-GEFI ENSG00000068831 "RAS guanyl releasing protein 2" Q7LDG7 11 64726911-64745456 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 147.3;lymphoid tissue: 140.5" "Cell type enhanced" "Detected in many" "B-cells: 125.5;dendritic cells: 86.1;Kupffer cells: 77.3;Macrophages: 72.2;NK-cells: 98.9;Sertoli cells: 131.5" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 103.4;HL-60: 192.8;NB-4: 347.1;REH: 105.0;THP-1: 108.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015635, HPA015667" Approved Supported "Plasma membrane" NA NA 1900000 "Cluster 37: B-cells - Transcription" "Cluster 2: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 57: B-cells - Immune response" "Plasma membrane" "HPA015635: , HPA015667: AB_1856090" "unprognostic (5.96e-2)" "unprognostic (3.24e-3)" "unprognostic (5.55e-2)" "unprognostic (1.50e-2)" "unprognostic (3.52e-2)" "unprognostic (4.74e-5)" "unprognostic (1.11e-2)" "unprognostic (7.36e-3)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (4.91e-3)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.38e-4)" "unprognostic (1.08e-1)" "unprognostic (5.40e-2)" "unprognostic (1.90e-1)" "unprognostic (1.23e-1)" 23.8 10.1 16.1 52.9 35.5 147.3 16.8 9.6 22.4 20.1 7.1 37.5 6.6 28.3 4.6 9.1 29.2 8.7 51.7 13.4 13.4 15.8 10.1 29.5 106.0 12.4 16.3 9.1 4.1 1.0 5.5 10.9 11.9 23.2 5.3 1.3 4.6 18.6 12.2 6.1 86.4 15.0 9.5 140.5 17.5 11.9 20.7 34.6 10.6 10.2 62.0 26.7 15.5 9.8 0.1 0.1 3.0 0.1 0.0 0.3 8.7 1.3 0.2 1.2 0.8 1.5 0.2 62.8 2.7 0.2 0.8 0.7 5.4 0.9 0.3 0.3 1.7 103.4 0.0 0.4 0.3 192.8 35.9 0.0 0.0 0.5 0.0 0.0 0.1 25.9 4.1 1.1 0.0 1.4 45.4 347.1 2.5 0.4 0.0 105.0 0.2 4.4 0.0 0.0 0.5 2.3 0.1 0.1 0.0 2.2 0.6 108.5 0.6 0.0 2.0 1.5 0.1 0.5 0.1 58.9 0.0 58.2 0.0 64.4 34.1 59.9 70.4 88.0 37.3 170.7 72.9 57.2 34.5 100.2 92.7 83.1 70.9 55.3 105.8 85.9 93.8 67.5 16.1 35.5 9.6 22.4 13.4 13.4 12.4 16.3 11.9 9.5 20.7 9.8 27.4 3.2 1.8 2.6 125.5 2.3 0.1 0.0 0.0 2.6 1.6 3.7 53.1 2.8 0.0 0.0 0.0 1.7 86.1 0.1 0.0 0.0 6.6 1.9 27.1 13.5 0.0 24.2 6.0 0.0 1.3 6.6 2.6 1.2 3.8 5.7 31.4 1.7 6.1 0.0 12.2 0.1 0.0 77.3 19.7 19.5 18.0 72.2 0.0 6.5 55.8 0.7 98.9 2.5 0.9 0.0 0.0 47.8 28.6 0.1 0.4 0.9 0.7 2.5 131.5 5.4 56.8 18.0 43.9 0.9 1.3 11.8 61.0 0.8 0.3 0.2 PYGM GSD5 ENSG00000068976 "Glycogen phosphorylase, muscle associated" P11217 11 64746389-64759974 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Allosteric enzyme, Glycosyltransferase, Transferase" "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 65 "skeletal muscle: 8468.3;tongue: 3594.2" "Cell type enhanced" "Detected in many" "Astrocytes: 29.7;Cardiomyocytes: 47.5;Late spermatids: 49.2;Peritubular cells: 44.0;Skeletal myocytes: 64.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "basophil: 8.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.1" "Cell line enhanced" "Detected in some" "HSkMC: 3.7;NB-4: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056003 Enhanced NA NA 10000000 "Cluster 10: Basophils - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 37: Myocytes - Muscle contraction" "HPA056003: AB_2683006" "unprognostic (3.33e-1)" "unprognostic (6.03e-3)" "unprognostic (3.87e-4)" "unprognostic (1.95e-3)" "unprognostic (8.71e-2)" "unprognostic (1.09e-2)" "unprognostic (1.25e-3)" "unprognostic (2.92e-1)" "unprognostic (3.88e-1)" "unprognostic (3.08e-2)" "unprognostic (1.12e-1)" "unprognostic (2.64e-1)" "unprognostic (6.33e-6)" "unprognostic (3.37e-3)" "unprognostic (1.81e-1)" "unprognostic (1.62e-2)" "unprognostic (5.68e-2)" 15.2 3.0 35.4 2.1 30.1 1.2 7.7 55.5 29.4 5.8 15.5 25.5 1.5 10.4 6.4 92.2 14.6 3.8 70.8 26.8 26.1 2.4 1.2 2.7 2.2 48.8 30.4 4.0 1.6 0.3 1.7 1.4 39.6 25.6 3.6 2.9 50.0 26.3 8468.3 4.2 7.0 14.7 44.9 3.3 6.9 6.7 47.3 1.3 5.2 3594.2 1.2 16.7 5.2 38.1 0.1 0.0 0.7 0.1 0.5 0.7 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.6 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.6 0.1 0.3 0.2 0.0 0.3 0.4 0.1 3.7 0.2 0.2 0.1 0.0 0.0 1.1 0.7 0.6 0.0 1.1 0.7 2.2 0.7 0.1 0.1 0.4 0.7 0.1 0.0 0.1 0.2 0.0 0.2 0.3 0.4 0.4 0.3 0.4 0.3 0.0 0.4 0.1 0.0 1.0 1.4 0.4 0.0 0.1 0.0 8.1 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.1 0.0 1.1 0.0 0.1 0.1 1.3 0.0 0.2 0.2 0.1 35.4 30.1 55.5 29.4 26.8 26.1 48.8 30.4 39.6 44.9 47.3 38.1 2.4 0.0 2.3 29.7 3.0 0.8 0.6 0.2 5.2 3.5 2.9 4.7 47.5 0.0 0.8 0.0 4.2 0.6 1.9 1.0 0.0 0.1 11.7 1.6 5.2 2.0 0.0 0.0 0.2 0.0 0.2 5.1 1.1 4.0 0.0 0.8 1.8 0.0 0.5 0.0 0.2 0.9 0.0 0.6 1.3 49.2 16.4 2.3 0.0 1.0 0.5 9.9 4.1 0.5 0.4 0.3 0.2 44.0 0.3 1.3 0.6 0.0 0.1 1.3 6.6 64.3 12.8 1.2 0.9 2.5 0.6 0.1 2.9 0.9 1.1 0.3 SF1 "ZCCHC25, ZFM1, ZNF162" ENSG00000168066 "Splicing factor 1" Q15637 11 64764606-64778786 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018883 Supported Supported Nucleoplasm NA NA 130000 "Cluster 39: Non-specific - mRNA processing" "Cluster 59: Non-specific - Translation" "Cluster 14: REH - Unknown function" "Cluster 57: B-cells - Immune response" Nucleoplasm "HPA018883: AB_1856763" "unprognostic (1.24e-1)" "unprognostic (2.42e-1)" "unprognostic (1.18e-1)" "unprognostic (4.01e-2)" "unprognostic (1.50e-1)" "unprognostic (4.35e-1)" "prognostic unfavorable (4.85e-5)" "unprognostic (3.72e-1)" "unprognostic (4.51e-3)" "unprognostic (1.39e-1)" "unprognostic (4.62e-3)" "unprognostic (6.20e-2)" "unprognostic (8.00e-2)" "unprognostic (2.18e-1)" "unprognostic (1.42e-1)" "unprognostic (2.62e-2)" "unprognostic (1.78e-1)" 111.7 89.1 47.2 73.1 47.9 230.4 100.8 70.8 73.7 106.8 39.7 112.6 62.3 110.5 46.3 98.2 118.7 53.8 93.0 44.2 64.4 97.9 100.4 85.0 95.8 51.5 40.2 142.4 103.3 52.0 97.7 53.4 42.2 105.7 42.5 46.3 87.4 58.4 149.2 96.3 110.5 63.4 27.7 133.6 104.5 110.2 53.3 91.2 99.6 73.3 80.4 98.4 92.3 57.9 141.2 165.4 151.1 131.0 82.4 65.5 178.8 98.9 83.6 130.3 100.3 142.0 154.8 223.6 120.2 111.4 119.4 163.8 172.2 171.0 110.3 167.1 115.0 144.6 107.6 107.0 130.7 155.0 143.7 86.0 87.1 165.2 172.3 77.0 118.9 145.0 216.4 141.5 100.8 145.1 294.2 217.9 206.5 126.2 117.5 253.2 104.7 177.7 87.5 151.8 119.6 157.4 138.1 118.8 138.3 95.6 182.7 163.6 104.6 145.1 131.7 134.5 158.2 163.6 139.4 205.6 129.1 132.2 180.2 3.4 9.7 10.7 12.9 10.8 12.9 9.3 9.6 12.7 9.6 7.3 11.2 11.9 13.7 9.2 9.7 10.9 10.5 9.4 47.2 47.9 70.8 73.7 44.2 64.4 51.5 40.2 42.2 27.7 53.3 57.9 131.9 60.9 88.7 82.3 326.5 184.2 205.1 121.4 350.0 267.2 158.4 127.8 63.5 107.2 87.2 55.2 225.2 118.6 194.5 133.6 37.2 80.4 156.9 156.6 180.5 134.3 209.8 115.7 60.6 73.8 116.8 126.1 138.6 170.1 107.8 212.6 164.2 120.7 98.2 175.0 52.1 115.6 109.9 137.2 167.6 67.1 157.5 122.0 96.0 72.1 146.4 121.9 166.9 62.4 141.0 88.3 106.3 113.2 188.1 192.8 118.5 56.0 83.1 325.8 78.9 145.3 132.0 116.8 84.3 246.9 183.8 148.7 250.2 249.6 129.6 194.3 MAP4K2 "BL44, GCK, RAB8IP" ENSG00000168067 "Mitogen-activated protein kinase kinase kinase kinase 2" Q12851 11 64784918-64803241 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007330 Enhanced Approved Vesicles NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 58: T-cells - T-cell receptor" Vesicles "HPA007330: AB_1079361" "unprognostic (1.66e-1)" "unprognostic (2.83e-1)" "unprognostic (3.07e-3)" "unprognostic (4.37e-3)" "unprognostic (2.67e-1)" "unprognostic (9.23e-2)" "prognostic unfavorable (3.10e-5)" "unprognostic (4.51e-2)" "unprognostic (3.65e-1)" "unprognostic (5.28e-2)" "unprognostic (1.24e-2)" "unprognostic (1.41e-1)" "unprognostic (2.47e-2)" "unprognostic (2.97e-1)" "unprognostic (1.57e-2)" "unprognostic (1.82e-1)" "unprognostic (1.95e-2)" 5.0 3.9 8.9 6.9 7.2 15.5 4.1 9.8 9.9 4.6 4.9 5.6 3.3 4.8 2.5 2.7 3.8 4.2 4.3 7.6 7.0 5.4 2.0 9.7 17.6 7.8 8.0 3.4 5.0 3.2 5.8 8.9 8.1 4.7 3.0 5.3 6.6 5.8 2.5 3.5 8.9 3.7 6.6 18.0 5.2 4.6 9.7 7.4 7.0 1.5 14.2 4.6 3.5 8.8 9.4 8.4 5.4 9.8 4.7 2.9 12.7 7.0 6.5 8.2 5.8 3.7 4.3 16.4 12.6 8.0 14.5 2.8 6.5 6.8 4.9 21.5 3.1 28.9 12.0 7.9 5.8 15.3 10.4 2.9 3.4 6.4 4.1 5.7 20.3 28.0 2.5 1.5 2.5 11.8 9.2 15.2 3.6 5.6 11.2 18.8 0.6 18.9 4.6 4.7 6.4 9.3 6.0 7.8 6.4 6.1 15.5 23.2 15.8 6.8 15.0 6.3 2.9 1.8 3.8 18.1 6.0 22.8 5.1 2.2 4.3 5.9 4.9 12.5 4.9 9.9 6.5 4.4 4.4 6.6 7.7 6.0 8.0 2.5 15.8 5.0 9.5 7.3 8.9 7.2 9.8 9.9 7.6 7.0 7.8 8.0 8.1 6.6 9.7 8.8 21.6 3.2 4.8 6.8 32.9 1.3 2.8 1.8 6.2 20.6 8.1 10.4 4.7 7.2 2.4 1.8 25.0 7.6 9.4 6.8 3.9 1.7 33.8 2.6 3.8 20.0 6.0 5.0 5.9 1.7 11.3 4.9 9.2 6.0 1.3 7.7 24.3 2.0 11.0 11.8 4.6 1.8 6.1 8.9 3.1 46.8 4.1 16.2 1.8 18.7 13.4 7.2 14.4 2.0 7.2 0.9 16.2 7.2 15.6 1.8 1.6 3.6 1.5 14.6 6.6 3.7 4.3 2.1 13.8 5.2 1.4 5.1 19.9 22.6 2.2 2.0 MEN1 ENSG00000133895 "Menin 1" O00255 11 64803510-64811294 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030342 Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Cytosol "HPA030342: AB_10610138" "unprognostic (2.06e-1)" "unprognostic (1.76e-1)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (1.05e-1)" "unprognostic (8.41e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.66e-1)" "unprognostic (2.59e-1)" "unprognostic (1.42e-2)" "unprognostic (4.96e-2)" "unprognostic (1.36e-1)" "unprognostic (7.39e-2)" "prognostic favorable (6.31e-5)" "unprognostic (1.40e-1)" "unprognostic (3.03e-1)" "unprognostic (3.76e-1)" 15.1 24.2 13.1 8.4 13.7 6.5 15.7 12.7 15.0 19.3 13.0 16.8 7.8 17.4 8.1 23.9 16.3 5.5 12.4 14.3 12.7 19.4 30.3 16.1 10.9 12.5 12.5 20.8 26.2 6.3 21.7 7.8 12.6 20.2 4.7 4.7 21.3 7.7 11.0 24.0 20.9 5.3 11.9 25.5 20.6 16.3 13.5 17.1 24.5 5.8 10.2 16.4 18.7 12.9 30.8 33.7 22.4 37.7 30.4 17.4 24.8 19.2 23.3 35.6 21.2 19.0 25.5 43.6 33.8 16.7 29.8 39.0 36.4 28.3 19.3 30.5 48.1 35.6 17.3 30.9 27.2 23.6 22.8 19.2 18.2 26.8 21.9 16.5 33.7 49.3 51.5 15.7 18.9 54.2 60.3 29.3 36.7 30.3 54.7 45.1 29.8 44.1 23.2 22.8 33.6 28.9 26.0 36.9 27.9 16.5 56.6 27.1 17.4 23.5 28.8 36.5 16.7 21.8 30.4 22.1 25.5 16.2 21.0 0.5 0.5 1.4 1.5 0.6 1.8 1.8 1.1 1.9 0.6 1.8 1.9 0.9 0.1 0.9 0.2 1.3 0.9 0.5 13.1 13.7 12.7 15.0 14.3 12.7 12.5 12.5 12.6 11.9 13.5 12.9 6.9 3.2 5.4 5.9 10.6 5.7 4.6 5.3 7.4 8.5 10.2 11.0 4.5 4.3 2.8 3.7 6.2 19.4 8.0 9.2 3.9 8.9 0.9 7.9 11.0 7.0 4.2 10.8 7.4 7.1 21.7 6.9 13.7 12.1 1.3 14.1 7.9 10.9 9.0 3.3 6.2 9.0 6.1 3.1 2.3 0.9 12.2 4.8 8.8 8.4 6.3 7.7 6.2 4.5 5.0 7.5 10.7 3.8 8.4 6.1 9.3 8.0 4.0 6.5 13.1 5.4 5.6 14.2 13.0 9.4 7.0 16.3 8.9 14.3 10.2 3.3 CDC42BPG "DMPK2, HSMDPKIN, kappa-200, MRCKgamma" ENSG00000171219 "CDC42 binding protein kinase gamma" Q6DT37 11 64823052-64844653 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 33.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 14.8;Gastric mucus-secreting cells: 23.0;Paneth cells: 18.3;Squamous epithelial cells: 19.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 8 "cerebellum: 9.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 29.3;HaCaT: 22.5;MCF7: 30.7;RT4: 18.4;SK-BR-3: 18.4;T-47d: 18.1" "Region enriched" "Detected in all" 4 "cerebellum: 10.5" "Low region specificity" "Detected in some" "HPA027382, HPA061836" Enhanced Supported Cytosol NA NA "Cluster 31: Skin - Epidermis development" "Cluster 28: BEWO - Transcription regulation" "Cluster 61: Squamous epithelial cells - Keratinization" Cytosol "HPA027382: AB_1846378, HPA061836: AB_2684622" "unprognostic (3.26e-2)" "unprognostic (1.58e-1)" "unprognostic (6.00e-2)" "unprognostic (2.60e-1)" "unprognostic (1.21e-1)" "unprognostic (2.50e-1)" "unprognostic (4.68e-1)" "unprognostic (5.27e-2)" "unprognostic (3.91e-2)" "unprognostic (3.65e-2)" "unprognostic (1.26e-1)" "unprognostic (1.81e-1)" "prognostic favorable (5.99e-13)" "unprognostic (2.60e-2)" "unprognostic (1.55e-1)" "unprognostic (2.14e-2)" "unprognostic (3.99e-3)" 0.5 4.9 0.2 1.4 0.3 2.1 4.8 9.7 1.2 5.4 5.5 8.8 10.6 0.4 2.0 26.5 3.8 2.8 0.4 0.4 0.3 7.7 0.9 7.8 1.3 0.4 0.7 2.2 14.1 6.4 11.0 4.2 1.0 8.5 4.5 0.3 17.7 3.7 0.2 33.7 9.3 0.2 0.3 1.8 12.2 3.3 0.3 2.4 6.0 0.0 2.0 5.8 13.0 0.3 8.9 1.2 0.8 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.0 11.7 7.5 0.1 4.3 0.0 0.4 22.5 1.3 8.8 0.0 0.4 3.6 0.7 5.3 3.8 0.0 0.3 2.2 0.0 10.9 0.1 0.1 0.1 0.1 3.5 6.1 0.1 0.0 30.7 0.2 1.7 2.7 8.3 1.3 1.3 0.5 4.3 5.5 18.4 15.6 0.7 2.8 18.4 0.5 4.3 18.1 0.4 0.1 0.0 3.1 0.1 0.1 2.1 2.2 2.2 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 9.7 1.2 0.4 0.3 0.4 0.7 1.0 0.3 0.3 0.3 1.0 9.6 7.9 0.0 1.2 6.5 2.3 3.6 9.6 0.0 5.1 5.8 1.8 2.8 9.6 1.8 0.0 6.4 1.7 14.8 0.0 2.4 0.6 13.2 0.7 0.4 3.6 0.8 0.1 6.2 4.9 0.7 23.0 7.9 1.3 0.4 0.0 0.0 1.0 0.0 0.1 4.8 2.0 0.0 0.4 0.8 0.0 1.3 0.0 0.0 1.2 0.8 1.0 0.0 0.1 2.9 18.3 0.0 0.1 1.6 12.4 0.5 9.5 0.0 0.0 2.2 0.8 1.7 1.3 19.3 8.1 6.7 1.4 0.6 5.7 3.4 EHD1 "FLJ42622, FLJ44618, H-PAST, HPAST1, PAST1" ENSG00000110047 "EH domain containing 1" Q9H4M9 11 64851642-64888296 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 151.6;testis: 159.9" "Group enriched" "Detected in all" 10 "Early spermatids: 1033.0;Late spermatids: 1950.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049890, HPA049986, HPA066751, HPA067747" Approved Supported "Plasma membrane" NA NA 10000000 "Cluster 49: Eosinophils - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 2: Karpas-707 - Immune response" "Cluster 34: Spermatids - Unknown function" "Plasma membrane" "HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713, HPA067747: AB_2685896" "unprognostic (1.51e-1)" "unprognostic (3.21e-1)" "unprognostic (6.35e-3)" "unprognostic (2.43e-1)" "unprognostic (1.62e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.81e-5)" "unprognostic (1.46e-3)" "unprognostic (9.10e-3)" "unprognostic (9.44e-2)" "unprognostic (2.11e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-1)" "unprognostic (6.37e-2)" "unprognostic (9.88e-2)" "unprognostic (2.74e-1)" "unprognostic (2.59e-2)" 39.7 25.4 21.5 59.7 26.6 151.6 21.8 38.6 32.6 26.2 18.2 32.3 33.8 28.1 8.4 26.0 27.0 25.0 39.3 24.9 26.8 31.2 22.0 44.7 65.6 32.7 28.2 13.6 11.1 8.9 7.0 35.4 29.9 18.8 14.5 3.0 16.6 20.9 32.1 34.4 38.5 28.3 31.0 74.4 29.3 159.9 30.5 28.9 19.3 31.5 50.3 55.3 23.0 33.4 109.4 74.1 26.2 28.9 31.2 50.2 15.4 108.2 97.4 89.5 51.8 96.5 66.2 142.0 37.8 129.9 76.5 86.6 27.3 108.9 34.5 89.5 15.2 94.8 37.1 49.1 36.8 30.9 24.6 22.8 22.9 138.7 43.2 40.6 89.8 27.6 39.6 243.8 68.7 57.8 62.5 51.4 17.5 27.5 95.9 24.8 83.5 49.9 84.5 35.7 18.6 16.6 60.8 109.3 48.6 29.5 149.2 21.8 127.9 39.6 35.4 106.0 52.6 100.2 48.5 112.1 103.3 40.1 22.0 18.0 13.9 99.6 39.0 16.1 39.2 24.0 27.3 33.8 7.2 18.2 16.2 23.1 57.1 25.4 33.7 8.7 31.8 30.7 21.5 26.6 38.6 32.6 24.9 26.8 32.7 28.2 29.9 31.0 30.5 33.4 31.2 76.9 30.3 4.2 46.0 67.3 52.8 39.4 17.6 3.8 28.8 24.8 29.2 18.6 22.9 14.7 2.1 88.6 76.5 75.9 7.9 29.4 1033.0 41.9 24.4 29.3 6.6 19.8 1.7 40.8 24.5 32.4 25.5 54.9 93.8 37.2 10.4 10.9 32.2 5.0 3.5 27.7 12.2 37.4 61.0 1950.6 30.1 79.6 26.6 1.9 34.3 5.9 78.2 2.5 12.2 101.5 47.7 27.1 50.8 28.2 38.9 41.9 16.5 2.8 78.9 47.9 53.5 55.0 27.4 19.9 49.2 137.0 71.7 19.8 22.1 42.7 ATG2A KIAA0404 ENSG00000110046 "Autophagy related 2A" Q2TAZ0 11 64894546-64917211 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 16.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 16.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038715 Uncertain Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Vesicles Nucleoplasm "HPA038715: AB_10673474" "unprognostic (3.05e-2)" "unprognostic (2.33e-1)" "unprognostic (7.55e-2)" "unprognostic (1.18e-1)" "unprognostic (3.42e-1)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (1.12e-1)" "unprognostic (1.37e-1)" "unprognostic (2.68e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-2)" "prognostic favorable (4.79e-5)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (3.37e-1)" "unprognostic (1.15e-1)" 16.4 20.1 11.4 6.5 10.9 60.2 16.9 8.6 40.1 19.9 11.4 18.9 7.5 18.2 1.8 15.7 19.2 4.2 18.4 11.5 9.8 22.0 59.2 24.2 6.1 13.9 12.3 24.9 22.7 4.9 21.6 4.9 12.7 21.6 2.6 1.9 15.2 5.7 26.7 34.9 21.4 3.3 9.0 25.7 23.2 15.3 11.4 5.4 19.3 4.4 3.3 17.7 15.6 10.4 13.2 12.6 4.4 12.0 5.7 4.0 12.3 7.1 10.3 9.4 6.8 11.0 9.9 9.3 14.7 6.0 12.0 10.8 4.5 8.3 2.5 9.1 15.7 8.7 19.1 10.0 8.4 6.5 18.2 10.9 7.1 11.8 6.3 5.4 7.9 9.5 16.1 7.3 4.1 21.3 7.8 21.9 5.1 3.5 14.3 8.6 7.1 13.5 5.0 10.9 16.5 6.7 10.6 14.6 13.3 3.3 14.3 8.1 10.1 9.0 8.6 18.3 5.3 14.7 5.5 6.5 13.0 5.2 5.6 3.0 2.0 2.2 2.5 2.1 2.1 0.8 1.7 2.2 1.4 0.9 1.3 2.4 16.9 1.8 1.7 2.4 0.9 1.2 11.4 10.9 8.6 40.1 11.5 9.8 13.9 12.3 12.7 9.0 11.4 10.4 9.8 9.6 16.2 20.2 17.0 28.9 8.7 35.7 16.5 16.6 15.8 10.3 8.1 7.2 17.6 9.2 33.3 12.7 40.1 38.8 1.9 10.2 2.5 12.4 9.2 10.2 35.9 16.2 7.6 10.3 5.3 12.6 16.8 24.4 9.5 15.4 7.9 23.2 10.9 13.5 8.4 17.6 24.4 20.1 19.9 3.6 12.8 24.2 30.2 5.6 11.9 12.3 19.6 6.6 7.1 14.9 21.7 10.1 27.3 12.2 26.8 6.6 13.3 26.0 13.1 11.6 10.6 9.0 6.2 16.3 38.4 66.9 40.2 27.2 19.0 15.9 PPP2R5B "B56B, B56beta, FLJ35411, PR61B" ENSG00000068971 "Protein phosphatase 2 regulatory subunit B'beta" Q15173 11 64917553-64934475 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "eosinophil: 8.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 8.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036607 Approved NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 6: Erythroid cells - Oxygen transport" "HPA036607: AB_10670235" "unprognostic (2.20e-2)" "unprognostic (7.31e-2)" "unprognostic (7.11e-2)" "unprognostic (1.45e-1)" "unprognostic (1.15e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (3.24e-5)" "unprognostic (1.98e-1)" "unprognostic (1.68e-1)" "unprognostic (3.33e-2)" "unprognostic (9.37e-3)" "unprognostic (8.00e-2)" "unprognostic (1.35e-1)" "unprognostic (1.45e-1)" "unprognostic (2.66e-1)" "unprognostic (1.40e-1)" "unprognostic (2.12e-2)" 16.7 14.4 39.0 9.1 43.2 14.6 14.5 42.8 48.2 13.4 13.8 26.2 7.6 16.9 11.3 11.2 14.4 16.5 25.2 42.2 37.0 21.3 13.7 21.8 9.6 45.7 38.8 11.6 18.0 12.4 26.0 10.1 43.3 17.7 8.5 22.7 13.3 14.8 20.1 17.0 16.6 14.4 28.1 24.9 16.8 5.7 41.1 6.9 19.1 12.8 8.4 16.6 14.3 44.6 12.2 5.9 7.7 18.0 15.8 11.6 1.2 13.4 12.2 18.7 15.0 4.4 9.1 3.0 9.2 15.9 20.7 8.1 7.4 11.6 10.5 17.7 5.2 3.5 12.0 2.9 15.1 1.4 15.2 7.4 19.5 20.3 22.8 21.3 15.1 10.3 6.9 7.5 14.1 4.8 2.1 5.5 2.4 3.7 16.9 3.6 2.1 7.0 14.0 5.4 20.0 18.7 8.2 6.0 12.6 6.6 6.8 2.9 15.2 23.9 7.9 25.9 5.1 9.0 7.9 2.4 29.8 2.2 11.1 0.9 0.6 8.9 0.6 1.0 0.5 0.7 0.3 0.6 0.4 0.9 0.3 0.4 0.3 0.7 1.3 0.3 0.8 0.2 39.0 43.2 42.8 48.2 42.2 37.0 45.7 38.8 43.3 28.1 41.1 44.6 17.1 0.0 3.0 17.6 5.9 8.5 6.4 19.2 9.1 35.6 6.4 3.0 3.3 5.7 6.2 1.8 27.1 1.8 7.2 16.4 13.7 9.9 0.9 3.2 4.9 12.4 15.6 44.8 19.3 6.6 4.0 5.7 7.1 6.2 4.5 2.7 15.0 3.3 6.8 28.6 22.5 8.4 10.2 5.5 4.0 1.5 5.9 6.3 7.2 11.2 3.7 15.4 6.2 13.0 20.9 17.0 7.6 8.2 6.1 11.1 6.1 14.4 3.8 19.3 13.1 6.3 8.9 0.7 2.7 3.6 9.7 2.9 5.6 3.9 3.7 18.3 GPHA2 "A2, GPA2, MGC126572, ZSIG51" ENSG00000149735 "Glycoprotein hormone subunit alpha 2" Q96T91 11 64934471-64935893 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "pancreas: 360.5" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 2.5;Exocrine glandular cells: 17.4;Pancreatic endocrine cells: 2.4;Spermatocytes: 7.7;Spermatogonia: 3.2" "Cancer enriched" "Detected in some" 7 "testis cancer: 15.8" "Region enhanced" "Detected in single" "cerebellum: 3.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "Hep G2: 21.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA067068 Approved Vesicles "Secreted to blood" NA NA "Cluster 25: Pancreas - Digestion" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 1: Pancreatic cells - Digestion" Vesicles "HPA067068: " "unprognostic (1.13e-1)" "unprognostic (8.31e-3)" "unprognostic (1.51e-2)" "unprognostic (9.22e-4)" "unprognostic (7.88e-3)" "unprognostic (2.62e-1)" "unprognostic (1.45e-1)" "unprognostic (3.20e-2)" "unprognostic (1.82e-1)" "unprognostic (1.75e-1)" "unprognostic (5.03e-2)" "unprognostic (9.86e-3)" "unprognostic (1.70e-1)" 0.0 0.1 0.3 0.2 0.6 0.1 0.1 3.6 0.6 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.4 16.9 0.0 0.3 0.3 0.8 0.7 0.3 0.6 0.4 0.3 2.7 360.5 0.0 28.0 0.0 0.6 0.7 0.0 0.1 0.3 0.5 0.0 0.5 0.5 0.0 0.2 0.6 1.1 10.8 0.4 0.1 0.3 0.0 0.5 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 21.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 3.6 0.6 0.3 0.3 0.4 0.3 0.6 0.2 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.1 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 17.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.4 0.0 0.5 0.2 0.0 0.0 0.0 0.0 7.7 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 MAJIN C11orf85 ENSG00000168070 "Membrane anchored junction protein" Q3KP22 11 64937517-64972108 "Predicted intracellular proteins" Meiosis DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 22.5" "Group enriched" "Detected in some" 8 "Distal tubular cells: 3.9;Proximal tubular cells: 9.5" "Cancer enhanced" "Detected in some" "cervical cancer: 1.0" "Region enriched" "Detected in single" 4 "cerebellum: 2.6" "Immune cell enhanced" "Detected in single" "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 5 "B-cells: 1.3" "Group enriched" "Detected in some" 10 "CAPAN-2: 7.5;SiHa: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 83: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "unprognostic (3.37e-1)" "unprognostic (6.43e-3)" "unprognostic (3.69e-2)" "unprognostic (7.05e-2)" "unprognostic (9.64e-3)" "unprognostic (2.92e-2)" "unprognostic (4.46e-2)" "unprognostic (1.06e-1)" "unprognostic (9.11e-2)" "unprognostic (4.11e-2)" "unprognostic (1.61e-2)" "unprognostic (2.58e-1)" "unprognostic (1.48e-2)" "unprognostic (2.43e-1)" "unprognostic (2.79e-1)" "unprognostic (4.18e-3)" "unprognostic (1.76e-2)" 0.0 0.2 0.2 0.2 0.6 0.1 0.2 2.6 0.6 0.1 0.0 0.1 0.0 0.0 2.0 0.1 1.1 2.9 0.0 0.1 0.1 1.4 1.2 0.2 1.4 0.5 0.2 0.0 0.3 0.0 0.0 0.1 0.3 0.3 0.2 0.2 0.1 0.6 0.0 1.2 0.4 0.0 0.2 0.6 0.2 22.5 0.1 0.1 0.9 0.0 1.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 2.6 0.6 0.1 0.1 0.5 0.2 0.3 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.3 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 BATF2 MGC20410 ENSG00000168062 "Basic leucine zipper ATF-like transcription factor 2" Q8N1L9 11 64987945-64997018 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 21.2;Intestinal goblet cells: 8.5;Proximal enterocytes: 7.9;Undifferentiated cells: 8.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 2.1;intermediate monocyte: 5.3;neutrophil: 7.3;non-classical monocyte: 2.8" "Group enriched" "Detected in many" 6 "granulocytes: 7.3;monocytes: 5.3" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 13.1;BJ hTERT+ SV40 Large T+ RasG12V: 20.0;GAMG: 19.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA062496 Approved Approved Nucleoli NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoli "HPA062496: AB_2684783" "unprognostic (5.29e-2)" "unprognostic (3.36e-2)" "unprognostic (1.44e-1)" "unprognostic (4.59e-2)" "unprognostic (2.31e-2)" "unprognostic (6.11e-2)" "unprognostic (5.08e-2)" "unprognostic (6.92e-3)" "unprognostic (1.03e-1)" "prognostic favorable (9.39e-5)" "prognostic unfavorable (2.12e-4)" "unprognostic (1.28e-1)" "unprognostic (9.09e-3)" "unprognostic (2.34e-3)" "unprognostic (3.17e-2)" "unprognostic (3.82e-2)" "unprognostic (1.12e-2)" 2.2 4.4 2.7 8.7 2.8 0.5 1.4 2.4 2.9 1.7 2.8 8.6 9.3 1.2 0.7 1.0 2.6 3.9 3.0 2.5 2.6 5.7 4.7 7.0 3.2 4.1 2.7 3.1 9.2 0.9 2.3 2.8 4.0 2.8 6.2 0.5 13.4 4.4 4.9 0.4 6.5 2.7 4.0 13.5 4.5 0.7 3.0 1.6 2.0 2.7 1.2 4.6 1.0 2.6 1.5 1.0 0.2 0.0 0.1 0.8 0.0 0.5 6.5 13.1 20.0 1.9 5.8 0.1 2.7 1.0 19.5 0.1 0.0 1.7 0.9 0.2 0.4 1.8 0.0 5.3 4.8 0.0 1.1 0.4 0.4 1.7 2.2 0.5 3.2 0.1 4.3 0.1 0.3 0.4 0.0 0.1 0.5 0.0 0.6 0.0 1.3 0.6 1.6 0.1 0.1 0.0 0.8 0.3 6.9 0.1 0.5 1.0 2.4 0.7 0.7 1.1 0.0 0.1 0.2 0.4 1.1 0.5 0.6 0.0 2.1 1.0 0.0 5.3 0.0 1.0 0.0 0.0 0.2 0.3 0.0 0.0 7.3 0.1 2.8 0.0 0.0 0.8 2.7 2.8 2.4 2.9 2.5 2.6 4.1 2.7 4.0 4.0 3.0 2.6 3.7 3.2 2.0 1.0 1.3 0.0 0.5 1.8 0.0 0.2 1.2 0.5 0.6 4.3 2.6 1.8 0.0 0.0 0.0 21.2 1.9 4.8 0.8 0.4 1.2 2.7 2.4 0.0 0.2 6.6 0.3 1.8 2.6 0.1 0.0 0.1 5.0 0.9 4.7 0.0 0.1 8.5 0.0 3.5 0.3 2.4 0.0 1.0 0.0 1.0 1.0 0.9 0.0 1.0 0.1 4.9 7.6 0.7 0.0 0.2 7.9 4.1 3.5 0.2 0.0 1.7 1.7 0.1 0.6 0.0 0.0 0.0 0.1 1.1 8.4 2.4 ARL2 ARFL2 ENSG00000213465 "ADP ribosylation factor like GTPase 2" P36404 11 65014160-65022184 "FDA approved drug targets, Predicted intracellular proteins" "Cell cycle" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 430.8;Late spermatids: 1125.1;Proximal tubular cells: 505.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044610 Supported Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Focal adhesion sites,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "Nucleoli, Golgi apparatus, Focal adhesion sites, Cytosol" "HPA044610: AB_10964207" "unprognostic (9.23e-2)" "unprognostic (3.66e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (4.58e-4)" "unprognostic (1.61e-1)" "unprognostic (5.08e-2)" "unprognostic (1.07e-3)" "unprognostic (2.34e-1)" "unprognostic (9.85e-3)" "unprognostic (6.43e-2)" "unprognostic (6.87e-3)" "prognostic favorable (7.70e-4)" "unprognostic (2.15e-2)" "unprognostic (1.85e-1)" "unprognostic (1.60e-1)" "unprognostic (4.39e-1)" "unprognostic (1.24e-2)" 124.8 93.7 161.5 40.6 190.2 51.3 112.0 172.4 200.2 106.3 132.3 123.1 52.7 121.2 28.2 67.2 94.6 48.0 169.1 157.0 168.7 138.5 22.5 90.4 37.7 171.5 167.9 95.7 75.3 65.3 68.5 56.1 167.2 84.7 32.9 43.5 67.9 66.6 214.2 95.8 73.4 60.9 171.4 63.4 85.2 116.1 167.4 33.5 85.7 158.1 29.0 112.2 93.5 184.4 162.0 257.0 76.5 115.8 207.4 156.5 70.5 82.5 181.7 111.2 109.1 72.8 110.0 62.1 144.5 112.7 168.1 101.4 82.9 140.0 53.1 65.5 130.6 61.9 109.2 111.9 157.8 77.9 54.9 123.7 114.6 92.6 204.4 160.5 150.4 74.0 152.8 110.1 76.4 194.1 63.1 174.5 120.3 77.7 208.6 33.4 81.6 152.9 120.9 70.6 143.3 79.3 66.4 67.6 225.8 74.4 72.3 94.3 109.2 205.9 68.6 164.7 82.1 37.9 57.6 38.5 97.2 112.5 171.3 46.5 78.2 72.5 120.4 80.2 130.9 163.1 110.0 116.9 101.7 149.0 123.5 137.2 10.2 83.3 48.2 140.1 79.0 136.9 161.5 190.2 172.4 200.2 157.0 168.7 171.5 167.9 167.2 171.4 167.4 184.4 179.1 22.4 43.6 0.0 42.7 81.4 94.4 118.4 63.7 70.2 66.8 83.9 103.2 51.5 66.4 82.8 29.2 179.7 40.0 110.0 268.0 142.0 430.8 42.2 59.0 148.0 83.3 69.4 0.0 76.0 193.5 107.0 29.6 50.7 95.7 71.5 137.4 19.7 98.3 69.0 0.0 68.4 83.4 49.7 73.5 1125.1 71.7 49.5 177.9 0.0 100.6 208.4 55.6 0.0 0.0 68.3 115.7 71.1 16.5 79.9 162.4 505.5 47.0 48.9 65.7 74.2 109.7 126.5 79.4 56.3 82.8 107.3 40.0 65.7 98.0 75.9 SNX15 ENSG00000110025 "Sorting nexin 15" Q9NRS6 11 65027439-65040572 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Distal enterocytes: 5.6;Enteroendocrine cells: 7.8;granulocytes: 8.2;monocytes: 7.9;Paneth cells: 8.0;Proximal enterocytes: 6.5;Undifferentiated cells: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038955 Approved Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoli, Cytosol" "Vesicles, Plasma membrane" "HPA038955: AB_10672834" "unprognostic (2.00e-2)" "unprognostic (4.90e-2)" "unprognostic (3.93e-1)" "unprognostic (9.61e-4)" "unprognostic (2.79e-1)" "unprognostic (4.06e-3)" "unprognostic (4.45e-3)" "unprognostic (4.74e-2)" "unprognostic (1.09e-1)" "unprognostic (9.55e-2)" "unprognostic (8.93e-3)" "unprognostic (1.79e-2)" "unprognostic (8.84e-2)" "unprognostic (7.86e-2)" "unprognostic (2.93e-2)" "unprognostic (1.88e-1)" "unprognostic (2.68e-4)" 17.1 13.3 17.3 10.2 18.5 10.5 15.3 19.4 19.2 16.6 9.0 22.5 15.3 15.8 6.4 14.9 12.9 7.4 15.0 18.4 17.1 17.0 10.1 11.9 9.3 19.3 18.2 14.8 12.7 10.7 9.4 7.3 16.1 12.9 8.8 5.8 12.3 10.9 25.7 17.5 16.8 8.9 16.1 10.8 16.4 5.3 17.8 9.4 10.6 15.5 7.4 18.0 14.9 18.5 31.1 22.3 14.7 14.2 17.3 12.4 7.9 10.0 13.6 23.3 21.3 17.6 23.7 30.7 16.7 17.4 29.3 16.8 16.8 15.2 9.8 47.0 14.0 15.8 18.2 30.2 18.3 10.7 24.5 10.6 22.2 24.7 14.5 13.0 14.1 22.6 27.0 19.6 12.5 18.8 29.2 36.8 15.5 12.0 21.9 23.7 8.4 34.0 17.6 6.7 25.6 19.2 25.3 23.0 23.2 9.7 23.4 18.6 27.5 23.5 22.9 24.1 14.7 20.9 38.3 30.3 23.2 14.5 8.4 9.2 13.6 13.6 7.6 16.2 6.2 8.9 7.8 6.8 9.4 8.7 5.6 5.1 2.1 4.3 23.6 6.4 8.3 7.3 17.3 18.5 19.4 19.2 18.4 17.1 19.3 18.2 16.1 16.1 17.8 18.5 0.3 0.0 3.3 0.0 0.8 1.0 0.1 0.4 4.0 0.0 0.5 0.3 0.4 0.0 0.2 0.0 0.0 0.4 0.1 5.6 0.0 4.8 0.0 0.1 0.2 0.9 7.8 1.3 0.0 3.1 0.6 0.4 1.1 0.1 8.2 0.4 0.7 0.1 1.0 0.0 0.0 3.3 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 7.9 0.2 0.0 0.0 0.0 3.9 8.0 0.4 1.1 0.0 6.5 0.6 0.7 0.4 0.0 0.7 1.0 0.0 0.0 1.5 0.4 0.4 1.1 0.2 5.6 0.1 SAC3D1 "HSU79266, SHD1" ENSG00000168061 "SAC3 domain containing 1" 11 65040901-65044828 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 94.1;Late spermatids: 121.5;Spermatocytes: 166.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042677 Uncertain Approved Cytosol NA NA "Cluster 24: B-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "HPA042677: AB_10797506" "unprognostic (1.35e-1)" "unprognostic (5.45e-3)" "unprognostic (5.00e-1)" "unprognostic (8.01e-2)" "unprognostic (3.56e-1)" "unprognostic (3.53e-2)" "prognostic unfavorable (9.67e-6)" "unprognostic (4.11e-1)" "unprognostic (1.70e-1)" "unprognostic (4.45e-2)" "unprognostic (4.71e-2)" "unprognostic (3.20e-1)" "prognostic unfavorable (5.66e-5)" "unprognostic (2.97e-3)" "unprognostic (5.71e-1)" "unprognostic (4.53e-2)" "unprognostic (2.49e-1)" 3.8 3.4 9.9 2.7 9.5 4.1 2.0 9.6 10.6 3.1 7.5 3.6 3.1 3.1 0.6 3.6 2.8 0.7 2.6 9.8 9.1 2.1 3.7 2.1 2.8 11.7 9.9 2.5 2.8 1.3 2.7 1.4 10.7 2.8 1.2 0.6 2.7 2.0 9.3 3.7 2.6 2.0 9.4 3.1 2.9 13.5 10.4 7.1 1.4 2.1 2.1 2.6 2.5 10.2 48.3 27.4 13.3 15.1 6.8 5.0 18.9 28.2 6.3 15.9 13.8 13.4 11.3 20.8 22.2 7.7 17.6 32.1 14.4 15.6 2.7 33.0 44.9 15.5 24.5 42.3 5.1 14.5 11.6 3.9 13.4 12.2 5.4 4.4 5.5 20.3 25.7 16.3 6.1 32.6 39.7 75.9 12.1 13.5 61.2 38.0 19.4 31.7 6.8 10.6 29.9 19.6 21.9 22.2 19.4 3.8 20.8 15.3 6.7 13.6 36.9 37.8 20.0 35.6 30.8 22.7 8.0 15.2 4.5 0.0 1.4 0.2 0.6 1.1 0.5 0.9 0.9 0.7 0.7 1.1 1.0 0.6 0.1 0.2 1.5 1.6 0.9 0.4 9.9 9.5 9.6 10.6 9.8 9.1 11.7 9.9 10.7 9.4 10.4 10.2 7.6 3.2 0.5 3.6 7.1 8.7 5.4 2.5 15.9 6.9 19.0 22.7 5.8 11.5 1.5 9.2 0.0 21.9 11.2 26.3 7.9 3.1 94.1 6.4 13.6 6.4 7.2 16.2 4.0 1.6 42.9 10.7 8.2 7.1 5.7 28.0 5.3 17.9 30.4 5.0 4.2 18.5 0.0 15.1 5.5 121.5 17.7 10.4 10.6 1.0 10.5 13.6 13.4 2.5 5.5 2.4 15.2 13.9 11.3 11.2 14.5 14.7 1.3 9.3 0.0 8.1 10.6 166.7 42.2 20.1 7.7 6.7 11.1 22.2 27.6 3.9 NAALADL1 ENSG00000168060 "N-acetylated alpha-linked acidic dipeptidase like 1" Q9UQQ1 11 65044818-65058553 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "intestine: 99.3" "Cell type enriched" "Detected in many" 11 "Proximal enterocytes: 588.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 182.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.8;fHDF/TERT166: 7.8;HHSteC: 20.2;HSkMC: 13.5;SCLC-21H: 10.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA047123 Enhanced Uncertain Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 9: Intestine - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 45: Enterocytes - Digestion" Cytosol "HPA047123: AB_2679942" "unprognostic (2.98e-2)" "unprognostic (2.06e-1)" "unprognostic (1.58e-1)" "unprognostic (8.76e-2)" "unprognostic (1.70e-1)" "unprognostic (1.28e-3)" "unprognostic (1.36e-1)" "unprognostic (1.40e-1)" "unprognostic (1.89e-2)" "unprognostic (1.38e-1)" "unprognostic (3.03e-1)" "unprognostic (2.18e-1)" "unprognostic (1.75e-4)" "unprognostic (2.10e-3)" "unprognostic (3.22e-2)" "unprognostic (1.45e-1)" "unprognostic (4.80e-2)" 13.9 3.2 4.4 6.6 4.1 21.1 12.1 4.7 6.0 23.5 7.0 18.4 19.8 18.8 4.6 7.3 15.2 9.4 10.5 3.9 4.1 7.4 2.6 10.9 10.9 4.7 4.3 16.6 2.3 2.0 6.0 2.3 4.6 13.8 7.1 1.9 4.9 11.5 2.7 5.4 99.3 10.5 4.6 15.3 8.2 8.7 4.4 3.4 5.7 4.1 6.9 12.7 14.5 4.0 0.0 0.0 0.1 0.2 0.5 5.8 1.0 2.3 0.0 2.8 1.3 0.0 0.0 0.1 0.0 7.8 0.0 0.0 0.0 0.2 0.1 0.9 0.4 0.0 0.2 3.5 20.2 0.0 0.0 13.5 0.0 2.7 0.0 0.1 3.6 0.1 0.0 0.3 0.0 0.2 0.2 0.7 0.0 0.1 0.1 0.1 0.0 1.0 0.2 0.0 10.5 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.8 0.0 0.1 0.1 182.0 21.2 35.9 29.6 14.6 15.8 25.7 23.8 14.8 16.3 29.8 27.0 15.0 3.7 80.2 8.8 0.7 45.2 24.6 4.4 4.1 4.7 6.0 3.9 4.1 4.7 4.3 4.6 4.6 4.4 4.0 19.1 0.0 0.0 0.0 8.0 3.6 3.4 5.6 6.2 2.0 0.8 9.1 1.8 1.5 0.4 0.0 0.0 0.2 9.8 31.3 3.9 0.1 0.8 0.4 5.8 11.1 1.2 2.5 0.3 0.8 0.3 11.4 1.1 0.2 19.7 4.3 16.8 0.4 2.8 10.1 0.4 21.0 2.0 5.6 5.7 2.6 11.8 5.2 16.0 1.0 17.3 12.2 41.2 1.0 0.1 0.2 50.0 18.0 1.1 0.5 588.6 0.5 0.5 0.9 0.0 8.3 11.1 1.6 3.5 1.3 3.3 0.4 11.1 3.9 11.8 0.4 CDCA5 ENSG00000146670 "Cell division cycle associated 5" Q96FF9 11 65066300-65084164 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 53.4;lymphoid tissue: 27.6;testis: 37.8" "Cell type enhanced" "Detected in many" "Early spermatids: 56.5;Extravillous trophoblasts: 38.3;Late spermatids: 116.9;Spermatocytes: 50.4;Spermatogonia: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "NK-cell: 2.8;T-reg: 2.0" "Group enriched" "Detected in many" 5 "NK-cells: 2.8;T-cells: 2.0" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "white matter: 1.4" "Low region specificity" "Detected in many" "HPA023691, HPA076007" Enhanced Enhanced Nucleoplasm Yes Yes "Cluster 15: NK-cells - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA023691: AB_1846392, HPA076007: " "unprognostic (3.14e-2)" "unprognostic (4.20e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.15e-1)" "unprognostic (2.68e-1)" "prognostic unfavorable (8.21e-6)" "unprognostic (1.41e-3)" "unprognostic (7.55e-3)" "unprognostic (6.93e-2)" "prognostic unfavorable (8.72e-6)" "unprognostic (2.16e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.55e-3)" "unprognostic (1.86e-1)" "unprognostic (1.35e-1)" "unprognostic (8.97e-2)" 1.4 1.2 1.3 10.5 1.3 53.4 2.0 0.8 1.8 1.9 0.9 6.8 5.8 1.3 0.3 9.3 0.9 0.9 0.9 1.5 0.9 0.9 1.3 1.9 17.0 1.6 1.3 0.6 0.7 0.4 0.5 6.5 1.6 0.8 7.7 0.5 1.4 0.5 0.6 4.2 5.8 3.1 0.8 6.6 3.1 37.8 1.8 27.6 0.6 0.4 16.2 2.2 2.8 1.3 131.7 74.9 67.2 57.3 4.5 7.3 57.8 92.7 37.4 103.6 81.5 77.7 75.4 121.3 52.3 29.4 120.8 87.9 110.3 49.5 98.6 122.0 52.2 107.7 54.4 64.1 0.4 116.8 81.8 2.5 4.5 96.3 44.0 10.8 32.6 138.4 126.6 206.6 63.5 109.2 164.7 116.9 107.8 63.0 92.4 140.4 76.8 111.9 21.2 49.6 89.1 68.4 59.3 80.7 62.8 41.6 104.7 54.7 19.9 92.7 97.2 99.5 101.7 106.9 187.8 195.4 37.2 69.5 97.4 0.0 0.1 0.2 0.4 0.0 0.0 0.3 0.5 0.3 0.4 0.5 0.0 0.3 0.0 2.8 0.3 0.3 2.0 0.7 1.3 1.3 0.8 1.8 1.5 0.9 1.6 1.3 1.6 0.8 1.8 1.3 0.9 0.0 0.5 0.0 4.6 3.8 1.2 1.3 0.6 0.6 2.3 4.4 1.0 0.0 0.8 0.0 2.1 19.7 2.2 4.6 1.9 0.8 56.5 1.1 1.5 2.3 0.0 21.8 1.1 0.8 38.3 3.5 3.1 1.5 3.8 14.5 1.1 0.0 11.7 1.7 0.6 4.7 2.0 2.8 1.5 116.9 2.8 1.7 0.0 1.0 2.1 0.9 2.1 0.0 0.6 0.6 0.1 1.5 16.2 1.1 1.1 0.6 0.4 0.2 0.0 0.5 2.7 50.4 31.1 7.1 1.0 3.7 4.2 1.9 9.4 1.6 ZFPL1 "D11S750, MCG4" ENSG00000162300 "Zinc finger protein like 1" O95159 11 65084210-65088398 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014909, HPA017347" Enhanced Enhanced "Golgi apparatus" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA014909: AB_1859055, HPA017347: AB_1859056" "unprognostic (2.03e-1)" "unprognostic (5.79e-2)" "unprognostic (6.08e-3)" "unprognostic (1.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.12e-6)" "unprognostic (1.19e-2)" "unprognostic (1.07e-1)" "unprognostic (2.16e-1)" "unprognostic (3.63e-1)" "unprognostic (7.34e-2)" "prognostic favorable (2.73e-5)" "unprognostic (1.88e-1)" "unprognostic (1.44e-1)" "unprognostic (4.34e-2)" "unprognostic (6.94e-2)" 30.8 32.5 23.0 11.5 25.7 29.3 29.3 24.9 29.8 29.5 22.6 30.4 17.9 31.4 18.7 30.0 27.8 10.0 30.7 22.4 23.9 27.9 32.6 21.4 11.9 25.1 24.5 29.3 32.0 15.6 40.5 12.8 24.0 31.5 9.1 7.6 30.8 16.8 37.8 35.2 28.1 12.7 23.8 25.4 30.4 27.5 25.2 11.0 27.1 20.4 8.3 31.1 26.5 26.3 60.3 41.1 25.4 26.5 22.3 31.5 40.5 26.0 33.8 31.8 25.2 27.5 40.9 19.5 51.2 39.5 31.0 30.8 15.0 34.4 11.1 27.7 25.0 20.0 29.3 54.3 48.0 14.8 27.0 29.7 45.2 24.0 40.6 20.2 31.2 30.4 24.3 29.4 23.9 83.1 25.6 35.8 17.2 19.9 35.7 23.3 14.5 53.7 25.0 27.9 27.6 22.3 21.5 41.8 63.5 12.1 61.7 25.4 30.1 21.2 35.0 47.2 21.4 19.4 21.0 24.0 33.2 14.6 41.2 77.1 19.7 42.2 15.1 21.4 16.3 18.0 14.0 15.9 20.0 20.1 15.3 13.8 27.3 23.8 21.2 19.6 26.1 12.0 23.0 25.7 24.9 29.8 22.4 23.9 25.1 24.5 24.0 23.8 25.2 26.3 22.6 12.8 18.4 6.8 16.1 11.0 29.6 45.0 19.4 20.4 27.4 27.1 4.4 21.5 35.3 12.9 4.2 49.9 19.0 49.6 58.7 39.4 18.6 24.1 17.9 17.9 22.8 14.5 6.4 47.9 47.1 19.4 25.0 29.6 9.5 30.0 16.4 20.7 32.1 23.5 6.1 40.1 32.6 15.7 11.9 47.0 20.5 12.8 17.8 3.7 25.0 39.2 18.6 5.0 23.7 44.0 44.4 20.3 29.5 29.8 55.0 32.6 25.8 19.5 19.7 17.5 27.5 35.7 18.3 24.4 12.5 68.3 13.6 17.0 37.5 36.1 TMEM262 ENSG00000187066 "Transmembrane protein 262" E9PQX1 11 65084979-65089375 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "testis: 21.1" "Cell type enriched" "Detected in some" 11 "Early spermatids: 179.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 74: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (4.36e-2)" "unprognostic (2.77e-1)" "unprognostic (1.78e-3)" "unprognostic (1.62e-1)" "unprognostic (1.61e-1)" "unprognostic (1.71e-4)" "unprognostic (1.85e-5)" "unprognostic (3.28e-1)" "unprognostic (2.87e-1)" "unprognostic (1.12e-1)" "unprognostic (3.19e-3)" "unprognostic (7.18e-3)" "unprognostic (7.13e-9)" "unprognostic (9.53e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (1.84e-3)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.0 0.3 0.2 0.0 1.4 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 179.5 0.3 0.2 0.2 0.0 0.4 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 16.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.1 0.0 0.1 0.1 0.1 0.5 0.0 0.4 0.2 1.1 1.2 0.5 0.3 0.4 0.5 0.1 0.1 0.1 VPS51 "ANG2, ANG3, C11orf2, C11orf3, FFR" ENSG00000149823 "VPS51 subunit of GARP complex" Q9UID3 11 65089324-65111862 "Disease related genes, Predicted intracellular proteins" "Lipid transport, Protein transport, Transport" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039650, HPA061447" Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 50: Non-specific - Ribosome" "Cluster 25: RPMI-8226 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus, Vesicles" Nucleoli "HPA039650: AB_10673147, HPA061447: AB_2684521" "unprognostic (2.36e-2)" "unprognostic (7.58e-2)" "unprognostic (8.35e-2)" "unprognostic (1.56e-1)" "unprognostic (2.11e-2)" "unprognostic (1.64e-1)" "unprognostic (9.72e-2)" "unprognostic (1.52e-1)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (2.03e-3)" "unprognostic (1.56e-1)" "prognostic favorable (2.41e-9)" "unprognostic (7.77e-3)" "unprognostic (4.63e-2)" "unprognostic (2.85e-1)" "unprognostic (2.18e-1)" 48.5 37.8 19.0 34.9 23.1 60.9 46.6 22.0 30.7 45.6 20.4 55.4 52.9 54.4 7.3 42.5 46.1 20.3 45.3 22.5 15.5 33.7 36.2 34.2 48.6 18.5 18.6 83.8 120.3 37.4 28.6 22.2 20.2 38.1 25.1 20.3 65.5 27.7 84.2 71.2 49.7 22.7 14.3 40.9 70.3 28.4 17.2 46.7 39.7 42.9 32.5 45.2 38.1 21.5 71.8 74.5 35.7 44.4 15.5 38.5 72.1 27.5 53.2 52.6 38.8 55.2 88.7 118.0 76.1 51.4 27.3 60.0 37.9 59.3 19.2 69.6 62.1 72.5 72.6 55.1 51.3 77.1 65.0 66.8 39.9 39.0 32.1 41.6 58.4 55.0 73.6 82.9 21.7 95.1 105.8 83.0 59.8 30.7 61.5 67.5 17.5 150.7 36.2 76.2 61.5 87.8 20.7 110.9 71.8 21.0 93.7 39.1 48.1 35.2 32.0 45.4 39.7 115.7 92.2 68.9 39.9 28.0 26.3 10.6 15.0 15.4 17.9 15.8 21.2 22.4 25.2 27.1 22.1 21.2 23.3 20.7 8.0 30.6 16.0 19.1 17.7 18.3 19.0 23.1 22.0 30.7 22.5 15.5 18.5 18.6 20.2 14.3 17.2 21.5 49.8 19.2 47.7 18.9 77.3 49.1 66.3 46.0 58.6 64.7 76.5 67.8 5.8 44.3 27.8 31.3 29.2 78.4 73.7 156.5 62.6 49.2 77.5 25.6 35.0 46.5 95.8 50.5 21.8 120.5 79.4 38.8 45.9 34.4 37.5 47.3 55.3 52.5 45.5 67.3 24.1 110.0 32.6 54.0 30.6 222.4 53.4 36.1 49.8 15.9 71.3 65.9 89.6 21.6 28.0 51.2 144.4 54.5 66.4 45.1 158.7 75.9 16.1 52.5 26.3 49.3 44.4 40.3 31.4 52.3 54.8 115.3 64.0 61.5 170.5 51.0 TM7SF2 "ANG1, DHCR14A, NET47" ENSG00000149809 "Transmembrane 7 superfamily member 2" O76062 11 65111845-65116384 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 246.0" "Cell type enhanced" "Detected in all" "Granulosa cells: 482.7;Hepatocytes: 220.6;Muller glia cells: 204.7;Theca cells: 204.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 38.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 69.2;RPTEC TERT1: 86.2;T-47d: 143.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030691, HPA072704" Enhanced Supported "Endoplasmic reticulum,Vesicles" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 40: Granulosa cells - Unknown function" "Endoplasmic reticulum" Vesicles "HPA030691: AB_10602480, HPA072704: AB_2686551" "unprognostic (1.62e-1)" "unprognostic (5.23e-2)" "unprognostic (1.70e-2)" "unprognostic (1.78e-1)" "unprognostic (5.74e-2)" "unprognostic (1.10e-1)" "unprognostic (5.98e-2)" "unprognostic (6.06e-2)" "unprognostic (5.72e-2)" "unprognostic (1.74e-2)" "unprognostic (7.06e-2)" "unprognostic (1.69e-1)" "prognostic favorable (8.49e-8)" "unprognostic (8.77e-2)" "unprognostic (1.90e-1)" "unprognostic (1.35e-1)" "unprognostic (3.44e-2)" 63.4 246.0 27.8 2.6 28.5 4.1 29.1 32.8 33.9 17.4 64.1 7.8 9.4 3.4 17.0 39.6 12.8 7.0 47.3 30.0 29.7 18.9 86.4 10.1 3.4 34.0 32.0 36.5 69.9 36.3 19.5 3.9 32.5 41.1 3.9 6.0 46.9 6.0 7.1 68.2 8.3 1.9 30.1 5.1 35.6 11.5 32.6 5.6 15.5 3.7 8.4 5.5 22.1 35.1 7.7 10.9 27.3 35.1 8.1 1.3 15.4 1.8 4.5 2.7 3.0 26.0 35.8 16.3 26.9 2.2 1.0 13.3 11.6 21.2 1.9 16.7 5.0 10.2 2.7 54.5 18.8 4.2 10.6 3.7 5.0 14.6 3.9 12.6 3.9 28.7 5.8 13.9 0.8 69.2 8.3 18.6 12.6 18.4 11.2 22.4 1.2 39.9 86.2 12.6 27.2 30.5 1.2 28.2 6.1 19.5 143.9 11.4 3.1 0.4 3.4 3.8 2.3 27.1 18.1 8.4 2.5 5.9 1.0 1.1 1.6 3.4 9.1 1.5 7.0 12.4 5.6 7.8 1.5 11.9 11.8 9.0 1.1 12.5 0.9 38.1 5.6 4.9 27.8 28.5 32.8 33.9 30.0 29.7 34.0 32.0 32.5 30.1 32.6 35.1 4.0 9.6 43.7 23.5 12.7 1.9 6.2 33.6 5.7 19.2 52.2 38.5 99.4 52.9 36.6 44.1 10.4 72.9 16.3 23.3 17.6 27.1 28.8 17.9 2.6 5.7 59.4 13.7 11.6 27.7 4.6 4.3 31.1 16.5 7.0 482.7 5.0 220.6 15.6 25.2 15.3 21.8 52.9 6.3 2.7 59.3 9.9 5.8 12.4 2.8 9.4 204.7 7.2 17.1 36.5 21.7 23.7 2.2 12.9 31.3 29.0 77.5 37.9 23.6 13.1 1.6 21.8 13.3 17.9 18.0 7.0 82.1 8.3 204.8 19.0 10.4 ZNHIT2 "C11orf5, FON" ENSG00000174276 "Zinc finger HIT-type containing 2" Q9UHR6 11 65116403-65117701 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 67.5" "Group enriched" "Detected in many" 8 "Early spermatids: 356.7;Late spermatids: 720.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058066 Uncertain NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" "HPA058066: AB_2683593" "unprognostic (1.73e-2)" "unprognostic (2.93e-1)" "unprognostic (3.11e-1)" "unprognostic (7.74e-3)" "unprognostic (3.07e-1)" "unprognostic (3.26e-2)" "unprognostic (4.55e-3)" "unprognostic (1.68e-1)" "unprognostic (1.08e-1)" "unprognostic (1.61e-2)" "unprognostic (2.13e-2)" "unprognostic (1.41e-1)" "unprognostic (2.16e-3)" "unprognostic (3.53e-3)" "unprognostic (2.00e-1)" "unprognostic (3.64e-1)" "unprognostic (7.53e-2)" 8.1 25.3 4.5 2.1 4.7 3.4 9.1 5.0 6.3 8.0 10.2 8.5 3.3 10.3 0.9 10.6 12.9 0.8 9.6 4.9 4.8 10.5 15.7 6.6 2.0 5.6 5.4 8.1 14.6 2.3 16.3 1.2 4.9 10.5 0.5 0.8 9.3 2.4 14.2 12.8 7.7 0.8 4.9 9.5 10.4 67.5 4.6 1.4 11.2 1.1 1.0 8.2 6.5 5.3 17.4 13.0 1.9 5.5 1.5 2.6 13.1 6.6 2.6 4.5 2.8 6.2 8.9 5.5 13.4 1.4 4.4 18.4 0.9 5.0 0.5 12.4 17.7 5.5 10.5 5.4 4.6 12.4 8.9 3.1 6.7 3.0 2.5 2.0 2.8 5.1 14.5 4.8 2.0 18.1 10.2 19.5 14.9 3.9 25.4 8.4 2.5 35.7 3.3 4.5 16.2 15.5 6.7 11.0 18.6 0.6 17.0 10.6 6.3 5.1 6.8 10.1 7.1 20.9 15.5 3.5 8.3 4.2 5.9 11.7 20.5 11.5 25.1 15.2 25.1 19.0 19.6 23.5 18.7 27.3 20.6 23.1 3.4 16.8 10.1 26.3 11.3 17.4 4.5 4.7 5.0 6.3 4.9 4.8 5.6 5.4 4.9 4.9 4.6 5.3 4.2 16.0 9.3 0.7 9.5 11.1 14.6 16.0 6.8 13.6 11.4 11.4 3.0 10.0 13.0 12.9 6.2 12.5 11.6 13.9 31.3 22.4 356.7 36.0 5.6 6.1 13.8 6.9 1.2 18.9 9.8 7.3 9.7 7.6 2.5 2.7 7.5 17.1 10.6 11.8 1.3 11.0 20.3 5.7 5.2 720.1 14.9 5.5 7.2 1.9 10.7 13.5 23.7 1.5 1.5 17.7 15.9 12.0 11.0 12.5 13.6 40.5 41.7 15.8 19.7 6.3 12.1 61.2 26.0 8.1 8.7 11.4 9.0 14.4 14.8 11.1 FAU "asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30" ENSG00000149806 "FAU ubiquitin like and ribosomal protein S30 fusion" "P35544, P62861" 11 65120630-65122177 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059015 Supported Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" No No "Cluster 30: Non-specific - Translation" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA059015: AB_2683881" "unprognostic (1.81e-3)" "unprognostic (3.47e-2)" "unprognostic (2.89e-1)" "unprognostic (2.91e-1)" "unprognostic (5.73e-2)" "unprognostic (1.63e-3)" "unprognostic (1.97e-1)" "unprognostic (5.40e-2)" "unprognostic (1.26e-1)" "unprognostic (7.06e-3)" "unprognostic (7.77e-2)" "unprognostic (1.14e-1)" "unprognostic (1.61e-2)" "unprognostic (1.13e-1)" "unprognostic (2.11e-1)" "unprognostic (1.13e-3)" "unprognostic (1.45e-2)" 817.0 787.0 976.0 655.4 1009.0 1898.7 878.5 956.5 1212.5 1024.2 887.1 905.9 604.0 780.6 535.3 720.0 907.5 590.1 862.2 928.0 953.5 632.1 756.3 614.0 1342.5 982.1 958.7 1403.7 1167.7 395.0 521.6 482.7 989.8 649.3 438.8 228.2 854.7 532.3 1191.2 905.1 712.9 441.6 1010.2 784.5 796.3 336.6 1011.9 843.5 619.9 642.1 818.5 796.7 794.0 1017.9 1305.1 1040.6 658.8 1067.9 766.4 1142.2 1033.3 727.3 887.7 1327.5 832.4 1258.7 1232.1 1782.0 1782.3 744.2 701.5 1101.2 821.5 1287.2 419.3 1075.4 1494.0 1428.1 907.1 1607.8 1612.2 1546.9 1184.9 1583.3 1944.0 1106.3 1286.5 842.2 998.5 1416.3 1334.4 1578.6 644.9 2003.0 1579.6 2925.2 1850.4 1007.2 2027.5 1464.8 622.2 2980.1 1036.0 744.3 1054.4 949.2 663.8 1490.6 2131.0 399.1 1393.3 1829.5 771.2 868.6 954.8 1327.5 1150.0 1629.0 1943.6 2802.6 1042.6 1285.4 979.3 2638.2 2997.4 1808.3 2906.6 2694.0 3986.3 7025.5 4689.8 3729.6 3181.0 6502.9 5484.9 4364.5 1905.5 2994.7 2398.9 4141.8 3794.9 10270.4 976.0 1009.0 956.5 1212.5 928.0 953.5 982.1 958.7 989.8 1010.2 1011.9 1017.9 2252.8 641.0 1035.7 17.6 3768.6 3773.3 3059.7 1883.6 2632.2 351.8 3483.5 5942.5 507.2 1712.8 1280.4 958.2 196.0 2277.7 2670.7 1454.5 2050.4 1540.6 875.1 954.7 1569.4 1671.7 1226.4 1786.0 15.9 2689.2 2487.3 1531.1 923.5 1298.4 1370.0 1483.3 1755.9 2176.7 2188.0 190.1 18.2 2143.3 907.3 2643.8 3977.8 2397.4 2285.9 2349.4 2123.8 16.9 3121.9 935.5 2472.7 15.6 40.8 2042.7 2666.5 1229.2 2317.3 3295.5 2501.4 2615.9 826.4 513.6 1117.5 2227.4 2678.6 654.4 590.6 2506.0 4195.9 2793.0 2897.4 1470.6 2184.8 3518.0 SYVN1 "DER3, HRD1" ENSG00000162298 "Synoviolin 1" Q86TM6 11 65121780-65134532 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Stress response, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 72.9;Plasma cells: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 205.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005480, HPA024300, CAB037030" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum,Plasma membrane" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" Nucleoplasm "Endoplasmic reticulum, Plasma membrane" "CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073" "unprognostic (1.12e-1)" "unprognostic (3.10e-1)" "unprognostic (1.22e-1)" "unprognostic (2.17e-2)" "unprognostic (2.85e-2)" "prognostic favorable (6.88e-4)" "unprognostic (7.67e-2)" "unprognostic (2.50e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.77e-2)" "unprognostic (1.56e-2)" "unprognostic (4.89e-1)" "unprognostic (3.85e-2)" "unprognostic (1.16e-1)" 29.2 40.3 19.3 37.1 25.6 31.0 27.6 23.2 21.4 30.7 26.7 29.2 26.1 29.1 38.8 28.4 30.6 19.7 25.3 18.6 21.2 24.5 117.5 27.0 60.9 27.9 25.6 30.9 90.9 35.0 38.2 26.2 24.6 28.5 29.0 18.7 55.9 30.3 34.2 29.3 39.4 25.9 22.8 51.2 39.4 24.3 23.4 18.3 43.4 19.0 81.1 25.8 24.8 25.9 32.4 40.6 24.0 32.5 59.8 33.8 23.8 32.8 33.5 40.9 28.8 22.2 55.0 181.0 43.8 42.4 53.8 48.8 26.4 33.3 33.6 28.4 20.0 28.6 46.8 50.2 72.3 43.3 49.6 43.3 59.0 36.1 81.0 36.4 27.0 19.0 36.4 90.1 24.3 47.9 19.1 31.2 26.1 33.6 28.0 31.9 20.3 74.0 25.7 31.5 15.6 32.0 30.4 74.1 53.3 21.0 55.4 28.2 25.9 28.3 18.6 51.2 22.4 178.1 134.2 205.9 38.1 21.8 32.3 16.8 7.4 14.0 7.4 4.7 6.5 21.9 5.2 6.9 4.4 22.6 3.7 3.9 7.0 3.5 4.7 18.4 5.3 6.6 19.3 25.6 23.2 21.4 18.6 21.2 27.9 25.6 24.6 22.8 23.4 25.9 11.5 16.0 21.4 11.1 43.5 17.6 6.9 13.8 12.0 10.7 21.0 15.5 4.0 22.8 20.8 11.0 33.3 14.5 16.4 23.1 1.9 13.6 6.6 14.2 16.2 11.3 8.4 13.2 9.6 18.9 16.5 14.2 17.9 22.1 1.3 10.1 15.0 72.9 15.1 13.5 9.5 33.6 16.2 15.3 13.2 4.1 20.5 10.8 12.4 9.4 10.5 11.0 13.4 13.0 15.8 18.2 11.7 13.2 90.5 14.9 14.0 7.7 15.1 18.7 13.1 11.9 10.7 19.3 13.2 9.7 16.1 42.8 11.7 13.6 18.6 13.8 MRPL49 "C11orf4, L49mt, NOF, NOF1" ENSG00000149792 "Mitochondrial ribosomal protein L49" Q13405 11 65122183-65127371 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 93.9;Syncytiotrophoblasts: 111.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046778 Approved NA NA "Cluster 44: Non-specific - Transcription" "Cluster 1: Thyroid gland - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "HPA046778: AB_2679802" "prognostic unfavorable (3.79e-4)" "unprognostic (2.21e-1)" "unprognostic (6.07e-3)" "unprognostic (1.05e-1)" "unprognostic (2.50e-1)" "unprognostic (9.32e-2)" "unprognostic (1.56e-2)" "unprognostic (2.74e-1)" "unprognostic (5.36e-2)" "unprognostic (1.44e-2)" "unprognostic (1.30e-3)" "unprognostic (2.53e-1)" "prognostic favorable (4.22e-15)" "unprognostic (9.09e-3)" "unprognostic (1.12e-2)" "unprognostic (6.68e-2)" "unprognostic (7.45e-3)" 23.1 87.3 25.5 21.9 26.5 26.7 35.2 24.1 27.5 29.4 29.5 33.6 28.1 28.3 41.8 43.0 42.1 21.3 32.4 26.6 29.2 55.1 50.9 28.1 30.9 26.3 25.7 42.8 26.9 42.8 36.0 27.0 26.2 35.4 34.8 16.9 29.2 39.4 38.0 41.6 28.3 30.0 25.3 26.0 29.1 18.1 29.0 33.9 45.8 36.4 44.1 31.1 28.5 23.6 68.7 64.0 48.0 44.0 39.7 26.4 47.9 49.4 73.8 98.9 70.2 77.4 95.2 68.7 70.9 56.2 93.6 69.3 97.7 71.1 78.9 57.5 33.5 64.0 43.3 62.0 63.7 65.8 54.6 43.3 61.7 81.6 119.7 54.6 61.2 82.4 82.7 40.1 59.2 99.4 82.3 70.9 79.8 77.9 87.5 71.2 46.0 91.0 81.5 51.9 69.3 48.9 76.7 98.2 89.3 38.1 174.4 51.1 31.2 41.7 62.5 61.6 46.5 75.5 110.0 141.4 57.2 44.7 72.7 133.5 39.3 78.4 68.2 39.5 77.8 77.9 73.6 83.8 52.1 74.8 81.2 69.3 32.7 95.8 56.8 50.2 74.8 96.2 25.5 26.5 24.1 27.5 26.6 29.2 26.3 25.7 26.2 25.3 29.0 23.6 19.8 16.0 15.9 2.3 20.6 11.1 22.8 21.1 13.1 15.3 22.7 21.6 16.6 20.0 16.6 12.9 10.4 60.4 21.6 23.1 93.9 31.6 1.0 17.4 11.2 16.0 22.7 44.8 5.3 20.3 51.1 14.9 10.2 16.2 12.6 21.6 12.8 17.9 21.5 11.8 4.8 23.5 18.3 6.5 9.9 3.4 14.6 12.4 23.2 1.9 35.4 31.1 13.4 0.5 4.3 28.2 16.6 24.5 24.3 20.8 22.3 49.2 28.6 17.9 6.6 10.4 24.6 5.9 15.6 12.8 16.1 111.0 24.6 77.9 22.9 21.4 SPDYC Ringo2 ENSG00000204710 "Speedy/RINGO cell cycle regulator family member C" Q5MJ68 11 65170154-65173244 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "liver: 3.0;testis: 1.0" "Cell type enhanced" "Detected in some" "Early spermatids: 2.3;Extravillous trophoblasts: 4.6;Hepatocytes: 3.0;Late spermatids: 9.8;Macrophages: 1.8;Spermatogonia: 3.3;Syncytiotrophoblasts: 1.9" "Cancer enhanced" "Detected in many" "breast cancer: 6.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.2;HEL: 7.1;Hep G2: 3.1;K-562: 17.2" "Not detected" "Not detected" HPA039891 Uncertain NA NA "Cluster 85: Liver - Metabolism" "Cluster 1: K-562 - Erythropoiesis" "Cluster 51: Myeloid cells - Hemostasis" "HPA039891: AB_10795260" "prognostic unfavorable (1.20e-5)" "unprognostic (7.35e-2)" "unprognostic (4.42e-2)" "unprognostic (4.45e-2)" "unprognostic (1.73e-1)" "unprognostic (1.93e-2)" "unprognostic (1.31e-3)" "unprognostic (5.08e-2)" "unprognostic (1.85e-2)" "unprognostic (1.97e-1)" "unprognostic (1.15e-1)" "unprognostic (4.75e-2)" "unprognostic (7.97e-2)" "unprognostic (2.53e-1)" "unprognostic (6.60e-4)" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.0 3.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 7.1 0.0 3.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 17.2 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 9.8 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.3 0.0 0.0 1.9 0.0 0.0 0.1 0.0 CAPN1 "CANP, CANPL1, muCANP, muCL" ENSG00000014216 "Calpain 1" P07384 11 65180566-65212006 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 276.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 516.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005992 Enhanced Supported Cytosol NA NA 9100000 "Cluster 46: Basophils - DNA binding" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 15: RT4 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "HPA005992: AB_1845924" "unprognostic (2.07e-1)" "unprognostic (2.15e-1)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (4.06e-2)" "unprognostic (1.10e-1)" "unprognostic (1.91e-2)" "unprognostic (2.48e-2)" "unprognostic (7.23e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (4.30e-4)" "unprognostic (3.33e-1)" "prognostic favorable (7.06e-8)" "unprognostic (5.70e-3)" "unprognostic (1.51e-1)" "unprognostic (1.86e-1)" "unprognostic (2.98e-1)" 44.8 43.1 27.8 51.9 26.1 66.5 48.4 29.7 30.1 80.9 28.3 78.6 80.4 56.3 27.5 276.2 92.3 55.5 53.1 27.7 33.0 53.1 44.3 56.9 57.0 41.4 31.5 44.5 71.7 36.6 40.8 56.2 43.4 62.1 57.6 9.6 118.7 67.4 84.8 125.1 88.1 45.3 33.9 50.2 65.5 6.1 37.9 49.5 71.5 55.3 86.4 83.4 117.4 27.4 285.6 147.9 42.9 97.2 77.9 104.3 127.0 84.1 144.2 103.0 74.9 94.8 250.2 71.2 136.0 179.3 111.1 409.8 60.9 366.9 32.2 76.4 44.1 170.8 80.4 93.7 76.2 40.6 228.0 107.3 196.8 85.9 43.2 92.6 178.5 50.6 103.1 55.9 87.4 181.8 83.1 130.6 120.5 145.2 133.8 80.7 43.0 43.2 138.1 516.5 76.2 55.7 87.4 331.4 80.3 45.8 142.8 77.9 147.1 73.1 50.5 159.0 38.5 33.8 26.9 86.6 127.5 48.8 82.3 87.6 57.5 77.9 39.4 51.2 31.0 30.8 30.7 35.8 48.4 31.7 17.6 24.9 33.1 34.8 30.4 38.1 35.9 74.8 27.8 26.1 29.7 30.1 27.7 33.0 41.4 31.5 43.4 33.9 37.9 27.4 27.3 25.6 27.9 21.5 39.6 59.9 127.3 120.5 56.9 10.7 44.7 36.6 22.0 74.4 81.0 77.3 20.9 238.5 61.4 184.2 39.2 180.5 0.5 41.9 26.3 31.3 44.3 58.3 15.9 115.8 111.7 39.6 57.6 58.2 46.9 48.6 37.9 36.7 88.7 21.9 15.2 76.9 59.0 51.2 34.0 2.0 43.5 67.1 48.0 14.0 112.7 38.5 61.8 6.6 1.9 179.4 124.1 50.8 17.7 78.6 155.6 34.6 71.1 16.2 39.5 25.3 36.7 0.5 2.8 102.0 68.9 196.6 40.2 35.4 125.3 156.6 POLA2 FLJ21662 ENSG00000014138 "DNA polymerase alpha 2, accessory subunit" Q14181 11 65261920-65305589 "Metabolic proteins, Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 23.2;Spermatocytes: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA037570 Supported Supported Nucleoplasm,Cytosol NA Yes "Cluster 44: Non-specific - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Cytosol "HPA037570: AB_10672280" "unprognostic (2.28e-1)" "prognostic favorable (4.61e-4)" "unprognostic (1.67e-2)" "unprognostic (7.44e-2)" "unprognostic (5.20e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (2.11e-6)" "unprognostic (1.14e-1)" "unprognostic (2.87e-2)" "unprognostic (1.15e-2)" "unprognostic (4.05e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (4.09e-8)" "unprognostic (1.60e-3)" "unprognostic (8.26e-2)" "unprognostic (8.16e-2)" "unprognostic (6.25e-3)" 3.3 2.6 1.9 5.3 2.9 6.9 3.5 4.8 3.3 4.5 1.7 5.3 3.6 5.0 3.3 4.5 3.8 1.8 2.9 1.9 1.5 3.5 3.7 3.5 10.0 4.5 2.8 5.1 3.3 3.2 1.9 2.1 3.7 3.0 4.9 3.6 4.2 3.1 3.1 5.1 4.2 4.1 3.1 5.7 3.8 5.2 2.6 15.9 3.3 3.4 13.2 3.2 3.2 7.0 32.6 21.9 47.3 20.4 3.7 3.6 19.5 25.6 15.9 64.4 43.3 6.9 24.0 48.1 20.4 11.0 35.5 18.9 38.8 25.1 61.1 21.3 14.7 32.4 39.4 10.4 0.9 33.5 25.6 3.7 2.9 47.4 8.5 10.3 14.6 20.2 30.2 25.3 44.4 34.9 62.6 13.2 38.6 16.1 16.2 33.4 29.9 40.7 14.1 21.8 32.5 18.1 14.9 15.9 7.9 29.7 28.6 14.1 3.9 25.4 18.7 19.8 16.0 12.0 14.7 45.0 14.9 18.8 33.7 10.0 5.2 2.3 3.8 3.2 4.5 3.9 4.2 4.2 7.4 3.9 3.5 3.1 1.4 3.8 1.7 5.9 4.6 5.3 1.9 2.9 4.8 3.3 1.9 1.5 4.5 2.8 3.7 3.1 2.6 7.0 2.6 0.0 3.4 1.0 5.1 1.7 4.2 5.7 2.2 2.2 3.0 2.3 2.9 7.2 3.7 5.5 2.1 15.6 4.3 3.0 3.9 5.3 2.7 1.8 2.9 3.7 3.0 23.2 4.3 3.4 19.0 7.7 5.6 2.5 0.0 11.0 5.3 2.1 9.7 3.3 3.6 3.5 2.0 2.8 3.7 4.0 7.5 5.3 0.0 12.2 8.0 2.2 5.2 1.5 8.7 4.9 2.2 7.5 10.4 3.4 1.7 2.0 3.2 5.4 6.6 19.6 5.0 23.7 17.7 4.3 1.4 7.3 5.5 4.0 6.3 3.7 CDC42EP2 "BORG1, CEP2" ENSG00000149798 "CDC42 effector protein 2" O14613 11 65314866-65322417 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 50.5;Langerhans cells: 77.7;Pancreatic endocrine cells: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 11 "classical monocyte: 50.4;intermediate monocyte: 118.8;neutrophil: 171.5;non-classical monocyte: 88.5" "Group enriched" "Detected in many" 15 "granulocytes: 171.5;monocytes: 118.8" "Cell line enhanced" "Detected in many" "HHSteC: 51.5;PC-3: 61.0;U-2197: 55.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038562 Approved Supported Microtubules,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 41: Macrophages - Immune response" "Microtubules, Cytosol" "HPA038562: AB_10671745" "unprognostic (1.69e-1)" "unprognostic (2.40e-2)" "unprognostic (9.91e-2)" "unprognostic (1.78e-1)" "unprognostic (1.24e-2)" "unprognostic (4.73e-3)" "prognostic unfavorable (2.89e-5)" "prognostic unfavorable (6.66e-4)" "unprognostic (1.01e-1)" "unprognostic (5.36e-2)" "unprognostic (8.57e-3)" "unprognostic (3.81e-1)" "unprognostic (1.68e-1)" "unprognostic (2.66e-2)" "unprognostic (3.67e-2)" "unprognostic (2.89e-2)" "unprognostic (1.89e-2)" 42.1 5.7 15.4 7.7 25.1 0.4 23.1 20.7 20.0 13.9 5.8 15.4 9.1 16.6 1.7 7.7 15.3 15.2 22.4 15.7 17.0 15.3 4.1 19.1 1.8 24.9 23.6 10.8 5.8 0.6 5.0 11.6 22.3 10.2 1.6 1.9 4.9 4.5 6.6 5.6 13.0 6.8 17.5 18.4 14.5 2.1 21.4 0.4 16.8 5.6 1.2 18.6 9.4 44.3 7.1 6.6 0.9 4.3 14.6 26.4 1.3 7.4 28.8 5.5 6.2 19.8 16.7 0.5 20.9 19.9 2.0 8.9 2.5 26.0 1.2 1.0 3.8 1.3 12.8 14.8 51.5 0.4 0.5 11.5 2.7 20.3 28.8 4.5 22.4 1.0 2.6 4.3 7.1 10.7 0.8 1.6 3.7 18.5 61.0 0.8 0.7 0.5 19.5 4.9 0.5 1.7 18.0 14.7 1.1 0.7 2.5 0.4 30.6 6.7 5.6 55.9 3.1 0.1 1.7 0.6 11.2 0.3 2.7 0.0 50.4 2.1 0.1 118.8 0.1 1.2 0.0 0.1 9.9 0.0 0.1 0.0 171.5 0.0 88.5 0.4 0.0 17.8 15.4 25.1 20.7 20.0 15.7 17.0 24.9 23.6 22.3 17.5 21.4 44.3 25.8 0.0 0.0 0.0 1.5 12.7 11.0 25.8 6.8 15.3 12.1 6.3 6.3 2.8 17.0 12.9 0.0 0.5 1.6 10.0 3.9 50.5 0.5 6.0 11.6 36.4 1.8 2.7 0.6 40.3 3.5 32.3 9.7 11.1 5.7 1.5 26.7 0.9 1.3 3.3 0.4 8.0 8.2 18.7 77.7 1.9 18.6 33.3 12.4 1.0 18.3 1.0 0.0 0.0 10.6 65.1 15.6 13.5 1.8 7.4 21.2 3.7 6.3 5.3 39.5 16.6 16.2 1.7 3.4 4.8 10.1 1.6 1.4 1.8 8.4 36.4 DPF2 "BAF45d, REQ, ubi-d4" ENSG00000133884 "Double PHD fingers 2" Q92785 11 65333852-65354262 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Chromatin regulator" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020880, HPA056786" Approved Supported Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "HPA020880: AB_1847845, HPA056786: AB_2683235" "unprognostic (2.06e-1)" "unprognostic (2.13e-1)" "unprognostic (3.45e-2)" "unprognostic (2.90e-3)" "unprognostic (1.40e-2)" "unprognostic (9.66e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (2.04e-1)" "unprognostic (3.29e-2)" "unprognostic (3.07e-1)" "unprognostic (2.43e-1)" "unprognostic (1.33e-1)" "unprognostic (6.93e-2)" "unprognostic (3.04e-2)" "unprognostic (3.24e-1)" "unprognostic (1.26e-2)" "unprognostic (1.34e-1)" 21.2 21.0 41.3 14.2 45.1 24.7 21.6 43.6 43.3 35.0 35.2 36.1 13.1 37.6 22.8 23.1 31.3 14.7 34.2 39.5 42.2 20.8 16.8 19.5 22.3 43.1 43.7 40.9 20.5 19.7 20.1 17.6 42.8 28.6 13.8 17.6 21.1 25.8 38.6 19.3 24.3 27.8 43.7 29.7 24.2 37.7 43.0 37.6 22.5 29.2 24.5 34.2 24.1 48.7 29.9 36.4 45.9 40.5 39.7 39.8 25.5 25.0 35.1 53.5 38.6 36.0 34.8 39.5 40.8 34.0 46.6 31.2 52.2 31.9 37.7 47.6 23.1 50.4 24.6 37.7 61.1 47.0 36.5 35.0 30.4 48.4 86.6 40.1 43.3 47.0 48.7 51.0 35.2 47.3 60.0 49.3 51.6 31.9 37.4 65.1 29.9 46.8 34.0 24.1 29.9 27.3 32.1 45.7 47.0 29.7 59.0 26.2 25.8 35.2 31.3 38.9 25.9 62.7 78.8 51.1 21.6 30.6 40.4 186.4 75.4 141.1 79.7 70.8 87.0 102.0 76.9 78.4 76.2 109.1 78.6 71.9 161.5 125.8 83.0 70.6 107.3 108.4 41.3 45.1 43.6 43.3 39.5 42.2 43.1 43.7 42.8 43.7 43.0 48.7 19.2 6.4 10.1 14.0 35.7 22.7 21.8 41.7 23.9 42.2 20.1 24.9 12.7 27.1 24.2 33.1 47.9 27.2 42.0 11.5 19.6 21.2 5.2 18.3 29.5 24.2 17.4 32.8 18.5 17.4 22.9 27.2 15.3 18.5 16.5 31.8 24.3 13.3 19.5 30.3 19.9 16.8 32.6 17.5 33.8 12.3 58.7 16.9 19.6 15.0 30.0 22.8 35.0 24.1 32.3 19.3 8.6 53.4 21.6 22.6 23.7 22.0 19.3 50.5 32.9 28.8 32.2 60.2 63.5 15.4 23.2 26.5 30.6 28.7 17.9 19.7 TIGD3 ENSG00000173825 "Tigger transposable element derived 3" Q6B0B8 11 65354751-65357613 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.5;intestine: 2.5;testis: 5.0" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 9.6;Spermatocytes: 40.5;Spermatogonia: 13.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 7.7;eosinophil: 10.9;neutrophil: 17.5" "Lineage enriched" "Detected in many" 11 "granulocytes: 17.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA040016 Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 78: Testis - Spermatogenesis" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nuclear membrane" "HPA040016: AB_10805600" "unprognostic (1.33e-1)" "unprognostic (1.81e-2)" "unprognostic (1.88e-2)" "unprognostic (1.60e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-3)" "unprognostic (9.04e-4)" "unprognostic (1.48e-4)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "unprognostic (3.94e-3)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (7.55e-3)" "unprognostic (1.01e-1)" "unprognostic (2.11e-1)" "unprognostic (1.75e-3)" 0.1 0.2 1.2 0.2 1.7 0.5 0.1 2.5 2.1 0.1 0.5 0.2 0.8 0.1 0.2 0.2 0.1 0.1 0.4 1.2 1.0 0.3 0.2 0.2 0.4 1.1 1.2 0.3 0.5 0.4 1.2 0.1 1.0 0.2 0.1 0.9 0.3 0.1 0.2 0.1 2.5 0.0 1.1 1.0 0.3 5.0 1.1 1.3 0.1 0.3 0.2 0.1 0.1 1.2 0.8 1.6 1.3 3.5 0.0 0.0 0.5 0.0 0.1 0.3 0.4 1.2 0.2 0.6 0.5 0.1 0.6 0.8 1.3 0.0 0.1 1.1 1.4 0.2 0.9 2.8 0.0 0.5 2.6 0.0 0.1 0.1 0.0 0.0 0.2 1.3 0.9 1.8 0.0 2.1 1.7 1.1 0.7 0.7 0.6 2.5 0.6 2.4 0.0 0.8 3.9 2.4 1.0 1.5 0.6 0.1 2.5 0.8 0.0 0.1 0.6 0.9 0.6 3.7 2.5 0.8 0.0 1.1 0.4 7.7 0.6 10.9 0.0 0.3 0.0 0.4 0.0 0.0 1.0 0.2 0.2 0.0 17.5 0.1 1.5 1.5 0.0 0.2 1.2 1.7 2.5 2.1 1.2 1.0 1.1 1.2 1.0 1.1 1.1 1.2 1.0 0.0 1.1 0.7 4.5 1.5 0.4 0.5 5.7 4.0 1.7 0.9 2.6 0.0 0.3 0.0 0.0 0.4 4.0 0.4 0.0 1.1 4.3 1.0 0.3 0.6 0.0 2.7 0.7 0.6 0.3 0.4 1.1 1.1 0.0 2.9 0.0 0.4 0.3 0.0 1.0 0.6 0.0 0.6 5.7 2.2 0.0 1.3 1.8 1.0 1.9 1.1 0.0 1.0 0.4 0.4 0.1 0.4 3.0 0.8 9.6 0.9 0.6 3.4 0.0 1.2 0.8 40.5 13.5 3.5 1.6 0.8 1.0 0.7 1.1 0.1 SLC25A45 ENSG00000162241 "Solute carrier family 25 member 45" Q8N413 11 65375192-65383701 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 34.2" "Cell type enhanced" "Detected in many" "dendritic cells: 46.7;NK-cells: 103.0;Proximal enterocytes: 90.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 17.5;Karpas-707: 22.8;RPMI-8226: 17.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA042495, HPA050821" Uncertain Approved Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 25: Pancreas - Digestion" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "HPA042495: , HPA050821: AB_2681249" "unprognostic (3.73e-2)" "unprognostic (2.19e-3)" "unprognostic (8.44e-4)" "unprognostic (6.17e-3)" "unprognostic (2.57e-2)" "unprognostic (2.84e-7)" "unprognostic (7.57e-3)" "unprognostic (4.59e-2)" "unprognostic (1.44e-1)" "unprognostic (4.06e-2)" "prognostic favorable (2.83e-4)" "unprognostic (1.96e-1)" "unprognostic (1.08e-2)" "unprognostic (1.45e-1)" "unprognostic (1.54e-1)" "unprognostic (6.18e-2)" "unprognostic (1.43e-1)" 3.7 3.3 3.1 5.8 3.3 4.9 4.7 2.8 4.1 1.9 2.6 3.4 5.6 1.8 2.5 2.5 2.0 2.0 3.8 3.1 3.1 6.5 12.1 3.9 10.1 3.7 3.1 1.9 34.2 3.0 6.6 1.9 3.5 3.8 1.8 0.3 6.3 1.9 7.1 2.9 7.6 1.3 3.3 13.3 2.8 1.9 3.1 8.0 12.1 3.7 6.6 2.0 1.9 4.0 0.4 5.8 0.2 8.5 1.5 0.7 4.2 1.0 2.6 0.5 0.5 1.4 2.7 5.2 4.7 2.4 2.1 0.8 0.6 0.4 0.0 17.5 1.2 5.7 3.2 0.4 0.9 1.8 5.7 1.9 0.1 0.7 0.5 0.4 0.9 9.9 0.8 22.8 0.9 1.9 4.2 0.1 0.3 0.3 2.6 7.7 1.1 17.1 0.9 0.1 2.8 3.7 1.8 4.5 1.0 0.5 2.4 0.9 1.7 0.6 2.0 5.5 0.4 9.5 6.4 1.5 1.7 1.3 3.3 10.5 6.3 4.8 8.8 11.2 9.3 10.6 7.8 8.5 6.9 11.9 12.4 9.3 3.9 17.1 13.3 23.0 7.7 3.1 3.1 3.3 2.8 4.1 3.1 3.1 3.7 3.1 3.5 3.3 3.1 4.0 5.0 0.0 5.6 0.3 40.0 2.8 5.9 4.2 3.4 12.3 10.7 7.7 5.6 8.6 4.7 12.9 0.0 2.1 46.7 14.4 0.0 5.9 5.1 6.2 3.1 6.0 6.7 3.0 5.2 5.4 1.7 7.7 5.6 7.9 4.5 21.8 6.8 14.0 7.3 6.7 0.6 16.7 4.1 9.7 14.4 3.9 6.8 11.7 5.4 4.7 18.4 5.5 103.0 1.5 3.9 5.2 12.5 3.8 15.3 7.0 90.9 6.9 12.3 0.4 6.6 12.6 3.6 2.2 0.4 2.2 2.0 1.5 31.6 11.8 13.3 4.6 FRMD8 "FKSG44, FLJ90369, iTAP" ENSG00000126391 "FERM domain containing 8" Q9BZ67 11 65386621-65413525 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Suprabasal keratinocytes: 83.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 129.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002861 Approved Approved "Nucleoplasm,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 71: Testis - DNA repair" "Cluster 17: WM-115 - Nervous system development" "Cluster 28: Keratinocytes - Keratinization" "Plasma membrane, Centriolar satellite" "Nucleoplasm, Cytosol" "HPA002861: AB_1078878" "unprognostic (1.54e-1)" "unprognostic (4.07e-1)" "unprognostic (6.28e-2)" "unprognostic (1.73e-2)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (9.94e-5)" "unprognostic (9.12e-3)" "unprognostic (1.51e-2)" "unprognostic (6.36e-3)" "unprognostic (1.90e-2)" "unprognostic (6.41e-3)" "unprognostic (4.19e-3)" "unprognostic (1.47e-2)" "unprognostic (7.36e-3)" "unprognostic (3.34e-1)" "unprognostic (2.91e-2)" 19.8 17.5 9.6 11.8 11.0 13.0 19.7 12.2 14.5 20.8 9.1 15.0 11.7 14.6 5.3 37.3 15.8 11.6 17.1 13.1 7.9 19.7 13.4 23.5 15.6 12.9 11.3 12.2 23.0 4.0 11.6 10.4 11.4 15.8 6.7 1.7 18.0 6.5 14.8 34.0 23.8 6.6 9.5 40.8 13.4 18.0 11.5 11.1 17.8 5.1 13.6 14.6 26.4 16.2 17.8 22.1 8.7 20.4 23.0 12.0 15.6 20.1 18.1 16.7 12.7 21.2 28.5 21.9 41.9 27.6 11.6 30.3 11.3 16.9 7.0 38.8 10.6 29.9 21.5 11.7 12.4 16.9 44.8 14.9 13.2 15.7 8.2 8.9 26.6 23.2 25.5 23.5 18.3 23.9 26.6 24.6 10.2 13.0 28.7 33.7 16.6 25.2 13.5 21.8 18.9 14.0 15.0 60.1 47.7 7.7 22.0 13.7 23.6 18.4 19.7 26.1 12.3 41.0 22.5 20.4 16.0 10.7 129.8 1.1 12.4 17.7 13.1 13.2 14.1 12.5 9.6 16.7 11.3 9.6 8.8 9.8 23.0 8.2 19.6 13.4 10.8 12.3 9.6 11.0 12.2 14.5 13.1 7.9 12.9 11.3 11.4 9.5 11.5 16.2 30.3 3.2 5.8 2.0 20.5 54.3 22.5 17.7 6.2 5.4 15.4 12.6 7.4 12.8 13.8 12.9 0.0 6.4 25.8 29.3 7.9 21.0 22.3 20.1 12.1 24.8 13.1 24.0 13.4 29.1 15.5 13.0 10.7 23.1 14.0 27.3 37.5 11.0 16.0 5.0 4.9 20.5 8.2 20.2 68.7 4.6 6.2 18.7 19.6 10.3 21.6 4.3 18.6 5.0 10.3 33.8 14.0 7.2 11.9 28.1 32.8 4.6 14.3 4.5 6.6 11.4 14.4 5.3 9.6 24.9 83.5 11.4 21.9 35.2 14.6 35.7 SCYL1 "GKLP, HT019, MGC78454, NKTL, NTKL, P105, TAPK, TEIF, TRAP" ENSG00000142186 "SCY1 like pseudokinase 1" Q96KG9 11 65525077-65538704 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transcription regulation, Transport" "Activator, DNA-binding" "Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 138.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015015 Uncertain Supported Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "HPA015015: AB_1856643" "unprognostic (5.56e-2)" "unprognostic (1.16e-1)" "unprognostic (1.03e-1)" "unprognostic (3.99e-1)" "unprognostic (1.23e-2)" "unprognostic (7.87e-2)" "unprognostic (1.23e-2)" "unprognostic (5.06e-2)" "unprognostic (1.14e-1)" "unprognostic (7.23e-2)" "unprognostic (4.41e-1)" "unprognostic (4.29e-1)" "unprognostic (7.86e-3)" "unprognostic (6.49e-3)" "unprognostic (4.27e-1)" "unprognostic (8.29e-2)" "unprognostic (2.29e-3)" 43.4 69.3 36.6 26.4 37.4 32.8 41.1 33.1 53.9 46.8 37.1 46.7 28.0 49.4 32.5 40.0 44.0 26.3 59.7 39.2 34.1 45.7 83.2 42.4 30.7 36.0 35.2 52.4 61.6 35.5 44.7 34.6 35.5 47.3 17.2 12.4 48.5 33.7 104.5 44.5 39.6 27.5 30.9 46.4 50.0 50.6 37.7 23.4 48.8 51.6 21.8 47.8 39.5 39.0 55.0 45.9 36.6 50.9 65.4 56.6 50.0 66.6 89.4 77.7 60.4 66.9 32.2 39.2 65.7 86.9 66.2 49.1 38.7 50.1 27.0 46.6 49.7 46.4 50.8 78.3 92.8 30.8 64.0 79.1 48.6 66.9 49.4 54.2 51.6 39.7 49.2 53.8 49.0 118.9 41.4 70.4 35.3 36.9 63.4 41.4 28.5 72.5 48.1 48.4 33.7 35.7 41.2 89.6 74.5 22.4 88.8 38.4 51.4 61.3 41.0 100.7 40.1 73.8 55.8 41.4 71.0 25.3 43.7 2.9 21.1 28.4 20.7 20.0 16.6 14.0 19.6 20.9 23.5 14.3 15.2 15.0 41.9 18.2 13.6 17.0 14.4 19.8 36.6 37.4 33.1 53.9 39.2 34.1 36.0 35.2 35.5 30.9 37.7 39.0 22.7 19.2 16.7 11.4 25.7 21.9 29.8 30.9 25.0 25.4 29.9 20.1 5.8 21.5 26.0 20.2 12.5 64.6 18.5 47.4 37.2 37.5 25.7 17.3 22.7 23.7 30.5 22.3 14.6 43.4 70.0 34.1 38.2 25.4 25.4 34.0 22.1 35.0 38.1 16.8 12.8 39.9 28.5 19.2 24.3 25.2 45.7 24.5 30.2 11.2 34.3 26.6 21.6 6.6 10.5 36.4 31.4 45.5 53.4 44.8 50.8 37.2 15.3 22.0 13.1 24.4 33.8 39.5 21.8 27.5 23.2 138.6 23.2 44.3 36.2 38.5 LTBP3 LTBP2 ENSG00000168056 "Latent transforming growth factor beta binding protein 3" Q9NS15 11 65538559-65558930 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding" "Amelogenesis imperfecta, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 61.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 293.8;U-87 MG: 157.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 2200000 "Cluster 43: B-cells - Humoral immune response" "Cluster 72: Non-specific - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 50: Fibroblasts - ECM organization" "unprognostic (3.35e-1)" "unprognostic (1.07e-1)" "unprognostic (8.50e-3)" "unprognostic (4.01e-2)" "unprognostic (1.04e-1)" "unprognostic (1.59e-1)" "unprognostic (2.24e-2)" "unprognostic (9.22e-2)" "unprognostic (9.88e-2)" "unprognostic (1.55e-2)" "unprognostic (1.04e-2)" "unprognostic (4.52e-2)" "unprognostic (1.45e-1)" "unprognostic (2.67e-2)" "unprognostic (1.51e-1)" "unprognostic (4.25e-2)" "unprognostic (2.24e-2)" 65.4 80.1 44.0 21.4 46.1 11.2 68.0 42.0 56.1 120.0 42.2 103.7 16.8 130.8 36.7 36.7 112.6 39.9 131.2 37.6 41.4 84.5 48.8 72.2 24.7 57.0 49.0 155.5 70.1 44.7 111.0 25.5 45.4 109.0 8.5 12.8 64.2 56.3 54.6 39.6 55.8 35.7 51.7 58.1 62.0 20.3 46.9 17.6 114.0 31.0 12.1 84.9 88.0 54.0 16.5 65.9 8.7 43.2 60.7 97.0 8.5 64.7 43.6 8.2 5.3 25.3 85.5 2.0 53.6 64.2 20.4 71.9 11.8 12.2 3.7 9.5 26.4 15.9 25.2 26.2 40.3 2.2 13.4 109.9 4.9 12.1 1.5 293.8 31.9 5.2 4.9 12.7 6.0 39.4 10.9 5.9 7.6 14.6 81.2 29.3 1.1 32.1 6.7 5.5 2.9 41.8 17.3 24.9 35.3 3.7 46.0 5.8 107.0 24.8 32.2 42.5 17.6 13.9 27.1 1.4 157.8 2.6 52.3 0.2 7.3 2.9 8.8 11.2 14.1 61.2 12.6 10.4 8.9 47.6 10.5 11.2 2.9 10.8 13.2 17.8 14.2 7.8 44.0 46.1 42.0 56.1 37.6 41.4 57.0 49.0 45.4 51.7 46.9 54.0 47.1 12.8 11.7 64.0 26.8 73.8 27.7 22.0 50.7 55.7 42.2 43.1 16.7 35.8 16.2 40.5 2.1 24.7 24.4 19.7 21.5 28.1 1.1 19.3 37.5 29.8 30.6 11.2 21.3 12.0 10.5 86.1 14.8 25.3 24.1 92.5 37.5 61.6 20.7 28.6 17.9 15.1 8.2 11.0 34.4 4.3 86.6 14.6 30.2 17.8 11.5 71.4 24.7 29.7 20.2 18.1 15.0 123.8 20.9 35.8 25.3 15.7 8.2 14.3 39.5 89.4 44.0 9.5 37.5 46.9 79.3 16.3 24.4 26.0 20.4 26.5 ZNRD2 "p27, SSSCA1" ENSG00000173465 "Zinc ribbon domain containing 2" O60232 11 65570460-65573942 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 44.9;Cytotrophoblasts: 81.1;Extravillous trophoblasts: 84.5;Hofbauer cells: 57.9;Syncytiotrophoblasts: 79.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039789, HPA064670" Uncertain Approved Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 24: Non-specific - Transcription regulation" Cytosol "HPA039789: AB_2676680, HPA064670: AB_2732718" "unprognostic (9.32e-2)" "unprognostic (3.57e-2)" "unprognostic (1.03e-1)" "unprognostic (2.04e-2)" "unprognostic (1.08e-1)" "unprognostic (3.35e-3)" "unprognostic (3.03e-2)" "unprognostic (2.65e-1)" "unprognostic (4.92e-2)" "unprognostic (1.36e-2)" "unprognostic (1.20e-1)" "unprognostic (3.11e-1)" "unprognostic (5.75e-2)" "unprognostic (2.23e-1)" "unprognostic (1.95e-1)" "unprognostic (5.86e-2)" "unprognostic (9.34e-2)" 39.1 46.0 16.3 32.8 20.2 48.2 38.9 14.0 28.5 38.4 9.1 50.7 22.5 45.9 8.8 41.5 42.5 20.2 50.5 21.7 14.4 45.4 47.6 38.7 32.8 16.1 16.5 38.8 61.8 19.9 31.2 23.3 14.8 41.9 9.1 7.2 45.2 20.7 104.0 42.4 30.9 16.1 9.9 41.4 41.2 50.6 14.7 25.7 35.9 37.0 16.4 43.1 35.7 18.7 79.4 61.5 39.2 72.0 23.5 20.1 61.0 55.0 31.2 50.8 35.5 59.1 79.9 75.3 93.4 30.8 37.0 68.9 29.5 59.2 18.1 54.7 45.8 67.7 61.0 48.0 32.8 81.6 53.8 31.5 40.2 39.4 40.2 39.2 40.6 68.0 79.8 97.0 28.8 110.0 100.1 72.1 63.9 28.2 104.7 77.4 29.0 142.1 30.3 40.2 78.2 81.3 33.4 82.3 79.8 15.9 111.4 41.3 47.3 92.1 50.5 111.1 69.0 69.0 102.8 66.1 74.3 57.1 83.5 15.4 62.8 27.1 56.5 55.5 59.1 103.5 57.2 57.4 51.5 89.5 66.1 57.7 20.1 85.4 37.5 85.9 69.8 50.7 16.3 20.2 14.0 28.5 21.7 14.4 16.1 16.5 14.8 9.9 14.7 18.7 16.7 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.9 0.0 0.0 0.0 0.0 81.1 16.2 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 84.5 13.5 0.0 0.0 0.0 0.0 0.0 0.0 57.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 79.9 2.3 0.0 0.0 0.0 FAM89B "LRAP25, MTVR1" ENSG00000176973 "Family with sequence similarity 89 member B" Q8N5H3 11 65572349-65574198 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046895 Approved NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" "HPA046895: AB_2679858" "unprognostic (1.16e-1)" "unprognostic (9.46e-3)" "unprognostic (1.02e-1)" "unprognostic (5.11e-2)" "unprognostic (4.09e-1)" "unprognostic (3.92e-3)" "prognostic unfavorable (2.98e-4)" "unprognostic (8.32e-2)" "unprognostic (1.51e-1)" "prognostic favorable (6.00e-4)" "unprognostic (1.69e-1)" "unprognostic (4.07e-3)" "prognostic unfavorable (9.48e-5)" "unprognostic (3.59e-2)" "unprognostic (2.63e-1)" "unprognostic (3.27e-2)" "unprognostic (1.12e-2)" 39.9 33.8 59.0 19.8 54.9 22.5 34.2 53.9 84.7 46.1 40.2 70.7 13.7 47.7 13.0 46.2 42.7 24.8 56.7 60.7 46.6 39.6 36.0 39.7 25.8 52.2 50.6 43.8 76.2 23.2 22.9 14.6 52.9 50.3 10.9 3.2 47.0 24.2 129.7 44.1 34.4 23.0 50.8 48.3 45.0 18.4 53.8 31.3 26.1 95.1 19.4 54.0 43.1 55.9 16.6 26.3 38.4 47.8 45.7 52.5 12.5 29.3 26.2 21.4 12.7 15.8 18.2 11.2 38.7 45.9 23.7 28.1 16.3 17.5 5.0 38.0 43.6 21.3 18.8 9.0 27.8 10.5 38.7 41.1 34.8 17.7 12.2 68.3 57.5 26.2 24.2 73.3 30.7 24.6 48.1 37.1 17.2 16.1 61.2 59.2 5.9 49.6 24.1 15.2 43.5 57.6 21.5 30.8 50.0 11.7 31.1 15.7 37.9 45.6 23.9 44.6 15.5 36.3 61.3 7.4 39.9 15.7 33.2 7.8 5.7 11.6 5.0 10.5 6.8 2.6 6.3 6.4 5.0 2.3 5.3 5.4 8.5 5.8 14.0 5.5 10.1 3.5 59.0 54.9 53.9 84.7 60.7 46.6 52.2 50.6 52.9 50.8 53.8 55.9 45.3 9.6 3.9 9.8 33.4 47.4 32.8 4.3 18.8 10.1 67.0 57.8 10.7 21.5 5.3 23.9 2.1 27.7 63.9 27.2 13.7 23.6 10.4 19.7 33.3 39.7 29.2 36.7 13.6 27.5 19.9 32.8 10.7 20.3 4.5 26.5 43.5 27.6 32.5 16.8 10.9 15.2 2.0 40.6 48.8 27.8 26.4 47.1 44.4 13.1 27.1 29.1 73.2 9.0 10.6 33.3 21.7 30.1 43.6 31.8 16.1 14.9 4.2 8.7 46.0 22.3 48.8 2.9 13.1 19.1 57.4 22.3 46.5 26.2 16.6 48.5 EHBP1L1 "DKFZp762C186, TANGERIN" ENSG00000173442 "EH domain binding protein 1 like 1" Q8N3D4 11 65576046-65592650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 255.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 79.1;Kupffer cells: 79.7;Macrophages: 67.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039479, HPA073476" Enhanced Approved "Vesicles,Plasma membrane" NA NA 110000 "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Vesicles, Plasma membrane" "HPA039479: AB_10795678, HPA073476: " "unprognostic (1.87e-2)" "unprognostic (1.10e-1)" "unprognostic (1.48e-2)" "unprognostic (7.73e-3)" "unprognostic (1.31e-1)" "unprognostic (2.84e-1)" "unprognostic (2.41e-3)" "unprognostic (2.35e-1)" "unprognostic (1.01e-1)" "unprognostic (1.84e-2)" "unprognostic (3.36e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.45e-4)" "unprognostic (6.10e-3)" "unprognostic (5.02e-2)" "unprognostic (3.50e-2)" "unprognostic (1.10e-1)" 27.2 9.9 7.5 51.9 6.2 59.7 21.5 5.9 9.4 35.9 7.3 108.1 26.0 56.1 5.7 45.4 48.0 18.0 45.6 7.1 6.3 17.7 10.8 39.6 30.7 9.8 8.1 19.6 8.1 4.1 9.8 16.3 7.7 45.2 12.2 0.4 22.9 39.5 255.7 22.6 46.6 32.8 8.0 73.3 41.0 7.3 9.4 14.5 13.0 70.7 16.6 71.3 40.8 9.0 40.6 41.0 1.3 21.8 10.5 26.4 8.2 31.4 22.9 14.8 7.8 13.7 34.9 14.0 52.4 45.8 41.2 55.9 7.6 29.7 3.4 39.3 1.2 32.4 51.0 12.0 10.0 7.1 30.1 22.7 19.8 37.2 6.8 26.9 15.2 20.8 50.5 55.9 13.8 34.5 12.4 27.5 1.8 15.1 34.8 33.6 0.2 46.8 13.7 20.0 0.9 17.2 17.4 15.2 32.9 3.0 21.9 33.7 26.3 40.3 42.9 57.3 0.6 98.5 66.6 7.3 60.2 18.8 23.9 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 7.5 6.2 5.9 9.4 7.1 6.3 9.8 8.1 7.7 8.0 9.4 9.0 33.1 0.0 6.9 6.2 23.9 10.1 8.5 2.9 15.9 1.4 12.2 14.2 22.0 7.2 7.4 1.8 0.0 3.4 27.3 79.1 0.0 3.6 0.2 11.9 12.2 26.0 4.2 61.6 4.4 5.1 1.4 13.8 61.2 14.2 2.5 5.3 18.9 5.7 32.6 0.0 2.2 16.3 2.0 79.7 33.9 1.7 11.5 67.6 7.2 15.0 49.1 0.7 20.6 1.5 1.3 27.8 53.0 38.0 19.5 11.6 19.5 0.4 8.6 1.1 26.3 27.3 30.7 2.7 5.9 15.3 14.8 2.6 23.2 23.0 21.9 17.0 KCNK7 K2p7.1 ENSG00000173338 "Potassium two pore domain channel subfamily K member 7" Q9Y2U2 11 65592836-65595996 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 90.0" "Cell type enriched" "Detected in some" 5 "Suprabasal keratinocytes: 103.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 2.1;naive B-cell: 2.2;neutrophil: 1.5" "Group enriched" "Detected in many" 16 "B-cells: 2.2;granulocytes: 2.1" "Cell line enhanced" "Detected in some" "SCLC-21H: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA077577 Approved "Plasma membrane" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 28: Keratinocytes - Keratinization" "Plasma membrane" "HPA077577: AB_2686845" "unprognostic (1.12e-2)" "unprognostic (1.21e-1)" "unprognostic (6.08e-2)" "unprognostic (5.71e-2)" "unprognostic (8.59e-2)" "unprognostic (1.34e-1)" "unprognostic (1.68e-3)" "unprognostic (8.53e-2)" "unprognostic (1.69e-1)" "unprognostic (2.87e-1)" "unprognostic (6.90e-2)" "unprognostic (4.88e-2)" "unprognostic (1.49e-2)" "unprognostic (2.65e-1)" "unprognostic (3.57e-1)" "unprognostic (1.16e-1)" "unprognostic (8.11e-2)" 2.0 0.7 2.7 0.2 2.9 5.4 2.9 3.4 5.7 4.6 1.7 2.1 0.4 1.4 0.1 18.0 2.3 0.3 1.6 2.7 2.4 0.7 0.9 1.7 0.3 2.8 2.8 1.8 0.4 0.0 1.3 0.4 3.0 1.4 0.0 0.7 2.5 0.3 2.6 90.0 1.2 0.2 2.7 2.0 1.2 1.1 2.7 0.4 0.6 0.5 1.0 1.7 9.5 3.4 0.3 1.6 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.1 1.0 0.4 0.4 0.1 0.2 2.2 0.0 0.0 0.0 0.5 1.1 0.5 0.9 0.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.8 0.6 1.3 0.4 1.0 0.5 0.4 0.6 0.6 0.6 0.9 0.0 0.2 0.6 0.1 6.8 1.5 0.3 0.4 0.7 0.0 0.4 1.1 0.0 0.3 1.1 1.0 0.1 0.9 0.7 0.2 0.5 0.6 0.6 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.2 0.0 0.0 1.5 0.1 0.1 0.0 0.0 0.0 2.7 2.9 3.4 5.7 2.7 2.4 2.8 2.8 3.0 2.7 2.7 3.4 1.1 0.0 0.5 0.3 0.8 19.1 0.4 0.7 0.6 2.1 0.7 1.8 0.2 0.0 0.7 0.0 0.0 0.1 1.6 1.0 0.0 0.1 0.7 0.7 0.3 1.2 1.2 0.0 0.9 0.0 0.1 0.4 0.0 1.7 0.0 0.2 0.7 0.3 0.5 0.0 0.9 0.4 0.0 1.3 4.0 1.8 0.6 0.7 3.6 0.0 0.4 0.1 0.0 1.0 1.8 0.1 4.8 0.0 0.0 0.3 0.3 0.1 1.1 1.1 6.6 0.4 0.8 0.1 1.3 16.3 103.7 0.0 0.6 0.1 0.8 1.3 MAP3K11 "MEKK11, MLK3, PTK1, SPRK" ENSG00000173327 "Mitogen-activated protein kinase kinase kinase 11" Q16584 11 65597756-65615382 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 123.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010165 Approved Supported "Centriolar satellite,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Centriolar satellite, Cytosol" "CAB010165: AB_631936" "unprognostic (8.36e-2)" "unprognostic (1.17e-2)" "unprognostic (1.06e-1)" "unprognostic (9.99e-2)" "unprognostic (3.40e-1)" "unprognostic (1.87e-1)" "unprognostic (7.56e-3)" "unprognostic (3.10e-2)" "unprognostic (4.50e-2)" "unprognostic (4.30e-1)" "unprognostic (4.69e-2)" "unprognostic (2.77e-2)" "unprognostic (3.13e-2)" "unprognostic (2.01e-2)" "unprognostic (7.62e-2)" "unprognostic (1.95e-1)" "unprognostic (8.27e-3)" 47.6 32.6 39.9 36.9 51.7 24.4 42.9 45.1 48.4 27.2 27.2 40.0 48.3 29.7 7.4 35.6 31.3 13.5 53.2 36.1 38.8 48.5 95.3 62.7 23.7 48.8 50.3 21.0 35.8 12.1 27.8 21.6 44.6 39.2 11.7 2.8 29.1 12.6 20.1 35.9 51.0 10.0 41.5 78.3 36.3 21.3 50.5 19.3 37.3 10.4 11.3 29.2 28.3 60.1 48.0 43.4 23.1 22.6 7.0 8.0 21.7 19.3 11.9 19.9 14.9 43.4 43.9 16.4 65.5 13.0 33.0 40.9 12.2 19.5 7.1 40.2 15.5 50.0 28.2 50.9 18.6 28.9 71.2 12.4 19.1 14.5 13.3 21.6 57.4 21.5 21.6 32.7 10.9 58.2 34.0 50.9 24.2 31.0 48.1 56.1 13.3 36.2 19.2 43.1 19.6 22.9 22.0 58.1 107.7 10.4 46.6 45.8 68.8 31.3 35.8 48.1 32.4 23.3 27.5 15.8 35.3 33.1 75.1 7.5 10.5 13.1 3.1 15.3 3.0 2.7 3.2 4.5 10.1 3.0 2.4 1.8 17.3 2.4 15.4 3.0 1.8 9.5 39.9 51.7 45.1 48.4 36.1 38.8 48.8 50.3 44.6 41.5 50.5 60.1 70.0 22.4 21.1 4.2 22.1 21.0 25.3 18.4 20.5 24.4 28.9 23.4 8.7 31.5 14.1 11.0 25.0 24.7 26.4 123.5 19.6 21.9 13.5 15.4 11.3 78.9 41.9 13.0 4.1 27.5 17.7 11.4 44.4 26.1 26.0 19.6 58.5 56.2 53.3 18.5 3.5 54.9 20.3 50.6 65.5 68.5 9.6 48.3 21.4 21.5 50.2 16.1 23.7 3.0 29.5 33.7 99.0 6.4 15.5 28.1 113.1 27.6 10.3 54.7 32.9 10.5 12.8 12.2 18.3 24.8 30.0 34.3 24.0 28.9 55.2 34.6 PCNX3 "FLJ22427, PCNXL3" ENSG00000197136 "Pecanex 3" Q9H6A9 11 65615773-65637439 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 12.9;Endometrial ciliated cells: 13.5;Glandular and luminal cells: 20.4;Granulosa cells: 17.7;Pancreatic endocrine cells: 13.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018084 Uncertain Approved Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 64: Macrophages - Immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA018084: AB_1855083" "unprognostic (9.93e-2)" "unprognostic (1.33e-1)" "unprognostic (5.46e-2)" "unprognostic (1.09e-2)" "unprognostic (2.54e-1)" "unprognostic (1.70e-2)" "unprognostic (3.13e-3)" "unprognostic (1.42e-1)" "unprognostic (1.16e-1)" "unprognostic (7.69e-3)" "unprognostic (7.06e-2)" "unprognostic (2.44e-2)" "unprognostic (8.52e-3)" "unprognostic (6.51e-3)" "unprognostic (1.93e-1)" "unprognostic (2.32e-2)" "unprognostic (4.82e-1)" 5.2 6.5 3.9 8.0 3.3 10.4 5.5 2.5 4.7 5.9 2.0 7.3 8.2 7.8 1.6 7.7 6.4 4.5 4.5 3.2 1.1 5.4 5.1 6.7 7.3 4.4 3.2 6.0 8.1 4.6 6.6 5.0 2.9 6.2 3.2 2.6 7.9 4.9 4.2 7.7 9.0 4.0 1.8 8.6 7.1 8.9 4.2 7.2 7.4 2.1 4.3 6.3 5.6 4.7 19.5 28.6 10.3 25.6 7.9 6.1 23.3 13.5 11.5 12.9 9.4 13.8 21.5 14.2 25.4 12.0 17.5 31.2 11.0 15.6 3.8 12.1 19.4 18.6 28.6 11.4 8.8 18.3 21.9 11.6 7.7 12.7 10.0 5.8 12.7 14.7 21.7 11.7 7.6 28.8 15.6 14.1 20.9 8.4 18.2 21.6 9.2 18.6 5.6 30.9 12.7 19.0 14.3 18.6 15.7 4.5 32.8 12.4 18.3 22.3 20.7 18.6 13.6 19.1 12.2 12.7 17.8 8.8 19.9 3.5 0.9 0.6 1.2 0.4 1.0 0.5 0.7 0.7 0.5 0.8 0.5 0.7 1.3 0.6 0.7 1.2 0.2 0.6 3.9 3.3 2.5 4.7 3.2 1.1 4.4 3.2 2.9 1.8 4.2 4.7 10.8 6.4 6.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 11.3 8.4 0.0 0.0 0.6 12.9 0.0 6.8 10.7 0.0 0.0 9.1 0.0 13.5 9.1 5.1 0.0 0.0 0.0 8.9 5.6 3.2 0.0 20.4 5.1 17.7 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 5.9 0.0 0.0 4.3 0.7 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 8.3 3.0 10.2 0.0 0.0 SIPA1 SPA1 ENSG00000213445 "Signal-induced proliferation-associated 1" Q96FS4 11 65638101-65650918 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 95.6" "Cell type enhanced" "Detected in many" "dendritic cells: 82.5;NK-cells: 88.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020833, HPA039867" Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 2: Immune cells - Immune response" "Cluster 36: HEL - Hemostasis" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoli "Nucleoplasm, Golgi apparatus, Plasma membrane" "CAB020833: , HPA039867: AB_2676716" "unprognostic (6.10e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.42e-4)" "unprognostic (1.35e-2)" "unprognostic (2.93e-1)" "unprognostic (2.32e-2)" "unprognostic (3.35e-2)" "unprognostic (1.09e-1)" "unprognostic (3.30e-2)" "unprognostic (6.44e-2)" "unprognostic (5.85e-2)" "unprognostic (4.86e-2)" "prognostic unfavorable (3.52e-6)" "unprognostic (1.60e-1)" "unprognostic (2.78e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-1)" 21.6 17.2 16.4 48.7 15.5 53.8 16.2 14.1 16.8 20.6 10.3 24.0 12.5 20.9 3.4 14.3 19.5 16.0 25.7 15.8 13.2 17.0 15.0 37.0 60.7 22.3 16.0 13.1 8.4 3.5 7.5 19.4 19.5 17.1 6.0 0.9 14.1 10.0 10.0 8.1 37.8 12.0 19.5 95.6 15.9 4.7 24.5 21.3 14.9 6.4 32.5 18.8 15.3 21.0 1.6 13.3 9.1 20.1 5.4 11.1 21.7 14.9 12.7 11.7 11.3 3.9 14.5 21.3 33.2 7.6 0.4 7.8 3.4 5.1 3.9 22.7 8.1 52.6 20.7 7.4 9.6 21.5 21.5 11.4 2.3 16.2 2.1 11.5 34.4 21.8 30.3 9.2 5.8 5.8 8.6 36.1 6.4 5.4 12.3 38.8 5.1 19.3 4.4 0.8 3.4 20.9 7.5 12.6 31.7 8.5 9.6 32.5 49.2 14.2 28.7 15.2 3.0 14.1 12.2 48.4 19.5 33.0 42.0 3.2 3.3 9.3 5.8 3.9 4.1 4.1 2.8 3.7 2.3 4.7 2.0 3.1 11.1 4.7 4.8 2.1 3.0 3.0 16.4 15.5 14.1 16.8 15.8 13.2 22.3 16.0 19.5 19.5 24.5 21.0 22.5 6.4 5.2 7.5 59.0 6.8 24.7 23.2 17.6 2.1 24.8 26.5 7.2 21.5 19.2 23.9 0.0 10.1 82.5 16.5 37.2 19.8 3.0 8.3 6.8 26.8 21.0 31.6 0.1 14.5 19.6 12.2 11.2 14.9 7.0 37.1 42.8 22.0 38.4 5.0 0.2 12.8 30.5 44.4 11.4 9.8 8.1 40.2 10.6 14.0 23.7 7.6 88.6 0.5 4.0 27.2 12.7 13.2 29.6 29.0 39.0 20.7 6.0 1.8 13.1 7.4 20.9 0.8 13.8 14.4 11.1 13.5 50.4 30.9 14.3 31.9 RELA "NFKB3, p65" ENSG00000173039 "RELA proto-oncogene, NF-kB subunit" Q04206 11 65653597-65663090 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004264, CAB005030, HPA063461" Supported Enhanced Cytosol NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 89: Fibroblasts - ECM organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "CAB004264: AB_628017, CAB005030: AB_562171, HPA063461: AB_2685016" "unprognostic (9.17e-2)" "unprognostic (1.79e-1)" "unprognostic (2.04e-1)" "unprognostic (3.22e-1)" "unprognostic (7.67e-2)" "unprognostic (5.39e-2)" "prognostic unfavorable (9.18e-4)" "unprognostic (1.30e-3)" "unprognostic (1.69e-2)" "unprognostic (1.33e-1)" "unprognostic (6.03e-2)" "unprognostic (2.37e-1)" "prognostic unfavorable (5.66e-4)" "unprognostic (2.78e-1)" "unprognostic (1.46e-1)" "unprognostic (9.81e-2)" "unprognostic (2.53e-1)" 67.3 42.8 27.4 38.5 29.9 79.7 63.1 28.7 35.0 61.7 26.9 63.3 31.3 61.0 23.0 60.8 62.3 34.7 49.4 27.3 29.6 50.0 66.6 70.3 39.7 35.5 30.0 65.3 49.0 25.9 32.3 27.8 31.8 55.6 23.8 9.8 54.4 35.4 74.9 66.1 49.1 39.8 29.1 59.7 56.8 24.1 31.4 30.3 45.0 26.9 36.7 60.3 59.4 33.4 66.9 68.4 31.4 45.2 49.1 49.6 32.2 52.9 65.6 62.3 49.9 33.0 71.1 53.0 85.5 75.4 72.0 63.9 36.8 66.6 35.5 62.1 53.2 57.5 50.1 47.5 56.7 43.8 78.8 55.4 65.3 70.4 79.2 58.9 76.6 43.7 56.6 61.4 48.5 90.3 74.1 38.5 20.9 43.6 64.6 61.5 29.6 80.6 50.7 60.9 26.6 59.5 47.1 72.7 72.4 22.2 82.3 29.4 100.3 65.8 55.3 103.3 50.9 86.0 80.5 53.6 71.7 30.8 65.4 12.5 14.0 18.6 22.7 17.1 25.5 17.3 19.8 22.4 15.4 14.0 18.4 20.0 21.2 25.2 15.4 15.3 21.4 16.5 27.4 29.9 28.7 35.0 27.3 29.6 35.5 30.0 31.8 29.1 31.4 33.4 43.2 32.1 25.5 9.1 33.9 47.3 54.4 41.3 33.0 9.4 31.6 27.9 23.1 17.2 30.9 11.0 8.4 24.0 40.7 30.9 29.4 41.4 5.1 32.8 25.7 43.9 19.7 19.0 5.5 45.1 24.8 30.1 33.1 50.0 44.3 26.2 32.9 20.3 24.3 15.2 5.9 25.0 32.6 24.9 40.4 7.7 28.9 28.0 32.0 10.3 35.2 14.5 28.8 7.5 13.8 65.4 20.8 26.4 30.7 66.8 22.2 17.4 23.4 9.5 13.1 30.5 34.7 14.3 20.3 29.2 43.2 43.6 37.9 21.0 21.6 75.1 KAT5 "cPLA2, ESA1, HTATIP, HTATIP1, PLIP, TIP60, ZC2HC5" ENSG00000172977 "Lysine acetyltransferase 5" Q92993 11 65711996-65719604 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Growth regulation, Host-virus interaction, Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016953, HPA074328" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "Vesicles, Cytosol" "HPA016953: AB_1851277, HPA074328: " "unprognostic (2.20e-1)" "unprognostic (3.58e-1)" "unprognostic (3.59e-2)" "unprognostic (2.74e-1)" "unprognostic (9.61e-2)" "unprognostic (7.16e-2)" "unprognostic (1.29e-3)" "unprognostic (1.20e-1)" "unprognostic (2.01e-1)" "unprognostic (2.74e-1)" "unprognostic (2.13e-1)" "unprognostic (2.54e-1)" "prognostic favorable (1.10e-13)" "unprognostic (1.37e-1)" "unprognostic (2.55e-1)" "unprognostic (1.85e-1)" "unprognostic (8.54e-2)" 31.6 30.0 38.7 23.8 41.0 52.9 32.1 41.7 48.8 39.5 38.6 43.6 21.6 45.1 33.7 34.9 44.9 20.5 32.4 37.9 38.9 32.9 26.3 29.5 28.0 40.0 39.5 39.2 32.7 45.6 33.7 29.9 41.2 33.1 27.0 31.0 29.6 36.3 42.8 47.6 32.2 35.2 40.0 34.3 35.9 45.2 39.9 39.3 38.2 34.6 30.2 39.5 34.8 43.8 37.2 44.1 40.1 29.6 31.3 32.7 41.1 26.7 43.6 44.0 38.0 32.6 42.2 34.3 36.2 47.4 47.5 30.8 50.8 45.1 26.4 44.4 32.5 50.6 36.3 38.9 44.6 55.7 56.4 35.2 49.7 28.9 59.0 33.7 28.1 39.1 52.5 51.1 42.0 68.2 45.7 62.3 33.9 26.8 28.4 38.2 26.5 63.3 40.6 56.2 37.1 38.9 25.4 46.5 51.2 20.8 45.9 34.2 36.3 33.9 30.4 27.6 28.0 38.7 43.7 50.4 29.7 27.0 29.3 42.7 33.6 58.8 33.4 32.0 29.6 28.2 28.8 34.2 34.1 30.4 36.5 29.8 34.8 35.8 34.6 20.9 31.0 36.4 38.7 41.0 41.7 48.8 37.9 38.9 40.0 39.5 41.2 40.0 39.9 43.8 17.6 12.8 17.5 10.7 26.0 21.2 44.2 60.2 17.6 44.9 17.3 15.0 1.0 25.8 33.8 29.5 31.3 51.3 25.6 27.1 35.2 42.2 11.1 20.2 14.2 18.7 30.4 12.4 7.5 51.5 42.6 21.1 20.4 19.8 33.7 27.0 18.2 10.9 36.3 38.7 8.7 25.1 42.7 17.6 15.2 11.1 28.0 20.4 42.7 3.7 38.8 40.3 33.0 7.1 13.8 39.4 30.6 38.7 10.4 24.2 23.3 32.6 30.0 44.8 46.0 27.6 27.0 61.1 27.8 14.6 21.3 102.5 21.6 29.2 26.2 31.0 RNASEH2C "AGS3, AYP1" ENSG00000172922 "Ribonuclease H2 subunit C" Q8TDP1 11 65714005-65720818 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Aicardi-Goutieres syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 388.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065375 Supported Approved Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA065375: AB_2685481" "unprognostic (1.61e-1)" "unprognostic (6.84e-2)" "unprognostic (2.06e-1)" "unprognostic (1.37e-1)" "unprognostic (1.43e-1)" "unprognostic (2.26e-2)" "unprognostic (7.88e-3)" "unprognostic (1.13e-1)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "prognostic favorable (3.68e-5)" "unprognostic (1.48e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (3.72e-2)" "unprognostic (1.84e-1)" "unprognostic (1.67e-2)" "unprognostic (9.99e-2)" 17.4 23.8 15.7 9.6 16.4 19.6 16.8 16.8 19.4 30.6 16.4 35.0 8.5 27.3 6.5 14.6 28.2 6.3 18.9 15.9 15.5 27.5 16.8 16.4 13.9 15.3 15.7 34.0 16.9 7.5 32.3 5.5 16.1 34.4 3.9 7.7 16.5 9.6 10.1 11.9 25.0 6.1 14.5 33.1 23.1 13.3 15.8 9.8 22.1 3.6 8.0 27.9 22.2 17.6 13.5 12.9 16.6 13.1 13.3 6.3 5.4 7.4 4.6 18.6 15.4 15.8 15.4 19.9 7.7 6.8 24.1 19.5 14.0 10.3 12.2 13.5 30.2 20.2 40.9 7.4 2.3 3.5 17.7 7.3 3.6 16.7 4.7 11.0 8.0 21.4 10.9 22.7 7.8 19.9 33.9 19.0 10.3 6.4 15.6 27.1 11.3 27.4 4.9 7.8 20.6 20.4 3.5 14.5 8.1 5.1 17.6 7.1 8.2 17.9 15.7 18.3 11.7 20.6 6.3 6.7 26.6 16.8 14.8 3.3 14.6 3.7 9.2 10.7 9.9 12.7 6.2 6.8 9.2 12.8 7.6 5.7 3.0 11.2 8.0 23.3 6.9 9.8 15.7 16.4 16.8 19.4 15.9 15.5 15.3 15.7 16.1 14.5 15.8 17.6 94.0 25.6 39.9 8.5 90.6 31.6 109.5 59.8 23.9 26.7 82.2 102.7 69.8 94.4 44.5 68.0 8.4 73.5 89.5 64.6 105.7 62.6 40.0 34.1 75.5 77.7 128.4 124.2 14.3 46.6 107.8 89.5 32.6 36.7 65.4 168.7 104.6 103.6 128.0 23.5 12.5 52.7 42.7 93.6 51.4 138.2 135.8 73.1 64.0 7.5 90.7 47.5 145.2 8.5 16.9 43.4 83.1 100.1 119.0 74.5 132.5 271.4 37.5 23.5 111.7 66.1 101.7 66.5 68.5 44.1 36.9 208.0 68.6 388.0 53.9 95.9 AP5B1 "AP-5, DKFZp761E198, PP1030" ENSG00000254470 "Adaptor related protein complex 5 subunit beta 1" Q2VPB7 11 65773898-65780976 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 44.0" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 14 "neutrophil: 25.0" "Lineage enriched" "Detected in many" 14 "granulocytes: 25.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065739, HPA067880" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 4: Macrophages - Innate immune response" "Nucleoplasm, Vesicles" "Golgi apparatus" "HPA065739: AB_2685550, HPA067880: AB_2685914" "unprognostic (3.64e-1)" "unprognostic (9.40e-2)" "unprognostic (4.37e-3)" "unprognostic (1.45e-2)" "unprognostic (5.56e-3)" "unprognostic (1.09e-2)" "unprognostic (1.29e-2)" "unprognostic (3.26e-2)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.25e-1)" "unprognostic (2.15e-1)" "prognostic favorable (2.31e-5)" "unprognostic (2.03e-2)" "unprognostic (2.15e-2)" "unprognostic (2.45e-1)" "unprognostic (1.67e-1)" 8.3 4.8 3.2 6.9 2.6 44.0 6.6 5.8 3.6 5.4 1.3 6.0 5.7 7.1 2.0 10.2 5.2 3.1 5.0 3.6 1.2 5.7 5.8 8.7 4.7 3.9 1.5 2.9 10.3 6.4 3.5 3.8 3.0 5.0 3.0 2.5 7.0 4.5 9.6 9.1 6.8 3.2 1.1 10.0 6.0 2.5 1.8 4.8 4.9 3.4 4.3 6.6 5.1 1.6 12.8 9.8 2.8 14.3 8.6 4.1 16.4 5.3 6.2 6.1 4.7 7.7 6.0 7.8 9.4 6.3 12.4 15.8 8.7 4.3 2.9 12.1 10.1 7.0 12.0 3.8 5.8 9.9 13.3 7.0 10.1 4.0 2.9 6.0 5.2 13.6 15.6 9.7 3.6 9.2 5.5 10.5 4.6 4.4 10.1 17.3 0.5 16.8 5.9 15.8 2.7 5.4 4.1 2.6 26.0 3.7 4.4 14.1 7.6 10.2 8.6 13.6 6.0 10.0 11.2 8.1 7.5 8.5 10.5 1.1 1.7 0.6 0.5 1.0 0.2 0.3 0.2 0.2 0.5 0.3 0.3 0.2 25.0 0.4 1.3 0.3 0.2 0.8 3.2 2.6 5.8 3.6 3.6 1.2 3.9 1.5 3.0 1.1 1.8 1.6 2.0 0.0 8.8 6.2 3.9 2.4 12.3 4.3 7.4 5.0 4.2 2.0 1.6 2.8 3.7 7.3 14.6 7.6 5.9 12.8 1.9 8.9 1.4 6.3 2.9 3.0 3.0 0.0 3.6 13.6 18.2 2.9 6.6 10.7 2.5 5.3 1.4 7.1 14.0 11.8 3.2 3.8 6.1 12.4 2.1 0.7 0.6 11.6 7.2 3.7 17.8 3.0 6.2 1.0 2.2 9.4 6.9 3.8 3.6 5.6 10.1 8.8 2.9 8.0 0.0 3.7 3.0 0.6 4.7 6.0 2.3 34.9 4.3 2.0 4.5 10.0 OVOL1 HOVO1 ENSG00000172818 "Ovo like transcriptional repressor 1" O14753 11 65787063-65797214 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 57.2;skin 1: 51.0;testis: 35.5" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 113.2;Squamous epithelial cells: 130.8;Syncytiotrophoblasts: 348.9;Urothelial cells: 114.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 19.0;BEWO: 52.2;CACO-2: 13.6;HaCaT: 31.4;MCF7: 12.6;RT4: 31.2;SK-BR-3: 24.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA003984 Uncertain Approved Nucleoplasm Yes NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 28: BEWO - Transcription regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA003984: AB_1854854" "unprognostic (4.26e-3)" "unprognostic (3.39e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (3.37e-1)" "unprognostic (1.26e-2)" "unprognostic (1.95e-1)" "unprognostic (2.31e-2)" "unprognostic (2.01e-3)" "unprognostic (1.91e-1)" "prognostic favorable (1.00e-13)" "unprognostic (4.26e-2)" "unprognostic (3.51e-2)" "unprognostic (2.42e-1)" "unprognostic (9.04e-3)" 0.1 0.0 0.0 1.0 0.1 0.1 2.8 0.2 0.1 13.6 0.0 10.3 15.5 0.5 0.1 57.2 0.6 0.9 0.0 0.1 0.0 7.4 0.2 0.3 0.0 0.0 0.0 0.0 9.1 15.0 0.1 6.9 0.0 1.4 8.3 0.1 8.8 1.0 0.1 51.0 9.1 0.3 0.0 0.1 1.6 35.5 0.0 0.4 1.3 0.0 5.5 27.4 21.3 0.1 19.0 0.0 0.0 0.0 0.0 0.0 52.2 0.0 0.0 0.0 0.0 13.6 5.0 0.0 0.1 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 9.7 0.1 0.3 0.0 0.1 1.4 31.2 0.2 0.1 0.0 24.0 0.2 5.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.3 0.3 2.3 26.6 62.6 14.5 54.1 0.0 59.4 25.4 0.5 7.2 13.0 3.7 0.0 19.5 1.3 57.6 0.0 2.5 81.9 76.2 11.7 1.8 31.6 0.0 0.1 3.8 14.0 0.9 0.0 113.2 2.5 0.0 0.0 0.1 2.1 0.0 0.1 54.9 20.3 0.0 1.4 87.2 1.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 44.5 1.9 3.0 34.1 39.1 6.7 11.3 0.0 0.0 0.0 1.1 83.9 4.8 130.8 57.4 348.9 1.7 0.0 52.0 114.9 CFL1 CFL ENSG00000172757 "Cofilin 1" P23528 11 65823022-65862026 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013086, CAB033687, CAB037077, HPA053761" Approved Supported Cytosol NA NA 290000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 16: Pancreatic endocrine cells - Mixed function" Cytosol "CAB013086: AB_2533565, CAB033687: AB_1121774, CAB037077: AB_1078547, HPA053761: AB_2682251" "unprognostic (1.14e-1)" "unprognostic (2.37e-2)" "unprognostic (7.69e-3)" "unprognostic (4.32e-3)" "unprognostic (3.14e-2)" "unprognostic (2.09e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (1.59e-3)" "unprognostic (2.52e-1)" "unprognostic (5.88e-3)" "unprognostic (6.57e-3)" "unprognostic (2.09e-1)" "unprognostic (6.19e-3)" "unprognostic (1.72e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (2.06e-1)" 609.5 435.4 578.8 932.7 598.8 1322.1 514.5 590.1 661.2 451.5 475.3 1145.1 1169.2 713.1 343.2 706.0 481.5 413.6 501.9 637.3 599.8 612.5 471.0 683.4 987.6 626.4 571.5 344.7 264.6 301.8 340.6 479.2 622.1 440.6 990.3 208.9 453.1 457.6 261.9 503.1 1120.7 847.3 608.3 775.2 633.8 267.4 632.2 939.6 370.9 230.6 1100.5 682.9 471.2 695.4 2284.3 1783.6 1908.5 1529.8 1142.6 1157.0 1031.6 2309.7 1942.4 2457.5 1460.7 1012.4 1815.2 1700.8 1755.3 2925.7 1780.5 1623.2 1389.2 2103.8 1824.9 1869.0 718.2 2185.8 1271.2 1162.1 1222.6 1890.2 2854.6 1339.3 1412.4 2166.7 1108.0 1494.0 2663.1 1099.4 1037.6 1648.5 2635.7 2133.0 2739.4 2965.4 2095.8 1985.4 1432.7 2050.3 941.1 2181.9 1847.8 1468.6 952.7 2106.6 1250.6 1733.6 1682.2 1053.4 2104.1 1427.8 2330.5 2087.3 1603.5 2672.6 2194.0 1193.1 2065.2 2251.0 2146.2 1161.7 2004.4 1690.2 2720.0 2973.1 2534.0 2955.4 1964.6 1561.4 1992.5 2296.2 3343.8 1527.0 1459.3 1905.2 2946.2 1961.1 3255.3 2558.6 2696.1 6842.2 578.8 598.8 590.1 661.2 637.3 599.8 626.4 571.5 622.1 608.3 632.2 695.4 805.5 246.8 223.0 24.5 890.8 1349.3 1253.3 1197.1 598.8 198.5 655.2 646.0 74.8 459.0 595.7 520.5 58.4 1239.8 1439.8 2052.9 892.1 2114.0 459.4 376.6 648.1 918.4 779.0 557.7 38.8 1965.0 2470.6 579.0 642.8 603.3 598.2 527.4 698.2 436.3 2911.0 203.6 30.3 1448.8 891.1 1185.5 1706.6 373.2 352.2 1474.2 985.4 38.4 2903.8 478.3 2075.2 22.6 62.0 3082.4 1894.7 502.9 639.1 991.2 2279.4 1246.5 295.5 118.0 420.7 448.2 1184.3 177.4 412.8 703.8 1267.4 1732.4 1276.2 621.7 1315.3 1383.3 SNX32 "FLJ30934, SNX6B" ENSG00000172803 "Sorting nexin 32" Q86XE0 11 65833834-65856896 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 37.8;choroid plexus: 15.0" "Cell type enhanced" "Detected in some" "Astrocytes: 25.5;Early spermatids: 11.3;Excitatory neurons: 48.4;Inhibitory neurons: 34.2;Late spermatids: 12.3;Oligodendrocyte precursor cells: 12.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 4.5;HSkMC: 5.8;REH: 1.9;SH-SY5Y: 2.3;U-266/70: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041775 Uncertain Uncertain "Cell Junctions,Focal adhesion sites" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Cell Junctions, Focal adhesion sites" "HPA041775: AB_10797268" "unprognostic (6.74e-4)" "unprognostic (1.06e-1)" "unprognostic (1.67e-2)" "unprognostic (4.50e-5)" "unprognostic (1.00e-1)" "unprognostic (9.28e-2)" "unprognostic (7.30e-2)" "unprognostic (9.17e-3)" "unprognostic (2.70e-1)" "unprognostic (2.87e-1)" "unprognostic (5.08e-2)" "unprognostic (1.52e-1)" "unprognostic (3.64e-4)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (9.80e-2)" "unprognostic (5.36e-2)" 0.3 0.1 22.8 0.1 24.0 0.3 0.3 17.1 37.8 0.6 15.0 1.0 1.0 0.7 0.2 0.1 0.7 0.8 0.2 23.7 17.8 0.2 0.0 0.1 0.1 18.1 18.2 0.7 0.1 0.2 0.4 0.0 18.3 0.2 0.4 1.1 0.0 0.1 0.0 0.4 0.5 0.5 16.9 0.2 0.2 2.1 18.7 0.4 0.1 0.2 0.2 0.4 0.2 23.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 0.0 0.5 5.8 0.1 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.3 0.0 0.4 0.2 0.1 0.0 0.0 1.9 0.0 1.8 0.0 0.0 0.0 2.3 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 7.0 1.2 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.3 0.1 0.7 0.0 0.3 0.2 0.3 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.3 0.0 22.8 24.0 17.1 37.8 23.7 17.8 18.1 18.2 18.3 16.9 18.7 23.1 0.3 0.0 0.6 25.5 0.6 0.4 0.3 0.0 1.2 2.4 0.7 1.0 0.8 0.0 0.6 0.0 0.0 0.1 0.1 0.6 0.0 0.1 11.3 0.3 3.6 0.6 0.0 0.8 48.4 0.0 0.4 0.9 1.1 0.5 3.8 2.8 0.4 0.0 0.3 0.0 34.2 0.8 0.0 0.3 0.3 12.3 0.3 0.2 1.8 3.7 0.0 0.9 1.0 12.1 10.2 0.2 0.5 1.2 0.5 0.2 3.9 0.4 0.7 0.6 0.0 1.0 0.8 6.1 1.7 0.5 0.4 0.0 0.7 1.3 1.7 0.1 MUS81 "FLJ44872, SLX3" ENSG00000172732 "MUS81 structure-specific endonuclease subunit" Q96NY9 11 65857126-65867653 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 130.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059530 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 34: Spermatids - Unknown function" "Nucleoli fibrillar center" Nucleoplasm "HPA059530: AB_2684052" "unprognostic (2.34e-3)" "unprognostic (2.52e-1)" "unprognostic (8.68e-2)" "unprognostic (1.35e-1)" "unprognostic (6.31e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (6.05e-4)" "unprognostic (2.06e-1)" "unprognostic (7.18e-2)" "unprognostic (5.24e-2)" "unprognostic (9.64e-2)" "unprognostic (4.27e-2)" "unprognostic (1.05e-3)" "unprognostic (5.37e-2)" "unprognostic (2.98e-1)" "unprognostic (1.20e-1)" "unprognostic (8.86e-2)" 20.6 18.0 15.2 13.3 15.6 11.3 20.3 15.7 20.0 32.0 14.4 31.4 16.9 35.4 7.7 16.9 30.8 10.9 25.3 14.6 13.4 28.8 19.4 21.6 18.6 16.6 15.6 29.8 19.9 10.2 22.4 11.0 15.9 26.2 7.1 8.1 16.6 15.9 24.3 14.1 23.7 12.4 14.8 29.0 22.5 16.6 16.7 16.1 23.5 16.9 13.6 29.7 22.5 18.8 21.6 13.3 22.1 22.0 9.5 11.5 28.2 22.7 17.9 28.2 18.8 17.7 34.4 20.4 30.0 17.8 35.2 20.6 19.9 19.9 6.3 44.5 14.7 37.3 39.8 10.8 29.0 26.9 38.2 18.3 36.2 35.8 28.0 20.7 24.0 36.5 22.9 55.4 18.7 14.2 38.1 41.0 16.1 14.1 29.2 37.2 10.6 39.7 21.5 13.3 22.1 25.3 15.5 27.7 48.7 13.5 32.6 27.3 21.5 21.2 18.0 27.3 24.9 37.6 26.9 29.7 24.1 17.5 36.3 22.6 13.7 27.4 21.0 16.3 21.0 13.1 15.9 18.4 14.7 10.4 12.3 15.4 9.4 13.3 18.5 14.7 15.1 13.0 15.2 15.6 15.7 20.0 14.6 13.4 16.6 15.6 15.9 14.8 16.7 18.8 19.3 12.8 18.4 15.0 17.2 8.0 21.5 13.5 10.2 19.2 11.8 15.6 10.0 11.5 16.0 7.3 20.9 20.8 22.0 27.0 5.9 24.7 62.8 12.2 22.0 16.1 16.8 25.7 9.0 22.2 23.6 13.5 27.0 13.0 14.0 15.0 16.8 9.2 19.6 23.5 8.8 23.9 10.2 13.3 8.8 130.0 21.8 14.3 10.6 9.4 27.1 15.0 32.0 8.5 12.9 26.6 24.5 27.1 12.6 11.0 36.1 12.4 16.0 24.7 39.5 11.5 21.9 27.9 16.7 8.4 7.4 19.7 19.9 15.0 21.4 10.2 EFEMP2 "FBLN4, UPH1" ENSG00000172638 "EGF containing fibulin extracellular matrix protein 2" O95967 11 65866441-65873592 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Fibroblasts: 122.8;Leydig cells: 93.5;Muller glia cells: 84.8;Peritubular cells: 107.2;Smooth muscle cells: 113.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 125.8;BJ hTERT+: 159.7;fHDF/TERT166: 232.6;HSkMC: 155.3;hTERT-RPE1: 159.1;LHCN-M2: 134.5;U-138 MG: 114.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023270 Approved "Secreted to extracellular matrix" NA NA 2600000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "HPA023270: AB_1848019" "unprognostic (3.13e-1)" "unprognostic (2.15e-3)" "unprognostic (3.23e-2)" "unprognostic (5.11e-2)" "unprognostic (8.57e-3)" "unprognostic (1.50e-1)" "unprognostic (1.67e-1)" "unprognostic (6.52e-2)" "unprognostic (1.13e-2)" "unprognostic (1.71e-1)" "unprognostic (4.89e-2)" "unprognostic (9.12e-2)" "prognostic unfavorable (3.94e-5)" "unprognostic (8.33e-3)" "unprognostic (6.35e-2)" "unprognostic (2.37e-1)" "unprognostic (2.58e-2)" 38.4 18.0 19.8 13.8 21.1 2.8 29.5 18.8 26.7 46.6 22.1 39.6 9.3 55.2 8.3 12.8 35.8 33.5 61.6 19.1 20.4 26.8 7.0 32.1 9.1 24.9 20.0 47.0 19.9 26.8 15.2 22.4 21.4 31.1 6.5 5.9 17.4 35.2 21.2 14.9 16.2 32.3 20.3 16.1 20.6 8.2 21.4 5.6 39.1 22.0 5.0 33.1 30.7 19.1 0.5 0.2 2.1 47.3 54.3 108.0 0.8 125.8 159.7 48.1 44.8 0.0 4.3 0.7 9.3 232.6 0.7 0.9 0.0 1.3 12.1 5.4 0.1 1.1 3.2 8.0 89.1 0.0 0.4 155.3 0.4 18.9 1.0 159.1 28.5 1.0 0.3 8.0 134.5 0.4 0.2 20.7 1.6 0.2 0.6 0.4 0.3 3.2 1.6 0.6 0.7 14.1 0.2 1.3 1.5 6.6 1.5 10.0 64.6 114.2 24.7 52.6 0.6 10.9 0.7 0.3 42.6 0.8 19.7 0.0 0.1 0.5 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.7 0.0 0.0 0.0 0.2 19.8 21.1 18.8 26.7 19.1 20.4 24.9 20.0 21.4 20.3 21.4 19.1 30.8 35.3 7.4 29.0 1.5 13.5 38.9 33.9 8.6 7.7 10.2 27.6 46.0 15.7 11.4 18.4 0.0 2.4 2.3 0.3 7.9 28.7 15.6 3.4 57.1 27.9 0.0 0.4 1.1 0.2 3.9 122.8 2.6 4.1 0.0 74.3 42.8 1.8 9.8 6.7 2.9 0.3 4.1 3.5 19.1 33.3 93.5 3.0 24.9 9.4 0.7 84.8 2.1 9.5 1.6 2.6 0.1 107.2 1.4 30.1 0.2 21.2 9.0 4.8 39.5 41.1 113.2 35.9 3.3 1.1 10.1 5.9 2.4 78.5 0.3 14.2 CTSW ENSG00000172543 "Cathepsin W" P56202 11 65879809-65883741 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 116.3;lymphoid tissue: 42.4" "Group enriched" "Detected in many" 9 "dendritic cells: 717.8;NK-cells: 867.2;T-cells: 352.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 8 "gdT-cell: 1376.3;MAIT T-cell: 869.4;memory CD8 T-cell: 892.8;naive CD8 T-cell: 636.3;NK-cell: 2276.1" "Group enriched" "Detected in all" 39 "NK-cells: 2276.1;T-cells: 1376.3" "Group enriched" "Detected in some" 22 "HEL: 156.7;NB-4: 363.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB016345, HPA066903" Enhanced "Intracellular and membrane" NA NA 270000 "Cluster 48: NK-cells - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "CAB016345: AB_626813, HPA066903: " "prognostic favorable (3.06e-4)" "unprognostic (2.06e-2)" "unprognostic (2.71e-2)" "prognostic favorable (8.36e-6)" "unprognostic (1.21e-1)" "prognostic favorable (9.89e-4)" "unprognostic (5.69e-2)" "unprognostic (1.09e-2)" "unprognostic (1.25e-3)" "unprognostic (5.14e-3)" "unprognostic (2.83e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (8.84e-6)" "unprognostic (3.86e-2)" "unprognostic (3.78e-1)" "unprognostic (1.26e-1)" "unprognostic (4.01e-3)" 5.1 2.9 0.8 12.9 0.9 116.3 3.7 1.8 1.6 2.6 0.6 5.6 6.1 6.7 2.8 3.1 4.0 6.2 2.9 0.8 0.9 2.1 6.5 24.0 29.5 1.6 0.7 2.4 1.8 0.5 1.1 3.3 1.2 2.1 6.3 0.0 9.1 3.9 1.3 2.7 6.1 2.7 1.2 42.4 8.3 1.2 1.1 7.8 3.2 0.4 13.9 8.6 2.5 1.1 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 156.7 0.3 0.0 0.0 11.8 0.4 0.0 0.0 0.0 0.1 0.0 0.0 5.0 0.0 9.1 0.2 0.2 1.9 363.4 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 1.1 0.0 0.0 5.6 0.1 0.0 0.1 0.4 0.1 0.3 0.5 0.0 0.2 9.9 0.3 46.4 3.4 4.8 1376.3 4.0 869.4 5.1 145.3 892.8 37.6 3.7 86.0 636.3 25.7 2276.1 5.4 23.3 23.7 809.3 0.8 0.9 1.8 1.6 0.8 0.9 1.6 0.7 1.2 1.2 1.1 1.1 5.1 0.0 4.2 0.0 9.7 4.6 0.4 0.0 1.8 0.0 2.3 2.2 0.4 2.8 1.4 0.0 0.0 0.4 717.8 0.3 0.0 0.3 2.0 0.9 0.9 1.9 0.0 44.1 0.0 0.0 0.2 4.0 12.8 1.1 71.7 0.1 5.7 1.6 1.9 0.0 0.0 0.2 0.0 5.6 34.1 11.1 0.0 9.9 17.8 0.0 6.1 0.0 867.2 0.0 0.2 0.0 0.0 0.0 57.7 0.3 0.0 1.1 0.8 0.0 0.0 1.6 1.9 0.3 1.2 0.8 6.3 0.3 352.6 0.1 0.3 0.3 FIBP FGFIBP ENSG00000172500 "FGF1 intracellular binding protein" O43427 11 65883740-65888531 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 608.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011729 Approved Supported "Nuclear speckles" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "Nuclear speckles" "HPA011729: AB_1848579" "unprognostic (1.70e-1)" "unprognostic (6.06e-2)" "unprognostic (1.06e-1)" "unprognostic (3.35e-1)" "unprognostic (1.37e-1)" "unprognostic (4.49e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (2.23e-1)" "unprognostic (2.95e-1)" "unprognostic (3.10e-3)" "unprognostic (2.13e-1)" "unprognostic (1.29e-1)" "unprognostic (5.50e-2)" "unprognostic (2.39e-1)" "unprognostic (3.18e-1)" "unprognostic (1.83e-2)" "unprognostic (4.89e-2)" 34.1 48.4 48.0 26.8 49.0 32.2 33.0 48.0 55.1 31.1 41.8 30.8 30.4 35.9 29.4 35.6 37.2 22.3 56.8 51.0 50.5 48.3 37.1 31.6 35.6 53.3 47.6 28.6 39.0 32.8 31.2 25.1 54.3 30.6 27.3 19.8 27.9 24.6 53.6 45.7 35.3 30.9 46.6 43.3 37.7 64.9 49.9 40.3 35.9 56.1 42.9 29.7 28.3 47.8 61.0 86.9 48.3 118.6 72.8 91.2 35.9 54.8 110.9 74.3 62.0 36.1 83.1 79.7 98.2 124.1 35.9 65.2 48.5 121.0 48.1 93.7 62.2 77.3 84.1 54.7 99.8 100.7 64.4 73.8 68.3 54.1 114.4 60.0 93.7 61.5 27.4 139.4 98.9 198.2 78.9 88.0 47.8 61.5 130.7 104.9 45.6 196.3 88.5 79.6 87.8 80.4 60.3 110.6 110.5 32.5 113.0 58.1 86.3 79.7 66.4 130.9 40.3 73.8 87.6 48.4 101.1 73.6 30.7 123.5 121.2 98.9 71.1 136.9 74.4 100.7 67.2 64.9 164.7 83.1 52.7 57.0 20.4 101.1 150.0 84.1 100.6 109.4 48.0 49.0 48.0 55.1 51.0 50.5 53.3 47.6 54.3 46.6 49.9 47.8 55.8 12.8 28.0 4.9 57.0 47.3 51.7 105.7 38.7 47.7 66.9 85.6 44.7 42.9 55.7 44.1 31.3 79.4 41.1 61.6 93.9 114.2 176.7 45.3 59.8 52.6 93.5 39.1 7.1 149.3 125.7 50.3 37.2 39.6 67.2 68.6 45.3 36.5 115.0 42.1 7.3 49.2 57.0 75.3 75.9 608.0 36.1 67.9 51.6 3.7 129.3 47.1 101.0 3.5 5.6 98.9 68.8 39.5 60.1 56.1 185.8 150.1 54.9 52.8 19.7 39.2 77.2 100.5 84.0 51.5 52.1 71.8 54.6 79.6 58.8 61.5 CCDC85B DIPA ENSG00000175602 "Coiled-coil domain containing 85B" Q15834 11 65890673-65891635 "Predicted intracellular proteins" "Differentiation, Growth regulation, Host-virus interaction, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 437.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 251.3;WM-115: 244.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054415 Uncertain NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 51: Myeloid cells - Hemostasis" "HPA054415: AB_2682481" "unprognostic (4.58e-2)" "unprognostic (1.64e-2)" "unprognostic (9.74e-2)" "unprognostic (1.40e-1)" "unprognostic (3.43e-1)" "unprognostic (8.01e-2)" "unprognostic (3.99e-2)" "unprognostic (2.43e-2)" "unprognostic (3.02e-2)" "unprognostic (1.31e-1)" "unprognostic (9.87e-2)" "unprognostic (5.33e-2)" "prognostic unfavorable (3.78e-5)" "unprognostic (4.44e-1)" "unprognostic (1.69e-1)" "unprognostic (1.60e-1)" "unprognostic (9.87e-2)" 60.3 48.5 66.9 8.7 47.4 12.2 42.4 26.1 119.8 37.5 0.6 45.3 7.5 45.6 1.2 30.7 44.6 2.0 83.8 85.2 21.2 33.7 23.0 53.3 5.1 51.3 32.2 43.0 25.7 1.8 27.0 5.8 38.8 37.9 0.8 1.4 16.8 5.0 49.7 43.5 26.0 2.2 30.5 57.6 32.1 22.9 62.8 1.4 31.7 1.9 1.9 50.0 35.4 45.9 136.2 19.9 4.6 19.6 6.7 12.4 17.4 123.9 16.9 5.9 7.1 5.8 45.9 87.0 118.0 9.0 34.0 61.7 2.4 9.4 0.6 94.2 43.6 63.8 12.7 20.3 10.1 56.2 30.3 11.0 3.5 5.2 8.3 15.1 20.3 12.2 50.0 29.2 4.3 50.9 37.2 180.7 59.1 3.2 251.3 98.5 37.5 79.2 3.4 4.1 42.2 46.1 34.7 21.1 128.4 0.8 16.0 17.8 134.6 50.4 77.7 131.0 86.4 32.3 38.8 22.1 90.8 47.3 244.8 1.8 9.0 20.7 15.9 6.5 21.6 23.3 18.7 22.0 8.3 19.5 24.8 19.9 1.6 16.0 10.8 16.3 16.1 5.1 66.9 47.4 26.1 119.8 85.2 21.2 51.3 32.2 38.8 30.5 62.8 45.9 382.8 0.0 4.2 13.7 126.0 275.6 173.8 59.7 171.4 181.4 103.4 171.8 27.5 35.8 17.5 36.8 150.1 18.4 177.2 47.8 33.2 41.6 6.5 30.5 159.9 362.1 57.6 64.1 33.7 70.6 53.1 112.9 38.2 36.1 85.2 90.6 437.6 38.5 99.5 101.0 30.2 46.7 28.5 152.9 188.6 17.8 84.5 150.3 156.5 22.5 168.9 121.9 346.1 19.1 16.3 49.8 12.6 100.8 91.7 177.0 24.3 32.9 17.8 102.3 164.3 71.4 143.0 3.9 20.5 111.8 212.1 19.0 167.0 121.0 54.9 95.4 FOSL1 fra-1 ENSG00000175592 "FOS like 1, AP-1 transcription factor subunit" P15407 11 65892049-65900573 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 56.4;urinary bladder: 84.3" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 338.0;Basal prostatic cells: 398.5;Basal squamous epithelial cells: 281.1;Prostatic glandular cells: 196.9;Squamous epithelial cells: 210.4;Suprabasal keratinocytes: 339.5;Urothelial cells: 456.4" "Cancer enhanced" "Detected in all" "head and neck cancer: 51.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "myeloid DC: 3.4" "Lineage enriched" "Detected in single" 4 "dendritic cells: 3.4" "Cell line enhanced" "Detected in many" "PC-3: 829.4;U-2197: 520.1;WM-115: 1123.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB004396, HPA030728" Enhanced Supported Nucleoplasm NA Yes "Cluster 28: Myeloid DCs - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 17: WM-115 - Nervous system development" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "CAB004396: AB_627632, HPA030728: " "unprognostic (2.88e-2)" "unprognostic (1.56e-1)" "unprognostic (9.46e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.80e-4)" "prognostic unfavorable (2.05e-4)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.12e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (9.26e-5)" "unprognostic (7.85e-2)" "prognostic unfavorable (6.40e-6)" "unprognostic (2.23e-1)" "unprognostic (1.53e-1)" "unprognostic (2.28e-1)" "unprognostic (2.82e-2)" 56.4 11.2 1.2 7.7 1.3 26.8 10.5 2.2 4.3 6.0 1.0 7.4 1.0 3.5 0.1 48.9 8.5 29.6 11.9 1.6 1.7 12.6 5.6 16.7 0.3 1.9 1.4 1.7 12.9 0.5 4.8 2.7 2.1 6.4 1.9 0.6 11.0 0.8 4.1 25.2 5.5 4.7 1.0 1.7 21.0 0.9 1.9 2.7 5.3 0.3 2.1 84.3 13.8 1.0 324.3 43.8 5.4 20.4 45.7 44.4 45.0 288.5 257.2 239.7 131.7 14.2 252.6 0.5 65.1 199.7 379.6 60.6 19.6 227.4 210.8 9.7 0.7 20.6 4.5 34.9 57.0 13.3 6.9 18.8 23.1 191.1 297.1 117.9 80.4 0.2 48.8 1.7 320.9 12.3 0.3 26.5 21.5 27.0 829.4 1.5 25.7 1.3 116.7 20.4 0.4 0.5 18.2 0.8 229.0 13.0 1.0 12.1 200.6 282.5 62.7 520.1 423.8 0.3 1.4 0.9 389.7 4.9 1123.6 0.0 0.8 0.0 0.1 0.5 0.0 0.0 0.2 0.1 3.4 0.0 0.2 0.0 0.5 0.0 0.3 0.4 0.0 0.5 1.2 1.3 2.2 4.3 1.6 1.7 1.9 1.4 2.1 1.0 1.9 1.0 15.2 6.4 4.4 0.3 2.0 338.0 398.5 56.2 281.1 0.0 27.6 12.2 1.0 4.3 26.2 0.0 0.0 1.3 4.3 11.8 0.0 25.1 0.3 24.4 12.2 30.1 11.3 0.8 0.1 3.5 4.3 45.8 74.9 56.3 9.5 0.3 6.1 0.4 1.9 0.0 0.1 6.8 10.2 1.0 46.6 0.0 0.3 15.5 44.4 1.0 1.1 0.1 0.0 0.5 0.2 39.0 11.1 0.0 6.2 196.9 1.2 0.2 10.7 0.0 0.0 32.4 26.1 0.4 0.7 210.4 339.5 17.6 6.8 0.1 4.2 456.4 C11orf68 "BLES03, P5326" ENSG00000175573 "Chromosome 11 open reading frame 68" Q9H3H3 11 65916810-65919062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045938 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" No Yes "Cluster 10: Basophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA045938: AB_10961633" "unprognostic (3.18e-1)" "unprognostic (3.35e-2)" "unprognostic (2.38e-2)" "unprognostic (4.48e-2)" "unprognostic (1.23e-1)" "unprognostic (9.25e-2)" "unprognostic (1.15e-2)" "unprognostic (9.88e-2)" "unprognostic (5.98e-2)" "unprognostic (9.88e-2)" "unprognostic (2.73e-1)" "unprognostic (1.50e-3)" "prognostic favorable (5.02e-6)" "unprognostic (2.16e-1)" "unprognostic (3.55e-1)" "unprognostic (3.07e-2)" "unprognostic (1.18e-1)" 36.0 29.3 68.1 14.9 70.3 10.1 33.5 74.7 82.3 50.4 59.4 50.1 17.2 56.1 39.0 29.7 40.5 20.7 50.7 71.0 65.1 31.2 28.0 31.9 24.8 69.0 67.0 43.4 27.2 25.6 24.0 23.4 67.6 42.6 15.7 12.5 30.9 31.7 81.1 32.8 31.0 27.0 66.3 41.6 32.8 53.9 67.9 29.1 32.6 51.4 21.3 45.9 39.5 71.4 76.4 33.6 20.4 22.2 70.0 67.3 17.6 59.7 90.2 74.3 45.2 12.6 83.9 15.6 40.6 89.5 118.6 24.0 15.9 36.6 39.8 24.2 16.1 18.5 23.4 33.2 55.7 14.9 23.7 62.9 53.8 53.9 58.9 76.6 56.1 26.1 25.1 37.7 136.2 34.5 19.7 35.9 20.5 16.5 165.8 28.8 23.1 44.4 39.6 14.5 13.9 21.6 23.1 30.1 59.8 21.0 39.0 14.0 61.4 118.0 57.9 162.1 30.9 25.3 11.9 13.1 69.8 11.1 94.1 6.8 2.5 3.7 5.3 3.9 3.8 3.0 3.4 4.4 2.0 5.3 5.2 5.2 9.1 3.8 2.1 2.7 4.2 2.2 68.1 70.3 74.7 82.3 71.0 65.1 69.0 67.0 67.6 66.3 67.9 71.4 17.8 16.0 5.1 6.5 7.3 15.3 32.9 4.2 6.8 11.4 14.7 22.5 16.6 14.3 2.3 16.5 10.4 16.4 14.5 10.8 7.9 14.5 7.9 8.1 17.8 13.8 4.8 2.1 7.9 11.7 16.5 18.5 7.1 11.8 3.8 12.9 18.2 10.5 14.2 16.8 7.5 13.1 4.1 13.9 7.5 24.5 21.5 8.7 10.6 7.5 14.1 26.7 22.6 4.5 8.6 19.3 3.4 35.3 3.6 23.2 11.8 5.4 1.9 9.9 19.7 13.5 16.4 15.0 17.1 6.2 12.8 21.9 8.3 23.3 9.2 31.3 DRAP1 NC2-alpha ENSG00000175550 "DR1 associated protein 1" Q14919 11 65919274-65921563 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 813.2;Suprabasal keratinocytes: 1015.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 1032.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006790 Uncertain Approved Cytosol NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 43: Testis - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 28: Keratinocytes - Keratinization" Cytosol "HPA006790: AB_1078702" "unprognostic (1.69e-2)" "unprognostic (1.02e-2)" "unprognostic (1.01e-1)" "unprognostic (3.01e-2)" "unprognostic (1.84e-2)" "unprognostic (4.06e-2)" "unprognostic (4.89e-3)" "unprognostic (5.58e-2)" "unprognostic (8.47e-2)" "unprognostic (4.23e-2)" "unprognostic (1.98e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (3.73e-5)" "unprognostic (4.70e-2)" "unprognostic (1.38e-1)" "prognostic favorable (4.96e-5)" "unprognostic (1.62e-1)" 87.4 86.4 119.0 71.0 120.8 96.8 80.3 121.2 162.8 91.0 103.7 104.4 56.1 89.3 27.9 107.5 74.0 34.9 129.2 120.3 132.4 75.0 76.2 75.1 71.0 119.9 119.6 67.4 73.3 62.6 81.2 43.1 121.5 73.1 21.1 25.1 58.3 48.0 197.1 112.5 62.9 40.2 118.1 85.6 69.9 173.1 120.7 96.6 118.9 78.5 39.2 84.2 83.4 131.6 578.7 226.8 108.3 200.0 99.9 195.3 75.9 634.9 273.2 344.1 223.6 85.6 302.7 142.2 277.3 420.3 395.5 222.7 42.7 292.0 138.2 187.7 70.1 173.4 103.8 85.4 186.0 145.8 228.2 123.7 126.6 365.8 246.7 191.4 142.2 138.9 78.5 223.6 377.4 301.9 255.0 263.6 167.5 73.1 575.9 216.3 107.1 305.4 113.6 82.3 122.2 137.7 149.6 137.8 348.9 46.1 188.2 104.8 413.0 470.1 461.4 1032.4 556.2 201.8 186.6 149.9 490.1 91.4 650.8 146.5 118.9 290.5 131.0 311.9 117.5 139.5 116.3 136.6 183.2 124.2 114.6 123.3 164.6 194.6 538.9 136.8 148.5 112.7 119.0 120.8 121.2 162.8 120.3 132.4 119.9 119.6 121.5 118.1 120.7 131.6 116.7 6.4 30.5 9.1 131.8 813.2 199.3 238.8 139.5 56.9 122.9 189.0 32.9 64.3 89.8 130.6 35.5 136.6 166.9 111.7 283.7 202.8 128.9 78.6 142.8 110.6 151.9 195.7 11.5 170.7 161.9 130.2 58.1 98.9 238.0 78.9 92.1 96.4 298.5 63.9 10.8 120.4 142.4 152.4 462.0 85.7 179.3 208.1 247.3 14.0 241.9 79.9 286.3 11.6 22.9 289.9 126.2 173.0 131.7 423.3 144.8 257.8 54.4 47.9 92.1 90.1 194.1 131.0 171.1 163.8 1015.8 174.4 197.2 107.1 125.0 425.3 TSGA10IP "FAM161C, FLJ32880" ENSG00000175513 "Testis specific 10 interacting protein" Q3SY00 11 65945445-65959963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 10.0" "Group enriched" "Detected in some" 5 "Early spermatids: 54.6;Late spermatids: 59.8" "Group enriched" "Detected in some" 7 "testis cancer: 1.5;thyroid cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 78: Testis - Spermatogenesis" "Cluster 5: NTERA-2 - Transcription" "Cluster 34: Spermatids - Unknown function" "unprognostic (1.69e-1)" "unprognostic (8.39e-3)" "unprognostic (3.84e-1)" "unprognostic (6.76e-2)" "unprognostic (2.31e-1)" "unprognostic (3.57e-4)" "unprognostic (8.66e-2)" "unprognostic (8.53e-3)" "unprognostic (1.69e-1)" "unprognostic (1.11e-1)" "unprognostic (5.47e-2)" "unprognostic (5.61e-1)" "unprognostic (1.62e-4)" "unprognostic (8.96e-2)" "unprognostic (2.31e-1)" "unprognostic (7.35e-2)" "unprognostic (6.66e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.6 0.0 59.8 0.9 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SART1 "Ara1, HAF, SNRNP110, Snu66" ENSG00000175467 "Spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP" O43290 11 65961728-65980137 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Allergen, Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031188, HPA031189, HPA031190" Supported Enhanced "Nuclear speckles,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Nuclear speckles" "Golgi apparatus" "HPA031188: AB_10600092, HPA031189: AB_10601854, HPA031190: AB_10602289" "unprognostic (2.93e-2)" "unprognostic (1.13e-2)" "unprognostic (1.09e-2)" "unprognostic (1.76e-1)" "unprognostic (1.45e-1)" "unprognostic (6.99e-2)" "unprognostic (2.52e-3)" "unprognostic (8.15e-2)" "unprognostic (8.97e-2)" "unprognostic (2.10e-1)" "unprognostic (2.11e-2)" "unprognostic (3.05e-1)" "unprognostic (1.39e-1)" "unprognostic (1.04e-1)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (4.24e-2)" 24.6 18.3 15.5 18.3 16.8 41.6 23.1 15.4 17.4 29.2 14.7 26.0 15.6 29.1 8.0 22.7 25.6 8.6 23.2 14.9 16.1 20.4 21.8 22.9 20.3 16.6 16.2 29.2 25.8 11.7 21.4 14.0 15.9 21.7 7.7 8.0 22.2 14.4 38.1 32.0 24.3 10.9 14.6 32.7 24.8 23.5 15.7 20.9 23.5 13.0 13.3 26.2 24.6 17.9 50.4 60.8 27.2 36.8 26.1 20.7 40.8 37.5 27.2 43.8 28.6 44.2 34.3 56.9 42.4 33.8 52.9 48.7 34.6 35.6 22.0 45.8 33.5 65.6 43.6 41.4 39.0 57.4 52.7 26.2 26.4 40.8 36.3 17.4 27.6 42.3 42.2 39.8 25.6 92.6 74.0 83.5 45.7 27.3 55.9 80.8 39.0 60.7 18.4 33.7 30.5 43.0 35.6 37.2 45.5 12.6 41.7 47.0 40.6 54.5 53.0 53.9 54.1 59.6 49.4 48.3 45.0 28.8 47.0 1.4 2.8 8.1 4.3 3.5 3.6 3.9 4.8 4.4 3.6 3.5 3.5 3.9 4.1 2.8 2.0 3.2 5.4 1.8 15.5 16.8 15.4 17.4 14.9 16.1 16.6 16.2 15.9 14.6 15.7 17.9 17.5 6.4 9.1 7.8 27.8 22.7 24.0 12.2 17.6 19.2 12.2 9.1 9.4 21.5 11.3 16.5 10.4 34.1 27.2 30.5 5.9 23.7 9.0 14.2 16.3 19.8 12.5 32.8 5.1 29.3 31.9 17.6 21.9 16.8 32.4 21.8 21.0 15.6 29.4 16.8 4.8 26.5 16.2 22.5 23.6 8.7 37.0 22.9 17.8 6.5 35.7 23.8 34.0 7.1 7.8 26.3 20.1 33.1 31.2 20.5 28.3 18.5 17.5 26.0 32.9 27.6 34.9 26.7 29.7 18.3 21.7 45.3 28.4 15.5 27.5 18.2 EIF1AD "haponin, MGC11102" ENSG00000175376 "Eukaryotic translation initiation factor 1A domain containing" Q8N9N8 11 65996545-66002176 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054991, HPA058735" Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 16: U-266 - Nucleosome" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Vesicles" Cytosol "HPA054991: AB_2682664, HPA058735: AB_2683802" "unprognostic (1.11e-1)" "unprognostic (8.83e-2)" "unprognostic (3.03e-1)" "prognostic unfavorable (3.59e-5)" "unprognostic (1.30e-2)" "unprognostic (5.69e-2)" "prognostic unfavorable (8.63e-5)" "unprognostic (1.86e-2)" "unprognostic (1.17e-1)" "unprognostic (8.76e-2)" "unprognostic (1.36e-3)" "unprognostic (2.31e-1)" "unprognostic (1.59e-3)" "unprognostic (7.63e-3)" "unprognostic (1.40e-1)" "unprognostic (1.28e-3)" "unprognostic (3.96e-1)" 15.7 17.7 15.3 19.9 15.8 44.6 16.0 18.7 19.8 13.1 14.4 15.8 15.1 15.9 16.2 21.0 15.3 13.0 17.1 16.4 17.7 15.2 17.3 15.0 23.4 16.1 15.7 20.4 19.2 17.1 16.6 21.1 16.3 13.4 14.7 16.6 16.8 14.9 27.2 23.1 16.9 14.8 14.8 20.0 16.1 19.4 17.3 19.9 13.8 23.3 27.6 17.1 14.5 18.4 51.0 43.9 35.0 35.9 27.6 28.8 32.8 36.4 34.6 44.2 37.7 44.8 47.5 38.2 62.6 41.2 38.0 34.9 42.2 48.8 41.5 35.1 21.7 54.4 52.0 46.4 33.7 50.3 41.8 24.1 41.9 65.3 44.1 31.2 31.0 40.9 81.1 54.4 64.7 68.7 46.6 55.1 25.9 23.3 47.5 50.3 35.9 75.0 25.6 31.8 26.5 31.2 39.3 54.7 41.5 28.1 53.1 31.0 36.5 59.7 39.9 47.8 36.1 66.7 85.5 79.8 42.9 33.8 39.5 52.6 20.5 13.5 17.7 16.6 13.6 19.4 15.0 13.0 21.3 19.0 14.1 13.5 13.1 16.4 21.3 12.7 15.3 13.3 15.3 15.8 18.7 19.8 16.4 17.7 16.1 15.7 16.3 14.8 17.3 18.4 8.2 3.2 5.4 3.3 16.2 37.7 12.2 13.4 12.5 7.2 14.2 9.1 16.2 14.3 7.3 5.5 14.6 16.3 17.7 11.6 15.6 12.7 18.3 9.0 8.3 11.6 2.4 21.0 3.0 13.1 23.0 11.4 7.1 10.5 12.7 31.7 16.4 16.5 24.5 11.8 2.8 11.2 6.1 10.4 29.5 14.3 12.2 14.4 12.4 1.0 17.6 10.5 17.5 5.5 4.5 29.0 15.2 5.7 22.6 13.2 13.8 15.7 10.6 18.5 6.6 9.8 27.0 31.3 23.2 15.7 48.9 25.3 16.2 7.4 10.9 13.2 BANF1 BAF ENSG00000175334 "BAF nuclear assembly factor 1" O75531 11 66002228-66004149 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB032896, HPA039242" Enhanced Supported Nucleoplasm,Cytosol NA NA 690000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Cytosol "CAB032896: AB_2061090, HPA039242: AB_2676409" "unprognostic (1.69e-1)" "unprognostic (4.46e-3)" "unprognostic (2.04e-1)" "unprognostic (9.59e-3)" "unprognostic (1.23e-1)" "unprognostic (3.70e-3)" "unprognostic (6.16e-3)" "unprognostic (8.39e-3)" "unprognostic (2.31e-1)" "unprognostic (5.07e-2)" "unprognostic (1.76e-2)" "unprognostic (4.57e-1)" "unprognostic (7.36e-3)" "unprognostic (3.06e-2)" "unprognostic (1.01e-1)" "unprognostic (1.83e-3)" "unprognostic (6.39e-2)" 116.4 149.0 252.8 144.8 256.8 127.2 151.4 261.0 312.9 135.4 248.4 153.7 107.2 168.0 248.5 136.0 279.6 100.9 272.2 249.9 259.6 115.6 174.0 111.3 178.5 258.4 254.4 207.6 132.5 148.8 69.0 120.8 261.1 139.2 155.9 98.7 148.2 169.7 582.1 121.0 105.0 190.0 258.5 116.0 92.7 111.1 254.8 220.7 164.6 394.8 211.9 140.6 82.4 274.5 665.5 712.0 452.8 427.9 237.7 306.5 220.5 364.7 349.4 715.9 447.0 415.3 496.1 606.5 651.8 503.3 544.0 433.5 641.7 600.1 559.1 476.4 411.5 699.5 431.3 537.0 296.0 503.4 480.4 292.5 404.6 453.8 418.1 404.6 494.6 526.5 552.5 459.6 687.5 1196.3 607.7 1023.8 494.7 410.4 525.6 507.0 447.1 1297.4 647.9 361.7 362.9 458.0 399.1 636.4 469.4 352.9 698.8 378.6 350.4 535.8 574.2 601.8 515.8 313.6 680.4 771.1 442.7 420.2 485.5 112.7 231.7 82.2 165.2 239.1 159.1 243.7 139.0 160.5 252.9 234.6 166.0 174.4 28.7 219.7 266.2 238.2 125.5 324.0 252.8 256.8 261.0 312.9 249.9 259.6 258.4 254.4 261.1 258.5 254.8 274.5 135.8 54.5 41.9 11.4 112.7 126.8 154.6 301.2 142.9 52.8 164.8 230.0 32.1 102.9 153.6 196.8 25.0 296.5 101.4 70.7 326.8 196.8 17.1 164.8 147.2 126.5 142.8 144.5 12.3 177.3 346.6 126.6 86.6 116.2 140.2 199.7 79.9 130.8 324.5 50.5 13.4 171.4 223.8 80.6 169.8 41.9 142.0 124.7 186.7 8.4 155.9 123.8 186.4 9.0 22.2 170.3 107.1 123.8 110.8 126.8 77.4 251.5 187.7 57.8 72.3 123.9 145.5 250.2 325.1 227.0 118.1 174.7 104.9 172.6 196.2 148.9 CST6 ENSG00000175315 "Cystatin E/M" Q15828 11 66012008-66013505 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "skin 1: 761.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 93.0;Club cells: 115.2;Pancreatic endocrine cells: 368.1;Respiratory ciliated cells: 404.0" "Group enriched" "Detected in many" 5 "thyroid cancer: 171.0;urothelial cancer: 43.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A-431: 130.2;CAPAN-2: 364.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB019316, HPA044963" Enhanced Approved "Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 82000000 "Cluster 61: Skin - Cornification" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane" Cytosol "CAB019316: , HPA044963: AB_2679158" "unprognostic (3.01e-2)" "unprognostic (5.10e-2)" "unprognostic (1.14e-1)" "unprognostic (3.59e-2)" "unprognostic (5.00e-2)" "unprognostic (2.60e-1)" "unprognostic (1.65e-1)" "unprognostic (8.38e-2)" "unprognostic (5.02e-1)" "unprognostic (8.89e-3)" "unprognostic (1.29e-3)" "unprognostic (1.46e-1)" "unprognostic (1.74e-3)" "unprognostic (5.89e-3)" "unprognostic (1.83e-1)" "unprognostic (1.64e-2)" "unprognostic (2.59e-2)" 3.2 0.3 0.1 0.3 0.1 0.2 28.5 0.8 0.4 7.4 0.8 0.4 0.0 0.3 0.6 34.6 14.9 0.5 2.8 0.1 0.3 2.6 0.3 18.3 0.0 0.2 0.2 0.7 0.7 2.1 1.6 8.1 0.1 0.9 0.0 0.0 7.4 4.9 2.0 761.4 0.3 0.1 0.1 0.2 0.6 1.8 0.4 2.7 21.4 0.0 2.2 1.2 22.5 0.2 130.2 0.0 0.0 0.6 0.0 0.0 37.6 1.4 0.0 0.3 0.2 1.0 364.6 0.0 1.8 5.1 0.1 4.5 0.0 32.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.8 0.6 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.5 0.5 0.8 0.2 0.7 0.0 0.0 35.8 0.4 0.1 0.8 0.1 0.0 0.2 2.5 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.8 0.4 0.1 0.3 0.2 0.2 0.1 0.1 0.4 0.2 0.1 93.0 6.1 0.0 0.6 1.1 1.7 41.4 0.6 0.0 5.3 7.1 1.2 0.0 115.2 58.8 0.0 33.3 0.0 0.1 0.0 57.4 0.2 7.7 0.1 0.9 0.0 0.0 0.0 21.6 24.4 2.0 0.0 0.6 21.6 0.1 0.4 0.1 41.1 0.0 0.0 0.0 24.4 1.4 10.0 0.8 0.0 5.3 5.4 0.0 1.1 1.3 0.0 0.0 0.0 368.1 1.1 0.4 9.8 1.9 0.0 0.5 404.0 0.1 0.0 0.3 16.0 5.2 17.6 1.0 27.6 64.2 0.7 0.0 0.4 6.1 CATSPER1 CATSPER ENSG00000175294 "Cation channel sperm associated 1" Q8NEC5 11 66016752-66026479 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 34 "testis: 17.3" "Cell type enhanced" "Detected in some" "Early spermatids: 44.0;granulocytes: 99.6;Hofbauer cells: 19.9;monocytes: 27.3;NK-cells: 42.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "basophil: 16.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.4;EFO-21: 4.0;HEL: 2.8;HMC-1: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "unprognostic (2.21e-2)" "unprognostic (3.00e-2)" "unprognostic (2.67e-2)" "unprognostic (1.91e-1)" "unprognostic (3.96e-3)" "unprognostic (1.71e-1)" "unprognostic (6.09e-3)" "unprognostic (1.88e-1)" "unprognostic (3.32e-1)" "unprognostic (2.44e-3)" "unprognostic (5.99e-3)" "unprognostic (1.61e-2)" "unprognostic (2.12e-8)" "unprognostic (8.79e-3)" "unprognostic (9.02e-3)" "unprognostic (2.18e-2)" "unprognostic (1.51e-1)" 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.4 0.3 0.0 4.4 0.0 4.0 0.8 1.4 0.0 0.0 0.8 0.4 0.0 0.0 2.8 0.1 0.0 0.0 0.0 5.1 0.0 0.0 0.3 0.5 0.9 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.5 0.0 0.0 0.3 0.0 1.5 0.1 1.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.2 1.1 2.2 0.1 0.2 0.0 0.0 0.0 0.8 0.3 0.6 16.9 5.8 0.1 0.2 0.8 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.6 3.7 0.0 0.0 0.0 2.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.2 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.3 9.6 0.0 0.0 0.4 44.0 0.1 0.1 0.4 0.0 0.8 0.1 0.7 6.0 0.2 0.0 0.0 99.6 0.0 1.4 0.1 19.9 0.0 0.2 0.0 0.0 17.0 12.2 4.3 0.9 15.4 1.8 0.0 27.3 0.0 42.2 0.5 0.0 3.7 0.0 0.4 1.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 1.9 1.2 0.0 0.3 0.4 4.5 0.0 0.0 0.3 GAL3ST3 GAL3ST2 ENSG00000175229 "Galactose-3-O-sulfotransferase 3" Q96A11 11 66040765-66049161 "Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.7;thyroid gland: 17.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.9;Cardiomyocytes: 3.6;Cone photoreceptor cells: 10.4;Excitatory neurons: 3.7;Horizontal cells: 5.0;Inhibitory neurons: 4.7;Oligodendrocyte precursor cells: 7.5;Rod photoreceptor cells: 15.4" "Group enriched" "Detected in many" 5 "glioma: 4.7;ovarian cancer: 5.5;thyroid cancer: 10.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "NTERA-2: 6.5;SH-SY5Y: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 5: NTERA-2 - Transcription" "Cluster 46: Photoreceptor cells - Phototransduction" "prognostic unfavorable (6.53e-6)" "unprognostic (1.24e-1)" "unprognostic (3.30e-1)" "unprognostic (1.57e-2)" "unprognostic (2.62e-1)" "unprognostic (6.08e-2)" "unprognostic (2.01e-3)" "unprognostic (7.26e-2)" "unprognostic (2.07e-2)" "unprognostic (1.40e-1)" "unprognostic (5.29e-1)" 0.0 0.0 5.3 0.0 7.7 0.0 0.0 4.8 5.7 2.9 0.1 0.0 0.0 3.9 0.1 0.0 2.6 0.0 7.1 4.8 2.1 5.3 0.0 0.0 0.0 2.0 2.6 0.2 0.6 0.3 4.1 0.0 1.6 0.8 0.0 5.7 0.0 1.6 0.3 0.1 0.0 2.8 1.5 0.0 0.0 2.1 2.8 0.0 17.1 0.3 0.0 0.0 0.3 3.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.7 4.8 5.7 4.8 2.1 2.0 2.6 1.6 1.5 2.8 3.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 3.6 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 5.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 7.5 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 15.4 0.0 0.0 0.3 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SF3B2 "Cus1, SAP145, SF3b1, SF3b145" ENSG00000087365 "Splicing factor 3b subunit 2" Q13435 11 66050729-66069308 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045028 Supported Enhanced "Nuclear speckles" NA NA 130000 "Cluster 5: Granulocytes - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear speckles" "HPA045028: AB_10965174" "unprognostic (1.48e-1)" "unprognostic (1.51e-1)" "unprognostic (6.45e-2)" "unprognostic (3.29e-1)" "unprognostic (9.86e-2)" "unprognostic (7.10e-2)" "prognostic unfavorable (6.43e-5)" "unprognostic (8.43e-2)" "unprognostic (4.69e-1)" "unprognostic (2.79e-1)" "unprognostic (3.15e-2)" "unprognostic (1.44e-1)" "prognostic favorable (3.51e-5)" "unprognostic (4.03e-2)" "unprognostic (3.56e-1)" "unprognostic (5.14e-2)" "unprognostic (2.60e-2)" 116.0 96.0 117.5 80.4 127.1 144.6 109.0 119.4 139.5 123.3 125.1 97.4 70.7 111.6 95.5 96.6 112.3 55.2 94.7 117.9 120.4 107.1 112.0 104.3 99.0 124.2 118.9 136.1 137.4 88.9 137.2 80.6 121.3 99.2 77.0 96.5 91.3 73.8 108.1 116.9 98.5 80.0 121.4 113.9 102.9 145.2 124.0 109.4 115.2 54.6 114.0 108.3 104.7 136.9 226.9 177.3 189.0 178.9 184.3 163.5 153.1 168.4 210.5 234.9 176.8 149.8 188.9 212.5 185.7 186.7 249.5 202.9 263.2 177.8 208.8 170.2 143.5 223.3 164.2 245.5 187.8 229.7 171.5 137.9 174.0 242.5 287.8 171.3 172.7 180.5 215.2 348.7 191.4 309.8 257.5 343.2 196.1 166.2 163.9 235.6 162.9 299.0 192.3 186.0 147.8 218.0 165.9 175.9 257.0 136.3 217.2 147.1 156.7 206.9 178.0 229.0 194.3 267.5 337.0 270.8 229.6 151.6 191.9 152.1 96.2 167.9 135.3 117.2 131.1 106.8 120.3 128.2 98.5 110.2 116.7 116.8 130.2 116.3 160.1 78.8 131.8 147.5 117.5 127.1 119.4 139.5 117.9 120.4 124.2 118.9 121.3 121.4 124.0 136.9 86.5 128.2 131.0 18.6 144.3 111.3 148.9 165.9 129.1 94.9 69.1 65.0 68.5 98.7 141.5 66.2 89.6 195.9 131.8 114.3 92.0 172.2 278.2 119.5 103.2 104.4 82.5 113.6 19.2 214.8 183.7 117.6 95.8 92.0 120.8 119.0 80.7 72.4 124.9 107.7 19.3 112.4 130.2 103.6 115.0 78.5 120.2 103.8 65.8 10.3 195.6 122.1 155.5 12.1 28.9 158.9 96.3 130.1 198.3 136.6 101.1 108.1 214.7 109.4 78.9 106.1 153.7 220.1 172.0 103.2 99.0 186.6 145.5 118.7 122.3 130.8 PACS1 "FLJ10209, KIAA1175" ENSG00000175115 "Phosphofurin acidic cluster sorting protein 1" Q6VY07 11 66070272-66244744 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038914 Approved Approved Microtubules,Cytosol NA NA 17000 "Cluster 46: Basophils - DNA binding" "Cluster 14: B-cells - Humoral immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Microtubules, Cytosol" "HPA038914: AB_10672831" "unprognostic (7.03e-2)" "unprognostic (3.43e-2)" "unprognostic (9.35e-3)" "unprognostic (1.40e-1)" "unprognostic (3.49e-2)" "unprognostic (1.46e-1)" "unprognostic (3.80e-3)" "unprognostic (1.40e-2)" "unprognostic (3.55e-2)" "unprognostic (1.10e-1)" "unprognostic (2.17e-2)" "unprognostic (3.55e-2)" "unprognostic (1.01e-1)" "unprognostic (2.37e-3)" "unprognostic (5.31e-2)" "unprognostic (5.23e-2)" "unprognostic (3.46e-1)" 30.6 24.0 26.4 33.7 28.4 26.0 26.4 28.4 29.0 30.4 11.0 29.7 13.3 26.7 17.7 32.1 22.2 23.6 45.4 27.2 18.5 28.0 11.4 30.2 49.8 18.2 20.4 32.4 26.8 18.7 21.6 18.9 17.1 34.6 10.2 35.1 92.8 22.2 22.4 27.6 25.6 30.3 13.0 34.9 24.9 42.2 20.7 35.1 34.0 17.2 46.2 33.9 29.6 18.8 44.1 45.6 21.1 13.3 38.5 46.1 23.7 59.3 41.9 40.6 25.2 28.4 34.3 27.6 38.2 102.5 37.7 27.9 15.6 42.7 54.4 43.7 18.3 45.0 41.7 41.2 45.8 6.5 34.6 46.8 19.8 37.0 47.2 78.1 39.8 18.2 16.7 52.2 44.7 83.3 48.1 16.8 9.8 12.0 21.2 31.6 21.5 47.9 28.9 43.4 29.8 33.6 61.5 34.5 29.1 33.9 39.7 8.3 54.4 52.2 23.1 71.9 25.6 26.2 19.1 7.4 45.0 10.4 26.0 3.7 1.3 2.8 3.4 1.0 2.2 2.9 3.1 2.9 1.3 4.8 3.5 3.1 7.4 2.0 2.9 0.8 4.0 3.0 26.4 28.4 28.4 29.0 27.2 18.5 18.2 20.4 17.1 13.0 20.7 18.8 19.9 3.2 3.0 93.7 41.3 10.1 17.6 8.8 16.5 31.4 16.5 16.3 16.9 8.6 12.1 12.9 50.1 8.1 31.9 2.8 5.9 20.5 17.0 11.1 17.3 18.2 6.1 14.1 113.5 62.7 10.9 15.8 13.7 16.3 23.5 80.3 26.0 4.6 13.1 92.5 90.0 2.2 6.1 14.5 14.7 27.6 18.6 22.7 10.6 96.5 33.4 13.9 38.1 87.4 49.2 54.7 1.2 18.0 13.5 23.3 1.0 13.1 11.8 41.2 13.1 12.3 16.5 20.6 21.8 16.5 9.9 5.7 36.3 16.5 3.6 17.0 KLC2 FLJ12387 ENSG00000174996 "Kinesin light chain 2" Q9H0B6 11 66257294-66267860 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein" "Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 55.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040416, HPA040434" Approved Supported "Nucleoplasm,Plasma membrane,Mitochondria,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 62: Horizontal cells - Visual perception" "Plasma membrane, Cytosol" "Nucleoplasm, Mitochondria" "HPA040416: AB_10795524, HPA040434: AB_10795367" "unprognostic (1.29e-1)" "unprognostic (4.95e-3)" "unprognostic (2.99e-1)" "unprognostic (3.24e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (3.16e-4)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (6.27e-3)" "unprognostic (1.60e-1)" "unprognostic (3.49e-2)" "unprognostic (1.64e-3)" "unprognostic (4.57e-3)" "unprognostic (1.96e-2)" "unprognostic (1.81e-1)" "unprognostic (1.72e-2)" "unprognostic (8.08e-2)" 15.2 18.0 18.8 9.5 25.4 3.6 15.9 33.0 78.1 27.3 0.0 28.5 9.8 27.1 6.3 18.2 21.6 8.9 32.1 26.6 12.7 22.4 8.2 18.9 9.1 39.8 10.8 24.6 15.5 15.2 48.3 7.2 37.0 28.7 4.7 28.4 15.9 16.0 57.8 18.3 16.3 11.2 5.7 13.7 20.2 32.2 23.1 25.1 17.7 14.2 6.4 27.2 21.7 35.8 49.4 58.2 28.3 16.9 16.9 13.5 21.9 34.1 24.2 34.2 26.1 31.9 14.3 21.3 31.9 25.6 43.9 40.7 29.3 33.2 11.4 35.7 37.2 4.4 48.0 22.4 32.1 9.9 22.7 13.5 42.7 40.1 32.8 22.0 16.1 26.2 24.1 29.0 27.8 69.2 56.8 15.0 27.8 14.2 49.2 21.4 14.6 30.1 27.2 27.4 76.3 37.5 24.6 22.1 41.3 15.7 36.3 6.7 26.8 55.5 49.8 68.2 45.5 30.7 27.4 11.9 39.3 6.7 22.9 0.0 0.2 0.5 2.4 0.1 3.1 1.9 1.1 1.6 0.3 3.2 1.1 1.4 0.3 1.3 0.2 2.1 0.3 1.1 18.8 25.4 33.0 78.1 26.6 12.7 39.8 10.8 37.0 5.7 23.1 35.8 4.0 3.2 1.5 8.8 8.9 8.9 9.2 11.1 7.4 34.4 10.1 7.2 2.4 7.2 5.5 12.9 12.5 9.9 5.1 3.1 13.7 14.8 10.1 7.7 6.2 5.2 37.1 0.8 20.7 8.2 18.2 6.5 13.7 9.7 0.0 8.6 3.9 2.3 3.1 55.5 19.0 7.2 18.3 3.2 4.0 4.6 8.7 2.8 12.4 5.6 6.3 14.6 4.1 4.0 6.2 19.1 4.9 13.9 9.1 18.2 3.9 10.3 7.3 35.2 0.0 9.5 13.3 26.2 29.8 8.9 9.7 12.7 8.2 3.4 4.9 8.5 RAB1B ENSG00000174903 "RAB1B, member RAS oncogene family" Q9H0U4 11 66268590-66277492 "Plasma proteins, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010225, HPA056141" Approved Supported "Endoplasmic reticulum,Golgi apparatus" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "Endoplasmic reticulum" "CAB010225: AB_2284660, HPA056141: AB_2683051" "unprognostic (6.07e-2)" "unprognostic (2.75e-1)" "unprognostic (1.44e-2)" "unprognostic (1.77e-1)" "unprognostic (2.90e-1)" "unprognostic (9.91e-2)" "unprognostic (2.61e-2)" "unprognostic (2.04e-3)" "unprognostic (2.10e-1)" "unprognostic (1.07e-1)" "unprognostic (1.43e-2)" "unprognostic (2.00e-1)" "prognostic favorable (1.09e-5)" "unprognostic (2.41e-2)" "unprognostic (9.45e-2)" "unprognostic (9.42e-2)" "unprognostic (5.85e-2)" 127.1 129.7 121.7 84.0 117.4 91.1 120.9 117.7 137.7 113.7 106.2 129.3 112.5 111.2 82.3 180.9 105.7 83.0 146.7 117.5 116.8 127.2 126.4 116.5 90.3 122.7 121.0 103.5 96.1 132.9 112.6 88.4 119.3 140.6 90.3 46.5 128.0 105.1 233.2 147.6 112.9 86.9 119.3 125.3 125.5 79.9 124.2 105.5 111.5 152.8 86.1 113.6 119.2 118.9 226.5 248.0 126.2 166.1 205.6 150.9 113.8 182.7 212.8 232.2 163.4 141.4 223.7 91.7 235.7 263.1 172.1 209.0 140.7 253.9 125.9 190.3 128.0 144.7 156.0 124.2 135.0 124.3 258.2 158.7 212.4 199.6 102.4 163.2 221.1 144.9 153.1 158.8 223.6 434.5 219.1 197.1 131.5 196.1 230.8 133.0 101.8 237.2 234.7 204.5 122.9 137.1 132.7 319.2 133.7 91.4 487.5 141.6 228.1 221.4 152.9 267.9 164.9 89.9 77.9 121.5 251.2 104.3 207.8 173.1 199.8 329.3 227.5 211.9 171.7 109.8 135.5 188.1 163.0 130.2 115.3 140.6 420.5 203.5 243.9 188.3 165.5 375.6 121.7 117.4 117.7 137.7 117.5 116.8 122.7 121.0 119.3 119.3 124.2 118.9 56.3 38.5 59.6 7.8 41.7 33.6 31.4 42.4 53.5 22.0 55.0 53.1 1.1 40.0 47.9 36.8 29.2 56.2 50.8 137.1 50.9 49.3 13.4 41.3 38.6 50.6 54.0 27.1 7.2 71.3 84.2 36.5 58.1 44.9 53.8 24.6 48.9 47.8 54.2 16.8 8.0 85.0 36.7 55.2 26.4 27.2 35.8 51.4 24.9 5.6 47.7 37.8 43.3 5.5 13.1 71.6 80.6 42.2 61.0 41.4 79.6 49.5 36.0 18.2 39.5 36.2 39.7 23.8 17.4 64.5 42.1 80.2 57.4 28.1 64.9 43.5 CNIH2 "CNIH-2, Cnil, MGC50896" ENSG00000174871 "Cornichon family AMPA receptor auxiliary protein 2" Q6PI25 11 66278175-66285301 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 270.1" "Cell type enhanced" "Detected in some" "Early spermatids: 75.7;Enteroendocrine cells: 49.6;Excitatory neurons: 17.7;Horizontal cells: 16.8;Late spermatids: 28.1" "Cancer enriched" "Detected in many" 5 "glioma: 20.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.8;AN3-CA: 13.9;MCF7: 13.9;NTERA-2: 15.1;SCLC-21H: 61.5;SH-SY5Y: 28.5;T-47d: 13.3" "Low region specificity" "Detected in all" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 34: Spermatids - Unknown function" "unprognostic (1.84e-2)" "unprognostic (3.53e-3)" "unprognostic (3.40e-3)" "unprognostic (1.04e-2)" "prognostic unfavorable (9.18e-4)" "unprognostic (1.81e-1)" "unprognostic (1.74e-2)" "unprognostic (3.29e-1)" "unprognostic (3.25e-1)" "unprognostic (3.80e-2)" "unprognostic (7.66e-3)" "unprognostic (4.16e-2)" "unprognostic (6.95e-8)" "unprognostic (3.53e-1)" "unprognostic (3.19e-2)" "unprognostic (3.17e-2)" "unprognostic (3.55e-2)" 0.4 3.3 88.4 0.2 74.6 1.6 0.3 28.8 270.1 0.6 11.0 1.0 0.6 0.4 0.0 0.8 0.6 0.2 0.3 234.9 61.3 0.5 0.4 0.7 0.1 28.3 37.1 0.4 3.4 0.1 45.9 0.5 34.5 0.5 0.2 1.1 0.3 0.0 0.1 1.4 0.6 0.2 30.3 0.6 1.0 5.1 53.4 1.3 0.4 0.0 0.0 0.3 0.5 47.5 0.4 0.8 15.8 13.9 0.2 0.3 2.0 1.0 1.1 2.0 0.1 0.4 0.0 0.1 0.3 0.2 0.9 0.2 3.6 0.0 0.3 1.5 1.4 0.0 0.5 0.0 0.0 0.1 1.1 0.0 0.3 0.1 0.0 0.3 0.0 1.6 0.2 2.1 0.9 13.9 2.1 0.3 15.1 0.0 1.0 6.8 0.0 0.1 0.1 0.8 61.5 28.5 0.1 7.6 0.6 0.7 13.3 0.2 0.0 1.8 0.7 0.5 0.6 0.3 0.4 0.6 4.2 0.4 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.4 74.6 28.8 270.1 234.9 61.3 28.3 37.1 34.5 30.3 53.4 47.5 0.8 0.0 0.5 2.9 0.2 0.6 0.3 1.4 0.6 2.3 1.6 1.3 0.7 1.5 0.8 0.0 0.0 1.4 0.7 0.1 0.0 0.2 75.7 5.7 0.6 0.4 49.6 0.0 17.7 0.2 1.6 0.7 2.0 0.6 0.0 0.5 0.4 0.1 0.2 16.8 11.7 1.5 0.0 0.0 0.3 28.1 0.6 0.4 0.0 1.9 0.1 0.7 0.0 1.5 2.7 0.6 0.1 0.4 0.9 0.3 0.2 0.2 6.8 2.6 0.0 0.9 0.7 6.0 0.9 0.6 0.4 1.2 1.4 0.1 0.4 0.3 YIF1A "54TM, FinGER7, YIF1, YIF1P" ENSG00000174851 "Yip1 interacting factor homolog A, membrane trafficking protein" O95070 11 66284580-66289145 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014840, HPA076194" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus, Vesicles" "HPA014840: AB_2217189, HPA076194: " "unprognostic (9.35e-2)" "unprognostic (7.86e-2)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "unprognostic (3.23e-1)" "unprognostic (4.38e-3)" "unprognostic (2.25e-3)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (2.13e-1)" "unprognostic (6.39e-3)" "unprognostic (1.35e-1)" "unprognostic (2.60e-2)" "unprognostic (2.03e-1)" "unprognostic (2.64e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (8.70e-4)" 49.2 54.7 33.4 28.4 36.0 16.7 47.5 38.5 41.4 42.7 42.4 50.8 56.5 53.5 34.5 50.9 45.7 25.5 57.8 33.5 35.6 50.9 149.5 44.9 22.9 38.9 36.1 42.1 86.0 40.6 74.1 34.5 38.2 47.3 37.7 12.3 51.1 29.6 96.2 43.0 47.4 41.1 38.5 35.9 56.1 36.4 35.6 21.6 49.9 59.3 24.7 45.4 40.6 41.9 80.7 131.3 39.4 72.6 130.0 138.7 73.8 114.4 122.3 95.5 94.3 126.0 95.5 67.9 111.5 161.4 107.8 119.9 60.7 107.9 75.6 77.7 72.0 42.5 93.3 158.7 147.4 59.3 61.5 97.4 144.4 98.6 158.9 76.6 91.3 67.0 80.7 114.8 84.3 199.3 71.3 64.4 40.3 147.4 136.6 54.9 61.2 203.9 81.9 70.9 58.5 57.9 62.5 106.7 103.4 49.6 155.5 43.5 81.0 80.8 69.0 165.3 54.1 78.1 86.0 63.0 125.4 56.2 90.2 19.4 95.6 20.6 71.3 141.4 78.4 95.9 60.6 67.2 116.4 82.4 48.0 55.3 9.4 51.2 140.0 141.6 54.9 99.8 33.4 36.0 38.5 41.4 33.5 35.6 38.9 36.1 38.2 38.5 35.6 41.9 63.4 38.5 48.0 6.2 52.2 36.1 88.1 170.4 38.1 27.1 84.4 92.7 34.5 82.9 115.5 46.0 22.9 114.3 42.6 66.8 64.6 137.9 28.1 42.1 84.8 53.6 87.4 21.0 1.9 149.4 248.5 90.4 55.0 42.8 29.9 38.8 49.2 172.0 105.4 26.9 3.9 140.9 116.0 38.4 44.9 48.6 75.5 45.0 72.9 8.4 40.8 73.7 28.8 10.1 10.4 132.1 93.3 82.4 92.4 195.2 202.2 135.2 101.4 34.0 39.5 60.8 150.0 61.0 56.8 63.3 46.3 154.3 36.5 88.1 107.2 112.1 TMEM151A "MGC33486, TMEM151" ENSG00000179292 "Transmembrane protein 151A" Q8N4L1 11 66291894-66296664 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 112.9" "Cell type enriched" "Detected in some" 4 "Oligodendrocytes: 70.1" "Cancer enhanced" "Detected in some" "glioma: 4.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041035 Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 70: Brain - Nervous system development" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoli Cytosol "HPA041035: AB_10794404" "unprognostic (1.20e-1)" "unprognostic (8.24e-3)" "unprognostic (4.80e-2)" "unprognostic (1.75e-2)" "unprognostic (3.44e-1)" "unprognostic (7.60e-2)" "unprognostic (9.48e-3)" "unprognostic (8.57e-2)" "unprognostic (8.73e-4)" "unprognostic (2.41e-3)" "unprognostic (2.02e-2)" "unprognostic (6.11e-3)" "unprognostic (1.69e-3)" "unprognostic (2.80e-2)" "unprognostic (2.64e-1)" "unprognostic (2.38e-2)" "unprognostic (2.67e-2)" 3.1 1.4 41.3 0.0 68.0 0.0 0.0 73.5 60.8 0.0 3.8 0.4 0.1 0.0 0.0 0.0 0.1 0.8 0.8 45.2 44.0 0.1 0.2 0.1 0.0 86.0 68.1 0.2 1.1 0.3 9.7 0.0 69.6 0.1 0.0 1.5 0.2 0.0 0.0 0.0 0.1 0.0 61.8 0.0 5.4 0.3 70.6 0.0 0.0 0.0 0.0 0.0 0.1 112.9 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.5 0.0 1.1 0.0 3.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 15.3 3.5 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.3 68.0 73.5 60.8 45.2 44.0 86.0 68.1 69.6 61.8 70.6 112.9 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 9.6 0.0 0.0 0.7 4.3 0.0 0.0 2.1 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.1 0.0 7.7 0.0 11.6 0.4 0.0 1.0 9.2 0.1 0.0 0.0 0.0 0.0 0.1 15.2 11.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.8 0.0 2.5 0.0 2.0 70.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.4 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 CD248 "CD164L1, TEM1" ENSG00000174807 "CD248 molecule" Q9HCU0 11 66314494-66317044 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 237.3;breast: 155.5" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 155.4;Fibroblasts: 166.9;Leydig cells: 74.9;Smooth muscle cells: 59.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "naive CD8 T-cell: 21.8" "Lineage enriched" "Detected in single" 144 "T-cells: 21.8" "Cell line enhanced" "Detected in many" "ASC diff: 492.4;ASC TERT1: 481.9;BJ: 222.2;BJ hTERT+: 330.1;fHDF/TERT166: 451.1;HSkMC: 516.8;U-2197: 794.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA051856 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 43000000 "Cluster 32: T-cells - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" Nucleoplasm "HPA051856: AB_2681640" "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.95e-2)" "unprognostic (2.77e-2)" "unprognostic (1.14e-2)" "unprognostic (2.61e-1)" "unprognostic (7.21e-3)" "unprognostic (1.36e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-2)" "unprognostic (6.31e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (2.69e-7)" "unprognostic (1.90e-2)" "unprognostic (2.92e-2)" "unprognostic (1.25e-1)" "unprognostic (1.30e-2)" 237.3 12.9 2.3 39.3 2.4 0.4 155.5 2.2 4.0 87.2 1.5 31.7 7.8 52.2 6.9 19.6 60.8 32.3 30.3 2.2 2.2 18.7 3.6 36.5 6.2 2.4 2.6 23.9 11.7 3.3 8.8 67.4 2.2 17.8 7.4 0.4 18.2 19.4 15.8 51.0 27.2 26.5 2.0 7.2 26.3 5.0 3.9 5.3 35.0 6.5 2.6 63.4 61.5 2.0 0.0 0.0 4.9 0.0 492.4 481.9 0.3 222.2 330.1 16.3 15.1 0.1 0.0 0.0 5.8 451.1 0.0 0.0 0.2 0.2 3.5 0.0 0.0 0.0 0.1 3.3 97.5 0.0 0.0 516.8 0.0 21.4 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.4 3.2 2.5 0.0 1.4 9.5 0.0 0.2 0.0 0.0 2.8 7.6 0.0 1.2 0.0 13.4 0.5 0.4 0.1 0.0 0.8 794.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 2.6 0.0 0.1 3.1 21.8 0.0 0.0 0.0 0.0 0.0 2.5 2.3 2.4 2.2 4.0 2.2 2.2 2.4 2.6 2.2 2.0 3.9 2.0 15.0 0.0 0.0 1.3 1.3 12.5 0.0 0.0 0.6 0.1 1.2 1.5 2.2 0.0 0.0 0.0 0.0 2.7 0.5 0.0 0.0 0.2 0.3 5.3 155.4 5.8 0.0 0.0 0.0 0.0 2.5 166.9 13.3 3.1 0.0 0.0 2.5 0.0 6.0 0.0 0.0 0.0 0.0 0.3 14.4 2.3 74.9 1.6 12.4 1.9 0.6 2.9 1.0 0.0 0.0 0.3 0.0 20.3 0.1 0.0 0.0 0.1 0.0 0.1 32.9 5.5 59.3 0.1 0.1 0.8 8.2 4.4 6.9 1.1 0.0 0.1 RIN1 ENSG00000174791 "Ras and Rab interactor 1" Q13671 11 66330241-66336840 "Predicted intracellular proteins, RAS pathway related proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 26.6" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 25.7;Basal squamous epithelial cells: 23.3;Squamous epithelial cells: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 9.7" "Lineage enriched" "Detected in many" 6 "monocytes: 9.7" "Cell line enhanced" "Detected in many" "hTCEpi: 44.3;U-2197: 40.7" "Low region specificity" "Detected in many" HPA035491 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear membrane" Nucleoplasm "HPA035491: AB_10601608" "unprognostic (1.25e-2)" "unprognostic (1.04e-1)" "unprognostic (4.69e-2)" "prognostic favorable (2.21e-4)" "unprognostic (1.11e-2)" "unprognostic (2.57e-1)" "unprognostic (6.82e-3)" "unprognostic (3.84e-2)" "unprognostic (1.11e-2)" "unprognostic (2.52e-3)" "unprognostic (8.32e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (9.34e-7)" "unprognostic (2.42e-2)" "unprognostic (1.14e-1)" "unprognostic (7.82e-3)" "unprognostic (2.46e-1)" 4.8 4.3 3.7 2.3 4.9 1.1 4.4 3.3 5.7 8.3 1.5 5.2 2.7 4.4 0.2 20.4 5.6 1.4 3.4 6.3 1.6 4.3 1.3 4.9 0.5 1.0 1.2 3.7 5.2 0.4 7.2 1.4 1.1 7.1 1.0 0.2 5.1 0.8 7.5 26.6 4.3 0.6 0.8 6.1 6.8 3.7 2.0 0.5 2.4 0.5 0.4 5.4 11.3 2.6 2.3 5.7 2.3 5.3 2.8 14.5 1.2 13.7 18.0 14.4 6.8 3.3 9.3 0.5 5.0 13.6 5.2 12.9 0.0 24.3 1.8 1.1 0.0 0.8 4.4 4.1 5.5 0.1 4.2 15.9 44.3 12.4 8.0 17.1 2.8 0.6 0.3 0.1 6.1 0.5 0.3 11.0 0.6 3.9 12.6 0.1 5.4 0.1 3.9 3.0 10.9 2.3 3.2 2.5 20.5 0.6 1.8 1.3 6.5 18.7 7.9 40.7 3.3 0.3 0.9 0.0 26.9 3.5 6.3 0.1 2.7 0.0 0.2 4.7 0.6 0.1 0.4 0.2 1.7 0.0 0.5 0.2 0.0 0.1 9.7 0.0 0.1 1.8 3.7 4.9 3.3 5.7 6.3 1.6 1.0 1.2 1.1 0.8 2.0 2.6 3.9 0.0 0.5 1.3 0.8 13.4 9.3 25.7 23.3 3.8 3.5 4.3 0.8 4.3 4.8 0.0 0.0 0.8 0.5 9.6 0.0 4.1 0.5 2.4 5.1 5.3 3.0 0.0 6.0 6.9 4.8 5.6 5.6 1.8 4.5 0.1 7.9 0.2 4.7 0.0 2.3 4.5 2.0 8.7 6.5 2.0 4.4 6.4 1.8 1.0 8.1 0.7 1.0 0.5 0.5 8.9 7.8 1.9 1.4 4.0 9.1 0.1 3.4 1.2 0.0 4.2 3.4 1.2 0.9 18.6 15.2 0.3 2.2 1.6 9.2 5.8 BRMS1 DKFZP564A063 ENSG00000174744 "BRMS1 transcriptional repressor and anoikis regulator" Q9HCU9 11 66337333-66345125 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Repressor "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010824, HPA019637" Approved Approved Centrosome NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Centrosome "CAB010824: , HPA019637: AB_1845448" "unprognostic (1.75e-1)" "unprognostic (2.64e-2)" "unprognostic (2.01e-1)" "unprognostic (4.31e-2)" "unprognostic (1.72e-2)" "unprognostic (5.50e-2)" "prognostic unfavorable (6.74e-4)" "unprognostic (2.99e-1)" "unprognostic (2.62e-1)" "unprognostic (4.48e-1)" "unprognostic (2.24e-1)" "unprognostic (2.39e-1)" "unprognostic (1.27e-1)" "unprognostic (5.67e-3)" "unprognostic (2.54e-1)" "unprognostic (6.32e-2)" "unprognostic (1.61e-1)" 27.2 28.1 25.3 24.1 27.0 52.2 27.1 27.2 28.5 22.0 26.9 28.9 26.0 20.5 17.5 36.7 20.0 18.0 26.0 26.6 25.4 35.0 29.1 25.0 32.2 27.4 27.1 19.9 40.9 19.3 17.9 19.5 26.8 33.9 19.2 9.1 30.5 18.3 38.0 41.5 29.6 13.1 26.5 38.3 31.6 31.5 27.1 28.7 26.5 13.8 25.6 25.1 25.8 28.0 80.3 102.4 33.8 56.6 35.1 36.1 47.8 54.4 58.9 95.9 63.9 84.1 51.2 53.5 78.9 53.8 82.5 91.7 64.9 99.2 45.0 63.9 53.9 49.2 54.2 62.1 65.1 71.3 54.9 41.2 104.5 97.0 72.2 29.1 59.9 60.1 59.0 24.3 58.0 128.9 87.5 169.1 73.3 61.2 95.3 73.2 62.2 100.0 60.1 45.6 70.8 57.0 67.2 68.6 180.9 24.6 83.5 43.7 58.2 71.9 68.2 117.1 68.8 50.2 53.8 85.3 93.0 46.2 78.8 45.6 79.4 80.8 61.1 77.3 65.1 79.2 65.2 58.6 62.4 75.6 56.3 54.3 104.2 51.3 69.9 67.3 79.9 67.3 25.3 27.0 27.2 28.5 26.6 25.4 27.4 27.1 26.8 26.5 27.1 28.0 27.2 16.0 26.9 4.2 42.7 58.1 28.5 45.0 33.6 12.3 31.7 27.6 11.7 40.0 22.6 22.0 6.2 61.5 37.1 109.0 54.8 72.6 7.4 25.6 16.6 30.8 32.3 33.7 2.9 117.9 68.5 22.9 33.1 18.6 27.8 21.4 28.2 21.5 67.6 11.8 2.2 54.0 32.6 51.3 41.7 9.9 22.4 39.1 28.4 5.6 68.3 31.7 56.7 3.0 5.1 85.7 85.6 14.7 30.5 40.6 80.5 51.1 22.2 14.9 6.6 23.1 27.3 35.8 39.4 32.2 60.0 71.7 42.5 21.1 61.3 29.8 B4GAT1 "B3GN-T1, B3GNT1, B3GNT6, BETA3GNTI, iGAT, iGNT" ENSG00000174684 "Beta-1,4-glucuronyltransferase 1" O43505 11 66345374-66347629 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 220.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 72.3;Horizontal cells: 158.2;Muller glia cells: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015484 Uncertain "Intracellular and membrane" NA NA 57000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 62: Horizontal cells - Visual perception" "HPA015484: AB_1845235" "unprognostic (1.80e-1)" "unprognostic (7.20e-2)" "unprognostic (1.70e-1)" "unprognostic (3.81e-2)" "unprognostic (3.96e-2)" "unprognostic (1.45e-1)" "unprognostic (9.23e-2)" "unprognostic (1.59e-1)" "unprognostic (2.65e-2)" "unprognostic (3.43e-3)" "prognostic favorable (3.55e-5)" "unprognostic (2.20e-1)" "unprognostic (3.50e-1)" "unprognostic (1.23e-1)" "unprognostic (2.02e-1)" "unprognostic (1.88e-1)" "unprognostic (2.76e-3)" 16.6 41.4 120.6 6.1 124.9 1.3 16.0 71.0 125.2 23.1 68.7 30.1 16.2 28.5 15.2 8.3 23.4 9.9 44.6 115.3 220.2 25.3 18.8 17.3 6.7 85.9 97.3 34.3 25.5 22.6 62.3 22.5 101.0 17.3 7.7 46.0 15.8 22.4 27.7 12.1 14.6 14.0 91.9 10.2 25.8 8.2 150.4 6.5 21.0 19.2 4.3 20.2 16.3 83.9 10.8 26.7 29.7 36.5 32.6 29.3 39.4 18.4 42.5 28.1 22.9 20.1 14.9 8.9 76.1 16.9 24.1 16.8 32.0 20.6 13.5 17.6 58.2 1.3 20.4 77.6 19.3 7.0 2.7 28.6 15.6 17.5 7.4 92.8 33.5 14.8 8.6 13.7 13.6 18.1 16.7 19.1 20.2 10.6 28.0 24.0 23.2 15.9 29.6 2.7 17.8 33.7 15.8 10.4 74.8 18.4 42.6 6.8 19.7 21.8 15.9 28.0 9.6 26.1 19.2 5.3 36.8 5.8 26.0 0.0 1.2 0.0 7.1 0.4 9.9 5.7 7.8 7.6 3.0 3.2 9.0 8.3 0.4 4.6 0.3 7.4 5.7 4.4 120.6 124.9 71.0 125.2 115.3 220.2 85.9 97.3 101.0 91.9 150.4 83.9 13.5 22.4 10.8 25.8 2.9 0.0 1.6 0.0 14.2 72.3 6.2 12.7 45.9 25.8 1.8 20.2 58.4 57.8 8.6 8.0 5.9 7.4 0.5 3.9 9.7 17.1 4.9 0.8 22.1 6.0 22.6 23.4 6.6 2.6 1.3 22.5 30.4 24.4 12.7 158.2 35.0 8.0 0.0 2.4 0.0 2.4 32.6 2.6 0.0 10.3 1.3 70.1 2.1 22.6 14.2 4.3 4.9 40.6 6.1 2.0 13.3 17.5 2.9 47.4 26.3 21.2 11.8 1.4 2.8 5.8 0.0 18.1 2.6 28.0 7.2 0.3 SLC29A2 "DER12, ENT2, HNP36" ENSG00000174669 "Solute carrier family 29 member 2" Q14542 11 66362521-66372214 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 90.8;tongue: 47.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 44.3;CAPAN-2: 53.5;T-47d: 55.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018168 Approved Uncertain Nucleoplasm NA Yes "Cluster 32: T-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 1: K-562 - Erythropoiesis" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm "HPA018168: AB_1857077" "unprognostic (3.20e-2)" "unprognostic (4.50e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (3.37e-1)" "unprognostic (5.08e-2)" "unprognostic (5.64e-2)" "unprognostic (1.60e-1)" "unprognostic (1.96e-1)" "unprognostic (2.09e-1)" "unprognostic (1.76e-1)" "unprognostic (5.28e-2)" "prognostic favorable (2.78e-4)" "unprognostic (2.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.13e-1)" "unprognostic (6.38e-3)" 6.7 0.9 4.2 2.5 4.3 0.8 7.4 9.8 5.6 1.9 4.2 5.7 7.8 0.9 3.1 3.3 3.6 1.4 11.9 4.1 4.0 6.9 1.5 4.4 2.8 7.4 6.9 0.7 8.7 12.9 6.1 4.1 8.2 5.2 4.1 3.1 7.2 2.4 90.8 2.8 7.4 0.3 4.1 2.1 9.4 0.5 5.9 2.3 5.4 47.3 1.9 1.2 2.6 3.7 14.2 11.4 8.2 1.8 1.2 0.3 44.3 0.6 0.0 0.4 0.6 20.2 53.5 6.1 10.4 0.1 3.1 12.9 11.4 9.7 0.0 0.5 18.6 11.7 12.4 1.5 1.3 21.9 0.4 0.7 4.3 1.5 4.1 5.2 0.5 5.1 33.0 0.0 0.0 34.5 1.6 31.9 21.8 35.1 8.1 1.3 0.3 26.4 22.2 10.4 16.1 6.6 1.0 18.4 1.2 2.4 55.2 4.1 0.0 0.3 11.2 0.4 0.0 0.3 0.8 0.5 0.9 0.5 0.7 0.0 0.0 0.0 1.3 0.0 0.4 0.2 0.7 1.7 0.3 0.7 1.7 1.7 0.1 0.0 0.0 0.6 0.1 0.5 4.2 4.3 9.8 5.6 4.1 4.0 7.4 6.9 8.2 4.1 5.9 3.7 0.6 3.2 6.3 9.4 2.2 0.6 4.7 5.4 1.2 2.5 7.6 5.8 12.3 4.3 6.5 14.7 12.5 46.4 0.7 6.0 3.9 5.0 0.1 2.1 0.5 0.9 2.4 2.1 11.2 6.7 16.5 1.7 11.2 5.4 4.5 1.8 0.4 0.9 4.4 5.0 10.8 9.2 4.1 0.8 0.4 0.0 0.0 0.5 0.0 2.8 0.9 2.3 0.0 7.5 0.8 3.5 4.7 0.4 1.5 4.7 1.6 0.5 3.8 3.7 0.0 4.4 2.1 0.4 0.5 3.5 0.0 13.5 2.1 0.4 10.6 3.4 NPAS4 "bHLHe79, Le-PAS, NXF, PASD10" ENSG00000174576 "Neuronal PAS domain protein 4" Q8IUM7 11 66421004-66426707 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 170.4" "Group enriched" "Detected in some" 4 "Bipolar cells: 10.2;Horizontal cells: 11.8;Rod photoreceptor cells: 5.4" "Not detected" "Not detected" "Group enriched" "Detected in many" 13 "cerebellum: 170.4;cerebral cortex: 55.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 4.9;cerebellum: 5.0;cerebral cortex: 7.5;hippocampal formation: 4.6;olfactory bulb: 3.8" HPA039255 Uncertain NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 62: Horizontal cells - Visual perception" "HPA039255: AB_10674282" "unprognostic (7.81e-2)" "unprognostic (9.93e-2)" "unprognostic (1.55e-2)" "unprognostic (1.24e-1)" "unprognostic (2.51e-1)" "unprognostic (1.78e-3)" "unprognostic (4.97e-1)" "unprognostic (7.84e-2)" "unprognostic (1.85e-2)" "unprognostic (3.29e-2)" "unprognostic (3.96e-2)" "unprognostic (1.12e-3)" "unprognostic (1.58e-1)" "unprognostic (1.37e-1)" "unprognostic (4.24e-1)" "unprognostic (3.21e-2)" 0.2 0.2 0.8 0.4 2.9 0.0 0.1 170.4 55.3 0.8 0.5 2.7 0.1 3.3 0.1 0.3 1.3 0.1 0.2 4.2 8.6 0.1 0.1 0.1 0.0 2.2 1.6 0.3 0.3 0.0 19.3 0.0 3.6 1.2 0.1 0.1 0.1 0.7 0.0 0.1 0.5 1.3 0.1 0.0 1.1 0.1 1.2 0.0 0.1 0.2 0.0 1.1 0.5 4.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.9 170.4 55.3 4.2 8.6 2.2 1.6 3.6 0.1 1.2 4.9 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.2 0.1 0.4 0.6 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 1.8 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRPL11 ENSG00000174547 "Mitochondrial ribosomal protein L11" Q9Y3B7 11 66435075-66466738 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057685 Approved Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA057685: AB_2683502" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (2.21e-2)" "unprognostic (1.79e-2)" "unprognostic (9.30e-2)" "unprognostic (1.12e-2)" "unprognostic (1.81e-3)" "unprognostic (1.58e-1)" "unprognostic (4.87e-1)" "unprognostic (8.32e-3)" "unprognostic (2.85e-2)" "unprognostic (3.21e-1)" "unprognostic (1.31e-2)" "unprognostic (9.34e-2)" "unprognostic (6.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.72e-1)" 14.6 11.0 12.5 11.8 13.2 23.0 17.3 13.1 21.8 12.8 14.6 21.8 16.5 13.8 16.0 19.4 16.6 8.0 20.6 12.8 12.8 17.1 22.1 10.3 19.0 12.8 12.8 17.7 18.9 17.1 7.9 12.2 13.0 11.6 23.7 11.1 18.0 13.1 49.3 13.3 17.2 14.4 12.6 14.3 17.3 9.8 14.2 18.5 11.6 35.9 20.5 14.7 12.7 12.8 62.1 48.3 44.9 43.3 22.0 24.5 64.2 35.2 40.0 65.8 50.2 135.8 74.7 77.3 59.8 33.6 73.0 52.9 66.5 69.1 46.2 35.8 44.1 48.6 42.6 72.9 26.4 81.4 31.4 29.3 40.6 40.6 49.9 31.7 49.5 73.1 72.1 32.9 28.9 105.6 94.1 129.5 82.3 165.7 69.8 59.2 89.5 97.6 29.1 42.0 47.0 40.8 38.9 58.0 127.4 37.9 66.0 42.4 28.1 39.3 53.1 37.6 42.1 24.1 40.3 87.0 40.7 51.8 27.1 2.1 34.3 7.7 35.9 44.9 38.1 51.6 39.1 35.3 54.5 40.3 40.9 37.8 2.3 37.9 40.7 32.9 43.8 42.5 12.5 13.2 13.1 21.8 12.8 12.8 12.8 12.8 13.0 12.6 14.2 12.8 45.7 12.8 28.3 3.6 61.9 49.8 94.2 80.8 58.1 21.8 69.4 96.3 66.6 60.1 49.0 33.1 8.4 139.6 46.5 66.3 123.3 67.7 40.7 38.0 47.3 51.8 51.0 63.9 4.5 85.6 196.6 54.2 47.4 35.2 31.6 93.9 50.7 82.9 126.2 20.2 4.7 97.3 30.5 60.6 60.3 11.1 50.7 59.5 67.6 1.9 77.6 32.3 66.9 2.5 4.5 59.6 69.4 45.9 61.4 75.0 94.4 124.5 43.7 22.1 26.3 48.9 77.1 78.9 60.5 95.7 49.0 77.4 51.7 68.5 165.2 91.4 PELI3 MGC35521 ENSG00000174516 "Pellino E3 ubiquitin protein ligase family member 3" Q8N2H9 11 66466327-66477337 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 26.5;Horizontal cells: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033750, HPA038875, HPA062281" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 62: Horizontal cells - Visual perception" "Nucleoplasm, Vesicles" Nucleoli "CAB033750: AB_2161361, HPA038875: AB_2676249, HPA062281: AB_2684735" "unprognostic (1.15e-1)" "unprognostic (1.58e-1)" "unprognostic (3.04e-1)" "unprognostic (1.43e-1)" "unprognostic (1.02e-2)" "unprognostic (1.89e-2)" "unprognostic (1.30e-2)" "unprognostic (1.94e-1)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.19e-3)" "unprognostic (7.91e-3)" "prognostic favorable (8.19e-4)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (3.01e-2)" 7.5 10.2 19.1 2.6 18.7 1.2 7.7 21.1 33.2 12.4 4.4 15.3 3.2 13.9 5.6 6.9 11.2 6.8 8.8 20.5 15.0 6.2 4.2 5.5 3.2 22.7 17.2 13.5 8.2 11.7 13.4 2.4 23.6 14.6 1.7 5.5 8.7 14.8 18.3 7.7 6.3 5.6 13.9 5.1 9.4 7.6 19.5 1.0 6.3 4.6 1.5 14.7 9.1 19.8 20.2 8.1 6.5 5.0 10.2 4.0 5.6 6.2 8.0 5.7 4.9 11.8 4.3 5.0 6.1 6.9 10.3 10.2 4.0 7.8 2.4 9.6 4.1 1.3 7.2 3.5 6.4 1.0 9.2 3.8 8.6 5.8 2.1 8.3 1.2 6.4 2.3 7.2 2.5 11.5 4.2 3.0 3.9 10.2 8.4 13.6 4.7 5.2 3.2 6.3 7.9 4.4 3.2 8.8 21.6 2.8 10.3 5.3 3.4 5.0 7.6 21.7 5.4 6.9 4.2 2.7 10.6 3.1 4.1 0.5 1.0 0.2 1.0 0.8 0.8 1.2 0.8 1.2 1.4 1.5 0.9 0.7 0.0 0.5 3.4 0.4 1.0 0.6 19.1 18.7 21.1 33.2 20.5 15.0 22.7 17.2 23.6 13.9 19.5 19.8 5.0 6.4 2.0 2.0 0.7 1.7 3.8 0.9 4.0 13.3 3.0 4.4 8.1 4.3 0.6 0.0 10.4 2.5 0.4 0.6 1.9 3.2 5.0 0.4 2.6 2.7 26.5 0.0 7.1 2.5 2.1 4.2 2.0 1.1 0.0 2.9 3.3 2.8 3.3 21.9 7.7 1.4 2.0 1.9 1.4 10.4 7.5 2.9 0.0 1.9 2.8 7.5 0.0 2.0 2.5 1.8 1.4 9.8 1.0 2.5 0.9 2.9 0.2 9.7 6.6 3.1 4.9 3.0 3.5 1.8 0.3 0.3 1.3 1.5 0.8 1.5 DPP3 ENSG00000254986 "Dipeptidyl peptidase 3" Q9NY33 11 66480013-66509657 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035780, HPA035781" Approved Supported Cytosol NA NA 3200000 "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 46: Photoreceptor cells - Phototransduction" Cytosol "HPA035780: AB_2674778, HPA035781: AB_10669529" "unprognostic (5.74e-2)" "unprognostic (1.16e-3)" "unprognostic (2.62e-3)" "unprognostic (4.77e-2)" "unprognostic (1.99e-1)" "unprognostic (5.44e-3)" "unprognostic (1.67e-3)" "unprognostic (1.25e-3)" "unprognostic (1.73e-2)" "unprognostic (9.87e-2)" "unprognostic (1.02e-2)" "unprognostic (3.87e-1)" "unprognostic (5.85e-2)" "prognostic favorable (1.34e-4)" "unprognostic (1.81e-2)" "unprognostic (3.43e-1)" "unprognostic (5.66e-2)" 11.6 17.5 8.2 21.4 9.1 20.7 11.2 10.2 10.4 11.0 5.4 30.2 24.8 11.7 7.8 23.5 9.8 14.5 10.3 8.4 8.9 17.1 18.6 14.3 21.8 10.2 8.8 6.8 17.3 11.9 8.7 14.3 10.8 14.4 26.3 15.9 18.8 12.9 26.5 13.6 20.5 16.2 8.6 15.4 19.2 9.8 10.2 18.6 11.7 7.4 23.3 17.3 13.5 9.9 84.1 71.6 32.5 36.3 26.4 28.3 50.4 46.5 61.8 61.4 40.7 90.8 68.4 48.7 154.0 52.9 52.2 73.6 52.1 57.0 39.4 92.5 23.8 63.1 32.1 54.2 40.7 77.6 101.1 40.5 54.5 46.2 22.8 26.5 47.8 50.1 45.1 28.2 56.7 95.3 91.0 78.7 55.5 82.0 43.2 63.1 32.7 79.6 52.6 71.7 61.1 52.2 39.7 45.6 62.5 30.3 70.8 44.7 50.1 36.5 39.4 40.7 46.2 23.3 46.6 56.6 48.5 36.5 45.9 20.7 18.8 21.3 21.4 40.0 13.3 11.5 15.8 17.7 32.3 11.1 9.4 13.9 3.2 30.8 27.9 22.5 29.6 17.7 8.2 9.1 10.2 10.4 8.4 8.9 10.2 8.8 10.8 8.6 10.2 9.9 5.8 16.0 13.2 6.8 11.6 6.0 17.4 34.8 8.6 11.4 7.1 3.8 3.0 10.0 27.0 23.9 10.4 46.9 11.5 41.6 13.7 45.6 24.6 8.7 6.2 10.5 18.6 3.4 3.4 61.3 34.2 7.4 29.0 11.5 1.3 9.9 3.6 14.7 37.4 6.7 4.0 19.5 63.1 7.9 9.0 7.0 2.1 10.8 16.0 3.7 31.3 21.6 18.6 4.5 5.6 40.8 25.2 5.3 15.7 11.0 26.4 28.7 17.3 72.9 13.1 4.4 16.2 8.8 20.7 14.4 6.0 36.0 13.1 20.1 29.5 19.5 AP002748.5 ENSG00000256349 "Novel protein" 11 66509079-66533613 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.9;choroid plexus: 1.9;retina: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "NTERA-2: 9.7;THP-1: 2.8" HPA058283 Uncertain Approved Midbody Yes NA "Cluster 77: Retina - Visual perception" "Cluster 5: NTERA-2 - Transcription" Midbody "HPA058283: AB_2683667" 0.0 0.1 2.1 0.0 2.2 0.0 0.2 1.9 2.9 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.0 2.3 0.4 0.2 0.2 0.2 2.3 2.1 0.0 0.9 0.2 0.0 0.2 2.3 0.1 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.2 2.3 0.1 0.1 0.0 2.4 0.1 0.1 0.0 0.0 0.1 0.0 2.5 0.6 0.0 0.4 0.0 0.0 0.0 0.3 0.3 0.4 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.7 0.0 0.2 0.6 0.2 0.0 0.1 1.1 0.1 0.0 1.3 0.1 0.4 0.0 0.6 0.3 0.6 9.7 0.8 0.0 0.8 0.0 0.0 0.7 1.4 0.2 0.1 0.2 0.5 0.4 0.2 0.9 2.8 0.1 0.4 0.2 0.0 0.0 0.0 0.2 0.4 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 2.2 1.9 2.9 2.0 2.3 2.3 2.1 2.3 2.3 2.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BBS1 FLJ23590 ENSG00000174483 "Bardet-Biedl syndrome 1" Q8NFJ9 11 66510606-66533613 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Olfaction, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 19.9;Excitatory neurons: 28.5;Inhibitory neurons: 28.4;Microglial cells: 14.0;Oligodendrocyte precursor cells: 13.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA058283 Uncertain Uncertain Midbody Yes NA "Cluster 27: Non-specific - Gene expression" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Midbody "HPA058283: AB_2683667" "unprognostic (1.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.14e-1)" "unprognostic (1.56e-1)" "unprognostic (1.08e-3)" "unprognostic (1.40e-2)" "unprognostic (6.68e-2)" "unprognostic (1.72e-2)" "unprognostic (2.76e-1)" "unprognostic (1.19e-3)" "unprognostic (2.61e-2)" "unprognostic (6.05e-2)" "unprognostic (3.04e-1)" "unprognostic (2.20e-1)" "unprognostic (2.38e-1)" "unprognostic (4.87e-4)" 10.5 15.2 11.5 4.9 13.0 2.9 11.9 10.8 17.8 18.9 13.9 18.0 6.5 20.7 17.7 9.0 28.0 12.6 10.1 11.6 12.7 24.2 7.0 10.4 5.1 10.2 13.5 27.5 13.5 38.0 17.9 8.2 10.1 15.8 7.3 21.4 16.8 22.0 8.1 9.6 9.4 14.1 10.5 6.0 13.8 10.5 13.3 8.0 27.1 8.2 5.0 15.4 10.9 10.7 5.7 6.0 13.7 5.4 24.9 17.2 6.3 4.8 9.6 6.3 6.0 9.5 10.1 0.8 10.0 11.5 5.6 10.6 10.1 10.6 6.8 5.2 5.8 2.5 8.9 5.3 11.7 4.7 1.8 17.7 9.7 9.7 7.1 17.8 8.9 8.5 5.5 4.3 7.8 5.1 3.7 4.1 10.4 18.0 10.5 9.2 9.0 7.4 19.3 6.4 14.0 9.3 8.1 8.7 18.6 6.6 18.7 2.5 8.7 5.0 5.7 6.0 1.6 3.1 1.5 1.4 16.3 1.3 5.4 0.0 1.5 0.2 1.8 1.6 2.6 2.2 2.5 2.0 1.2 1.1 1.7 2.2 0.9 3.1 3.0 0.5 0.8 1.9 11.5 13.0 10.8 17.8 11.6 12.7 10.2 13.5 10.1 10.5 13.3 10.7 0.5 0.0 2.2 19.9 2.5 0.5 1.3 1.6 0.6 3.9 0.9 1.0 0.5 1.5 1.1 0.0 8.4 1.6 0.5 0.6 0.0 0.8 4.1 2.3 1.8 1.3 1.2 3.0 28.5 0.4 0.6 3.1 7.1 0.9 0.0 2.9 0.7 0.3 0.6 0.0 28.4 0.7 2.0 0.9 0.7 2.6 0.9 0.5 0.0 14.0 0.8 1.7 1.0 13.6 9.0 0.4 0.5 1.5 2.5 0.8 0.4 1.7 9.2 10.8 0.0 1.5 1.6 4.9 2.6 2.2 1.0 1.0 1.4 2.0 0.9 0.9 ZDHHC24 ENSG00000174165 "Zinc finger DHHC-type containing 24" Q6UX98 11 66520637-66546235 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016619 Approved Approved Vesicles,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 4: Macrophages - Innate immune response" "Vesicles, Cytosol" "HPA016619: AB_2288672" "unprognostic (2.77e-1)" "unprognostic (2.51e-1)" "unprognostic (2.52e-1)" "unprognostic (1.55e-3)" "prognostic unfavorable (3.28e-4)" "unprognostic (8.76e-2)" "unprognostic (7.74e-3)" "unprognostic (7.11e-2)" "unprognostic (6.20e-2)" "unprognostic (1.41e-1)" "unprognostic (3.73e-2)" "unprognostic (1.48e-1)" "unprognostic (8.10e-2)" "unprognostic (6.99e-3)" "unprognostic (3.10e-1)" "unprognostic (4.88e-1)" "unprognostic (1.35e-1)" 5.2 6.9 5.8 3.3 4.5 5.0 4.7 4.2 5.4 3.6 5.8 3.5 2.8 4.3 5.1 4.3 3.9 2.2 3.6 4.9 5.2 6.2 4.6 4.5 4.3 5.5 5.2 2.7 7.1 6.0 4.7 2.5 4.8 4.5 2.1 2.6 5.0 2.7 2.9 5.1 4.7 1.9 4.4 7.2 4.8 3.7 6.4 3.1 5.9 1.1 3.0 4.0 3.4 4.5 5.2 7.4 2.4 6.5 5.8 4.7 6.2 3.9 3.4 3.1 2.1 6.5 7.7 1.6 11.5 3.3 8.3 11.9 1.9 3.4 2.1 7.6 4.9 2.9 3.7 4.1 5.5 3.4 6.9 5.6 6.2 2.5 3.6 3.7 5.1 13.0 4.2 4.3 4.0 10.4 7.4 8.6 5.3 12.2 7.6 8.8 5.3 9.3 3.9 3.6 3.5 5.6 6.7 6.5 11.6 2.7 9.5 2.4 8.0 7.1 2.4 8.3 3.1 6.9 2.2 2.1 6.2 1.5 8.2 3.0 5.9 1.0 7.3 5.7 6.6 6.4 6.0 8.4 7.2 7.5 3.8 5.9 2.2 8.0 5.0 23.1 6.6 6.1 5.8 4.5 4.2 5.4 4.9 5.2 5.5 5.2 4.8 4.4 6.4 4.5 21.7 12.8 8.3 7.8 21.9 8.0 15.2 26.8 10.8 9.6 21.5 15.2 4.5 22.8 17.3 23.9 10.4 33.0 49.9 29.0 9.8 50.3 13.5 15.1 14.4 23.3 14.4 6.3 7.6 49.4 37.2 15.0 17.9 19.8 8.9 18.5 23.2 14.9 63.9 23.5 7.0 17.8 20.3 42.8 14.8 12.1 7.5 27.9 17.8 5.6 36.4 16.9 46.4 4.0 8.5 42.8 40.6 9.8 15.8 24.9 54.8 35.2 14.7 10.3 19.7 11.2 15.1 29.6 4.1 21.6 8.1 24.1 23.3 18.5 21.8 23.1 ACTN3 ENSG00000248746 "Actinin alpha 3" Q08043 11 66546395-66563334 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 72 "skeletal muscle: 1670.4" "Group enriched" "Detected in some" 6 "Early spermatids: 6.3;Late spermatids: 16.2;Skeletal myocytes: 15.2" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "HDLM-2: 13.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA006035 Uncertain Uncertain "Actin filaments" NA NA 11000000 "Cluster 33: Striated muscle - Muscle contraction" "Cluster 44: HDLM-2 - Immune response" "Cluster 37: Myocytes - Muscle contraction" "Actin filaments" "HPA006035: AB_1078095" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (6.16e-2)" "unprognostic (1.46e-1)" "unprognostic (1.70e-1)" "unprognostic (3.35e-4)" "unprognostic (1.40e-3)" "unprognostic (5.37e-3)" "unprognostic (5.09e-3)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.66e-2)" "unprognostic (6.71e-9)" "unprognostic (2.06e-1)" "unprognostic (6.98e-2)" "unprognostic (5.16e-2)" "unprognostic (2.48e-1)" 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.9 0.1 0.2 0.0 0.2 0.0 0.1 0.0 1.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.3 0.1 1670.4 0.1 0.1 0.0 0.0 0.1 0.1 4.0 0.0 0.0 0.3 23.3 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 6.3 0.0 0.0 0.2 1.8 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.2 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.2 1.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CTSF "CATSF, CLN13" ENSG00000174080 "Cathepsin F" Q9UBX1 11 66563464-66568879 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 320.9;Muller glia cells: 196.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 23.1;SK-MEL-30: 59.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002141, HPA031431" Approved Supported "Endoplasmic reticulum,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 5800000 "Cluster 15: NK-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 5: Muller glia cells - Visual perception" Vesicles "Endoplasmic reticulum, Plasma membrane" "CAB002141: AB_563471, HPA031431: " "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (7.22e-3)" "unprognostic (2.25e-2)" "unprognostic (6.72e-2)" "unprognostic (2.67e-2)" "unprognostic (2.76e-2)" "unprognostic (3.69e-1)" "unprognostic (4.14e-1)" "unprognostic (1.69e-2)" "unprognostic (9.12e-2)" "prognostic favorable (8.92e-7)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (3.89e-1)" "unprognostic (2.42e-1)" 57.8 70.0 68.1 0.8 76.3 0.3 62.2 74.5 74.0 78.8 90.2 76.7 3.0 89.2 21.9 15.6 70.8 10.0 100.2 63.2 74.2 46.9 66.0 32.9 3.6 75.0 70.3 99.1 31.7 20.0 43.3 3.8 68.4 53.5 3.5 26.2 55.7 17.1 91.9 44.4 29.5 12.2 77.2 25.0 54.3 109.7 71.0 3.0 40.6 27.6 3.0 56.6 58.7 86.6 0.0 17.0 3.1 5.4 14.2 8.6 3.4 13.0 11.4 6.3 2.3 0.0 2.2 0.0 21.3 10.4 0.0 1.2 6.8 2.6 4.8 3.7 0.0 0.5 7.0 0.0 9.9 0.3 4.4 22.3 9.1 0.8 1.6 13.7 3.8 2.0 5.4 1.6 5.2 4.6 0.1 1.7 0.9 3.7 9.7 0.0 0.0 1.5 7.1 0.3 4.3 6.9 23.1 0.3 59.5 0.3 7.4 0.6 3.3 1.8 2.9 1.5 1.2 21.2 0.2 0.0 2.2 0.0 2.9 0.0 0.4 0.3 3.9 0.6 4.1 1.5 3.5 4.6 0.6 1.4 6.4 4.1 0.1 4.6 0.2 0.9 1.3 2.2 68.1 76.3 74.5 74.0 63.2 74.2 75.0 70.3 68.4 77.2 71.0 86.6 36.6 12.8 15.6 31.3 5.9 39.8 62.4 8.5 37.5 107.9 45.3 80.6 57.9 41.5 7.4 36.8 41.7 31.6 9.6 0.6 15.6 13.1 163.3 1.7 22.8 27.2 12.0 11.4 26.5 7.5 9.5 118.1 8.2 5.3 9.5 52.1 56.0 67.8 14.9 134.6 31.3 3.1 18.3 21.5 32.8 320.9 145.7 13.1 156.5 12.2 3.1 196.6 17.5 21.6 29.4 5.9 3.2 121.9 12.9 50.5 1.3 44.7 3.3 77.9 78.9 62.0 45.9 169.6 43.3 3.6 25.3 23.7 9.5 30.7 4.3 32.9 CCDC87 FLJ10786 ENSG00000182791 "Coiled-coil domain containing 87" Q9NVE4 11 66590176-66593063 "Predicted intracellular proteins" "Differentiation, Fertilization, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 13.8" "Group enriched" "Detected in some" 4 "Early spermatids: 32.1;Spermatocytes: 19.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.3;SCLC-21H: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (3.48e-2)" "unprognostic (1.06e-1)" "unprognostic (4.96e-2)" "unprognostic (6.37e-2)" "unprognostic (2.25e-3)" "unprognostic (2.71e-2)" "unprognostic (8.59e-3)" "unprognostic (1.66e-1)" "unprognostic (1.37e-1)" "unprognostic (5.17e-2)" "unprognostic (2.16e-3)" "unprognostic (2.56e-2)" "unprognostic (3.97e-3)" "unprognostic (8.25e-2)" "unprognostic (2.29e-1)" "unprognostic (3.39e-2)" "unprognostic (2.42e-1)" 0.0 0.2 0.3 0.1 0.2 0.0 0.2 0.1 0.2 0.2 0.4 0.1 0.1 0.2 1.7 0.1 0.3 0.1 0.2 0.2 0.3 0.3 0.2 0.1 0.0 0.1 0.2 0.0 0.1 1.1 0.4 0.0 0.2 0.2 0.1 1.4 0.1 0.5 0.1 0.1 0.0 0.2 0.1 0.0 0.1 13.8 0.2 0.2 0.9 0.1 0.0 0.1 0.0 0.2 0.4 1.3 0.2 0.3 0.3 0.1 0.1 0.1 0.3 0.2 0.1 0.8 0.3 0.0 0.5 0.2 0.5 0.6 0.2 0.0 0.1 0.2 0.0 0.2 0.2 0.1 0.3 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.2 0.5 0.2 0.2 0.4 0.8 0.2 0.4 0.3 0.0 0.5 0.0 2.3 0.3 0.5 0.5 0.1 0.3 0.6 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.2 0.1 0.2 0.2 0.3 0.1 0.2 0.2 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.5 0.0 0.1 1.8 2.1 0.0 0.0 0.0 0.0 0.5 32.1 0.2 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.6 0.0 0.0 0.0 19.5 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 CCS ENSG00000173992 "Copper chaperone for superoxide dismutase" O14618 11 66593153-66606019 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 204.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008672, HPA040026, HPA044090" Approved NA NA 190000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 6: Erythroid cells - Oxygen transport" "CAB008672: AB_1623300, HPA040026: AB_2676806, HPA044090: AB_2678805" "unprognostic (1.19e-1)" "unprognostic (8.46e-3)" "unprognostic (3.14e-3)" "unprognostic (1.11e-1)" "unprognostic (2.57e-2)" "unprognostic (3.22e-2)" "unprognostic (3.67e-2)" "unprognostic (1.53e-1)" "unprognostic (3.01e-1)" "unprognostic (3.00e-1)" "unprognostic (8.22e-3)" "unprognostic (1.10e-1)" "unprognostic (1.97e-1)" "unprognostic (1.44e-1)" "unprognostic (1.60e-1)" "unprognostic (1.84e-1)" "unprognostic (3.25e-3)" 21.1 26.6 29.6 18.5 30.5 34.4 14.1 33.4 40.5 18.5 30.7 21.9 27.9 19.8 18.3 16.5 17.7 21.1 21.4 30.7 31.1 21.3 56.2 15.6 23.8 32.4 30.9 23.6 31.1 22.6 17.3 17.9 30.4 22.6 14.7 24.9 36.8 20.0 19.1 21.9 30.1 17.2 30.3 21.8 23.3 16.9 31.3 15.9 17.3 14.2 17.3 17.7 14.7 35.0 24.6 34.1 24.4 26.9 22.0 21.4 29.9 22.4 18.7 15.9 10.7 38.8 26.5 14.4 31.3 19.9 23.8 24.6 7.2 25.8 5.3 26.8 10.9 23.3 30.5 51.1 42.3 6.0 18.3 35.8 18.9 16.9 11.1 33.6 26.0 16.5 12.3 19.2 16.5 55.0 9.5 30.1 22.7 40.2 23.9 17.4 23.3 29.8 25.0 25.6 19.9 12.9 37.2 25.4 49.7 14.4 38.9 17.4 23.6 10.8 17.7 24.4 10.8 32.1 19.2 7.6 29.7 9.2 26.5 23.6 26.4 60.0 19.7 21.0 17.0 32.5 16.9 16.0 31.1 25.3 17.7 17.9 17.8 19.1 13.0 83.7 18.4 17.3 29.6 30.5 33.4 40.5 30.7 31.1 32.4 30.9 30.4 30.3 31.3 35.0 37.8 19.2 33.7 58.8 56.1 24.2 52.9 44.7 31.3 42.4 33.6 37.5 29.9 45.8 30.4 36.8 25.0 55.2 59.3 49.7 82.2 34.1 25.4 16.5 38.0 28.7 73.0 204.4 20.2 59.8 43.8 60.4 44.4 27.2 21.5 63.9 39.3 163.5 64.9 11.8 19.1 41.1 26.4 35.8 32.3 12.6 71.4 43.8 44.4 23.4 38.5 65.4 44.3 15.1 20.6 40.5 44.9 57.2 50.6 31.2 90.4 132.9 19.7 104.2 19.7 31.8 67.1 46.7 31.4 30.1 20.3 51.6 41.0 191.3 46.7 37.2 RBM14 "COAA, DKFZp779J0927, SIP, SYTIP1" ENSG00000239306 "RNA binding motif protein 14" Q96PK6 11 66616626-66629934 "Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006628 Supported Supported "Nuclear speckles" NA NA 31000 "Cluster 39: Non-specific - mRNA processing" "Cluster 43: Testis - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 39: Non-specific - Basic cellular processes" "Nuclear speckles" "HPA006628: AB_1078546" "unprognostic (6.96e-2)" "unprognostic (4.79e-2)" "unprognostic (4.34e-3)" "unprognostic (4.45e-2)" "unprognostic (2.15e-1)" "unprognostic (9.56e-3)" "prognostic unfavorable (2.02e-7)" "unprognostic (4.21e-2)" "unprognostic (1.54e-3)" "unprognostic (1.08e-2)" "prognostic favorable (1.04e-4)" "unprognostic (9.38e-3)" "unprognostic (8.59e-3)" "unprognostic (1.29e-2)" "unprognostic (3.32e-1)" "unprognostic (1.02e-1)" "unprognostic (1.94e-1)" 26.9 32.0 39.9 25.0 40.2 32.6 24.1 52.6 48.0 37.2 48.5 29.4 15.7 30.8 19.1 33.9 37.6 10.7 33.2 40.1 38.9 50.6 40.4 27.3 28.3 39.4 40.6 45.1 34.1 17.5 34.5 19.6 39.4 36.3 18.2 35.8 25.3 14.6 29.7 28.4 29.1 15.6 37.1 40.4 30.1 44.0 39.6 25.7 28.4 11.6 29.2 30.4 28.6 48.6 83.0 77.9 55.9 43.2 25.3 16.8 97.0 45.0 16.4 40.8 24.0 79.2 60.6 130.9 49.2 21.9 45.0 69.0 63.4 36.5 43.3 63.9 68.7 81.7 67.1 71.2 14.1 71.5 70.0 11.8 13.3 41.9 23.3 24.1 31.0 38.2 98.6 83.9 40.2 70.3 122.4 79.4 107.2 69.0 85.7 125.3 65.4 67.3 34.2 71.5 67.0 61.9 78.0 55.9 33.9 45.9 77.3 63.5 50.5 49.4 97.9 40.5 72.6 49.8 75.2 109.0 41.8 68.9 120.1 19.7 24.3 27.3 27.9 26.1 27.2 21.3 24.1 26.8 33.6 21.8 24.3 28.2 9.0 21.7 27.2 21.3 23.1 34.0 39.9 40.2 52.6 48.0 40.1 38.9 39.4 40.6 39.4 37.1 39.6 48.6 12.6 9.6 17.0 0.0 27.4 38.1 45.7 20.7 15.4 24.8 19.1 16.3 16.3 18.6 17.2 14.7 29.2 56.3 32.7 17.7 17.6 26.5 37.3 18.1 16.5 21.3 21.6 23.1 0.0 18.4 54.4 20.1 9.7 17.5 19.7 20.4 22.5 24.5 29.0 11.8 0.0 20.9 24.4 16.0 30.2 27.0 17.1 20.1 12.4 0.0 25.4 18.1 34.0 0.0 0.0 19.3 21.7 16.1 20.7 26.9 19.0 12.2 23.2 49.4 6.6 15.1 21.5 53.9 40.1 20.9 31.1 69.2 29.0 13.7 25.2 32.6 RBM14-RBM4 ENSG00000248643 "RBM14-RBM4 readthrough" 11 66616626-66646469 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 5.5;Club cells: 5.0;Excitatory neurons: 8.7;Inhibitory neurons: 8.7;Microglial cells: 5.6;Oligodendrocytes: 10.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 10.0" HPA047849 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "HPA047849: AB_2680180" "unprognostic (2.41e-1)" "unprognostic (1.11e-1)" "unprognostic (2.98e-2)" "unprognostic (1.10e-2)" "unprognostic (2.52e-2)" "unprognostic (2.01e-2)" "unprognostic (1.37e-1)" "unprognostic (7.25e-2)" "unprognostic (1.77e-4)" "unprognostic (3.92e-2)" "unprognostic (2.52e-1)" "unprognostic (3.77e-4)" "unprognostic (5.74e-7)" "unprognostic (1.43e-1)" "unprognostic (2.53e-2)" "unprognostic (1.30e-1)" "unprognostic (3.10e-2)" 0.6 0.8 3.5 0.4 2.5 3.0 0.5 3.4 3.4 0.6 2.9 1.3 0.1 0.8 0.8 1.0 0.7 0.6 2.7 2.6 3.6 1.0 3.0 0.7 0.6 2.9 1.9 0.6 1.1 0.3 1.0 0.4 1.8 1.1 0.4 0.7 0.9 0.5 1.0 0.6 1.0 0.5 1.3 1.1 1.0 0.5 2.6 0.8 1.0 0.4 0.4 1.1 0.7 3.4 1.6 0.9 0.7 1.3 1.0 0.1 0.8 0.9 0.5 1.6 0.3 2.6 0.5 0.9 1.3 0.7 1.2 2.5 1.8 0.6 0.6 0.8 0.7 2.7 1.8 2.0 0.5 1.7 1.5 0.4 0.5 0.8 0.2 0.6 0.0 1.4 3.8 1.4 1.0 3.2 2.5 10.0 1.7 1.9 4.4 2.8 3.4 1.5 0.7 1.8 2.2 1.0 0.7 2.3 5.9 0.5 1.4 1.2 0.7 2.1 1.5 1.7 1.1 1.1 1.0 1.7 1.8 1.2 1.8 4.8 4.3 5.9 4.6 4.8 2.7 5.9 2.9 3.1 4.3 5.9 1.9 2.5 2.8 3.5 5.0 8.4 2.1 3.6 3.5 2.5 3.4 3.4 2.6 3.6 2.9 1.9 1.8 1.3 2.6 3.4 0.5 0.0 1.1 5.5 1.1 0.0 0.5 0.1 1.2 1.1 0.4 0.4 0.0 1.5 5.0 0.0 4.2 0.5 2.0 0.3 0.0 0.5 1.7 1.4 0.9 0.6 0.0 0.4 8.7 0.2 0.4 0.8 1.1 1.1 0.0 0.7 0.0 0.5 0.2 0.0 8.7 0.5 0.0 0.3 0.3 0.9 0.0 1.2 0.0 5.6 0.0 0.1 0.0 4.0 10.3 0.4 0.1 0.0 1.0 0.5 0.0 0.4 3.6 0.8 0.0 0.8 0.4 1.0 0.9 1.0 0.1 1.1 1.0 0.5 0.2 0.8 RBM4 "LARK, RBM4A, ZCCHC21, ZCRB3A" ENSG00000173933 "RNA binding motif protein 4" Q9BWF3 11 66638667-66668374 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, RNA-mediated gene silencing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042174, HPA047849" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "HPA042174: AB_2677885, HPA047849: AB_2680180" "unprognostic (8.43e-2)" "unprognostic (1.55e-1)" "unprognostic (2.17e-1)" "unprognostic (1.53e-2)" "unprognostic (9.46e-3)" "unprognostic (1.13e-1)" "unprognostic (5.41e-3)" "unprognostic (6.42e-2)" "unprognostic (4.34e-3)" "unprognostic (1.57e-1)" "unprognostic (1.22e-1)" "unprognostic (4.42e-2)" "unprognostic (2.53e-1)" "unprognostic (2.13e-1)" "unprognostic (2.27e-1)" "unprognostic (4.76e-2)" "unprognostic (3.07e-3)" 82.6 111.5 60.8 71.0 63.3 131.5 75.8 81.1 66.7 90.8 69.4 96.1 67.8 87.1 90.3 100.3 79.4 59.0 75.6 61.5 67.1 119.8 82.3 77.4 97.5 59.0 58.5 103.6 115.5 77.2 86.1 72.8 58.9 95.9 62.6 74.4 89.1 60.0 96.6 80.9 83.6 69.1 61.1 104.8 98.4 74.3 69.5 109.8 85.7 72.4 99.1 84.2 84.1 65.4 127.2 163.6 246.5 136.4 90.1 95.6 153.9 128.6 106.1 134.1 97.3 281.5 160.9 161.1 174.4 132.3 120.5 136.4 263.5 159.1 142.9 162.1 138.4 220.7 163.5 170.3 173.1 152.8 91.9 138.8 134.3 158.6 213.9 136.4 184.3 155.0 180.1 115.0 147.3 263.3 252.9 157.9 309.7 246.8 176.0 234.2 224.6 181.7 180.7 199.5 204.5 149.5 227.1 168.6 379.9 163.8 315.3 154.4 180.9 140.4 124.0 86.5 107.3 143.9 162.5 258.8 109.9 118.3 205.8 210.0 119.4 131.3 135.5 123.2 122.3 119.3 139.8 149.9 116.2 130.4 147.5 149.8 137.5 155.4 144.0 103.6 194.3 159.1 60.8 63.3 81.1 66.7 61.5 67.1 59.0 58.5 58.9 61.1 69.5 65.4 19.7 28.9 42.2 8.1 64.0 17.8 61.4 36.3 112.7 58.2 24.2 12.7 4.6 15.7 36.5 20.2 93.8 36.2 48.7 16.6 15.6 25.1 39.8 26.6 28.0 28.5 34.7 42.5 23.9 23.1 30.1 33.6 53.0 30.7 36.8 38.1 25.7 11.1 14.5 62.2 21.4 15.5 32.6 18.8 29.2 9.3 27.4 27.5 19.6 7.5 28.8 15.9 69.0 15.1 18.8 19.6 23.6 20.3 60.2 62.6 32.9 10.6 41.1 90.0 19.7 29.7 28.3 41.1 40.1 68.6 22.3 43.8 66.3 42.4 24.8 65.5 RBM4B "MGC10871, RBM30, RBM4L, ZCCHC15, ZCCHC21B, ZCRB3B" ENSG00000173914 "RNA binding motif protein 4B" Q9BQ04 11 66664998-66677887 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042174, HPA047849" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 21: Non-specific - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm Cytosol "HPA042174: AB_2677885, HPA047849: AB_2680180" "unprognostic (1.65e-2)" "unprognostic (1.83e-1)" "unprognostic (3.32e-2)" "unprognostic (1.98e-3)" "unprognostic (3.57e-1)" "unprognostic (1.87e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.28e-1)" "unprognostic (1.09e-2)" "unprognostic (6.22e-2)" "prognostic favorable (2.10e-4)" "unprognostic (1.05e-2)" "prognostic unfavorable (1.02e-4)" "unprognostic (1.10e-2)" "unprognostic (1.40e-1)" "unprognostic (4.29e-2)" "unprognostic (1.71e-2)" 8.1 16.2 25.9 11.1 26.2 4.9 10.7 36.5 31.5 21.9 23.2 15.2 10.0 19.8 20.4 13.7 18.7 10.4 10.9 25.7 27.7 15.2 14.3 9.4 16.1 25.2 24.9 30.0 13.6 13.1 23.6 13.1 25.3 18.6 12.0 34.5 15.3 14.9 16.3 18.8 14.5 14.5 24.7 15.6 12.6 16.2 26.2 13.3 16.1 15.3 17.3 14.0 15.5 29.9 21.3 21.0 45.1 37.7 21.7 22.3 15.3 19.9 20.0 21.9 22.3 29.5 21.9 23.8 27.9 25.5 21.5 27.2 30.1 27.7 23.2 23.0 20.4 25.7 26.6 31.9 15.9 26.4 24.4 23.3 18.6 22.5 19.1 25.1 21.5 19.0 20.0 23.1 29.8 34.3 16.5 20.4 26.7 47.8 27.9 33.4 35.8 24.4 20.2 21.1 27.7 25.2 23.9 12.1 47.3 28.8 32.3 24.7 20.1 24.1 24.6 23.7 18.3 11.2 20.5 24.2 22.2 18.4 21.7 26.4 15.1 43.9 16.1 22.6 15.7 34.6 14.9 15.8 18.2 28.9 18.1 13.5 9.8 22.6 25.9 15.1 12.2 13.8 25.9 26.2 36.5 31.5 25.7 27.7 25.2 24.9 25.3 24.7 26.2 29.9 7.5 12.8 5.9 15.3 25.9 8.0 14.7 29.8 24.5 36.3 14.4 13.6 6.9 12.8 15.9 18.4 33.3 36.5 11.5 8.1 11.7 11.9 26.5 13.4 12.8 9.5 19.2 12.0 20.0 5.8 16.5 14.9 11.2 11.7 8.9 17.0 12.8 9.0 13.0 25.2 25.8 11.7 26.4 9.8 6.1 53.9 18.3 9.8 16.0 11.2 10.5 23.3 13.4 29.1 31.1 4.7 12.4 13.5 13.4 7.0 21.2 13.4 22.6 60.4 6.6 12.0 14.2 50.8 42.8 13.6 7.1 22.2 14.6 12.2 10.9 5.7 SPTBN2 SCA5 ENSG00000173898 "Spectrin beta, non-erythrocytic 2" O15020 11 66682497-66729226 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 73.6;skin 1: 85.5" "Cell type enhanced" "Detected in many" "Collecting duct cells: 86.5;Cone photoreceptor cells: 104.3;Early spermatids: 30.9;Late spermatids: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 45.6;NTERA-2: 49.1;SCLC-21H: 49.9;SK-BR-3: 52.3;T-47d: 67.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009844, HPA039293, HPA043529" Enhanced Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 9: Photoreceptor cells - Phototransduction" "Plasma membrane, Cytosol" Vesicles "CAB009844: AB_2194521, HPA039293: AB_2676430, HPA043529: AB_2678531" "unprognostic (9.34e-2)" "unprognostic (5.71e-2)" "unprognostic (4.89e-2)" "unprognostic (3.41e-3)" "unprognostic (4.91e-1)" "unprognostic (6.05e-3)" "unprognostic (4.45e-2)" "unprognostic (1.38e-2)" "unprognostic (7.25e-2)" "unprognostic (1.67e-2)" "prognostic unfavorable (3.14e-5)" "unprognostic (1.64e-1)" "unprognostic (1.05e-3)" "unprognostic (1.34e-1)" "unprognostic (1.84e-1)" "unprognostic (3.99e-2)" "unprognostic (1.00e-3)" 1.3 14.4 26.8 1.0 32.6 2.3 7.7 29.7 73.6 14.3 0.0 0.9 0.9 1.7 1.2 39.8 3.7 1.7 1.4 38.8 0.3 37.5 23.3 1.1 0.2 4.8 0.9 0.9 16.7 13.1 16.4 0.4 3.2 12.4 0.7 14.7 29.6 4.7 0.5 85.5 1.0 1.1 0.0 0.9 2.9 52.8 4.6 1.0 0.3 0.1 6.7 1.6 16.5 24.2 20.5 7.4 3.4 0.3 0.1 0.0 0.6 0.3 0.1 0.1 0.0 4.8 28.2 0.2 3.7 0.0 0.7 16.9 25.2 2.4 0.0 0.1 10.4 0.1 45.6 3.0 0.8 7.3 0.6 0.2 11.5 0.0 7.4 4.2 6.3 5.2 7.3 0.1 0.1 35.2 6.3 3.5 49.1 28.7 21.1 23.8 2.8 14.7 9.6 4.8 49.9 29.4 14.0 52.3 3.2 2.7 67.2 2.4 1.4 0.1 8.6 1.3 11.5 0.7 3.0 14.7 0.1 0.1 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 26.8 32.6 29.7 73.6 38.8 0.3 4.8 0.9 3.2 0.0 4.6 24.2 0.7 3.2 1.1 4.9 0.3 3.7 2.7 3.2 2.8 11.0 4.7 4.6 1.8 1.5 4.6 86.5 104.3 0.9 0.0 0.6 0.0 2.6 30.9 3.6 1.8 1.1 3.0 7.2 29.3 10.0 0.3 0.8 1.5 3.6 0.0 1.4 1.4 24.7 0.1 0.0 20.7 1.6 0.0 0.3 0.7 77.6 1.8 0.1 0.0 2.8 0.6 1.6 0.0 7.5 4.6 7.5 0.2 1.5 0.8 3.2 0.2 1.3 3.5 21.3 0.0 0.2 0.5 8.5 9.4 14.6 12.5 0.3 0.2 0.1 0.8 1.7 C11orf80 "FLJ22531, TOPOVIBL" ENSG00000173715 "Chromosome 11 open reading frame 80" Q8N6T0 11 66744451-66843516 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Meiosis "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 41.0" "Cell type enhanced" "Detected in many" "Early spermatids: 66.0;Excitatory neurons: 101.2;Inhibitory neurons: 73.8;Late spermatids: 125.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038932, HPA038933" Approved Approved Centrosome NA NA "Cluster 37: B-cells - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 21: OE19 - Mitochondria" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Centrosome "HPA038932: AB_2676275, HPA038933: AB_10671867" "unprognostic (2.81e-1)" "unprognostic (4.39e-2)" "unprognostic (1.71e-2)" "unprognostic (6.69e-2)" "unprognostic (3.30e-1)" "unprognostic (2.09e-1)" "unprognostic (5.54e-3)" "unprognostic (4.16e-1)" "unprognostic (4.26e-2)" "unprognostic (6.59e-2)" "unprognostic (4.04e-2)" "unprognostic (2.53e-2)" "unprognostic (6.31e-2)" "unprognostic (1.23e-1)" "unprognostic (4.98e-1)" "unprognostic (3.72e-2)" "unprognostic (1.26e-1)" 4.0 10.8 5.9 5.9 6.5 5.5 11.1 14.3 8.3 8.8 1.9 9.4 9.0 4.1 14.0 23.8 5.5 2.9 5.9 5.8 5.7 24.6 3.1 6.0 6.8 1.8 2.5 4.0 5.9 10.1 12.2 3.3 3.2 13.8 9.3 12.2 14.4 7.0 1.2 41.0 14.2 4.4 0.6 9.9 5.6 23.8 5.6 13.0 4.2 1.4 15.0 5.0 13.4 3.9 16.1 8.7 17.1 11.7 0.9 5.3 3.2 6.8 7.9 7.8 9.8 28.7 19.5 26.4 3.8 5.8 5.2 28.8 7.8 9.8 7.7 6.9 4.5 4.7 12.0 7.3 2.1 3.2 4.7 1.4 35.0 6.1 11.0 11.9 25.2 9.6 7.7 10.0 4.7 17.9 10.8 9.7 26.9 46.4 11.6 6.5 8.1 20.4 33.6 5.8 12.8 12.6 11.2 30.0 24.2 15.1 21.3 2.0 11.7 5.5 9.9 6.0 9.9 7.2 16.2 19.1 6.2 5.5 6.9 2.2 0.8 3.0 1.8 0.4 3.6 10.7 3.3 2.6 0.5 7.4 3.5 3.0 1.6 1.5 0.9 9.1 4.1 0.7 5.9 6.5 14.3 8.3 5.8 5.7 1.8 2.5 3.2 0.6 5.6 3.9 2.8 19.2 3.6 9.8 17.0 11.6 3.2 11.9 4.6 3.6 9.4 7.6 0.5 4.3 8.0 35.0 18.8 1.7 6.0 10.7 9.8 17.0 66.0 5.0 2.1 3.0 13.8 5.7 101.2 11.7 2.3 2.5 5.6 4.4 4.5 3.2 2.2 2.7 3.3 0.0 73.8 12.4 14.2 1.0 5.2 125.5 2.5 1.3 3.6 14.0 4.3 2.0 8.2 9.5 8.5 14.6 12.1 0.4 43.6 2.8 46.2 4.1 4.8 8.7 6.6 2.3 3.0 22.0 22.9 20.4 20.0 1.5 5.9 0.8 10.3 3.2 RCE1 "FACE-2, FACE2, hRCE1, RCE1A, RCE1B" ENSG00000173653 "Ras converting CAAX endopeptidase 1" Q9Y256 11 66842835-66846552 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074124 Approved NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 27: Brain & Skin - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 10: Non-specific - Unknown function" "HPA074124: " "unprognostic (1.11e-1)" "unprognostic (7.23e-2)" "unprognostic (1.15e-1)" "unprognostic (8.16e-3)" "unprognostic (3.11e-1)" "unprognostic (6.40e-3)" "unprognostic (1.98e-3)" "unprognostic (7.69e-3)" "unprognostic (1.39e-1)" "unprognostic (9.14e-3)" "unprognostic (2.35e-3)" "unprognostic (5.31e-3)" "unprognostic (1.06e-1)" "unprognostic (4.48e-3)" "unprognostic (2.17e-2)" "unprognostic (1.04e-1)" "unprognostic (4.28e-2)" 10.1 10.9 14.9 7.2 15.1 20.9 9.3 17.9 18.2 10.7 13.7 13.3 10.1 8.4 5.9 19.9 8.9 8.6 7.3 14.7 14.9 25.7 7.9 8.9 9.9 14.0 14.1 10.8 15.5 9.5 13.9 11.8 14.2 12.0 8.2 10.0 12.6 6.1 4.4 19.9 12.4 5.9 13.5 12.0 12.0 13.5 15.5 9.5 7.0 4.2 6.1 11.9 12.9 14.6 22.7 24.5 14.7 13.8 9.0 7.8 32.3 11.6 11.2 17.7 15.8 46.6 47.2 17.2 21.8 11.1 29.3 39.6 17.1 17.4 10.2 20.7 19.3 15.5 17.0 18.0 31.7 20.3 22.0 12.6 32.7 19.9 17.6 13.7 14.6 23.5 21.7 26.0 9.0 42.8 28.2 38.3 43.5 43.1 24.0 22.9 11.0 34.1 19.5 12.0 18.3 16.5 16.8 22.3 74.1 14.3 26.2 16.3 9.7 24.2 18.7 26.4 18.5 14.6 15.2 19.6 16.4 20.8 18.4 23.1 21.1 14.6 17.1 24.0 15.6 15.3 14.7 22.1 18.9 12.0 11.8 17.8 7.2 14.3 21.5 29.1 6.7 17.8 14.9 15.1 17.9 18.2 14.7 14.9 14.0 14.1 14.2 13.5 15.5 14.6 12.5 0.0 4.8 4.2 16.9 31.2 26.6 46.2 14.2 9.2 16.4 20.6 1.8 10.0 20.3 16.5 29.2 54.6 24.9 12.4 3.9 24.3 10.1 11.3 12.5 12.2 10.7 10.7 7.7 27.4 65.0 12.0 11.7 17.1 8.2 13.3 8.2 3.0 22.8 3.3 6.2 16.0 26.4 8.9 15.1 20.2 6.8 13.3 14.2 3.7 12.9 6.4 9.2 6.0 4.0 30.0 18.0 6.4 14.5 19.6 23.2 7.4 8.9 18.0 13.1 5.6 32.1 9.7 25.7 17.1 24.9 58.6 19.1 10.3 16.2 23.9 PC PCB ENSG00000173599 "Pyruvate carboxylase" P11498 11 66848417-66958386 "Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Gluconeogenesis, Lipid biosynthesis, Lipid metabolism" "Ligase, Multifunctional enzyme" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 148.0" "Cell type enhanced" "Detected in many" "Hepatocytes: 201.9;Late spermatids: 53.2" "Cancer enhanced" "Detected in all" "liver cancer: 37.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 57.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033742, HPA043922, HPA058765" Enhanced Enhanced Mitochondria Yes No 200000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 15: Liver - Metabolism" "Cluster 20: HeLa - Mitochondria" "Cluster 15: Hepatocytes - Hemostasis" Mitochondria "CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812" "unprognostic (2.10e-1)" "unprognostic (1.51e-1)" "unprognostic (1.36e-2)" "unprognostic (8.24e-3)" "unprognostic (3.67e-1)" "unprognostic (3.18e-2)" "unprognostic (2.97e-1)" "unprognostic (3.00e-1)" "unprognostic (3.63e-1)" "prognostic unfavorable (7.86e-5)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "prognostic favorable (8.22e-5)" "unprognostic (8.58e-3)" "unprognostic (5.67e-2)" "unprognostic (9.15e-3)" "unprognostic (1.05e-1)" 60.9 23.7 35.7 2.9 35.5 3.5 28.4 36.6 35.8 3.7 17.5 4.7 6.5 3.8 1.8 9.3 3.2 2.8 4.3 32.4 41.0 23.3 148.0 2.6 1.3 43.4 40.1 5.1 4.9 18.2 8.6 4.4 37.6 7.2 2.8 2.4 35.3 9.3 12.1 4.7 7.7 1.4 37.8 1.5 9.1 10.7 49.0 2.0 4.6 6.6 2.0 2.9 4.4 37.0 6.1 19.3 6.5 17.2 25.4 8.9 6.6 3.4 15.5 6.9 7.5 8.8 6.0 0.0 7.4 6.0 9.6 6.8 7.7 39.5 1.5 2.8 11.0 10.3 57.4 41.2 21.0 0.1 10.8 40.2 10.1 5.8 12.4 4.4 5.7 14.3 17.4 0.0 2.1 44.6 9.2 4.6 12.0 15.1 16.2 8.3 13.0 3.2 5.7 1.9 15.2 21.0 33.6 18.0 15.5 4.8 14.6 2.7 6.3 7.8 6.6 8.8 4.7 3.5 4.8 0.1 7.7 5.7 6.7 0.0 1.3 0.0 0.5 0.3 0.5 0.0 0.1 0.5 0.9 0.2 0.9 0.5 0.1 0.1 0.1 0.3 0.5 0.7 35.7 35.5 36.6 35.8 32.4 41.0 43.4 40.1 37.6 37.8 49.0 37.0 0.9 0.0 3.0 26.4 1.4 1.3 1.6 9.1 2.8 5.6 4.8 5.8 4.4 11.5 3.0 3.7 2.1 17.4 0.6 27.6 1.9 3.1 18.4 2.3 7.1 1.5 9.0 28.0 18.5 1.8 4.2 3.2 5.6 3.0 8.9 16.0 4.6 201.9 12.3 0.0 18.6 5.0 0.0 7.0 1.8 53.2 0.6 1.8 5.4 7.5 18.9 9.4 2.1 10.1 16.7 2.3 8.5 4.1 0.1 3.1 23.6 39.0 1.5 4.8 0.0 2.2 2.2 11.2 4.7 4.1 0.6 25.4 1.2 6.0 6.4 1.3 LRFN4 "FIGLER6, MGC3103, SALM3." ENSG00000173621 "Leucine rich repeat and fibronectin type III domain containing 4" Q6PJG9 11 66856647-66860475 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077570 Enhanced NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA077570: " "unprognostic (2.25e-2)" "unprognostic (5.90e-3)" "unprognostic (7.51e-2)" "unprognostic (2.01e-2)" "unprognostic (4.35e-2)" "unprognostic (6.73e-2)" "unprognostic (1.80e-2)" "unprognostic (1.03e-3)" "unprognostic (6.56e-2)" "unprognostic (6.93e-2)" "unprognostic (5.69e-2)" "unprognostic (9.45e-2)" "unprognostic (1.93e-1)" "unprognostic (6.80e-3)" "unprognostic (1.81e-1)" "unprognostic (2.85e-1)" "unprognostic (3.53e-1)" 15.3 13.4 10.8 2.2 9.2 3.9 12.7 10.6 14.1 11.5 0.0 14.8 1.5 13.4 0.1 8.0 11.6 0.7 12.3 10.6 4.5 12.0 2.6 8.4 1.6 3.8 5.2 6.3 3.0 1.2 7.9 0.9 2.3 8.8 1.3 0.5 9.2 2.3 9.6 9.4 5.9 1.0 2.1 7.7 8.3 22.9 6.0 1.2 5.8 2.0 0.6 9.2 10.7 6.3 22.5 18.9 3.0 8.7 2.3 4.5 0.2 14.5 4.7 8.7 4.7 12.0 10.8 10.6 17.1 5.4 9.6 13.2 5.2 5.0 1.0 5.2 16.7 7.8 51.3 4.6 14.6 16.5 19.8 6.6 7.8 4.0 4.0 5.3 6.4 14.4 21.0 0.4 1.3 47.2 30.5 55.0 25.0 10.2 32.4 22.0 11.8 35.0 3.8 0.1 16.6 16.0 21.1 17.5 51.1 0.6 24.0 12.7 15.1 12.1 23.0 35.0 14.0 10.2 10.1 2.3 7.6 18.2 9.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.1 10.8 9.2 10.6 14.1 10.6 4.5 3.8 5.2 2.3 2.1 6.0 6.3 4.8 0.0 1.1 10.7 1.1 2.2 2.5 7.1 0.0 18.7 3.6 5.7 0.7 0.0 2.9 3.7 4.2 0.2 1.9 15.9 0.0 1.6 17.1 7.6 18.4 4.0 1.8 1.3 9.1 0.8 1.2 4.9 4.1 10.2 1.3 9.5 2.2 0.2 5.3 13.5 9.5 12.3 6.1 3.1 2.2 29.6 3.7 4.3 5.4 1.9 7.6 2.0 3.1 5.0 6.8 4.3 9.6 1.5 1.9 5.9 0.3 0.5 2.6 8.6 0.0 3.8 6.0 5.5 2.2 2.1 1.7 0.3 2.1 11.8 16.2 1.8 C11orf86 FLJ22675 ENSG00000173237 "Chromosome 11 open reading frame 86" A6NJI1 11 66975277-66977004 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 68.0" "Group enriched" "Detected in some" 20 "Distal enterocytes: 212.2;Paneth cells: 132.8;Proximal enterocytes: 506.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 7.2;SiHa: 24.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA039348 Uncertain NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 20: HeLa - Mitochondria" "Cluster 45: Enterocytes - Digestion" "HPA039348: AB_10673421" "unprognostic (1.54e-2)" "unprognostic (7.67e-3)" "unprognostic (3.02e-2)" "unprognostic (1.20e-1)" "unprognostic (3.90e-4)" "prognostic unfavorable (8.97e-4)" "unprognostic (4.17e-1)" "prognostic unfavorable (6.97e-5)" "prognostic unfavorable (1.02e-5)" "unprognostic (7.04e-2)" "unprognostic (1.51e-1)" "unprognostic (1.69e-2)" "unprognostic (3.58e-3)" 0.1 15.4 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.0 0.1 10.4 68.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 1.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.1 0.0 6.5 0.0 0.0 0.0 0.0 0.0 64.2 0.7 0.1 0.0 2.1 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 24.9 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 212.2 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 132.8 0.0 0.0 0.0 506.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 8.4 0.2 SYT12 SRG1 ENSG00000173227 "Synaptotagmin 12" Q8IV01 11 67006778-67050863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 22.5;liver: 17.6;parathyroid gland: 63.8" "Cell type enhanced" "Detected in many" "Astrocytes: 8.8;Basal respiratory cells: 10.9;Excitatory neurons: 39.3;Inhibitory neurons: 21.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 8.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HeLa: 49.8;MCF7: 38.0;SiHa: 44.3;SK-BR-3: 20.9;T-47d: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011006, HPA074255" Enhanced NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 20: HeLa - Mitochondria" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA011006: AB_2286996, HPA074255: " "unprognostic (2.72e-2)" "unprognostic (2.77e-2)" "unprognostic (2.23e-2)" "unprognostic (1.12e-3)" "unprognostic (4.47e-3)" "unprognostic (3.88e-2)" "unprognostic (1.20e-1)" "unprognostic (3.73e-2)" "unprognostic (2.04e-1)" "unprognostic (7.85e-3)" "prognostic unfavorable (4.13e-4)" "unprognostic (2.75e-1)" "unprognostic (9.86e-4)" "unprognostic (4.21e-2)" "unprognostic (7.38e-2)" "unprognostic (2.42e-2)" "unprognostic (9.85e-2)" 0.6 6.9 9.4 0.2 10.9 0.0 4.6 22.5 19.0 0.2 1.7 0.0 0.7 0.1 5.1 0.4 3.8 0.6 0.7 9.9 7.6 0.3 17.6 0.0 0.1 10.3 9.5 0.1 0.3 63.8 5.6 0.8 10.9 1.6 0.0 0.4 1.6 0.8 0.3 0.8 0.3 0.0 4.8 0.0 0.3 1.4 7.9 0.0 0.4 0.0 0.1 1.2 0.2 10.9 0.0 2.0 0.3 3.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 8.1 1.5 3.4 1.3 0.3 1.5 0.2 4.5 0.0 0.0 0.4 0.0 49.8 0.1 0.0 0.0 0.1 0.5 0.3 0.1 0.0 4.6 0.0 0.0 0.1 0.1 0.0 38.0 0.0 0.1 0.9 0.2 1.7 0.0 0.0 0.0 0.6 0.0 0.3 0.0 44.3 20.9 0.1 0.1 19.3 0.2 0.0 0.0 7.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 10.9 22.5 19.0 9.9 7.6 10.3 9.5 10.9 4.8 7.9 10.9 0.2 0.0 0.0 8.8 0.1 1.3 3.8 10.9 0.0 2.2 6.9 6.6 1.2 1.5 3.1 1.8 0.0 0.4 0.1 0.5 0.0 2.9 0.5 0.8 0.3 0.4 0.0 0.0 39.3 0.0 1.5 1.1 0.0 0.5 0.0 0.3 0.0 5.8 0.1 0.0 21.6 0.0 0.0 0.0 1.2 0.2 0.0 0.1 0.0 4.7 0.0 0.1 0.0 3.0 2.3 0.4 0.0 0.4 0.1 1.2 0.2 0.1 1.6 1.2 0.0 1.2 1.6 0.8 1.2 0.0 1.1 1.9 0.5 0.0 0.4 1.3 RHOD "ARHD, Rho, RhoHP1" ENSG00000173156 "Ras homolog family member D" O00212 11 67056847-67072017 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 182.2;liver: 122.9" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 124.7;Ductal cells: 102.8;Exocrine glandular cells: 141.6;Pancreatic endocrine cells: 271.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 156.0;CAPAN-2: 109.2;HaCaT: 135.9;HBEC3-KT: 179.8;hTCEpi: 208.6;MCF7: 101.0;T-47d: 148.7" "Group enriched" "Detected in many" 4 "cerebellum: 14.9;pons and medulla: 5.1" "Low region specificity" "Detected in some" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "unprognostic (2.12e-2)" "prognostic unfavorable (9.17e-4)" "unprognostic (3.89e-3)" "unprognostic (1.65e-1)" "unprognostic (3.61e-3)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (3.10e-4)" "unprognostic (5.85e-2)" "unprognostic (4.39e-2)" "unprognostic (1.38e-3)" "unprognostic (8.89e-2)" "unprognostic (2.56e-2)" "unprognostic (2.24e-1)" "unprognostic (5.89e-2)" "unprognostic (2.40e-1)" "unprognostic (2.35e-2)" 13.0 2.5 3.3 2.5 3.0 0.0 13.9 4.0 4.7 36.7 18.1 9.1 9.1 12.5 1.1 182.2 11.4 6.6 53.4 3.5 2.7 24.0 122.9 8.9 1.1 3.5 2.9 11.8 36.2 24.8 15.6 7.3 3.1 18.0 1.2 0.8 34.9 7.1 28.2 58.6 7.3 3.3 2.8 2.6 15.6 4.9 2.7 1.4 23.0 5.0 6.0 7.8 60.1 2.5 156.0 12.2 0.8 15.8 2.3 1.7 23.1 13.7 22.5 8.2 8.1 11.4 109.2 0.0 24.6 16.1 0.0 135.9 1.6 179.8 1.5 0.0 0.5 0.0 62.6 1.3 21.7 0.1 0.2 21.4 208.6 2.5 54.2 10.1 8.3 0.0 0.0 10.6 2.5 101.0 0.2 0.1 17.8 16.6 62.6 0.0 0.0 0.3 76.3 11.2 1.0 0.0 70.9 4.0 6.1 2.9 148.7 0.5 5.1 0.1 0.4 2.2 0.8 0.0 3.5 0.2 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 3.0 4.0 4.7 3.5 2.7 3.5 2.9 3.1 2.8 2.7 2.5 6.6 16.0 4.4 0.7 1.3 32.9 34.6 124.7 56.9 0.2 38.8 57.7 28.2 28.6 29.0 16.5 0.0 29.9 0.6 67.7 45.0 102.8 16.7 6.5 8.1 7.2 4.2 3.6 0.4 141.6 34.1 14.8 24.5 9.7 0.0 8.0 5.7 46.3 3.6 0.0 0.3 4.5 10.2 1.0 4.0 9.4 11.8 1.0 8.8 1.0 0.6 13.6 0.0 0.5 0.2 271.3 66.1 22.2 1.7 61.0 90.8 24.7 19.3 0.6 0.0 2.1 9.1 0.9 4.7 55.4 57.7 36.0 2.8 1.5 6.6 71.8 KDM2A "CXXC8, DKFZP434M1735, FBL11, FBL7, FBXL11, FLJ00115, JHDM1A, KIAA1004, LILINA" ENSG00000173120 "Lysine demethylase 2A" Q9Y2K7 11 67119263-67258082 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012272, HPA044251" Supported Supported Nucleoplasm NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 6: T47d - Mammary gland" "Cluster 44: Endometrium - Transcription" Nucleoplasm "CAB012272: , HPA044251: " "unprognostic (7.43e-2)" "unprognostic (1.84e-1)" "unprognostic (4.09e-1)" "unprognostic (8.66e-2)" "unprognostic (1.67e-1)" "unprognostic (2.30e-2)" "unprognostic (6.05e-2)" "unprognostic (2.84e-1)" "unprognostic (4.46e-1)" "unprognostic (2.04e-3)" "unprognostic (3.27e-2)" "unprognostic (5.08e-2)" "unprognostic (2.67e-2)" "unprognostic (3.30e-1)" "unprognostic (1.05e-1)" "unprognostic (5.61e-2)" "unprognostic (9.45e-3)" 19.5 13.2 10.7 27.2 10.6 47.1 19.7 18.0 12.1 24.3 14.1 23.3 14.7 29.1 17.4 31.9 19.3 19.0 17.4 10.6 11.2 14.3 19.9 24.0 27.5 12.6 10.7 24.5 13.0 16.1 13.1 18.0 10.9 21.6 17.1 18.5 21.3 19.2 33.8 29.4 23.9 24.0 9.7 27.0 18.9 29.0 11.9 27.8 19.0 24.5 28.7 23.9 25.9 10.9 49.9 31.8 17.6 27.7 17.1 27.0 13.5 21.5 26.6 41.0 27.9 48.7 25.4 38.8 37.5 33.3 23.8 48.2 31.3 22.5 33.1 66.4 13.4 28.9 39.2 11.7 16.9 24.5 38.1 21.7 23.9 39.4 25.7 20.7 29.9 22.7 27.4 54.4 18.6 35.4 32.5 18.1 36.1 29.8 25.6 39.9 29.4 21.4 14.7 33.7 24.2 18.9 71.0 38.6 39.0 21.6 59.9 23.9 38.7 25.0 16.7 34.5 18.8 29.3 35.4 25.4 22.0 17.2 17.8 0.4 1.1 0.3 2.5 0.8 2.7 3.6 1.9 2.3 0.6 3.6 1.9 1.9 2.7 2.7 0.5 0.9 2.6 1.9 10.7 10.6 18.0 12.1 10.6 11.2 12.6 10.7 10.9 9.7 11.9 10.9 41.4 38.5 35.8 75.1 56.6 41.2 23.3 23.4 75.7 75.3 40.3 30.9 31.1 34.3 31.0 16.5 137.6 23.9 77.5 43.2 0.0 17.3 20.6 84.8 63.0 38.4 31.8 22.1 89.4 14.5 13.4 32.4 42.8 112.3 27.3 42.1 29.3 35.5 21.5 95.9 89.8 27.5 24.4 46.5 59.6 11.2 21.5 49.1 19.6 104.0 43.3 19.8 33.0 96.0 99.5 25.9 25.5 23.0 72.5 37.2 21.2 10.3 40.0 111.7 19.7 40.2 32.3 52.0 38.1 78.7 47.7 32.3 66.9 33.8 29.5 48.7 GRK2 "ADRBK1, BARK1" ENSG00000173020 "G protein-coupled receptor kinase 2" P25098 11 67266473-67286556 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 197.1" "Cell type enhanced" "Detected in many" "Adipocytes: 33.4;dendritic cells: 80.2;Hofbauer cells: 35.8;Macrophages: 37.6;Pancreatic endocrine cells: 32.4;T-cells: 31.0;Theca cells: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 318.0;REH: 417.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005021, CAB037248, HPA060707" Enhanced Approved Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 14: REH - Unknown function" "Cluster 7: Non-specific - Mitochondria" Cytosol "CAB005021: AB_562360, CAB037248: AB_1078280, HPA060707: " "unprognostic (5.58e-2)" "unprognostic (1.75e-1)" "unprognostic (2.01e-2)" "unprognostic (5.33e-2)" "unprognostic (1.38e-1)" "unprognostic (1.29e-3)" "unprognostic (3.31e-2)" "unprognostic (6.17e-2)" "unprognostic (1.11e-1)" "unprognostic (6.35e-2)" "unprognostic (2.22e-1)" "unprognostic (2.55e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (3.66e-1)" "unprognostic (2.40e-1)" "unprognostic (4.04e-2)" "unprognostic (5.19e-3)" 41.2 35.6 42.4 73.0 42.7 197.1 38.0 31.6 63.8 41.3 16.9 54.3 38.2 34.7 10.4 68.1 41.6 28.8 49.1 44.4 32.5 38.6 47.4 64.1 102.4 36.4 31.6 30.1 33.1 16.2 37.5 25.5 36.5 59.1 33.3 7.9 47.1 22.8 55.6 68.3 88.7 25.1 29.1 186.8 45.4 24.1 36.9 74.7 32.2 40.9 77.8 41.3 47.4 41.8 43.1 29.8 28.1 48.0 22.2 19.9 28.7 24.7 23.4 33.0 27.4 67.1 69.0 215.3 39.5 23.0 44.0 56.7 41.3 33.5 17.2 264.4 26.3 122.5 35.4 30.8 27.9 259.5 238.3 18.0 38.2 26.5 34.8 24.4 42.8 87.7 45.3 107.7 29.0 80.7 147.5 318.0 35.3 125.8 44.4 417.0 55.3 65.2 34.0 54.6 57.0 30.8 36.9 52.9 90.5 16.9 49.7 283.0 24.5 26.7 34.8 33.6 28.4 69.2 67.5 195.3 34.0 153.6 24.6 12.6 17.8 19.2 8.4 27.6 6.3 6.1 6.3 7.0 10.2 6.4 5.0 4.9 35.7 6.9 33.7 9.0 4.4 15.9 42.4 42.7 31.6 63.8 44.4 32.5 36.4 31.6 36.5 29.1 36.9 41.8 33.4 3.2 17.9 0.0 16.7 0.0 0.0 0.0 0.0 0.0 24.5 19.7 0.0 0.0 4.3 5.5 0.0 8.9 80.2 0.0 1.9 10.3 0.0 16.6 14.7 9.0 0.0 0.0 0.0 12.6 5.9 6.1 0.0 18.9 21.5 22.3 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.6 0.0 0.0 8.8 0.0 0.0 0.0 0.0 32.4 0.0 0.0 17.7 0.0 0.0 5.6 0.7 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 9.6 31.0 36.3 0.0 0.0 ANKRD13D ENSG00000172932 "Ankyrin repeat domain 13D" Q6ZTN6 11 67289300-67302485 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NB-4: 63.9;SK-MEL-30: 57.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039950 Approved Approved Nucleoplasm,Mitochondria No No "Cluster 10: Basophils - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Mitochondria "HPA039950: AB_10796337" "unprognostic (1.10e-1)" "unprognostic (1.18e-3)" "unprognostic (1.37e-3)" "unprognostic (4.19e-2)" "unprognostic (9.83e-3)" "unprognostic (1.58e-1)" "unprognostic (4.87e-3)" "unprognostic (3.72e-2)" "unprognostic (1.44e-1)" "unprognostic (1.16e-2)" "unprognostic (5.06e-3)" "unprognostic (3.71e-2)" "prognostic unfavorable (5.73e-10)" "unprognostic (1.62e-1)" "unprognostic (1.80e-1)" "unprognostic (4.01e-2)" "unprognostic (6.74e-2)" 12.0 14.7 13.3 6.8 14.3 0.3 11.4 10.9 20.7 19.5 10.8 13.8 3.1 12.5 2.9 24.4 15.3 7.9 12.0 16.5 12.9 16.2 8.9 13.8 15.0 13.8 11.7 14.1 9.5 6.0 28.9 5.2 15.1 23.8 2.3 2.0 14.4 7.3 3.7 15.0 13.8 6.5 10.2 39.2 12.8 12.1 15.8 10.0 11.2 3.8 5.7 17.5 20.5 19.6 9.7 7.2 5.8 12.3 10.9 10.1 3.8 7.0 8.4 7.2 5.6 6.4 10.1 11.6 12.4 5.6 10.7 12.4 4.5 8.6 1.0 19.9 5.3 11.6 11.3 4.3 16.8 14.0 27.8 10.4 11.8 6.2 6.8 14.1 9.5 9.2 6.3 12.4 8.0 14.1 18.0 63.9 2.5 19.8 10.1 28.5 4.9 9.9 13.6 6.0 6.0 9.8 7.0 16.7 57.0 4.5 14.3 33.1 7.7 7.1 6.1 7.9 8.2 9.8 9.4 5.6 17.4 21.4 8.2 6.6 0.6 5.7 2.0 2.1 1.3 0.8 1.5 2.8 1.2 0.5 0.5 3.2 1.9 3.1 1.4 1.8 1.6 1.2 13.3 14.3 10.9 20.7 16.5 12.9 13.8 11.7 15.1 10.2 15.8 19.6 23.2 0.0 18.8 18.9 22.2 14.1 11.7 15.4 17.6 61.1 21.5 20.8 7.0 8.6 14.5 16.5 75.0 8.3 73.6 7.5 1.9 8.3 18.0 27.7 19.7 17.9 10.8 8.2 29.8 6.9 9.0 15.7 20.4 18.0 25.3 25.7 22.1 3.0 20.0 42.1 29.7 7.9 18.3 52.0 21.4 6.0 22.1 45.8 12.4 18.7 49.7 20.8 49.4 17.6 18.4 9.9 4.6 17.0 30.7 19.9 2.3 2.6 30.4 51.7 13.1 13.6 18.5 3.1 8.1 19.3 25.1 7.5 49.9 28.9 8.4 19.8 SSH3 "FLJ10928, FLJ20515" ENSG00000172830 "Slingshot protein phosphatase 3" Q8TE77 11 67303478-67312607 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 11.6;eosinophil: 11.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.6" "Cell line enhanced" "Detected in many" "HaCaT: 64.9;MCF7: 64.1;RT4: 111.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019949, HPA019957" Approved Approved "Nuclear speckles,Plasma membrane,Actin filaments,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 15: RT4 - Unknown function" "Cluster 30: Mammary glandular cells - Lactation" "Nuclear speckles, Cytosol" "Plasma membrane, Actin filaments" "HPA019949: AB_1857498, HPA019957: AB_1857499" "unprognostic (4.38e-2)" "unprognostic (1.37e-1)" "unprognostic (3.50e-3)" "unprognostic (3.73e-2)" "unprognostic (2.61e-3)" "unprognostic (9.30e-2)" "unprognostic (2.99e-1)" "unprognostic (1.84e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (2.89e-4)" "unprognostic (1.50e-1)" "unprognostic (2.06e-2)" "unprognostic (1.47e-1)" "unprognostic (3.20e-1)" "unprognostic (4.94e-3)" "unprognostic (6.78e-3)" 14.4 7.8 8.9 4.0 12.0 9.3 16.2 14.1 11.6 25.9 9.5 19.3 13.3 16.0 7.5 41.9 18.3 11.5 12.5 9.1 10.1 13.1 10.9 12.7 3.1 14.6 10.8 23.5 15.3 9.8 9.7 6.5 13.2 29.9 9.3 1.2 26.2 28.8 6.8 25.2 15.0 6.1 12.3 9.4 20.1 2.3 11.5 1.9 16.3 3.8 4.8 37.4 32.5 14.9 17.3 18.7 0.4 0.6 11.4 11.8 18.8 10.3 13.7 5.6 5.1 21.2 46.8 1.0 32.5 10.5 11.9 64.9 6.0 46.4 2.8 3.6 6.3 4.3 32.2 9.9 8.2 0.9 16.0 12.2 40.5 8.3 8.3 12.9 6.3 0.4 0.1 1.5 6.2 64.1 0.8 7.3 4.2 48.9 13.8 20.6 0.6 3.1 18.2 111.2 3.7 5.8 24.8 41.0 12.8 6.3 57.1 15.3 10.4 4.5 9.8 12.7 2.7 1.5 0.9 0.5 12.7 6.9 4.9 11.6 1.5 11.1 2.0 2.3 1.7 0.2 1.9 1.7 1.7 0.1 0.8 0.8 4.4 1.5 1.1 1.1 1.8 1.1 8.9 12.0 14.1 11.6 9.1 10.1 14.6 10.8 13.2 12.3 11.5 14.9 7.6 3.2 8.7 8.5 0.9 7.0 20.8 25.2 11.4 0.8 21.3 17.3 3.8 20.0 23.4 16.5 0.0 15.1 3.3 28.3 3.9 19.4 0.1 8.3 5.6 4.7 3.6 5.2 4.2 21.6 24.9 8.0 20.9 17.8 3.8 8.1 3.9 5.0 7.7 1.7 5.3 14.4 24.4 6.2 3.1 0.6 13.1 4.8 8.8 2.8 9.2 4.8 7.2 0.0 15.9 20.0 21.0 12.0 0.7 15.4 20.2 7.4 11.6 0.5 0.0 4.9 9.2 0.5 0.4 27.0 10.4 15.7 4.4 5.3 21.4 26.8 RAD9A RAD9 ENSG00000172613 "RAD9 checkpoint clamp component A" Q99638 11 67317871-67398410 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006725, HPA048155, CAB079979" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Nuclear bodies" "CAB079979: , HPA006725: AB_1856041, HPA048155: AB_2680290" "unprognostic (7.64e-2)" "prognostic favorable (6.95e-4)" "unprognostic (8.83e-3)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (2.12e-3)" "unprognostic (9.64e-3)" "unprognostic (1.05e-2)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (9.19e-2)" "unprognostic (2.50e-2)" "prognostic unfavorable (2.82e-5)" "unprognostic (6.16e-2)" "unprognostic (3.72e-3)" "unprognostic (2.19e-1)" "prognostic favorable (7.52e-6)" 5.8 5.0 3.3 6.9 3.6 10.2 6.9 2.1 6.0 9.2 2.9 7.3 10.9 7.4 2.1 9.0 10.9 5.7 4.2 3.8 2.4 7.1 6.6 6.7 8.3 2.9 3.6 8.0 8.0 3.4 10.1 4.4 2.2 10.8 3.0 1.8 9.8 6.1 5.2 11.4 11.1 2.4 2.2 9.4 8.4 8.6 2.5 6.1 9.7 2.1 3.7 6.5 8.5 2.2 10.8 15.8 9.5 13.8 2.8 1.1 12.0 5.7 4.9 8.0 7.1 23.2 20.9 11.1 12.4 1.8 13.0 18.7 6.0 5.5 0.9 13.0 16.3 16.8 8.5 10.4 3.8 12.3 20.3 3.2 5.3 7.2 3.5 6.1 5.5 23.2 14.7 15.6 2.3 33.2 21.9 21.8 13.2 15.9 12.1 18.8 12.5 13.6 2.2 9.0 9.8 10.6 9.9 27.2 21.1 2.4 19.1 10.9 4.2 11.7 14.3 23.3 8.7 14.6 14.2 11.5 7.5 11.6 9.6 5.3 1.8 6.0 5.2 2.3 3.8 4.3 4.1 4.3 1.2 3.1 2.9 3.2 2.8 3.1 2.5 3.4 2.4 1.5 3.3 3.6 2.1 6.0 3.8 2.4 2.9 3.6 2.2 2.2 2.5 2.2 16.0 22.4 17.1 10.1 31.0 17.1 17.7 17.9 23.3 19.6 19.7 18.4 1.1 12.8 22.2 20.2 70.9 27.9 31.3 54.2 13.7 11.3 27.3 32.1 13.4 16.3 14.3 17.7 8.5 13.1 22.4 13.8 27.0 14.9 20.3 26.0 11.0 6.6 15.1 21.9 6.0 48.9 10.2 10.3 31.4 13.2 10.5 14.0 19.6 11.2 8.9 15.0 56.7 2.5 5.3 11.6 31.6 12.4 38.5 16.6 61.8 10.9 44.0 32.1 13.1 10.5 14.5 32.0 17.6 18.3 17.3 40.6 30.3 15.3 38.7 18.0 POLD4 "p12, POLDS" ENSG00000175482 "DNA polymerase delta 4, accessory subunit" Q9HCU8 11 67350772-67356972 "Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, DNA replication" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 272.0" "Cell type enhanced" "Detected in all" "Distal enterocytes: 538.2;Paneth cells: 572.5;Proximal enterocytes: 403.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 177.0" "Low region specificity" "Detected in all" HPA078008 Approved "Centriolar satellite" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 18: Non-specific - Mitochondria" "Cluster 38: EFO-21 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Centriolar satellite" "HPA078008: " "unprognostic (7.55e-3)" "unprognostic (2.71e-1)" "unprognostic (3.93e-2)" "unprognostic (2.75e-1)" "unprognostic (1.19e-2)" "unprognostic (1.03e-1)" "unprognostic (8.25e-2)" "unprognostic (1.43e-2)" "unprognostic (4.82e-1)" "unprognostic (2.02e-1)" "unprognostic (3.19e-2)" "unprognostic (2.53e-1)" "unprognostic (2.39e-3)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" "unprognostic (1.95e-1)" "unprognostic (9.36e-2)" 80.6 78.1 9.5 60.4 9.8 37.1 66.5 8.3 19.6 60.6 9.7 110.1 86.0 53.1 5.6 118.3 47.3 19.1 98.4 8.9 8.5 106.9 272.0 73.5 83.1 12.0 11.1 48.3 104.8 4.0 39.7 17.2 11.2 87.1 14.7 3.0 72.7 9.5 91.7 56.2 118.8 9.8 8.9 111.5 81.7 27.9 11.4 8.7 49.3 9.3 25.3 82.1 75.4 10.0 48.0 125.5 2.0 13.6 14.4 27.8 7.6 58.3 12.1 8.5 6.0 21.9 147.7 126.4 177.0 16.9 31.1 64.2 0.4 39.5 1.1 53.4 7.2 29.1 29.6 29.2 31.9 10.3 142.1 31.4 19.7 15.4 13.1 42.6 25.4 19.5 27.1 42.2 14.3 79.4 13.2 22.7 10.1 94.7 83.7 21.6 23.4 34.7 19.9 33.1 1.0 13.2 29.7 21.9 95.8 6.9 51.8 37.5 82.5 28.7 20.2 75.2 19.8 52.9 19.1 72.4 95.8 24.3 34.3 129.3 147.8 258.6 63.2 192.4 59.1 333.3 72.5 65.6 143.8 354.7 78.9 71.0 143.4 50.7 376.9 101.1 115.6 128.9 9.5 9.8 8.3 19.6 8.9 8.5 12.0 11.1 11.2 8.9 11.4 10.0 8.0 19.2 44.9 12.4 115.3 43.3 3.1 152.6 47.8 2.6 14.8 8.6 2.3 12.8 86.1 7.3 6.2 8.6 15.5 538.2 15.6 144.7 7.8 4.8 7.8 19.1 83.1 26.1 6.5 188.5 10.5 25.3 180.4 11.9 68.5 5.6 22.1 40.7 31.3 3.3 4.9 226.0 105.8 31.3 92.5 18.7 6.8 66.9 60.5 34.7 114.1 4.2 36.0 5.5 12.6 220.3 572.5 3.8 66.8 4.5 403.3 30.2 18.7 4.2 6.6 5.8 26.8 4.7 3.0 96.4 68.9 12.4 49.4 2.2 130.8 4.5 AP003419.1 ENSG00000256514 "Novel protein" 11 67351572-67373584 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.5;Club cells: 1.8;granulocytes: 3.8;Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 160.8" HPA078008 Approved "Centriolar satellite" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 11: Alveolar cells - Smell perception" "Centriolar satellite" "HPA078008: " "unprognostic (1.64e-3)" "unprognostic (1.63e-1)" "unprognostic (2.44e-1)" 23.9 26.6 48.0 45.6 50.8 38.9 26.6 51.4 57.0 28.9 47.4 68.1 46.8 14.8 38.4 46.1 25.4 49.9 44.4 47.0 50.4 32.0 91.9 36.6 83.5 51.9 49.9 23.6 68.1 20.1 14.6 28.7 51.2 36.7 71.9 8.2 42.0 32.1 37.4 30.6 44.0 34.1 51.8 38.5 45.9 20.5 53.9 58.0 25.9 75.0 123.1 47.0 11.3 54.3 14.4 14.9 8.1 12.1 81.4 124.2 3.4 18.9 82.0 26.0 26.9 0.0 160.8 15.4 49.2 122.4 48.9 19.3 8.1 102.3 15.5 10.1 0.2 17.3 2.3 0.0 122.6 5.4 40.2 122.2 96.3 64.0 111.7 115.7 80.3 31.0 7.1 41.8 94.7 3.9 13.5 15.4 3.3 138.1 1.0 15.7 22.0 18.9 80.9 2.5 1.4 6.1 13.9 17.6 53.9 34.4 50.4 19.4 45.8 42.5 7.0 42.8 8.6 16.5 2.4 25.6 99.3 12.2 25.8 43.2 39.6 74.0 45.8 48.6 43.7 87.9 60.8 60.3 39.1 96.3 61.9 51.7 34.6 24.3 90.4 72.9 84.0 62.0 48.0 50.8 51.4 57.0 47.0 50.4 51.9 49.9 51.2 51.8 53.9 54.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CLCF1 "BSF-3, BSF3, CISS2, CLC, NNT-1, NNT1, NR6" ENSG00000175505 "Cardiotrophin like cytokine factor 1" Q9UBD9 11 67364168-67374177 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins" Cytokine "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 41.8;Glandular and luminal cells: 104.9;Pancreatic endocrine cells: 56.2;Prostatic glandular cells: 56.4;Urothelial cells: 65.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 57.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA042444 Uncertain Approved "Nuclear bodies,Vesicles" "Secreted to blood" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 44: Endometrium - Transcription" "Nuclear bodies, Vesicles" "HPA042444: AB_10794527" "unprognostic (2.68e-1)" "unprognostic (7.87e-3)" "unprognostic (6.21e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (9.91e-4)" "unprognostic (1.61e-2)" "unprognostic (1.09e-3)" "unprognostic (1.47e-2)" "unprognostic (5.08e-2)" "unprognostic (2.65e-2)" "unprognostic (1.84e-2)" "unprognostic (1.54e-1)" "unprognostic (1.67e-2)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" "unprognostic (1.17e-2)" "unprognostic (2.37e-1)" 16.2 6.0 1.3 8.0 0.5 13.7 5.3 0.0 1.5 13.9 0.9 13.4 1.4 16.6 1.0 4.4 17.1 17.7 8.8 1.0 0.6 19.0 4.2 9.3 5.3 1.4 0.5 6.7 6.5 0.2 6.5 4.2 0.4 7.2 1.7 1.4 9.1 1.8 1.5 2.6 9.4 8.3 0.0 8.1 11.2 1.9 2.1 0.7 9.7 1.9 4.4 18.1 7.6 0.2 15.1 31.4 2.2 9.7 4.2 5.8 0.0 20.9 11.6 14.4 7.0 5.1 40.3 9.1 17.1 26.8 17.5 10.3 0.4 10.7 6.3 0.5 0.3 0.1 23.9 4.0 13.6 1.9 2.4 7.6 2.6 15.0 6.5 27.4 3.1 0.0 3.5 0.4 15.0 12.0 0.1 6.8 8.1 18.9 28.8 0.9 4.8 0.5 22.7 0.8 0.1 1.6 57.8 2.2 1.3 4.4 1.3 2.5 12.5 27.6 11.6 35.4 31.5 2.0 0.1 1.0 35.4 1.8 11.1 0.0 0.9 15.2 10.5 3.4 6.2 10.8 4.8 8.3 1.3 13.8 0.1 3.5 0.3 0.2 10.5 0.0 1.1 3.2 1.3 0.5 0.0 1.5 1.0 0.6 1.4 0.5 0.4 0.0 2.1 0.2 4.2 16.0 4.8 1.3 10.6 3.7 25.9 6.5 1.8 0.0 14.5 2.4 0.8 25.8 9.6 7.3 0.0 0.4 10.0 3.8 1.9 24.0 1.8 41.8 19.4 6.2 1.2 0.0 0.7 11.8 0.6 14.0 5.1 104.9 3.8 2.1 2.9 1.0 1.2 0.0 0.5 2.3 6.1 0.3 10.7 4.7 3.4 6.7 8.8 1.0 6.5 1.7 3.1 0.5 0.1 56.2 14.3 0.0 9.5 56.4 0.2 5.2 1.7 0.3 0.0 32.6 10.4 0.3 0.9 1.6 4.4 0.1 9.7 0.1 1.5 65.2 PPP1CA "PP-1A, PP1A, PP1alpha, PPP1A" ENSG00000172531 "Protein phosphatase 1 catalytic subunit alpha" P62136 11 67398181-67421183 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004545, HPA046833" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3600000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 52: Non-specific - Ribosome" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Plasma membrane, Cytosol" "CAB004545: AB_628177, HPA046833: AB_2679829" "unprognostic (1.03e-1)" "unprognostic (5.82e-3)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (2.09e-1)" "unprognostic (1.51e-2)" "unprognostic (3.15e-3)" "unprognostic (3.93e-2)" "unprognostic (2.07e-1)" "unprognostic (3.89e-2)" "unprognostic (5.05e-3)" "unprognostic (8.00e-2)" "unprognostic (1.66e-1)" "unprognostic (9.96e-2)" "unprognostic (7.69e-2)" "prognostic favorable (1.17e-4)" "unprognostic (7.60e-2)" 70.0 102.4 61.2 102.6 70.8 127.8 63.5 64.0 70.7 62.1 61.2 110.8 95.9 50.5 66.8 184.0 61.1 51.2 122.0 63.5 63.6 121.8 128.2 78.9 147.8 68.3 62.4 33.1 105.1 64.2 59.8 83.5 63.8 81.1 89.6 21.6 100.4 51.0 123.2 105.8 107.1 56.1 63.9 148.7 102.7 34.6 65.8 113.7 88.7 81.3 155.6 74.9 80.6 68.2 283.1 305.6 181.1 270.3 88.4 108.9 185.6 136.1 158.4 267.4 202.3 445.8 328.5 237.2 227.3 208.1 198.4 238.7 213.9 280.2 169.6 256.3 139.9 227.5 129.3 232.7 195.2 295.2 281.1 123.3 181.1 225.7 130.7 125.4 272.2 226.0 217.4 191.1 220.5 619.4 378.2 562.2 303.5 526.7 241.1 262.7 254.0 209.8 262.2 220.7 142.5 236.7 159.2 283.0 439.8 135.3 338.5 201.2 196.4 208.5 208.9 245.3 179.0 190.1 193.2 271.8 244.6 199.9 224.3 921.6 735.9 1234.1 779.2 962.9 604.3 733.4 679.9 792.5 705.3 779.6 412.6 584.2 853.8 688.8 1186.1 500.4 1098.7 2042.5 61.2 70.8 64.0 70.7 63.5 63.6 68.3 62.4 63.8 63.9 65.8 68.2 49.2 76.9 92.2 8.8 165.8 99.9 143.5 305.9 64.3 35.5 81.7 79.1 8.4 102.9 157.8 86.5 10.4 360.4 151.2 377.5 213.2 265.6 2.5 63.1 67.2 101.6 96.9 108.8 8.8 311.1 507.0 68.8 132.0 107.1 109.6 87.1 89.3 113.9 377.1 43.7 7.7 241.3 181.0 219.8 138.5 7.7 49.0 186.5 136.9 9.4 353.0 53.8 408.8 6.0 13.1 318.4 308.4 28.6 206.5 139.0 341.3 297.4 70.5 30.5 98.6 67.1 100.7 13.6 94.6 142.0 121.6 427.3 176.3 100.1 231.7 205.4 TBC1D10C "Carabin, EPI64C, FLJ00332" ENSG00000175463 "TBC1 domain family member 10C" Q8IV04 11 67403915-67410089 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 40.4;intestine: 25.6;lymphoid tissue: 58.6" "Group enriched" "Detected in many" 4 "B-cells: 109.6;dendritic cells: 144.4;NK-cells: 284.2;T-cells: 147.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 19.0;JURKAT: 27.3;MOLT-4: 47.1;NB-4: 64.7;U-937: 24.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA069743 Enhanced Approved "Nuclear bodies" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nuclear bodies" "HPA069743: AB_2686186" "prognostic favorable (3.83e-4)" "prognostic favorable (4.20e-4)" "unprognostic (9.23e-2)" "unprognostic (3.84e-2)" "unprognostic (1.28e-3)" "prognostic favorable (1.86e-5)" "unprognostic (6.22e-3)" "unprognostic (1.17e-2)" "unprognostic (3.65e-2)" "unprognostic (3.55e-2)" "unprognostic (3.28e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (4.35e-7)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" "unprognostic (7.18e-2)" "unprognostic (3.81e-2)" 2.3 0.7 0.7 25.8 1.2 40.4 1.1 0.4 1.2 1.4 0.8 4.1 5.5 0.9 0.1 2.3 1.9 3.2 0.9 0.6 0.6 2.5 2.6 8.9 56.7 0.9 0.5 0.5 0.8 0.2 0.5 0.8 0.6 1.9 1.5 0.0 3.8 0.7 0.9 1.4 25.6 0.5 0.5 58.6 7.6 0.5 0.7 46.0 7.6 0.6 21.8 3.2 1.7 1.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 8.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.7 0.1 1.2 0.0 6.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.1 0.0 0.0 0.3 47.1 64.7 0.0 0.0 0.0 6.6 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 4.5 0.0 0.0 0.1 0.2 0.0 0.4 0.5 12.2 0.0 24.6 0.0 191.0 46.0 270.4 237.7 120.4 169.7 177.3 201.5 208.3 65.6 184.2 206.7 192.0 237.6 148.0 167.0 55.8 286.6 261.6 0.7 1.2 0.4 1.2 0.6 0.6 0.9 0.5 0.6 0.5 0.7 1.1 2.5 6.4 19.5 0.0 109.6 1.1 0.1 0.1 0.6 1.0 1.4 1.9 1.5 2.8 2.5 0.0 0.0 0.2 144.4 0.2 0.0 0.2 0.2 2.4 0.4 1.9 1.2 12.6 0.2 0.0 0.3 2.0 2.0 1.1 23.4 0.1 5.0 1.4 23.7 0.0 0.1 0.0 0.0 16.0 6.9 0.6 0.0 23.1 3.6 1.0 24.5 0.3 284.2 0.0 0.5 0.0 0.0 0.0 40.2 0.1 0.1 1.1 1.3 0.5 0.0 1.3 1.1 0.1 0.2 0.0 1.0 0.4 147.7 0.1 0.1 0.1 CARNS1 "ATPGD1, KIAA1394" ENSG00000172508 "Carnosine synthase 1" A5YM72 11 67414968-67425607 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 278.3;skeletal muscle: 75.5" "Cell type enriched" "Detected in some" 19 "Oligodendrocytes: 447.9" "Group enriched" "Detected in many" 5 "glioma: 4.1;thyroid cancer: 10.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 12 "RPMI-8226: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA038569 Enhanced "Intracellular and membrane" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 70: Brain - Nervous system development" "Cluster 25: RPMI-8226 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA038569: AB_2676089" "unprognostic (1.07e-4)" "unprognostic (4.33e-3)" "unprognostic (2.00e-2)" "unprognostic (6.15e-2)" "unprognostic (9.45e-2)" "unprognostic (1.05e-1)" "unprognostic (7.28e-2)" "unprognostic (7.54e-3)" "unprognostic (1.29e-1)" "unprognostic (1.82e-1)" "unprognostic (5.19e-3)" "unprognostic (1.00e-1)" "unprognostic (6.14e-6)" "unprognostic (3.44e-2)" "unprognostic (1.33e-1)" "unprognostic (3.83e-3)" "unprognostic (8.33e-2)" 11.7 0.3 62.1 0.4 149.5 0.5 0.7 127.6 119.0 0.7 20.4 0.7 0.4 0.5 1.4 0.9 1.3 0.5 8.8 64.6 89.6 0.8 0.4 0.9 1.2 168.6 137.6 0.9 1.2 0.9 0.6 0.0 145.9 0.7 0.2 0.0 1.3 0.2 75.5 0.6 0.9 0.2 101.8 2.1 7.5 0.2 122.2 0.4 5.6 30.1 0.5 0.5 0.6 278.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.6 0.3 0.1 0.1 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.5 0.3 1.0 0.0 0.6 0.4 1.0 0.0 0.5 0.0 0.0 0.2 0.3 62.1 149.5 127.6 119.0 64.6 89.6 168.6 137.6 145.9 101.8 122.2 278.3 0.6 3.2 0.5 1.0 3.5 0.3 0.2 0.2 0.0 0.0 0.3 0.4 13.5 7.2 0.7 0.0 0.0 0.1 6.1 0.6 0.0 0.5 0.0 0.3 0.2 1.0 3.0 0.0 1.2 0.0 0.1 1.5 23.0 0.5 0.0 0.1 0.4 0.4 0.2 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 4.1 2.5 447.9 0.1 0.1 0.4 4.0 0.2 0.2 0.3 0.9 0.5 0.0 3.5 3.0 0.0 0.3 0.1 0.9 0.0 2.3 0.3 0.2 0.1 RPS6KB2 "KLS, P70-BETA, p70S6Kb, S6Kβ, S6KB, S6Kbeta, STK14B" ENSG00000175634 "Ribosomal protein S6 kinase B2" Q9UBS0 11 67428460-67435401 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010010, CAB019404" Approved Supported Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "CAB019404: AB_331355, HPA010010: AB_1856469" "unprognostic (1.38e-1)" "unprognostic (2.36e-3)" "unprognostic (8.50e-2)" "unprognostic (2.56e-2)" "unprognostic (1.84e-1)" "unprognostic (1.41e-1)" "unprognostic (9.01e-3)" "unprognostic (5.10e-2)" "unprognostic (1.22e-1)" "unprognostic (9.49e-3)" "unprognostic (7.66e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.03e-7)" "unprognostic (1.28e-2)" "unprognostic (1.55e-1)" "unprognostic (2.12e-1)" "unprognostic (2.66e-1)" 16.2 28.0 9.7 13.8 10.8 28.2 17.0 9.9 12.4 23.5 13.2 22.8 26.5 17.7 6.0 71.9 20.0 10.6 22.1 9.1 9.3 21.3 50.2 19.5 18.4 10.9 10.3 16.2 35.4 17.5 20.6 13.6 10.6 31.6 12.8 4.2 31.5 9.9 37.9 81.6 25.4 10.1 10.2 33.7 35.2 9.6 9.9 24.0 20.1 26.0 20.1 19.3 31.4 11.3 58.2 42.7 22.8 39.0 10.4 20.0 30.0 27.4 33.9 49.7 34.2 67.2 37.5 21.1 46.3 26.9 31.0 41.8 25.9 41.4 19.9 36.9 70.0 34.5 54.2 55.5 35.2 43.7 40.4 25.5 42.8 26.3 26.9 12.5 37.5 54.8 55.8 54.8 25.4 88.5 68.1 68.4 24.9 83.7 54.6 50.0 31.8 100.5 23.0 32.6 34.4 37.1 28.0 76.8 59.8 13.2 90.4 35.7 15.8 25.8 27.6 63.1 31.1 48.8 43.9 34.4 42.4 27.3 33.1 18.8 37.2 28.5 23.8 42.6 24.5 23.4 22.9 23.9 44.1 21.9 16.1 17.9 24.7 29.6 49.9 30.4 34.5 37.3 9.7 10.8 9.9 12.4 9.1 9.3 10.9 10.3 10.6 10.2 9.9 11.3 22.0 9.6 20.5 6.8 48.1 49.8 28.0 48.9 19.9 25.3 32.6 27.8 1.3 28.6 31.2 7.3 10.4 71.8 45.0 66.9 43.0 44.5 14.9 16.0 16.9 17.9 46.2 65.0 7.7 64.8 89.1 21.9 48.9 19.3 27.9 23.2 18.2 57.4 61.3 33.7 7.1 67.7 34.6 45.8 29.1 29.4 20.2 36.9 19.6 3.7 56.6 28.5 73.2 5.0 12.1 46.6 70.4 17.3 82.1 43.7 115.0 42.2 16.0 27.6 19.7 16.7 26.9 15.8 16.0 52.5 63.6 103.6 41.7 27.5 58.3 39.4 CORO1B coronin-2 ENSG00000172725 "Coronin 1B" Q9BR76 11 67435510-67443821 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 301.4;Paneth cells: 324.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 221.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017616, HPA040113, HPA070456" Enhanced Supported "Plasma membrane,Cytosol" NA NA 960000 "Cluster 51: Monocytes - Innate immune response" "Cluster 4: Stomach - Digestion" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Cytosol" "CAB017616: AB_2087018, HPA040113: AB_2676850, HPA070456: AB_2686268" "unprognostic (1.94e-1)" "unprognostic (2.40e-1)" "unprognostic (3.21e-1)" "prognostic favorable (1.65e-4)" "unprognostic (1.02e-1)" "unprognostic (8.23e-3)" "unprognostic (1.49e-3)" "unprognostic (7.22e-2)" "unprognostic (1.86e-1)" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (3.88e-2)" "unprognostic (8.58e-3)" "unprognostic (1.85e-1)" "unprognostic (1.04e-1)" "unprognostic (1.21e-2)" "unprognostic (6.64e-3)" 54.4 56.4 20.2 29.7 23.8 20.3 53.4 23.4 27.0 55.7 21.1 70.2 62.9 72.8 14.6 80.2 54.2 44.1 26.1 19.4 22.7 48.2 47.2 53.7 41.9 28.0 23.6 42.7 52.5 24.6 35.1 31.2 25.1 71.0 34.5 6.6 73.2 39.6 13.0 42.4 62.3 36.7 24.2 66.0 77.1 13.9 25.1 21.1 55.8 9.9 18.4 58.3 53.5 26.3 80.9 81.4 37.5 76.0 94.1 81.3 56.6 58.5 118.0 94.2 70.8 134.1 116.0 6.4 111.3 80.8 95.8 67.9 41.9 74.9 16.8 19.4 40.7 54.9 47.3 57.9 148.1 2.3 120.8 110.6 66.3 80.1 37.2 59.7 120.7 49.4 42.7 9.2 54.2 238.4 14.4 11.2 47.7 198.2 73.4 11.2 41.0 14.9 62.6 104.3 40.7 50.8 52.4 139.6 181.6 26.0 178.5 63.0 92.2 63.4 47.4 87.4 35.2 1.6 3.3 14.6 103.4 8.2 66.4 57.3 102.8 8.0 10.9 212.9 8.3 20.0 37.6 14.6 79.0 11.0 21.2 11.4 47.8 11.9 221.8 60.8 55.2 57.8 20.2 23.8 23.4 27.0 19.4 22.7 28.0 23.6 25.1 24.2 25.1 26.3 58.7 3.2 2.2 4.6 53.4 27.9 60.1 90.8 40.9 13.0 53.8 39.0 1.6 50.1 66.4 47.8 8.4 87.8 39.2 301.4 60.7 111.4 8.9 43.6 32.9 52.0 99.0 19.8 1.8 105.0 229.8 35.8 111.1 64.8 28.0 46.7 47.8 22.4 251.8 15.2 2.4 188.6 81.4 138.6 66.4 5.0 39.4 96.3 71.2 10.3 195.3 30.0 41.2 4.5 6.8 136.9 324.9 34.6 64.3 55.6 263.5 84.0 41.2 14.6 52.6 22.1 55.1 8.1 6.6 47.6 31.0 150.5 100.3 54.8 128.0 74.5 PTPRCAP "CD45-AP, LPAP" ENSG00000213402 "Protein tyrosine phosphatase receptor type C associated protein" Q14761 11 67435510-67437682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 79.7;lymphoid tissue: 174.1" "Group enriched" "Detected in some" 6 "B-cells: 203.3;Plasma cells: 283.5;T-cells: 233.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 351.1;HDLM-2: 242.3;HL-60: 140.6;MOLT-4: 206.8;NB-4: 996.9;U-698: 248.9" "Region enhanced" "Detected in single" "basal ganglia: 1.0" "Low region specificity" "Detected in many" HPA043734 Enhanced Approved "Plasma membrane" "Intracellular and membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 58: T-cells - T-cell receptor" "Plasma membrane" "HPA043734: AB_10962214" 7.1 2.9 3.0 73.0 2.9 27.0 5.3 2.6 4.9 7.0 3.1 14.3 14.0 4.6 0.0 7.9 7.9 3.0 3.5 2.5 2.5 9.9 8.9 14.4 126.5 3.9 2.8 5.0 3.8 0.3 4.2 0.6 3.4 10.6 2.4 0.0 10.2 0.6 2.2 4.2 79.7 0.9 3.4 174.1 24.7 1.5 3.0 109.2 13.0 0.2 51.3 7.5 7.0 3.5 0.4 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.2 351.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 242.3 0.5 0.2 0.9 0.0 0.0 140.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 95.5 1.1 33.3 0.1 3.7 206.8 996.9 0.0 0.0 0.3 65.8 0.2 0.6 0.0 1.1 0.2 0.4 0.2 0.0 1.1 0.0 0.6 0.3 1.4 0.0 1.5 0.0 0.3 0.3 0.3 248.9 0.0 0.3 0.1 23.6 6.7 75.0 1559.9 5.6 1322.2 1334.4 955.3 1380.5 12.7 1714.2 688.5 1083.9 33.4 826.7 8.0 848.7 1374.2 1237.9 3.0 2.9 2.6 4.9 2.5 2.5 3.9 2.8 3.4 3.4 3.0 3.5 0.0 0.0 0.0 7.2 203.3 12.7 0.0 0.9 1.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 15.1 0.2 0.0 0.0 4.4 17.9 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.3 20.6 0.0 0.0 5.0 39.2 7.5 0.5 0.0 1.0 0.5 3.1 0.0 0.0 0.0 283.5 0.0 0.0 0.1 1.4 0.0 0.0 0.0 3.5 0.0 0.0 1.6 9.7 0.0 233.3 0.0 0.0 0.0 GPR152 PGR5 ENSG00000175514 "G protein-coupled receptor 152" Q8TDT2 11 67451301-67452729 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035078 Uncertain NA NA "HPA035078: AB_10670286" "unprognostic (3.81e-2)" "unprognostic (1.69e-1)" "unprognostic (2.70e-1)" "unprognostic (1.22e-1)" "unprognostic (3.76e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CABP4 CSNB2B ENSG00000175544 "Calcium binding protein 4" P57796 11 67452406-67461752 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "retina: 68.2" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 141.8;Rod photoreceptor cells: 254.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 12.1" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "HMC-1: 19.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 79: Retina - Phototransduction" "Cluster 3: HMC-1 - Innate immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "unprognostic (2.24e-1)" "unprognostic (1.26e-1)" "unprognostic (4.23e-2)" "unprognostic (1.22e-2)" "unprognostic (3.78e-3)" "unprognostic (2.91e-2)" "unprognostic (1.03e-3)" "unprognostic (1.76e-1)" "unprognostic (1.49e-1)" "unprognostic (1.44e-2)" "unprognostic (2.32e-3)" "unprognostic (2.57e-1)" "unprognostic (7.10e-4)" "unprognostic (5.35e-2)" "unprognostic (4.63e-2)" "unprognostic (1.10e-1)" "unprognostic (3.44e-3)" 1.2 0.6 1.2 0.5 1.4 0.7 1.4 2.2 1.7 1.4 1.5 0.7 0.6 0.5 1.7 0.3 0.4 0.8 0.5 1.3 1.2 0.8 0.7 1.7 1.0 1.6 1.2 0.2 0.8 0.1 0.1 1.4 1.6 1.4 0.4 68.2 0.9 0.6 0.9 0.7 1.2 0.3 1.1 7.2 1.4 0.2 1.5 0.2 0.5 0.2 0.4 0.6 0.3 2.4 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 4.5 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.1 0.2 0.1 4.1 0.1 0.0 0.1 19.4 0.0 0.0 0.1 0.0 0.1 0.6 0.1 0.0 0.6 1.0 0.3 0.0 0.5 0.1 0.0 0.1 0.1 0.1 0.6 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.0 1.9 0.1 0.1 0.3 0.1 0.2 0.0 0.6 0.1 0.2 0.1 4.0 3.3 0.8 0.7 1.7 0.5 0.6 0.6 0.5 2.5 1.1 0.6 0.7 2.7 1.3 12.1 0.9 0.4 3.5 1.2 1.4 2.2 1.7 1.3 1.2 1.6 1.2 1.6 1.1 1.5 2.4 2.2 0.0 0.5 0.3 1.9 0.9 1.2 0.0 0.6 17.0 2.2 2.0 2.0 2.8 0.0 5.5 141.8 0.1 0.9 0.4 0.0 1.6 0.4 3.8 0.6 3.6 0.0 0.0 0.2 1.5 0.2 0.7 2.6 2.8 0.0 0.1 3.9 0.2 3.9 13.5 0.3 0.7 0.0 9.5 1.9 0.2 0.3 1.9 1.8 2.8 0.3 28.9 5.2 0.0 0.4 1.7 0.1 0.0 1.5 1.5 0.1 1.2 0.7 254.4 0.0 4.8 0.6 0.0 0.3 0.2 0.3 0.8 1.4 0.0 0.2 1.0 TMEM134 FLJ21749 ENSG00000172663 "Transmembrane protein 134" Q9H6X4 11 67461710-67469272 "Predicted membrane proteins, Transporters" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043744 Approved Supported Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 16: Pancreatic endocrine cells - Mixed function" Cytosol "HPA043744: AB_10794773" "unprognostic (1.44e-1)" "unprognostic (1.08e-1)" "unprognostic (1.22e-1)" "unprognostic (4.67e-2)" "unprognostic (8.66e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-1)" "unprognostic (7.22e-2)" "unprognostic (3.85e-1)" "unprognostic (1.39e-2)" "unprognostic (4.30e-2)" "unprognostic (3.48e-1)" "unprognostic (1.75e-1)" "unprognostic (3.12e-2)" "unprognostic (1.70e-1)" "unprognostic (1.30e-2)" "unprognostic (4.43e-3)" 12.6 24.3 22.5 8.6 23.2 4.7 14.8 21.2 29.9 15.6 19.9 14.0 8.3 9.6 11.0 55.5 10.2 6.5 46.8 21.6 22.2 25.2 33.9 11.2 11.9 22.8 22.6 8.6 42.9 7.9 8.7 5.3 22.4 25.7 4.5 2.8 20.6 7.3 57.4 57.5 14.5 4.4 22.7 16.2 22.4 26.5 22.9 6.6 13.5 26.0 8.8 15.9 25.4 22.5 12.3 4.6 6.5 14.0 4.3 7.3 7.2 2.5 4.6 2.9 1.2 5.8 14.3 11.7 27.2 6.2 9.2 10.0 2.9 10.7 1.8 11.3 4.9 2.2 4.5 5.9 6.6 2.3 3.2 7.3 13.4 2.3 7.7 12.7 3.0 7.9 3.0 6.6 6.3 29.0 13.3 8.6 11.0 20.4 16.3 6.5 3.8 38.5 11.3 12.5 6.0 13.3 9.1 14.2 28.6 4.4 34.5 2.3 5.8 10.4 9.0 12.5 3.3 27.8 19.4 8.2 15.6 3.0 8.5 58.2 54.3 98.5 71.4 132.7 78.8 203.7 84.2 80.6 66.6 195.7 85.6 80.6 25.7 90.2 176.0 87.3 123.9 73.3 22.5 23.2 21.2 29.9 21.6 22.2 22.8 22.6 22.4 22.7 22.9 22.5 43.3 16.0 41.5 11.8 83.0 90.0 87.7 177.7 99.0 29.3 139.9 173.4 53.4 60.1 93.5 68.0 10.4 69.5 46.5 64.7 133.1 95.0 50.2 53.0 35.3 36.6 71.4 22.3 9.4 126.0 147.9 31.3 120.3 73.4 23.4 52.5 29.3 69.6 84.0 11.8 8.2 100.3 97.6 43.6 49.3 46.2 20.8 49.0 110.3 2.8 61.2 39.5 63.8 9.5 14.1 189.9 81.7 24.8 47.2 142.6 150.8 148.9 75.0 29.5 6.6 24.4 45.9 105.8 80.1 185.1 180.1 72.8 53.3 37.6 73.5 152.2 AIP "ARA9, FKBP16, FKBP37, XAP2" ENSG00000110711 "Aryl hydrocarbon receptor interacting protein" O00170 11 67483026-67491103 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cushing syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033674, HPA050217, CAB069477" Approved Supported Cytosol NA NA 13000 "Cluster 44: Non-specific - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "CAB033674: AB_2224981, CAB069477: AB_10002466, HPA050217: AB_2681055" "unprognostic (2.59e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (8.15e-2)" "unprognostic (9.54e-2)" "unprognostic (4.02e-2)" "unprognostic (2.17e-2)" "unprognostic (1.14e-1)" "unprognostic (6.19e-3)" "unprognostic (2.18e-1)" "unprognostic (9.75e-2)" "unprognostic (1.16e-1)" "unprognostic (5.28e-2)" "unprognostic (3.10e-1)" "unprognostic (2.70e-1)" "unprognostic (2.40e-2)" "unprognostic (9.45e-2)" 62.9 58.1 72.5 47.4 77.6 40.4 58.5 74.7 82.4 84.5 66.7 78.4 33.7 71.0 32.4 38.9 66.9 39.4 72.1 70.3 74.3 68.0 51.6 62.3 89.5 75.9 72.7 77.9 48.8 35.4 51.1 33.5 74.6 60.8 20.1 22.9 40.6 36.0 46.4 39.5 64.7 28.8 71.8 85.1 57.0 29.7 73.1 78.7 63.6 45.8 49.1 73.1 62.6 80.4 80.8 91.1 51.6 49.9 64.8 64.2 39.3 49.7 61.2 83.6 60.9 143.7 77.9 142.2 118.1 55.3 63.5 63.9 59.2 51.9 32.1 209.3 63.5 86.5 98.7 87.0 67.1 87.5 145.1 77.8 48.3 74.6 48.4 81.4 43.0 138.6 50.0 83.6 55.5 153.7 187.7 214.6 49.0 122.0 115.7 82.2 78.5 126.5 59.5 47.2 81.4 81.3 64.4 45.5 204.3 19.9 60.9 87.2 71.5 73.4 71.1 108.9 46.3 67.4 99.8 112.7 100.4 67.4 57.7 192.5 117.9 135.6 194.3 144.6 212.0 241.6 227.4 227.6 179.8 221.5 203.4 194.7 78.2 165.3 175.0 207.9 352.4 182.4 72.5 77.6 74.7 82.4 70.3 74.3 75.9 72.7 74.6 71.8 73.1 80.4 57.2 32.1 25.6 6.8 69.4 30.3 35.8 54.2 31.9 36.8 24.6 33.1 23.1 30.0 33.7 49.7 4.2 56.4 61.9 50.1 82.2 46.8 25.3 12.7 31.0 54.0 31.8 22.5 4.0 42.2 63.5 51.0 23.4 18.0 77.3 51.7 45.7 23.3 66.7 37.0 4.9 34.7 48.8 65.0 54.6 14.2 53.1 56.1 56.9 5.6 72.5 49.6 76.2 5.0 10.5 41.2 53.5 35.3 50.2 42.7 86.1 98.3 17.4 29.4 39.5 36.4 86.5 21.7 28.4 19.4 21.2 59.5 90.6 42.0 25.4 52.2 PITPNM1 "DRES9, NIR2, PITPNM, Rd9, RDGB, RDGB1, RDGBA1" ENSG00000110697 "Phosphatidylinositol transfer protein membrane associated 1" O00562 11 67491768-67506263 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 64.6;Distal enterocytes: 69.9;Endometrial ciliated cells: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 91.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060227 Approved Supported Vesicles,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol Vesicles "HPA060227: AB_2684226" "unprognostic (1.13e-1)" "unprognostic (1.90e-1)" "unprognostic (1.69e-2)" "unprognostic (1.71e-1)" "unprognostic (2.83e-2)" "unprognostic (8.68e-2)" "unprognostic (8.16e-2)" "unprognostic (4.55e-2)" "unprognostic (1.77e-1)" "unprognostic (2.26e-2)" "unprognostic (4.61e-1)" "unprognostic (3.27e-2)" "unprognostic (2.32e-2)" "unprognostic (1.14e-2)" "unprognostic (1.58e-1)" "unprognostic (4.62e-2)" "unprognostic (5.69e-2)" 10.6 24.5 19.6 24.3 12.6 26.8 6.4 6.1 23.2 10.7 13.9 14.4 18.7 9.3 2.4 19.5 23.1 9.0 22.3 13.3 23.8 37.8 11.0 16.3 27.6 14.2 31.0 4.0 9.8 10.3 26.7 8.0 13.5 10.4 7.5 40.7 8.7 10.3 6.9 5.0 21.1 5.9 2.3 21.6 16.0 8.8 51.5 17.4 15.7 18.4 17.2 16.2 9.3 5.5 12.7 31.2 18.8 13.9 20.3 12.1 30.5 12.2 21.5 14.8 8.4 28.5 22.6 12.5 28.7 17.5 28.4 32.4 14.5 27.0 4.8 91.0 6.0 17.0 55.8 10.8 16.0 19.4 35.3 15.0 17.0 22.4 14.7 27.4 17.9 18.7 13.2 11.0 12.5 19.1 33.2 45.6 19.3 35.9 13.5 23.7 6.0 17.3 24.4 25.1 18.1 11.5 27.3 37.6 29.6 9.0 7.4 16.9 17.7 26.5 20.1 16.9 8.9 16.0 8.3 11.2 37.1 22.7 10.6 0.0 1.4 0.9 1.1 3.3 1.0 0.7 0.8 1.0 1.0 0.5 0.3 0.8 1.4 0.1 2.7 0.4 0.7 1.1 19.6 12.6 6.1 23.2 13.3 23.8 14.2 31.0 13.5 2.3 51.5 5.5 7.5 3.2 5.8 2.0 10.8 8.2 6.3 9.3 13.6 45.7 5.4 5.2 8.4 5.7 9.7 20.2 64.6 4.6 10.6 69.9 3.9 11.3 6.1 63.3 16.5 4.9 11.4 0.4 5.1 9.3 8.9 4.2 34.7 24.6 2.5 7.1 3.3 3.4 8.4 38.7 6.6 16.8 10.2 13.2 14.0 17.0 2.1 15.2 3.6 10.3 13.5 20.7 3.1 0.5 0.5 15.9 32.7 1.2 7.5 9.8 39.0 18.9 37.8 53.7 0.0 6.3 9.8 1.4 5.5 11.2 3.3 15.2 14.9 1.4 24.0 19.4 CDK2AP2 "DOC-1R, p14" ENSG00000167797 "Cyclin dependent kinase 2 associated protein 2" O75956 11 67506497-67508649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038872, HPA047599" Uncertain Approved Nucleoplasm NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "HPA038872: , HPA047599: AB_10963069" "unprognostic (2.44e-1)" "unprognostic (5.01e-2)" "unprognostic (1.42e-1)" "prognostic favorable (8.80e-4)" "unprognostic (6.24e-2)" "unprognostic (2.30e-2)" "unprognostic (8.85e-3)" "unprognostic (1.42e-1)" "unprognostic (5.65e-2)" "unprognostic (3.85e-3)" "unprognostic (4.91e-3)" "unprognostic (2.06e-1)" "prognostic unfavorable (5.20e-4)" "unprognostic (7.58e-2)" "unprognostic (3.11e-1)" "unprognostic (6.96e-2)" "unprognostic (1.73e-3)" 45.6 69.3 83.5 46.1 87.6 32.1 34.2 90.5 107.0 40.7 76.3 46.6 42.9 41.2 85.8 45.2 37.5 27.2 98.5 82.8 87.3 103.0 109.7 46.1 64.8 99.2 89.3 27.9 67.9 25.1 43.7 29.8 95.5 41.9 28.1 25.7 47.2 45.7 23.3 19.7 40.5 30.3 91.5 47.1 47.8 12.6 87.1 55.7 78.0 22.6 48.2 42.8 27.2 93.1 92.9 77.6 33.3 72.4 55.0 19.8 46.9 30.0 25.7 54.8 43.6 104.2 121.6 58.1 111.0 32.6 64.4 67.7 59.5 77.4 16.7 156.0 29.7 36.2 60.8 81.8 113.2 32.7 48.8 17.5 84.8 47.3 93.5 44.2 64.3 86.9 32.5 204.4 23.7 183.5 196.6 111.3 35.2 221.7 83.4 83.6 18.4 245.3 129.1 30.4 23.2 50.9 44.2 130.5 150.8 30.3 73.0 70.0 35.6 26.5 46.4 61.7 27.7 55.0 39.8 65.7 73.2 49.3 34.6 284.3 119.2 266.2 297.9 222.7 261.5 229.6 221.4 267.7 174.8 222.3 117.4 176.3 97.5 292.7 266.1 793.7 291.1 215.2 83.5 87.6 90.5 107.0 82.8 87.3 99.2 89.3 95.5 91.5 87.1 93.1 54.6 64.1 86.2 4.2 112.0 67.0 47.0 118.3 186.1 27.8 88.8 75.3 76.6 88.6 80.3 117.7 31.3 94.9 206.5 187.0 215.2 85.1 1.7 98.2 50.4 56.8 102.8 42.5 3.5 53.2 192.7 49.0 78.5 104.1 74.8 49.5 45.7 131.3 84.6 33.7 3.6 151.1 81.4 46.8 94.9 2.6 24.5 71.5 113.8 11.2 109.8 61.1 171.0 6.0 14.0 99.1 158.5 30.5 240.8 71.1 139.6 329.7 64.6 29.4 26.3 22.0 76.2 10.2 31.1 170.3 51.0 194.4 131.4 30.1 123.2 76.4 CABP2 DFNB93 ENSG00000167791 "Calcium binding protein 2" Q9NPB3 11 67518912-67524517 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Hearing, Sensory transduction, Vision" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "retina: 7.3" "Cell type enriched" "Detected in some" 14 "Bipolar cells: 100.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 22 "cerebellum: 9.3" "Not detected" "Not detected" NA NA "Cluster 79: Retina - Phototransduction" "Cluster 56: Bipolar cells - Visual perception" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.2 0.0 0.0 0.1 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GSTP1 "FAEES3, GST3, GSTP" ENSG00000084207 "Glutathione S-transferase pi 1" P09211 11 67583742-67586656 "Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 2087.9" "Cell type enhanced" "Detected in all" "Squamous epithelial cells: 4033.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 4998.3;OE19: 7810.3" "Low region specificity" "Detected in all" "HPA019779, HPA019869" Enhanced Supported Mitochondria,Cytosol No No 69000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 21: OE19 - Mitochondria" "Cluster 61: Squamous epithelial cells - Keratinization" "Mitochondria, Cytosol" "HPA019779: AB_1849799, HPA019869: AB_1849801" "unprognostic (9.81e-2)" "unprognostic (6.52e-2)" "unprognostic (7.24e-2)" "unprognostic (2.72e-2)" "unprognostic (1.06e-2)" "unprognostic (1.30e-3)" "unprognostic (3.27e-1)" "unprognostic (4.98e-2)" "unprognostic (1.28e-1)" "unprognostic (5.16e-3)" "unprognostic (2.14e-3)" "unprognostic (9.37e-2)" "unprognostic (5.72e-2)" "unprognostic (7.78e-2)" "unprognostic (2.23e-1)" "unprognostic (6.72e-3)" "unprognostic (1.48e-1)" 290.5 276.2 346.8 232.1 370.3 601.3 288.7 358.9 425.7 641.9 695.8 329.6 394.6 331.9 280.3 2087.9 647.5 435.8 367.2 341.4 381.9 567.7 45.1 468.3 321.8 375.7 379.2 306.9 340.9 737.4 320.2 326.9 378.5 291.7 197.1 137.9 541.2 780.4 355.0 731.4 321.7 214.2 367.0 257.2 535.5 45.8 378.1 296.9 579.0 312.5 380.8 526.5 946.2 377.7 1202.5 1599.4 763.7 1198.9 577.8 645.2 705.3 511.3 678.1 761.2 589.3 2956.3 1225.0 3.3 1144.7 813.5 683.7 1707.8 2073.9 2248.5 214.4 848.0 765.3 59.9 1107.6 0.5 852.2 400.3 667.6 807.2 4998.3 609.9 583.3 560.9 1160.2 847.2 1318.2 321.8 605.7 4.3 918.2 1100.6 1475.2 7810.3 681.3 844.8 129.6 3.8 1236.8 3.6 260.6 754.3 719.1 230.9 2394.0 598.2 3.6 656.3 634.5 351.6 883.8 740.6 378.6 200.0 1353.9 447.1 400.0 652.4 747.8 56.0 3145.4 246.6 720.0 2470.8 271.9 509.2 322.4 597.7 3582.7 476.3 267.8 466.5 130.5 1443.8 1608.5 1435.1 363.3 3948.4 346.8 370.3 358.9 425.7 341.4 381.9 375.7 379.2 378.5 367.0 378.1 377.7 466.7 1153.8 872.3 25.5 296.8 865.6 1914.8 3813.8 767.2 170.0 628.7 838.3 297.3 987.9 2763.5 1230.4 33.3 2116.8 372.4 655.0 1805.9 1811.9 4.9 1381.0 589.0 431.4 368.2 166.3 6.8 1444.4 1703.9 710.5 781.9 1020.9 269.9 795.0 382.3 10.5 861.2 70.7 10.1 992.4 1930.7 597.9 1090.3 25.5 572.3 703.5 1531.5 27.2 2166.5 558.5 459.3 17.6 38.4 1412.1 948.9 400.2 591.6 2266.2 844.4 3495.5 3715.4 274.4 361.6 401.3 941.7 4.8 54.9 4033.7 1061.7 1645.5 342.5 527.8 1118.5 3418.6 NDUFV1 CI-51K ENSG00000167792 "NADH:ubiquinone oxidoreductase core subunit V1" P49821 11 67605653-67612554 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease variant, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 526.2" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 482.4;Proximal tubular cells: 499.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045211, HPA075051" Enhanced Supported Mitochondria,Cytosol No No 37000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Cytosol "HPA045211: AB_10962830, HPA075051: AB_2686732" "unprognostic (4.57e-2)" "unprognostic (2.17e-2)" "unprognostic (2.84e-1)" "unprognostic (7.07e-2)" "unprognostic (1.54e-1)" "unprognostic (4.54e-3)" "unprognostic (1.19e-1)" "unprognostic (3.31e-2)" "unprognostic (2.19e-1)" "unprognostic (4.95e-2)" "unprognostic (4.02e-2)" "unprognostic (3.03e-2)" "prognostic favorable (7.49e-10)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" 95.0 126.5 87.6 52.5 93.7 72.5 90.9 105.6 107.1 93.9 104.8 142.3 124.5 85.2 33.8 114.0 84.6 47.1 400.2 91.6 97.0 188.4 187.0 77.1 66.7 103.3 91.5 101.9 117.2 169.8 84.5 46.7 110.4 77.4 73.7 81.6 90.2 73.2 526.2 117.7 96.6 51.1 86.9 98.8 132.0 76.0 104.9 51.6 107.6 440.5 62.8 88.1 88.6 99.9 132.9 133.6 68.8 141.3 85.6 83.4 130.6 84.1 76.4 122.2 82.6 256.8 155.3 241.9 167.3 69.2 99.7 176.8 146.1 126.4 38.4 125.2 114.9 100.0 189.1 127.9 119.0 136.9 106.9 126.7 119.0 100.4 88.0 76.9 109.3 173.9 180.9 192.6 75.8 190.2 163.1 268.0 68.5 295.3 168.8 184.5 135.8 399.1 99.3 95.3 109.9 104.6 104.3 347.4 275.3 46.0 177.4 138.0 90.7 118.9 88.8 172.3 87.5 187.7 116.8 122.6 138.0 144.6 117.7 39.0 72.8 38.1 65.1 83.4 71.6 59.8 55.0 63.2 110.7 60.1 50.2 63.7 13.1 104.0 51.2 73.0 78.1 77.0 87.6 93.7 105.6 107.1 91.6 97.0 103.3 91.5 110.4 86.9 104.9 99.9 54.6 60.9 75.0 33.3 76.2 80.3 95.9 187.6 77.4 68.7 82.1 94.4 482.4 61.5 120.7 86.5 50.1 203.5 72.8 235.7 397.2 114.9 74.0 43.1 47.5 56.7 98.5 85.0 32.9 112.1 158.8 82.4 137.1 55.2 61.4 99.6 56.4 136.2 136.5 63.9 36.5 155.9 152.5 68.8 81.4 222.7 65.6 68.4 113.8 13.1 81.0 89.3 60.8 19.1 34.6 70.1 122.8 59.0 146.6 55.0 199.4 499.2 80.3 78.5 46.0 90.8 136.9 100.7 83.3 127.0 80.6 189.1 79.3 145.9 274.8 111.7 NUDT8 FLJ41567 ENSG00000167799 "Nudix hydrolase 8" Q8WV74 11 67627938-67629937 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 78.9" "Cell type enhanced" "Detected in many" "Hepatocytes: 222.8;Intestinal goblet cells: 102.5;Proximal enterocytes: 139.4;Proximal tubular cells: 237.1;Squamous epithelial cells: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 218.9" "HPA041252, HPA041466" Enhanced Approved Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 25: RPMI-8226 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoli Cytosol "HPA041252: AB_10794551, HPA041466: AB_10793967" "unprognostic (8.31e-2)" "unprognostic (7.26e-3)" "unprognostic (7.31e-2)" "unprognostic (7.32e-2)" "unprognostic (2.87e-1)" "unprognostic (2.36e-3)" "unprognostic (2.69e-1)" "unprognostic (4.12e-2)" "unprognostic (8.28e-2)" "unprognostic (2.69e-2)" "unprognostic (3.11e-2)" "unprognostic (2.74e-1)" "prognostic favorable (3.70e-4)" "unprognostic (4.70e-2)" "unprognostic (2.29e-1)" "unprognostic (3.50e-1)" "unprognostic (2.19e-1)" 10.3 5.3 6.9 1.9 8.7 3.2 9.9 10.3 10.4 10.1 6.9 12.4 14.2 4.3 2.2 57.6 5.0 1.6 78.9 6.2 8.6 25.5 58.7 6.1 1.8 9.2 8.7 4.6 13.1 12.0 3.0 1.7 8.6 9.3 5.4 0.8 24.1 4.3 58.8 31.7 11.6 1.5 8.4 4.5 9.1 4.4 9.2 2.5 20.4 41.8 3.7 3.7 12.6 9.1 33.5 13.3 5.1 8.4 4.7 5.9 8.1 6.9 3.2 2.7 2.8 11.0 8.5 35.1 10.6 5.4 3.9 16.1 5.9 4.1 0.3 34.3 14.7 2.0 6.1 34.2 1.4 11.2 16.0 3.6 8.1 3.4 1.1 0.7 6.0 42.6 9.9 30.1 2.2 55.9 18.6 16.0 3.1 58.7 28.0 11.4 2.7 218.9 8.4 5.8 2.6 3.7 1.8 18.7 7.1 1.8 10.2 4.6 1.6 7.1 10.1 45.7 1.3 21.6 15.3 7.1 5.0 14.8 4.1 0.0 1.1 1.1 2.9 4.7 2.5 3.2 1.7 3.5 4.6 6.4 1.5 1.8 0.0 9.5 13.7 12.4 1.3 2.1 6.9 8.7 10.3 10.4 6.2 8.6 9.2 8.7 8.6 8.4 9.2 9.1 8.7 0.0 6.5 6.2 12.0 12.1 12.7 9.4 17.6 4.5 42.3 39.9 79.5 15.7 12.1 29.5 0.0 29.7 7.2 76.5 84.1 14.3 3.3 8.2 11.0 9.2 2.4 34.5 0.6 23.9 21.4 12.5 23.4 13.8 8.9 3.7 8.6 222.8 9.4 5.0 0.7 102.5 12.2 5.3 10.8 8.0 5.0 5.0 28.4 0.0 2.5 7.9 4.1 1.0 2.9 9.9 26.4 5.3 15.7 18.5 139.4 237.1 4.5 7.8 6.6 7.8 17.7 13.9 8.8 129.6 25.6 17.4 7.6 6.6 69.8 25.0 TBX10 "TBX13, TBX7" ENSG00000167800 "T-box transcription factor 10" O75333 11 67631303-67639560 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "intestine: 9.7" "Cell type enhanced" "Detected in some" "Distal enterocytes: 14.8;Intestinal goblet cells: 103.8;Paneth cells: 20.4;Proximal enterocytes: 42.7" "Cancer enhanced" "Detected in some" "colorectal cancer: 2.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.4;NTERA-2: 5.3;RPMI-8226: 3.6;SK-BR-3: 12.5;U-2 OS: 2.5" "Low region specificity" "Detected in single" "HPA047881, HPA076197" Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 9: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" Nucleoplasm Cytosol "HPA047881: AB_2680199, HPA076197: " "unprognostic (4.66e-2)" "unprognostic (2.96e-2)" "unprognostic (7.71e-3)" "unprognostic (1.79e-1)" "unprognostic (2.37e-1)" "unprognostic (1.83e-4)" "unprognostic (3.12e-1)" "unprognostic (3.29e-2)" "unprognostic (5.10e-2)" "unprognostic (1.83e-1)" "unprognostic (4.90e-1)" "unprognostic (1.17e-10)" "unprognostic (6.77e-2)" "unprognostic (1.68e-1)" "unprognostic (2.95e-1)" "unprognostic (2.75e-1)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 8.4 5.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 8.0 0.0 0.4 0.0 0.0 0.0 9.7 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.1 0.0 12.5 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.9 0.0 0.0 0.0 103.8 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 20.4 0.0 0.0 0.2 42.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.9 0.1 ACY3 "ACY-3, HCBP1, MGC9740" ENSG00000132744 "Aminoacylase 3" Q96HD9 11 67642555-67650730 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 77.7;kidney: 58.2;liver: 33.8;pancreas: 22.2" "Group enriched" "Detected in many" 8 "Proximal enterocytes: 255.7;Proximal tubular cells: 437.6" "Cancer enhanced" "Detected in many" "renal cancer: 24.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 34.1" "Group enriched" "Detected in many" 5 "dendritic cells: 8.7;monocytes: 34.1" "Cell line enhanced" "Detected in some" "CACO-2: 9.6;CAPAN-2: 15.3;Daudi: 57.7;OE19: 15.3;RPMI-8226: 9.8" "Low region specificity" "Detected in all" "HPA039219, HPA048187" Enhanced NA NA 13000 "Cluster 51: Monocytes - Innate immune response" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA039219: AB_10671872, HPA048187: AB_2680306" "unprognostic (8.37e-3)" "unprognostic (1.29e-1)" "unprognostic (1.04e-1)" "prognostic favorable (4.80e-4)" "unprognostic (1.07e-1)" "unprognostic (1.99e-2)" "unprognostic (1.38e-2)" "unprognostic (1.43e-1)" "unprognostic (7.37e-4)" "unprognostic (2.44e-3)" "unprognostic (1.15e-1)" "unprognostic (3.21e-1)" "unprognostic (2.63e-3)" "unprognostic (1.07e-1)" "unprognostic (8.24e-2)" "unprognostic (2.68e-2)" "unprognostic (1.48e-3)" 0.1 0.1 4.0 4.2 3.0 1.4 0.9 3.6 3.5 10.5 2.0 6.7 77.7 0.5 0.8 0.8 0.9 1.9 0.0 4.1 5.0 58.2 33.8 0.2 7.0 5.0 3.5 0.2 22.2 0.4 0.3 0.2 4.3 0.6 4.5 0.0 2.4 0.4 0.0 0.2 70.8 0.3 5.7 1.4 11.9 0.1 5.1 1.9 0.1 0.0 8.9 0.3 0.1 4.6 0.2 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 9.6 15.3 57.7 0.6 0.0 1.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 5.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.1 2.1 2.5 0.0 15.3 0.0 1.8 0.0 9.8 0.0 0.0 0.0 0.1 0.3 1.3 0.1 0.0 0.1 2.8 0.2 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.0 6.4 0.5 0.0 0.7 0.0 0.2 7.6 0.7 1.3 0.4 0.2 3.8 1.4 1.3 0.9 0.0 3.9 34.1 8.7 0.0 1.9 4.0 3.0 3.6 3.5 4.1 5.0 5.0 3.5 4.3 5.7 5.1 4.6 0.1 0.0 1.7 0.0 4.7 0.0 0.1 0.7 0.0 0.0 1.6 2.2 0.5 8.6 1.6 22.0 0.0 0.2 0.1 9.2 31.3 4.1 0.0 0.5 0.2 0.1 1.2 0.0 0.0 10.4 0.3 0.1 19.4 0.9 0.0 0.0 0.0 25.3 2.2 0.0 0.0 40.8 0.0 0.6 0.9 0.0 0.0 3.0 5.4 10.3 0.4 0.0 0.0 0.0 0.0 5.7 10.6 0.0 3.3 0.5 255.7 437.6 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 2.7 0.1 14.7 0.9 ALDH3B2 ALDH8 ENSG00000132746 "Aldehyde dehydrogenase 3 family member B2" P48448 11 67662160-67681224 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 73.0;esophagus: 152.2;skin 1: 123.0;vagina: 41.0" "Cell type enhanced" "Detected in some" "Breast glandular cells: 26.2;Endometrial ciliated cells: 12.6;Glandular and luminal cells: 28.1;Squamous epithelial cells: 53.3;Suprabasal keratinocytes: 14.8;Syncytiotrophoblasts: 14.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "MCF7: 71.9;SK-BR-3: 70.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA045132 Approved NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA045132: AB_10795993" "unprognostic (2.25e-1)" "unprognostic (2.41e-1)" "unprognostic (1.65e-1)" "unprognostic (8.65e-2)" "unprognostic (2.13e-1)" "unprognostic (6.09e-2)" "unprognostic (3.12e-2)" "unprognostic (6.32e-2)" "unprognostic (1.48e-1)" "unprognostic (5.56e-2)" "unprognostic (1.24e-2)" "unprognostic (1.40e-2)" "unprognostic (2.59e-2)" "unprognostic (1.61e-1)" "unprognostic (1.15e-2)" "unprognostic (5.92e-2)" 0.3 0.0 0.1 0.1 0.0 0.2 73.0 0.0 0.0 14.4 0.0 0.1 0.1 0.8 6.8 152.2 4.6 0.3 0.1 0.0 0.0 0.7 0.1 0.4 0.0 0.0 0.0 0.0 0.3 5.2 0.1 3.2 0.0 3.3 0.1 0.5 17.3 4.8 0.3 123.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 2.4 0.0 0.0 21.1 8.3 41.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 7.9 0.0 0.0 0.1 0.0 1.3 3.5 3.3 0.1 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.9 6.8 0.0 0.1 9.0 0.0 0.0 0.0 1.9 0.0 13.0 0.0 0.1 0.0 70.7 0.1 0.4 15.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 1.7 1.2 4.9 1.2 0.0 26.2 7.2 0.4 0.0 7.3 5.5 0.0 10.6 0.2 0.0 1.9 1.1 0.0 12.6 2.6 0.2 0.0 0.0 0.1 0.2 10.6 0.2 0.0 28.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.0 0.0 0.8 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.8 0.0 0.0 0.0 0.5 0.0 0.0 53.3 14.8 14.6 0.2 0.0 0.0 7.6 UNC93B1 UNC93 ENSG00000110057 "Unc-93 homolog B1, TLR signaling regulator" Q9H1C4 11 67991100-68004982 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 76.7" "Cell type enhanced" "Detected in many" "Hofbauer cells: 96.2;Kupffer cells: 78.3;Macrophages: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 14.8" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "CAPAN-2: 128.9;RPMI-8226: 368.2;SK-BR-3: 95.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038716, HPA038717, HPA042803" Approved Approved Nucleoplasm No No "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 4: Macrophages - Innate immune response" Nucleoplasm "HPA038716: AB_2676169, HPA038717: AB_10674836, HPA042803: AB_2678176" "unprognostic (3.32e-2)" "unprognostic (1.75e-1)" "unprognostic (3.32e-2)" "unprognostic (2.52e-1)" "unprognostic (1.14e-1)" "unprognostic (7.66e-2)" "unprognostic (1.29e-2)" "unprognostic (9.36e-2)" "unprognostic (5.82e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (1.73e-4)" "unprognostic (4.76e-2)" "prognostic unfavorable (7.38e-4)" "unprognostic (1.73e-2)" "unprognostic (1.85e-2)" "unprognostic (7.05e-3)" "unprognostic (5.23e-3)" 18.7 17.7 4.9 19.9 5.6 19.9 15.4 5.0 7.5 19.0 6.4 20.2 22.5 7.7 0.8 20.5 15.7 9.8 7.3 4.9 5.0 16.4 15.3 29.5 29.5 10.7 6.5 6.2 17.1 2.6 6.7 6.4 8.1 16.4 3.1 0.1 27.9 8.8 3.5 16.3 35.8 3.1 7.9 76.7 20.6 1.7 6.8 3.5 14.8 1.5 7.3 20.6 15.0 10.2 18.9 34.1 2.5 13.8 7.2 2.7 28.2 8.3 7.7 13.0 11.8 2.8 128.9 40.9 30.8 4.0 11.0 44.9 1.0 7.0 0.4 14.1 9.3 4.2 11.1 6.4 11.2 30.0 22.7 6.0 7.6 3.8 1.5 5.0 2.6 6.4 3.0 19.3 2.0 18.7 0.2 23.9 6.2 46.8 16.7 24.5 0.0 368.2 11.8 10.7 3.9 5.5 14.0 95.6 19.3 1.0 35.4 39.0 9.2 8.6 12.2 12.8 0.8 13.2 18.8 7.0 16.0 30.7 10.5 0.1 3.8 6.6 0.1 7.2 0.2 2.5 0.2 0.2 5.1 2.7 0.0 0.0 3.2 2.1 7.7 14.8 0.0 1.2 4.9 5.6 5.0 7.5 4.9 5.0 10.7 6.5 8.1 7.9 6.8 10.2 12.5 9.6 9.1 4.6 45.3 4.0 21.9 12.5 9.1 0.0 16.4 13.1 1.8 40.0 21.0 16.5 0.0 10.3 63.3 23.2 1.9 36.8 0.8 32.0 5.9 10.0 4.2 3.0 1.1 23.4 47.8 8.0 20.9 17.2 7.0 9.3 10.0 5.4 96.2 5.0 0.1 17.2 14.2 78.3 28.4 0.1 4.4 85.3 23.2 13.1 57.5 4.7 8.2 0.0 0.7 49.7 25.6 4.1 33.8 27.0 31.7 6.9 57.3 0.5 0.0 8.3 9.8 0.2 1.1 12.9 6.5 7.3 10.5 2.1 23.1 37.7 ALDH3B1 ALDH7 ENSG00000006534 "Aldehyde dehydrogenase 3 family member B1" P43353 11 68008578-68029282 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 46.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 115.4;Alveolar cells type 2: 58.4;Endometrial ciliated cells: 54.5;Kupffer cells: 59.0;Respiratory ciliated cells: 211.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 163.2" "Group enriched" "Detected in many" 10 "dendritic cells: 67.5;granulocytes: 163.2;monocytes: 125.8" "Cell line enhanced" "Detected in many" "A549: 154.4;CAPAN-2: 154.9;RPMI-8226: 85.9;U-87 MG: 89.1" "Low region specificity" "Detected in all" HPA038525 Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "HPA038525: AB_2676062" "unprognostic (3.50e-1)" "unprognostic (4.22e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (1.56e-2)" "unprognostic (9.66e-3)" "unprognostic (9.73e-2)" "unprognostic (7.93e-3)" "unprognostic (2.62e-1)" "unprognostic (2.01e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.07e-4)" "unprognostic (8.27e-2)" "unprognostic (6.49e-3)" "unprognostic (1.00e-1)" "unprognostic (2.75e-2)" "unprognostic (6.69e-3)" "unprognostic (1.06e-1)" 12.7 26.7 2.9 10.6 4.5 46.5 5.5 5.1 4.2 11.4 8.9 9.8 23.4 6.4 0.9 13.9 39.6 8.8 4.0 2.5 3.8 16.3 4.1 44.4 5.6 6.0 5.6 3.6 8.0 0.6 7.7 11.7 4.9 4.7 6.5 0.5 11.1 4.1 2.0 5.7 18.0 5.6 4.5 20.0 20.7 2.1 5.4 1.3 2.5 1.7 2.6 10.8 8.9 6.2 11.4 154.4 1.1 3.3 9.9 31.0 26.8 15.1 24.8 10.9 5.3 5.7 154.9 0.7 26.9 35.9 15.3 12.9 0.3 2.1 2.7 0.4 0.9 1.6 64.3 13.4 61.0 9.1 0.5 22.5 6.8 5.4 14.6 24.6 0.6 0.8 0.4 27.3 17.8 9.5 0.9 9.0 1.2 76.1 9.2 3.7 5.9 85.9 17.9 1.5 1.8 0.8 35.7 29.7 15.2 0.8 34.3 19.7 16.2 15.7 21.3 76.2 5.3 0.4 3.0 0.2 89.1 24.5 7.4 47.6 91.0 163.2 0.2 125.8 0.3 0.4 0.2 0.2 67.5 0.5 0.2 0.1 26.6 11.8 118.1 7.0 0.1 47.7 2.9 4.5 5.1 4.2 2.5 3.8 6.0 5.6 4.9 4.5 5.4 6.2 0.4 115.4 58.4 1.0 1.4 2.2 2.7 8.4 1.2 0.5 1.7 1.3 3.1 20.0 53.6 5.5 0.0 0.8 2.9 6.6 0.0 7.4 21.6 54.5 9.2 1.8 2.4 7.8 0.2 2.5 8.2 6.5 12.8 5.1 25.2 2.0 1.4 2.3 34.0 3.3 0.1 9.0 12.2 59.0 10.6 10.0 1.8 33.1 3.6 1.9 30.9 2.1 1.0 0.5 5.7 19.3 7.5 1.5 1.3 3.1 36.2 30.1 211.6 0.4 0.0 6.9 6.5 0.4 0.4 1.0 1.0 0.7 2.2 0.0 9.8 6.2 NDUFS8 "CI-23k, TYKY" ENSG00000110717 "NADH:ubiquinone oxidoreductase core subunit S8" O00217 11 68030617-68036644 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 833.5;Late spermatids: 797.2;Proximal tubular cells: 927.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018524, HPA067429" Enhanced Approved Mitochondria "Intracellular and membrane" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA018524: AB_1854355, HPA067429: " "unprognostic (2.90e-1)" "unprognostic (1.41e-3)" "unprognostic (2.41e-1)" "unprognostic (5.20e-2)" "unprognostic (1.37e-1)" "unprognostic (1.30e-3)" "unprognostic (1.36e-1)" "unprognostic (7.75e-2)" "unprognostic (3.15e-1)" "unprognostic (1.77e-2)" "unprognostic (3.81e-2)" "unprognostic (1.81e-1)" "prognostic favorable (3.27e-8)" "unprognostic (2.29e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (9.45e-2)" 99.2 308.4 141.2 38.8 153.2 56.2 87.7 157.2 180.4 73.2 172.3 142.0 81.4 89.2 27.2 115.3 81.3 29.1 468.2 144.2 152.0 188.6 152.0 73.1 42.2 149.6 144.9 68.2 97.7 74.6 130.6 33.6 145.8 118.2 36.7 49.5 96.2 66.7 406.4 93.0 84.4 39.0 142.2 76.9 137.8 104.7 154.0 40.3 101.8 275.5 30.1 94.4 76.0 150.2 152.9 366.4 94.6 137.0 70.9 63.5 132.4 102.3 88.5 155.6 118.9 338.4 159.6 118.4 186.8 85.9 134.6 181.2 108.8 128.4 53.1 139.4 264.9 107.2 217.1 186.3 171.8 99.1 112.1 80.5 126.5 111.1 124.8 82.0 106.2 159.9 110.3 121.1 99.2 358.6 219.2 216.9 125.2 377.7 308.0 154.4 95.9 384.9 192.8 123.3 125.5 102.2 75.7 171.7 392.3 66.5 245.6 105.9 84.1 155.6 133.9 224.8 148.8 165.2 188.5 99.7 252.3 121.8 111.2 84.7 220.1 124.0 182.4 232.0 170.1 183.3 154.6 165.5 309.4 156.3 146.2 164.2 20.7 309.6 131.7 324.3 202.2 232.4 141.2 153.2 157.2 180.4 144.2 152.0 149.6 144.9 145.8 142.2 154.0 150.2 88.7 89.8 90.1 18.6 92.3 85.4 95.5 284.3 104.7 83.4 147.2 156.7 301.9 143.0 164.9 213.3 54.2 279.6 97.8 301.0 833.5 200.8 225.7 101.1 74.8 85.3 205.0 149.8 13.6 199.3 165.9 109.6 147.3 79.7 95.8 156.5 73.5 231.7 276.6 50.5 19.3 277.2 240.1 124.1 108.0 797.2 100.6 128.7 163.7 13.1 187.4 143.6 128.8 12.1 15.4 173.7 194.9 108.0 157.8 118.6 337.1 927.8 120.8 118.7 59.2 81.2 208.6 105.9 72.7 209.7 116.2 172.4 102.7 278.7 318.2 139.1 TCIRG1 "a3, Atp6i, ATP6N1C, ATP6V0A3, OC-116, OC116, TIRC7" ENSG00000110719 "T cell immune regulator 1, ATPase H+ transporting V0 subunit a3" Q13488 11 68039025-68050895 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Disease variant, Osteopetrosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 289.2" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 135.5;Kupffer cells: 115.2;Macrophages: 132.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 131.9;RPMI-8226: 138.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038742 Approved Approved Mitochondria NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Mitochondria "HPA038742: AB_10795138" "unprognostic (5.35e-2)" "unprognostic (5.01e-2)" "unprognostic (1.81e-2)" "unprognostic (1.50e-2)" "unprognostic (6.98e-3)" "unprognostic (1.25e-1)" "unprognostic (5.07e-2)" "unprognostic (6.43e-2)" "unprognostic (7.03e-2)" "unprognostic (2.47e-2)" "unprognostic (1.36e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.50e-11)" "unprognostic (2.48e-3)" "unprognostic (7.88e-3)" "unprognostic (2.50e-1)" "prognostic favorable (9.45e-6)" 56.8 112.5 7.1 46.1 7.1 97.7 47.2 9.2 14.5 85.1 11.4 66.6 44.2 58.0 18.6 45.3 61.4 11.7 27.9 6.6 7.2 35.5 61.7 113.9 30.9 10.9 9.3 49.1 289.2 4.4 20.3 14.1 12.0 72.2 8.0 0.3 57.9 16.1 10.5 25.9 87.0 12.1 9.1 194.8 59.2 6.7 18.1 12.1 52.5 3.9 13.4 56.1 60.7 10.8 31.8 57.2 0.8 0.2 25.1 19.7 39.0 61.5 29.4 17.2 16.3 1.3 92.0 2.7 32.9 21.9 26.2 39.0 3.7 23.5 3.6 82.1 1.9 22.0 80.6 18.9 23.4 16.3 131.9 22.8 13.5 21.2 1.4 0.0 11.8 1.2 11.6 8.4 5.7 10.7 0.8 97.8 3.5 44.6 14.4 26.8 0.9 138.6 16.2 17.6 3.0 0.7 26.0 33.4 16.8 6.1 36.3 41.1 42.3 33.2 25.9 93.3 11.4 1.3 1.2 4.8 74.0 26.7 16.2 21.7 65.5 72.8 15.7 109.0 12.7 11.3 11.7 16.9 49.0 7.5 6.6 7.2 150.0 32.1 144.3 33.8 12.1 47.8 7.1 7.1 9.2 14.5 6.6 7.2 10.9 9.3 12.0 9.1 18.1 10.8 40.6 28.9 59.8 0.3 37.1 6.2 13.2 36.2 7.4 0.7 14.9 8.9 1.6 18.6 57.1 7.3 0.0 21.7 60.6 74.2 0.0 30.4 0.4 13.3 16.7 22.1 23.9 15.2 0.3 67.0 54.1 24.9 135.5 21.5 50.0 29.5 21.0 17.8 105.1 0.0 0.6 32.4 18.3 115.2 22.8 0.6 5.9 132.3 5.4 8.4 74.9 0.7 45.3 0.5 0.1 51.8 85.4 13.2 59.1 10.6 45.5 2.0 47.9 1.0 39.5 7.7 26.0 0.1 2.9 10.4 5.3 26.5 46.5 9.0 36.2 19.0 CHKA "CHK, CKI" ENSG00000110721 "Choline kinase alpha" P35790 11 68052859-68121444 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 179.6;Early spermatids: 357.3;Late spermatids: 267.3;Oligodendrocytes: 203.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 6.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-MEL-30: 183.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024153, CAB072803" Approved Approved "Endoplasmic reticulum" NA Yes "Cluster 52: Eosinophils - Transcription" "Cluster 43: Testis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 34: Spermatids - Unknown function" "Endoplasmic reticulum" "CAB072803: , HPA024153: AB_1846664" "unprognostic (5.16e-2)" "unprognostic (1.46e-1)" "unprognostic (2.52e-1)" "unprognostic (2.51e-1)" "unprognostic (2.66e-1)" "unprognostic (2.81e-1)" "prognostic unfavorable (7.75e-4)" "unprognostic (2.36e-3)" "unprognostic (1.66e-3)" "unprognostic (1.67e-2)" "unprognostic (1.33e-1)" "unprognostic (1.99e-1)" "unprognostic (5.97e-3)" "unprognostic (5.00e-2)" "unprognostic (6.06e-2)" "unprognostic (1.82e-1)" "unprognostic (4.73e-2)" 17.0 35.8 49.4 7.1 54.2 33.8 20.9 51.8 57.8 18.3 53.5 25.8 21.6 12.2 20.5 6.2 13.2 10.3 14.5 49.5 50.7 23.9 43.3 17.8 9.0 56.6 53.6 20.1 38.0 8.0 21.6 5.2 61.5 31.0 12.8 21.1 44.9 16.4 8.3 8.7 23.1 5.4 51.0 30.0 40.0 75.5 54.0 5.7 43.6 4.5 5.5 19.4 9.3 71.7 25.6 21.3 24.2 24.1 8.0 6.1 24.5 7.7 13.6 22.5 14.4 92.2 70.5 18.9 27.4 12.4 23.2 16.2 34.4 5.6 18.5 8.7 12.1 23.8 29.6 106.9 22.9 25.6 12.5 11.0 9.4 10.0 4.8 12.3 12.7 11.9 23.1 34.7 12.0 19.4 14.6 68.4 40.1 83.2 14.2 21.3 26.1 54.6 18.1 27.3 17.9 19.6 14.9 74.6 183.8 19.9 31.6 34.4 7.3 14.2 16.3 32.4 10.4 37.0 42.5 34.4 14.6 32.8 13.0 0.0 0.8 6.1 0.1 1.5 0.0 0.7 0.1 0.2 0.9 0.3 0.4 0.2 0.4 1.1 0.9 0.7 0.2 0.2 49.4 54.2 51.8 57.8 49.5 50.7 56.6 53.6 61.5 51.0 54.0 71.7 27.2 44.8 36.6 179.6 10.1 15.8 16.6 6.5 18.2 10.6 49.4 35.7 3.6 35.8 20.2 3.7 33.3 8.2 14.2 48.1 13.7 9.6 357.3 42.7 16.2 13.6 28.1 6.7 89.0 19.3 3.4 9.2 37.2 59.0 19.0 23.4 11.7 19.8 17.6 57.2 63.2 16.3 0.0 28.5 19.4 267.3 6.2 31.0 23.2 59.0 8.5 21.4 2.1 100.0 203.5 18.4 18.0 2.6 10.1 17.3 21.6 4.6 23.1 28.4 0.0 9.6 9.8 121.9 20.7 9.2 10.4 13.0 8.2 16.9 31.7 39.2 KMT5B "CGI-85, SUV420H1" ENSG00000110066 "Lysine methyltransferase 5B" Q4FZB7 11 68154863-68213828 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 128.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063648 Supported Nucleoplasm NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA063648: AB_2685073" "unprognostic (5.82e-2)" "unprognostic (4.25e-2)" "unprognostic (2.54e-1)" "unprognostic (5.36e-3)" "unprognostic (3.52e-1)" "unprognostic (2.94e-1)" "unprognostic (1.83e-2)" "unprognostic (1.08e-1)" "unprognostic (3.16e-2)" "unprognostic (1.71e-1)" "unprognostic (5.54e-2)" "unprognostic (1.21e-1)" "unprognostic (3.79e-3)" "unprognostic (2.62e-1)" "unprognostic (4.26e-2)" "unprognostic (3.21e-2)" "prognostic favorable (9.30e-4)" 18.6 16.5 16.3 15.7 17.5 28.5 27.5 26.2 17.6 20.2 17.3 22.3 22.8 26.2 19.0 17.2 18.2 15.0 15.9 15.8 17.2 19.7 22.4 18.1 19.2 16.1 16.3 22.4 22.8 20.6 15.6 22.3 15.6 22.0 21.6 33.4 23.4 16.3 16.9 21.7 21.8 20.7 14.8 17.2 20.7 20.7 16.1 27.0 31.0 16.7 20.4 16.5 17.6 21.3 25.3 18.8 37.6 24.5 8.6 21.4 40.8 17.7 12.3 21.7 12.8 59.7 39.6 20.5 30.2 24.4 21.4 13.0 26.2 20.6 31.6 23.2 15.1 19.4 21.9 24.7 31.0 27.7 25.6 21.3 41.6 26.2 27.3 20.0 21.8 20.3 29.3 23.4 18.7 52.2 19.6 28.9 40.4 50.4 13.9 31.9 29.4 55.4 16.2 24.2 32.7 39.1 27.5 27.4 128.7 20.3 35.1 17.9 23.1 29.2 38.9 22.5 18.4 29.5 13.8 43.0 18.4 17.3 31.8 10.0 3.7 16.5 4.4 5.2 3.1 3.2 4.6 5.4 3.5 3.8 5.3 4.8 10.9 9.6 5.3 5.4 4.1 2.8 16.3 17.5 26.2 17.6 15.8 17.2 16.1 16.3 15.6 14.8 16.1 21.3 39.8 60.9 61.3 0.0 32.9 0.0 42.3 0.0 50.7 50.0 45.8 34.7 0.0 25.8 25.4 25.8 12.5 27.4 37.6 32.6 21.5 27.9 22.0 42.6 46.3 31.7 25.5 31.4 0.0 32.7 29.6 26.3 37.2 44.3 22.7 40.7 30.0 37.7 17.9 63.9 0.0 26.6 0.0 32.4 0.0 21.0 28.0 27.7 0.0 0.0 38.2 29.6 43.3 0.0 0.0 37.1 25.7 31.6 34.8 43.7 36.4 22.7 32.1 39.6 32.9 44.8 28.6 45.8 58.9 38.0 0.0 51.7 30.7 31.8 25.1 53.6 C11orf24 DM4E3 ENSG00000171067 "Chromosome 11 open reading frame 24" Q96F05 11 68261338-68272001 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 107.7;Proximal enterocytes: 162.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 222.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012411, HPA012748" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Golgi apparatus" Vesicles "HPA012411: , HPA012748: AB_1845526" "unprognostic (1.13e-2)" "unprognostic (2.03e-2)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "prognostic unfavorable (7.38e-4)" "unprognostic (2.31e-2)" "unprognostic (7.91e-2)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.56e-1)" "unprognostic (2.68e-2)" "unprognostic (4.99e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.60e-9)" "unprognostic (2.18e-2)" "unprognostic (1.61e-1)" "unprognostic (2.21e-1)" "unprognostic (8.67e-3)" 25.0 17.6 8.9 20.7 12.2 4.7 21.0 12.1 12.7 23.3 8.2 29.2 53.8 39.2 7.3 15.5 22.2 17.6 31.5 9.7 10.5 17.0 87.4 24.1 15.5 14.4 11.6 19.3 27.3 7.3 14.5 16.1 12.5 22.9 17.4 3.0 34.0 17.6 13.7 15.4 59.4 32.6 11.0 20.8 23.6 14.6 12.8 6.4 17.0 15.2 16.7 22.3 19.4 15.2 44.8 45.5 26.4 51.6 62.1 62.5 29.7 105.4 67.5 51.8 53.1 96.2 26.9 20.1 31.7 131.3 47.2 49.4 39.1 47.4 33.2 22.1 23.1 21.4 44.8 65.3 50.1 18.3 68.7 52.1 34.6 78.8 32.0 31.0 21.2 10.6 37.9 32.2 44.6 55.7 4.5 26.4 44.2 72.1 53.8 8.2 44.8 104.1 23.9 21.1 17.3 31.8 33.3 27.1 222.8 21.8 25.6 15.3 23.3 80.8 50.2 103.3 47.3 39.4 41.4 18.8 65.1 14.1 79.9 16.7 12.1 12.6 14.0 19.0 9.4 26.7 7.9 8.9 19.5 35.7 7.3 7.7 1.8 9.9 14.1 26.7 8.4 12.6 8.9 12.2 12.1 12.7 9.7 10.5 14.4 11.6 12.5 11.0 12.8 15.2 6.8 9.6 3.6 3.3 25.5 14.0 12.2 11.7 9.6 4.8 8.2 8.9 10.4 11.5 6.9 9.2 2.1 11.9 12.4 36.2 1.9 21.9 3.5 5.3 17.8 6.6 4.8 9.1 4.1 31.5 30.7 21.1 18.3 6.8 45.0 5.0 9.3 107.7 15.8 0.0 4.2 50.0 6.1 12.9 23.5 7.1 14.0 12.3 28.4 5.6 14.9 6.8 18.6 6.6 8.5 26.9 16.6 16.1 67.0 13.0 162.5 10.6 9.4 2.9 13.1 11.2 20.2 20.7 27.1 9.6 11.2 10.5 6.5 9.6 15.5 10.6 LRP5 "BMND1, EVR1, EVR4, HBM, LR3, LRP7, OPPG, OPS, OPTA1, VBCH2" ENSG00000162337 "LDL receptor related protein 5" O75197 11 68312591-68449275 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Disease variant, Osteogenesis imperfecta, Osteopetrosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 129.7" "Cell type enhanced" "Detected in many" "Granulosa cells: 84.7;Proximal enterocytes: 54.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 161.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013001, HPA030505" Approved NA NA 1500000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 85: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" "CAB013001: AB_2533267, HPA030505: AB_2673505" "unprognostic (3.67e-1)" "unprognostic (2.98e-2)" "unprognostic (1.11e-1)" "unprognostic (3.13e-2)" "unprognostic (3.33e-1)" "unprognostic (1.97e-2)" "unprognostic (1.05e-1)" "unprognostic (2.94e-2)" "unprognostic (9.63e-2)" "unprognostic (2.54e-1)" "unprognostic (2.78e-1)" "unprognostic (6.82e-2)" "prognostic favorable (3.55e-10)" "unprognostic (2.28e-2)" "unprognostic (1.62e-2)" "unprognostic (1.58e-1)" "unprognostic (7.42e-2)" 35.6 37.6 9.6 6.9 11.4 3.2 36.9 10.9 11.2 26.0 44.4 32.4 43.1 30.6 4.1 18.5 26.4 21.0 35.7 8.6 9.2 30.3 129.7 23.3 4.3 12.6 11.9 27.9 34.9 11.6 15.9 23.2 11.7 25.1 11.2 1.7 73.3 20.0 10.4 19.3 44.8 11.1 10.1 8.9 31.8 5.6 10.2 9.6 33.4 7.3 2.6 24.5 19.4 10.6 30.9 103.6 11.0 25.4 20.6 11.4 47.0 14.0 12.1 8.3 7.5 58.7 104.2 0.0 87.5 18.2 35.1 38.9 9.9 37.3 1.2 5.0 22.6 21.6 52.8 77.2 20.8 15.8 2.0 16.4 12.5 0.4 13.6 22.3 23.7 18.8 38.5 1.6 6.0 69.5 23.7 62.7 19.6 161.2 41.7 29.6 30.1 49.7 14.2 82.1 10.6 21.6 37.0 49.4 41.0 5.3 34.6 36.2 31.5 0.2 9.0 11.6 15.8 6.3 0.8 6.3 0.0 9.7 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 9.6 11.4 10.9 11.2 8.6 9.2 12.6 11.9 11.7 10.1 10.2 10.6 37.4 6.4 5.4 17.0 1.1 9.2 8.5 11.3 10.8 0.2 24.4 23.2 5.6 21.5 9.6 7.3 0.0 49.0 0.0 42.7 0.0 11.7 1.1 19.2 6.5 20.4 17.5 10.7 1.1 9.8 6.7 10.6 30.5 12.5 1.3 84.7 31.8 52.5 8.4 0.0 5.7 43.0 18.3 3.2 4.6 1.0 3.1 1.7 1.8 11.2 1.3 8.8 0.0 13.0 5.2 12.5 32.4 9.8 5.7 13.0 54.9 8.5 4.8 0.1 6.6 18.5 10.9 0.8 7.3 7.6 5.3 24.8 1.0 1.3 25.1 13.8 PPP6R3 "C11orf23, DKFZp781E17107, DKFZp781E2374, DKFZp781O2362, FLJ11058, FLJ43065, KIAA1558, MGC125711, MGC125712, PP6R3, SAP190, SAPL, SAPLa, SAPS3" ENSG00000110075 "Protein phosphatase 6 regulatory subunit 3" Q5H9R7 11 68460731-68615334 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 186.0;Oligodendrocytes: 213.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017183, HPA038467, HPA038468" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA 6600 "Cluster 49: Eosinophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Plasma membrane, Cytosol" "CAB017183: , HPA038467: AB_2676029, HPA038468: AB_2676030" "unprognostic (9.46e-3)" "unprognostic (1.45e-1)" "unprognostic (4.62e-2)" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "unprognostic (6.19e-2)" "unprognostic (1.97e-2)" "unprognostic (1.11e-1)" "unprognostic (1.71e-2)" "unprognostic (3.33e-2)" "unprognostic (1.02e-1)" "unprognostic (2.38e-2)" "unprognostic (2.20e-3)" "unprognostic (3.29e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (1.54e-2)" "unprognostic (6.43e-2)" 28.7 28.0 20.4 31.1 26.7 53.0 31.1 35.0 23.1 27.2 29.4 33.4 27.3 30.9 23.3 32.6 26.2 30.7 32.9 20.0 21.9 29.2 31.9 28.1 37.0 24.2 23.4 38.4 22.7 42.9 24.1 34.7 24.8 32.4 33.5 33.8 28.3 26.1 48.8 29.9 31.0 34.5 21.8 32.9 30.0 36.9 23.1 44.4 43.9 49.0 36.6 32.7 26.4 34.6 72.8 83.6 85.0 59.6 44.5 44.9 66.3 62.0 59.7 70.7 64.2 148.3 71.3 83.4 59.4 58.1 74.3 66.6 94.6 70.2 92.3 81.4 40.6 96.1 83.0 49.8 42.6 92.3 82.5 44.8 46.1 72.6 78.0 39.6 65.3 65.4 83.1 59.7 51.1 96.5 92.8 70.8 42.9 142.1 49.5 86.1 116.0 80.9 46.9 103.8 47.8 57.4 88.5 68.8 128.7 70.4 102.4 48.5 65.3 69.1 65.0 74.4 53.4 47.1 71.2 107.0 50.1 40.1 75.1 14.5 9.9 13.2 11.8 13.3 11.4 11.3 12.6 11.7 6.4 12.8 13.7 12.8 14.1 10.1 15.8 13.2 13.2 6.8 20.4 26.7 35.0 23.1 20.0 21.9 24.2 23.4 24.8 21.8 23.1 34.6 41.5 44.8 37.6 134.8 39.6 33.1 25.4 17.6 25.6 49.8 32.1 24.9 42.3 25.8 33.1 27.6 56.3 19.4 36.6 40.9 15.6 15.4 65.8 33.3 33.1 31.0 30.5 35.6 133.3 16.7 17.0 29.8 36.7 43.1 27.8 31.6 29.6 25.3 17.5 26.9 155.0 29.6 16.2 24.9 27.6 24.8 31.1 29.4 21.4 163.9 22.1 28.6 17.5 186.0 213.6 23.9 36.2 31.6 35.9 37.9 29.4 16.1 25.9 50.2 19.7 29.0 30.2 33.8 31.0 29.2 35.5 32.8 38.6 28.6 26.5 42.2 GAL "GAL-GMAP, GALN, GLNN, GMAP" ENSG00000069482 "Galanin and GMAP prepropeptide" P22466 11 68683779-68691175 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Hormone, Neuropeptide" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 23 "brain: 645.9;pituitary gland: 885.8" "Group enriched" "Detected in many" 4 "Basal prostatic cells: 22.2;Ductal cells: 38.9;Endometrial ciliated cells: 64.2;Endometrial stromal cells: 50.8;Exocrine glandular cells: 52.1;Extravillous trophoblasts: 48.7;Glandular and luminal cells: 26.4;Pancreatic endocrine cells: 39.5;Prostatic glandular cells: 82.5;Urothelial cells: 24.3" "Cancer enhanced" "Detected in many" "testis cancer: 22.2" "Region enriched" "Detected in many" 13 "hypothalamus: 645.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 267.2;HEK 293: 119.3;K-562: 139.5;NB-4: 493.5;SH-SY5Y: 189.6" "Region enhanced" "Detected in many" "hypothalamus: 82.6" "Low region specificity" "Detected in all" "HPA049864, CAB079779" Enhanced Supported Supported "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 60000 200000 "Cluster 7: Monocytes - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 24: NB-4 - Immune response" "Cluster 36: Stromal cells - Cell proliferation" "Golgi apparatus" Vesicles "CAB079779: , HPA049864: AB_2680922" "unprognostic (8.56e-2)" "unprognostic (1.45e-2)" "unprognostic (7.50e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (8.07e-3)" "prognostic unfavorable (8.17e-4)" "unprognostic (5.98e-2)" "unprognostic (1.07e-2)" "unprognostic (8.84e-2)" "unprognostic (7.42e-2)" "unprognostic (1.20e-1)" "unprognostic (8.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.38e-2)" "unprognostic (3.24e-2)" 3.2 0.9 2.8 14.9 2.1 0.7 4.4 1.1 5.2 1.0 0.8 17.6 1.8 0.2 0.0 0.8 1.0 0.2 1.0 2.2 645.9 1.5 0.3 0.5 0.1 48.5 5.1 0.2 2.1 0.1 885.8 0.3 13.8 4.4 4.0 0.0 0.9 0.2 0.4 33.3 4.1 9.9 0.6 0.3 9.7 1.0 19.5 0.7 0.4 0.0 0.0 0.7 2.9 2.6 0.0 11.0 1.1 0.3 0.0 0.0 24.0 36.7 0.0 0.7 0.0 267.2 9.9 0.0 12.7 1.3 0.4 0.1 0.0 0.2 0.0 0.0 119.3 6.4 74.6 0.0 1.3 3.7 0.0 1.7 4.0 0.0 0.1 0.0 6.3 0.0 139.5 0.0 0.2 77.2 0.0 493.5 60.3 2.9 23.7 0.0 0.1 51.1 0.6 0.0 49.8 189.6 25.8 1.5 0.0 26.8 1.5 57.6 0.0 0.0 0.0 0.3 2.9 0.0 0.0 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.1 1.1 5.2 2.2 645.9 48.5 5.1 13.8 0.6 19.5 2.6 0.6 0.0 0.0 0.0 0.2 2.0 22.2 0.1 0.0 0.0 3.2 5.8 1.4 0.0 0.0 0.0 0.0 0.6 0.1 0.7 0.0 38.9 0.1 64.2 50.8 3.4 1.8 4.2 2.1 52.1 48.7 6.6 2.0 26.4 4.5 0.4 0.0 0.0 2.0 0.0 0.2 1.1 4.1 0.0 1.2 0.2 0.0 0.7 1.8 0.0 0.6 0.0 0.0 0.0 0.3 39.5 0.1 0.0 1.0 82.5 0.0 0.4 0.0 0.0 0.0 1.6 6.7 2.2 10.9 1.1 3.4 1.9 0.8 0.0 1.3 24.3 TESMIN "CXCDC2, MTL5" ENSG00000132749 "Testis expressed metallothionein like protein" Q9Y4I5 11 68707440-68751520 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 52.5" "Cell type enhanced" "Detected in some" "Breast glandular cells: 9.6;Breast myoepithelial cells: 7.4;Endometrial ciliated cells: 31.5;Glandular and luminal cells: 27.0;Proximal tubular cells: 11.5" "Cancer enhanced" "Detected in many" "breast cancer: 6.8" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 11.9;T-47d: 23.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA018539 Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 6: T47d - Mammary gland" "Cluster 44: Endometrium - Transcription" Nucleoplasm "Vesicles, Cytosol" "HPA018539: " "unprognostic (1.99e-1)" "unprognostic (3.97e-3)" "unprognostic (1.34e-2)" "prognostic unfavorable (1.75e-5)" "unprognostic (3.22e-2)" "unprognostic (6.71e-2)" "unprognostic (1.76e-2)" "unprognostic (6.99e-3)" "unprognostic (2.54e-1)" "unprognostic (5.33e-2)" "unprognostic (2.19e-2)" "unprognostic (8.47e-2)" "unprognostic (5.27e-2)" "unprognostic (6.39e-2)" "unprognostic (2.99e-1)" "unprognostic (9.85e-2)" "unprognostic (3.17e-1)" 0.3 0.5 0.7 1.0 0.7 7.4 4.3 0.6 0.6 0.7 0.6 2.5 1.4 0.7 0.7 1.6 1.7 0.4 0.2 0.5 0.8 3.1 0.4 0.4 1.3 1.2 0.7 0.8 1.1 2.1 2.3 0.3 1.2 2.3 2.9 1.5 1.9 1.1 0.0 0.6 1.4 0.4 0.5 1.3 0.9 52.5 0.7 2.1 1.1 0.1 1.1 0.4 0.9 0.5 7.2 3.1 1.3 0.1 0.0 0.0 3.5 1.6 0.8 2.2 1.0 0.9 7.1 2.9 1.6 0.3 0.0 3.4 1.0 1.4 1.7 3.0 2.5 2.1 1.0 0.0 0.0 1.5 11.9 0.0 3.8 0.1 2.2 3.0 0.7 3.4 4.5 5.4 0.3 4.8 0.8 4.2 7.3 3.3 3.1 1.9 0.4 0.8 2.6 0.1 4.4 4.7 0.0 1.5 0.0 3.7 23.8 10.0 2.7 0.2 0.5 0.2 0.1 2.1 2.0 2.8 0.1 4.2 1.9 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.1 0.7 0.7 0.6 0.6 0.5 0.8 1.2 0.7 1.2 0.5 0.7 0.5 0.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 9.6 7.4 0.0 0.0 0.6 0.0 0.0 1.8 0.7 0.0 5.9 6.3 0.0 31.5 2.6 0.3 0.0 0.0 0.0 4.0 4.7 0.3 0.0 27.0 2.5 4.2 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.5 0.0 0.0 11.5 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 1.1 0.2 0.0 0.0 CPT1A "CPT1, CPT1-L, L-CPT1" ENSG00000110090 "Carnitine palmitoyltransferase 1A" P50416 11 68754620-68844410 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 110.0;Hepatocytes: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008835 Supported Supported Mitochondria NA NA 45000 "Cluster 2: Granulocytes - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 25: RPMI-8226 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Mitochondria "HPA008835: AB_1078563" "prognostic unfavorable (3.84e-4)" "unprognostic (1.38e-3)" "unprognostic (3.04e-3)" "unprognostic (2.46e-2)" "unprognostic (1.45e-1)" "unprognostic (7.25e-2)" "unprognostic (2.17e-1)" "unprognostic (4.99e-2)" "unprognostic (2.72e-1)" "unprognostic (1.47e-2)" "unprognostic (2.92e-2)" "unprognostic (2.34e-1)" "prognostic favorable (2.67e-7)" "unprognostic (9.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.49e-1)" "unprognostic (2.46e-3)" 24.3 27.7 16.0 22.3 18.4 38.9 22.7 20.2 17.3 20.4 32.0 67.4 70.7 25.1 7.3 22.0 25.4 27.7 25.4 14.7 17.7 38.4 67.9 25.3 15.9 20.6 22.0 18.3 23.6 27.6 14.3 18.4 19.3 20.3 44.6 22.6 26.0 21.9 9.9 17.0 71.3 34.9 15.9 27.4 35.6 13.5 22.1 14.0 15.4 14.3 12.3 18.7 18.0 13.9 29.4 50.9 7.3 48.6 31.2 28.0 2.1 22.9 18.8 17.7 3.6 2.0 96.0 0.1 82.2 60.4 62.2 93.5 63.9 13.6 5.3 46.8 6.3 71.5 52.3 24.0 46.4 41.9 82.6 29.2 6.6 35.5 21.4 24.1 63.5 28.2 7.6 56.8 16.5 83.6 34.4 73.7 0.8 149.7 53.2 94.7 1.2 127.1 41.7 71.7 1.0 31.8 63.0 119.9 20.2 4.8 107.4 40.0 64.5 38.3 0.9 77.7 33.5 43.9 60.1 29.2 40.3 30.3 42.8 8.2 6.6 9.5 7.3 7.7 4.2 1.9 4.4 4.4 4.4 2.0 2.7 5.5 3.2 4.9 6.7 10.4 2.8 2.7 16.0 18.4 20.2 17.3 14.7 17.7 20.6 22.0 19.3 15.9 22.1 13.9 44.4 38.5 28.8 35.6 13.5 9.4 11.0 9.0 28.5 4.8 9.6 7.6 25.5 22.8 18.0 23.9 64.6 15.9 39.3 110.0 19.6 13.8 14.7 33.2 22.6 30.4 16.2 30.9 5.6 9.5 3.9 16.6 31.1 56.7 29.7 23.0 40.7 108.3 15.7 1.7 5.7 48.9 10.2 39.1 11.5 43.9 9.6 24.6 0.0 28.1 31.4 12.7 23.7 7.1 1.7 8.5 43.4 32.0 28.6 9.6 83.4 11.8 23.8 43.0 39.5 18.3 21.1 14.5 10.0 14.8 7.7 7.8 24.0 17.3 67.4 9.2 MRPL21 ENSG00000197345 "Mitochondrial ribosomal protein L21" Q7Z2W9 11 68891276-68903835 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051657 Approved Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA "Cluster 37: B-cells - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Mitochondria" "HPA051657: AB_2681565" "unprognostic (1.80e-1)" "unprognostic (6.09e-2)" "unprognostic (4.80e-2)" "unprognostic (8.96e-3)" "unprognostic (9.25e-3)" "prognostic unfavorable (5.97e-4)" "unprognostic (3.23e-2)" "unprognostic (1.51e-1)" "unprognostic (1.09e-1)" "unprognostic (1.06e-1)" "unprognostic (4.84e-2)" "unprognostic (7.36e-2)" "unprognostic (1.26e-2)" "unprognostic (3.73e-2)" "unprognostic (1.72e-1)" "unprognostic (4.36e-2)" "unprognostic (3.12e-1)" 43.5 44.4 56.0 34.0 57.3 60.5 52.5 62.8 71.9 45.3 57.7 67.1 38.7 50.4 48.4 58.4 45.2 27.1 120.2 57.6 59.5 68.0 66.1 31.5 43.8 59.5 57.4 48.6 53.6 56.3 44.7 33.1 59.6 44.1 42.5 29.7 99.5 39.1 131.0 50.4 46.0 35.1 56.9 37.0 53.0 47.0 57.9 37.2 44.7 109.1 42.9 49.8 44.9 56.9 105.2 145.6 86.0 82.3 59.1 63.5 101.4 71.8 77.2 132.8 90.4 297.3 132.7 163.5 157.2 78.0 122.0 129.9 143.8 138.6 102.8 109.7 112.6 114.4 102.4 181.0 116.6 201.4 83.4 95.0 69.4 134.1 156.0 64.7 93.7 115.1 229.2 119.4 80.7 196.7 95.5 210.5 78.0 307.6 210.3 135.2 102.9 253.0 134.0 120.8 139.3 111.3 91.1 181.6 302.7 68.7 188.7 115.4 79.3 90.6 90.6 201.3 135.5 88.9 149.5 232.3 120.6 120.4 125.7 79.6 113.0 61.6 72.4 122.8 77.1 162.2 94.5 78.8 124.2 105.8 89.3 74.1 32.1 93.3 114.2 92.0 113.2 114.0 56.0 57.3 62.8 71.9 57.6 59.5 59.5 57.4 59.6 56.9 57.9 56.9 38.9 35.3 38.7 5.5 47.4 50.2 76.8 145.1 68.9 36.3 56.5 65.4 179.8 67.2 82.0 80.9 8.4 122.8 34.6 127.7 299.3 106.7 176.9 72.2 59.8 50.4 61.7 56.0 5.6 105.3 114.8 53.9 42.8 63.0 65.2 31.8 40.7 115.9 110.4 11.8 6.4 115.6 85.5 56.3 41.3 227.3 74.9 47.0 78.2 1.0 69.8 69.0 34.0 2.0 5.1 86.3 93.0 72.2 63.8 79.6 150.6 272.9 72.8 51.4 26.3 59.3 85.8 86.6 60.5 83.2 51.9 81.3 44.2 55.0 141.6 75.0 IGHMBP2 "CATF1, CMT2S, HCSA, HMN6, SMARD1, SMUBP2, ZFAND7" ENSG00000132740 "Immunoglobulin mu DNA binding protein 2" P38935 11 68903863-68940602 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase, Ribonucleoprotein, RNA-binding, tRNA-binding" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 94.6;Late spermatids: 46.9;Spermatocytes: 51.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004092, HPA060994" Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 71: Testis - DNA repair" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Nuclear bodies" "HPA004092: , HPA060994: AB_2684406" "unprognostic (1.17e-1)" "unprognostic (1.04e-1)" "unprognostic (7.17e-2)" "unprognostic (3.96e-1)" "unprognostic (1.54e-1)" "unprognostic (1.69e-1)" "unprognostic (3.59e-3)" "unprognostic (4.31e-2)" "unprognostic (3.81e-1)" "unprognostic (1.19e-1)" "prognostic favorable (5.89e-4)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.29e-8)" "unprognostic (1.69e-1)" "unprognostic (3.73e-2)" "unprognostic (4.06e-2)" "unprognostic (2.18e-2)" 5.2 4.0 1.2 2.5 1.3 6.0 5.4 0.7 1.7 7.0 0.1 11.8 1.5 7.8 0.6 5.5 6.7 1.7 5.2 1.6 1.2 4.4 6.3 5.1 3.3 0.8 0.4 6.1 5.2 2.8 4.0 2.0 0.7 6.3 1.5 1.4 6.4 3.1 8.5 7.7 6.3 2.6 0.5 5.7 6.2 15.4 0.6 4.3 4.9 3.8 1.7 6.3 5.8 1.1 5.1 7.3 4.0 7.4 3.6 3.1 5.2 5.8 3.9 7.8 4.6 14.5 7.0 7.3 9.7 3.3 6.9 8.0 5.8 4.9 1.8 8.3 6.2 6.6 9.6 5.6 5.5 6.5 7.4 1.8 4.9 9.2 4.6 4.5 4.6 11.1 10.6 4.6 2.3 5.1 11.1 8.9 2.3 7.9 10.3 9.4 5.7 7.6 3.3 5.9 8.6 5.4 7.4 6.1 16.6 3.0 9.3 6.0 6.6 5.3 3.8 7.7 6.6 6.0 6.3 6.9 5.3 6.1 5.1 0.0 2.0 0.8 1.5 1.8 1.3 1.0 0.9 1.0 1.8 0.6 0.5 0.7 0.6 0.1 1.1 0.3 0.6 1.3 1.2 1.3 0.7 1.7 1.6 1.2 0.8 0.4 0.7 0.5 0.6 1.1 6.6 6.4 7.7 7.5 5.7 5.7 3.8 3.5 6.2 9.1 5.6 3.8 6.3 8.6 6.1 1.8 20.9 4.9 10.2 6.0 1.9 5.1 94.6 7.0 8.1 6.4 3.0 9.3 7.4 5.1 4.4 5.5 6.1 14.0 7.0 10.7 3.3 6.1 5.8 11.8 6.4 4.1 2.0 3.5 4.3 46.9 7.8 7.2 1.8 5.6 7.3 6.6 9.2 6.0 5.2 6.5 8.4 7.2 5.8 7.5 3.9 2.9 3.8 10.1 0.0 5.1 10.1 51.6 7.1 5.3 6.7 6.7 8.0 4.6 7.1 6.3 MRGPRD mrgD ENSG00000172938 "MAS related GPR family member D" Q8TDS7 11 68980021-68980986 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031346 Uncertain NA NA "HPA031346: AB_10602710" "unprognostic (1.92e-1)" "unprognostic (7.14e-2)" "unprognostic (1.72e-1)" 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.3 0.2 0.0 0.7 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRGPRF "GPR140, GPR168, MGC21621, mrgF" ENSG00000172935 "MAS related GPR family member F" Q96AM1 11 69004395-69013382 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 171.2;intestine: 159.2" "Cell type enhanced" "Detected in many" "Fibroblasts: 33.3;Leydig cells: 66.2;Peritubular cells: 100.8;Sertoli cells: 52.6;Smooth muscle cells: 63.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 67.6;ASC TERT1: 30.0;BJ: 39.5;BJ hTERT+: 99.1;BJ hTERT+ SV40 Large T+: 36.8;fHDF/TERT166: 30.8;U-2197: 46.8" "Region enriched" "Detected in many" 5 "cerebellum: 14.8" "Region enhanced" "Detected in some" "spinal cord: 4.8" HPA028811 Approved Supported "Nuclear membrane,Plasma membrane" NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Nuclear membrane, Plasma membrane" "HPA028811: AB_10603875" "unprognostic (2.49e-2)" "unprognostic (3.89e-2)" "unprognostic (1.20e-1)" "unprognostic (9.03e-2)" "unprognostic (5.16e-2)" "unprognostic (6.52e-3)" "unprognostic (3.20e-1)" "unprognostic (1.33e-1)" "unprognostic (1.00e-1)" "unprognostic (1.36e-1)" "unprognostic (8.32e-2)" "unprognostic (1.47e-1)" "unprognostic (4.55e-7)" "unprognostic (2.75e-2)" "unprognostic (2.27e-1)" "unprognostic (2.86e-2)" "unprognostic (3.62e-3)" 41.7 3.8 2.6 12.8 2.9 0.0 32.5 12.0 3.9 103.6 5.5 159.2 9.3 171.2 14.2 16.2 98.0 16.7 13.7 2.4 3.1 17.1 7.0 18.7 4.5 4.7 2.8 37.0 3.4 0.5 4.1 11.6 3.3 48.3 8.9 0.2 10.8 45.6 5.1 15.2 38.3 59.3 2.8 13.4 44.1 7.3 2.8 0.7 10.7 3.0 1.3 75.2 65.6 2.5 0.0 0.1 0.1 0.0 67.6 30.0 1.4 39.5 99.1 36.8 24.3 0.0 1.8 0.0 0.8 30.8 0.1 0.1 0.1 0.0 6.8 0.0 0.0 0.0 2.8 0.0 8.5 0.0 0.0 22.1 0.0 23.5 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.0 0.0 2.9 1.5 0.8 0.1 0.0 3.4 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 2.5 0.0 0.0 0.0 22.4 0.0 46.8 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.9 12.0 3.9 2.4 3.1 4.7 2.8 3.3 2.8 2.8 2.5 3.2 0.0 0.0 0.0 0.6 5.0 0.2 0.0 1.2 0.0 0.3 2.3 0.6 2.8 0.0 11.0 0.0 0.7 0.1 0.0 0.0 0.0 4.9 1.1 20.6 2.3 0.0 0.0 1.1 0.0 0.6 33.3 0.5 0.8 0.0 0.0 3.9 3.8 1.1 0.0 0.2 0.0 0.0 0.0 7.3 7.9 66.2 0.2 7.2 3.7 0.0 3.0 0.0 0.0 0.2 0.1 0.0 100.8 0.1 0.3 0.0 0.9 0.0 0.3 52.6 19.1 63.7 1.3 0.5 0.4 3.8 1.1 0.6 0.6 0.0 0.4 TPCN2 TPC2 ENSG00000162341 "Two pore segment channel 2" Q8NHX9 11 69048932-69136316 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 30.5;Melanocytes: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA016561, HPA027080" Supported Approved Nucleoli NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 20: HeLa - Mitochondria" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoli "HPA016561: AB_1858207, HPA027080: AB_10600917" "unprognostic (1.29e-1)" "unprognostic (1.53e-2)" "unprognostic (1.39e-1)" "unprognostic (2.95e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.96e-4)" "unprognostic (7.60e-2)" "unprognostic (7.04e-2)" "unprognostic (3.59e-1)" "prognostic unfavorable (1.49e-4)" "unprognostic (4.15e-2)" "unprognostic (1.89e-2)" "unprognostic (6.87e-2)" "unprognostic (2.22e-1)" "unprognostic (2.24e-3)" "unprognostic (5.01e-2)" "unprognostic (4.88e-2)" 5.8 3.8 2.2 4.8 2.9 4.4 5.2 4.8 3.1 8.9 0.2 11.7 7.6 8.9 3.2 4.6 8.5 3.8 3.9 2.2 1.3 7.5 11.1 4.5 5.8 0.7 0.2 5.8 3.6 2.7 4.2 3.0 0.8 7.2 3.9 4.4 4.1 5.7 4.2 10.0 7.2 4.8 0.1 6.3 4.7 3.2 1.5 3.0 4.3 1.4 4.2 6.3 5.9 3.2 4.6 8.8 3.5 4.9 2.7 3.0 10.5 3.6 3.9 4.7 2.4 8.5 12.4 3.5 5.0 6.9 3.2 9.6 3.2 5.8 2.0 2.7 3.3 7.7 13.7 1.9 3.2 6.5 8.5 4.0 3.2 2.2 2.8 2.4 4.9 8.4 4.7 16.7 2.7 6.9 4.4 9.4 2.4 11.5 3.1 4.6 3.3 6.8 5.1 8.0 2.8 3.6 5.9 11.4 17.0 4.3 7.0 9.1 5.2 3.5 4.5 6.4 4.0 6.8 2.9 4.0 7.7 5.5 8.3 2.9 10.2 2.6 0.9 9.9 0.8 2.4 1.8 2.1 7.7 1.8 1.8 1.9 7.0 6.2 11.7 3.1 2.7 4.4 2.2 2.9 4.8 3.1 2.2 1.3 0.7 0.2 0.8 0.1 1.5 3.2 4.5 9.6 1.5 10.1 6.7 4.0 2.7 3.0 2.2 1.8 2.8 2.5 3.1 5.7 2.3 12.9 2.1 2.6 6.1 4.4 17.6 7.2 17.7 2.1 5.6 4.2 0.0 8.2 30.5 8.6 4.8 4.0 8.6 3.4 2.5 7.3 5.3 18.4 11.9 0.0 22.4 2.6 2.0 12.6 5.5 2.7 6.2 10.2 35.6 4.7 7.7 2.5 3.1 26.2 4.5 4.8 2.6 6.8 8.3 1.5 8.8 9.1 0.8 4.9 6.6 5.1 5.7 2.2 4.4 1.9 3.4 1.9 3.6 3.2 3.6 2.1 SMIM38 ENSG00000284713 "Small integral membrane protein 38" A0A286YFK9 11 69155478-69159752 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "stomach 1: 22.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.1 0.1 0.0 0.7 0.0 0.1 0.3 1.7 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.3 0.1 0.1 0.3 0.0 1.8 0.0 0.1 0.2 0.1 0.0 1.1 2.9 0.0 0.1 0.1 0.3 0.0 0.3 0.0 0.4 0.4 0.3 0.0 0.2 0.0 0.5 22.8 1.3 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.3 1.7 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYEOV OCIM ENSG00000172927 "Myeloma overexpressed" Q96EZ4 11 69294151-69367726 "Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 5.4;breast: 5.3;esophagus: 9.6;stomach 1: 6.0" "Cell type enriched" "Detected in many" 5 "Pancreatic endocrine cells: 199.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 172.8;A549: 83.5;CAPAN-2: 24.3;U-2 OS: 36.1" HPA012949 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm Vesicles "HPA012949: AB_1854241" "unprognostic (1.42e-2)" "unprognostic (8.56e-2)" "unprognostic (7.07e-2)" "unprognostic (3.36e-1)" "unprognostic (5.60e-2)" "unprognostic (7.28e-3)" "unprognostic (7.58e-3)" "prognostic unfavorable (2.00e-4)" "unprognostic (3.49e-1)" "unprognostic (6.33e-2)" "prognostic unfavorable (1.54e-7)" "unprognostic (2.83e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (3.35e-1)" "unprognostic (3.69e-2)" 5.4 0.1 0.0 0.6 0.0 0.1 5.3 0.0 0.0 1.8 0.0 0.5 0.3 0.0 0.7 9.6 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.1 0.1 0.1 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.6 0.0 0.0 4.1 0.2 0.0 0.0 0.2 6.0 0.0 0.0 0.0 0.1 0.0 1.0 0.1 3.9 0.0 172.8 83.5 0.0 0.0 0.0 0.0 2.5 0.2 0.1 0.0 0.0 0.5 24.3 0.5 6.3 0.0 0.1 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.4 0.0 0.0 6.4 0.0 0.0 0.1 0.0 0.1 8.5 0.0 2.4 0.2 0.1 3.8 0.1 0.1 0.2 3.4 6.8 0.0 0.1 3.5 0.6 0.2 0.0 0.0 0.0 2.4 0.6 0.0 2.9 0.7 1.6 0.1 36.1 0.0 1.4 0.3 1.7 0.2 0.2 0.5 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 1.0 0.8 0.8 3.8 0.0 0.0 30.7 37.7 0.4 0.0 17.6 3.7 0.0 0.0 0.9 7.8 0.0 12.6 12.7 1.2 0.1 0.5 0.0 0.0 0.0 9.4 0.4 3.4 23.9 1.5 0.0 0.1 0.0 0.2 2.4 0.0 0.0 1.3 2.0 0.0 0.0 6.9 0.3 4.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 199.3 22.3 0.0 3.9 1.4 0.0 0.0 1.5 0.0 0.0 0.1 2.9 0.0 0.4 3.4 1.3 0.1 0.4 0.0 2.7 8.5 CCND1 "BCL1, D11S287E, PRAD1, U21B31" ENSG00000110092 "Cyclin D1" P24385 11 69641156-69654474 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, Transcription, Transcription regulation" "Cyclin, Repressor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 499.7;Ductal cells: 504.0;Pancreatic endocrine cells: 622.1;Urothelial cells: 412.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-266/70: 874.2;WM-115: 1239.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000024, HPA027802" Uncertain Supported Nucleoplasm Yes No "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 18: Non-specific - Mitochondria" "Cluster 17: WM-115 - Nervous system development" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "CAB000024: AB_563678, HPA027802: AB_2672390" "unprognostic (4.90e-2)" "unprognostic (1.54e-1)" "unprognostic (7.62e-2)" "unprognostic (1.39e-2)" "unprognostic (2.18e-1)" "prognostic unfavorable (5.51e-4)" "unprognostic (1.38e-1)" "unprognostic (2.53e-2)" "unprognostic (9.46e-2)" "unprognostic (4.84e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (4.39e-2)" "unprognostic (2.61e-3)" "unprognostic (4.38e-3)" "unprognostic (1.16e-1)" "unprognostic (6.40e-3)" "unprognostic (2.57e-1)" 55.6 29.2 12.1 10.0 14.6 1.5 40.2 15.0 11.9 17.0 33.4 19.8 22.7 14.8 27.6 72.9 30.8 19.5 64.9 10.8 14.6 32.2 107.3 61.1 10.5 17.5 15.5 4.6 86.3 82.7 25.7 63.7 18.3 53.3 17.2 3.2 30.4 50.4 3.6 120.3 16.0 23.3 15.9 37.2 52.7 3.2 21.7 9.9 45.5 5.2 19.0 29.5 43.9 24.0 467.3 183.0 59.5 1.8 178.3 186.7 127.4 717.5 264.9 82.1 47.6 206.9 349.9 0.1 317.6 375.5 137.2 332.1 6.5 195.2 146.0 1.2 36.5 0.3 46.7 211.7 43.3 3.3 6.7 106.5 37.9 116.0 44.0 192.5 142.1 0.2 0.6 1.3 654.2 197.1 0.4 26.6 109.0 190.7 198.3 1.2 187.9 11.3 379.4 282.8 10.0 231.4 9.2 167.7 458.4 143.5 102.6 9.5 600.4 399.5 111.0 176.1 496.2 874.2 559.4 1.5 341.6 5.9 1239.0 0.2 0.0 0.0 0.2 0.0 0.0 0.9 0.1 0.0 1.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.1 14.6 15.0 11.9 10.8 14.6 17.5 15.5 18.3 15.9 21.7 24.0 84.6 182.7 115.6 0.3 8.3 202.5 234.7 499.7 133.1 2.3 163.4 140.0 80.0 92.9 271.6 125.0 2.1 10.9 2.4 44.8 31.3 504.0 0.4 104.2 23.5 141.0 56.5 2.5 0.5 142.6 1.2 67.6 127.4 199.5 29.1 0.0 98.2 165.2 75.0 0.0 2.2 42.6 75.3 18.8 61.9 2.0 4.1 23.6 51.6 17.8 2.4 79.1 0.0 49.8 0.3 622.1 118.0 57.6 0.5 262.0 19.4 57.1 85.9 3.1 131.5 13.0 184.8 0.5 23.4 292.3 351.1 2.5 8.8 3.4 82.2 412.6 LTO1 "CIAB1, ORAOV1, TAOS1" ENSG00000149716 "LTO1 maturation factor of ABCE1" Q8WV07 11 69653076-69675416 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 4.2;Cardiomyocytes: 2.7;Cytotrophoblasts: 7.9;dendritic cells: 3.6;Extravillous trophoblasts: 3.5;Hofbauer cells: 6.7;Syncytiotrophoblasts: 5.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 75.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062696 Approved Nucleoplasm NA NA "Cluster 35: T-regs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA062696: AB_2684837" "unprognostic (2.15e-1)" "unprognostic (1.37e-2)" "unprognostic (3.63e-1)" "unprognostic (1.60e-1)" "unprognostic (2.20e-1)" "unprognostic (2.09e-2)" "unprognostic (6.76e-3)" "unprognostic (4.65e-2)" "unprognostic (9.87e-3)" "unprognostic (1.82e-1)" "unprognostic (6.51e-3)" "unprognostic (1.18e-2)" "prognostic unfavorable (1.51e-5)" "unprognostic (1.10e-1)" "unprognostic (1.54e-1)" "unprognostic (2.77e-1)" "unprognostic (5.19e-3)" 10.9 15.7 20.3 8.1 21.6 8.4 11.6 20.7 22.4 13.7 18.1 14.0 8.8 13.0 17.8 16.0 12.9 4.7 16.8 20.2 20.2 15.4 14.7 9.9 9.9 21.2 20.6 14.8 19.5 5.7 16.2 5.4 21.8 17.5 6.6 5.8 12.3 6.0 10.3 17.9 13.7 5.8 19.5 18.0 15.1 13.2 20.9 8.6 13.9 5.3 8.9 14.4 13.9 25.4 75.8 16.1 11.1 12.9 11.0 9.5 13.4 24.6 13.4 18.5 10.6 26.6 24.1 17.3 12.8 15.0 14.0 30.6 15.5 13.1 22.7 9.9 20.3 18.0 32.1 17.2 16.9 13.5 10.8 11.1 16.6 20.4 20.5 10.7 13.7 15.8 18.7 11.5 18.2 24.9 12.6 25.6 11.8 33.1 30.7 11.5 18.8 14.8 12.1 11.9 13.2 12.0 16.9 13.0 58.9 9.4 19.4 14.3 14.9 19.7 16.3 31.5 20.1 15.4 11.0 13.5 30.9 15.0 18.9 1.5 3.3 2.8 5.5 2.9 4.3 5.7 5.0 3.8 3.8 4.5 6.1 5.3 3.4 2.9 7.4 5.4 6.4 2.9 20.3 21.6 20.7 22.4 20.2 20.2 21.2 20.6 21.8 19.5 20.9 25.4 4.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 7.9 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 3.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 5.7 0.5 0.0 0.0 0.0 FGF19 ENSG00000162344 "Fibroblast growth factor 19" O95750 11 69698238-69704022 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "gallbladder: 237.1" "Group enriched" "Detected in some" 4 "Cholangiocytes: 24.3;Ductal cells: 15.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "CAPAN-2: 138.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA036082 Approved "Secreted to blood" NA NA 133000 "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" "HPA036082: AB_10669665" "unprognostic (7.46e-3)" "unprognostic (2.43e-3)" "unprognostic (5.52e-3)" "unprognostic (1.22e-1)" "unprognostic (4.68e-3)" "unprognostic (6.45e-2)" "unprognostic (5.72e-3)" "unprognostic (2.26e-1)" "unprognostic (6.39e-3)" "unprognostic (1.66e-2)" "unprognostic (8.82e-3)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.3 0.4 0.1 0.0 237.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 138.2 0.0 0.1 0.0 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.9 0.2 0.0 0.0 0.7 1.4 0.6 24.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 15.1 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.5 4.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 1.3 0.0 0.0 0.0 0.3 1.8 FGF4 "HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF" ENSG00000075388 "Fibroblast growth factor 4" P08620 11 69771022-69775341 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 1.1;Early spermatids: 3.1;Late spermatids: 1.4;Spermatocytes: 1.5" "Cancer enriched" "Detected in some" 5 "testis cancer: 13.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 62 "NTERA-2: 16.1;SuSa: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA011209 Uncertain "Secreted in other tissues" NA NA 326000 "Cluster 5: NTERA-2 - Transcription" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA011209: AB_1848527" "unprognostic (1.47e-2)" "unprognostic (6.22e-2)" "unprognostic (7.77e-2)" "unprognostic (8.56e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FGF3 "HBGF-3, INT2" ENSG00000186895 "Fibroblast growth factor 3" P11487 11 69809968-69819416 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Mitogen" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 36 "brain: 3.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.4" "Region enriched" "Detected in single" 5 "cerebellum: 3.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 3.1" "Not detected" "Not detected" HPA012692 Enhanced "Secreted in brain" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA012692: AB_1848526" "unprognostic (6.42e-3)" "unprognostic (7.82e-2)" "unprognostic (1.89e-1)" "unprognostic (3.61e-1)" "unprognostic (7.75e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.1 0.6 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANO1 "DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A" ENSG00000131620 "Anoctamin 1" Q5XXA6 11 70078302-70189528 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Developmental protein, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 181.7;salivary gland: 180.5;seminal vesicle: 209.2" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 70.2;Early spermatids: 54.9;Hepatocytes: 141.3;Late spermatids: 75.1;Sertoli cells: 46.0;Smooth muscle cells: 52.5;Suprabasal keratinocytes: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A-431: 140.2;CAPAN-2: 207.9;HaCaT: 254.0;OE19: 182.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 6.6" "HPA032148, HPA057356" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 2: Hepatocytes - Metabolism" "Plasma membrane" Nucleoplasm "HPA032148: AB_2674180, HPA057356: AB_2732610" "unprognostic (2.73e-1)" "unprognostic (7.91e-2)" "unprognostic (3.66e-2)" "prognostic favorable (4.58e-6)" "unprognostic (1.90e-1)" "prognostic unfavorable (7.28e-5)" "unprognostic (1.16e-3)" "prognostic unfavorable (2.40e-4)" "unprognostic (2.13e-2)" "unprognostic (3.51e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.21e-1)" "prognostic unfavorable (4.09e-6)" "unprognostic (1.56e-1)" "unprognostic (1.06e-1)" "unprognostic (8.85e-3)" "unprognostic (1.81e-1)" 16.3 2.2 0.3 3.6 1.6 0.1 86.8 0.8 1.3 46.7 0.1 14.3 3.6 40.0 181.7 12.7 59.1 54.4 21.9 0.5 0.1 6.4 108.5 16.1 3.4 1.0 0.2 2.9 9.1 48.0 4.4 5.2 1.1 17.1 11.0 0.9 180.5 209.2 12.7 97.4 4.6 30.1 0.2 1.2 48.3 10.4 0.1 1.5 35.4 33.0 4.0 6.7 12.8 0.5 140.2 5.3 0.3 4.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 207.9 0.0 2.5 0.0 0.3 254.0 0.0 0.7 0.0 0.4 0.2 0.1 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.4 0.2 0.0 0.6 0.0 0.0 0.1 0.0 1.0 0.5 0.3 1.1 182.2 19.6 0.3 0.0 0.7 0.0 0.2 7.3 0.2 0.1 43.1 0.8 1.4 16.2 0.5 0.5 0.3 1.1 0.0 3.5 0.1 0.3 0.2 0.2 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.8 1.3 0.5 0.1 1.0 0.2 1.1 0.2 0.1 0.5 7.2 0.0 0.0 0.7 0.4 17.7 21.5 4.2 0.0 0.0 30.5 70.2 3.5 17.2 2.0 0.0 0.0 1.3 0.2 0.4 0.0 4.1 54.9 10.0 27.5 5.6 0.0 2.7 0.7 0.0 0.6 4.2 36.7 18.5 4.5 0.0 3.3 141.3 0.2 0.0 20.4 13.3 0.0 1.6 3.0 75.1 1.8 0.7 5.4 2.8 0.0 0.8 0.0 1.5 0.7 1.0 0.5 1.5 0.3 22.6 0.0 0.7 0.3 0.4 46.0 1.1 52.5 1.4 2.3 1.4 46.7 4.1 0.7 0.1 0.4 20.9 FADD "GIG3, MORT1" ENSG00000168040 "Fas associated via death domain" Q13158 11 70203296-70207390 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Immunity, Innate immunity" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 75.0;Ductal cells: 55.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 331.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001464, CAB010209" Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoplasm, Cytosol" "CAB010209: AB_2100622, HPA001464: AB_1848348" "unprognostic (2.08e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (6.91e-2)" "unprognostic (9.51e-2)" "unprognostic (3.89e-1)" "prognostic unfavorable (8.22e-5)" "unprognostic (7.25e-3)" "prognostic unfavorable (2.21e-5)" "unprognostic (1.16e-1)" "unprognostic (1.06e-1)" "unprognostic (2.45e-3)" "unprognostic (2.78e-3)" "unprognostic (1.29e-1)" "unprognostic (2.04e-2)" "unprognostic (2.07e-1)" "prognostic favorable (3.45e-4)" "unprognostic (7.29e-2)" 9.8 13.8 10.6 14.0 10.5 8.8 13.6 10.9 10.1 13.1 10.6 14.8 14.1 12.6 17.6 14.3 13.2 12.1 8.4 9.9 10.8 14.2 16.0 10.6 16.9 12.6 10.8 12.5 8.2 9.1 6.4 15.3 11.6 9.2 12.8 4.0 11.3 13.4 10.9 12.5 13.9 10.3 11.2 13.2 14.8 5.7 11.4 20.3 11.3 9.0 16.9 11.4 9.2 11.3 331.2 54.7 26.6 24.3 31.6 25.4 23.8 55.3 43.6 47.5 31.6 47.1 52.3 48.7 51.9 37.1 44.8 47.7 26.3 49.3 36.8 45.7 28.8 22.3 30.6 24.3 28.5 28.0 28.4 25.4 34.5 51.4 64.7 38.1 45.3 26.7 37.0 24.4 42.1 48.5 34.4 49.5 42.1 75.1 89.1 26.3 64.3 47.0 46.8 24.1 23.5 22.3 41.0 38.0 117.1 30.3 41.3 30.7 51.0 36.6 35.7 56.7 53.9 33.8 27.8 28.6 53.2 28.0 52.6 37.1 36.2 28.2 41.7 38.4 47.5 38.7 44.1 48.9 37.1 33.9 44.6 40.7 88.6 37.7 45.3 33.7 45.7 36.1 10.6 10.5 10.9 10.1 9.9 10.8 12.6 10.8 11.6 11.2 11.4 11.3 7.8 0.0 5.3 0.7 12.1 11.9 14.8 18.1 6.2 6.8 14.0 15.7 0.1 14.3 7.7 18.4 0.0 75.0 9.3 22.9 21.5 55.9 0.7 7.3 11.7 15.6 2.4 19.8 1.4 34.7 37.3 10.0 12.8 10.6 1.3 13.8 14.6 8.5 31.2 3.3 1.6 14.3 0.0 11.0 8.8 2.4 13.4 10.8 32.0 2.8 20.9 10.0 18.6 0.5 1.4 49.0 15.3 16.6 9.6 11.8 24.5 33.7 5.4 4.1 0.0 5.2 14.5 10.4 14.2 14.4 10.5 30.8 13.3 18.9 17.4 14.4 PPFIA1 "LIP.1, LIPRIN" ENSG00000131626 "PTPRF interacting protein alpha 1" Q13136 11 70270690-70385312 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 190.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "A-431: 261.2;SK-MEL-30: 156.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017032, HPA042271" Uncertain Supported "Focal adhesion sites,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol "Focal adhesion sites" "CAB017032: , HPA042271: AB_2677923" "unprognostic (1.89e-1)" "unprognostic (1.28e-2)" "unprognostic (6.27e-2)" "unprognostic (9.92e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.58e-4)" "unprognostic (7.20e-3)" "unprognostic (2.20e-1)" "unprognostic (3.02e-2)" "unprognostic (5.45e-3)" "prognostic unfavorable (8.26e-4)" "unprognostic (1.14e-1)" "prognostic favorable (3.76e-4)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.80e-1)" "unprognostic (2.14e-2)" 26.6 14.6 17.5 16.1 18.2 20.6 17.6 16.0 19.2 13.1 22.1 18.2 14.0 17.9 13.7 16.4 12.1 22.1 14.5 15.6 15.8 16.4 15.0 19.8 15.7 25.9 21.0 15.1 15.9 18.0 13.2 24.1 20.6 12.4 15.8 14.9 13.4 14.0 31.6 18.0 16.2 17.4 17.6 15.3 13.5 26.3 20.1 15.7 23.3 26.8 14.0 17.0 12.1 25.1 261.2 30.4 31.8 22.5 33.1 20.3 34.9 30.0 24.4 40.8 26.0 66.8 22.8 25.8 39.6 27.3 39.4 38.3 30.7 28.3 35.9 15.5 21.5 19.7 34.3 24.7 33.4 26.2 22.1 24.9 46.8 53.1 44.6 31.4 27.9 21.3 33.1 19.9 37.3 30.8 19.3 17.7 19.7 59.5 34.3 20.6 80.2 22.2 20.6 32.9 31.9 21.5 45.2 59.1 156.6 36.0 37.5 31.2 30.0 38.0 29.8 54.3 32.4 24.7 15.8 37.3 28.2 20.1 43.0 0.0 1.6 1.1 0.8 1.2 1.2 1.5 1.2 1.1 1.3 1.0 0.9 0.6 5.0 0.4 3.5 1.7 1.2 0.6 17.5 18.2 16.0 19.2 15.6 15.8 25.9 21.0 20.6 17.6 20.1 25.1 33.0 25.6 53.5 114.6 19.3 27.4 26.4 14.2 30.1 39.1 32.8 24.1 27.2 20.0 25.1 18.4 31.3 44.2 14.2 39.3 11.7 21.8 190.4 28.7 44.4 31.4 26.9 24.8 57.8 20.3 13.7 33.3 25.5 45.4 8.8 94.3 20.7 25.2 25.2 33.7 52.8 19.8 16.2 35.5 28.8 97.7 27.7 40.4 21.4 38.4 28.8 71.8 17.5 47.7 56.4 36.2 24.7 25.6 23.6 36.7 19.2 22.7 27.1 45.8 19.7 45.4 30.0 60.7 61.9 36.1 33.1 74.3 22.2 42.2 25.1 37.2 CTTN EMS1 ENSG00000085733 Cortactin Q14247 11 70398404-70436584 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Endocytosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 1.2;neutrophil: 2.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.1" "Cell line enhanced" "Detected in many" "A-431: 450.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011235, HPA057242" Supported Supported "Golgi apparatus,Vesicles,Plasma membrane,Cytosol" NA NA 11000000 "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Plasma membrane, Cytosol" "Golgi apparatus, Vesicles" "CAB011235: , HPA057242: AB_2683379" "unprognostic (6.34e-2)" "unprognostic (2.65e-2)" "unprognostic (2.05e-1)" "unprognostic (3.13e-2)" "unprognostic (5.81e-2)" "prognostic unfavorable (2.19e-6)" "prognostic unfavorable (4.45e-4)" "unprognostic (6.10e-2)" "unprognostic (2.39e-1)" "unprognostic (1.10e-1)" "unprognostic (1.25e-3)" "unprognostic (1.20e-1)" "unprognostic (1.50e-2)" "unprognostic (6.97e-2)" "unprognostic (2.79e-1)" "unprognostic (3.72e-3)" "unprognostic (1.94e-1)" 91.7 142.5 28.3 15.6 30.0 4.9 82.9 29.7 32.3 112.3 28.5 84.9 28.4 117.8 18.7 131.6 85.0 35.1 106.9 27.7 28.2 109.6 66.9 74.8 9.0 33.2 30.8 112.9 79.5 18.1 94.1 23.9 30.9 101.6 23.8 8.4 92.9 27.0 65.7 104.4 70.9 31.8 29.5 53.3 92.2 62.0 30.3 8.7 89.5 14.5 12.7 88.1 101.2 32.5 450.2 97.2 32.0 37.2 53.2 81.9 52.5 93.8 92.5 80.7 63.4 129.5 110.3 17.5 90.6 121.1 86.3 97.3 38.6 98.7 58.7 35.5 39.1 1.7 73.6 61.1 113.9 0.4 22.6 116.6 68.0 89.4 50.2 84.4 68.8 0.5 51.3 3.3 80.9 122.9 0.9 6.4 35.0 163.4 58.6 0.2 39.3 14.3 90.5 143.7 26.3 44.9 68.3 93.2 158.0 57.2 75.8 1.9 86.8 70.8 45.3 111.2 63.6 7.4 5.2 1.0 141.1 0.4 98.9 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 2.1 0.0 0.1 0.4 0.0 6.8 28.3 30.0 29.7 32.3 27.7 28.2 33.2 30.8 30.9 29.5 30.3 32.5 95.3 44.8 51.8 61.7 4.0 151.9 102.8 85.8 46.1 39.4 81.0 57.9 64.1 80.1 95.4 134.3 18.8 83.8 1.6 224.4 64.6 146.5 12.4 86.4 84.8 89.9 74.4 18.9 93.4 221.5 95.6 89.1 76.0 116.1 6.3 117.7 78.9 44.1 10.4 38.7 65.4 123.8 57.0 8.9 34.1 26.1 103.2 38.6 122.7 28.1 5.9 42.5 0.0 40.2 145.8 260.6 177.8 98.9 3.1 153.5 108.4 164.3 89.4 32.5 59.2 61.0 87.5 32.0 47.0 76.7 174.9 106.3 5.4 91.4 111.9 258.1 SHANK2 "CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3" ENSG00000162105 "SH3 and multiple ankyrin repeat domains 2" Q9UPX8 11 70467854-71252577 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 31.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 153.5;Horizontal cells: 136.3;Inhibitory neurons: 167.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 8 "amygdala: 7.7;basal ganglia: 7.5;cerebral cortex: 9.3;hippocampal formation: 9.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 11.5;Karpas-707: 17.5;RT4: 15.9;T-47d: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008174, HPA017220" Approved Approved "Nuclear speckles,Vesicles,Plasma membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Vesicles, Plasma membrane" "Nuclear speckles" "HPA008174: AB_1856822, HPA017220: " "unprognostic (3.08e-1)" "unprognostic (1.31e-3)" "unprognostic (1.79e-1)" "unprognostic (1.51e-2)" "unprognostic (1.51e-1)" "unprognostic (7.23e-5)" "unprognostic (1.24e-1)" "unprognostic (6.67e-2)" "unprognostic (1.83e-2)" "unprognostic (8.42e-2)" "unprognostic (4.87e-2)" "unprognostic (4.01e-1)" "prognostic favorable (1.94e-6)" "unprognostic (3.46e-2)" "unprognostic (2.34e-1)" "unprognostic (4.03e-2)" "unprognostic (4.80e-2)" 1.3 1.2 7.7 0.5 7.5 0.0 4.5 0.2 9.3 1.3 31.7 2.4 1.5 1.0 2.2 3.4 5.1 0.8 0.0 9.5 0.0 4.9 3.8 3.7 0.1 0.0 0.0 0.1 7.5 0.1 2.2 1.9 0.0 3.2 2.0 5.5 9.8 1.8 0.0 0.9 1.3 0.4 0.0 1.1 3.0 0.9 1.0 0.0 6.0 0.0 0.4 1.1 0.3 0.9 0.5 7.4 4.1 0.0 0.6 0.4 4.5 0.7 0.3 0.0 0.0 6.6 3.1 6.2 2.2 0.0 0.1 1.1 0.0 4.8 0.0 0.0 0.2 0.0 0.0 11.5 0.0 0.0 1.9 0.1 1.8 0.0 0.0 1.6 0.0 0.1 0.0 17.5 1.7 10.5 0.0 0.1 3.5 10.2 0.3 0.0 9.9 8.2 5.2 15.9 3.5 1.1 0.0 8.4 0.0 5.2 16.4 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 7.5 0.2 9.3 9.5 0.0 0.0 0.0 0.0 0.0 1.0 0.9 8.0 41.7 17.0 21.5 0.2 0.0 3.2 3.2 0.6 17.9 26.9 13.0 3.7 11.5 5.4 7.3 0.0 12.8 0.4 3.2 3.9 8.4 1.7 30.0 3.2 1.3 0.0 0.0 153.5 2.2 2.9 1.8 10.2 13.0 2.5 1.2 0.4 21.9 1.2 136.3 167.5 7.9 8.2 0.0 0.3 2.1 0.0 0.4 5.4 14.0 0.0 4.6 0.0 41.7 5.3 10.7 2.7 0.7 0.4 10.9 0.6 10.8 23.3 1.0 0.0 0.3 1.3 0.7 0.9 1.3 0.6 14.6 0.3 0.1 5.5 4.0 DHCR7 SLOS ENSG00000172893 "7-dehydrocholesterol reductase" Q9UBM7 11 71428193-71452868 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 161.1" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 77.9;Granulosa cells: 81.3;Hepatocytes: 156.1;Theca cells: 103.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044280 Approved Supported "Endoplasmic reticulum" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 15: Hepatocytes - Hemostasis" "Endoplasmic reticulum" "HPA044280: AB_10794893" "unprognostic (1.76e-1)" "unprognostic (1.50e-3)" "unprognostic (1.32e-2)" "unprognostic (7.16e-3)" "unprognostic (2.69e-1)" "unprognostic (2.18e-3)" "unprognostic (8.57e-3)" "unprognostic (3.02e-2)" "unprognostic (4.91e-2)" "unprognostic (1.13e-1)" "unprognostic (1.08e-2)" "unprognostic (5.45e-2)" "prognostic favorable (6.93e-7)" "unprognostic (1.73e-1)" "unprognostic (1.01e-1)" "unprognostic (8.15e-2)" "prognostic unfavorable (5.67e-4)" 23.7 97.2 28.1 13.0 35.4 46.7 36.3 42.4 37.0 16.2 15.6 21.1 48.1 10.6 59.2 42.2 12.5 8.9 28.8 28.8 35.8 16.3 161.1 21.8 6.0 55.3 38.8 54.4 16.6 24.4 18.4 8.3 55.8 21.6 14.4 8.7 27.8 7.1 13.6 68.2 19.3 9.9 34.4 9.6 19.1 31.0 38.0 4.7 11.9 13.2 9.4 7.9 22.7 58.9 126.4 112.3 106.7 118.9 49.0 75.8 33.7 50.9 134.1 43.1 114.5 419.8 401.5 87.1 79.0 48.6 376.2 235.9 128.8 276.7 44.5 33.5 98.7 33.4 89.3 183.1 127.8 63.7 15.6 89.2 122.1 159.3 108.4 34.6 63.8 112.7 159.6 180.7 43.2 341.1 52.4 72.6 154.1 124.9 67.4 46.9 150.6 377.3 162.3 187.3 144.7 53.9 48.4 157.6 113.9 51.4 153.2 34.5 60.4 11.5 62.4 3.7 61.5 59.3 78.7 95.8 33.8 110.9 48.9 5.6 2.1 1.9 10.5 1.4 12.6 6.5 8.9 9.8 2.8 5.4 11.0 13.0 1.1 5.8 1.5 7.1 6.0 6.9 28.1 35.4 42.4 37.0 28.8 35.8 55.3 38.8 55.8 34.4 38.0 58.9 7.1 3.2 19.1 7.2 7.1 0.8 10.1 77.9 3.4 8.4 21.8 14.9 13.1 15.7 39.2 22.0 12.5 15.5 11.9 9.9 7.9 36.9 0.1 3.9 1.5 11.8 9.5 5.2 3.2 49.9 27.6 12.8 11.7 9.3 0.0 81.3 7.9 156.1 11.9 0.0 4.5 12.3 54.9 3.8 3.3 1.7 8.4 5.6 5.4 1.0 5.8 21.2 4.1 5.0 14.7 26.7 11.5 4.9 10.0 16.5 8.9 3.8 7.6 8.7 13.1 3.9 9.0 0.5 7.0 11.9 1.1 54.2 13.8 103.6 15.0 9.5 NADSYN1 FLJ10631 ENSG00000172890 "NAD synthetase 1" Q6IA69 11 71453109-71524107 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Ligase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017798, HPA038523, HPA038524" Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 45: Enterocytes - Digestion" Vesicles "Golgi apparatus, Cytosol" "CAB017798: , HPA038523: AB_2676060, HPA038524: AB_2676061" "unprognostic (1.45e-1)" "unprognostic (1.29e-1)" "unprognostic (7.30e-2)" "unprognostic (2.63e-3)" "unprognostic (1.75e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (5.17e-6)" "unprognostic (1.19e-2)" "unprognostic (4.38e-2)" "unprognostic (1.41e-1)" "unprognostic (9.41e-2)" "unprognostic (1.99e-2)" "prognostic unfavorable (8.72e-5)" "unprognostic (4.12e-3)" "unprognostic (1.38e-1)" "unprognostic (1.54e-2)" "prognostic favorable (5.10e-4)" 29.5 34.1 18.8 24.1 20.4 67.6 26.2 18.5 21.2 30.4 20.3 48.6 39.5 26.0 24.2 56.3 31.2 25.8 20.3 17.8 18.3 33.2 49.8 35.3 33.3 22.4 19.6 27.6 29.5 13.4 36.0 16.5 21.0 45.3 36.0 6.9 32.9 22.8 11.0 31.1 51.1 19.3 18.8 58.4 34.3 25.6 21.7 27.9 31.8 5.1 28.2 43.4 33.4 24.4 15.9 37.8 12.0 21.6 35.0 50.6 32.4 29.7 27.2 15.4 17.0 32.4 25.7 13.4 33.1 35.3 20.7 55.2 15.9 42.6 8.2 27.9 12.8 22.2 27.6 36.3 43.3 45.1 40.9 72.0 65.8 19.9 17.8 34.9 54.6 24.2 11.9 18.5 21.9 49.7 22.4 29.9 7.0 69.6 21.3 27.5 37.2 13.5 37.8 72.1 8.9 12.7 21.2 27.9 56.0 17.9 24.9 24.4 66.2 16.7 14.2 30.9 11.8 24.3 11.0 11.7 29.9 25.6 12.0 6.1 28.0 17.3 15.3 25.0 12.7 12.2 13.5 13.8 31.1 9.2 8.8 11.4 17.7 16.3 22.6 23.0 17.7 21.4 18.8 20.4 18.5 21.2 17.8 18.3 22.4 19.6 21.0 18.8 21.7 24.4 12.6 22.4 32.3 4.2 24.0 6.2 17.8 18.4 26.2 7.8 13.5 10.9 8.3 12.8 19.8 11.0 4.2 17.4 27.3 65.3 3.9 16.5 22.6 21.1 11.1 15.6 23.4 20.2 5.1 17.3 14.5 12.8 51.0 19.7 22.1 23.1 13.9 16.7 20.1 13.5 5.8 30.3 16.2 23.2 18.5 60.9 9.3 25.4 8.8 8.4 25.8 5.9 29.9 7.5 18.5 20.0 55.8 10.1 18.0 17.9 73.3 16.2 16.5 7.3 13.1 9.6 9.8 15.9 5.0 38.3 12.8 17.2 22.3 17.1 43.7 24.2 KRTAP5-7 "KRTAP5-3, KRTAP5.7" ENSG00000244411 "Keratin associated protein 5-7" Q6L8G8 11 71527267-71528669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 5.3;testis: 1.9" "Group enriched" "Detected in some" 4 "Early spermatids: 1.6;Late spermatids: 3.5;Spermatocytes: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "RT4: 1.7" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (3.69e-1)" "unprognostic (2.49e-4)" "unprognostic (1.64e-1)" "unprognostic (1.82e-2)" "unprognostic (3.40e-2)" "unprognostic (7.48e-2)" "unprognostic (2.10e-2)" "unprognostic (3.83e-1)" "unprognostic (2.87e-2)" "unprognostic (4.35e-3)" "unprognostic (2.35e-1)" "unprognostic (5.68e-3)" 0.0 0.0 0.6 0.0 0.6 0.0 0.1 0.3 1.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.5 0.7 0.4 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.1 5.3 0.0 0.0 0.4 0.0 0.0 1.9 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.3 1.0 0.5 0.5 0.8 0.5 0.7 0.4 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.3 0.0 3.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 KRTAP5-8 "KRTAP5-2, KRTAP5.8, UHSKerB" ENSG00000241233 "Keratin associated protein 5-8" O75690 11 71538025-71539209 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 6.0;skin 1: 7.6" "Cell type enhanced" "Detected in single" "Distal tubular cells: 1.9" "Cancer enhanced" "Detected in single" "renal cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 39: Non-specific - Basic cellular processes" "unprognostic (9.72e-2)" "unprognostic (8.49e-2)" "unprognostic (9.79e-2)" "unprognostic (1.52e-1)" "unprognostic (1.66e-1)" "unprognostic (2.58e-2)" "unprognostic (1.99e-1)" "unprognostic (6.92e-2)" "unprognostic (2.89e-2)" "unprognostic (2.42e-2)" "unprognostic (2.08e-1)" "unprognostic (3.02e-2)" "unprognostic (1.14e-1)" "unprognostic (3.62e-2)" "unprognostic (2.21e-3)" 0.1 0.1 0.4 0.0 0.5 0.0 0.1 0.3 0.8 0.1 0.2 0.1 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.4 0.4 6.0 0.2 0.1 0.0 0.4 0.4 0.0 0.1 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.1 7.6 0.1 0.0 0.3 0.1 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.5 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.3 0.8 0.4 0.4 0.4 0.4 0.5 0.3 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 KRTAP5-9 "KRN1, KRTAP5-1, KRTAP5.9" ENSG00000254997 "Keratin associated protein 5-9" P26371 11 71548420-71549608 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 3.1" "Group enriched" "Detected in some" 7 "Early spermatids: 2.3;Late spermatids: 5.6" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.0" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "RT4: 8.6" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (1.72e-3)" "unprognostic (2.20e-1)" "unprognostic (2.22e-2)" "unprognostic (2.16e-1)" "unprognostic (4.13e-1)" "unprognostic (6.53e-2)" "unprognostic (8.10e-2)" "unprognostic (2.09e-1)" "unprognostic (1.06e-1)" "unprognostic (7.76e-2)" "unprognostic (7.23e-2)" "unprognostic (2.56e-1)" "unprognostic (3.29e-1)" "unprognostic (2.05e-2)" "unprognostic (2.01e-1)" "unprognostic (4.82e-4)" "prognostic favorable (9.25e-4)" 0.4 0.3 0.7 0.0 0.7 0.2 0.3 0.3 1.2 0.3 0.3 0.5 0.1 0.2 1.7 0.5 0.4 0.3 0.1 0.7 0.6 0.5 0.8 0.4 0.1 0.5 0.8 0.1 0.2 0.2 0.8 0.1 0.5 0.6 0.2 0.3 0.3 0.3 0.4 0.9 0.5 0.0 0.3 0.6 0.2 3.1 0.5 0.0 0.3 0.0 0.1 1.3 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.3 1.2 0.7 0.6 0.5 0.8 0.5 0.3 0.5 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 KRTAP5-10 KRTAP5.10 ENSG00000204572 "Keratin associated protein 5-10" Q6L8G5 11 71565563-71566735 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "epididymis: 1.4;skin 1: 4.9" "Cell type enhanced" "Detected in some" "Early spermatids: 2.7;Late spermatids: 1.0;Respiratory ciliated cells: 1.0" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "RT4: 3.5" NA NA "Cluster 61: Skin - Cornification" "Cluster 15: RT4 - Unknown function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (4.05e-2)" "unprognostic (5.64e-3)" "unprognostic (1.39e-2)" "unprognostic (6.47e-2)" "unprognostic (7.81e-2)" "unprognostic (4.70e-2)" "unprognostic (5.55e-2)" "unprognostic (1.68e-1)" "unprognostic (3.53e-1)" "unprognostic (9.81e-2)" "unprognostic (1.21e-1)" "unprognostic (2.53e-1)" "unprognostic (8.39e-4)" "unprognostic (9.43e-2)" "unprognostic (1.37e-1)" "unprognostic (6.21e-2)" "unprognostic (2.27e-4)" 0.2 0.1 0.2 0.0 0.2 0.0 0.2 0.2 0.4 0.0 0.1 0.1 0.0 0.0 1.4 0.1 0.2 0.1 0.0 0.2 0.2 0.4 0.2 0.1 0.0 0.2 0.2 0.0 0.5 0.0 0.2 0.0 0.2 0.3 0.1 0.1 0.1 0.3 0.2 4.9 0.1 0.0 0.2 0.2 0.1 0.6 0.2 0.0 0.2 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.5 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.6 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.4 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.6 KRTAP5-11 "KRTAP5-6, KRTAP5.11" ENSG00000204571 "Keratin associated protein 5-11" Q6L8G4 11 71579714-71603353 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "skin 1: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 61: Skin - Cornification" "unprognostic (2.08e-1)" 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.3 0.3 0.2 0.2 0.5 0.3 0.5 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF705E ENSG00000214534 "Zinc finger protein 705E" A8MWA4 11 71814045-71821548 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 50: Fibroblasts - ECM organization" "unprognostic (3.65e-2)" "unprognostic (1.34e-2)" "unprognostic (5.02e-2)" "unprognostic (3.80e-1)" "unprognostic (7.34e-3)" "unprognostic (8.00e-5)" "unprognostic (6.79e-2)" "unprognostic (1.37e-2)" "unprognostic (5.38e-2)" "unprognostic (1.97e-1)" "unprognostic (5.94e-2)" "unprognostic (2.70e-1)" "unprognostic (5.13e-4)" "unprognostic (9.18e-3)" "unprognostic (1.05e-1)" "unprognostic (8.89e-2)" "unprognostic (2.34e-2)" 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 DEFB108B ENSG00000184276 "Defensin beta 108B" Q8NET1 11 71833200-71837710 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 86 "epididymis: 12.8" "Cell type enriched" "Detected in single" 18 "Collecting duct cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 67: Proximal tubular cells - Tubular reabsorption" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP002495.1 ENSG00000254469 "XRCC1 N-terminal domain containing 1-like" Q6ZNB5 11 71865504-71928665 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Cytotrophoblasts: 6.0;Extravillous trophoblasts: 2.2;Hofbauer cells: 2.0;Respiratory ciliated cells: 1.5;Syncytiotrophoblasts: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051121, HPA051124" Uncertain Enhanced "Nucleoli,Mitotic chromosome" Yes NA "Cluster 20: T-cells - T-cell receptor" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoli "Mitotic chromosome" "HPA051121: AB_2681349, HPA051124: " "unprognostic (1.66e-1)" "unprognostic (1.19e-2)" "unprognostic (2.23e-1)" "unprognostic (1.73e-2)" "unprognostic (2.39e-1)" "unprognostic (2.42e-1)" "unprognostic (2.32e-3)" "unprognostic (9.79e-4)" "unprognostic (5.91e-3)" "unprognostic (5.04e-3)" "unprognostic (7.21e-2)" "unprognostic (2.23e-1)" "unprognostic (1.92e-2)" "unprognostic (1.33e-2)" "unprognostic (2.07e-1)" "unprognostic (3.60e-1)" "unprognostic (3.12e-3)" 1.9 2.1 1.9 2.2 2.8 4.7 3.2 4.3 2.6 2.8 2.8 2.2 2.6 3.7 5.3 2.6 2.4 2.1 2.1 1.7 2.2 2.9 2.2 1.8 4.2 2.5 1.5 4.6 3.1 2.9 2.5 2.0 2.4 3.1 3.5 7.3 2.2 2.8 1.6 4.2 2.6 2.4 0.6 2.9 2.4 3.3 2.8 3.2 3.2 1.5 3.4 2.3 2.2 5.0 2.6 6.2 4.7 4.5 1.8 1.6 3.1 2.9 2.3 3.1 3.0 6.5 6.4 5.8 2.6 2.0 3.9 8.4 4.9 3.3 3.2 8.4 4.5 9.4 7.7 4.2 1.1 4.2 3.1 2.2 1.6 5.2 3.6 2.6 4.9 8.0 6.3 7.6 3.0 4.9 4.8 3.5 4.9 9.6 4.5 3.6 16.3 4.0 3.5 3.1 6.9 6.6 4.6 4.1 9.2 3.3 5.1 2.3 4.6 2.5 4.1 4.9 1.9 5.5 8.4 7.0 4.0 4.6 3.7 2.7 1.9 1.7 2.9 3.0 1.7 2.5 5.1 3.8 2.2 3.3 4.8 4.1 2.0 1.2 1.9 4.8 4.9 1.9 1.9 2.8 4.3 2.6 1.7 2.2 2.5 1.5 2.4 0.6 2.8 5.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 0.0 0.0 DEFB131B ENSG00000225805 "Defensin beta 131B" A0A096LNP1 11 71878453-71884561 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 19 "epididymis: 68.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RH-30: 15.6" "Secreted in male reproductive system" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "unprognostic (5.87e-2)" "unprognostic (1.44e-1)" "unprognostic (4.78e-2)" "unprognostic (7.44e-2)" "unprognostic (3.57e-2)" "unprognostic (3.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.91e-1)" "unprognostic (3.09e-3)" "unprognostic (7.45e-2)" "unprognostic (1.41e-1)" "unprognostic (1.43e-1)" "unprognostic (5.21e-2)" "unprognostic (3.39e-1)" "unprognostic (1.05e-2)" "unprognostic (3.62e-1)" 0.2 0.6 0.7 1.1 0.5 0.4 0.0 0.7 1.3 0.0 0.0 0.7 1.8 0.4 68.9 0.1 0.0 2.5 0.4 0.4 0.2 0.5 0.0 0.2 1.8 0.5 0.5 1.2 0.0 0.0 0.0 0.2 1.7 0.4 0.0 3.6 0.7 0.1 0.4 0.8 1.0 0.0 0.2 0.7 0.6 0.8 0.7 0.0 3.2 0.0 0.0 1.0 0.0 1.3 0.5 0.0 3.1 1.4 0.0 0.0 0.4 3.6 0.0 0.0 0.0 4.4 2.8 3.0 1.1 0.0 1.5 3.4 0.0 0.0 0.0 2.8 2.8 3.8 0.0 2.5 0.0 4.8 1.6 0.0 0.0 0.0 0.0 1.1 0.0 6.2 7.3 5.9 0.0 3.2 2.1 0.9 0.5 3.7 3.7 3.0 15.6 1.0 0.0 1.1 2.9 1.6 2.5 1.4 2.6 2.5 3.0 0.4 2.1 1.2 3.4 2.0 0.3 2.5 1.1 4.4 2.0 2.8 0.8 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.7 0.2 0.0 0.7 0.5 0.7 1.3 0.4 0.2 0.5 0.5 1.7 0.2 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF121 FLJ11099 ENSG00000137522 "Ring finger protein 121" Q9H920 11 71929018-71997597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046041 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA046041: AB_10965850" "unprognostic (1.36e-2)" "unprognostic (8.84e-2)" "unprognostic (9.72e-2)" "unprognostic (1.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.38e-2)" "unprognostic (1.41e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" "unprognostic (6.54e-2)" "unprognostic (1.85e-2)" "unprognostic (1.90e-1)" "prognostic favorable (2.72e-6)" "unprognostic (1.54e-1)" "unprognostic (1.81e-1)" "unprognostic (2.57e-2)" "unprognostic (1.70e-1)" 7.2 9.5 8.8 6.6 8.7 5.8 11.3 8.5 9.2 9.8 9.7 8.1 15.9 8.4 20.0 7.4 11.6 7.8 10.0 8.8 9.0 16.4 11.5 7.6 8.1 8.8 9.1 11.2 10.9 24.3 9.5 11.1 8.8 10.6 10.3 15.7 15.1 13.6 17.2 8.3 13.9 11.8 9.0 6.7 9.2 8.7 9.1 7.7 12.9 14.9 10.4 9.1 7.1 8.7 10.9 22.7 20.5 14.6 19.1 15.2 13.8 16.7 17.7 25.4 26.9 46.0 20.9 9.2 14.9 18.5 26.7 22.1 22.7 21.2 26.7 13.8 13.1 14.0 21.5 21.9 14.3 12.8 11.5 14.8 17.9 28.7 18.2 27.9 46.7 13.5 23.2 8.6 22.7 23.5 9.0 14.1 13.7 43.4 21.9 11.0 44.5 7.9 28.3 18.4 13.7 14.6 22.9 20.4 30.4 20.6 22.5 9.5 32.8 19.0 17.2 11.8 14.6 9.6 10.2 9.4 16.5 8.3 17.1 4.4 2.2 2.2 3.0 2.9 3.5 3.2 2.3 2.4 2.3 1.3 2.7 2.9 1.2 3.2 2.1 3.7 2.1 2.9 8.8 8.7 8.5 9.2 8.8 9.0 8.8 9.1 8.8 9.0 9.1 8.7 9.6 6.4 9.6 12.7 9.4 8.8 11.2 22.8 10.2 16.1 12.1 10.9 9.7 12.8 13.3 20.2 20.9 32.0 17.9 15.2 7.9 26.0 6.3 8.9 10.3 6.5 9.6 13.0 19.3 32.3 26.5 11.8 9.2 10.9 7.0 11.6 8.9 14.4 14.2 10.1 16.9 13.2 26.4 6.6 12.9 3.0 13.1 7.6 10.6 15.0 15.0 19.0 10.3 18.1 19.0 29.0 11.0 12.4 17.1 10.3 31.0 20.9 10.3 21.1 19.7 10.0 14.2 25.1 19.6 6.4 5.8 31.1 10.0 13.4 9.4 9.9 IL18BP IL18BPa ENSG00000137496 "Interleukin 18 binding protein" O95998 11 71998613-72005715 "Disease related genes, Metabolic proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 49.2" "Cell type enhanced" "Detected in many" "Adipocytes: 14.0;Exocrine glandular cells: 13.6;Kupffer cells: 14.2;Langerhans cells: 12.9;Macrophages: 15.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025980, HPA041061" Enhanced Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 3070000 16000000 "Cluster 52: Eosinophils - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Endoplasmic reticulum" "CAB025980: , HPA041061: AB_2677280" "unprognostic (2.66e-3)" "unprognostic (2.04e-3)" "unprognostic (9.14e-3)" "unprognostic (1.70e-2)" "unprognostic (5.58e-3)" "unprognostic (7.75e-2)" "unprognostic (1.41e-1)" "unprognostic (6.20e-2)" "unprognostic (1.19e-2)" "unprognostic (1.75e-3)" "unprognostic (1.74e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.93e-6)" "unprognostic (1.19e-1)" "unprognostic (4.14e-2)" "unprognostic (6.76e-2)" "unprognostic (1.93e-2)" 14.4 18.4 6.0 25.0 6.3 7.9 13.6 7.1 9.1 12.5 4.9 12.7 8.3 10.4 3.5 6.4 10.1 8.1 10.9 5.8 8.3 24.9 15.0 31.1 26.2 8.7 7.8 11.1 8.4 2.5 10.7 17.1 9.0 16.5 11.0 3.8 8.9 4.2 5.0 7.4 17.2 13.5 6.1 49.2 10.2 6.1 8.5 6.5 12.6 2.4 11.9 12.2 8.5 7.3 1.7 2.3 5.1 2.9 1.0 1.6 5.9 3.3 1.8 3.0 4.0 11.7 2.4 1.2 2.2 1.3 3.4 4.0 2.5 2.4 2.0 2.5 3.8 4.5 7.6 3.7 1.3 2.4 12.3 2.4 2.3 2.4 1.2 3.5 6.3 7.9 7.4 2.0 1.8 3.2 3.8 5.7 3.6 1.9 2.2 6.1 5.4 1.9 2.1 4.4 2.8 5.3 3.0 4.2 3.7 4.8 3.6 2.7 13.6 4.2 3.5 5.1 1.9 3.3 1.8 2.1 1.7 11.5 2.3 7.0 20.2 56.1 52.5 72.9 23.9 31.9 27.5 31.6 36.9 20.2 22.5 32.5 8.6 5.2 60.9 53.7 15.1 39.8 6.0 6.3 7.1 9.1 5.8 8.3 8.7 7.8 9.0 6.1 8.5 7.3 14.0 6.4 3.3 0.7 8.0 2.0 0.4 0.7 0.0 3.3 2.1 1.9 1.8 1.5 1.0 0.0 10.4 1.0 7.2 0.5 0.0 3.0 0.0 1.1 1.9 11.1 0.0 0.8 0.7 13.6 1.4 3.4 1.1 1.8 7.6 2.2 10.4 0.5 11.2 3.3 0.5 0.8 0.0 14.2 12.9 0.0 0.9 15.4 0.0 1.0 4.6 1.1 7.2 0.5 0.0 5.4 0.2 0.7 2.3 1.0 1.1 1.9 1.8 3.7 0.0 1.8 1.6 0.7 0.5 0.6 2.0 0.8 6.4 1.6 0.8 0.2 NUMA1 ENSG00000137497 "Nuclear mitotic apparatus protein 1" Q14980 11 72002864-72080693 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019841, HPA019859, HPA029912" Enhanced Supported Nucleoplasm,Cytosol NA Yes 62000 "Cluster 39: Non-specific - mRNA processing" "Cluster 89: Fibroblasts - ECM organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm Cytosol "HPA019841: AB_1854708, HPA019859: AB_1854709, HPA029912: AB_10602811" "unprognostic (1.60e-2)" "unprognostic (3.31e-1)" "unprognostic (2.06e-2)" "unprognostic (2.84e-1)" "unprognostic (1.14e-1)" "unprognostic (6.47e-2)" "unprognostic (5.75e-2)" "unprognostic (8.74e-3)" "unprognostic (5.91e-2)" "unprognostic (9.45e-2)" "unprognostic (1.60e-2)" "unprognostic (2.51e-2)" "prognostic favorable (7.92e-4)" "unprognostic (1.28e-1)" "unprognostic (1.37e-1)" "unprognostic (1.49e-1)" "unprognostic (1.39e-1)" 55.2 59.9 27.8 51.1 45.6 69.6 67.1 37.4 40.5 75.4 36.2 77.7 59.6 111.2 43.3 67.9 82.7 62.7 47.6 24.0 33.0 49.9 29.8 65.4 57.9 40.4 34.3 112.3 68.8 98.6 42.1 60.8 41.9 111.4 54.5 46.2 78.1 85.6 82.5 93.8 61.9 86.7 28.4 56.8 59.0 42.4 36.0 79.3 73.9 54.8 53.2 75.2 65.9 83.4 64.4 80.0 97.2 66.4 85.1 88.2 48.8 85.0 97.2 86.4 74.6 83.9 115.5 86.7 72.0 104.0 61.6 134.2 89.7 85.8 78.0 89.9 43.1 105.8 130.4 64.1 69.1 81.1 74.0 94.0 55.7 84.1 84.3 133.0 74.0 76.7 63.4 101.1 59.4 124.2 105.6 45.2 61.2 122.3 57.6 127.9 170.0 67.6 64.2 98.6 117.3 166.6 134.9 123.5 123.6 42.3 166.4 47.1 103.0 90.6 69.9 130.1 56.9 64.8 69.7 120.0 61.1 38.0 53.0 3.7 4.1 1.9 6.4 2.3 4.7 3.4 4.0 5.0 3.5 5.8 4.9 3.6 2.8 5.0 4.4 8.2 5.2 6.0 27.8 45.6 37.4 40.5 24.0 33.0 40.4 34.3 41.9 28.4 36.0 83.4 52.4 41.7 41.3 42.7 36.6 25.9 30.1 25.3 74.0 60.7 62.3 63.4 5.7 34.3 32.2 53.3 73.0 25.5 42.6 56.3 17.6 27.9 31.9 55.5 48.5 44.9 47.4 43.3 27.5 32.1 13.4 41.9 57.6 92.8 31.0 84.7 37.9 23.6 28.7 52.2 34.0 68.3 32.6 32.1 24.9 17.8 69.0 36.3 19.6 33.7 26.8 51.8 53.5 27.6 58.9 30.9 31.2 50.8 40.8 29.6 57.0 26.9 35.4 59.8 39.5 64.3 36.9 14.8 21.4 51.9 28.1 45.0 44.8 44.2 52.2 26.0 AP000812.4 ENSG00000284922 "Leucine rich transmembrane and O-methyltransferase domain containing" Q8WZ04 11 72080331-72110782 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Catecholamine metabolism, Hearing, Neurotransmitter degradation" "Methyltransferase, Transferase" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "fallopian tube: 14.1;testis: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 2.9;HBEC3-KT: 2.9;MCF7: 3.0" HPA039949 Approved Uncertain Microtubules NA NA "Cluster 40: Non-specific - Basic cellular processes" Microtubules "HPA039949: AB_10960708" 0.1 0.0 0.4 0.0 0.5 0.0 0.2 0.6 1.8 0.0 0.1 0.0 0.0 0.9 0.0 0.0 14.1 0.0 0.0 0.3 0.6 0.4 0.2 0.6 0.0 0.4 0.4 0.2 0.0 0.5 0.0 0.4 0.0 0.1 0.1 0.0 0.2 0.4 0.0 0.2 0.2 0.3 0.2 0.0 9.5 0.4 0.0 0.1 0.0 0.0 0.1 0.6 0.2 0.1 0.0 0.2 0.7 0.2 0.1 0.4 0.5 0.3 1.2 0.2 0.2 0.0 0.1 2.9 0.5 0.6 0.4 2.9 0.3 1.2 0.5 0.5 0.2 0.2 0.0 0.0 0.0 0.8 0.0 1.3 0.4 0.1 0.1 0.6 0.0 0.0 0.4 3.0 0.0 0.0 0.1 1.0 0.0 0.6 0.5 0.2 0.9 0.5 0.3 0.1 0.4 0.3 0.0 0.0 0.9 0.1 0.0 0.2 0.2 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.6 1.8 0.3 0.6 0.4 0.4 0.4 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRTOMT "CFAP111, COMT2, DFNB63, LRRC51, LRTOMT1, LRTOMT2" ENSG00000184154 "Leucine rich transmembrane and O-methyltransferase domain containing" Q96E66 11 72080337-72096895 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 67.1;testis: 49.3" "Group enriched" "Detected in many" 12 "Early spermatids: 574.9;Late spermatids: 2222.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 39.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039949 Approved Uncertain Microtubules NA NA "Cluster 15: NK-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 25: Spermatids - Spermatogenesis" Microtubules "HPA039949: AB_10960708" "unprognostic (2.68e-1)" "unprognostic (6.43e-2)" "unprognostic (1.85e-2)" "prognostic favorable (7.70e-4)" "unprognostic (8.09e-2)" "unprognostic (9.07e-2)" "unprognostic (1.42e-1)" "unprognostic (1.90e-1)" "unprognostic (4.22e-2)" "prognostic favorable (5.36e-4)" "unprognostic (6.12e-2)" "unprognostic (8.43e-2)" "unprognostic (2.64e-2)" "unprognostic (1.58e-1)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (1.44e-1)" 5.0 4.5 21.1 2.5 21.8 2.1 8.7 19.5 24.2 8.7 25.1 5.4 3.7 7.2 17.1 3.8 67.1 3.4 3.7 19.1 19.2 11.7 7.9 7.7 3.2 23.0 25.7 8.1 8.9 10.3 8.9 5.4 21.4 9.3 7.7 19.7 4.4 5.4 7.5 5.8 3.4 5.7 23.4 4.0 5.5 49.3 21.0 4.5 11.0 4.6 3.6 4.1 3.8 22.0 3.9 13.7 8.9 6.9 7.3 6.7 2.1 4.4 3.6 4.0 3.5 6.6 20.4 5.1 6.6 7.8 9.6 7.3 6.3 10.8 4.5 9.4 6.2 3.5 6.3 4.8 1.3 3.0 3.9 2.9 5.4 6.0 4.6 6.4 1.5 10.2 4.0 7.8 6.0 13.6 9.0 6.0 4.4 22.8 3.6 10.8 8.6 7.7 15.9 4.7 8.2 6.2 8.7 19.4 10.4 6.1 39.6 3.3 6.5 4.0 5.7 11.3 3.1 8.0 9.4 5.8 4.0 2.5 4.5 1.8 1.7 3.5 2.0 1.9 1.9 3.2 2.1 1.6 1.0 3.5 1.8 1.8 6.1 6.6 1.3 2.8 4.6 1.4 21.1 21.8 19.5 24.2 19.1 19.2 23.0 25.7 21.4 23.4 21.0 22.0 4.6 0.0 1.5 3.3 2.5 2.3 7.5 10.0 1.8 3.5 8.4 7.5 2.2 5.7 10.7 3.7 12.5 12.7 1.4 4.4 11.7 7.5 574.9 84.3 3.0 6.5 1.2 3.6 2.0 2.5 7.7 5.3 4.1 7.2 0.0 2.2 3.6 6.0 3.1 6.7 1.9 10.8 10.2 1.6 2.8 2222.2 14.9 3.3 1.8 1.9 1.4 21.3 4.1 2.0 3.6 2.0 2.5 10.1 5.1 6.8 4.0 19.9 113.1 16.6 6.6 6.1 7.9 90.3 28.1 2.2 2.4 13.1 1.7 2.9 3.4 6.5 LAMTOR1 "C11orf59, FLJ20625, p18, p27RF-Rho, Pdro, Ragulator1" ENSG00000149357 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 1" Q6IAA8 11 72085895-72103297 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002997 Approved Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA 160000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 51: Myeloid cells - Hemostasis" "Golgi apparatus" "Vesicles, Plasma membrane" "HPA002997: AB_1845531" "unprognostic (7.32e-2)" "unprognostic (1.79e-1)" "unprognostic (3.94e-2)" "unprognostic (3.77e-2)" "unprognostic (2.30e-1)" "unprognostic (2.71e-2)" "prognostic unfavorable (3.63e-4)" "unprognostic (1.00e-1)" "unprognostic (2.18e-1)" "unprognostic (1.94e-1)" "unprognostic (5.45e-2)" "unprognostic (2.10e-3)" "unprognostic (1.78e-3)" "unprognostic (3.08e-1)" "unprognostic (2.46e-1)" "unprognostic (1.00e-1)" "unprognostic (1.04e-1)" 100.7 143.8 171.2 69.1 177.8 118.6 96.2 173.2 180.4 87.0 162.1 88.6 67.5 86.5 90.0 114.1 74.9 65.8 131.9 163.5 169.5 129.5 114.2 91.3 80.6 177.4 177.2 81.5 85.6 87.0 92.0 67.4 174.9 102.4 76.5 46.6 85.8 71.7 126.4 89.9 82.5 73.7 175.4 130.9 96.6 41.2 176.1 75.4 112.3 109.3 79.4 88.5 77.9 172.5 94.2 181.0 97.3 132.0 224.7 152.3 97.6 129.0 201.6 206.2 151.7 230.9 139.7 93.1 162.3 216.9 214.2 138.1 171.1 260.1 155.8 117.8 99.3 245.6 108.5 156.5 291.4 97.2 147.7 252.3 199.2 224.4 224.0 116.4 173.1 102.5 104.1 96.0 211.4 295.6 86.2 146.1 93.9 291.8 194.9 73.7 178.9 78.8 246.8 195.1 65.7 103.3 127.6 127.5 343.7 106.4 192.6 93.2 125.3 137.5 98.0 323.8 93.0 111.6 139.0 80.4 81.8 81.8 113.0 113.4 414.3 274.1 80.6 228.8 77.7 132.1 75.6 81.1 332.6 146.2 63.4 77.9 229.5 122.8 180.6 197.1 98.8 397.5 171.2 177.8 173.2 180.4 163.5 169.5 177.4 177.2 174.9 175.4 176.1 172.5 132.6 44.8 71.6 9.1 109.7 55.7 161.7 271.1 117.8 58.5 159.9 195.7 66.4 121.5 120.2 128.8 12.5 266.5 110.7 235.4 295.4 276.4 12.4 61.2 98.9 134.9 116.4 133.5 9.8 340.2 300.1 111.6 71.4 85.2 97.7 71.5 142.1 86.9 468.0 77.4 12.9 140.2 170.9 248.5 111.6 19.2 107.8 311.5 113.8 8.4 413.6 223.7 177.1 10.1 24.2 307.3 202.6 102.7 87.9 193.4 230.3 370.9 61.0 56.1 111.7 102.5 116.3 58.7 103.3 126.1 55.4 282.0 89.4 178.5 170.8 157.2 AP000812.3 ENSG00000284844 "Novel protein, ortholog of mouse Tomt" 11 72105924-72109329 "Metabolic proteins, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANAPC15 "APC15, C11orf51, DKFZP564M082, HSPC020" ENSG00000110200 "Anaphase promoting complex subunit 15" P60006 11 72106378-72112780 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036596 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm Vesicles "HPA036596: AB_10671961" "unprognostic (1.17e-1)" "unprognostic (5.83e-2)" "unprognostic (4.23e-2)" "unprognostic (3.05e-2)" "unprognostic (1.86e-2)" "unprognostic (2.09e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (9.18e-2)" "unprognostic (3.35e-2)" "prognostic favorable (2.55e-4)" "unprognostic (9.34e-3)" "unprognostic (1.76e-1)" "unprognostic (1.26e-3)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (2.77e-1)" "unprognostic (9.08e-2)" 28.9 44.2 47.0 30.0 47.5 95.9 30.0 47.8 61.1 24.3 45.8 67.1 30.7 43.4 38.3 53.2 30.4 18.3 62.2 47.2 47.7 48.8 44.0 30.0 43.5 46.4 46.8 22.4 39.2 25.4 32.8 19.2 47.2 52.0 40.6 42.8 39.9 38.8 95.2 39.6 40.1 31.9 46.4 41.2 46.5 72.0 46.3 72.6 44.7 64.3 44.3 41.6 29.5 49.0 74.0 109.4 87.5 55.8 25.5 41.2 41.4 77.1 70.1 121.3 80.2 128.8 78.4 98.8 72.9 110.3 59.0 122.6 133.4 144.0 113.9 64.0 63.3 113.1 124.9 84.5 30.2 110.8 101.3 43.2 56.2 68.9 91.6 45.4 80.7 136.7 83.3 66.6 80.0 127.2 214.5 102.9 70.9 155.3 62.3 89.6 217.4 67.2 106.1 50.5 61.9 53.8 79.0 76.5 127.0 46.8 89.6 58.6 73.4 55.5 72.9 110.5 82.8 68.0 71.5 125.3 34.0 87.8 31.7 29.7 168.5 136.3 73.3 114.2 78.0 94.5 93.4 86.3 148.8 71.4 110.9 101.5 68.4 72.4 107.4 119.1 153.0 124.1 47.0 47.5 47.8 61.1 47.2 47.7 46.4 46.8 47.2 46.4 46.3 49.0 20.1 16.0 16.5 2.9 36.1 41.8 71.2 83.5 44.3 32.9 43.2 55.6 3.9 12.8 50.6 23.9 27.1 84.7 40.5 82.9 123.3 49.4 15.4 38.8 21.3 22.8 49.6 34.1 7.1 102.7 78.8 18.3 36.7 27.8 30.4 27.2 15.0 44.1 82.8 13.5 7.3 66.2 61.1 48.5 47.5 13.4 6.8 48.0 26.6 1.0 58.8 44.1 36.0 5.5 5.2 53.1 61.4 23.0 47.1 43.8 56.2 123.6 45.6 43.3 19.7 16.0 35.3 115.9 139.9 53.8 41.1 46.7 41.1 32.3 71.5 61.7 FOLR3 "FR-G, FRγ" ENSG00000110203 "Folate receptor gamma" P41439 11 72114869-72139892 "Metabolic proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "bone marrow: 98.7;lymphoid tissue: 28.4" "Group enriched" "Detected in some" 10 "Distal tubular cells: 406.9;monocytes: 103.0" "Cancer enhanced" "Detected in some" "ovarian cancer: 5.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 11 "classical monocyte: 330.8;neutrophil: 492.8" "Group enriched" "Detected in many" 11 "granulocytes: 492.8;monocytes: 330.8" "Group enriched" "Detected in some" 5 "hTERT-HME1: 72.4;U-2197: 64.7" "Secreted to blood" NA NA 12000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 39: Non-specific - Basic cellular processes" "unprognostic (1.47e-2)" "unprognostic (6.26e-3)" "unprognostic (1.94e-2)" "unprognostic (8.72e-3)" "unprognostic (6.87e-3)" "unprognostic (9.56e-2)" "unprognostic (1.58e-1)" "unprognostic (3.72e-1)" "unprognostic (1.72e-1)" "unprognostic (1.54e-1)" "unprognostic (7.35e-2)" "unprognostic (7.90e-2)" "unprognostic (8.39e-2)" "unprognostic (9.99e-4)" "unprognostic (1.96e-1)" "unprognostic (2.03e-6)" "unprognostic (4.17e-1)" 5.7 0.4 0.3 10.6 0.2 98.7 0.2 0.2 0.5 0.2 0.3 0.2 0.4 0.0 0.0 1.0 0.9 0.3 0.5 0.2 0.3 8.6 0.8 5.9 0.1 0.3 0.3 0.0 0.2 0.0 0.1 0.7 0.3 0.2 0.1 0.0 0.6 0.1 0.1 0.6 0.5 0.6 0.2 28.4 0.4 0.9 0.6 1.3 1.7 0.5 0.0 0.5 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.2 0.3 10.4 13.1 3.7 9.2 0.0 0.0 0.0 1.3 2.0 0.2 1.1 0.0 6.9 8.4 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 8.8 5.4 72.4 1.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.6 0.3 64.7 0.0 0.1 0.0 0.0 2.7 0.0 0.0 15.1 330.8 30.9 0.5 26.1 1.8 0.3 0.1 0.2 36.2 0.1 0.1 0.0 492.8 0.5 1.4 6.3 0.4 294.4 0.3 0.2 0.2 0.5 0.2 0.3 0.3 0.3 0.3 0.2 0.6 0.3 0.1 0.0 7.9 0.0 1.1 0.3 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.0 1.9 23.9 0.0 0.1 1.3 0.0 406.9 0.1 3.5 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 3.8 0.0 1.1 0.0 1.6 0.0 0.0 0.0 0.0 22.4 1.7 10.9 0.0 17.4 0.0 0.0 103.0 0.0 2.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 18.1 1.5 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 1.0 0.1 0.0 0.1 FOLR1 "FOLR, FRα" ENSG00000110195 "Folate receptor alpha" P15328 11 72189558-72196323 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" Transport Receptor Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 480.2;fallopian tube: 187.2;lung: 193.5;salivary gland: 219.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 496.8;Alveolar cells type 2: 213.3;Breast glandular cells: 211.3;Club cells: 276.3;Collecting duct cells: 318.2;Cytotrophoblasts: 462.2;Proximal tubular cells: 366.0;Syncytiotrophoblasts: 259.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 259.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HeLa: 444.2;RPTEC TERT1: 476.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077030 Approved "Nuclear membrane" "Secreted to blood" NA NA 448000 140000 "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 30: Mammary glandular cells - Lactation" "Nuclear membrane" "HPA077030: " "unprognostic (3.30e-1)" "unprognostic (2.19e-1)" "unprognostic (6.55e-2)" "unprognostic (3.49e-2)" "unprognostic (7.67e-3)" "unprognostic (1.98e-2)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.18e-2)" "unprognostic (8.13e-2)" "unprognostic (2.47e-2)" "unprognostic (2.58e-2)" "unprognostic (2.87e-3)" "unprognostic (1.67e-1)" "unprognostic (2.52e-1)" "unprognostic (1.11e-1)" "unprognostic (2.20e-1)" "unprognostic (2.69e-1)" 0.1 1.7 2.7 0.2 1.8 0.1 28.3 11.8 1.8 123.5 480.2 0.5 0.3 1.9 7.6 3.4 187.2 2.4 0.6 14.1 4.1 153.0 0.2 193.5 0.0 5.7 7.8 0.7 7.1 17.5 8.1 36.2 3.8 1.5 0.4 0.5 219.5 15.2 0.1 2.5 0.4 0.2 3.2 0.2 33.0 0.2 7.7 0.2 45.9 0.0 0.4 0.1 0.1 2.7 0.2 0.2 0.0 0.2 0.0 0.0 64.7 0.1 0.1 0.1 0.1 44.5 46.0 0.0 45.5 0.8 0.0 0.9 2.4 2.1 0.2 0.1 1.4 1.0 444.2 1.3 0.0 0.0 0.1 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.3 0.5 0.1 0.1 2.2 0.7 0.0 0.5 15.1 0.0 476.5 0.0 0.1 3.0 1.4 7.1 0.1 38.5 65.7 0.5 0.0 0.0 8.4 0.3 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.8 11.8 1.8 14.1 4.1 5.7 7.8 3.8 3.2 7.7 2.7 1.0 496.8 213.3 0.0 1.3 0.9 7.9 80.3 0.0 0.0 211.3 62.9 0.2 34.3 276.3 318.2 0.0 462.2 1.1 0.0 133.1 14.3 0.1 33.6 2.3 3.4 1.8 0.0 0.0 1.4 110.9 4.3 9.7 33.7 5.1 0.0 0.0 0.0 29.5 0.0 0.0 0.1 87.5 0.0 0.4 0.0 0.6 3.8 0.0 0.0 0.0 2.2 0.0 0.0 0.0 6.7 0.0 0.0 0.0 6.3 0.0 366.0 149.1 0.1 0.0 0.1 6.3 0.0 0.5 3.2 0.1 259.0 2.2 0.3 0.3 10.4 FOLR2 FRβ ENSG00000165457 "Folate receptor beta" P14207 11 72216601-72221950 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Transport Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 168.4" "Cell type enriched" "Detected in many" 4 "Hofbauer cells: 1114.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 64.2;intermediate monocyte: 50.6" "Group enriched" "Detected in many" 4 "dendritic cells: 18.7;monocytes: 64.2" "Cell line enriched" "Detected in some" 5 "U-698: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 15000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 28: Placenta - Pregnancy" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 4: Macrophages - Innate immune response" "unprognostic (2.03e-1)" "unprognostic (6.58e-3)" "prognostic unfavorable (8.42e-4)" "unprognostic (1.47e-1)" "unprognostic (2.76e-1)" "unprognostic (2.83e-1)" "unprognostic (1.39e-1)" "unprognostic (3.36e-1)" "unprognostic (3.38e-1)" "unprognostic (2.51e-1)" "unprognostic (8.11e-2)" "unprognostic (1.16e-1)" "unprognostic (3.91e-3)" "unprognostic (6.16e-3)" "unprognostic (1.14e-1)" "prognostic favorable (8.41e-4)" "unprognostic (7.98e-3)" 119.1 55.0 10.7 28.2 11.0 10.8 31.7 8.2 18.6 27.9 13.8 36.0 19.5 13.5 12.4 31.6 16.8 80.1 38.6 10.9 9.5 10.8 44.8 39.7 78.5 9.3 10.7 16.0 7.1 7.9 6.1 168.4 11.4 6.1 46.7 0.2 12.8 16.7 5.9 9.8 29.6 46.3 9.3 27.7 21.0 13.0 16.2 28.7 9.1 26.3 29.0 81.3 6.3 16.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.2 0.2 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.2 0.0 0.2 0.0 18.6 0.5 0.8 0.0 0.0 64.2 0.0 0.3 50.6 0.0 9.5 0.0 0.0 18.7 4.0 0.0 0.0 1.1 1.8 13.7 0.2 0.0 20.4 10.7 11.0 8.2 18.6 10.9 9.5 9.3 10.7 11.4 9.3 16.2 16.1 3.4 0.0 0.6 0.0 8.0 7.9 0.1 0.0 1.2 0.0 0.1 1.1 2.2 1.5 0.0 0.0 0.0 7.6 0.6 0.0 0.0 0.0 0.9 0.3 0.1 2.3 0.0 0.0 0.0 0.0 6.0 2.4 0.0 0.5 2.5 0.0 2.2 1.7 1114.8 0.0 0.0 0.0 0.0 229.3 98.8 2.5 1.5 199.4 0.0 15.9 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 2.1 0.1 0.0 0.2 0.0 0.3 0.0 2.5 1.2 0.6 0.7 1.3 5.1 16.0 1.2 0.1 0.0 0.1 INPPL1 SHIP2 ENSG00000165458 "Inositol polyphosphate phosphatase like 1" O15357 11 72223701-72239147 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell adhesion, Immunity" "Actin-binding, Hydrolase" "Cancer-related genes, Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 344.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037601 Approved Supported "Golgi apparatus,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 20: HeLa - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "Golgi apparatus" "HPA037601: AB_10672281" "unprognostic (2.68e-1)" "unprognostic (2.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.12e-1)" "unprognostic (3.68e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (7.37e-4)" "unprognostic (2.49e-2)" "unprognostic (3.54e-2)" "unprognostic (1.51e-2)" "unprognostic (1.64e-1)" "unprognostic (4.34e-2)" "unprognostic (3.66e-2)" "unprognostic (2.33e-1)" "unprognostic (2.88e-1)" "unprognostic (1.99e-3)" "unprognostic (2.07e-1)" 45.2 56.4 39.0 34.4 43.4 51.3 44.7 41.3 40.5 63.8 47.3 87.5 35.9 56.1 18.2 34.6 61.3 33.7 73.6 33.2 42.5 60.0 36.6 61.8 36.8 53.9 43.2 68.6 55.7 36.4 60.5 39.7 45.8 68.7 23.3 14.9 53.8 39.5 116.6 31.4 57.1 33.4 45.0 66.1 60.8 24.2 48.8 19.3 67.7 43.0 23.2 59.9 43.4 41.2 28.7 62.1 71.5 49.8 35.4 41.1 122.5 118.9 61.2 80.6 49.6 84.3 72.2 79.5 125.6 101.7 57.8 106.7 60.4 37.6 28.0 101.9 59.1 84.8 344.5 31.9 68.1 56.1 176.7 58.2 39.1 78.0 31.4 100.5 44.2 29.3 59.7 34.7 45.1 78.8 42.1 224.9 67.7 20.7 93.7 185.0 161.0 18.2 94.8 48.6 33.8 48.6 133.9 85.1 182.8 36.6 88.8 106.0 74.5 86.4 96.7 129.9 43.1 94.5 17.5 80.1 24.7 51.7 47.2 2.5 3.5 3.3 1.9 2.0 1.7 0.9 1.6 1.3 2.4 1.0 1.1 1.6 2.3 2.2 3.6 1.8 1.5 1.8 39.0 43.4 41.3 40.5 33.2 42.5 53.9 43.2 45.8 45.0 48.8 41.2 13.9 3.2 12.8 47.0 8.1 7.1 4.9 10.8 14.2 1.7 20.3 17.3 13.6 11.5 11.7 12.9 27.1 27.9 9.1 28.3 1.9 11.6 1.5 14.6 16.3 11.2 22.7 5.7 2.6 12.5 15.4 10.8 24.5 25.5 7.6 21.0 8.9 12.5 21.7 10.1 2.2 16.4 18.3 27.6 16.2 2.1 9.9 29.8 10.6 18.7 17.6 16.8 14.4 15.1 6.1 14.9 17.5 13.9 7.8 7.8 15.2 16.2 10.2 17.2 6.6 12.9 14.5 1.4 4.9 6.7 4.8 32.4 11.6 10.1 21.8 5.4 PHOX2A "ARIX, CFEOM2, FEOM2, PMX2A" ENSG00000165462 "Paired like homeobox 2A" O14813 11 72239077-72245664 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 19.9;brain: 18.3" "Cell type enriched" "Detected in single" 4 "Spermatogonia: 2.9" "Cancer enriched" "Detected in some" 9 "ovarian cancer: 9.3" "Region enriched" "Detected in some" 9 "pons: 18.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 226 "SH-SY5Y: 569.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA053810, HPA065621, HPA078004" Enhanced Supported Nucleoplasm No NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "HPA053810: , HPA065621: AB_2685522, HPA078004: AB_2732367" "unprognostic (5.84e-2)" "unprognostic (8.51e-2)" "unprognostic (5.07e-2)" "unprognostic (2.19e-1)" "unprognostic (2.13e-1)" "unprognostic (9.92e-4)" "unprognostic (3.03e-2)" 0.3 19.9 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.9 0.0 0.2 0.0 0.5 0.0 18.3 0.1 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.3 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 569.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.9 18.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLPB "ANKCLB, FLJ13152, HSP78, SKD3" ENSG00000162129 "Caseinolytic mitochondrial matrix peptidase chaperone subunit B" Q9H078 11 72285495-72434680 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Cataract, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "testis: 144.6" "Cell type enriched" "Detected in many" 4 "Late spermatids: 5136.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 25.5" "Group enriched" "Detected in all" 5 "dendritic cells: 25.5;granulocytes: 7.7;monocytes: 15.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039005, HPA039006, HPA064571" Enhanced NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 83: Testis - Spermatogenesis" "Cluster 39: CACO-2 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "HPA039005: AB_2676305, HPA039006: AB_10672767, HPA064571: AB_2685290" "unprognostic (9.36e-2)" "unprognostic (1.06e-2)" "unprognostic (2.51e-1)" "unprognostic (1.23e-1)" "unprognostic (2.99e-1)" "unprognostic (2.05e-2)" "unprognostic (8.22e-2)" "unprognostic (8.37e-2)" "unprognostic (2.61e-1)" "unprognostic (1.02e-1)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "prognostic favorable (8.36e-8)" "unprognostic (9.29e-2)" "unprognostic (1.25e-1)" "unprognostic (5.83e-2)" "unprognostic (3.28e-2)" 6.0 7.2 3.2 6.6 4.2 11.7 3.5 6.3 7.7 2.9 0.4 3.7 3.9 3.4 2.0 4.0 3.2 3.0 6.2 3.9 6.2 9.0 11.2 3.5 3.7 7.6 5.0 2.9 5.9 9.3 2.2 6.1 8.6 2.3 3.4 6.7 5.9 3.8 8.8 2.4 2.6 6.4 5.0 3.9 3.8 144.6 6.6 4.0 5.7 7.2 3.3 3.8 2.6 5.2 12.7 39.4 9.5 20.5 12.2 9.8 28.8 12.9 8.9 21.8 15.5 55.5 19.1 28.6 30.5 13.0 35.0 26.5 30.6 31.0 23.0 26.3 24.0 23.5 38.3 28.4 10.1 28.0 45.3 14.6 7.7 37.7 33.2 6.4 23.3 26.9 39.7 20.3 12.7 33.0 26.7 23.3 10.5 40.4 35.4 22.2 16.6 14.3 9.9 22.6 27.7 16.9 16.8 39.9 30.8 11.5 22.4 22.0 16.9 29.0 18.0 27.4 25.9 9.9 16.6 18.4 14.6 22.2 19.5 7.7 15.7 0.8 3.0 13.5 3.1 1.9 1.6 2.8 25.5 1.8 2.1 1.8 1.1 2.6 7.8 4.3 1.1 7.8 3.2 4.2 6.3 7.7 3.9 6.2 7.6 5.0 8.6 5.0 6.6 5.2 9.0 16.0 9.7 4.6 6.1 0.4 5.3 5.9 2.2 4.1 7.7 5.0 3.7 2.8 8.6 9.2 4.2 13.0 3.2 3.9 5.9 13.7 1135.5 7.2 13.4 8.0 0.0 11.4 9.8 16.3 17.1 5.5 7.1 9.7 3.8 9.2 1.4 10.7 21.6 3.3 9.8 1.8 10.2 5.9 4.2 5136.8 25.1 13.2 1.8 14.0 8.8 1.9 2.1 11.1 10.4 10.4 1.4 18.4 14.2 6.3 4.3 24.3 5.3 5.5 13.1 3.5 8.1 40.9 22.9 6.0 1.1 33.1 3.6 16.7 2.6 6.6 PDE2A ENSG00000186642 "Phosphodiesterase 2A" O00408 11 72576141-72674591 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 197.0" "Group enriched" "Detected in many" 6 "Adipocytes: 114.9;Endothelial cells: 58.5;Enteroendocrine cells: 34.4;Excitatory neurons: 70.1;Hepatic stellate cells: 118.2;Inhibitory neurons: 35.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 75.1;basal ganglia: 84.7;cerebral cortex: 102.1;hippocampal formation: 84.4;white matter: 48.3" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 2.8;T-cells: 7.3" "Cell line enriched" "Detected in some" 8 "HeLa: 513.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in all" 5 "amygdala: 83.5;basal ganglia: 146.9;cerebral cortex: 90.5;hippocampal formation: 94.0" "CAB009752, HPA031192" Enhanced Supported Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 64: Macrophages - Immune response" "Cluster 20: HeLa - Mitochondria" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "CAB009752: AB_2268159, HPA031192: AB_2673781" "unprognostic (1.92e-1)" "unprognostic (1.52e-3)" "unprognostic (4.58e-2)" "unprognostic (1.49e-1)" "unprognostic (1.26e-1)" "unprognostic (2.50e-1)" "prognostic favorable (1.76e-6)" "unprognostic (3.06e-2)" "unprognostic (1.35e-1)" "unprognostic (3.01e-3)" "unprognostic (3.13e-3)" "unprognostic (1.50e-2)" "unprognostic (1.77e-2)" "unprognostic (2.85e-3)" "unprognostic (6.31e-2)" "unprognostic (7.72e-2)" "unprognostic (7.96e-4)" 89.2 44.1 75.1 5.1 84.7 4.7 83.6 0.0 102.1 38.1 0.0 34.6 6.0 27.2 8.3 18.6 39.3 22.7 41.1 84.4 7.0 32.5 19.4 12.6 6.7 6.4 5.1 11.6 6.9 5.5 11.8 12.0 10.1 20.7 8.9 3.0 9.2 10.7 16.8 18.1 18.7 18.5 0.0 197.0 17.1 7.4 17.9 3.8 24.1 28.9 3.5 28.8 27.1 48.3 0.3 0.2 0.7 0.2 0.2 0.1 0.3 0.1 0.2 0.2 0.4 0.4 2.5 0.8 12.2 0.2 1.9 0.2 0.9 0.1 0.1 0.1 0.1 0.0 513.6 0.8 0.9 0.0 7.8 0.1 1.1 2.7 20.5 1.1 11.3 0.5 0.8 0.9 0.1 0.0 0.2 0.2 7.4 0.2 14.0 0.0 0.2 1.4 0.1 0.3 44.5 2.4 0.4 0.2 2.2 0.7 0.3 0.1 65.2 0.1 9.4 3.5 0.4 0.4 0.2 0.1 3.9 0.1 0.6 0.0 0.6 0.0 7.3 0.8 4.2 2.8 4.3 4.3 1.0 1.8 2.7 2.3 0.1 0.0 0.4 0.0 1.8 1.5 75.1 84.7 0.0 102.1 84.4 7.0 6.4 5.1 10.1 0.0 17.9 48.3 114.9 0.0 0.5 2.0 0.7 2.5 0.1 0.0 0.0 4.9 0.6 1.0 7.8 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.6 0.0 0.1 58.5 34.4 5.3 70.1 0.0 0.3 2.1 0.0 0.1 1.3 0.1 118.2 2.1 0.5 1.7 35.6 1.2 0.0 9.4 8.2 2.5 0.3 4.9 1.8 11.2 0.0 0.0 0.0 9.0 5.7 0.1 0.0 0.4 1.5 0.1 0.0 0.1 0.0 0.4 0.0 1.8 6.6 4.8 2.5 0.5 2.8 0.0 0.6 0.2 0.1 0.3 ARAP1 CENTD2 ENSG00000186635 "ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1" Q96P48 11 72685069-72793599 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020703, HPA070383" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA 36000 "Cluster 51: Monocytes - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "CAB020703: , HPA070383: AB_2686262" "unprognostic (3.60e-2)" "unprognostic (7.68e-2)" "unprognostic (6.19e-2)" "unprognostic (5.98e-2)" "unprognostic (5.76e-2)" "unprognostic (1.64e-2)" "prognostic unfavorable (6.45e-4)" "unprognostic (4.01e-2)" "unprognostic (4.07e-1)" "unprognostic (5.95e-2)" "prognostic favorable (2.04e-5)" "unprognostic (1.84e-1)" "unprognostic (1.05e-3)" "unprognostic (6.93e-2)" "unprognostic (2.57e-2)" "prognostic favorable (6.41e-4)" "unprognostic (7.56e-3)" 41.5 63.5 40.0 58.6 48.6 97.5 33.4 37.9 50.4 44.1 62.9 35.5 29.6 38.9 14.0 37.7 48.3 44.2 42.9 42.2 38.5 47.8 40.2 71.8 53.4 50.6 42.3 49.4 37.1 20.4 48.9 35.5 45.9 44.9 18.2 8.6 33.3 25.7 20.1 47.1 43.3 28.7 40.1 117.5 31.3 16.4 50.8 32.2 46.6 20.1 25.2 39.7 37.5 56.8 19.7 41.9 15.2 18.5 63.4 42.9 23.1 26.2 46.5 29.8 29.3 56.0 50.8 42.9 51.3 44.4 40.7 64.5 23.2 64.4 12.5 50.9 28.4 36.6 40.3 81.9 43.7 25.1 98.7 47.5 65.4 48.7 23.4 36.2 33.2 31.3 31.5 17.4 13.9 40.3 38.9 89.3 9.5 35.1 25.9 36.8 23.2 21.3 27.5 61.1 15.7 32.0 19.1 27.9 84.8 19.5 25.1 56.8 37.5 41.0 28.5 42.8 16.4 27.4 14.3 23.0 21.8 37.4 22.3 19.3 24.8 30.7 8.9 39.4 5.2 6.6 5.9 6.8 15.9 4.7 4.5 5.4 50.8 13.4 51.3 5.3 6.7 17.6 40.0 48.6 37.9 50.4 42.2 38.5 50.6 42.3 45.9 40.1 50.8 56.8 8.9 28.9 32.3 33.6 16.1 7.4 7.5 14.3 15.4 4.3 8.7 7.9 2.6 7.2 9.0 16.5 33.3 9.2 18.3 16.5 9.8 13.5 50.1 14.1 11.7 7.8 23.3 9.9 7.7 7.5 8.9 22.4 16.3 9.1 10.8 36.9 9.7 10.8 43.0 0.0 7.0 12.8 12.2 45.6 25.1 6.4 20.8 57.3 8.8 30.0 29.0 7.4 21.6 17.6 31.5 12.1 10.9 15.1 12.3 4.8 20.9 5.3 20.2 2.8 0.0 8.6 8.8 0.4 2.8 10.8 5.4 4.9 12.4 10.5 15.1 7.4 STARD10 "CGI-52, NY-CO-28, PCTP2, SDCCAG28" ENSG00000214530 "StAR related lipid transfer domain containing 10" Q9Y365 11 72754729-72794047 "Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 709.7" "Cell type enhanced" "Detected in all" "Early spermatids: 520.2;Hepatocytes: 660.0;Intestinal goblet cells: 717.9;Late spermatids: 2055.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 21.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 617.7;OE19: 1316.9;SK-BR-3: 427.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026661 Uncertain Supported Cytosol NA NA 13000 "Cluster 52: Eosinophils - Transcription" "Cluster 85: Liver - Metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "HPA026661: AB_1857538" "prognostic favorable (6.92e-4)" "unprognostic (2.07e-1)" "unprognostic (8.03e-2)" "unprognostic (1.74e-3)" "unprognostic (3.71e-2)" "unprognostic (1.37e-2)" "unprognostic (2.50e-2)" "unprognostic (2.16e-1)" "unprognostic (4.16e-1)" "unprognostic (4.69e-2)" "unprognostic (5.81e-2)" "unprognostic (1.67e-1)" "unprognostic (4.24e-3)" "unprognostic (8.42e-2)" "unprognostic (2.29e-1)" "unprognostic (2.12e-2)" "unprognostic (1.04e-1)" 11.8 178.2 35.1 17.7 37.6 10.3 62.1 39.2 41.8 71.9 40.9 180.6 48.5 27.3 102.9 52.0 26.4 59.5 72.5 33.9 34.1 50.1 709.7 37.7 14.5 38.0 33.0 31.0 212.6 73.2 36.2 40.2 38.2 86.2 188.1 18.7 94.5 30.9 66.7 62.6 66.0 26.7 29.9 20.2 266.9 184.3 34.4 15.6 47.9 157.9 21.8 24.5 41.1 35.7 51.2 15.3 7.7 28.7 9.8 9.6 98.3 5.6 26.2 17.3 17.3 209.8 36.7 4.4 16.7 19.2 42.3 31.8 23.4 46.8 20.2 28.3 9.0 5.9 11.1 217.6 35.2 1.6 10.0 6.6 127.0 19.1 26.7 47.2 17.8 10.0 12.1 21.5 3.9 617.7 4.8 11.1 3.4 1316.9 20.1 4.5 13.3 3.4 23.5 61.4 13.0 10.1 8.6 427.4 73.3 32.8 235.5 6.3 13.6 17.0 11.4 6.0 10.1 22.2 19.8 7.5 4.3 5.6 6.5 12.9 2.6 16.0 1.6 1.1 1.2 4.2 1.5 1.7 1.2 2.4 1.6 1.6 21.7 7.5 0.6 2.6 2.1 1.1 35.1 37.6 39.2 41.8 33.9 34.1 38.0 33.0 38.2 29.9 34.4 35.7 10.6 35.3 74.1 8.1 18.1 31.5 76.3 41.0 25.0 10.5 163.3 125.3 45.3 270.2 76.4 55.2 22.9 212.8 17.1 362.8 123.3 70.7 520.2 26.5 6.8 18.5 302.2 22.9 11.6 94.3 93.1 21.1 372.1 25.3 25.4 10.1 30.0 660.0 26.4 33.7 13.9 717.9 85.5 26.0 34.4 2055.8 26.1 12.3 16.0 5.6 7.7 64.4 7.2 8.0 11.8 93.9 398.9 25.2 13.3 150.9 73.5 58.0 34.5 16.6 6.6 11.3 19.6 101.2 22.7 30.2 55.0 352.2 15.6 7.7 440.7 132.7 ATG16L2 "ATG16B, FLJ00012, WDR80" ENSG00000168010 "Autophagy related 16 like 2" Q8NAA4 11 72814406-72843674 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 136.8;lymphoid tissue: 129.0" "Cell type enhanced" "Detected in many" "Paneth cells: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 45.4;neutrophil: 59.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 58.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045444, HPA050312" Approved Enhanced Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 57: B-cells - Immune response" Nucleoplasm "HPA045444: AB_2679324, HPA050312: AB_2681082" "unprognostic (7.20e-3)" "unprognostic (1.16e-1)" "unprognostic (1.54e-1)" "unprognostic (4.26e-2)" "unprognostic (2.12e-1)" "unprognostic (1.31e-3)" "unprognostic (1.61e-2)" "unprognostic (4.74e-3)" "unprognostic (1.89e-1)" "unprognostic (1.90e-1)" "prognostic favorable (7.06e-4)" "unprognostic (2.49e-2)" "prognostic unfavorable (3.39e-4)" "unprognostic (1.74e-1)" "unprognostic (4.38e-2)" "unprognostic (1.08e-1)" "unprognostic (4.83e-2)" 20.2 18.1 18.1 33.0 19.2 136.8 14.9 20.2 24.1 21.6 16.2 20.4 10.8 14.6 7.5 26.1 22.1 18.9 20.8 18.0 16.0 20.1 18.5 41.2 34.3 18.9 17.7 23.4 15.1 6.3 13.7 10.2 18.0 14.4 17.0 2.9 13.6 8.2 7.7 72.9 34.0 15.0 15.3 129.0 17.7 6.5 21.1 9.7 15.9 7.4 25.2 18.9 22.2 20.9 2.7 2.5 7.5 5.9 8.7 7.2 4.6 6.1 5.9 2.9 4.4 3.1 6.4 18.3 4.0 7.7 5.3 5.2 0.9 20.1 5.0 14.2 3.0 14.5 14.4 5.1 6.4 18.8 58.2 6.9 2.7 6.6 8.0 32.2 9.0 32.7 1.9 24.1 3.4 9.1 22.5 32.0 1.1 12.0 2.9 10.6 5.5 8.6 9.7 9.2 5.5 4.4 2.6 13.2 5.8 5.9 6.6 25.5 12.6 7.9 2.9 14.4 5.0 11.0 2.9 8.1 3.5 16.4 4.5 5.9 16.3 45.4 2.7 9.3 2.7 2.6 3.9 5.4 10.9 4.6 2.2 2.6 59.6 5.2 11.8 1.7 4.0 4.0 18.1 19.2 20.2 24.1 18.0 16.0 18.9 17.7 18.0 15.3 21.1 20.9 19.5 6.4 14.4 11.4 37.6 16.7 5.1 6.1 10.2 3.6 8.7 9.0 5.0 4.3 6.2 5.5 2.1 9.6 29.0 13.0 0.0 5.0 0.8 8.9 12.0 12.7 13.1 9.9 14.0 1.0 3.7 7.1 17.9 7.9 22.9 10.6 18.9 3.8 16.2 5.0 11.1 9.1 8.2 48.5 18.1 2.1 10.2 45.7 3.6 23.4 39.2 4.4 30.9 18.1 9.7 2.7 59.1 7.9 17.3 2.5 8.3 2.5 8.1 3.5 0.0 8.8 11.4 4.9 13.4 15.7 17.3 12.3 21.3 7.2 14.0 6.0 FCHSD2 "KIAA0769, SH3MD3" ENSG00000137478 "FCH and double SH3 domains 2" O94868 11 72836745-73142318 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 219.6;Microglial cells: 387.8;Oligodendrocyte precursor cells: 471.0;Oligodendrocytes: 198.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 164.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038545, HPA038546" Uncertain Approved "Nuclear speckles,Plasma membrane,Actin filaments,Focal adhesion sites" Yes No "Cluster 10: Basophils - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Plasma membrane, Actin filaments" "Nuclear speckles, Focal adhesion sites" "HPA038545: AB_2676074, HPA038546: AB_10673013" "unprognostic (1.80e-2)" "unprognostic (1.50e-2)" "prognostic favorable (1.71e-4)" "unprognostic (1.63e-1)" "unprognostic (3.14e-2)" "unprognostic (2.62e-3)" "unprognostic (1.41e-2)" "unprognostic (2.62e-1)" "unprognostic (1.27e-2)" "unprognostic (2.56e-1)" "unprognostic (3.69e-2)" "unprognostic (6.16e-2)" "unprognostic (2.89e-3)" "unprognostic (2.02e-1)" "unprognostic (4.70e-1)" "unprognostic (2.92e-1)" "unprognostic (1.23e-1)" 22.2 19.2 43.3 33.4 47.9 28.6 16.8 31.5 38.7 14.9 34.6 14.5 8.9 16.0 6.9 11.7 13.8 22.6 25.5 37.0 44.5 13.0 17.6 23.9 45.2 36.6 36.4 32.3 10.4 9.9 8.1 31.2 35.4 11.6 14.4 19.6 9.3 13.8 8.8 9.0 17.7 17.2 32.5 42.3 13.1 22.6 41.3 28.5 14.9 14.7 46.1 21.6 11.7 45.0 14.2 12.3 26.0 31.3 9.8 23.9 21.8 26.7 50.6 14.8 12.0 9.6 21.0 76.3 31.3 31.0 15.6 20.0 15.3 14.1 21.0 27.2 7.0 64.2 14.3 33.4 25.7 30.6 7.6 14.6 15.6 15.1 17.7 33.4 35.7 26.7 13.7 49.6 19.5 16.1 36.4 54.7 5.5 15.6 13.8 56.4 39.8 164.1 24.8 21.4 13.1 16.9 9.6 16.2 31.9 12.2 12.4 23.7 47.9 45.9 18.5 32.9 7.5 46.8 29.4 71.2 8.4 51.4 13.8 18.3 8.4 18.7 2.8 5.1 1.9 22.2 2.8 3.2 8.1 26.9 3.2 4.1 19.9 2.0 3.0 32.3 3.2 3.6 43.3 47.9 31.5 38.7 37.0 44.5 36.6 36.4 35.4 32.5 41.3 45.0 47.3 9.6 14.0 114.9 76.7 8.5 5.2 3.6 9.1 13.5 5.9 4.7 16.0 8.6 6.1 3.7 25.0 12.4 39.4 1.9 1.9 4.1 6.2 6.6 8.3 30.2 4.8 19.4 79.4 6.2 9.2 9.4 7.7 5.4 2.5 33.6 46.1 11.3 19.9 10.1 219.6 7.7 4.1 30.8 29.9 10.0 10.8 32.8 5.4 387.8 20.6 10.6 5.2 471.0 198.1 5.3 5.7 16.6 70.1 3.8 1.8 3.5 3.9 17.0 6.6 13.0 26.1 9.6 13.0 7.1 5.8 12.0 14.9 6.0 3.7 4.8 P2RY2 P2U ENSG00000175591 "Purinergic receptor P2Y2" P41231 11 73218281-73242427 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 29.7;skeletal muscle: 50.2;tongue: 31.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 16.5;Distal enterocytes: 18.0;Pancreatic endocrine cells: 18.9;Proximal enterocytes: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 57.6" "Group enriched" "Detected in many" 12 "granulocytes: 57.6;monocytes: 20.2" "Cell line enhanced" "Detected in many" "HaCaT: 32.8;HL-60: 30.8;MCF7: 25.1;NB-4: 26.1;PC-3: 24.5;SK-BR-3: 29.6;THP-1: 76.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB022642 Uncertain Uncertain Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 59: Non-specific - Translation" "Cluster 43: THP-1 - Innate immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "CAB022642: " "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" "unprognostic (6.36e-2)" "unprognostic (7.97e-3)" "unprognostic (6.50e-4)" "unprognostic (2.04e-2)" "unprognostic (4.66e-3)" "unprognostic (8.93e-2)" "unprognostic (2.87e-1)" "unprognostic (4.17e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (9.69e-2)" "unprognostic (4.92e-4)" "unprognostic (1.34e-1)" "unprognostic (2.82e-1)" "unprognostic (1.05e-1)" "unprognostic (8.57e-3)" 0.8 3.8 1.4 1.8 1.6 15.8 1.7 1.3 1.0 6.9 1.1 3.3 2.7 0.5 0.3 29.7 1.4 0.7 10.0 1.3 1.8 2.7 3.9 3.5 0.1 2.1 1.9 0.4 0.7 4.8 1.6 2.0 1.6 2.1 2.8 1.2 6.2 1.2 50.2 6.0 5.9 0.5 1.3 3.9 1.1 1.2 2.6 0.2 8.8 31.3 2.8 2.2 19.0 1.4 7.2 6.7 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 17.2 5.4 0.0 10.4 0.4 0.0 32.8 0.9 15.2 0.0 0.0 0.6 2.3 0.6 3.2 0.1 30.8 0.0 0.0 6.8 2.3 0.5 0.0 1.4 0.0 1.4 0.0 0.0 25.1 0.1 26.1 0.4 6.8 24.5 0.0 0.0 1.1 2.4 17.9 0.0 0.0 0.5 29.6 0.0 0.2 12.9 76.5 10.2 0.0 0.3 0.0 0.0 1.0 0.4 0.0 0.0 5.6 0.0 0.5 6.6 57.6 0.0 20.2 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.3 0.0 13.5 0.0 0.0 2.5 1.4 1.6 1.3 1.0 1.3 1.8 2.1 1.9 1.6 1.3 2.6 1.4 0.7 3.2 0.5 0.0 0.2 3.7 8.6 13.2 1.2 0.7 2.8 0.5 6.1 5.7 10.3 0.0 0.0 16.5 0.0 18.0 1.9 5.8 6.0 1.4 0.1 1.5 0.0 0.8 0.0 6.3 1.3 0.7 0.5 0.8 0.0 1.2 0.0 5.2 2.6 0.0 0.0 5.1 0.0 3.7 0.7 8.8 0.0 4.5 0.0 0.0 2.8 6.0 0.0 0.0 0.1 18.9 10.9 0.0 0.2 5.3 14.2 0.3 2.8 0.4 0.0 0.8 1.4 0.1 0.1 12.6 7.2 10.9 0.1 0.1 3.0 11.7 P2RY6 P2Y6 ENSG00000171631 "Pyrimidinergic receptor P2Y6" Q15077 11 73264498-73305103 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 32.5" "Group enriched" "Detected in many" 10 "Cytotrophoblasts: 124.3;Syncytiotrophoblasts: 272.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 12 "myeloid DC: 27.2;plasmacytoid DC: 87.5" "Lineage enriched" "Detected in many" 19 "dendritic cells: 87.5" "Cell line enhanced" "Detected in many" "AN3-CA: 59.2;EFO-21: 18.1;MCF7: 30.4;SK-BR-3: 53.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074751 Enhanced NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 64: Macrophages - Immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "HPA074751: " "unprognostic (2.55e-2)" "unprognostic (1.12e-1)" "unprognostic (2.04e-2)" "unprognostic (5.54e-3)" "unprognostic (4.18e-3)" "unprognostic (1.94e-2)" "unprognostic (3.93e-3)" "unprognostic (4.00e-3)" "unprognostic (1.86e-4)" "unprognostic (3.08e-1)" "unprognostic (1.25e-2)" "unprognostic (2.18e-1)" "prognostic unfavorable (2.50e-7)" "unprognostic (1.48e-2)" "unprognostic (1.38e-3)" "unprognostic (7.67e-2)" "unprognostic (1.05e-1)" 2.9 1.5 0.9 7.0 1.1 0.8 1.2 0.6 1.8 1.7 0.8 2.2 2.4 0.8 0.5 2.5 1.1 1.5 2.8 1.4 0.7 7.5 0.9 2.9 3.1 1.2 0.8 0.3 1.4 0.2 2.3 10.7 1.0 2.0 1.7 0.8 1.4 0.6 2.7 0.7 4.0 2.7 0.5 32.5 1.8 0.5 1.3 1.4 4.9 0.3 1.3 3.1 1.4 1.4 1.3 12.9 0.1 59.2 0.0 0.1 13.7 0.2 0.0 0.2 0.1 11.6 0.2 0.1 18.1 0.4 0.1 3.0 0.1 0.1 0.1 0.3 0.1 0.1 1.2 8.1 0.0 0.2 0.3 0.2 0.0 0.7 0.0 1.0 0.1 0.1 0.1 0.4 0.2 30.4 0.1 2.8 0.2 0.4 0.2 0.1 0.1 1.4 11.0 0.2 0.2 0.7 1.7 53.4 0.1 1.2 13.4 2.7 0.3 2.0 0.1 1.8 0.1 0.5 0.2 0.1 2.7 4.0 0.1 2.3 2.7 0.2 0.1 4.6 0.3 0.1 0.1 0.1 27.2 0.2 0.1 0.1 0.6 3.4 1.5 87.5 0.1 2.2 0.9 1.1 0.6 1.8 1.4 0.7 1.2 0.8 1.0 0.5 1.3 1.4 0.3 0.0 0.6 0.3 1.5 0.1 0.4 0.4 0.6 0.0 0.6 1.0 0.8 0.0 0.7 9.2 0.0 124.3 16.9 0.1 3.9 2.7 0.4 0.3 0.1 8.9 0.0 2.7 0.7 14.4 11.6 1.8 0.0 0.4 0.0 0.2 1.1 0.1 19.8 0.0 0.1 0.3 0.0 9.2 9.8 2.3 0.0 12.9 0.0 13.1 13.4 1.1 0.0 0.5 0.0 14.9 0.0 0.0 12.6 0.3 2.9 12.0 0.9 0.1 0.0 2.4 0.8 0.0 0.1 0.2 0.4 272.5 0.6 0.5 0.2 0.5 ARHGEF17 "KIAA0337, p164-RhoGEF, TEM4" ENSG00000110237 "Rho guanine nucleotide exchange factor 17" Q96PE2 11 73308276-73369388 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 38.5;Endometrial stromal cells: 40.5;Sertoli cells: 85.5;Smooth muscle cells: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007991 Uncertain Approved Cytosol NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" Cytosol "HPA007991: AB_1845005" "unprognostic (2.36e-1)" "unprognostic (4.33e-2)" "prognostic unfavorable (8.27e-5)" "unprognostic (6.96e-2)" "unprognostic (1.57e-1)" "unprognostic (1.39e-1)" "unprognostic (1.17e-1)" "unprognostic (1.91e-1)" "unprognostic (1.69e-1)" "unprognostic (1.46e-3)" "unprognostic (1.15e-2)" "unprognostic (2.39e-1)" "unprognostic (1.47e-1)" "unprognostic (7.54e-3)" "unprognostic (7.12e-3)" "unprognostic (6.85e-3)" "unprognostic (3.42e-3)" 32.8 12.2 32.7 9.1 39.5 3.3 24.1 24.1 45.7 37.0 15.3 38.2 5.5 39.9 15.2 10.0 30.5 17.6 34.5 29.6 33.7 24.9 5.4 31.2 5.9 38.2 31.6 24.2 8.2 19.1 15.3 23.6 37.6 25.4 5.3 7.2 11.7 27.3 11.5 10.7 16.4 22.6 21.3 12.8 19.8 7.1 36.9 3.1 36.0 12.2 2.7 26.9 20.2 28.8 9.6 11.4 24.1 28.4 18.7 15.7 14.8 26.6 38.2 25.9 16.5 30.2 8.2 0.0 18.2 50.7 11.8 14.5 8.1 10.8 10.8 16.9 2.4 0.0 21.0 11.9 21.6 0.8 0.5 27.1 12.2 15.6 9.3 16.9 19.4 1.2 0.9 0.2 14.6 13.7 0.3 17.4 3.2 6.4 2.4 4.0 27.3 0.6 16.5 6.7 15.8 12.1 22.6 26.4 31.3 22.0 43.8 8.2 12.9 12.5 25.5 5.3 8.6 1.6 0.3 0.1 4.4 1.9 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 32.7 39.5 24.1 45.7 29.6 33.7 38.2 31.6 37.6 21.3 36.9 28.8 13.9 16.0 16.3 38.5 0.2 3.4 2.4 6.0 5.7 12.6 11.1 12.3 25.5 8.6 7.4 7.3 0.0 7.2 0.1 1.5 0.0 6.4 1.1 10.5 40.5 10.9 1.2 1.3 29.5 0.7 5.3 10.7 2.6 8.9 0.0 13.7 10.8 0.6 2.0 23.5 24.8 0.7 0.0 0.3 4.2 2.0 10.8 1.4 1.8 8.4 1.1 11.1 0.0 10.6 2.0 2.4 0.4 20.3 1.6 4.1 0.0 4.3 5.4 2.3 85.5 5.2 67.5 1.6 8.3 1.1 2.7 6.2 0.6 2.0 1.0 1.5 RELT "FLJ14993, TNFRSF19L" ENSG00000054967 "RELT TNF receptor" Q969Z4 11 73376399-73397474 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Receptor "Amelogenesis imperfecta, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "bone marrow: 154.7" "Cell type enhanced" "Detected in many" "Langerhans cells: 43.9;Macrophages: 43.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062824, HPA071518" Supported Nucleoplasm NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 41: Macrophages - Immune response" Nucleoplasm "HPA062824: AB_2684875, HPA071518: AB_2686408" "unprognostic (3.49e-1)" "unprognostic (2.43e-1)" "unprognostic (2.25e-1)" "unprognostic (1.67e-2)" "unprognostic (1.80e-3)" "unprognostic (9.92e-3)" "unprognostic (1.67e-3)" "unprognostic (1.17e-1)" "unprognostic (1.21e-1)" "unprognostic (2.87e-1)" "unprognostic (8.42e-2)" "unprognostic (4.13e-2)" "prognostic unfavorable (4.07e-11)" "unprognostic (1.64e-1)" "unprognostic (3.07e-3)" "unprognostic (2.01e-2)" "unprognostic (1.69e-1)" 4.9 2.2 3.4 12.9 6.5 154.7 2.5 6.7 7.7 1.4 0.4 2.3 2.3 1.4 0.5 3.9 1.9 4.5 6.2 3.6 7.0 3.7 2.1 10.9 11.9 8.9 6.8 1.8 0.8 1.1 3.5 4.6 8.1 2.1 1.4 2.2 1.9 0.4 24.3 3.2 7.1 2.6 7.0 20.8 2.2 3.2 6.9 4.6 2.2 6.4 6.9 4.8 2.3 12.6 9.1 8.9 7.0 6.8 0.8 1.0 7.5 9.6 6.2 11.1 6.7 8.5 3.9 16.4 30.9 6.4 8.8 13.1 4.4 4.7 4.3 9.9 8.3 15.4 12.4 3.1 1.8 15.6 26.3 1.1 2.0 11.9 3.5 2.6 4.1 8.4 11.8 21.0 3.1 8.5 11.5 16.5 6.1 6.9 11.0 21.9 11.7 14.2 2.3 3.9 8.9 8.5 8.3 7.5 10.0 1.7 4.1 13.9 5.4 13.8 9.7 23.1 17.6 7.5 6.1 18.2 8.5 15.5 14.8 0.7 12.5 22.2 0.9 25.4 2.0 7.6 1.0 1.7 11.8 5.8 1.3 0.6 19.9 0.4 35.3 11.7 0.5 6.3 3.4 6.5 6.7 7.7 3.6 7.0 8.9 6.8 8.1 7.0 6.9 12.6 5.7 6.4 2.2 3.6 24.2 26.5 15.4 2.8 2.8 3.5 6.1 5.5 2.7 1.5 3.4 0.0 12.5 1.6 33.0 4.7 0.0 3.6 0.9 5.4 5.2 7.2 3.5 5.7 3.1 0.9 10.7 10.1 11.2 10.8 24.8 6.8 1.8 0.2 23.0 30.3 4.5 2.8 6.1 24.2 43.9 1.2 0.0 43.9 5.4 2.8 32.8 8.9 3.1 1.5 4.8 6.7 2.4 0.0 19.2 9.9 1.0 0.5 1.4 2.8 6.6 7.2 14.5 11.7 10.5 4.6 18.3 21.1 16.1 0.6 3.1 17.8 FAM168A "KIAA0280, TCRP1" ENSG00000054965 "Family with sequence similarity 168 member A" Q92567 11 73400487-73598189 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 125.0;Excitatory neurons: 171.0;Inhibitory neurons: 161.2;Oligodendrocyte precursor cells: 166.9;Oligodendrocytes: 149.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 6.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037580 Enhanced Approved Nucleoplasm NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA037580: AB_10672906" "unprognostic (2.65e-1)" "unprognostic (2.10e-1)" "unprognostic (1.15e-2)" "prognostic unfavorable (5.51e-4)" "unprognostic (4.60e-2)" "unprognostic (3.24e-2)" "unprognostic (3.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.64e-1)" "unprognostic (2.18e-2)" "unprognostic (3.07e-1)" "unprognostic (1.58e-1)" "prognostic favorable (6.41e-5)" "unprognostic (2.10e-1)" "unprognostic (1.04e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (9.70e-4)" 13.5 10.9 43.7 10.8 44.9 11.0 13.3 48.8 48.8 14.6 2.3 16.0 8.1 15.3 18.0 8.9 14.1 13.9 13.6 42.6 50.0 12.1 11.3 10.4 9.0 59.1 48.3 16.7 9.7 21.9 12.4 9.8 54.0 12.9 9.6 49.7 12.7 15.7 19.9 8.7 12.0 18.1 49.7 9.4 10.7 8.5 56.0 13.2 14.8 15.3 8.3 12.8 8.8 46.8 13.4 15.6 33.6 19.0 24.2 27.0 5.1 19.6 22.5 21.5 20.5 17.6 17.4 14.9 16.9 34.9 20.1 12.3 19.4 19.3 26.3 10.3 14.3 17.1 17.3 9.6 9.4 9.2 30.8 25.3 13.5 21.3 11.2 29.2 13.8 23.9 4.3 10.9 22.3 20.2 21.4 9.4 11.5 27.4 19.7 30.3 56.7 8.1 12.8 12.0 22.3 34.6 23.1 17.5 37.8 12.3 28.4 10.7 17.8 24.5 20.6 31.9 16.2 24.9 18.7 25.7 13.0 11.3 22.9 6.0 1.3 0.9 0.8 2.3 0.4 0.4 0.3 0.6 1.1 0.5 0.6 0.6 2.9 0.5 1.5 1.4 0.6 0.3 43.7 44.9 48.8 48.8 42.6 50.0 59.1 48.3 54.0 49.7 56.0 46.8 18.3 3.2 8.2 125.0 4.0 3.8 2.3 7.1 3.4 21.8 11.0 9.7 20.3 15.7 9.9 7.3 45.9 2.3 5.7 5.2 0.0 3.3 22.4 13.1 12.5 9.7 12.7 2.1 171.0 2.7 3.6 9.4 5.6 19.2 22.9 31.9 11.0 16.6 9.8 3.3 161.2 8.6 2.0 14.8 6.8 25.4 7.5 10.0 5.4 59.0 7.3 26.7 5.2 166.9 149.1 3.4 2.8 12.8 2.9 1.8 8.4 4.2 7.2 24.4 6.6 12.3 19.1 7.0 6.1 5.3 3.8 2.7 4.9 6.9 6.7 1.7 PLEKHB1 "KPL1, PHR1, PHRET1" ENSG00000021300 "Pleckstrin homology domain containing B1" Q9UF11 11 73646178-73662819 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 1531.3;choroid plexus: 728.4;retina: 758.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 344.0;Early spermatids: 145.6;Late spermatids: 184.4;Muller glia cells: 496.6;Rod photoreceptor cells: 460.4" "Cancer enhanced" "Detected in all" "glioma: 59.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 83.7" "Lineage enriched" "Detected in many" 5 "T-cells: 83.7" "Cell line enhanced" "Detected in many" "Hep G2: 77.2;OE19: 53.3;U-266/84: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 46: Photoreceptor cells - Phototransduction" "unprognostic (1.20e-1)" "unprognostic (5.07e-1)" "unprognostic (2.91e-1)" "unprognostic (9.72e-2)" "unprognostic (2.16e-1)" "unprognostic (1.48e-1)" "unprognostic (2.46e-2)" "unprognostic (1.41e-3)" "unprognostic (3.01e-1)" "unprognostic (3.94e-2)" "prognostic favorable (6.02e-4)" "unprognostic (3.59e-1)" "prognostic favorable (1.99e-6)" "unprognostic (2.64e-1)" "unprognostic (7.23e-2)" "unprognostic (4.47e-1)" "unprognostic (7.44e-2)" 2.7 6.7 1011.3 7.7 1362.5 1.3 10.4 1275.8 1156.9 6.9 728.4 52.9 11.6 3.0 15.0 4.7 24.3 10.3 14.7 914.2 1059.3 12.3 2.1 15.2 8.9 1472.5 1259.8 3.0 22.9 88.1 135.2 0.9 1433.2 13.2 9.0 758.1 59.0 8.6 9.4 5.2 19.8 3.0 1263.6 4.2 20.5 20.2 1172.4 5.6 28.8 11.9 7.6 8.2 5.5 1531.3 0.7 2.0 4.8 3.8 2.0 0.6 0.2 0.2 0.1 0.3 0.3 8.5 16.2 0.1 20.0 0.5 0.6 0.4 2.6 0.4 0.4 11.0 12.5 0.0 1.0 77.2 1.2 0.0 0.2 0.7 0.0 0.3 0.0 4.1 0.1 19.4 0.3 10.5 0.3 6.3 5.3 0.3 3.1 53.3 1.0 3.8 0.1 2.6 0.7 1.4 11.8 2.8 0.0 0.3 1.7 3.5 5.6 1.0 0.0 0.0 2.2 0.1 1.6 17.5 30.4 11.3 2.8 0.0 0.8 0.2 0.5 1.1 17.1 0.0 41.5 18.3 41.4 30.6 0.5 7.9 83.7 47.3 0.9 4.3 0.1 0.9 26.9 27.4 1011.3 1362.5 1275.8 1156.9 914.2 1059.3 1472.5 1259.8 1433.2 1263.6 1172.4 1531.3 0.7 6.4 13.5 25.5 5.3 0.4 1.1 1.7 0.6 53.6 19.1 11.8 8.1 25.8 4.5 7.3 344.0 0.5 1.9 0.8 11.7 30.6 145.6 27.4 0.5 3.9 62.8 0.0 1.1 0.8 0.1 2.0 13.7 3.7 11.4 10.4 1.8 0.2 2.7 20.2 0.6 11.2 22.4 0.3 0.3 184.4 2.5 0.9 10.6 7.5 1.6 496.6 6.2 15.6 96.4 2.9 3.9 0.7 1.0 4.0 0.9 13.9 42.8 460.4 0.0 2.5 1.8 2.6 1.7 0.3 0.1 0.1 9.7 0.1 6.5 1.6 RAB6A RAB6 ENSG00000175582 "RAB6A, member RAS oncogene family" P20340 11 73675638-73761137 "Predicted intracellular proteins" "ER-Golgi transport, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009936, HPA059131" Approved Approved "Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 39: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "CAB009936: AB_2175466, HPA059131: AB_2683916" "unprognostic (2.84e-1)" "unprognostic (7.18e-2)" "unprognostic (1.10e-2)" "prognostic unfavorable (8.18e-5)" "unprognostic (1.79e-1)" "unprognostic (9.44e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (8.67e-3)" "unprognostic (1.16e-2)" "unprognostic (4.61e-2)" "prognostic unfavorable (2.24e-4)" "unprognostic (9.96e-2)" "unprognostic (1.11e-1)" "unprognostic (1.57e-1)" "unprognostic (2.77e-1)" "unprognostic (4.93e-2)" "unprognostic (2.36e-1)" 71.2 69.8 87.7 53.0 96.5 38.4 50.6 85.4 112.8 64.4 79.3 66.2 71.6 66.9 53.0 100.2 54.0 55.6 99.5 101.8 100.9 75.1 85.3 68.5 45.7 106.0 90.1 64.5 49.0 67.5 36.4 91.4 112.9 64.0 70.6 56.1 47.8 64.9 107.5 55.0 83.4 79.8 80.0 56.9 54.9 36.1 97.4 54.2 98.7 101.7 60.8 78.9 62.4 93.4 86.2 66.3 105.8 68.5 135.9 154.3 141.7 130.4 124.6 111.1 100.8 131.5 146.4 73.2 136.6 174.0 94.9 94.6 68.4 135.3 142.5 84.6 25.6 118.2 68.6 110.9 114.2 78.1 113.1 114.7 246.8 113.5 165.0 124.4 135.9 75.7 71.3 111.5 133.3 99.6 85.7 54.7 42.2 192.0 62.3 64.8 193.9 132.5 135.2 146.6 83.0 70.5 136.1 136.7 290.9 104.7 107.2 71.0 165.0 113.3 56.9 193.5 56.6 71.9 89.5 149.5 46.3 63.2 104.6 227.9 81.8 133.2 84.2 87.6 76.2 56.1 70.3 75.5 62.9 50.7 52.0 61.8 61.9 78.6 88.6 33.7 86.3 111.1 87.7 96.5 85.4 112.8 101.8 100.9 106.0 90.1 112.9 80.0 97.4 93.4 66.3 32.1 51.0 79.7 59.2 83.5 49.4 57.2 88.2 53.9 45.8 30.4 64.2 35.8 42.7 68.0 87.6 109.9 55.3 85.2 43.0 66.0 8.8 51.5 41.3 78.7 52.0 47.5 133.6 49.5 162.3 60.5 52.5 51.2 48.8 83.7 72.5 63.7 65.7 40.4 119.0 61.8 75.3 58.4 85.7 9.5 52.8 58.3 72.9 49.6 74.2 47.7 52.5 130.7 109.4 79.0 61.7 61.7 86.3 57.8 102.7 54.1 47.2 54.2 26.3 47.4 65.5 74.2 53.4 106.5 112.7 173.6 63.8 45.0 50.8 69.8 MRPL48 CGI-118 ENSG00000175581 "Mitochondrial ribosomal protein L48" Q96GC5 11 73787872-73865133 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 156.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040241, HPA040864" Approved Supported Mitochondria NA NA "Cluster 44: Non-specific - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA040241: AB_2676899, HPA040864: AB_2677175" "unprognostic (2.41e-1)" "unprognostic (1.80e-2)" "unprognostic (1.56e-2)" "unprognostic (1.18e-3)" "unprognostic (1.99e-1)" "unprognostic (2.90e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (8.89e-2)" "unprognostic (4.41e-2)" "unprognostic (3.97e-2)" "unprognostic (1.14e-1)" "unprognostic (5.85e-2)" "unprognostic (4.61e-3)" "unprognostic (1.25e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-2)" "unprognostic (3.30e-1)" 10.8 17.4 30.3 10.2 33.8 12.1 13.3 33.6 50.0 16.8 31.1 17.5 14.1 12.3 14.8 16.6 13.6 5.6 22.5 30.0 31.9 24.2 21.2 10.2 12.8 35.5 32.3 14.2 19.3 21.2 10.9 10.6 36.5 14.6 15.8 11.5 13.9 10.0 28.6 12.5 14.8 8.1 31.6 14.5 15.1 5.8 31.9 23.2 14.1 26.9 14.4 12.3 14.6 41.5 29.6 33.2 36.7 20.8 20.9 16.8 16.2 18.0 20.3 27.9 23.0 63.9 26.6 71.0 35.7 25.6 18.7 35.6 37.3 37.7 24.6 28.3 40.9 36.3 33.3 45.4 24.5 61.5 24.9 14.1 41.0 23.8 33.0 24.5 39.1 40.5 46.9 37.7 28.1 47.1 72.9 58.9 27.5 95.5 35.0 32.1 43.8 81.3 31.0 35.3 28.9 28.0 14.2 48.8 156.9 17.0 31.4 38.5 13.6 21.6 27.9 15.3 24.2 18.1 39.3 103.1 9.5 39.8 18.0 40.7 23.6 12.5 25.8 30.4 27.3 27.5 30.1 31.6 33.6 29.8 32.3 31.3 4.1 28.1 28.1 37.6 35.3 29.5 30.3 33.8 33.6 50.0 30.0 31.9 35.5 32.3 36.5 31.6 31.9 41.5 17.3 9.6 20.5 11.1 29.4 19.2 35.3 66.7 25.6 10.2 28.5 35.1 33.0 21.5 33.9 25.8 4.2 92.0 27.6 28.3 88.0 37.1 6.3 31.0 21.0 18.9 24.1 36.6 16.1 39.7 73.5 22.5 19.9 22.9 21.0 32.5 16.4 28.0 42.9 15.2 22.6 38.0 42.7 25.4 19.4 16.5 18.3 20.5 44.4 3.7 29.4 16.6 22.6 24.6 45.2 30.9 36.1 18.0 30.0 22.0 63.4 76.5 39.1 8.5 0.0 22.5 29.7 18.6 26.3 38.2 19.7 59.8 26.8 26.6 49.1 37.1 COA4 "CHCHD8, CMC3, E2IG2" ENSG00000181924 "Cytochrome c oxidase assembly factor 4 homolog" Q9NYJ1 11 73872667-73876901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040126 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli fibrillar center" Mitochondria "HPA040126: AB_10795415" "unprognostic (7.30e-2)" "unprognostic (8.69e-2)" "unprognostic (2.09e-1)" "unprognostic (2.60e-2)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (3.64e-3)" "unprognostic (1.49e-1)" "unprognostic (2.22e-2)" "prognostic favorable (3.87e-4)" "unprognostic (1.31e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (2.14e-4)" "unprognostic (2.51e-1)" "unprognostic (1.89e-1)" "unprognostic (1.25e-1)" "unprognostic (8.17e-2)" 45.1 96.2 46.9 36.8 52.5 25.4 39.0 51.6 52.0 37.1 46.2 44.5 49.0 35.8 32.5 48.0 40.2 40.3 63.1 46.0 49.4 70.4 99.7 31.3 47.3 51.0 50.4 37.8 46.5 49.6 34.2 37.6 51.0 45.1 42.2 15.7 42.7 36.2 72.2 33.1 49.6 32.4 50.6 37.1 41.6 31.6 50.3 32.3 55.7 55.9 36.0 54.6 37.4 56.9 106.4 201.9 80.2 119.0 70.6 86.6 79.3 107.4 75.5 126.0 107.2 147.4 132.5 91.3 214.7 90.2 99.9 105.7 124.2 146.1 98.3 120.6 115.1 156.3 118.1 141.8 130.5 107.2 115.0 109.4 136.1 207.0 136.6 70.9 120.0 87.0 135.3 87.5 118.3 210.8 83.7 168.1 104.3 422.7 205.9 96.2 174.3 244.0 137.5 101.3 72.5 121.3 99.0 110.7 295.3 78.8 162.3 108.0 83.8 102.8 91.7 212.9 142.8 103.3 125.1 313.1 57.0 132.0 121.4 18.5 49.6 12.7 35.9 52.2 47.0 58.1 42.0 37.8 61.1 48.5 44.6 48.2 3.4 43.1 51.4 80.2 47.7 38.6 46.9 52.5 51.6 52.0 46.0 49.4 51.0 50.4 51.0 50.6 50.3 56.9 48.9 35.3 36.0 6.8 48.6 53.5 75.7 89.7 47.8 19.5 64.3 86.1 66.7 85.8 55.5 55.2 22.9 168.8 36.7 97.8 129.1 89.2 37.3 77.2 90.9 49.7 72.6 68.3 3.6 94.9 111.3 54.2 69.3 72.0 62.1 83.9 33.2 184.1 97.5 18.5 5.8 98.6 28.5 44.8 34.2 13.3 55.0 44.7 28.4 2.8 55.2 67.5 49.4 8.5 18.8 98.2 85.1 38.4 47.3 139.5 174.2 266.2 47.1 18.5 6.6 81.6 51.0 78.7 34.2 86.3 51.3 122.3 39.9 150.7 121.2 98.7 PAAF1 "FLJ11848, Rpn14, WDR71" ENSG00000175575 "Proteasomal ATPase associated factor 1" Q9BRP4 11 73876699-73931114 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 130.1" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 112.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039952, HPA040020" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm Cytosol "HPA039952: AB_10793925, HPA040020: AB_2676802" "unprognostic (3.13e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.05e-1)" "unprognostic (2.13e-2)" "unprognostic (4.51e-2)" "unprognostic (1.33e-1)" "unprognostic (4.58e-3)" "unprognostic (1.74e-1)" "unprognostic (4.48e-1)" "unprognostic (2.30e-2)" "unprognostic (1.24e-1)" "unprognostic (4.23e-1)" "unprognostic (2.73e-1)" "unprognostic (4.42e-1)" 17.3 29.0 85.2 11.3 92.6 9.0 17.6 82.3 130.1 19.4 68.8 25.0 11.8 16.6 23.8 14.4 19.6 12.0 25.2 80.3 85.9 23.9 21.9 12.6 12.6 88.0 88.6 24.6 22.2 19.1 25.8 11.7 87.3 22.0 16.3 46.4 15.4 19.8 19.8 19.2 14.3 15.5 85.4 16.3 18.5 30.3 85.7 15.9 18.8 7.5 17.2 21.7 16.3 101.2 13.5 30.6 27.2 21.3 28.9 29.6 15.5 22.6 25.9 35.3 25.0 60.2 10.4 40.4 34.4 23.2 32.8 30.2 33.5 27.2 52.2 30.4 20.8 41.4 28.0 50.3 34.6 39.1 15.3 30.5 41.7 38.8 47.2 28.4 27.0 32.1 50.7 33.7 33.2 26.3 34.5 40.5 12.7 71.0 23.7 31.6 72.6 66.5 26.5 22.9 28.8 33.8 26.8 17.7 70.6 25.4 53.1 21.8 19.7 24.8 15.7 35.3 22.3 41.3 50.3 82.2 17.4 25.0 26.5 53.4 26.2 32.3 26.8 17.2 29.5 40.8 28.7 27.3 34.4 36.1 37.0 31.7 2.2 32.4 6.3 24.8 36.8 27.9 85.2 92.6 82.3 130.1 80.3 85.9 88.0 88.6 87.3 85.4 85.7 101.2 9.0 3.2 12.5 40.1 11.5 4.7 11.6 27.3 6.8 50.4 6.8 9.1 19.6 8.6 15.6 16.5 112.6 33.5 9.5 5.5 13.7 15.9 38.4 10.7 12.2 9.8 3.6 20.2 17.4 13.8 4.8 11.5 6.6 9.4 19.6 30.1 11.7 13.6 18.8 47.1 23.7 7.7 20.3 9.5 6.6 22.6 16.8 9.5 14.2 14.0 16.3 37.6 18.6 24.6 55.5 7.3 5.7 18.0 15.3 9.6 12.0 53.5 14.1 51.7 6.6 18.2 12.5 48.9 28.6 9.6 8.1 18.3 9.8 29.9 10.3 8.0 DNAJB13 "RSPH16A, TSARG6" ENSG00000187726 "DnaJ heat shock protein family (Hsp40) member B13" P59910 11 73951026-73970366 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Chaperone "Ciliopathy, Disease variant, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 53.2;testis: 18.9" "Group enriched" "Detected in some" 4 "Early spermatids: 90.6;Endometrial ciliated cells: 114.8;Late spermatids: 62.9;Respiratory ciliated cells: 104.2" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.7;Karpas-707: 2.6;RPTEC TERT1: 4.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA052465, HPA061330" Enhanced Approved "Plasma membrane" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane" "HPA052465: AB_2681842, HPA061330: AB_2732659" "unprognostic (1.07e-1)" "unprognostic (3.23e-2)" "unprognostic (3.27e-3)" "unprognostic (1.56e-2)" "unprognostic (1.03e-1)" "unprognostic (1.20e-4)" "unprognostic (1.30e-2)" "unprognostic (1.72e-4)" "unprognostic (5.00e-2)" "unprognostic (4.73e-2)" "unprognostic (6.30e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (2.10e-6)" "unprognostic (3.32e-2)" "unprognostic (1.41e-1)" "unprognostic (9.44e-2)" "unprognostic (2.40e-2)" 0.1 0.1 1.5 1.2 1.5 4.4 0.2 1.0 1.4 5.5 12.2 0.1 0.6 2.0 5.2 0.1 53.2 2.2 0.1 2.0 1.9 1.0 0.1 3.1 2.1 4.8 5.7 0.3 0.8 0.1 1.1 0.5 3.6 0.9 0.0 0.4 0.6 2.9 0.3 0.1 2.9 0.1 4.0 1.3 0.2 18.9 2.4 0.0 0.2 0.0 0.0 0.2 0.1 1.8 0.0 0.4 0.3 0.7 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.7 0.2 0.9 2.1 0.2 0.3 0.5 0.1 0.0 0.0 2.7 0.3 1.0 0.9 0.3 0.0 0.2 0.6 0.0 0.4 0.1 0.0 0.0 0.0 1.4 0.2 2.6 0.4 0.3 0.6 0.9 0.2 0.2 1.5 0.4 1.2 1.1 4.5 0.5 0.3 1.0 0.5 2.2 0.2 0.4 0.3 0.7 0.0 0.0 0.6 0.6 0.0 2.2 2.0 1.9 0.0 0.3 0.1 0.7 0.1 0.2 0.2 0.0 0.0 0.3 0.2 0.1 0.1 0.2 0.1 0.3 0.0 0.1 0.0 0.7 0.2 0.1 1.5 1.5 1.0 1.4 2.0 1.9 4.8 5.7 3.6 4.0 2.4 1.8 0.2 3.2 0.0 2.0 0.0 0.0 1.9 11.1 0.0 0.2 0.1 0.3 0.2 0.0 7.6 1.8 0.0 0.1 0.0 0.1 0.0 1.7 90.6 114.8 2.4 0.2 0.0 0.0 0.4 0.0 0.1 0.5 0.0 13.4 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.3 10.2 0.0 0.0 62.9 1.2 0.3 1.8 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 1.2 0.0 1.3 1.4 1.0 104.2 0.9 0.0 1.1 3.3 19.5 1.5 0.0 0.0 0.0 0.3 0.0 0.0 1.2 UCP2 "BMIQ4, SLC25A8" ENSG00000175567 "Uncoupling protein 2" P55851 11 73974672-73982843 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 278.1" "Cell type enhanced" "Detected in many" "dendritic cells: 404.4;Enteroendocrine cells: 297.3;Erythroid cells: 695.6;Hofbauer cells: 442.2;Kupffer cells: 326.6;monocytes: 533.6;NK-cells: 509.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 360.2;SK-BR-3: 395.6;U-698: 293.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025583, HPA075202" Approved Supported Mitochondria NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 3: T-cells - Adaptive immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 6: Erythroid cells - Oxygen transport" Mitochondria "CAB025583: , HPA075202: AB_2732284" "unprognostic (1.13e-1)" "prognostic favorable (4.65e-5)" "unprognostic (8.07e-2)" "unprognostic (1.21e-2)" "unprognostic (1.08e-1)" "unprognostic (1.15e-2)" "unprognostic (1.92e-1)" "unprognostic (1.82e-3)" "unprognostic (2.07e-1)" "unprognostic (4.59e-2)" "unprognostic (1.13e-3)" "unprognostic (1.37e-1)" "prognostic unfavorable (7.80e-6)" "unprognostic (3.77e-2)" "unprognostic (1.58e-1)" "unprognostic (3.77e-3)" "unprognostic (3.88e-3)" 70.9 20.5 12.2 142.9 14.6 132.8 37.6 12.9 24.1 41.3 22.1 33.2 53.4 17.4 7.6 17.7 175.7 42.3 14.1 12.1 15.9 34.9 26.2 69.3 278.1 19.7 19.8 4.9 12.6 8.1 13.8 27.3 19.8 19.7 44.8 6.9 42.7 23.0 99.1 9.2 56.6 30.4 17.6 183.1 55.2 14.5 22.4 217.3 45.1 141.7 240.2 73.6 4.9 26.1 0.9 78.7 20.2 43.5 9.5 0.0 11.6 14.1 9.3 54.9 14.8 153.1 59.0 360.2 165.1 19.5 5.5 3.5 13.3 0.0 28.6 97.1 5.6 241.5 26.4 28.3 32.2 123.9 77.5 8.9 0.0 43.9 0.0 11.0 5.7 144.6 101.5 119.0 9.5 147.5 108.5 55.8 12.8 9.0 21.7 99.7 120.7 202.0 150.4 211.0 23.6 32.3 68.2 395.6 26.6 55.9 123.3 79.3 10.0 0.2 59.7 14.4 21.5 48.4 24.4 293.8 7.2 45.0 0.4 809.1 1116.7 1465.3 1462.8 1945.8 925.0 1914.8 1176.3 1233.5 1228.7 1851.8 1092.9 1143.1 154.2 1816.8 1692.3 3009.5 2589.5 2966.6 12.2 14.6 12.9 24.1 12.1 15.9 19.7 19.8 19.8 17.6 22.4 26.1 4.7 3.2 27.6 0.3 287.4 3.4 2.7 20.2 0.6 0.9 30.9 19.8 5.2 5.7 43.9 92.0 8.4 8.3 404.4 6.2 7.9 1.9 18.7 122.1 10.5 8.9 297.3 695.6 0.0 7.5 12.1 9.9 46.4 102.4 86.2 12.4 9.7 5.0 442.2 0.0 0.1 31.5 89.5 326.6 146.2 46.0 0.9 232.3 26.6 1.9 533.6 4.3 509.8 1.0 1.0 1.8 45.9 0.4 117.9 12.8 4.5 2.7 137.6 8.1 6.6 6.1 11.2 15.2 14.5 1.9 4.5 11.2 189.9 13.5 21.7 43.4 UCP3 SLC25A9 ENSG00000175564 "Uncoupling protein 3" P55916 11 74000277-74009085 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Diabetes mellitus, Disease variant, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 80 "skeletal muscle: 393.2;tongue: 263.1" "Cell type enhanced" "Detected in some" "Early spermatids: 15.4;Late spermatids: 14.0;NK-cells: 6.2;Skeletal myocytes: 6.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "HDLM-2: 15.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB010771, HPA072225" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 44: HDLM-2 - Immune response" "Cluster 37: Myocytes - Muscle contraction" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB010771: AB_261839, HPA072225: AB_2686498" "unprognostic (3.76e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-1)" "unprognostic (5.98e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-2)" "unprognostic (3.95e-3)" "unprognostic (6.61e-2)" "unprognostic (1.25e-1)" "unprognostic (8.58e-2)" "unprognostic (2.13e-4)" "unprognostic (1.61e-2)" "unprognostic (3.25e-6)" "unprognostic (2.68e-1)" "unprognostic (1.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.50e-4)" 1.2 1.7 2.5 1.3 2.6 2.2 1.3 3.9 3.0 1.4 2.3 1.7 0.7 1.4 2.0 2.9 1.5 0.8 2.4 2.7 2.1 1.7 1.3 1.4 1.3 2.4 2.1 1.1 1.1 0.9 2.7 0.5 2.3 1.8 0.7 4.0 3.7 0.7 393.2 1.4 1.7 0.8 1.8 3.1 1.2 3.9 2.4 1.6 2.6 263.1 0.7 1.4 0.9 2.8 0.2 1.8 1.7 1.5 0.7 0.3 0.3 0.5 0.4 0.4 0.2 0.4 0.4 0.9 0.2 0.3 0.2 1.9 0.7 0.3 0.7 15.8 0.5 0.3 2.4 0.2 0.5 1.1 1.4 0.4 1.1 1.1 0.1 0.3 0.5 0.9 0.4 1.2 0.6 1.0 0.7 1.4 0.9 1.4 1.1 1.4 3.6 0.5 0.9 0.5 0.9 1.0 0.4 0.7 0.6 0.3 0.2 1.0 0.3 0.2 1.1 0.6 1.1 1.4 1.5 0.7 0.2 1.0 0.5 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.3 0.3 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.5 2.6 3.9 3.0 2.7 2.1 2.4 2.1 2.3 1.8 2.4 2.8 0.8 0.0 0.0 1.6 0.8 0.1 0.1 0.5 0.6 2.3 1.0 1.1 0.7 0.0 1.1 0.0 0.0 0.3 2.0 0.3 0.0 0.3 15.4 1.2 1.1 0.6 0.0 0.4 1.6 0.5 0.2 0.4 0.0 0.8 0.0 0.7 1.1 0.3 0.7 0.0 1.6 0.5 2.0 0.8 0.0 14.0 0.0 0.6 0.0 1.0 0.7 0.8 6.2 0.5 0.6 0.4 0.1 0.7 0.5 0.2 0.3 0.1 3.0 2.1 0.0 6.5 0.5 1.5 0.8 0.4 0.3 0.3 1.5 0.3 0.6 0.1 C2CD3 DKFZP586P0123 ENSG00000168014 "C2 domain containing 3 centriole elongation regulator" Q4AC94 11 74012718-74171210 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 70.5;Alveolar cells type 2: 114.6;Excitatory neurons: 57.4;Respiratory ciliated cells: 57.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 17.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 60.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038552, HPA038553, HPA040433" Approved Approved Nucleoplasm,Centrosome NA NA "Cluster 46: Basophils - DNA binding" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Centrosome" "HPA038552: AB_10669542, HPA038553: AB_2676080, HPA040433: AB_2676981" "unprognostic (3.94e-1)" "unprognostic (7.89e-2)" "unprognostic (3.68e-2)" "unprognostic (8.86e-3)" "unprognostic (1.31e-1)" "unprognostic (1.18e-1)" "unprognostic (8.48e-5)" "unprognostic (1.99e-1)" "unprognostic (4.96e-3)" "unprognostic (2.20e-1)" "unprognostic (1.74e-1)" "unprognostic (5.86e-2)" "unprognostic (2.21e-1)" "unprognostic (1.91e-1)" "unprognostic (3.11e-1)" "unprognostic (1.18e-1)" "unprognostic (2.92e-1)" 3.9 4.7 15.4 5.1 14.8 9.9 3.7 21.7 22.9 4.2 16.7 4.0 3.9 4.8 4.5 3.9 7.8 3.7 2.9 18.5 14.4 4.9 5.8 4.2 5.0 16.9 13.8 4.7 2.2 6.2 3.7 5.9 15.3 4.3 5.2 8.2 4.3 3.5 3.5 6.0 4.2 4.2 11.2 5.9 4.3 11.0 15.8 7.7 7.0 3.4 5.4 3.9 2.7 19.4 9.3 14.3 11.7 14.3 5.2 4.8 5.6 13.7 8.8 16.0 13.0 24.4 7.4 9.0 9.2 5.2 15.5 13.9 14.7 3.8 19.3 12.4 7.0 12.4 21.3 10.8 8.8 12.0 16.9 4.8 4.8 13.4 9.7 5.1 9.0 11.1 14.2 15.7 13.3 7.7 14.1 8.3 9.4 17.8 7.7 14.3 60.4 9.0 4.6 13.0 15.6 9.2 22.4 8.4 21.2 11.9 16.5 7.8 12.7 10.3 17.0 10.1 11.0 11.7 8.5 26.1 4.0 6.0 11.1 17.8 2.0 3.0 2.2 2.3 2.0 2.3 1.4 1.8 1.3 4.4 2.1 2.1 12.6 2.9 4.7 2.0 1.0 0.7 15.4 14.8 21.7 22.9 18.5 14.4 16.9 13.8 15.3 11.2 15.8 19.4 6.5 70.5 114.6 28.1 10.5 5.2 3.6 4.8 9.6 8.7 6.2 5.8 5.1 4.3 36.0 9.2 4.2 3.8 5.6 7.6 0.0 4.0 33.0 18.4 9.4 9.8 7.7 12.2 57.4 2.6 2.9 9.6 15.3 8.9 36.6 8.5 5.0 3.0 5.0 11.8 52.1 5.0 4.1 7.6 6.6 24.7 4.4 12.7 7.2 26.2 4.9 4.8 10.3 37.7 38.5 3.8 2.8 6.4 9.5 3.4 3.4 1.8 57.1 14.8 6.6 7.2 5.2 11.1 6.9 6.4 4.5 2.3 14.0 5.4 5.4 4.7 PPME1 "ABDH19, PME-1" ENSG00000214517 "Protein phosphatase methylesterase 1" Q9Y570 11 74171267-74254703 "Enzymes, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 96.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 432.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004541, HPA043900, HPA064396" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA 45000 "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoplasm "Nuclear bodies" "CAB004541: AB_628161, HPA043900: AB_2678722, HPA064396: AB_2685254" "unprognostic (2.99e-2)" "unprognostic (1.27e-2)" "unprognostic (2.28e-1)" "unprognostic (1.98e-1)" "unprognostic (9.26e-2)" "unprognostic (5.77e-3)" "prognostic unfavorable (4.45e-6)" "unprognostic (2.31e-2)" "unprognostic (7.92e-2)" "unprognostic (9.76e-2)" "unprognostic (1.57e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.84e-1)" "unprognostic (1.54e-1)" "unprognostic (4.14e-3)" "unprognostic (1.33e-3)" 14.7 25.1 16.8 10.0 18.1 16.9 14.9 8.5 21.3 17.3 7.8 15.2 11.0 16.8 29.1 20.8 24.1 14.0 21.4 18.8 19.4 18.6 10.1 13.0 9.3 12.7 14.5 18.3 15.4 62.5 14.5 14.9 17.5 23.8 15.7 23.8 20.1 24.9 29.7 28.7 11.5 21.4 9.8 8.1 13.4 31.9 13.4 18.8 23.1 24.1 14.7 22.3 13.9 14.0 50.5 62.3 42.4 45.9 45.4 36.0 41.3 71.8 48.4 134.8 103.6 139.1 32.3 26.3 47.7 55.1 73.6 79.9 63.4 50.3 123.1 36.4 23.8 38.7 66.6 64.1 96.7 28.9 33.2 34.6 41.8 69.7 32.7 54.8 39.1 37.5 93.0 22.5 236.6 34.1 38.0 36.1 34.4 71.2 50.3 39.9 432.4 39.9 56.7 33.9 57.2 49.2 85.1 38.7 108.4 46.2 72.7 29.1 23.5 52.1 67.6 51.5 55.2 41.4 54.6 46.9 39.2 26.7 43.4 1.4 8.7 11.3 10.4 10.5 13.2 7.2 13.4 12.6 11.2 8.3 13.3 10.9 4.9 13.7 9.5 11.8 10.9 9.2 16.8 18.1 8.5 21.3 18.8 19.4 12.7 14.5 17.5 9.8 13.4 14.0 16.1 28.9 12.8 28.7 10.8 20.3 24.4 30.5 23.3 31.3 18.5 17.7 18.0 7.2 28.5 35.0 37.5 14.1 11.2 15.4 17.6 16.9 51.4 44.9 32.8 15.0 25.7 96.4 65.3 13.4 38.9 19.1 23.9 24.2 8.2 21.2 10.8 9.7 13.6 33.7 59.3 13.5 34.6 6.7 14.8 13.4 13.7 11.1 3.6 20.6 10.8 15.2 16.5 35.7 40.5 16.6 12.0 25.2 8.2 19.2 10.3 11.6 40.9 18.8 6.6 19.0 33.0 61.9 45.6 21.5 24.9 15.5 12.4 18.8 13.4 17.3 P4HA3 C-P4Halpha(III) ENSG00000149380 "Prolyl 4-hydroxylase subunit alpha 3" Q7Z4N8 11 74235801-74311640 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 10.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6;Early spermatids: 25.6;Erythroid cells: 13.5;Horizontal cells: 18.5;Rod photoreceptor cells: 12.8;Spermatocytes: 13.1;Spermatogonia: 12.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 19.5;fHDF/TERT166: 9.5;HSkMC: 9.1;HUVEC TERT2: 38.2;TIME: 27.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA007897 Approved "Intracellular and membrane" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA007897: AB_2156427" "unprognostic (2.74e-2)" "unprognostic (1.37e-4)" "unprognostic (1.31e-3)" "unprognostic (3.19e-2)" "unprognostic (2.54e-4)" "unprognostic (9.65e-3)" "unprognostic (4.34e-2)" "unprognostic (3.89e-2)" "unprognostic (2.02e-1)" "unprognostic (4.21e-3)" "unprognostic (1.38e-2)" "unprognostic (8.31e-2)" "prognostic unfavorable (3.34e-9)" "unprognostic (1.96e-3)" "unprognostic (9.29e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (7.83e-4)" 1.6 0.7 0.1 3.9 0.0 0.0 0.9 0.1 0.3 1.3 0.3 1.6 0.3 4.5 0.5 0.3 1.2 5.6 0.3 0.0 0.1 1.0 1.3 1.4 0.9 0.1 0.1 1.0 0.2 0.0 3.7 3.9 0.1 6.3 0.7 0.0 0.5 4.3 0.1 0.3 0.4 10.5 0.0 0.1 0.4 1.5 0.1 0.1 2.6 0.1 0.3 5.4 1.7 0.1 0.0 1.4 1.7 0.0 6.2 0.7 0.0 19.5 1.4 1.0 2.1 0.0 0.0 0.0 1.8 9.5 0.7 0.0 0.0 0.3 0.2 0.0 0.1 0.0 1.2 0.0 8.0 0.0 0.0 9.1 0.0 6.5 0.7 1.1 38.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 27.4 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.0 0.0 0.0 0.0 0.2 0.4 0.7 0.9 0.0 9.1 0.5 0.1 0.4 0.0 0.2 0.0 14.6 0.2 3.1 0.2 0.0 0.2 25.6 3.8 2.5 3.2 0.0 13.5 2.4 0.0 0.4 5.2 0.0 1.0 0.0 4.3 6.1 0.0 0.4 18.5 3.3 0.2 0.0 0.9 1.1 3.2 0.0 0.3 0.0 6.5 1.6 1.9 3.1 1.5 0.9 0.8 0.2 0.4 0.0 1.1 0.2 0.0 0.7 12.8 0.0 2.1 5.4 13.1 12.2 0.1 0.3 0.1 0.4 1.3 0.2 0.6 PGM2L1 "BM32A, FLJ32029" ENSG00000165434 "Phosphoglucomutase 2 like 1" Q6PCE3 11 74330316-74398433 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Isomerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 90.1;Exocrine glandular cells: 124.5;Pancreatic endocrine cells: 140.1;Respiratory ciliated cells: 95.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 16.6;LHCN-M2: 19.9;RH-30: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056995, HPA060948" Enhanced Approved Mitochondria No No 140000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 10: Brain - Neuronal signaling" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 1: Pancreatic cells - Digestion" Mitochondria "HPA056995: AB_2683305, HPA060948: AB_2684394" "unprognostic (7.44e-3)" "unprognostic (1.33e-1)" "unprognostic (7.28e-3)" "unprognostic (8.91e-2)" "unprognostic (6.16e-2)" "unprognostic (1.55e-1)" "unprognostic (7.16e-6)" "unprognostic (1.43e-1)" "unprognostic (1.95e-1)" "unprognostic (5.97e-3)" "unprognostic (1.70e-2)" "unprognostic (2.98e-1)" "unprognostic (9.33e-3)" "unprognostic (3.71e-1)" "unprognostic (1.97e-1)" "unprognostic (3.04e-1)" "unprognostic (1.03e-2)" 1.9 2.6 17.6 3.7 22.1 3.2 1.9 0.0 21.5 4.9 0.0 3.2 1.3 4.4 0.8 1.0 3.2 3.3 1.1 23.1 16.2 1.6 1.0 1.8 3.0 1.9 4.5 0.9 3.1 0.7 3.9 1.1 2.2 2.9 3.5 2.6 2.6 1.3 5.9 0.7 1.5 4.0 0.3 1.5 2.1 1.3 5.7 8.1 2.7 11.1 2.7 6.4 1.9 7.8 2.7 3.8 14.5 2.7 4.3 1.9 0.4 3.5 2.6 3.0 3.3 1.4 6.8 0.3 8.5 2.3 5.3 1.3 2.9 0.7 2.8 1.1 1.5 2.1 2.0 1.1 0.5 2.4 3.2 1.0 0.7 6.8 1.2 3.2 16.6 5.0 2.8 1.8 19.9 0.3 9.9 2.1 2.9 2.0 3.3 3.1 18.9 0.1 7.8 0.5 0.7 2.9 5.7 1.3 2.6 3.9 0.2 0.4 14.0 6.6 6.0 2.7 3.7 2.4 3.8 0.3 0.6 3.4 1.6 1.2 0.3 0.5 0.9 0.3 1.3 1.1 1.6 1.1 0.2 0.8 1.5 0.8 0.3 1.4 0.2 0.8 3.9 0.5 17.6 22.1 0.0 21.5 23.1 16.2 1.9 4.5 2.2 0.3 5.7 7.8 19.6 6.4 6.4 8.5 20.9 7.6 41.2 14.3 10.8 23.9 26.5 19.4 7.3 17.2 30.2 9.2 16.7 0.6 17.6 13.8 5.9 37.4 14.1 28.1 23.5 32.1 11.9 47.5 90.1 124.5 5.3 21.0 7.1 25.5 8.2 16.1 29.3 1.0 5.4 8.4 64.8 16.2 18.3 23.0 21.6 3.6 2.5 9.9 16.0 20.6 4.6 4.4 12.3 14.6 7.1 140.1 9.3 3.8 13.4 50.4 4.2 5.3 95.4 11.0 26.3 21.3 16.7 34.2 21.2 9.0 5.3 0.1 25.0 8.8 20.9 55.6 KCNE3 "HOKPP, MiRP2" ENSG00000175538 "Potassium voltage-gated channel subfamily E regulatory subunit 3" Q9Y6H6 11 74454841-74467729 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Brugada syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 70.5;stomach 1: 56.2" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 41.8;granulocytes: 33.7;Hofbauer cells: 40.6;Kupffer cells: 104.0;Macrophages: 37.8;monocytes: 59.0;Undifferentiated cells: 44.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 48 "basophil: 51.4;classical monocyte: 38.5;eosinophil: 23.4;intermediate monocyte: 41.8;myeloid DC: 18.3;neutrophil: 53.1;non-classical monocyte: 36.6" "Group enriched" "Detected in many" 115 "dendritic cells: 18.3;granulocytes: 53.1;monocytes: 41.8" "Cell line enhanced" "Detected in some" "HEL: 70.3;NB-4: 44.7;OE19: 155.3;THP-1: 32.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014849 Approved Supported "Plasma membrane" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 9: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Plasma membrane" "HPA014849: AB_1852112" "unprognostic (1.61e-2)" "unprognostic (2.94e-1)" "unprognostic (1.11e-1)" "unprognostic (8.69e-2)" "unprognostic (3.58e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (4.67e-3)" "unprognostic (4.89e-4)" "unprognostic (4.12e-3)" "unprognostic (2.56e-2)" "unprognostic (2.97e-2)" "unprognostic (1.45e-3)" "unprognostic (7.86e-2)" "unprognostic (1.33e-2)" "unprognostic (1.73e-1)" "unprognostic (2.00e-1)" 7.3 2.8 2.8 20.7 2.9 8.2 5.2 2.5 3.6 9.9 7.0 34.9 70.5 8.8 1.9 4.6 9.4 24.6 5.0 3.0 3.0 20.1 5.0 13.8 5.0 3.8 3.6 14.0 10.8 3.6 3.1 12.7 3.6 8.0 47.3 8.1 15.4 3.4 1.3 1.3 40.0 11.1 3.3 12.6 56.2 1.8 4.1 1.9 33.5 3.0 3.2 6.2 4.5 4.9 0.1 0.1 0.1 0.2 8.1 2.1 7.1 0.1 0.0 1.0 0.8 23.0 2.0 0.3 21.3 0.1 0.1 0.3 1.8 0.0 0.7 0.0 0.2 70.3 0.4 4.7 2.9 0.6 12.0 7.1 0.0 0.6 0.0 0.3 0.3 0.1 1.9 0.3 0.8 0.1 0.1 44.7 0.9 155.3 0.1 7.6 0.3 0.5 1.7 0.0 0.0 0.4 0.1 0.0 0.0 5.4 0.1 32.7 0.1 0.1 0.2 0.2 0.1 0.3 0.3 0.4 0.1 12.9 0.1 51.4 38.5 23.4 0.1 41.8 0.2 0.2 0.1 0.1 18.3 0.3 0.1 0.1 53.1 0.2 36.6 0.7 0.0 13.2 2.8 2.9 2.5 3.6 3.0 3.0 3.8 3.6 3.6 3.3 4.1 4.9 4.4 0.0 6.8 0.3 0.7 0.3 0.6 1.1 3.4 0.2 0.2 0.3 0.7 8.6 5.6 1.8 0.0 0.4 0.0 8.6 3.9 0.5 0.1 3.1 3.4 8.9 2.4 2.1 0.2 7.3 7.4 4.5 41.8 5.0 33.7 0.2 5.7 2.0 40.6 0.0 0.3 27.9 4.1 104.0 2.9 0.3 3.7 37.8 0.0 8.4 59.0 22.7 1.0 0.0 0.0 3.3 8.9 2.6 0.2 0.4 8.6 23.4 4.6 1.2 0.0 4.7 0.7 0.0 0.4 2.7 0.1 2.1 1.0 8.8 44.3 0.6 LIPT2 ENSG00000175536 "Lipoyl(octanoyl) transferase 2" A6NK58 11 74490519-74493724 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Ligase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.3" "Cell type enhanced" "Detected in many" "Early spermatids: 55.4;Late spermatids: 29.4;Proximal tubular cells: 17.7;Spermatocytes: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040249 Approved NA NA "Cluster 30: Non-specific - Translation" "Cluster 23: Testis - Cell cycle regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA040249: AB_10795275" "unprognostic (8.80e-2)" "unprognostic (9.67e-2)" "unprognostic (5.12e-3)" "unprognostic (1.09e-1)" "unprognostic (6.74e-3)" "unprognostic (1.43e-1)" "unprognostic (1.50e-2)" "unprognostic (8.96e-2)" "unprognostic (1.11e-2)" "prognostic favorable (1.63e-4)" "unprognostic (6.11e-2)" "unprognostic (2.02e-1)" "unprognostic (1.17e-2)" "unprognostic (9.45e-2)" "unprognostic (1.01e-1)" "unprognostic (1.51e-2)" "unprognostic (1.35e-1)" 1.3 2.0 1.8 1.6 2.0 2.1 2.4 1.8 1.8 1.5 1.2 2.1 3.7 1.6 3.2 1.8 3.2 1.9 1.5 1.6 1.8 4.6 3.1 1.7 2.2 2.4 1.9 3.4 2.9 2.1 2.1 2.1 2.4 1.8 2.3 1.9 2.1 2.7 8.0 1.6 3.6 0.6 1.8 2.1 3.5 12.3 2.8 2.7 3.0 7.1 2.2 1.7 1.2 3.3 2.1 3.3 6.6 3.1 2.1 0.4 6.9 0.8 1.5 3.3 2.3 9.8 3.0 11.5 4.0 0.6 8.0 3.2 2.8 1.9 1.2 2.2 2.6 4.0 3.2 2.9 2.9 4.4 5.0 1.4 2.2 2.2 2.2 1.5 0.2 12.7 3.0 4.1 1.3 4.0 6.6 6.1 4.9 13.0 2.6 4.3 7.0 3.7 2.6 7.3 5.5 3.6 5.6 2.0 8.1 6.2 5.6 3.2 0.6 1.0 2.1 1.5 1.8 5.7 5.8 9.3 0.6 2.7 2.9 0.1 4.7 7.5 5.5 3.0 7.6 10.6 7.3 6.6 5.3 10.5 13.3 10.9 1.1 8.4 3.4 6.3 3.7 4.8 1.8 2.0 1.8 1.8 1.6 1.8 2.4 1.9 2.4 1.8 2.8 3.3 0.6 0.0 0.0 1.0 2.5 0.8 1.1 2.9 4.0 0.9 1.7 1.9 1.1 2.8 1.4 3.7 0.0 13.2 0.7 0.9 5.9 2.6 55.4 1.5 0.7 1.0 0.0 4.0 0.3 4.4 14.1 1.4 2.0 1.1 0.0 1.9 2.2 4.2 5.4 3.3 0.2 3.1 4.1 1.3 0.0 29.4 1.8 2.3 1.8 0.0 0.7 9.8 2.1 0.5 1.1 2.8 0.5 1.2 0.8 1.0 4.3 17.7 1.9 1.6 0.0 1.3 0.9 46.7 10.7 2.9 0.6 8.1 1.4 3.0 3.1 0.3 POLD3 "KIAA0039, P66, P68, PPP1R128" ENSG00000077514 "DNA polymerase delta 3, accessory subunit" Q15054 11 74493851-74669117 "Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA058846 Enhanced Supported Nucleoplasm NA Yes "Cluster 14: Monocytes - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA058846: AB_2683833" "unprognostic (3.68e-1)" "unprognostic (3.22e-2)" "unprognostic (2.05e-3)" "unprognostic (3.28e-1)" "unprognostic (1.74e-1)" "unprognostic (3.49e-1)" "prognostic unfavorable (9.17e-4)" "unprognostic (1.08e-1)" "prognostic unfavorable (5.48e-4)" "unprognostic (3.99e-3)" "unprognostic (1.54e-3)" "unprognostic (9.21e-3)" "prognostic unfavorable (7.90e-6)" "unprognostic (7.92e-3)" "unprognostic (2.65e-1)" "unprognostic (9.11e-2)" "unprognostic (1.23e-1)" 7.9 6.2 6.1 14.6 6.0 10.1 11.1 6.0 7.3 10.6 7.6 17.2 15.7 16.5 12.0 12.9 16.3 14.9 8.9 5.9 6.1 44.5 7.1 11.5 14.5 4.9 5.6 16.0 11.4 7.8 4.6 11.5 5.6 8.3 17.9 14.9 6.8 10.1 7.7 11.6 14.4 15.3 5.1 11.4 15.4 19.6 5.5 15.7 15.0 12.5 15.2 12.7 7.5 7.4 32.2 28.6 43.6 29.8 13.2 22.5 30.9 42.7 23.9 43.7 37.0 37.8 40.8 45.7 30.9 20.5 25.3 41.2 36.3 28.0 54.6 34.5 23.3 29.1 44.3 12.8 9.5 56.4 25.3 10.0 17.3 51.1 27.3 13.8 17.1 39.8 26.7 35.5 25.6 25.3 63.4 25.3 26.4 95.3 29.1 60.0 109.4 37.9 20.2 30.6 29.0 19.5 50.7 25.3 49.7 26.2 29.5 35.7 16.4 42.9 30.8 48.8 34.2 24.8 56.6 102.4 24.5 35.1 33.2 7.3 22.6 15.9 9.2 18.5 9.1 10.1 11.7 8.2 17.7 8.0 11.6 9.6 19.4 10.8 19.0 5.2 13.7 13.0 6.1 6.0 6.0 7.3 5.9 6.1 4.9 5.6 5.6 5.1 5.5 7.4 14.8 12.8 20.0 13.1 9.7 5.9 7.0 11.4 12.5 12.3 10.5 12.8 7.8 7.2 17.7 9.2 8.4 19.7 11.1 17.9 5.9 17.2 28.3 24.8 17.1 14.2 5.4 24.2 20.1 32.1 26.7 13.1 16.8 14.4 19.0 20.9 8.2 4.9 15.6 23.5 15.3 12.7 12.2 12.9 7.2 23.1 12.5 16.9 3.6 15.0 25.3 15.3 9.2 6.6 18.7 17.4 13.4 8.6 11.4 11.4 10.7 39.1 45.2 19.1 6.6 13.7 12.4 60.3 37.7 11.2 5.4 13.0 11.8 10.0 19.9 10.5 CHRDL2 BNF1 ENSG00000054938 "Chordin like 2" Q6WN34 11 74696429-74731426 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 145.1;gallbladder: 106.0;lymphoid tissue: 115.8;smooth muscle: 122.1" "Cell type enhanced" "Detected in some" "Breast glandular cells: 194.1;Hepatocytes: 112.2;Skeletal myocytes: 533.4" "Cancer enhanced" "Detected in many" "stomach cancer: 14.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 2.4;PC-3: 1.3;SiHa: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA021771, HPA076522" Uncertain Approved Vesicles "Secreted to extracellular matrix" NA NA 9700000 "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 20: HeLa - Mitochondria" "Cluster 30: Mammary glandular cells - Lactation" Vesicles "HPA021771: AB_1846689, HPA076522: " "unprognostic (2.38e-2)" "unprognostic (1.80e-1)" "unprognostic (7.24e-2)" "unprognostic (3.41e-3)" "unprognostic (9.45e-2)" "unprognostic (2.09e-1)" "unprognostic (4.08e-2)" "unprognostic (4.33e-2)" "unprognostic (6.64e-2)" "unprognostic (2.57e-1)" "unprognostic (1.86e-1)" "unprognostic (1.23e-1)" "unprognostic (7.58e-6)" "unprognostic (8.39e-2)" "unprognostic (1.32e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (6.08e-4)" 2.7 0.2 0.6 115.8 0.4 0.0 5.1 0.4 0.7 64.7 0.1 88.7 4.1 145.1 0.8 4.1 9.4 106.0 24.4 0.4 0.6 5.2 46.3 2.9 0.4 1.0 0.6 2.5 3.1 0.4 0.4 4.5 0.7 22.6 2.6 0.5 0.5 8.9 6.6 1.2 10.8 122.1 2.3 1.3 57.7 3.4 0.7 0.0 0.9 4.8 2.8 46.3 21.2 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 2.4 0.3 0.0 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.4 0.7 0.4 0.6 1.0 0.6 0.7 2.3 0.7 0.2 1.2 0.0 2.6 0.7 0.3 0.3 0.5 0.2 0.0 0.0 194.1 3.8 2.2 15.7 0.1 9.2 0.0 0.0 0.8 0.0 0.0 13.8 31.4 0.6 0.2 2.1 0.0 0.0 0.1 10.3 0.1 5.3 0.0 0.5 0.0 0.2 2.9 112.2 0.1 0.0 0.2 0.0 0.0 2.4 0.0 2.4 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.5 0.1 4.1 0.0 0.7 0.1 0.9 0.0 0.0 0.0 0.0 0.0 533.4 1.2 0.6 4.3 0.0 0.0 0.1 0.5 0.4 0.0 0.5 RNF169 KIAA1991 ENSG00000166439 "Ring finger protein 169" Q8NCN4 11 74748849-74842413 "Enzymes, Predicted intracellular proteins" "DNA damage, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038505, HPA046138, HPA047952" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "Nucleoli, Nucleoli rim, Cytosol" "HPA038505: , HPA046138: AB_2679553, HPA047952: " "unprognostic (1.71e-1)" "unprognostic (4.18e-2)" "unprognostic (4.34e-2)" "unprognostic (3.72e-2)" "unprognostic (3.86e-2)" "unprognostic (3.25e-2)" "unprognostic (1.74e-1)" "unprognostic (1.35e-1)" "unprognostic (2.68e-1)" "unprognostic (6.47e-2)" "prognostic unfavorable (8.04e-4)" "unprognostic (2.76e-1)" "unprognostic (1.46e-1)" "unprognostic (3.23e-1)" "unprognostic (2.34e-1)" "unprognostic (9.55e-3)" "unprognostic (1.21e-1)" 4.2 2.8 3.8 6.7 6.2 14.4 5.6 6.2 4.4 5.5 5.4 4.4 4.0 7.6 4.2 10.1 5.6 4.8 3.2 4.0 4.4 4.6 5.0 5.9 6.3 5.4 5.0 7.6 4.4 5.6 2.1 4.7 5.4 5.2 5.3 6.1 4.5 4.3 6.8 5.5 4.4 7.6 4.4 7.3 4.6 2.9 4.6 7.7 5.8 5.8 6.7 5.2 5.4 9.2 10.2 7.7 9.1 9.0 5.8 7.7 3.7 7.9 7.4 8.6 7.4 13.0 7.5 18.2 7.9 9.5 5.8 9.6 12.4 9.3 11.2 9.1 8.0 12.6 15.3 5.1 6.6 6.8 10.1 7.1 7.2 9.8 22.1 9.6 14.0 12.2 11.4 14.1 8.7 8.6 11.6 12.0 3.6 12.9 5.0 10.7 21.7 9.9 5.5 10.6 4.1 7.4 10.6 8.0 16.6 7.3 9.9 8.6 9.4 14.2 11.8 9.0 7.1 10.2 5.8 21.1 2.8 7.3 8.4 1.2 0.5 0.4 0.4 0.3 0.3 0.0 0.4 0.2 0.2 0.1 0.3 0.2 1.4 0.3 0.3 0.2 0.3 0.2 3.8 6.2 6.2 4.4 4.0 4.4 5.4 5.0 5.4 4.4 4.6 9.2 18.8 9.6 11.4 51.6 18.4 19.9 30.6 7.1 20.5 58.2 12.6 9.8 3.0 17.2 8.3 3.7 52.1 5.5 24.6 9.8 5.9 10.2 2.8 30.5 26.7 17.2 12.0 18.3 40.8 11.1 6.4 16.0 14.8 30.1 7.0 24.4 10.8 12.3 8.5 37.0 43.2 8.7 2.0 15.6 19.9 3.1 7.5 16.6 10.6 25.3 12.6 22.9 26.8 42.7 68.7 10.1 6.8 10.5 18.5 49.7 6.3 12.1 8.9 33.7 26.3 31.9 18.7 9.4 11.7 16.4 18.6 8.1 22.2 14.0 10.4 42.2 XRRA1 FLJ00225 ENSG00000166435 "X-ray radiation resistance associated 1" Q6P2D8 11 74807739-74949200 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 19.4" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 139.7;Spermatocytes: 125.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 36.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA039263 Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "Nuclear bodies" "HPA039263: AB_2676419" "unprognostic (3.58e-1)" "unprognostic (1.04e-2)" "unprognostic (1.24e-1)" "unprognostic (3.11e-2)" "unprognostic (7.33e-2)" "unprognostic (1.20e-1)" "unprognostic (2.69e-1)" "unprognostic (1.71e-1)" "unprognostic (3.31e-1)" "unprognostic (1.23e-1)" "unprognostic (3.04e-1)" "unprognostic (1.62e-1)" "unprognostic (5.94e-3)" "unprognostic (2.13e-1)" "unprognostic (3.31e-2)" "unprognostic (2.06e-1)" "unprognostic (2.27e-1)" 3.4 3.8 2.3 1.1 2.9 1.6 3.4 2.4 2.5 5.1 1.9 4.5 2.6 4.8 3.8 4.1 4.4 2.9 4.4 2.1 2.7 4.2 5.0 3.8 1.9 2.6 2.7 4.9 4.5 3.2 4.2 2.4 2.7 5.0 2.3 2.3 5.5 3.0 6.0 3.6 2.9 4.8 2.3 4.2 3.8 19.4 3.2 2.6 7.1 11.6 2.7 4.6 3.9 4.3 5.4 3.0 0.7 4.9 7.5 4.9 2.1 2.3 2.5 1.3 1.3 1.6 2.8 2.2 8.3 2.5 11.1 4.3 6.1 3.0 2.8 8.8 0.5 1.9 2.0 3.1 2.2 1.2 0.9 4.7 3.4 5.6 36.1 10.5 2.7 7.2 5.1 5.0 6.5 2.0 2.0 2.8 1.7 6.5 2.7 0.9 3.9 1.7 1.1 4.1 4.7 3.9 10.7 4.5 14.2 2.3 2.8 5.6 1.8 7.8 5.0 5.7 2.2 7.0 6.7 6.1 1.8 1.1 2.7 1.4 2.0 1.9 2.9 2.5 3.2 1.6 2.1 2.2 1.7 1.5 2.1 2.0 3.3 1.0 1.7 1.2 4.4 1.5 2.3 2.9 2.4 2.5 2.1 2.7 2.6 2.7 2.7 2.3 3.2 4.3 22.8 9.6 8.8 40.5 27.7 11.0 10.4 15.7 10.8 56.7 18.3 15.0 5.9 8.6 12.3 22.0 139.7 12.3 15.1 13.9 15.6 8.2 51.9 18.7 19.5 13.8 12.1 9.0 38.4 8.0 10.6 16.0 11.2 13.6 12.0 14.7 15.0 14.0 7.8 48.8 39.1 16.3 8.2 10.3 11.0 78.9 29.8 8.9 28.4 30.0 7.7 19.9 25.7 36.7 55.5 6.5 16.2 30.5 29.8 10.5 17.6 22.1 22.5 76.6 26.3 23.4 13.9 125.2 37.7 6.5 7.5 10.9 21.1 7.1 18.4 7.8 SPCS2 KIAA0102 ENSG00000118363 "Signal peptidase complex subunit 2" Q15005 11 74949247-74979033 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 933.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013386 Approved Approved Nucleoplasm NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm "HPA013386: AB_1857426" "unprognostic (2.43e-1)" "unprognostic (7.01e-2)" "unprognostic (1.65e-2)" "unprognostic (7.09e-3)" "unprognostic (9.30e-2)" "unprognostic (2.31e-2)" "unprognostic (7.04e-3)" "unprognostic (9.61e-2)" "unprognostic (8.83e-2)" "unprognostic (2.02e-3)" "unprognostic (1.25e-2)" "unprognostic (1.74e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-2)" "unprognostic (5.70e-2)" "unprognostic (1.37e-1)" "unprognostic (8.62e-2)" 81.0 99.4 86.4 104.9 96.6 60.1 108.2 98.7 131.1 127.5 88.8 119.3 90.5 92.2 220.1 72.8 95.9 66.5 76.2 86.3 102.7 105.6 151.6 79.5 98.2 98.5 93.3 84.3 137.3 147.7 75.1 81.2 98.9 106.9 115.1 75.4 139.0 93.3 71.4 56.6 83.3 93.1 99.7 92.5 105.5 50.4 94.3 97.8 143.9 69.5 154.8 95.0 68.1 107.7 141.7 163.4 213.2 192.2 183.2 122.0 115.9 198.6 192.4 179.0 154.8 322.9 311.7 228.2 244.1 168.9 213.6 254.2 187.3 146.1 220.5 190.0 136.4 232.2 189.7 268.9 208.1 249.3 156.7 109.7 186.1 151.5 245.5 156.8 173.7 166.6 271.9 578.0 163.9 215.0 179.1 158.0 131.0 558.3 153.5 219.2 328.2 522.4 208.2 232.3 172.3 172.6 198.1 262.9 687.6 146.7 254.1 187.6 142.0 201.9 124.9 212.1 177.5 245.1 268.8 423.8 83.0 173.4 209.4 546.3 229.2 219.2 279.8 231.0 315.2 400.7 253.7 269.4 222.0 344.3 191.7 229.5 148.5 260.9 209.8 459.5 272.0 428.3 86.4 96.6 98.7 131.1 86.3 102.7 98.5 93.3 98.9 99.7 94.3 107.7 192.3 86.6 143.6 40.5 323.2 304.5 314.0 812.0 129.7 97.6 212.6 199.9 69.1 214.4 406.0 239.1 52.1 330.8 233.5 130.3 189.8 290.0 36.5 126.4 250.4 181.4 125.4 191.5 46.6 288.0 334.4 239.4 104.5 240.2 155.2 114.7 158.1 338.0 278.9 95.9 55.4 255.1 431.3 140.1 283.3 27.2 240.8 159.7 521.2 23.4 188.6 215.6 197.8 48.7 73.5 253.2 140.0 195.6 933.5 355.5 141.7 280.8 231.1 87.3 170.9 153.6 253.6 127.8 133.1 112.1 229.4 464.8 204.6 192.2 189.5 298.1 NEU3 ENSG00000162139 "Neuraminidase 3" Q9UQ49 11 74988279-75018893 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 62.6;Spermatocytes: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038729, HPA070381" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 34: Basophils - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm Vesicles "HPA038729: AB_2676179, HPA070381: " "unprognostic (1.67e-1)" "unprognostic (2.10e-1)" "unprognostic (2.55e-2)" "unprognostic (1.13e-3)" "unprognostic (2.95e-2)" "unprognostic (5.42e-2)" "unprognostic (1.63e-1)" "unprognostic (5.11e-2)" "unprognostic (3.91e-3)" "unprognostic (8.50e-2)" "prognostic favorable (5.98e-4)" "unprognostic (3.57e-3)" "unprognostic (3.80e-2)" "unprognostic (3.79e-1)" "unprognostic (2.38e-1)" "unprognostic (3.73e-1)" "unprognostic (1.84e-1)" 3.2 12.7 8.1 6.4 9.7 23.7 6.5 5.1 10.8 3.8 2.9 4.2 4.3 4.9 5.2 2.6 4.2 4.5 6.2 5.3 5.0 5.1 8.2 5.1 8.3 4.1 4.0 8.0 6.1 10.4 5.7 3.9 5.4 11.5 6.4 10.4 4.2 3.2 26.4 8.0 4.3 4.8 1.1 6.2 4.8 13.9 5.1 12.3 8.1 22.6 7.8 3.5 2.5 7.5 9.1 8.2 6.7 11.7 5.2 4.4 7.1 8.7 5.7 9.4 7.7 24.3 7.2 25.7 8.5 7.2 12.9 8.1 16.1 11.4 14.7 13.2 7.9 21.8 14.4 10.8 5.6 34.7 19.3 5.5 9.4 9.9 15.0 6.5 7.2 37.3 35.1 17.5 11.2 9.7 33.1 16.8 8.0 18.5 10.3 27.0 17.5 22.2 12.8 9.3 12.0 7.2 13.7 8.4 37.0 8.0 18.9 8.2 10.4 11.6 11.7 8.0 9.1 15.5 15.8 51.8 3.6 17.2 9.8 1.2 2.6 2.4 1.5 1.4 1.1 1.0 1.2 1.5 1.5 1.2 1.2 1.5 1.5 0.5 1.8 1.1 0.9 0.9 8.1 9.7 5.1 10.8 5.3 5.0 4.1 4.0 5.4 1.1 5.1 7.5 1.4 3.2 4.6 4.6 5.3 0.5 2.0 0.4 0.6 8.6 3.5 3.9 7.7 2.8 2.7 1.8 62.6 2.1 4.1 1.0 0.0 1.2 9.2 2.2 2.3 2.3 7.2 5.0 12.5 3.1 1.4 2.1 3.1 2.7 1.3 3.7 3.6 6.9 5.4 11.8 10.3 2.9 2.0 10.1 1.1 7.6 1.5 6.2 0.0 8.4 6.8 3.4 3.1 9.5 9.9 2.6 1.0 1.9 5.8 3.0 1.6 3.7 1.6 6.4 0.0 5.8 1.8 32.0 2.2 1.6 0.6 1.4 3.9 3.8 2.8 0.6 OR2AT4 ENSG00000171561 "Olfactory receptor family 2 subfamily AT member 4" A6NND4 11 75081753-75096876 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.2;retina: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "K-562: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 6: Brain - Smell perception" "Cluster 1: K-562 - Erythropoiesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" 0.3 0.2 0.7 0.3 0.9 1.4 0.2 3.2 2.1 0.1 0.0 0.2 0.2 0.2 0.6 0.2 0.1 0.3 0.2 0.7 0.1 0.2 0.4 0.2 0.4 0.1 0.0 0.4 0.2 0.1 0.0 0.2 0.5 0.2 0.2 1.8 0.3 0.1 0.3 0.7 0.3 0.1 0.0 0.4 0.2 0.5 0.3 0.2 0.3 0.0 0.2 0.2 0.0 1.8 0.3 0.2 0.3 0.3 0.1 0.2 0.3 0.1 0.1 0.0 0.1 0.3 0.3 0.6 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.5 0.7 0.3 0.1 0.5 0.4 0.1 0.1 0.1 0.2 0.3 0.1 0.4 2.1 0.8 0.1 0.3 0.2 0.4 0.5 0.1 0.1 0.3 0.4 0.5 0.1 0.5 0.4 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.4 0.3 0.3 0.3 0.2 0.4 0.4 0.3 0.2 0.3 0.3 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.0 0.7 0.9 3.2 2.1 0.7 0.1 0.1 0.0 0.5 0.0 0.3 1.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLCO2B1 "OATP-B, OATP2B1, SLC21A9" ENSG00000137491 "Solute carrier organic anion transporter family member 2B1" O94956 11 75100563-75206549 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 229.6" "Cell type enhanced" "Detected in many" "Hepatocytes: 204.5;Hofbauer cells: 122.2;Kupffer cells: 155.8;Macrophages: 92.4;Microglial cells: 232.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 90.3;GAMG: 21.2;Hep G2: 20.4;HMC-1: 25.8;OE19: 111.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020659 Uncertain NA NA "Cluster 15: Liver - Metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 4: Macrophages - Innate immune response" "HPA020659: AB_1857219" "unprognostic (8.25e-2)" "unprognostic (5.30e-2)" "unprognostic (2.02e-2)" "unprognostic (3.57e-1)" "unprognostic (3.40e-1)" "unprognostic (1.03e-1)" "unprognostic (1.58e-2)" "unprognostic (1.09e-1)" "unprognostic (2.61e-1)" "unprognostic (2.00e-3)" "unprognostic (1.99e-1)" "unprognostic (2.09e-1)" "unprognostic (9.75e-3)" "unprognostic (2.54e-2)" "unprognostic (4.57e-3)" "unprognostic (1.04e-1)" "unprognostic (3.87e-2)" 39.9 31.5 40.1 34.0 35.9 2.9 12.1 34.0 37.4 18.1 21.3 30.9 42.1 9.5 3.6 19.7 13.2 28.4 15.6 31.9 47.2 21.0 229.6 60.7 60.1 75.7 53.4 9.4 22.1 7.9 5.1 43.9 63.0 6.1 23.6 1.5 8.4 9.6 5.6 4.3 51.3 26.3 49.7 46.4 15.0 6.0 80.4 16.7 10.1 8.0 28.5 26.3 6.2 55.1 0.0 0.7 2.8 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 90.3 0.0 0.1 0.1 0.0 21.2 0.2 0.0 0.0 0.0 1.1 0.0 15.0 1.0 20.4 0.0 1.1 25.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.3 8.7 0.0 0.1 0.0 0.1 0.1 111.1 0.0 0.0 2.4 9.6 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.8 0.0 0.0 1.9 0.0 0.1 0.3 0.0 1.5 1.8 0.0 1.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.1 35.9 34.0 37.4 31.9 47.2 75.7 53.4 63.0 49.7 80.4 55.1 4.7 0.0 8.9 1.3 0.7 1.9 0.0 0.0 1.8 3.4 0.9 1.4 2.8 11.5 1.8 0.0 0.0 0.9 0.1 14.7 1.9 0.0 2.8 0.0 0.1 28.8 0.0 2.7 0.5 0.2 2.3 3.6 0.5 0.0 22.9 6.1 3.6 204.5 122.2 0.0 0.5 6.6 0.0 155.8 8.9 1.7 10.8 92.4 0.0 232.3 2.0 0.2 0.0 1.5 0.6 0.1 14.6 10.5 1.4 0.0 46.7 8.2 0.7 0.7 0.0 3.0 1.1 0.4 0.2 4.5 0.4 2.5 0.7 0.4 13.3 0.1 TPBGL ENSG00000261594 "Trophoblast glycoprotein like" P0DKB5 11 75240774-75243704 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 10.7;testis: 4.4" "Cell type enhanced" "Detected in some" "Bipolar cells: 16.9;Melanocytes: 3.6;Muller glia cells: 10.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.1" "Region enhanced" "Detected in many" "medulla oblongata: 10.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.4;HMC-1: 1.8;SCLC-21H: 1.8" "Low region specificity" "Detected in many" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 3: HMC-1 - Innate immune response" "Cluster 5: Muller glia cells - Visual perception" "unprognostic (1.55e-2)" "unprognostic (4.38e-2)" "unprognostic (3.08e-2)" "unprognostic (2.70e-3)" "unprognostic (1.93e-2)" "unprognostic (5.52e-2)" "unprognostic (1.50e-1)" "unprognostic (2.27e-2)" "unprognostic (1.02e-1)" "unprognostic (3.73e-2)" "unprognostic (3.12e-2)" "unprognostic (3.47e-2)" "unprognostic (1.49e-14)" "unprognostic (3.04e-2)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (4.62e-2)" 0.3 1.6 2.0 0.4 3.7 0.0 0.2 0.0 4.0 0.4 0.0 0.3 0.1 0.9 0.0 0.1 0.3 0.3 0.2 1.1 0.6 0.2 0.1 0.2 0.2 10.7 0.3 0.1 0.1 0.0 0.3 0.0 0.7 0.1 0.1 1.4 0.1 0.1 0.0 0.2 0.2 0.6 0.8 0.2 0.1 4.4 0.3 0.1 0.1 0.0 0.2 0.2 0.2 0.8 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.7 0.0 4.0 1.1 0.6 10.7 0.3 0.7 0.8 0.3 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 16.9 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.5 0.0 0.0 0.8 0.2 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.2 1.7 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 3.6 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.2 0.0 0.8 0.1 0.0 0.0 0.1 0.1 0.0 0.0 ARRB1 ARR1 ENSG00000137486 "Arrestin beta 1" P49407 11 75260122-75351705 "Predicted intracellular proteins, Transporters" "Protein transport, Transcription, Transcription regulation, Transport" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 136.8" "Group enriched" "Detected in many" 5 "dendritic cells: 42.5;granulocytes: 49.5;monocytes: 136.8" "Cell line enhanced" "Detected in many" "HEL: 168.9;RH-30: 114.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003763, HPA049318, HPA070249" Approved Supported Nucleoplasm NA NA 1500000 "Cluster 51: Monocytes - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 36: HEL - Hemostasis" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "CAB003763: AB_562248, HPA049318: AB_2680711, HPA070249: AB_2732151" "unprognostic (3.40e-1)" "unprognostic (8.37e-2)" "unprognostic (1.63e-1)" "unprognostic (1.88e-1)" "unprognostic (2.35e-1)" "unprognostic (3.27e-3)" "unprognostic (1.33e-2)" "unprognostic (1.15e-2)" "unprognostic (1.23e-2)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (9.35e-2)" "unprognostic (2.34e-2)" "unprognostic (2.29e-1)" "unprognostic (7.10e-2)" "unprognostic (3.90e-1)" "unprognostic (1.26e-1)" 30.7 7.1 49.7 21.9 49.4 15.7 24.1 28.3 49.5 10.0 0.0 26.4 21.9 10.2 6.1 19.0 15.9 12.9 17.6 54.3 43.6 14.2 10.1 53.0 15.3 41.1 55.6 16.2 24.5 3.8 4.1 25.1 49.4 16.3 22.5 5.3 12.7 9.7 11.4 16.8 27.2 21.8 23.2 40.1 33.9 4.3 49.9 9.9 8.8 10.9 10.3 16.5 11.0 36.7 5.1 23.6 24.2 12.0 20.2 17.6 48.8 5.0 17.2 6.2 4.3 34.5 23.9 2.0 58.9 4.5 4.7 1.1 9.5 0.1 2.4 0.2 5.5 168.9 3.3 20.6 5.5 5.1 63.9 8.9 1.2 10.3 0.0 7.4 70.4 6.1 83.5 0.2 12.2 14.1 3.1 58.4 17.8 76.9 7.1 18.8 114.4 6.8 26.8 20.4 12.5 13.5 8.7 61.7 15.0 49.3 44.8 27.6 61.0 4.7 5.9 19.3 0.6 0.1 0.1 0.1 3.5 78.0 5.8 33.7 65.7 45.9 11.6 106.5 4.3 0.4 5.5 6.6 42.5 0.2 5.0 6.6 49.5 14.8 136.8 0.9 5.7 41.1 49.7 49.4 28.3 49.5 54.3 43.6 41.1 55.6 49.4 23.2 49.9 36.7 24.2 28.9 14.8 52.2 1.9 1.9 2.0 1.9 2.8 3.1 9.0 14.7 4.6 8.6 5.8 3.7 6.2 41.7 10.7 38.5 1.9 5.0 2.6 0.8 4.3 19.4 5.4 10.3 35.6 8.4 4.1 9.1 17.3 0.9 23.5 2.3 25.7 2.1 39.6 0.0 48.9 11.1 8.2 55.2 17.9 21.4 15.8 31.2 3.6 55.3 42.1 0.2 29.9 8.0 23.9 9.2 19.1 16.6 1.0 3.6 29.9 0.2 4.7 1.1 13.1 4.5 7.7 0.2 0.8 1.0 3.0 33.7 5.9 9.4 20.0 2.8 RPS3 "FLJ26283, FLJ27450, MGC87870, S3" ENSG00000149273 "Ribosomal protein S3" P23396 11 75399515-75422280 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation, Translation regulation" "DNA-binding, Lyase, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA063339 Uncertain Supported "Endoplasmic reticulum,Cytosol" NA NA 560000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" "HPA063339: AB_2684990" "unprognostic (3.62e-2)" "unprognostic (6.94e-3)" "unprognostic (2.64e-1)" "unprognostic (1.44e-2)" "unprognostic (5.55e-2)" "unprognostic (1.08e-2)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (2.69e-1)" "unprognostic (5.75e-2)" "unprognostic (3.27e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (6.92e-6)" "unprognostic (3.22e-1)" "unprognostic (2.94e-1)" "unprognostic (1.89e-2)" "unprognostic (2.19e-1)" 1139.4 747.7 431.1 955.9 446.8 2080.0 1950.0 427.3 575.6 1529.6 427.4 1220.4 946.0 1060.9 708.7 1669.8 1270.5 556.5 734.1 417.1 441.6 672.3 631.7 846.0 1663.4 446.6 430.8 2914.0 1761.9 356.4 660.5 760.6 442.8 929.1 919.3 352.7 1049.9 662.1 1125.5 1783.9 1128.2 739.8 444.4 1346.4 1082.2 287.7 435.1 1403.5 717.1 749.0 1360.4 1054.9 1384.5 446.9 1899.8 1145.7 1595.6 1767.5 1970.0 3482.1 2060.8 1763.7 2256.3 2289.4 1481.2 3331.6 2196.8 6547.1 2108.6 1598.8 1261.5 2672.3 2085.6 3290.7 2093.8 1749.1 1618.9 2688.6 1042.6 1490.2 2931.1 4398.6 1690.0 4124.1 4397.7 1568.8 4323.1 2684.0 3055.0 2876.5 2736.9 1809.7 2089.7 2071.2 2660.9 2112.4 2007.4 6591.3 1342.5 2482.3 5580.2 4834.0 2275.9 1551.8 1366.7 1933.6 1299.3 3050.2 1897.1 1535.9 3123.3 3289.9 2470.7 1099.6 1822.9 1515.3 1627.3 1647.2 2198.0 7283.3 660.4 2409.4 1138.1 430.3 770.8 245.5 1405.7 515.5 1924.9 1602.2 1823.1 1489.0 1099.3 1454.0 2102.1 1633.9 174.3 1142.6 512.4 960.4 1283.7 4244.2 431.1 446.8 427.3 575.6 417.1 441.6 446.6 430.8 442.8 444.4 435.1 446.9 1993.9 932.7 1604.3 18.6 4790.5 6297.7 7369.7 5554.5 4497.7 423.9 6945.0 9521.7 418.9 2088.9 2555.7 726.4 133.5 6188.6 4009.1 1694.4 2183.4 2376.0 430.9 939.2 3054.9 2780.8 2067.1 3428.9 28.3 5373.2 9079.0 2364.6 1651.9 1363.9 1641.6 4246.7 2916.7 1369.0 3662.5 132.9 32.6 4425.4 1621.5 3089.2 4666.7 968.5 3755.0 2393.1 2835.3 38.4 3626.4 957.1 4120.5 19.6 47.5 3805.0 3535.7 1803.2 2848.0 5827.8 2969.4 2226.4 797.6 505.5 1117.5 3204.8 3221.9 449.3 618.6 5734.6 7842.8 5867.5 4904.4 4865.2 5657.1 7206.9 KLHL35 FLJ33790 ENSG00000149243 "Kelch like family member 35" Q6PF15 11 75422394-75433203 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 5.2;testis: 9.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 39.6;Early spermatids: 25.9;Late spermatids: 28.4;Spermatogonia: 56.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 15.8;HMC-1: 10.3;PC-3: 8.9;SiHa: 18.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039864, HPA070736" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Centrosome" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 78: Testis - Spermatogenesis" "Cluster 39: CACO-2 - Unknown function" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Centrosome" "Nucleoli fibrillar center" "HPA039864: AB_10794204, HPA070736: " "unprognostic (3.53e-2)" "prognostic favorable (4.63e-4)" "unprognostic (5.40e-2)" "unprognostic (1.97e-1)" "unprognostic (6.88e-2)" "unprognostic (4.15e-3)" "unprognostic (4.98e-2)" "unprognostic (3.92e-2)" "unprognostic (6.52e-2)" "unprognostic (2.87e-1)" "unprognostic (2.67e-1)" "unprognostic (4.39e-2)" "unprognostic (8.68e-3)" "unprognostic (1.59e-1)" "unprognostic (1.05e-1)" "unprognostic (3.11e-2)" "unprognostic (1.28e-1)" 0.6 0.8 3.9 0.0 4.9 0.0 0.9 1.9 3.9 0.7 1.3 0.2 0.0 0.3 0.0 0.4 0.4 0.1 0.8 3.5 5.1 0.3 0.0 0.7 0.0 4.4 3.4 0.2 1.8 0.0 0.9 0.0 5.2 0.2 0.0 0.6 0.8 0.1 0.4 0.9 0.1 0.1 2.7 1.1 1.1 9.3 4.4 0.1 0.6 0.2 0.0 0.3 0.3 3.8 0.0 0.3 0.1 0.0 0.2 1.3 0.0 0.9 0.0 0.9 0.1 15.8 1.3 0.0 4.3 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.8 4.1 10.3 0.2 0.2 0.0 0.0 0.1 0.4 2.7 0.0 0.0 1.1 0.7 0.3 0.1 0.2 3.2 8.9 0.0 0.0 0.9 0.7 0.2 1.2 1.0 18.4 3.4 0.0 0.0 3.4 2.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.8 0.0 0.2 0.0 0.4 0.2 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.4 3.9 4.9 1.9 3.9 3.5 5.1 4.4 3.4 5.2 2.7 4.4 3.8 0.7 9.6 3.4 0.3 1.1 1.3 1.8 0.5 4.0 39.6 6.4 4.8 1.0 1.5 2.8 3.7 8.4 1.5 0.7 0.6 3.9 1.7 25.9 2.1 3.0 1.1 4.2 0.4 3.9 3.1 1.7 3.0 2.6 4.0 4.5 1.5 2.9 0.1 1.2 1.7 3.5 1.4 0.0 1.2 2.1 28.4 2.8 2.9 1.8 0.0 1.6 2.5 3.1 0.0 4.4 3.7 0.4 1.2 0.1 1.3 0.3 0.4 1.6 11.1 6.6 1.3 1.6 10.2 56.7 0.9 2.3 2.5 1.1 2.2 0.7 1.4 GDPD5 "GDE2, PP1665" ENSG00000158555 "Glycerophosphodiester phosphodiesterase domain containing 5" Q8WTR4 11 75434640-75525941 "Enzymes, Predicted membrane proteins" Neurogenesis Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 116.6;retina: 83.5" "Group enriched" "Detected in many" 4 "Bipolar cells: 60.9;Cone photoreceptor cells: 148.0;Early spermatids: 52.1;Late spermatids: 178.0;Rod photoreceptor cells: 88.4;Syncytiotrophoblasts: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 7.7" "Group enriched" "Detected in many" 6 "granulocytes: 7.7;T-cells: 2.0" "Cell line enhanced" "Detected in many" "EFO-21: 32.8;fHDF/TERT166: 32.4;HDLM-2: 66.9;U-2 OS: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065257, HPA066762, HPA069281" Uncertain Approved "Golgi apparatus" No No "Cluster 38: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 44: HDLM-2 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "HPA065257: AB_2685447, HPA066762: AB_2685715, HPA069281: AB_2686107" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (2.37e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.48e-1)" "unprognostic (6.12e-2)" "unprognostic (9.97e-3)" "unprognostic (4.05e-1)" "unprognostic (1.44e-1)" "unprognostic (3.49e-1)" "unprognostic (3.07e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (6.59e-9)" "unprognostic (8.64e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.65e-1)" 31.0 8.7 19.5 4.8 22.1 12.8 24.6 17.4 12.9 12.4 6.0 7.3 2.7 17.9 1.8 3.3 10.3 4.3 9.5 10.5 14.5 7.8 8.1 15.2 6.7 14.2 27.0 7.3 38.1 0.8 19.1 14.0 10.2 11.5 1.6 83.5 21.3 5.3 13.1 7.4 10.0 6.5 7.4 116.6 4.8 38.9 42.1 3.1 7.7 8.7 4.7 12.6 9.9 12.4 2.1 7.5 3.2 3.7 2.2 1.1 11.1 2.3 3.1 1.1 0.7 10.0 4.4 14.2 32.8 32.4 8.1 4.7 4.0 3.8 0.6 66.9 3.1 2.6 11.7 21.2 3.2 1.6 10.7 2.4 2.0 0.8 1.6 3.2 26.7 12.7 4.7 6.3 1.5 4.5 3.9 7.1 5.7 3.7 10.6 4.5 0.9 3.9 0.9 3.6 1.7 1.2 4.8 18.3 9.3 4.1 2.7 6.3 7.9 7.5 30.4 5.8 2.6 1.6 0.3 2.8 1.7 8.5 0.8 7.7 0.8 0.5 1.2 0.3 1.7 0.6 1.3 0.9 0.2 0.2 0.7 0.9 0.1 0.0 0.0 0.7 2.0 0.5 19.5 22.1 17.4 12.9 10.5 14.5 14.2 27.0 10.2 7.4 42.1 12.4 4.2 6.4 0.0 1.6 5.4 1.0 0.3 0.7 0.6 60.9 3.6 3.4 3.0 1.5 1.3 0.0 148.0 3.2 9.1 0.5 0.0 4.2 52.1 1.0 10.4 7.0 0.0 8.2 5.0 9.3 1.5 6.6 1.1 1.5 4.5 1.6 20.7 2.4 1.9 5.0 15.8 0.7 0.0 2.8 3.7 178.0 5.9 3.1 5.4 8.4 4.9 8.9 1.0 1.0 0.8 4.7 0.3 2.6 5.0 0.8 0.3 0.1 0.8 88.4 0.0 4.6 1.9 12.9 8.2 0.1 1.1 46.0 7.0 0.9 2.0 0.6 SERPINH1 "CBP1, CBP2, colligen, HSP47, SERPINH2" ENSG00000149257 "Serpin family H member 1" P50454 11 75562056-75572783 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 473.6;Endometrial stromal cells: 273.3;Extravillous trophoblasts: 342.1;Fibroblasts: 287.6;Smooth muscle cells: 295.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebral cortex: 291.0" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 1018.3;fHDF/TERT166: 1215.2;HHSteC: 1029.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004441, HPA029198" Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA Yes 920000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 39: CACO-2 - Unknown function" "Cluster 33: Fibroblasts - ECM organization" "Endoplasmic reticulum" "CAB004441: AB_627757, HPA029198: AB_10601712" "unprognostic (3.80e-1)" "prognostic unfavorable (2.10e-4)" "unprognostic (5.93e-2)" "unprognostic (2.81e-3)" "unprognostic (3.25e-2)" "prognostic unfavorable (1.85e-4)" "unprognostic (2.39e-2)" "unprognostic (1.72e-3)" "unprognostic (2.35e-2)" "unprognostic (7.40e-2)" "unprognostic (1.57e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (3.22e-15)" "unprognostic (2.75e-2)" "unprognostic (1.27e-1)" "unprognostic (3.93e-2)" "unprognostic (1.96e-2)" 214.1 101.9 46.2 106.5 50.4 3.7 107.1 51.1 291.0 137.7 66.7 95.2 23.2 160.7 27.6 41.7 119.4 72.1 159.3 46.1 50.5 116.9 52.5 199.3 21.1 59.9 47.3 157.4 40.1 18.1 50.8 251.3 58.3 66.1 36.7 2.0 40.7 53.2 22.2 47.6 51.3 207.3 51.6 53.9 76.9 27.7 54.0 21.6 91.2 33.2 18.2 156.8 85.9 60.1 57.7 192.9 349.5 722.0 528.8 484.2 162.2 514.3 349.6 380.4 483.5 1018.3 294.1 0.4 470.2 1215.2 3.1 337.2 242.2 163.2 182.5 27.5 47.0 42.7 174.0 216.5 1029.5 0.9 7.2 580.9 165.2 365.0 121.3 475.5 530.8 22.1 90.5 16.1 182.5 457.6 1.2 74.8 315.6 215.8 50.7 29.3 200.3 48.8 95.6 107.8 9.1 119.1 326.9 59.7 102.0 539.6 144.4 72.7 284.6 388.6 324.6 270.6 128.3 23.1 25.5 6.1 168.0 0.2 535.6 4.1 1.1 0.1 6.0 1.1 5.2 0.9 3.9 4.0 4.4 0.7 4.0 3.3 0.2 5.9 0.1 3.7 3.5 2.1 46.2 50.4 51.1 291.0 46.1 50.5 59.9 47.3 58.3 51.6 54.0 60.1 142.3 38.5 32.0 4.9 2.9 81.8 473.6 56.5 74.0 5.3 28.3 39.5 36.6 14.3 21.0 25.8 58.4 217.0 3.2 33.0 0.0 64.5 2.9 21.8 273.3 194.9 61.1 11.4 0.4 11.9 342.1 287.6 15.3 33.0 9.5 144.1 124.9 9.9 94.2 6.7 0.2 55.7 22.4 5.7 110.0 6.0 164.4 43.6 44.4 18.7 9.8 14.3 8.2 1.0 0.5 22.5 24.3 120.7 6.5 139.8 12.4 22.8 11.9 1.2 92.1 31.4 295.1 29.3 23.0 14.1 44.5 165.8 68.8 79.8 62.8 73.4 MAP6 "FLJ41346, KIAA1878, MAP6-N, STOP" ENSG00000171533 "Microtubule associated protein 6" Q96JE9 11 75586918-75669038 "Predicted intracellular proteins" Transport Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 76.8;retina: 96.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 81.2;Cone photoreceptor cells: 158.4;Excitatory neurons: 75.8;Horizontal cells: 50.5;Inhibitory neurons: 43.3;Late spermatids: 41.9" "Cancer enhanced" "Detected in many" "glioma: 9.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 37.8;CACO-2: 38.1;HDLM-2: 21.5;SCLC-21H: 62.4;SH-SY5Y: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015442, CAB022600, HPA039061, HPA039062" Enhanced Uncertain "Plasma membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 77: Retina - Visual perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "Plasma membrane" "CAB015442: AB_2140997, CAB022600: , HPA039061: AB_2676325, HPA039062: AB_2676326" "unprognostic (3.04e-2)" "unprognostic (6.18e-2)" "unprognostic (3.15e-2)" "unprognostic (9.07e-2)" "unprognostic (7.54e-2)" "unprognostic (4.49e-2)" "unprognostic (8.29e-2)" "unprognostic (2.51e-2)" "unprognostic (5.99e-2)" "unprognostic (7.99e-2)" "prognostic favorable (3.41e-4)" "prognostic favorable (9.15e-4)" "unprognostic (2.43e-2)" "unprognostic (3.96e-3)" "unprognostic (8.09e-3)" "unprognostic (1.77e-1)" "unprognostic (2.03e-1)" 4.8 19.0 68.3 2.0 68.0 0.0 3.5 50.7 70.6 10.6 64.4 23.0 1.7 18.1 21.0 4.2 40.7 6.4 8.6 67.7 71.5 17.0 1.2 7.8 0.7 70.2 64.6 8.0 3.6 22.0 76.8 1.5 70.8 17.8 3.5 96.1 3.6 21.1 1.0 8.1 4.8 13.1 52.9 2.4 10.7 18.6 68.5 0.8 7.9 1.3 0.5 7.1 8.4 59.7 0.2 0.7 37.8 0.1 0.1 0.0 0.0 3.8 0.2 0.3 0.0 38.1 0.1 0.6 1.4 6.3 1.3 0.0 3.4 0.5 0.0 21.5 0.5 0.0 0.0 0.0 1.0 0.0 0.0 2.1 0.5 0.1 0.2 5.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 5.9 0.0 2.9 0.0 0.0 0.1 0.1 0.5 62.4 31.7 4.6 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.1 0.1 0.5 0.0 0.0 0.0 6.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.3 68.0 50.7 70.6 67.7 71.5 70.2 64.6 70.8 52.9 68.5 59.7 1.2 3.2 3.7 25.8 0.1 0.8 1.7 0.7 0.0 81.2 0.8 1.8 8.4 1.5 3.1 11.0 158.4 0.2 0.2 0.0 1.9 0.1 27.7 28.2 4.6 1.6 13.1 0.0 75.8 0.2 0.0 2.9 0.0 0.8 0.0 0.8 2.2 0.3 0.1 50.5 43.3 0.0 6.1 0.0 1.1 41.9 7.5 0.3 5.4 1.9 0.0 18.7 0.0 13.0 13.3 0.2 0.0 18.4 0.1 1.4 0.0 1.2 25.4 10.2 0.0 1.9 5.7 23.5 4.3 0.1 0.4 0.0 0.3 0.1 0.0 0.4 MOGAT2 "DGAT2L5, FLJ22644, MGAT2" ENSG00000166391 "Monoacylglycerol O-acyltransferase 2" Q3SYC2 11 75717838-75732958 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "intestine: 48.2;liver: 25.2" "Cell type enhanced" "Detected in some" "Distal enterocytes: 73.8;Hepatocytes: 79.6;Intestinal goblet cells: 36.2;Proximal enterocytes: 159.6;Undifferentiated cells: 32.4" "Cancer enhanced" "Detected in many" "liver cancer: 6.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Hep G2: 4.5;RPMI-8226: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA028834 Uncertain NA NA "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 45: Enterocytes - Digestion" "HPA028834: AB_10601865" "unprognostic (5.63e-2)" "unprognostic (2.71e-2)" "unprognostic (6.37e-2)" "unprognostic (6.88e-3)" "unprognostic (1.15e-4)" "unprognostic (2.66e-3)" "unprognostic (1.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.42e-2)" "unprognostic (1.12e-1)" "unprognostic (4.21e-2)" "unprognostic (3.02e-1)" "unprognostic (1.24e-5)" "unprognostic (2.13e-3)" "unprognostic (1.84e-2)" "unprognostic (2.13e-1)" "unprognostic (2.83e-3)" 0.0 0.0 0.0 1.9 0.2 0.0 1.4 0.0 0.1 0.1 0.0 13.9 44.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 25.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 12.6 0.0 0.2 0.2 0.0 0.6 48.2 0.7 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.6 0.3 1.5 0.2 0.0 0.0 0.0 0.0 73.8 0.0 0.0 0.0 0.1 0.0 0.0 2.4 2.7 0.0 0.5 0.0 0.0 2.6 0.1 0.0 0.0 0.4 79.6 0.0 0.0 0.0 36.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 21.3 0.0 0.0 0.6 159.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.4 0.1 DGAT2 ENSG00000062282 "Diacylglycerol O-acyltransferase 2" Q96PD7 11 75759512-75801535 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adipose tissue: 476.0;breast: 133.6;liver: 331.8;skin 1: 151.5" "Cell type enhanced" "Detected in many" "Early spermatids: 259.3;Hepatocytes: 116.4;Late spermatids: 64.1;Spermatocytes: 53.9;Spermatogonia: 53.5" "Cancer enhanced" "Detected in many" "liver cancer: 19.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 11 "eosinophil: 137.7;neutrophil: 348.6" "Lineage enriched" "Detected in many" 16 "granulocytes: 348.6" "Cell line enhanced" "Detected in many" "ASC diff: 80.4;HDLM-2: 62.5;Hep G2: 64.9;OE19: 124.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 22.0" HPA013351 Approved Vesicles,Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 21: OE19 - Mitochondria" "Cluster 29: Early spermatids - Spermatogenesis" "Vesicles, Cytosol" "HPA013351: AB_1847630" "unprognostic (2.28e-1)" "unprognostic (3.69e-1)" "unprognostic (9.38e-2)" "prognostic unfavorable (2.84e-4)" "unprognostic (3.63e-1)" "unprognostic (4.99e-2)" "unprognostic (1.10e-2)" "unprognostic (7.59e-2)" "unprognostic (4.46e-1)" "unprognostic (4.12e-3)" "unprognostic (2.87e-1)" "unprognostic (2.99e-1)" "unprognostic (1.49e-7)" "unprognostic (2.03e-1)" "unprognostic (2.85e-1)" "unprognostic (2.74e-2)" "unprognostic (5.60e-2)" 476.0 5.1 5.8 19.4 11.7 7.2 133.6 2.9 6.1 2.6 5.3 9.0 14.5 1.2 1.8 24.1 2.1 5.8 11.7 5.7 6.4 3.4 331.8 5.6 4.0 3.7 3.9 1.8 4.6 2.1 1.6 1.5 5.5 2.2 4.9 0.6 10.5 1.6 4.1 151.5 16.5 2.8 3.4 15.0 12.8 38.1 6.9 4.3 8.8 5.6 18.2 21.3 12.6 5.1 13.3 6.4 0.4 11.2 80.4 6.4 1.0 1.3 1.7 1.6 1.0 46.6 13.5 21.1 16.8 0.3 11.9 0.5 1.8 6.5 4.4 62.5 1.2 1.5 4.0 64.9 0.9 7.4 7.2 26.8 33.6 7.3 10.6 4.4 1.2 20.9 1.2 27.6 0.7 8.5 5.1 16.7 3.6 124.0 31.5 0.0 0.1 24.8 1.2 35.8 22.6 1.4 12.3 1.9 2.9 2.7 4.4 26.6 1.6 14.1 7.0 0.3 9.1 16.3 40.0 28.8 10.2 23.7 25.3 19.4 22.1 137.7 0.0 4.4 0.4 7.4 0.4 0.0 6.1 7.6 0.1 0.2 348.6 0.0 5.0 1.8 0.0 5.7 5.8 11.7 2.9 6.1 5.7 6.4 3.7 3.9 5.5 3.4 6.9 5.1 3.2 6.4 5.4 0.3 5.0 1.1 0.9 3.0 0.6 0.9 5.2 7.0 3.5 0.0 2.7 0.0 2.1 0.5 0.3 0.6 0.0 1.7 259.3 3.3 0.2 0.5 1.2 2.7 2.9 0.5 0.1 0.7 10.7 0.2 0.0 2.1 2.9 116.4 2.2 1.7 1.3 4.8 0.0 4.1 13.1 64.1 2.1 4.2 1.8 0.0 4.0 0.4 0.0 0.0 1.0 3.7 2.2 0.7 0.9 2.8 1.2 2.2 3.4 0.0 6.6 0.6 1.0 53.9 53.5 0.3 8.0 0.8 0.5 0.2 3.0 15.7 UVRAG VPS38 ENSG00000198382 "UV radiation resistance associated" Q9P2Y5 11 75815210-76144232 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 144.6;Microglial cells: 178.9;Oligodendrocytes: 361.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016932 Uncertain NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 57: B-cells - Immune response" "HPA016932: AB_1858707" "unprognostic (3.92e-2)" "unprognostic (1.20e-1)" "unprognostic (1.10e-1)" "unprognostic (4.22e-3)" "unprognostic (2.29e-1)" "unprognostic (1.02e-1)" "unprognostic (1.15e-2)" "unprognostic (2.89e-1)" "unprognostic (2.96e-1)" "unprognostic (3.01e-1)" "unprognostic (7.89e-2)" "unprognostic (2.18e-2)" "unprognostic (6.90e-2)" "unprognostic (1.08e-1)" "unprognostic (1.34e-1)" "unprognostic (6.94e-2)" "unprognostic (3.03e-1)" 32.1 12.8 11.4 17.9 16.9 33.9 20.7 12.1 15.4 13.7 35.9 14.5 10.6 13.3 14.3 10.1 13.3 15.3 10.7 11.4 12.8 11.6 15.3 15.4 26.5 15.0 15.9 12.4 8.2 21.3 7.3 18.2 16.9 10.5 12.4 19.2 8.0 11.4 14.5 11.8 10.6 14.9 16.0 21.4 12.7 7.9 13.9 25.2 12.9 14.7 25.4 13.1 8.9 25.2 10.3 14.4 11.2 9.7 27.2 20.2 16.3 15.0 27.5 17.4 13.8 19.7 18.9 49.5 30.5 20.5 30.7 10.8 19.5 17.5 19.9 27.2 7.8 18.3 12.2 16.8 24.2 30.6 19.1 17.4 14.6 23.8 42.6 13.1 51.0 22.0 19.6 29.7 16.5 24.1 20.9 19.6 11.1 32.1 15.7 17.3 28.5 40.9 14.8 35.0 15.3 10.8 16.6 16.7 13.2 17.1 20.9 27.4 45.3 16.8 12.7 62.4 10.3 18.4 23.3 51.0 7.6 16.0 21.3 5.8 9.9 8.4 7.0 8.8 6.4 23.4 6.1 6.9 16.8 26.6 8.2 6.6 13.9 8.1 11.4 24.0 6.3 4.7 11.4 16.9 12.1 15.4 11.4 12.8 15.0 15.9 16.9 16.0 13.9 25.2 97.3 12.8 21.3 53.8 97.0 9.2 9.4 9.8 26.7 52.2 17.5 19.4 16.1 10.0 11.3 7.3 68.8 37.6 41.6 9.5 7.9 11.5 6.2 13.6 28.1 36.5 5.4 24.6 144.6 8.7 10.3 24.7 34.1 18.5 10.8 16.0 20.0 9.2 17.3 53.8 124.6 10.0 8.2 22.0 50.8 2.6 21.5 46.3 8.8 178.9 45.8 19.0 34.0 89.0 361.8 10.5 11.4 16.1 40.4 12.1 10.8 11.0 6.5 53.1 13.1 27.2 28.6 13.5 19.1 19.4 12.6 32.8 28.1 25.1 10.1 9.1 WNT11 ENSG00000085741 "Wnt family member 11" O96014 11 76186325-76210736 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 37.4" "Group enriched" "Detected in some" 5 "Adipocytes: 41.5;Fibroblasts: 23.2;Theca cells: 24.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "NK-cell: 2.9" "Lineage enriched" "Detected in single" 6 "NK-cells: 2.9" "Cell line enhanced" "Detected in some" "BEWO: 36.2;CACO-2: 12.1;CAPAN-2: 17.8;EFO-21: 57.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA050101 Uncertain "Secreted to extracellular matrix" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 82: Adipose tissue - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "HPA050101: AB_2681015" "prognostic favorable (5.97e-4)" "unprognostic (9.27e-2)" "unprognostic (2.01e-2)" "unprognostic (2.52e-1)" "unprognostic (1.87e-2)" "unprognostic (8.43e-2)" "unprognostic (7.88e-2)" "unprognostic (1.03e-2)" "unprognostic (1.44e-1)" "unprognostic (3.85e-2)" "unprognostic (2.88e-2)" "unprognostic (4.36e-2)" "unprognostic (3.10e-1)" "unprognostic (2.37e-2)" "unprognostic (2.87e-1)" "unprognostic (3.16e-3)" "unprognostic (1.09e-3)" 37.4 20.8 1.7 0.4 3.5 0.9 23.7 4.1 2.2 4.8 14.3 3.6 2.5 2.7 1.3 1.2 6.7 2.1 8.3 3.8 3.5 2.8 8.0 6.3 1.1 7.4 2.7 4.5 9.5 1.2 3.1 4.1 6.9 4.3 1.1 0.3 4.3 1.1 12.3 8.1 3.3 0.6 2.8 3.5 1.4 0.9 2.8 0.9 17.2 7.1 0.2 4.0 3.8 2.1 0.0 0.0 0.0 0.0 2.9 0.2 36.2 0.0 0.0 0.1 0.2 12.1 17.8 0.0 57.0 0.1 0.2 5.5 1.1 0.0 0.0 5.5 2.1 2.9 1.4 2.2 0.0 0.0 0.4 0.1 1.0 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.1 0.0 1.4 0.3 0.0 0.4 0.9 0.0 2.9 0.4 0.0 2.1 0.2 0.0 2.5 0.1 1.4 0.0 0.0 2.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.2 1.7 3.5 4.1 2.2 3.8 3.5 7.4 2.7 6.9 2.8 2.8 2.1 41.5 0.0 0.0 0.3 0.5 1.3 0.5 0.0 1.2 0.0 0.9 1.9 4.7 0.0 0.0 0.0 0.0 0.9 2.3 2.2 0.0 0.0 0.0 5.0 2.9 1.8 0.0 0.0 0.2 0.2 3.3 23.2 0.0 1.1 0.0 0.4 0.7 2.5 0.1 0.0 0.5 0.5 0.0 0.3 2.3 0.0 0.0 0.7 1.8 0.0 0.1 0.0 0.0 0.0 0.1 0.1 2.6 0.7 0.7 0.1 3.8 0.0 0.0 0.0 0.0 1.8 5.7 0.4 0.5 0.1 0.9 1.4 0.9 24.3 1.5 0.1 THAP12 "DAP4, P52rIPK, PRKRIR, THAP0" ENSG00000137492 "THAP domain containing 12" O43422 11 76349956-76381132 "Plasma proteins, Predicted membrane proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 42.4;dendritic cells: 31.6;Endometrial stromal cells: 34.7;Theca cells: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 241.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008758, HPA077077" Approved Approved Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA008758: AB_1855714, HPA077077: " "unprognostic (2.79e-1)" "unprognostic (9.79e-2)" "unprognostic (1.16e-3)" "unprognostic (6.47e-2)" "unprognostic (8.85e-3)" "unprognostic (1.23e-1)" "unprognostic (4.03e-3)" "unprognostic (1.08e-1)" "unprognostic (6.68e-3)" "unprognostic (1.48e-1)" "unprognostic (1.57e-2)" "unprognostic (2.65e-2)" "unprognostic (7.98e-2)" "unprognostic (2.06e-1)" "unprognostic (3.95e-2)" "unprognostic (1.54e-1)" "unprognostic (4.79e-2)" 25.7 21.9 13.8 20.1 14.2 33.4 29.7 13.6 16.3 21.4 13.2 24.1 19.9 24.2 21.1 11.2 19.0 16.7 17.2 14.4 13.8 19.6 19.5 21.8 33.0 13.1 14.2 20.3 41.6 14.2 9.5 26.2 13.1 17.1 25.7 37.2 15.6 19.0 31.7 14.5 20.0 22.0 13.9 26.0 21.5 18.1 14.2 30.6 22.1 32.9 28.7 20.4 15.0 13.6 37.7 29.3 54.6 31.1 36.4 51.5 33.4 38.0 38.9 46.4 40.8 58.9 38.9 100.8 57.1 36.2 40.7 36.5 67.4 44.6 73.9 78.3 21.5 72.2 20.2 27.4 40.2 92.3 34.9 37.1 57.8 41.3 76.9 28.1 40.7 70.5 85.3 55.3 42.0 40.4 81.4 51.9 22.7 98.5 31.8 60.3 124.7 105.0 27.1 38.8 53.1 35.6 36.7 40.1 20.5 36.5 40.6 35.8 36.7 55.4 91.7 114.2 33.9 49.9 56.6 241.7 13.3 50.8 30.6 0.7 1.5 1.7 4.5 1.6 5.2 3.3 4.7 5.0 2.1 3.6 3.4 4.4 0.5 5.6 1.5 0.9 4.7 1.7 13.8 14.2 13.6 16.3 14.4 13.8 13.1 14.2 13.1 13.9 14.2 13.6 42.4 25.6 25.3 0.0 13.6 0.0 0.0 0.0 0.0 0.0 29.6 24.0 0.0 0.0 6.2 11.0 0.0 14.2 31.6 0.0 13.7 10.9 0.0 13.6 34.7 9.8 0.0 0.0 0.0 26.4 21.5 11.3 0.0 19.3 7.6 24.5 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 8.3 0.0 0.0 0.0 0.0 14.1 0.0 0.0 7.6 0.0 0.0 16.3 5.8 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 16.3 13.4 34.4 0.0 0.0 GVQW3 ENSG00000179240 "GVQW motif containing 3" Q3ZCU0 11 76381303-76414619 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 14.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.9;Distal tubular cells: 9.8;granulocytes: 3.8;Granulosa cells: 7.0;Proximal tubular cells: 6.7;Theca cells: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057405 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Centrosome" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Centrosome" "Endoplasmic reticulum" "HPA057405: AB_2683429" "unprognostic (8.90e-2)" "unprognostic (1.16e-1)" "unprognostic (8.27e-2)" "unprognostic (1.92e-1)" "unprognostic (9.04e-3)" "unprognostic (8.56e-2)" "unprognostic (8.87e-2)" "unprognostic (2.91e-2)" "unprognostic (7.28e-3)" "unprognostic (2.21e-1)" "unprognostic (1.04e-2)" "unprognostic (1.49e-1)" "unprognostic (4.05e-4)" "unprognostic (7.45e-2)" "unprognostic (1.09e-1)" "unprognostic (9.28e-2)" "unprognostic (2.13e-1)" 1.1 1.5 1.5 1.4 1.6 1.1 1.9 3.2 2.1 1.7 4.4 1.3 1.4 1.8 1.9 0.4 2.0 0.7 1.0 1.4 0.8 1.4 0.7 0.9 1.9 0.5 0.1 2.2 6.5 1.0 2.4 0.8 0.6 1.2 1.5 14.2 1.9 0.8 1.1 1.4 1.3 0.9 0.0 1.7 1.4 3.4 1.2 2.4 1.9 0.6 1.6 0.9 1.3 1.5 1.1 1.2 4.4 3.2 1.2 1.6 1.5 0.6 0.5 1.1 1.1 3.0 2.0 3.6 1.2 0.5 1.3 2.6 1.9 0.8 1.9 2.0 1.2 1.9 5.0 1.3 0.7 2.5 1.2 0.7 1.2 1.4 0.8 1.0 0.9 4.9 1.2 2.3 0.4 1.3 2.4 3.8 0.9 0.9 1.4 3.7 2.9 1.9 0.7 0.8 6.5 2.9 1.2 0.7 0.7 1.7 2.1 0.8 0.6 2.1 2.2 3.2 0.7 2.1 1.6 4.6 0.8 1.7 1.1 1.5 0.3 0.4 0.4 0.2 0.3 0.5 0.6 0.5 0.2 0.6 0.6 0.6 1.0 0.8 0.2 0.3 0.8 0.2 1.5 1.6 3.2 2.1 1.4 0.8 0.5 0.1 0.6 0.0 1.2 1.5 2.1 0.0 3.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.8 2.3 0.0 0.0 2.5 1.8 0.0 1.1 1.7 0.0 9.8 1.2 0.0 2.4 2.5 0.8 0.0 0.0 0.0 0.6 0.6 1.4 0.0 0.6 3.8 7.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 6.7 2.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.9 5.5 0.0 0.0 EMSY C11orf30 ENSG00000158636 "EMSY transcriptional repressor, BRCA2 interacting" Q7Z589 11 76444923-76553025 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012234, HPA050777" Supported Supported Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "CAB012234: AB_449325, HPA050777: AB_2681232" "unprognostic (1.69e-2)" "unprognostic (8.15e-2)" "unprognostic (1.51e-3)" "unprognostic (3.66e-2)" "unprognostic (2.60e-2)" "unprognostic (1.54e-2)" "unprognostic (3.32e-2)" "unprognostic (3.87e-2)" "unprognostic (2.01e-2)" "unprognostic (7.70e-2)" "unprognostic (8.47e-2)" "unprognostic (5.37e-2)" "unprognostic (2.99e-2)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (6.64e-2)" "unprognostic (8.74e-2)" 6.8 5.8 4.6 7.7 7.5 13.1 8.7 15.3 8.6 8.1 6.9 7.6 5.2 10.0 7.6 6.1 8.6 6.4 9.0 4.9 8.0 7.3 5.6 9.0 8.9 6.0 5.9 11.4 8.8 9.8 5.7 12.2 6.7 7.7 8.7 17.8 7.1 7.7 9.3 5.7 6.6 10.1 4.3 7.9 6.6 8.7 6.3 13.3 8.2 12.6 8.4 7.3 7.4 12.3 8.6 11.9 26.8 16.5 9.9 9.8 11.8 13.5 13.3 17.3 18.9 20.3 11.5 11.7 12.7 14.7 14.3 16.8 21.9 13.0 26.6 18.7 8.2 18.2 18.5 8.8 6.3 20.0 15.8 8.9 8.5 19.8 16.3 11.0 15.8 19.6 12.9 20.0 14.1 22.8 26.9 12.0 11.7 26.9 15.6 17.1 49.2 16.4 12.0 10.0 16.7 7.3 19.0 12.8 4.1 16.5 25.9 12.2 11.9 16.2 21.8 42.0 9.6 11.1 12.8 33.1 5.4 12.0 12.1 11.9 3.5 7.5 4.5 3.3 4.3 4.3 4.3 5.5 2.6 4.9 3.9 3.7 7.3 3.6 2.7 4.2 4.7 3.0 4.6 7.5 15.3 8.6 4.9 8.0 6.0 5.9 6.7 4.3 6.3 12.3 14.0 16.0 7.8 0.0 15.1 0.0 7.5 0.0 17.1 19.7 12.1 10.2 0.0 2.8 6.2 12.9 35.5 15.6 14.0 4.8 13.7 6.2 1.8 13.7 14.0 10.7 7.3 13.5 0.0 4.3 7.7 9.2 10.2 10.1 2.5 17.2 12.8 7.3 8.6 15.2 0.0 12.0 0.0 7.9 0.0 2.0 11.5 9.0 0.0 0.0 7.3 8.9 14.4 0.0 0.0 5.9 4.4 12.4 20.1 14.1 8.4 10.1 6.6 22.8 13.1 11.5 10.6 25.8 12.3 15.0 0.0 21.1 13.3 12.3 8.1 11.7 LRRC32 "D11S833E, GARP" ENSG00000137507 "Leucine rich repeat containing 32" Q14392 11 76657524-76670747 "Predicted intracellular proteins, Predicted membrane proteins" "Growth factor binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 78.0;Endothelial cells: 88.3;Extravillous trophoblasts: 164.2;Hepatic stellate cells: 95.3;Sertoli cells: 39.5;Smooth muscle cells: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 2.2" "Lineage enhanced" "Detected in single" "T-cells: 2.2" "Group enriched" "Detected in some" 6 "ASC diff: 115.0;ASC TERT1: 70.3;HSkMC: 44.0;HUVEC TERT2: 51.4;U-2197: 108.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055775, HPA058434" Enhanced Nucleoplasm "Intracellular and membrane" NA NA 98000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 82: Adipose tissue - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "HPA055775: AB_2732600, HPA058434: AB_2732622" "unprognostic (3.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (4.19e-3)" "unprognostic (1.16e-1)" "unprognostic (8.84e-2)" "unprognostic (1.39e-2)" "unprognostic (2.24e-2)" "unprognostic (6.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.58e-1)" "unprognostic (9.86e-2)" "prognostic unfavorable (3.93e-5)" "unprognostic (7.99e-3)" "unprognostic (1.15e-2)" "unprognostic (5.22e-3)" "prognostic unfavorable (2.64e-4)" 104.5 34.3 12.6 10.5 12.6 2.4 63.6 11.2 11.8 56.2 8.4 23.2 8.9 36.4 6.2 10.3 31.6 29.0 55.7 9.6 10.6 64.7 11.3 109.0 4.3 12.2 13.8 13.5 12.0 7.5 16.7 53.0 13.0 24.9 6.1 1.3 12.8 11.0 23.6 26.6 21.4 15.2 10.9 28.9 21.3 3.6 15.0 2.0 42.3 6.2 1.5 36.7 28.8 11.5 0.0 0.0 1.3 0.0 115.0 70.3 1.4 0.4 0.8 0.1 0.1 0.0 0.0 0.2 3.1 1.9 0.0 0.1 0.2 0.0 0.1 0.0 0.0 11.8 0.6 0.0 2.2 0.0 0.1 44.0 0.0 4.1 0.2 0.9 51.4 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 7.6 0.2 0.0 13.8 7.5 0.8 108.3 0.0 0.1 0.0 1.9 5.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.2 4.3 12.6 12.6 11.2 11.8 9.6 10.6 12.2 13.8 13.0 10.9 15.0 11.5 78.0 0.0 4.3 0.0 1.7 14.5 0.3 0.0 1.8 0.0 0.6 0.6 10.4 0.0 1.3 0.0 0.0 1.9 0.1 0.2 0.0 0.3 1.3 0.1 1.9 88.3 0.0 5.3 0.0 0.0 164.2 26.4 0.5 0.3 2.5 0.5 95.3 0.6 3.6 0.0 0.1 0.4 0.0 3.1 19.0 1.9 9.0 2.9 17.8 14.0 0.0 0.4 0.0 0.0 0.1 0.0 2.2 9.1 0.2 1.4 0.0 0.4 0.7 0.1 39.5 2.1 47.6 0.4 4.7 0.6 12.5 8.3 1.6 0.4 0.1 1.2 TSKU "E2IG4, LRRC54, TSK" ENSG00000182704 "Tsukushi, small leucine rich proteoglycan" Q8WUA8 11 76782251-76798153 "Predicted secreted proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 237.3" "Cell type enriched" "Detected in many" 7 "Hepatocytes: 506.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 168.0;ASC diff: 282.5;OE19: 188.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA008164 Approved Approved "Nucleoplasm,Nuclear bodies" "Secreted to blood" NA NA 6200000 "Cluster 6: Non-specific - Transcription" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 2: Hepatocytes - Metabolism" Nucleoplasm "Nuclear bodies" "HPA008164: AB_1853327" "unprognostic (1.07e-2)" "unprognostic (2.29e-3)" "unprognostic (6.15e-2)" "prognostic favorable (3.66e-4)" "unprognostic (7.05e-2)" "unprognostic (2.39e-1)" "unprognostic (3.08e-1)" "unprognostic (2.17e-3)" "unprognostic (4.81e-2)" "unprognostic (4.62e-2)" "prognostic unfavorable (2.87e-4)" "prognostic favorable (1.66e-4)" "prognostic unfavorable (2.80e-8)" "unprognostic (1.47e-1)" "unprognostic (4.93e-2)" "unprognostic (6.71e-2)" "unprognostic (3.88e-2)" 96.5 12.1 4.2 8.3 4.5 2.1 80.4 6.5 5.8 147.1 27.8 23.5 37.1 46.4 20.6 62.8 67.7 14.9 34.8 6.5 2.7 41.5 237.3 15.0 2.4 4.4 3.1 47.0 16.8 6.4 14.8 30.3 5.0 44.0 14.4 4.1 33.9 24.6 9.5 60.0 32.3 41.1 1.9 6.9 28.2 9.1 3.9 4.7 37.6 5.7 5.6 41.6 99.6 4.4 3.7 168.0 19.1 18.4 282.5 36.1 34.6 5.9 32.2 12.6 12.0 22.2 48.0 0.3 32.7 21.1 53.7 68.6 10.9 42.7 3.9 35.7 5.9 8.3 43.5 63.1 53.6 3.0 11.9 37.3 46.0 22.5 18.2 24.0 15.7 6.4 19.9 1.4 11.7 81.9 0.5 6.5 24.5 188.9 7.4 5.9 18.3 28.7 29.7 29.7 16.8 28.5 32.7 25.7 15.4 15.8 34.5 2.7 4.9 35.4 28.2 86.8 14.2 1.1 0.6 1.4 16.6 8.9 6.4 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.3 0.1 0.2 0.3 0.1 0.0 0.1 0.1 0.0 4.2 4.5 6.5 5.8 6.5 2.7 4.4 3.1 5.0 1.9 3.9 4.4 6.2 0.0 0.5 1.0 0.5 17.3 12.1 25.8 27.9 3.5 13.6 13.2 3.2 11.5 12.1 1.8 0.0 50.0 0.1 33.2 0.0 6.7 0.2 8.1 35.6 5.8 7.8 13.5 0.5 21.7 71.8 33.0 14.8 10.6 1.3 38.7 9.7 506.3 9.9 0.0 0.1 12.4 26.4 9.1 6.4 2.0 37.3 0.8 5.4 1.9 1.6 9.2 0.0 0.0 0.0 21.3 21.2 45.1 0.1 14.6 28.6 21.9 3.0 0.6 0.0 1.0 11.3 0.4 2.0 22.3 22.6 43.8 1.6 8.6 13.8 20.1 ACER3 "APHC, FLJ11238, PHCA" ENSG00000078124 "Alkaline ceramidase 3" Q9NUN7 11 76860859-77026797 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 335.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070087 Approved NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA070087: AB_2732147" "unprognostic (1.32e-1)" "unprognostic (1.51e-1)" "unprognostic (9.54e-3)" "unprognostic (1.37e-1)" "unprognostic (4.06e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (7.13e-2)" "unprognostic (2.35e-3)" "unprognostic (8.45e-3)" "unprognostic (1.30e-1)" "unprognostic (3.68e-3)" "prognostic unfavorable (2.73e-4)" "unprognostic (5.24e-2)" "unprognostic (3.37e-1)" "unprognostic (9.88e-2)" "unprognostic (7.97e-2)" 10.9 3.0 6.2 4.8 8.5 3.0 5.4 8.5 9.3 5.2 4.0 6.4 6.2 4.2 3.1 6.9 4.1 3.2 3.4 6.3 8.5 4.7 2.5 8.0 4.2 8.6 7.1 2.3 2.9 3.5 2.1 6.2 9.5 4.1 5.5 2.3 4.2 2.3 1.6 2.9 4.6 3.9 8.4 5.6 3.4 6.0 7.3 2.2 3.3 1.2 3.8 4.5 4.4 12.0 7.3 7.7 6.4 7.6 29.2 14.0 5.7 11.2 10.7 8.2 9.2 6.0 7.3 6.4 8.4 8.0 10.3 12.9 10.9 10.6 10.0 8.6 4.3 9.0 4.8 3.6 8.1 9.3 15.0 6.3 5.0 11.8 10.9 4.8 16.8 5.8 6.1 4.2 9.9 5.9 0.7 6.2 3.6 19.3 8.8 4.3 22.8 5.0 6.8 7.2 2.2 5.5 13.9 12.6 3.5 4.9 10.7 5.1 22.2 8.2 6.4 23.3 8.3 3.1 7.1 8.6 5.1 4.7 8.9 0.1 4.3 2.5 0.7 3.1 0.8 1.2 0.5 0.9 4.6 0.4 0.3 0.4 0.9 0.2 2.4 1.5 1.2 1.6 6.2 8.5 8.5 9.3 6.3 8.5 8.6 7.1 9.5 8.4 7.3 12.0 32.4 41.7 35.0 52.9 11.5 31.9 21.4 17.0 33.0 18.8 11.3 11.0 7.5 11.5 27.6 9.2 10.4 13.6 11.3 54.6 7.9 15.5 66.8 6.3 29.0 29.4 2.4 13.5 65.0 17.6 7.5 17.0 26.0 11.5 83.5 30.9 27.8 10.0 44.4 43.7 71.9 30.5 18.3 64.1 67.1 31.7 20.2 64.0 17.8 61.8 40.0 11.3 12.3 159.3 335.1 18.6 37.9 25.9 8.6 15.6 20.0 15.3 12.3 10.0 6.6 17.0 21.0 69.8 25.9 26.3 16.8 26.8 15.2 7.2 20.1 24.1 B3GNT6 B3Gn-T6 ENSG00000198488 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6" Q6ZMB0 11 77034398-77041973 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 21.8;salivary gland: 6.4;stomach 1: 24.9" "Group enriched" "Detected in some" 20 "Gastric mucus-secreting cells: 23.0;Intestinal goblet cells: 60.8" "Group enriched" "Detected in some" 14 "colorectal cancer: 6.3;lung cancer: 3.9;pancreatic cancer: 5.1;prostate cancer: 5.0;stomach cancer: 4.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039805 Enhanced "Intracellular and membrane" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" "HPA039805: AB_2676690" "unprognostic (1.71e-1)" "prognostic favorable (2.31e-4)" "unprognostic (4.79e-2)" "unprognostic (5.42e-2)" "unprognostic (7.64e-2)" "unprognostic (1.95e-1)" "unprognostic (2.72e-1)" "unprognostic (1.23e-2)" "unprognostic (7.77e-2)" "unprognostic (2.19e-1)" "unprognostic (9.30e-2)" "unprognostic (1.71e-1)" 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 21.8 5.4 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 16.8 0.0 6.4 0.0 0.0 0.0 7.0 0.3 0.0 0.0 24.9 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.1 0.1 0.4 0.0 1.0 0.0 0.0 0.0 1.4 2.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.2 23.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 60.8 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.6 1.4 0.0 0.0 0.3 1.2 0.1 0.2 0.0 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.5 0.2 CAPN5 "ADNIV, HTRA3, nCL-3, VRNI" ENSG00000149260 "Calpain 5" O15484 11 77066961-77126155 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 60.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 170.3;Gastric mucus-secreting cells: 80.0;Intestinal goblet cells: 89.8;Paneth cells: 72.6;Proximal enterocytes: 75.6;Undifferentiated cells: 69.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.3" "Lineage enriched" "Detected in single" 4 "T-cells: 1.3" "Cell line enhanced" "Detected in many" "OE19: 106.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033237, HPA072319" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Cytosol "CAB033237: AB_2069673, HPA072319: AB_2686512" "unprognostic (6.81e-3)" "unprognostic (1.31e-1)" "unprognostic (3.36e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (3.47e-3)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (5.30e-2)" "unprognostic (2.52e-1)" "unprognostic (2.21e-2)" "unprognostic (5.35e-3)" "unprognostic (4.64e-1)" "unprognostic (3.17e-3)" "unprognostic (8.58e-3)" "unprognostic (3.25e-1)" "unprognostic (2.31e-2)" "unprognostic (2.30e-3)" 6.7 12.2 8.5 10.9 7.9 2.7 4.9 6.4 8.6 13.5 3.5 60.5 60.7 10.0 5.7 31.6 10.8 36.3 7.2 8.5 8.7 15.1 52.1 4.8 1.9 11.7 8.2 13.2 5.6 1.0 5.1 2.8 12.5 16.0 49.9 3.8 7.7 8.9 1.6 3.1 52.4 11.3 9.9 3.5 47.9 21.5 7.9 2.8 4.7 1.7 2.7 15.4 10.5 8.1 0.8 12.5 8.6 7.8 32.0 30.4 0.7 11.8 22.9 13.4 10.0 6.9 3.6 0.4 7.7 24.5 14.4 0.5 3.8 1.0 6.4 0.5 0.8 2.1 0.5 0.9 7.9 0.2 0.4 16.1 1.4 22.6 5.2 18.8 14.4 5.1 0.2 0.0 26.9 19.9 1.8 0.3 6.6 106.6 9.3 2.0 27.0 0.4 4.6 16.4 0.5 13.5 1.0 2.7 5.9 5.7 1.7 0.1 23.9 25.4 12.3 34.8 1.3 0.8 1.7 0.1 13.1 0.3 5.7 0.0 0.2 0.0 1.3 0.3 0.1 0.0 0.1 0.5 0.2 0.0 0.6 0.8 0.0 0.0 0.0 0.1 0.0 0.7 8.5 7.9 6.4 8.6 8.5 8.7 11.7 8.2 12.5 9.9 7.9 8.1 1.6 0.0 0.5 4.2 1.0 1.7 0.3 2.2 0.0 3.1 0.5 1.8 1.7 24.3 10.3 23.9 0.0 0.1 3.4 170.3 1.9 10.3 1.1 1.9 5.9 2.4 22.3 5.7 4.6 32.7 0.4 7.6 80.0 3.5 0.0 10.2 2.9 40.4 0.9 1.7 6.7 89.8 10.2 1.6 1.8 1.3 12.5 1.2 7.2 1.0 0.3 5.8 5.2 11.6 0.7 22.4 72.6 4.5 0.9 2.0 75.6 9.9 11.1 2.1 0.0 8.3 4.1 0.5 2.3 2.5 0.9 0.0 1.5 5.3 69.2 2.4 OMP ENSG00000254550 "Olfactory marker protein" P47874 11 77102840-77103331 "Predicted intracellular proteins" "Olfaction, Sensory transduction" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 2.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;OE19: 1.4" "Region enriched" "Detected in some" 62 "olfactory bulb: 96.7" "Low region specificity" "Detected in some" NA NA "Cluster 9: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "unprognostic (2.22e-1)" "unprognostic (2.44e-1)" "unprognostic (8.53e-2)" "unprognostic (3.54e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "unprognostic (3.52e-3)" "unprognostic (2.10e-1)" "unprognostic (3.20e-2)" "unprognostic (4.23e-1)" "unprognostic (5.33e-3)" "unprognostic (3.94e-3)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (8.17e-2)" 0.0 0.4 0.3 0.2 0.2 1.1 0.0 0.8 0.5 0.1 0.0 1.5 2.6 0.0 0.0 0.4 0.1 1.2 0.1 0.4 0.5 0.5 1.4 0.0 0.1 1.0 0.3 0.1 0.1 0.0 0.0 0.0 1.1 0.2 1.9 0.0 0.1 0.1 0.1 0.0 2.5 0.2 0.3 0.1 1.0 0.3 0.4 0.0 0.2 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.3 0.0 0.8 0.1 1.0 0.0 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.8 0.5 0.4 0.5 1.0 0.3 1.1 0.3 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYO7A "DFNA11, DFNB2, NSRD2, USH1B" ENSG00000137474 "Myosin VIIA" Q13402 11 77128246-77215241 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hearing "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease variant, Leber congenital amaurosis, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 41.9;choroid plexus: 53.2" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 47.9;Cytotrophoblasts: 42.3;Hofbauer cells: 30.1;Kupffer cells: 17.8;Rod photoreceptor cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 2.6;intermediate monocyte: 1.7" "Lineage enhanced" "Detected in single" "monocytes: 2.6" "Cell line enhanced" "Detected in some" "BEWO: 11.8;CACO-2: 9.0;RH-30: 19.5;RPMI-8226: 13.8;SK-BR-3: 10.5;U-937: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB034059 Uncertain NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 77: Retina - Visual perception" "Cluster 32: U-937 - Innate immune response" "Cluster 47: Cytotrophoblasts - Unknown function" "CAB034059: AB_2148626" "unprognostic (1.14e-3)" "unprognostic (2.58e-2)" "unprognostic (2.94e-2)" "unprognostic (1.61e-1)" "unprognostic (9.66e-2)" "unprognostic (4.02e-3)" "unprognostic (1.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-1)" "unprognostic (1.32e-1)" "unprognostic (3.65e-2)" "unprognostic (6.81e-2)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.31e-1)" "unprognostic (1.14e-1)" "unprognostic (1.10e-2)" "unprognostic (3.03e-2)" 5.2 41.9 2.5 3.0 2.9 1.0 3.1 2.2 2.7 1.9 53.2 2.8 2.2 1.5 1.2 1.0 2.7 2.8 2.5 4.0 8.6 4.3 23.3 2.3 2.9 5.0 8.3 5.2 5.4 0.5 19.1 16.0 8.4 2.4 1.2 27.4 1.5 0.8 1.4 0.8 2.8 2.2 3.5 15.8 2.2 24.5 5.1 1.4 2.0 0.7 1.1 2.0 1.6 4.4 0.0 1.3 0.2 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 9.0 2.0 0.0 2.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 1.7 0.0 0.3 5.7 0.2 0.4 0.0 0.1 0.0 0.0 0.5 0.0 3.9 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.6 1.2 0.3 0.0 19.5 13.8 0.0 0.3 2.9 0.9 0.1 10.5 0.1 2.2 1.3 1.3 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 2.6 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.8 2.5 2.9 2.2 2.7 4.0 8.6 5.0 8.3 8.4 3.5 5.1 4.4 1.7 0.0 0.0 0.0 0.2 0.3 0.3 0.0 0.0 14.2 0.5 0.5 4.4 4.3 0.0 0.0 47.9 42.3 0.3 0.2 0.0 0.6 1.9 0.1 0.5 2.2 1.2 0.0 0.7 1.7 10.5 1.4 5.6 0.3 0.0 0.8 16.4 16.1 30.1 0.0 0.8 0.7 0.0 17.8 0.9 6.4 3.1 7.3 0.0 6.5 0.8 17.0 0.0 3.0 0.1 0.7 0.2 0.4 0.1 0.1 1.7 2.7 0.1 31.4 0.0 5.2 0.3 0.4 0.6 0.1 0.3 16.1 1.4 3.2 0.6 0.2 GDPD4 GDE6 ENSG00000178795 "Glycerophosphodiester phosphodiesterase domain containing 4" Q6W3E5 11 77216558-77301687 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "retina: 1.5;testis: 3.7" "Group enriched" "Detected in some" 9 "Early spermatids: 10.9;Late spermatids: 18.0;Spermatocytes: 17.7;Spermatogonia: 5.3;Theca cells: 5.6" "Cancer enriched" "Detected in single" 10 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 23 "olfactory bulb: 2.3" NA NA "Cluster 77: Retina - Visual perception" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "unprognostic (6.73e-6)" "unprognostic (3.30e-1)" "unprognostic (2.01e-2)" "unprognostic (1.68e-1)" "unprognostic (2.12e-1)" "unprognostic (3.55e-4)" "unprognostic (4.13e-2)" "unprognostic (5.41e-2)" "unprognostic (1.53e-1)" "unprognostic (2.63e-2)" "unprognostic (3.10e-2)" "unprognostic (4.75e-2)" "unprognostic (1.05e-4)" "unprognostic (1.68e-2)" "unprognostic (1.19e-1)" "unprognostic (1.29e-2)" "unprognostic (1.64e-2)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.5 0.0 0.0 0.0 0.0 18.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 17.7 5.3 0.0 0.0 0.3 0.0 5.6 0.0 0.0 PAK1 ENSG00000149269 "P21 (RAC1) activated kinase 1" Q13153 11 77322017-77474635 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Exocytosis" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 219.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 9 "classical monocyte: 182.2;eosinophil: 292.7;intermediate monocyte: 177.7;myeloid DC: 264.3;neutrophil: 431.8;non-classical monocyte: 202.6" "Group enriched" "Detected in all" 11 "dendritic cells: 264.3;granulocytes: 431.8;monocytes: 202.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003565, CAB005312" Enhanced Supported Supported "Plasma membrane,Cytosol" NA NA 560000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane, Cytosol" "CAB005312: AB_2160720, HPA003565: AB_1854935" "unprognostic (1.15e-2)" "unprognostic (3.23e-2)" "prognostic favorable (5.87e-4)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (6.62e-2)" "unprognostic (8.19e-3)" "unprognostic (4.84e-2)" "unprognostic (1.05e-1)" "unprognostic (1.22e-3)" "unprognostic (1.86e-2)" "unprognostic (2.76e-1)" "unprognostic (1.02e-1)" "unprognostic (6.91e-2)" "unprognostic (1.57e-1)" "unprognostic (4.00e-3)" "unprognostic (1.52e-2)" 12.7 13.4 32.4 33.9 44.5 59.0 18.2 13.9 57.7 21.1 0.0 43.2 43.1 20.9 29.8 21.4 21.9 30.9 9.4 58.3 8.0 26.1 14.5 16.8 20.4 19.2 12.2 21.1 17.5 20.5 20.7 14.7 19.4 19.1 46.5 25.1 19.9 19.7 87.0 16.2 45.7 27.0 0.9 29.3 41.2 25.7 17.1 29.1 40.6 18.8 23.1 27.7 20.7 30.0 39.9 26.7 56.7 25.5 22.8 37.6 45.9 44.6 32.1 42.0 48.7 38.7 52.8 36.3 16.0 39.4 54.4 20.2 40.2 47.8 65.5 41.4 32.6 38.2 17.6 2.3 15.3 64.3 53.5 28.2 28.8 49.2 73.1 36.6 10.1 41.3 25.5 61.2 77.6 2.9 42.3 30.2 84.5 166.2 22.5 62.6 72.3 1.4 10.6 32.9 24.6 23.9 23.6 9.7 19.5 55.0 45.4 29.0 0.9 27.3 47.5 148.9 37.9 165.7 92.4 23.4 23.0 42.5 30.6 2.5 182.2 292.7 11.2 177.7 9.4 16.8 8.4 10.7 264.3 12.9 7.4 14.5 431.8 28.4 202.6 22.9 7.3 92.3 32.4 44.5 13.9 57.7 58.3 8.0 19.2 12.2 19.4 0.9 17.1 30.0 3.1 3.2 20.5 24.2 23.9 11.9 33.3 28.2 23.9 51.6 25.1 19.7 6.2 35.8 30.8 25.8 8.4 25.4 10.2 78.6 45.0 32.4 38.8 37.3 13.5 3.2 37.8 30.5 219.1 56.3 53.5 24.0 45.9 39.7 132.2 35.2 3.6 11.4 49.8 1.7 118.5 50.8 28.5 59.6 152.9 28.3 14.3 80.0 30.2 54.4 121.7 14.9 10.3 53.3 70.7 50.9 57.9 13.2 28.6 28.7 47.9 55.7 39.0 6.4 13.1 13.8 25.2 50.4 53.8 23.6 10.4 95.0 19.3 10.3 52.8 33.2 CLNS1A "CLCI, ICln" ENSG00000074201 "Chloride nucleotide-sensitive channel 1A" P54105 11 77514936-77637794 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017840, HPA031707, HPA031708, HPA032045" Approved Supported Nucleoplasm,Microtubules,Cytosol No No 17000 "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 32: Non-specific - Translation" Cytosol "Nucleoplasm, Microtubules" "CAB017840: , HPA031707: AB_2674002, HPA031708: AB_2674003, HPA032045: AB_2674123" "unprognostic (1.30e-1)" "unprognostic (3.26e-1)" "unprognostic (5.16e-2)" "unprognostic (1.30e-2)" "unprognostic (5.12e-3)" "unprognostic (5.09e-2)" "unprognostic (9.63e-2)" "unprognostic (5.56e-2)" "unprognostic (2.06e-3)" "unprognostic (5.56e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (2.05e-1)" "unprognostic (9.19e-2)" "unprognostic (5.99e-3)" "unprognostic (1.17e-1)" 53.1 88.7 86.1 63.1 91.8 72.3 79.9 89.3 92.7 62.2 82.0 72.7 49.7 63.5 99.6 85.3 74.8 53.2 76.4 79.9 94.1 59.6 105.6 45.7 99.5 88.0 86.6 103.3 90.0 60.2 54.0 65.6 89.8 61.2 77.5 97.0 58.2 57.5 98.4 54.0 53.6 56.8 90.5 61.9 65.7 45.7 87.9 102.8 79.0 100.7 105.4 74.6 61.0 94.8 138.4 134.7 216.6 160.7 157.1 224.8 86.8 119.1 181.3 189.0 168.9 326.5 190.0 308.6 194.5 144.6 148.1 162.8 263.0 245.6 227.2 178.6 160.1 301.9 161.7 188.8 132.5 451.8 134.1 182.9 278.9 165.9 311.7 185.5 217.4 187.1 404.8 91.9 186.6 205.0 299.2 364.5 205.7 458.8 243.9 161.5 419.8 332.7 136.7 191.9 219.0 250.1 158.2 177.7 112.1 155.2 241.8 195.8 144.4 138.7 171.2 274.4 116.8 184.3 276.6 330.1 55.0 166.9 114.4 48.1 100.6 39.1 61.1 107.1 68.9 96.5 76.1 66.3 138.7 99.5 91.1 77.8 7.1 101.2 93.6 85.3 72.8 105.7 86.1 91.8 89.3 92.7 79.9 94.1 88.0 86.6 89.8 90.5 87.9 94.8 47.9 16.0 20.3 14.7 91.6 82.7 107.0 248.2 116.7 67.2 75.4 78.6 71.6 71.4 102.6 58.8 50.1 132.9 70.0 27.4 84.1 76.4 17.0 45.1 57.4 53.1 31.8 123.6 21.7 87.5 145.9 72.5 43.8 34.5 78.0 117.0 57.5 62.2 91.1 58.9 24.3 65.3 87.5 108.7 99.3 13.6 87.7 74.9 76.5 10.3 153.8 221.9 57.7 17.6 24.9 65.4 54.3 68.4 64.8 108.2 79.3 97.6 71.6 60.3 52.6 61.8 54.5 116.0 109.4 128.0 86.1 80.6 69.2 126.7 112.5 103.9 AQP11 ENSG00000178301 "Aquaporin 11" Q8NBQ7 11 77589391-77610356 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 28.6;liver: 16.1" "Cell type enhanced" "Detected in many" "Early spermatids: 42.0;Hepatocytes: 35.9;Late spermatids: 65.0;Muller glia cells: 30.7;Proximal enterocytes: 33.2;Spermatocytes: 56.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 8.2;GAMG: 12.3;Hep G2: 13.6;OE19: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042879 Approved Nucleoplasm,Vesicles NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Vesicles "HPA042879: AB_10794919" "unprognostic (4.95e-2)" "unprognostic (7.61e-2)" "unprognostic (2.15e-2)" "unprognostic (9.62e-5)" "unprognostic (2.42e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-1)" "unprognostic (3.48e-2)" "unprognostic (2.65e-1)" "prognostic favorable (9.89e-4)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (1.73e-1)" "unprognostic (1.73e-2)" "unprognostic (2.44e-1)" "unprognostic (6.46e-2)" "unprognostic (1.66e-3)" 1.0 13.2 3.4 0.7 3.0 0.6 1.2 4.6 3.3 0.8 1.0 2.3 28.6 0.8 1.0 0.4 0.8 1.2 0.8 2.6 3.4 6.0 16.1 0.5 0.8 3.3 3.1 6.0 4.0 0.5 1.5 0.8 3.5 4.0 2.1 5.6 0.7 0.4 0.9 0.9 25.3 0.4 2.7 0.9 2.4 8.1 3.0 0.1 1.5 0.2 0.1 0.8 0.6 3.0 1.0 3.4 1.4 2.2 3.1 0.8 1.3 1.6 0.8 1.6 0.7 8.2 1.6 1.6 0.7 0.8 12.3 0.9 0.6 0.1 0.8 4.7 1.2 1.3 1.3 13.6 1.0 2.8 1.4 0.8 0.3 0.9 0.2 1.9 0.3 0.4 0.9 1.0 1.9 1.7 0.9 2.0 1.4 7.8 3.1 1.3 3.3 0.6 0.9 1.2 1.3 0.9 2.1 0.5 0.8 1.1 1.5 0.3 0.9 1.2 3.7 2.4 1.0 1.0 0.8 1.3 0.4 0.2 1.8 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.2 0.4 0.0 0.5 0.6 0.2 0.0 0.7 0.0 0.0 0.0 0.2 3.4 3.0 4.6 3.3 2.6 3.4 3.3 3.1 3.5 2.7 3.0 3.0 0.6 0.0 0.0 3.9 0.8 0.1 0.9 0.4 1.8 7.5 2.1 1.3 0.7 7.2 0.2 1.8 0.0 7.5 0.6 10.8 0.0 1.1 42.0 1.2 0.8 0.5 4.2 0.0 13.5 4.0 11.4 1.5 3.6 0.8 4.5 17.1 0.4 35.9 1.2 0.0 14.6 2.9 0.0 0.6 0.4 65.0 15.5 0.5 1.8 1.0 0.0 30.7 0.0 9.0 9.9 2.5 5.5 11.3 0.3 1.4 33.2 19.9 0.2 5.0 0.0 0.5 1.2 56.0 6.4 0.4 0.1 15.9 0.7 21.4 6.4 0.4 RSF1 "HBXAP, p325, RSF-1, XAP8" ENSG00000048649 "Remodeling and spacing factor 1" Q96T23 11 77659996-77821017 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022626, HPA046129, HPA057547, HPA064567" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "CAB022626: , HPA046129: AB_2679550, HPA057547: AB_2683462, HPA064567: AB_2685289" "unprognostic (2.67e-1)" "unprognostic (2.02e-1)" "unprognostic (2.39e-1)" "unprognostic (4.35e-3)" "unprognostic (5.00e-3)" "unprognostic (5.57e-2)" "unprognostic (1.23e-2)" "unprognostic (2.46e-1)" "unprognostic (7.33e-3)" "unprognostic (2.35e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (6.19e-2)" "prognostic favorable (5.94e-4)" "unprognostic (1.71e-1)" "unprognostic (2.22e-1)" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" 12.5 17.9 10.8 16.5 12.9 25.7 15.4 43.9 13.7 17.1 1.5 12.8 9.4 20.0 8.9 14.1 14.5 16.6 14.0 8.7 15.4 14.3 11.7 13.2 15.3 8.3 8.5 26.3 16.9 17.3 6.5 18.5 8.5 15.4 12.6 25.9 10.2 13.4 11.7 9.3 10.8 17.5 8.0 16.3 13.5 23.8 12.0 22.6 22.3 13.4 13.5 17.0 8.4 15.5 27.7 18.2 62.0 33.3 20.6 25.9 23.3 31.7 31.0 25.5 31.4 48.0 37.5 46.7 33.2 22.3 39.4 28.1 36.8 23.8 47.7 33.4 16.3 43.9 25.1 13.0 19.6 42.2 30.0 21.8 17.5 35.0 55.8 29.7 32.7 15.2 72.8 43.0 29.7 18.7 29.7 23.4 36.1 32.9 24.8 49.1 107.5 30.6 13.5 35.5 37.3 37.6 48.8 19.1 18.5 32.2 34.3 20.6 41.2 45.0 38.8 71.0 23.1 25.7 35.7 106.3 11.9 28.1 34.5 49.3 17.8 32.8 27.4 16.9 18.8 34.3 16.6 17.6 14.2 35.0 22.7 22.9 46.4 23.7 30.1 32.0 17.0 7.5 10.8 12.9 43.9 13.7 8.7 15.4 8.3 8.5 8.5 8.0 12.0 15.5 100.3 118.6 113.5 99.6 98.0 90.5 69.3 89.7 93.9 123.0 68.8 85.1 97.1 54.3 84.3 73.5 75.0 57.8 85.1 53.0 46.9 79.2 112.4 72.9 95.2 96.5 85.6 71.8 129.4 55.3 50.6 90.5 51.0 86.0 95.5 132.5 79.9 46.2 45.6 146.4 129.3 64.7 71.2 62.9 68.5 40.3 126.8 66.5 56.9 98.4 93.9 124.6 120.5 157.8 144.7 73.1 63.4 118.1 74.8 97.6 44.1 38.2 69.7 97.6 105.2 99.3 100.4 114.8 109.4 57.2 84.0 67.5 99.9 141.7 58.1 91.6 AAMDC "C11orf67, CK067, FLJ21035, PTD015" ENSG00000087884 "Adipogenesis associated Mth938 domain containing" Q9H7C9 11 77821109-77918432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 656.7" "Cell type enhanced" "Detected in all" "Theca cells: 385.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 143.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 280.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA037918, HPA037919" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 39: CACO-2 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA037918: AB_2675737, HPA037919: AB_2675738" "unprognostic (3.10e-2)" "unprognostic (9.04e-3)" "unprognostic (6.02e-2)" "unprognostic (4.67e-1)" "unprognostic (1.27e-1)" "unprognostic (3.51e-2)" "unprognostic (3.00e-1)" "unprognostic (1.44e-1)" "unprognostic (1.08e-1)" "unprognostic (1.07e-2)" "unprognostic (1.23e-1)" "unprognostic (7.08e-2)" "unprognostic (1.90e-1)" "unprognostic (2.08e-1)" "unprognostic (1.35e-1)" "unprognostic (1.37e-1)" "unprognostic (3.84e-2)" 75.8 180.9 30.1 13.0 35.8 21.0 62.5 35.2 42.6 51.0 31.4 66.6 37.4 41.4 27.9 24.6 47.5 23.4 178.9 30.5 31.7 56.0 57.9 46.9 13.8 37.2 34.4 56.7 34.4 27.4 28.6 21.7 35.9 46.0 29.2 20.1 36.6 34.6 656.7 55.4 47.5 40.2 31.9 31.7 62.4 42.2 34.3 23.7 42.2 173.0 13.6 48.1 42.7 42.7 30.3 24.3 37.2 26.5 106.0 73.3 10.0 49.2 33.4 43.8 54.1 280.1 44.6 20.3 46.5 83.0 43.2 16.9 56.4 32.9 51.9 47.1 45.3 19.5 43.5 52.4 52.2 11.2 17.1 98.3 22.2 46.0 24.2 40.2 131.3 27.0 23.1 32.0 93.2 35.6 23.8 44.3 17.3 84.5 41.4 22.3 63.6 19.6 58.2 18.1 13.1 49.2 62.4 26.7 36.0 55.1 41.2 21.1 138.2 45.5 24.7 87.5 16.5 34.2 58.4 37.8 17.7 18.0 26.2 143.1 28.9 33.3 14.6 17.7 18.8 18.3 28.4 24.2 32.6 25.2 24.8 18.4 16.9 35.9 17.5 33.8 47.3 16.3 30.1 35.8 35.2 42.6 30.5 31.7 37.2 34.4 35.9 31.9 34.3 42.7 68.4 83.3 25.4 19.6 10.0 64.2 82.7 51.0 24.5 10.0 58.7 67.2 114.1 62.9 42.5 79.1 4.2 29.1 11.8 70.2 144.8 60.0 100.1 37.7 27.8 55.7 22.7 19.1 6.9 73.1 43.1 64.5 39.3 35.8 41.2 53.4 93.9 122.2 46.9 11.8 8.9 48.7 44.7 29.9 35.9 36.3 68.3 22.5 83.6 8.4 56.2 101.3 16.5 18.1 24.8 70.2 132.2 64.3 10.2 46.6 160.3 200.8 50.1 13.9 46.0 53.5 65.8 154.0 85.4 29.2 100.7 15.7 14.8 385.5 61.0 71.2 INTS4 "INT4, MGC16733, MST093" ENSG00000149262 "Integrator complex subunit 4" Q96HW7 11 77878720-77994671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042378 Uncertain Supported "Nucleoli rim" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoli rim" "HPA042378: AB_10797388" "unprognostic (2.72e-1)" "unprognostic (1.93e-1)" "unprognostic (4.07e-2)" "unprognostic (9.09e-2)" "unprognostic (1.24e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (9.44e-6)" "unprognostic (2.04e-2)" "unprognostic (1.17e-2)" "unprognostic (5.59e-2)" "unprognostic (1.60e-2)" "unprognostic (1.77e-1)" "unprognostic (4.20e-2)" "unprognostic (5.44e-2)" "unprognostic (4.20e-1)" "prognostic favorable (9.66e-4)" "unprognostic (9.39e-2)" 12.8 16.8 13.6 12.8 15.7 18.5 13.4 19.1 14.8 16.7 13.6 13.7 9.5 12.9 11.9 13.7 13.6 9.2 12.8 13.5 15.0 14.3 18.0 12.7 16.7 15.9 14.9 17.0 17.7 11.5 13.1 11.4 16.6 15.7 11.9 14.5 13.2 9.6 11.5 14.2 15.6 10.8 15.8 21.0 13.9 9.9 15.2 17.8 13.8 7.8 16.9 14.4 14.8 21.9 11.1 18.2 23.2 27.3 18.7 16.8 19.1 13.0 14.5 16.6 14.6 37.8 30.0 19.2 27.0 23.3 25.5 27.2 25.6 25.8 26.5 28.0 16.2 29.8 24.2 22.2 17.1 30.5 17.2 17.1 13.9 33.9 29.4 18.1 26.6 20.6 28.9 28.3 25.6 23.2 28.5 49.7 22.1 40.4 19.8 27.2 21.5 36.5 20.8 22.0 16.6 24.0 23.1 15.2 9.9 26.8 28.2 16.3 17.7 22.7 30.4 60.0 16.9 30.7 32.2 40.7 8.1 20.5 22.7 12.6 14.0 7.7 12.3 15.3 17.7 12.2 12.8 14.5 15.1 13.1 17.1 13.3 3.5 17.0 14.0 6.0 17.2 11.3 13.6 15.7 19.1 14.8 13.5 15.0 15.9 14.9 16.6 15.8 15.2 21.9 5.6 9.6 3.1 18.3 15.1 4.8 7.1 8.2 8.6 13.4 5.4 6.3 5.6 10.0 6.0 5.5 16.7 13.4 18.7 5.5 5.9 7.5 5.0 6.8 5.4 7.0 1.8 9.1 20.0 4.0 11.5 7.3 8.2 5.5 12.7 12.8 5.0 3.1 10.2 5.0 19.4 6.4 6.1 8.1 4.5 4.2 6.5 7.9 7.2 20.6 14.8 7.8 13.4 26.2 30.8 6.0 7.8 4.9 7.3 4.4 11.0 6.6 8.6 16.9 6.6 10.0 11.1 12.1 17.7 7.1 2.4 11.5 13.5 8.1 6.4 5.3 KCTD14 MGC2376 ENSG00000151364 "Potassium channel tetramerization domain containing 14" Q9BQ13 11 78015715-78046191 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast glandular cells: 13.7;Breast myoepithelial cells: 12.8;Exocrine glandular cells: 17.1;Gastric mucus-secreting cells: 14.3;Intestinal goblet cells: 20.8;Prostatic glandular cells: 14.3;Proximal tubular cells: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 26.1;Hep G2: 29.0;RPTEC TERT1: 45.9;U-2 OS: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041118, HPA042181" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 30: Mammary glandular cells - Lactation" Nucleoplasm "Vesicles, Cytosol" "HPA041118: AB_10963117, HPA042181: AB_10968059" "unprognostic (7.37e-3)" "unprognostic (4.27e-2)" "unprognostic (7.03e-2)" "unprognostic (6.93e-2)" "unprognostic (1.59e-2)" "unprognostic (2.28e-2)" "unprognostic (2.04e-3)" "unprognostic (3.26e-1)" "prognostic unfavorable (3.96e-5)" "prognostic favorable (8.01e-4)" "prognostic unfavorable (1.05e-4)" "unprognostic (3.19e-1)" "prognostic favorable (6.92e-5)" "unprognostic (2.42e-2)" "unprognostic (2.05e-1)" "prognostic favorable (5.93e-4)" "unprognostic (1.63e-1)" 3.4 23.1 2.0 1.6 2.0 0.1 20.4 5.1 2.9 10.4 3.2 8.1 4.9 3.4 14.3 1.5 11.7 6.7 0.6 2.1 2.1 11.5 10.3 8.2 0.3 1.9 2.3 0.8 27.2 8.3 2.5 1.3 2.2 7.0 11.9 1.6 28.7 19.1 0.2 1.9 5.2 2.1 1.6 0.6 20.8 0.6 2.5 1.3 15.9 0.6 0.5 2.3 1.4 1.7 0.0 3.5 0.6 0.5 1.3 0.8 3.5 1.8 1.6 3.4 8.4 13.5 8.8 0.1 9.3 1.1 0.4 1.0 0.6 26.1 8.9 0.5 13.2 0.0 3.0 29.0 4.9 0.2 0.1 4.0 0.7 13.9 11.0 2.5 1.0 0.2 0.3 0.1 1.4 0.2 0.3 0.8 6.5 0.5 0.5 0.4 0.0 0.0 45.9 3.5 2.3 0.2 0.0 0.2 4.5 0.8 1.4 1.1 0.8 0.2 20.2 0.7 0.4 0.3 0.2 0.2 0.2 0.2 3.7 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.3 0.0 0.2 0.2 0.2 0.0 0.0 2.0 2.0 5.1 2.9 2.1 2.1 1.9 2.3 2.2 1.6 2.5 1.7 0.6 3.2 10.8 0.0 0.2 0.4 12.2 2.0 2.8 0.4 13.7 12.8 0.0 1.5 4.1 5.5 0.0 0.6 0.3 5.2 3.9 2.6 0.3 2.7 2.0 0.9 4.8 0.0 0.0 17.1 1.3 1.1 14.3 3.7 1.3 0.5 0.0 4.8 0.2 0.0 0.0 20.8 0.0 0.0 0.0 0.0 3.4 0.4 1.8 0.0 0.1 2.1 0.0 0.0 0.0 10.5 6.6 5.3 0.0 14.3 2.2 15.1 0.1 0.0 0.0 0.0 1.8 0.2 0.3 0.7 0.1 0.7 0.3 0.7 8.5 7.4 NDUFC2-KCTD14 ENSG00000259112 "NDUFC2-KCTD14 readthrough" E9PQ53 11 78016971-78079865 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 2.0;Club cells: 1.3;Excitatory neurons: 4.0;Inhibitory neurons: 3.2;Melanocytes: 1.8;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 2.4;Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 58.3;EFO-21: 47.1" "HPA038873, HPA056195" Approved Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 39: CACO-2 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Mitochondria "HPA038873: AB_10673480, HPA056195: AB_2683063" 6.8 6.4 5.3 3.3 5.9 10.6 6.1 6.3 9.4 3.5 3.6 5.1 12.3 1.9 0.9 4.0 7.1 3.6 10.5 6.0 5.9 2.8 5.6 3.6 7.8 5.4 4.8 1.7 2.7 4.8 0.3 2.9 4.9 5.2 2.7 1.3 11.6 11.8 10.9 4.9 8.1 3.6 5.1 2.5 7.2 2.3 4.7 10.4 10.1 17.0 3.8 3.6 0.4 5.8 4.6 12.6 4.2 1.2 4.2 2.7 6.4 12.8 13.1 14.8 10.8 58.3 6.1 6.6 47.1 6.8 11.1 5.8 4.5 11.5 1.9 17.2 18.1 3.5 3.9 42.1 26.7 3.0 15.7 3.4 4.8 11.3 3.0 8.6 11.0 28.9 9.0 3.8 10.7 19.9 18.8 13.3 5.9 36.1 27.0 9.8 5.6 23.9 7.1 8.3 4.9 8.0 12.0 2.6 6.3 1.8 7.0 8.5 5.1 3.7 19.4 17.4 5.0 7.5 16.7 14.4 2.5 7.9 5.8 113.1 104.9 108.0 98.8 82.2 84.2 119.8 98.4 93.8 131.3 103.5 89.8 84.1 31.4 69.4 93.3 213.4 135.7 194.6 5.3 5.9 6.3 9.4 6.0 5.9 5.4 4.8 4.9 5.1 4.7 5.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.8 1.0 0.0 0.0 0.0 2.5 2.4 0.0 0.2 0.0 0.0 0.1 0.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.3 0.0 THRSP "Lpgp, LPGP1, S14, SPOT14, THRP" ENSG00000151365 "Thyroid hormone responsive" Q92748 11 78063861-78068351 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 210.0;liver: 408.9" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 128.4" "Cancer enhanced" "Detected in many" "liver cancer: 44.1" "Region enriched" "Detected in single" 6 "cerebellum: 2.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "ASC diff: 76.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040642 Approved Approved Nucleoplasm NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 15: Hepatocytes - Hemostasis" Nucleoplasm "HPA040642: AB_10794878" "unprognostic (1.19e-1)" "unprognostic (2.88e-1)" "unprognostic (2.84e-1)" "unprognostic (2.73e-2)" "unprognostic (3.07e-1)" "unprognostic (9.91e-3)" "unprognostic (1.59e-2)" "unprognostic (9.60e-2)" "unprognostic (1.07e-2)" "unprognostic (8.23e-2)" "unprognostic (1.68e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (9.64e-2)" "unprognostic (1.57e-1)" "prognostic favorable (3.28e-4)" "unprognostic (1.69e-3)" 210.0 5.9 0.1 0.4 0.1 0.0 95.3 2.7 0.3 0.1 0.0 2.6 0.0 0.1 0.4 0.3 1.0 3.4 18.6 0.2 0.0 4.6 408.9 0.1 0.7 0.0 0.2 0.1 3.6 15.5 0.1 0.0 0.4 0.1 0.2 1.5 48.9 2.3 8.2 33.7 4.6 0.5 0.0 0.1 0.7 0.1 0.0 0.2 5.7 3.3 0.0 0.8 1.1 0.1 0.0 0.0 0.0 0.0 76.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.7 0.3 0.2 0.0 0.0 0.2 0.4 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 2.3 21.1 11.2 0.1 4.3 0.0 0.0 0.0 0.0 0.2 0.0 9.8 0.0 0.0 0.6 0.1 0.4 0.0 2.7 0.5 0.0 0.0 0.1 0.0 0.3 0.0 0.1 2.9 128.4 0.0 0.0 0.4 0.3 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.1 NDUFC2 "B14.5b, HLC-1" ENSG00000151366 "NADH:ubiquinone oxidoreductase subunit C2" O95298 11 78068297-78079862 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038873, HPA056195" Approved Supported Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 39: CACO-2 - Unknown function" "Cluster 2: Hepatocytes - Metabolism" Mitochondria "HPA038873: AB_10673480, HPA056195: AB_2683063" "unprognostic (7.32e-2)" "unprognostic (5.91e-3)" "unprognostic (4.00e-2)" "unprognostic (6.14e-2)" "unprognostic (1.94e-1)" "unprognostic (8.97e-2)" "unprognostic (1.60e-1)" "unprognostic (4.23e-3)" "unprognostic (4.75e-3)" "unprognostic (3.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "prognostic favorable (5.00e-5)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (4.18e-2)" "unprognostic (3.61e-3)" 202.3 278.0 118.8 84.5 126.1 126.1 143.0 128.7 150.7 103.0 125.6 143.6 218.4 125.3 68.4 142.6 120.2 108.6 240.7 129.0 145.8 151.1 286.8 100.0 109.1 121.6 117.1 96.2 168.8 186.1 133.5 74.8 124.2 88.7 66.1 59.8 275.1 83.2 487.6 121.9 194.3 63.6 136.8 96.2 130.0 103.0 126.1 73.5 207.0 254.0 62.8 97.1 100.1 136.3 287.6 342.2 183.3 118.8 168.3 105.6 227.2 335.7 190.9 252.4 179.9 910.4 311.8 166.3 583.3 155.8 210.2 293.1 136.1 190.9 99.5 318.8 386.7 183.8 337.4 727.9 270.9 409.7 164.2 147.9 177.8 195.6 75.2 156.0 172.9 158.8 365.3 278.4 137.9 478.7 254.5 722.4 212.4 670.4 415.6 224.5 352.5 570.5 196.4 420.7 261.2 229.0 235.0 499.5 182.3 158.8 391.4 328.2 241.0 256.4 314.9 611.8 297.9 251.5 541.9 400.4 146.4 236.6 251.0 374.5 337.6 354.0 150.1 293.0 138.3 230.8 172.4 163.4 363.5 212.1 144.5 159.8 102.2 225.4 243.0 290.4 202.7 410.9 118.8 126.1 128.7 150.7 129.0 145.8 121.6 117.1 124.2 136.8 126.1 136.3 256.6 166.7 194.7 0.0 106.4 95.5 166.1 443.7 40.5 145.8 346.2 414.0 240.9 243.1 288.2 391.8 66.7 408.8 166.4 206.3 305.2 395.6 311.8 413.8 129.3 183.7 167.9 106.5 0.0 431.5 392.8 165.7 43.3 241.7 153.2 158.1 184.9 856.9 346.2 90.9 0.0 317.9 429.3 174.5 110.7 84.7 215.6 129.4 245.5 0.0 246.7 310.0 175.1 0.0 0.0 456.5 329.1 201.6 102.5 239.0 461.8 454.6 300.0 131.6 236.7 154.5 222.7 384.4 162.1 67.5 114.4 387.1 109.9 226.3 373.2 215.6 ALG8 MGC2840 ENSG00000159063 "ALG8 alpha-1,3-glucosyltransferase" Q9BVK2 11 78095244-78139660 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 105.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051898 Approved Approved Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm "HPA051898: AB_2681656" "unprognostic (1.37e-1)" "unprognostic (9.24e-2)" "unprognostic (4.60e-2)" "unprognostic (2.69e-2)" "unprognostic (2.65e-1)" "unprognostic (6.49e-2)" "unprognostic (5.38e-3)" "unprognostic (5.91e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-3)" "unprognostic (5.29e-2)" "unprognostic (1.20e-1)" "unprognostic (1.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.34e-1)" "unprognostic (3.78e-2)" "unprognostic (6.37e-2)" 22.8 33.0 12.7 13.4 14.3 9.2 25.6 13.9 16.4 18.7 15.4 17.5 13.3 15.9 33.2 19.0 18.8 12.0 17.9 12.9 13.3 24.9 47.1 15.0 14.6 14.1 13.1 22.1 23.8 23.7 19.8 18.7 13.8 19.1 21.8 10.4 21.7 18.0 12.1 16.6 15.5 16.4 13.5 18.3 20.2 43.5 13.1 17.8 22.4 8.9 19.8 18.4 16.0 15.2 27.8 74.4 62.8 56.6 63.7 42.5 37.6 38.6 57.8 68.6 67.4 127.9 102.0 61.4 74.5 51.5 92.3 86.5 87.0 56.5 111.9 46.3 50.8 74.3 56.5 62.2 38.9 71.8 39.6 34.4 36.4 81.8 37.9 37.5 50.3 58.0 98.2 65.8 97.7 38.6 53.3 61.9 81.9 200.5 38.1 63.6 32.6 168.3 70.0 40.4 20.2 44.8 62.0 102.2 29.4 65.6 106.5 50.8 32.0 43.5 50.6 102.5 35.1 46.6 88.0 80.3 26.7 71.4 84.4 1.2 30.0 5.4 25.1 34.5 29.1 37.2 25.5 25.7 34.2 31.3 29.7 26.2 2.6 29.1 39.9 33.1 22.5 27.6 12.7 14.3 13.9 16.4 12.9 13.3 14.1 13.1 13.8 13.5 13.1 15.2 11.9 12.8 11.6 12.4 21.0 10.5 23.3 49.6 26.2 14.7 18.3 16.3 6.9 20.0 35.2 20.2 18.8 53.8 9.1 7.0 5.9 24.4 18.9 11.0 16.9 17.2 7.8 9.9 21.3 25.4 59.5 19.4 11.7 13.8 11.4 36.4 9.3 40.2 31.4 16.8 18.0 15.9 32.6 17.0 10.8 14.0 18.0 15.3 26.6 12.2 12.3 8.2 21.6 13.0 20.7 17.7 6.4 15.8 43.1 16.9 7.7 15.8 21.7 13.5 0.0 14.2 19.6 105.0 37.8 20.9 8.9 32.7 15.2 16.9 16.8 15.2 KCTD21 KCASH2 ENSG00000188997 "Potassium channel tetramerization domain containing 21" Q4G0X4 11 78171249-78188626 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041964 Uncertain Approved Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 18: U-2197 - ECM organization" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA041964: AB_10795647" "unprognostic (1.17e-1)" "unprognostic (5.45e-2)" "unprognostic (3.74e-3)" "unprognostic (6.40e-3)" "unprognostic (8.06e-2)" "unprognostic (2.48e-2)" "unprognostic (1.52e-1)" "unprognostic (6.82e-2)" "unprognostic (8.85e-2)" "unprognostic (1.37e-3)" "unprognostic (2.49e-1)" "unprognostic (1.31e-1)" "unprognostic (4.35e-2)" "unprognostic (1.77e-1)" "unprognostic (4.70e-1)" "prognostic favorable (9.57e-5)" "unprognostic (3.43e-2)" 7.3 13.4 14.4 6.2 13.6 3.5 4.4 13.1 14.3 5.8 8.7 6.5 5.0 5.0 9.2 9.6 6.2 7.9 6.3 13.7 14.3 5.5 15.9 6.7 5.4 14.7 16.3 13.7 3.5 5.7 5.9 7.7 15.0 4.2 4.8 4.3 5.8 5.2 8.5 4.9 4.5 7.1 12.4 4.6 4.5 4.0 14.6 5.9 11.2 7.0 6.2 7.1 5.9 14.7 5.2 11.8 6.7 5.0 23.8 16.9 4.1 10.1 9.6 7.1 7.1 11.1 7.8 5.0 9.9 11.4 9.5 10.1 6.5 8.4 7.3 6.9 3.9 3.8 15.4 9.8 13.2 2.4 4.7 16.4 15.4 15.5 8.8 14.8 11.0 6.1 8.1 4.5 9.7 7.3 3.8 7.3 3.0 19.0 8.9 5.0 5.1 3.1 8.3 9.3 4.6 7.1 6.4 4.6 4.9 12.1 10.6 2.6 12.9 11.3 11.0 30.0 3.9 8.6 9.2 4.8 5.9 3.9 6.4 2.0 5.4 7.5 0.9 6.0 1.4 0.6 1.4 1.7 3.7 1.4 1.3 1.0 8.3 1.4 5.1 0.8 1.1 2.2 14.4 13.6 13.1 14.3 13.7 14.3 14.7 16.3 15.0 12.4 14.6 14.7 1.9 0.0 2.7 4.6 0.7 1.8 1.2 1.5 0.6 1.7 2.4 2.2 3.5 5.7 2.0 0.0 0.0 1.2 0.6 2.8 1.9 1.5 0.3 1.4 2.5 2.3 0.0 0.0 4.1 2.2 1.1 2.8 1.1 1.9 5.7 7.0 3.6 7.4 2.3 6.7 3.4 1.3 0.0 3.1 1.1 0.5 4.4 1.3 1.8 4.7 2.8 1.0 0.0 4.0 4.2 2.5 1.7 9.1 1.0 1.9 2.3 2.7 1.1 0.9 0.0 1.2 2.9 1.5 2.7 3.6 1.4 1.9 1.8 3.8 1.7 2.1 USP35 KIAA1372 ENSG00000118369 "Ubiquitin specific peptidase 35" Q9P2H5 11 78188812-78215232 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 9 "Early spermatids: 39.1;Granulosa cells: 30.8;Late spermatids: 121.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055213, HPA058592" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoli fibrillar center" Nucleoplasm "HPA055213: AB_2682740, HPA058592: AB_2683766" "unprognostic (6.69e-2)" "unprognostic (1.17e-2)" "unprognostic (1.69e-1)" "unprognostic (6.87e-3)" "unprognostic (3.38e-2)" "unprognostic (1.08e-2)" "unprognostic (2.00e-1)" "unprognostic (1.46e-1)" "unprognostic (3.57e-2)" "unprognostic (3.84e-3)" "unprognostic (1.03e-2)" "unprognostic (3.11e-2)" "unprognostic (1.29e-3)" "unprognostic (2.93e-1)" "unprognostic (1.31e-1)" "unprognostic (4.38e-2)" "unprognostic (1.49e-2)" 6.1 19.8 8.0 3.6 7.4 2.5 5.1 5.1 8.0 9.2 7.4 7.6 3.5 6.7 3.2 6.0 6.4 3.5 10.2 8.3 7.1 6.2 16.8 7.0 3.3 9.0 8.2 7.4 5.9 12.4 13.4 4.7 9.4 5.9 1.9 2.1 3.9 3.2 4.1 3.0 4.5 4.7 3.9 4.9 4.6 4.5 8.3 6.2 8.7 4.0 2.6 6.6 7.7 6.4 2.2 3.3 5.7 6.1 9.7 8.7 3.9 5.0 5.8 5.8 4.0 8.4 4.7 1.7 5.0 9.5 6.2 5.8 3.8 7.8 3.4 12.8 2.0 2.9 9.8 5.0 7.4 1.8 8.3 7.4 5.1 12.1 3.5 11.4 7.2 6.5 4.1 4.2 4.6 2.0 4.7 7.6 1.7 6.2 5.3 2.9 5.2 2.0 4.5 4.1 2.8 5.9 3.9 5.1 1.9 8.1 4.3 1.6 8.9 10.6 5.9 12.8 2.7 5.7 2.0 2.7 3.1 2.0 6.3 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 7.4 5.1 8.0 8.3 7.1 9.0 8.2 9.4 3.9 8.3 6.4 1.3 0.0 1.8 5.9 1.2 0.8 0.2 0.7 3.4 0.8 1.0 0.6 3.5 0.0 0.3 0.0 6.2 0.7 1.0 1.2 0.0 1.1 39.1 1.3 2.7 1.9 0.0 0.4 5.2 2.0 1.6 2.0 5.1 1.2 0.0 30.8 1.4 2.7 1.6 0.0 4.8 0.9 0.0 0.6 0.8 121.6 1.5 1.4 1.8 2.8 2.7 0.4 0.0 3.5 2.8 2.0 0.1 3.0 0.8 0.3 0.8 1.0 0.5 0.6 6.6 0.7 1.3 1.2 2.4 4.1 1.0 0.3 2.9 2.1 1.3 0.2 GAB2 KIAA0571 ENSG00000033327 "GRB2 associated binding protein 2" Q9UQC2 11 78215293-78418348 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 97.9" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 147.9;Microglial cells: 204.2;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 480.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 13.0;neutrophil: 20.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 20.1" "Cell line enhanced" "Detected in many" "SH-SY5Y: 62.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000271, HPA001368, CAB022159" Enhanced Supported "Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 70: Brain - Nervous system development" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane" "CAB022159: , HPA000271: AB_1078925, HPA001368: AB_2666287" "unprognostic (2.51e-2)" "unprognostic (1.90e-1)" "unprognostic (3.56e-3)" "unprognostic (1.99e-3)" "unprognostic (1.04e-2)" "unprognostic (4.69e-2)" "unprognostic (4.47e-2)" "unprognostic (1.08e-1)" "unprognostic (6.54e-2)" "unprognostic (1.37e-1)" "unprognostic (2.25e-1)" "unprognostic (1.74e-1)" "prognostic favorable (9.32e-5)" "unprognostic (6.95e-2)" "unprognostic (4.35e-1)" "unprognostic (3.99e-2)" "unprognostic (1.67e-2)" 18.5 8.2 69.5 12.9 80.7 39.9 11.6 56.2 65.3 14.8 31.2 9.4 14.4 19.8 3.1 8.9 13.6 9.3 14.5 54.5 68.4 6.7 4.4 20.0 7.0 79.4 70.9 20.0 6.8 6.8 8.8 15.5 74.0 7.0 11.0 3.5 7.1 7.1 6.4 13.3 10.7 17.3 68.0 13.1 8.2 5.7 72.0 21.3 6.6 6.8 5.8 10.6 10.9 97.9 3.7 3.1 8.8 1.0 12.7 5.4 39.1 5.7 6.8 4.0 3.3 23.8 1.9 1.1 24.8 7.9 1.0 5.9 21.2 0.5 5.2 36.3 2.2 14.6 5.9 4.2 6.3 5.6 2.8 6.1 1.9 15.6 2.4 11.8 23.4 4.2 38.8 1.2 6.7 1.5 2.8 13.8 2.8 8.4 4.4 27.4 8.5 0.5 7.3 13.4 7.6 62.1 1.4 2.9 14.4 12.7 13.2 15.5 19.4 1.8 4.5 15.2 1.4 9.8 1.5 0.6 1.5 8.6 16.8 13.0 3.1 0.9 0.0 1.7 0.0 0.7 0.0 0.0 1.0 0.4 0.0 0.0 20.1 0.0 4.9 2.2 0.2 1.0 69.5 80.7 56.2 65.3 54.5 68.4 79.4 70.9 74.0 68.0 72.0 97.9 6.6 3.2 20.7 57.5 8.7 2.0 0.7 0.5 0.6 4.3 3.6 2.7 10.9 1.5 1.1 0.0 0.0 5.0 4.0 9.2 0.0 2.5 7.0 5.5 9.1 7.6 10.7 4.2 80.7 6.4 16.6 6.9 6.6 10.6 5.7 50.4 5.3 0.8 12.1 16.8 147.9 4.0 4.1 29.5 17.5 5.1 8.1 22.8 7.2 204.2 17.5 0.5 1.0 142.7 480.3 8.2 3.3 10.9 4.2 4.3 10.5 0.8 2.6 2.1 13.1 8.3 5.4 3.7 1.7 1.8 2.8 22.2 3.5 3.5 8.9 2.2 NARS2 "DFNB94, FLJ23441, SLM5" ENSG00000137513 "Asparaginyl-tRNA synthetase 2, mitochondrial" Q96I59 11 78435968-78574874 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease variant, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026793 Supported Approved Nucleoplasm,Mitochondria,Cytosol No No "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Mitochondria" Cytosol "HPA026793: AB_1848833" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (5.73e-3)" "unprognostic (1.79e-3)" "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (5.62e-2)" "unprognostic (4.62e-3)" "prognostic favorable (1.39e-5)" "unprognostic (1.96e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.22e-6)" "unprognostic (8.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.93e-1)" "unprognostic (1.60e-1)" 7.3 11.9 10.7 6.8 12.3 6.2 11.1 12.4 13.3 9.6 19.8 11.3 10.3 9.1 11.2 8.1 9.9 7.0 11.7 10.4 11.7 19.0 23.5 7.6 9.6 11.7 13.9 11.4 10.6 11.4 7.6 8.0 13.1 10.8 10.9 13.4 10.7 7.3 23.5 7.2 9.7 7.4 11.3 7.4 9.9 7.5 11.4 11.7 11.5 19.6 9.7 8.7 8.1 12.3 16.7 22.8 23.5 15.4 16.1 13.5 19.5 13.5 13.1 20.6 16.9 39.4 17.4 40.9 34.1 8.7 19.8 21.5 39.9 26.3 28.3 27.0 21.3 28.9 17.3 33.7 13.3 31.3 10.1 9.4 16.8 18.1 32.0 18.3 17.9 33.7 44.5 11.0 23.1 19.4 32.7 50.3 25.6 67.3 27.3 33.6 38.2 55.5 27.2 23.0 27.8 17.5 20.1 25.4 35.5 25.1 24.1 12.3 10.9 27.7 32.8 32.0 23.1 18.1 33.1 91.1 5.4 27.7 19.2 9.5 9.3 4.4 11.1 10.4 13.8 17.6 12.8 12.5 16.6 15.0 18.5 16.7 2.0 20.3 12.8 12.7 10.5 10.3 10.7 12.3 12.4 13.3 10.4 11.7 11.7 13.9 13.1 11.3 11.4 12.3 5.8 19.2 26.4 27.7 14.5 13.5 14.2 12.0 12.5 5.2 9.4 6.5 8.8 5.7 10.3 5.5 2.1 20.0 4.4 4.0 29.4 9.5 13.1 10.1 7.4 6.6 12.0 9.2 34.7 7.3 23.6 9.0 10.2 9.0 8.2 14.0 2.5 19.8 12.4 0.0 45.1 8.3 22.4 6.3 11.6 5.4 7.8 6.3 17.8 45.0 2.9 6.3 4.1 42.7 47.7 7.5 9.9 4.9 14.6 17.5 7.0 28.9 10.2 9.0 6.6 7.5 8.8 8.6 19.5 12.0 13.8 15.3 7.8 9.0 14.6 10.7 TENM4 "KIAA1302, ODZ4, Ten-M4, TEN4" ENSG00000149256 "Teneurin transmembrane protein 4" Q6N022 11 78652829-79441030 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.8;ovary: 16.6;parathyroid gland: 14.0" "Cell type enhanced" "Detected in many" "Astrocytes: 134.5;Early spermatids: 96.8;Excitatory neurons: 337.4;Inhibitory neurons: 297.7;Microglial cells: 117.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 9.1;hTERT-RPE1: 9.5;PC-3: 10.8;REH: 10.4;SH-SY5Y: 17.4" "Low region specificity" "Detected in all" "HPA019521, HPA065961" Approved NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA019521: AB_2670171, HPA065961: AB_2685588" "unprognostic (2.81e-1)" "unprognostic (9.25e-2)" "unprognostic (1.64e-1)" "unprognostic (2.96e-3)" "unprognostic (1.87e-1)" "unprognostic (2.48e-1)" "unprognostic (1.18e-2)" "unprognostic (1.24e-1)" "unprognostic (3.01e-1)" "unprognostic (3.79e-1)" "unprognostic (1.01e-1)" "unprognostic (4.71e-1)" "unprognostic (6.51e-3)" "unprognostic (5.40e-3)" "unprognostic (5.64e-2)" "unprognostic (7.07e-2)" "unprognostic (9.81e-3)" 1.9 1.4 7.5 1.0 13.4 0.0 0.7 0.3 12.6 2.5 0.0 0.5 0.1 1.3 0.2 2.0 2.1 0.4 0.4 9.0 7.5 1.5 0.0 0.4 0.5 10.9 9.2 16.6 0.3 14.0 7.1 0.1 7.9 0.4 0.3 2.6 0.5 0.2 0.4 3.3 0.3 1.0 13.0 0.3 0.5 1.6 11.8 1.9 5.8 1.0 1.2 0.5 1.5 17.8 0.0 0.0 3.4 0.0 3.7 5.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 7.8 6.7 0.0 2.1 5.0 5.3 0.0 4.5 0.9 0.0 0.0 0.0 0.1 0.0 0.0 9.1 2.3 2.5 4.5 9.5 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.0 1.8 0.3 10.8 10.4 0.0 0.0 6.4 1.1 7.1 17.4 0.0 0.0 0.0 6.2 0.0 0.1 0.5 0.1 1.2 0.1 5.9 0.0 0.0 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 13.4 0.3 12.6 9.0 7.5 10.9 9.2 7.9 13.0 11.8 17.8 0.1 0.0 0.0 134.5 0.2 0.9 0.8 3.4 17.1 7.5 0.1 0.0 1.9 4.3 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 96.8 1.1 1.7 0.3 0.0 0.0 337.4 0.0 0.2 2.6 0.0 0.8 1.3 0.8 0.0 0.0 0.1 0.0 297.7 0.0 0.0 0.6 0.4 56.6 5.3 0.7 0.0 117.1 0.4 13.9 0.0 58.3 21.3 0.0 0.0 1.9 0.0 0.4 0.0 0.4 7.0 1.0 0.0 25.1 2.8 4.8 1.0 7.3 2.0 0.1 0.1 0.3 0.0 0.6 FAM181B "LOC220382, MGC33846" ENSG00000182103 "Family with sequence similarity 181 member B" A6NEQ2 11 82729940-82733864 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 26.9" "Cell type enhanced" "Detected in some" "Astrocytes: 56.2;Endometrial ciliated cells: 24.1;Muller glia cells: 18.4;Oligodendrocyte precursor cells: 22.1;Oligodendrocytes: 19.0" "Cancer enriched" "Detected in many" 19 "glioma: 29.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 2.4;SH-SY5Y: 1.2;U-2 OS: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066861 Enhanced Approved "Nuclear membrane,Mitochondria" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 15: RT4 - Unknown function" "Cluster 64: Astrocytes - Nervous system maintenance" Mitochondria "Nuclear membrane" "HPA066861: AB_2685738" "unprognostic (2.84e-4)" "unprognostic (3.47e-2)" "unprognostic (1.80e-1)" "prognostic favorable (8.07e-4)" "unprognostic (6.71e-3)" "unprognostic (3.18e-2)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (1.90e-1)" "unprognostic (5.50e-2)" "unprognostic (6.27e-4)" "unprognostic (2.52e-3)" "unprognostic (6.81e-2)" "unprognostic (1.53e-2)" "unprognostic (2.56e-1)" "unprognostic (7.20e-3)" "unprognostic (7.20e-2)" 0.5 0.6 18.0 0.2 20.3 0.1 0.4 19.8 14.3 1.3 5.9 1.4 0.2 0.7 0.1 0.3 1.0 0.0 1.7 14.5 14.7 0.7 0.0 0.0 0.0 26.9 20.8 0.8 0.5 0.1 1.2 0.0 16.3 0.6 0.0 0.6 0.8 0.5 0.2 0.3 0.4 0.1 23.9 0.0 0.4 0.2 19.9 0.0 0.8 0.1 0.2 1.1 0.7 23.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.3 1.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 20.3 19.8 14.3 14.5 14.7 26.9 20.8 16.3 23.9 19.9 23.6 0.7 0.0 0.0 56.2 0.0 0.3 0.2 0.1 0.0 0.8 1.0 3.6 2.9 0.0 0.1 5.5 0.0 0.0 0.0 0.0 3.9 0.1 0.0 24.1 1.8 1.3 0.0 0.0 0.4 0.0 0.0 1.2 0.0 2.4 0.0 0.6 0.0 0.0 0.1 0.0 0.6 1.5 0.0 0.0 0.3 0.4 0.6 0.2 1.8 1.9 0.0 18.4 0.0 22.1 19.0 0.0 0.0 0.4 0.0 0.2 0.1 0.4 0.1 1.1 0.0 1.6 7.0 0.1 1.6 0.3 0.0 0.0 0.1 2.2 0.2 0.1 PRCP "HUMPCP, PCP" ENSG00000137509 Prolylcarboxypeptidase P42785 11 82822936-82970584 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatic stellate cells: 348.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 463.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017065, HPA071115" Approved Supported Vesicles "Intracellular and membrane" NA NA 42000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles "HPA017065: AB_1855676, HPA071115: " "unprognostic (3.24e-1)" "unprognostic (2.25e-1)" "unprognostic (1.76e-1)" "unprognostic (1.51e-1)" "unprognostic (2.54e-1)" "unprognostic (1.33e-2)" "unprognostic (9.22e-2)" "unprognostic (1.42e-1)" "unprognostic (7.97e-2)" "unprognostic (2.61e-1)" "unprognostic (2.70e-1)" "unprognostic (1.88e-2)" "prognostic favorable (2.65e-6)" "unprognostic (7.16e-2)" "unprognostic (1.73e-2)" "unprognostic (3.49e-1)" "unprognostic (4.07e-1)" 74.8 87.3 81.1 57.8 82.1 37.7 70.0 84.3 109.1 91.9 95.0 49.3 28.6 62.9 81.4 62.1 57.0 64.3 70.0 76.6 85.6 144.7 151.9 58.1 92.1 84.4 82.1 53.5 37.9 78.4 34.5 152.8 80.9 52.5 46.6 21.9 85.6 55.5 15.9 54.1 31.8 80.8 89.0 54.0 32.0 41.8 86.0 33.7 63.7 28.5 85.0 100.2 57.5 86.7 34.9 41.8 49.6 121.0 463.5 146.7 67.1 67.5 131.9 70.9 97.0 103.5 70.7 55.9 100.7 117.9 72.6 53.2 53.7 45.2 72.0 43.9 38.3 37.7 56.5 76.7 86.2 31.0 124.7 122.0 39.3 72.7 68.6 166.5 224.0 26.3 39.1 69.8 72.7 19.5 4.9 171.7 33.9 90.3 31.1 27.1 97.0 65.1 118.0 71.2 24.0 51.9 101.9 60.2 41.5 80.6 66.6 49.6 65.0 78.8 77.4 71.1 33.5 64.2 113.6 46.3 32.9 41.7 44.5 53.5 76.9 50.9 13.7 79.0 16.1 31.7 14.0 15.9 140.2 34.2 12.0 17.4 89.0 34.7 64.8 27.9 14.8 49.6 81.1 82.1 84.3 109.1 76.6 85.6 84.4 82.1 80.9 89.0 86.0 86.7 86.9 19.2 12.9 58.8 45.5 31.4 41.5 53.4 25.0 11.7 26.2 25.1 26.6 37.1 25.2 62.5 2.1 65.1 29.0 9.8 29.4 32.9 44.9 17.4 37.7 180.4 19.7 13.7 42.2 12.0 120.1 73.6 23.9 29.9 12.7 18.2 348.7 65.4 80.7 16.8 38.5 19.1 14.2 152.9 118.9 47.6 44.1 88.0 71.2 33.7 79.5 53.5 28.8 34.7 10.5 8.2 10.2 46.3 62.2 23.3 3.9 83.8 9.1 5.3 65.7 25.5 25.6 60.8 6.3 54.3 34.9 52.9 22.3 27.7 20.9 39.2 DDIAS "C11orf82, FLJ25416, FLJ38838, noxin" ENSG00000165490 "DNA damage induced apoptosis suppressor" Q8IXT1 11 82899975-82958277 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 7.9;testis: 10.8" "Cell type enhanced" "Detected in many" "Plasma cells: 8.2;Spermatocytes: 17.2;Spermatogonia: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038540, HPA038541" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Plasma membrane, Cytosol" "HPA038540: AB_10672648, HPA038541: AB_2676071" "unprognostic (2.53e-1)" "unprognostic (2.27e-1)" "unprognostic (5.04e-3)" "unprognostic (1.25e-2)" "unprognostic (1.20e-1)" "unprognostic (5.32e-2)" "unprognostic (3.86e-6)" "unprognostic (4.65e-3)" "unprognostic (1.01e-3)" "unprognostic (8.24e-3)" "unprognostic (2.04e-4)" "unprognostic (4.72e-2)" "unprognostic (1.11e-16)" "unprognostic (7.17e-3)" "unprognostic (9.59e-2)" "unprognostic (1.89e-1)" "unprognostic (9.13e-2)" 0.9 0.4 0.6 3.3 0.9 7.9 2.1 0.9 1.0 0.7 0.4 1.8 1.6 1.2 1.0 2.9 0.5 0.7 0.5 0.8 0.4 0.4 1.2 3.4 4.4 0.8 0.8 0.5 0.9 0.1 0.1 1.9 0.7 0.5 2.2 0.5 0.8 0.4 1.0 2.2 1.5 1.8 0.5 2.9 0.9 10.8 0.8 5.3 0.4 0.9 6.2 3.5 0.9 1.8 13.6 22.6 21.0 15.2 1.9 3.1 15.3 25.4 10.5 26.8 31.0 22.4 16.2 16.1 36.1 5.7 21.6 24.7 36.0 15.5 36.8 30.7 19.7 23.1 10.6 9.1 0.2 28.6 19.7 0.7 1.4 33.8 15.6 2.3 12.8 20.5 23.9 27.0 23.9 19.6 27.0 23.2 25.1 36.5 24.4 20.0 40.5 20.6 5.7 23.3 15.6 21.5 15.2 15.6 5.7 20.2 16.5 11.7 6.0 26.7 35.9 71.1 30.4 15.4 44.3 56.4 8.4 20.2 26.3 0.7 10.3 4.1 0.5 7.9 0.2 1.1 0.3 0.7 4.5 1.7 0.6 0.4 5.5 2.2 8.5 1.4 0.5 3.2 0.6 0.9 0.9 1.0 0.8 0.4 0.8 0.8 0.7 0.5 0.8 1.8 0.3 0.0 0.0 0.0 4.3 0.0 0.6 0.0 1.8 0.0 1.1 1.1 0.9 1.5 0.0 0.0 0.0 2.7 1.0 0.6 0.0 0.9 4.2 1.0 0.6 0.8 0.0 6.5 0.6 0.6 5.5 0.8 1.1 1.2 0.0 2.5 0.7 0.7 2.5 0.0 0.3 0.7 0.0 6.4 0.0 1.9 0.3 3.5 0.0 1.9 4.5 0.0 4.1 0.5 0.6 0.5 0.1 0.7 8.2 0.7 0.3 0.3 0.0 0.0 0.0 0.8 1.1 17.2 18.2 5.4 0.0 0.3 1.5 0.5 1.6 0.9 RAB30 ENSG00000137502 "RAB30, member RAS oncogene family" Q15771 11 82973133-83071923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.7" "Cell type enhanced" "Detected in many" "Astrocytes: 87.8;Oligodendrocytes: 243.1;Plasma cells: 260.9" "Cancer enhanced" "Detected in all" "breast cancer: 6.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 54.4;naive B-cell: 55.0" "Lineage enriched" "Detected in many" 5 "B-cells: 55.0" "Cell line enhanced" "Detected in many" "Daudi: 55.7;HDLM-2: 57.6;U-698: 164.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054514, HPA060565" Approved Enhanced Vesicles NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 70: Brain - Nervous system development" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "HPA054514: AB_2682512, HPA060565: AB_2684320" "unprognostic (3.21e-1)" "unprognostic (1.03e-1)" "unprognostic (1.82e-1)" "unprognostic (5.18e-2)" "unprognostic (7.21e-2)" "unprognostic (8.06e-2)" "unprognostic (2.91e-2)" "unprognostic (3.14e-2)" "unprognostic (4.36e-1)" "unprognostic (1.71e-2)" "unprognostic (1.53e-1)" "unprognostic (3.75e-2)" "unprognostic (1.64e-2)" "unprognostic (2.37e-1)" "unprognostic (2.42e-1)" "unprognostic (3.93e-2)" "unprognostic (1.85e-1)" 11.2 11.0 12.3 13.9 28.0 14.5 12.4 20.5 12.9 8.3 0.0 13.1 17.8 8.4 5.8 6.9 5.5 5.7 9.3 10.5 24.2 3.7 7.7 6.5 19.8 28.0 19.1 14.0 4.3 2.9 4.4 8.5 28.6 7.2 13.8 11.2 6.1 5.2 12.9 7.4 21.3 10.2 20.3 10.1 11.6 4.0 21.8 10.4 5.8 11.8 28.4 8.9 4.4 39.7 4.1 5.6 5.8 2.9 11.1 16.7 6.8 9.8 9.1 19.0 7.9 8.7 1.8 55.7 10.0 14.9 4.9 4.8 8.3 6.4 11.3 57.6 1.6 12.6 16.4 5.1 2.6 2.0 2.5 9.5 4.4 8.5 6.5 7.2 14.0 5.0 1.9 15.0 9.8 7.9 2.1 0.6 7.7 5.5 10.0 4.8 15.2 23.7 9.5 3.4 6.7 4.6 22.6 5.3 2.7 8.6 12.4 0.2 17.9 8.1 19.1 8.0 2.7 24.0 14.3 164.6 3.1 1.4 5.7 1.4 0.7 1.0 4.9 0.3 3.6 54.4 4.8 4.8 2.0 55.0 11.2 10.0 0.9 2.3 0.8 5.8 9.5 6.2 12.3 28.0 20.5 12.9 10.5 24.2 28.0 19.1 28.6 20.3 21.8 39.7 15.2 9.6 3.3 87.8 80.5 24.9 10.7 9.9 73.4 8.3 11.7 13.0 14.5 0.0 2.7 3.7 16.7 7.0 6.8 5.4 1.9 2.4 0.7 3.3 6.1 10.5 10.1 3.2 60.7 4.0 30.8 23.5 5.1 4.2 0.0 0.9 18.2 6.4 1.9 11.8 78.2 1.5 8.2 1.6 15.2 1.3 14.3 6.4 42.7 67.5 24.8 13.9 3.1 80.4 243.1 4.3 3.5 18.0 260.9 8.9 9.3 4.6 2.3 10.5 6.6 20.3 13.5 0.7 2.2 11.0 11.5 2.9 12.9 24.0 1.8 2.0 PCF11 KIAA0824 ENSG00000165494 "PCF11 cleavage and polyadenylation factor subunit" O94913 11 83156988-83187451 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Skeletal myocytes: 227.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 124.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040779 Supported Nucleoplasm,Mitochondria NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Mitochondria "HPA040779: AB_2677133" "unprognostic (1.53e-1)" "unprognostic (7.24e-2)" "unprognostic (3.99e-2)" "unprognostic (1.18e-1)" "unprognostic (3.24e-3)" "prognostic favorable (1.34e-4)" "unprognostic (3.74e-2)" "unprognostic (4.89e-3)" "unprognostic (1.12e-3)" "unprognostic (9.53e-2)" "unprognostic (6.07e-2)" "unprognostic (5.63e-2)" "unprognostic (1.55e-1)" "unprognostic (3.91e-3)" "unprognostic (1.15e-1)" "unprognostic (1.07e-1)" "prognostic favorable (2.03e-5)" 20.1 13.9 9.8 23.5 15.0 42.5 23.7 29.1 13.6 19.2 6.0 19.6 16.3 22.4 15.2 19.5 17.7 17.2 13.5 9.3 10.9 14.9 16.9 22.8 32.4 13.1 12.7 28.3 17.0 16.6 10.4 16.7 14.0 18.7 19.9 26.6 15.4 16.2 26.3 27.8 20.8 23.8 10.9 28.7 16.4 24.7 12.1 33.4 24.3 19.5 29.6 17.0 13.5 17.9 26.3 18.4 29.4 25.3 34.4 33.4 23.5 24.7 18.2 23.2 17.7 31.5 25.7 58.9 18.1 18.0 21.9 25.8 43.2 17.0 22.3 42.1 14.8 34.5 26.3 22.4 19.4 40.9 36.8 23.9 32.1 17.7 25.6 31.2 23.8 38.8 40.9 27.9 21.9 27.9 38.7 45.2 30.7 44.6 20.5 36.4 37.1 35.2 20.2 38.4 24.4 27.0 30.1 23.7 24.3 26.9 23.7 28.0 24.6 33.0 16.9 24.5 16.6 25.0 45.2 124.6 14.5 26.8 26.0 14.8 7.2 14.9 10.1 6.8 8.5 10.9 6.9 7.3 6.9 9.9 7.8 8.2 17.1 13.5 5.5 7.1 5.5 5.8 9.8 15.0 29.1 13.6 9.3 10.9 13.1 12.7 14.0 10.9 12.1 17.9 96.4 41.7 63.5 58.1 90.6 53.7 79.8 30.7 101.9 48.4 84.4 81.0 42.7 35.8 43.4 46.0 33.3 30.2 90.1 49.8 25.4 22.9 203.3 55.5 70.8 66.8 31.8 62.5 32.0 18.1 26.9 58.8 40.2 83.6 37.2 48.0 56.7 21.7 37.6 55.5 37.9 51.0 26.4 57.8 41.0 40.3 60.3 87.4 28.4 45.0 52.5 34.5 58.7 40.7 72.0 19.2 46.2 45.1 69.0 71.6 83.4 14.2 29.0 55.3 39.5 227.3 66.8 46.7 17.9 100.4 62.7 39.4 81.7 42.7 50.3 71.1 ANKRD42 "FLJ37874, PPP1R79, SARP" ENSG00000137494 "Ankyrin repeat domain 42" Q8N9B4 11 83193712-83260694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.2" "Cell type enhanced" "Detected in all" "Early spermatids: 170.5;Late spermatids: 63.2;Respiratory ciliated cells: 61.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039917 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No "Cluster 14: Monocytes - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 18: U-2197 - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039917: AB_10672894" "unprognostic (6.59e-2)" "unprognostic (9.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.31e-3)" "unprognostic (9.12e-2)" "unprognostic (3.78e-1)" "unprognostic (1.67e-2)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" "unprognostic (2.99e-2)" "unprognostic (1.59e-1)" "unprognostic (1.09e-2)" "unprognostic (3.10e-3)" "unprognostic (1.79e-1)" "unprognostic (4.25e-1)" "unprognostic (1.90e-1)" 5.2 13.3 8.0 5.2 8.9 9.0 6.0 4.3 11.8 7.4 15.8 5.8 5.2 6.0 19.7 4.8 15.8 7.6 5.3 11.6 14.3 11.1 4.7 6.6 3.8 10.0 9.2 8.7 5.9 12.3 13.1 3.9 7.9 7.2 4.2 17.8 6.0 7.4 2.7 5.5 4.9 5.3 7.6 4.5 6.2 37.2 10.7 2.8 11.8 2.2 4.1 7.3 5.5 8.2 5.6 9.7 4.7 9.5 14.3 15.0 4.1 11.4 8.8 6.7 4.1 5.9 6.8 2.2 14.1 10.3 13.4 11.9 5.0 7.8 5.5 3.2 3.7 4.0 14.5 4.0 10.0 11.6 9.0 8.9 8.8 17.0 8.9 12.3 7.0 4.0 12.0 2.0 9.8 7.9 1.7 12.2 3.9 8.8 6.1 2.7 6.5 2.8 21.8 6.6 3.7 4.9 14.9 9.2 2.9 6.1 13.9 6.2 10.2 10.2 7.1 37.1 5.4 2.9 7.1 4.5 7.9 6.7 4.3 5.7 2.6 3.2 2.9 3.0 1.9 5.0 2.5 2.9 3.5 3.8 1.2 2.0 2.0 4.4 8.0 1.4 1.1 1.7 8.0 8.9 4.3 11.8 11.6 14.3 10.0 9.2 7.9 7.6 10.7 8.2 7.6 9.6 16.0 7.5 8.5 11.2 21.5 6.5 4.0 3.9 11.9 9.8 7.8 8.6 8.0 7.3 39.6 3.1 7.1 5.2 9.8 7.7 170.5 53.1 21.9 8.5 3.0 2.1 33.3 6.7 3.3 13.0 7.7 15.4 13.9 7.8 9.3 4.8 5.0 1.7 27.3 3.1 12.2 7.2 9.9 63.2 8.7 8.8 7.2 7.5 7.3 7.4 2.1 4.5 2.9 5.7 4.9 10.5 4.7 10.6 5.8 14.8 61.6 22.4 13.1 16.6 9.0 55.5 17.3 4.7 15.3 5.5 9.1 14.5 3.9 11.5 CCDC90B "MDS011, MDS025" ENSG00000137500 "Coiled-coil domain containing 90B" Q9GZT6 11 83259097-83286407 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 447.3;Late spermatids: 233.9;Spermatocytes: 333.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011130, HPA011931" Supported Enhanced Mitochondria NA NA "Cluster 10: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 34: Spermatids - Unknown function" Mitochondria "HPA011130: AB_1846170, HPA011931: AB_2072332" "unprognostic (5.85e-2)" "unprognostic (1.33e-1)" "unprognostic (7.34e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-1)" "unprognostic (7.48e-2)" "unprognostic (2.99e-1)" "unprognostic (3.57e-3)" "unprognostic (5.76e-3)" "unprognostic (3.53e-2)" "unprognostic (6.01e-3)" "unprognostic (2.01e-2)" "unprognostic (1.00e-2)" "unprognostic (2.31e-1)" "unprognostic (3.03e-1)" "unprognostic (1.62e-1)" "unprognostic (2.41e-1)" 16.4 37.3 23.2 13.0 24.5 16.1 21.3 24.2 29.8 17.1 23.3 18.1 14.7 14.7 33.8 16.2 15.6 18.2 22.1 22.9 25.4 18.4 38.9 13.5 20.5 25.3 25.0 22.3 18.3 14.9 19.4 22.2 25.0 16.0 17.3 12.6 17.1 16.3 16.2 14.1 16.6 16.7 25.2 15.5 16.9 54.5 24.4 17.2 25.6 17.7 17.0 15.3 14.2 27.1 19.1 27.3 46.1 15.2 59.6 44.7 27.7 37.4 31.6 22.7 24.3 32.2 63.0 46.7 47.7 55.0 47.5 23.5 20.1 47.3 30.3 31.9 16.0 28.2 17.7 27.3 50.1 29.2 23.5 50.2 62.3 29.5 83.8 45.3 52.3 49.6 41.9 37.9 83.7 33.5 29.4 36.7 37.9 80.2 33.4 33.1 40.9 39.3 47.3 27.5 22.2 50.9 26.4 21.0 26.1 60.8 53.9 26.4 51.6 44.8 28.8 85.9 26.0 36.3 51.2 46.8 18.1 23.2 45.5 77.7 18.7 71.6 24.2 41.3 31.2 39.8 34.7 34.2 27.0 37.9 30.2 30.2 9.8 50.7 43.8 20.4 46.0 27.4 23.2 24.5 24.2 29.8 22.9 25.4 25.3 25.0 25.0 25.2 24.4 27.1 50.8 12.8 13.1 14.0 40.5 23.6 49.6 102.8 26.7 36.3 33.5 49.7 58.0 28.6 48.3 36.8 14.6 74.0 41.4 21.0 68.4 59.4 447.3 39.5 38.0 45.8 33.6 36.2 16.0 48.5 55.4 44.5 26.5 31.4 49.4 83.0 35.7 43.3 63.7 42.1 23.3 35.2 52.9 34.6 32.4 233.9 42.6 38.6 21.4 10.3 52.8 35.3 53.5 31.2 48.2 67.6 32.9 25.6 44.6 38.9 44.1 78.0 32.6 50.0 26.3 40.3 43.5 333.0 107.8 32.5 29.0 51.7 37.1 86.8 31.2 49.9 DLG2 "chapsyn-110, PPP1R58, PSD-93, PSD93" ENSG00000150672 "Discs large MAGUK scaffold protein 2" Q15700 11 83455012-85627922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 88.4" "Group enriched" "Detected in many" 4 "Excitatory neurons: 3292.3;Inhibitory neurons: 2602.7;Oligodendrocyte precursor cells: 2331.8;Oligodendrocytes: 4213.8" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 8.2;SH-SY5Y: 8.1;T-47d: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021307, HPA023896, CAB072341" Enhanced Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 6: T47d - Mammary gland" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane" Vesicles "CAB072341: , HPA021307: AB_1846625, HPA023896: AB_2671353" "unprognostic (2.61e-3)" "unprognostic (2.81e-2)" "unprognostic (4.05e-2)" "unprognostic (9.03e-2)" "unprognostic (3.25e-1)" "unprognostic (1.09e-1)" "unprognostic (9.44e-3)" "unprognostic (7.78e-2)" "unprognostic (4.32e-1)" "unprognostic (4.61e-2)" "unprognostic (9.28e-3)" "unprognostic (4.84e-1)" "unprognostic (7.66e-6)" "unprognostic (2.92e-2)" "unprognostic (2.41e-1)" "unprognostic (6.52e-2)" "unprognostic (8.89e-2)" 1.6 11.0 29.5 1.1 48.7 0.3 2.1 3.6 55.8 1.8 0.0 2.3 1.2 2.9 4.1 7.5 5.7 2.1 3.0 64.4 18.1 3.6 2.8 1.7 1.1 13.5 8.2 5.7 3.3 7.3 10.0 2.4 10.3 4.0 1.4 25.4 3.1 4.6 0.8 20.2 1.2 2.2 11.9 2.5 1.5 8.1 10.5 7.3 15.5 0.7 2.9 1.7 2.6 88.4 0.6 0.3 0.9 0.5 0.6 0.7 8.2 0.2 0.5 0.4 0.3 7.4 1.1 1.3 1.3 0.4 0.5 0.8 2.3 0.7 0.4 0.8 0.9 1.3 5.0 0.2 0.1 0.4 1.1 0.5 0.5 1.0 1.0 0.4 0.5 1.9 1.2 3.5 0.7 0.9 0.6 1.3 6.0 0.8 1.3 1.4 2.0 0.9 0.4 0.3 5.9 8.1 0.8 5.1 0.4 7.2 21.2 0.0 0.3 2.2 1.8 2.1 0.3 0.8 2.9 5.6 0.8 0.7 0.2 0.0 0.0 0.2 0.1 0.0 0.5 0.1 0.1 0.2 0.0 0.6 0.6 0.2 0.0 0.0 0.1 0.5 0.0 0.0 29.5 48.7 3.6 55.8 64.4 18.1 13.5 8.2 10.3 11.9 10.5 88.4 7.0 3.2 10.4 742.8 1.3 3.3 3.6 0.3 9.1 298.1 4.4 5.2 8.3 2.8 1.8 7.3 275.2 7.9 1.8 1.5 9.8 0.7 21.5 1.3 2.7 3.6 4.2 0.0 3292.3 0.4 0.5 7.4 1.1 2.4 0.0 1.6 2.2 4.6 4.0 23.5 2602.7 1.1 0.0 0.3 0.0 16.4 7.8 0.8 1.8 487.2 0.6 11.0 0.0 2331.8 4213.8 0.4 0.1 6.4 0.1 2.0 0.6 2.7 0.9 48.2 6.6 7.1 4.1 11.3 3.2 6.2 8.5 2.1 1.7 12.1 0.9 0.8 TMEM126B HT007 ENSG00000171204 "Transmembrane protein 126B" Q8IUX1 11 85628573-85636539 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Chaperone "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014480, HPA019186" Uncertain Supported Mitochondria NA NA "Cluster 44: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA014480: AB_1858083, HPA019186: AB_1858084" "unprognostic (1.11e-1)" "unprognostic (4.97e-2)" "unprognostic (1.10e-1)" "unprognostic (2.79e-2)" "unprognostic (5.67e-1)" "unprognostic (1.44e-1)" "unprognostic (5.55e-3)" "unprognostic (1.22e-1)" "unprognostic (1.45e-2)" "unprognostic (6.70e-3)" "unprognostic (4.42e-2)" "unprognostic (4.30e-2)" "unprognostic (1.94e-2)" "unprognostic (1.78e-1)" "unprognostic (6.50e-2)" "unprognostic (5.86e-2)" "unprognostic (2.66e-2)" 16.1 16.7 29.2 13.0 29.4 6.5 19.3 28.9 38.9 18.2 25.9 21.4 19.6 19.3 30.7 14.3 15.8 17.3 24.7 30.4 31.7 15.3 17.2 15.8 18.7 29.7 30.0 16.4 15.9 11.0 20.8 13.3 30.9 17.0 17.6 18.6 15.7 14.1 16.2 13.8 19.8 21.4 30.1 16.5 17.6 10.9 30.2 16.0 16.8 20.1 17.5 18.6 14.8 32.3 37.9 29.8 33.1 16.0 60.2 49.6 10.6 33.1 36.1 25.6 38.1 84.8 37.1 39.9 72.2 27.1 28.6 45.0 53.2 33.0 23.8 56.5 49.7 30.1 49.1 36.1 35.6 75.4 34.7 37.9 38.3 38.6 47.0 41.1 38.6 49.5 72.5 31.2 58.8 47.9 29.4 91.3 36.1 129.6 50.1 25.0 25.4 33.6 49.5 42.1 30.8 19.1 31.2 24.9 31.9 42.5 50.1 45.4 20.5 38.2 26.5 96.9 35.4 14.6 91.1 47.7 19.4 60.4 20.6 21.5 15.6 7.9 19.0 18.2 24.8 18.3 23.4 23.5 20.1 17.7 23.3 23.4 5.9 23.4 14.5 18.4 25.9 15.9 29.2 29.4 28.9 38.9 30.4 31.7 29.7 30.0 30.9 30.1 30.2 32.3 44.9 22.4 40.7 16.6 34.6 26.1 32.2 80.8 22.8 32.5 36.8 31.1 87.3 54.3 57.2 40.5 14.6 41.0 54.2 33.6 168.3 76.0 5.4 27.2 39.2 46.1 34.6 34.5 19.3 49.0 54.5 45.1 15.8 25.8 42.5 27.8 42.5 43.6 84.1 23.5 20.1 41.3 81.4 47.4 44.6 8.3 66.5 43.5 72.9 9.4 48.8 79.0 80.3 20.6 29.7 51.5 52.8 88.4 22.4 35.3 56.5 162.9 51.3 31.2 39.5 30.0 43.8 34.4 46.8 23.1 36.9 25.2 49.7 45.4 52.0 45.4 TMEM126A "DKFZp586C1924, OPA7" ENSG00000171202 "Transmembrane protein 126A" Q9H061 11 85647967-85656547 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046648 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" Cytosol Nucleoplasm "HPA046648: AB_2679737" "unprognostic (3.79e-2)" "unprognostic (4.75e-3)" "unprognostic (2.08e-3)" "unprognostic (1.08e-3)" "unprognostic (2.08e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (8.60e-5)" "unprognostic (8.25e-2)" "unprognostic (6.00e-3)" "unprognostic (2.66e-2)" "unprognostic (1.02e-2)" "unprognostic (6.93e-2)" "unprognostic (1.25e-1)" "unprognostic (1.87e-2)" "unprognostic (2.70e-1)" "unprognostic (6.94e-2)" "unprognostic (2.17e-1)" 31.9 28.0 40.3 23.1 41.5 43.8 33.5 41.4 52.3 21.8 39.5 28.0 32.6 20.0 31.2 27.2 19.8 19.9 82.1 41.4 42.3 33.1 49.0 20.5 27.3 40.7 40.6 21.0 33.9 26.3 22.2 22.8 41.5 23.5 29.3 23.9 31.3 19.5 81.6 19.4 26.0 27.6 41.1 21.0 32.8 38.5 41.4 24.2 26.6 98.7 27.8 30.5 20.1 42.4 46.7 53.2 50.9 33.0 67.2 66.7 38.0 55.9 60.1 82.3 77.6 65.9 67.5 25.4 61.3 69.2 32.0 48.9 53.8 59.5 70.7 72.5 31.0 72.5 56.9 73.7 82.4 89.0 54.8 58.0 65.8 73.1 78.0 43.5 71.6 72.2 51.1 39.0 86.2 57.5 48.6 112.3 48.1 175.1 68.4 48.3 49.5 79.2 54.5 57.0 34.3 34.7 49.4 72.9 44.7 44.5 88.1 64.4 42.8 70.4 52.7 134.6 65.3 27.5 54.4 70.4 37.0 63.6 85.2 6.6 23.9 11.6 21.2 28.1 26.0 29.8 26.4 23.8 32.9 27.3 24.4 24.1 1.9 15.1 23.4 24.7 26.4 18.7 40.3 41.5 41.4 52.3 41.4 42.3 40.7 40.6 41.5 41.1 41.4 42.4 40.5 28.9 24.3 12.7 39.6 31.7 55.3 87.9 29.6 14.8 45.8 62.1 110.8 28.6 57.5 38.6 6.2 67.8 38.5 23.6 146.8 51.0 147.8 26.8 32.8 36.7 21.7 46.1 8.6 93.2 73.3 40.8 23.4 24.2 37.4 33.6 26.7 68.5 94.6 8.4 9.0 46.6 40.7 54.4 43.3 80.6 29.5 48.4 33.8 5.6 66.3 35.1 38.1 8.5 11.8 64.5 34.8 26.7 45.4 73.4 61.8 109.4 39.7 21.9 19.7 40.0 40.9 119.0 57.9 49.4 42.1 52.9 42.1 42.2 57.1 71.2 CREBZF ZF ENSG00000137504 "CREB/ATF bZIP transcription factor" Q9NS37 11 85657990-85682908 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HeLa: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021526, HPA063652" Uncertain Approved Nucleoplasm,Mitochondria NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Mitochondria" "HPA021526: AB_2670738, HPA063652: AB_2685075" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (6.46e-2)" "unprognostic (2.23e-3)" "unprognostic (2.21e-1)" "unprognostic (1.17e-2)" "unprognostic (1.19e-2)" "unprognostic (4.51e-2)" "unprognostic (1.04e-3)" "unprognostic (2.23e-3)" "unprognostic (1.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.34e-2)" "unprognostic (2.38e-3)" 17.1 12.4 9.8 12.9 11.1 9.7 16.8 18.3 15.4 15.9 11.3 12.8 14.1 21.3 12.2 10.1 15.1 10.3 8.2 10.1 9.9 8.8 10.8 15.4 18.7 10.6 10.0 21.7 14.8 11.8 8.7 13.2 11.1 12.9 13.7 27.9 16.4 10.2 9.9 17.2 16.4 10.3 10.5 17.2 12.7 6.1 10.3 13.6 16.3 6.8 15.3 12.1 14.9 13.5 5.6 12.4 18.4 7.6 8.4 8.8 13.7 9.8 6.0 8.4 11.0 15.6 22.5 16.4 9.1 5.8 22.1 19.6 12.7 6.2 14.1 9.3 11.9 14.9 53.1 7.2 5.7 14.1 8.0 7.8 12.2 8.5 11.8 11.5 5.3 10.8 11.7 18.6 10.1 7.9 12.0 27.5 6.8 16.3 8.7 19.2 15.7 10.1 9.2 10.7 14.5 12.4 12.6 19.3 4.2 11.6 20.8 20.8 6.3 17.4 10.7 24.3 11.0 6.4 7.6 16.8 4.1 10.4 10.9 0.3 0.1 0.1 0.4 0.1 0.7 0.2 0.3 0.3 0.2 0.2 0.4 0.4 0.2 0.4 0.3 0.2 0.6 0.1 9.8 11.1 18.3 15.4 10.1 9.9 10.6 10.0 11.1 10.5 10.3 13.5 30.3 19.2 21.5 58.1 41.9 41.3 21.6 12.4 31.3 97.5 35.1 20.6 13.9 17.2 17.9 22.0 91.8 16.9 53.1 30.0 9.8 13.2 34.5 27.6 31.1 25.1 39.4 30.1 57.6 8.6 14.9 34.7 46.9 34.0 22.2 64.3 23.2 29.5 9.9 90.9 60.7 23.8 10.2 19.2 27.3 16.6 30.7 15.6 33.8 25.3 24.8 47.9 46.4 56.8 114.5 9.2 22.8 33.4 39.1 29.5 29.8 8.0 22.5 113.5 13.1 34.6 30.9 27.4 11.4 27.7 41.3 14.4 43.0 51.9 25.7 26.5 CCDC89 FLJ38159 ENSG00000179071 "Coiled-coil domain containing 89" Q8N998 11 85683848-85686195 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 43.6" "Cell type enriched" "Detected in some" 9 "Early spermatids: 434.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "LHCN-M2: 3.1;SCLC-21H: 3.9;U-2197: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040628 Enhanced Approved Nucleoplasm NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 18: U-2197 - ECM organization" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "HPA040628: AB_2677053" "unprognostic (5.81e-2)" "unprognostic (1.93e-1)" "unprognostic (1.99e-1)" "unprognostic (3.04e-2)" "unprognostic (5.37e-2)" "unprognostic (6.38e-2)" "unprognostic (1.40e-1)" "unprognostic (4.92e-2)" "unprognostic (8.22e-2)" "unprognostic (2.87e-1)" "unprognostic (9.16e-2)" "unprognostic (2.00e-1)" "unprognostic (2.41e-3)" "unprognostic (7.75e-3)" "unprognostic (5.10e-2)" "unprognostic (8.47e-2)" "unprognostic (3.52e-1)" 0.7 0.9 0.6 0.3 0.7 0.0 1.3 1.4 0.6 1.2 0.9 0.7 0.3 2.6 1.0 0.3 7.8 1.0 0.9 0.5 0.9 1.1 0.2 1.1 0.3 1.5 1.5 4.8 0.1 1.3 1.2 0.7 1.6 1.3 0.7 1.6 0.3 1.5 0.3 0.4 0.5 1.5 1.3 0.4 1.1 43.6 0.7 0.4 0.2 0.4 0.1 0.7 0.6 1.1 0.0 0.0 0.0 0.0 2.3 2.6 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.1 2.5 2.1 2.5 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 1.1 0.0 0.0 1.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.1 1.3 3.9 0.9 0.0 0.4 0.0 0.0 0.3 0.0 0.0 2.1 0.0 4.8 1.7 0.0 2.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 1.4 0.6 0.5 0.9 1.5 1.5 1.6 1.3 0.7 1.1 0.1 0.0 0.6 1.0 0.0 0.3 0.1 1.0 0.0 0.3 0.4 0.4 0.1 0.0 1.8 0.0 0.0 0.0 0.2 0.2 0.0 0.1 434.9 7.3 2.0 0.4 0.0 0.0 0.5 0.0 0.1 1.7 0.0 0.2 0.0 0.4 0.4 0.0 1.7 6.7 0.6 0.1 2.0 0.8 0.0 43.1 3.1 0.2 0.0 1.9 0.0 1.0 0.0 0.5 0.5 0.0 0.0 4.5 0.4 0.0 0.0 1.5 30.2 0.8 0.0 1.7 1.4 45.9 1.4 0.0 0.3 0.0 0.2 0.8 0.0 0.1 SYTL2 "CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2" ENSG00000137501 "Synaptotagmin like 2" Q9HCH5 11 85694224-85811159 "Plasma proteins, Predicted intracellular proteins, Transporters" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 74.2;stomach 1: 127.7" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 382.2;granulocytes: 130.8;Intestinal goblet cells: 185.9;Respiratory ciliated cells: 138.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 14.0;MAIT T-cell: 23.7" "Lineage enriched" "Detected in many" 5 "T-cells: 23.7" "Cell line enhanced" "Detected in many" "MCF7: 91.1;OE19: 148.1;RH-30: 175.8;RPTEC TERT1: 124.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039651 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Nucleoplasm, Golgi apparatus" "Plasma membrane" "HPA039651: AB_10795153" "unprognostic (8.07e-3)" "unprognostic (6.72e-3)" "prognostic favorable (2.67e-4)" "unprognostic (9.34e-4)" "unprognostic (6.60e-3)" "unprognostic (2.19e-4)" "unprognostic (2.24e-2)" "unprognostic (5.37e-2)" "unprognostic (5.56e-2)" "unprognostic (5.45e-2)" "unprognostic (1.92e-2)" "unprognostic (2.97e-2)" "unprognostic (2.85e-2)" "unprognostic (4.03e-1)" "unprognostic (1.87e-2)" "unprognostic (9.72e-2)" "prognostic favorable (9.07e-4)" 16.7 9.6 19.3 12.9 24.6 3.3 16.0 8.7 35.7 10.7 11.9 51.7 21.6 9.1 16.3 17.0 7.6 27.8 8.4 29.0 25.1 20.2 6.9 14.8 11.1 26.4 14.0 4.8 2.7 6.4 6.1 18.2 17.9 13.6 74.2 13.3 8.9 9.8 5.1 6.8 25.0 10.2 15.6 10.4 127.7 5.1 13.8 7.1 4.7 2.7 6.8 50.9 7.4 29.1 3.5 8.0 12.2 1.0 2.8 15.4 0.2 30.3 39.4 26.3 59.2 34.7 4.5 0.7 11.1 21.3 38.0 22.3 0.8 2.7 34.5 2.4 0.2 0.0 0.2 0.3 1.8 2.7 0.5 19.6 3.8 56.8 0.8 6.2 0.2 1.0 0.4 0.4 33.6 91.1 0.1 0.9 20.6 148.1 13.6 1.3 175.8 0.1 124.2 46.8 0.3 0.6 6.7 5.4 3.0 10.2 0.6 0.5 0.1 40.8 15.6 25.9 1.5 0.2 0.0 16.1 41.9 0.5 25.7 0.0 0.0 0.0 14.0 0.0 23.7 0.0 2.8 8.4 0.0 0.1 2.3 4.1 0.0 4.6 0.1 1.0 1.1 2.6 19.3 24.6 8.7 35.7 29.0 25.1 26.4 14.0 17.9 15.6 13.8 29.1 7.5 22.4 32.5 15.3 3.0 3.6 11.7 15.8 1.8 10.4 45.4 14.0 2.3 8.6 62.1 68.0 8.4 0.7 45.6 115.2 0.0 9.1 1.2 8.0 2.2 6.4 19.2 4.0 103.9 16.9 0.4 11.5 382.2 2.3 130.8 0.8 5.0 0.5 0.5 1.7 23.2 185.9 2.0 5.9 5.0 0.9 1.8 4.6 10.6 20.6 1.6 14.0 63.8 35.7 91.9 16.5 40.6 30.1 31.6 30.7 16.3 8.6 138.4 8.1 32.9 42.1 59.8 3.6 2.6 2.2 5.7 0.4 50.1 2.3 36.7 60.9 CCDC83 "CT148, FLJ42119, KP-CoT-23, MGC34732" ENSG00000150676 "Coiled-coil domain containing 83" Q8IWF9 11 85855101-85920021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 115 "testis: 35.5" "Group enriched" "Detected in some" 46 "Early spermatids: 222.2;Late spermatids: 194.2;Spermatocytes: 160.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "MCF7: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039707, HPA039882" Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Plasma membrane, Cytosol" "HPA039707: AB_10795259, HPA039882: AB_10795410" "unprognostic (1.14e-1)" "unprognostic (4.09e-1)" "unprognostic (1.49e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-6)" "unprognostic (3.52e-1)" "unprognostic (2.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 222.2 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 194.2 4.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 160.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PICALM "CALM, CLTH" ENSG00000073921 "Phosphatidylinositol binding clathrin assembly protein" Q13492 11 85957175-86069882 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Endocytosis "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 500.3;Oligodendrocytes: 709.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 40.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019053, HPA019061" Enhanced Enhanced Vesicles NA NA 40000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 1: K-562 - Erythropoiesis" "Cluster 10: Non-specific - Unknown function" Vesicles "HPA019053: AB_1855361, HPA019061: AB_1855362" "unprognostic (9.27e-3)" "unprognostic (7.29e-2)" "unprognostic (3.51e-1)" "unprognostic (6.83e-2)" "unprognostic (5.13e-2)" "unprognostic (1.93e-1)" "unprognostic (5.36e-3)" "unprognostic (9.02e-3)" "unprognostic (9.80e-2)" "unprognostic (6.27e-3)" "prognostic unfavorable (6.61e-4)" "unprognostic (4.31e-1)" "prognostic favorable (2.02e-6)" "unprognostic (1.26e-2)" "unprognostic (5.21e-3)" "unprognostic (2.52e-1)" "unprognostic (1.02e-1)" 183.5 62.5 97.1 120.4 162.1 111.4 111.5 119.3 118.7 86.4 43.8 86.3 106.3 79.3 52.4 109.1 66.1 127.0 87.9 91.7 110.8 168.5 147.0 99.4 82.7 125.2 130.7 94.4 80.6 120.6 36.5 157.2 131.6 73.1 83.1 71.5 62.3 93.6 75.8 74.2 115.5 135.3 106.0 126.5 73.0 64.9 120.7 93.1 75.7 101.9 96.7 139.5 73.5 194.7 167.0 78.4 121.1 85.9 185.5 188.8 228.5 211.7 274.7 164.4 143.0 310.7 222.4 126.0 210.8 342.6 171.1 134.6 129.4 154.2 232.8 38.6 45.0 364.9 101.5 98.9 185.6 87.2 158.3 166.6 161.7 308.7 253.3 275.1 178.7 85.9 239.1 103.0 305.2 98.2 103.9 76.8 66.9 269.0 42.7 69.8 182.2 91.1 312.5 139.2 72.9 58.7 258.4 85.4 68.7 156.5 115.6 67.0 196.9 298.6 104.1 355.0 170.2 36.7 107.1 118.4 70.8 64.6 206.6 6.4 13.5 7.5 5.7 11.7 4.9 3.1 4.2 8.0 11.4 2.1 4.2 4.0 40.6 7.1 12.5 3.9 6.4 5.3 97.1 162.1 119.3 118.7 91.7 110.8 125.2 130.7 131.6 106.0 120.7 194.7 147.1 35.3 58.9 134.5 33.3 116.0 44.4 33.0 30.1 20.8 34.8 28.6 46.4 42.9 34.3 71.7 12.5 42.9 43.9 64.2 31.3 57.7 59.3 32.3 32.8 98.7 25.1 88.8 144.7 37.6 127.1 44.6 34.1 50.9 48.2 23.2 71.4 52.3 85.0 40.4 140.7 30.1 30.5 142.8 229.2 95.4 35.8 127.4 60.5 500.3 92.1 22.6 32.0 188.0 709.3 90.2 55.3 43.6 39.1 49.5 71.4 84.0 41.0 16.3 78.9 36.4 92.7 17.3 14.1 34.4 96.5 41.3 38.9 23.6 30.6 77.7 EED "HEED, WAIT-1" ENSG00000074266 "Embryonic ectoderm development" O75530 11 86244753-86278813 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012211, HPA060089, HPA061140" Supported Supported Nucleoplasm NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 16: Immune cells - Immune response" "Cluster 21: OE19 - Mitochondria" "Cluster 59: Non-specific - Transcription" Nucleoplasm "CAB012211: AB_2262066, HPA060089: AB_2684201, HPA061140: AB_2684437" "unprognostic (7.46e-2)" "unprognostic (4.40e-2)" "unprognostic (1.65e-1)" "unprognostic (1.02e-2)" "unprognostic (1.33e-1)" "unprognostic (3.13e-2)" "prognostic unfavorable (1.80e-5)" "unprognostic (2.90e-1)" "unprognostic (1.32e-2)" "unprognostic (2.39e-1)" "unprognostic (2.31e-1)" "unprognostic (9.19e-3)" "prognostic unfavorable (1.36e-7)" "unprognostic (1.67e-1)" "unprognostic (1.71e-1)" "unprognostic (1.33e-2)" "prognostic favorable (2.27e-5)" 9.3 9.0 13.2 16.3 13.1 9.2 11.4 15.0 15.8 13.8 13.1 12.1 12.1 11.5 15.2 12.7 10.6 9.3 8.9 12.8 13.5 11.5 11.9 8.5 28.8 12.9 12.8 12.1 10.5 9.1 9.4 14.5 13.1 11.7 11.9 16.4 10.3 10.6 10.5 12.1 11.6 10.2 12.9 14.4 10.9 10.3 13.6 17.8 10.7 11.1 32.1 13.0 12.1 13.9 34.2 37.8 40.9 16.8 22.6 20.2 47.0 49.2 22.6 46.3 46.8 121.0 64.4 79.8 50.6 15.8 44.2 41.4 48.7 26.8 43.2 79.7 22.7 51.4 38.7 36.3 19.8 54.2 33.4 12.4 18.0 46.8 20.1 17.5 20.9 34.7 58.8 16.2 39.0 55.2 51.5 55.4 30.4 107.8 18.4 56.2 49.1 38.8 29.1 55.4 27.5 22.4 63.5 29.6 14.5 29.1 49.2 22.6 19.0 48.1 44.1 70.0 43.2 9.2 32.1 63.9 13.7 46.6 36.8 31.0 9.1 15.0 25.4 15.3 22.1 45.0 33.2 32.0 13.9 47.3 26.4 29.6 3.9 19.3 16.8 9.2 58.6 19.1 13.2 13.1 15.0 15.8 12.8 13.5 12.9 12.8 13.1 12.9 13.6 13.9 15.4 6.4 9.3 28.1 32.7 25.6 11.6 27.5 25.0 26.4 13.3 11.8 9.5 11.5 15.4 7.3 18.8 45.2 31.0 16.1 19.6 14.5 7.7 17.6 17.1 16.6 7.2 15.8 35.0 10.2 36.8 14.8 16.3 15.5 15.9 15.0 13.2 11.4 16.9 32.0 45.6 12.8 12.2 14.5 32.5 3.6 22.7 15.2 19.6 37.5 30.4 11.5 25.7 31.2 38.9 11.9 11.1 17.3 17.6 11.9 11.7 8.6 21.3 18.3 6.6 14.3 24.5 18.7 20.0 16.9 16.8 24.9 31.6 17.5 15.0 20.9 HIKESHI "C11orf73, HSPC138, HSPC179, OPI10" ENSG00000149196 "Heat shock protein nuclear import factor hikeshi" Q53FT3 11 86302211-86345943 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 129.6;Extravillous trophoblasts: 146.2;Hofbauer cells: 94.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012708, HPA035063, HPA035064" Approved Approved "Nucleoplasm,Nuclear speckles,Nuclear bodies" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" "Nucleoplasm, Nuclear bodies" "HPA012708: , HPA035063: AB_10601143, HPA035064: AB_2674441" "unprognostic (1.10e-3)" "unprognostic (5.09e-2)" "unprognostic (1.92e-1)" "unprognostic (2.40e-2)" "unprognostic (1.50e-1)" "unprognostic (2.18e-1)" "prognostic unfavorable (8.81e-4)" "unprognostic (9.92e-2)" "unprognostic (1.16e-1)" "unprognostic (2.67e-2)" "unprognostic (8.24e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (4.01e-12)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.33e-3)" "unprognostic (1.71e-1)" 34.7 27.0 46.1 17.8 46.7 19.0 31.4 47.8 71.5 33.9 44.5 40.8 10.4 32.3 24.7 33.4 31.0 15.0 57.1 46.1 47.2 17.0 24.7 23.9 26.0 46.6 46.0 37.5 22.8 22.9 31.5 28.3 47.1 24.5 19.1 32.5 19.8 28.6 59.9 29.5 20.8 31.1 49.1 28.5 23.5 19.0 47.1 32.9 17.7 57.8 30.8 32.8 31.8 50.9 28.6 30.5 72.7 40.5 59.9 74.2 38.2 43.2 52.0 44.2 52.6 90.8 77.8 29.0 96.9 57.4 83.9 59.9 54.2 95.1 47.0 62.0 47.6 47.0 47.5 68.2 80.8 58.0 36.8 52.7 94.9 52.8 62.5 56.9 85.9 54.7 51.1 64.6 91.5 78.0 69.6 136.7 59.5 186.3 20.1 53.0 35.7 65.4 77.2 53.2 44.8 38.7 53.8 39.8 31.1 72.7 64.1 38.5 44.2 52.1 36.4 105.8 32.7 27.7 68.3 57.6 26.6 54.4 52.6 47.8 53.4 44.4 48.6 52.5 54.3 61.8 59.1 53.6 68.9 52.9 51.1 52.3 11.2 57.9 53.9 53.7 84.5 43.2 46.1 46.7 47.8 71.5 46.1 47.2 46.6 46.0 47.1 49.1 47.1 50.9 59.9 38.5 32.1 0.0 16.1 0.0 0.0 0.0 0.0 0.0 53.4 81.3 0.0 0.0 14.9 27.6 0.0 129.6 28.7 0.0 41.1 76.1 0.0 41.4 60.4 28.7 0.0 0.0 0.0 66.3 146.2 30.2 0.0 36.8 22.7 52.1 0.0 0.0 94.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 50.1 0.0 0.0 0.0 0.0 49.8 0.0 0.0 4.1 0.0 0.0 43.2 27.7 0.0 0.0 0.0 34.7 0.0 0.0 0.0 0.0 77.6 18.1 59.3 0.0 0.0 CCDC81 "FLJ16339, FLJ23514" ENSG00000149201 "Coiled-coil domain containing 81" Q6ZN84 11 86374736-86423109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 10.2;fallopian tube: 27.4" "Cell type enhanced" "Detected in many" "Early spermatids: 37.5;Endometrial ciliated cells: 72.7;Extravillous trophoblasts: 35.8;Respiratory ciliated cells: 38.4" "Cancer enhanced" "Detected in single" "testis cancer: 1.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 3.4;BJ hTERT+: 1.8;HBF TERT88: 1.9;SuSa: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.02e-1)" "unprognostic (6.06e-2)" "unprognostic (1.19e-2)" "unprognostic (2.30e-1)" "unprognostic (1.53e-1)" "unprognostic (6.76e-2)" "unprognostic (7.00e-3)" "unprognostic (8.54e-3)" "unprognostic (1.46e-3)" "unprognostic (2.82e-1)" "unprognostic (1.72e-1)" "unprognostic (1.57e-1)" "unprognostic (8.14e-4)" "unprognostic (1.61e-1)" "unprognostic (1.17e-1)" "unprognostic (2.27e-1)" "unprognostic (6.62e-2)" 0.7 0.3 1.5 0.2 1.4 0.2 0.4 1.8 1.4 1.9 10.2 0.5 0.0 1.6 0.5 0.2 27.4 0.4 0.4 1.8 2.3 0.4 0.3 1.4 0.4 4.0 5.5 0.8 0.2 0.1 1.8 0.6 3.9 0.7 0.2 1.0 0.2 0.7 0.8 0.4 0.3 1.1 3.5 0.4 0.4 5.8 2.0 0.8 0.7 0.1 0.3 0.6 0.5 2.4 0.0 0.1 1.1 0.0 0.3 0.1 0.4 3.4 1.8 0.5 0.4 0.4 0.3 0.2 1.3 0.6 0.1 0.2 0.6 0.1 1.9 0.2 0.2 0.3 0.1 0.3 0.1 0.2 0.3 0.0 0.6 0.9 0.3 0.6 0.6 0.2 0.2 0.0 0.4 0.5 0.4 1.0 0.1 0.5 0.0 0.2 0.1 0.3 0.2 0.0 0.1 0.2 0.1 0.2 0.0 2.1 0.2 0.4 0.1 0.8 0.4 0.8 0.1 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 1.8 1.4 1.8 2.3 4.0 5.5 3.9 3.5 2.0 2.4 0.1 3.2 0.5 4.6 0.0 0.3 0.2 1.0 0.0 1.8 0.7 0.6 1.1 0.0 5.2 0.0 0.0 4.0 0.2 0.1 0.0 0.1 37.5 72.7 1.0 0.4 0.0 0.0 2.3 0.0 35.8 1.0 0.0 1.3 0.0 0.3 1.8 0.0 2.1 0.0 3.8 0.0 2.0 0.6 0.7 5.1 1.5 0.5 0.0 1.0 0.6 0.4 0.0 2.5 3.5 0.0 0.1 0.7 0.0 0.6 0.1 0.1 38.4 1.0 13.1 0.7 0.9 5.8 0.3 0.0 0.6 2.7 0.2 1.0 0.1 0.2 ME3 ENSG00000151376 "Malic enzyme 3" Q16798 11 86441108-86672636 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 54.2;Excitatory neurons: 103.7;Inhibitory neurons: 147.8;Oligodendrocyte precursor cells: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 54.4;hTERT-RPE1: 64.1;HUVEC TERT2: 36.3;TIME: 40.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA038473 Approved NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA038473: AB_10672747" "unprognostic (1.83e-3)" "unprognostic (8.00e-2)" "unprognostic (1.99e-1)" "unprognostic (1.04e-1)" "unprognostic (2.13e-1)" "unprognostic (2.91e-1)" "unprognostic (5.01e-2)" "unprognostic (1.51e-1)" "unprognostic (1.29e-1)" "unprognostic (2.71e-1)" "unprognostic (1.20e-1)" "unprognostic (5.74e-2)" "unprognostic (2.97e-1)" "unprognostic (1.65e-1)" "unprognostic (2.73e-1)" "unprognostic (2.96e-2)" "prognostic favorable (3.86e-4)" 17.4 24.4 25.5 5.0 27.2 6.2 19.5 12.2 31.5 24.5 14.4 16.4 7.1 16.7 5.6 4.2 13.6 11.5 26.2 27.0 15.7 25.1 6.2 11.3 4.2 24.8 25.9 27.9 15.9 16.2 22.4 4.7 22.9 19.9 13.7 10.8 12.6 9.0 21.9 4.5 8.9 14.1 5.3 10.9 21.0 13.0 20.4 3.5 12.5 19.5 2.4 17.1 14.2 16.5 0.0 18.1 5.2 0.0 7.9 16.6 0.1 5.9 9.6 12.9 16.0 14.0 54.4 0.0 5.3 5.7 31.5 0.2 0.0 0.1 5.6 9.2 0.0 9.6 16.8 0.0 11.9 1.2 0.0 11.8 2.8 10.2 0.1 64.1 36.3 0.0 0.2 0.0 9.1 1.8 2.7 0.1 1.2 1.7 7.7 8.3 0.0 0.6 11.4 21.4 6.2 0.1 3.8 0.1 0.0 2.1 0.9 1.5 40.0 1.5 1.2 26.3 0.9 0.1 3.3 0.0 1.4 17.1 1.6 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.7 1.2 2.3 0.0 0.9 1.1 0.0 1.0 0.1 0.3 0.0 0.5 25.5 27.2 12.2 31.5 27.0 15.7 24.8 25.9 22.9 5.3 20.4 16.5 13.6 3.2 3.3 30.3 1.1 2.3 4.6 5.4 5.7 16.5 7.5 9.1 54.2 2.8 8.1 3.7 0.0 0.3 1.9 19.2 43.0 9.1 0.7 3.2 6.1 11.5 9.0 4.2 103.7 7.9 0.4 8.4 19.9 1.6 0.0 33.4 14.6 1.6 6.8 20.2 147.8 14.8 4.1 1.6 3.5 2.5 6.2 1.8 1.8 14.0 1.1 2.0 1.0 75.4 4.8 11.5 21.1 6.4 0.5 6.4 3.5 6.5 14.9 2.5 13.1 7.0 8.2 0.4 0.2 2.6 1.6 0.0 1.6 38.8 11.0 6.6 PRSS23 "SIG13, SPUVE" ENSG00000150687 "Serine protease 23" O95084 11 86791059-86952910 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix: 249.1" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 367.1;Endothelial cells: 502.1;Granulosa cells: 347.3;Hepatic stellate cells: 591.8;Theca cells: 445.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 104.6" "Group enriched" "Detected in many" 25 "NK-cells: 34.2;T-cells: 104.6" "Cell line enhanced" "Detected in many" "GAMG: 1093.7;hTERT-RPE1: 1296.9;TIME: 1138.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030591 Uncertain "Secreted to blood" NA NA 440000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA030591: AB_10602067" "unprognostic (2.68e-2)" "unprognostic (1.20e-2)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (2.40e-3)" "prognostic unfavorable (2.12e-4)" "unprognostic (1.89e-2)" "unprognostic (4.30e-2)" "unprognostic (2.08e-1)" "unprognostic (2.09e-1)" "prognostic unfavorable (5.56e-4)" "unprognostic (5.35e-2)" "prognostic unfavorable (3.06e-4)" "unprognostic (5.13e-3)" "unprognostic (9.44e-2)" "unprognostic (1.99e-3)" "unprognostic (8.01e-2)" 55.0 21.4 7.8 35.3 7.8 2.1 43.2 7.1 8.7 249.1 12.9 103.6 19.2 103.4 13.4 22.1 24.9 83.8 28.3 7.9 8.0 42.4 15.0 63.3 21.8 14.0 13.9 26.8 29.8 36.0 16.4 61.7 8.8 61.3 50.3 2.7 52.4 128.2 79.6 19.4 29.0 115.5 7.1 18.0 54.2 31.8 14.1 17.5 40.9 18.7 10.2 99.6 79.1 7.4 62.7 153.3 161.1 1.0 70.4 172.3 0.7 269.0 244.4 293.2 232.6 368.1 484.7 0.2 208.2 414.7 1093.7 126.2 2.6 205.0 70.9 0.7 13.0 21.1 74.7 1.4 36.3 0.1 0.9 137.4 26.8 143.2 162.1 1296.9 604.8 0.9 1.3 0.3 223.4 87.7 0.2 0.3 9.8 211.7 16.8 0.0 0.0 0.7 111.5 82.3 1.5 1.0 59.9 4.5 18.7 397.6 6.0 0.6 1138.2 174.0 2.3 351.7 154.5 1.3 1.3 0.8 124.2 0.5 176.3 0.2 0.2 0.1 104.6 0.1 0.2 0.2 17.8 60.0 0.2 0.0 4.7 50.4 1.6 34.2 2.7 0.2 0.0 39.9 7.8 7.8 7.1 8.7 7.9 8.0 14.0 13.9 8.8 7.1 14.1 7.4 95.8 28.9 14.5 14.0 3.2 15.4 96.2 367.1 2.8 1.6 44.7 78.0 4.3 37.1 231.3 53.3 2.1 18.4 53.4 154.8 7.9 162.6 3.1 10.3 130.3 502.1 13.8 20.4 26.3 83.5 15.7 117.1 22.4 7.0 2.5 347.3 591.8 5.2 5.0 0.0 16.5 30.6 85.5 36.6 18.2 6.6 14.3 5.4 72.9 39.4 1.5 0.8 180.2 11.6 2.3 257.7 80.1 7.5 5.8 100.1 5.2 5.7 90.1 0.9 39.5 14.4 105.9 3.0 7.3 1.7 9.8 4.5 24.0 445.1 11.1 60.2 FZD4 "CD344, EVR1" ENSG00000174804 "Frizzled class receptor 4" Q9ULV1 11 86945679-86955395 "CD markers, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 120.1" "Cell type enhanced" "Detected in many" "Adipocytes: 83.0;Collecting duct cells: 36.8;Endothelial cells: 51.2;Hepatic stellate cells: 99.6;Sertoli cells: 32.9" "Cancer enhanced" "Detected in all" "renal cancer: 22.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 63.6;Hep G2: 85.2;HSkMC: 46.0;HUVEC TERT2: 93.6;TIME: 46.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042328, HPA074833" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane" Nucleoplasm "HPA042328: AB_10962494, HPA074833: AB_2686716" "unprognostic (6.49e-2)" "unprognostic (1.49e-2)" "unprognostic (1.03e-1)" "unprognostic (1.03e-1)" "unprognostic (5.87e-2)" "unprognostic (5.51e-2)" "unprognostic (1.82e-1)" "unprognostic (6.97e-2)" "unprognostic (3.33e-2)" "unprognostic (3.79e-2)" "unprognostic (1.36e-2)" "unprognostic (2.22e-1)" "prognostic favorable (8.60e-5)" "unprognostic (1.05e-2)" "unprognostic (9.96e-2)" "unprognostic (9.22e-2)" "unprognostic (1.97e-1)" 120.1 9.5 6.7 5.8 6.2 0.3 55.6 5.1 7.3 12.5 7.8 14.9 2.8 12.2 7.6 6.5 16.3 11.5 27.4 5.6 5.9 27.1 14.6 32.9 6.2 6.5 6.3 12.9 9.5 6.4 8.7 11.7 7.0 12.5 6.3 1.1 12.2 30.2 31.5 5.9 8.8 13.4 5.6 14.1 14.1 5.1 8.5 3.9 18.1 40.6 4.6 10.5 9.5 5.9 1.3 1.1 2.7 5.2 63.6 16.5 3.7 8.4 7.6 3.2 3.3 7.1 0.9 0.0 1.8 2.6 4.4 2.8 3.1 1.3 2.5 0.2 2.1 2.8 2.3 85.2 18.9 0.0 0.1 46.0 0.5 2.8 0.5 7.5 93.6 0.1 3.9 0.4 2.2 2.2 0.0 0.0 3.9 7.5 18.8 0.1 4.8 0.2 9.0 13.7 0.6 0.8 3.5 1.0 1.4 5.6 12.0 0.0 46.3 7.8 5.1 9.2 1.7 0.4 1.3 0.0 1.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.7 6.2 5.1 7.3 5.6 5.9 6.5 6.3 7.0 5.6 8.5 5.9 83.0 0.0 1.3 9.8 0.5 1.5 0.5 1.3 2.2 0.7 5.5 3.2 8.3 7.2 2.0 36.8 10.4 0.2 0.5 1.0 3.9 0.5 0.7 0.4 2.7 51.2 0.0 2.7 8.1 1.6 0.2 17.7 4.1 0.5 0.0 9.1 99.6 14.1 0.2 0.0 3.4 1.3 0.0 6.7 1.8 2.2 9.3 0.6 0.0 10.3 0.0 0.2 2.1 3.0 0.7 1.0 0.1 6.8 0.3 1.4 0.7 9.4 2.1 0.2 32.9 14.4 26.6 0.3 3.2 1.3 0.6 0.3 0.4 16.6 1.1 0.2 TMEM135 FLJ22104 ENSG00000166575 "Transmembrane protein 135" Q86UB9 11 87037844-87328824 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 121.8;Excitatory neurons: 99.6;Inhibitory neurons: 93.7;Oligodendrocyte precursor cells: 123.1;Oligodendrocytes: 202.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 88.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056685, HPA069473" Uncertain Supported Vesicles NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles "HPA056685: AB_2683208, HPA069473: AB_2686139" "unprognostic (1.55e-2)" "unprognostic (1.11e-1)" "unprognostic (2.70e-2)" "unprognostic (6.51e-2)" "unprognostic (3.10e-2)" "unprognostic (4.42e-1)" "unprognostic (1.45e-2)" "unprognostic (2.63e-1)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.26e-1)" "unprognostic (1.65e-1)" "prognostic favorable (9.02e-4)" "unprognostic (3.48e-2)" "unprognostic (7.34e-2)" "unprognostic (1.35e-2)" "unprognostic (1.80e-1)" 26.1 14.9 4.2 5.6 6.0 3.7 14.2 2.8 5.2 5.6 5.8 10.5 15.6 6.4 4.7 4.4 6.0 8.3 6.7 4.9 5.2 12.0 24.7 6.5 5.9 5.0 5.8 7.3 6.2 9.4 5.4 10.2 5.6 10.7 8.5 7.0 10.0 6.4 8.4 3.9 14.5 6.9 2.5 5.8 7.4 10.2 4.3 6.6 10.1 7.5 4.8 5.5 4.4 6.7 8.8 15.7 9.8 13.7 31.3 28.6 9.2 6.5 16.7 7.6 17.0 27.1 39.9 24.2 17.1 8.9 19.9 8.3 13.3 14.9 8.5 22.7 7.5 18.5 14.0 88.5 17.6 10.8 9.2 34.8 9.2 11.0 7.6 10.2 19.5 26.4 19.3 35.9 9.0 5.9 28.3 10.8 11.5 47.2 11.7 12.5 7.5 19.2 17.5 28.1 4.8 11.0 9.6 30.0 13.6 18.8 42.0 9.6 10.3 7.9 10.3 30.6 4.6 13.4 28.2 28.2 6.0 11.5 15.7 0.9 4.8 1.4 7.5 5.1 6.7 4.7 4.7 8.1 5.6 3.4 5.3 5.1 1.5 7.2 2.2 5.7 5.4 4.1 4.2 6.0 2.8 5.2 4.9 5.2 5.0 5.8 5.6 2.5 4.3 6.7 14.4 9.6 7.5 121.8 7.1 4.2 4.0 4.6 8.6 5.6 12.7 7.1 6.3 5.7 6.8 1.8 4.2 2.6 7.7 10.5 5.9 2.8 2.8 5.8 11.0 8.1 3.6 3.8 99.6 3.2 8.6 11.0 8.6 4.2 9.5 11.5 7.9 16.2 4.9 1.7 93.7 6.8 10.2 7.8 6.0 7.7 7.2 5.4 5.4 48.7 4.1 5.0 9.2 123.1 202.4 3.1 10.9 7.2 10.3 6.1 21.8 10.6 8.7 4.2 32.9 5.7 8.4 2.2 3.8 4.8 4.8 1.5 8.3 24.6 8.7 3.8 RAB38 NY-MEL-1 ENSG00000123892 "RAB38, member RAS oncogene family" P57729 11 88113251-88175443 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 48.6;skin 1: 44.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 46.4;Basal respiratory cells: 74.8;Cytotrophoblasts: 94.5;Melanocytes: 131.6;Suprabasal keratinocytes: 98.5;Syncytiotrophoblasts: 54.7" "Cancer enhanced" "Detected in all" "melanoma: 73.8" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 4 "NK-cell: 18.0" "Lineage enriched" "Detected in many" 4 "NK-cells: 18.0" "Cell line enhanced" "Detected in many" "HBEC3-KT: 87.7;hTCEpi: 308.0;hTERT-HME1: 271.4;SK-MEL-30: 175.6" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "basal ganglia: 1.1" HPA071701 Uncertain "Nuclear bodies,Mitochondria" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 47: Cytotrophoblasts - Unknown function" "Nuclear bodies, Mitochondria" "HPA071701: " "unprognostic (2.85e-1)" "unprognostic (1.30e-1)" "unprognostic (4.40e-2)" "unprognostic (2.66e-2)" "unprognostic (1.36e-2)" "unprognostic (7.95e-2)" "unprognostic (3.96e-4)" "unprognostic (2.36e-1)" "unprognostic (1.44e-1)" "unprognostic (9.34e-2)" "unprognostic (1.00e-2)" "unprognostic (8.23e-2)" "prognostic favorable (8.26e-4)" "unprognostic (3.82e-2)" "unprognostic (2.60e-1)" "unprognostic (1.61e-1)" "unprognostic (2.65e-2)" 2.6 27.8 0.4 1.4 0.4 1.6 8.6 0.3 0.8 11.8 6.3 1.9 2.4 4.7 6.7 48.6 5.6 6.0 1.1 0.7 0.6 4.5 1.8 5.8 1.7 0.5 0.7 3.3 1.6 1.8 2.8 14.7 0.5 2.4 1.3 2.9 7.7 6.4 0.6 44.3 2.3 3.6 0.4 1.6 1.6 2.5 0.8 3.5 7.9 0.4 17.9 8.7 23.5 0.6 10.7 1.4 0.3 0.5 0.4 2.4 0.6 6.5 26.1 10.4 19.0 4.7 4.8 0.5 6.3 6.9 1.2 71.2 5.7 87.7 14.1 1.3 5.1 54.0 6.2 0.0 1.0 0.6 0.6 2.2 308.0 1.4 271.4 13.0 12.3 1.0 0.3 0.9 0.0 0.0 0.7 18.4 8.2 0.7 0.1 0.5 0.1 0.8 20.0 40.6 1.9 1.2 0.3 0.1 175.6 6.2 15.7 4.6 6.7 0.0 4.6 0.0 1.1 1.5 6.5 0.2 1.7 2.2 1.2 0.0 0.8 0.1 1.5 0.6 0.8 0.0 0.4 1.8 1.6 0.0 0.1 0.8 0.6 18.0 1.3 4.4 1.0 0.7 0.4 0.4 0.3 0.8 0.7 0.6 0.5 0.7 0.5 0.4 0.8 0.6 1.0 0.0 6.7 0.7 0.1 46.4 15.9 74.8 21.1 0.1 6.9 9.7 0.2 8.6 25.0 0.0 0.0 94.5 2.7 0.5 3.9 1.7 0.0 2.1 0.9 2.7 0.0 5.5 0.6 1.1 10.5 9.1 3.1 2.3 16.5 5.3 1.1 0.0 17.5 0.0 0.4 0.3 14.2 1.6 21.2 0.1 3.4 3.9 131.6 3.7 6.3 0.6 1.0 2.0 0.1 2.6 2.6 1.2 0.1 9.5 2.1 5.3 7.4 6.4 0.0 0.6 5.3 0.1 5.9 38.1 98.5 54.7 2.7 5.9 2.5 23.3 CTSC "DPP1, PALS, PLS" ENSG00000109861 "Cathepsin C" P53634 11 88265069-88359684 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Thiol protease" "Disease variant, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 900.7;Club cells: 471.8;Hofbauer cells: 1100.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+: 1078.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025364, HPA066610, HPA068434" Enhanced Supported Vesicles "Intracellular and membrane" No No 19000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 19: Lung - Lung function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Vesicles "CAB025364: , HPA066610: AB_2685694, HPA068434: AB_2685989" "unprognostic (4.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.50e-1)" "unprognostic (1.10e-1)" "unprognostic (3.70e-2)" "unprognostic (1.45e-2)" "prognostic unfavorable (9.30e-5)" "unprognostic (1.62e-1)" "unprognostic (1.04e-1)" "unprognostic (1.56e-2)" "unprognostic (3.11e-2)" "unprognostic (3.35e-1)" "prognostic favorable (4.80e-4)" "unprognostic (2.93e-1)" "unprognostic (4.35e-2)" "unprognostic (8.10e-2)" "unprognostic (4.07e-2)" 173.2 60.7 9.9 185.1 9.6 71.7 63.4 11.1 24.9 77.9 14.2 143.1 121.0 43.9 28.5 63.3 54.0 182.0 38.5 9.5 10.1 234.7 82.0 272.6 243.7 14.0 11.9 22.1 52.2 42.4 39.3 253.3 13.3 26.0 191.5 3.7 131.6 28.9 18.8 29.6 128.8 88.9 11.5 197.2 73.6 22.8 19.5 63.7 43.6 31.9 140.6 176.3 43.3 21.3 80.3 75.9 27.6 69.9 103.7 286.1 218.4 626.5 1078.4 372.8 270.3 194.7 361.3 117.3 278.9 365.2 84.3 133.6 50.4 269.2 341.9 204.7 82.8 144.5 188.0 233.5 140.2 188.9 108.7 419.1 198.8 284.5 697.4 302.1 377.6 122.3 155.3 145.4 54.8 14.8 89.1 295.1 172.2 551.5 244.9 113.6 30.7 227.0 451.3 106.6 8.8 66.8 81.2 114.9 80.6 185.4 27.9 152.7 149.3 23.5 190.5 156.8 364.6 61.9 81.0 122.9 56.8 435.8 122.4 85.5 203.8 309.7 230.1 415.6 194.9 47.2 99.6 198.2 209.9 26.3 49.5 115.3 215.0 200.5 582.9 425.0 162.7 243.3 9.9 9.6 11.1 24.9 9.5 10.1 14.0 11.9 13.3 11.5 19.5 21.3 78.6 22.4 88.1 0.3 40.8 30.1 7.3 900.7 33.6 1.5 15.9 14.6 4.4 52.9 471.8 40.5 0.0 414.1 330.6 37.9 29.4 29.8 1.6 13.4 135.6 94.8 11.4 29.7 3.0 90.6 159.2 114.4 39.8 21.2 75.3 25.5 26.4 15.8 1100.6 0.0 8.2 19.4 158.7 344.7 200.7 7.9 198.5 391.7 48.0 61.8 185.4 0.5 299.7 13.6 0.4 44.8 72.3 25.6 78.5 8.5 20.2 166.4 93.7 0.8 59.2 4.4 150.8 3.0 11.1 43.3 27.1 227.3 170.6 286.7 44.9 16.1 GRM5 "GPRC1E, mGlu5, MGLUR5, PPP1R86" ENSG00000168959 "Glutamate metabotropic receptor 5" P41594 11 88504576-89065945 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 23.8" "Group enriched" "Detected in some" 26 "Excitatory neurons: 903.1;Inhibitory neurons: 968.3;Oligodendrocyte precursor cells: 1040.5" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "amygdala: 14.9;basal ganglia: 17.3;cerebral cortex: 23.8;hippocampal formation: 20.4;white matter: 6.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 10: Brain - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (1.94e-1)" "unprognostic (9.62e-2)" "unprognostic (9.57e-2)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (2.62e-1)" "unprognostic (1.26e-1)" "unprognostic (7.16e-2)" "unprognostic (8.15e-4)" "unprognostic (3.43e-2)" 0.0 0.0 14.9 0.0 17.3 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 20.4 1.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.3 0.0 0.0 2.8 0.0 0.0 1.7 3.7 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 17.3 0.0 23.8 20.4 1.0 0.0 0.0 0.0 2.8 3.7 6.4 0.1 0.0 0.0 36.6 0.0 0.0 0.0 0.0 0.0 28.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 7.5 0.1 0.0 0.0 0.0 903.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.7 968.3 0.0 0.0 0.0 0.0 23.6 0.3 0.0 0.0 22.5 0.0 0.8 0.0 1040.5 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 1.8 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 TYR "OCA1, OCA1A, OCAIA" ENSG00000077498 Tyrosinase P14679 11 89177875-89295759 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Melanin biosynthesis" "Monooxygenase, Oxidoreductase, Tumor antigen" "Albinism, Deafness, Disease variant, FDA approved drug targets, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 37 "skin 1: 31.6" "Cell type enriched" "Detected in some" 5 "Melanocytes: 184.9" "Cancer enriched" "Detected in single" 1755 "melanoma: 351.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 995 "SK-MEL-30: 426.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000079, HPA043241, HPA050889, HPA064583" Enhanced Enhanced Vesicles NA NA "Cluster 61: Skin - Cornification" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 23: Spermatids - Flagellum & Golgi organization" Vesicles "CAB000079: AB_564045, HPA043241: AB_2678383, HPA050889: AB_2681264, HPA064583: " "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (1.85e-3)" "unprognostic (9.75e-3)" 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 31.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 426.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.9 0.3 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.5 5.2 0.3 0.0 184.9 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 2.0 0.0 0.1 0.0 0.0 0.0 NOX4 "KOX, KOX-1" ENSG00000086991 "NADPH oxidase 4" Q9NPH5 11 89324353-89498187 "Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "kidney: 138.0" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 164.0" "Cancer enhanced" "Detected in many" "renal cancer: 5.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 14.3;HUVEC TERT2: 27.7;TIME: 70.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "unprognostic (2.91e-2)" "unprognostic (1.08e-1)" "unprognostic (1.74e-3)" "unprognostic (6.58e-3)" "unprognostic (1.92e-1)" "unprognostic (2.33e-1)" "unprognostic (8.83e-3)" "unprognostic (8.95e-3)" "unprognostic (3.80e-1)" "unprognostic (6.88e-2)" "unprognostic (1.56e-2)" "unprognostic (1.73e-1)" "prognostic favorable (6.14e-4)" "unprognostic (1.99e-4)" "unprognostic (9.71e-2)" "unprognostic (5.69e-2)" "unprognostic (3.03e-3)" 7.8 0.7 0.7 0.7 1.2 0.2 3.8 0.7 1.2 1.5 0.0 1.2 0.2 4.9 0.4 0.4 1.3 2.4 7.6 0.4 0.6 138.0 0.3 1.5 0.2 1.0 0.7 0.8 0.3 3.6 0.9 3.1 0.9 1.0 0.3 17.1 3.0 1.3 1.7 1.4 0.6 3.4 0.8 0.4 0.5 0.3 0.7 0.1 2.1 3.5 0.5 1.4 1.1 1.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 3.5 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.7 0.1 0.0 0.1 14.3 27.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 6.1 0.0 0.0 0.3 7.1 0.4 0.0 70.6 0.2 5.0 0.0 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.7 1.2 0.7 1.2 0.4 0.6 1.0 0.7 0.9 0.8 0.7 1.7 4.4 0.0 0.0 2.9 1.0 0.6 0.1 0.4 0.0 7.5 0.2 0.3 1.0 0.0 0.0 11.0 6.2 2.2 0.2 0.1 15.6 0.0 0.8 1.0 1.4 5.9 0.0 0.0 30.0 0.0 0.8 9.2 0.0 3.0 0.0 0.6 2.5 0.1 0.2 0.0 21.1 0.0 0.0 0.0 0.5 0.7 0.3 1.3 0.0 6.5 0.1 4.5 0.0 7.1 28.4 0.1 0.0 1.2 0.3 0.1 0.0 164.0 0.0 27.1 0.0 1.2 1.0 0.6 0.7 0.1 0.3 2.5 1.1 0.1 0.0 0.1 TRIM77 TRIM77P ENSG00000214414 "Tripartite motif containing 77" I1YAP6 11 89710299-89717872 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039896 Uncertain NA NA "HPA039896: AB_2676732" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49 "RNF18, TRIM49A" ENSG00000168930 "Tripartite motif containing 49" P0CI25 11 89797655-89808575 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "unprognostic (7.23e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM64B ENSG00000189253 "Tripartite motif containing 64B" A6NI03 11 89869282-89876017 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "placenta: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 332 "basophil: 33.2" "Lineage enriched" "Detected in single" 332 "granulocytes: 33.2" "Not detected" "Not detected" HPA045370 Approved NA NA "Cluster 38: Basophils - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 38: Extravillous trophoblasts - Unknown function" "HPA045370: AB_2679298" "unprognostic (2.08e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 33.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49D1 "TRIM49D, TRIM49D1P, TRIM49DP" ENSG00000223417 "Tripartite motif containing 49D1" C9J1S8 11 89911111-89921767 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 285 "basophil: 28.5" "Lineage enriched" "Detected in single" 285 "granulocytes: 28.5" "Not detected" "Not detected" HPA072153 Approved Nucleoplasm,Cytosol NA NA "Cluster 46: Basophils - DNA binding" Nucleoplasm Cytosol "HPA072153: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49D2 "TRIM49D2P, TRIM49L, TRIM49L1" ENSG00000233802 "Tripartite motif containing 49D2" C9J1S8 11 89924064-89933063 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 186 "basophil: 18.6" "Lineage enriched" "Detected in single" 186 "granulocytes: 18.6" "Not detected" "Not detected" HPA072153 Approved Nucleoplasm,Cytosol NA NA "Cluster 46: Basophils - DNA binding" Nucleoplasm Cytosol "HPA072153: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM64 "C11orf28, TRIM64A" ENSG00000204450 "Tripartite motif containing 64" A6NGJ6 11 89968502-89974072 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "placenta: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 266 "basophil: 26.5" "Lineage enriched" "Detected in single" 266 "granulocytes: 26.5" "Not detected" "Not detected" HPA045370 Approved NA NA "Cluster 38: Basophils - Unknown function" "Cluster 28: Placenta - Pregnancy" "HPA045370: AB_2679298" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49C TRIM49L2 ENSG00000204449 "Tripartite motif containing 49C" P0CI26 11 90031106-90042025 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "unprognostic (9.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBTFL1 C11orf27 ENSG00000255009 "Upstream binding transcription factor like 1" P0CB47 11 90085950-90087131 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "Distal tubular cells: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 39: Non-specific - Basic cellular processes" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NAALAD2 "GCPIII, NAALADASE2" ENSG00000077616 "N-acetylated alpha-linked acidic dipeptidase 2" Q9Y3Q0 11 90131515-90192894 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 19.9;testis: 13.9" "Group enriched" "Detected in many" 4 "Early spermatids: 39.7;Excitatory neurons: 109.3;Horizontal cells: 70.7;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 153.8;Oligodendrocytes: 83.7" "Cancer enhanced" "Detected in some" "testis cancer: 1.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 19.2;SH-SY5Y: 6.1;SuSa: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060820, HPA065419" Approved Approved Nucleoplasm NA NA "Cluster 43: Testis - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA060820: AB_2684373, HPA065419: AB_2685487" "unprognostic (1.68e-1)" "unprognostic (2.66e-3)" "unprognostic (1.49e-1)" "unprognostic (4.52e-3)" "unprognostic (4.73e-3)" "unprognostic (2.97e-1)" "unprognostic (3.82e-3)" "unprognostic (1.77e-2)" "unprognostic (2.44e-1)" "unprognostic (2.30e-1)" "unprognostic (3.30e-2)" "unprognostic (8.00e-2)" "unprognostic (9.97e-4)" "unprognostic (1.52e-2)" "unprognostic (2.54e-1)" "unprognostic (1.63e-2)" "unprognostic (2.93e-1)" 3.8 10.0 2.3 0.4 3.3 0.1 3.3 1.5 5.3 10.3 0.0 1.9 0.2 4.1 1.9 0.8 3.4 1.2 2.1 2.4 2.8 1.5 0.9 2.1 0.4 3.6 3.5 7.4 0.7 0.1 19.9 3.5 3.4 3.2 0.6 3.5 1.1 1.2 1.1 0.7 1.3 1.1 2.0 2.6 1.2 13.9 3.0 0.1 1.4 0.7 0.1 2.2 4.0 4.2 0.1 0.2 1.8 0.1 0.5 0.1 2.2 0.1 0.1 0.1 0.0 19.2 0.7 0.3 0.2 0.0 0.3 0.3 1.3 0.0 0.0 0.0 0.3 1.9 0.4 1.7 0.2 0.1 0.1 1.9 0.0 0.0 0.0 0.5 0.4 0.2 0.1 0.0 0.0 0.0 0.3 0.3 1.8 0.5 0.2 0.3 0.0 0.2 0.0 0.0 0.2 6.1 0.0 0.2 0.0 4.3 0.2 0.4 2.4 0.1 1.4 0.3 0.3 1.0 0.3 0.3 0.6 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.3 3.3 1.5 5.3 2.4 2.8 3.6 3.5 3.4 2.0 3.0 4.2 2.6 0.0 0.0 3.3 0.1 0.3 0.1 0.0 0.0 17.3 0.0 0.0 2.4 1.5 0.6 0.0 0.0 1.2 0.1 0.0 0.0 0.1 39.7 0.8 13.7 1.2 0.0 0.0 109.3 0.0 0.6 7.5 1.1 0.6 0.0 1.7 0.7 0.2 0.3 70.7 110.2 0.0 0.0 7.2 0.4 17.7 11.1 0.5 0.0 12.2 0.0 8.4 0.0 153.8 83.7 0.0 0.0 14.7 0.4 0.4 0.0 0.1 0.0 2.4 0.0 6.4 4.6 0.6 11.3 0.4 0.0 0.8 0.2 19.4 0.2 0.1 CHORDC1 "CHP-1, CHP1" ENSG00000110172 "Cysteine and histidine rich domain containing 1" Q9UHD1 11 90200429-90223077 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 94.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041040 Approved Approved Cytosol NA NA 160000 "Cluster 15: NK-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "HPA041040: AB_10794185" "unprognostic (2.29e-3)" "unprognostic (3.08e-1)" "unprognostic (5.26e-2)" "unprognostic (3.10e-2)" "unprognostic (3.27e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (4.93e-7)" "unprognostic (1.84e-1)" "unprognostic (1.04e-3)" "unprognostic (5.27e-3)" "unprognostic (2.25e-1)" "unprognostic (2.73e-2)" "prognostic unfavorable (1.88e-4)" "unprognostic (4.23e-2)" "unprognostic (2.63e-1)" "unprognostic (2.59e-1)" "unprognostic (1.52e-1)" 20.2 19.8 17.4 10.5 18.4 10.7 12.0 18.2 94.5 16.2 18.6 14.0 5.4 15.3 8.4 17.5 14.5 7.1 21.7 19.6 20.7 15.9 21.7 18.1 13.4 18.8 18.4 25.4 12.9 5.0 22.3 12.2 18.7 15.4 6.9 7.7 12.3 7.2 18.0 10.3 12.4 6.9 18.4 16.5 14.2 13.7 18.9 10.6 16.9 13.1 13.7 17.0 17.2 26.4 28.1 74.8 26.0 17.0 24.7 14.9 39.6 34.1 11.6 34.9 29.3 113.9 21.9 49.3 54.0 15.1 60.8 35.0 76.7 17.3 38.7 42.4 37.3 46.6 45.1 55.7 19.0 35.0 29.6 5.5 22.9 29.4 33.8 18.7 26.9 28.5 71.8 19.9 41.5 13.9 32.2 45.9 29.9 96.0 63.3 49.2 15.5 29.3 28.5 12.7 24.8 10.2 37.3 28.8 13.8 29.7 49.0 16.6 24.0 25.4 51.1 35.5 40.6 9.4 80.0 38.9 7.3 49.9 22.1 8.6 8.0 8.9 12.0 13.6 13.1 13.1 13.0 12.7 12.7 11.5 13.6 13.2 2.4 16.5 9.2 9.8 17.9 11.2 17.4 18.4 18.2 94.5 19.6 20.7 18.8 18.4 18.7 18.4 18.9 26.4 49.4 19.2 27.4 18.6 55.5 70.7 164.8 20.1 32.5 45.1 33.2 31.8 30.7 12.8 29.3 11.0 135.5 41.3 62.1 30.1 11.7 23.8 93.9 112.7 75.0 48.2 68.8 25.7 65.7 16.1 76.5 50.2 20.4 93.9 87.0 34.0 15.7 14.8 39.2 65.6 60.0 32.7 22.4 19.2 109.2 57.1 32.6 61.7 28.4 30.0 30.5 22.9 39.1 46.8 81.5 20.9 28.5 31.2 42.9 97.5 10.7 25.3 48.0 53.7 13.1 32.6 71.0 98.1 47.0 26.5 81.8 50.9 104.9 51.6 37.0 89.6 FAT3 "CDHF15, CDHR10, KIAA1989" ENSG00000165323 "FAT atypical cadherin 3" Q8TDW7 11 92224818-92896473 "Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 19.3" "Cell type enhanced" "Detected in some" "Astrocytes: 265.8;Excitatory neurons: 512.9;Inhibitory neurons: 149.2;Oligodendrocyte precursor cells: 88.4" "Cancer enriched" "Detected in single" 6 "glioma: 1.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.3;fHDF/TERT166: 2.2;NTERA-2: 2.5;SuSa: 2.2;U-2 OS: 2.1;U-251 MG: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026878, HPA074824" Uncertain Approved "Cell Junctions" NA NA 4700 "Cluster 65: Brain - Ion transport" "Cluster 12: NES - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Cell Junctions" "HPA026878: AB_1848430, HPA074824: " "unprognostic (5.00e-2)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (4.76e-6)" "unprognostic (1.27e-1)" "unprognostic (1.79e-1)" "unprognostic (1.56e-1)" "unprognostic (9.32e-2)" "unprognostic (1.08e-1)" "unprognostic (3.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (5.79e-2)" "unprognostic (3.66e-4)" "unprognostic (8.83e-2)" "unprognostic (7.72e-2)" "unprognostic (2.25e-1)" 0.5 0.0 5.5 0.0 19.3 0.0 0.1 1.3 9.0 0.6 0.0 0.2 0.0 0.6 0.6 0.1 0.6 0.0 0.2 4.0 15.5 0.2 0.0 1.2 0.0 0.5 4.7 0.5 0.0 0.0 2.9 0.1 1.9 2.0 0.1 1.3 0.0 3.8 0.1 0.2 0.0 0.1 0.8 0.1 2.2 0.7 7.5 0.1 0.0 0.2 0.2 2.3 1.0 1.0 0.0 0.3 7.3 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.4 0.0 0.0 0.0 1.4 2.2 0.0 1.2 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.6 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 2.1 0.0 4.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 19.3 1.3 9.0 4.0 15.5 0.5 4.7 1.9 0.8 7.5 1.0 0.0 0.0 0.0 265.8 0.0 0.1 0.3 0.9 0.0 20.8 0.1 0.5 1.8 0.0 0.1 14.7 0.0 0.1 0.0 0.1 0.0 0.7 4.8 0.1 0.2 0.2 0.0 0.0 512.9 0.0 0.1 1.9 0.0 0.0 0.0 3.7 1.4 0.0 0.1 0.0 149.2 0.0 24.4 0.0 0.0 3.8 1.2 0.3 0.0 13.1 0.0 0.8 0.0 88.4 7.0 0.2 0.0 7.5 0.0 0.6 0.0 0.0 0.0 1.7 0.0 2.5 4.4 1.0 6.5 0.1 0.0 0.0 0.0 44.8 0.0 0.1 MTNR1B ENSG00000134640 "Melatonin receptor 1B" P49286 11 92969651-92985066 "FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 3.1;placenta: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "GAMG: 4.9;SuSa: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA074024 Supported NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 64: Astrocytes - Nervous system maintenance" "HPA074024: " "unprognostic (3.61e-1)" "unprognostic (1.43e-1)" 0.0 0.0 2.2 0.0 2.8 0.0 0.0 0.7 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.2 0.0 0.0 0.0 0.0 3.0 2.8 0.0 0.0 0.0 0.0 1.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.8 0.7 1.1 2.3 1.2 3.0 2.8 3.1 2.1 1.2 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 SLC36A4 "FLJ38932, PAT4" ENSG00000180773 "Solute carrier family 36 member 4" Q6YBV0 11 93144174-93197991 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017887 Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus, Plasma membrane, Cytosol" "HPA017887: AB_2190238" "unprognostic (1.23e-2)" "unprognostic (1.08e-1)" "unprognostic (2.17e-3)" "unprognostic (1.32e-3)" "unprognostic (3.66e-2)" "unprognostic (8.77e-2)" "unprognostic (1.08e-3)" "unprognostic (7.83e-3)" "unprognostic (3.06e-2)" "unprognostic (7.97e-2)" "unprognostic (2.09e-2)" "unprognostic (8.04e-3)" "unprognostic (7.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.74e-1)" "unprognostic (9.45e-3)" "unprognostic (4.20e-2)" 5.8 7.4 4.2 9.3 4.6 19.4 4.6 8.1 5.8 5.1 6.2 5.4 2.0 7.1 2.1 5.3 4.8 5.7 6.0 4.0 8.5 9.4 7.8 6.0 5.3 7.2 6.9 5.7 5.7 6.5 7.7 6.2 7.7 4.9 6.4 15.3 3.7 5.9 2.4 4.1 3.1 8.1 5.5 4.1 4.3 4.3 6.1 7.3 8.8 2.3 6.7 6.9 3.6 7.0 10.4 18.2 36.5 7.3 12.7 25.6 20.5 17.6 29.2 25.6 31.0 14.6 33.1 12.5 9.9 16.5 13.3 12.5 11.4 6.5 23.4 21.1 13.3 14.5 35.3 9.8 10.0 36.6 20.6 12.4 20.0 14.9 9.2 12.0 14.0 17.6 1.3 0.2 26.5 2.6 16.3 27.4 14.8 4.0 18.4 7.2 21.7 5.1 8.7 15.1 33.6 43.8 25.7 9.9 6.4 26.4 18.0 10.6 15.7 48.0 14.8 28.6 26.0 5.1 10.9 0.0 10.9 15.0 25.4 0.1 4.9 5.3 0.8 2.6 1.0 0.9 0.6 1.0 1.9 1.0 1.5 1.0 1.5 0.5 1.7 0.7 0.5 1.1 4.2 4.6 8.1 5.8 4.0 8.5 7.2 6.9 7.7 5.5 6.1 7.0 11.9 12.8 11.5 35.9 29.5 30.7 43.2 9.7 25.6 21.2 10.3 8.0 11.5 20.0 7.1 20.2 22.9 10.7 13.6 3.1 35.2 24.4 9.9 15.5 19.2 18.5 27.6 5.5 66.8 43.6 25.8 21.9 18.8 5.7 4.5 29.0 13.2 9.1 13.6 26.9 71.0 19.6 10.2 52.3 47.1 4.2 18.0 50.1 21.4 27.2 42.8 20.7 13.4 45.2 59.4 33.2 6.3 15.4 22.1 70.4 0.4 16.2 20.8 24.2 6.6 18.0 18.1 7.3 3.3 11.8 32.0 16.3 15.7 20.6 4.3 30.6 DEUP1 "CCDC67, FLJ25393" ENSG00000165325 "Deuterosome assembly protein 1" Q05D60 11 93329971-93438487 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 4.8;testis: 16.4" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 16.8;Respiratory ciliated cells: 21.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (4.68e-1)" "unprognostic (3.25e-1)" "unprognostic (3.93e-1)" "unprognostic (7.24e-3)" "unprognostic (2.09e-1)" "unprognostic (4.13e-1)" "unprognostic (2.29e-1)" "unprognostic (1.79e-2)" "unprognostic (1.16e-1)" "unprognostic (1.84e-1)" "unprognostic (1.25e-1)" "unprognostic (1.41e-3)" "unprognostic (1.33e-1)" "unprognostic (6.03e-3)" "unprognostic (8.59e-2)" "unprognostic (2.25e-1)" 0.0 0.5 0.4 0.0 0.2 0.0 0.4 0.0 0.1 0.0 1.8 0.1 0.0 0.0 1.1 0.0 4.8 0.1 0.0 0.4 2.1 0.3 0.0 0.3 0.0 0.7 1.1 0.3 0.8 0.3 1.5 0.0 0.6 0.9 0.1 0.1 0.2 0.3 0.0 0.2 0.0 0.1 0.5 0.1 0.0 16.4 3.6 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.4 2.1 0.7 1.1 0.6 0.5 3.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 16.8 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 21.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 SMCO4 "C11orf75, FN5" ENSG00000166002 "Single-pass membrane protein with coiled-coil domains 4" Q9NRQ5 11 93478472-93543391 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 195.8" "Cell type enhanced" "Detected in many" "Distal tubular cells: 211.3;Paneth cells: 165.3;Proximal enterocytes: 200.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 113.7" "Low region specificity" "Detected in all" HPA041120 Uncertain NA Yes "Cluster 7: Monocytes - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 2: Karpas-707 - Immune response" "Cluster 45: Enterocytes - Digestion" "HPA041120: AB_2677309" "unprognostic (7.45e-2)" "unprognostic (1.70e-3)" "unprognostic (2.54e-1)" "unprognostic (1.01e-2)" "unprognostic (1.58e-1)" "unprognostic (6.47e-2)" "unprognostic (8.56e-2)" "unprognostic (1.93e-1)" "unprognostic (3.43e-1)" "unprognostic (5.51e-1)" "unprognostic (4.23e-2)" "unprognostic (9.45e-2)" "prognostic unfavorable (5.81e-7)" "unprognostic (1.61e-1)" "unprognostic (3.05e-1)" "unprognostic (1.55e-2)" "unprognostic (5.01e-2)" 21.0 70.4 8.9 30.6 8.2 7.3 23.0 8.2 12.6 17.0 17.3 35.3 45.9 18.9 13.9 23.1 27.9 16.8 53.5 10.2 22.9 66.3 135.1 35.8 31.4 11.9 14.7 25.3 60.0 5.8 48.0 11.4 11.2 55.2 25.7 3.4 195.8 11.5 17.0 24.3 37.6 15.2 11.1 61.8 50.1 43.4 32.4 17.5 71.7 5.9 22.9 12.4 22.8 12.8 8.3 15.3 23.9 5.5 8.0 10.6 15.4 25.2 7.5 10.8 19.9 26.6 33.0 24.6 29.0 22.1 16.8 5.0 24.1 3.5 7.3 68.6 22.2 5.9 32.4 58.0 7.4 24.4 26.1 15.0 13.2 5.0 3.8 13.6 16.7 81.5 13.8 113.7 3.3 13.9 24.4 50.2 25.0 62.6 23.9 42.8 12.0 11.2 21.5 19.8 4.2 18.5 19.6 26.3 2.1 30.2 10.4 33.7 10.9 9.7 40.6 33.4 20.8 4.6 0.7 19.7 7.6 40.9 4.9 40.2 263.5 6.9 4.1 316.4 18.4 25.0 26.9 8.0 150.3 26.9 3.7 3.2 61.4 32.0 296.3 155.5 11.7 91.5 8.9 8.2 8.2 12.6 10.2 22.9 11.9 14.7 11.2 11.1 32.4 12.8 26.0 25.6 18.4 0.3 11.5 32.8 33.4 17.4 6.2 2.1 62.0 50.5 36.7 70.1 17.2 49.7 0.0 6.6 27.7 105.1 211.3 43.2 123.5 14.3 2.9 24.9 44.9 6.1 4.8 70.2 9.0 19.0 27.5 16.1 2.5 21.3 15.7 103.9 140.4 3.3 10.6 116.4 6.1 91.3 80.3 146.8 12.8 87.7 30.2 13.1 123.3 6.4 11.3 0.5 4.4 31.1 165.3 10.5 15.0 92.8 200.0 64.8 9.6 1.3 6.6 4.2 14.1 11.2 46.6 16.6 21.3 4.8 15.0 6.4 58.7 47.3 CEP295 KIAA1731 ENSG00000166004 "Centrosomal protein 295" Q9C0D2 11 93661682-93730358 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 78.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038595, HPA038596, HPA038597" Approved Enhanced "Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" "Plasma membrane, Cytosol" "HPA038595: AB_2676104, HPA038596: AB_10672720, HPA038597: AB_2676106" "unprognostic (1.35e-2)" "unprognostic (3.08e-1)" "unprognostic (7.66e-2)" "unprognostic (5.56e-2)" "unprognostic (5.73e-2)" "unprognostic (4.08e-3)" "unprognostic (6.03e-3)" "unprognostic (2.14e-1)" "unprognostic (5.54e-3)" "unprognostic (3.73e-2)" "unprognostic (4.99e-4)" "unprognostic (1.34e-1)" "unprognostic (5.29e-3)" "unprognostic (1.46e-2)" "unprognostic (1.20e-1)" "unprognostic (1.52e-1)" "unprognostic (2.18e-2)" 6.6 5.8 7.5 6.3 8.1 16.0 8.3 14.4 10.5 7.6 5.0 8.7 6.2 7.0 7.4 5.8 6.8 5.2 5.3 7.3 6.9 6.2 5.0 6.0 11.1 6.3 5.9 8.3 6.6 4.7 8.4 6.3 6.6 8.3 6.8 14.7 5.5 5.2 5.3 8.9 7.5 5.5 4.9 9.4 6.2 12.0 7.6 10.3 8.7 5.8 7.4 7.7 6.6 10.2 10.5 9.4 23.9 20.4 10.8 10.4 11.6 13.2 9.7 12.2 14.2 17.3 19.2 3.1 19.1 8.3 16.9 18.7 11.8 9.5 12.4 15.0 9.4 19.0 28.2 8.6 6.5 17.1 17.4 7.7 5.6 11.6 10.0 11.5 10.4 16.9 21.6 19.4 15.8 8.8 8.9 28.1 7.5 19.6 9.7 17.7 22.6 12.6 10.1 17.9 13.9 12.9 20.9 13.8 3.7 14.8 22.8 9.4 9.6 11.3 14.8 20.9 10.1 6.9 16.7 20.2 6.7 19.7 15.9 3.3 1.7 3.6 1.5 0.9 1.2 3.2 1.3 1.0 0.8 3.5 1.6 1.4 5.2 1.6 1.3 1.7 1.1 0.4 7.5 8.1 14.4 10.5 7.3 6.9 6.3 5.9 6.6 4.9 7.6 10.2 10.9 9.6 14.3 24.2 14.0 0.0 3.3 0.0 5.2 30.5 7.0 8.9 9.4 5.7 5.6 5.5 27.1 12.8 8.6 2.5 3.9 7.8 78.7 12.4 15.0 9.6 3.6 25.7 41.2 7.8 10.3 8.8 11.2 10.2 16.4 48.8 6.8 4.2 8.0 18.5 40.8 5.5 0.0 7.9 0.0 21.4 12.8 7.7 0.0 15.0 10.3 10.3 10.3 23.6 33.5 5.3 4.1 14.3 12.2 5.6 5.8 4.0 5.1 38.1 6.6 9.4 8.7 48.8 18.6 7.5 0.0 6.6 9.8 15.8 5.8 2.8 TAF1D "JOSD3, MGC5306, TAF(I)41" ENSG00000166012 "TATA-box binding protein associated factor, RNA polymerase I subunit D" Q9H5J8 11 93729948-93784391 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030703, HPA055935, HPA060385" Uncertain Supported "Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite" Yes No "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nucleoli, Mitotic spindle, Centriolar satellite" "HPA030703: , HPA055935: AB_2682974, HPA060385: AB_2684271" "unprognostic (9.91e-3)" "unprognostic (4.38e-2)" "unprognostic (6.80e-2)" "unprognostic (1.71e-1)" "unprognostic (5.40e-3)" "unprognostic (6.46e-2)" "unprognostic (3.68e-3)" "unprognostic (9.70e-2)" "unprognostic (5.24e-3)" "unprognostic (3.55e-2)" "unprognostic (4.50e-3)" "unprognostic (1.09e-2)" "prognostic unfavorable (3.17e-7)" "unprognostic (1.95e-1)" "unprognostic (2.51e-1)" "unprognostic (2.34e-1)" "unprognostic (6.37e-2)" 10.0 9.3 2.5 18.2 3.0 16.4 12.6 5.0 6.7 7.7 1.2 9.5 13.7 14.1 9.0 9.5 7.7 15.4 7.1 2.9 3.5 6.8 6.9 8.1 20.6 2.3 0.6 13.8 20.9 5.3 4.9 18.0 2.3 9.9 12.5 8.2 10.1 7.3 8.0 11.4 13.3 9.1 0.5 11.9 11.9 5.5 1.7 10.9 10.1 7.1 13.1 13.8 7.2 7.8 18.2 8.6 17.5 17.9 14.0 47.8 29.2 27.0 11.5 18.4 13.8 28.6 38.8 32.6 34.0 15.6 12.6 44.3 21.5 25.9 21.2 10.6 7.8 34.8 55.6 20.2 16.4 31.9 25.1 19.5 25.8 16.0 35.7 35.0 23.7 22.7 24.2 50.4 22.8 5.0 25.8 66.4 12.1 16.7 9.6 23.3 19.1 30.9 22.7 17.4 10.7 19.5 10.8 38.2 16.5 19.3 32.7 12.4 28.7 26.9 30.5 44.2 28.7 22.9 26.2 32.5 11.2 36.9 10.3 44.2 16.7 28.8 17.3 12.5 17.7 39.1 24.9 19.8 12.0 39.8 28.4 24.1 42.7 18.1 10.8 26.1 18.2 5.2 2.5 3.0 5.0 6.7 2.9 3.5 2.3 0.6 2.3 0.5 1.7 7.8 106.7 89.8 95.5 20.9 246.1 244.2 252.4 66.6 255.0 86.6 129.4 130.9 26.2 134.4 105.3 29.5 39.6 176.0 162.5 94.5 45.0 95.2 19.9 144.9 184.9 121.3 110.2 98.4 41.6 146.3 170.2 147.1 125.4 245.6 104.4 257.2 63.1 54.2 69.3 69.0 38.2 148.0 24.4 103.7 153.6 16.5 128.6 112.0 80.0 24.4 102.1 34.8 89.6 35.2 44.0 110.4 87.5 67.7 162.2 269.2 71.1 101.5 67.7 78.2 72.3 187.4 123.1 49.0 71.5 251.4 203.0 160.9 182.3 119.7 174.1 356.8 C11orf54 PTD012 ENSG00000182919 "Chromosome 11 open reading frame 54" Q9H0W9 11 93741591-93764749 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "kidney: 569.9;liver: 258.8" "Cell type enhanced" "Detected in all" "Hepatocytes: 370.4;Proximal tubular cells: 1136.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040088, HPA040511" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA 1300000 "Cluster 5: Granulocytes - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 25: RPMI-8226 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nuclear bodies" Nucleoplasm "HPA040088: AB_10795518, HPA040511: AB_10795369" "unprognostic (3.32e-2)" "unprognostic (3.51e-1)" "unprognostic (1.67e-3)" "unprognostic (2.62e-2)" "unprognostic (1.82e-2)" "unprognostic (1.90e-2)" "unprognostic (2.81e-2)" "unprognostic (1.01e-1)" "unprognostic (2.46e-2)" "unprognostic (2.87e-1)" "unprognostic (2.10e-3)" "unprognostic (1.58e-1)" "prognostic favorable (5.06e-6)" "unprognostic (2.19e-1)" "unprognostic (6.10e-2)" "unprognostic (2.41e-2)" "unprognostic (6.53e-3)" 20.1 24.6 10.2 19.1 16.4 7.4 31.4 15.2 14.8 20.7 18.0 40.8 53.0 21.7 19.6 17.6 32.3 47.2 21.5 9.5 14.8 569.9 258.8 30.3 21.5 18.3 12.9 30.1 51.6 20.9 16.7 25.3 16.5 39.6 43.8 20.7 28.9 25.0 41.8 21.2 51.5 20.8 13.0 17.3 37.9 19.8 12.9 28.1 35.9 54.7 23.4 17.0 12.9 25.2 9.4 13.5 30.9 18.3 23.5 26.8 36.1 13.8 23.6 13.8 19.0 5.6 52.9 39.4 85.5 25.6 14.4 22.2 37.5 10.0 19.4 39.9 11.4 21.7 34.9 26.5 27.7 20.7 11.0 24.7 17.0 24.7 16.6 34.8 21.6 26.2 29.6 26.6 12.8 8.0 33.0 23.7 10.5 64.9 22.1 31.4 40.8 62.2 74.6 19.6 15.2 20.2 23.0 28.2 27.7 22.7 65.9 13.4 13.5 13.0 10.0 22.5 6.6 12.0 38.2 37.8 9.8 29.2 23.3 75.0 30.0 74.0 21.7 21.5 22.3 27.1 22.1 24.7 23.0 23.0 27.0 23.7 100.9 24.8 19.0 31.9 31.5 18.8 10.2 16.4 15.2 14.8 9.5 14.8 18.3 12.9 16.5 13.0 12.9 25.2 25.1 64.1 54.7 28.1 27.4 5.5 10.6 18.4 21.1 18.0 21.6 14.6 34.7 190.1 33.5 47.8 16.7 51.4 21.6 53.6 178.1 17.4 14.4 34.2 20.5 18.3 22.2 23.1 23.7 13.9 14.8 23.9 32.6 43.6 15.2 40.2 29.6 370.4 17.5 15.2 27.8 37.1 28.5 29.2 7.2 6.4 25.7 22.2 8.8 15.9 18.2 17.0 10.3 25.6 37.8 13.1 38.4 23.0 25.7 29.0 75.0 1136.3 36.2 19.7 6.6 28.9 17.0 38.6 17.4 17.6 9.9 62.0 21.1 16.3 35.6 22.9 AP001273.2 ENSG00000284057 "Novel protein, C11orf54-MED17 readthrough" 11 93741664-93812378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 9.5" "Cell type enriched" "Detected in single" 7 "Respiratory ciliated cells: 4.4" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA040511, HPA046619" Approved Approved "Nuclear speckles,Cytosol" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear speckles" Cytosol "HPA040511: AB_10795369, HPA046619: " 1.3 2.1 0.6 2.1 0.5 0.0 1.1 0.5 1.0 1.5 0.3 1.8 4.9 1.2 0.4 0.3 1.4 1.9 1.5 0.4 0.6 9.5 4.6 1.1 0.8 0.6 0.5 2.3 0.3 2.0 0.5 1.7 0.7 2.3 1.6 1.4 1.6 1.0 1.1 1.6 3.3 0.5 0.5 0.7 1.8 1.3 0.5 1.6 1.5 1.8 1.2 0.9 0.2 0.7 0.6 0.0 3.3 0.6 1.9 0.0 1.9 0.0 1.0 0.7 1.3 0.6 1.4 2.2 4.0 2.5 1.0 2.2 4.0 0.9 0.4 3.3 0.3 0.7 1.4 0.0 1.4 0.0 0.7 1.4 0.6 0.0 1.5 2.9 1.0 1.7 1.3 0.5 3.9 0.0 2.6 2.2 1.4 6.0 0.1 0.8 2.3 1.3 3.5 0.0 0.7 0.3 2.1 2.4 4.9 2.8 2.5 0.9 2.8 0.3 0.8 0.4 1.3 0.6 1.3 2.9 0.2 1.8 1.3 1.9 1.2 1.8 1.1 1.2 1.3 1.0 1.1 1.4 1.5 0.4 1.1 1.4 1.8 1.2 1.4 0.8 2.1 1.2 0.6 0.5 0.5 1.0 0.4 0.6 0.6 0.5 0.7 0.5 0.5 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MED17 "CRSP6, CRSP77, DRIP80, SRB4, TRAP80" ENSG00000042429 "Mediator complex subunit 17" Q9NVC6 11 93784227-93814963 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 4 "cerebellum: 2.3;cerebral cortex: 1.3;white matter: 1.7" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046619 Approved "Nuclear speckles,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Cytosol "HPA046619: " "prognostic unfavorable (4.94e-4)" "unprognostic (2.92e-1)" "unprognostic (2.72e-3)" "unprognostic (1.38e-1)" "unprognostic (6.71e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (4.04e-6)" "unprognostic (1.50e-1)" "unprognostic (4.48e-3)" "unprognostic (7.73e-2)" "unprognostic (1.41e-1)" "unprognostic (4.59e-2)" "unprognostic (1.02e-2)" "unprognostic (1.77e-1)" "unprognostic (2.22e-1)" "unprognostic (5.56e-3)" "unprognostic (1.48e-1)" 1.3 0.9 0.2 1.5 0.4 1.5 1.0 2.3 1.3 1.4 1.2 1.5 0.4 1.8 1.0 1.0 1.5 0.6 1.7 0.3 0.2 0.9 0.5 1.1 1.1 0.4 0.2 1.6 1.4 0.5 0.8 1.3 0.3 1.0 0.5 1.1 1.0 0.7 1.6 1.1 2.1 1.0 0.1 2.3 1.7 0.9 0.4 1.3 0.9 1.1 1.0 1.0 1.0 1.7 3.3 1.1 2.7 5.9 3.3 0.4 5.3 7.3 2.5 4.7 2.8 5.9 6.6 5.3 11.6 0.6 1.3 9.8 2.5 1.4 1.3 6.5 2.9 6.0 3.7 1.7 1.7 10.5 10.1 1.3 3.4 3.5 2.1 1.1 1.9 1.4 5.5 3.4 2.7 1.0 12.3 3.1 5.1 0.7 0.8 9.5 7.8 4.4 2.8 2.3 9.7 12.3 5.8 4.7 2.8 0.6 7.2 2.5 6.5 7.2 5.7 9.9 6.3 4.9 10.1 3.9 1.9 7.2 8.5 3.3 3.0 7.6 4.0 3.7 4.5 8.2 5.1 5.0 3.8 5.8 5.2 2.9 3.3 6.7 2.2 4.5 5.3 3.5 0.2 0.4 2.3 1.3 0.3 0.2 0.4 0.2 0.3 0.1 0.4 1.7 7.7 6.4 9.3 16.3 32.1 30.1 39.6 19.4 25.6 24.6 10.1 4.6 15.5 14.3 19.5 7.3 16.7 39.3 25.5 12.4 1.9 15.8 1.0 9.3 14.9 14.2 26.8 9.7 25.8 9.7 27.4 17.2 17.3 13.6 10.8 22.9 16.8 8.6 14.5 15.2 27.7 13.4 16.2 15.5 27.0 3.0 15.8 12.8 14.2 19.7 18.4 13.4 23.7 22.1 25.1 10.4 14.8 21.4 25.6 26.9 13.8 2.7 19.4 43.9 65.7 19.3 16.4 23.1 16.3 18.1 25.7 34.1 28.1 10.4 17.6 36.3 VSTM5 "C11orf90, LOC387804" ENSG00000214376 "V-set and transmembrane domain containing 5" A8MXK1 11 93818232-93850618 "Predicted membrane proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.7;placenta: 4.4" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 22.3;Excitatory neurons: 5.2;Inhibitory neurons: 9.2;Syncytiotrophoblasts: 5.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.2;OE19: 3.7;PC-3: 5.4;SH-SY5Y: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029525, HPA063591" Uncertain Uncertain "Endoplasmic reticulum" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 47: Cytotrophoblasts - Unknown function" "Endoplasmic reticulum" "HPA029525: AB_10600789, HPA063591: AB_2732704" "unprognostic (1.26e-1)" "unprognostic (4.48e-3)" "unprognostic (2.78e-1)" "unprognostic (1.54e-4)" "unprognostic (2.45e-2)" "unprognostic (9.91e-2)" "unprognostic (8.56e-2)" "unprognostic (1.37e-2)" "unprognostic (1.68e-2)" "unprognostic (1.04e-1)" "unprognostic (2.52e-2)" "unprognostic (2.13e-1)" "unprognostic (1.31e-1)" "unprognostic (3.53e-2)" "unprognostic (2.37e-1)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" 0.2 0.2 2.2 0.1 1.9 0.0 0.4 1.0 3.4 1.1 0.1 1.1 0.1 0.4 1.2 0.1 0.2 0.4 0.1 1.8 3.7 0.8 0.0 0.1 0.0 3.1 2.0 0.1 0.5 0.1 0.6 4.4 3.3 0.5 1.7 0.5 0.4 0.4 0.0 0.1 0.7 0.7 1.4 0.0 1.9 0.2 3.3 0.0 0.1 0.0 0.1 0.2 0.1 2.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.5 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 5.4 0.0 0.0 0.1 0.0 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.9 1.0 3.4 1.8 3.7 3.1 2.0 3.3 1.4 3.3 2.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.9 0.5 0.5 0.3 0.0 0.1 0.0 0.0 22.3 0.1 1.1 0.0 0.4 0.0 0.3 0.2 0.1 0.0 0.0 5.2 3.0 0.7 0.3 1.5 0.7 0.0 0.1 0.0 0.0 1.5 0.0 9.2 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.2 1.1 2.1 0.4 0.0 0.1 0.5 1.5 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.0 0.1 5.9 0.0 0.0 1.6 0.1 HEPHL1 DKFZp686F22190 ENSG00000181333 "Hephaestin like 1" Q6MZM0 11 94021354-94114208 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 4.5;lymphoid tissue: 9.5;skin 1: 3.8;vagina: 4.5" "Cell type enriched" "Detected in some" 5 "Basal keratinocytes: 10.5" "Cancer enriched" "Detected in some" 5 "head and neck cancer: 20.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 1.4;HBEC3-KT: 2.6" "Region enriched" "Detected in single" 12 "olfactory bulb: 1.2" "Not detected" "Not detected" HPA031517 Uncertain NA NA 260000000 "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 28: Keratinocytes - Keratinization" "HPA031517: AB_10603769" "unprognostic (9.16e-2)" "prognostic unfavorable (4.94e-4)" "unprognostic (2.40e-1)" "unprognostic (3.26e-6)" "unprognostic (3.17e-1)" "unprognostic (3.45e-1)" "unprognostic (1.72e-2)" "unprognostic (6.71e-2)" "unprognostic (5.34e-1)" "unprognostic (1.09e-1)" "unprognostic (7.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.20e-2)" "unprognostic (1.00e-1)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 9.5 0.0 4.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.4 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 10.5 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 1.8 0.0 0.6 0.0 0.1 0.0 0.0 1.4 0.0 0.1 0.1 0.0 0.4 1.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.3 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.5 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 PANX1 "MRS1, PX1, UNQ2529" ENSG00000110218 "Pannexin 1" Q96RD7 11 94128841-94181968 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Differentiation, Ion transport, Oogenesis, Transport" "Calcium channel, Ion channel" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 102.0;Suprabasal keratinocytes: 72.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016930 Uncertain Enhanced "Plasma membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 28: Keratinocytes - Keratinization" "Plasma membrane" "HPA016930: AB_1854954" "unprognostic (1.65e-2)" "unprognostic (2.32e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.16e-1)" "unprognostic (7.02e-2)" "unprognostic (6.04e-2)" "prognostic unfavorable (7.09e-5)" "unprognostic (1.79e-1)" "unprognostic (1.43e-1)" "unprognostic (1.00e-3)" "unprognostic (3.26e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (1.15e-2)" "unprognostic (9.45e-2)" "unprognostic (1.79e-1)" "unprognostic (1.26e-3)" 11.4 7.2 5.1 12.1 5.2 4.1 6.4 1.2 5.5 7.9 2.7 8.4 5.4 8.5 5.2 7.9 5.2 11.5 9.9 5.0 7.1 6.9 16.8 10.2 6.4 2.1 2.9 7.1 7.4 4.4 4.7 9.7 3.3 7.7 7.2 3.1 6.0 7.0 20.8 8.3 5.8 12.8 2.8 5.8 7.4 9.9 4.9 8.1 8.7 10.8 7.0 21.9 6.5 2.7 24.6 10.2 26.2 16.0 23.9 32.3 17.1 29.8 63.0 25.1 30.7 26.2 37.6 7.8 27.3 30.5 46.1 50.5 20.9 49.2 25.2 33.6 10.9 36.0 10.2 13.5 23.1 18.7 31.0 25.7 33.9 32.8 29.2 16.1 21.2 20.1 23.8 27.5 28.3 7.8 31.3 4.4 21.0 19.7 18.2 36.7 35.0 9.7 16.3 24.0 11.0 31.9 20.9 11.9 14.4 13.3 25.2 9.5 15.4 49.5 25.5 16.4 29.9 4.5 18.2 12.6 20.6 19.0 32.2 3.2 4.0 0.3 2.1 2.2 2.4 1.3 1.7 2.3 2.7 1.2 1.6 1.7 0.2 2.6 1.4 0.4 2.9 3.2 5.1 5.2 1.2 5.5 5.0 7.1 2.1 2.9 3.3 2.8 4.9 2.7 3.8 0.0 8.7 4.6 6.6 102.0 12.3 14.9 13.6 1.3 4.5 2.0 4.7 4.3 4.7 1.8 0.0 12.8 5.3 4.7 0.0 15.7 5.3 9.1 13.0 6.8 2.4 5.2 8.9 18.2 32.4 17.5 7.1 13.9 9.5 4.0 2.2 8.1 20.5 0.0 15.4 4.1 0.0 3.1 21.6 3.9 4.4 11.5 17.8 8.4 3.7 1.1 1.0 9.5 5.8 26.1 3.4 3.8 7.4 10.2 2.6 2.1 6.2 1.1 0.0 16.9 10.6 1.7 8.2 8.3 72.2 23.8 6.6 10.1 4.2 12.7 IZUMO1R "Folbp3, FOLR4, JUNO" ENSG00000183560 "IZUMO1 receptor, JUNO" A6ND01 11 94305592-94307721 "Predicted intracellular proteins, Transporters" Fertilization Receptor "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.56e-3)" "unprognostic (1.37e-1)" "unprognostic (7.22e-3)" "unprognostic (8.39e-2)" "unprognostic (2.92e-3)" "unprognostic (2.47e-1)" "unprognostic (5.08e-2)" "unprognostic (8.61e-2)" 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR83 GPR72 ENSG00000123901 "G protein-coupled receptor 83" Q9NYM4 11 94377316-94401419 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "brain: 11.5;thyroid gland: 3.0" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 2.7;Excitatory neurons: 2.6;Inhibitory neurons: 4.4" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.6" "Region enhanced" "Detected in many" "basal ganglia: 67.5" "Low region specificity" "Detected in many" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 39: CACO-2 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (6.74e-2)" "unprognostic (7.78e-3)" "unprognostic (8.58e-2)" "unprognostic (2.60e-1)" "unprognostic (1.82e-1)" "unprognostic (2.88e-1)" "unprognostic (6.36e-3)" "unprognostic (6.89e-2)" "unprognostic (6.03e-2)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "unprognostic (6.17e-2)" "unprognostic (1.47e-12)" "unprognostic (3.16e-1)" "unprognostic (1.64e-1)" "unprognostic (1.33e-2)" "unprognostic (8.28e-3)" 0.1 0.7 1.3 0.1 3.0 0.4 0.0 11.5 3.4 0.3 0.1 0.4 0.1 0.1 0.2 0.0 0.1 0.1 0.4 4.4 4.1 0.3 0.2 0.0 0.2 0.3 4.9 0.1 0.1 0.0 0.3 0.0 0.9 0.1 0.1 0.7 0.1 0.0 0.3 0.2 0.1 0.1 0.8 0.2 0.1 0.4 2.2 0.1 3.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.6 0.2 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 1.3 3.0 11.5 3.4 4.4 4.1 0.3 4.9 0.9 0.8 2.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 2.7 0.1 0.0 0.0 0.0 2.6 0.4 0.0 0.2 0.0 0.2 0.0 0.1 0.4 0.1 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 MRE11 "ATLD, MRE11A" ENSG00000020922 "MRE11 homolog, double strand break repair nuclease" P49959 11 94415570-94493885 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Meiosis" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Cancer-related genes, Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 28.9;Cytotrophoblasts: 39.2;Granulosa cells: 34.1;Syncytiotrophoblasts: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002691, CAB004081" Supported Enhanced Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB004081: AB_2145100, HPA002691: AB_1079409" "unprognostic (5.59e-3)" "unprognostic (4.35e-2)" "unprognostic (8.55e-2)" "unprognostic (2.76e-2)" "unprognostic (9.82e-2)" "unprognostic (5.17e-2)" "prognostic unfavorable (7.14e-4)" "unprognostic (2.85e-1)" "unprognostic (1.03e-2)" "unprognostic (1.34e-1)" "unprognostic (8.66e-3)" "unprognostic (6.96e-3)" "unprognostic (1.57e-3)" "unprognostic (1.39e-1)" "unprognostic (1.77e-1)" "unprognostic (1.22e-1)" "unprognostic (8.06e-3)" 9.1 6.1 3.4 11.7 3.7 22.6 13.9 6.8 3.4 8.8 6.0 7.6 6.8 11.7 8.9 7.1 7.9 7.3 5.0 3.3 3.5 6.0 6.4 7.7 12.6 5.1 4.4 11.1 7.5 5.6 3.1 12.1 3.8 9.3 11.5 6.3 7.8 7.3 5.0 15.6 7.7 9.9 4.0 12.7 7.3 8.3 4.4 14.3 7.4 5.4 16.1 8.5 7.4 6.7 21.5 21.5 39.9 5.0 13.1 18.2 22.8 29.4 19.0 25.9 30.6 39.4 43.3 55.8 47.0 15.3 32.5 40.1 33.7 22.1 34.1 37.5 20.0 48.7 31.5 22.7 6.0 32.7 33.6 12.8 13.4 33.7 21.0 11.7 23.0 26.8 34.9 35.6 20.9 15.5 33.2 30.5 13.0 49.3 23.3 29.0 35.3 28.1 16.8 29.6 14.1 19.8 40.6 26.0 8.6 33.2 43.4 19.3 16.9 38.7 28.6 33.9 21.5 8.8 33.2 54.4 10.4 50.3 31.5 5.7 8.0 6.5 8.2 10.0 8.3 6.4 6.0 8.9 11.6 6.9 5.1 8.4 3.8 8.6 8.4 8.7 8.8 6.7 3.4 3.7 6.8 3.4 3.3 3.5 5.1 4.4 3.8 4.0 4.4 6.7 23.6 28.9 14.3 0.0 6.3 0.0 0.0 0.0 0.0 0.0 12.5 13.7 0.0 0.0 9.3 9.2 0.0 39.2 20.8 0.0 3.9 11.4 0.0 19.5 22.2 8.4 0.0 0.0 0.0 8.1 15.8 8.9 0.0 16.3 17.7 34.1 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 8.8 0.0 0.0 6.1 0.0 0.0 6.5 11.7 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 28.0 7.2 16.8 0.0 0.0 ANKRD49 "FGIF, FLJ20189, GBIF" ENSG00000168876 "Ankyrin repeat domain 49" Q8WVL7 11 94493979-94499578 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040273, HPA048137" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA040273: AB_10674991, HPA048137: AB_2680279" "unprognostic (1.52e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "unprognostic (5.22e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-3)" "unprognostic (1.46e-2)" "unprognostic (7.21e-3)" "unprognostic (1.36e-1)" "unprognostic (1.23e-1)" "unprognostic (4.21e-3)" "prognostic unfavorable (9.96e-4)" "unprognostic (6.32e-3)" "unprognostic (2.82e-1)" "unprognostic (3.40e-2)" "prognostic favorable (6.16e-4)" 7.8 6.8 8.3 12.7 8.9 25.2 13.1 11.1 11.4 9.7 8.2 10.8 11.4 10.4 18.3 9.5 8.5 8.4 5.3 8.3 8.4 7.8 8.6 7.5 20.8 8.2 7.7 12.6 13.4 9.3 8.9 12.1 8.0 10.9 13.6 11.8 10.7 10.8 5.8 10.2 16.2 8.8 7.8 15.6 12.7 5.4 9.3 17.1 14.2 7.3 20.8 7.9 8.5 9.5 8.9 4.4 11.0 9.4 10.2 12.0 13.5 13.3 12.0 14.9 17.1 20.7 18.4 23.4 20.9 8.5 12.5 20.5 14.0 9.8 12.2 17.9 12.1 18.9 16.8 7.8 11.1 17.8 15.8 9.1 23.1 10.7 14.9 10.4 11.3 20.9 18.4 14.4 9.4 6.1 19.8 32.8 6.3 17.5 9.8 14.9 11.3 12.0 12.9 9.2 10.5 10.9 10.2 9.8 8.7 18.4 18.0 12.9 7.5 13.0 9.3 13.8 7.2 7.6 20.0 24.6 4.4 21.8 7.4 77.8 23.1 23.9 21.9 19.5 23.7 34.1 23.4 19.4 18.4 28.8 28.4 25.9 42.7 27.2 15.8 30.5 31.4 17.8 8.3 8.9 11.1 11.4 8.3 8.4 8.2 7.7 8.0 7.8 9.3 9.5 20.5 12.8 9.3 11.1 43.2 5.6 10.0 15.1 14.2 16.3 14.0 11.3 9.1 24.3 15.4 25.8 14.6 31.1 36.1 27.8 21.5 20.3 10.1 11.9 18.1 15.4 13.3 40.0 11.1 23.0 13.8 16.5 27.0 15.1 21.5 18.7 16.4 18.8 14.3 11.8 9.5 23.6 8.2 28.5 8.4 3.7 35.8 18.5 10.6 8.4 28.1 21.8 57.7 5.5 12.7 22.8 35.2 23.7 28.0 11.3 45.3 19.3 8.1 14.4 26.3 11.3 18.4 21.0 19.9 11.6 6.8 28.0 36.5 9.8 22.0 5.8 C11orf97 LINC01171 ENSG00000257057 "Chromosome 11 open reading frame 97" A0A1B0GVM6 11 94512461-94532123 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "fallopian tube: 19.1;testis: 18.2" "Group enriched" "Detected in some" 5 "Early spermatids: 239.3;Endometrial ciliated cells: 258.2;Respiratory ciliated cells: 109.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (3.62e-3)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (4.18e-1)" "unprognostic (4.70e-1)" "unprognostic (9.64e-3)" "unprognostic (9.44e-3)" "unprognostic (3.86e-3)" 0.0 0.0 1.4 0.0 2.6 0.3 0.0 0.2 1.7 1.2 4.0 0.0 0.0 0.5 0.1 0.0 19.1 0.1 0.0 1.5 1.1 0.9 1.3 2.5 0.0 2.2 2.5 0.0 0.5 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 18.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.6 0.2 1.7 1.5 1.1 2.2 2.5 1.6 1.9 1.5 1.5 0.0 3.2 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 11.2 0.0 0.0 0.3 0.0 0.1 0.0 0.4 239.3 258.2 1.4 0.6 0.0 0.0 3.4 0.2 0.0 0.5 0.0 3.2 0.0 0.0 0.0 4.5 0.1 0.0 2.0 0.0 0.0 0.0 0.0 34.4 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.9 0.0 0.0 0.0 18.1 109.3 0.0 0.0 0.0 0.0 37.9 9.6 0.0 0.0 0.0 0.5 0.0 0.0 0.1 PIWIL4 "FLJ36156, HIWI2, Miwi2" ENSG00000134627 "Piwi like RNA-mediated gene silencing 4" Q7Z3Z4 11 94543840-94621421 "Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.3" "Cell type enhanced" "Detected in many" "Intestinal goblet cells: 8.7;Spermatogonia: 12.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "NB-4: 93.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA036587, HPA036588, HPA057508" Enhanced Supported Nucleoplasm,Mitochondria NA NA "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 27: Mucus-secreting cells - Mucin production" "Nucleoplasm, Mitochondria" "HPA036587: AB_2732473, HPA036588: AB_10673502, HPA057508: AB_2683452" "unprognostic (1.43e-1)" "unprognostic (9.46e-2)" "unprognostic (2.59e-3)" "unprognostic (2.22e-3)" "unprognostic (3.16e-2)" "unprognostic (1.07e-3)" "unprognostic (1.96e-2)" "unprognostic (5.18e-2)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (6.17e-2)" "unprognostic (2.68e-1)" "unprognostic (1.21e-4)" "unprognostic (6.89e-2)" "unprognostic (1.68e-1)" "unprognostic (2.50e-1)" "unprognostic (2.80e-2)" 3.3 1.1 5.5 2.8 5.3 24.3 3.6 4.9 5.0 4.4 3.4 5.8 5.8 3.7 2.3 1.6 3.6 4.6 2.8 5.6 4.7 3.2 1.3 2.7 3.9 4.5 4.4 3.4 11.3 0.4 2.2 2.0 4.5 2.5 6.0 6.7 8.8 2.6 1.0 1.7 6.3 2.0 4.5 3.7 5.1 13.3 4.9 3.0 2.0 1.0 2.7 3.3 3.0 5.4 0.2 0.1 0.4 0.0 6.6 4.3 0.5 0.5 0.3 0.2 0.9 0.7 0.6 0.0 0.4 2.8 0.2 0.0 0.9 0.0 0.2 2.7 0.3 0.2 0.6 0.0 2.5 6.5 0.1 1.5 0.0 0.5 0.0 0.1 0.1 0.5 0.3 0.0 1.1 0.4 0.3 93.2 0.1 9.2 0.6 0.4 0.0 0.0 2.1 0.0 0.4 0.3 0.4 0.9 0.4 0.3 0.0 20.7 1.2 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.1 9.9 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 5.5 5.3 4.9 5.0 5.6 4.7 4.5 4.4 4.5 4.5 4.9 5.4 1.1 0.0 0.5 3.3 0.2 1.3 0.2 0.4 0.0 0.6 1.3 1.3 3.5 7.2 1.4 0.0 0.0 4.0 0.2 4.1 1.9 6.2 4.7 0.7 0.7 0.6 0.0 0.4 5.4 2.0 0.5 1.6 7.7 1.3 0.0 0.9 0.7 0.0 1.7 0.0 4.9 8.7 0.0 3.0 1.7 2.1 0.3 1.7 0.0 3.7 2.0 0.7 1.0 5.0 6.0 3.0 4.9 1.2 0.1 0.5 4.4 0.6 1.7 3.3 0.0 2.2 1.3 1.2 12.0 0.6 0.1 1.0 0.3 0.3 5.3 0.1 FUT4 "CD15, ELFT, FCT3A, FUC-TIV" ENSG00000196371 "Fucosyltransferase 4" P22083 11 94543840-94549898 "Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "bone marrow: 100.8" "Cell type enhanced" "Detected in many" "Cholangiocytes: 22.8;Ductal cells: 19.3;Gastric mucus-secreting cells: 21.9;Intestinal goblet cells: 23.7;Pancreatic endocrine cells: 22.5" "Cancer enhanced" "Detected in all" "colorectal cancer: 11.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HL-60: 37.4;NB-4: 24.2;THP-1: 46.6;U-937: 32.9" "Low region specificity" "Detected in single" "CAB000014, CAB016129" Enhanced Approved Vesicles NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 27: Mucus-secreting cells - Mucin production" Vesicles "CAB000014: , CAB016129: AB_626918" "unprognostic (6.36e-2)" "unprognostic (7.53e-2)" "unprognostic (4.70e-3)" "unprognostic (2.46e-3)" "unprognostic (1.46e-2)" "unprognostic (2.29e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (3.64e-4)" "unprognostic (7.26e-2)" "unprognostic (4.14e-1)" "unprognostic (4.81e-3)" "unprognostic (1.27e-1)" "unprognostic (9.08e-3)" "unprognostic (8.17e-2)" "unprognostic (1.37e-1)" "unprognostic (4.04e-1)" "unprognostic (3.10e-3)" 3.7 1.2 1.3 4.7 1.1 100.8 2.5 1.2 1.4 2.3 0.2 9.2 12.3 2.8 1.2 1.8 2.1 3.7 1.7 1.6 1.1 1.9 1.5 2.1 3.7 1.3 1.0 2.9 6.7 0.5 1.3 3.1 1.3 1.6 8.7 1.6 6.8 2.2 0.9 0.8 10.8 2.5 1.6 3.6 10.8 1.3 1.4 3.7 1.2 1.1 2.8 2.1 1.3 1.9 2.9 1.4 1.7 0.0 5.3 4.8 8.9 2.6 1.3 2.3 2.5 12.5 4.0 0.0 6.1 4.4 1.2 1.4 2.9 0.3 2.1 19.1 2.9 9.4 2.2 0.3 2.7 37.4 8.0 4.1 0.1 2.9 0.0 0.5 3.6 8.3 9.7 0.0 2.7 1.4 7.9 24.2 3.4 11.6 3.4 6.9 0.0 0.0 2.4 1.9 2.4 0.9 1.5 3.7 1.5 5.1 2.1 46.6 3.3 1.8 4.9 0.0 1.0 1.1 0.6 0.0 1.6 32.9 1.1 0.5 0.8 0.7 0.2 0.4 0.1 0.1 0.2 0.3 0.4 0.1 0.2 0.1 0.3 0.2 1.2 0.5 0.5 0.2 1.3 1.1 1.2 1.4 1.6 1.1 1.3 1.0 1.3 1.6 1.4 1.9 2.9 0.0 0.0 1.3 1.8 1.7 3.0 0.9 1.2 1.0 1.8 1.8 0.9 22.8 1.9 1.8 4.2 15.6 2.6 12.1 0.0 19.3 0.3 1.1 2.8 2.3 10.2 3.4 1.5 17.9 3.2 6.0 21.9 3.3 0.0 2.6 3.9 1.0 9.0 0.0 1.9 23.7 0.0 12.9 3.5 0.8 4.4 5.2 3.6 3.7 13.6 0.4 0.0 3.0 3.4 22.5 5.8 1.2 0.5 2.9 11.6 2.4 1.7 7.9 0.0 3.1 2.6 1.7 3.5 2.1 0.6 2.2 3.1 2.0 17.9 1.4 AMOTL1 JEAP ENSG00000166025 "Angiomotin like 1" Q8IY63 11 94706431-94876748 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 112.0" "Cell type enhanced" "Detected in many" "Early spermatids: 127.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 111.4;WM-115: 105.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001196 Approved Approved "Cell Junctions,Cytosol" NA NA 59000 "Cluster 24: B-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol "Cell Junctions" "HPA001196: AB_1078147" "unprognostic (2.21e-1)" "unprognostic (5.25e-2)" "unprognostic (4.23e-2)" "unprognostic (5.43e-2)" "unprognostic (7.58e-2)" "unprognostic (3.29e-2)" "unprognostic (1.05e-1)" "unprognostic (2.40e-1)" "unprognostic (2.09e-1)" "unprognostic (7.97e-2)" "unprognostic (1.85e-1)" "unprognostic (5.95e-2)" "prognostic favorable (5.03e-6)" "unprognostic (7.47e-3)" "unprognostic (1.39e-1)" "unprognostic (1.68e-2)" "unprognostic (1.29e-2)" 15.4 10.3 15.1 7.6 9.8 1.7 15.0 7.8 7.2 11.7 8.7 36.5 4.5 14.2 5.9 30.4 13.3 13.3 19.1 12.2 12.4 6.4 7.8 15.8 3.5 12.0 28.8 4.8 15.6 13.8 14.1 24.1 13.2 32.4 7.3 6.6 10.9 23.1 112.0 21.7 8.4 20.5 7.3 9.2 12.4 11.7 30.4 27.9 9.7 71.7 9.7 27.5 14.0 6.2 57.1 16.0 41.9 0.0 44.1 38.1 19.9 31.0 53.7 13.9 16.2 29.7 1.5 2.7 14.9 42.2 11.4 72.4 20.1 111.4 14.6 4.6 15.4 30.7 16.2 0.1 10.2 6.8 0.2 22.7 67.3 47.7 78.9 35.9 29.3 11.9 79.0 2.9 33.1 16.6 21.3 4.1 6.3 0.1 10.5 0.0 76.2 4.9 19.4 23.6 31.7 38.3 2.0 42.4 11.2 28.1 2.2 9.6 27.1 38.0 27.6 0.8 21.6 1.5 0.0 16.0 10.6 0.1 105.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 15.1 9.8 7.8 7.2 12.2 12.4 12.0 28.8 13.2 7.3 30.4 6.2 28.4 35.3 35.0 17.0 0.8 35.4 19.7 11.7 29.0 4.7 6.9 14.9 51.0 10.0 10.1 7.3 4.2 30.1 1.0 0.0 0.0 17.3 127.0 22.3 12.7 31.1 0.0 6.3 26.8 17.0 15.6 30.9 0.5 27.4 2.5 4.9 36.4 17.0 4.9 15.2 61.3 0.0 4.1 4.0 10.0 62.9 8.1 3.2 10.6 46.9 1.4 14.4 0.0 20.6 1.4 10.8 0.0 12.4 0.7 19.4 0.0 4.0 4.2 1.1 13.1 32.7 30.2 16.7 11.4 21.7 26.9 27.9 1.4 3.4 0.0 8.4 CWC15 "AD002, C11orf5, Cwf15, HSPC148" ENSG00000150316 "CWC15 spliceosome associated protein homolog" Q9P013 11 94962620-94973586 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 883.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039878 Supported Approved "Nuclear speckles,Mitochondria" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 39: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear speckles, Mitochondria" "HPA039878: AB_2676722" "unprognostic (1.97e-1)" "unprognostic (5.51e-2)" "unprognostic (1.66e-2)" "unprognostic (8.64e-2)" "unprognostic (3.81e-1)" "unprognostic (6.85e-2)" "unprognostic (1.29e-1)" "unprognostic (1.52e-1)" "unprognostic (4.84e-3)" "prognostic favorable (9.75e-4)" "unprognostic (4.69e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (1.44e-1)" "unprognostic (1.34e-1)" "prognostic favorable (7.17e-4)" "unprognostic (5.23e-2)" 23.1 21.8 37.3 14.2 37.5 32.3 30.5 38.5 46.3 22.5 33.9 20.4 16.0 20.8 34.1 23.6 21.3 13.9 35.0 37.1 39.1 31.2 37.6 17.3 25.1 38.3 39.8 27.0 22.4 25.9 15.7 25.6 38.5 19.9 19.4 25.2 27.0 19.7 68.7 18.1 18.3 17.4 38.6 18.9 21.7 40.0 38.0 30.8 25.1 60.1 24.4 22.0 20.7 39.4 27.1 16.5 63.3 32.3 54.4 50.1 33.0 40.1 52.4 59.9 51.0 80.6 62.4 40.3 76.2 51.1 41.2 28.9 33.8 47.3 66.3 50.7 30.5 51.3 20.5 40.0 45.3 65.9 31.8 47.9 54.1 36.7 54.0 50.2 59.5 44.3 58.2 37.2 56.1 29.4 65.2 87.6 32.0 66.6 42.9 43.7 38.2 44.2 61.1 30.2 35.2 28.8 42.0 44.7 35.9 53.3 72.1 50.8 35.8 44.4 35.2 60.7 41.0 16.9 41.2 57.4 25.5 73.4 44.8 45.9 22.6 33.9 23.6 28.1 32.3 28.7 31.3 29.0 29.6 25.2 29.7 30.7 27.4 26.8 35.9 28.7 34.4 23.7 37.3 37.5 38.5 46.3 37.1 39.1 38.3 39.8 38.5 38.6 38.0 39.4 67.1 73.7 63.9 12.4 69.3 59.3 84.6 150.1 54.7 59.3 56.1 80.0 170.3 92.9 112.2 51.5 14.6 146.7 75.5 62.4 221.1 122.2 883.6 57.7 60.9 74.3 28.4 96.2 15.4 144.0 126.3 80.0 42.8 57.9 104.4 68.6 96.0 121.3 128.7 40.4 17.0 68.3 83.4 69.5 62.4 203.6 112.8 68.8 71.2 14.0 109.1 142.6 104.0 13.0 21.5 125.7 85.4 92.9 59.2 90.9 99.0 245.9 89.1 59.1 138.1 72.5 98.8 267.7 196.2 80.2 63.9 119.3 71.3 69.9 65.2 70.9 KDM4D "FLJ10251, JMJD2D" ENSG00000186280 "Lysine demethylase 4D" Q6B0I6 11 94973709-94999519 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 33.3" "Group enriched" "Detected in many" 7 "Early spermatids: 115.7;Late spermatids: 43.7;Spermatocytes: 102.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 2.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA055854, HPA064037" Approved Approved Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 74: Testis - Spermatogenesis" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA055854: AB_2682944, HPA064037: AB_2685180" "unprognostic (1.98e-1)" "unprognostic (5.71e-2)" "unprognostic (1.83e-1)" "unprognostic (9.65e-3)" "unprognostic (3.19e-1)" "unprognostic (5.12e-2)" "unprognostic (2.84e-2)" "unprognostic (3.16e-1)" "unprognostic (3.11e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-2)" "unprognostic (5.62e-2)" "unprognostic (4.49e-2)" "unprognostic (8.14e-2)" "unprognostic (1.84e-1)" "unprognostic (2.45e-1)" "unprognostic (2.88e-1)" 0.5 0.6 0.5 0.3 0.5 0.0 0.8 0.5 0.6 0.5 0.4 0.2 0.1 0.5 0.8 0.3 1.0 0.4 1.0 0.5 0.5 0.5 0.3 0.4 0.7 0.5 0.5 0.9 0.3 0.9 0.5 0.4 0.4 0.5 0.3 2.1 0.6 0.6 0.6 0.7 0.3 0.5 0.6 0.6 0.3 33.3 0.5 0.6 0.7 0.7 0.6 0.4 0.3 0.6 0.5 0.8 3.3 2.4 0.7 0.8 1.5 1.1 1.2 3.0 2.6 0.9 1.0 1.2 3.5 0.9 2.9 1.0 2.1 2.3 2.3 1.4 2.2 1.1 0.4 1.3 0.6 0.5 0.3 1.5 1.2 3.0 2.7 0.4 1.1 4.4 1.2 0.5 1.2 1.0 1.9 1.2 1.4 0.8 4.0 2.6 1.4 0.9 0.7 0.3 1.9 2.3 1.3 1.1 0.9 1.7 1.2 0.4 0.9 2.0 1.2 3.2 1.7 0.7 2.5 0.2 0.7 0.6 2.3 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.4 0.6 0.1 0.5 0.5 0.5 0.6 0.5 0.5 0.5 0.5 0.4 0.6 0.5 0.6 0.8 0.0 0.0 2.6 0.2 0.0 0.2 0.8 0.6 7.0 0.8 0.9 1.1 1.5 0.4 0.0 2.1 0.9 1.6 0.0 3.9 0.8 115.7 1.3 1.4 1.1 0.0 0.4 1.8 0.6 0.9 0.9 0.5 0.4 0.0 2.6 2.2 1.3 0.7 3.3 2.6 0.1 0.0 0.6 0.3 43.7 2.1 0.8 0.0 4.7 0.7 3.9 1.0 3.5 4.3 0.2 0.1 1.2 0.5 0.2 0.0 1.3 1.0 3.3 0.0 0.8 0.7 102.5 11.4 0.7 0.0 0.3 0.3 2.5 0.3 0.2 KDM4E "JMJD2E, KDM4DL, KDM5E" ENSG00000235268 "Lysine demethylase 4E" B2RXH2 11 95025258-95027596 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051740, HPA054225" Uncertain NA NA "HPA051740: AB_2681586, HPA054225: AB_2682421" "unprognostic (1.32e-1)" "unprognostic (6.31e-2)" "unprognostic (4.74e-2)" "unprognostic (3.69e-1)" "unprognostic (9.27e-2)" "unprognostic (5.54e-2)" "unprognostic (8.10e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KDM4F JMJD2F ENSG00000255855 "Lysine demethylase 4F" 11 95049422-95051338 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SRSF8 "SFRS2B, SRP46" ENSG00000263465 "Serine and arginine rich splicing factor 8" Q9BRL6 11 95066919-95071225 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA049905 Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 32: Non-specific - Translation" Nucleoplasm Cytosol "HPA049905: AB_2680945" "unprognostic (2.03e-2)" "unprognostic (2.51e-1)" "unprognostic (5.23e-2)" "unprognostic (2.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.68e-1)" "unprognostic (2.62e-1)" "unprognostic (2.08e-2)" "unprognostic (2.12e-1)" "unprognostic (3.00e-1)" "unprognostic (1.55e-2)" "unprognostic (1.05e-1)" "prognostic favorable (9.99e-7)" "unprognostic (2.26e-1)" "unprognostic (1.88e-1)" "unprognostic (5.39e-2)" "unprognostic (2.75e-3)" 14.8 13.5 16.3 12.1 16.0 14.7 16.7 16.5 18.0 14.7 16.8 15.1 15.7 17.3 16.0 14.5 15.3 12.0 13.4 15.8 17.0 19.3 15.1 13.5 17.4 15.0 15.5 20.7 21.9 17.9 15.7 14.3 15.3 19.0 15.6 10.4 19.9 16.8 13.2 14.9 17.4 14.7 16.2 20.0 15.8 5.3 17.5 12.3 23.2 14.1 14.7 13.2 13.6 17.7 7.6 7.7 19.1 0.0 24.9 15.5 21.7 11.1 12.2 5.1 5.5 18.4 24.2 40.3 32.2 16.9 9.4 16.3 16.2 24.1 5.9 24.4 17.8 33.8 9.0 16.6 18.3 34.3 17.7 20.3 25.1 5.4 25.3 15.0 16.2 18.1 25.9 21.5 10.1 10.3 17.9 30.4 10.2 19.8 21.7 22.1 5.8 32.1 20.1 24.8 24.2 24.7 13.8 24.1 16.7 12.0 9.6 18.7 15.3 9.9 13.3 13.5 11.6 11.6 19.1 21.4 5.1 22.5 22.1 10.1 2.1 0.7 5.4 1.2 7.9 9.2 9.4 8.1 4.0 7.1 12.0 9.1 0.6 6.2 1.1 3.7 10.9 4.1 16.3 16.0 16.5 18.0 15.8 17.0 15.0 15.5 15.3 16.2 17.5 17.7 32.5 44.8 29.3 8.8 82.8 0.0 51.4 0.0 57.5 49.3 54.4 60.3 21.4 58.6 11.8 33.1 33.3 39.2 56.5 41.1 150.6 36.7 1.8 22.1 27.6 45.8 56.9 122.9 18.3 45.7 52.7 31.4 40.2 33.8 10.2 43.2 52.5 57.8 26.1 18.5 16.6 82.6 0.0 24.2 0.0 6.0 41.0 41.9 0.0 18.7 40.2 45.7 97.9 13.6 29.6 28.9 40.8 60.9 46.8 46.4 53.4 110.1 9.5 50.9 32.9 34.6 31.0 7.2 6.4 63.5 0.0 51.2 58.4 52.1 67.5 38.0 ENDOD1 KIAA0830 ENSG00000149218 "Endonuclease domain containing 1" O94919 11 95089846-95132645 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 99.5;Granulosa cells: 93.4;Oligodendrocytes: 122.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 194.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008932, HPA010517" Enhanced Approved "Nuclear membrane" "Secreted - unknown location" NA NA 5200000 "Cluster 51: Monocytes - Innate immune response" "Cluster 70: Brain - Nervous system development" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Nuclear membrane" "HPA008932: AB_2262252, HPA010517: AB_1852351" "unprognostic (8.81e-3)" "unprognostic (1.92e-2)" "unprognostic (2.22e-2)" "unprognostic (1.43e-1)" "unprognostic (6.34e-2)" "unprognostic (2.78e-2)" "unprognostic (4.43e-2)" "unprognostic (2.23e-1)" "unprognostic (1.41e-1)" "unprognostic (3.65e-1)" "prognostic unfavorable (8.86e-4)" "unprognostic (2.84e-1)" "prognostic favorable (6.64e-7)" "unprognostic (5.92e-2)" "unprognostic (2.35e-1)" "unprognostic (5.62e-3)" "prognostic unfavorable (3.27e-4)" 21.9 17.3 32.6 10.7 56.4 5.8 16.7 48.0 38.5 22.2 12.8 34.7 10.8 17.6 15.1 24.7 18.5 15.8 13.1 30.3 43.2 24.3 5.9 13.9 10.2 48.2 49.9 14.6 5.7 36.3 14.9 15.9 55.8 47.5 38.6 3.4 17.1 28.3 52.3 30.1 19.4 20.8 43.4 32.5 10.3 10.3 47.4 4.0 16.2 34.7 8.8 13.6 23.4 77.9 3.7 5.8 7.0 4.3 194.4 61.9 29.3 27.2 6.0 7.2 7.4 28.3 48.8 26.4 32.7 21.7 16.0 36.0 6.9 37.3 2.8 21.3 5.2 57.4 2.6 12.1 21.3 10.7 71.0 56.3 47.6 4.1 13.3 48.5 24.9 24.8 11.8 16.7 26.8 9.9 4.5 0.4 1.6 41.2 18.2 19.5 0.0 11.1 21.0 30.6 3.7 2.9 11.5 11.4 21.2 9.6 11.6 2.9 17.9 38.6 11.3 26.1 11.7 13.8 11.0 2.2 11.7 5.6 87.8 1.2 0.8 0.6 3.6 2.2 3.4 4.6 2.3 3.1 1.9 4.7 1.9 2.3 0.4 2.2 3.9 0.8 1.5 4.2 32.6 56.4 48.0 38.5 30.3 43.2 48.2 49.9 55.8 43.4 47.4 77.9 34.1 9.6 19.4 22.9 15.6 8.0 18.9 14.9 7.4 2.4 8.4 15.9 10.9 20.0 16.2 11.0 0.0 3.6 9.9 99.5 1.9 5.5 2.7 7.1 13.8 32.4 16.2 29.9 24.9 8.9 7.8 16.9 10.2 22.9 14.5 93.4 43.2 3.9 3.1 0.0 30.2 22.2 8.2 3.4 4.9 4.4 10.2 15.6 28.4 16.9 4.3 2.2 23.7 19.1 122.9 7.9 44.5 15.1 3.3 17.7 26.9 9.2 5.8 0.8 39.5 15.9 34.5 0.4 2.5 27.8 12.5 12.4 8.8 18.5 21.0 8.8 SESN3 "MGC29667, SEST3" ENSG00000149212 "Sestrin 3" P58005 11 95165513-95232541 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 680.7;Late spermatids: 529.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 46.7;ASC TERT1: 50.7;SuSa: 110.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037935 Approved Nucleoplasm,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA037935: AB_10670534" "unprognostic (2.72e-2)" "unprognostic (3.06e-1)" "unprognostic (2.67e-1)" "unprognostic (8.09e-3)" "unprognostic (5.45e-2)" "unprognostic (4.98e-2)" "unprognostic (1.18e-1)" "unprognostic (8.19e-3)" "unprognostic (1.38e-1)" "unprognostic (3.78e-1)" "unprognostic (2.34e-3)" "unprognostic (4.43e-2)" "unprognostic (1.67e-3)" "unprognostic (1.69e-1)" "unprognostic (1.96e-1)" "unprognostic (1.76e-2)" "unprognostic (9.42e-2)" 9.6 17.5 42.3 14.3 56.4 17.9 14.7 24.3 37.8 11.8 26.0 5.7 6.5 11.4 14.1 8.9 8.4 12.4 5.4 32.6 30.7 10.5 7.5 9.1 24.4 21.4 40.6 21.9 3.1 25.8 11.2 7.1 22.5 10.2 6.5 23.4 9.9 5.5 5.3 10.7 12.5 9.2 28.8 17.3 4.9 57.7 54.6 21.8 21.7 13.1 24.2 11.2 8.8 26.6 0.0 1.0 28.2 0.1 46.7 50.7 0.1 0.2 0.0 0.0 0.1 1.2 0.9 7.7 3.4 0.1 1.3 5.7 17.3 12.5 0.0 6.4 9.0 3.9 15.4 1.2 0.9 3.4 0.7 28.1 21.4 0.1 6.3 8.7 1.1 4.5 0.4 1.4 2.3 0.2 2.5 9.0 11.5 0.2 1.2 5.7 1.7 0.6 6.2 19.1 3.6 7.9 0.3 0.2 1.6 110.9 0.0 11.0 0.3 3.2 7.1 0.6 1.1 0.3 0.0 1.0 1.4 4.0 6.9 0.5 0.3 0.2 0.2 0.7 0.3 1.8 0.8 0.5 0.3 1.1 1.6 0.6 0.3 0.3 1.5 0.4 1.7 0.3 42.3 56.4 24.3 37.8 32.6 30.7 21.4 40.6 22.5 28.8 54.6 26.6 13.4 25.6 7.9 152.8 97.6 23.1 26.2 38.3 76.2 48.2 16.1 25.5 7.6 2.8 15.6 35.0 22.9 0.7 7.1 6.9 1.9 6.0 680.7 7.7 45.4 36.4 7.3 73.4 130.8 2.3 0.6 36.5 10.7 14.5 7.0 28.0 35.3 6.4 23.4 0.0 95.1 11.4 8.2 54.8 58.8 529.5 40.7 36.7 32.0 97.4 82.0 98.9 10.3 48.2 37.2 2.2 7.3 87.3 11.9 13.6 27.7 22.5 4.5 14.8 6.6 31.5 28.9 45.4 11.1 38.2 12.5 1.6 41.3 76.4 14.8 14.9 FAM76B MGC33371 ENSG00000077458 "Family with sequence similarity 76 member B" Q5HYJ3 11 95768953-95790409 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.5" "Group enriched" "Detected in many" 7 "Early spermatids: 261.6;Late spermatids: 372.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036608 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" No No "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "Nucleoli fibrillar center" "HPA036608: AB_2675215" "unprognostic (8.17e-2)" "unprognostic (2.26e-1)" "unprognostic (8.21e-2)" "unprognostic (2.39e-2)" "unprognostic (3.12e-2)" "unprognostic (1.43e-2)" "unprognostic (2.30e-1)" "unprognostic (2.64e-2)" "unprognostic (1.01e-2)" "unprognostic (1.65e-2)" "unprognostic (1.22e-1)" "unprognostic (3.90e-3)" "prognostic unfavorable (7.17e-5)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (2.43e-1)" "prognostic favorable (2.72e-4)" 5.8 5.0 1.1 12.5 1.6 39.5 5.2 4.2 2.3 4.2 1.7 4.9 9.2 6.8 1.6 4.0 3.9 5.3 4.0 1.2 1.0 3.1 8.2 5.0 17.1 1.9 1.8 5.5 6.1 3.7 2.3 6.7 1.8 4.7 5.1 5.3 4.7 3.3 3.9 5.8 6.4 4.5 1.1 8.4 5.9 17.7 1.8 14.2 5.5 3.7 17.6 4.9 3.7 3.4 8.0 6.0 22.1 12.0 3.6 3.6 18.4 13.4 6.4 9.6 11.0 22.4 15.3 29.8 16.5 6.4 12.5 15.0 13.1 4.5 10.1 16.1 9.5 35.0 10.9 11.8 9.2 25.0 19.3 4.7 7.3 11.1 9.9 6.3 9.3 17.5 21.1 16.1 5.5 5.8 28.0 29.9 12.3 8.5 5.4 30.0 16.5 17.7 7.3 8.8 9.3 26.3 16.3 9.1 10.1 7.4 12.1 10.9 9.5 13.4 14.1 15.8 12.3 8.8 19.7 45.5 3.2 23.8 19.2 0.1 1.9 3.5 3.3 2.0 2.7 1.8 3.0 3.4 1.3 1.5 2.7 4.1 5.7 3.3 1.9 4.8 5.2 1.8 1.1 1.6 4.2 2.3 1.2 1.0 1.9 1.8 1.8 1.1 1.8 3.4 27.9 6.4 16.5 14.7 41.5 13.8 12.5 8.4 22.8 16.1 17.0 16.4 12.9 8.6 14.0 5.5 27.1 8.5 28.9 10.5 0.0 7.7 261.6 23.2 23.4 19.2 20.4 34.1 18.7 7.5 10.1 14.9 15.3 18.3 10.8 21.0 15.4 19.8 8.3 11.8 15.9 14.0 4.1 18.0 18.0 372.1 17.1 20.0 16.0 13.1 17.7 12.4 19.6 16.6 30.1 9.1 16.0 15.4 16.2 12.5 10.3 2.4 12.3 15.1 26.3 17.6 21.3 31.8 20.9 14.4 16.1 7.7 26.4 15.0 10.8 10.7 CEP57 "KIAA0092, Translokin, TSP57" ENSG00000166037 "Centrosomal protein 57" Q86XR8 11 95789965-95832693 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 462.9;Late spermatids: 372.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA018315 Approved Approved Microtubules,Cytosol "Intracellular and membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 34: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 34: Spermatids - Unknown function" Microtubules Cytosol "HPA018315: AB_1846537" "unprognostic (1.64e-1)" "unprognostic (2.30e-1)" "unprognostic (1.45e-2)" "unprognostic (2.66e-1)" "prognostic favorable (7.24e-4)" "unprognostic (1.69e-1)" "unprognostic (2.25e-2)" "unprognostic (8.10e-2)" "unprognostic (9.04e-3)" "unprognostic (7.93e-2)" "unprognostic (2.38e-3)" "unprognostic (7.81e-2)" "unprognostic (1.06e-1)" "unprognostic (4.31e-2)" "unprognostic (1.35e-1)" "unprognostic (6.69e-3)" "unprognostic (3.25e-1)" 16.6 14.0 10.6 19.2 11.4 29.0 21.6 15.0 13.3 19.0 12.6 17.7 32.4 21.8 19.8 15.0 17.7 27.3 15.6 10.4 11.2 15.7 44.6 16.9 30.1 12.2 11.2 31.2 22.8 12.2 14.9 16.1 10.8 16.2 18.6 25.9 14.1 17.3 12.8 17.8 21.9 15.5 10.9 20.5 17.8 27.9 11.7 34.2 22.7 14.3 30.6 14.0 15.1 12.4 26.7 13.1 42.0 32.7 19.4 38.6 34.4 29.8 48.6 41.4 46.1 47.5 55.1 47.1 39.6 22.4 24.2 43.8 34.7 29.5 43.8 38.1 21.8 66.4 36.9 38.4 33.9 67.0 37.2 25.9 42.5 43.2 80.4 39.3 33.4 49.6 43.8 25.3 33.8 13.1 74.7 89.1 23.3 30.2 29.2 43.8 53.2 40.7 34.8 27.8 21.5 28.9 36.1 34.4 38.3 29.7 35.1 44.0 17.2 35.2 28.3 52.0 28.2 16.9 38.1 51.7 14.6 74.4 31.0 19.0 11.8 24.3 19.5 14.4 25.9 23.6 25.7 22.7 15.6 21.7 24.8 23.5 11.6 26.0 13.2 21.1 33.7 17.5 10.6 11.4 15.0 13.3 10.4 11.2 12.2 11.2 10.8 10.9 11.7 12.4 43.7 54.5 51.1 35.9 58.5 36.3 30.6 35.7 51.2 72.3 30.6 42.7 41.3 85.8 41.7 29.5 35.5 44.1 42.8 16.2 54.8 34.2 462.9 52.2 33.0 38.2 28.8 88.1 68.0 25.7 50.8 41.1 18.3 33.0 27.3 58.4 30.7 71.5 33.1 57.2 78.3 34.0 16.2 35.0 37.3 372.7 33.8 33.2 17.8 27.2 37.6 29.6 44.3 57.8 60.9 26.2 23.9 35.7 57.8 28.8 45.2 40.2 52.6 59.0 65.7 34.4 37.8 75.8 46.1 42.0 32.0 38.4 59.1 53.0 47.2 27.6 MTMR2 "CMT4B, KIAA1073" ENSG00000087053 "Myotubularin related protein 2" Q13614 11 95821766-95925315 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 120.1;Oligodendrocytes: 226.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049831 Approved Supported Vesicles NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 77: Retina - Visual perception" "Cluster 15: RT4 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles "HPA049831: AB_2680904" "unprognostic (1.71e-2)" "unprognostic (2.55e-3)" "unprognostic (7.81e-3)" "unprognostic (4.16e-1)" "unprognostic (4.18e-3)" "unprognostic (5.36e-2)" "prognostic unfavorable (1.61e-8)" "unprognostic (3.23e-3)" "unprognostic (3.42e-2)" "unprognostic (1.77e-2)" "prognostic unfavorable (3.60e-4)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (1.50e-1)" "unprognostic (1.14e-1)" "unprognostic (8.03e-3)" 14.7 9.3 11.0 11.2 16.8 4.4 11.8 16.3 18.3 12.2 12.2 12.9 7.1 12.3 6.2 14.7 12.4 14.3 13.5 10.8 14.3 16.4 4.3 12.3 9.5 15.1 14.4 11.5 7.8 12.7 6.4 24.5 15.8 16.1 13.9 18.6 20.5 11.4 6.2 8.2 8.3 18.0 13.5 8.6 13.0 31.0 14.1 15.1 9.9 8.9 12.1 15.2 10.4 22.4 24.1 25.3 54.1 39.2 19.2 29.0 47.5 43.3 37.9 42.4 37.8 57.3 47.1 16.2 50.3 45.5 35.9 30.9 47.7 48.2 38.9 30.8 21.3 31.5 55.0 33.0 42.8 59.3 26.7 24.0 31.2 56.6 54.5 41.8 64.4 35.4 44.7 14.2 39.6 17.9 29.0 27.2 46.6 59.0 34.9 23.2 32.2 16.8 43.9 125.0 35.6 40.6 43.6 36.4 19.2 35.1 27.6 26.5 64.4 47.7 45.1 34.4 41.1 13.1 42.4 14.3 20.4 15.6 50.6 9.8 3.9 1.7 12.4 4.7 13.4 5.8 7.9 15.7 7.6 4.9 4.0 11.3 0.9 14.1 7.2 3.7 8.1 7.8 11.0 16.8 16.3 18.3 10.8 14.3 15.1 14.4 15.8 13.5 14.1 22.4 19.6 3.2 8.6 28.7 9.6 10.3 15.0 9.0 8.6 0.0 8.0 6.7 17.3 0.0 11.6 9.2 0.0 9.0 8.8 9.1 9.8 17.8 74.8 18.1 14.1 20.2 16.2 12.8 69.8 16.9 34.3 17.0 9.7 8.7 19.0 49.1 11.0 1.0 12.5 0.0 37.5 9.8 24.4 10.3 8.2 120.1 11.1 8.3 3.6 40.3 6.8 0.0 14.4 63.8 226.6 17.7 4.7 12.0 7.0 15.1 6.0 29.3 17.0 0.0 32.9 7.9 29.0 46.8 19.2 15.4 6.0 9.0 8.8 12.9 10.6 15.6 MAML2 "KIAA1819, MAM3" ENSG00000184384 "Mastermind like transcriptional coactivator 2" Q8IZL2 11 95976598-96343195 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Notch signaling pathway, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 690.5;Microglial cells: 579.9;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 311.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 52.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035223 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Cluster 40: NK-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 44: HDLM-2 - Immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA035223: AB_10671101" "unprognostic (8.11e-2)" "unprognostic (2.51e-1)" "unprognostic (7.08e-2)" "unprognostic (9.07e-2)" "unprognostic (3.57e-3)" "unprognostic (3.32e-2)" "unprognostic (3.66e-2)" "unprognostic (2.33e-1)" "unprognostic (3.99e-2)" "unprognostic (8.05e-2)" "prognostic unfavorable (3.89e-4)" "unprognostic (9.11e-2)" "prognostic favorable (1.90e-4)" "unprognostic (9.76e-2)" "unprognostic (1.73e-2)" "unprognostic (1.99e-1)" "unprognostic (7.19e-2)" 10.9 2.7 5.8 6.3 5.5 3.1 14.2 17.2 3.9 10.6 6.9 6.1 3.0 5.4 1.8 5.5 8.0 7.7 4.4 7.1 10.6 9.9 2.4 9.8 8.7 9.0 9.0 7.9 5.9 5.9 4.0 12.2 7.4 7.4 6.2 6.8 11.0 5.7 2.0 7.9 4.8 6.5 7.0 10.3 4.8 2.3 7.5 13.7 6.5 4.8 7.0 8.8 6.5 6.6 10.7 2.0 17.8 4.7 18.1 20.7 3.8 12.1 17.9 7.8 8.1 1.3 22.1 2.3 27.7 28.1 4.1 9.6 3.6 11.7 10.7 52.8 1.3 1.4 3.7 4.1 10.5 0.1 0.0 30.4 1.1 13.9 8.2 14.3 4.5 0.3 6.1 3.2 14.0 0.9 0.2 2.9 1.9 5.5 3.3 3.7 3.4 12.3 11.6 14.8 0.1 1.6 4.5 1.9 5.0 5.7 1.7 0.5 19.7 13.6 3.2 4.7 7.7 2.2 0.4 3.3 6.5 2.0 25.6 0.1 0.6 0.0 0.8 0.3 1.3 0.9 1.6 2.1 0.6 1.2 3.2 2.2 2.6 2.4 0.4 0.5 0.6 1.2 5.8 5.5 17.2 3.9 7.1 10.6 9.0 9.0 7.4 7.0 7.5 6.6 43.5 16.0 8.6 690.5 35.4 19.5 21.5 12.6 19.9 44.1 28.6 43.1 5.3 18.6 16.6 12.9 91.8 15.4 21.8 31.0 11.7 19.3 1.4 61.6 49.4 24.0 6.7 2.7 81.6 0.4 26.0 41.6 20.9 52.3 1.3 44.0 9.3 0.4 18.6 0.0 36.8 7.6 4.1 19.2 21.2 3.0 8.7 29.3 12.4 579.9 26.0 21.9 16.5 1300.8 311.4 15.0 16.8 8.6 18.1 19.1 9.4 17.1 24.2 25.9 32.9 3.6 51.5 0.6 0.8 19.4 13.5 13.0 38.1 9.0 14.3 19.2 CCDC82 FLJ23518 ENSG00000149231 "Coiled-coil domain containing 82" Q8N4S0 11 96349241-96389956 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Early spermatids: 493.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038704, HPA070631" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "Nuclear bodies, Cytosol" "HPA038704: AB_10674835, HPA070631: " "unprognostic (3.04e-1)" "unprognostic (1.09e-1)" "unprognostic (3.00e-1)" "unprognostic (1.99e-1)" "unprognostic (4.05e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.37e-1)" "unprognostic (9.94e-3)" "unprognostic (5.94e-2)" "unprognostic (3.68e-1)" "unprognostic (3.41e-1)" "unprognostic (7.68e-3)" "unprognostic (1.42e-1)" "unprognostic (9.84e-2)" "unprognostic (1.44e-1)" "unprognostic (1.31e-2)" 22.2 15.1 16.5 19.6 19.7 17.1 17.6 32.0 26.6 15.9 8.7 18.1 13.0 18.4 13.9 10.4 15.9 16.8 13.7 17.4 24.6 16.6 22.1 17.9 23.4 18.2 16.5 18.3 13.8 11.8 18.2 17.4 19.5 13.0 13.3 43.2 12.8 15.8 14.3 14.3 16.9 13.8 12.4 20.3 16.7 23.7 17.9 22.3 17.9 14.9 20.1 16.7 14.5 31.1 12.9 17.9 52.4 21.0 35.9 30.0 20.8 47.0 28.0 29.9 42.4 31.1 41.3 26.1 42.8 23.1 50.5 29.1 17.5 14.7 42.5 44.5 11.7 49.1 42.7 26.0 25.6 41.5 33.2 18.3 9.2 58.9 22.8 28.0 35.9 25.3 31.4 28.1 40.5 1.1 34.9 40.2 12.0 21.6 12.7 23.7 44.2 21.0 22.6 32.9 9.6 22.7 26.6 2.7 23.0 35.5 5.0 19.5 42.6 50.1 28.1 43.7 25.3 9.5 29.9 36.0 16.2 30.7 38.6 59.4 12.5 25.1 23.7 15.2 24.5 22.5 24.7 23.6 14.0 19.3 26.9 25.5 17.9 35.7 16.2 18.7 28.5 17.9 16.5 19.7 32.0 26.6 17.4 24.6 18.2 16.5 19.5 12.4 17.9 31.1 57.9 19.2 31.4 30.7 32.9 30.5 27.0 31.5 19.4 58.9 14.0 18.5 37.2 18.6 28.9 31.3 100.1 16.6 55.1 10.7 27.4 34.6 493.8 57.6 37.0 53.6 19.8 16.4 67.0 17.5 20.5 44.9 13.7 26.4 40.4 36.4 38.6 32.1 25.2 32.0 67.0 9.0 24.4 27.4 38.4 76.8 43.8 32.5 26.6 23.4 37.2 41.6 42.2 54.3 119.7 32.3 12.2 42.9 27.2 14.5 8.8 40.1 71.8 50.6 32.9 45.4 48.4 85.4 57.0 13.0 20.5 8.2 40.7 24.9 10.3 18.7 JRKL HHMJG ENSG00000183340 "JRK like" Q9Y4A0 11 96389989-96507574 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 171.1;Late spermatids: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046184, HPA060341" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Yes No "Cluster 10: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 24: NB-4 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "Cytokinetic bridge" "HPA046184: AB_10963576, HPA060341: AB_2732646" "unprognostic (4.59e-3)" "unprognostic (9.21e-2)" "unprognostic (3.42e-1)" "unprognostic (1.80e-2)" "unprognostic (6.90e-2)" "unprognostic (2.44e-1)" "unprognostic (5.00e-3)" "unprognostic (4.94e-2)" "unprognostic (7.55e-3)" "unprognostic (6.12e-2)" "unprognostic (3.99e-3)" "unprognostic (1.31e-1)" "unprognostic (3.20e-3)" "unprognostic (6.21e-2)" "unprognostic (1.21e-1)" "unprognostic (2.97e-1)" "unprognostic (9.57e-3)" 7.4 6.2 4.2 7.6 4.4 1.7 8.8 4.5 4.9 9.8 4.3 7.1 7.2 8.4 7.4 5.9 10.1 6.6 6.1 4.0 5.3 6.7 4.2 6.2 9.3 4.7 4.7 13.2 5.1 6.9 4.1 8.4 4.8 8.4 9.0 11.1 8.8 6.9 4.1 7.8 8.4 6.9 4.4 7.5 8.6 11.7 4.7 9.6 9.6 4.4 9.2 6.8 6.0 5.3 9.4 5.8 11.8 8.9 23.1 25.7 8.6 15.6 10.5 10.9 14.2 9.8 22.2 12.8 22.3 14.4 13.9 14.5 5.9 10.6 12.6 13.9 5.5 11.9 17.0 7.5 18.7 6.8 7.4 12.2 16.3 15.8 19.6 20.3 10.0 14.5 6.4 5.5 17.9 1.9 8.8 19.8 1.8 16.7 7.9 8.9 11.5 10.5 13.5 9.7 4.7 8.6 9.1 6.2 7.1 11.0 7.6 9.1 12.4 21.1 9.4 18.6 6.4 4.7 10.9 7.5 9.8 10.9 9.2 3.3 2.6 2.6 1.6 2.1 2.3 2.2 2.6 2.0 2.6 1.6 3.2 2.9 0.9 1.8 2.5 4.1 1.3 1.6 4.2 4.4 4.5 4.9 4.0 5.3 4.7 4.7 4.8 4.4 4.7 5.3 6.2 9.6 5.8 4.2 5.0 4.7 10.3 6.6 2.8 7.4 7.6 8.9 6.8 15.7 12.0 0.0 4.2 6.0 11.7 9.0 1.9 11.5 171.1 9.9 13.6 5.8 6.0 4.8 3.4 5.1 5.0 9.9 7.1 6.8 3.8 5.0 6.4 2.2 5.0 8.4 3.0 10.5 4.1 7.2 5.2 49.3 8.4 6.0 1.8 1.0 6.9 5.2 6.2 3.5 8.2 8.2 4.5 9.4 2.4 8.4 7.6 6.1 25.3 12.3 0.0 6.0 9.6 9.9 4.9 5.3 6.0 4.0 4.8 7.5 9.7 8.4 CNTN5 "hNB-2, NB-2" ENSG00000149972 "Contactin 5" O94779 11 99020949-100358885 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.7;placenta: 2.6;salivary gland: 2.0;thyroid gland: 2.0" "Group enriched" "Detected in some" 14 "Excitatory neurons: 968.9;Inhibitory neurons: 2295.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039492, HPA041223" Approved "Intracellular and membrane" NA NA 480000 "Cluster 65: Brain - Ion transport" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA039492: AB_10795108, HPA041223: AB_10794549" "unprognostic (2.09e-2)" "unprognostic (3.40e-1)" "unprognostic (8.99e-3)" "unprognostic (4.20e-2)" "unprognostic (6.51e-5)" "unprognostic (3.85e-2)" "unprognostic (9.25e-2)" "unprognostic (6.13e-2)" "unprognostic (3.02e-2)" "unprognostic (8.72e-2)" "unprognostic (5.48e-3)" "unprognostic (1.81e-2)" "unprognostic (1.76e-1)" "unprognostic (5.25e-2)" "unprognostic (1.25e-1)" 0.0 0.0 1.3 0.0 1.4 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 4.7 1.1 0.3 0.0 0.1 0.0 0.0 1.3 0.0 0.2 0.2 0.5 2.6 0.5 0.0 0.0 0.7 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.4 0.0 4.1 4.7 1.1 0.0 1.3 0.5 0.0 2.9 0.1 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.1 0.0 6.6 0.0 0.0 0.7 0.0 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.5 3.5 0.1 0.0 0.0 0.0 968.9 0.0 0.2 1.1 0.0 0.4 0.0 0.0 1.1 0.0 0.2 0.0 2295.2 0.0 2.0 0.0 0.0 0.4 0.9 0.0 0.0 42.2 0.0 0.1 0.0 112.1 23.2 0.1 0.0 1.9 0.0 0.0 0.0 0.2 12.5 0.7 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 ARHGAP42 "AD031, FLJ32810, GRAF3, TMEM133" ENSG00000165895 "Rho GTPase activating protein 42" A6NI28 11 100687288-100993941 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 31.6" "Cell type enhanced" "Detected in many" "Astrocytes: 102.8;Early spermatids: 74.7;Oligodendrocyte precursor cells: 226.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 30.2;RH-30: 20.4;RT4: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039924, HPA060528" Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 77: Retina - Visual perception" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 68: Oligodendrocytes - Mixed function" "Nuclear speckles" Cytosol "HPA039924: AB_10674428, HPA060528: AB_2684308" "unprognostic (1.04e-1)" "unprognostic (9.84e-2)" "unprognostic (3.21e-3)" "unprognostic (2.74e-1)" "unprognostic (1.50e-2)" "unprognostic (4.17e-2)" "unprognostic (1.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.30e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (9.29e-4)" "unprognostic (1.32e-1)" "unprognostic (1.75e-2)" "unprognostic (1.51e-1)" "unprognostic (2.65e-1)" "unprognostic (8.45e-2)" "unprognostic (1.03e-1)" 6.6 2.9 5.7 3.8 6.7 1.2 3.7 5.9 6.7 6.4 7.9 6.7 7.7 5.8 3.1 3.2 3.4 6.7 4.7 5.3 8.0 9.2 10.1 6.2 4.6 6.9 7.1 3.1 1.2 5.6 1.3 15.1 6.8 2.8 6.1 31.6 3.1 2.8 3.3 3.1 7.9 4.2 6.7 4.6 9.4 2.1 7.3 9.3 8.1 5.1 2.9 5.3 1.7 7.3 0.6 4.6 5.0 0.1 2.7 4.7 4.0 0.7 1.1 1.2 2.7 6.3 30.2 0.9 8.3 2.1 5.5 9.4 2.8 1.6 1.2 0.0 2.7 15.3 13.0 2.1 5.2 0.1 0.1 3.6 2.8 5.3 0.9 2.9 1.9 3.9 0.5 0.0 4.2 0.9 1.8 0.0 6.8 7.5 6.7 5.4 20.4 0.5 6.8 21.1 3.4 1.8 10.9 0.4 8.0 10.6 1.0 1.8 4.0 4.1 5.3 4.6 2.3 4.6 0.0 6.2 4.1 3.3 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 5.7 6.7 5.9 6.7 5.3 8.0 6.9 7.1 6.8 6.7 7.3 7.3 8.7 48.1 5.3 102.8 3.7 2.4 6.5 1.5 2.2 3.1 2.9 4.6 6.8 14.3 13.4 3.7 25.0 0.7 3.4 22.2 1.9 4.5 74.7 16.0 19.6 6.1 1.8 3.6 2.4 3.9 2.1 12.6 16.3 18.1 0.0 21.8 6.8 6.3 1.6 1.7 47.7 3.6 2.0 0.3 1.2 38.9 1.2 1.4 10.6 39.4 0.0 32.2 0.0 226.2 0.5 10.0 12.1 2.6 5.6 14.6 7.9 19.8 11.8 62.0 39.5 4.5 38.6 3.6 2.3 2.3 3.4 6.4 0.6 6.2 4.7 18.3 PGR "NR3C3, PR" ENSG00000082175 "Progesterone receptor" P06401 11 101029624-101129813 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix: 63.9;endometrium 1: 103.4;fallopian tube: 34.3;smooth muscle: 78.4" "Cell type enhanced" "Detected in many" "Early spermatids: 64.0;Endometrial ciliated cells: 90.1;Endometrial stromal cells: 177.1;Glandular and luminal cells: 76.3;Late spermatids: 40.9" "Group enriched" "Detected in some" 13 "breast cancer: 10.1;endometrial cancer: 11.1" "Group enriched" "Detected in many" 5 "hypothalamus: 7.7;thalamus: 9.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 338 "T-47d: 170.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000068, HPA004751, HPA008428, HPA017176, CAB055100" Enhanced NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 6: T47d - Mammary gland" "Cluster 36: Stromal cells - Cell proliferation" "CAB000068: AB_442124, CAB055100: AB_2532076, HPA004751: AB_1079681, HPA008428: AB_1079680, HPA017176: AB_1855728" "unprognostic (2.59e-2)" "unprognostic (9.80e-3)" "unprognostic (5.23e-3)" "prognostic favorable (5.76e-8)" "unprognostic (2.81e-2)" "unprognostic (1.56e-1)" "unprognostic (4.11e-1)" "unprognostic (1.64e-1)" "unprognostic (2.08e-1)" "unprognostic (2.50e-1)" "unprognostic (3.29e-2)" "unprognostic (1.77e-1)" "unprognostic (7.71e-3)" "unprognostic (1.90e-2)" "unprognostic (2.35e-2)" "unprognostic (1.15e-1)" "unprognostic (5.44e-3)" 1.4 1.7 1.3 0.3 1.0 0.0 7.0 0.8 0.9 63.9 0.6 2.4 0.5 103.4 0.8 0.7 34.3 0.9 3.7 0.8 7.7 1.1 0.3 1.4 0.2 1.7 1.7 16.3 0.6 0.3 1.0 1.7 1.7 3.7 0.7 0.1 3.8 9.0 0.6 0.5 0.7 78.4 1.5 1.7 0.6 3.5 9.2 0.2 1.3 1.8 0.2 1.6 10.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 170.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.0 0.8 0.9 0.8 7.7 1.7 1.7 1.7 1.5 9.2 1.2 1.3 3.2 0.0 0.3 0.7 0.1 1.1 0.0 0.0 1.3 35.9 19.8 18.7 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 64.0 90.1 177.1 3.5 0.0 0.0 0.1 0.0 0.1 12.5 0.0 76.3 0.0 34.7 2.9 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.3 40.9 14.6 1.9 0.0 22.5 0.0 0.0 0.0 1.0 0.3 0.1 0.0 10.5 0.0 0.3 0.0 0.0 0.0 0.2 6.6 1.4 14.9 3.9 2.3 0.0 0.6 0.0 2.3 15.1 0.0 1.0 TRPC6 "FSGS2, TRP6" ENSG00000137672 "Transient receptor potential cation channel subfamily C member 6" Q9Y210 11 101451564-101872562 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 13.3;placenta: 20.8" "Cell type enhanced" "Detected in many" "Club cells: 10.5;Excitatory neurons: 19.3;Inhibitory neurons: 47.2;Microglial cells: 12.2;Smooth muscle cells: 20.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "eosinophil: 2.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.3" "Cell line enhanced" "Detected in some" "A549: 4.9;ASC diff: 8.8;BJ hTERT+: 4.9;HEL: 4.8;RPTEC TERT1: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045098 Approved NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA045098: AB_10959600" "unprognostic (1.45e-1)" "unprognostic (4.21e-1)" "unprognostic (2.43e-1)" "unprognostic (8.71e-5)" "unprognostic (1.86e-1)" "unprognostic (1.36e-2)" "unprognostic (4.33e-2)" "unprognostic (1.14e-1)" "unprognostic (4.30e-2)" "unprognostic (3.04e-1)" "unprognostic (1.98e-2)" "unprognostic (1.30e-1)" "unprognostic (5.47e-4)" "unprognostic (1.99e-3)" "unprognostic (4.88e-2)" "unprognostic (7.16e-2)" "unprognostic (1.32e-2)" 4.3 0.5 1.2 0.7 1.5 0.2 3.3 0.6 1.3 3.4 5.8 2.8 1.2 4.8 1.6 5.7 5.4 2.3 0.5 1.5 1.9 1.4 0.1 13.3 1.1 1.8 3.4 1.2 0.7 0.9 0.2 20.8 1.2 2.2 1.6 0.3 0.9 5.4 0.4 1.9 1.2 4.0 1.6 2.2 1.6 0.6 2.0 0.2 9.4 1.0 0.8 1.8 2.0 1.2 0.0 4.9 0.2 0.0 8.8 2.1 0.0 3.2 4.9 0.7 0.1 0.2 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 4.8 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 1.2 1.5 0.6 1.3 1.5 1.9 1.8 3.4 1.2 1.6 2.0 1.2 3.4 0.0 2.6 2.0 0.0 2.3 1.9 0.0 0.0 1.4 0.4 2.9 0.7 0.0 10.5 3.7 0.0 1.3 0.0 0.1 0.0 0.0 1.0 3.0 4.0 1.6 0.0 0.0 19.3 0.2 0.0 3.1 0.0 8.0 0.0 0.1 0.0 0.0 0.3 0.0 47.2 0.0 0.0 0.0 5.3 0.5 6.2 1.8 1.8 12.2 0.1 0.0 0.0 2.0 0.3 0.0 5.1 0.7 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.3 20.2 0.1 0.7 0.1 3.4 0.4 0.1 2.1 0.0 1.5 ANGPTL5 ENSG00000187151 "Angiopoietin like 5" Q86XS5 11 101890674-101916522 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "ovary: 22.4" "Cell type enhanced" "Detected in some" "Fibroblasts: 19.4;Langerhans cells: 11.3;Leydig cells: 27.7;Melanocytes: 7.2;Peritubular cells: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "ASC diff: 2.7" "Region enhanced" "Detected in some" "spinal cord: 3.3" HPA038516 Uncertain "Secreted in other tissues" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "HPA038516: AB_10672749" "unprognostic (8.28e-3)" "unprognostic (3.08e-2)" "unprognostic (1.21e-1)" "unprognostic (2.62e-1)" "unprognostic (3.23e-2)" "unprognostic (2.18e-1)" "unprognostic (4.88e-2)" "unprognostic (6.74e-4)" "unprognostic (1.96e-1)" "unprognostic (1.53e-8)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" "unprognostic (1.94e-1)" "unprognostic (3.17e-3)" 4.3 0.2 0.1 0.0 0.2 0.0 5.5 0.2 0.4 0.2 0.4 0.3 0.1 0.0 4.4 0.2 0.3 0.2 2.7 0.2 0.2 0.0 0.0 0.9 0.1 0.2 0.1 22.4 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.4 0.2 0.4 2.4 0.2 0.0 0.2 0.0 0.1 1.6 0.1 0.0 0.7 1.9 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 2.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.4 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.5 0.0 0.0 0.3 0.0 6.2 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.0 0.0 1.8 0.0 0.9 0.0 0.0 0.0 0.0 2.1 0.9 0.6 0.8 0.0 0.0 2.7 0.0 0.1 19.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 2.0 0.0 0.0 0.0 11.3 0.8 27.7 0.1 7.2 4.7 0.0 0.2 0.0 1.0 0.2 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.2 1.0 0.2 0.2 0.0 5.5 0.1 0.5 5.7 0.0 0.0 CEP126 KIAA1377 ENSG00000110318 "Centrosomal protein 126" Q9P2H0 11 101915010-102001062 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 143.7;Horizontal cells: 102.6;Respiratory ciliated cells: 138.5;Spermatocytes: 96.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 6.1;EFO-21: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038381, HPA038399" Uncertain Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "HPA038381: AB_10669780, HPA038399: AB_10670157" "unprognostic (7.61e-2)" "unprognostic (6.75e-2)" "unprognostic (9.07e-2)" "unprognostic (1.02e-2)" "unprognostic (9.31e-2)" "unprognostic (8.87e-2)" "unprognostic (1.55e-4)" "unprognostic (1.52e-2)" "unprognostic (5.77e-2)" "unprognostic (9.55e-2)" "unprognostic (7.72e-3)" "unprognostic (8.87e-2)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.30e-2)" "unprognostic (3.41e-1)" "unprognostic (9.61e-2)" "unprognostic (6.99e-3)" 5.4 4.9 8.2 0.8 9.9 0.9 3.8 9.5 12.3 7.1 16.2 4.2 0.6 4.3 2.6 2.0 9.2 1.9 4.2 9.1 7.1 2.2 0.4 4.4 1.4 9.2 8.9 7.8 2.0 1.4 18.1 0.9 7.4 3.5 1.9 11.1 2.4 3.0 1.0 3.9 2.2 2.1 9.2 1.8 1.9 16.8 8.9 0.8 4.1 1.5 0.8 3.7 5.1 9.0 0.5 1.0 0.6 0.8 6.1 3.3 0.3 0.9 1.1 0.5 0.4 0.3 1.8 0.6 5.7 1.1 2.6 0.5 0.7 1.4 0.4 1.8 0.9 0.1 2.6 0.7 0.7 0.1 0.1 1.0 3.0 0.7 1.5 3.3 1.5 0.8 0.1 0.2 1.3 0.6 0.6 0.1 0.5 0.7 0.9 0.1 0.6 0.0 1.3 0.8 1.7 2.7 0.8 1.2 0.1 1.2 2.2 0.2 1.0 1.7 0.9 0.5 1.4 1.3 0.7 0.1 1.9 0.1 0.5 0.3 0.1 0.3 0.4 0.0 0.3 0.5 0.3 0.4 0.1 0.6 0.4 0.4 0.4 0.9 0.0 1.2 0.1 0.1 8.2 9.9 9.5 12.3 9.1 7.1 9.2 8.9 7.4 9.2 8.9 9.0 6.7 9.6 6.7 0.0 7.2 0.0 5.1 0.0 5.2 29.7 6.4 11.9 6.9 8.6 23.5 18.4 45.9 1.3 20.2 0.5 3.9 2.4 21.7 143.7 45.1 4.0 66.7 2.5 0.0 0.4 0.6 33.4 8.2 3.6 0.0 19.0 3.3 0.0 0.4 102.6 0.0 9.4 0.0 0.3 0.0 12.0 53.7 2.8 0.0 0.0 0.7 25.8 20.6 0.0 0.0 1.1 1.7 51.1 3.5 3.0 0.5 6.0 138.5 53.7 6.6 18.3 11.3 96.3 26.2 1.4 0.0 0.1 6.3 39.3 1.7 2.0 CFAP300 "C11orf70, FBB5, MGC13040" ENSG00000137691 "Cilia and flagella associated protein 300" Q9BRQ4 11 102047437-102084554 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 29.2;testis: 30.2" "Cell type enriched" "Detected in some" 4 "Endometrial ciliated cells: 142.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038585 Enhanced Approved Centrosome NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" Centrosome "HPA038585: AB_10795357" "unprognostic (9.70e-2)" "unprognostic (3.18e-1)" "unprognostic (3.02e-1)" "unprognostic (2.20e-3)" "unprognostic (1.05e-1)" "unprognostic (2.04e-1)" "unprognostic (4.16e-2)" "unprognostic (2.62e-1)" "unprognostic (3.03e-2)" "unprognostic (5.00e-2)" "unprognostic (2.66e-2)" "unprognostic (1.18e-1)" "unprognostic (1.77e-6)" "unprognostic (1.76e-2)" "unprognostic (8.68e-3)" "unprognostic (2.94e-2)" "unprognostic (6.73e-3)" 2.7 3.4 2.3 0.4 2.6 0.0 2.6 2.2 2.1 5.4 10.9 1.3 0.8 4.3 10.7 1.8 29.2 3.3 1.3 2.5 3.3 1.7 0.1 3.0 0.9 5.8 6.7 4.1 0.8 2.7 4.0 3.3 5.5 4.0 0.8 1.4 0.8 6.6 0.2 1.3 0.8 2.9 4.7 0.1 1.8 30.2 3.3 0.6 3.6 0.0 0.5 3.0 1.9 4.0 0.1 8.5 8.5 0.0 7.5 17.9 0.2 3.4 8.6 4.6 6.5 0.6 11.1 0.0 2.0 6.7 2.3 2.1 2.1 1.0 3.3 0.0 1.3 0.0 1.3 0.0 5.3 0.0 0.0 7.8 10.5 11.9 8.0 8.9 0.1 0.1 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.2 3.5 0.0 0.0 0.0 12.6 2.4 9.4 0.0 11.0 0.1 0.0 0.0 9.6 0.0 1.3 1.1 3.5 11.2 2.8 0.1 0.0 0.0 3.7 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 2.6 2.2 2.1 2.5 3.3 5.8 6.7 5.5 4.7 3.3 4.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.4 3.8 0.0 0.0 0.0 29.5 0.0 7.1 0.1 0.0 1.9 4.0 0.0 142.5 9.8 0.2 0.0 0.0 0.0 0.0 0.5 3.4 0.0 2.1 0.0 2.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.9 0.2 6.0 0.0 0.0 YAP1 YAP65 ENSG00000137693 "Yes1 associated transcriptional regulator" P46937 11 102110447-102233424 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 145.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009370, HPA038884, HPA038885, CAB069915, HPA070359" Enhanced Supported "Nucleoplasm,Nucleoli,Cell Junctions" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Nucleoli, Cell Junctions" "CAB009370: AB_2273277, CAB069915: AB_922796, HPA038884: , HPA038885: AB_2676255, HPA070359: AB_2732154" "unprognostic (9.56e-2)" "unprognostic (6.75e-2)" "unprognostic (2.08e-1)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (3.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.28e-1)" "unprognostic (2.66e-3)" "unprognostic (3.73e-1)" "prognostic unfavorable (2.03e-4)" "unprognostic (9.26e-2)" "unprognostic (4.80e-2)" "unprognostic (8.38e-2)" "unprognostic (1.77e-1)" "unprognostic (1.04e-1)" "unprognostic (1.29e-2)" 57.2 27.8 19.1 25.9 19.1 0.3 42.7 18.6 17.1 62.5 44.3 41.5 27.2 78.1 45.9 74.7 65.6 49.3 48.1 15.9 22.1 39.3 33.5 45.7 13.0 31.8 30.2 93.1 22.3 37.0 9.9 83.1 21.8 59.2 30.1 12.9 40.6 83.7 48.3 44.2 27.4 100.5 27.3 14.7 31.6 15.0 27.0 13.8 85.9 58.2 22.7 60.9 52.6 20.2 56.9 52.1 141.5 69.6 151.1 143.1 118.7 130.4 147.8 124.2 101.5 130.2 134.9 0.0 105.4 171.6 92.1 98.0 71.0 186.4 130.6 16.8 25.5 0.1 67.3 89.5 115.3 0.1 2.5 115.2 119.4 136.6 220.2 138.4 39.4 6.7 0.0 0.1 142.1 27.2 2.6 0.4 66.8 135.9 49.3 0.1 79.7 0.3 90.9 99.5 0.4 4.7 153.6 57.2 43.5 129.1 103.2 0.8 43.4 175.4 68.8 89.6 55.7 0.1 0.2 0.8 51.0 0.2 130.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 19.1 18.6 17.1 15.9 22.1 31.8 30.2 21.8 27.3 27.0 20.2 28.4 35.3 69.4 145.3 1.5 113.7 47.8 43.5 71.2 0.4 48.1 43.8 39.2 62.9 37.2 92.0 0.0 91.4 0.4 16.2 11.7 27.6 6.7 61.8 53.3 28.9 7.3 0.0 1.5 18.3 20.3 49.0 23.9 85.1 0.0 127.2 26.0 45.2 10.6 0.0 1.6 13.1 14.2 1.6 21.5 4.6 37.9 2.2 44.4 60.0 1.0 27.6 0.0 5.0 0.7 25.2 16.3 40.6 0.1 66.0 27.2 26.1 41.6 1.2 39.5 21.6 62.0 2.5 5.3 59.5 123.2 61.6 2.1 15.9 27.8 65.6 BIRC3 "API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49" ENSG00000023445 "Baculoviral IAP repeat containing 3" Q13489 11 102317450-102339403 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 89.0;lymphoid tissue: 141.5" "Cell type enhanced" "Detected in many" "granulocytes: 554.8;Langerhans cells: 1400.9;monocytes: 1117.0;Proximal enterocytes: 817.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "memory B-cell: 209.0;naive B-cell: 159.9" "Group enriched" "Detected in all" 13 "B-cells: 209.0;T-cells: 83.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 146.5;Daudi: 140.7;EFO-21: 74.3;HDLM-2: 140.1;hTERT-HME1: 140.2;U-266/70: 89.2;U-266/84: 85.8" "Low region specificity" "Detected in all" HPA002317 Enhanced Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 3: Monocytes - Immune response regulation" "Nucleoplasm, Cytosol" "HPA002317: AB_1846748" "prognostic favorable (3.60e-4)" "unprognostic (2.89e-1)" "prognostic favorable (9.35e-4)" "unprognostic (3.28e-2)" "prognostic unfavorable (7.28e-4)" "unprognostic (5.83e-3)" "unprognostic (2.23e-1)" "unprognostic (3.88e-3)" "unprognostic (9.62e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (3.03e-4)" "unprognostic (3.21e-1)" "prognostic unfavorable (6.66e-6)" "unprognostic (6.42e-2)" "unprognostic (6.23e-3)" "unprognostic (1.00e-1)" "unprognostic (3.85e-2)" 9.0 14.7 2.7 104.8 2.9 26.3 18.4 1.6 3.4 19.1 3.4 24.9 26.6 10.5 3.7 16.0 8.5 51.0 7.7 2.8 3.5 12.6 26.3 24.6 141.5 2.6 2.7 6.6 12.0 4.3 3.6 5.3 2.3 10.6 24.7 0.6 12.7 11.4 2.7 8.1 89.0 10.7 2.5 73.2 54.3 8.2 2.7 59.2 3.9 4.3 134.4 46.9 4.8 3.6 26.4 24.5 0.2 0.4 0.7 3.9 2.4 2.5 17.5 3.3 3.7 4.6 146.5 140.7 74.3 1.4 22.8 13.0 0.1 4.6 7.8 140.1 0.3 0.5 7.3 1.4 30.7 2.4 3.7 3.5 18.1 8.4 140.2 4.9 0.4 10.2 0.5 0.0 3.0 0.1 8.3 1.3 0.3 14.2 1.0 0.1 0.8 6.8 34.3 12.9 0.1 0.3 2.1 2.1 1.8 0.5 6.4 1.8 7.5 25.6 3.4 1.4 28.3 89.2 85.8 48.8 4.0 7.4 3.0 8.6 3.9 2.2 5.8 10.1 9.8 209.0 41.7 14.1 3.6 159.9 28.4 8.3 2.6 9.9 11.0 1.7 83.6 11.9 2.7 2.9 1.6 3.4 2.8 3.5 2.6 2.7 2.3 2.5 2.7 3.6 41.2 144.2 70.8 0.0 420.1 101.2 324.9 267.2 51.2 0.3 26.6 22.9 12.5 134.4 146.9 40.5 0.0 2.0 71.2 142.4 7.9 230.3 1.8 231.3 16.8 101.4 15.0 23.6 1.1 179.7 0.5 63.4 184.5 289.4 554.8 1.8 6.4 4.4 11.7 0.0 3.2 38.0 75.3 25.4 1400.9 2.1 5.0 170.0 192.1 2.8 1117.0 0.5 14.4 0.0 0.4 207.4 281.1 2.2 288.4 455.1 817.3 19.5 88.1 0.0 0.0 60.8 90.9 0.7 0.5 31.8 84.5 0.5 278.0 0.7 49.4 193.3 BIRC2 "API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48" ENSG00000110330 "Baculoviral IAP repeat containing 2" Q13490 11 102347211-102378670 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005513, CAB020661" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 2: Hepatocytes - Metabolism" "Nucleoli fibrillar center, Cytosol" Nucleoplasm "CAB020661: , HPA005513: AB_1846746" "unprognostic (1.36e-1)" "unprognostic (3.29e-1)" "unprognostic (9.52e-3)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (7.02e-2)" "unprognostic (2.72e-2)" "unprognostic (1.04e-2)" "unprognostic (1.17e-2)" "unprognostic (9.59e-2)" "unprognostic (1.05e-2)" "unprognostic (3.02e-2)" "unprognostic (1.84e-2)" "unprognostic (1.07e-1)" "unprognostic (9.20e-2)" "unprognostic (5.00e-2)" "unprognostic (1.64e-2)" 23.2 27.6 18.4 25.8 19.6 36.4 28.2 20.0 23.4 27.5 22.5 27.2 23.6 25.7 30.2 18.1 19.7 24.8 23.6 17.9 19.9 28.8 44.3 22.6 34.5 19.7 19.4 21.8 33.7 20.4 18.8 29.4 19.8 21.4 26.0 22.2 21.1 16.1 29.7 18.2 25.2 21.6 20.1 26.7 23.5 24.6 18.8 50.6 22.2 32.9 27.1 30.4 20.4 24.9 34.0 24.7 37.3 29.3 46.1 63.3 23.9 128.3 48.8 71.9 43.4 30.9 81.7 37.1 123.5 59.2 40.3 36.7 24.5 33.8 85.7 50.0 12.6 37.2 17.6 37.8 46.9 22.9 23.0 40.8 64.4 41.2 52.3 66.2 50.1 22.2 34.4 0.2 131.0 10.9 24.3 20.1 18.1 40.1 23.7 11.9 48.4 24.9 55.4 38.5 15.5 20.3 44.7 26.9 40.7 56.7 42.5 27.3 82.7 150.7 34.4 46.2 84.2 14.9 21.9 25.0 32.6 28.2 112.5 97.2 43.3 104.4 22.9 42.2 18.9 15.7 21.5 21.3 33.8 15.1 27.4 27.7 67.6 34.3 46.7 20.4 33.2 27.5 18.4 19.6 20.0 23.4 17.9 19.9 19.7 19.4 19.8 20.1 18.8 24.9 61.8 41.7 41.1 17.0 52.6 67.2 109.2 53.6 39.9 24.4 52.3 52.8 58.6 67.2 49.5 64.4 29.2 38.4 77.9 85.7 43.0 49.8 20.8 63.2 54.0 51.0 48.5 80.0 22.4 73.7 27.8 55.9 28.5 85.7 62.7 43.7 59.3 182.1 41.5 20.2 21.7 54.3 46.8 84.3 71.5 11.2 36.4 71.1 51.6 26.2 81.2 34.3 55.6 21.6 33.1 54.5 71.1 29.0 49.2 75.0 82.1 110.1 56.6 31.0 26.3 45.7 48.9 44.7 42.4 28.4 62.8 35.2 57.1 36.4 44.2 82.5 TMEM123 "KCT3, PORIMIN" ENSG00000152558 "Transmembrane protein 123" Q8N131 11 102396332-102470384 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 988.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026001, HPA062862" Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 85: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 32: Non-specific - Translation" "Golgi apparatus" "Vesicles, Cytosol" "CAB026001: , HPA062862: AB_2732691" "unprognostic (2.64e-1)" "unprognostic (8.39e-2)" "unprognostic (4.18e-3)" "unprognostic (1.40e-1)" "unprognostic (7.32e-2)" "unprognostic (2.33e-1)" "unprognostic (9.91e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.36e-4)" "unprognostic (3.08e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (1.67e-1)" "unprognostic (1.38e-2)" "unprognostic (8.10e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-2)" "unprognostic (3.65e-2)" 56.0 80.2 53.0 120.2 60.3 225.1 153.3 56.7 68.2 114.9 67.0 120.0 63.5 174.7 47.8 100.1 91.7 99.6 71.2 48.0 61.0 93.2 393.7 119.2 196.4 71.2 68.6 86.8 82.5 70.7 15.8 98.5 65.1 105.2 97.1 9.2 224.0 104.1 20.4 95.6 78.8 130.6 61.3 111.2 125.5 73.3 61.5 238.6 312.3 49.7 142.9 146.8 70.7 89.8 220.5 195.8 186.9 174.8 233.5 185.6 135.8 169.7 352.0 324.4 358.1 247.9 988.1 370.2 423.9 387.9 234.5 228.3 212.3 272.9 339.4 228.4 82.5 192.0 67.8 352.3 207.5 404.1 137.4 219.1 280.7 240.1 352.3 433.9 361.8 187.8 134.3 0.9 257.7 71.8 353.0 135.4 115.8 340.3 181.1 214.7 532.0 359.3 291.3 207.9 90.7 110.5 201.8 267.6 109.9 197.2 161.3 154.0 451.9 211.3 249.4 190.5 126.6 139.4 84.3 366.6 62.0 432.7 143.2 159.7 113.3 207.0 102.6 121.8 155.3 70.1 158.8 123.8 126.1 95.3 208.6 181.7 72.4 223.9 111.0 33.7 183.8 248.7 53.0 60.3 56.7 68.2 48.0 61.0 71.2 68.6 65.1 61.3 61.5 89.8 93.3 125.0 78.1 33.0 179.3 160.3 257.1 307.3 157.6 0.7 144.9 118.4 53.9 143.0 202.8 163.7 0.0 45.8 91.8 48.2 80.3 153.7 41.3 141.1 47.6 140.0 90.5 68.3 1.0 118.8 41.1 82.2 88.2 161.4 58.9 126.6 271.3 317.6 107.1 1.7 2.2 163.1 160.7 249.6 419.9 23.6 94.1 189.8 161.9 63.7 229.4 4.7 83.4 25.6 114.0 127.8 55.1 93.3 117.8 324.2 31.0 52.9 257.0 1.1 65.7 181.9 80.2 23.1 74.9 146.3 177.2 30.4 164.8 109.4 146.3 270.2 MMP7 "MPSL1, PUMP-1" ENSG00000137673 "Matrix metallopeptidase 7" P09237 11 102520508-102530750 "Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 509.9;salivary gland: 267.9;urinary bladder: 211.2" "Cell type enriched" "Detected in many" 8 "Ductal cells: 8176.2" "Cancer enhanced" "Detected in all" "pancreatic cancer: 352.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 145.9;CAPAN-2: 815.9;EFO-21: 189.8;RPTEC TERT1: 350.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025869, HPA051358" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" NA NA 2810000 35000 "Cluster 5: Breast - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Vesicles" "CAB025869: , HPA051358: AB_2681452" "unprognostic (1.06e-3)" "unprognostic (9.51e-2)" "unprognostic (4.15e-2)" "unprognostic (1.38e-1)" "unprognostic (7.70e-3)" "unprognostic (7.28e-2)" "prognostic unfavorable (2.53e-4)" "prognostic unfavorable (3.38e-4)" "unprognostic (3.96e-2)" "unprognostic (5.63e-2)" "unprognostic (6.59e-3)" "unprognostic (1.51e-1)" "unprognostic (6.36e-3)" "unprognostic (1.42e-2)" "unprognostic (5.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" 3.8 0.1 0.0 2.0 0.0 0.3 168.7 0.0 0.3 13.3 0.0 1.6 0.6 97.4 27.9 21.3 91.2 509.9 0.2 0.0 0.0 140.2 3.4 31.6 1.9 0.0 0.0 0.7 85.2 0.0 0.3 0.8 0.0 54.0 1.0 0.0 267.9 34.9 0.1 32.4 0.6 4.8 0.0 0.2 7.3 0.6 0.4 3.3 0.4 0.0 29.3 211.2 1.7 0.0 0.2 145.9 0.0 0.4 0.0 0.0 0.2 0.0 2.1 0.1 0.1 1.9 815.9 0.0 189.8 0.0 0.0 1.1 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.6 1.0 0.1 0.2 0.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.5 11.8 0.0 0.0 0.0 0.0 350.1 1.0 0.0 0.0 0.0 0.0 0.0 3.9 0.3 0.1 0.0 0.7 3.0 0.0 1.6 0.1 0.6 0.4 1.0 5.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 86.6 43.3 0.0 1.5 1.0 382.2 135.4 1.2 0.0 124.2 93.7 0.7 100.1 401.2 1017.0 0.0 0.7 2.9 1.2 0.0 8176.2 6.1 62.1 3.3 8.8 0.0 0.0 0.0 209.4 0.3 3.4 0.0 124.6 2.5 0.0 0.0 0.0 98.0 0.0 0.0 0.0 38.7 0.6 0.3 10.3 11.8 12.6 0.0 0.0 65.2 0.0 0.0 0.0 0.0 850.9 0.0 0.0 0.1 603.3 0.0 33.9 72.6 0.0 0.0 0.0 31.4 0.1 0.2 17.0 2.4 0.8 3.6 0.0 2.3 840.8 MMP20 ENSG00000137674 "Matrix metallopeptidase 20" O60882 11 102576832-102625332 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Amelogenesis imperfecta" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 7 "Early spermatids: 91.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "OE19: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "Cluster 21: OE19 - Mitochondria" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (4.62e-3)" "unprognostic (2.61e-2)" "unprognostic (1.68e-3)" "unprognostic (1.75e-1)" "unprognostic (2.13e-1)" "unprognostic (3.06e-1)" "unprognostic (2.97e-2)" "unprognostic (6.75e-2)" "unprognostic (9.58e-5)" "unprognostic (6.10e-2)" "unprognostic (2.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 12.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 6.6 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.4 MMP27 ENSG00000137675 "Matrix metallopeptidase 27" Q9H306 11 102691487-102705769 "Enzymes, Predicted intracellular proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 4.7;salivary gland: 1.9;skin 1: 2.4" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 1.2;Fibroblasts: 4.2;Langerhans cells: 1.8;Suprabasal keratinocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA069097 Approved "Intracellular and membrane" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 50: Fibroblasts - ECM organization" "HPA069097: AB_2686085" "unprognostic (3.99e-2)" "unprognostic (2.37e-4)" "unprognostic (1.25e-3)" "unprognostic (1.63e-1)" "unprognostic (4.60e-1)" 1.2 0.0 0.0 0.0 0.0 1.3 4.7 0.0 0.0 0.2 0.0 0.4 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.9 0.0 0.4 2.4 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 MMP8 CLG1 ENSG00000118113 "Matrix metallopeptidase 8" P22894 11 102711796-102727050 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "bone marrow: 501.1" "Group enriched" "Detected in some" 6 "Hofbauer cells: 4.0;Macrophages: 1.5" "Cancer enriched" "Detected in single" 17 "melanoma: 5.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.7" "Lineage enhanced" "Detected in single" "monocytes: 1.7" "Cell line enriched" "Detected in some" 8 "WM-115: 70.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021221, HPA021763, HPA022935" Enhanced Approved Vesicles "Secreted to extracellular matrix" NA NA 360000 "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 17: WM-115 - Nervous system development" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Vesicles "HPA021221: AB_1854043, HPA021763: , HPA022935: AB_1854044" "unprognostic (3.03e-1)" "unprognostic (8.49e-5)" "unprognostic (1.08e-2)" "unprognostic (3.95e-3)" "unprognostic (1.80e-1)" "unprognostic (1.01e-2)" "unprognostic (7.68e-3)" "unprognostic (1.27e-1)" "unprognostic (4.92e-2)" "unprognostic (6.64e-3)" "unprognostic (2.45e-6)" "unprognostic (2.33e-4)" "unprognostic (1.33e-1)" "unprognostic (4.97e-1)" "unprognostic (2.30e-2)" 0.5 0.0 0.0 0.3 0.1 501.1 0.2 0.1 0.2 0.0 0.2 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.6 4.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.2 0.0 13.8 0.1 0.0 0.6 2.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.9 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MMP10 STMY2 ENSG00000166670 "Matrix metallopeptidase 10" P09238 11 102770502-102780628 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 34 "endometrium 1: 265.4" "Cell type enriched" "Detected in some" 38 "Basal respiratory cells: 3913.2" "Group enriched" "Detected in many" 4 "cervical cancer: 47.8;head and neck cancer: 102.2;lung cancer: 42.3" "Region enhanced" "Detected in single" "thalamus: 1.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 11.8;HUVEC TERT2: 15.1;SCLC-21H: 4.7" CAB002159 Uncertain Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 765000 "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Cytosol "Plasma membrane" "CAB002159: AB_564103" "unprognostic (8.76e-2)" "unprognostic (3.38e-1)" "unprognostic (1.98e-3)" "unprognostic (2.72e-3)" "unprognostic (7.17e-3)" "unprognostic (1.52e-2)" "unprognostic (5.67e-8)" "unprognostic (2.08e-3)" "unprognostic (2.20e-1)" "unprognostic (1.75e-1)" "unprognostic (1.67e-2)" "unprognostic (2.67e-1)" "unprognostic (6.99e-5)" "unprognostic (2.66e-2)" "unprognostic (7.98e-2)" "unprognostic (5.46e-2)" "prognostic favorable (7.12e-4)" 0.1 0.0 0.1 7.7 0.0 0.1 0.1 0.0 0.8 1.2 0.0 0.4 1.1 265.4 0.0 0.2 0.0 1.3 0.0 0.2 0.3 0.1 1.0 2.0 0.1 0.1 0.3 0.2 0.2 0.0 0.0 1.3 0.3 1.4 0.2 0.0 1.6 0.0 0.0 0.1 0.8 0.2 0.0 0.0 2.9 0.5 1.9 0.6 0.0 0.2 0.7 4.4 3.2 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.2 11.8 0.6 0.1 0.1 0.3 0.0 0.0 3.3 1.8 0.2 2.7 0.0 1.3 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.5 0.0 15.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 2.8 0.5 1.6 0.0 0.0 0.0 0.0 0.6 4.7 0.0 2.4 0.0 0.0 0.8 0.0 0.0 1.9 3.5 1.2 0.4 0.5 0.0 0.0 0.1 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.2 0.3 0.1 0.3 0.3 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.8 51.3 3913.2 0.0 0.0 0.7 0.0 0.1 0.0 85.4 29.5 0.0 0.0 0.0 0.4 0.0 34.0 6.1 6.4 2.5 9.0 0.0 0.0 0.0 14.6 0.0 6.3 0.0 12.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.4 0.0 9.5 1.3 0.0 0.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 102.5 0.1 0.0 0.0 42.5 0.0 0.1 29.3 0.0 0.0 0.0 11.7 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 8.2 MMP1 CLG ENSG00000196611 "Matrix metallopeptidase 1" P03956 11 102789401-102798160 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Collagen degradation, Host-virus interaction" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 75.7;stomach 1: 47.6;urinary bladder: 52.2" "Cell type enriched" "Detected in many" 10 "Pancreatic endocrine cells: 2239.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 344.2" "Region enriched" "Detected in single" 7 "cerebral cortex: 1.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 1139.1;HBF TERT88: 1094.4;HUVEC TERT2: 2954.4;WM-115: 1454.1" "Not detected" "Not detected" HPA004920 Approved Vesicles "Secreted to extracellular matrix" NA NA 7730000 55000 "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 17: WM-115 - Nervous system development" "Cluster 16: Pancreatic endocrine cells - Mixed function" Vesicles "HPA004920: AB_2667293" "unprognostic (4.11e-3)" "prognostic unfavorable (4.66e-4)" "unprognostic (4.20e-3)" "unprognostic (1.19e-3)" "unprognostic (6.46e-2)" "unprognostic (6.50e-2)" "prognostic unfavorable (4.22e-6)" "unprognostic (7.83e-3)" "unprognostic (2.94e-2)" "unprognostic (5.44e-2)" "unprognostic (1.11e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.86e-10)" "unprognostic (1.67e-2)" "unprognostic (1.49e-1)" "unprognostic (1.26e-2)" "unprognostic (5.11e-2)" 0.3 0.1 0.0 26.7 0.0 0.3 0.2 0.0 1.3 0.1 0.0 6.1 7.9 10.7 0.0 4.2 0.1 75.7 0.4 0.0 0.1 1.0 0.8 6.7 0.1 0.0 0.0 0.0 1.8 0.0 0.1 7.2 0.0 0.4 6.8 0.0 6.9 0.2 0.0 0.6 13.0 1.2 0.0 2.1 47.6 0.1 0.1 0.3 0.2 0.0 1.7 52.2 0.2 0.0 0.0 0.0 0.0 1.0 0.0 1.1 0.0 517.1 1139.1 456.6 118.2 9.1 1.0 0.0 5.2 275.5 175.2 4.6 0.0 160.0 1094.4 0.0 1.0 0.0 0.0 0.0 2.9 0.0 0.5 0.3 0.8 470.1 39.6 0.1 2954.4 0.0 1.5 0.5 0.3 0.0 0.0 0.0 0.4 189.3 20.8 0.0 0.1 0.0 0.7 2.2 0.0 0.1 4.8 0.0 1.6 0.1 0.5 0.0 155.0 374.1 0.6 16.8 1.3 0.1 0.0 0.0 8.8 0.0 1454.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.3 3.2 2.6 0.0 0.2 2.3 22.4 90.4 0.0 0.0 0.0 0.0 0.1 30.0 15.8 3.7 0.0 0.0 0.0 0.2 0.0 143.7 0.0 0.1 0.2 113.2 0.0 0.0 0.1 204.8 0.1 11.5 25.5 2.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.0 1.9 0.4 0.0 0.0 15.5 0.0 0.0 4.2 0.0 0.0 0.0 0.0 2239.5 1.2 0.0 0.0 30.9 0.7 0.2 1.3 0.0 0.0 1.8 10.5 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.1 44.3 MMP3 "STMY, STMY1" ENSG00000149968 "Matrix metallopeptidase 3" P08254 11 102835801-102843609 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 90.7;salivary gland: 286.1" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 20.4;Basal respiratory cells: 25.8;Early spermatids: 24.2;Extravillous trophoblasts: 13.4;Fibroblasts: 17.9;Prostatic glandular cells: 11.9;Smooth muscle cells: 10.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 59.9" "Region enriched" "Detected in some" 4 "thalamus: 7.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "BJ: 1545.7;BJ hTERT+: 4229.3;fHDF/TERT166: 1846.6" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hippocampal formation: 3.2" HPA007875 Uncertain Supported Vesicles "Secreted to extracellular matrix" NA NA 2540000 460000 "Cluster 24: Salivary gland - Salivary secretion" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Vesicles "HPA007875: AB_1079396" "unprognostic (2.27e-1)" "prognostic unfavorable (9.73e-4)" "unprognostic (1.63e-3)" "unprognostic (5.11e-3)" "unprognostic (3.78e-1)" "unprognostic (5.11e-2)" "unprognostic (5.26e-6)" "unprognostic (3.46e-2)" "unprognostic (7.14e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (4.09e-4)" "unprognostic (3.26e-2)" "unprognostic (1.22e-15)" "unprognostic (3.17e-1)" "unprognostic (1.55e-1)" "unprognostic (3.43e-2)" "unprognostic (2.34e-1)" 90.7 0.1 0.3 20.1 0.4 0.0 36.6 0.2 1.6 0.3 0.1 6.1 2.4 38.1 0.2 0.8 0.2 1.9 0.2 0.4 1.6 0.4 1.6 0.3 0.0 0.4 0.4 0.1 0.3 0.1 0.9 0.4 0.3 2.2 2.3 0.0 286.1 2.2 39.6 63.7 4.5 1.6 0.3 0.0 10.5 0.1 7.3 0.1 2.6 0.4 1.3 13.9 0.5 0.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1545.7 4229.3 27.0 8.7 0.1 0.2 0.0 0.0 1846.6 96.9 0.0 0.1 0.1 45.1 0.0 0.0 0.0 0.0 1.0 0.7 0.0 0.0 4.6 0.2 122.0 5.3 0.0 0.0 0.0 0.2 0.3 4.7 0.0 0.0 0.0 0.2 0.4 0.9 0.0 0.2 0.0 0.1 0.0 0.1 0.0 2.3 0.0 0.0 0.9 0.0 0.3 0.0 140.5 13.1 1.6 0.5 0.0 0.0 0.2 56.8 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 1.6 0.4 1.6 0.4 0.4 0.3 0.3 7.3 0.3 0.0 3.2 0.0 0.0 0.0 8.4 20.4 25.8 0.0 0.0 0.1 0.1 0.3 4.3 7.6 0.0 0.0 0.1 0.0 0.0 0.0 0.8 24.2 0.0 0.3 0.5 0.0 0.0 0.2 1.4 13.4 17.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 4.1 0.0 2.2 1.2 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.5 4.0 0.0 0.0 11.9 1.0 0.9 0.1 0.0 0.0 1.8 10.2 0.0 1.8 0.0 3.4 0.3 0.6 0.0 0.8 7.4 MMP12 HME ENSG00000262406 "Matrix metallopeptidase 12" P39900 11 102862736-102874982 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 15.7;lymphoid tissue: 40.4;urinary bladder: 16.0" "Cell type enriched" "Detected in some" 9 "Extravillous trophoblasts: 303.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "BJ: 3.3;fHDF/TERT166: 11.4;hTEC/SVTERT24-B: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "Cluster 14: B-cells - Humoral immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 38: Extravillous trophoblasts - Unknown function" "unprognostic (7.33e-2)" "unprognostic (3.20e-2)" "unprognostic (1.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.74e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (1.42e-4)" "unprognostic (1.69e-2)" "unprognostic (7.31e-2)" "unprognostic (1.52e-2)" "unprognostic (1.52e-3)" "unprognostic (5.45e-2)" "unprognostic (3.05e-6)" "unprognostic (1.08e-2)" "unprognostic (4.66e-2)" "unprognostic (1.73e-1)" "unprognostic (6.92e-2)" 0.5 0.0 0.0 40.4 0.1 0.0 0.4 0.0 0.0 0.1 0.0 13.5 6.8 0.6 0.0 0.4 0.0 2.6 0.0 0.0 0.3 0.9 0.1 0.6 7.0 0.1 0.1 0.0 0.1 0.0 0.0 7.4 0.1 1.3 15.7 0.0 2.4 0.0 0.0 0.5 7.8 2.2 0.1 3.7 3.5 0.0 0.1 3.9 0.0 0.0 19.4 16.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 11.4 0.1 0.4 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 18.6 303.4 0.4 0.0 0.2 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.0 2.2 MMP13 CLG3 ENSG00000137745 "Matrix metallopeptidase 13" P45452 11 102942995-102955732 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "urinary bladder: 12.9" "Cell type enriched" "Detected in some" 12 "Basal respiratory cells: 426.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 70.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 17.9;PC-3: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" CAB002742 Supported "Secreted to extracellular matrix" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "CAB002742: " "unprognostic (8.98e-3)" "unprognostic (1.54e-1)" "unprognostic (4.75e-2)" "unprognostic (4.57e-2)" "unprognostic (3.05e-2)" "unprognostic (1.59e-3)" "unprognostic (1.32e-1)" "unprognostic (6.35e-3)" "unprognostic (1.69e-1)" "unprognostic (7.55e-3)" "unprognostic (2.24e-1)" "unprognostic (1.73e-8)" "unprognostic (2.12e-2)" "unprognostic (3.14e-1)" "unprognostic (4.14e-2)" "unprognostic (4.33e-2)" 0.1 0.0 0.0 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 12.9 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 17.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 6.7 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 2.4 1.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.7 426.0 0.0 0.0 0.0 0.0 0.2 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 6.8 0.0 0.0 0.0 2.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 15.8 DCUN1D5 "FLJ32431, MGC2714" ENSG00000137692 "Defective in cullin neddylation 1 domain containing 5" Q9BTE7 11 103050686-103092194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050863 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 6: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoli Nucleoplasm "HPA050863: AB_2681259" "unprognostic (4.47e-2)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (1.47e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (4.62e-4)" "prognostic unfavorable (2.01e-7)" "unprognostic (1.92e-3)" "unprognostic (1.21e-2)" "prognostic favorable (9.52e-5)" "unprognostic (2.08e-2)" "prognostic unfavorable (4.12e-4)" "unprognostic (2.64e-3)" "unprognostic (1.40e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-2)" "unprognostic (1.43e-3)" 15.8 14.6 11.9 4.2 12.7 4.7 13.2 16.6 17.5 11.3 7.9 11.3 1.4 11.1 3.8 21.4 10.3 1.8 23.9 13.3 12.8 14.3 13.7 11.0 5.1 11.8 13.0 9.1 14.2 3.0 13.0 3.3 12.1 11.3 2.2 7.5 12.2 3.0 31.3 11.8 9.4 2.7 13.2 12.3 13.3 18.5 13.5 4.5 9.2 7.7 4.1 11.9 12.1 13.0 18.2 14.5 18.8 16.3 11.6 13.2 10.0 17.9 6.8 9.0 12.7 51.2 24.8 8.0 32.8 13.3 29.0 21.3 24.3 24.0 16.1 9.7 22.4 21.6 16.2 22.3 18.7 33.7 12.4 7.6 23.8 17.7 22.8 18.3 18.1 32.6 26.3 0.1 10.5 21.6 24.4 46.5 24.5 33.6 32.9 9.5 15.1 22.4 15.4 33.9 12.8 11.0 10.0 21.8 21.4 25.1 20.4 22.4 4.0 12.4 14.8 16.6 17.6 7.8 12.5 33.0 7.9 31.4 13.0 12.8 6.6 6.5 8.7 8.5 10.2 11.3 10.8 9.5 9.5 9.3 9.3 10.3 2.5 15.1 7.1 11.1 11.8 9.3 11.9 12.7 16.6 17.5 13.3 12.8 11.8 13.0 12.1 13.2 13.5 13.0 24.9 16.0 11.0 26.8 30.2 79.5 63.2 101.6 38.1 11.7 34.4 36.2 30.7 15.7 42.8 9.2 8.4 57.2 29.3 8.2 49.0 59.5 5.0 26.5 38.2 27.2 14.4 52.1 50.7 55.6 88.6 35.6 21.9 25.3 15.8 37.3 16.1 25.3 44.7 6.7 39.6 17.9 67.1 29.8 32.4 8.4 14.3 22.7 30.2 15.9 26.5 18.9 15.5 25.6 27.5 63.1 12.2 19.5 52.8 92.6 8.6 39.2 28.0 14.1 26.3 31.5 74.6 121.6 119.8 59.0 83.7 43.8 30.9 59.8 23.2 73.0 DYNC2H1 "DHC1b, DHC2, DNCH2, DYH1B, hdhc11" ENSG00000187240 "Dynein cytoplasmic 2 heavy chain 1" Q8NCM8 11 103109410-103479863 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein, Motor protein" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 173.7;Cone photoreceptor cells: 112.6;Endometrial ciliated cells: 124.0;Excitatory neurons: 164.7;Inhibitory neurons: 101.8;Respiratory ciliated cells: 171.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039015, HPA039016" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 30: Epithelial cell lines - Translation" "Cluster 49: Ciliated cells - Cilium organization" Mitochondria "Nucleoplasm, Cytosol" "HPA039015: AB_2676309, HPA039016: AB_10673410" "unprognostic (3.11e-1)" "unprognostic (2.60e-1)" "unprognostic (1.28e-2)" "unprognostic (1.54e-1)" "unprognostic (7.11e-2)" "unprognostic (2.08e-1)" "unprognostic (4.14e-3)" "unprognostic (2.07e-2)" "unprognostic (2.05e-1)" "unprognostic (4.10e-2)" "unprognostic (2.87e-2)" "unprognostic (7.13e-2)" "prognostic favorable (8.49e-5)" "unprognostic (3.75e-3)" "unprognostic (1.62e-1)" "unprognostic (3.88e-2)" "unprognostic (4.11e-3)" 4.2 3.0 5.0 1.2 5.2 0.3 3.5 5.6 10.2 5.1 14.6 3.2 1.6 4.6 3.7 1.6 6.5 3.2 2.0 4.1 6.1 3.7 0.8 2.8 0.9 8.3 8.9 5.6 2.9 6.7 6.8 1.4 6.3 2.6 0.7 10.5 2.6 2.5 0.8 2.8 2.1 2.3 5.5 1.9 2.2 7.9 6.7 1.8 4.6 1.5 0.7 3.3 3.0 5.9 1.3 2.7 7.0 3.3 9.5 21.2 0.4 4.0 6.4 6.5 7.0 1.6 1.5 0.0 5.5 8.0 3.1 5.5 5.5 7.7 5.3 0.0 4.6 1.2 4.8 0.2 9.3 2.2 1.3 13.6 2.8 14.9 16.9 10.3 2.7 1.4 0.2 0.0 8.6 5.4 0.7 0.7 1.9 0.0 7.7 0.0 5.9 0.1 7.5 0.9 4.6 3.6 6.5 1.7 3.1 1.7 6.8 1.5 6.4 7.9 3.3 7.7 3.0 0.0 0.0 0.1 2.3 6.7 2.4 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 5.0 5.2 5.6 10.2 4.1 6.1 8.3 8.9 6.3 5.5 6.7 5.9 12.7 0.0 13.1 173.7 2.3 6.6 13.4 17.3 9.6 25.9 8.2 9.7 10.1 4.3 18.0 27.6 112.6 0.3 2.1 0.2 1.9 7.0 26.1 124.0 43.7 11.1 17.3 1.3 164.7 3.4 0.5 32.0 5.6 7.5 3.8 15.4 9.3 0.8 2.5 32.0 101.8 1.0 4.1 0.8 5.8 11.1 20.8 3.1 8.8 45.0 0.9 16.5 1.0 86.0 72.6 10.5 2.9 18.4 3.3 4.9 0.9 16.9 171.0 85.1 19.7 40.8 18.5 90.6 11.6 5.0 5.5 0.5 5.0 23.5 1.7 5.9 PDGFD "IEGF, MSTP036, SCDGF-B" ENSG00000170962 "Platelet derived growth factor D" Q9GZP0 11 103907189-104164379 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 106.5;ovary: 78.0" "Cell type enhanced" "Detected in many" "Cholangiocytes: 32.9;dendritic cells: 30.0;Ductal cells: 30.6;Fibroblasts: 44.3;Inhibitory neurons: 95.0;Microglial cells: 28.1;NK-cells: 46.4" "Cancer enhanced" "Detected in all" "renal cancer: 17.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "eosinophil: 9.5;gdT-cell: 16.4;memory CD8 T-cell: 7.2;naive CD8 T-cell: 6.0;NK-cell: 17.1" "Group enriched" "Detected in many" 29 "granulocytes: 9.5;NK-cells: 17.1;T-cells: 16.4" "Group enriched" "Detected in many" 6 "ASC diff: 139.8;HHSteC: 42.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 39.4" "HPA046183, HPA066271" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 95000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus, Vesicles" "HPA046183: AB_2679573, HPA066271: AB_2685645" "unprognostic (2.21e-1)" "unprognostic (9.35e-2)" "unprognostic (5.60e-2)" "unprognostic (1.72e-1)" "unprognostic (5.81e-2)" "unprognostic (8.83e-2)" "unprognostic (2.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.66e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (2.26e-1)" "unprognostic (7.01e-3)" "prognostic unfavorable (9.60e-4)" "unprognostic (1.19e-1)" "unprognostic (6.72e-2)" "unprognostic (3.57e-3)" 20.4 106.5 0.5 3.4 0.8 0.9 21.7 0.7 1.3 25.1 9.0 8.8 4.1 11.8 7.1 1.9 9.3 34.0 23.2 0.8 2.2 7.7 2.3 3.1 7.4 5.1 6.6 78.0 25.7 17.1 13.4 7.0 9.4 10.0 9.8 1.5 8.6 37.4 2.2 7.9 4.8 9.7 1.8 2.8 23.4 3.3 2.0 3.7 18.3 8.8 5.4 15.8 15.4 2.3 0.0 7.8 4.0 0.0 139.8 4.2 0.1 0.9 0.8 0.7 0.8 0.0 1.3 7.4 1.4 7.3 5.2 0.4 0.0 0.2 0.3 0.0 3.2 0.2 1.6 0.3 42.6 0.0 0.1 14.7 0.0 0.1 0.0 0.2 8.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.0 1.4 0.0 2.1 0.0 6.7 0.0 0.1 9.6 0.0 13.8 3.2 1.8 0.0 2.0 1.0 0.1 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.8 0.6 0.0 9.5 16.4 0.0 1.4 0.4 1.7 7.2 0.0 0.0 0.2 6.0 0.2 17.1 0.1 0.0 0.1 4.2 0.5 0.8 0.7 1.3 0.8 2.2 5.1 6.6 9.4 1.8 2.0 2.3 15.6 0.0 0.0 1.0 1.6 3.1 7.7 0.2 1.8 2.3 1.7 9.4 4.5 32.9 0.6 5.5 0.0 0.2 30.0 0.2 0.0 30.6 8.2 0.8 1.8 10.3 1.8 1.3 13.9 4.4 0.2 44.3 0.0 1.4 0.0 8.1 2.9 0.0 0.3 26.9 95.0 1.0 0.0 1.3 3.7 13.3 0.3 0.8 0.0 28.1 0.9 1.5 46.4 2.0 2.8 3.0 0.5 2.2 8.4 1.6 0.0 0.3 0.0 0.5 6.6 1.9 3.7 0.4 4.3 0.3 2.0 0.0 10.2 5.2 0.6 3.2 DDI1 FLJ36017 ENSG00000170967 "DNA damage inducible 1 homolog 1" Q8WTU0 11 104036640-104039196 "Predicted intracellular proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 34 "testis: 25.5" "Group enriched" "Detected in some" 74 "Early spermatids: 409.1;Late spermatids: 921.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA079511 Enhanced NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 25: Spermatids - Spermatogenesis" "HPA079511: " "unprognostic (2.98e-1)" "unprognostic (2.14e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 409.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 921.4 7.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.9 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CASP4 "ICE(rel)II, ICH-2, TX" ENSG00000196954 "Caspase 4" P49662 11 104942866-104969366 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity, Necrosis" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA027588, CAB037167" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "Plasma membrane" "CAB037167: AB_258864, HPA027588: AB_10603781" "unprognostic (1.19e-2)" "unprognostic (3.73e-1)" "unprognostic (3.44e-1)" "unprognostic (1.99e-2)" "unprognostic (7.19e-3)" "unprognostic (2.63e-2)" "unprognostic (1.26e-2)" "unprognostic (1.56e-2)" "unprognostic (5.31e-2)" "unprognostic (2.71e-1)" "unprognostic (2.38e-3)" "unprognostic (8.39e-3)" "prognostic unfavorable (3.27e-11)" "unprognostic (6.75e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-2)" "unprognostic (4.08e-3)" 45.7 21.7 7.0 69.4 7.2 48.5 44.4 7.4 12.4 26.4 8.6 27.6 62.4 18.4 33.1 47.7 34.9 50.1 17.8 7.5 8.0 33.3 54.1 61.3 80.2 9.7 8.1 43.2 52.5 4.7 11.0 70.2 8.7 21.7 30.7 2.0 55.2 15.5 7.5 46.7 58.8 32.2 8.3 71.1 42.4 4.9 9.0 57.2 15.6 18.1 82.1 76.5 30.5 8.7 33.8 9.5 0.0 12.9 58.2 140.4 27.8 68.0 103.2 80.5 117.0 22.4 128.5 22.3 123.1 71.5 110.4 52.7 0.0 94.3 78.8 22.4 0.4 53.1 7.4 55.8 158.2 48.5 19.2 122.6 127.0 97.9 144.4 104.7 143.8 0.5 1.3 0.0 64.4 2.8 26.1 46.7 0.0 71.6 28.2 21.4 21.5 14.2 64.9 46.2 0.6 0.4 60.8 31.6 49.3 0.7 11.9 62.5 93.2 84.4 30.4 80.8 40.5 0.0 0.0 0.3 42.2 105.5 63.4 136.4 292.0 50.6 208.9 312.9 224.8 141.9 155.6 193.9 205.5 144.4 93.4 138.5 667.2 226.2 255.4 35.4 257.9 410.9 7.0 7.2 7.4 12.4 7.5 8.0 9.7 8.1 8.7 8.3 9.0 8.7 78.1 60.9 60.8 0.3 87.4 55.8 63.3 130.1 21.1 0.0 40.8 48.4 5.6 47.1 107.0 22.0 0.0 129.1 80.4 12.4 15.6 157.5 0.6 35.9 27.7 73.0 20.9 12.4 0.0 189.9 103.0 53.6 33.1 45.7 34.8 32.6 82.1 34.7 116.7 0.0 0.2 37.8 73.2 168.0 81.2 2.1 29.2 105.2 30.2 23.4 141.5 1.9 177.1 1.5 0.2 148.5 8.6 20.7 50.5 31.1 85.4 41.1 86.1 0.4 6.6 38.1 34.2 0.2 0.5 25.8 45.9 115.9 102.1 36.8 32.9 80.0 CASP5 ICE(rel)III ENSG00000137757 "Caspase 5" P51878 11 104994235-105023168 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 5.0;intestine: 16.8;lymphoid tissue: 14.6" "Cell type enhanced" "Detected in some" "Distal enterocytes: 31.4;Paneth cells: 18.7;Proximal enterocytes: 17.2;Undifferentiated cells: 7.3" "Group enriched" "Detected in some" 7 "colorectal cancer: 3.9;stomach cancer: 1.3" "Region enhanced" "Detected in some" "cerebral cortex: 5.0" "Group enriched" "Detected in some" 13 "intermediate monocyte: 18.1;neutrophil: 13.0;non-classical monocyte: 41.2" "Group enriched" "Detected in many" 15 "granulocytes: 13.0;monocytes: 41.2" "Cell line enriched" "Detected in single" 6 "HHSteC: 3.7" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 9: Intestine - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (4.30e-2)" "unprognostic (8.86e-2)" "unprognostic (1.07e-1)" "unprognostic (4.74e-2)" "unprognostic (1.66e-1)" "unprognostic (5.22e-2)" "unprognostic (9.90e-2)" "unprognostic (8.29e-3)" "unprognostic (1.47e-1)" "unprognostic (4.38e-3)" "unprognostic (7.39e-3)" "unprognostic (3.25e-1)" "unprognostic (1.82e-9)" "unprognostic (7.30e-2)" "unprognostic (2.67e-3)" "unprognostic (1.87e-1)" "unprognostic (1.50e-1)" 0.7 0.1 0.5 14.6 0.6 0.2 0.1 0.5 5.0 0.2 0.6 15.6 10.0 0.1 0.2 0.1 0.2 0.4 0.1 0.5 0.5 0.2 0.2 1.6 0.9 0.7 0.8 0.1 0.0 0.0 0.1 0.9 1.5 0.1 12.9 0.0 0.1 0.1 0.0 0.0 16.8 1.8 0.6 2.7 0.1 0.3 0.8 0.1 0.1 0.4 0.3 2.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.7 0.0 0.0 0.1 0.4 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 18.1 0.1 0.1 0.0 0.0 1.8 0.0 0.0 0.1 13.0 0.0 41.2 0.5 0.0 1.4 0.5 0.6 0.5 5.0 0.5 0.5 0.7 0.8 1.5 0.6 0.8 0.9 0.0 3.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 2.3 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 5.3 0.0 4.7 0.4 0.7 0.0 4.8 0.0 1.9 2.4 0.0 0.0 0.0 0.1 0.1 18.7 0.0 0.0 0.0 17.2 0.0 0.8 0.0 0.0 0.2 0.1 0.5 0.7 0.0 0.0 0.0 0.3 0.0 7.3 0.1 CASP1 "ICE, IL1BC" ENSG00000137752 "Caspase 1" P29466 11 105025443-105035250 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 126.0;lymphoid tissue: 91.0" "Cell type enhanced" "Detected in many" "Kupffer cells: 125.3;Langerhans cells: 120.7;Macrophages: 136.6;monocytes: 185.6;Proximal enterocytes: 116.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 112.7;HBEC3-KT: 53.8;HHSteC: 58.2;U-937: 136.2" "Region enhanced" "Detected in all" "olfactory bulb: 18.4" "Low region specificity" "Detected in all" "CAB002685, HPA003056" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 14: B-cells - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol Nucleoplasm "CAB002685: , HPA003056: AB_1846037" "unprognostic (1.21e-3)" "unprognostic (3.02e-1)" "unprognostic (9.47e-3)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (5.24e-2)" "unprognostic (1.97e-1)" "unprognostic (1.66e-1)" "unprognostic (6.67e-2)" "unprognostic (2.75e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (9.03e-2)" "unprognostic (2.30e-2)" "unprognostic (3.18e-1)" "unprognostic (5.19e-2)" 20.4 10.5 8.7 59.1 8.8 36.3 21.9 9.3 14.6 11.9 9.8 47.7 124.6 8.7 12.0 27.2 12.3 27.4 12.2 8.5 9.6 13.3 21.6 48.3 52.1 11.2 9.4 11.7 6.4 2.7 5.0 30.0 11.1 13.0 49.7 1.1 20.8 12.5 6.2 30.9 126.0 20.8 10.7 91.0 22.5 2.4 10.7 23.2 7.8 7.3 35.5 35.7 19.4 11.9 1.3 0.3 0.0 5.3 5.8 12.1 1.0 5.7 112.7 14.0 38.5 0.2 0.7 18.7 2.3 6.6 25.7 8.1 0.0 53.8 3.3 12.3 0.0 0.9 0.7 1.3 58.2 22.1 0.2 20.9 37.4 11.4 30.3 36.2 6.1 0.3 0.2 0.0 3.4 0.0 0.6 30.7 0.0 0.1 0.3 18.1 0.4 14.9 0.3 8.9 0.4 0.4 16.9 1.1 26.2 0.1 1.2 50.1 7.2 12.8 0.6 1.2 1.6 0.1 5.4 0.1 8.1 136.2 2.7 83.8 246.1 134.9 132.9 359.9 178.5 40.2 92.7 115.8 220.2 35.5 50.2 82.7 220.0 63.0 383.0 7.7 129.0 213.3 8.7 8.8 9.3 14.6 8.5 9.6 11.2 9.4 11.1 10.7 10.7 11.9 26.3 19.2 30.0 0.0 27.2 26.0 42.5 91.5 14.2 0.1 5.8 23.0 2.9 8.6 37.7 11.0 0.0 2.1 34.1 33.1 1.9 23.3 0.2 5.8 2.5 24.0 6.0 10.3 0.2 12.9 1.3 17.8 11.7 3.4 15.8 0.2 22.9 3.1 96.5 0.0 0.0 50.6 14.2 125.3 120.7 1.3 3.4 136.6 5.4 12.2 185.6 0.1 64.9 0.0 0.1 5.3 73.4 3.4 20.0 8.7 116.0 2.2 28.4 0.2 0.0 1.0 8.1 0.0 0.1 17.9 22.3 1.1 58.4 3.3 90.5 43.6 CARD18 "ICEBERG, pseudo-ICE, UNQ5804" ENSG00000255501 "Caspase recruitment domain family member 18" P57730 11 105137714-105531697 "Predicted intracellular proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 41.8" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 3.2;Basal respiratory cells: 1.9;Early spermatids: 8.7;Late spermatids: 8.2;Suprabasal keratinocytes: 2.3" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.0;hTCEpi: 2.5;K-562: 2.9;OE19: 2.3;U-2 OS: 4.8" HPA038582 Approved NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 61: Skin - Cornification" "Cluster 1: K-562 - Erythropoiesis" "Cluster 34: Spermatids - Unknown function" "HPA038582: AB_10960549" "unprognostic (3.90e-1)" "unprognostic (2.95e-1)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" "unprognostic (3.42e-1)" 0.0 0.0 0.0 0.0 0.1 0.1 7.4 0.1 0.4 0.7 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.7 0.4 0.0 0.1 41.8 0.1 0.0 0.0 0.0 0.0 0.9 0.1 1.1 0.0 0.0 0.0 0.0 2.8 0.1 0.1 0.0 0.1 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 4.8 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 3.2 0.0 1.9 0.0 0.0 0.0 0.6 0.4 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 8.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.2 2.3 1.1 0.0 0.0 0.0 0.0 GRIA4 "GluA4, GLUR4, GLURD" ENSG00000152578 "Glutamate ionotropic receptor AMPA type subunit 4" P48058 11 105609994-105982092 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 105.5;retina: 32.1" "Group enriched" "Detected in some" 5 "Excitatory neurons: 799.1;Horizontal cells: 471.1;Inhibitory neurons: 1045.0;Oligodendrocyte precursor cells: 755.5" "Cancer enriched" "Detected in some" 5 "glioma: 5.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.1;NTERA-2: 4.0;RPMI-8226: 2.4;SCLC-21H: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (1.45e-1)" "unprognostic (2.63e-1)" "unprognostic (4.09e-4)" "unprognostic (4.45e-3)" "unprognostic (1.92e-3)" "unprognostic (4.14e-4)" "unprognostic (1.40e-2)" "unprognostic (3.73e-4)" "unprognostic (1.62e-1)" "unprognostic (3.89e-1)" "unprognostic (2.04e-1)" "unprognostic (1.53e-1)" "unprognostic (1.70e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (3.35e-2)" "unprognostic (1.28e-1)" 0.1 5.6 5.3 0.5 20.7 0.0 3.1 105.5 32.2 1.4 0.0 1.5 0.0 0.5 1.6 0.0 1.0 0.2 0.1 27.7 21.4 0.5 0.0 0.0 0.6 30.5 24.2 0.2 0.8 0.0 2.3 0.3 36.7 0.2 0.9 32.1 3.0 0.4 0.1 0.5 3.2 0.0 21.0 0.0 5.7 0.1 18.9 0.0 0.1 0.0 0.4 0.0 0.1 19.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 4.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 20.7 105.5 32.2 27.7 21.4 30.5 24.2 36.7 21.0 18.9 19.0 0.0 0.0 0.0 36.9 0.0 0.1 0.0 0.0 0.0 48.2 0.9 7.4 1.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.8 0.0 2.2 0.4 0.0 0.0 799.1 0.0 0.0 1.2 0.5 0.1 0.0 0.0 0.0 0.0 1.1 471.1 1045.0 3.7 0.0 0.0 0.4 0.2 0.6 0.0 0.0 100.2 0.0 20.4 0.0 755.5 129.9 0.0 0.0 0.0 0.0 0.0 9.1 0.9 0.0 8.9 0.0 1.6 0.2 0.0 0.3 0.0 0.1 0.3 0.1 0.0 5.2 0.0 MSANTD4 KIAA1826 ENSG00000170903 "Myb/SANT DNA binding domain containing 4 with coiled-coils" Q8NCY6 11 105995623-106022403 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 48.3;Muller glia cells: 140.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014411 Approved Approved Nucleoplasm NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 5: Muller glia cells - Visual perception" Nucleoplasm "HPA014411: AB_2668995" "prognostic unfavorable (4.95e-4)" "unprognostic (1.64e-1)" "unprognostic (1.74e-1)" "unprognostic (1.30e-1)" "unprognostic (7.04e-3)" "unprognostic (8.21e-3)" "unprognostic (1.41e-2)" "unprognostic (2.13e-2)" "unprognostic (8.84e-3)" "unprognostic (1.09e-1)" "unprognostic (3.14e-2)" "unprognostic (1.83e-1)" "prognostic favorable (1.26e-5)" "unprognostic (2.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.78e-2)" "unprognostic (2.90e-1)" 8.4 10.1 11.7 8.4 13.4 3.2 8.3 15.5 16.0 11.7 6.6 7.1 5.2 11.6 6.9 8.8 7.4 7.1 15.8 12.4 11.3 9.5 7.0 8.5 9.9 11.9 12.0 10.8 9.6 8.2 9.7 7.3 10.4 9.6 6.2 33.3 7.3 12.0 11.9 4.4 5.8 10.6 9.5 8.5 7.2 10.3 12.7 8.3 13.4 16.6 10.0 8.8 5.6 15.2 8.3 12.0 26.6 0.2 28.4 31.2 0.2 23.1 31.7 17.7 22.5 21.2 15.9 18.1 38.3 19.6 19.5 21.0 30.1 14.8 22.0 33.3 14.5 35.5 14.3 13.2 42.6 28.0 26.9 21.3 17.8 24.0 47.2 22.1 16.0 19.2 16.8 11.4 26.3 3.4 26.4 14.0 10.3 12.3 24.3 17.7 34.4 26.1 24.3 10.2 17.5 33.5 6.1 20.8 16.8 16.4 16.5 14.2 23.0 26.1 20.3 13.8 23.5 11.3 13.9 9.5 12.1 11.0 19.4 2.4 5.7 3.2 8.7 8.7 8.6 6.5 7.8 6.2 7.2 7.5 9.2 8.0 1.4 8.5 5.2 6.1 6.4 5.4 11.7 13.4 15.5 16.0 12.4 11.3 11.9 12.0 10.4 9.5 12.7 15.2 5.8 16.0 15.4 16.6 6.9 5.4 3.3 6.4 6.2 48.3 6.2 6.3 25.1 10.0 14.4 3.7 20.9 1.6 6.2 2.4 1.9 6.7 39.0 6.6 16.8 8.3 8.4 2.5 8.6 5.8 1.3 13.0 5.6 7.2 6.3 11.9 6.1 6.2 5.3 37.0 10.3 3.3 8.2 9.5 5.3 16.0 14.0 6.2 12.4 5.6 8.8 140.7 8.2 31.7 17.3 6.5 1.0 9.8 6.4 2.0 1.8 10.2 9.0 20.1 0.0 15.0 8.2 12.3 6.9 6.1 5.8 0.3 7.4 10.8 3.2 1.5 KBTBD3 BKLHD3 ENSG00000182359 "Kelch repeat and BTB domain containing 3" Q8NAB2 11 106051098-106077459 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 103.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047385 Uncertain NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 25: RPMI-8226 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA047385: AB_2680023" "unprognostic (9.57e-2)" "unprognostic (1.65e-1)" "unprognostic (1.70e-2)" "unprognostic (2.17e-1)" "unprognostic (1.36e-2)" "unprognostic (2.43e-2)" "unprognostic (4.09e-2)" "unprognostic (8.73e-3)" "unprognostic (6.35e-3)" "unprognostic (1.01e-1)" "unprognostic (3.63e-2)" "unprognostic (2.43e-1)" "prognostic favorable (3.42e-7)" "unprognostic (2.36e-1)" "unprognostic (1.40e-1)" "unprognostic (1.54e-3)" "unprognostic (1.55e-2)" 2.4 2.5 4.3 1.7 5.4 1.2 2.9 9.7 6.9 2.7 2.3 2.6 1.9 2.5 4.4 1.9 2.4 1.1 3.4 4.3 5.5 4.2 2.8 2.3 1.7 5.9 4.7 3.6 3.8 2.8 3.9 1.0 6.7 2.4 1.7 10.3 3.9 2.9 3.5 2.2 2.3 1.9 5.8 2.0 2.4 3.7 5.9 2.1 3.9 3.1 1.9 2.4 2.4 9.3 1.9 1.3 2.6 3.1 3.3 3.4 0.6 1.6 2.0 1.4 0.9 1.1 3.6 1.0 4.2 0.5 1.9 1.2 1.3 1.3 1.0 2.0 0.5 2.7 0.8 1.0 1.5 1.1 2.4 1.3 3.9 1.2 1.2 2.9 1.9 1.8 1.0 2.6 1.3 0.3 2.6 2.7 1.1 2.2 1.7 1.2 1.6 4.7 4.9 0.4 2.1 2.6 2.4 2.4 2.0 1.9 3.0 1.5 1.6 0.7 1.1 0.6 0.6 0.9 0.6 2.4 1.4 2.4 1.2 30.8 5.6 18.5 12.1 3.2 11.0 13.2 13.7 12.6 7.5 10.9 12.9 11.6 3.6 15.0 3.4 4.5 15.5 7.2 4.3 5.4 9.7 6.9 4.3 5.5 5.9 4.7 6.7 5.8 5.9 9.3 13.0 9.6 12.8 11.1 10.8 6.2 16.5 38.6 12.5 17.6 13.3 16.0 28.5 18.6 18.9 12.9 20.9 10.8 9.3 8.8 37.2 14.4 103.5 11.5 5.3 12.7 6.0 5.7 23.5 29.5 8.8 14.3 6.1 14.3 16.5 6.9 15.7 19.2 9.7 16.8 22.6 15.0 40.7 6.3 10.4 22.8 11.8 6.4 19.6 10.3 14.5 21.4 18.6 23.1 44.3 13.4 14.1 17.0 5.6 6.2 19.0 34.3 17.8 19.3 13.1 10.9 10.2 21.5 4.6 5.2 9.8 2.6 15.4 10.3 13.5 10.1 AASDHPPT "AASD-PPT, ACPS, CGI-80, LYS5" ENSG00000149313 "Aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase" Q9NRN7 11 106075501-106098699 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Early spermatids: 388.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026687 Approved NA NA "Cluster 42: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 29: Early spermatids - Spermatogenesis" "HPA026687: AB_1844414" "unprognostic (1.96e-2)" "unprognostic (4.40e-1)" "unprognostic (8.71e-3)" "unprognostic (2.12e-1)" "unprognostic (1.11e-1)" "unprognostic (9.04e-3)" "unprognostic (2.82e-3)" "unprognostic (1.41e-1)" "unprognostic (2.44e-2)" "unprognostic (7.92e-2)" "unprognostic (2.09e-1)" "unprognostic (1.32e-1)" "prognostic favorable (4.27e-4)" "unprognostic (2.13e-1)" "unprognostic (2.15e-1)" "unprognostic (1.19e-1)" "unprognostic (1.43e-1)" 16.9 23.5 28.7 18.4 30.7 15.8 21.2 28.1 47.9 17.6 20.9 13.6 13.6 20.3 25.8 21.1 20.6 13.4 27.7 32.1 32.5 34.1 33.6 15.4 22.6 27.5 26.6 20.9 33.3 20.1 11.4 27.9 27.5 18.9 14.0 32.3 24.5 17.1 32.8 17.1 11.9 18.3 29.9 17.3 13.5 37.5 28.2 21.3 22.1 32.4 23.9 18.4 11.6 32.6 29.6 28.2 84.7 63.5 41.4 54.6 34.3 43.1 36.7 58.7 45.0 61.2 53.3 91.4 98.2 28.2 57.2 37.8 77.0 57.6 59.0 55.8 39.3 84.6 19.5 45.0 64.3 73.5 35.2 53.8 72.8 47.0 63.8 40.5 49.6 39.8 95.2 22.2 57.6 16.7 79.8 63.6 36.9 40.2 39.4 55.7 81.3 103.7 70.4 32.5 63.0 58.3 47.5 45.8 43.6 49.1 60.2 50.0 41.9 49.7 47.6 35.3 45.6 30.7 53.7 90.0 22.4 100.0 57.9 63.2 21.6 23.9 20.6 27.9 29.2 26.7 23.9 22.7 21.8 20.8 27.4 26.4 6.9 31.9 28.1 19.2 30.6 18.2 28.7 30.7 28.1 47.9 32.1 32.5 27.5 26.6 27.5 29.9 28.2 32.6 32.4 32.1 31.7 18.3 33.8 20.0 28.2 39.4 56.3 35.0 23.4 31.9 24.1 34.3 29.8 18.4 2.1 78.4 27.7 7.3 39.2 33.5 388.5 31.6 42.2 23.9 18.6 47.9 36.0 24.3 63.8 33.9 23.4 29.4 29.8 41.9 17.2 36.5 39.0 21.9 34.8 12.6 30.5 24.9 13.0 70.2 32.3 27.9 32.0 15.0 29.9 67.4 19.6 32.6 43.4 22.6 10.2 26.7 45.1 23.5 11.1 81.4 47.6 20.0 13.1 30.8 38.2 47.8 37.5 46.2 24.4 39.4 33.1 62.9 13.5 19.6 GUCY1A2 "GC-SA2, GUC1A2" ENSG00000152402 "Guanylate cyclase 1 soluble subunit alpha 2" P33402 11 106674019-107018476 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "cGMP biosynthesis" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.4;placenta: 17.9" "Group enriched" "Detected in many" 4 "Excitatory neurons: 353.8;Inhibitory neurons: 141.8;Oligodendrocyte precursor cells: 208.6;Sertoli cells: 105.2;Smooth muscle cells: 107.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 11.8;BJ hTERT+ SV40 Large T+ RasG12V: 13.4;HBF TERT88: 7.1;TIME: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009534 Uncertain NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "CAB009534: AB_2279509" "unprognostic (7.53e-2)" "unprognostic (6.67e-2)" "unprognostic (7.99e-2)" "unprognostic (1.10e-1)" "unprognostic (1.08e-1)" "unprognostic (1.22e-2)" "unprognostic (1.23e-2)" "unprognostic (1.24e-1)" "unprognostic (6.53e-3)" "unprognostic (9.70e-3)" "unprognostic (8.00e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.02e-5)" "unprognostic (2.48e-4)" "unprognostic (1.62e-1)" "unprognostic (3.50e-2)" "unprognostic (1.09e-2)" 3.4 2.0 5.3 0.6 18.4 0.0 1.9 1.6 13.8 12.7 0.0 0.7 0.2 12.3 3.1 0.4 5.9 1.5 2.7 7.1 3.9 1.8 1.7 4.6 0.7 4.7 2.6 1.2 4.3 0.6 0.5 17.9 4.9 1.8 0.5 3.5 0.6 6.8 1.8 0.6 0.4 13.1 0.4 6.0 0.3 1.7 8.6 0.2 1.4 3.6 0.3 0.9 2.8 7.4 0.0 0.2 4.0 0.0 0.2 2.4 2.2 0.3 11.8 1.5 13.4 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.1 0.0 7.1 0.0 1.1 0.0 0.1 0.0 0.2 0.0 1.6 0.6 0.0 1.8 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.4 3.6 0.0 0.7 0.5 0.8 0.2 4.6 3.7 3.0 0.8 1.2 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 18.4 1.6 13.8 7.1 3.9 4.7 2.6 4.9 0.4 8.6 7.4 29.5 0.0 0.5 20.2 0.5 1.7 2.2 0.0 1.2 24.0 0.4 0.9 5.1 0.0 0.0 3.7 12.5 0.1 0.0 0.1 0.0 5.8 2.5 0.9 24.2 12.5 0.0 2.7 353.8 0.2 0.0 8.2 0.0 1.1 0.0 42.7 2.2 0.2 0.4 18.5 141.8 0.0 0.0 0.8 1.5 6.5 24.5 1.1 3.6 18.7 0.0 29.3 0.0 208.6 10.7 0.3 0.0 25.2 1.2 2.4 0.0 0.1 0.0 4.8 105.2 20.7 107.0 1.6 1.5 0.7 1.1 0.3 0.5 19.6 0.0 1.5 CWF19L2 FLJ32343 ENSG00000152404 "CWF19 like cell cycle control factor 2" Q2TBE0 11 107326345-107457844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038166 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Cytosol "HPA038166: AB_10669518" "unprognostic (1.38e-1)" "unprognostic (9.41e-2)" "unprognostic (1.37e-1)" "unprognostic (7.35e-2)" "unprognostic (7.17e-2)" "unprognostic (6.42e-2)" "unprognostic (8.78e-2)" "unprognostic (1.63e-1)" "unprognostic (4.19e-2)" "unprognostic (1.46e-1)" "unprognostic (1.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.40e-2)" "unprognostic (4.48e-2)" "unprognostic (1.26e-1)" "unprognostic (4.74e-2)" "unprognostic (1.76e-2)" 8.8 5.8 15.4 6.2 16.6 8.2 11.3 20.3 30.9 8.8 16.8 7.3 5.0 10.9 8.2 6.4 7.5 6.0 5.4 14.7 16.7 11.2 8.5 7.1 10.4 16.1 15.9 14.2 5.9 7.8 4.7 8.4 16.2 8.3 6.2 8.6 6.2 8.5 7.0 7.3 5.5 6.9 15.8 9.8 6.7 5.9 16.1 11.8 9.7 8.4 11.0 6.9 6.7 17.7 7.4 5.9 12.5 6.0 10.2 11.5 9.4 9.5 8.8 7.3 9.7 13.9 17.0 12.8 17.7 6.7 9.3 17.6 14.0 7.3 12.7 14.4 7.8 14.2 6.6 9.1 6.6 16.9 11.5 5.9 12.6 8.5 12.7 8.4 10.0 7.6 21.9 7.2 10.7 5.5 13.1 15.3 11.9 12.2 8.3 11.3 11.9 17.3 8.6 9.0 7.2 6.0 13.9 10.3 5.4 10.5 13.8 8.0 9.1 12.1 9.7 6.4 8.6 3.8 7.5 12.3 3.5 16.4 11.3 45.6 10.1 19.3 14.2 9.3 15.7 29.4 16.5 14.4 4.5 27.6 19.9 15.3 19.4 17.4 10.4 19.2 15.7 4.3 15.4 16.6 20.3 30.9 14.7 16.7 16.1 15.9 16.2 15.8 16.1 17.7 56.2 38.5 53.2 38.5 66.1 17.8 16.1 19.1 18.2 97.2 24.2 21.0 28.9 57.2 33.2 82.8 95.9 24.0 57.9 18.3 33.2 22.1 3.1 31.8 39.8 40.8 13.1 23.8 42.3 18.4 22.8 29.3 17.3 34.0 46.2 35.2 51.4 56.1 15.8 69.0 37.4 27.0 14.2 33.7 15.4 9.5 54.3 24.5 14.2 43.1 32.7 47.5 69.0 42.3 68.1 16.3 31.6 63.9 36.1 6.7 25.6 60.5 18.3 131.8 39.5 41.1 30.8 48.0 47.2 9.1 13.4 17.0 55.3 21.4 21.3 7.8 ALKBH8 "MGC10235, TRM9, TRMT9A" ENSG00000137760 "AlkB homolog 8, tRNA methyltransferase" Q96BT7 11 107502727-107565742 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Multifunctional enzyme, RNA-binding, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 25.2;Inhibitory neurons: 27.4;Oligodendrocyte precursor cells: 23.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038724, HPA038725, HPA061514" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 16: Immune cells - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear bodies" Nucleoplasm "HPA038724: AB_2676176, HPA038725: AB_10674838, HPA061514: AB_2684547" "unprognostic (2.66e-2)" "unprognostic (3.82e-1)" "unprognostic (8.19e-2)" "unprognostic (3.76e-1)" "unprognostic (4.04e-2)" "unprognostic (2.97e-1)" "unprognostic (1.22e-2)" "unprognostic (1.95e-1)" "unprognostic (4.45e-2)" "unprognostic (7.67e-2)" "unprognostic (1.89e-2)" "unprognostic (7.95e-2)" "unprognostic (2.81e-1)" "unprognostic (2.03e-1)" "unprognostic (2.04e-1)" "unprognostic (2.34e-3)" "unprognostic (1.01e-1)" 3.1 2.9 2.4 4.0 3.0 3.3 5.0 2.6 2.8 2.9 1.7 3.0 3.2 3.8 3.2 3.1 2.9 2.8 3.8 2.4 2.6 3.9 4.5 3.6 6.0 2.2 2.6 4.4 2.3 4.1 1.7 3.3 2.5 3.5 3.6 3.3 2.9 3.3 5.1 4.6 2.6 3.6 2.2 4.6 3.3 2.8 2.3 4.6 5.2 4.7 5.9 3.5 2.8 2.3 5.4 6.5 6.6 7.2 3.6 7.9 5.4 10.2 7.5 7.4 8.0 12.1 9.7 12.6 5.8 10.0 10.2 9.6 9.9 8.5 9.6 11.4 6.6 10.6 2.5 5.6 5.3 13.7 12.6 4.9 9.2 9.5 12.0 3.8 9.3 9.9 15.2 4.1 5.9 4.9 12.4 6.8 8.7 10.5 10.6 11.1 10.2 8.7 5.9 5.8 6.0 6.7 5.9 4.4 4.5 4.0 7.2 4.1 8.8 16.1 9.6 5.3 12.9 3.8 4.3 9.7 4.5 9.0 16.1 0.0 1.1 0.3 2.2 2.1 2.1 0.9 1.6 1.9 1.7 1.9 3.0 2.6 0.0 2.8 1.5 1.0 1.8 1.1 2.4 3.0 2.6 2.8 2.4 2.6 2.2 2.6 2.5 2.2 2.3 2.3 4.4 0.0 5.3 4.6 8.5 2.0 1.7 1.5 7.4 5.7 3.2 3.0 11.2 5.7 3.5 1.8 6.2 2.3 3.0 1.3 0.0 1.9 0.4 2.4 4.6 4.2 1.2 4.6 25.2 3.3 2.7 4.3 7.7 2.3 10.1 5.1 2.9 6.6 2.8 1.7 27.4 2.8 2.0 3.8 2.2 0.2 2.8 4.1 3.6 14.0 4.7 3.0 3.1 23.1 14.3 2.7 5.2 4.1 3.8 1.3 1.3 3.6 0.8 3.8 0.0 4.0 3.0 1.8 3.2 6.9 4.1 0.8 6.6 5.2 3.5 0.6 ELMOD1 DKFZp547C176 ENSG00000110675 "ELMO domain containing 1" Q8N336 11 107591091-107666779 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 32.8;pituitary gland: 21.7;retina: 32.6;skin 1: 28.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 33.5;Excitatory neurons: 126.1;Horizontal cells: 37.0;Inhibitory neurons: 103.9;Oligodendrocyte precursor cells: 80.9" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 14.9;RH-30: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038435, HPA066479" Uncertain Nucleoplasm,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Cytosol "HPA038435: AB_10795575, HPA066479: " "unprognostic (2.74e-1)" "unprognostic (1.72e-4)" "unprognostic (2.58e-2)" "unprognostic (9.13e-2)" "unprognostic (3.93e-2)" "unprognostic (2.12e-2)" "unprognostic (1.34e-1)" "unprognostic (6.59e-3)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (6.29e-2)" "unprognostic (9.44e-2)" "unprognostic (1.34e-4)" "unprognostic (1.91e-2)" "unprognostic (3.15e-1)" "unprognostic (4.21e-2)" "unprognostic (1.39e-1)" 0.4 2.6 17.2 0.3 27.1 0.1 2.4 13.2 32.8 0.5 0.0 0.5 0.2 0.4 0.1 0.1 2.1 0.1 4.8 24.6 23.5 3.1 0.3 0.4 0.1 15.1 24.8 0.1 0.1 0.9 21.7 0.0 11.8 0.8 0.2 32.6 0.1 0.1 2.6 28.9 0.2 0.3 14.3 0.1 0.1 1.6 18.8 0.4 0.1 1.8 0.0 0.0 0.1 10.7 0.0 0.0 5.6 0.1 0.0 0.1 0.2 0.2 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.2 4.4 0.5 2.8 0.4 0.5 0.0 2.3 0.1 0.0 0.1 1.5 0.1 0.0 0.5 0.1 0.0 0.0 0.1 14.9 1.9 0.0 0.1 1.1 0.1 0.0 0.1 0.6 0.0 2.2 0.1 33.9 0.0 0.0 0.0 0.3 1.7 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.4 1.6 0.0 0.9 0.2 0.0 0.0 4.5 0.0 2.7 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.0 17.2 27.1 13.2 32.8 24.6 23.5 15.1 24.8 11.8 14.3 18.8 10.7 0.0 0.0 3.9 24.2 0.2 0.0 0.4 0.1 0.0 33.5 0.0 0.1 12.8 0.0 1.3 0.0 16.7 0.1 0.0 0.0 0.0 0.0 11.4 2.2 1.0 1.6 0.0 0.0 126.1 0.0 0.1 0.5 0.0 0.2 0.0 0.1 0.4 1.1 0.1 37.0 103.9 0.0 0.0 0.3 2.2 13.6 0.3 0.4 0.0 7.5 0.0 10.0 0.0 80.9 5.9 0.0 0.0 0.4 0.0 0.3 0.0 4.2 4.8 18.3 0.0 0.7 0.8 5.0 1.5 0.0 3.1 0.0 0.2 0.0 0.0 0.2 SLN "MGC12301, MGC125854, MGC125855" ENSG00000170290 Sarcolipin O00631 11 107707378-107719693 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "skeletal muscle: 8190.2;tongue: 3399.6" "Group enriched" "Detected in some" 11 "Cardiomyocytes: 730.3;Muller glia cells: 462.5;Skeletal myocytes: 225.1" "Group enriched" "Detected in many" 5 "glioma: 21.6;head and neck cancer: 22.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;HSkMC: 2.5;Karpas-707: 1.2;PC-3: 1.1;SuSa: 2.5;U-2 OS: 1.1" CAB011628 Approved Microtubules NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 37: Myocytes - Muscle contraction" Microtubules "CAB011628: AB_2195046" "unprognostic (6.85e-2)" "unprognostic (6.18e-8)" "unprognostic (2.60e-1)" "unprognostic (3.66e-2)" "unprognostic (2.40e-3)" "unprognostic (4.12e-3)" "unprognostic (5.28e-3)" "unprognostic (1.31e-2)" "unprognostic (2.76e-1)" "unprognostic (6.35e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (3.52e-9)" "unprognostic (3.27e-2)" "unprognostic (2.54e-1)" "unprognostic (5.09e-4)" "unprognostic (3.77e-2)" 5.1 8.3 2.8 0.0 3.4 0.0 2.1 3.9 7.8 0.2 1.3 4.7 0.3 0.2 0.8 149.2 0.7 0.3 975.1 2.4 1.4 2.6 0.7 6.4 0.2 1.5 2.3 0.6 1.8 0.2 0.7 1.3 2.3 37.0 0.1 60.7 59.4 0.3 8190.2 4.4 1.5 1.4 1.3 0.3 0.8 1.3 1.4 2.7 2.0 3399.6 0.9 0.4 1.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 3.4 3.9 7.8 2.4 1.4 1.5 2.3 2.3 1.3 1.4 2.0 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.0 0.0 2.4 0.0 0.0 730.3 0.0 0.0 0.0 2.1 1.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 10.5 0.0 0.0 0.3 0.4 1.9 42.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.3 0.0 0.0 0.0 0.0 1.1 8.8 0.0 1.0 0.0 0.0 0.0 462.5 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.2 0.0 0.4 0.0 19.9 0.0 225.1 40.5 0.1 0.0 0.0 1.4 5.7 1.0 0.0 0.0 0.1 SLC35F2 FLJ13018 ENSG00000110660 "Solute carrier family 35 member F2" Q8IXU6 11 107790991-107928293 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 37.4" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 46.0;Basal prostatic cells: 34.5;Suprabasal keratinocytes: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 188.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA048185, HPA060150" Enhanced Approved "Golgi apparatus" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 37: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA048185: AB_2680304, HPA060150: " "unprognostic (7.73e-2)" "unprognostic (3.28e-3)" "unprognostic (8.37e-3)" "unprognostic (5.77e-2)" "unprognostic (1.38e-3)" "unprognostic (3.07e-2)" "unprognostic (7.26e-2)" "prognostic unfavorable (4.03e-4)" "unprognostic (6.22e-2)" "unprognostic (8.20e-2)" "prognostic unfavorable (5.92e-6)" "unprognostic (1.24e-1)" "unprognostic (4.10e-2)" "unprognostic (1.34e-1)" "unprognostic (7.33e-2)" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" 4.1 1.2 3.3 7.2 3.9 5.1 5.5 2.3 3.6 16.3 3.2 17.9 19.0 6.3 11.6 12.2 13.5 5.1 3.5 3.8 4.2 10.0 0.5 5.7 7.9 3.5 3.4 5.0 5.4 6.0 3.4 3.2 3.3 22.3 20.4 12.7 37.4 6.1 1.1 20.5 17.8 4.6 4.3 4.0 7.0 4.5 3.5 5.5 7.2 1.5 13.9 7.9 9.5 3.6 30.8 19.8 2.3 30.1 15.2 22.6 29.0 6.8 3.9 17.3 22.7 84.2 31.4 51.2 67.7 20.1 94.1 63.1 37.3 60.5 34.2 40.3 34.8 28.5 18.1 34.1 24.8 65.0 14.2 15.7 36.9 58.3 123.1 53.2 91.7 38.3 74.0 20.7 13.0 17.0 28.3 69.7 20.5 67.5 188.4 57.7 23.9 68.9 100.1 26.7 46.6 20.1 21.9 54.8 14.8 24.7 38.1 15.2 68.0 33.4 53.9 0.8 73.5 54.6 62.5 53.9 21.4 22.0 22.4 0.3 0.2 0.0 3.1 0.1 8.2 10.6 5.3 5.4 6.9 6.5 1.9 2.7 0.6 3.7 0.0 0.3 13.5 1.8 3.3 3.9 2.3 3.6 3.8 4.2 3.5 3.4 3.3 4.3 3.5 3.6 2.7 9.6 1.5 2.0 10.3 46.0 34.5 6.4 14.8 1.1 3.7 2.3 0.6 7.2 9.6 3.7 12.5 0.9 2.5 21.5 3.9 9.5 0.3 13.6 2.8 13.7 6.0 1.7 3.9 8.2 19.1 8.3 6.1 22.9 2.5 5.0 0.7 0.0 4.8 0.0 4.4 10.1 4.1 0.3 15.0 1.0 0.9 3.6 23.2 6.5 3.7 1.2 1.0 4.0 0.4 25.9 10.0 2.6 23.6 20.6 15.1 6.4 0.1 8.0 6.6 2.8 3.1 0.3 7.5 8.6 50.3 4.5 5.7 4.9 24.7 16.6 RAB39A RAB39 ENSG00000179331 "RAB39A, member RAS oncogene family" Q14964 11 107928448-107963482 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.9;lymphoid tissue: 3.0" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 4.2;Excitatory neurons: 5.2;Inhibitory neurons: 8.8;Microglial cells: 20.6;Spermatocytes: 6.4" "Cancer enhanced" "Detected in some" "testis cancer: 1.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 11.6;NTERA-2: 8.6;RPMI-8226: 15.5;SCLC-21H: 27.8;SH-SY5Y: 17.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042505 Uncertain NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA042505: AB_2678030" "unprognostic (1.45e-1)" "unprognostic (1.48e-2)" "unprognostic (1.83e-1)" "unprognostic (3.40e-2)" "unprognostic (4.99e-1)" "unprognostic (4.30e-2)" "unprognostic (4.26e-3)" "unprognostic (1.20e-1)" "unprognostic (5.55e-2)" "unprognostic (7.36e-2)" "unprognostic (4.22e-3)" "unprognostic (2.24e-2)" "unprognostic (1.41e-3)" "unprognostic (1.11e-1)" "unprognostic (1.36e-1)" "unprognostic (5.02e-2)" "unprognostic (2.43e-1)" 0.7 0.9 1.7 2.9 1.4 0.6 0.3 3.1 3.2 0.2 0.2 0.5 0.5 0.2 0.0 0.3 0.2 0.8 0.2 3.2 3.9 0.6 0.6 0.9 2.1 3.1 2.6 0.2 0.3 0.2 0.4 1.2 3.5 0.2 0.8 1.1 0.2 0.1 0.0 0.3 0.7 0.7 2.6 3.0 0.6 0.8 2.2 2.6 0.3 0.1 1.4 0.9 0.0 2.3 0.0 1.8 7.3 0.1 0.0 0.0 0.9 0.1 0.0 0.8 0.6 0.0 0.0 0.4 0.1 0.0 11.6 0.0 7.4 0.0 0.1 0.0 0.9 0.1 0.1 0.0 0.0 0.5 6.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 8.6 0.0 0.2 0.0 4.0 15.5 0.1 0.0 27.8 17.1 0.0 0.0 0.4 1.6 0.4 3.0 0.0 0.1 1.9 0.0 1.3 0.1 4.3 0.0 0.4 1.7 4.1 0.1 1.4 0.0 0.0 2.2 0.0 0.8 0.0 0.0 1.0 0.5 0.0 0.0 0.1 0.0 1.6 0.1 0.0 0.4 1.7 1.4 3.1 3.2 3.2 3.9 3.1 2.6 3.5 2.6 2.2 2.3 0.0 0.0 1.1 0.7 0.8 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.1 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 1.8 0.0 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 8.8 0.0 0.0 4.1 3.7 0.8 0.0 4.1 0.0 20.6 1.8 0.0 0.0 4.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.1 6.4 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CUL5 VACM-1 ENSG00000166266 "Cullin 5" Q93034 11 108008898-108107761 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002185, CAB017787" Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 59: Non-specific - Translation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus, Cytosol" "CAB017787: , HPA002185: AB_1078587" "unprognostic (5.66e-2)" "unprognostic (6.58e-2)" "unprognostic (7.16e-3)" "unprognostic (1.30e-1)" "unprognostic (5.54e-2)" "unprognostic (1.62e-1)" "unprognostic (2.32e-2)" "unprognostic (2.80e-1)" "unprognostic (5.97e-3)" "unprognostic (1.78e-1)" "unprognostic (9.17e-2)" "unprognostic (1.77e-2)" "prognostic favorable (1.06e-5)" "unprognostic (3.83e-2)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (1.10e-1)" 9.8 11.5 6.8 9.5 7.0 28.3 13.0 10.9 9.1 11.8 7.3 9.1 9.0 13.1 9.9 10.6 9.6 8.5 15.2 6.8 8.0 16.3 14.2 8.8 11.2 6.4 6.8 12.4 8.9 13.4 5.7 11.4 6.5 12.1 9.1 12.7 8.5 9.5 46.4 11.4 8.6 10.5 7.4 9.8 9.4 6.5 6.8 12.7 14.4 37.5 10.3 10.0 7.0 10.3 14.4 6.6 19.6 15.1 12.5 20.2 9.7 15.0 16.3 13.4 15.0 21.3 16.5 20.1 27.3 18.8 14.0 18.0 18.4 12.3 19.4 13.2 11.1 18.9 6.2 15.7 21.1 21.8 14.9 15.8 16.1 14.1 18.6 17.5 18.7 16.2 25.0 7.2 21.4 7.9 20.9 18.1 10.3 18.4 11.6 15.0 14.6 21.8 16.4 21.2 13.9 19.6 20.4 21.1 12.3 12.0 31.1 17.0 19.7 24.6 11.4 17.6 16.2 7.2 6.2 26.5 9.6 24.0 16.0 1.2 2.3 1.6 2.1 2.1 2.0 1.7 2.1 1.9 2.3 2.2 2.3 2.3 0.4 1.6 2.2 2.5 1.7 1.3 6.8 7.0 10.9 9.1 6.8 8.0 6.4 6.8 6.5 7.4 6.8 10.3 50.2 57.7 42.5 66.3 49.0 29.8 29.3 26.0 44.3 52.7 35.1 25.7 111.9 37.1 39.2 31.3 66.7 37.6 49.2 21.8 50.9 29.6 6.0 45.4 48.7 41.3 17.6 34.3 84.9 23.5 23.6 42.6 33.1 40.9 43.1 42.8 40.0 54.8 27.1 55.5 83.8 28.7 22.4 41.6 20.3 8.0 30.7 41.2 14.2 61.8 51.7 31.5 30.9 74.4 101.7 29.1 29.0 38.0 48.4 36.6 27.9 76.7 36.6 59.4 19.7 56.0 53.1 35.5 44.0 43.9 30.3 35.8 38.8 48.0 30.3 32.9 ACAT1 "ACAT, THIL" ENSG00000075239 "Acetyl-CoA acetyltransferase 1" P24752 11 108116695-108147603 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 622.7;liver: 969.5" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 508.4;Distal tubular cells: 698.5;Hepatocytes: 663.4;Proximal tubular cells: 1484.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 420.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004428, HPA007569" Enhanced Enhanced Mitochondria NA NA 1400000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 8: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "HPA004428: AB_1078088, HPA007569: AB_1844482" "unprognostic (3.70e-3)" "unprognostic (2.23e-2)" "unprognostic (7.84e-3)" "unprognostic (4.65e-2)" "unprognostic (3.05e-2)" "unprognostic (1.12e-1)" "prognostic favorable (1.43e-5)" "unprognostic (3.59e-3)" "unprognostic (1.26e-1)" "unprognostic (5.20e-2)" "unprognostic (2.64e-2)" "unprognostic (1.13e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.96e-1)" "unprognostic (1.68e-1)" "unprognostic (8.06e-2)" "unprognostic (6.62e-3)" 135.4 151.3 45.2 24.3 45.3 38.4 56.9 47.1 60.1 41.0 91.8 96.3 103.9 44.0 34.1 45.0 39.1 25.6 289.4 42.7 46.8 622.7 969.5 43.7 28.2 44.8 45.2 64.7 110.6 95.9 30.9 24.7 45.2 45.6 85.6 26.2 104.1 60.2 461.1 45.3 53.2 57.1 46.7 29.3 81.9 66.3 45.6 19.1 65.5 410.8 29.7 44.1 34.6 47.7 76.9 57.7 48.2 139.3 155.9 138.7 25.1 71.7 78.8 77.7 91.7 168.1 77.3 41.3 116.8 83.6 119.7 78.1 142.3 70.3 83.3 84.9 114.6 117.4 64.6 163.9 107.6 112.9 64.9 124.6 77.1 69.2 127.4 91.5 85.0 92.3 172.1 61.8 128.6 45.8 57.4 122.4 48.2 103.1 135.0 88.1 96.9 420.4 114.7 50.4 75.7 88.1 111.6 152.7 83.0 37.0 132.2 97.6 87.4 83.2 44.5 73.5 88.8 18.9 57.8 77.7 37.6 233.1 59.6 1.4 17.1 4.7 25.3 25.5 29.9 29.2 28.8 30.0 33.5 13.8 25.5 22.4 1.8 13.4 27.8 11.3 35.7 23.4 45.2 45.3 47.1 60.1 42.7 46.8 44.8 45.2 45.2 46.7 45.6 47.7 50.5 54.5 91.8 17.9 37.2 43.1 52.2 48.9 23.9 30.1 34.6 29.6 508.4 78.6 33.5 104.8 27.1 39.9 29.2 125.0 698.5 43.1 345.7 62.2 42.1 62.5 30.0 74.7 35.1 60.5 41.5 57.1 29.0 25.7 27.8 48.6 99.2 663.4 97.9 38.7 37.8 38.5 97.6 73.6 27.8 65.3 66.5 39.1 58.7 30.0 50.1 39.1 25.7 22.6 26.5 33.8 93.8 82.4 52.7 27.8 51.4 1484.0 101.8 28.8 65.7 54.2 69.2 172.7 27.2 39.2 48.4 25.2 38.1 61.6 84.5 24.4 NPAT "E14, p220" ENSG00000149308 "Nuclear protein, coactivator of histone transcription" Q14207 11 108157215-108222638 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045908, HPA066370" Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "HPA045908: AB_2679493, HPA066370: AB_2685665" "unprognostic (6.93e-2)" "unprognostic (5.81e-2)" "unprognostic (1.09e-2)" "unprognostic (3.82e-2)" "unprognostic (5.37e-2)" "unprognostic (2.60e-2)" "unprognostic (4.89e-2)" "unprognostic (7.38e-2)" "unprognostic (5.03e-3)" "unprognostic (1.26e-1)" "unprognostic (7.04e-2)" "unprognostic (4.14e-2)" "unprognostic (2.76e-3)" "unprognostic (1.97e-1)" "unprognostic (1.86e-1)" "unprognostic (5.76e-2)" "unprognostic (1.93e-1)" 4.6 4.2 1.6 8.1 2.1 4.5 6.9 7.4 2.8 6.4 3.9 5.4 4.1 6.7 5.9 4.6 4.6 4.7 4.3 1.4 2.4 5.6 5.6 5.4 14.9 2.6 3.0 7.6 3.1 6.8 3.2 6.6 2.4 5.6 6.2 6.6 4.4 4.4 3.1 5.2 4.9 5.1 2.2 9.9 5.9 7.0 2.3 12.0 8.3 5.3 13.3 7.0 3.8 3.0 7.9 6.3 9.7 12.1 11.7 8.5 7.9 11.6 14.6 10.0 14.9 13.0 16.8 13.5 15.2 7.3 11.2 14.6 13.4 11.7 17.8 12.2 5.3 22.5 6.8 6.7 5.0 17.0 14.3 8.1 6.7 17.6 11.2 7.8 14.3 15.5 21.2 6.5 14.1 3.9 21.0 9.1 8.0 12.6 8.7 14.3 13.6 18.5 6.4 11.3 10.3 9.5 14.9 8.8 11.3 10.1 10.0 8.3 11.8 17.3 9.3 10.3 10.5 4.5 6.1 51.9 4.3 12.4 13.7 6.8 1.6 2.9 4.9 2.6 5.5 4.1 5.7 6.3 1.8 4.3 8.9 7.5 1.9 5.3 2.9 1.5 4.6 3.2 1.6 2.1 7.4 2.8 1.4 2.4 2.6 3.0 2.4 2.2 2.3 3.0 23.1 19.2 13.2 24.2 40.8 16.3 16.4 10.5 27.3 16.5 12.0 7.6 15.2 4.3 13.2 12.9 29.2 10.3 32.8 5.6 1.9 8.4 4.9 11.1 15.0 21.1 10.3 29.5 25.5 6.8 8.2 15.9 12.2 14.2 19.6 16.7 22.9 9.1 7.4 10.1 32.2 7.9 8.2 13.0 12.8 3.2 15.8 13.8 8.8 19.7 14.5 11.8 27.8 19.6 24.3 6.8 6.5 17.0 37.8 14.1 7.1 5.6 10.9 16.9 6.6 19.8 13.1 26.2 32.5 14.0 13.2 14.1 35.3 14.9 8.7 15.9 ATM "ATA, ATC, ATD, ATDC, TEL1, TELO1" ENSG00000149311 "ATM serine/threonine kinase" Q13315 11 108222832-108369102 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Neurodegeneration, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 210.6;NK-cells: 339.8;Oligodendrocytes: 217.6;Rod photoreceptor cells: 200.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 78.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000102, HPA067142" Supported Supported Nucleoplasm,Vesicles NA NA "Cluster 44: Non-specific - Transcription" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm Vesicles "CAB000102: , HPA067142: AB_2685789" "unprognostic (9.77e-2)" "unprognostic (1.47e-1)" "unprognostic (3.04e-1)" "unprognostic (2.36e-1)" "unprognostic (5.70e-2)" "unprognostic (2.86e-2)" "unprognostic (6.32e-3)" "unprognostic (1.05e-1)" "unprognostic (8.19e-2)" "unprognostic (1.63e-1)" "unprognostic (7.68e-2)" "unprognostic (6.16e-2)" "unprognostic (2.17e-3)" "unprognostic (3.10e-1)" "unprognostic (7.87e-2)" "unprognostic (1.21e-1)" "unprognostic (2.81e-1)" 6.2 7.4 8.2 17.5 15.0 16.2 8.5 17.0 12.3 8.7 16.1 6.7 5.2 10.0 9.9 4.0 7.5 8.2 7.0 7.3 11.3 5.8 7.8 7.6 33.7 15.8 13.1 15.8 14.8 9.3 12.1 8.0 17.0 6.3 7.0 20.6 11.4 6.1 4.4 7.5 12.6 6.9 10.3 22.2 8.6 5.2 12.7 18.2 8.8 6.0 25.9 7.1 6.9 28.8 4.3 6.8 14.8 7.6 20.2 29.1 3.1 10.9 13.5 6.4 11.3 7.1 10.3 18.3 14.0 10.2 9.6 7.7 11.6 10.8 9.0 12.3 5.7 15.2 8.7 10.2 10.5 16.4 17.0 18.3 6.3 10.0 21.2 15.2 14.1 16.5 12.4 9.9 14.3 3.4 10.6 18.5 9.8 8.6 7.4 9.7 9.7 24.9 8.1 7.5 9.0 10.5 11.1 4.7 20.6 13.2 9.3 10.1 23.7 15.8 8.4 7.3 9.0 6.2 7.0 78.3 7.0 19.0 18.8 21.3 5.5 4.0 16.5 5.7 11.1 11.6 11.7 12.5 2.6 13.0 21.1 20.4 9.9 9.7 13.3 6.2 6.1 5.3 8.2 15.0 17.0 12.3 7.3 11.3 15.8 13.1 17.0 10.3 12.7 28.8 23.7 38.5 20.8 62.7 146.4 12.6 17.5 21.1 28.5 111.0 19.6 14.2 39.9 12.8 19.5 22.0 210.6 16.9 140.2 4.2 5.9 9.9 19.2 14.4 52.1 25.9 20.4 39.1 70.2 12.3 13.2 39.0 12.8 20.9 13.3 45.9 32.9 23.3 29.1 60.6 82.8 14.9 26.4 96.4 34.0 5.1 39.4 69.2 26.6 178.9 63.2 27.3 339.8 85.5 217.6 7.6 7.6 27.8 96.5 9.1 8.9 11.1 16.0 200.1 26.3 41.4 29.2 31.5 37.4 15.8 12.4 4.2 147.7 52.3 11.5 10.2 C11orf65 "MFI, MGC33948" ENSG00000166323 "Chromosome 11 open reading frame 65" Q8NCR3 11 108308519-108467531 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 50.9" "Group enriched" "Detected in many" 4 "Early spermatids: 689.1;Spermatocytes: 192.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 78: Testis - Spermatogenesis" "Cluster 6: T47d - Mammary gland" "Cluster 29: Early spermatids - Spermatogenesis" "unprognostic (8.05e-2)" "unprognostic (4.89e-2)" "unprognostic (1.62e-1)" "unprognostic (2.11e-2)" "unprognostic (4.15e-2)" "unprognostic (3.79e-2)" "unprognostic (2.07e-1)" "unprognostic (5.78e-2)" "unprognostic (3.54e-5)" "unprognostic (2.72e-1)" "unprognostic (2.48e-1)" "unprognostic (1.02e-1)" "unprognostic (1.04e-2)" "unprognostic (1.25e-1)" "unprognostic (1.84e-1)" "unprognostic (8.87e-2)" "unprognostic (2.50e-2)" 0.5 1.0 0.8 0.7 1.7 0.3 0.6 1.2 1.2 0.4 0.6 0.3 0.1 0.3 2.5 0.3 1.5 0.8 0.7 0.7 1.2 2.1 2.6 0.3 0.7 1.4 1.3 0.4 0.9 0.9 0.5 0.4 1.6 0.6 0.4 2.9 0.5 0.5 0.5 0.7 0.3 0.1 1.4 0.6 0.4 50.9 1.2 0.8 1.7 0.2 0.4 0.4 0.2 2.5 0.6 0.2 0.5 0.7 0.8 1.5 1.3 0.5 0.2 0.1 0.1 0.9 2.0 0.6 1.8 0.5 0.7 1.0 1.3 1.0 0.5 0.7 0.5 0.9 0.3 0.1 0.6 0.9 0.1 1.6 0.6 0.3 2.2 0.5 0.5 2.7 1.6 0.8 1.1 1.0 0.9 0.6 0.3 1.5 0.7 0.7 0.6 0.9 0.9 0.7 1.8 0.3 0.8 0.3 0.8 0.4 3.5 0.1 0.8 0.7 0.8 0.3 0.1 1.2 0.6 2.5 0.6 0.8 0.7 0.4 0.0 0.0 0.1 0.3 0.5 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.4 0.3 0.1 0.8 1.7 1.2 1.2 0.7 1.2 1.4 1.3 1.6 1.4 1.2 2.5 1.0 0.0 1.1 23.2 2.2 0.4 1.8 1.3 1.8 16.9 1.4 1.3 1.3 0.0 1.8 3.7 31.3 1.6 0.4 0.3 3.9 2.0 689.1 10.7 1.6 1.1 1.2 0.0 3.4 2.0 0.9 1.3 1.1 1.5 2.5 1.1 0.7 2.2 0.7 6.7 4.9 0.6 2.0 0.0 0.3 97.2 5.3 0.6 3.6 11.2 0.2 5.9 1.0 17.6 25.1 1.1 0.1 4.1 0.9 0.3 0.6 5.2 6.1 43.2 6.6 2.4 0.9 192.1 33.5 1.1 0.1 1.0 1.6 2.5 0.5 1.0 POGLUT3 "KDELC2, MGC33424" ENSG00000178202 "Protein O-glucosyltransferase 3" Q7Z4H8 11 108472112-108498384 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 6.8;Cardiomyocytes: 13.1;Cytotrophoblasts: 27.6;Extravillous trophoblasts: 14.5;Fibroblasts: 14.7;Hofbauer cells: 18.0;Syncytiotrophoblasts: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039315, HPA039817, HPA066134" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 32: U-937 - Innate immune response" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm Vesicles "HPA039315: AB_10960861, HPA039817: AB_10966564, HPA066134: AB_2685624" "unprognostic (1.29e-1)" "unprognostic (2.80e-1)" "unprognostic (3.62e-1)" "unprognostic (7.65e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (6.04e-2)" "unprognostic (3.49e-3)" "unprognostic (1.49e-1)" "unprognostic (6.00e-3)" "unprognostic (4.08e-3)" "unprognostic (1.66e-3)" "unprognostic (1.85e-2)" "unprognostic (1.31e-1)" "unprognostic (1.90e-1)" "prognostic unfavorable (6.27e-5)" 24.6 13.2 5.0 17.3 5.0 7.6 16.2 4.6 5.4 33.6 7.0 16.8 9.4 35.0 27.3 21.0 23.0 21.7 15.2 4.2 5.9 15.6 13.2 16.0 10.4 5.5 6.1 36.5 8.3 25.2 5.4 32.7 5.4 28.4 16.9 5.8 13.9 28.4 5.5 13.7 11.2 37.1 5.3 12.4 11.3 5.8 5.5 16.4 12.1 13.9 9.5 22.5 18.8 6.0 10.9 12.4 46.5 47.8 76.5 88.5 44.8 47.0 43.7 66.0 71.1 58.9 78.1 0.1 28.6 61.6 73.1 7.9 35.6 1.2 69.3 19.4 27.4 18.1 12.1 27.2 30.8 47.7 0.2 51.1 14.6 35.0 1.0 40.1 56.6 0.3 41.5 0.3 101.0 7.9 30.9 27.2 20.3 11.5 34.8 1.5 72.5 0.2 12.3 30.3 9.7 29.5 89.1 6.2 13.3 21.4 42.3 18.0 56.8 127.0 24.9 10.8 49.7 0.4 0.1 0.3 32.6 48.9 103.1 0.1 0.1 0.0 2.0 0.7 1.7 0.2 1.0 1.7 0.5 0.3 1.0 1.5 0.1 1.9 0.4 1.0 0.9 0.5 5.0 5.0 4.6 5.4 4.2 5.9 5.5 6.1 5.4 5.3 5.5 6.0 6.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 27.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 14.5 14.7 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 21.2 0.5 0.0 0.0 0.0 EXPH5 SLAC2-B ENSG00000110723 "Exophilin 5" Q8NEV8 11 108505435-108593768 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Epidermolysis bullosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.7;skin 1: 25.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 147.4;Basal keratinocytes: 107.7;Glandular and luminal cells: 89.5;Respiratory ciliated cells: 98.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 15 "cerebellum: 67.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 7.9;hTERT-HME1: 11.2;RT4: 20.5;SK-BR-3: 9.7" "Group enriched" "Detected in many" 4 "cerebellum: 20.9;cerebral cortex: 6.7" "Region enriched" "Detected in many" 8 "cerebellum: 30.9" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 15: RT4 - Unknown function" "Cluster 44: Endometrium - Transcription" "unprognostic (1.34e-3)" "unprognostic (8.36e-2)" "unprognostic (1.18e-1)" "prognostic favorable (3.42e-6)" "unprognostic (2.91e-1)" "prognostic favorable (1.46e-4)" "unprognostic (4.57e-3)" "prognostic favorable (5.12e-4)" "unprognostic (1.26e-1)" "unprognostic (3.03e-1)" "unprognostic (5.56e-3)" "unprognostic (1.33e-1)" "prognostic favorable (2.43e-4)" "unprognostic (1.18e-2)" "unprognostic (2.57e-1)" "unprognostic (3.36e-1)" "unprognostic (4.51e-1)" 0.4 0.1 1.3 0.5 2.5 0.2 2.9 67.7 2.3 2.2 12.8 3.9 0.7 0.7 2.7 7.4 1.7 0.3 0.2 2.1 1.9 2.4 7.7 3.9 0.1 1.5 3.6 0.3 1.0 4.7 0.5 2.8 4.6 1.5 4.4 0.3 4.4 0.3 0.1 25.8 0.8 0.4 1.1 0.2 3.2 0.7 1.7 0.8 1.0 0.2 1.4 0.7 3.8 3.4 3.9 0.4 0.2 0.1 0.0 0.1 3.2 0.2 0.1 0.0 0.6 1.0 5.9 0.0 0.2 0.2 0.9 7.9 5.7 2.1 0.2 0.1 1.7 1.6 0.8 0.0 0.5 0.8 0.1 0.1 3.3 0.0 11.2 0.5 0.0 1.3 3.0 0.0 3.1 0.6 1.0 0.0 0.2 6.4 2.4 0.0 0.1 0.0 0.6 20.5 1.4 0.8 1.0 9.7 0.2 1.1 6.4 0.1 0.1 0.0 2.3 0.0 1.1 0.1 0.0 0.0 0.1 0.4 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.1 0.1 0.1 0.5 0.5 0.8 0.9 0.1 0.2 0.0 0.1 1.3 2.5 67.7 2.3 2.1 1.9 1.5 3.6 4.6 1.1 1.7 3.4 0.6 147.4 60.0 18.6 0.9 107.7 12.9 16.6 58.6 0.6 14.1 8.6 5.7 4.3 65.3 20.2 14.6 44.5 2.4 47.9 3.9 5.4 10.3 74.8 7.8 2.5 4.9 3.2 9.0 4.9 4.9 5.6 20.9 89.5 1.3 0.9 0.7 24.2 3.8 0.0 4.9 38.6 14.2 0.6 15.2 2.3 0.6 1.8 5.4 16.9 1.3 0.5 1.0 3.0 0.6 3.6 17.5 0.0 1.5 30.4 1.9 3.7 98.5 1.4 0.0 0.3 2.1 1.1 0.5 46.9 72.2 54.6 2.8 0.4 29.1 19.3 DDX10 "Dbp4, HRH-J8" ENSG00000178105 "DEAD-box helicase 10" Q13206 11 108665069-108940927 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 133.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 162.3" "Low region specificity" "Detected in all" HPA004691 Approved Approved Nucleoli NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoli "HPA004691: AB_1078629" "unprognostic (9.49e-2)" "unprognostic (9.32e-2)" "unprognostic (1.34e-1)" "unprognostic (2.58e-1)" "unprognostic (7.97e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (2.52e-5)" "unprognostic (2.86e-2)" "unprognostic (1.23e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (1.00e-1)" "prognostic favorable (2.14e-5)" "unprognostic (5.20e-2)" "unprognostic (1.98e-1)" "unprognostic (4.64e-1)" "unprognostic (2.43e-3)" 7.3 6.8 3.7 6.8 3.9 6.3 9.2 4.2 5.1 7.9 1.6 6.6 5.0 10.4 7.3 7.3 8.5 5.0 6.1 4.4 3.0 11.7 7.0 5.3 8.5 2.2 3.3 10.6 7.5 7.6 4.5 7.8 2.8 7.0 7.7 11.1 6.2 6.8 7.1 7.6 4.7 9.9 2.0 7.2 5.8 15.8 3.7 8.4 7.8 4.7 8.8 10.3 6.9 4.0 21.3 20.7 19.3 27.0 18.5 15.0 20.0 22.6 12.2 26.7 26.3 59.3 30.6 71.8 41.3 17.3 28.7 23.5 55.4 27.3 37.8 27.8 25.0 48.5 11.6 22.3 33.0 49.9 22.4 13.5 21.0 30.4 37.6 15.9 24.6 18.4 70.0 7.8 26.7 14.0 42.7 42.5 24.8 40.0 31.0 35.9 31.3 67.9 16.3 18.2 35.2 18.4 31.7 27.4 12.3 25.4 33.4 17.7 26.0 27.8 28.3 26.8 30.9 11.7 22.0 162.3 9.5 59.7 28.7 1.6 4.4 1.2 7.8 6.7 10.8 10.5 7.0 9.6 8.5 12.0 7.4 7.2 0.4 10.1 6.8 8.0 6.3 4.4 3.7 3.9 4.2 5.1 4.4 3.0 2.2 3.3 2.8 2.0 3.7 4.0 20.2 16.0 28.8 29.0 23.7 28.4 24.5 11.0 28.5 21.1 14.9 11.9 20.5 12.8 17.6 3.7 95.9 24.3 19.8 9.7 19.6 18.7 47.2 16.9 31.4 24.3 15.0 11.6 84.7 21.3 21.3 26.3 15.3 23.3 14.5 28.1 10.4 11.0 14.7 18.5 75.9 9.7 6.1 8.8 12.0 10.9 29.5 15.4 7.2 51.5 20.6 8.9 27.8 67.3 59.5 17.2 5.7 21.4 13.2 24.8 3.7 133.3 13.1 25.1 13.1 32.6 20.3 63.0 45.8 19.3 29.0 25.9 17.7 26.6 15.6 14.8 C11orf87 "LOC399947, LOH11CR1A, NEURIM1" ENSG00000185742 "Chromosome 11 open reading frame 87" Q6NUJ2 11 109422190-109429167 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 15.3" "Group enriched" "Detected in some" 6 "Excitatory neurons: 52.4;Horizontal cells: 20.2;Inhibitory neurons: 33.3" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Region enhanced" "Detected in many" "cerebral cortex: 15.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 2.9;fHDF/TERT166: 11.7;SCLC-21H: 2.9" "Low region specificity" "Detected in all" HPA034656 Approved NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA034656: AB_10600788" "unprognostic (5.42e-2)" "unprognostic (2.09e-1)" "unprognostic (2.28e-1)" "unprognostic (8.55e-2)" "unprognostic (3.87e-2)" "unprognostic (1.85e-1)" "unprognostic (1.63e-1)" "unprognostic (1.55e-2)" "unprognostic (1.62e-1)" "unprognostic (2.44e-2)" "unprognostic (2.45e-1)" "unprognostic (5.28e-5)" "unprognostic (8.38e-2)" "unprognostic (9.65e-2)" "unprognostic (2.72e-6)" 0.0 0.1 2.2 0.0 3.2 0.0 0.0 0.0 15.3 0.9 0.0 0.0 0.0 0.9 0.3 0.0 0.2 0.0 0.0 6.5 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.9 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.4 0.0 0.1 0.1 2.9 1.4 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.2 0.0 15.3 6.5 0.1 0.0 1.1 0.0 1.5 9.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 52.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 20.2 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 4.5 5.1 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RDX DFNB24 ENSG00000137710 Radixin P35241 11 109864295-110296712 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin capping, Actin-binding" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 155.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 484.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000263, HPA000763, CAB037312" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 38000000 "Cluster 2: Granulocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "Plasma membrane" Nucleoplasm "CAB037312: AB_261933, HPA000263: AB_1856043, HPA000763: AB_1856042" "unprognostic (2.23e-3)" "unprognostic (2.56e-2)" "unprognostic (3.85e-1)" "unprognostic (2.74e-2)" "unprognostic (6.93e-2)" "unprognostic (9.82e-2)" "unprognostic (2.01e-2)" "unprognostic (1.44e-2)" "unprognostic (3.91e-2)" "unprognostic (6.91e-2)" "unprognostic (1.32e-3)" "unprognostic (6.47e-2)" "unprognostic (4.14e-3)" "unprognostic (5.43e-2)" "unprognostic (4.40e-1)" "unprognostic (1.24e-1)" "unprognostic (1.08e-3)" 40.3 155.0 38.0 17.4 57.7 12.0 16.4 50.0 42.7 32.1 32.8 15.2 6.8 28.8 12.9 27.4 19.7 27.2 41.0 35.1 44.7 50.2 68.5 48.8 11.4 52.7 48.2 52.8 52.7 33.2 7.6 35.3 54.3 25.4 11.1 19.2 20.8 26.0 82.1 11.9 7.4 35.0 45.1 26.6 15.0 33.7 47.7 14.3 45.7 59.7 14.6 27.1 10.1 77.6 69.6 35.3 137.3 54.8 78.8 87.4 79.3 85.8 47.6 54.3 59.2 99.7 115.4 0.1 127.4 104.7 84.9 61.5 77.3 80.4 80.5 41.9 44.2 51.5 107.7 74.1 73.6 19.0 33.2 89.7 45.6 68.0 120.1 89.3 149.8 11.1 73.5 29.5 127.0 120.0 11.0 15.6 44.0 4.0 58.4 31.2 96.8 30.1 68.1 33.5 37.2 40.5 148.5 65.9 52.7 102.5 85.0 29.9 92.6 89.5 66.8 43.9 67.4 9.5 17.3 65.9 34.2 11.3 210.9 29.5 14.8 22.0 11.6 12.5 15.5 11.5 10.2 8.8 12.8 8.3 6.8 5.8 2.0 17.6 9.9 10.3 22.0 8.4 38.0 57.7 50.0 42.7 35.1 44.7 52.7 48.2 54.3 45.1 47.7 77.6 248.8 484.0 98.8 53.5 30.0 56.1 51.8 124.6 56.9 85.9 47.4 45.7 159.3 70.1 77.9 75.4 43.8 122.1 21.6 17.7 109.5 128.1 15.5 109.1 117.2 289.2 22.2 104.8 27.1 423.4 189.8 88.4 19.9 135.3 67.2 132.0 319.2 260.1 85.1 101.0 57.6 7.3 61.1 103.2 59.9 43.6 275.2 71.6 72.9 42.2 135.4 77.0 36.0 68.3 229.4 134.3 22.1 266.7 36.1 65.9 0.1 236.9 52.2 94.8 124.9 74.0 143.8 73.9 257.4 52.8 40.5 227.3 29.2 229.9 11.8 45.9 ZC3H12C "KIAA1726, MCPIP3" ENSG00000149289 "Zinc finger CCCH-type containing 12C" Q9C0D7 11 110093392-110171841 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 102.2;Oligodendrocyte precursor cells: 52.3;Oligodendrocytes: 56.1;Suprabasal keratinocytes: 66.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 36 "basophil: 5.9" "Lineage enriched" "Detected in single" 36 "granulocytes: 5.9" "Cell line enhanced" "Detected in many" "HSkMC: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038836, HPA038837" Approved Approved "Nuclear membrane,Golgi apparatus" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 64: Astrocytes - Nervous system maintenance" "Nuclear membrane, Golgi apparatus" "HPA038836: AB_2676229, HPA038837: AB_10675953" "unprognostic (1.22e-1)" "unprognostic (2.08e-1)" "unprognostic (2.13e-3)" "unprognostic (6.96e-3)" "unprognostic (2.41e-1)" "unprognostic (1.09e-1)" "unprognostic (6.77e-2)" "unprognostic (8.91e-3)" "unprognostic (1.30e-2)" "unprognostic (3.20e-1)" "unprognostic (2.34e-2)" "unprognostic (8.90e-2)" "prognostic favorable (9.90e-6)" "unprognostic (4.42e-3)" "unprognostic (2.32e-1)" "unprognostic (8.03e-2)" "unprognostic (1.11e-1)" 4.6 4.2 4.0 2.4 6.7 3.2 2.5 6.5 3.9 4.0 2.7 4.6 1.7 3.7 1.7 3.2 3.2 4.7 4.4 4.2 4.9 3.4 4.0 4.0 1.5 6.8 5.6 6.7 3.5 4.7 3.2 2.6 5.5 3.5 3.7 4.1 2.3 3.3 10.5 5.9 2.6 4.4 4.1 1.8 2.4 3.4 5.4 1.5 8.1 13.2 1.4 5.4 2.1 6.5 6.1 3.6 14.0 0.0 6.4 14.8 2.7 2.3 15.7 4.1 6.8 4.6 5.6 0.1 8.7 7.1 10.3 5.8 2.8 8.5 8.1 23.2 2.0 9.7 4.5 1.7 7.2 0.0 4.4 23.8 8.0 7.2 11.7 8.1 5.8 0.0 0.9 1.3 8.6 0.9 0.0 0.0 2.2 0.1 12.7 0.0 4.9 0.6 4.6 12.4 6.4 11.5 5.6 0.4 10.5 2.7 3.5 3.6 9.8 9.1 4.4 4.8 5.2 0.5 0.0 0.0 5.5 1.7 10.8 5.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 6.7 6.5 3.9 4.2 4.9 6.8 5.6 5.5 4.1 5.4 6.5 21.1 35.3 8.6 102.2 1.1 47.4 4.8 19.1 7.4 8.8 3.5 5.0 15.5 2.8 9.1 5.5 4.2 1.5 0.2 17.0 0.0 6.1 10.6 8.6 6.7 14.9 8.9 2.1 23.8 3.5 0.5 8.9 5.6 14.1 0.0 5.2 13.6 6.4 10.9 15.2 50.0 8.1 0.0 5.7 39.3 11.8 9.6 9.9 23.2 26.2 3.9 5.6 0.0 52.3 56.1 3.4 15.2 8.2 0.6 21.0 5.7 6.6 8.9 2.7 0.0 9.1 5.7 4.6 0.8 3.2 66.5 0.8 1.1 5.6 8.0 7.8 FDX1 "ADX, FDX" ENSG00000137714 "Ferredoxin 1" P10109 11 110429948-110464884 "Predicted intracellular proteins" "Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Steroidogenesis, Sterol metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "adrenal gland: 313.7" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 1139.6;Theca cells: 745.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 71.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041630, HPA062087" Enhanced Enhanced Mitochondria NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Mitochondria "HPA041630: AB_10793970, HPA062087: AB_2630366" "unprognostic (1.66e-1)" "unprognostic (1.68e-2)" "unprognostic (5.29e-3)" "unprognostic (4.67e-2)" "unprognostic (2.39e-1)" "unprognostic (4.32e-3)" "unprognostic (1.23e-2)" "unprognostic (2.07e-1)" "unprognostic (2.19e-2)" "unprognostic (4.12e-1)" "unprognostic (3.10e-2)" "unprognostic (5.48e-2)" "prognostic favorable (3.58e-7)" "prognostic favorable (2.53e-4)" "unprognostic (1.10e-1)" "unprognostic (1.94e-1)" "unprognostic (2.80e-1)" 9.0 313.7 6.9 6.8 7.5 12.1 8.5 7.5 8.6 7.4 8.7 12.9 22.0 6.2 8.2 9.3 5.9 9.1 16.3 6.8 7.6 29.6 44.3 10.8 7.9 7.3 7.8 5.4 13.4 9.3 6.1 17.7 7.6 8.2 10.7 5.3 8.6 26.3 20.6 6.2 18.4 6.1 7.5 6.7 13.5 7.6 7.9 12.0 20.3 18.5 7.5 10.5 5.5 8.8 10.2 7.0 10.6 11.6 10.1 17.8 23.5 9.2 11.2 8.0 13.5 24.1 16.7 23.8 26.4 11.9 14.2 11.8 12.4 13.9 10.8 22.9 15.8 12.0 12.0 14.8 17.7 12.7 18.8 31.3 11.4 7.3 17.1 13.8 16.5 16.2 12.2 34.4 17.3 11.3 18.2 28.3 9.5 19.3 13.1 26.4 10.1 22.1 17.4 18.1 14.4 7.4 17.5 19.7 12.5 12.3 11.7 8.7 9.8 8.0 9.8 9.8 9.9 7.7 6.4 71.7 6.0 25.5 10.5 1.8 4.5 2.8 3.8 3.3 4.1 9.7 5.2 5.4 5.2 7.5 6.2 4.4 0.5 3.4 4.6 4.0 7.4 2.6 6.9 7.5 7.5 8.6 6.8 7.6 7.3 7.8 7.6 7.5 7.9 8.8 53.2 19.2 38.1 15.0 68.6 68.3 104.3 45.4 42.7 33.0 40.3 37.0 57.1 102.9 28.3 80.9 8.4 174.3 65.7 109.5 244.6 71.4 53.4 49.6 35.6 36.7 47.9 28.8 22.6 144.8 169.4 48.1 61.2 42.0 45.7 36.3 45.0 192.7 113.3 42.1 25.8 56.2 34.6 58.4 68.3 11.0 46.9 77.3 69.4 15.0 57.3 42.3 50.4 22.1 19.6 78.5 76.5 45.5 102.7 114.2 183.9 338.7 18.6 17.3 26.3 50.6 43.6 48.0 67.0 75.3 97.5 1139.6 74.0 745.1 96.4 149.6 ARHGAP20 KIAA1391 ENSG00000137727 "Rho GTPase activating protein 20" Q9P2F6 11 110577042-110713189 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 78.0;Excitatory neurons: 97.9;Inhibitory neurons: 159.9;Leydig cells: 48.7;Oligodendrocyte precursor cells: 90.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 24.6;ASC TERT1: 8.2;HHSteC: 5.5;SiHa: 7.2;U-2197: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038458, HPA038459, HPA076303" Uncertain Approved Mitochondria NA NA "Cluster 71: Testis - DNA repair" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Mitochondria "HPA038458: AB_10672517, HPA038459: AB_2676022, HPA076303: AB_2686792" "unprognostic (1.69e-2)" "unprognostic (3.97e-2)" "unprognostic (6.83e-2)" "unprognostic (1.34e-1)" "unprognostic (2.66e-1)" "unprognostic (8.47e-3)" "unprognostic (2.75e-1)" "unprognostic (2.90e-2)" "unprognostic (4.15e-2)" "unprognostic (5.70e-2)" "unprognostic (1.38e-1)" "unprognostic (9.52e-2)" "unprognostic (2.82e-5)" "unprognostic (1.84e-2)" "unprognostic (9.15e-2)" "unprognostic (6.21e-3)" "unprognostic (4.10e-2)" 8.9 2.3 3.8 1.3 4.1 0.0 4.5 1.8 3.5 4.4 0.3 1.9 0.8 4.4 3.6 2.2 3.1 2.2 0.4 3.5 2.5 0.3 1.7 4.1 1.2 0.5 0.7 1.2 0.2 0.8 0.9 1.7 0.5 3.9 2.8 1.1 1.3 8.8 0.9 1.0 1.5 3.3 1.2 1.3 1.8 8.3 2.0 0.4 4.8 1.3 0.8 3.2 2.2 0.8 0.0 0.0 0.0 0.0 24.6 8.2 0.0 1.1 3.3 0.4 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.3 0.0 5.5 0.0 0.0 3.0 0.0 0.0 0.0 0.1 2.4 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.1 0.3 7.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 4.4 0.0 0.1 0.0 2.1 0.9 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 4.1 1.8 3.5 3.5 2.5 0.5 0.7 0.5 1.2 2.0 0.8 1.7 0.0 2.3 5.2 1.7 0.8 4.9 1.1 10.2 9.9 0.5 6.0 0.9 1.5 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 13.1 1.7 78.0 4.3 0.0 0.0 97.9 0.4 0.1 15.1 0.0 1.2 1.3 1.1 9.7 2.0 0.2 3.3 159.9 0.2 0.0 0.8 1.6 4.6 48.7 2.1 3.6 22.5 0.0 0.7 0.0 90.0 3.2 0.7 0.0 36.5 1.2 1.9 0.0 0.0 0.0 1.4 0.0 2.3 4.6 11.8 11.7 1.6 0.4 0.7 0.5 3.6 0.0 0.8 C11orf53 MGC50104 ENSG00000150750 "Chromosome 11 open reading frame 53" Q8IXP5 11 111245726-111286401 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "stomach 1: 3.4;testis: 5.5" "Cell type enhanced" "Detected in some" "Cholangiocytes: 14.3;Early spermatids: 38.1;Exocrine glandular cells: 56.6;Late spermatids: 12.4;Respiratory ciliated cells: 9.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "OE19: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA056128, HPA073101" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm Vesicles "HPA056128: AB_2683046, HPA073101: " "unprognostic (3.51e-2)" "unprognostic (3.60e-2)" "unprognostic (4.84e-2)" "unprognostic (5.84e-2)" "unprognostic (1.94e-1)" "unprognostic (8.07e-3)" "unprognostic (5.60e-3)" "unprognostic (3.09e-1)" "unprognostic (2.50e-1)" "unprognostic (9.95e-2)" "unprognostic (8.66e-2)" "unprognostic (3.52e-2)" 0.9 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.1 0.0 1.4 0.9 0.9 0.0 0.0 0.9 1.4 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.5 0.6 1.3 0.4 0.7 0.0 0.3 1.0 0.0 2.1 0.0 1.8 0.0 1.2 0.0 0.0 0.0 3.4 5.5 0.0 0.4 0.0 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 4.6 0.0 0.0 0.0 0.1 0.1 14.3 3.3 0.0 0.0 0.0 0.1 1.5 0.0 1.9 38.1 0.0 1.4 0.0 7.7 0.0 0.1 56.6 0.1 1.9 3.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 3.0 8.2 0.0 0.0 12.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.4 0.2 0.3 4.0 0.0 9.9 0.0 0.0 0.1 0.6 1.0 1.1 0.0 0.0 0.0 0.0 0.0 1.7 4.4 COLCA2 "C11orf93, CASC13" ENSG00000214290 "Colorectal cancer associated 2" A8K830 11 111298555-111308735 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 25.9;Cholangiocytes: 24.3;Early spermatids: 73.2;Ionocytes: 38.7;Late spermatids: 67.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 11.7;OE19: 41.4;RT4: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 34: Spermatids - Unknown function" "unprognostic (2.73e-3)" "unprognostic (5.15e-2)" "unprognostic (6.97e-3)" "unprognostic (1.30e-3)" "unprognostic (1.15e-1)" "unprognostic (9.04e-2)" "unprognostic (1.13e-3)" "unprognostic (3.28e-2)" "unprognostic (6.03e-3)" "unprognostic (3.54e-2)" "unprognostic (3.34e-2)" "unprognostic (1.90e-1)" "prognostic favorable (8.97e-6)" "unprognostic (6.77e-3)" "unprognostic (1.22e-1)" "unprognostic (1.05e-2)" "unprognostic (2.46e-1)" 3.6 2.9 9.2 1.9 10.0 0.1 4.5 9.1 11.1 6.0 8.7 10.4 10.8 8.6 27.2 8.4 19.5 9.9 1.8 9.4 8.7 14.8 2.6 4.2 4.7 9.1 10.9 12.3 8.4 19.0 2.9 2.6 8.8 9.7 11.1 0.2 17.8 15.9 2.1 1.7 8.5 6.5 8.4 0.7 20.1 11.2 9.8 3.3 10.4 3.0 4.7 10.6 7.9 8.9 0.0 3.2 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 3.1 1.9 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 11.7 0.1 0.0 0.0 0.2 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.6 41.4 0.0 0.7 0.0 0.0 0.0 10.6 1.9 0.5 0.4 4.2 0.0 1.0 5.6 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 10.0 9.1 11.1 9.4 8.7 9.1 10.9 8.8 8.4 9.8 8.9 0.3 0.0 0.5 13.1 1.6 0.4 9.7 25.9 0.6 0.0 0.1 3.9 0.6 24.3 14.8 7.3 0.0 0.0 0.1 3.6 11.7 7.6 73.2 7.9 7.0 0.2 1.8 0.0 2.3 16.7 0.0 5.3 7.7 1.4 1.3 0.9 0.0 0.9 0.0 0.0 2.7 13.1 38.7 0.0 0.7 67.5 8.4 0.4 1.8 1.9 0.0 0.0 0.0 0.5 0.2 5.6 3.3 5.7 1.0 2.1 5.6 3.5 23.5 0.0 0.0 0.9 2.0 1.1 1.4 4.1 0.1 0.0 0.2 0.3 5.7 5.6 POU2AF1 "BOB1, OBF1" ENSG00000110777 "POU class 2 homeobox associating factor 1" Q16633 11 111352255-111455630 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 38.6;lymphoid tissue: 119.4;stomach 1: 40.1" "Cell type enriched" "Detected in many" 4 "Plasma cells: 566.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 33.5;naive B-cell: 24.0" "Lineage enriched" "Detected in many" 9 "B-cells: 33.5" "Group enriched" "Detected in many" 4 "Daudi: 307.2;Karpas-707: 339.3;U-266/70: 326.6;U-266/84: 159.9;U-698: 610.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB011193 Enhanced NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "CAB011193: AB_532299" "prognostic favorable (1.68e-4)" "prognostic favorable (1.63e-4)" "unprognostic (1.04e-2)" "unprognostic (5.50e-3)" "unprognostic (1.88e-1)" "prognostic favorable (3.59e-4)" "unprognostic (2.09e-1)" "unprognostic (3.63e-3)" "unprognostic (7.15e-2)" "unprognostic (2.52e-2)" "unprognostic (1.34e-1)" "unprognostic (4.81e-2)" "unprognostic (8.51e-8)" "unprognostic (2.35e-1)" "unprognostic (3.90e-1)" "unprognostic (7.14e-3)" "unprognostic (1.23e-1)" 1.9 1.2 6.4 49.0 4.9 8.1 5.6 4.2 7.0 1.7 20.3 15.7 22.2 1.5 1.3 2.9 1.3 4.7 1.4 5.4 3.6 1.4 1.4 3.3 99.3 6.2 6.1 1.1 0.6 0.3 0.1 2.8 7.2 1.8 13.4 6.5 12.9 1.9 1.8 1.1 38.6 1.2 2.7 79.5 40.1 1.6 5.4 9.6 2.8 0.3 119.4 9.3 1.9 7.3 0.9 0.9 0.3 0.4 5.6 5.2 1.0 0.2 0.1 0.1 0.1 1.1 0.3 307.2 0.7 0.3 0.2 0.8 0.9 0.4 0.1 0.9 0.2 0.5 1.0 1.1 0.1 0.6 1.7 0.2 0.3 0.3 0.6 0.5 0.3 3.4 11.8 339.3 0.3 0.8 1.5 1.6 0.4 0.5 0.5 65.3 0.7 83.0 0.2 0.8 0.6 6.1 0.7 0.3 0.2 2.4 1.3 0.9 2.7 0.5 3.1 0.6 0.5 326.6 159.9 610.8 0.4 0.7 0.5 3.8 0.2 0.6 0.3 0.2 0.2 33.5 0.5 0.2 0.1 24.0 0.4 0.2 1.6 0.5 0.4 0.3 1.2 1.2 6.4 4.9 4.2 7.0 5.4 3.6 6.2 6.1 7.2 2.7 5.4 7.3 0.0 0.0 3.6 0.3 131.3 0.3 7.1 12.3 0.0 0.0 0.0 0.9 1.9 10.0 20.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 8.4 24.9 0.6 0.2 3.0 6.6 0.1 5.7 0.0 0.8 4.6 0.5 0.0 0.1 0.7 2.4 0.1 0.0 0.1 0.7 2.0 0.6 0.4 10.9 0.3 0.8 8.8 1.0 0.3 0.0 1.0 0.0 4.6 0.4 1.2 0.4 566.8 1.2 0.0 0.4 65.0 0.0 0.0 0.1 1.0 6.3 1.8 0.8 0.0 0.0 4.2 0.0 0.8 8.4 BTG4 "APRO3, PC3B" ENSG00000137707 "BTG anti-proliferation factor 4" Q9NY30 11 111467526-111512354 "Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 26.4" "Group enriched" "Detected in some" 6 "Early spermatids: 61.3;Late spermatids: 80.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.3;Karpas-707: 4.5;U-266/70: 3.1;U-266/84: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA057157 Approved "Endoplasmic reticulum,Golgi apparatus" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 34: Spermatids - Unknown function" "Endoplasmic reticulum, Golgi apparatus" "HPA057157: AB_2683354" "unprognostic (1.58e-1)" "unprognostic (2.68e-3)" "unprognostic (3.20e-2)" "unprognostic (2.80e-4)" "unprognostic (1.42e-2)" "unprognostic (3.14e-1)" "unprognostic (9.39e-2)" "unprognostic (1.31e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 5.2 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.7 1.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 26.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.1 0.2 3.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.0 0.0 0.0 0.5 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.2 3.1 1.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.7 1.0 0.5 0.4 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.3 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.0 80.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 10.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HOATZ "C11orf88, FLJ46266" ENSG00000183644 "HOATZ cilia and flagella associated protein" Q6PI97 11 111514785-111537031 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "choroid plexus: 32.5;fallopian tube: 88.9;testis: 29.2" "Cell type enriched" "Detected in single" 28 "Cardiomyocytes: 5.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;Karpas-707: 1.7;SuSa: 1.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 8.9" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 2: Karpas-707 - Immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "unprognostic (2.25e-1)" "unprognostic (3.07e-5)" "unprognostic (3.85e-4)" "unprognostic (4.16e-2)" "unprognostic (4.44e-5)" "unprognostic (2.56e-3)" "unprognostic (6.91e-2)" "unprognostic (5.49e-3)" "unprognostic (2.86e-1)" "unprognostic (9.96e-3)" "unprognostic (2.70e-1)" "unprognostic (4.40e-2)" "unprognostic (6.80e-3)" "unprognostic (7.57e-2)" "unprognostic (6.22e-2)" "unprognostic (8.45e-2)" "unprognostic (1.11e-1)" 0.0 0.0 2.1 0.1 2.2 0.1 0.0 1.0 0.5 6.9 32.5 0.0 0.2 3.1 0.4 0.0 88.9 0.2 0.0 2.2 2.7 0.0 0.0 11.6 0.1 9.7 12.4 0.1 0.0 0.0 0.4 0.3 7.6 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.0 6.7 0.2 0.1 29.2 2.1 0.1 0.8 0.0 0.0 0.0 0.0 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.2 0.2 0.1 0.3 0.9 0.1 0.0 0.1 0.1 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 2.1 2.2 1.0 0.5 2.2 2.7 9.7 12.4 7.6 6.7 2.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LAYN "FLJ30977, FLJ31092" ENSG00000204381 Layilin Q6UX15 11 111540280-111561745 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Prostatic glandular cells: 233.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 22 "myeloid DC: 11.2;T-reg: 13.4" "Group enriched" "Detected in many" 123 "dendritic cells: 11.2;T-cells: 13.4" "Cell line enhanced" "Detected in many" "BJ: 150.7;BJ hTERT+: 153.7;BJ hTERT+ SV40 Large T+ RasG12V: 96.7;fHDF/TERT166: 95.1;HSkMC: 88.8;hTERT-RPE1: 94.0;U-138 MG: 108.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040087 Approved Approved Cytosol NA NA 340000 "Cluster 35: T-regs - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "HPA040087: AB_10793927" "unprognostic (2.27e-1)" "unprognostic (3.03e-2)" "unprognostic (2.22e-3)" "unprognostic (1.96e-1)" "unprognostic (3.90e-2)" "unprognostic (1.83e-2)" "unprognostic (5.62e-3)" "unprognostic (1.99e-1)" "unprognostic (1.38e-1)" "unprognostic (7.75e-3)" "unprognostic (4.47e-2)" "unprognostic (1.18e-1)" "unprognostic (1.61e-2)" "unprognostic (5.01e-2)" "unprognostic (1.65e-1)" "unprognostic (2.91e-2)" "unprognostic (1.35e-2)" 10.7 2.0 15.6 5.7 21.4 1.0 8.5 15.7 19.6 15.6 13.7 29.2 3.8 15.8 10.1 4.7 17.7 17.0 7.0 16.6 17.1 5.7 0.9 11.3 7.1 17.4 19.7 39.1 2.0 6.4 6.2 14.1 16.3 14.6 3.3 0.8 5.5 17.0 6.1 2.6 10.6 22.5 14.2 8.2 13.1 4.4 18.0 10.3 27.4 6.1 5.0 8.8 12.2 23.7 0.4 3.9 0.8 0.0 25.4 48.0 7.6 150.7 153.7 71.0 96.7 0.2 0.1 0.0 1.4 95.1 18.7 3.2 9.9 0.7 74.2 0.2 0.5 0.8 0.0 0.2 41.7 0.0 0.2 88.8 0.0 30.8 0.2 94.0 0.9 0.0 0.0 0.1 29.4 0.0 0.1 0.1 4.8 0.0 0.0 0.0 11.4 0.2 0.6 0.0 4.9 18.9 0.5 0.2 0.4 34.9 0.1 0.7 0.6 108.8 81.2 1.0 74.3 0.0 0.0 0.2 14.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 11.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 13.4 0.4 15.6 21.4 15.7 19.6 16.6 17.1 17.4 19.7 16.3 14.2 18.0 23.7 22.2 19.2 2.8 0.3 0.3 2.2 48.8 44.8 0.6 0.4 0.7 15.0 2.7 2.8 23.3 0.0 0.0 1.6 2.6 0.0 0.0 6.5 2.5 3.9 7.7 50.9 0.0 2.7 0.3 0.2 2.1 13.1 0.0 0.9 1.3 9.6 6.8 0.1 0.7 0.0 1.4 0.0 6.1 0.6 13.6 1.8 22.7 1.2 0.0 2.8 0.6 0.2 0.0 4.0 30.1 0.8 0.0 55.3 2.8 233.0 0.0 0.2 32.0 0.2 32.9 2.6 17.3 0.1 2.3 0.1 2.3 0.5 14.5 11.2 0.0 50.3 SIK2 "DKFZp434K1115, KIAA0781, LOH11CR1I, QIK, SNF1LK2" ENSG00000170145 "Salt inducible kinase 2" Q9H0K1 11 111602449-111730855 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 113.3;Excitatory neurons: 217.6;Inhibitory neurons: 132.4;Oligodendrocytes: 191.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "ASC diff: 50.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016026, HPA071049" Approved Approved "Nucleoplasm,Nuclear speckles,Vesicles,Intermediate filaments,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Vesicles" "Nuclear speckles, Intermediate filaments, Cytosol" "HPA016026: AB_1857321, HPA071049: " "unprognostic (2.35e-1)" "unprognostic (1.10e-1)" "unprognostic (1.08e-1)" "unprognostic (1.10e-2)" "unprognostic (1.59e-2)" "unprognostic (4.81e-2)" "prognostic favorable (4.93e-4)" "unprognostic (6.41e-2)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (3.72e-3)" "unprognostic (9.27e-2)" "prognostic favorable (1.17e-9)" "unprognostic (1.23e-1)" "unprognostic (2.79e-1)" "unprognostic (2.82e-3)" "unprognostic (2.13e-2)" 29.7 9.3 9.2 5.3 12.4 3.1 20.7 7.9 11.1 7.6 11.0 7.9 5.9 7.3 5.0 5.9 8.1 10.0 12.3 9.5 14.7 11.4 22.7 11.7 4.4 11.9 11.9 14.9 31.8 21.3 16.6 5.8 10.6 6.7 6.2 30.7 13.8 6.2 33.1 8.9 7.5 5.9 5.5 4.6 17.6 3.0 9.3 5.4 8.7 23.2 4.3 7.7 6.1 11.6 9.2 6.0 10.3 11.1 50.3 14.8 6.1 7.9 11.2 5.9 6.7 20.5 9.6 7.2 10.7 9.2 6.9 12.7 8.2 5.9 7.6 5.4 3.4 7.9 5.2 10.1 10.9 7.7 4.9 14.5 8.6 8.7 11.1 11.7 7.1 7.1 7.4 10.3 9.4 4.3 8.0 7.0 3.5 7.6 5.9 10.6 11.0 8.7 13.1 8.2 4.8 11.3 11.6 4.7 4.5 9.4 11.5 6.2 9.9 12.9 7.7 8.3 10.9 2.9 2.4 14.8 4.2 10.6 8.8 0.3 0.7 0.6 0.7 0.7 0.3 0.4 0.5 0.5 0.6 0.4 0.2 0.4 0.3 0.5 0.6 0.3 0.5 0.5 9.2 12.4 7.9 11.1 9.5 14.7 11.9 11.9 10.6 5.5 9.3 11.6 22.1 19.2 24.8 113.3 14.1 14.7 6.2 5.2 18.2 15.7 10.5 9.9 21.3 27.1 10.0 16.5 66.7 4.4 11.4 15.6 5.9 10.4 16.5 27.7 14.9 18.8 18.0 12.4 217.6 7.9 4.6 20.1 27.5 45.3 9.5 24.3 9.3 38.7 5.4 32.0 132.4 11.3 4.1 12.4 16.9 14.1 11.5 13.3 19.6 73.1 6.0 14.5 4.1 86.0 191.9 8.4 10.3 14.7 8.9 6.9 8.3 23.1 13.4 60.9 0.0 19.1 19.0 3.9 6.4 10.3 11.9 5.2 12.6 5.0 11.5 7.1 PPP2R1B "PP2A-Abeta, PR65B" ENSG00000137713 "Protein phosphatase 2 scaffold subunit Abeta" P30154 11 111726908-111766389 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 170.7" "Cell type enhanced" "Detected in all" "Early spermatids: 306.1;Late spermatids: 160.7;Spermatocytes: 135.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 173.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004034, HPA018908" Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 85: Liver - Metabolism" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Plasma membrane, Cytosol" "CAB004034: AB_490763, HPA018908: AB_1855655" "unprognostic (8.37e-2)" "unprognostic (3.87e-2)" "unprognostic (4.84e-3)" "unprognostic (3.27e-3)" "unprognostic (3.43e-1)" "unprognostic (4.93e-2)" "prognostic favorable (3.80e-4)" "unprognostic (4.58e-1)" "unprognostic (8.20e-3)" "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.41e-2)" "unprognostic (1.25e-3)" "unprognostic (1.25e-1)" "unprognostic (5.30e-1)" "unprognostic (2.12e-2)" "unprognostic (1.22e-1)" 58.5 10.5 11.3 14.1 18.0 16.2 21.5 20.0 13.9 13.0 17.3 14.7 13.9 8.7 8.1 12.6 8.0 13.4 6.3 11.7 13.8 14.6 170.7 8.8 12.1 14.7 13.7 13.3 33.2 12.9 10.7 9.2 14.2 7.7 14.7 8.5 9.6 6.1 9.6 10.7 15.2 7.8 10.6 6.3 22.3 54.0 13.8 15.9 10.6 8.9 14.1 12.2 7.4 20.7 38.4 25.1 35.6 24.2 34.9 18.7 35.8 37.2 25.9 27.0 24.6 86.0 39.3 48.3 27.1 24.1 25.6 35.4 53.4 30.5 34.3 33.7 16.6 47.2 14.5 37.8 17.3 55.7 36.1 21.5 18.1 30.6 22.2 19.1 33.8 49.7 58.3 62.3 30.1 12.4 60.8 22.6 43.8 41.4 27.3 45.9 23.6 58.6 40.2 41.9 11.6 31.4 33.1 30.2 6.1 38.3 35.0 20.6 36.7 31.3 37.8 15.6 23.9 6.6 17.4 173.8 11.1 63.9 40.7 6.1 10.1 10.4 13.0 11.7 12.7 10.0 12.9 12.1 14.9 12.5 11.2 12.0 2.6 15.3 11.4 6.4 15.0 12.2 11.3 18.0 20.0 13.9 11.7 13.8 14.7 13.7 14.2 10.6 13.8 20.7 21.2 19.2 10.5 63.3 11.0 14.3 11.0 12.0 18.2 5.4 14.1 8.5 3.2 15.7 13.4 12.9 8.4 13.5 11.0 23.8 13.7 18.7 306.1 29.6 13.4 20.2 15.6 32.4 23.8 22.9 20.3 12.3 15.3 46.1 8.2 34.3 9.3 89.4 9.5 1.7 14.5 11.5 22.4 5.8 9.2 160.7 6.5 7.5 8.8 17.8 8.9 9.9 7.2 26.2 49.1 23.6 9.0 7.5 9.0 10.9 16.2 17.6 16.8 11.0 13.1 14.5 14.4 135.9 20.8 12.0 14.6 17.6 11.0 9.7 13.9 15.0 ALG9 DIBD1 ENSG00000086848 "ALG9 alpha-1,2-mannosyltransferase" Q9H6U8 11 111782195-111871581 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 26.6;Inhibitory neurons: 31.8;Oligodendrocytes: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA038575 Approved Approved "Endoplasmic reticulum" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 59: Non-specific - Transcription" "Endoplasmic reticulum" "HPA038575: AB_10672718" "unprognostic (1.48e-1)" "unprognostic (5.39e-2)" "unprognostic (6.22e-2)" "unprognostic (5.34e-3)" "unprognostic (8.72e-2)" "unprognostic (2.90e-1)" "unprognostic (2.43e-2)" "unprognostic (1.04e-2)" "unprognostic (7.07e-3)" "unprognostic (5.11e-2)" "unprognostic (8.75e-3)" "unprognostic (1.52e-2)" "prognostic unfavorable (7.29e-5)" "unprognostic (9.15e-2)" "unprognostic (7.76e-2)" "unprognostic (4.20e-2)" "unprognostic (1.10e-2)" 14.0 9.7 6.3 8.6 7.1 7.8 12.4 8.2 7.8 12.9 6.3 10.9 12.1 11.5 10.9 11.4 9.2 7.9 10.1 6.3 6.6 9.5 13.4 9.6 6.6 6.5 6.8 12.5 19.7 12.7 10.0 9.6 6.7 9.6 10.3 12.0 17.5 11.3 9.1 15.2 10.2 11.1 5.6 8.4 12.0 13.6 6.1 9.8 12.3 8.3 9.2 11.3 11.1 6.4 16.6 16.5 30.7 31.1 19.0 18.0 23.7 20.5 16.5 16.4 17.9 28.7 27.4 27.1 28.7 23.8 21.4 29.8 16.6 25.4 23.4 20.2 12.2 19.7 8.6 21.2 22.0 22.2 13.6 15.5 17.2 17.7 17.8 24.2 16.2 20.2 20.3 41.0 28.4 12.5 22.2 20.3 10.7 23.3 15.9 20.4 26.9 51.5 18.5 13.7 15.0 25.4 18.0 28.0 11.4 21.6 29.0 9.3 16.9 35.0 25.2 17.1 22.6 13.3 10.2 24.4 15.1 27.4 24.7 4.5 3.1 3.8 4.0 4.5 4.7 4.0 4.1 4.6 5.2 3.1 5.8 3.6 1.1 4.2 4.0 5.6 4.5 3.3 6.3 7.1 8.2 7.8 6.3 6.6 6.5 6.8 6.7 5.6 6.1 6.4 3.2 0.0 4.4 21.5 5.9 2.0 1.5 3.2 9.6 8.9 3.8 3.4 5.6 1.5 3.9 7.3 8.4 3.5 4.6 3.2 3.9 7.5 5.1 2.0 5.2 4.1 4.2 6.3 26.6 7.1 12.6 4.7 4.6 3.8 0.0 5.5 2.2 6.8 3.2 15.2 31.8 4.0 4.1 1.9 1.9 4.3 4.7 3.5 0.0 12.2 3.1 4.9 3.1 21.1 31.8 6.5 2.9 3.8 22.8 1.3 4.6 2.3 2.2 9.7 6.6 3.5 5.4 4.2 5.7 8.6 1.6 9.0 5.8 2.5 4.4 0.8 AP001781.2 ENSG00000258529 "Novel protein" 11 111786286-111879425 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 2.8;HeLa: 3.0" HPA038575 Uncertain Approved "Endoplasmic reticulum" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 20: HeLa - Mitochondria" "Cluster 11: Alveolar cells - Smell perception" "Endoplasmic reticulum" "HPA038575: AB_10672718" 0.6 0.0 0.0 0.2 0.0 0.6 0.3 0.0 0.6 0.0 0.0 0.7 0.7 0.4 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.5 0.2 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.4 0.4 0.0 0.0 0.2 0.7 0.0 0.2 0.1 0.3 0.3 1.1 0.1 0.4 0.2 0.2 0.4 0.0 0.0 0.1 0.1 0.0 0.5 0.5 0.0 0.7 0.1 0.8 0.0 0.1 0.0 2.8 0.0 0.1 0.5 0.0 0.8 1.0 0.0 0.0 0.6 0.2 0.0 1.7 3.0 0.2 0.0 0.0 0.3 1.0 1.0 0.7 1.5 0.4 0.0 1.0 0.1 1.0 0.0 0.0 0.6 1.3 0.2 0.0 0.0 0.0 0.0 1.1 0.4 0.9 0.0 0.0 0.7 0.0 0.1 0.0 0.6 0.6 0.0 1.2 0.3 0.5 0.1 0.8 0.7 2.1 0.3 1.5 0.2 0.3 0.5 0.5 1.2 0.6 0.8 0.5 0.7 0.7 0.6 0.6 1.3 0.6 0.0 0.7 0.5 0.7 0.2 1.1 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FDXACB1 "hCG_2033039, LOC91893" ENSG00000255561 "Ferredoxin-fold anticodon binding domain containing 1" Q9BRP7 11 111874056-111881243 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 37.1;Late spermatids: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039012, HPA061375" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Cytosol" "HPA039012: AB_10670916, HPA061375: " "unprognostic (2.91e-2)" "unprognostic (3.32e-3)" "unprognostic (1.32e-2)" "unprognostic (6.81e-7)" "unprognostic (1.32e-1)" "unprognostic (9.64e-2)" "unprognostic (2.05e-1)" "unprognostic (7.11e-3)" "unprognostic (3.95e-2)" "unprognostic (7.42e-2)" "unprognostic (3.67e-1)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (6.57e-2)" "unprognostic (4.42e-1)" "unprognostic (4.61e-2)" "unprognostic (1.79e-2)" 1.1 1.9 0.9 1.9 1.0 2.0 2.1 0.8 1.2 1.7 0.7 1.4 1.6 1.4 2.4 1.1 1.5 1.0 0.9 1.0 1.2 1.5 1.6 1.7 3.1 1.0 1.0 1.5 1.5 1.6 0.9 1.2 0.9 1.2 1.7 0.7 0.8 0.9 0.7 2.7 1.5 1.1 1.0 2.4 1.0 3.1 1.2 1.7 1.3 0.8 3.2 1.6 0.8 1.1 1.4 1.9 2.1 5.3 2.0 1.8 1.2 1.1 1.2 1.2 1.2 2.4 3.1 5.5 2.7 1.0 1.5 4.3 2.6 2.5 2.7 6.9 1.1 6.1 1.1 1.8 1.2 6.4 5.3 1.5 1.5 1.7 2.2 1.0 2.2 6.5 4.4 6.4 2.3 1.8 6.0 6.2 1.4 6.0 2.7 3.6 1.6 6.5 2.8 2.5 1.0 1.6 1.5 3.2 1.4 1.2 4.5 3.9 1.7 2.5 2.7 3.0 2.6 3.6 5.5 14.1 1.6 9.1 3.7 0.3 2.3 1.5 5.0 3.7 6.5 4.6 4.4 4.4 3.8 3.8 6.5 7.5 0.7 4.8 3.0 3.6 2.5 3.7 0.9 1.0 0.8 1.2 1.0 1.2 1.0 1.0 0.9 1.0 1.2 1.1 2.2 6.4 0.6 0.7 3.1 0.8 1.3 4.2 1.2 3.0 1.6 1.4 1.6 0.0 3.0 0.0 0.0 3.4 1.3 1.2 5.9 2.5 37.1 1.5 1.2 1.8 2.4 0.8 1.0 3.3 1.9 1.3 1.1 0.9 1.3 2.2 2.2 1.8 4.0 1.7 1.3 1.4 4.1 1.3 1.2 14.2 3.1 2.0 0.0 1.9 2.2 3.2 4.1 1.0 1.2 2.1 0.5 0.4 1.6 1.9 0.9 2.3 1.6 2.5 6.6 1.1 1.2 7.5 9.1 1.0 1.3 2.2 2.6 3.8 1.6 0.8 C11orf1 FLJ23499 ENSG00000137720 "Chromosome 11 open reading frame 1" Q9H5F2 11 111878935-111885975 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 402.4;Late spermatids: 1147.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038410, HPA057519" Uncertain Enhanced Nucleoplasm NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA038410: AB_10672591, HPA057519: AB_2683454" "unprognostic (1.33e-2)" "unprognostic (1.61e-1)" "unprognostic (1.96e-1)" "prognostic favorable (9.32e-4)" "unprognostic (1.30e-1)" "unprognostic (1.42e-2)" "unprognostic (1.10e-1)" "unprognostic (1.14e-1)" "unprognostic (9.26e-2)" "unprognostic (3.23e-2)" "unprognostic (1.41e-2)" "unprognostic (2.86e-2)" "prognostic favorable (1.39e-4)" "unprognostic (3.76e-2)" "unprognostic (2.12e-1)" "unprognostic (1.97e-1)" "unprognostic (2.08e-1)" 21.5 37.0 25.9 10.4 29.0 18.1 49.2 26.4 36.1 20.5 24.6 26.3 20.4 17.2 64.2 24.0 28.6 19.6 33.0 26.1 27.5 70.3 54.9 16.3 15.1 26.1 26.7 28.0 48.0 39.9 28.4 9.4 26.5 27.4 26.4 22.3 33.0 26.8 16.2 34.8 21.4 14.9 25.7 11.6 30.6 61.2 27.1 20.3 41.1 21.1 17.8 22.7 18.4 27.0 25.1 31.9 40.3 44.6 45.6 34.3 42.0 13.5 34.2 10.9 13.8 54.5 45.6 91.9 63.5 23.2 31.4 28.9 16.5 50.2 17.0 40.6 23.4 30.9 6.9 42.0 28.6 45.7 20.9 63.8 76.9 39.0 74.4 48.4 13.5 96.2 45.3 66.8 36.9 25.0 62.2 70.8 46.3 86.8 48.0 31.5 42.0 127.6 69.4 46.0 36.3 34.1 8.7 31.5 31.3 38.4 63.1 31.8 11.7 40.2 28.8 17.6 19.1 38.8 61.2 136.7 20.3 53.1 24.9 6.5 7.4 9.0 13.0 14.6 24.9 26.0 22.0 17.0 11.1 17.7 34.5 26.5 1.7 16.7 10.1 32.8 17.6 10.2 25.9 29.0 26.4 36.1 26.1 27.5 26.1 26.7 26.5 25.7 27.1 27.0 14.3 25.6 19.8 3.6 22.6 23.7 67.5 60.6 71.2 8.6 56.5 79.6 57.6 28.6 43.4 35.0 6.2 28.9 17.3 15.1 201.5 21.8 402.4 30.5 17.3 15.3 26.4 26.3 3.5 27.2 22.5 16.5 22.4 22.6 29.2 23.3 11.0 43.4 23.0 15.2 4.7 39.8 28.5 7.9 11.4 1147.2 27.4 14.3 24.9 3.7 19.3 43.5 20.6 1.0 3.7 18.9 22.3 24.5 41.9 36.4 40.6 197.9 44.4 15.5 19.7 10.8 17.0 54.4 30.9 53.4 29.5 21.1 22.6 49.2 44.4 72.7 CRYAB "CRYA2, HSPB5" ENSG00000109846 "Crystallin alpha B" P02511 11 111908564-111923722 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Chaperone, Eye lens protein" "Cancer-related genes, Cardiomyopathy, Cataract, Disease variant, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 5623.2;heart muscle: 10683.1;skeletal muscle: 6972.0;tongue: 9406.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 2889.5;Cardiomyocytes: 6878.2;Muller glia cells: 1664.3;Proximal tubular cells: 7285.9" "Group enriched" "Detected in all" 6 "glioma: 426.4;renal cancer: 575.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "ASC diff: 2663.1;fHDF/TERT166: 775.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002053, CAB040560, HPA057100" Enhanced Enhanced "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 370000 "Cluster 39: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Plasma membrane, Cytosol" "CAB002053: AB_442024, CAB040560: , HPA057100: AB_2683337" "unprognostic (1.06e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (4.90e-5)" "unprognostic (2.46e-2)" "unprognostic (3.02e-2)" "unprognostic (8.41e-3)" "unprognostic (9.29e-3)" "unprognostic (7.35e-2)" "unprognostic (8.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.68e-2)" "unprognostic (7.02e-2)" "unprognostic (3.68e-2)" "unprognostic (7.92e-2)" "unprognostic (8.83e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.70e-5)" 1035.0 106.6 2466.0 113.9 3113.8 0.4 592.2 3032.2 5623.2 439.1 2077.7 678.9 24.6 351.4 179.1 312.2 204.0 71.7 10683.1 2424.9 2666.2 2123.2 37.2 253.4 15.0 3215.2 2856.7 136.0 50.6 24.9 209.2 107.8 3147.1 317.9 78.2 478.7 428.7 358.5 6972.0 317.3 158.5 338.1 2877.3 88.5 263.8 23.5 2815.5 20.9 477.7 9406.7 34.4 490.0 477.5 4060.6 0.1 0.5 0.1 45.0 2663.1 90.9 15.0 54.5 2.5 0.8 2.5 1.7 0.2 0.0 41.7 775.8 0.2 2.0 1.8 2.3 1.4 0.3 0.0 0.0 11.9 3.9 16.9 0.4 0.7 77.1 11.1 0.6 6.2 44.3 0.2 0.0 4.6 2.5 169.5 0.1 0.1 1.1 0.5 0.0 1.0 0.2 0.0 0.6 29.8 0.8 0.1 0.4 5.3 9.1 39.8 63.5 4.9 0.0 1.7 310.1 105.0 6.5 4.1 0.5 0.1 0.6 7.1 0.4 39.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2466.0 3113.8 3032.2 5623.2 2424.9 2666.2 3215.2 2856.7 3147.1 2877.3 2815.5 4060.6 38.4 83.3 4.1 96.0 51.3 174.9 2889.5 32.1 72.8 16.2 334.4 696.1 6878.2 84.4 15.2 1338.9 18.8 3.9 6.8 0.4 677.0 320.3 24.7 345.4 265.3 88.4 7.1 0.0 6.7 11.5 7.4 880.6 0.0 1008.4 0.0 16.1 35.7 0.7 5.8 10.1 12.6 2.4 8.2 0.3 85.8 12.6 228.6 67.7 483.8 11.2 3.6 1664.3 0.0 7.5 615.7 12.1 0.0 187.7 1.6 855.4 0.0 7285.9 23.2 59.4 138.1 799.9 1053.3 21.6 1.4 56.5 155.1 33.4 55.4 6.7 1.2 249.0 HSPB2 "Hs.78846, MKBP" ENSG00000170276 "Heat shock protein family B (small) member 2" Q16082 11 111912734-111914093 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "heart muscle: 153.2;skeletal muscle: 251.3;tongue: 316.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 115.7;Fibroblasts: 39.1;Leydig cells: 43.5;Melanocytes: 37.4;Smooth muscle cells: 39.8" "Cancer enhanced" "Detected in many" "melanoma: 5.1;renal cancer: 4.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 48.4;ASC TERT1: 23.4;fHDF/TERT166: 59.7;HSkMC: 23.3;LHCN-M2: 35.2;U-138 MG: 31.5" HPA079414 Approved NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "HPA079414: " "unprognostic (5.46e-2)" "unprognostic (1.46e-1)" "unprognostic (2.30e-1)" "unprognostic (7.69e-3)" "unprognostic (6.82e-2)" "unprognostic (1.51e-2)" "unprognostic (4.37e-2)" "unprognostic (3.25e-1)" "unprognostic (2.04e-1)" "unprognostic (1.67e-2)" "unprognostic (3.55e-2)" "unprognostic (2.19e-1)" "unprognostic (1.36e-1)" "unprognostic (1.69e-3)" "unprognostic (2.63e-1)" "unprognostic (1.99e-1)" "unprognostic (1.46e-2)" 39.8 5.3 26.7 4.3 28.9 0.0 21.5 37.4 32.5 30.2 24.4 21.1 3.4 25.0 5.7 15.4 22.2 18.5 153.2 25.8 26.7 13.3 2.3 17.3 5.4 29.0 27.3 14.0 1.4 1.4 3.8 12.2 27.2 13.1 4.0 1.8 7.1 13.0 251.3 14.7 9.1 19.1 27.2 7.3 9.6 2.3 28.9 1.4 9.6 316.8 2.0 16.1 19.0 26.2 0.0 0.0 0.0 7.0 48.4 23.4 0.2 5.6 0.0 0.0 0.3 0.0 0.0 0.0 0.5 59.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.0 23.3 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 35.2 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.2 31.5 3.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.7 28.9 37.4 32.5 25.8 26.7 29.0 27.3 27.2 27.2 28.9 26.2 8.5 0.0 0.0 0.0 0.0 7.0 0.3 0.0 1.2 0.4 5.1 16.4 115.7 1.5 0.6 1.8 0.0 0.8 0.1 0.0 1.9 0.4 0.1 0.1 7.9 3.5 0.0 0.0 0.0 0.0 0.7 39.1 0.0 0.2 0.0 0.4 4.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 10.3 1.1 43.5 0.6 37.4 0.0 0.0 7.6 0.0 0.0 0.0 0.1 0.0 21.8 0.0 0.3 0.0 23.5 0.0 0.5 13.1 22.8 39.8 0.8 0.6 0.6 5.8 1.5 1.0 0.4 0.0 0.0 C11orf52 "FLJ25219, MGC14839" ENSG00000149300 "Chromosome 11 open reading frame 52" Q96A22 11 111918032-111926871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 2.8;Breast glandular cells: 3.3;Cholangiocytes: 2.8;Endometrial ciliated cells: 3.1;Gastric mucus-secreting cells: 4.1;Respiratory ciliated cells: 6.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 17.7;CAPAN-2: 23.5;Hep G2: 18.2;MCF7: 17.6;RPTEC TERT1: 27.1;SK-BR-3: 22.9;T-47d: 76.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038387, HPA038388" Uncertain Enhanced "Cell Junctions" NA NA "Cluster 1: Thyroid gland - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Cell Junctions" "HPA038387: AB_10670167, HPA038388: AB_2675987" "unprognostic (1.30e-2)" "unprognostic (1.13e-1)" "unprognostic (5.84e-4)" "unprognostic (1.48e-4)" "unprognostic (2.57e-1)" "unprognostic (8.04e-2)" "unprognostic (6.77e-2)" "unprognostic (2.07e-2)" "unprognostic (2.26e-1)" "unprognostic (2.77e-1)" "unprognostic (3.80e-1)" "unprognostic (5.38e-4)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "unprognostic (3.03e-1)" 3.3 0.7 1.0 0.4 0.9 0.0 25.9 4.1 1.3 3.8 2.2 5.2 10.4 2.3 23.7 6.4 17.7 12.3 3.2 0.9 0.9 43.9 22.8 9.7 0.1 1.1 1.0 1.5 25.8 30.8 16.4 10.1 1.7 15.4 6.2 0.1 26.8 10.2 9.3 9.7 9.2 0.8 1.1 0.9 20.9 1.0 1.1 1.0 20.1 8.3 1.3 4.6 3.2 1.5 4.3 0.0 0.0 0.0 2.9 0.4 17.7 1.0 0.8 0.1 0.0 6.8 23.5 0.0 10.6 2.3 0.0 5.4 0.0 1.4 0.1 0.0 0.7 0.0 0.5 18.2 0.0 0.0 0.0 0.3 5.2 0.0 0.2 0.2 1.0 0.0 0.0 0.0 1.5 17.6 0.0 0.2 0.1 12.5 1.8 0.0 1.5 0.0 27.1 15.6 1.2 0.0 0.0 22.9 0.0 2.4 76.5 1.6 2.0 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.9 4.1 1.3 0.9 0.9 1.1 1.0 1.7 1.1 1.1 1.5 0.0 6.4 2.8 0.0 0.0 0.1 1.6 0.2 1.2 0.0 3.3 0.9 0.6 2.8 0.1 0.0 0.0 0.6 0.0 0.0 0.0 1.3 0.0 3.1 0.2 0.2 0.0 0.0 0.0 1.0 0.3 0.5 4.1 1.9 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 1.9 1.3 6.7 0.0 0.0 0.3 0.3 0.1 0.1 0.6 0.3 1.4 0.0 0.2 0.2 0.7 DIXDC1 "Dixin, KIAA1735" ENSG00000150764 "DIX domain containing 1" Q155Q3 11 111927144-112022653 "Predicted intracellular proteins" "Wnt signaling pathway" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 104.3;Horizontal cells: 121.1;Oligodendrocytes: 140.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 11 "eosinophil: 5.2" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.2" "Cell line enhanced" "Detected in many" "hTERT-HME1: 42.7;TIME: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039424, HPA039658, HPA061366" Approved Supported Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 9: Photoreceptor cells - Phototransduction" Cytosol "HPA039424: AB_2676500, HPA039658: AB_2676611, HPA061366: " "unprognostic (1.93e-1)" "unprognostic (2.90e-2)" "unprognostic (8.93e-3)" "unprognostic (2.84e-1)" "unprognostic (2.98e-2)" "unprognostic (1.44e-1)" "unprognostic (2.37e-1)" "unprognostic (1.41e-1)" "unprognostic (7.23e-2)" "unprognostic (1.59e-1)" "unprognostic (7.85e-2)" "unprognostic (5.11e-2)" "prognostic favorable (6.89e-5)" "unprognostic (4.10e-2)" "unprognostic (2.11e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (4.19e-5)" 17.8 17.7 16.4 8.6 23.2 0.7 15.0 36.8 22.6 18.7 22.8 29.5 5.6 24.8 18.6 12.7 20.4 12.6 23.3 17.0 16.9 11.4 7.0 9.4 2.6 20.1 21.8 15.8 3.8 17.1 7.1 10.8 19.1 23.4 10.0 22.0 7.8 35.8 13.7 5.4 9.1 25.6 18.0 2.9 14.9 19.1 19.7 2.6 10.7 12.3 2.5 25.3 12.0 34.4 0.8 3.7 9.9 18.5 29.9 17.5 2.1 7.7 5.3 2.9 5.2 0.6 2.0 1.6 2.0 21.5 3.4 0.9 4.4 2.4 2.9 6.4 3.7 0.8 5.8 10.3 4.6 5.3 0.7 14.2 19.3 6.3 42.7 21.5 30.6 4.0 5.2 0.6 11.9 0.9 3.3 4.6 5.9 0.8 6.6 1.6 2.9 6.1 12.1 0.3 8.0 16.7 5.7 4.6 2.5 4.3 6.8 2.0 50.4 13.1 5.6 2.4 12.9 1.2 5.5 0.8 7.2 13.5 4.7 0.0 0.1 5.2 0.3 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.1 16.4 23.2 36.8 22.6 17.0 16.9 20.1 21.8 19.1 18.0 19.7 34.4 12.8 16.0 10.3 40.1 0.4 6.4 16.3 4.1 11.4 22.3 23.7 28.8 35.6 7.2 10.1 18.4 104.3 1.4 0.9 2.6 15.6 6.4 23.1 32.1 48.6 28.1 2.4 2.1 47.7 7.7 5.1 32.8 11.7 11.3 1.3 6.3 62.8 19.3 1.7 121.1 83.8 13.9 6.1 3.4 5.3 17.5 39.7 1.5 12.4 20.6 1.0 30.2 0.0 34.7 140.4 7.0 6.2 36.9 2.0 10.8 2.7 15.4 35.5 69.2 13.1 25.3 31.8 62.3 16.4 3.3 4.1 1.4 2.0 3.5 4.5 3.1 DLAT "DLTA, E2, PDC-E2" ENSG00000150768 "Dihydrolipoamide S-acetyltransferase" P10515 11 112025408-112064404 "Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 89.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 100.5;Distal tubular cells: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003782, HPA040786, HPA062766" Supported Supported Mitochondria NA NA 44000 "Cluster 44: Non-specific - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864" "unprognostic (4.57e-3)" "unprognostic (1.75e-1)" "prognostic favorable (6.19e-6)" "unprognostic (7.68e-2)" "unprognostic (2.41e-1)" "unprognostic (1.70e-2)" "prognostic unfavorable (7.49e-5)" "unprognostic (8.68e-2)" "unprognostic (5.36e-2)" "unprognostic (2.93e-1)" "unprognostic (2.23e-3)" "unprognostic (6.25e-2)" "prognostic favorable (1.95e-14)" "unprognostic (5.82e-2)" "unprognostic (4.12e-2)" "unprognostic (2.17e-1)" "unprognostic (6.15e-2)" 24.7 16.5 7.7 13.3 8.3 7.9 14.5 9.5 9.3 11.0 10.4 24.7 18.3 10.0 13.4 19.5 13.0 8.5 69.4 8.1 11.1 33.8 15.5 11.7 16.1 8.3 8.9 9.5 6.8 31.7 8.5 13.1 9.7 14.5 26.0 10.8 16.8 14.8 75.4 10.3 16.5 13.4 8.2 9.9 14.3 9.9 9.4 12.7 20.2 89.4 18.2 14.2 8.1 8.0 18.7 16.4 28.2 34.4 41.6 30.5 26.5 26.6 18.2 34.8 38.7 52.8 56.7 85.4 46.0 28.7 42.6 41.0 65.7 34.2 38.9 27.3 30.2 51.9 17.9 39.2 29.0 64.9 26.6 36.9 37.7 32.0 35.2 24.2 33.9 41.7 88.4 42.6 41.2 16.6 25.4 66.9 30.3 58.6 35.4 45.4 38.0 93.3 64.4 21.4 51.2 27.8 30.7 93.4 20.5 30.9 67.4 42.9 17.8 29.1 29.1 29.1 33.0 11.1 19.4 127.5 7.7 73.0 22.7 9.1 3.8 3.0 4.3 5.8 5.4 5.6 4.9 5.1 5.8 4.0 5.6 5.1 0.3 4.7 6.1 4.5 5.8 5.0 7.7 8.3 9.5 9.3 8.1 11.1 8.3 8.9 9.7 8.2 9.4 8.0 7.6 12.8 14.5 15.3 13.8 11.2 9.2 18.2 14.2 8.1 9.2 5.8 100.5 15.7 13.2 11.0 0.0 21.2 6.4 26.3 74.3 18.7 3.9 15.8 11.6 9.6 17.3 18.1 18.0 11.4 39.6 11.7 11.7 12.1 3.8 13.5 7.5 15.5 18.7 8.4 24.4 17.8 24.4 8.8 7.5 3.2 6.2 9.5 17.8 9.4 16.7 10.4 4.1 11.1 19.7 14.1 9.2 10.9 19.4 7.0 19.0 37.6 30.3 11.1 0.0 14.2 19.9 25.1 18.3 21.1 9.8 17.4 8.5 26.3 26.7 9.3 PIH1D2 ENSG00000150773 "PIH1 domain containing 2" Q8WWB5 11 112063218-112074274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 66.5" "Cell type enhanced" "Detected in many" "Early spermatids: 425.9;Endometrial ciliated cells: 68.8;Late spermatids: 157.5;Respiratory ciliated cells: 115.3;Spermatocytes: 215.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039496 Uncertain Nucleoplasm,Cytosol NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "HPA039496: AB_10959385" "unprognostic (8.74e-2)" "unprognostic (6.64e-3)" "unprognostic (1.29e-1)" "unprognostic (3.01e-3)" "unprognostic (4.72e-2)" "unprognostic (1.35e-2)" "unprognostic (3.74e-2)" "unprognostic (1.17e-1)" "unprognostic (2.43e-3)" "unprognostic (5.82e-2)" "unprognostic (9.05e-3)" "unprognostic (1.03e-1)" "unprognostic (2.81e-3)" "unprognostic (1.59e-1)" "unprognostic (6.08e-2)" "unprognostic (3.38e-2)" "unprognostic (1.12e-1)" 0.8 1.0 1.8 0.5 1.8 0.4 1.9 1.6 1.8 1.8 9.6 0.9 0.5 1.7 4.8 1.2 14.8 1.6 1.3 1.9 2.0 3.9 0.7 2.9 0.4 4.0 4.6 1.2 1.1 4.1 3.3 0.7 3.4 0.9 0.8 12.4 1.3 1.4 1.0 1.2 0.4 0.6 3.5 0.3 1.0 66.5 2.1 0.6 5.3 0.4 0.4 0.8 0.8 2.5 1.9 1.1 3.1 1.6 0.7 0.8 2.3 0.7 2.2 1.8 2.3 3.0 6.4 0.9 2.4 1.8 2.5 2.6 0.6 1.8 1.9 0.9 2.1 1.3 1.4 1.6 1.3 1.8 0.3 1.2 2.3 4.7 2.6 1.6 0.9 1.3 2.0 0.6 1.3 0.7 0.7 2.5 1.0 1.0 1.6 1.1 2.0 2.6 5.6 0.9 3.6 1.0 2.9 0.5 1.0 0.7 8.0 0.5 0.1 1.6 1.4 0.8 0.6 0.4 0.3 1.3 1.9 0.1 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 1.8 1.6 1.8 1.9 2.0 4.0 4.6 3.4 3.5 2.1 2.5 1.4 6.4 0.5 10.1 0.0 0.6 1.6 7.8 1.8 2.6 1.9 2.2 3.1 5.7 9.9 3.7 2.1 0.9 0.0 0.5 15.6 3.8 425.9 68.8 2.8 1.3 3.0 0.0 5.1 2.3 0.7 1.5 0.0 2.6 1.3 1.5 1.1 0.2 0.7 1.7 5.8 0.5 10.2 0.3 0.4 157.5 2.8 0.8 3.6 1.9 0.6 5.6 0.0 4.0 3.9 1.6 0.4 1.5 0.0 0.6 0.2 10.4 115.3 16.9 0.0 0.7 3.3 215.5 8.4 0.4 1.0 0.3 0.6 1.6 0.4 0.9 NKAPD1 "C11orf57, FLJ10726" ENSG00000150776 "NKAP domain containing 1" Q6ZUT1 11 112074086-112085150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 32.1;Endometrial stromal cells: 35.4;Proximal tubular cells: 32.9;Theca cells: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039493, HPA039892" Approved Approved Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA039493: AB_10795036, HPA039892: AB_10795372" "unprognostic (5.93e-2)" "unprognostic (3.24e-1)" "unprognostic (6.45e-3)" "unprognostic (1.80e-1)" "unprognostic (1.45e-2)" "unprognostic (5.20e-2)" "prognostic unfavorable (2.70e-4)" "unprognostic (1.17e-1)" "unprognostic (1.45e-2)" "unprognostic (8.61e-2)" "unprognostic (4.67e-3)" "unprognostic (3.17e-2)" "unprognostic (7.05e-3)" "unprognostic (1.15e-2)" "unprognostic (2.86e-1)" "unprognostic (8.24e-2)" "unprognostic (1.41e-1)" 14.2 11.4 9.5 11.6 10.2 13.0 16.7 12.9 11.8 12.1 8.4 12.2 11.3 15.3 11.8 13.9 13.7 11.8 13.0 9.4 10.4 14.6 11.8 11.0 14.2 9.6 9.7 20.1 12.3 14.1 7.7 15.8 10.5 10.7 11.6 33.4 13.7 11.2 18.6 12.1 11.0 12.5 9.6 12.6 11.5 13.6 9.7 16.9 16.0 10.1 14.0 11.5 9.6 11.4 19.5 12.8 26.6 42.9 26.8 31.0 19.5 28.0 23.8 23.1 26.4 39.8 34.2 54.1 41.8 25.3 26.1 27.4 32.1 30.1 30.0 39.0 22.3 41.6 12.7 19.2 24.8 63.3 26.3 31.8 40.5 27.8 63.7 35.1 20.9 44.0 62.4 32.5 23.4 11.8 57.0 39.2 26.5 32.7 28.3 43.5 32.7 44.6 26.6 17.3 22.1 40.4 29.0 35.3 26.1 23.3 44.2 25.9 21.4 30.7 34.4 19.1 24.5 24.5 58.4 111.4 13.0 58.6 31.7 9.1 7.3 4.8 9.8 7.8 10.2 8.4 10.4 6.8 8.1 9.1 10.9 9.5 4.2 13.4 8.9 20.6 9.0 4.8 9.5 10.2 12.9 11.8 9.4 10.4 9.6 9.7 10.5 9.6 9.7 11.4 19.9 32.1 20.7 0.0 9.4 0.0 0.0 0.0 0.0 0.0 24.5 21.0 0.0 0.0 17.3 16.5 0.0 19.6 15.1 0.0 13.7 20.2 0.0 26.0 35.4 8.7 0.0 0.0 0.0 21.4 17.8 11.3 0.0 20.9 8.8 21.8 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 13.9 0.0 0.0 0.0 0.0 20.0 0.0 0.0 5.0 0.0 0.0 32.9 17.5 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 20.0 6.0 35.6 0.0 0.0 TIMM8B "DDP2, FLJ21744, MGC102866, MGC117373, TIM8B" ENSG00000150779 "Translocase of inner mitochondrial membrane 8 homolog B" Q9Y5J9 11 112084800-112086798 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 577.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041173 Approved NA NA 11000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 39: CACO-2 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" "HPA041173: AB_10796340" "unprognostic (1.36e-1)" "unprognostic (8.82e-2)" "unprognostic (1.19e-2)" "unprognostic (1.56e-3)" "unprognostic (6.45e-2)" "unprognostic (2.79e-2)" "unprognostic (4.38e-2)" "unprognostic (5.54e-2)" "unprognostic (1.19e-2)" "unprognostic (2.40e-3)" "unprognostic (8.17e-2)" "unprognostic (4.81e-2)" "unprognostic (3.48e-1)" "unprognostic (2.24e-1)" "unprognostic (1.48e-1)" "unprognostic (3.29e-2)" "unprognostic (2.44e-2)" 35.2 55.8 35.0 23.3 36.1 34.9 30.9 37.5 49.0 27.3 36.4 31.2 19.0 22.0 25.2 65.7 19.6 9.0 137.9 35.8 36.3 38.0 51.2 21.2 21.2 36.3 35.6 18.2 21.9 24.1 22.1 17.5 35.6 25.1 23.7 15.6 28.3 17.7 106.5 34.6 23.3 20.1 36.3 27.6 27.8 31.9 36.4 29.6 21.4 97.9 22.5 27.2 32.3 36.5 43.4 56.0 105.5 89.6 45.0 27.7 50.6 43.8 29.3 55.4 54.6 198.2 53.4 19.3 96.0 53.5 46.9 57.9 82.6 61.5 29.0 55.0 116.0 86.7 77.4 125.6 70.1 98.8 45.3 53.5 28.3 59.4 20.6 20.6 84.9 84.4 74.5 86.2 52.5 114.8 75.9 113.9 52.3 126.0 97.4 65.5 49.5 121.6 107.5 118.6 85.1 61.9 71.6 100.9 33.5 47.5 123.5 75.1 62.5 58.6 77.8 48.6 54.1 30.7 73.5 137.7 21.0 97.6 55.9 100.8 146.8 157.0 54.5 156.2 52.6 91.1 55.8 53.0 157.2 85.8 64.7 54.4 80.3 93.2 133.4 213.2 91.1 113.6 35.0 36.1 37.5 49.0 35.8 36.3 36.3 35.6 35.6 36.3 36.4 36.5 83.5 54.5 41.1 6.8 66.3 82.7 69.3 247.1 66.6 44.6 136.2 167.3 577.5 178.7 142.1 101.2 31.3 222.2 78.9 257.3 360.0 229.6 96.1 103.4 141.4 94.0 142.7 118.9 7.7 227.3 184.5 100.0 95.3 124.8 60.9 90.5 110.3 444.8 297.2 33.7 8.8 166.9 185.1 138.9 76.3 181.0 98.8 115.3 168.9 2.8 185.5 125.6 116.4 4.5 12.0 220.0 210.3 88.8 106.0 107.4 195.8 515.8 96.2 69.0 72.3 63.4 132.8 193.9 158.9 224.2 148.6 129.7 54.8 185.9 208.6 94.0 SDHD "cybS, PGL, PGL1" ENSG00000204370 "Succinate dehydrogenase complex subunit D" O14521 11 112086824-112120016 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Electron transport, Transport, Tricarboxylic acid cycle" "Cancer-related genes, Disease variant, FDA approved drug targets, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 530.2;Proximal tubular cells: 449.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045727 Approved "Intracellular and membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 39: Non-specific - Basic cellular processes" "HPA045727: AB_10963114" "unprognostic (9.13e-2)" "unprognostic (3.51e-2)" "unprognostic (4.47e-3)" "unprognostic (4.21e-2)" "unprognostic (1.93e-1)" "unprognostic (4.98e-2)" "unprognostic (5.69e-2)" "unprognostic (2.50e-1)" "unprognostic (1.83e-3)" "unprognostic (7.10e-2)" "unprognostic (3.03e-2)" "unprognostic (1.80e-1)" "prognostic favorable (1.99e-10)" "unprognostic (5.14e-2)" "unprognostic (1.58e-2)" "unprognostic (1.56e-2)" "unprognostic (7.51e-2)" 117.5 95.7 60.0 84.5 63.1 72.9 102.6 68.6 76.3 92.5 65.1 185.2 208.1 88.2 96.7 126.7 92.6 85.6 254.7 60.1 65.4 319.9 391.8 79.3 131.7 63.4 62.5 91.6 77.8 152.4 37.0 95.0 63.2 87.9 190.8 37.4 112.6 100.9 354.7 64.3 175.6 98.1 64.7 85.1 101.1 34.1 63.7 102.5 136.8 449.6 124.8 117.9 76.4 68.2 84.0 67.3 58.1 89.4 212.0 170.7 97.3 97.5 147.6 106.8 132.2 244.8 222.1 155.5 288.4 131.0 156.1 203.5 175.4 139.8 129.8 129.9 92.4 142.8 51.9 140.1 165.6 222.4 107.5 189.6 160.2 110.5 189.1 124.6 153.0 109.6 156.0 208.7 135.0 95.2 143.9 215.0 77.4 333.8 211.6 126.2 145.8 294.4 221.6 175.2 83.5 55.8 135.3 194.8 107.0 81.8 198.9 164.2 108.0 103.8 132.3 114.7 95.0 59.1 73.2 270.7 58.8 297.0 100.5 233.7 293.3 208.8 158.4 390.1 173.1 235.2 170.8 168.8 308.7 198.1 204.3 191.8 257.5 207.9 322.9 151.7 189.9 348.9 60.0 63.1 68.6 76.3 60.1 65.4 63.4 62.5 63.2 64.7 63.7 68.2 104.3 80.1 51.1 12.4 78.0 81.6 102.2 262.2 83.6 12.2 61.0 78.4 216.5 120.1 108.1 90.1 8.4 154.3 55.2 203.8 530.2 82.9 9.9 41.6 67.6 76.4 50.4 70.2 9.6 58.9 124.1 104.6 75.4 41.2 65.9 32.3 76.8 169.7 162.9 11.8 11.2 129.1 154.6 97.1 74.4 37.0 104.1 94.2 76.5 9.4 118.6 52.9 75.2 8.0 9.7 54.1 134.2 99.6 80.9 61.6 253.1 449.9 60.5 18.9 92.1 78.3 110.7 70.4 55.8 127.1 74.4 179.0 71.4 86.2 176.0 98.6 IL18 "IGIF, IL-18, IL-1g, IL1F4" ENSG00000150782 "Interleukin 18" Q14116 11 112143253-112164096 "Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 124.5;skin 1: 149.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 173.1;Basal respiratory cells: 186.4;Basal squamous epithelial cells: 215.1;Kupffer cells: 241.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 25.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 117.9;CAPAN-2: 182.3;HaCaT: 167.0;HBEC3-KT: 125.8;hTCEpi: 188.5;PC-3: 110.2;U-2 OS: 208.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003980, CAB007772" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA Yes 196000 16000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Golgi apparatus" Cytosol "CAB007772: AB_562304, HPA003980: AB_1851670" "unprognostic (2.31e-3)" "unprognostic (3.25e-1)" "prognostic favorable (2.78e-4)" "unprognostic (3.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.62e-1)" "unprognostic (1.65e-1)" "unprognostic (8.15e-2)" "unprognostic (3.23e-1)" "unprognostic (2.78e-1)" "unprognostic (1.96e-3)" "unprognostic (4.13e-1)" "unprognostic (3.58e-2)" "unprognostic (1.51e-1)" "unprognostic (3.19e-2)" "unprognostic (3.15e-2)" "unprognostic (9.01e-2)" 19.9 6.1 5.3 18.2 5.4 31.6 12.6 5.9 8.6 38.0 7.0 34.1 22.0 2.4 3.3 124.5 8.0 23.0 3.0 5.3 6.0 23.8 9.1 23.0 67.8 7.5 6.2 1.9 17.9 1.3 2.9 6.7 7.4 6.1 29.1 6.9 15.0 3.0 6.0 149.6 22.0 3.6 6.7 29.3 13.4 1.9 5.7 8.0 3.7 2.1 25.7 25.3 77.0 11.3 117.9 40.0 0.0 0.4 0.0 0.0 0.7 2.0 0.0 0.0 0.1 22.4 182.3 0.1 25.7 0.3 3.2 167.0 0.0 125.8 0.0 0.3 1.2 17.5 35.6 9.9 3.9 9.3 32.6 0.2 188.5 0.3 43.5 0.2 0.1 0.1 0.5 0.3 1.6 0.2 0.2 0.9 0.2 31.9 110.2 0.1 0.1 0.4 79.9 24.8 0.1 0.0 78.4 52.1 0.5 1.0 31.0 25.4 0.3 0.4 208.9 1.2 35.9 0.4 0.3 0.6 0.2 67.1 0.2 6.8 8.7 16.0 0.1 10.9 0.0 0.7 0.1 0.0 25.8 0.7 0.0 0.5 9.5 19.6 6.3 5.6 0.0 2.5 5.3 5.4 5.9 8.6 5.3 6.0 7.5 6.2 7.4 6.7 5.7 11.3 1.0 173.1 38.4 0.7 6.0 122.9 33.5 186.4 215.1 2.6 4.6 7.7 1.0 41.5 66.1 9.2 0.0 2.3 10.8 109.9 80.3 24.7 2.4 94.9 1.4 4.6 14.5 26.3 3.8 143.0 3.7 18.8 20.9 32.5 101.2 2.8 8.2 1.9 68.4 0.0 4.6 30.1 57.0 241.0 37.3 1.9 0.0 123.8 3.6 61.8 38.8 2.7 6.2 2.0 1.1 161.4 104.6 4.5 4.6 23.6 67.5 22.3 69.6 39.1 6.6 0.6 3.9 1.5 1.3 152.6 111.2 1.8 9.6 0.3 47.8 90.5 TEX12 ENSG00000150783 "Testis expressed 12" Q9BXU0 11 112167372-112172556 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "retina: 8.6;testis: 20.7" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 211.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-698: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA038289, HPA038290" Enhanced NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA038289: AB_10672742, HPA038290: AB_2675934" "unprognostic (1.49e-1)" "unprognostic (6.57e-2)" "unprognostic (1.01e-1)" "unprognostic (2.92e-2)" "unprognostic (1.07e-1)" "unprognostic (2.93e-3)" "unprognostic (2.03e-1)" "unprognostic (1.55e-1)" "unprognostic (1.26e-1)" "unprognostic (1.21e-1)" "unprognostic (2.91e-1)" "unprognostic (9.20e-4)" "unprognostic (1.71e-2)" "unprognostic (2.97e-1)" "unprognostic (6.54e-2)" "unprognostic (4.10e-2)" "unprognostic (3.16e-3)" 0.3 0.0 0.1 0.1 0.1 0.4 0.4 0.5 0.3 0.2 0.1 0.3 0.6 0.2 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.2 8.6 0.2 0.1 0.9 0.7 0.4 0.2 0.0 0.2 0.2 20.7 0.2 0.1 0.1 0.7 0.2 0.2 0.2 0.1 0.0 0.0 0.2 0.1 0.3 0.2 0.0 0.0 0.1 0.1 0.3 0.1 0.4 0.7 0.2 0.2 0.1 0.0 0.1 0.2 0.2 0.5 0.0 0.3 0.0 0.0 0.4 0.4 0.2 0.2 0.2 0.3 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.3 0.7 0.1 0.4 0.2 0.2 0.1 0.6 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.1 0.4 0.2 0.1 0.0 0.0 1.4 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.3 0.4 0.0 0.5 0.1 0.3 0.4 0.0 0.1 0.0 4.2 0.1 0.3 0.3 0.0 0.2 2.0 0.0 0.1 0.1 0.0 0.0 1.7 0.2 0.1 0.2 0.0 0.2 0.0 0.3 0.0 0.4 0.3 0.0 2.2 0.1 0.0 0.0 1.9 5.1 0.9 0.3 0.0 1.0 0.6 0.3 0.0 0.5 0.2 0.1 0.1 0.7 0.1 0.2 0.3 0.1 0.0 0.4 6.6 0.2 0.4 211.7 36.1 0.0 0.4 0.0 0.3 0.2 0.2 0.3 BCO2 "B-DIOX-II, BCDO2, FLJ34464" ENSG00000197580 "Beta-carotene oxygenase 2" Q9BYV7 11 112175510-112224699 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 47.2;liver: 52.3;retina: 55.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 410.8;Horizontal cells: 134.6;Rod photoreceptor cells: 254.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.9;HHSteC: 12.3;U-937: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061542 Supported NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA061542: " "unprognostic (2.92e-1)" "unprognostic (1.89e-1)" "unprognostic (3.76e-2)" "unprognostic (1.40e-1)" "unprognostic (1.91e-1)" "unprognostic (1.50e-2)" "unprognostic (7.60e-3)" "unprognostic (1.88e-1)" "unprognostic (3.18e-2)" "unprognostic (6.40e-2)" "unprognostic (2.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.36e-4)" "unprognostic (2.31e-2)" "unprognostic (9.86e-2)" "unprognostic (1.07e-2)" "unprognostic (1.34e-1)" 3.8 21.3 4.9 0.3 5.8 0.2 0.8 5.0 9.3 2.2 10.0 2.6 0.5 1.6 1.0 3.4 9.7 5.1 47.2 4.8 6.4 2.5 52.3 1.7 0.4 7.4 6.7 1.3 1.1 0.3 4.4 3.8 7.0 1.9 0.5 55.9 0.9 0.9 21.4 1.1 1.7 1.1 5.9 1.1 0.9 3.0 6.5 0.3 2.5 14.3 0.8 2.3 4.6 8.3 0.1 1.0 0.4 0.6 0.4 0.4 0.0 0.3 0.2 0.1 0.5 0.0 5.9 0.4 0.5 0.6 0.6 1.2 0.0 0.2 0.4 0.1 0.1 0.7 0.5 0.4 12.3 0.4 0.2 0.1 2.3 0.1 0.3 1.1 0.0 0.1 0.1 0.3 0.1 0.0 0.5 1.3 0.1 0.6 0.2 0.3 0.1 0.2 0.2 0.2 0.5 0.2 0.4 0.2 0.0 0.1 0.3 0.2 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.3 0.0 2.6 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 4.9 5.8 5.0 9.3 4.8 6.4 7.4 6.7 7.0 5.9 6.5 8.3 1.7 3.2 3.1 10.1 2.0 3.3 20.3 8.6 6.8 12.6 2.2 1.5 51.3 58.6 8.2 5.5 410.8 0.3 4.4 5.0 0.0 3.7 3.1 26.5 3.0 4.5 8.3 0.0 50.7 2.1 0.4 16.3 1.1 1.2 5.7 4.0 16.4 83.1 1.0 134.6 51.5 1.6 2.0 2.8 3.8 2.4 4.1 7.9 1.8 47.8 3.7 13.9 7.2 7.1 51.3 1.6 2.6 3.8 1.2 10.3 18.2 1.3 67.6 254.6 0.0 5.0 3.8 8.3 2.5 1.8 3.1 0.7 5.2 6.8 3.5 8.7 PTS PTPS ENSG00000150787 "6-pyruvoyltetrahydropterin synthase" Q03393 11 112226367-112269955 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" Lyase "Disease variant, Phenylketonuria" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001481 Uncertain Approved Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 16: Pancreatic endocrine cells - Mixed function" Cytosol "HPA001481: AB_1079716" "unprognostic (2.08e-2)" "unprognostic (1.91e-1)" "unprognostic (9.66e-3)" "unprognostic (8.38e-3)" "unprognostic (4.58e-1)" "unprognostic (3.28e-3)" "unprognostic (2.38e-2)" "unprognostic (1.81e-2)" "unprognostic (2.05e-2)" "unprognostic (8.74e-2)" "unprognostic (2.59e-1)" "unprognostic (7.07e-2)" "unprognostic (3.81e-2)" "unprognostic (1.20e-2)" "unprognostic (2.97e-1)" "unprognostic (1.52e-3)" "unprognostic (1.65e-1)" 11.7 63.0 17.6 10.2 18.7 22.7 20.5 20.2 27.6 17.5 20.2 18.9 15.0 13.6 29.7 29.0 11.7 20.6 8.8 16.5 25.1 44.7 68.9 7.8 10.5 23.1 26.1 9.9 15.0 29.0 32.8 18.0 24.6 21.1 21.5 19.0 17.5 16.4 18.5 17.0 16.1 13.0 19.7 7.7 27.4 10.3 20.5 4.4 23.2 10.9 12.4 21.7 19.2 21.6 24.5 24.2 33.4 12.9 23.9 26.8 35.4 78.3 38.8 45.5 48.5 57.0 26.1 28.5 53.5 51.6 60.8 38.0 47.5 54.8 50.6 19.7 28.8 7.5 44.6 55.8 70.9 18.4 4.0 47.8 77.1 43.9 53.0 36.5 35.2 24.6 24.9 16.8 30.1 29.8 14.8 23.8 23.1 54.2 48.3 9.4 6.3 37.6 101.2 38.8 32.2 32.5 41.1 43.8 26.0 109.0 32.3 15.2 40.2 42.5 43.0 49.7 60.7 9.9 20.8 69.4 29.3 19.4 44.1 1.1 0.4 0.4 1.2 0.7 1.3 1.5 1.7 1.8 0.7 1.6 1.1 1.5 0.2 1.5 2.0 2.0 1.9 0.7 17.6 18.7 20.2 27.6 16.5 25.1 23.1 26.1 24.6 19.7 20.5 21.6 43.7 19.2 26.5 13.1 28.6 122.6 80.4 146.2 59.2 17.4 69.4 69.0 95.0 47.1 85.7 55.2 0.0 56.7 41.4 80.0 211.3 91.9 5.5 66.4 37.0 42.8 80.0 23.2 16.8 78.9 120.7 47.9 37.8 72.6 20.8 45.1 34.6 123.6 36.9 10.1 25.4 73.1 150.5 21.4 38.1 7.6 14.6 28.4 26.6 15.0 26.1 48.5 22.6 17.6 36.1 114.4 74.4 25.9 33.0 91.9 58.3 151.0 80.8 18.3 26.3 22.7 70.8 23.3 92.6 65.4 131.1 70.3 28.5 59.6 44.4 114.9 PLET1 C11orf34 ENSG00000188771 "Placenta expressed transcript 1" Q6UQ28 11 112248153-112260860 "Predicted membrane proteins" Differentiation "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Astrocytes: 1.0;Excitatory neurons: 1.7;Inhibitory neurons: 2.0;Microglial cells: 1.0;Oligodendrocytes: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.8" HPA040237 Uncertain NA NA "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA040237: AB_10793960" "unprognostic (8.70e-2)" "unprognostic (1.75e-1)" "unprognostic (8.51e-3)" "unprognostic (5.19e-2)" 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.2 0.1 0.6 0.3 0.3 0.4 0.1 0.3 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NCAM1 "CD56, NCAM" ENSG00000149294 "Neural cell adhesion molecule 1" P13591 11 112961247-113278436 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 290.1;heart muscle: 145.5" "Cell type enhanced" "Detected in many" "Astrocytes: 530.8;Excitatory neurons: 461.4;Inhibitory neurons: 441.2;Oligodendrocyte precursor cells: 939.0;Oligodendrocytes: 1013.5" "Cancer enriched" "Detected in many" 8 "glioma: 31.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 15 "NK-cell: 53.7" "Lineage enriched" "Detected in many" 15 "NK-cells: 53.7" "Cell line enhanced" "Detected in many" "HEL: 61.3;RH-30: 132.5;SCLC-21H: 107.4;SH-SY5Y: 52.7;U-138 MG: 72.8;WM-115: 79.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000142, CAB018071, HPA039835" Enhanced Enhanced "Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 1200000 2300000000 "Cluster 48: NK-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane" Cytosol "CAB000142: , CAB018071: AB_627129, HPA039835: AB_2676705" "unprognostic (7.04e-2)" "unprognostic (1.16e-1)" "unprognostic (2.77e-2)" "unprognostic (2.18e-2)" "unprognostic (2.91e-1)" "unprognostic (1.74e-3)" "unprognostic (2.82e-1)" "unprognostic (4.42e-3)" "unprognostic (2.13e-1)" "unprognostic (1.63e-2)" "prognostic favorable (9.11e-6)" "unprognostic (8.13e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (2.97e-2)" "unprognostic (2.24e-1)" "unprognostic (3.75e-2)" "unprognostic (5.82e-5)" 4.6 65.7 124.0 3.9 169.1 1.5 2.7 118.1 140.3 35.1 0.0 47.8 4.6 62.7 3.5 7.0 40.4 4.8 145.5 135.6 179.1 3.2 2.9 1.8 1.3 140.4 134.2 43.8 2.6 0.0 22.2 0.5 147.4 14.9 6.6 117.7 3.6 17.7 31.2 2.1 18.3 46.9 129.7 4.7 23.0 5.0 137.0 0.4 30.2 29.5 1.0 34.8 24.3 290.1 0.1 0.0 20.8 0.3 0.2 0.5 0.3 1.0 0.0 0.7 1.2 0.3 0.3 3.1 18.2 20.1 0.8 0.3 0.1 0.0 0.0 0.4 12.1 61.3 0.1 0.0 2.1 0.0 9.5 12.4 0.1 0.1 18.6 0.1 0.0 0.1 0.0 1.0 20.8 0.0 0.2 5.2 1.8 0.0 0.4 0.1 132.5 10.0 0.0 0.0 107.4 52.7 0.1 0.5 0.1 2.0 0.2 0.8 0.2 72.8 33.4 0.3 31.8 0.1 0.5 0.1 8.3 28.4 79.0 0.0 0.2 0.0 3.6 0.0 1.2 0.0 0.1 0.5 0.1 0.0 0.0 1.4 0.7 53.7 0.0 0.0 0.2 1.9 124.0 169.1 118.1 140.3 135.6 179.1 140.4 134.2 147.4 129.7 137.0 290.1 13.7 0.0 0.0 530.8 0.4 1.7 0.5 0.0 0.0 123.5 5.7 0.6 131.7 0.0 0.0 0.0 37.5 0.6 27.7 0.1 1.9 18.3 6.7 0.3 2.4 2.8 5.4 0.0 461.4 0.0 0.2 12.8 5.1 0.5 1.3 11.7 7.1 0.7 0.4 175.0 441.2 0.0 8.2 4.7 3.8 5.9 15.2 1.8 0.0 35.6 1.2 216.6 59.8 939.0 1013.5 1.3 0.0 10.1 5.6 0.4 0.0 0.2 0.7 98.0 0.0 107.5 4.8 1.0 2.8 0.4 1.7 0.1 13.4 5.6 0.0 0.2 TTC12 "FLJ13859, FLJ20535, TPARM" ENSG00000149292 "Tetratricopeptide repeat domain 12" Q9H892 11 113314579-113383544 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 51.9" "Group enriched" "Detected in many" 4 "Early spermatids: 158.8;Late spermatids: 210.5;Respiratory ciliated cells: 62.0;Spermatocytes: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 26.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038542, HPA038543, HPA061364" Enhanced Approved Nucleoplasm NA NA "Cluster 24: B-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA038542: AB_2676072, HPA038543: AB_10674686, HPA061364: AB_2684492" "unprognostic (2.32e-1)" "unprognostic (1.17e-1)" "prognostic favorable (3.14e-4)" "prognostic favorable (2.48e-5)" "unprognostic (2.11e-2)" "unprognostic (3.27e-1)" "unprognostic (1.13e-3)" "unprognostic (3.33e-3)" "unprognostic (7.67e-2)" "unprognostic (1.57e-1)" "unprognostic (6.03e-2)" "unprognostic (5.46e-2)" "prognostic favorable (5.95e-5)" "unprognostic (3.04e-2)" "unprognostic (1.44e-1)" "unprognostic (1.26e-1)" "unprognostic (1.35e-2)" 4.1 8.3 4.5 3.7 4.5 2.0 11.0 4.7 4.7 6.8 15.7 5.4 3.8 6.8 12.1 4.3 17.7 5.3 7.5 3.4 5.5 9.3 5.7 5.7 6.5 7.4 6.7 8.7 5.5 24.4 12.6 4.6 5.3 10.3 6.6 11.3 7.8 11.6 4.0 5.8 4.9 4.1 5.2 4.9 5.3 51.9 5.8 4.5 16.2 6.6 7.7 5.7 4.7 5.9 5.6 3.7 8.3 9.0 6.0 7.3 4.9 5.0 9.4 6.5 6.3 4.2 15.8 3.0 7.3 0.2 5.3 12.0 0.0 24.2 9.8 3.4 4.0 1.2 11.8 6.5 12.0 0.0 2.0 8.1 9.7 0.0 14.3 12.8 4.7 0.0 5.1 2.0 12.0 7.3 0.0 1.1 5.3 19.4 6.3 0.0 1.3 5.4 12.1 4.2 7.2 10.0 26.4 9.3 5.3 11.3 16.9 3.4 1.7 1.2 5.9 5.2 9.0 1.7 3.0 0.1 5.6 0.5 0.0 0.0 1.0 1.5 1.7 1.0 2.6 2.3 2.2 1.8 2.0 3.3 2.5 2.5 1.5 1.4 0.9 1.6 0.9 1.2 4.5 4.5 4.7 4.7 3.4 5.5 7.4 6.7 5.3 5.2 5.8 5.9 2.3 0.0 5.4 31.6 6.6 1.3 4.9 9.0 5.2 7.5 4.0 4.1 7.5 7.2 14.4 5.5 2.1 6.8 4.2 3.0 5.9 6.3 158.8 24.6 3.7 2.4 4.8 1.7 10.9 4.9 2.0 3.8 2.0 4.8 2.5 5.2 0.4 2.7 2.6 1.7 3.1 3.3 4.1 1.0 1.3 210.5 3.4 1.7 1.8 9.4 1.6 6.0 5.2 7.1 11.7 3.8 3.5 3.8 4.9 2.5 3.9 8.9 62.0 9.1 6.6 3.6 4.3 84.7 7.5 3.6 1.7 2.7 3.8 4.9 4.6 2.6 ANKK1 X-kinase ENSG00000170209 "Ankyrin repeat and kinase domain containing 1" Q8NFD2 11 113387779-113400416 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 3.5" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 7.2;Club cells: 2.4;Ionocytes: 6.1;Respiratory ciliated cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 2.1;RT4: 1.0" "Not detected" "Not detected" HPA012813 Uncertain NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA012813: AB_1844832" "unprognostic (5.63e-3)" "unprognostic (6.67e-3)" "unprognostic (5.09e-3)" "unprognostic (6.27e-3)" "unprognostic (5.56e-4)" "unprognostic (7.02e-2)" "unprognostic (2.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.50e-1)" "unprognostic (3.15e-1)" "unprognostic (3.36e-2)" "unprognostic (2.18e-1)" "unprognostic (5.39e-6)" "unprognostic (3.17e-2)" "unprognostic (3.83e-2)" "unprognostic (2.79e-1)" "unprognostic (4.65e-2)" 0.2 0.5 0.6 0.2 2.7 0.1 0.7 0.5 1.0 1.1 2.0 0.3 0.1 0.4 0.3 0.5 2.0 0.0 0.1 0.4 0.7 0.4 0.3 0.6 0.4 1.0 3.1 0.7 0.3 0.1 3.0 0.0 0.7 1.5 0.0 0.6 1.3 0.3 0.3 3.5 0.6 0.0 0.7 0.8 0.2 1.0 1.1 0.1 0.7 0.0 0.2 0.4 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.7 0.5 1.0 0.4 0.7 1.0 3.1 0.7 0.7 1.1 0.7 0.2 0.0 0.5 1.6 0.2 0.6 0.8 7.2 0.0 1.2 0.3 1.1 0.4 0.0 2.4 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.2 1.9 0.1 0.2 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.7 0.2 0.2 6.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.5 1.1 0.0 1.1 0.0 0.0 0.5 0.0 0.0 6.0 0.9 0.0 1.3 0.4 0.1 0.1 0.0 0.6 0.0 0.5 0.2 0.0 0.5 DRD2 ENSG00000149295 "Dopamine receptor D2" P14416 11 113409605-113475691 "FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 77.8;pituitary gland: 59.6" "Cell type enriched" "Detected in some" 12 "Horizontal cells: 60.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "basal ganglia: 77.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 88.3" "Region enriched" "Detected in many" 10 "basal ganglia: 205.3" "Region enriched" "Detected in many" 4 "basal ganglia: 146.3" "HPA015139, HPA015691" Supported Supported NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 62: Horizontal cells - Visual perception" "HPA015139: , HPA015691: AB_1847834" "unprognostic (8.49e-2)" "unprognostic (2.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.29e-4)" "unprognostic (2.32e-2)" "unprognostic (1.15e-1)" "unprognostic (1.97e-2)" "unprognostic (5.89e-2)" "unprognostic (4.40e-2)" "unprognostic (8.33e-4)" "unprognostic (1.10e-1)" "unprognostic (6.65e-3)" "unprognostic (2.29e-1)" "unprognostic (1.71e-1)" "unprognostic (4.82e-2)" "unprognostic (8.49e-3)" 0.3 8.4 6.1 0.1 77.8 0.0 1.3 0.2 18.3 1.6 0.0 0.4 0.0 1.1 0.1 0.5 1.3 0.2 0.1 1.4 13.6 1.2 0.0 0.2 0.0 3.9 40.7 0.2 0.2 0.0 59.6 0.0 21.1 0.9 0.3 11.7 11.9 0.7 0.8 0.9 0.2 1.5 0.7 0.0 0.1 1.0 14.8 0.0 0.0 0.3 0.0 0.2 0.6 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 7.6 0.2 0.0 0.0 0.0 6.1 0.0 0.0 0.1 0.1 4.9 0.1 0.0 0.0 0.0 0.0 0.0 10.0 0.0 1.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 3.1 0.4 0.0 0.0 1.0 0.1 0.0 0.0 9.6 0.0 0.0 0.1 88.3 10.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 2.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 77.8 0.2 18.3 1.4 13.6 3.9 40.7 21.1 0.7 14.8 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 4.7 0.1 2.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 60.6 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMPRSS5 "MGC141886, MGC148044" ENSG00000166682 "Transmembrane serine protease 5" Q9H3S3 11 113687547-113706373 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.6;choroid plexus: 20.8" "Cell type enhanced" "Detected in some" "Astrocytes: 26.4;Excitatory neurons: 5.4;Horizontal cells: 5.0;Oligodendrocytes: 15.5" "Cancer enhanced" "Detected in some" "glioma: 5.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.0;CAPAN-2: 3.2;OE19: 2.0;WM-115: 2.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010992 Approved Nucleoplasm NA NA "Cluster 70: Brain - Nervous system development" "Cluster 17: WM-115 - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm "HPA010992: AB_1858152" "unprognostic (1.53e-2)" "unprognostic (3.81e-2)" "unprognostic (2.97e-1)" "unprognostic (1.05e-1)" "unprognostic (1.93e-1)" "unprognostic (8.73e-2)" "unprognostic (2.99e-3)" "unprognostic (3.08e-1)" "unprognostic (5.19e-3)" "unprognostic (8.49e-2)" "unprognostic (8.13e-2)" "unprognostic (3.38e-2)" "unprognostic (1.96e-3)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (4.04e-3)" 1.3 0.5 28.1 0.2 34.7 1.4 2.0 24.9 39.0 0.8 20.8 0.7 0.1 0.5 0.2 0.5 0.7 0.7 1.0 28.2 27.0 1.0 1.0 0.7 0.2 34.0 29.8 0.6 0.5 0.0 1.6 0.2 33.1 0.8 0.3 1.1 9.6 0.3 2.6 2.1 0.7 0.3 28.5 0.8 0.8 2.1 32.1 0.3 0.6 0.5 0.3 0.7 1.0 50.6 0.2 0.3 2.0 1.1 0.2 0.1 0.3 0.5 0.2 0.3 0.4 1.1 3.2 0.1 1.4 0.2 0.3 0.4 0.1 0.2 0.1 0.2 0.6 0.4 0.3 0.0 0.1 0.5 0.4 0.2 0.2 0.2 0.5 0.2 0.3 0.7 0.4 0.2 0.4 0.0 0.4 0.6 0.2 2.0 0.1 0.4 0.2 0.0 0.3 0.2 0.3 0.4 0.2 0.0 1.6 0.2 0.2 0.2 0.2 0.4 0.7 0.3 0.3 0.2 0.1 0.0 0.1 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 34.7 24.9 39.0 28.2 27.0 34.0 29.8 33.1 28.5 32.1 50.6 0.2 0.0 0.0 26.4 0.2 0.3 0.2 0.0 0.0 0.5 1.0 0.9 0.5 0.0 0.1 1.8 2.1 0.0 0.2 0.2 0.0 0.3 0.1 0.3 0.2 0.3 0.0 1.3 5.4 0.9 0.0 0.3 0.0 0.4 0.0 0.4 0.4 0.2 0.1 5.0 2.8 0.0 0.0 0.0 0.3 0.3 0.3 0.1 0.0 2.8 0.1 3.2 0.0 3.5 15.5 0.6 0.0 0.0 0.3 0.2 0.0 0.0 0.1 1.3 0.0 0.5 0.1 1.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.2 ZW10 KNTC1AP ENSG00000086827 "Zw10 kinetochore protein" O43264 11 113733187-113773735 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, ER-Golgi transport, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 44.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011565, HPA051253, HPA055410" Enhanced Supported "Endoplasmic reticulum,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Endoplasmic reticulum, Cytosol" "CAB011565: AB_779030, HPA051253: AB_2681408, HPA055410: AB_2682809" "unprognostic (4.33e-3)" "unprognostic (6.65e-2)" "prognostic favorable (2.70e-4)" "unprognostic (3.12e-1)" "unprognostic (5.51e-2)" "unprognostic (6.52e-2)" "prognostic unfavorable (8.57e-4)" "unprognostic (7.44e-2)" "unprognostic (8.01e-3)" "unprognostic (5.91e-2)" "unprognostic (1.18e-3)" "unprognostic (2.78e-2)" "unprognostic (8.57e-3)" "unprognostic (6.00e-2)" "unprognostic (8.73e-2)" "unprognostic (2.95e-1)" "unprognostic (1.17e-3)" 6.9 6.0 3.5 8.1 4.1 9.2 10.9 5.0 4.8 8.1 3.7 8.3 7.2 7.6 7.3 9.6 6.1 5.9 5.6 3.8 3.8 8.8 13.0 6.4 9.4 4.2 4.7 6.9 9.1 7.2 5.1 7.7 4.6 7.9 10.0 6.8 8.3 7.3 13.4 13.7 7.1 8.7 3.8 7.0 7.3 13.5 4.2 12.1 6.7 12.0 12.0 8.5 7.5 5.7 25.0 14.4 30.2 22.1 18.4 20.0 17.4 26.1 21.4 32.2 32.5 38.1 46.1 29.0 34.5 25.8 28.1 34.2 36.7 31.6 46.0 19.1 15.1 30.9 12.0 23.5 20.6 31.7 18.8 16.5 20.8 34.1 27.4 14.2 33.5 31.7 36.3 11.8 33.8 12.2 29.3 20.9 21.7 29.8 29.0 27.0 34.4 32.7 21.2 22.2 13.3 15.7 29.1 24.2 11.8 24.2 44.9 17.4 21.1 28.8 44.2 14.4 28.8 6.1 10.6 30.6 9.9 38.1 33.0 8.5 7.4 7.4 6.3 10.4 8.5 5.9 5.9 5.6 9.5 5.1 5.4 6.8 1.9 6.2 9.2 3.0 5.6 5.6 3.5 4.1 5.0 4.8 3.8 3.8 4.2 4.7 4.6 3.8 4.2 5.7 5.6 0.0 4.8 11.1 5.8 12.1 7.6 7.5 8.0 2.9 5.9 5.0 6.8 7.2 7.3 0.0 0.0 9.2 3.9 3.9 9.8 10.1 10.7 7.7 7.1 6.9 3.6 10.7 12.5 11.8 10.0 6.5 8.2 12.7 3.8 7.8 3.9 8.1 9.2 3.3 11.1 4.6 4.1 6.0 5.4 7.3 5.0 6.1 3.6 10.3 8.0 7.6 3.1 12.1 18.7 8.4 3.8 5.7 10.4 5.6 5.3 7.2 4.8 4.9 19.7 7.0 7.0 44.4 17.5 9.4 12.5 10.5 5.9 6.9 6.4 5.8 CLDN25 ENSG00000228607 "Claudin 25" C9JDP6 11 113779747-113780500 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA053555 Uncertain NA NA "HPA053555: AB_2682186" "unprognostic (1.02e-2)" "unprognostic (3.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP28 KIAA1515 ENSG00000048028 "Ubiquitin specific peptidase 28" Q96RU2 11 113797874-113875570 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 62.7;skeletal muscle: 68.3;tongue: 66.5" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 152.2;Excitatory neurons: 57.0;NK-cells: 73.2" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 20.1" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006778, HPA006779" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 38: Heart - Muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "Nuclear bodies" "HPA006778: AB_1080520, HPA006779: AB_1080517" "unprognostic (2.54e-1)" "unprognostic (2.72e-1)" "unprognostic (2.99e-2)" "unprognostic (3.72e-2)" "unprognostic (5.51e-2)" "unprognostic (2.30e-1)" "unprognostic (9.73e-3)" "unprognostic (3.00e-1)" "unprognostic (2.04e-3)" "unprognostic (1.82e-3)" "unprognostic (3.17e-2)" "unprognostic (1.19e-1)" "unprognostic (5.11e-2)" "unprognostic (2.06e-2)" "unprognostic (9.03e-2)" "unprognostic (1.35e-3)" "unprognostic (5.03e-2)" 5.8 6.7 3.2 9.5 4.3 5.8 10.4 20.1 9.5 21.1 0.6 10.4 9.6 11.5 11.3 9.6 9.8 7.7 62.7 4.6 1.8 9.9 11.3 7.5 15.6 2.1 1.7 14.1 8.2 15.5 7.4 8.0 3.4 11.3 11.7 27.1 12.0 14.2 68.3 7.0 10.4 13.1 1.2 13.8 9.2 9.2 1.9 9.0 10.1 66.5 15.5 9.8 8.4 5.3 18.3 20.2 26.7 35.4 21.3 20.9 18.8 13.2 18.0 17.5 29.7 30.2 25.6 24.2 29.3 18.0 40.1 35.1 37.9 24.8 24.1 27.1 17.2 12.9 13.8 16.3 13.0 16.8 12.4 12.6 18.5 20.2 23.8 25.4 32.0 11.9 22.7 15.3 18.5 9.3 12.9 27.1 32.0 33.6 14.4 31.3 37.1 29.4 19.3 17.8 11.6 12.6 31.4 10.7 10.1 82.7 25.8 5.8 17.1 19.2 28.3 17.8 13.8 10.4 15.9 20.1 1.9 32.1 12.8 0.2 5.0 3.4 23.2 3.7 12.1 15.5 5.7 16.8 6.4 12.3 3.8 13.1 1.4 28.6 6.4 1.9 9.2 10.3 3.2 4.3 20.1 9.5 4.6 1.8 2.1 1.7 3.4 1.2 1.9 5.3 7.3 9.6 8.8 18.3 17.8 1.7 7.3 9.9 13.6 18.7 9.7 9.8 152.2 5.7 9.9 5.5 18.8 4.4 32.1 3.3 5.9 6.7 1.7 6.6 11.6 7.9 4.9 2.5 57.0 3.9 4.7 12.2 11.7 8.7 1.3 18.9 7.5 8.8 4.4 5.0 34.1 9.6 4.1 6.5 2.5 2.0 6.8 7.4 1.8 10.3 8.2 10.3 73.2 29.1 21.3 3.5 5.3 13.9 21.7 7.1 7.3 7.1 14.6 21.5 6.6 10.3 11.0 15.8 11.4 7.7 2.0 1.1 18.6 9.0 8.9 5.8 HTR3B 5-HT3B ENSG00000149305 "5-hydroxytryptamine receptor 3B" O95264 11 113904677-113949078 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "brain: 2.5" "Cell type enhanced" "Detected in some" "Excitatory neurons: 4.4;Oligodendrocytes: 1.2" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 2.5" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039559 Approved NA NA "Cluster 11: Basophils - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA039559: AB_10672779" "unprognostic (1.60e-2)" "unprognostic (8.37e-2)" "unprognostic (2.84e-1)" "unprognostic (3.28e-1)" "unprognostic (1.71e-1)" "unprognostic (2.46e-1)" 0.0 0.1 0.0 0.2 0.5 0.5 0.0 0.0 2.5 0.0 0.0 0.1 0.1 0.1 0.2 0.5 0.0 0.1 0.0 1.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.0 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.2 0.9 0.4 0.1 0.3 0.2 0.1 0.0 0.5 0.0 2.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR3A "5-HT3A, 5-HT3R, HTR3" ENSG00000166736 "5-hydroxytryptamine receptor 3A" P46098 11 113974881-113990313 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 8.0;salivary gland: 5.0" "Group enriched" "Detected in some" 11 "Ductal cells: 23.9;Exocrine glandular cells: 53.3;Pancreatic endocrine cells: 34.7" "Cancer enriched" "Detected in many" 7 "ovarian cancer: 15.2" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 15 "memory B-cell: 3.9;naive B-cell: 13.8;plasmacytoid DC: 11.6" "Group enriched" "Detected in many" 127 "B-cells: 13.8;dendritic cells: 11.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.0;Daudi: 5.9;NTERA-2: 3.6;SCLC-21H: 18.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 16 "amygdala: 1.7;cerebral cortex: 2.7;hippocampal formation: 2.5" HPA069442 Supported NA NA "Cluster 24: B-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 1: Pancreatic cells - Digestion" "HPA069442: AB_2732132" "unprognostic (6.46e-3)" "prognostic favorable (6.26e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (1.26e-4)" "unprognostic (3.36e-3)" "unprognostic (8.36e-3)" "unprognostic (1.65e-5)" "unprognostic (1.46e-2)" "unprognostic (8.87e-2)" "unprognostic (6.21e-2)" "unprognostic (6.80e-3)" "unprognostic (3.00e-2)" "unprognostic (1.65e-2)" "unprognostic (8.72e-2)" "unprognostic (2.01e-1)" "unprognostic (3.79e-1)" "unprognostic (3.40e-2)" 0.0 0.4 0.7 2.1 1.2 0.0 0.0 0.4 1.0 0.0 0.4 2.1 0.6 0.1 0.0 0.5 0.0 0.0 0.0 1.1 0.5 0.1 0.0 0.0 6.5 0.4 0.5 0.0 2.6 0.0 0.0 0.0 0.4 0.0 0.4 0.0 5.0 0.0 0.0 0.7 1.7 0.7 0.4 0.5 0.8 0.1 0.5 0.4 0.0 0.0 8.0 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 5.9 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.6 13.8 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.2 0.7 1.2 0.4 1.0 1.1 0.5 0.4 0.5 0.4 0.4 0.5 0.6 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.8 0.0 0.0 3.0 0.1 0.0 23.9 0.0 0.3 0.0 0.0 0.0 0.0 0.3 53.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.1 34.7 0.1 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ZBTB16 "PLZF, ZNF145" ENSG00000109906 "Zinc finger and BTB domain containing 16" Q05516 11 114059711-114256765 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor" "Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 105.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 134.8;Inhibitory neurons: 125.9;NK-cells: 119.4;Skeletal myocytes: 163.9" "Cancer enhanced" "Detected in many" "prostate cancer: 5.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 23.3;MAIT T-cell: 39.4;naive B-cell: 11.0;NK-cell: 10.9" "Group enriched" "Detected in many" 5 "B-cells: 11.0;NK-cells: 10.9;T-cells: 39.4" "Cell line enhanced" "Detected in some" "ASC diff: 71.5;ASC TERT1: 38.6;HEL: 40.7;HHSteC: 26.6;HSkMC: 26.7;hTCEpi: 30.6;hTERT-HME1: 25.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001499, CAB004540" Uncertain NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "CAB004540: AB_2218941, HPA001499: AB_1079640" "unprognostic (2.21e-1)" "unprognostic (2.17e-1)" "unprognostic (7.30e-2)" "unprognostic (1.18e-1)" "unprognostic (2.53e-1)" "unprognostic (3.05e-1)" "unprognostic (1.25e-2)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (8.79e-4)" "unprognostic (1.68e-1)" "unprognostic (1.18e-1)" "prognostic favorable (2.21e-4)" "unprognostic (2.57e-3)" "unprognostic (2.67e-1)" "unprognostic (1.00e-1)" "unprognostic (5.90e-2)" 55.8 20.8 5.1 3.4 14.9 7.6 32.3 11.7 24.8 25.9 17.7 20.9 0.9 29.6 4.0 28.1 30.9 13.1 28.1 9.9 8.4 10.6 14.5 27.1 8.8 20.1 8.4 51.4 61.7 34.3 6.4 9.6 15.2 15.1 3.3 2.2 13.3 7.0 88.6 28.5 16.3 15.8 4.9 13.2 18.3 4.0 7.1 6.5 29.3 105.8 2.0 29.4 19.7 18.0 0.0 0.0 13.0 0.0 71.5 38.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 40.7 0.0 0.0 26.6 0.9 0.7 26.7 30.6 0.0 25.6 0.0 4.6 5.5 0.1 0.0 0.8 0.0 2.2 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 4.2 1.2 23.3 1.2 39.4 0.4 1.2 3.5 0.1 11.0 1.3 0.6 0.3 10.9 1.2 0.0 0.4 5.7 5.1 14.9 11.7 24.8 9.9 8.4 20.1 8.4 15.2 4.9 7.1 18.0 95.3 22.4 7.7 59.1 16.3 11.1 81.7 7.7 8.6 32.6 12.6 16.8 35.1 42.9 7.1 9.2 0.0 0.1 51.2 0.7 1.9 1.9 21.1 1.7 41.3 49.5 7.2 18.1 134.8 0.9 0.2 59.8 1.1 3.8 14.5 38.2 65.7 50.9 0.8 0.0 125.9 3.7 8.2 27.0 5.3 27.7 89.8 32.1 7.2 65.6 7.6 20.2 119.4 45.8 43.4 0.3 0.1 92.2 17.7 38.6 28.8 6.6 6.8 1.9 105.2 163.9 75.3 0.4 9.9 1.8 6.8 0.3 27.8 0.2 3.5 9.4 NNMT ENSG00000166741 "Nicotinamide N-methyltransferase" P40261 11 114257787-114313536 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 388.9" "Group enriched" "Detected in many" 6 "Hepatocytes: 3913.2;Skeletal myocytes: 1639.1" "Cancer enhanced" "Detected in all" "renal cancer: 204.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 255.3;LHCN-M2: 144.1;RPTEC TERT1: 479.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059180 Approved Approved "Golgi apparatus,Cytosol" NA NA 410000 "Cluster 85: Liver - Metabolism" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" Cytosol "HPA059180: AB_2683940" "unprognostic (1.62e-1)" "unprognostic (2.33e-2)" "unprognostic (1.61e-2)" "unprognostic (6.14e-2)" "unprognostic (3.51e-1)" "prognostic unfavorable (2.07e-4)" "unprognostic (1.76e-1)" "unprognostic (5.84e-2)" "unprognostic (2.71e-2)" "unprognostic (2.48e-2)" "unprognostic (1.20e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.02e-6)" "prognostic unfavorable (1.75e-4)" "unprognostic (1.11e-1)" "unprognostic (3.37e-3)" "unprognostic (2.77e-2)" 130.9 11.4 1.0 25.2 1.1 0.9 91.9 1.4 1.5 36.0 1.9 37.1 1.5 31.0 2.8 15.4 55.0 43.1 35.5 1.3 1.4 24.1 388.9 64.6 9.6 3.9 1.6 21.3 11.4 1.6 10.6 23.8 2.2 31.9 8.7 0.3 21.1 3.1 73.1 49.3 32.2 30.1 1.7 36.7 30.1 2.2 1.2 2.7 33.0 5.3 8.8 48.6 33.9 3.1 0.2 17.6 0.3 18.6 92.0 118.3 0.1 21.2 58.7 35.2 69.2 0.0 17.5 0.2 58.1 45.1 4.2 0.2 0.0 8.0 34.1 0.2 0.0 0.2 16.7 0.0 123.3 0.2 0.0 255.3 89.4 24.1 37.3 29.8 50.1 0.1 0.3 0.2 144.1 0.1 0.1 0.2 0.1 0.0 0.5 0.2 79.0 0.0 479.6 0.1 0.2 0.2 97.7 0.1 0.3 5.3 0.0 0.2 37.4 18.3 34.3 23.8 3.1 0.3 0.3 0.4 6.4 0.3 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.0 1.1 1.4 1.5 1.3 1.4 3.9 1.6 2.2 1.7 1.2 3.1 411.8 44.8 411.3 1.0 11.2 103.6 13.2 16.5 2.2 1.9 38.5 73.9 4.7 75.8 13.3 80.9 0.0 1.0 1.6 0.0 9.8 238.3 0.3 19.0 89.9 190.0 5.3 147.2 1.3 157.0 2.5 452.2 5.1 80.5 13.9 0.5 195.2 3913.2 28.4 0.0 1.6 0.0 0.0 126.8 142.1 1.6 74.3 9.2 96.0 1.9 5.7 0.0 0.0 0.0 0.2 323.1 0.0 13.2 1.5 10.8 0.0 99.2 11.9 0.2 0.0 1639.1 154.3 0.3 0.8 1.9 92.1 2.2 20.1 0.0 0.0 3.1 C11orf71 FLJ20010 ENSG00000180425 "Chromosome 11 open reading frame 71" Q6IPW1 11 114391443-114400511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 139.0" "Cell type enriched" "Detected in many" 4 "Late spermatids: 2360.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063943, HPA074787" Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 78: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "HPA063943: AB_2685157, HPA074787: AB_2686712" "unprognostic (1.24e-1)" "unprognostic (2.53e-2)" "unprognostic (1.42e-2)" "prognostic favorable (6.94e-4)" "unprognostic (7.35e-2)" "unprognostic (4.53e-2)" "unprognostic (1.83e-1)" "unprognostic (2.30e-3)" "unprognostic (1.58e-1)" "unprognostic (3.04e-3)" "unprognostic (1.39e-2)" "unprognostic (2.85e-2)" "prognostic favorable (7.01e-9)" "unprognostic (5.68e-2)" "unprognostic (5.43e-2)" "unprognostic (1.87e-1)" "unprognostic (1.17e-2)" 5.8 10.7 11.8 5.1 13.7 3.7 7.6 12.3 13.8 5.5 10.8 6.9 7.6 5.1 22.6 4.3 7.1 4.4 9.3 11.7 13.9 13.9 22.1 5.9 6.7 14.0 16.7 7.2 8.7 8.9 13.4 3.7 13.2 8.5 6.2 15.9 9.8 5.7 15.0 9.4 7.5 2.9 12.2 9.4 7.3 139.0 12.7 8.9 12.4 15.2 4.7 4.6 4.1 16.0 1.2 3.9 4.2 13.6 6.2 3.6 2.9 0.6 1.7 1.7 1.5 3.0 23.6 6.8 7.8 1.0 8.1 6.3 2.8 2.9 2.1 7.5 1.6 5.1 3.2 6.9 5.9 3.0 5.5 5.9 3.2 2.2 6.7 1.9 2.1 10.8 5.1 6.0 3.2 5.5 5.5 4.6 2.2 5.5 2.5 3.9 3.4 17.3 3.8 3.0 11.6 4.6 15.3 1.8 2.4 4.4 11.5 1.6 2.1 0.4 5.9 4.6 1.2 5.8 10.1 5.2 0.9 6.9 1.7 15.9 15.4 10.3 8.8 9.8 5.5 5.9 5.7 6.0 9.3 8.3 9.5 9.9 12.3 12.1 11.9 12.0 7.1 10.1 11.8 13.7 12.3 13.8 11.7 13.9 14.0 16.7 13.2 12.2 12.7 16.0 12.7 3.2 13.4 5.2 8.0 2.7 15.7 6.3 8.6 10.3 18.3 15.9 19.0 0.0 6.2 5.5 4.2 16.1 6.4 15.0 82.2 15.7 589.6 21.2 8.1 8.7 18.1 7.2 4.7 18.9 3.4 9.5 18.8 12.8 6.3 14.1 0.0 0.0 11.5 13.5 5.6 16.7 10.2 0.0 4.1 2360.8 13.1 13.6 5.4 2.8 11.2 31.5 7.2 4.0 18.5 10.5 15.5 9.1 17.2 9.2 33.0 78.6 18.9 14.1 6.6 7.6 8.0 70.6 9.9 10.4 2.6 14.6 7.4 19.6 12.7 11.4 RBM7 ENSG00000076053 "RNA binding motif protein 7" Q9Y580 11 114400030-114414203 "Predicted intracellular proteins" Meiosis RNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 196.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013993, HPA048003" Supported Enhanced Nucleoplasm NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "HPA013993: AB_1856137, HPA048003: AB_2680231" "unprognostic (2.90e-3)" "unprognostic (8.21e-3)" "prognostic favorable (6.14e-4)" "unprognostic (1.03e-2)" "unprognostic (1.43e-1)" "unprognostic (2.58e-2)" "unprognostic (1.93e-2)" "unprognostic (2.89e-1)" "unprognostic (9.38e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (1.05e-1)" "unprognostic (3.62e-2)" "unprognostic (5.49e-2)" "unprognostic (4.74e-2)" "unprognostic (1.84e-1)" "unprognostic (8.30e-2)" 18.5 9.1 3.4 6.5 5.3 39.8 15.3 7.6 7.8 12.9 3.6 13.1 6.2 13.9 4.9 13.3 13.9 10.5 9.9 4.0 5.1 12.7 18.0 13.7 6.8 6.3 5.0 16.4 10.0 9.6 7.2 11.3 5.0 10.1 11.2 6.8 12.7 8.7 12.2 10.8 11.3 10.9 5.2 10.1 12.1 11.5 4.0 15.2 10.4 14.6 9.3 12.6 13.2 6.6 13.1 13.4 17.0 11.5 21.9 27.6 11.3 31.1 43.5 34.6 37.8 30.7 28.1 24.2 34.5 28.0 26.0 11.0 19.7 23.6 40.4 15.3 8.4 27.5 14.5 27.3 36.7 18.9 15.3 32.2 25.0 31.2 41.7 32.6 30.1 17.1 19.8 2.9 20.8 6.4 23.0 9.5 13.9 13.1 19.7 14.5 29.5 18.2 26.1 22.2 13.1 12.5 18.8 10.4 8.9 27.5 6.8 5.0 26.6 9.1 17.2 10.2 22.8 10.8 12.4 18.8 7.3 22.7 14.9 53.0 15.3 17.8 11.5 13.7 15.2 11.9 11.6 10.5 15.2 9.7 14.8 11.6 14.0 17.3 16.5 14.0 14.7 10.6 3.4 5.3 7.6 7.8 4.0 5.1 6.3 5.0 5.0 5.2 4.0 6.6 49.4 16.0 25.7 2.0 44.0 67.4 78.4 48.4 41.5 11.5 47.4 31.9 15.1 30.0 34.2 29.5 12.5 51.0 52.4 30.8 66.5 49.8 196.4 37.6 38.8 45.0 47.4 26.1 5.4 35.1 78.0 51.7 26.0 51.3 40.0 20.1 37.9 27.5 29.8 8.4 5.6 30.9 40.7 27.4 55.3 29.5 31.4 30.8 42.7 7.5 32.2 24.5 28.8 8.5 10.2 39.0 37.6 17.0 18.0 71.2 38.1 46.5 27.8 13.0 0.0 49.1 47.6 35.3 16.9 32.8 68.6 92.5 46.6 18.7 38.4 82.6 REXO2 "CGI-114, DKFZP566E144, SFN" ENSG00000076043 "RNA exonuclease 2" Q9Y3B8 11 114439435-114450279 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038450, HPA038451" Enhanced Supported "Nucleoli,Focal adhesion sites,Mitochondria" NA NA 340000 "Cluster 6: Non-specific - Transcription" "Cluster 46: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" Mitochondria "Nucleoli, Focal adhesion sites" "HPA038450: AB_10672516, HPA038451: AB_10697391" "unprognostic (3.26e-3)" "unprognostic (2.36e-2)" "prognostic favorable (6.51e-4)" "unprognostic (6.84e-3)" "unprognostic (5.80e-3)" "unprognostic (1.06e-1)" "unprognostic (1.40e-3)" "unprognostic (1.78e-1)" "unprognostic (8.18e-3)" "unprognostic (2.49e-2)" "unprognostic (2.17e-3)" "unprognostic (1.02e-1)" "unprognostic (1.73e-2)" "unprognostic (6.75e-2)" "unprognostic (1.23e-1)" "unprognostic (7.69e-2)" "prognostic unfavorable (6.70e-4)" 51.1 57.2 23.5 40.3 25.9 55.0 57.1 26.3 31.5 73.4 28.6 80.4 24.3 71.5 46.5 65.8 38.1 47.8 140.3 24.0 29.5 102.5 50.2 42.0 32.5 30.3 28.1 69.0 45.5 154.5 32.5 56.9 29.7 72.5 47.2 9.2 115.3 58.0 40.8 50.5 33.1 106.7 26.6 44.8 65.4 53.5 25.7 30.4 36.5 40.5 37.1 68.3 64.4 29.9 159.3 92.7 32.1 88.4 254.6 268.7 81.9 266.3 192.9 122.6 155.4 244.9 261.2 88.8 258.2 220.8 185.4 97.4 74.1 219.5 201.5 86.9 61.3 98.1 136.0 144.7 339.2 72.3 29.5 190.8 206.0 157.4 163.7 214.1 223.1 84.7 183.9 48.6 278.5 38.7 49.4 84.0 102.3 119.1 160.3 45.7 112.1 317.1 177.0 126.9 59.8 38.5 122.7 86.7 110.8 134.8 184.9 35.6 231.4 162.5 194.2 124.0 161.6 39.7 52.4 146.3 111.3 165.2 89.7 64.3 14.0 21.3 32.2 19.2 37.2 37.6 47.9 41.1 18.8 29.2 43.0 35.1 3.5 45.2 20.6 70.1 75.3 29.1 23.5 25.9 26.3 31.5 24.0 29.5 30.3 28.1 29.7 26.6 25.7 29.9 82.9 105.8 56.4 20.9 42.3 138.9 146.5 189.1 88.2 14.9 99.2 100.6 370.0 47.1 126.5 95.6 2.1 171.6 55.3 27.2 277.8 126.6 83.6 75.3 110.8 98.4 80.9 315.2 20.0 70.7 188.5 176.8 48.4 85.2 31.8 40.1 89.6 80.0 98.2 5.0 17.4 82.9 89.5 21.0 56.7 48.1 210.6 33.9 241.9 15.9 41.9 36.5 29.9 25.1 33.5 110.0 33.7 176.8 103.8 199.6 26.7 371.4 126.5 8.3 52.6 90.6 177.0 237.3 82.1 119.9 162.7 269.1 47.5 120.6 72.4 130.4 NXPE1 "FAM55A, MGC34290" ENSG00000095110 "Neurexophilin and PC-esterase domain family member 1" Q8N323 11 114521645-114559895 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "intestine: 79.7" "Cell type enhanced" "Detected in some" "Distal enterocytes: 27.0;Early spermatids: 73.6;Intestinal goblet cells: 35.1;Late spermatids: 53.5;Paneth cells: 18.1;Undifferentiated cells: 36.2" "Cancer enriched" "Detected in single" 23 "colorectal cancer: 3.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049133 Enhanced "Intracellular and membrane" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA049133: AB_2680647" "unprognostic (2.81e-1)" "unprognostic (2.19e-3)" "unprognostic (3.40e-3)" "unprognostic (4.10e-1)" "unprognostic (1.05e-1)" "unprognostic (1.15e-1)" "unprognostic (1.69e-1)" "unprognostic (3.40e-2)" "unprognostic (1.76e-1)" 0.0 0.0 0.0 4.9 0.1 0.0 0.1 0.0 0.2 0.0 0.0 64.9 1.2 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.4 0.3 79.7 0.0 1.2 0.0 0.0 0.0 3.5 2.3 0.1 0.0 0.1 4.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.3 0.1 0.4 0.1 0.2 0.3 0.0 0.0 0.0 2.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 73.6 0.0 0.0 0.0 3.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 35.1 0.0 0.0 0.0 53.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 0.0 18.1 0.0 0.0 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 36.2 0.1 NXPE4 "C11orf33, FAM55D, FLJ20127" ENSG00000137634 "Neurexophilin and PC-esterase domain family member 4" Q6UWF7 11 114570591-114595786 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "intestine: 119.6;salivary gland: 77.2" "Group enriched" "Detected in some" 4 "Distal enterocytes: 95.5;Intestinal goblet cells: 88.1;Paneth cells: 41.8;Undifferentiated cells: 115.8" "Cancer enriched" "Detected in some" 15 "colorectal cancer: 13.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042801 Approved "Secreted to digestive system" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA042801: AB_10793986" "unprognostic (1.35e-2)" "unprognostic (1.14e-1)" "unprognostic (2.82e-3)" "unprognostic (1.27e-1)" "unprognostic (3.51e-3)" "unprognostic (1.06e-1)" "unprognostic (1.32e-1)" "unprognostic (1.47e-1)" "unprognostic (1.66e-1)" "unprognostic (7.47e-3)" "unprognostic (4.36e-2)" "unprognostic (2.05e-1)" 0.1 0.0 0.1 7.8 0.1 0.0 0.4 0.0 0.2 0.0 0.0 114.2 0.6 0.2 6.8 0.2 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 5.3 119.6 0.0 77.2 0.2 0.0 0.0 0.7 5.2 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.2 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.5 0.0 0.0 0.5 0.0 0.0 0.0 17.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 88.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 41.8 0.0 0.1 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 115.8 0.2 NXPE2 "FAM55B, FLJ25224" ENSG00000204361 "Neurexophilin and PC-esterase domain family member 2" Q96DL1 11 114678527-114707069 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "epididymis: 25.3;intestine: 9.9;salivary gland: 21.2" "Cell type enhanced" "Detected in some" "Astrocytes: 2.6;Distal enterocytes: 3.2;Early spermatids: 1.4;Enteroendocrine cells: 1.8;Intestinal goblet cells: 3.2;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 1.7;Paneth cells: 1.4;Prostatic glandular cells: 1.4;Undifferentiated cells: 1.4" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039744, HPA039876" Enhanced NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 27: Mucus-secreting cells - Mucin production" "HPA039744: AB_2676660, HPA039876: AB_2676721" "unprognostic (2.85e-1)" "prognostic favorable (9.29e-5)" "unprognostic (1.35e-2)" "unprognostic (2.64e-1)" "unprognostic (3.46e-2)" "unprognostic (9.35e-2)" "unprognostic (1.27e-1)" "unprognostic (6.40e-2)" "unprognostic (1.61e-1)" "unprognostic (3.96e-4)" "unprognostic (9.00e-2)" "unprognostic (9.22e-2)" 0.1 0.0 0.1 1.0 0.1 0.0 0.4 0.0 0.2 0.1 0.0 9.9 0.6 0.2 25.3 0.3 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.1 0.0 0.0 0.3 0.1 9.1 0.0 21.2 0.2 0.0 0.1 2.6 0.8 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.3 0.2 0.3 0.3 0.1 0.1 0.2 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 1.4 0.0 0.1 0.1 1.8 0.0 1.3 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.7 0.0 1.4 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.5 CADM1 "BL2, IGSF4, IGSF4A, Necl-2, NECL2, RA175, ST17, SYNCAM, SYNCAM1, TSLC1" ENSG00000182985 "Cell adhesion molecule 1" Q9BY67 11 115169218-115504957 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Differentiation, Host-virus interaction, Immunity, Spermatogenesis" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 287.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 464.8;Astrocytes: 980.7;Bipolar cells: 566.6;Muller glia cells: 489.9;Oligodendrocyte precursor cells: 676.5;Oligodendrocytes: 622.8;Rod photoreceptor cells: 759.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "gdT-cell: 8.0;myeloid DC: 8.1" "Group enriched" "Detected in many" 5 "dendritic cells: 8.1;T-cells: 8.0" "Cell line enhanced" "Detected in many" "CACO-2: 294.7;WM-115: 187.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037266 Enhanced Supported "Cell Junctions" NA NA 220000000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 77: Retina - Visual perception" "Cluster 39: CACO-2 - Unknown function" "Cluster 56: Bipolar cells - Visual perception" "Cell Junctions" "CAB037266: AB_532287" "unprognostic (1.50e-1)" "unprognostic (2.15e-1)" "unprognostic (1.92e-2)" "prognostic favorable (1.32e-4)" "unprognostic (4.11e-3)" "unprognostic (1.50e-1)" "unprognostic (2.75e-3)" "unprognostic (1.13e-2)" "unprognostic (1.77e-1)" "unprognostic (2.67e-1)" "unprognostic (6.61e-3)" "unprognostic (9.22e-2)" "unprognostic (2.92e-3)" "unprognostic (1.77e-2)" "unprognostic (1.54e-1)" "unprognostic (3.67e-2)" "unprognostic (5.40e-2)" 7.1 29.9 46.9 6.1 59.2 0.4 17.0 78.7 53.0 21.3 6.1 11.7 7.8 17.4 103.7 12.6 22.6 12.1 25.7 47.6 57.4 29.1 65.3 72.0 14.1 41.1 40.1 12.3 16.0 56.6 26.0 37.9 44.6 15.2 8.1 287.7 38.0 28.0 7.2 10.9 8.8 8.6 30.3 8.0 12.5 50.5 55.8 8.6 69.7 8.1 14.6 13.1 4.8 38.0 0.4 23.3 25.6 0.1 0.0 0.0 0.1 24.1 41.1 3.1 0.3 294.7 26.1 0.0 75.9 36.5 25.2 4.8 4.8 27.4 2.0 1.0 38.3 0.0 7.8 114.5 0.3 0.1 56.5 0.0 38.6 0.0 63.8 16.5 1.1 17.3 0.0 2.7 4.3 19.3 20.0 0.6 24.0 0.3 0.0 0.1 0.4 61.6 44.8 0.9 50.2 107.1 0.0 25.4 21.7 102.4 92.4 1.3 0.0 2.3 44.9 23.3 13.0 64.9 98.9 18.7 36.3 0.2 187.5 0.2 0.0 0.0 8.0 0.0 3.4 1.5 2.9 2.1 8.1 0.3 0.1 1.8 0.0 0.5 0.1 0.0 4.7 1.9 46.9 59.2 78.7 53.0 47.6 57.4 41.1 40.1 44.6 30.3 55.8 38.0 14.0 464.8 195.3 980.7 6.5 20.6 26.7 2.8 19.4 566.6 22.1 22.5 61.7 34.3 27.5 36.8 350.3 71.6 6.8 1.5 11.7 39.2 189.1 88.5 6.0 10.6 7.8 5.3 301.7 2.0 5.0 13.2 3.6 126.9 24.1 36.8 2.9 45.9 36.8 30.3 310.9 2.1 4.1 8.5 20.9 224.0 5.9 14.2 44.4 60.0 13.3 489.9 2.1 676.5 622.8 9.3 0.5 4.1 88.9 38.5 0.3 8.2 8.7 759.5 0.0 13.3 11.7 55.2 23.0 9.2 23.4 32.2 8.1 5.2 4.3 13.5 BUD13 "Cwc26, fSAP71, MGC13125" ENSG00000137656 "BUD13 homolog" Q9BRD0 11 116748170-116772987 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 51.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038340, HPA038341" Enhanced Enhanced Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA038340: AB_2675967, HPA038341: AB_10671528" "unprognostic (1.89e-1)" "unprognostic (1.73e-1)" "unprognostic (1.01e-2)" "unprognostic (2.77e-2)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (5.07e-5)" "unprognostic (1.77e-1)" "unprognostic (8.39e-2)" "unprognostic (1.46e-1)" "unprognostic (4.23e-2)" "unprognostic (9.10e-2)" "unprognostic (1.81e-1)" "unprognostic (4.53e-2)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.63e-1)" 10.8 7.5 7.4 12.2 8.9 12.7 13.5 10.5 9.3 11.8 8.5 11.9 11.0 15.4 10.5 11.4 13.7 8.1 8.0 7.3 8.8 9.1 9.7 12.2 16.4 8.6 8.1 16.0 11.3 10.5 8.0 11.0 8.8 10.2 13.4 10.6 10.1 10.6 12.3 11.2 12.8 12.8 7.7 12.7 11.3 21.6 8.5 25.5 12.0 14.0 18.8 11.0 11.2 10.4 22.4 12.0 33.3 20.1 10.4 12.5 16.6 21.6 23.9 24.3 23.5 28.6 33.0 47.1 26.8 17.9 25.4 30.7 27.2 16.8 26.6 27.8 11.1 55.1 8.8 21.8 12.7 46.9 31.6 11.3 19.2 20.6 20.8 15.6 24.0 46.1 36.0 22.8 20.2 17.7 57.5 41.0 20.0 31.6 19.0 42.9 28.6 36.3 17.0 25.5 19.7 26.2 25.3 18.3 10.0 21.0 25.1 30.6 13.7 27.7 17.5 14.3 29.0 9.3 12.4 39.1 9.0 42.6 25.3 15.8 7.6 20.2 10.0 7.8 10.8 10.4 8.6 7.9 8.2 7.4 9.5 8.1 9.1 7.5 8.7 7.2 8.1 5.7 7.4 8.9 10.5 9.3 7.3 8.8 8.6 8.1 8.8 7.7 8.5 10.4 11.7 9.6 5.6 6.2 14.3 7.6 10.8 7.1 11.4 6.8 6.6 6.0 4.9 2.8 6.5 9.2 12.5 9.2 9.5 11.7 7.9 8.5 13.5 10.4 8.7 8.5 9.6 17.7 7.2 8.1 10.5 7.8 7.1 9.3 11.4 9.6 7.1 8.0 8.2 3.3 6.8 6.9 2.0 12.0 6.7 5.3 9.0 7.8 7.2 3.7 9.4 7.3 26.8 9.0 11.2 6.4 8.5 10.9 16.6 6.4 15.4 5.8 10.9 7.3 6.6 8.5 7.7 51.2 21.8 11.0 4.8 9.9 13.1 7.9 11.3 7.0 ZPR1 ZNF259 ENSG00000109917 "ZPR1 zinc finger" O75312 11 116773799-116788039 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 228.5;Late spermatids: 418.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022596, HPA030979" Uncertain Approved Vesicles NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 23: Testis - Cell cycle regulation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 31: Spermatids - Spermatogenesis" Vesicles "CAB022596: , HPA030979: AB_2673684" "unprognostic (2.12e-2)" "unprognostic (3.55e-1)" "unprognostic (6.22e-2)" "unprognostic (1.44e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (8.01e-4)" "prognostic unfavorable (5.87e-6)" "unprognostic (1.04e-1)" "unprognostic (1.09e-1)" "unprognostic (9.42e-2)" "unprognostic (4.96e-3)" "unprognostic (4.79e-2)" "unprognostic (2.17e-2)" "unprognostic (1.48e-1)" "unprognostic (1.73e-1)" "unprognostic (1.71e-2)" "unprognostic (6.66e-2)" 21.2 12.3 12.2 14.3 12.7 35.2 16.5 10.9 13.4 13.4 8.3 13.9 10.6 14.0 13.0 16.5 13.5 11.6 14.3 13.7 13.6 16.3 24.5 14.4 15.6 12.4 12.2 15.2 21.1 9.6 11.8 12.8 12.6 13.3 12.6 5.6 12.3 12.3 28.4 15.3 14.2 15.6 13.6 14.1 16.1 27.3 14.0 13.9 14.1 14.3 18.7 20.3 13.6 14.2 23.3 33.3 19.4 36.9 29.0 30.1 25.7 39.0 30.6 34.4 36.6 84.0 41.1 53.2 67.4 39.1 61.9 31.0 53.9 35.7 48.5 34.7 26.5 112.6 18.1 45.6 57.4 51.4 45.2 28.7 49.3 65.6 105.6 23.0 38.7 33.8 54.4 35.3 50.7 28.9 42.3 64.0 35.5 63.9 49.7 32.9 29.6 58.9 33.1 40.0 25.3 43.7 32.0 42.2 28.1 33.1 28.5 34.9 33.3 44.3 22.0 26.2 55.6 24.6 19.8 64.3 24.2 89.9 43.5 12.7 20.7 16.5 15.9 22.2 18.5 28.1 21.6 20.5 22.5 22.6 21.2 19.3 3.0 24.5 18.5 16.2 23.7 20.3 12.2 12.7 10.9 13.4 13.7 13.6 12.4 12.2 12.6 13.6 14.0 14.2 23.8 9.6 15.9 0.7 37.0 0.0 66.3 0.0 32.5 8.8 21.6 20.1 11.7 20.0 9.9 20.2 0.0 34.5 36.3 13.6 45.0 45.8 228.5 18.9 20.1 22.0 23.4 14.7 1.1 40.2 58.0 21.3 18.8 24.2 28.0 29.9 13.9 19.9 36.3 5.0 1.4 19.2 0.0 19.5 0.0 418.8 19.0 25.1 0.0 1.9 36.6 7.9 26.8 1.0 2.4 62.5 20.3 12.4 29.4 83.1 42.5 28.8 2.9 6.2 6.6 29.3 23.3 75.2 33.2 30.4 0.0 45.8 34.3 27.1 25.4 84.2 APOA5 "APOA-V, RAP3" ENSG00000110243 "Apolipoprotein A5" Q6Q788 11 116789367-116792420 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Lipid transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 216 "liver: 582.1" "Cell type enriched" "Detected in some" 88 "Hepatocytes: 1249.5" "Cancer enriched" "Detected in single" 489 "liver cancer: 112.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 55 "Hep G2: 35.6" "Not detected" "Not detected" "Secreted to blood" NA NA 114000000 21000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "unprognostic (1.57e-4)" "unprognostic (4.67e-3)" "unprognostic (5.57e-2)" "unprognostic (2.60e-3)" "unprognostic (2.40e-1)" "unprognostic (2.31e-4)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 582.1 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 35.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 10.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 11.4 1249.5 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 APOA4 ENSG00000110244 "Apolipoprotein A4" P06727 11 116820700-116823304 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "intestine: 3112.4" "Cell type enriched" "Detected in some" 44 "Proximal enterocytes: 10311.5" "Cancer enriched" "Detected in some" 29 "liver cancer: 291.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.7;CACO-2: 8.0;Hep G2: 7.7;NB-4: 7.3;RPMI-8226: 12.5;SH-SY5Y: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001352, HPA002549, CAB068250, CAB068251, CAB068252" Enhanced Approved Vesicles "Secreted to blood" NA NA 61200000000 74000000000 "Cluster 56: Intestine - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 45: Enterocytes - Digestion" Vesicles "CAB068250: AB_2665657, CAB068251: AB_2665659, CAB068252: AB_2665658, HPA001352: AB_1078179, HPA002549: AB_1078177" "unprognostic (8.81e-2)" "unprognostic (2.12e-2)" "unprognostic (1.75e-2)" "unprognostic (7.91e-2)" 0.3 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.9 2204.9 1.8 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 257.2 0.0 2.4 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 3112.4 3.0 0.0 0.1 4.6 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 3.1 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 77.5 0.0 0.0 0.0 234.3 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 221.5 0.0 0.0 0.0 10311.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 87.7 0.0 APOC3 ENSG00000110245 "Apolipoprotein C3" P02656 11 116829706-116833072 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Lipid transport, Transport" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "liver: 27649.0" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 84691.9" "Cancer enriched" "Detected in many" 643 "liver cancer: 4021.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "CACO-2: 107.3;Hep G2: 296.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA065365, HPA073918" Supported Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Secreted to blood" NA NA 106000000000 45000000000 "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" Nucleoplasm "Nucleoli, Cell Junctions" "HPA065365: AB_2732733, HPA073918: " "prognostic favorable (3.77e-4)" "unprognostic (2.33e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (1.60e-2)" "unprognostic (5.21e-2)" 4.1 1.2 0.0 1.0 0.0 0.0 2.5 0.0 0.1 0.4 0.0 7.2 907.0 0.5 0.0 1.1 1.9 0.0 1.6 0.0 0.0 18.2 27649.0 1.4 0.9 0.0 0.0 0.8 2.4 0.0 0.8 0.9 0.0 0.6 0.0 0.0 0.6 0.0 0.6 1.2 1106.7 0.5 0.0 8.0 1.5 1.0 0.0 0.5 0.8 0.2 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 4.2 0.0 0.0 0.0 0.1 107.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 296.2 0.0 10.7 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.2 2.3 0.2 0.0 0.0 0.0 6.3 3.9 0.0 0.1 1.1 3.8 4.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.2 0.0 3.4 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 67.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 674.9 0.0 0.0 0.0 0.2 0.0 0.0 3.9 0.0 4.2 0.0 0.0 39.7 0.0 823.7 0.0 0.4 1.5 0.1 0.0 0.0 0.0 0.3 707.9 84691.9 1.1 0.0 0.0 264.5 0.0 1107.4 0.0 12.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 224.0 0.0 0.0 0.0 10473.3 121.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 39.8 0.0 135.5 0.0 APOA1 ENSG00000118137 "Apolipoprotein A1" P02647 11 116835751-116837622 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Amyloidosis, Atherosclerosis, Cancer-related genes, Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 19248.5" "Group enriched" "Detected in many" 21 "Hepatocytes: 27332.1;Proximal enterocytes: 18348.1" "Cancer enriched" "Detected in many" 48 "liver cancer: 4515.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 17 "Hep G2: 3460.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB016778, HPA046715" Supported Approved Vesicles,Cytosol "Secreted to blood" NA NA 1450000000000 110000000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" Vesicles Cytosol "CAB016778: , HPA046715: AB_2679768" "unprognostic (1.88e-3)" "unprognostic (4.53e-2)" "unprognostic (7.46e-2)" "unprognostic (4.00e-3)" "unprognostic (3.70e-2)" "unprognostic (1.41e-1)" "prognostic favorable (5.05e-4)" "unprognostic (5.40e-2)" "unprognostic (1.89e-1)" "unprognostic (9.60e-3)" "unprognostic (1.59e-3)" "unprognostic (7.02e-2)" "prognostic unfavorable (1.67e-8)" "unprognostic (3.46e-3)" "unprognostic (1.15e-1)" "unprognostic (6.24e-2)" "unprognostic (9.54e-2)" 3.2 1.4 1.2 3.6 1.2 0.0 2.1 1.1 1.4 0.8 0.8 7.4 1709.3 3.5 0.4 1.1 6.1 1.7 67.2 1.0 1.1 3.7 19248.5 2.7 3.2 1.1 1.1 23.1 2.5 0.0 4.2 1.6 1.1 1.1 0.2 0.1 0.7 1.0 0.8 1.0 4053.7 2.1 1.1 9.0 14.6 384.5 1.2 0.9 3.7 0.2 0.1 0.5 1.5 1.2 0.0 0.0 0.6 0.1 0.0 0.0 15.0 0.0 0.0 0.0 0.0 203.4 0.3 3.1 6.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 7.3 1.9 3460.4 0.0 16.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.2 0.3 15.0 1.2 1.2 0.1 0.5 15.0 20.3 0.0 2.6 5.7 20.7 8.9 0.0 0.0 3.9 0.0 0.1 2.6 0.0 0.4 2.1 0.1 1.2 0.2 4.9 0.0 5.5 0.2 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.5 0.2 0.1 0.2 0.5 0.0 0.2 0.0 1.2 0.6 0.1 1.2 1.2 1.1 1.4 1.0 1.1 1.1 1.1 1.1 1.1 1.2 1.2 2.0 3.2 3.3 0.3 49.7 0.1 0.5 0.2 0.6 0.5 0.9 0.9 37.0 479.0 1.3 0.0 0.0 0.6 5.1 0.4 0.0 0.1 36.9 15.2 4.3 50.3 1.8 541.9 0.5 1.1 4.2 5.8 17.9 1.7 2.5 419.2 458.7 27332.1 3.3 0.0 0.8 458.8 0.0 681.2 2.0 149.7 22.4 2.1 0.0 0.0 0.0 0.3 3.1 0.0 0.3 0.3 458.2 4.9 1.0 0.1 18348.1 9.0 0.4 0.6 6.6 1.6 13.0 39.8 11.2 0.0 0.6 4.2 35.7 1051.7 175.7 0.3 SIK3 "FLJ12240, KIAA0999, L19, QSK" ENSG00000160584 "SIK family kinase 3" Q9Y2K2 11 116843402-117098437 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 375.5;Excitatory neurons: 384.4;Inhibitory neurons: 399.6;Oligodendrocyte precursor cells: 457.9;Oligodendrocytes: 1679.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045245, HPA048161" Enhanced Enhanced Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 36: HEL - Hemostasis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA045245: AB_2679270, HPA048161: AB_2680293" "unprognostic (3.19e-2)" "unprognostic (3.31e-1)" "unprognostic (2.78e-2)" "unprognostic (8.21e-2)" "unprognostic (1.31e-1)" "unprognostic (2.30e-2)" "unprognostic (2.73e-1)" "unprognostic (2.33e-2)" "unprognostic (7.63e-2)" "unprognostic (2.46e-2)" "unprognostic (1.28e-3)" "unprognostic (1.89e-1)" "prognostic favorable (1.12e-5)" "unprognostic (1.82e-1)" "unprognostic (6.85e-2)" "unprognostic (1.02e-2)" "unprognostic (3.28e-2)" 10.1 7.2 19.3 11.4 36.6 12.7 9.2 15.0 34.3 9.6 0.0 11.7 8.5 12.6 7.2 10.4 12.4 9.8 12.8 19.7 19.4 10.3 13.8 9.7 9.9 22.0 23.1 16.5 15.4 17.7 10.0 12.1 22.5 8.2 8.8 19.1 9.8 11.3 19.5 7.5 8.7 14.1 11.5 11.8 9.7 21.4 36.1 12.3 17.1 14.4 10.4 10.1 7.5 41.1 11.8 8.9 13.9 14.7 11.7 12.6 22.2 8.8 15.7 6.8 7.6 21.8 13.3 13.9 14.0 16.3 15.0 18.1 11.6 12.7 9.4 38.5 7.4 31.2 9.7 13.6 10.9 11.2 11.8 13.9 7.2 14.5 23.3 8.7 9.2 9.0 15.2 10.1 9.4 4.0 10.2 12.1 7.7 8.0 6.6 12.9 8.0 11.1 9.3 2.2 13.5 10.8 23.7 10.3 4.4 10.5 6.8 11.8 10.6 8.3 10.4 14.0 8.9 7.1 5.6 17.5 7.7 18.2 11.4 2.0 0.4 0.0 0.3 0.5 0.5 0.1 0.3 0.1 0.6 1.0 0.0 0.0 0.9 0.6 1.5 0.0 0.0 0.2 19.3 36.6 15.0 34.3 19.7 19.4 22.0 23.1 22.5 11.5 36.1 41.1 25.8 9.6 22.1 375.5 34.9 26.5 26.0 6.8 7.4 42.6 26.1 21.5 22.2 10.0 12.4 5.5 112.6 8.7 47.3 12.5 5.9 7.6 89.2 64.4 27.9 20.4 17.3 12.4 384.4 7.3 2.8 22.1 12.8 71.5 17.2 37.4 17.2 26.3 7.7 47.1 399.6 11.1 6.1 21.7 45.1 214.9 10.2 31.4 16.0 161.1 25.6 36.3 12.3 457.9 1679.9 9.2 8.2 14.3 28.1 22.0 9.7 6.9 20.5 63.9 0.0 35.0 23.2 18.0 14.8 7.4 24.3 29.7 44.2 14.8 11.4 30.0 PAFAH1B2 ENSG00000168092 "Platelet activating factor acetylhydrolase 1b catalytic subunit 2" P68402 11 117144284-117176894 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051836 Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA 250000 "Cluster 49: Eosinophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "Nucleoli, Plasma membrane" "HPA051836: AB_2681630" "unprognostic (1.08e-2)" "unprognostic (3.14e-2)" "unprognostic (2.07e-2)" "unprognostic (3.88e-2)" "unprognostic (9.94e-2)" "unprognostic (1.21e-3)" "prognostic unfavorable (9.44e-4)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.01e-1)" "prognostic favorable (4.25e-4)" "prognostic unfavorable (7.79e-5)" "unprognostic (8.18e-2)" "unprognostic (1.11e-2)" "unprognostic (9.97e-2)" "unprognostic (3.25e-1)" "unprognostic (2.46e-1)" "unprognostic (1.34e-1)" 23.1 34.3 35.1 21.2 42.2 41.2 20.6 43.9 45.0 20.8 28.4 21.7 22.4 23.8 22.7 23.9 20.9 19.9 28.2 33.9 45.4 25.3 23.8 21.7 20.7 47.6 45.0 23.3 20.3 21.9 24.5 25.4 51.0 22.3 20.0 23.2 17.4 16.1 15.7 22.0 19.4 20.4 48.7 20.4 23.0 30.0 43.6 21.5 31.9 20.3 22.2 26.9 20.9 51.6 43.4 48.5 54.9 79.7 60.1 41.7 42.6 71.0 61.7 38.8 35.2 89.2 92.9 46.6 99.4 85.8 38.7 67.7 80.6 92.0 50.9 41.8 31.1 120.0 41.3 57.9 53.8 42.1 44.0 46.6 71.7 77.4 96.7 42.4 64.8 25.6 65.0 34.6 60.3 27.7 40.8 61.7 50.4 60.0 37.8 44.9 62.2 51.2 59.8 66.7 60.9 80.5 82.2 61.6 28.1 46.6 68.4 35.6 103.8 70.4 46.3 34.8 51.4 10.8 17.9 61.5 28.3 78.8 60.4 63.4 51.4 48.6 39.0 58.7 46.4 43.8 44.7 41.0 37.4 41.2 45.8 49.2 63.7 33.1 66.3 27.4 35.1 53.1 35.1 42.2 43.9 45.0 33.9 45.4 47.6 45.0 51.0 48.7 43.6 51.6 48.5 28.9 34.8 17.9 41.4 122.4 44.5 45.9 54.7 38.6 55.4 32.1 37.6 58.6 32.8 66.2 47.9 40.4 44.4 48.0 46.9 61.3 13.1 63.6 54.8 64.8 82.6 39.4 29.2 39.5 86.7 40.8 33.6 78.4 19.0 36.8 79.6 47.0 43.0 47.1 32.5 41.8 36.7 65.4 175.9 13.7 45.4 52.1 49.8 20.6 59.3 36.2 21.6 13.0 61.2 99.0 50.5 34.3 28.9 67.0 33.7 54.8 32.9 38.3 13.1 42.8 40.0 54.7 84.7 53.2 115.9 54.6 41.6 35.2 45.4 50.6 SIDT2 CGI-40 ENSG00000149577 "SID1 transmembrane family member 2" Q8NBJ9 11 117178736-117197445 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 67.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "intermediate monocyte: 83.5;non-classical monocyte: 151.0" "Lineage enriched" "Detected in all" 7 "monocytes: 151.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052352 Approved NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 25: Pancreas - Digestion" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 41: Macrophages - Immune response" "HPA052352: AB_2681797" "unprognostic (3.83e-1)" "unprognostic (4.30e-2)" "unprognostic (9.92e-2)" "unprognostic (1.03e-1)" "unprognostic (3.01e-2)" "unprognostic (1.69e-1)" "unprognostic (3.34e-1)" "unprognostic (1.84e-1)" "unprognostic (1.39e-1)" "unprognostic (3.12e-1)" "unprognostic (2.67e-3)" "unprognostic (1.29e-1)" "prognostic unfavorable (4.18e-5)" "unprognostic (2.74e-2)" "unprognostic (2.20e-1)" "unprognostic (4.36e-2)" "unprognostic (5.22e-3)" 40.2 25.1 23.5 21.2 28.4 12.4 36.3 27.4 27.1 32.8 19.4 28.8 44.2 30.5 16.0 15.1 31.3 18.5 31.8 24.1 23.2 20.6 40.8 36.4 23.4 37.0 29.2 60.2 113.4 13.6 35.7 22.4 33.9 48.6 23.1 14.4 31.5 21.2 25.2 32.7 42.3 20.8 29.7 34.6 75.9 28.5 29.2 10.0 31.7 12.3 20.4 26.2 20.4 48.9 8.7 8.8 10.5 15.4 34.4 30.7 34.8 14.8 19.5 9.3 8.6 25.1 32.8 8.9 23.1 39.1 11.7 9.0 10.2 11.5 7.6 13.2 12.4 6.3 15.8 17.3 17.8 5.3 15.5 38.1 12.8 12.0 12.9 28.6 19.1 11.4 12.0 19.2 22.1 18.2 7.5 6.2 4.9 45.6 6.5 5.6 7.2 25.5 12.2 9.1 3.2 7.9 15.8 38.1 2.6 11.7 30.8 6.3 11.9 12.3 7.9 8.2 3.4 13.6 5.3 9.4 7.1 10.8 9.2 0.3 14.2 0.5 1.9 83.5 1.5 18.3 1.1 1.3 11.5 21.2 1.7 1.3 1.7 1.5 151.0 6.2 1.4 9.6 23.5 28.4 27.4 27.1 24.1 23.2 37.0 29.2 33.9 29.7 29.2 48.9 12.2 6.4 12.3 11.8 24.1 67.7 25.4 4.1 4.0 13.0 11.1 13.0 7.9 4.3 4.5 11.0 6.2 9.2 6.7 16.7 0.0 4.4 7.4 11.6 22.2 12.7 11.4 8.2 7.7 9.6 33.4 19.7 61.2 11.2 2.5 43.5 16.4 25.6 16.9 18.5 8.8 32.9 2.0 54.2 29.3 11.5 13.4 30.6 19.6 7.5 13.6 6.1 7.2 12.1 16.8 8.0 9.4 13.5 6.6 20.5 40.7 1.8 6.0 12.1 19.7 46.1 18.7 5.8 4.8 4.2 42.9 32.3 9.5 38.2 13.5 15.5 TAGLN "DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10" ENSG00000149591 Transgelin Q01995 11 117199370-117207464 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 9628.1;intestine: 11712.2" "Group enriched" "Detected in many" 4 "Breast myoepithelial cells: 2508.6;Peritubular cells: 2306.4;Sertoli cells: 2866.2;Smooth muscle cells: 4563.9" "Cancer enhanced" "Detected in all" "prostate cancer: 279.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "intermediate monocyte: 41.6;non-classical monocyte: 63.1" "Lineage enriched" "Detected in many" 12 "monocytes: 63.1" "Cell line enhanced" "Detected in all" "BJ: 1913.4;BJ hTERT+ SV40 Large T+: 1641.8;CACO-2: 1531.4;EFO-21: 2145.6;fHDF/TERT166: 2094.4;hTERT-RPE1: 1499.7;LHCN-M2: 1377.1;U-138 MG: 1598.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001447, HPA019467" Enhanced Approved Microtubules,Mitochondria,Cytosol No No 6300000 "Cluster 51: Monocytes - Innate immune response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Microtubules, Mitochondria" Cytosol "CAB001447: AB_564012, HPA019467: AB_1857245" "unprognostic (1.36e-2)" "unprognostic (1.06e-1)" "unprognostic (3.57e-3)" "unprognostic (1.91e-1)" "unprognostic (6.58e-2)" "unprognostic (1.02e-2)" "unprognostic (2.39e-2)" "unprognostic (7.16e-2)" "unprognostic (2.35e-2)" "unprognostic (1.24e-1)" "unprognostic (4.43e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (2.12e-7)" "unprognostic (9.58e-3)" "unprognostic (3.03e-1)" "unprognostic (1.10e-1)" "unprognostic (2.52e-3)" 2235.7 512.7 118.5 963.9 144.4 12.1 1680.5 126.1 215.9 3611.3 172.5 11712.2 451.2 9628.1 693.9 1954.6 4610.6 893.8 1583.5 119.6 120.4 774.5 302.8 1258.6 245.5 137.0 127.0 1643.4 218.6 65.3 254.6 348.0 129.2 4624.1 1154.6 22.9 461.8 6383.6 356.4 619.8 1948.4 7108.7 127.2 532.0 3148.4 202.5 138.2 52.2 723.2 152.4 59.9 5521.7 2331.2 130.0 17.5 5.5 293.3 8.2 140.0 123.8 226.7 1913.4 788.1 1641.8 609.0 1531.4 28.4 3.2 2145.6 2094.4 1.7 46.1 4.4 16.8 543.3 6.8 4.4 5.0 66.9 130.2 708.7 1.7 5.2 304.6 57.5 267.1 36.1 1499.7 3.3 4.5 3.3 6.7 1377.1 4.5 1.7 15.8 84.6 18.8 2.1 2.7 23.1 12.0 4.4 25.8 1.9 9.6 29.9 11.0 1.5 807.6 9.2 5.1 182.0 1598.8 276.9 14.4 86.6 8.9 8.8 21.7 9.1 7.7 6.2 1.8 2.7 0.1 0.3 41.6 0.5 3.6 0.1 0.0 3.2 5.1 0.2 0.1 0.3 0.0 63.1 1.6 0.5 2.1 118.5 144.4 126.1 215.9 119.6 120.4 137.0 127.0 129.2 127.2 138.2 130.0 264.8 38.5 6.1 4.6 10.3 63.9 453.4 248.6 10.8 9.9 74.0 2508.6 1.3 4.3 22.5 40.5 18.8 57.0 8.6 3.1 0.0 577.8 3.3 14.6 455.5 260.3 3.0 2.7 4.5 74.5 35.3 464.4 41.3 12.8 1.3 32.4 639.7 8.9 41.5 1.7 6.5 18.3 24.4 23.1 91.8 23.9 48.4 33.8 96.0 37.5 8.1 4.9 2.1 3.0 11.9 38.4 4.5 2306.4 3.2 414.0 12.1 2.2 23.0 9.9 2866.2 177.6 4563.9 6.0 13.7 8.6 60.9 32.2 15.1 8.3 3.1 62.0 PCSK7 "LPC, PC7, PC8, SPC7" ENSG00000160613 "Proprotein convertase subtilisin/kexin type 7" Q16549 11 117204337-117232525 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "NK-cells: 310.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 8400 "Cluster 15: NK-cells - Transcription" "Cluster 14: B-cells - Humoral immune response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (7.11e-2)" "unprognostic (2.90e-2)" "unprognostic (8.33e-3)" "unprognostic (4.24e-2)" "unprognostic (1.32e-1)" "unprognostic (2.77e-2)" "unprognostic (1.56e-1)" "unprognostic (2.60e-1)" "unprognostic (1.96e-1)" "unprognostic (2.41e-1)" "unprognostic (8.80e-2)" "unprognostic (1.09e-1)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.00e-1)" "unprognostic (3.03e-2)" 31.8 16.4 16.4 27.9 17.6 25.7 24.0 15.9 20.9 27.5 16.7 69.5 29.2 72.4 7.6 24.0 35.7 12.9 20.1 19.9 16.6 15.7 19.6 25.6 31.6 18.1 17.0 17.5 29.7 11.8 16.6 13.5 18.0 35.4 37.5 10.0 15.9 11.2 15.6 20.7 35.4 13.5 15.7 30.7 45.1 12.5 18.3 25.0 18.1 10.7 29.2 39.4 22.2 20.2 14.6 27.5 19.1 21.4 23.3 19.0 15.0 48.5 22.2 24.1 23.9 38.3 82.6 24.8 33.5 38.6 31.1 48.0 25.2 34.7 15.5 34.2 24.2 36.7 40.7 17.5 26.1 23.2 49.4 32.9 22.5 33.0 26.4 12.4 41.2 28.0 22.5 22.0 34.8 19.0 31.5 24.3 17.6 63.4 28.1 19.1 16.9 29.5 30.1 33.7 24.9 32.3 39.6 51.1 7.5 14.8 32.3 18.6 36.4 36.4 16.4 31.5 34.3 13.4 8.7 14.0 18.6 33.1 33.3 7.9 7.1 9.0 38.1 9.8 33.0 23.5 29.7 35.6 7.6 18.5 20.8 24.7 5.3 41.0 11.5 8.8 42.8 20.6 16.4 17.6 15.9 20.9 19.9 16.6 18.1 17.0 18.0 15.7 18.3 20.2 47.4 48.1 36.2 44.4 93.3 70.1 50.0 35.2 19.4 124.1 31.2 23.5 8.1 35.8 42.5 47.8 246.0 50.7 97.4 204.9 5.9 27.4 6.4 21.0 40.3 47.5 62.4 27.4 47.2 54.5 39.0 38.5 110.6 36.5 34.1 30.2 77.4 27.8 32.4 87.5 41.4 91.2 24.4 60.6 83.9 7.5 33.5 39.2 53.4 25.3 54.6 21.8 310.0 48.2 62.0 73.7 132.2 39.9 58.7 39.0 98.2 9.2 22.9 178.8 72.3 87.5 107.7 64.4 24.5 27.4 94.3 62.5 127.3 42.7 110.3 53.3 RNF214 DKFZp547C195 ENSG00000167257 "Ring finger protein 214" Q8ND24 11 117232625-117286454 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "T-reg: 20.5" "Group enriched" "Detected in all" 5 "granulocytes: 6.4;T-cells: 20.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039332 Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Golgi apparatus, Cytosol" "HPA039332: AB_10671874" "unprognostic (7.36e-2)" "unprognostic (4.91e-2)" "unprognostic (9.90e-2)" "unprognostic (1.66e-2)" "unprognostic (6.34e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (6.03e-5)" "unprognostic (2.06e-1)" "unprognostic (6.47e-2)" "unprognostic (1.40e-1)" "unprognostic (5.67e-2)" "unprognostic (8.48e-2)" "unprognostic (1.25e-2)" "unprognostic (3.04e-1)" "unprognostic (1.82e-1)" "unprognostic (2.33e-1)" "unprognostic (2.28e-2)" 10.9 11.7 8.9 8.8 10.2 12.4 10.8 10.5 9.9 11.4 6.0 10.8 9.4 11.0 8.5 9.2 9.9 8.9 10.5 7.8 10.1 10.3 13.2 9.1 10.8 9.9 9.4 13.2 21.8 11.5 12.5 11.0 9.6 9.6 9.4 12.2 11.3 10.0 17.9 10.1 10.1 11.2 7.3 11.4 12.7 18.6 10.4 14.4 13.5 13.4 10.6 11.0 9.6 11.9 12.0 14.1 31.7 19.1 15.6 15.6 17.9 19.3 17.5 20.5 21.7 21.6 28.1 16.8 32.7 22.6 19.6 15.7 34.8 16.9 21.1 31.3 10.2 53.3 11.7 16.6 30.5 25.2 19.8 14.4 18.2 25.4 37.6 23.1 25.7 29.0 30.7 17.9 21.1 9.0 20.8 21.0 17.2 20.7 14.0 22.5 21.1 22.4 19.3 17.8 20.5 22.2 22.1 14.8 10.4 24.7 25.1 16.9 24.4 20.7 16.6 11.4 16.3 10.3 7.7 20.2 7.6 20.3 24.3 6.4 2.5 2.7 2.3 2.4 1.4 1.9 7.8 4.0 2.2 1.9 2.2 2.1 1.1 1.2 2.5 2.5 20.5 1.6 8.9 10.2 10.5 9.9 7.8 10.1 9.9 9.4 9.6 7.3 10.4 11.9 19.1 25.6 15.1 23.5 14.8 5.0 9.6 10.6 21.6 23.8 11.1 14.5 12.8 15.7 14.8 5.5 10.4 14.9 10.0 9.0 9.8 13.3 46.8 15.7 26.2 11.9 9.0 14.7 20.9 12.7 13.6 12.9 14.8 15.5 5.1 21.6 7.9 7.1 12.8 13.5 24.7 8.5 10.2 10.6 6.3 20.0 10.2 13.5 8.8 12.2 12.7 14.0 14.4 33.7 24.5 10.6 9.8 12.8 14.9 7.1 10.6 12.1 10.0 37.1 13.1 20.9 19.5 64.6 57.5 15.5 5.1 19.4 17.8 28.2 8.8 7.6 BACE1 BACE ENSG00000186318 "Beta-secretase 1" P56817 11 117285207-117316259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 119.1;pancreas: 271.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 118.9;Early spermatids: 99.9;Late spermatids: 343.0;Oligodendrocytes: 99.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 88.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016358 Approved Supported "Plasma membrane" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 31: Spermatids - Spermatogenesis" "Plasma membrane" "CAB016358: AB_626716" "unprognostic (7.96e-3)" "unprognostic (8.05e-2)" "unprognostic (3.55e-2)" "unprognostic (3.05e-3)" "unprognostic (8.94e-2)" "unprognostic (3.39e-1)" "unprognostic (1.03e-1)" "unprognostic (2.60e-1)" "unprognostic (4.54e-2)" "unprognostic (8.04e-2)" "unprognostic (8.09e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.35e-2)" "unprognostic (1.16e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.76e-4)" 15.4 16.0 34.3 8.0 68.5 3.3 11.7 68.7 44.0 18.3 11.9 13.7 6.1 19.7 8.8 13.5 15.9 19.1 11.4 34.3 44.5 14.8 25.6 14.4 5.1 89.7 67.0 20.5 271.5 18.5 10.7 13.8 76.6 13.4 7.6 44.7 11.0 18.3 12.5 11.4 7.7 21.3 61.6 12.4 9.8 11.2 59.9 3.8 12.2 9.1 5.0 12.4 14.3 119.1 11.5 10.7 22.9 37.3 80.9 82.3 1.0 62.9 44.4 24.4 19.0 4.5 16.4 1.4 14.6 88.3 18.4 17.9 24.3 12.1 20.5 3.1 12.1 6.0 17.3 5.1 36.5 2.5 1.7 68.1 20.2 29.7 31.8 68.0 21.4 3.8 2.7 1.1 46.5 33.4 2.5 2.1 15.5 10.6 25.9 6.4 11.6 1.6 12.2 5.9 31.7 36.7 22.5 2.6 5.9 23.5 26.2 7.6 31.4 45.2 5.0 48.2 19.4 0.7 1.0 1.1 23.8 2.0 34.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 34.3 68.5 68.7 44.0 34.3 44.5 89.7 67.0 76.6 61.6 59.9 119.1 12.1 19.2 10.1 16.3 0.3 4.7 4.1 3.4 9.1 53.7 8.7 9.0 8.7 18.6 13.3 5.5 118.9 1.0 0.1 2.0 5.9 7.4 99.9 5.1 32.1 8.3 21.7 1.7 24.9 20.0 1.3 19.5 3.1 8.9 2.5 15.8 6.8 38.6 9.4 57.2 32.0 5.1 2.0 17.2 7.7 343.0 19.3 7.9 3.6 14.0 4.0 17.9 0.0 22.1 99.8 4.3 6.3 22.2 0.1 2.4 1.7 6.3 3.4 55.2 6.6 18.1 14.2 3.4 1.7 10.6 3.4 0.8 1.2 68.0 4.5 3.4 CEP164 "KIAA1052, NPHP15" ENSG00000110274 "Centrosomal protein 164" Q9UPV0 11 117314557-117413266 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, DNA damage, DNA repair, Mitosis" "Ciliopathy, Disease variant, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 454.5;Early spermatids: 241.0;Late spermatids: 291.7;Rod photoreceptor cells: 268.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037605, HPA037606" Uncertain Supported Nucleoplasm,Centrosome NA NA "Cluster 17: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoplasm, Centrosome" "HPA037605: AB_10672908, HPA037606: AB_10672498" "unprognostic (1.92e-1)" "unprognostic (8.99e-2)" "unprognostic (7.98e-2)" "unprognostic (1.14e-1)" "unprognostic (1.47e-1)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.40e-5)" "unprognostic (1.82e-1)" "unprognostic (3.14e-2)" "unprognostic (1.90e-1)" "prognostic favorable (5.93e-4)" "unprognostic (6.54e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "unprognostic (2.13e-1)" "unprognostic (7.93e-2)" 7.0 5.8 6.7 9.7 8.2 7.3 6.8 10.8 8.0 10.5 11.5 7.3 4.2 10.8 8.1 8.6 11.4 8.4 4.3 5.5 7.9 5.1 7.3 6.7 7.6 8.2 7.5 11.9 26.3 5.6 11.1 4.6 8.1 6.9 5.1 26.0 5.7 5.8 3.1 8.0 6.2 10.3 4.9 8.5 5.8 23.9 9.2 7.7 8.4 1.3 8.5 7.1 7.5 14.0 13.2 18.0 13.0 25.9 12.8 21.7 4.2 25.6 14.3 18.0 17.5 22.4 20.8 25.9 18.1 15.9 17.7 17.1 14.6 15.0 15.3 25.8 12.0 7.8 18.9 7.1 18.9 11.3 16.8 15.2 12.6 27.3 26.5 16.1 23.6 12.6 21.7 16.4 14.4 11.2 10.6 10.2 9.2 8.5 19.4 14.0 15.5 10.1 7.9 11.3 15.1 21.8 20.3 12.2 14.4 14.4 16.9 13.2 25.7 21.3 13.2 20.7 23.8 5.8 7.7 15.2 10.3 12.6 14.5 96.2 34.3 23.4 35.4 30.9 22.9 38.8 44.3 40.4 13.9 41.0 41.4 32.6 82.5 29.6 42.0 49.4 52.6 10.8 6.7 8.2 10.8 8.0 5.5 7.9 8.2 7.5 8.1 4.9 9.2 14.0 21.0 6.4 13.1 28.1 15.4 7.6 10.3 13.2 10.8 97.7 14.5 23.6 5.8 15.7 10.3 11.0 454.5 4.5 14.3 9.0 1.9 11.1 241.0 26.5 30.3 18.3 15.5 8.0 19.0 14.7 6.8 17.2 17.9 14.7 19.6 17.6 13.2 9.0 12.9 74.0 26.3 10.2 10.2 11.7 11.4 291.7 23.9 14.5 5.4 8.4 21.2 23.4 15.5 21.6 28.7 11.7 5.8 17.0 11.0 9.8 5.4 6.2 31.6 268.7 0.0 30.3 21.4 37.6 17.2 11.4 8.1 2.2 16.4 45.0 11.9 5.6 DSCAML1 KIAA1132 ENSG00000177103 "DS cell adhesion molecule like 1" Q8TD84 11 117427772-117817525 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 27.0;retina: 20.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 87.9;Excitatory neurons: 178.8;Inhibitory neurons: 232.4;Oligodendrocyte precursor cells: 352.8;Oligodendrocytes: 465.3;Rod photoreceptor cells: 137.7" "Cancer enhanced" "Detected in some" "glioma: 1.9;renal cancer: 2.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.6;HDLM-2: 1.7;RPTEC TERT1: 4.8;T-47d: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035230 Uncertain NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 77: Retina - Visual perception" "Cluster 6: T47d - Mammary gland" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA035230: AB_2674527" "unprognostic (5.12e-2)" "unprognostic (2.44e-2)" "unprognostic (1.07e-2)" "unprognostic (6.27e-5)" "unprognostic (8.48e-2)" "unprognostic (1.56e-2)" "unprognostic (2.28e-1)" "unprognostic (1.76e-1)" "unprognostic (7.96e-2)" "unprognostic (2.89e-2)" "unprognostic (2.39e-3)" "unprognostic (8.37e-2)" "prognostic favorable (8.37e-4)" "unprognostic (1.64e-1)" "unprognostic (1.86e-1)" "unprognostic (1.59e-1)" "unprognostic (1.12e-2)" 1.5 0.3 8.4 0.1 12.6 0.2 0.4 4.3 12.4 1.0 0.0 2.0 0.4 2.0 0.5 0.2 2.7 1.2 1.0 11.0 10.2 3.0 0.4 0.7 0.3 13.2 12.7 5.0 0.9 0.0 4.3 0.1 12.3 0.8 0.6 20.1 1.1 0.3 0.5 0.2 0.7 0.8 2.9 1.0 0.7 2.1 14.9 0.5 0.7 0.3 0.4 1.2 0.7 27.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 6.6 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.8 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.9 0.1 0.0 0.0 0.0 0.3 9.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 8.4 12.6 4.3 12.4 11.0 10.2 13.2 12.7 12.3 2.9 14.9 27.0 0.4 0.0 0.0 23.8 0.1 0.1 0.1 0.1 0.6 87.9 0.0 0.0 2.7 4.3 0.1 0.0 41.7 0.0 0.0 0.3 0.0 0.4 6.1 2.1 0.3 0.7 6.7 0.0 178.8 0.0 0.0 1.3 0.0 0.4 0.0 0.2 0.7 0.0 0.1 3.3 232.4 3.7 0.0 0.0 1.2 10.5 1.2 0.2 0.0 3.7 0.0 4.0 0.0 352.8 465.3 0.0 0.1 1.9 0.0 0.2 0.0 1.8 5.5 137.7 0.0 1.2 1.2 0.3 0.8 0.0 0.0 0.1 0.3 0.1 0.9 0.1 FXYD2 "ATP1G1, HOMG2, MGC12372" ENSG00000137731 "FXYD domain containing ion transport regulator 2" P54710 11 117800844-117828698 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Disease variant, FDA approved drug targets, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 3645.4" "Group enriched" "Detected in many" 5 "Cholangiocytes: 1595.6;Distal tubular cells: 2952.4;Ductal cells: 892.8;Proximal tubular cells: 3423.7" "Cancer enriched" "Detected in some" 8 "renal cancer: 49.9" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "memory CD8 T-cell: 14.8;naive CD4 T-cell: 5.1;naive CD8 T-cell: 4.3;NK-cell: 9.6;plasmacytoid DC: 3.8" "Group enriched" "Detected in many" 7 "dendritic cells: 3.8;NK-cells: 9.6;T-cells: 14.8" "Group enriched" "Detected in some" 25 "MOLT-4: 2255.4;RPTEC TERT1: 4711.9" "Low region specificity" "Detected in many" "Region enriched" "Detected in some" 5 "spinal cord: 27.7" "HPA064218, HPA068838" Supported Approved Mitochondria NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "HPA064218: AB_2685214, HPA068838: AB_2686047" "unprognostic (4.11e-4)" "unprognostic (1.14e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-3)" "unprognostic (1.09e-3)" "unprognostic (2.30e-2)" "unprognostic (3.65e-2)" "unprognostic (4.62e-1)" "unprognostic (4.01e-2)" "unprognostic (4.91e-2)" "unprognostic (1.24e-2)" "unprognostic (2.64e-1)" "prognostic favorable (3.23e-9)" "unprognostic (3.22e-3)" "unprognostic (4.38e-2)" "unprognostic (4.62e-1)" "unprognostic (3.00e-2)" 2.0 0.9 0.7 1.4 0.6 3.3 1.2 1.4 1.7 1.0 0.0 2.1 1.4 1.5 1.2 0.8 1.8 353.1 1.2 0.8 0.0 3645.4 23.8 4.4 8.9 0.0 0.1 2.4 612.6 0.2 1.6 0.8 0.0 1.7 0.8 1.1 835.6 0.7 0.3 1.0 1.6 2.2 0.0 3.1 2.8 0.6 0.0 74.8 1.0 0.6 4.5 1.8 0.9 0.4 0.0 118.6 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.4 3.5 0.0 0.2 0.4 0.2 0.0 0.3 0.2 0.0 0.1 0.2 83.6 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.9 140.3 0.0 0.0 0.2 0.3 2255.4 0.0 1.2 0.0 0.0 0.6 0.0 4.6 4711.9 0.0 1.9 0.0 0.0 2.9 0.2 0.2 0.8 0.3 0.8 0.0 1.3 0.5 0.0 1.0 0.3 0.2 0.1 0.2 0.0 0.0 1.2 0.0 1.0 0.0 1.0 0.2 1.8 14.8 0.2 0.3 5.1 4.3 0.0 9.6 0.0 3.8 1.7 2.1 0.7 0.6 1.4 1.7 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.4 1.0 0.0 0.6 0.0 33.6 1.1 0.1 0.8 0.6 0.2 0.1 0.5 1.2 1595.6 0.1 435.9 0.0 0.1 0.7 0.0 2952.4 892.8 21.8 1.6 4.1 2.2 15.1 2.7 0.0 10.0 0.1 3.5 0.5 41.3 0.0 0.6 4.2 3.9 3.6 0.0 0.0 0.3 16.2 4.5 4.1 25.9 9.3 24.8 0.0 0.0 8.8 0.5 1.0 0.0 0.0 23.2 0.0 7.5 0.4 0.2 0.0 3423.7 0.1 3.3 6.6 1.6 3.8 0.3 0.3 0.2 0.9 0.3 27.7 1.2 0.1 0.0 FXYD6-FXYD2 ENSG00000255245 "FXYD6-FXYD2 readthrough" 11 117820163-117876667 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 7.5;salivary gland: 4.5" "Cell type enriched" "Detected in some" 6 "Distal tubular cells: 97.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "MOLT-4: 6.5;RPTEC TERT1: 7.3" "HPA068838, HPA075209" Approved Approved "Nuclear membrane,Vesicles" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 39: Non-specific - Basic cellular processes" "Nuclear membrane, Vesicles" "HPA068838: AB_2686047, HPA075209: AB_2732285" 0.3 0.2 0.4 0.0 0.4 0.0 0.2 0.5 0.5 0.4 0.2 0.9 0.1 1.0 0.8 0.1 0.6 0.9 0.6 0.4 0.4 7.5 0.2 0.4 0.0 0.3 0.3 1.3 1.9 0.0 0.3 0.2 0.3 0.3 0.0 0.0 4.5 0.1 0.2 0.1 0.3 0.3 0.3 0.9 0.3 0.3 0.3 0.4 0.3 0.2 0.1 0.4 0.2 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.5 0.0 0.4 0.0 0.0 0.0 0.2 0.0 7.3 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.5 0.5 0.4 0.4 0.3 0.3 0.3 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.6 0.0 11.0 0.0 0.0 0.0 0.0 97.8 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.3 2.5 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 15.8 0.0 0.0 6.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 FXYD6 ENSG00000137726 "FXYD domain containing ion transport regulator 6" Q9H0Q3 11 117836976-117877486 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 163.9;Leydig cells: 237.9;Muller glia cells: 128.7;Peritubular cells: 363.8;Sertoli cells: 355.0;Theca cells: 141.8" "Cancer enriched" "Detected in all" 6 "glioma: 71.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "classical monocyte: 37.7" "Lineage enriched" "Detected in many" 6 "monocytes: 37.7" "Cell line enhanced" "Detected in some" "AF22: 136.0;HAP1: 92.9;RH-30: 57.1;SCLC-21H: 204.5;SH-SY5Y: 114.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041334, HPA042284" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Cytosol" "HPA041334: AB_10970752, HPA042284: AB_2677931" "unprognostic (2.18e-3)" "unprognostic (2.70e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (1.05e-5)" "unprognostic (3.31e-2)" "unprognostic (1.15e-1)" "prognostic favorable (5.87e-4)" "unprognostic (4.51e-2)" "unprognostic (3.78e-2)" "unprognostic (1.07e-2)" "prognostic favorable (5.97e-4)" "unprognostic (3.44e-2)" "prognostic favorable (4.38e-5)" "unprognostic (4.64e-2)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.60e-4)" 58.4 116.3 230.8 30.1 258.5 9.8 39.5 82.5 293.2 112.3 28.1 371.1 22.2 321.5 61.0 29.8 181.6 93.1 117.1 244.3 187.3 70.6 32.8 86.6 30.0 91.8 173.6 281.1 30.1 9.8 175.0 16.7 149.5 107.8 35.9 47.1 29.5 73.2 37.3 22.2 104.6 197.6 71.4 151.9 98.9 86.6 136.4 31.2 66.5 78.3 18.9 202.9 80.4 179.3 0.3 0.9 136.0 2.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.6 0.1 4.8 0.7 92.9 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.3 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.2 2.6 0.0 1.7 6.3 0.5 27.2 0.0 0.0 0.1 57.1 1.0 3.5 0.1 204.5 114.0 0.0 0.5 5.1 36.9 2.4 2.4 0.0 0.0 30.0 0.5 0.0 0.4 0.3 0.1 1.0 0.4 0.4 0.0 37.7 0.0 0.0 9.4 0.6 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.9 0.0 0.1 0.6 0.0 9.9 230.8 258.5 82.5 293.2 244.3 187.3 91.8 173.6 149.5 71.4 136.4 179.3 72.2 6.4 2.2 0.0 1.1 6.6 2.4 1.1 0.6 3.5 2.1 21.5 9.3 1.5 0.7 0.0 2.1 0.8 1.0 0.0 1.9 6.4 3.6 0.6 23.9 71.8 12.5 10.7 0.0 0.4 1.1 78.6 0.5 1.0 0.0 29.7 163.9 1.6 72.7 1.7 0.0 0.2 6.1 32.4 9.6 14.3 237.9 18.7 16.0 0.0 9.8 128.7 1.0 0.0 0.0 0.4 0.0 363.8 1.2 4.9 0.0 0.1 1.7 4.4 355.0 49.6 79.6 4.6 3.5 1.4 3.8 1.4 1.4 141.8 0.0 1.7 TMPRSS13 "MSPL, MSPS, TMPRSS11" ENSG00000137747 "Transmembrane serine protease 13" Q9BYE2 11 117900641-117929459 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 15.7;skin 1: 41.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 15.9;Extravillous trophoblasts: 21.2;Glandular and luminal cells: 10.9;Ionocytes: 16.2;Syncytiotrophoblasts: 19.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 13.8;BEWO: 29.9;MCF7: 27.0;SK-BR-3: 42.8;T-47d: 43.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 6: T47d - Mammary gland" "Cluster 38: Extravillous trophoblasts - Unknown function" "unprognostic (1.08e-3)" "unprognostic (5.18e-2)" "unprognostic (6.59e-2)" "unprognostic (1.06e-3)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "unprognostic (5.61e-2)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" "unprognostic (1.92e-2)" "unprognostic (2.03e-1)" "unprognostic (3.16e-6)" "unprognostic (2.05e-1)" "unprognostic (7.75e-2)" "unprognostic (1.08e-1)" "unprognostic (3.44e-1)" 0.3 0.4 0.2 0.7 0.2 0.6 7.1 0.0 0.7 6.7 0.0 0.4 0.3 0.6 0.6 15.7 0.3 0.4 0.1 0.9 0.0 2.6 0.2 3.9 1.2 0.0 0.0 0.1 2.5 0.0 0.3 2.9 0.0 1.4 0.4 0.0 11.0 0.1 0.2 41.0 0.8 0.2 0.0 1.5 0.2 0.4 0.0 0.9 6.6 0.0 4.8 0.5 9.3 0.1 13.8 0.1 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.0 0.0 10.2 0.1 0.7 0.1 0.0 0.0 1.3 0.0 0.1 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.5 0.7 0.0 27.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 1.4 0.0 4.0 0.4 0.1 0.0 42.8 0.6 1.7 43.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.1 0.2 0.2 0.2 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 4.6 0.0 0.2 1.7 4.6 1.7 1.2 0.0 7.4 4.6 1.4 7.2 5.3 0.0 0.0 15.9 0.2 0.3 0.0 8.3 0.3 2.4 1.3 0.2 0.0 0.0 0.2 1.2 21.2 0.3 0.5 10.9 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.5 16.2 1.2 1.9 0.8 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 5.7 3.9 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.2 5.2 8.0 19.4 0.4 0.5 0.8 9.0 IL10RA "CD210, CD210a, CDW210A, HIL-10R, IL10R" ENSG00000110324 "Interleukin 10 receptor subunit alpha" Q13651 11 117986370-118003037 "CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins" Receptor "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 63.6;lymphoid tissue: 73.7" "Cell type enhanced" "Detected in many" "dendritic cells: 87.5;Extravillous trophoblasts: 93.0;Kupffer cells: 190.7;Langerhans cells: 145.0;Macrophages: 128.6;monocytes: 175.7;NK-cells: 110.2;Plasma cells: 129.5;T-cells: 105.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 30.5;HDLM-2: 76.6;Karpas-707: 27.7;RPMI-8226: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065647, HPA069086" Supported "Plasma membrane,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 2: Immune cells - Immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane" Cytosol "HPA065647: , HPA069086: " "unprognostic (1.01e-2)" "unprognostic (2.07e-3)" "unprognostic (1.58e-2)" "unprognostic (7.08e-2)" "unprognostic (8.27e-2)" "prognostic favorable (4.47e-4)" "unprognostic (5.27e-2)" "unprognostic (4.84e-2)" "unprognostic (7.70e-3)" "unprognostic (5.94e-2)" "unprognostic (2.14e-2)" "unprognostic (3.83e-1)" "prognostic unfavorable (1.45e-5)" "unprognostic (1.82e-1)" "unprognostic (8.43e-3)" "unprognostic (2.19e-1)" "unprognostic (1.27e-1)" 13.9 8.9 4.7 39.8 4.9 63.6 6.1 4.4 7.0 5.6 4.9 12.0 8.0 3.5 2.7 6.4 5.2 17.9 5.3 4.2 5.9 4.1 13.1 23.8 51.7 6.9 5.1 3.1 2.4 2.6 3.6 14.2 5.5 4.7 14.5 0.5 5.2 3.2 1.7 3.2 24.8 10.4 6.0 73.7 9.2 1.9 5.3 16.9 4.2 3.3 32.4 20.7 3.7 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.5 0.2 0.0 0.7 0.0 0.5 0.0 0.0 76.6 0.0 0.2 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 5.6 27.7 0.0 0.0 0.4 6.0 0.1 0.0 0.0 0.0 0.0 35.5 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.1 0.0 5.6 1.0 8.0 0.0 11.4 0.0 3.3 48.9 2.4 52.8 68.6 38.3 12.6 51.0 62.1 44.7 6.2 17.9 33.3 3.4 70.2 58.6 17.3 88.7 84.1 4.7 4.9 4.4 7.0 4.2 5.9 6.9 5.1 5.5 6.0 5.3 7.5 2.2 6.4 16.0 0.3 52.8 5.7 0.4 0.0 5.7 0.1 1.0 1.9 2.7 0.0 1.3 0.0 0.0 1.3 87.5 0.5 0.0 0.2 0.1 0.4 0.5 4.9 0.0 9.3 0.8 0.8 93.0 2.3 6.6 0.7 12.6 0.0 3.6 1.4 60.4 0.0 1.2 0.0 0.0 190.7 145.0 0.5 0.3 128.6 17.8 22.5 175.7 0.4 110.2 0.0 0.6 0.1 0.1 0.0 129.5 0.0 0.0 1.0 1.5 0.1 0.0 1.6 2.7 0.1 0.3 1.2 4.1 3.3 105.5 0.0 0.7 0.4 SMIM35 TMPRSS4-AS1 ENSG00000255274 "Small integral membrane protein 35" A0A1B0GVV1 11 118003634-118088299 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.2;kidney: 1.1" "Cell type enhanced" "Detected in single" "Collecting duct cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "Karpas-707: 10.9;RPMI-8226: 7.2" "Group enriched" "Detected in some" 5 "basal ganglia: 1.2;olfactory bulb: 3.5" "Region enriched" "Detected in some" 6 "basal ganglia: 7.9" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 10: Non-specific - Unknown function" "unprognostic (8.83e-2)" "unprognostic (3.42e-2)" "unprognostic (2.64e-1)" "unprognostic (1.58e-1)" "unprognostic (3.04e-4)" "unprognostic (2.92e-1)" "unprognostic (1.09e-1)" "unprognostic (1.64e-1)" "unprognostic (1.88e-1)" 0.1 0.1 0.2 0.5 0.3 1.2 0.2 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.2 1.1 0.1 0.1 0.7 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.7 0.1 0.0 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 7.2 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.2 0.3 0.2 0.1 0.0 0.1 0.0 0.4 0.2 0.2 1.6 0.1 0.2 0.3 0.1 0.5 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMPRSS4 "MT-SP2, TMPRSS3" ENSG00000137648 "Transmembrane serine protease 4" Q9NRS4 11 118077012-118121890 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 108.7;intestine: 43.5;urinary bladder: 74.6" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 101.7;Club cells: 103.5;Distal enterocytes: 187.9;Squamous epithelial cells: 119.2;Urothelial cells: 258.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "cerebellum: 1.8" "Immune cell enriched" "Detected in single" 7 "basophil: 2.1" "Lineage enriched" "Detected in single" 10 "granulocytes: 2.1" "Group enriched" "Detected in some" 5 "CAPAN-2: 103.7;HaCaT: 39.2;OE19: 141.6;RPTEC TERT1: 70.6;RT4: 95.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA006238 Uncertain "Secreted in other tissues" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA006238: AB_1080316" "unprognostic (1.48e-1)" "unprognostic (3.27e-2)" "unprognostic (1.19e-2)" "unprognostic (1.23e-1)" "unprognostic (5.23e-2)" "unprognostic (5.50e-2)" "unprognostic (8.17e-3)" "unprognostic (1.95e-2)" "unprognostic (2.41e-1)" "unprognostic (9.62e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.87e-3)" "unprognostic (2.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.06e-1)" "unprognostic (1.10e-2)" "unprognostic (9.96e-3)" 0.2 0.0 0.1 6.1 0.1 0.8 0.3 1.8 0.3 16.6 0.3 43.5 25.4 2.1 3.2 108.7 1.0 14.3 0.2 0.1 0.0 21.1 0.2 1.4 0.2 0.1 0.0 0.1 0.3 0.0 0.2 0.1 0.2 7.8 42.9 0.4 6.5 0.2 0.2 4.1 22.4 1.5 0.0 0.2 31.4 1.1 0.2 1.1 0.2 0.1 14.9 74.6 16.7 0.3 18.5 0.1 0.1 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.7 103.7 0.1 3.5 0.0 0.1 39.2 0.0 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 3.4 0.3 0.0 1.3 0.3 4.5 0.1 141.6 0.0 0.1 0.1 0.2 70.6 95.9 0.1 0.1 0.0 8.4 0.1 0.2 0.5 0.1 0.1 0.2 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.1 0.1 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 1.8 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.3 0.1 0.0 1.7 0.0 0.4 1.1 35.2 101.7 38.1 0.0 0.0 0.0 0.7 0.0 103.5 11.0 0.0 0.2 0.0 187.9 0.0 1.5 3.0 45.3 4.6 0.8 4.2 0.0 0.2 7.3 3.0 0.5 53.5 66.4 5.7 0.0 0.0 0.1 0.2 0.0 0.2 55.3 34.6 0.3 0.3 2.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 52.6 67.5 0.0 2.7 17.5 55.2 2.4 69.4 0.0 0.0 0.0 4.7 0.0 0.1 119.2 6.3 0.3 0.5 0.0 71.2 258.6 SCN4B LQT10 ENSG00000177098 "Sodium voltage-gated channel beta subunit 4" Q8IWT1 11 118133377-118152888 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Disease variant, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 109.6;tongue: 56.8" "Cell type enhanced" "Detected in many" "Adipocytes: 12.3;Excitatory neurons: 18.2;Sertoli cells: 46.0;Smooth muscle cells: 38.8" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;HBEC3-KT: 1.0;NTERA-2: 1.4;U-2 OS: 1.2" "Region enriched" "Detected in all" 11 "basal ganglia: 816.3" "Region enriched" "Detected in many" 4 "basal ganglia: 134.6" HPA017293 Approved NA NA "Cluster 65: Brain - Ion transport" "Cluster 5: NTERA-2 - Transcription" "Cluster 48: Smooth muscle cells - ECM organization" "HPA017293: AB_2184174" "unprognostic (1.98e-1)" "unprognostic (1.13e-1)" "unprognostic (1.13e-1)" "unprognostic (2.43e-1)" "unprognostic (1.45e-1)" "unprognostic (1.07e-1)" "unprognostic (9.82e-3)" "unprognostic (9.17e-3)" "unprognostic (1.20e-2)" "unprognostic (1.23e-2)" "unprognostic (1.03e-2)" "unprognostic (3.27e-2)" "unprognostic (1.07e-1)" "unprognostic (2.07e-2)" "unprognostic (2.18e-3)" "unprognostic (1.53e-1)" "unprognostic (5.31e-4)" 23.5 5.4 2.6 1.2 86.6 0.0 9.2 41.3 109.6 2.1 0.0 2.6 2.4 3.1 1.6 5.3 5.4 3.2 11.8 2.1 14.0 2.1 0.4 8.9 2.1 53.3 15.4 0.5 5.1 6.8 2.7 1.8 45.9 2.2 2.1 0.9 2.5 2.3 30.4 3.9 4.7 7.1 15.2 0.0 2.9 0.7 23.1 8.6 14.5 56.8 0.7 3.0 1.4 28.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 86.6 41.3 109.6 2.1 14.0 53.3 15.4 45.9 15.2 23.1 28.5 12.3 0.0 0.0 2.9 0.0 1.3 0.6 2.0 2.8 1.7 0.5 5.7 4.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.1 3.0 0.0 0.0 18.2 0.0 0.1 3.9 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 8.2 0.0 2.0 1.2 1.4 8.7 2.1 1.1 0.0 1.9 0.0 0.5 0.0 1.5 1.4 0.0 0.0 1.5 0.0 0.1 0.0 0.1 5.8 0.8 46.0 0.6 38.8 0.1 0.6 0.5 1.1 0.0 0.1 0.0 0.0 0.2 SCN2B ENSG00000149575 "Sodium voltage-gated channel beta subunit 2" O60939 11 118162806-118176639 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.0;heart muscle: 12.8" "Cell type enhanced" "Detected in some" "Bipolar cells: 8.8;Cardiomyocytes: 16.8;Excitatory neurons: 21.9;Horizontal cells: 13.5;Inhibitory neurons: 32.0;Oligodendrocytes: 7.4" "Cancer enhanced" "Detected in some" "glioma: 1.3;thyroid cancer: 1.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (9.01e-2)" "unprognostic (3.50e-2)" "unprognostic (7.58e-2)" "unprognostic (2.12e-2)" "unprognostic (1.41e-2)" "unprognostic (4.02e-1)" "unprognostic (2.71e-4)" "unprognostic (5.17e-2)" "unprognostic (8.59e-2)" "unprognostic (2.77e-1)" "unprognostic (7.89e-2)" "unprognostic (1.61e-2)" "unprognostic (3.51e-2)" "unprognostic (1.27e-2)" "unprognostic (4.35e-2)" "unprognostic (4.55e-1)" "unprognostic (2.88e-3)" 0.6 1.5 19.1 0.3 20.7 0.0 0.7 14.9 34.0 1.4 0.0 1.7 0.6 1.6 1.3 1.8 1.3 1.3 12.8 20.9 12.3 0.4 0.0 1.1 0.0 5.7 13.3 1.3 0.1 0.0 0.8 0.0 9.1 1.0 0.7 3.7 0.5 1.2 7.3 0.2 1.1 1.9 4.9 0.1 0.3 0.2 19.5 1.8 0.7 7.5 0.0 0.3 0.4 22.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 19.1 20.7 14.9 34.0 20.9 12.3 5.7 13.3 9.1 4.9 19.5 22.1 0.1 0.0 0.0 3.9 0.0 0.4 0.6 0.7 1.8 8.8 0.1 2.0 16.8 0.0 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.5 0.2 0.0 0.0 21.9 0.0 0.0 1.6 0.0 0.3 0.0 0.2 0.0 0.0 0.1 13.5 32.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 1.9 0.0 0.9 0.0 2.5 7.4 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.1 1.9 0.0 0.9 0.8 0.1 0.6 0.0 0.1 0.0 0.1 0.5 0.0 0.3 JAML "AMICA, AMICA1, Gm638" ENSG00000160593 "Junction adhesion molecule like" Q86YT9 11 118193725-118225094 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 43.3;lymphoid tissue: 68.7" "Group enriched" "Detected in many" 4 "dendritic cells: 136.9;Kupffer cells: 125.8;Macrophages: 166.6;monocytes: 204.7;T-cells: 56.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "eosinophil: 3529.6" "Group enriched" "Detected in all" 5 "dendritic cells: 1017.6;granulocytes: 3529.6;monocytes: 1023.8" "Cell line enriched" "Detected in some" 5 "HMC-1: 28.0" "Region enriched" "Detected in many" 11 "cerebellum: 58.0" "HPA005854, HPA047919" Approved Supported "Nucleoplasm,Plasma membrane" NA NA 1400000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Plasma membrane" Nucleoplasm "HPA005854: , HPA047919: AB_2680209" "unprognostic (3.91e-3)" "unprognostic (1.55e-3)" "unprognostic (3.00e-2)" "unprognostic (1.28e-3)" "unprognostic (2.87e-3)" "prognostic favorable (3.11e-4)" "unprognostic (2.80e-1)" "prognostic favorable (3.92e-4)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (8.69e-2)" "unprognostic (5.08e-1)" "unprognostic (6.43e-3)" "unprognostic (8.96e-2)" "unprognostic (3.12e-2)" "unprognostic (4.10e-2)" "unprognostic (1.58e-2)" 13.9 4.5 0.9 68.7 1.0 20.9 5.6 2.4 2.1 5.6 2.3 16.8 17.8 3.5 1.5 8.5 4.3 20.4 3.2 0.7 0.9 3.4 9.8 43.3 31.1 1.3 0.9 1.8 2.9 1.0 1.6 7.8 1.0 4.4 22.7 0.3 2.9 3.6 1.2 4.6 32.1 15.3 1.0 60.0 9.4 1.5 1.0 24.3 2.9 7.8 31.6 24.9 3.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.9 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.1 0.0 2.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.3 3.1 0.4 3.1 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.2 0.0 137.4 1023.8 3529.6 60.1 616.5 386.5 7.1 107.4 113.7 1017.6 2.9 124.7 103.1 2121.1 24.3 310.3 765.1 191.3 844.1 0.9 1.0 2.4 2.1 0.7 0.9 1.3 0.9 1.0 1.0 1.0 1.1 1.2 6.4 34.2 0.0 6.9 0.0 0.2 0.0 0.0 0.3 0.9 1.3 0.0 2.8 5.6 1.8 0.0 0.3 136.9 0.9 0.0 0.1 1.0 0.4 0.2 1.3 0.0 5.0 0.0 0.4 0.4 1.8 2.6 0.6 15.2 0.0 5.7 2.8 31.0 0.0 0.0 0.2 0.0 125.8 0.0 1.1 0.0 166.6 0.0 0.0 204.7 0.0 9.2 0.0 0.0 0.1 0.1 0.0 6.3 0.1 0.6 0.8 2.2 0.2 0.0 0.4 0.5 2.2 5.9 0.2 0.0 0.4 56.0 0.0 0.1 0.2 MPZL3 ENSG00000160588 "Myelin protein zero like 3" Q6UWV2 11 118226690-118252365 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 33.3;skin 1: 30.4" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 43.8;Suprabasal keratinocytes: 63.9;T-cells: 44.3;Urothelial cells: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in all" 6 "basophil: 44.3;eosinophil: 99.4;MAIT T-cell: 28.9;neutrophil: 87.8" "Group enriched" "Detected in all" 8 "granulocytes: 99.4;T-cells: 28.9" "Cell line enhanced" "Detected in many" "CAPAN-2: 26.3;HMC-1: 29.0;MCF7: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA029116 Approved "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "HPA029116: AB_10610142" "unprognostic (2.54e-2)" "unprognostic (1.24e-1)" "unprognostic (5.87e-2)" "unprognostic (1.25e-1)" "unprognostic (3.13e-3)" "unprognostic (1.52e-1)" "unprognostic (8.74e-3)" "unprognostic (2.86e-2)" "unprognostic (9.82e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (4.98e-4)" "unprognostic (4.86e-2)" "unprognostic (1.58e-2)" "unprognostic (1.89e-1)" "unprognostic (3.90e-1)" "prognostic favorable (3.64e-4)" "unprognostic (1.20e-1)" 3.3 0.5 0.7 4.7 1.0 7.3 8.2 2.8 0.7 11.5 1.7 5.6 5.4 1.5 4.9 33.3 5.4 7.6 1.6 0.7 0.8 3.1 7.5 7.9 4.8 1.0 0.7 0.5 7.2 6.7 3.8 0.8 0.9 5.6 6.1 1.3 11.7 2.7 1.7 30.4 5.3 1.5 0.7 6.0 6.8 1.1 0.8 2.8 6.1 0.9 12.6 4.4 16.8 0.7 5.0 0.6 0.0 0.7 0.0 0.0 0.7 0.6 0.1 0.1 0.1 16.7 26.3 4.9 12.5 0.0 1.9 6.8 1.2 5.6 0.1 0.3 2.0 3.0 1.4 8.1 0.2 4.1 29.0 0.3 13.6 0.0 5.4 0.0 8.8 3.3 3.8 2.7 0.1 17.1 1.9 2.2 2.4 16.5 1.2 0.0 0.0 7.4 10.0 6.2 3.4 0.3 6.6 8.6 0.5 1.3 15.4 2.2 4.3 0.1 1.3 0.1 0.1 0.4 5.1 3.1 0.1 0.1 0.3 44.3 6.0 99.4 7.0 3.7 28.9 1.7 11.3 9.6 8.1 1.9 8.4 6.9 87.8 8.2 2.6 1.1 8.4 5.3 0.7 1.0 2.8 0.7 0.7 0.8 1.0 0.7 0.9 0.7 0.8 0.7 2.4 16.0 26.9 0.0 4.9 35.6 21.7 11.8 9.6 0.3 28.2 14.7 1.7 5.7 15.9 9.2 2.1 0.6 9.6 19.6 0.0 10.5 7.4 32.7 4.1 4.9 12.0 0.4 2.2 8.8 0.7 1.6 18.3 34.0 1.3 0.1 2.2 8.2 1.3 0.0 2.3 5.1 14.2 5.1 18.7 7.7 0.0 5.5 10.6 1.9 3.8 0.3 4.1 0.5 0.3 16.7 9.1 0.4 6.6 30.6 9.3 1.1 43.8 1.7 0.0 0.4 2.3 1.7 0.8 14.3 63.9 1.6 44.3 0.2 8.1 46.4 MPZL2 "EVA, EVA1" ENSG00000149573 "Myelin protein zero like 2" O60487 11 118253416-118264536 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Cell adhesion" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 222.5;urinary bladder: 155.9" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 332.5;Basal prostatic cells: 504.4;Basal respiratory cells: 289.1;Squamous epithelial cells: 336.4;Suprabasal keratinocytes: 467.4;Urothelial cells: 489.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 11.6;intermediate monocyte: 9.2;myeloid DC: 17.0;neutrophil: 13.2" "Group enriched" "Detected in many" 10 "dendritic cells: 17.0;granulocytes: 13.2;monocytes: 11.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 120.9;EFO-21: 130.4;HaCaT: 166.9;RT4: 321.7;TIME: 351.9" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 5 "spinal cord: 38.8" HPA060740 Approved Approved "Cell Junctions" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 15: RT4 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "Cell Junctions" "HPA060740: AB_2684352" "unprognostic (1.74e-1)" "unprognostic (6.02e-2)" "unprognostic (8.23e-2)" "unprognostic (3.28e-3)" "unprognostic (9.95e-3)" "unprognostic (1.56e-1)" "unprognostic (2.11e-3)" "unprognostic (3.58e-1)" "unprognostic (7.39e-2)" "unprognostic (5.45e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.91e-1)" "unprognostic (3.91e-2)" "unprognostic (3.07e-2)" "unprognostic (1.80e-1)" "prognostic favorable (1.62e-4)" "unprognostic (2.08e-2)" 28.6 4.7 2.5 11.9 2.1 0.7 19.6 2.3 4.8 56.7 5.2 31.1 17.0 16.9 38.5 222.5 46.4 33.5 7.2 2.3 2.6 26.4 23.2 47.0 2.3 3.2 3.0 3.8 13.5 27.1 10.7 1.7 3.2 48.6 30.8 0.9 58.0 69.5 4.7 38.8 11.3 14.7 3.6 4.6 37.0 0.9 3.4 18.1 30.3 1.0 52.6 155.9 120.5 2.8 65.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 27.0 120.9 0.3 130.4 0.0 0.6 166.9 0.0 38.9 0.0 0.2 9.5 0.1 1.7 35.8 0.0 0.0 0.4 0.0 90.2 0.0 3.0 0.0 86.8 0.8 0.0 0.2 0.0 51.3 0.2 0.2 1.6 34.2 0.1 0.0 0.0 6.4 14.9 321.7 0.1 0.0 5.8 61.4 0.0 0.5 26.1 0.7 351.9 0.1 0.2 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.0 2.3 11.6 3.0 0.1 9.2 1.3 0.0 0.6 0.4 17.0 0.0 0.8 0.9 13.2 0.4 1.4 0.3 0.2 3.8 2.5 2.1 2.3 4.8 2.3 2.6 3.2 3.0 3.2 3.6 3.4 2.8 5.9 83.3 123.3 0.0 0.2 332.5 504.4 289.1 127.5 0.0 29.0 17.4 3.4 30.0 221.1 128.8 0.0 1.7 0.5 52.0 0.0 39.4 0.0 91.6 18.8 33.6 5.3 3.6 0.0 51.1 0.2 8.2 29.6 194.0 7.0 0.0 45.3 16.5 0.8 0.0 0.0 6.3 81.4 6.4 27.0 0.3 0.0 7.8 21.4 1.9 4.9 0.0 1.0 0.0 0.0 68.2 20.8 0.0 1.2 186.3 3.3 6.9 65.2 0.0 0.0 0.3 9.2 0.2 0.7 336.4 467.4 17.8 5.4 0.0 33.4 489.7 CD3E ENSG00000198851 "CD3e molecule" P07766 11 118304730-118316175 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 640.4" "Group enriched" "Detected in many" 7 "dendritic cells: 213.6;NK-cells: 154.5;T-cells: 601.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 26 "gdT-cell: 490.6;MAIT T-cell: 420.8;memory CD4 T-cell: 414.4;memory CD8 T-cell: 463.5;naive CD4 T-cell: 491.7;naive CD8 T-cell: 501.3;NK-cell: 202.2;T-reg: 426.3" "Group enriched" "Detected in all" 21 "NK-cells: 202.2;T-cells: 501.3" "Group enriched" "Detected in some" 67 "JURKAT: 544.9;MOLT-4: 764.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000010, HPA040957, HPA043955, CAB072863, CAB072864" Enhanced Supported "Endoplasmic reticulum,Golgi apparatus,Plasma membrane" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "Endoplasmic reticulum, Plasma membrane" "Golgi apparatus" "CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747" "prognostic favorable (1.72e-4)" "prognostic favorable (1.62e-4)" "unprognostic (1.51e-2)" "prognostic favorable (2.30e-6)" "unprognostic (4.31e-2)" "prognostic favorable (1.32e-4)" "unprognostic (3.60e-3)" "unprognostic (3.85e-2)" "prognostic favorable (1.18e-4)" "unprognostic (6.11e-3)" "unprognostic (1.59e-1)" "unprognostic (3.59e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (5.46e-2)" "unprognostic (9.28e-2)" "unprognostic (3.13e-2)" "unprognostic (1.12e-2)" 6.4 5.6 0.9 85.8 1.1 36.7 6.7 0.9 1.2 7.1 1.3 15.3 22.0 5.8 4.6 9.5 5.4 20.1 3.8 0.7 1.0 3.5 9.7 23.0 209.6 1.8 0.9 3.8 2.2 0.7 1.0 1.6 1.4 6.6 19.3 0.0 11.6 3.0 1.9 5.4 36.4 5.1 1.2 78.9 24.4 1.7 1.3 640.4 5.3 1.6 147.0 24.8 4.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 544.9 0.9 2.0 0.0 0.0 764.9 0.6 0.3 0.0 0.0 0.2 0.1 1.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 1.6 8.0 9.8 0.0 0.6 0.0 16.4 1.8 2.4 490.6 1.3 420.8 1.6 414.4 463.5 1.5 2.1 491.7 501.3 12.2 202.2 2.0 8.6 426.3 333.0 0.9 1.1 0.9 1.2 0.7 1.0 1.8 0.9 1.4 1.2 1.3 1.6 4.9 0.0 8.6 0.0 12.9 5.2 0.3 0.0 0.0 0.0 3.8 4.8 0.3 0.0 0.6 1.8 0.0 0.2 213.6 0.4 0.0 0.2 7.0 0.5 0.9 2.5 0.0 6.9 0.1 0.0 0.0 5.3 24.5 0.9 7.6 0.0 8.9 2.4 0.3 0.0 0.1 0.0 0.0 7.6 8.3 0.2 0.0 12.6 12.4 1.0 8.4 0.0 154.5 0.0 0.1 0.0 1.1 0.0 41.4 0.1 0.2 2.1 0.0 0.0 0.0 1.3 2.7 0.0 0.0 1.6 5.4 0.3 601.4 0.0 0.6 0.3 CD3D T3D ENSG00000167286 "CD3d molecule" P04234 11 118339075-118342705 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 30 "lymphoid tissue: 906.7" "Group enriched" "Detected in many" 14 "dendritic cells: 231.0;T-cells: 665.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in all" 52 "gdT-cell: 1462.4;MAIT T-cell: 990.0;memory CD4 T-cell: 1206.1;memory CD8 T-cell: 1368.7;naive CD4 T-cell: 1091.4;naive CD8 T-cell: 1338.9;T-reg: 1660.4" "Lineage enriched" "Detected in all" 66 "T-cells: 1660.4" "Group enriched" "Detected in some" 4 "JURKAT: 621.5;MOLT-4: 1299.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB013055, HPA071778" Enhanced Uncertain "Endoplasmic reticulum" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Endoplasmic reticulum" "CAB013055: , HPA071778: " "prognostic favorable (3.00e-4)" "prognostic favorable (8.46e-5)" "unprognostic (1.05e-2)" "prognostic favorable (1.73e-7)" "unprognostic (6.00e-2)" "prognostic favorable (1.70e-4)" "unprognostic (3.82e-1)" "unprognostic (2.40e-2)" "unprognostic (2.24e-3)" "unprognostic (1.01e-2)" "unprognostic (5.69e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (3.07e-5)" "unprognostic (9.00e-2)" "unprognostic (2.02e-1)" "unprognostic (3.66e-2)" "prognostic favorable (6.16e-4)" 4.1 3.8 0.3 77.5 0.4 28.6 9.9 0.4 1.4 5.2 0.7 18.8 21.7 3.6 5.7 7.6 4.5 15.7 3.7 0.3 0.6 2.3 7.9 20.6 222.7 1.1 0.4 3.2 1.3 0.9 0.8 1.2 0.6 5.9 22.4 0.3 8.3 3.1 2.5 4.0 30.1 3.9 0.7 60.9 23.8 2.4 0.5 906.7 3.8 1.4 166.9 26.7 3.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 621.5 49.8 0.0 0.0 0.0 1299.8 237.2 1.2 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.2 0.8 0.0 0.5 0.0 1.5 1.1 0.0 0.9 1.1 0.4 0.0 0.1 0.0 10.1 5.3 4.6 1462.4 3.3 990.0 9.6 1206.1 1368.7 5.0 3.7 1091.4 1338.9 25.1 4.2 5.3 6.0 1660.4 1138.7 0.3 0.4 0.4 1.4 0.3 0.6 1.1 0.4 0.6 0.7 0.5 0.8 5.9 6.4 29.6 0.0 18.6 15.3 0.3 0.0 1.8 0.0 5.4 6.7 2.8 7.2 2.6 3.7 0.0 0.4 231.0 0.9 0.0 1.3 0.4 0.8 0.8 5.0 1.2 16.8 0.0 0.0 0.0 8.3 21.4 0.9 12.6 0.0 7.9 3.1 0.6 0.0 0.0 0.2 0.0 14.9 28.4 0.7 0.0 14.2 12.4 1.0 25.0 0.0 32.0 0.0 0.0 0.1 0.2 0.0 21.0 0.3 0.0 3.4 1.5 0.0 0.0 2.5 5.8 0.1 1.2 1.4 11.8 0.3 665.7 0.0 1.1 0.2 CD3G ENSG00000160654 "CD3g molecule" P09693 11 118344344-118355161 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 94.7" "Group enriched" "Detected in many" 11 "dendritic cells: 139.6;T-cells: 294.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 21 "gdT-cell: 229.0;MAIT T-cell: 135.6;memory CD4 T-cell: 187.3;memory CD8 T-cell: 197.3;naive CD4 T-cell: 192.6;naive CD8 T-cell: 241.7;T-reg: 200.0" "Lineage enriched" "Detected in many" 26 "T-cells: 241.7" "Group enriched" "Detected in some" 52 "JURKAT: 70.9;MOLT-4: 193.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017520, HPA038494" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane, Cytosol" "CAB017520: AB_831094, HPA038494: AB_2676044" "prognostic favorable (6.33e-4)" "prognostic favorable (2.61e-4)" "unprognostic (4.58e-3)" "unprognostic (3.12e-5)" "unprognostic (6.30e-2)" "prognostic favorable (3.00e-4)" "unprognostic (1.98e-2)" "unprognostic (1.54e-2)" "unprognostic (8.25e-3)" "unprognostic (1.08e-3)" "unprognostic (1.54e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (9.33e-5)" "unprognostic (1.60e-1)" "unprognostic (2.37e-2)" "unprognostic (4.13e-2)" "unprognostic (2.10e-3)" 0.7 0.8 0.6 10.5 0.8 1.3 1.0 1.1 0.8 0.7 1.1 2.3 3.3 0.5 0.6 1.4 0.9 2.5 0.5 0.5 0.4 0.6 1.6 2.8 27.9 0.9 0.6 0.4 0.5 0.2 0.0 0.3 0.8 0.9 2.7 0.4 1.6 0.3 10.5 0.9 4.6 0.6 0.3 11.5 4.1 0.4 0.8 94.7 0.6 0.3 20.4 3.0 0.4 1.9 0.2 0.2 0.1 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.6 0.6 0.0 0.4 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 70.9 2.5 0.3 0.0 0.6 193.8 1.3 0.2 0.0 0.1 0.2 0.0 0.3 0.0 0.1 0.5 0.2 0.0 1.1 0.1 0.0 0.6 0.2 0.0 0.2 0.2 0.2 0.1 0.2 0.7 0.3 0.2 0.2 0.1 9.2 1.2 1.2 229.0 0.6 135.6 0.8 187.3 197.3 0.6 0.9 192.6 241.7 6.4 1.4 1.2 1.5 200.0 90.4 0.6 0.8 1.1 0.8 0.5 0.4 0.9 0.6 0.8 0.3 0.8 1.9 3.2 3.2 6.9 0.0 7.8 2.3 0.1 0.0 1.8 0.2 2.0 2.9 0.8 1.5 1.9 0.0 0.0 0.1 139.6 0.4 0.0 0.3 1.0 0.4 0.4 1.4 0.0 3.4 0.1 0.0 0.0 2.3 13.7 0.4 6.3 0.0 4.2 1.7 0.1 0.0 0.1 0.2 0.0 3.8 5.8 1.4 0.0 7.7 5.4 1.0 8.1 0.0 14.4 0.0 0.3 0.0 0.1 0.0 18.5 0.0 0.0 0.6 0.7 0.8 0.0 1.3 1.6 0.2 0.4 0.6 2.4 0.3 294.0 0.1 0.3 0.0 UBE4A "E4, KIAA0126, UBOX2, UFD2" ENSG00000110344 "Ubiquitination factor E4A" Q14139 11 118359600-118399211 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA055035, HPA064010" Approved Supported "Nuclear speckles" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 59: Non-specific - Transcription" "Nuclear speckles" "HPA055035: AB_2682679, HPA064010: AB_2685174" "unprognostic (1.32e-2)" "unprognostic (8.15e-2)" "unprognostic (5.23e-3)" "unprognostic (3.34e-1)" "unprognostic (2.80e-2)" "unprognostic (1.97e-1)" "unprognostic (7.67e-3)" "unprognostic (3.31e-1)" "unprognostic (1.30e-1)" "unprognostic (4.67e-2)" "unprognostic (6.01e-2)" "unprognostic (5.83e-2)" "unprognostic (7.73e-3)" "unprognostic (4.74e-2)" "unprognostic (5.94e-2)" "unprognostic (2.72e-1)" "unprognostic (8.86e-2)" 18.6 14.1 15.9 20.3 17.8 17.7 18.0 25.5 20.5 16.1 15.7 17.4 19.1 18.9 18.6 15.0 15.5 15.6 19.7 15.1 20.2 18.0 27.6 17.0 22.5 18.9 18.1 19.1 19.5 19.0 9.5 17.5 20.2 19.0 20.7 18.4 16.1 14.9 22.1 24.0 20.5 18.1 16.5 19.7 23.9 17.7 19.7 21.3 18.4 15.9 21.6 14.7 12.7 24.4 18.8 17.9 22.4 22.5 38.0 34.9 22.3 27.1 28.1 19.7 24.0 49.7 44.9 39.3 51.0 34.4 26.5 40.3 31.9 25.7 32.6 22.3 14.8 64.5 15.4 25.7 32.6 36.8 47.3 35.4 18.2 40.4 39.3 26.3 33.3 33.9 37.2 35.9 28.7 35.4 31.5 36.5 20.9 37.7 22.7 20.0 32.5 40.2 21.6 43.1 20.3 21.1 39.2 33.5 12.3 24.2 44.8 16.6 34.6 29.0 19.0 25.1 22.8 10.5 13.8 36.4 16.1 41.6 30.4 14.2 9.5 9.7 7.5 10.5 5.8 5.1 5.6 5.4 9.8 3.5 6.0 5.4 9.6 6.5 12.8 5.7 7.0 4.8 15.9 17.8 25.5 20.5 15.1 20.2 18.9 18.1 20.2 16.5 19.7 24.4 28.7 12.8 31.9 45.7 27.5 26.8 22.0 20.4 25.6 19.5 26.3 18.0 18.2 10.0 27.8 14.7 18.8 20.3 30.6 25.5 5.9 19.8 18.0 23.7 35.3 20.9 18.6 26.9 46.2 28.5 19.8 24.2 41.8 31.7 10.8 25.7 19.2 44.6 21.9 16.8 56.3 20.1 30.5 27.9 23.1 15.2 17.1 33.2 24.9 36.5 32.4 20.5 24.7 55.8 80.9 27.0 18.3 21.4 42.0 23.1 29.0 11.5 37.5 16.8 19.7 23.4 23.6 35.3 22.0 30.3 39.2 24.8 31.0 26.0 20.3 26.1 AP001267.5 ENSG00000285827 "Novel protein" 11 118401602-118482737 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 7.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 16.0;Alveolar cells type 2: 24.1;Club cells: 14.9;granulocytes: 20.2;Respiratory ciliated cells: 13.8" "Region enhanced" "Detected in many" "cerebellum: 3.8" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA044629 Uncertain Approved Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 2: Karpas-707 - Immune response" "Cluster 11: Alveolar cells - Smell perception" Mitochondria "HPA044629: AB_2679028" 1.2 1.2 0.7 1.5 0.9 7.2 1.3 3.8 1.3 0.8 0.4 1.3 1.8 0.8 1.1 0.6 0.8 0.7 1.2 0.7 1.4 1.2 1.2 0.9 2.4 0.2 0.1 0.8 0.8 1.6 0.7 0.2 1.4 1.2 1.5 1.4 0.8 1.5 0.5 1.8 0.8 0.0 1.0 1.4 0.7 0.2 2.6 1.1 1.8 1.3 1.0 1.6 3.1 0.7 2.0 2.7 0.9 0.8 3.8 1.5 1.2 1.9 1.9 3.3 2.5 2.6 3.6 1.9 4.0 2.4 2.8 2.4 2.8 4.0 1.8 4.3 1.2 1.6 1.8 2.9 3.0 1.4 1.3 2.3 3.0 1.2 2.4 6.1 3.4 6.7 1.7 2.4 4.5 5.7 1.7 5.5 2.6 3.9 2.2 3.4 3.4 1.2 3.3 2.3 2.4 1.2 1.5 3.0 1.9 1.5 1.3 2.0 4.2 1.1 1.9 1.7 1.6 5.2 0.7 3.1 1.0 5.5 5.1 6.0 4.9 4.2 4.1 6.1 4.4 4.0 5.0 5.1 4.2 4.0 4.1 3.7 4.0 7.2 5.8 10.6 0.7 0.9 3.8 1.3 0.7 1.4 0.2 0.1 0.2 0.0 0.2 1.6 0.0 16.0 24.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 ATP5MG "ATP5JG, ATP5L" ENSG00000167283 "ATP synthase membrane subunit g" O75964 11 118401606-118431496 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1407.2;Distal tubular cells: 2907.4;Hofbauer cells: 1367.3;Proximal tubular cells: 2520.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA044629 Approved Supported Mitochondria NA NA 44000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA044629: AB_2679028" "unprognostic (1.70e-1)" "unprognostic (2.40e-2)" "unprognostic (2.21e-1)" "unprognostic (5.45e-2)" "unprognostic (1.61e-1)" "unprognostic (3.27e-2)" "unprognostic (3.90e-2)" "unprognostic (8.19e-2)" "unprognostic (5.13e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (7.41e-2)" "prognostic favorable (4.09e-5)" "unprognostic (6.26e-2)" "unprognostic (2.56e-1)" "unprognostic (1.50e-2)" "unprognostic (3.05e-2)" 119.8 137.2 154.2 103.3 158.5 165.6 132.5 158.5 184.3 81.1 168.3 153.6 146.4 79.3 143.3 116.9 96.5 68.1 329.8 157.2 160.8 205.1 154.5 77.9 150.0 155.5 153.1 112.0 110.9 140.7 49.5 83.7 154.0 83.5 164.3 100.8 133.9 92.2 340.7 55.3 118.2 95.2 153.6 86.0 112.3 46.9 155.5 204.1 87.5 373.6 183.1 105.3 41.5 154.7 163.1 87.9 209.3 183.1 167.6 198.0 200.1 149.0 175.9 138.4 146.6 259.9 259.9 314.3 352.7 167.5 206.2 190.4 204.4 214.8 155.3 247.6 138.0 472.8 112.5 197.4 175.3 279.3 210.2 207.1 203.4 169.0 162.9 164.1 189.8 216.6 227.4 253.1 199.5 305.8 365.2 497.3 130.1 427.9 224.0 247.0 174.9 422.9 371.1 260.3 184.3 161.9 232.3 361.1 161.9 221.6 303.0 307.7 172.8 123.0 144.7 109.2 190.9 112.8 184.8 402.1 93.8 353.0 154.7 325.4 437.2 299.0 241.8 360.8 339.7 462.7 398.8 321.5 481.2 378.5 472.9 379.7 214.8 357.2 333.3 534.3 464.5 1112.1 154.2 158.5 158.5 184.3 157.2 160.8 155.5 153.1 154.0 153.6 155.5 154.7 324.3 362.2 364.1 0.0 211.2 0.0 0.0 0.0 0.0 0.0 893.9 1061.2 0.0 0.0 166.5 610.6 0.0 1407.2 378.3 0.0 2907.4 748.6 0.0 449.8 327.9 188.9 0.0 0.0 0.0 986.0 935.6 204.7 0.0 404.6 258.6 368.2 0.0 0.0 1367.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 427.7 0.0 0.0 678.1 0.0 0.0 0.0 0.0 922.2 0.0 0.0 94.9 0.0 0.0 2520.3 188.0 0.0 0.0 0.0 217.5 0.0 0.0 0.0 0.0 1001.4 224.2 370.0 0.0 0.0 KMT2A "ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1" ENSG00000118058 "Lysine methyltransferase 2A" Q03164 11 118436490-118526832 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Apoptosis, Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017794, CAB024270, HPA044910" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "CAB017794: , CAB024270: , HPA044910: AB_2679141" "unprognostic (6.80e-2)" "unprognostic (8.93e-2)" "unprognostic (1.83e-1)" "unprognostic (4.56e-1)" "unprognostic (4.96e-2)" "unprognostic (1.72e-3)" "unprognostic (4.52e-3)" "unprognostic (6.07e-2)" "unprognostic (1.61e-1)" "unprognostic (8.46e-2)" "unprognostic (3.21e-1)" "unprognostic (1.16e-1)" "unprognostic (5.91e-3)" "unprognostic (7.90e-2)" "unprognostic (3.73e-1)" "unprognostic (1.67e-1)" "unprognostic (1.02e-1)" 9.9 6.7 8.0 8.5 8.6 19.5 9.9 21.2 9.3 10.3 1.6 10.8 5.4 10.7 8.2 6.8 10.3 6.4 6.5 7.4 9.6 6.7 6.0 10.5 12.4 6.3 6.3 21.2 11.1 9.8 10.2 5.6 6.6 9.2 6.4 23.9 9.4 8.4 7.4 10.4 9.8 7.6 3.2 9.7 8.2 5.3 7.0 14.1 9.9 8.4 11.3 10.7 9.3 11.9 17.9 8.6 20.1 14.5 11.1 16.1 6.2 8.7 11.8 9.0 9.6 17.3 11.4 23.1 15.9 10.8 14.6 16.0 22.9 7.2 17.9 26.0 10.0 45.7 8.9 9.3 6.1 28.5 7.8 7.2 7.4 20.3 24.0 8.9 12.8 13.3 32.8 18.8 9.2 12.7 18.2 12.7 13.6 6.6 13.7 13.8 21.9 6.9 9.8 13.8 18.0 11.8 22.0 6.7 3.9 9.8 11.9 9.1 20.4 14.1 12.7 9.4 14.7 5.1 4.4 15.6 4.7 17.6 8.3 2.1 0.6 1.9 1.6 0.6 1.6 2.5 1.8 1.5 0.3 1.8 1.8 1.2 0.5 2.0 0.7 1.4 1.7 0.4 8.0 8.6 21.2 9.3 7.4 9.6 6.3 6.3 6.6 3.2 7.0 11.9 87.1 70.5 65.8 93.4 83.4 86.9 67.6 29.4 64.9 158.1 76.8 73.9 44.5 40.0 32.2 38.6 152.2 13.9 81.0 26.2 3.9 33.0 10.1 62.1 101.4 74.4 66.4 67.3 146.0 25.6 10.2 65.6 44.4 85.2 29.0 57.5 60.0 27.3 16.8 195.2 170.1 29.6 20.3 37.0 63.7 5.8 66.8 44.8 42.7 62.8 49.9 98.9 78.2 106.6 131.9 28.2 20.1 78.6 83.3 88.3 22.7 10.5 52.7 152.4 65.7 113.4 84.6 25.5 30.7 46.3 80.6 6.0 102.8 55.8 30.6 64.8 TTC36 HBP21 ENSG00000172425 "Tetratricopeptide repeat domain 36" A6NLP5 11 118527472-118531197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "liver: 171.5" "Group enriched" "Detected in many" 13 "Hepatocytes: 492.9;Proximal enterocytes: 185.5;Proximal tubular cells: 172.9" "Group enriched" "Detected in some" 7 "breast cancer: 5.0;liver cancer: 12.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SK-BR-3: 9.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA038731 Enhanced Uncertain Nucleoplasm NA NA 100000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 2: Hepatocytes - Metabolism" Nucleoplasm "HPA038731: AB_10672651" "unprognostic (1.57e-3)" "unprognostic (2.58e-3)" "unprognostic (1.16e-1)" "unprognostic (6.50e-2)" "unprognostic (1.02e-2)" "unprognostic (2.17e-1)" "prognostic favorable (1.81e-5)" "unprognostic (6.32e-2)" "unprognostic (8.80e-2)" "unprognostic (6.14e-2)" "unprognostic (4.77e-3)" "unprognostic (3.38e-2)" "unprognostic (5.77e-7)" "unprognostic (5.60e-2)" "unprognostic (2.24e-1)" "unprognostic (1.59e-1)" "unprognostic (8.95e-3)" 8.0 1.3 0.8 0.1 0.8 0.0 11.1 0.8 0.7 0.3 0.7 0.5 5.9 0.4 18.5 0.5 0.5 0.1 1.0 0.3 0.6 8.9 171.5 0.3 0.1 1.1 0.7 0.6 1.2 0.0 1.6 0.1 0.6 1.0 0.0 0.3 0.9 0.0 1.4 0.5 4.1 0.0 0.6 0.2 0.7 0.8 0.6 0.0 0.7 0.4 0.0 0.5 0.3 1.0 0.0 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.5 0.2 0.7 0.0 0.0 0.2 0.0 0.0 9.7 0.0 0.0 0.8 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.4 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.8 0.8 0.7 0.3 0.6 1.1 0.7 0.6 0.6 0.6 1.0 0.3 0.0 0.0 0.3 2.4 0.3 0.6 0.2 0.6 0.1 21.2 11.3 0.3 11.5 0.1 12.9 0.0 1.5 0.1 0.8 17.6 0.2 0.1 1.2 0.6 1.1 2.4 16.4 0.2 0.5 0.2 0.3 2.0 1.7 0.0 0.4 9.7 492.9 0.1 0.0 0.3 9.3 0.0 14.2 0.3 0.2 0.3 0.9 0.0 0.0 0.6 1.1 0.0 0.0 0.1 0.2 7.6 0.0 0.3 1.9 185.5 172.9 0.2 0.8 0.0 0.2 0.2 0.3 0.3 0.3 0.1 2.1 1.1 0.4 11.7 1.3 TMEM25 FLJ14399 ENSG00000149582 "Transmembrane protein 25" Q86YD3 11 118531041-118547280 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 149.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 35.9;SK-BR-3: 33.7;T-47d: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA012163, HPA051562" Approved Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 6900000 "Cluster 48: NK-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus, Vesicles" "HPA012163: AB_1858112, HPA051562: AB_2681535" "unprognostic (1.53e-2)" "unprognostic (7.18e-2)" "unprognostic (2.43e-1)" "unprognostic (6.69e-2)" "unprognostic (3.61e-1)" "unprognostic (6.50e-2)" "unprognostic (1.71e-1)" "unprognostic (4.45e-3)" "unprognostic (1.58e-1)" "unprognostic (3.42e-1)" "unprognostic (1.66e-2)" "unprognostic (8.19e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.15e-1)" "unprognostic (2.51e-1)" "unprognostic (1.26e-1)" "unprognostic (7.01e-2)" 6.9 25.3 35.0 3.8 36.0 2.2 14.6 33.9 44.3 14.9 32.2 16.0 46.0 15.3 25.7 11.1 13.7 8.9 8.9 37.5 36.7 18.6 23.1 9.9 4.8 32.1 30.3 23.4 17.6 23.3 29.5 6.0 32.0 15.7 3.7 22.3 21.0 18.3 18.5 8.7 35.2 10.8 31.5 5.3 13.3 6.5 35.1 5.1 15.9 9.9 5.3 14.4 11.6 35.1 3.4 0.7 5.8 9.5 6.0 0.9 5.6 5.2 9.9 4.9 9.8 27.1 18.8 0.3 20.1 5.3 10.9 14.8 0.0 18.3 4.4 11.9 11.1 0.5 5.4 6.0 16.0 0.3 0.5 7.3 10.9 5.3 0.9 35.9 7.2 13.7 2.6 11.7 4.9 4.1 6.0 0.5 4.9 0.1 12.8 8.1 4.2 12.3 25.3 0.3 17.0 11.5 5.1 33.7 0.1 8.7 43.8 0.6 2.5 2.1 10.6 0.4 1.6 11.7 8.3 3.1 0.4 0.2 0.2 0.7 0.2 0.2 5.1 0.2 7.1 4.0 7.3 2.9 0.5 2.6 10.0 5.4 0.4 7.4 0.2 3.4 6.0 3.5 35.0 36.0 33.9 44.3 37.5 36.7 32.1 30.3 32.0 31.5 35.1 35.1 5.1 6.4 3.9 11.1 6.2 5.7 10.7 14.7 13.1 27.7 27.7 30.6 6.1 14.3 9.3 16.5 29.2 37.1 4.8 0.9 11.7 16.6 2.8 4.1 5.0 6.4 11.4 5.2 20.1 6.4 16.9 8.7 2.6 5.5 8.9 18.0 3.6 9.6 2.9 11.8 22.0 7.8 10.2 0.0 1.9 5.5 23.3 1.1 7.2 2.8 3.4 28.8 5.2 8.5 6.5 5.0 5.5 23.3 5.5 5.5 149.1 25.6 7.4 41.1 0.0 12.1 7.5 3.9 5.2 4.0 3.7 16.3 4.7 15.3 15.0 5.7 IFT46 "C11orf2, C11orf60, CFAP32, FLJ21827" ENSG00000118096 "Intraflagellar transport 46" Q9NQC8 11 118544528-118572970 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 64.9;Respiratory ciliated cells: 84.3;Spermatocytes: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037909, HPA057550" Approved Approved "Actin filaments" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "Actin filaments" "HPA037909: AB_10672731, HPA057550: AB_2683464" "unprognostic (8.77e-2)" "unprognostic (1.22e-1)" "unprognostic (2.79e-1)" "unprognostic (2.35e-3)" "unprognostic (6.76e-2)" "unprognostic (1.55e-2)" "unprognostic (1.07e-1)" "unprognostic (3.29e-2)" "unprognostic (3.75e-3)" "unprognostic (1.47e-1)" "unprognostic (1.37e-1)" "unprognostic (3.61e-1)" "unprognostic (9.02e-3)" "unprognostic (1.42e-1)" "unprognostic (2.48e-1)" "unprognostic (6.53e-2)" "unprognostic (2.41e-1)" 14.7 19.4 29.0 8.8 29.7 5.6 26.8 33.9 35.8 23.1 37.3 18.6 7.7 19.4 24.8 13.7 66.8 16.4 21.3 28.5 32.5 26.9 17.0 15.1 11.0 32.1 37.2 27.2 16.7 18.4 28.9 8.7 31.8 20.9 11.1 35.7 15.9 20.2 17.9 13.5 10.3 20.7 31.5 11.8 15.0 28.1 31.4 16.0 27.5 17.6 12.8 16.0 16.7 32.1 15.6 18.4 26.1 16.9 42.8 35.7 3.2 31.9 46.2 29.3 27.6 22.5 28.8 23.8 46.1 38.6 7.2 22.1 26.7 31.8 34.4 9.1 21.8 49.2 9.0 8.6 32.0 11.8 13.8 32.4 37.0 49.0 46.2 26.6 28.9 32.1 27.4 16.0 37.3 71.7 31.3 15.6 7.7 27.3 38.0 25.6 20.0 19.0 23.5 21.4 16.7 18.3 23.2 29.9 20.1 15.0 46.2 16.7 24.6 31.6 20.2 18.4 12.0 9.9 14.3 26.7 16.0 21.2 23.2 2.8 5.2 5.9 8.6 4.3 9.9 11.1 7.6 7.9 6.9 8.3 9.2 5.5 1.6 11.0 4.2 7.0 9.9 4.8 29.0 29.7 33.9 35.8 28.5 32.5 32.1 37.2 31.8 31.5 31.4 32.1 5.5 9.6 10.3 10.4 4.9 4.0 8.3 14.4 8.0 12.5 11.6 8.4 14.5 10.0 15.4 11.0 18.8 5.3 3.8 1.6 5.9 17.1 20.5 64.9 11.7 9.3 4.2 6.6 8.7 11.6 7.1 9.5 4.1 9.6 12.0 10.2 8.6 5.9 8.8 1.7 8.9 4.3 14.2 2.4 3.5 15.7 10.2 3.1 1.8 5.6 5.5 14.8 2.1 4.0 6.4 10.2 4.2 18.4 6.1 6.1 3.4 14.3 84.3 16.5 0.0 11.3 11.5 44.9 38.4 6.5 7.0 1.9 4.2 9.8 5.3 3.9 ARCN1 COPD ENSG00000095139 "Archain 1" P48444 11 118572390-118603033 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037573, HPA044874" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA 140000 "Cluster 18: Basophils - Vesicular transport" "Cluster 29: Non-specific - Vesicular transport" "Cluster 1: K-562 - Erythropoiesis" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "Golgi apparatus, Cytosol" "HPA037573: AB_10696938, HPA044874: AB_2679126" "unprognostic (1.46e-2)" "unprognostic (4.97e-2)" "unprognostic (1.66e-1)" "unprognostic (3.20e-1)" "unprognostic (9.99e-2)" "unprognostic (2.30e-2)" "prognostic unfavorable (2.97e-5)" "unprognostic (3.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.31e-1)" "unprognostic (1.67e-3)" "unprognostic (9.39e-2)" "unprognostic (3.56e-2)" "unprognostic (7.99e-2)" "unprognostic (9.20e-2)" "unprognostic (4.14e-3)" "unprognostic (5.56e-3)" 75.4 67.7 47.5 53.8 51.0 30.4 67.5 52.0 60.5 78.0 61.2 65.0 59.2 69.2 111.1 72.5 60.5 51.6 75.6 46.8 50.9 58.3 91.6 62.6 53.2 51.2 51.3 65.5 119.7 61.9 88.7 54.7 51.1 68.8 67.1 39.2 79.6 64.5 51.1 60.9 64.9 71.0 50.0 57.9 71.8 46.2 50.5 58.8 65.2 55.0 62.2 66.4 60.9 57.2 90.9 72.6 135.3 98.9 174.0 172.7 66.6 244.8 208.5 102.4 120.7 239.4 116.6 96.4 199.7 275.7 148.0 123.7 160.5 139.5 151.5 128.0 66.3 211.6 56.7 151.4 197.1 140.4 121.8 157.8 117.6 175.0 168.7 149.3 162.2 95.0 106.8 139.2 201.3 157.0 123.2 130.8 85.3 207.7 92.4 107.9 134.2 147.4 137.3 107.0 88.3 86.6 130.2 129.0 70.1 132.5 155.9 111.4 144.0 129.4 65.1 118.4 109.5 79.9 78.5 147.6 74.3 122.6 161.4 118.1 49.8 50.7 52.7 59.8 69.0 39.5 51.7 51.3 54.0 35.4 48.0 44.7 41.5 64.5 64.5 44.9 53.9 55.8 47.5 51.0 52.0 60.5 46.8 50.9 51.2 51.3 51.1 50.0 50.5 57.2 43.6 35.3 47.9 12.4 32.2 31.6 38.5 31.5 23.9 22.4 39.4 27.9 46.5 24.3 41.9 31.3 4.2 17.2 45.6 68.4 9.8 34.3 11.1 38.4 72.2 43.1 40.2 14.9 15.4 37.8 36.1 44.9 39.3 50.4 39.3 31.9 31.4 55.7 30.3 18.5 17.7 80.2 22.4 36.0 37.6 8.5 48.1 35.3 23.2 11.2 49.0 17.3 26.8 17.1 20.2 46.9 35.8 41.3 68.3 51.5 56.2 30.5 46.2 13.6 19.7 52.7 45.7 44.8 47.6 30.4 34.7 30.2 38.4 43.9 42.6 51.6 PHLDB1 "FLJ00141, KIAA0638, LL5a" ENSG00000019144 "Pleckstrin homology like domain family B member 1" Q86UU1 11 118606440-118658031 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 133.7" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 87.2;Late spermatids: 87.7;Oligodendrocytes: 244.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 105.2;ASC TERT1: 105.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037959, HPA038448" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA No "Cluster 57: Non-specific - Angiogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" "Vesicles, Cytosol" "Plasma membrane" "HPA037959: AB_10673651, HPA038448: AB_10697390" "unprognostic (7.81e-2)" "unprognostic (8.32e-3)" "unprognostic (1.13e-1)" "unprognostic (9.36e-3)" "unprognostic (8.28e-2)" "unprognostic (1.55e-1)" "unprognostic (4.37e-3)" "unprognostic (1.22e-1)" "unprognostic (3.21e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (1.57e-1)" "prognostic unfavorable (6.36e-6)" "unprognostic (7.09e-2)" "unprognostic (2.42e-2)" "unprognostic (3.69e-2)" "unprognostic (1.44e-1)" 52.6 8.1 39.2 11.5 79.7 0.5 38.9 42.5 66.0 39.1 3.8 23.8 9.2 38.4 2.6 9.1 30.2 21.6 33.0 42.3 49.2 15.8 3.2 26.8 4.6 64.3 64.6 31.9 22.2 4.5 8.8 24.6 56.0 16.7 6.4 1.6 11.1 15.8 13.3 15.1 15.3 18.6 33.4 12.5 14.3 12.0 75.3 3.1 20.3 13.6 2.3 21.9 22.9 133.7 4.8 7.5 28.9 14.2 105.2 105.9 10.1 21.9 26.6 12.7 7.4 11.2 31.8 0.0 40.2 44.3 17.2 18.6 6.6 44.8 2.0 0.7 4.2 8.6 5.7 5.5 27.2 0.0 15.8 55.8 9.6 17.8 12.5 28.3 36.6 0.7 7.5 0.3 16.7 3.4 0.1 0.5 10.2 0.4 3.8 1.1 7.5 0.7 12.5 6.8 6.5 14.5 55.8 4.7 15.6 11.3 20.1 2.7 45.4 25.9 22.9 13.2 18.3 0.2 0.0 0.1 7.5 1.5 29.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 39.2 79.7 42.5 66.0 42.3 49.2 64.3 64.6 56.0 33.4 75.3 133.7 34.4 6.4 13.7 53.2 1.6 18.4 9.2 13.7 14.2 4.0 7.2 19.6 5.6 1.5 6.3 31.3 0.0 1.0 2.5 34.2 0.0 9.4 78.3 11.6 87.2 32.1 8.4 0.0 4.1 4.4 1.5 54.9 11.7 8.6 1.3 25.6 26.4 0.9 5.9 3.3 8.3 20.4 0.0 2.5 34.4 87.7 67.1 8.2 12.4 23.4 2.2 7.6 0.0 67.3 244.5 24.3 29.8 44.4 0.7 4.2 10.7 7.8 0.5 2.3 39.5 42.9 53.8 21.9 10.1 1.9 9.1 1.5 5.4 11.0 16.8 2.4 TREH "MGC129621, TRE, TREA" ENSG00000118094 Trehalase O43280 11 118657316-118679690 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 66.3" "Group enriched" "Detected in some" 5 "Late spermatids: 315.7;Proximal enterocytes: 186.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039913, HPA042045" Enhanced Approved Vesicles,Cytosol "Intracellular and membrane" NA NA 12000000 "Cluster 56: Intestine - Transmembrane transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 45: Enterocytes - Digestion" Cytosol Vesicles "HPA039913: AB_10674988, HPA042045: AB_2677817" "unprognostic (1.29e-1)" "unprognostic (1.58e-1)" "unprognostic (1.01e-2)" "unprognostic (5.22e-4)" "unprognostic (2.52e-1)" "unprognostic (9.83e-2)" "prognostic favorable (3.76e-4)" "unprognostic (1.17e-1)" "unprognostic (1.34e-1)" "unprognostic (2.42e-1)" "unprognostic (1.04e-1)" "unprognostic (1.63e-2)" "prognostic favorable (2.33e-6)" "unprognostic (2.09e-2)" "unprognostic (6.30e-2)" "unprognostic (1.22e-1)" "unprognostic (1.15e-1)" 0.7 0.2 1.6 0.3 3.7 0.0 0.4 0.6 3.8 0.3 0.0 1.6 60.0 0.4 0.6 1.6 0.3 2.6 1.0 1.1 2.7 13.4 6.1 0.2 0.1 2.1 2.0 0.2 1.8 0.0 0.3 0.1 1.9 0.5 1.3 0.0 0.2 0.0 0.0 0.1 66.3 0.1 0.6 0.1 1.7 1.8 2.5 0.0 0.4 0.0 0.0 0.4 0.3 6.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.5 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.7 0.6 3.8 1.1 2.7 2.1 2.0 1.9 0.6 2.5 6.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.3 0.3 1.5 0.0 1.8 0.0 0.1 0.0 2.3 7.9 0.2 45.6 0.8 1.6 0.1 3.0 0.0 0.1 2.5 0.0 0.3 4.6 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.1 7.0 0.0 0.0 0.4 315.7 2.1 0.1 0.0 0.0 0.0 0.0 0.0 1.5 5.3 0.9 6.3 1.9 0.1 0.3 186.3 32.8 0.0 0.0 0.0 0.3 0.2 1.7 0.8 2.1 0.0 0.0 0.1 0.0 3.7 0.0 DDX6 "HLR2, RCK, Rck/p54" ENSG00000110367 "DEAD-box helicase 6" P26196 11 118747763-118791164 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004668, HPA024201, HPA026644" Approved Supported "Cytosol,Cytoplasmic bodies" NA NA 19000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 24: Non-specific - Transcription regulation" "Cytoplasmic bodies" Cytosol "CAB004668: AB_436960, HPA024201: AB_10603562, HPA026644: AB_1847582" "unprognostic (1.26e-1)" "unprognostic (1.40e-1)" "unprognostic (1.89e-1)" "unprognostic (3.40e-2)" "unprognostic (4.12e-2)" "unprognostic (5.82e-2)" "prognostic unfavorable (6.56e-4)" "unprognostic (3.43e-1)" "unprognostic (1.48e-2)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (7.76e-2)" "unprognostic (1.98e-1)" "unprognostic (4.91e-3)" "unprognostic (1.88e-1)" "unprognostic (9.58e-2)" "unprognostic (4.55e-2)" 31.5 28.4 29.1 34.9 36.0 69.0 34.9 50.7 31.9 33.2 12.7 30.0 23.7 30.5 30.5 33.1 29.1 23.6 37.2 31.5 35.4 30.6 34.2 27.3 49.0 28.4 29.3 48.8 30.7 28.3 17.3 31.6 25.2 32.9 27.9 48.7 32.4 29.2 43.2 27.2 26.2 30.6 29.9 45.4 29.9 28.8 37.1 54.9 37.5 41.9 60.9 30.0 21.9 36.6 33.9 50.4 73.6 71.7 64.0 64.8 47.2 45.6 62.0 43.0 40.4 72.1 50.9 77.6 47.1 78.8 44.3 53.2 88.8 69.1 69.0 62.7 17.4 154.5 30.8 57.1 42.0 110.9 55.8 67.1 49.5 63.5 100.8 54.8 69.1 53.2 72.5 110.4 59.2 96.8 81.0 52.1 53.3 50.1 33.6 89.3 59.2 60.1 50.1 92.7 48.7 63.9 84.7 67.2 28.5 56.2 79.2 44.2 81.2 67.2 38.4 39.8 47.6 34.1 47.8 91.7 26.8 52.2 59.2 13.8 4.8 13.2 10.2 6.2 12.3 12.1 10.0 10.8 5.1 12.0 12.2 11.0 19.0 8.3 12.4 7.1 9.9 6.8 29.1 36.0 50.7 31.9 31.5 35.4 28.4 29.3 25.2 29.9 37.1 36.6 84.6 60.9 57.9 37.9 140.1 30.2 75.2 31.3 69.4 82.2 49.8 43.2 116.9 42.9 41.4 44.1 50.1 38.4 184.0 58.6 31.3 32.2 4.2 77.3 81.5 64.6 85.7 88.2 57.3 35.5 36.5 55.6 42.3 91.7 52.5 54.2 61.8 41.5 38.3 62.2 60.9 59.8 42.7 66.9 44.3 10.5 54.0 70.1 33.8 68.4 75.9 90.0 119.4 50.3 80.9 51.2 57.0 45.1 106.0 49.8 57.2 41.3 35.9 91.3 39.5 92.6 69.7 71.1 76.8 73.4 30.5 76.5 130.2 48.8 53.1 78.2 CXCR5 "BLR1, CD185, MDR15" ENSG00000160683 "C-X-C motif chemokine receptor 5" P32302 11 118883892-118897787 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "B-cell activation" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 10.6;intestine: 10.2;lymphoid tissue: 28.9" "Cell type enriched" "Detected in some" 13 "B-cells: 83.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "memory B-cell: 67.7;naive B-cell: 92.4" "Lineage enriched" "Detected in many" 8 "B-cells: 92.4" "Group enriched" "Detected in some" 11 "Daudi: 18.9;U-698: 65.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026149, HPA042432" Enhanced NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "CAB026149: , HPA042432: AB_2677995" "unprognostic (8.51e-2)" "unprognostic (1.52e-2)" "unprognostic (1.68e-1)" "unprognostic (1.19e-1)" "unprognostic (4.02e-5)" "unprognostic (2.08e-2)" "unprognostic (3.23e-3)" "unprognostic (1.19e-2)" "unprognostic (3.66e-1)" "unprognostic (2.41e-3)" "unprognostic (1.52e-5)" "unprognostic (4.21e-1)" "unprognostic (2.03e-3)" "unprognostic (1.38e-1)" "unprognostic (1.90e-1)" 0.5 1.9 0.4 11.2 0.3 10.6 0.2 0.7 0.5 2.7 0.0 4.4 0.4 0.3 0.1 2.5 0.1 1.0 0.9 0.4 0.2 2.1 1.5 1.4 28.9 0.3 0.4 0.7 0.9 0.0 1.0 0.2 0.3 3.7 0.4 0.6 1.3 0.0 2.1 1.9 10.2 0.0 0.1 21.1 2.0 0.3 0.5 1.9 0.8 0.0 15.9 2.3 1.4 0.0 0.1 0.0 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 18.9 0.5 0.0 0.7 2.1 0.0 0.0 0.0 0.4 0.3 3.9 0.0 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.0 1.0 0.0 0.9 0.0 0.6 0.0 1.1 0.8 1.6 0.0 0.7 0.0 0.8 0.1 0.3 0.0 0.0 0.6 0.5 0.0 0.1 0.9 0.2 0.4 0.8 0.0 0.6 0.9 0.0 0.2 0.3 0.0 65.2 0.1 0.7 0.0 0.1 0.1 0.0 1.0 0.0 0.9 67.7 10.9 3.0 0.1 92.4 1.1 1.0 0.1 0.2 0.1 0.1 1.7 6.2 0.4 0.3 0.7 0.5 0.4 0.2 0.3 0.4 0.3 0.1 0.5 0.0 0.1 0.0 1.8 0.0 83.0 0.1 0.0 0.0 1.2 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.5 1.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.8 0.2 1.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.9 0.6 0.3 6.1 0.1 0.1 0.1 BCL9L "B9L, Bcl9-2, DLNB11" ENSG00000186174 "BCL9 like" Q86UU0 11 118893875-118925608 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 61.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049370, HPA053421" Uncertain Enhanced Nucleoplasm NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 39: CACO-2 - Unknown function" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA049370: AB_2680732, HPA053421: AB_2682145" "unprognostic (1.67e-2)" "unprognostic (1.48e-2)" "unprognostic (1.20e-1)" "unprognostic (2.71e-1)" "unprognostic (2.87e-1)" "unprognostic (1.90e-1)" "unprognostic (6.61e-3)" "unprognostic (1.17e-3)" "unprognostic (1.03e-1)" "unprognostic (4.61e-2)" "unprognostic (4.66e-3)" "unprognostic (1.39e-1)" "unprognostic (2.83e-3)" "unprognostic (4.85e-3)" "unprognostic (2.24e-2)" "unprognostic (2.14e-1)" "unprognostic (2.90e-3)" 24.3 24.8 5.7 24.1 4.6 20.5 21.1 17.7 6.7 28.5 4.7 23.8 17.4 32.3 4.7 26.4 29.6 18.1 20.9 4.9 1.2 12.1 10.8 24.4 19.5 3.3 3.7 29.4 21.3 8.5 7.8 24.4 1.3 18.1 5.4 2.9 25.9 16.6 29.0 30.8 19.8 17.7 1.1 19.6 18.5 6.4 5.3 13.7 16.8 12.3 12.8 24.6 24.8 1.8 40.5 71.6 10.2 18.5 32.2 30.8 64.3 54.6 41.4 16.9 9.9 77.0 78.2 11.0 70.8 57.4 68.7 76.0 5.0 99.9 4.4 13.4 2.6 10.9 41.2 26.8 36.1 3.7 10.0 39.2 60.8 20.3 40.5 32.5 15.1 6.4 14.3 12.4 11.9 67.2 8.2 3.1 12.1 24.1 40.8 17.2 4.3 7.4 17.5 27.6 5.5 8.1 76.7 114.2 10.3 18.0 90.3 4.5 51.1 53.7 40.7 16.4 46.9 2.6 0.1 3.3 29.0 12.5 31.3 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.2 0.2 0.0 0.1 0.3 0.3 0.2 0.1 0.0 0.1 0.0 0.2 5.7 4.6 17.7 6.7 4.9 1.2 3.3 3.7 1.3 1.1 5.3 1.8 16.3 16.0 11.5 9.1 18.3 38.7 9.3 18.5 13.1 20.0 23.8 16.5 2.4 15.7 14.1 7.3 4.2 12.7 42.2 10.9 0.0 14.0 0.1 36.6 31.5 12.3 5.4 1.3 3.9 15.1 8.4 14.1 13.3 61.9 2.5 12.2 11.4 9.7 4.4 13.5 4.8 5.4 4.1 6.1 11.6 0.5 14.6 8.0 7.2 12.2 16.5 5.5 32.0 5.0 1.1 29.3 7.4 14.3 14.8 23.5 10.8 3.3 14.0 3.1 26.3 12.4 26.4 0.6 1.4 34.7 45.3 35.4 33.0 8.6 6.8 11.1 UPK2 "MGC138598, UP2, UPII" ENSG00000110375 "Uroplakin 2" O00526 11 118925164-118958559 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "urinary bladder: 70.1" "Group enriched" "Detected in some" 7 "Club cells: 3.2;Cytotrophoblasts: 10.5;Syncytiotrophoblasts: 9.6;Urothelial cells: 6.9" "Cancer enriched" "Detected in many" 72 "urothelial cancer: 339.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "MCF7: 144.4;RT4: 160.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043312, HPA061106" Enhanced NA NA "Cluster 35: T-regs - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 15: RT4 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA043312: AB_2678420, HPA061106: AB_2684429" "unprognostic (6.04e-3)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "unprognostic (3.97e-2)" "unprognostic (1.21e-1)" "unprognostic (4.12e-4)" "unprognostic (1.65e-1)" "prognostic unfavorable (9.57e-4)" "unprognostic (3.13e-3)" "unprognostic (1.37e-1)" "unprognostic (1.05e-3)" "unprognostic (6.35e-3)" "prognostic unfavorable (7.30e-7)" "unprognostic (6.69e-2)" "unprognostic (7.45e-2)" "unprognostic (2.98e-1)" "unprognostic (1.00e-1)" 1.4 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.5 2.4 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.5 0.0 0.0 0.2 70.1 2.4 0.2 4.0 0.4 0.1 0.4 0.0 0.1 26.2 0.0 0.0 0.0 0.1 0.2 9.0 0.0 0.2 0.4 0.2 6.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 144.4 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.1 160.9 0.0 0.1 0.3 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.3 0.6 0.0 0.2 0.9 0.0 0.4 0.6 1.0 0.0 0.0 3.2 0.0 0.0 10.5 0.4 0.0 0.0 0.1 0.5 0.3 0.1 0.5 0.0 0.0 0.1 0.2 0.8 0.1 0.0 0.2 0.0 1.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.3 0.0 0.6 0.0 0.2 0.0 0.0 0.6 0.9 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.5 0.1 9.6 0.1 0.4 0.0 6.9 FOXR1 "DLNB13, FOXN5" ENSG00000176302 "Forkhead box R1" Q6PIV2 11 118971712-118981287 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 4.2" "Group enriched" "Detected in some" 19 "Spermatocytes: 13.1;Spermatogonia: 33.5" "Cancer enriched" "Detected in single" 34 "testis cancer: 2.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA038124 Approved Nucleoplasm NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "HPA038124: " "unprognostic (1.84e-2)" "unprognostic (4.80e-2)" "unprognostic (1.16e-1)" "unprognostic (1.52e-1)" "unprognostic (1.47e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 13.1 33.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 CENATAC "CCDC84, DLNB14" ENSG00000186166 "Centrosomal AT-AC splicing factor" Q86UT8 11 118998138-119015793 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 9.1;Cardiomyocytes: 8.5;Cytotrophoblasts: 15.3;dendritic cells: 12.1;Hofbauer cells: 9.2;Plasma cells: 8.1;Syncytiotrophoblasts: 7.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 19.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039906, HPA071715" Uncertain Approved Nucleoplasm No No "Cluster 37: B-cells - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 39: CACO-2 - Unknown function" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA039906: AB_2676740, HPA071715: AB_2686436" "unprognostic (5.83e-2)" "unprognostic (2.64e-1)" "unprognostic (1.36e-1)" "unprognostic (8.12e-2)" "unprognostic (1.54e-1)" "unprognostic (4.06e-2)" "unprognostic (1.15e-2)" "unprognostic (1.03e-3)" "unprognostic (3.60e-3)" "unprognostic (3.45e-2)" "unprognostic (4.64e-3)" "unprognostic (1.20e-2)" "prognostic unfavorable (2.93e-5)" "unprognostic (8.14e-2)" "unprognostic (8.24e-2)" "unprognostic (3.15e-1)" "unprognostic (2.09e-3)" 11.1 14.0 6.8 2.0 6.9 3.5 11.1 7.3 11.5 14.2 8.6 13.6 1.9 9.5 3.0 11.2 11.7 1.3 12.7 6.8 7.0 15.4 19.0 15.4 2.9 6.8 6.9 11.0 11.2 2.2 15.1 1.7 6.9 16.2 1.7 3.6 10.4 2.7 10.9 13.0 13.9 1.8 6.7 21.7 10.7 7.0 7.0 2.8 15.3 2.1 2.8 13.1 11.8 7.2 3.8 3.2 2.7 3.7 2.7 0.9 3.0 3.4 3.5 2.9 1.8 19.1 2.4 1.4 10.7 3.8 4.5 9.8 1.3 1.8 2.9 5.3 2.2 6.4 6.2 5.5 2.6 2.7 3.5 1.1 1.9 2.9 3.3 3.0 1.7 4.3 1.4 4.8 2.9 6.1 7.0 5.1 3.7 5.6 8.6 9.5 5.5 6.4 4.4 5.6 3.8 2.6 8.6 2.4 0.8 4.3 7.7 2.7 1.9 2.8 13.7 4.0 2.3 3.9 4.0 5.8 2.3 5.3 5.3 0.4 1.3 2.6 2.7 0.9 3.4 4.1 3.6 3.0 2.2 4.2 3.4 2.6 2.1 3.7 0.9 2.6 5.8 1.9 6.8 6.9 7.3 11.5 6.8 7.0 6.8 6.9 6.9 6.7 7.0 7.2 9.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 15.3 12.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 4.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 7.3 1.7 0.0 0.0 0.0 RPS25 S25 ENSG00000118181 "Ribosomal protein S25" P62851 11 119015712-119018691 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031801, HPA078683" Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 150000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA031801: AB_10610419, HPA078683: " "unprognostic (1.60e-2)" "unprognostic (1.79e-1)" "unprognostic (2.12e-1)" "unprognostic (1.40e-1)" "unprognostic (8.32e-2)" "unprognostic (1.78e-2)" "unprognostic (1.55e-2)" "unprognostic (8.47e-2)" "unprognostic (5.23e-2)" "unprognostic (1.54e-2)" "unprognostic (2.36e-2)" "unprognostic (7.75e-3)" "prognostic unfavorable (3.00e-7)" "unprognostic (1.16e-1)" "unprognostic (1.07e-1)" "unprognostic (8.58e-2)" "unprognostic (2.20e-1)" 1030.5 759.2 703.6 735.1 728.1 1650.9 1487.8 698.3 1133.9 1226.7 679.4 957.6 596.1 817.3 1030.4 898.8 1058.0 573.8 771.4 675.6 730.6 879.4 830.1 672.8 1488.5 718.4 700.7 2254.5 1279.5 535.1 807.7 633.7 726.5 841.2 697.9 460.2 1068.5 606.0 1873.7 1107.6 773.8 578.5 748.0 889.7 875.5 283.5 722.1 1100.8 817.0 1278.8 1307.1 967.1 1005.4 749.3 960.2 646.9 1024.1 1063.6 1461.7 2371.7 994.2 1098.1 1159.2 724.7 635.6 1753.4 1580.0 2269.6 2031.5 853.8 782.5 1146.8 951.4 1305.8 852.5 1166.9 1278.1 3013.6 598.3 1718.0 1102.2 2122.0 924.8 2043.3 2460.8 647.0 1673.7 2154.5 1384.9 1739.3 1670.1 1288.7 1072.8 2396.1 2072.1 3727.7 1045.8 2204.6 1573.1 1447.7 1055.6 2743.5 1319.2 1228.3 830.4 1737.6 578.1 1850.5 1467.1 1175.2 1533.2 2972.9 1144.8 703.2 768.0 724.7 1198.9 1051.5 1232.2 2109.6 489.5 2563.2 806.5 997.3 1197.8 775.1 1976.3 1284.0 3220.0 3716.4 3654.3 2784.5 1945.5 3077.2 4507.9 3661.8 319.1 2123.4 1145.7 2384.0 2614.1 5186.2 703.6 728.1 698.3 1133.9 675.6 730.6 718.4 700.7 726.5 748.0 722.1 749.3 1697.5 810.9 1658.7 42.7 4105.7 3970.2 4377.8 2769.0 2486.4 284.5 3671.0 4464.2 177.0 2040.3 1857.3 932.5 114.7 3745.3 2579.2 1009.2 3273.2 1883.0 1859.4 927.5 1934.9 1947.4 1330.6 2078.2 25.4 3163.4 4115.0 1768.2 946.5 1319.1 2024.6 5691.5 2726.5 2709.6 2534.6 134.6 27.4 2786.8 895.2 3338.1 3963.7 2384.8 3824.6 2101.3 2186.0 30.9 4048.0 1305.0 2802.3 16.6 39.3 2301.3 2254.2 1713.3 1821.2 4000.4 2308.2 4494.5 909.9 475.7 1334.5 2501.7 2382.7 788.8 827.3 3140.7 4661.0 3656.0 3604.7 1427.9 2788.0 4153.7 TRAPPC4 "PTD009, SBDN, TRS23" ENSG00000196655 "Trafficking protein particle complex 4" Q9Y296 11 119018763-119025454 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 335.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039752, HPA041371" Approved Approved Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 6: T47d - Mammary gland" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA039752: AB_2676664, HPA041371: AB_2677439" "unprognostic (5.26e-2)" "unprognostic (5.00e-2)" "unprognostic (2.64e-1)" "unprognostic (1.18e-2)" "unprognostic (9.42e-2)" "unprognostic (7.12e-3)" "prognostic unfavorable (2.03e-5)" "unprognostic (1.07e-1)" "unprognostic (1.12e-1)" "unprognostic (2.36e-2)" "unprognostic (4.34e-2)" "unprognostic (2.01e-2)" "unprognostic (7.49e-3)" "unprognostic (3.64e-1)" "unprognostic (1.17e-1)" "unprognostic (6.28e-2)" "unprognostic (1.32e-1)" 20.8 37.8 14.6 4.3 14.8 8.2 20.2 15.3 18.6 17.9 15.5 22.9 8.4 17.9 11.8 21.3 18.0 5.2 27.2 14.4 16.7 36.8 26.1 19.5 8.1 15.6 15.0 15.5 25.5 13.5 29.2 5.6 15.0 20.8 6.1 9.2 18.9 12.3 38.3 19.6 23.6 4.0 15.3 22.1 22.6 31.5 14.7 16.9 17.6 18.2 6.1 19.3 16.0 16.2 15.5 14.1 16.9 20.2 25.2 19.3 8.7 59.6 44.3 45.6 40.0 35.1 6.4 18.6 40.3 27.2 23.6 14.5 32.0 25.9 32.9 31.5 15.3 28.5 14.2 40.0 33.4 25.3 14.8 25.1 29.2 40.1 30.1 23.5 42.3 20.7 34.7 7.3 28.8 38.6 30.0 24.9 13.7 30.0 44.4 26.3 13.1 25.9 34.7 20.2 7.4 16.2 10.5 13.1 15.4 19.8 58.5 21.5 24.9 10.5 18.8 13.1 19.7 9.2 18.9 45.9 11.8 20.1 18.5 68.3 37.0 77.0 50.8 45.8 53.5 59.1 59.6 59.8 37.2 55.5 54.7 59.6 32.6 54.6 58.3 52.4 96.4 61.2 14.6 14.8 15.3 18.6 14.4 16.7 15.6 15.0 15.0 15.3 14.7 16.2 50.3 38.5 34.4 7.5 38.8 51.4 59.1 166.1 37.5 60.1 38.4 38.7 30.8 41.5 83.4 71.7 14.6 90.7 61.1 30.4 140.8 107.6 41.9 46.0 39.1 47.7 67.6 45.3 9.0 76.2 56.5 45.1 15.3 33.2 62.1 335.0 46.1 21.8 80.4 38.7 11.7 33.5 152.5 27.3 30.7 16.4 44.4 33.1 30.2 10.3 76.3 88.5 41.2 10.1 15.0 103.4 44.3 60.9 26.9 51.1 83.0 206.1 89.0 61.2 46.0 21.6 82.2 78.2 67.0 28.7 59.0 87.3 52.7 49.1 36.8 52.4 SLC37A4 "G6PT1, G6PT2, G6PT3, GSD1b, GSD1c, GSD1d" ENSG00000137700 "Solute carrier family 37 member 4" 11 119024114-119030906 "Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 139.9" "Cell type enhanced" "Detected in many" "Cholangiocytes: 171.6;Hepatocytes: 175.9;Proximal enterocytes: 277.2;Proximal tubular cells: 183.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 29.3;HEK 293: 28.0;Hep G2: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038939, HPA038940" Enhanced Approved Mitochondria NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 39: CACO-2 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "HPA038939: AB_2676279, HPA038940: AB_2676280" "unprognostic (4.77e-2)" "unprognostic (3.49e-1)" "unprognostic (2.08e-2)" "unprognostic (2.35e-2)" "unprognostic (4.70e-2)" "unprognostic (6.95e-3)" "unprognostic (1.09e-1)" "unprognostic (1.39e-1)" "unprognostic (4.08e-2)" "unprognostic (8.27e-3)" "unprognostic (4.72e-2)" "unprognostic (3.89e-1)" "unprognostic (1.98e-1)" "unprognostic (4.04e-2)" "unprognostic (2.60e-1)" "unprognostic (4.34e-2)" "unprognostic (5.39e-2)" 4.5 8.0 4.6 2.5 4.7 2.4 5.0 4.5 6.9 5.1 4.6 10.8 36.1 3.5 20.8 4.7 5.5 1.7 5.4 4.8 4.7 49.4 139.9 4.6 1.5 4.9 4.7 5.3 40.1 3.4 6.3 2.5 4.7 9.4 6.6 4.6 7.0 5.5 30.0 4.9 27.3 1.3 4.8 7.1 12.0 7.1 4.7 1.1 5.3 3.8 0.9 4.6 4.7 4.9 1.2 12.2 5.6 6.2 7.5 3.2 4.9 0.7 9.7 2.6 6.9 29.3 2.8 3.8 7.2 3.9 5.4 0.7 2.3 14.9 4.4 4.1 28.0 10.3 3.4 37.1 2.8 6.0 2.0 0.5 4.2 1.5 7.1 10.7 8.7 0.6 4.7 11.2 4.5 25.9 0.3 13.3 0.1 3.6 13.6 8.4 0.0 21.1 5.5 12.9 7.3 6.4 0.0 2.6 5.4 5.8 5.4 4.2 0.0 0.0 4.9 1.3 5.4 1.7 2.9 1.3 1.2 15.6 2.0 0.0 0.9 1.3 1.4 1.6 1.2 0.7 1.0 1.7 0.3 0.5 1.0 1.1 0.0 0.9 0.7 0.1 1.0 0.6 4.6 4.7 4.5 6.9 4.8 4.7 4.9 4.7 4.7 4.8 4.7 4.9 7.9 3.2 7.8 7.5 5.8 1.8 8.3 10.1 5.7 7.5 13.0 10.7 4.5 171.6 8.2 16.5 0.0 30.1 3.2 23.8 31.3 29.5 14.0 11.5 6.6 9.2 24.7 28.6 4.5 25.3 21.4 5.5 13.7 11.2 0.0 72.3 19.2 175.9 28.8 16.8 4.2 26.3 14.2 11.1 2.4 3.3 9.6 7.9 3.6 7.5 10.0 93.4 2.1 3.5 2.9 19.7 27.5 10.5 5.7 12.5 277.2 183.0 12.6 11.3 0.0 4.4 5.6 11.2 25.8 5.9 2.7 15.2 5.4 6.7 50.3 8.4 HYOU1 "Grp170, HSP12A, ORP150" ENSG00000149428 "Hypoxia up-regulated 1" Q9Y4L1 11 119044188-119057227 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Stress response" Chaperone "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 201.9" "Cell type enhanced" "Detected in all" "Plasma cells: 118.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 35.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 418.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049296 Approved "Intracellular and membrane" NA NA 130000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA049296: AB_2680702" "unprognostic (2.97e-2)" "unprognostic (2.48e-2)" "unprognostic (8.46e-2)" "prognostic favorable (2.58e-4)" "unprognostic (2.19e-1)" "unprognostic (1.35e-2)" "unprognostic (1.61e-3)" "unprognostic (1.81e-1)" "unprognostic (8.98e-2)" "unprognostic (7.93e-2)" "unprognostic (2.01e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (5.10e-5)" "unprognostic (3.86e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.38e-2)" 38.2 48.5 30.7 27.1 32.2 18.6 31.0 28.3 34.1 37.2 25.5 40.9 18.1 44.6 51.2 47.4 40.8 14.0 56.5 32.9 41.0 63.0 201.9 47.7 17.4 32.6 34.5 36.1 165.9 18.8 100.1 19.9 34.2 47.9 21.3 11.9 46.3 20.7 19.1 25.0 39.0 19.0 28.5 47.6 60.3 85.7 35.2 21.7 87.2 8.4 20.9 39.9 31.7 32.9 40.5 34.5 77.2 224.4 41.2 19.7 107.7 56.1 38.0 63.1 47.2 105.0 103.0 85.3 418.9 40.7 122.1 59.5 71.5 69.3 53.8 92.8 26.1 151.8 32.6 76.7 187.7 88.6 73.5 23.9 91.1 55.2 185.3 57.9 100.2 57.2 53.5 136.8 33.9 97.8 59.4 49.6 55.5 83.2 33.6 63.1 55.9 144.3 48.6 67.8 45.7 70.0 80.4 103.8 53.3 65.5 78.8 82.9 75.0 59.9 46.4 27.2 77.5 88.1 64.0 61.2 53.8 76.2 135.6 4.4 4.5 2.2 11.7 6.1 12.6 5.4 6.4 8.7 5.0 4.0 4.0 6.1 1.3 7.6 4.4 35.9 5.5 4.7 30.7 32.2 28.3 34.1 32.9 41.0 32.6 34.5 34.2 28.5 35.2 32.9 16.4 9.6 14.1 6.2 22.7 17.8 18.5 17.5 14.2 11.5 28.5 21.1 12.4 15.7 16.8 25.8 43.8 11.2 36.6 35.3 9.8 20.7 74.0 20.4 29.1 20.0 35.8 17.0 12.0 18.8 26.6 21.0 39.8 38.1 15.8 43.1 13.9 49.9 22.2 25.2 13.7 52.1 18.3 8.2 21.6 38.8 13.1 17.8 23.2 5.6 15.5 8.7 17.5 4.5 9.3 31.4 24.2 13.5 118.7 44.4 14.9 17.6 16.7 14.5 13.1 16.4 15.6 27.8 29.1 16.2 19.9 19.3 20.8 14.8 27.3 24.7 VPS11 "PEP5, RNF108" ENSG00000160695 "VPS11 core subunit of CORVET and HOPS complexes" Q9H270 11 119067818-119081972 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039020 Approved Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 89: Fibroblasts - ECM organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 4: Macrophages - Innate immune response" Cytosol "HPA039020: AB_10674847" "unprognostic (6.97e-2)" "unprognostic (3.76e-1)" "unprognostic (1.77e-1)" "unprognostic (1.15e-2)" "unprognostic (1.43e-2)" "unprognostic (1.28e-1)" "unprognostic (2.59e-3)" "unprognostic (1.11e-1)" "unprognostic (3.21e-1)" "unprognostic (9.17e-2)" "unprognostic (6.01e-2)" "unprognostic (1.56e-1)" "prognostic favorable (1.44e-4)" "unprognostic (4.07e-2)" "unprognostic (4.05e-2)" "unprognostic (2.71e-2)" "unprognostic (2.25e-1)" 21.6 25.1 16.7 14.7 16.8 17.6 19.4 16.7 18.6 20.8 15.3 19.6 13.4 23.5 19.0 14.6 20.1 12.8 16.6 17.6 17.8 16.9 11.5 16.8 18.1 17.0 17.6 22.5 18.0 22.4 22.8 17.3 17.3 18.4 13.4 17.6 18.2 16.5 21.7 21.4 17.9 19.5 16.0 21.7 18.5 13.3 17.5 20.1 21.1 21.1 17.2 21.0 17.4 18.4 11.6 11.8 12.8 9.8 27.5 24.2 14.0 15.4 18.4 15.3 16.5 19.9 24.2 16.6 21.5 30.2 27.1 21.0 16.1 20.7 15.1 17.1 8.0 36.6 12.0 19.5 30.8 22.9 21.5 29.6 21.3 23.2 15.9 27.2 24.4 13.9 29.5 28.8 20.2 30.5 19.3 21.6 6.4 21.2 22.5 21.7 21.1 12.6 18.2 24.1 10.2 17.5 19.2 25.3 16.8 13.7 38.3 20.1 24.5 19.1 7.1 6.9 11.5 11.3 11.0 15.6 14.0 27.2 17.0 24.8 16.8 12.8 16.4 13.9 16.8 11.3 13.7 15.2 20.7 11.9 12.9 16.6 3.8 16.5 19.0 8.7 16.5 13.9 16.7 16.8 16.7 18.6 17.6 17.8 17.0 17.6 17.3 16.0 17.5 18.4 9.9 6.4 10.5 8.1 10.2 2.9 4.4 7.0 8.6 10.2 8.1 9.8 7.6 8.6 12.1 9.2 12.5 11.2 16.2 9.7 9.8 8.2 7.8 9.9 10.0 10.7 9.6 6.3 9.6 10.1 7.0 9.7 11.2 9.9 15.2 10.2 13.2 6.0 17.0 5.0 9.9 10.1 6.1 14.8 8.9 3.0 17.1 12.6 7.2 7.5 11.6 9.2 5.2 6.6 14.4 7.2 6.8 15.4 11.5 3.6 9.2 11.0 10.5 15.5 13.1 6.2 10.2 11.3 7.3 6.5 4.8 14.1 12.2 9.4 9.5 3.8 HMBS "PBGD, PORC, UPS" ENSG00000256269 "Hydroxymethylbilane synthase" P08397 11 119084866-119093549 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "bone marrow: 170.8" "Cell type enriched" "Detected in many" 15 "Erythroid cells: 935.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006114, HPA050659" Supported Approved "Lipid droplets" NA NA 21000000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "Lipid droplets" "HPA006114: AB_1079067, HPA050659: AB_2681206" "unprognostic (6.24e-2)" "unprognostic (9.10e-3)" "unprognostic (1.42e-2)" "unprognostic (4.98e-2)" "unprognostic (1.04e-1)" "unprognostic (1.30e-1)" "unprognostic (2.29e-3)" "unprognostic (2.81e-1)" "unprognostic (2.18e-1)" "unprognostic (1.13e-2)" "unprognostic (6.83e-2)" "unprognostic (5.06e-2)" "unprognostic (2.90e-3)" "unprognostic (3.91e-3)" "unprognostic (9.53e-2)" "unprognostic (1.32e-1)" "unprognostic (6.11e-2)" 10.3 15.9 9.3 9.3 10.4 170.8 9.4 11.5 10.4 7.9 10.1 13.7 12.5 10.2 11.9 14.4 7.7 4.0 17.3 9.1 10.0 12.3 22.8 8.8 9.2 10.7 10.2 3.8 16.2 9.2 8.5 10.6 10.6 8.6 14.9 5.9 9.9 8.6 30.4 10.5 10.1 10.5 10.4 15.2 11.7 5.7 10.7 7.6 8.9 23.9 11.9 9.6 8.0 12.6 40.0 59.9 27.7 47.5 21.6 27.2 41.7 31.1 34.8 45.0 38.2 74.4 60.2 59.4 68.3 40.1 42.0 53.7 41.6 60.1 28.2 42.0 42.4 97.2 22.5 55.0 40.8 37.6 31.2 29.8 38.0 71.5 53.1 18.7 21.5 55.9 154.6 25.7 35.9 158.4 36.3 72.6 32.1 72.8 36.5 41.9 27.8 59.5 45.3 36.2 31.1 41.4 24.6 38.4 29.3 19.3 64.7 52.3 20.0 33.0 25.5 32.9 36.0 14.2 16.7 36.6 22.7 47.4 40.0 48.5 38.5 4.4 13.6 35.2 17.8 21.4 12.5 15.1 52.8 24.4 19.7 14.7 1.3 11.5 22.2 35.1 14.2 26.6 9.3 10.4 11.5 10.4 9.1 10.0 10.7 10.2 10.6 10.4 10.7 12.6 5.2 9.6 9.0 4.2 12.1 7.9 11.0 26.7 13.6 5.6 14.5 16.8 13.7 18.6 12.8 11.0 27.1 57.8 12.1 12.4 19.6 25.6 1.7 5.8 10.4 6.2 13.2 935.9 3.8 31.2 61.1 9.0 5.6 5.8 2.5 6.3 4.6 23.7 29.1 10.1 5.7 19.1 14.2 13.0 10.4 3.0 5.9 9.5 14.2 1.9 15.3 7.5 8.2 4.5 8.6 23.3 13.0 8.6 25.0 14.5 9.2 24.5 13.6 25.9 0.0 8.6 11.7 1.7 32.0 18.8 8.1 23.3 6.1 16.7 31.0 10.5 H2AX H2AFX ENSG00000188486 "H2A.X variant histone" P16104 11 119093854-119095467 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 43.7;Cytotrophoblasts: 83.2;dendritic cells: 34.0;Extravillous trophoblasts: 106.6;Hofbauer cells: 45.8;Syncytiotrophoblasts: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012264, HPA041189, HPA051647" Supported Supported "Nucleoplasm,Nuclear speckles" Yes Yes "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "Nuclear speckles" "CAB012264: AB_297215, HPA041189: AB_2677357, HPA051647: AB_2681563" "unprognostic (1.44e-1)" "unprognostic (1.96e-1)" "unprognostic (6.46e-2)" "unprognostic (6.41e-2)" "unprognostic (3.07e-1)" "unprognostic (3.25e-1)" "prognostic unfavorable (1.51e-4)" "unprognostic (2.32e-3)" "unprognostic (1.93e-1)" "unprognostic (3.07e-3)" "unprognostic (6.78e-2)" "unprognostic (9.31e-2)" "prognostic unfavorable (5.47e-9)" "unprognostic (1.21e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (1.99e-2)" 13.2 20.7 35.2 12.6 37.8 24.9 8.0 39.0 42.2 13.3 20.6 18.6 13.3 14.0 2.1 43.6 13.1 3.1 13.4 33.7 32.3 17.0 13.9 14.3 16.0 43.9 38.9 18.7 11.6 3.4 24.3 11.0 37.8 15.7 4.3 6.6 11.4 4.7 12.4 18.1 18.8 3.5 38.0 24.0 16.1 15.4 37.8 30.5 10.4 3.6 12.0 11.8 15.7 51.8 132.1 77.9 120.3 72.3 10.9 7.9 126.4 146.0 44.0 80.3 70.4 124.0 55.1 89.7 85.9 34.0 60.5 134.0 57.5 41.7 21.5 133.4 161.0 182.2 20.7 129.8 11.4 90.5 108.9 6.7 9.0 34.2 21.0 13.1 40.7 115.4 149.9 143.1 38.9 335.6 207.8 269.9 87.5 60.0 162.6 200.7 141.6 42.7 37.5 56.3 127.6 152.0 116.0 66.6 20.6 20.6 99.8 68.2 50.9 77.7 204.2 63.8 110.2 38.7 40.8 92.3 17.9 145.2 155.0 3.8 1.3 4.2 1.6 0.6 0.8 0.9 1.7 1.7 1.8 0.8 1.1 1.0 0.6 2.2 0.8 0.8 1.6 1.2 35.2 37.8 39.0 42.2 33.7 32.3 43.9 38.9 37.8 38.0 37.8 51.8 43.7 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 83.2 34.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 106.6 9.4 0.0 0.0 0.0 0.0 0.0 0.0 45.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 64.2 7.2 0.0 0.0 0.0 DPAGT1 "ALG7, CDG-Ij, D11S366, DGPT, DPAGT, DPAGT2, GPT" ENSG00000172269 "Dolichyl-phosphate N-acetylglucosaminephosphotransferase 1" Q9H3H5 11 119096503-119108331 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053878 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 1: K-562 - Erythropoiesis" "Cluster 55: Plasma cells - Humoral immune response" "HPA053878: AB_2682288" "unprognostic (1.66e-2)" "unprognostic (3.14e-3)" "unprognostic (1.76e-1)" "unprognostic (7.83e-3)" "unprognostic (6.50e-2)" "unprognostic (8.53e-3)" "prognostic unfavorable (2.03e-5)" "unprognostic (2.52e-1)" "unprognostic (3.95e-1)" "unprognostic (9.05e-2)" "unprognostic (2.08e-2)" "unprognostic (7.12e-2)" "unprognostic (2.19e-3)" "unprognostic (1.87e-3)" "unprognostic (1.08e-2)" "unprognostic (2.52e-2)" "unprognostic (4.57e-2)" 11.3 14.1 13.0 13.7 13.3 9.1 14.8 13.9 22.4 16.1 17.6 17.7 16.8 10.2 21.8 12.4 17.3 14.5 8.6 13.5 14.1 12.8 21.2 11.4 11.5 14.2 14.4 9.0 27.1 18.6 4.4 15.8 14.2 14.3 20.0 7.4 27.8 16.3 5.6 9.0 14.9 17.7 13.4 9.8 14.4 4.8 14.6 8.2 15.5 8.5 14.3 16.8 6.2 14.9 22.0 39.2 22.2 55.7 60.0 37.0 24.6 33.7 38.3 25.7 32.2 43.4 88.3 41.5 62.8 45.4 57.7 77.1 42.0 60.7 31.1 29.4 23.8 83.5 14.1 51.6 50.7 53.9 47.4 40.3 48.7 62.4 85.3 29.9 53.3 25.2 51.7 84.1 50.9 67.7 19.5 39.9 22.5 148.3 49.4 26.2 26.6 61.3 60.3 44.7 23.0 30.1 30.7 99.3 17.1 32.3 116.8 19.4 29.1 57.3 24.5 30.3 23.7 19.6 32.2 13.9 14.3 68.3 48.9 28.4 35.7 4.4 25.2 35.5 28.4 24.5 20.1 24.8 43.3 25.6 16.6 15.8 3.0 20.7 32.7 37.5 19.6 20.2 13.0 13.3 13.9 22.4 13.5 14.1 14.2 14.4 14.2 13.4 14.6 14.9 11.5 6.4 8.1 7.2 10.7 13.3 15.2 34.4 13.1 6.1 18.4 12.1 5.0 14.3 22.8 14.7 14.6 34.2 9.6 10.3 3.9 32.9 0.9 15.6 12.3 16.0 10.2 8.6 7.3 13.3 44.4 11.0 14.3 11.2 12.7 12.7 15.7 23.1 28.8 3.3 5.7 19.8 32.6 13.0 11.4 1.9 14.0 14.1 8.8 5.6 20.9 6.2 13.4 7.5 5.4 13.9 11.1 8.2 33.2 14.5 19.3 11.3 37.2 4.6 0.0 6.0 10.7 6.8 10.3 14.1 12.5 23.5 10.0 15.9 20.7 12.9 C2CD2L "KIAA0285, TMEM24" ENSG00000172375 "C2CD2 like" O14523 11 119102198-119118544 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 37.5;Distal enterocytes: 40.6;Proximal enterocytes: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HMC-1: 50.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011044, HPA075369" Approved Supported "Plasma membrane" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 10: Brain - Neuronal signaling" "Cluster 3: HMC-1 - Innate immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "HPA011044: AB_2668414, HPA075369: " "unprognostic (3.43e-2)" "unprognostic (2.81e-2)" "unprognostic (1.03e-3)" "prognostic favorable (4.92e-4)" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (2.25e-3)" "unprognostic (3.37e-3)" "unprognostic (5.28e-2)" "unprognostic (2.09e-1)" "unprognostic (3.99e-3)" "unprognostic (8.19e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (8.02e-2)" "unprognostic (8.32e-3)" "unprognostic (4.10e-2)" "unprognostic (2.60e-1)" 6.6 8.2 26.9 6.5 27.6 13.6 5.8 15.5 28.9 6.4 15.3 11.1 16.1 6.2 4.8 10.8 8.8 5.3 10.2 26.8 19.6 11.6 13.1 10.3 8.1 18.0 18.4 6.0 11.0 5.7 23.9 3.9 18.4 7.1 7.3 14.1 9.6 5.3 15.3 15.3 17.1 5.1 15.2 14.9 8.1 4.3 21.4 8.5 6.7 7.3 5.7 7.0 6.6 23.7 6.1 4.5 6.0 12.5 7.7 3.2 3.9 9.0 7.8 8.7 7.2 7.3 6.3 9.1 23.1 6.3 9.1 13.4 7.6 3.9 3.4 14.3 6.2 35.7 5.9 5.3 10.2 10.5 50.5 3.7 7.9 16.4 6.1 9.8 5.4 13.5 15.1 16.1 8.3 16.2 11.9 24.9 2.2 15.0 11.8 7.4 5.3 10.5 8.7 3.8 18.7 10.5 3.8 20.1 5.9 2.3 35.3 13.9 6.7 8.1 2.8 9.9 16.1 6.8 4.5 3.5 4.9 17.6 9.1 0.5 1.3 2.7 0.2 1.4 0.4 0.1 0.6 0.6 0.5 0.0 0.6 0.3 0.4 0.8 2.0 0.3 0.6 0.5 26.9 27.6 15.5 28.9 26.8 19.6 18.0 18.4 18.4 15.2 21.4 23.7 5.1 6.4 4.2 9.4 3.7 10.7 1.6 2.3 10.2 15.6 6.8 5.0 2.4 2.8 4.3 1.8 37.5 0.9 7.4 40.6 3.9 3.4 5.4 12.1 2.6 5.7 1.2 7.0 15.1 2.8 1.7 2.5 3.6 4.6 2.5 2.2 11.4 5.4 9.4 21.9 15.0 8.0 0.0 13.9 16.1 1.3 2.1 11.4 7.2 5.6 15.3 5.9 7.2 4.5 8.4 5.1 10.4 1.5 7.2 3.2 33.0 4.0 21.9 29.9 6.6 2.1 3.6 3.7 2.0 10.3 10.9 1.1 8.6 3.6 5.5 1.9 HINFP "DKFZP434F162, HiNF-P, MIZF, ZNF743" ENSG00000172273 "Histone H4 transcription factor" Q9BQA5 11 119121580-119136059 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061008 Uncertain NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 36: HEL - Hemostasis" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA061008: AB_2684414" "unprognostic (2.79e-1)" "unprognostic (2.63e-2)" "unprognostic (8.77e-2)" "unprognostic (8.41e-2)" "unprognostic (8.39e-2)" "unprognostic (7.44e-2)" "prognostic unfavorable (4.44e-8)" "unprognostic (4.17e-2)" "unprognostic (7.39e-2)" "unprognostic (3.78e-1)" "unprognostic (5.33e-2)" "unprognostic (2.95e-3)" "unprognostic (4.21e-2)" "unprognostic (1.19e-1)" "unprognostic (2.72e-1)" "prognostic favorable (5.26e-4)" "unprognostic (1.25e-2)" 5.1 4.8 8.4 4.6 9.8 4.6 5.2 12.4 9.9 6.2 7.8 7.5 6.9 5.7 4.4 5.5 7.1 3.8 5.5 8.5 7.7 6.7 4.3 5.1 6.8 8.6 7.8 6.8 7.1 6.0 5.2 4.3 8.6 5.7 7.1 11.0 6.6 5.1 9.2 8.6 7.1 5.8 6.7 7.1 6.7 6.6 9.4 11.5 6.2 8.1 7.0 6.5 5.5 11.9 5.9 9.4 10.3 9.6 8.4 5.7 9.3 4.5 7.1 10.1 11.1 17.0 12.9 7.6 15.7 6.3 11.2 13.7 18.0 4.5 6.7 16.9 8.9 39.1 6.8 5.8 9.9 11.7 9.0 8.0 16.0 10.6 9.2 11.7 8.1 14.1 15.7 12.9 5.7 11.5 14.7 10.5 9.1 10.7 8.6 14.5 11.4 8.7 6.8 5.5 14.6 7.1 7.7 11.3 6.3 10.0 15.4 13.3 6.1 8.9 3.5 6.0 5.5 6.1 6.8 8.3 3.3 10.0 6.8 12.8 12.9 9.3 10.0 10.2 11.2 10.0 12.3 11.9 16.5 12.5 16.3 10.0 8.0 17.2 6.9 7.9 16.6 10.4 8.4 9.8 12.4 9.9 8.5 7.7 8.6 7.8 8.6 6.7 9.4 11.9 7.9 0.0 8.8 12.4 11.0 14.4 7.4 10.3 10.8 19.1 12.6 8.6 5.5 8.6 9.2 9.2 35.5 7.4 13.8 17.6 5.9 9.4 9.4 8.3 8.7 10.3 8.4 7.8 16.6 11.0 8.0 7.5 7.1 8.2 5.1 11.3 12.1 4.5 5.4 15.2 16.2 9.7 4.1 7.2 9.5 3.4 8.4 7.2 8.8 4.7 18.1 9.6 12.3 7.5 9.1 9.3 10.3 6.4 12.4 8.6 15.5 5.6 9.5 29.5 0.0 7.4 9.2 38.6 31.8 7.7 16.3 8.3 11.6 12.4 10.7 6.5 ABCG4 WHITE2 ENSG00000172350 "ATP binding cassette subfamily G member 4" Q9H172 11 119149052-119162653 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 52.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 13.8;Cone photoreceptor cells: 58.4;Inhibitory neurons: 9.8;Rod photoreceptor cells: 46.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.9;HAP1: 1.0;U-2 OS: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057635 Enhanced NA NA "Cluster 77: Retina - Visual perception" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA057635: " "unprognostic (3.26e-2)" "unprognostic (4.75e-4)" "unprognostic (6.31e-2)" "unprognostic (1.83e-3)" "unprognostic (3.76e-2)" "unprognostic (3.66e-2)" "unprognostic (1.13e-1)" "unprognostic (9.35e-2)" "unprognostic (1.67e-1)" "unprognostic (9.07e-2)" "unprognostic (3.29e-2)" "unprognostic (8.78e-2)" "unprognostic (2.25e-1)" "unprognostic (4.15e-4)" "unprognostic (2.26e-1)" "unprognostic (6.48e-3)" "unprognostic (2.65e-3)" 0.3 0.4 4.0 0.1 4.4 0.0 0.1 7.5 11.3 0.4 0.0 0.3 0.2 0.5 0.3 0.9 0.2 0.3 0.8 4.2 5.8 0.4 0.1 0.1 0.0 6.9 3.9 0.1 0.3 1.8 0.3 0.1 6.8 0.3 0.1 52.0 0.2 0.6 0.1 0.3 0.2 0.4 1.5 0.1 0.2 5.8 6.2 2.9 0.8 0.2 0.5 0.1 0.6 5.6 0.1 0.4 0.4 1.9 0.2 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.0 0.8 0.1 1.0 0.1 0.2 0.1 0.3 0.3 0.0 0.0 0.6 0.0 0.5 0.1 0.0 0.3 0.0 0.2 0.4 0.9 0.0 0.0 0.3 0.0 0.1 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.0 0.0 0.1 0.1 0.0 0.1 0.1 1.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.4 7.5 11.3 4.2 5.8 6.9 3.9 6.8 1.5 6.2 5.6 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.9 0.0 0.0 0.0 58.4 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.2 0.5 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.1 6.7 9.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.0 2.2 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.4 0.0 0.0 0.3 2.7 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 NLRX1 "CLR11.3, NOD9" ENSG00000160703 "NLR family member X1" Q86UT6 11 119166568-119184016 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 43.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 15.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 15.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA061516 Supported Supported "Plasma membrane,Cell Junctions,Mitochondria" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 6: T47d - Mammary gland" "Cluster 54: Cardiomyocytes - Muscle contraction" Mitochondria "Plasma membrane, Cell Junctions" "HPA061516: AB_2684548" "unprognostic (7.58e-2)" "unprognostic (3.71e-1)" "unprognostic (6.36e-2)" "prognostic favorable (2.47e-5)" "unprognostic (5.60e-3)" "unprognostic (2.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.43e-2)" "unprognostic (8.80e-2)" "unprognostic (1.17e-1)" "unprognostic (3.49e-1)" "unprognostic (3.29e-1)" "prognostic favorable (2.59e-6)" "unprognostic (3.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.83e-2)" "unprognostic (4.22e-2)" 8.1 10.7 4.9 4.7 5.0 6.5 7.0 4.7 5.5 10.5 6.4 10.8 4.8 10.1 3.4 43.2 9.8 5.2 17.0 4.7 4.6 8.8 9.1 5.5 5.0 5.3 5.1 4.0 9.6 6.0 4.8 4.2 5.4 8.3 3.4 2.7 10.3 6.8 24.1 21.5 6.4 5.8 5.1 8.1 7.3 3.5 5.1 4.7 7.9 13.7 10.5 9.6 16.5 5.2 5.3 15.6 1.6 12.2 5.1 5.9 2.4 7.0 8.0 3.4 5.9 0.9 13.0 9.5 21.0 8.9 5.1 13.1 4.7 4.0 1.1 12.5 5.0 12.6 5.5 8.6 7.7 4.4 7.0 6.6 16.4 4.5 8.7 6.9 7.0 12.5 0.1 6.2 3.6 14.2 7.5 10.7 7.5 6.9 8.6 14.6 2.1 3.1 8.2 6.8 2.3 7.9 10.4 5.5 4.5 2.4 17.7 13.0 8.2 6.8 6.0 6.1 3.6 2.2 2.6 3.3 1.0 13.4 4.9 2.8 3.5 15.4 0.8 1.5 1.0 0.5 0.8 1.2 2.1 0.4 0.9 1.0 8.1 1.4 1.4 0.9 1.4 2.3 4.9 5.0 4.7 5.5 4.7 4.6 5.3 5.1 5.4 5.1 5.1 5.2 3.0 0.0 7.9 5.9 3.2 2.5 1.7 4.5 2.8 1.3 4.1 4.2 12.8 2.8 4.2 7.3 2.1 3.6 1.4 7.3 1.9 7.1 2.0 8.7 2.8 3.8 2.4 3.8 5.9 3.8 2.2 3.5 8.2 4.1 0.0 5.7 5.3 10.2 6.5 0.0 4.0 3.7 2.0 6.0 1.8 4.7 1.2 4.0 1.8 2.8 6.2 6.1 5.2 5.5 2.8 5.5 7.6 1.2 1.8 1.6 3.9 5.3 7.2 3.2 0.0 2.9 2.7 1.9 2.0 10.8 4.7 0.5 2.8 2.1 5.5 1.2 PDZD3 "FLJ22756, IKEPP, PDZK2" ENSG00000172367 "PDZ domain containing 3" Q86UT5 11 119185457-119190223 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 19.3;kidney: 17.4" "Cell type enhanced" "Detected in some" "Distal enterocytes: 93.4;Gastric mucus-secreting cells: 30.5;Paneth cells: 74.8;Proximal enterocytes: 79.1;Proximal tubular cells: 29.5;Undifferentiated cells: 21.0" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.3;renal cancer: 2.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "OE19: 1.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA077887 Enhanced NA NA "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA077887: " "unprognostic (2.42e-2)" "unprognostic (1.51e-1)" "unprognostic (2.65e-1)" "unprognostic (5.51e-2)" "unprognostic (1.59e-1)" "unprognostic (5.39e-2)" "unprognostic (6.07e-2)" "unprognostic (3.22e-1)" "unprognostic (1.86e-2)" "unprognostic (6.58e-3)" "unprognostic (9.00e-2)" "unprognostic (6.08e-2)" "unprognostic (8.72e-2)" "unprognostic (1.08e-1)" "unprognostic (3.37e-1)" "unprognostic (1.38e-1)" "unprognostic (3.41e-3)" 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 17.1 0.0 0.0 0.0 1.0 2.8 0.1 0.0 0.0 17.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 19.3 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.3 8.6 0.0 0.0 6.2 0.0 0.0 93.4 3.9 0.1 0.0 0.2 0.1 0.2 1.2 0.0 0.0 0.2 0.0 0.4 30.5 0.1 0.0 0.1 1.1 0.1 0.2 0.0 0.0 8.5 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 74.8 0.0 0.2 0.1 79.1 29.5 0.7 0.7 0.0 0.5 0.1 0.0 0.0 0.3 0.1 0.0 0.2 0.1 21.0 0.1 CCDC153 LOC283152 ENSG00000248712 "Coiled-coil domain containing 153" Q494R4 11 119189638-119196769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 11.1" "Group enriched" "Detected in many" 7 "Endometrial ciliated cells: 92.3;Respiratory ciliated cells: 186.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 4.0;neutrophil: 15.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 15.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.8;EFO-21: 4.2;HEL: 5.0;T-47d: 8.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041497 Uncertain Uncertain Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA041497: AB_10794378" "unprognostic (4.66e-2)" "unprognostic (1.86e-2)" "unprognostic (3.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.53e-1)" "unprognostic (3.22e-2)" "unprognostic (6.87e-2)" "unprognostic (2.23e-3)" "unprognostic (5.19e-2)" "unprognostic (9.43e-3)" "unprognostic (1.36e-1)" "unprognostic (2.36e-1)" "unprognostic (2.92e-3)" "unprognostic (1.15e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-3)" "unprognostic (1.98e-3)" 1.1 0.7 1.5 0.5 1.2 2.5 0.7 2.7 1.6 0.9 2.7 0.7 0.3 0.8 0.2 1.0 11.1 1.1 0.3 1.3 1.6 1.3 0.4 1.5 0.3 2.0 1.9 0.2 0.3 2.8 3.3 0.9 1.4 0.4 0.5 1.5 0.5 1.1 0.4 0.7 0.6 0.5 1.7 0.5 1.1 1.8 2.0 0.3 0.8 0.0 0.2 0.4 0.5 1.8 0.6 0.9 0.9 1.0 0.2 0.1 2.8 0.6 1.1 0.4 0.5 1.9 4.8 0.2 4.2 0.2 1.3 0.5 0.3 1.1 0.1 1.1 0.6 5.0 0.4 0.3 0.7 0.6 0.3 0.5 0.7 1.2 0.3 1.4 1.2 0.6 0.7 0.9 0.1 3.4 0.3 0.7 0.3 1.2 1.0 0.7 0.1 0.3 0.4 0.8 1.0 0.2 1.3 0.8 0.7 0.3 8.8 1.4 1.2 0.7 0.5 0.3 0.4 0.4 0.5 0.2 0.3 0.2 0.3 0.5 2.3 4.0 0.3 1.6 0.1 0.3 0.2 0.4 1.7 0.3 0.5 0.4 15.8 0.2 1.6 1.7 0.4 0.8 1.5 1.2 2.7 1.6 1.3 1.6 2.0 1.9 1.4 1.7 2.0 1.8 4.4 0.0 6.1 0.0 0.6 2.8 1.7 14.9 1.8 0.4 2.3 2.2 0.4 1.5 19.8 7.3 0.0 4.3 0.7 5.3 0.0 1.1 3.5 92.3 1.9 3.3 1.8 0.0 0.5 2.0 3.5 2.1 4.6 2.3 0.0 1.5 3.3 1.8 3.6 0.0 0.4 4.2 12.2 4.6 5.5 7.0 0.3 2.7 3.6 1.0 4.5 0.8 1.0 0.0 0.6 1.1 11.3 2.6 3.0 1.0 3.3 4.8 186.9 2.0 6.6 0.7 9.9 5.9 4.0 1.6 2.3 3.3 0.6 0.5 2.9 2.7 CBL "c-Cbl, CBL2, RNF55" ENSG00000110395 "Cbl proto-oncogene" P22681 11 119206298-119313926 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 8.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004350, HPA027956" Enhanced Approved Cytosol NA NA 67000 "Cluster 1: Neutrophils - Mixed function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol "CAB004350: AB_2244054, HPA027956: AB_10601094" "unprognostic (2.52e-1)" "unprognostic (1.32e-3)" "unprognostic (1.60e-1)" "unprognostic (1.15e-1)" "unprognostic (1.50e-2)" "unprognostic (2.92e-1)" "unprognostic (4.10e-3)" "unprognostic (9.75e-2)" "unprognostic (1.72e-1)" "unprognostic (1.52e-1)" "unprognostic (1.03e-2)" "unprognostic (5.23e-2)" "unprognostic (5.21e-2)" "unprognostic (5.27e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (5.85e-2)" 6.8 4.0 5.6 9.5 5.7 8.5 5.6 5.3 6.5 5.0 0.2 6.2 3.9 6.5 3.4 5.6 5.6 3.9 4.1 5.3 8.1 4.4 2.7 7.9 10.7 5.8 6.3 3.7 3.8 6.1 2.9 6.4 6.5 4.0 5.0 8.3 3.6 4.6 2.5 5.2 6.6 7.4 5.2 9.9 5.2 18.2 7.9 22.5 4.1 3.2 11.2 5.8 4.9 6.0 10.7 7.6 26.6 16.7 7.8 9.2 16.0 11.2 11.4 10.8 10.2 16.7 12.6 25.1 10.0 14.0 21.7 15.2 18.4 9.4 22.7 14.8 4.7 26.4 6.2 5.1 9.5 30.3 27.9 8.1 10.1 26.7 28.4 11.1 26.3 23.7 21.7 9.9 19.1 11.3 16.2 17.0 14.0 9.2 8.8 17.5 13.5 4.6 9.3 8.2 3.7 11.3 20.9 8.8 7.3 18.1 9.4 24.8 22.8 16.0 11.5 11.6 14.7 3.3 5.3 19.9 6.7 25.4 11.9 0.8 2.4 2.0 0.9 2.8 0.8 1.5 1.1 0.9 2.6 1.2 1.2 1.3 8.6 0.4 2.5 1.4 1.0 0.9 5.6 5.7 5.3 6.5 5.3 8.1 5.8 6.3 6.5 5.2 7.9 6.0 23.2 9.6 8.3 23.5 23.2 18.0 5.9 7.5 19.4 14.0 13.6 11.7 8.8 5.7 6.0 11.0 45.9 6.3 24.0 7.6 1.9 6.1 28.2 9.9 19.6 23.2 8.4 5.7 38.5 6.7 10.5 9.4 9.2 16.8 3.8 20.8 20.0 3.1 16.0 13.5 39.1 4.9 2.0 59.1 43.2 42.0 7.8 41.2 16.0 45.0 46.8 13.2 22.6 26.2 19.6 10.6 11.6 12.8 19.7 8.0 5.1 5.4 4.8 33.3 26.3 11.6 22.7 38.0 36.2 18.5 21.9 7.0 24.9 10.6 5.1 10.9 MCAM "CD146, HEMCAM, MelCAM, METCAM, MUC18" ENSG00000076706 "Melanoma cell adhesion molecule" P43121 11 119308529-119321521 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 128.5;Endothelial cells: 153.5;Muller glia cells: 89.8;Sertoli cells: 322.1;Smooth muscle cells: 384.6" "Cancer enhanced" "Detected in all" "melanoma: 83.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "HUVEC TERT2: 1121.0;TIME: 1107.4;WM-115: 869.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002147, HPA008848" Enhanced Approved "Plasma membrane" NA NA 1900000000 "Cluster 13: T-cells - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Plasma membrane" "CAB002147: AB_563499, HPA008848: AB_1078445" "unprognostic (6.45e-2)" "prognostic unfavorable (7.61e-4)" "unprognostic (7.03e-2)" "unprognostic (1.22e-2)" "unprognostic (6.67e-2)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (8.42e-2)" "unprognostic (2.09e-2)" "unprognostic (1.45e-1)" "unprognostic (1.58e-1)" "unprognostic (9.39e-2)" "prognostic unfavorable (5.14e-4)" "unprognostic (8.75e-3)" "unprognostic (7.84e-2)" "unprognostic (2.31e-1)" "unprognostic (2.79e-3)" 332.7 30.0 36.6 68.4 46.1 1.2 180.6 45.7 45.3 96.6 25.3 166.3 29.2 175.8 47.0 89.2 136.4 66.8 118.0 35.3 44.7 42.0 10.5 116.4 19.6 59.4 43.1 60.9 22.0 93.9 17.8 168.0 52.2 78.1 32.2 12.2 39.5 148.0 40.7 50.9 73.0 160.9 36.2 35.4 97.7 9.7 50.2 15.5 58.7 37.4 15.4 174.5 79.8 44.8 0.7 5.1 4.7 0.3 21.5 0.3 23.2 3.2 0.3 29.9 13.3 17.9 0.9 1.2 94.5 10.7 44.7 3.2 38.3 8.1 15.0 56.9 14.5 1.2 102.4 19.8 51.0 0.1 0.4 15.2 0.3 40.8 18.7 1.1 1121.0 7.1 38.7 1.5 6.1 0.0 1.2 9.3 19.9 0.2 4.4 0.9 147.8 32.9 27.1 0.0 12.5 3.9 87.1 2.1 249.2 46.2 4.3 0.9 1107.4 3.1 156.7 0.2 89.1 2.4 2.3 0.6 43.1 0.1 869.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 36.6 46.1 45.7 45.3 35.3 44.7 59.4 43.1 52.2 36.2 50.2 44.8 128.5 0.0 2.3 1.3 1.4 4.7 0.6 11.1 8.0 1.2 9.9 19.7 65.8 18.6 1.1 0.0 22.9 0.5 2.5 0.1 0.0 17.3 1.7 7.8 14.0 153.5 0.0 0.0 1.4 0.4 38.7 14.1 1.5 10.3 0.0 18.2 60.0 0.6 0.8 0.0 3.5 0.0 0.0 1.3 7.0 0.7 0.9 2.4 21.4 14.0 0.6 89.8 1.0 18.6 45.2 1.6 0.0 25.2 3.1 1.7 0.0 0.9 1.3 4.0 322.1 9.9 384.6 2.1 1.6 1.7 3.3 0.4 9.3 4.9 0.1 1.8 RNF26 MGC2642 ENSG00000173456 "Ring finger protein 26" Q9BY78 11 119334527-119337309 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027620 Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA Yes "Cluster 39: Non-specific - mRNA processing" "Cluster 85: Liver - Metabolism" "Cluster 1: K-562 - Erythropoiesis" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Vesicles, Cytosol" "HPA027620: AB_1856356" "unprognostic (9.23e-3)" "unprognostic (3.54e-2)" "unprognostic (1.36e-1)" "unprognostic (8.68e-3)" "unprognostic (3.40e-1)" "unprognostic (1.07e-2)" "prognostic unfavorable (3.19e-4)" "unprognostic (2.14e-2)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (7.24e-3)" "unprognostic (6.22e-2)" "prognostic favorable (3.45e-6)" "unprognostic (9.61e-2)" "unprognostic (3.50e-2)" "unprognostic (4.41e-2)" "prognostic unfavorable (7.73e-4)" 14.3 15.8 12.7 11.5 12.6 22.0 13.3 13.7 15.1 15.4 10.6 19.2 14.5 23.5 10.3 20.9 16.6 10.5 13.2 12.7 12.5 13.6 23.6 12.4 11.8 15.2 13.1 17.1 13.8 18.5 10.4 14.2 15.5 14.8 12.6 8.4 14.9 18.6 8.5 15.7 17.0 19.0 12.7 14.6 19.1 15.1 14.7 13.3 13.2 7.1 12.8 18.9 14.2 13.1 43.8 47.4 43.4 51.4 41.8 32.8 46.0 46.3 49.7 52.8 41.5 80.6 88.9 38.3 62.5 55.5 80.1 77.2 61.9 69.8 33.0 46.0 34.2 101.0 21.8 67.3 31.9 42.8 40.4 34.3 35.2 66.1 59.0 34.7 40.8 58.1 50.0 58.4 36.9 94.9 39.5 44.3 43.5 50.2 59.8 40.5 44.5 30.4 32.7 31.1 30.8 29.9 37.4 46.8 12.5 41.4 106.1 35.4 27.0 63.5 41.8 33.7 43.0 14.0 24.6 0.4 21.3 71.0 50.6 9.5 21.6 5.6 20.8 19.2 13.4 11.1 15.7 18.4 19.0 16.7 17.5 15.5 1.5 14.0 20.2 11.0 8.7 24.9 12.7 12.6 13.7 15.1 12.7 12.5 15.2 13.1 15.5 12.7 14.7 13.1 5.1 3.2 9.4 1.0 9.1 6.9 13.3 15.4 12.5 9.2 10.9 9.8 0.8 22.8 11.1 11.0 2.1 44.0 6.2 9.3 5.9 20.8 6.6 5.9 7.9 8.6 13.8 18.5 3.2 17.0 66.0 11.5 9.2 5.9 7.6 16.9 11.4 23.4 21.5 5.0 2.9 13.0 8.2 14.8 5.9 8.6 14.0 6.6 1.8 1.0 11.6 11.6 15.5 4.5 2.7 14.1 7.5 17.7 4.3 14.2 15.6 12.5 4.8 9.4 6.6 6.5 10.6 19.9 10.5 14.3 8.5 24.4 8.3 8.8 18.6 9.8 C1QTNF5 "CTRP5, DKFZp586B0621, LORD" ENSG00000223953 "C1q and TNF related 5" Q9BXJ0 11 119338942-119340940 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Ductal cells: 4.7;Endothelial cells: 1.5;Exocrine glandular cells: 1.1;Fibroblasts: 3.6;Gastric mucus-secreting cells: 1.5;Smooth muscle cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 17.7;fHDF/TERT166: 14.7;HHSteC: 35.8;hTERT-RPE1: 28.5;HUVEC TERT2: 54.7;TIME: 50.5" "Low region specificity" "Detected in all" "CAB025607, HPA038604" Uncertain "Secreted to blood" NA NA 219000000 1500000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 50: Fibroblasts - ECM organization" "CAB025607: , HPA038604: AB_2676110" 51.9 13.4 19.1 12.9 20.8 0.1 36.6 20.3 20.7 38.4 25.5 23.0 14.9 50.7 7.5 11.5 27.2 45.5 36.1 17.3 19.8 42.4 11.1 42.0 8.9 21.8 22.2 11.3 18.8 6.8 14.8 13.6 20.4 19.5 7.8 2.2 16.9 8.7 8.8 20.4 24.2 26.8 21.7 32.3 27.1 2.6 27.5 2.8 32.0 15.2 4.6 31.6 20.8 21.7 0.0 0.0 3.3 0.0 17.7 4.9 0.2 4.6 0.3 0.6 2.7 0.1 0.0 0.1 2.0 14.7 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 35.8 0.0 0.0 8.4 0.0 0.3 0.0 28.5 54.7 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.9 0.0 0.1 0.0 4.1 0.0 0.1 0.0 0.0 6.5 0.0 0.0 1.1 0.9 0.0 0.0 50.5 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 20.8 20.3 20.7 17.3 19.8 21.8 22.2 20.4 21.7 27.5 21.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.1 1.5 0.0 0.0 0.0 1.1 0.0 3.6 1.5 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 MFRP "C1QTNF5, FLJ30570, NNO2, rd6" ENSG00000235718 "Membrane frizzled-related protein" Q9BY79 11 119338942-119346705 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Microphthalmia, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "choroid plexus: 355.6" "Cell type enhanced" "Detected in single" "Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "hippocampal formation: 24.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 3.5;hippocampal formation: 11.8;pons and medulla: 10.3;thalamus: 8.4" "Region enhanced" "Detected in all" "medulla oblongata: 17.6" NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 49: Ciliated cells - Cilium organization" 0.0 0.0 0.7 0.0 0.3 0.0 0.0 3.5 0.9 0.0 355.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.2 0.0 0.0 0.0 0.0 0.6 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 3.5 0.9 24.9 0.2 0.6 1.4 0.2 0.2 3.7 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP2 UBP41 ENSG00000036672 "Ubiquitin specific peptidase 2" O75604 11 119355215-119381711 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 168.3" "Group enriched" "Detected in many" 5 "Early spermatids: 460.0;Late spermatids: 1094.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 14.5;U-266/70: 56.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006777, HPA007222" Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 54: Non-specific - Microtubule organization" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "Plasma membrane" "HPA006777: AB_1080507, HPA007222: AB_1080505" "unprognostic (6.83e-2)" "unprognostic (2.02e-2)" "unprognostic (5.54e-2)" "unprognostic (1.37e-2)" "unprognostic (1.25e-1)" "unprognostic (7.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.27e-2)" "unprognostic (1.24e-1)" "unprognostic (5.24e-3)" "unprognostic (8.02e-3)" "unprognostic (7.33e-2)" "prognostic favorable (3.09e-11)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "unprognostic (1.96e-2)" "unprognostic (2.66e-2)" 7.0 13.4 11.9 1.6 22.6 1.9 4.1 18.8 19.0 6.0 32.7 10.2 13.9 5.2 5.7 9.8 11.6 2.3 73.5 18.6 9.4 53.4 18.9 3.4 0.1 12.0 13.1 6.2 18.1 24.2 18.9 1.3 7.7 4.1 6.0 76.2 7.6 3.0 168.3 12.8 17.4 6.8 8.2 0.6 6.2 86.5 15.1 0.6 3.8 62.8 0.6 4.5 4.8 17.5 6.0 0.5 0.9 3.2 0.1 0.2 1.3 0.7 0.4 0.0 0.6 6.1 0.8 10.2 1.8 1.1 1.4 1.0 7.9 2.9 0.2 7.2 1.0 2.8 4.4 12.5 2.7 0.0 2.8 0.9 0.6 0.7 2.0 1.3 0.6 7.6 14.5 0.8 1.7 4.1 0.0 0.6 1.6 2.0 1.3 0.1 2.1 1.5 4.6 0.3 11.9 3.6 3.4 2.6 0.7 1.7 8.8 6.2 0.0 0.0 1.5 0.8 1.0 56.9 13.5 0.2 0.1 2.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 22.6 18.8 19.0 18.6 9.4 12.0 13.1 7.7 8.2 15.1 17.5 0.6 3.2 2.7 10.7 0.6 2.4 5.3 1.5 1.2 75.2 3.3 2.4 85.2 7.2 6.1 5.5 95.9 0.5 1.6 25.5 113.5 3.1 460.0 39.0 3.0 3.6 0.0 0.4 15.7 1.6 0.9 7.4 2.0 8.4 0.0 2.0 2.2 23.0 17.2 10.1 11.6 2.0 0.0 1.3 2.9 1094.1 6.5 2.1 0.0 1.9 0.0 49.7 0.0 8.0 12.5 1.2 11.8 7.2 0.1 1.1 41.3 41.6 35.0 140.0 19.7 43.3 24.0 50.5 16.5 12.9 4.0 1.4 1.3 0.5 2.6 2.9 THY1 CD90 ENSG00000154096 "Thy-1 cell surface antigen" P04216 11 119415476-119424985 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 286.8;smooth muscle: 304.7;urinary bladder: 216.7" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 141.6;Excitatory neurons: 116.0;Fibroblasts: 201.9;Inhibitory neurons: 104.1;Muller glia cells: 108.1;Proximal tubular cells: 199.9;Smooth muscle cells: 226.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 461.3;BJ: 738.4;BJ hTERT+: 832.5;fHDF/TERT166: 1330.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003733, CAB068243, CAB068244" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 14000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Plasma membrane" "CAB068243: AB_2665687, CAB068244: AB_2665688, HPA003733: AB_1846340" "unprognostic (9.98e-2)" "unprognostic (2.71e-1)" "unprognostic (5.13e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (6.87e-4)" "unprognostic (7.43e-2)" "unprognostic (1.43e-3)" "unprognostic (2.38e-2)" "unprognostic (1.29e-1)" "unprognostic (2.90e-3)" "unprognostic (3.38e-2)" "unprognostic (3.52e-1)" "prognostic unfavorable (2.40e-6)" "unprognostic (1.75e-2)" "unprognostic (1.90e-2)" "unprognostic (3.03e-2)" "unprognostic (1.14e-2)" 90.6 16.4 97.9 78.6 114.8 0.2 25.6 12.9 286.8 78.9 0.0 35.4 10.2 58.6 27.8 29.4 23.1 101.0 12.9 135.4 73.3 142.2 7.4 21.6 40.4 83.6 37.0 9.2 14.8 39.4 18.1 62.0 60.8 15.5 41.8 25.3 8.5 47.0 3.4 13.9 14.5 304.7 35.4 21.9 17.4 11.4 43.6 73.2 37.9 8.3 35.6 216.7 21.7 108.7 0.7 3.9 108.5 0.1 461.3 331.5 0.3 738.4 832.5 263.6 289.3 0.2 0.2 0.4 0.1 1330.6 121.9 0.9 4.3 1.1 200.7 65.1 0.0 41.5 14.4 0.0 142.7 0.0 0.2 247.5 0.0 335.6 11.6 355.2 0.3 22.6 0.0 0.6 206.5 0.1 0.6 0.1 173.9 0.0 1.4 0.5 50.7 0.3 0.1 0.2 18.1 47.9 0.1 0.4 0.2 32.9 1.0 2.1 0.0 368.6 120.9 107.3 110.1 0.3 19.7 0.4 1.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 97.9 114.8 12.9 286.8 135.4 73.3 83.6 37.0 60.8 35.4 43.6 108.7 68.2 0.0 1.8 17.3 2.1 17.7 0.3 1.7 0.0 27.2 1.6 40.0 0.9 0.0 0.0 9.2 0.0 1.9 0.2 0.0 21.5 0.9 1.0 5.1 141.6 69.2 0.0 0.0 116.0 0.0 2.6 201.9 1.5 3.2 1.3 0.0 17.5 0.1 4.0 32.0 104.1 0.0 0.0 0.0 25.0 2.7 96.3 2.7 17.8 21.5 0.0 108.1 0.0 64.3 22.7 0.4 0.0 77.5 0.1 0.3 0.0 199.9 0.0 27.5 32.9 9.3 226.6 0.3 0.6 0.2 17.6 4.0 4.5 6.2 0.0 0.6 NECTIN1 "CD111, CLPED1, ED4, HIgR, HVEC, OFC7, PRR, PRR1, PVRL1, PVRR1, SK-12" ENSG00000110400 "Nectin cell adhesion molecule 1" Q15223 11 119623408-119729200 "CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 128.8;skin 1: 134.4" "Cell type enhanced" "Detected in many" "Breast glandular cells: 12.1;Breast myoepithelial cells: 27.3;Exocrine glandular cells: 12.3;Granulosa cells: 68.7;Pancreatic endocrine cells: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 229.2;hTCEpi: 139.2;RT4: 157.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016135, HPA026846" Approved "Secreted in other tissues" NA NA 180000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" "CAB016135: AB_626865, HPA026846: AB_1846226" "unprognostic (1.62e-1)" "unprognostic (1.16e-1)" "unprognostic (1.11e-1)" "unprognostic (3.87e-2)" "unprognostic (1.26e-1)" "unprognostic (3.20e-2)" "unprognostic (2.25e-3)" "unprognostic (2.03e-1)" "unprognostic (3.76e-2)" "unprognostic (3.42e-1)" "unprognostic (3.58e-2)" "unprognostic (3.28e-1)" "unprognostic (3.59e-3)" "unprognostic (2.13e-2)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (9.62e-2)" 4.4 4.0 14.8 4.7 25.6 24.3 8.2 17.4 32.3 14.0 0.0 12.4 16.6 3.4 2.3 128.8 4.0 3.4 8.1 30.5 15.3 5.1 4.3 3.4 2.1 23.8 26.5 2.3 18.8 2.7 7.8 7.3 18.4 12.8 12.9 18.5 18.0 6.2 1.9 134.4 12.0 4.5 16.3 3.3 4.6 1.3 26.9 6.7 2.2 1.6 27.9 28.9 36.8 38.8 16.6 13.6 12.6 18.2 6.5 2.1 88.2 6.6 6.1 5.4 3.8 28.8 55.2 21.8 26.1 7.6 10.9 229.2 32.5 117.6 2.4 51.8 4.9 3.0 4.4 13.2 2.6 14.9 35.4 2.0 139.2 17.1 62.5 2.1 16.3 6.2 0.6 113.2 7.2 42.7 0.3 9.0 41.6 55.3 18.7 1.2 75.7 26.3 5.1 157.4 30.6 68.6 22.1 57.4 1.8 18.8 52.3 2.2 9.0 4.8 17.6 39.2 5.9 20.6 28.0 0.2 1.7 11.9 11.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 1.6 0.0 0.0 14.8 25.6 17.4 32.3 30.5 15.3 23.8 26.5 18.4 16.3 26.9 38.8 4.2 0.0 3.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 12.1 27.3 0.0 0.0 4.3 1.8 0.0 4.1 4.1 0.0 0.0 8.7 0.0 4.6 3.2 1.3 0.0 0.0 0.0 12.3 1.3 2.1 0.0 10.9 0.0 68.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 15.5 0.0 0.0 1.9 0.0 0.0 3.3 1.5 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 8.9 1.3 1.7 0.0 0.0 TRIM29 "ATDC, FLJ36085" ENSG00000137699 "Tripartite motif containing 29" Q14134 11 120111286-120185529 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 600.1;skin 1: 551.2;vagina: 269.1" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 272.0;Basal squamous epithelial cells: 250.4;Late spermatids: 150.3;Squamous epithelial cells: 552.9;Suprabasal keratinocytes: 460.6;Urothelial cells: 159.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 93.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 399.9;HBEC3-KT: 107.5;hTCEpi: 476.0;RT4: 190.5;SiHa: 268.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "spinal cord: 4.0" "HPA020053, HPA074841" Enhanced Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "Intermediate filaments" "Nucleoplasm, Cytosol" "HPA020053: AB_1858280, HPA074841: " "unprognostic (1.10e-1)" "unprognostic (6.22e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (2.88e-4)" "unprognostic (9.79e-3)" "unprognostic (3.08e-2)" "unprognostic (3.30e-1)" "unprognostic (5.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.46e-4)" "unprognostic (9.37e-2)" "unprognostic (4.29e-3)" "prognostic favorable (4.93e-4)" "unprognostic (2.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.15e-2)" 2.5 1.0 0.1 0.4 0.2 0.4 41.7 0.0 0.4 133.8 1.6 3.0 1.7 2.6 4.8 600.1 17.4 3.5 0.4 0.3 0.0 1.7 1.8 3.7 0.0 1.8 0.6 0.4 1.0 0.0 8.1 30.7 1.8 31.4 2.6 0.3 131.5 23.7 2.2 551.2 1.0 1.5 2.6 0.3 1.4 2.7 0.0 19.9 0.4 0.2 107.2 55.8 269.1 0.6 34.4 2.5 0.0 0.0 0.0 0.0 0.9 0.1 0.8 0.2 0.1 0.8 25.6 0.2 3.9 0.2 0.5 399.9 0.0 107.5 0.0 0.1 0.0 0.2 25.4 0.4 0.0 0.2 0.5 0.0 476.0 0.0 2.6 0.0 0.0 0.0 0.2 0.7 0.0 4.4 0.0 0.0 0.1 11.4 0.1 0.0 0.3 0.0 0.3 190.5 1.3 5.9 268.3 35.2 0.1 0.2 1.9 0.0 0.4 0.1 2.1 0.2 0.1 0.2 0.3 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.3 0.0 1.8 0.6 1.8 2.6 0.0 0.6 0.5 0.0 1.5 3.3 0.2 272.0 106.1 76.4 250.4 0.0 9.5 58.8 1.2 1.5 39.2 0.0 0.0 41.0 0.2 11.3 0.0 5.0 28.1 8.7 0.8 3.4 2.4 0.0 0.5 4.3 7.1 5.6 1.1 3.6 1.3 0.0 0.0 0.4 5.0 0.0 0.1 2.1 12.2 0.0 30.3 150.3 0.6 1.4 23.2 1.0 0.0 0.0 0.0 0.0 0.1 57.1 11.3 0.0 0.0 66.0 0.2 0.6 64.6 0.0 0.0 0.1 4.9 0.8 2.6 552.9 460.6 24.8 2.4 0.1 3.7 159.3 OAF MGC52117 ENSG00000184232 "Out at first homolog" Q86UD1 11 120211032-120230334 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 396.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 135.9;Fibroblasts: 135.9;Hepatocytes: 218.8;Muller glia cells: 279.4;Theca cells: 149.0;Urothelial cells: 192.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 3.3;intermediate monocyte: 1.6;myeloid DC: 2.4" "Group enriched" "Detected in many" 14 "dendritic cells: 2.4;monocytes: 3.3" "Cell line enhanced" "Detected in many" "EFO-21: 115.5;Hep G2: 190.1;NB-4: 139.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047412 Uncertain Approved Nucleoplasm "Secreted - unknown location" NA NA 69000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "HPA047412: AB_10960631" "unprognostic (1.59e-1)" "unprognostic (2.10e-2)" "unprognostic (1.40e-1)" "unprognostic (2.80e-1)" "unprognostic (5.69e-2)" "prognostic unfavorable (5.71e-5)" "unprognostic (2.11e-1)" "unprognostic (3.98e-3)" "unprognostic (5.09e-2)" "unprognostic (3.90e-2)" "unprognostic (3.28e-2)" "unprognostic (1.52e-2)" "unprognostic (1.07e-2)" "unprognostic (1.12e-2)" "unprognostic (7.15e-2)" "unprognostic (2.13e-1)" "unprognostic (1.95e-1)" 66.0 91.5 47.7 18.0 56.8 10.8 42.6 35.8 57.1 66.7 40.5 61.9 47.7 54.2 16.0 22.8 54.6 34.5 55.1 48.1 36.5 51.4 396.6 19.2 5.8 39.0 37.8 61.0 74.1 6.7 27.4 8.1 37.1 33.5 36.5 30.7 53.9 13.7 13.2 12.0 57.3 29.1 35.9 54.4 33.5 3.7 45.0 4.6 25.9 12.2 3.7 42.6 40.4 44.6 24.9 7.5 30.9 14.4 47.8 53.4 1.7 47.7 53.8 20.5 30.0 7.5 37.3 0.0 115.5 35.6 33.7 25.7 8.9 13.2 8.2 18.7 21.1 21.1 4.7 190.1 42.4 46.7 7.9 66.8 7.9 19.8 54.8 39.9 59.7 12.7 14.0 22.7 5.0 9.4 0.3 139.9 11.6 7.3 40.8 11.8 0.9 23.7 31.8 13.4 1.5 10.0 14.0 15.2 40.2 8.6 4.8 74.7 32.7 39.3 14.7 40.8 4.6 0.8 0.7 0.4 30.3 76.2 14.1 0.0 3.3 0.0 0.1 1.6 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.1 0.0 0.3 0.5 0.1 0.8 47.7 56.8 35.8 57.1 48.1 36.5 39.0 37.8 37.1 35.9 45.0 44.6 19.4 0.0 0.6 102.2 3.7 9.4 33.6 7.3 12.5 3.2 6.0 7.0 5.5 34.3 3.5 71.7 2.1 2.1 1.1 135.9 27.4 14.8 0.2 4.7 70.9 40.0 22.8 12.8 0.6 28.7 5.5 135.9 11.7 12.2 1.3 2.6 12.5 218.8 6.0 0.0 2.3 56.5 4.1 11.5 20.9 1.1 16.8 11.0 16.0 23.4 10.2 279.4 0.0 5.5 11.0 28.2 56.5 4.5 14.5 31.3 111.1 79.3 0.4 10.6 52.6 8.6 40.8 0.7 6.9 11.3 10.2 6.2 3.1 149.0 45.8 192.5 POU2F3 "Epoc-1, OCT11, PLA-1, Skn-1a" ENSG00000137709 "POU class 2 homeobox 3" Q9UKI9 11 120236640-120319945 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 48.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 20.9;Pancreatic endocrine cells: 20.8;Suprabasal keratinocytes: 37.6;Urothelial cells: 14.2" "Cancer enhanced" "Detected in many" "ovarian cancer: 3.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.4;CAPAN-2: 3.6;EFO-21: 1.3;SK-BR-3: 2.5;T-47d: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA019652, HPA073468" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Cluster 61: Skin - Cornification" "Cluster 6: T47d - Mammary gland" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm "Nucleoli, Nuclear bodies, Plasma membrane, Cytosol" "HPA019652: AB_1855585, HPA073468: " "unprognostic (1.75e-1)" "unprognostic (2.12e-2)" "unprognostic (6.37e-2)" "unprognostic (2.41e-4)" "unprognostic (2.60e-1)" "unprognostic (4.46e-3)" "unprognostic (8.56e-3)" "unprognostic (9.34e-2)" "unprognostic (3.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.40e-3)" "unprognostic (2.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.69e-3)" "unprognostic (1.70e-1)" "prognostic favorable (8.14e-4)" "unprognostic (1.45e-1)" 0.1 0.1 0.2 0.1 0.1 0.2 2.0 0.3 0.4 0.8 0.0 0.6 0.9 0.0 1.7 1.3 0.5 0.7 0.1 0.1 0.1 0.3 0.1 1.0 0.2 0.1 0.1 0.1 0.2 6.3 0.4 0.3 0.1 0.6 0.2 0.1 1.1 2.0 0.2 48.0 0.7 0.3 0.0 0.2 0.7 0.1 0.1 0.2 0.7 0.0 0.5 0.4 2.1 0.3 1.4 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.3 0.0 0.0 0.0 3.6 0.1 1.3 0.0 0.0 0.6 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 2.5 0.0 0.3 3.9 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.2 0.0 8.2 0.3 0.0 20.9 10.6 5.0 1.8 0.0 3.0 1.5 0.8 0.0 3.9 11.0 0.0 1.5 0.1 0.9 0.0 5.3 2.2 1.3 0.7 0.3 3.0 0.0 0.4 1.3 0.4 0.6 10.2 4.8 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.2 8.2 0.0 2.2 5.5 0.0 0.1 5.4 0.0 0.0 0.4 0.0 0.0 0.5 20.8 1.1 0.0 0.0 5.0 0.4 0.1 1.8 0.0 0.0 0.0 0.4 0.0 0.1 7.0 37.6 7.9 0.5 0.2 0.6 14.2 TLCD5 "MGC17839, TMEM136" ENSG00000181264 "TLC domain containing 5" Q6ZRR5 11 120325296-120333686 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 51.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 28.3;Cytotrophoblasts: 10.0;Extravillous trophoblasts: 4.2;Fibroblasts: 6.1;Syncytiotrophoblasts: 9.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "plasmacytoid DC: 2.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074432 Approved Vesicles,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 12: NES - Nervous system development" "Cluster 24: Non-specific - Transcription regulation" Vesicles Cytosol "HPA074432: AB_2686689" "unprognostic (1.02e-1)" "unprognostic (6.56e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (6.65e-4)" "unprognostic (1.65e-2)" "unprognostic (3.31e-2)" "unprognostic (6.81e-3)" "unprognostic (1.22e-1)" "unprognostic (1.39e-2)" "unprognostic (2.58e-1)" "unprognostic (2.86e-3)" "unprognostic (2.39e-1)" "unprognostic (2.71e-2)" "unprognostic (2.78e-2)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (7.28e-2)" 4.4 13.1 11.3 1.0 15.2 0.2 3.3 13.4 10.9 5.0 8.8 2.8 0.6 5.1 7.6 1.5 5.7 3.2 11.0 10.9 12.1 3.6 0.8 4.8 1.4 12.3 15.3 7.7 3.9 4.5 7.0 7.2 12.0 4.9 1.1 51.9 2.0 3.3 1.2 1.3 1.9 3.8 11.3 2.6 2.5 3.1 12.6 0.8 5.4 1.9 1.4 3.5 3.5 14.0 2.4 6.0 15.8 10.9 10.9 16.8 3.0 5.0 12.3 8.4 12.7 3.2 10.2 0.0 15.3 3.2 16.2 1.6 10.1 3.8 9.8 0.0 6.3 8.1 6.1 5.4 12.4 0.0 0.0 14.7 2.8 11.4 17.0 19.7 9.2 9.5 2.2 14.8 10.9 2.9 0.0 0.1 5.1 0.6 3.8 6.3 4.9 0.8 10.4 2.2 8.3 7.2 7.3 0.9 1.5 13.4 9.3 0.2 6.9 8.7 9.0 2.0 3.1 0.2 0.0 0.0 2.6 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.4 0.0 11.3 15.2 13.4 10.9 10.9 12.1 12.3 15.3 12.0 11.3 12.6 14.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 10.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.2 6.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 ARHGEF12 "KIAA0382, LARG" ENSG00000196914 "Rho guanine nucleotide exchange factor 12" Q9NZN5 11 120336413-120489937 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 274.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018911, CAB025581" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 44: Endometrium - Transcription" "Plasma membrane, Cytosol" Nucleoplasm "CAB025581: , HPA018911: AB_1845003" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (6.91e-3)" "unprognostic (1.28e-1)" "unprognostic (7.28e-2)" "unprognostic (5.39e-2)" "unprognostic (1.56e-1)" "unprognostic (5.55e-2)" "unprognostic (4.79e-2)" "unprognostic (7.77e-2)" "unprognostic (4.34e-3)" "unprognostic (4.78e-2)" "prognostic favorable (5.43e-6)" "unprognostic (1.29e-1)" "unprognostic (4.38e-2)" "unprognostic (2.13e-1)" "unprognostic (1.48e-1)" 25.6 30.6 27.2 14.3 26.9 11.4 31.9 26.8 32.1 32.9 26.4 27.6 25.0 27.8 25.4 27.6 29.3 28.4 40.3 30.9 23.0 67.4 66.4 36.7 11.9 17.8 25.6 25.2 26.1 68.4 14.6 42.9 17.3 26.5 29.1 47.7 25.0 30.9 32.2 49.5 25.5 30.3 20.1 21.5 32.2 9.7 35.9 13.5 51.5 31.8 18.7 28.7 22.0 19.3 38.1 31.6 41.9 39.8 55.0 54.5 16.7 43.8 49.8 26.1 33.1 37.5 27.2 3.2 51.7 79.8 46.6 27.5 54.1 56.0 51.3 31.1 25.8 61.8 34.0 29.2 49.2 0.1 43.7 52.4 39.7 57.8 63.8 58.0 80.7 32.7 52.4 122.5 67.0 26.6 0.1 0.1 11.4 49.3 26.1 13.4 47.4 11.9 65.1 66.1 30.0 36.4 61.5 51.0 16.2 25.0 43.1 5.1 80.1 57.2 24.2 37.6 32.4 35.1 15.4 20.2 23.6 7.9 44.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 27.2 26.9 26.8 32.1 30.9 23.0 17.8 25.6 17.3 20.1 35.9 19.3 86.2 73.7 88.4 274.9 8.6 90.5 69.1 47.2 42.1 134.6 55.1 26.9 87.6 68.6 57.8 97.5 185.6 16.7 11.5 59.7 35.2 45.6 6.4 61.4 55.7 94.0 37.8 69.7 239.0 50.9 10.4 44.0 34.7 140.3 11.4 44.9 85.6 118.3 7.3 90.9 192.4 39.6 18.3 31.2 25.6 14.8 29.8 18.2 51.6 118.0 8.7 41.0 13.4 143.2 55.0 53.5 52.1 33.4 9.3 85.6 48.1 76.3 48.7 80.9 26.3 58.4 60.3 16.3 13.8 55.3 85.1 28.7 16.1 43.1 41.3 99.1 GRIK4 "GluK4, GRIK, KA1" ENSG00000149403 "Glutamate ionotropic receptor kainate type subunit 4" Q16099 11 120511746-120988906 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.3" "Cell type enhanced" "Detected in some" "Astrocytes: 82.9;Cone photoreceptor cells: 35.5;Excitatory neurons: 115.6;Inhibitory neurons: 43.7;Oligodendrocyte precursor cells: 196.1;Oligodendrocytes: 108.3" "Cancer enriched" "Detected in some" 5 "glioma: 3.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HDLM-2: 6.1;HEL: 18.9;T-47d: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074453 Enhanced NA NA "Cluster 65: Brain - Ion transport" "Cluster 36: HEL - Hemostasis" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA074453: AB_2732255" "unprognostic (9.63e-2)" "unprognostic (4.96e-2)" "unprognostic (1.58e-1)" "unprognostic (2.49e-1)" "unprognostic (2.37e-1)" "unprognostic (6.64e-4)" "unprognostic (1.48e-2)" "unprognostic (7.26e-2)" "unprognostic (3.16e-1)" "unprognostic (2.38e-1)" "unprognostic (4.53e-2)" "unprognostic (2.50e-1)" "unprognostic (4.84e-11)" "unprognostic (1.35e-1)" "unprognostic (2.81e-1)" "unprognostic (4.47e-3)" "unprognostic (2.58e-2)" 0.0 1.7 6.8 0.0 6.5 0.0 0.4 5.6 6.4 0.1 0.9 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.3 10.3 6.0 0.2 0.0 1.5 0.1 7.2 6.2 2.8 0.0 0.0 1.6 0.2 7.3 0.3 0.1 1.0 0.1 0.0 0.0 0.2 0.1 0.1 4.9 0.4 0.0 0.8 9.6 0.1 2.0 0.1 0.1 0.1 0.2 5.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 6.1 0.6 18.9 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.6 4.7 0.0 0.2 0.0 0.2 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 6.5 5.6 6.4 10.3 6.0 7.2 6.2 7.3 4.9 9.6 5.5 0.0 0.0 0.6 82.9 0.1 0.0 0.1 0.0 1.2 0.8 0.5 0.5 1.6 0.0 0.0 0.0 35.5 0.0 0.7 0.0 0.0 0.0 4.4 0.3 0.0 0.2 0.0 0.0 115.6 0.0 0.0 0.7 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 43.7 0.0 0.0 0.8 0.0 7.5 0.3 1.0 0.0 4.7 0.2 0.0 8.2 196.1 108.3 0.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 7.8 0.2 0.8 3.3 0.1 0.0 0.1 0.4 0.1 0.0 0.5 TBCEL "LRRC35, MGC10233" ENSG00000154114 "Tubulin folding cofactor E like" Q5QJ74 11 121024072-121090775 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 104.0;Oligodendrocytes: 39.4;Plasma cells: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "HPA038593, HPA038594" Approved Uncertain Cytosol NA NA 22000 "Cluster 48: NK-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 6: Erythroid cells - Oxygen transport" Cytosol "HPA038593: AB_10669647, HPA038594: AB_2676103" "unprognostic (9.06e-3)" "unprognostic (3.42e-2)" "unprognostic (2.65e-1)" "unprognostic (2.29e-1)" "unprognostic (5.80e-2)" "unprognostic (3.13e-1)" "unprognostic (1.22e-1)" "unprognostic (2.55e-2)" "unprognostic (1.27e-2)" "unprognostic (1.06e-2)" "unprognostic (4.20e-2)" "unprognostic (3.14e-1)" "unprognostic (8.55e-2)" "unprognostic (3.07e-3)" "unprognostic (1.86e-1)" "unprognostic (1.66e-2)" "unprognostic (1.02e-1)" 7.4 7.6 10.7 5.9 14.2 5.6 9.0 14.4 11.5 7.2 15.0 7.4 5.4 8.5 9.6 5.7 6.2 7.7 9.8 8.5 11.0 8.3 15.1 9.6 7.5 10.5 10.5 9.2 6.3 16.5 7.9 10.8 9.8 9.0 5.9 8.3 7.2 12.3 6.1 5.1 5.8 9.6 10.2 8.4 6.0 14.8 14.2 7.2 10.3 8.2 7.4 6.6 4.7 13.6 6.2 5.8 9.8 8.5 17.5 16.5 7.5 11.5 14.2 8.7 12.7 6.0 9.7 7.6 17.3 14.3 8.4 1.6 10.8 3.8 11.4 9.1 8.0 13.2 4.5 6.0 21.6 9.4 8.8 18.2 12.8 8.4 9.1 8.8 14.4 4.3 3.9 14.3 12.3 4.2 3.9 7.8 5.8 0.2 5.6 3.3 14.3 3.5 11.7 3.8 5.2 12.0 11.3 11.7 7.9 8.3 11.3 7.9 18.9 19.2 4.2 7.8 6.4 5.5 4.3 4.0 2.7 0.1 7.3 0.0 0.2 0.1 0.3 0.3 0.4 0.1 0.4 0.4 0.2 0.2 0.4 0.3 0.1 0.6 0.2 0.4 0.2 0.2 10.7 14.2 14.4 11.5 8.5 11.0 10.5 10.5 9.8 10.2 14.2 13.6 9.4 6.4 11.3 15.7 7.8 2.9 1.8 2.0 2.8 9.0 4.4 2.9 10.3 7.2 1.7 7.3 14.6 1.7 3.4 2.0 1.9 4.7 11.3 9.3 8.2 8.0 3.6 104.0 34.1 2.6 1.9 7.0 1.5 3.7 1.3 6.7 13.2 20.7 3.1 8.4 32.9 2.5 4.1 6.7 2.8 5.8 9.3 4.3 10.6 20.6 10.1 5.5 6.2 36.2 39.4 3.3 1.0 9.8 42.7 2.7 2.0 4.3 8.4 9.2 0.0 14.8 6.0 14.9 6.0 3.7 1.7 1.4 3.7 6.8 2.3 1.2 TBCEL-TECTA ENSG00000285509 "TBCEL-TECTA readthrough" 11 121024125-121113108 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEL: 1.3" "HPA038593, HPA038594" Uncertain Uncertain Cytosol NA NA "Cluster 36: HEL - Hemostasis" Cytosol "HPA038593: AB_10669647, HPA038594: AB_2676103" 0.1 0.0 0.4 0.1 0.6 0.0 0.1 0.3 0.6 0.2 0.5 0.1 0.1 0.2 0.0 0.1 0.0 0.2 0.2 0.4 1.1 0.3 0.1 0.2 0.0 0.7 0.6 0.2 0.6 0.4 0.2 0.7 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.5 1.1 0.1 0.0 0.0 0.0 0.1 0.6 0.1 0.2 0.5 0.1 0.0 0.1 0.0 0.6 0.7 0.7 0.1 0.3 0.4 0.2 0.2 0.2 0.3 0.0 0.2 0.1 0.7 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.3 0.0 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.8 0.2 0.0 0.2 0.7 0.9 0.2 0.0 0.0 0.7 0.4 0.0 0.0 0.6 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.3 0.6 0.4 1.1 0.7 0.6 0.7 0.3 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TECTA "DFNA12, DFNA8, DFNB21" ENSG00000109927 "Tectorin alpha" O75443 11 121101243-121191490 "Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" Hearing "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Astrocytes: 5.2;Cone photoreceptor cells: 4.2;Early spermatids: 5.6;Excitatory neurons: 9.9;Hepatic stellate cells: 8.9;Inhibitory neurons: 7.2;Oligodendrocyte precursor cells: 5.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.1;SH-SY5Y: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA018870 Approved "Secreted in other tissues" NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA018870: AB_1857879" "unprognostic (1.12e-3)" "unprognostic (2.42e-1)" "unprognostic (1.42e-2)" "unprognostic (1.45e-2)" "unprognostic (4.30e-2)" "unprognostic (3.11e-1)" "unprognostic (3.00e-2)" "unprognostic (3.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.14e-1)" "unprognostic (1.39e-6)" "unprognostic (1.22e-1)" "unprognostic (4.15e-3)" "unprognostic (6.97e-3)" "unprognostic (1.12e-1)" "unprognostic (3.28e-2)" "unprognostic (4.19e-2)" 0.3 0.5 1.6 0.2 2.1 0.2 0.3 1.0 1.6 0.3 1.5 0.5 0.1 0.3 0.6 0.1 0.3 0.3 1.1 1.3 2.0 0.5 0.4 0.4 0.1 1.5 1.4 0.7 0.3 0.8 1.3 0.2 1.5 0.5 0.1 1.1 0.3 0.5 0.8 0.1 0.2 0.2 0.9 0.3 0.3 0.9 1.6 0.2 0.7 0.4 0.1 0.3 0.2 1.9 0.0 0.0 1.1 0.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.7 1.7 0.1 0.0 0.1 0.7 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.1 1.0 1.6 1.3 2.0 1.5 1.4 1.5 0.9 1.6 1.9 0.5 3.2 0.5 5.2 0.1 0.0 0.1 0.0 0.0 1.8 0.2 0.3 1.9 1.5 0.6 0.0 4.2 0.0 0.2 0.0 0.0 0.2 5.6 0.6 0.3 0.5 0.0 0.0 9.9 0.4 0.1 0.4 0.0 0.3 0.0 0.6 8.9 0.6 0.1 0.0 7.2 0.0 0.0 0.3 0.0 2.7 0.3 0.2 0.0 1.0 0.2 0.9 0.0 5.0 2.8 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.2 0.7 0.0 1.9 0.4 0.9 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 SC5D SC5DL ENSG00000109929 Sterol-C5-desaturase O75845 11 121292681-121313410 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 393.6" "Cell type enhanced" "Detected in all" "Hepatic stellate cells: 141.0;Hepatocytes: 307.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066283, HPA070248" Enhanced Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" No No "Cluster 44: Non-specific - Transcription" "Cluster 85: Liver - Metabolism" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 15: Hepatocytes - Hemostasis" "Nucleoplasm, Endoplasmic reticulum" "Plasma membrane, Cytosol" "HPA066283: AB_2685648, HPA070248: AB_2686240" "unprognostic (4.78e-2)" "unprognostic (7.29e-2)" "unprognostic (2.26e-2)" "unprognostic (2.36e-1)" "unprognostic (3.98e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (2.79e-2)" "unprognostic (7.96e-2)" "prognostic unfavorable (3.98e-4)" "unprognostic (4.03e-2)" "unprognostic (3.18e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.07e-7)" "unprognostic (4.29e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (1.98e-1)" 28.6 35.3 18.4 12.6 20.4 5.7 56.6 37.1 29.3 20.7 17.6 23.2 48.2 15.1 73.2 39.6 16.5 18.2 22.0 19.9 29.9 49.1 393.6 24.6 13.5 42.9 28.0 16.9 21.5 48.6 15.6 14.7 39.1 101.4 19.9 29.5 22.4 56.6 7.7 13.8 24.7 16.2 32.2 8.8 21.7 24.3 24.6 13.5 23.9 13.0 19.5 21.5 27.1 36.5 26.5 14.3 184.8 39.5 72.1 59.9 27.8 27.8 53.5 18.2 32.4 83.1 95.9 25.4 89.0 32.3 156.6 100.8 59.2 70.9 18.1 12.5 80.0 34.6 73.4 64.4 57.9 24.8 12.5 51.0 57.4 60.4 60.2 15.6 29.8 22.8 25.0 34.6 89.0 27.4 9.4 29.2 59.8 74.4 39.7 13.2 51.0 21.6 133.6 116.5 51.1 28.8 73.4 14.6 38.0 125.4 62.2 38.6 58.3 19.0 29.7 32.5 14.0 6.4 11.2 33.3 7.0 49.5 33.5 7.8 3.7 1.0 3.5 4.9 5.9 4.4 4.7 4.2 6.5 4.1 6.8 6.7 0.3 5.3 3.6 7.7 5.5 2.6 18.4 20.4 37.1 29.3 19.9 29.9 42.9 28.0 39.1 32.2 24.6 36.5 10.4 19.2 31.9 23.8 62.6 9.7 49.9 48.9 14.8 26.8 33.7 12.4 20.8 18.6 40.8 20.2 31.3 15.9 47.5 26.4 5.9 24.1 3.0 11.5 8.8 15.7 14.4 18.1 29.6 28.9 16.7 16.3 18.3 19.6 17.7 11.1 141.0 307.1 21.0 23.5 29.4 15.3 59.0 22.1 17.0 1.3 19.3 17.6 19.6 20.6 15.6 38.7 13.4 27.6 34.0 19.3 18.8 17.0 20.9 50.1 24.1 15.8 18.7 28.3 13.1 12.9 14.7 6.7 12.7 36.2 15.5 18.6 56.5 42.8 13.3 54.4 SORL1 "C11orf32, gp250, LR11, LRP9, SorLA, SorLA-1" ENSG00000137642 "Sortilin related receptor 1" Q92673 11 121452314-121633763 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Endocytosis, Transport" Receptor "Alzheimer disease, Amyloidosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 79.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 387.8;Excitatory neurons: 247.4;Microglial cells: 404.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 125.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 125.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 142.8;Daudi: 68.7;OE19: 93.5;RT4: 102.1;U-698: 139.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011500, HPA031321" Uncertain "Secreted to blood" NA NA 79000 "Cluster 5: Granulocytes - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "CAB011500: AB_443414, HPA031321: AB_2673826" "unprognostic (1.54e-1)" "unprognostic (1.74e-1)" "unprognostic (4.08e-2)" "unprognostic (9.53e-2)" "unprognostic (3.06e-1)" "unprognostic (1.18e-2)" "unprognostic (1.59e-2)" "unprognostic (1.59e-3)" "unprognostic (1.74e-1)" "unprognostic (1.86e-2)" "unprognostic (2.85e-1)" "unprognostic (1.45e-1)" "prognostic favorable (1.80e-7)" "unprognostic (2.48e-1)" "unprognostic (1.87e-1)" "unprognostic (5.07e-2)" "unprognostic (1.21e-2)" 7.0 6.1 29.1 24.4 39.1 47.4 13.9 49.5 35.5 44.4 0.0 17.3 11.6 5.4 8.9 5.4 40.1 7.3 2.4 33.8 39.7 19.0 58.2 10.4 21.1 40.3 46.8 9.0 8.0 10.4 16.8 2.3 47.0 20.8 16.9 20.3 21.8 25.4 1.7 3.4 18.1 4.5 45.3 21.8 10.3 5.1 38.8 17.0 13.5 4.0 23.0 15.7 6.6 79.1 1.3 8.1 7.3 1.1 0.0 0.0 7.4 0.4 2.4 0.3 0.0 11.9 142.8 68.7 8.5 1.8 10.5 47.4 9.1 7.0 0.1 0.0 2.6 0.0 10.3 16.8 0.1 29.6 0.1 0.0 7.6 0.0 25.8 4.0 0.0 8.7 0.0 0.7 0.0 9.7 7.1 15.3 8.8 93.5 10.8 7.7 0.4 1.6 15.8 102.1 5.1 1.5 15.2 21.5 0.0 16.0 21.0 9.5 0.3 0.1 4.9 1.0 0.0 0.0 0.0 139.8 0.1 38.6 0.4 44.3 15.9 59.1 22.1 6.9 29.3 1.9 24.6 20.0 6.6 5.1 23.1 20.8 125.7 20.9 9.4 16.4 19.3 21.2 29.1 39.1 49.5 35.5 33.8 39.7 40.3 46.8 47.0 45.3 38.8 79.1 1.6 6.4 23.3 160.9 20.7 4.5 42.3 23.3 18.2 68.8 44.5 22.0 12.3 18.6 36.8 79.1 387.8 0.4 130.1 132.1 0.0 10.3 1.2 21.6 2.9 10.3 6.1 8.8 247.4 0.7 0.7 5.8 14.3 24.7 12.0 20.6 34.6 114.5 39.1 50.5 80.1 54.6 40.7 62.4 16.9 5.0 77.9 67.0 3.6 404.7 97.5 28.0 146.2 74.9 86.0 6.4 81.1 57.9 28.6 36.1 168.6 1.0 15.6 31.2 0.0 19.5 10.3 2.9 18.8 20.8 2.4 0.4 60.2 32.7 42.2 33.4 BLID BRCC2 ENSG00000259571 "BH3-like motif containing, cell death inducer" Q8IZY5 11 122115340-122116215 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "brain: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.9;hTEC/SVTERT24-B: 1.0;hTERT-RPE1: 1.0;LHCN-M2: 1.4;U-87 MG: 1.7" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 50: Fibroblasts - ECM organization" 0.0 0.0 1.1 0.0 3.4 0.0 0.0 1.6 1.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 2.5 0.0 0.0 0.0 0.0 3.8 1.9 0.1 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.1 0.0 0.3 0.2 0.3 0.0 0.9 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.4 1.9 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.9 1.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.4 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.4 1.6 1.7 1.2 2.5 3.8 1.9 3.0 1.7 3.0 5.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 UBASH3B "KIAA1959, STS-1, TULA-2, TULA2" ENSG00000154127 "Ubiquitin associated and SH3 domain containing B" Q8TF42 11 122655722-122814473 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.0;lymphoid tissue: 15.6;placenta: 13.8" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 54.9;Inhibitory neurons: 166.3;Langerhans cells: 51.2;Syncytiotrophoblasts: 47.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 122.2;HMC-1: 88.9;hTEC/SVTERT24-B: 72.9;REH: 73.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038605, HPA038606, HPA038607" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 23000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "Nucleoplasm, Nuclear bodies" "HPA038605: AB_10669648, HPA038606: , HPA038607: AB_2676112" "unprognostic (4.94e-2)" "unprognostic (6.03e-3)" "unprognostic (1.34e-1)" "unprognostic (2.98e-1)" "unprognostic (2.02e-1)" "unprognostic (1.49e-1)" "unprognostic (9.09e-2)" "unprognostic (4.67e-3)" "unprognostic (1.21e-1)" "unprognostic (1.95e-1)" "unprognostic (1.46e-3)" "unprognostic (6.20e-2)" "unprognostic (9.02e-3)" "unprognostic (1.54e-1)" "unprognostic (3.22e-2)" "unprognostic (2.72e-3)" "unprognostic (1.53e-1)" 3.4 0.7 1.1 4.8 1.5 6.7 1.1 15.0 1.9 3.0 0.1 1.2 1.3 1.0 0.2 1.1 0.5 1.9 0.9 1.2 5.5 1.7 1.3 4.6 5.7 10.3 7.1 0.2 0.6 0.4 0.3 13.8 10.2 0.7 1.4 1.9 0.7 0.7 1.1 3.4 1.7 1.9 1.2 15.6 1.4 1.2 2.8 15.1 2.3 0.3 3.2 4.4 0.5 1.4 13.1 31.5 5.6 7.5 2.4 4.4 29.1 45.6 25.1 18.1 13.9 12.5 6.8 5.3 3.5 24.3 17.2 6.4 0.1 16.3 28.7 0.2 0.9 122.2 1.0 10.8 6.7 15.0 88.9 3.9 1.0 72.9 26.9 19.7 12.4 5.3 0.1 0.1 17.8 0.5 18.5 9.6 2.5 13.3 7.4 73.3 3.3 0.7 28.6 10.9 12.7 0.2 12.1 0.9 10.1 11.7 0.2 4.0 32.3 23.4 12.6 13.9 19.1 1.0 0.0 15.1 12.4 20.6 43.4 0.0 1.3 9.9 1.8 6.3 1.9 0.3 2.3 1.7 1.7 1.1 2.6 1.4 2.7 6.4 11.1 0.2 4.7 1.8 1.1 1.5 15.0 1.9 1.2 5.5 10.3 7.1 10.2 1.2 2.8 1.4 2.2 0.0 4.7 9.1 4.6 7.1 4.2 3.4 2.8 1.8 1.2 1.3 1.1 0.0 2.0 3.7 0.0 32.5 10.0 0.6 0.0 8.4 2.4 0.6 4.0 4.5 0.0 1.7 24.8 9.7 54.9 4.9 2.0 1.5 12.7 11.5 5.0 0.6 35.7 11.8 166.3 0.5 4.1 26.0 51.2 3.9 0.0 26.5 1.8 30.0 9.1 0.2 17.5 26.2 2.7 26.3 0.3 0.4 11.4 4.7 0.2 0.6 2.5 1.1 0.0 3.8 3.4 0.1 0.8 2.4 6.0 47.6 16.8 0.1 0.4 3.1 CRTAM CD355 ENSG00000109943 "Cytotoxic and regulatory T cell molecule" O95727 11 122838500-122872643 "CD markers, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 38.2" "Group enriched" "Detected in some" 4 "dendritic cells: 63.8;Plasma cells: 16.0;T-cells: 54.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 9 "cerebellum: 38.2" "Immune cell enhanced" "Detected in many" "NK-cell: 54.0" "Group enriched" "Detected in many" 4 "NK-cells: 54.0;T-cells: 33.3" "Cell line enriched" "Detected in single" 34 "SCLC-21H: 12.9" "Region enriched" "Detected in some" 44 "cerebellum: 102.6" "Region enriched" "Detected in all" 7 "cerebellum: 25.7" NA NA 6800000 "Cluster 48: NK-cells - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (3.51e-3)" "unprognostic (6.73e-4)" "unprognostic (1.33e-2)" "unprognostic (3.73e-3)" "unprognostic (2.40e-2)" "unprognostic (5.25e-4)" "unprognostic (1.25e-1)" "unprognostic (3.66e-2)" "unprognostic (5.27e-2)" "unprognostic (1.71e-1)" "unprognostic (5.49e-3)" "unprognostic (2.32e-1)" "unprognostic (1.83e-4)" "unprognostic (6.01e-2)" "unprognostic (4.26e-2)" "unprognostic (3.87e-2)" "unprognostic (6.59e-2)" 0.3 0.3 0.3 2.3 0.5 1.8 0.5 38.2 1.4 0.3 0.3 0.5 0.6 0.8 0.5 0.3 0.3 1.5 0.2 0.2 0.4 0.1 1.0 1.8 8.8 1.1 1.4 0.3 0.1 0.1 0.1 0.2 4.2 0.3 0.6 0.0 0.7 0.2 0.1 0.3 1.2 0.2 0.5 3.6 0.8 0.2 0.7 4.9 0.2 0.0 3.5 0.8 0.1 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 4.6 0.6 13.0 5.6 12.9 0.1 1.5 27.0 3.6 0.2 4.3 33.3 1.2 54.0 10.5 0.2 0.1 6.0 0.3 0.5 38.2 1.4 0.2 0.4 1.1 1.4 4.2 0.5 0.7 1.6 1.1 0.0 1.1 0.3 0.8 1.5 0.4 0.1 0.0 0.0 0.4 0.9 0.3 0.0 0.0 0.0 0.0 0.1 63.8 0.1 0.0 0.0 1.2 0.4 0.4 0.3 0.0 0.4 0.5 0.0 0.2 1.6 2.0 0.6 1.3 0.0 0.4 0.2 5.9 0.0 0.7 0.0 0.0 8.8 8.1 1.2 0.0 10.3 3.6 0.0 9.4 0.0 4.1 0.0 0.0 0.0 0.0 0.0 16.0 0.3 0.0 0.1 0.0 0.0 0.0 0.8 0.6 0.3 0.5 0.0 0.9 0.1 54.1 0.0 0.0 0.5 JHY "C11orf63, FLJ23554" ENSG00000109944 "Junctional cadherin complex regulator" Q6NUN7 11 122882683-122963862 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 35.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Endometrial ciliated cells: 41.5;Glandular and luminal cells: 8.7;Proximal tubular cells: 12.0;Respiratory ciliated cells: 19.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 13.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA039612, HPA040344, HPA077658, HPA077748" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Golgi apparatus" "HPA039612: AB_10674424, HPA040344: AB_2676931, HPA077658: AB_2732355, HPA077748: AB_2732360" "unprognostic (5.27e-2)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" "prognostic favorable (7.94e-5)" "unprognostic (9.97e-5)" "unprognostic (1.64e-1)" "unprognostic (2.02e-3)" "unprognostic (1.94e-3)" "unprognostic (1.77e-1)" "unprognostic (1.49e-1)" "unprognostic (4.13e-2)" "unprognostic (2.97e-1)" "prognostic favorable (8.77e-4)" "unprognostic (6.46e-3)" "unprognostic (2.54e-1)" "prognostic unfavorable (2.58e-4)" "unprognostic (7.79e-2)" 6.0 1.8 1.7 2.2 2.7 1.1 3.6 3.4 2.4 3.1 17.3 3.5 1.5 2.1 2.7 1.8 7.4 2.6 2.2 1.8 3.8 7.8 0.4 4.5 2.2 4.1 5.4 3.2 2.8 5.6 4.8 1.3 3.8 3.5 1.7 1.6 1.4 2.5 0.2 1.9 1.9 2.0 3.8 2.5 2.0 35.7 3.2 3.2 5.1 0.8 2.0 2.6 1.8 3.6 2.8 3.9 2.2 0.1 0.6 0.4 0.7 5.9 6.8 2.5 1.1 0.3 10.3 0.1 1.5 9.1 13.6 2.4 2.7 1.4 1.1 9.5 2.8 0.1 1.8 0.1 0.9 1.7 4.7 2.8 7.4 0.4 0.6 6.3 3.8 4.1 0.0 0.1 2.0 1.8 0.1 0.6 0.3 8.2 3.5 1.0 0.0 1.3 7.0 3.2 5.8 4.2 7.1 3.9 2.6 2.8 4.7 0.6 1.2 7.9 1.0 0.2 4.8 0.1 0.0 0.1 2.1 2.1 5.3 0.5 0.3 0.1 1.3 0.1 1.8 1.1 1.3 1.7 2.4 0.6 0.9 1.0 0.4 2.4 0.1 0.6 0.3 0.5 1.7 2.7 3.4 2.4 1.8 3.8 4.1 5.4 3.8 3.8 3.2 3.6 4.4 12.8 4.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 3.3 3.2 0.0 0.0 7.4 5.5 0.0 0.2 2.2 0.0 3.9 5.5 0.0 41.5 3.1 1.1 0.0 0.0 0.0 1.4 0.9 2.2 0.0 8.7 0.0 2.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.7 0.0 0.0 12.0 19.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 1.8 1.3 0.0 0.0 BSX BSX1 ENSG00000188909 "Brain specific homeobox" Q3C1V8 11 122977570-122981834 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 48 "brain: 12.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "hypothalamus: 12.0;thalamus: 4.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "hypothalamus: 4.5" "Region enriched" "Detected in single" 10 "hypothalamus: 3.4" HPA015654 Uncertain NA NA "Cluster 73: Brain - Neuropeptide signaling" "HPA015654: AB_1845470" 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 12.0 0.0 0.8 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSPA8 "HSC70, HSC71, HSP73, HSPA10" ENSG00000109971 "Heat shock protein family A (Hsp70) member 8" P11142 11 123057489-123063230 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation" "Chaperone, Hydrolase, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 2455.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002056, HPA052504" Uncertain Approved Nucleoplasm,Vesicles NA Yes 140000000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm Vesicles "CAB002056: , HPA052504: AB_2681854" "unprognostic (2.28e-3)" "unprognostic (1.19e-3)" "prognostic favorable (6.14e-6)" "unprognostic (1.75e-1)" "unprognostic (1.84e-2)" "unprognostic (5.70e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (9.65e-3)" "unprognostic (3.82e-1)" "unprognostic (9.64e-2)" "unprognostic (2.93e-1)" "unprognostic (3.22e-1)" "prognostic favorable (3.81e-4)" "unprognostic (2.53e-1)" "unprognostic (1.83e-1)" "unprognostic (2.74e-1)" "unprognostic (7.16e-2)" 539.8 604.9 456.3 542.1 498.1 442.4 448.9 591.6 887.9 326.6 571.4 435.8 506.9 367.3 614.7 554.2 498.5 508.6 892.4 535.1 614.9 850.5 763.2 480.1 685.0 564.8 564.2 421.4 1238.1 593.8 501.9 487.1 620.0 411.2 525.8 531.5 404.1 439.8 1519.0 224.4 453.5 508.4 554.2 520.3 676.7 395.0 559.8 628.6 422.6 1508.5 879.6 866.0 302.4 656.8 1369.6 2077.3 1370.5 1176.5 1259.4 1337.4 1775.6 2730.9 1550.4 3373.2 2004.8 3151.7 1787.3 2318.5 1614.6 1591.9 2337.3 1835.9 4091.6 1027.2 3323.5 1955.4 605.9 2570.4 881.5 1532.0 347.5 2418.0 1757.1 721.8 1594.5 1045.0 320.7 1753.4 1845.6 321.7 2727.8 1147.0 2704.5 1235.5 2507.0 1761.3 2063.2 3463.3 1874.0 2214.4 962.2 1281.3 1665.1 1008.4 1371.8 1023.9 1980.4 2110.5 763.6 1491.1 1837.1 901.9 1767.0 1621.1 1246.1 1404.5 2402.7 740.6 1985.0 1890.9 1791.1 3316.9 1970.0 517.7 592.3 587.8 1245.4 1159.8 1499.6 1009.2 1441.8 1366.1 656.1 752.2 1367.5 1326.5 201.8 1110.7 1255.0 465.5 1761.7 3439.4 456.3 498.1 591.6 887.9 535.1 614.9 564.8 564.2 620.0 554.2 559.8 656.8 795.5 192.3 228.2 72.5 576.3 282.3 2455.6 315.3 507.6 206.7 454.5 380.1 396.3 278.8 352.8 130.6 127.2 926.1 740.3 513.1 528.3 589.0 49.8 404.1 380.1 512.8 519.8 551.7 33.4 628.8 1032.6 609.7 366.0 366.5 434.8 633.8 249.9 223.9 810.9 181.7 45.6 511.1 303.2 359.8 1060.8 58.2 222.4 590.6 528.3 35.6 530.9 307.4 639.5 28.1 50.3 513.8 552.1 270.0 573.6 779.5 823.0 1002.2 465.7 278.1 243.3 416.3 893.1 248.9 419.2 590.6 284.6 1512.1 1123.5 430.3 632.0 1171.5 CLMP "ACAM, ASAM, FLJ22415" ENSG00000166250 "CXADR like membrane protein" Q9H6B4 11 123069872-123195248 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 63.2" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 75.7;Fibroblasts: 95.1;Inhibitory neurons: 31.9;Peritubular cells: 57.9;Skeletal myocytes: 65.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 124.8;BJ: 171.8;BJ hTERT+: 160.3;fHDF/TERT166: 126.6;hTEC/SVTERT24-B: 129.1;hTERT-HME1: 155.6;U-138 MG: 232.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 310000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "unprognostic (1.63e-2)" "unprognostic (6.65e-3)" "unprognostic (1.06e-1)" "unprognostic (1.09e-1)" "unprognostic (3.46e-2)" "unprognostic (9.42e-3)" "unprognostic (1.31e-1)" "unprognostic (1.35e-3)" "unprognostic (9.66e-3)" "unprognostic (3.25e-2)" "unprognostic (4.02e-3)" "unprognostic (3.87e-2)" "unprognostic (9.78e-8)" "unprognostic (3.88e-3)" "unprognostic (1.26e-1)" "unprognostic (1.19e-2)" "unprognostic (1.69e-2)" 63.2 6.5 0.9 14.7 0.8 0.4 24.5 7.8 2.7 20.5 3.6 41.1 7.3 30.3 4.3 10.1 18.4 23.1 12.9 5.3 0.4 6.0 0.4 8.1 7.4 4.2 2.1 9.1 2.0 0.2 1.9 26.3 1.8 7.4 10.6 0.9 5.4 8.5 1.7 6.5 17.3 36.3 2.0 8.1 16.0 2.6 2.1 0.8 2.4 3.4 5.0 16.7 14.0 5.2 3.0 3.3 7.5 15.2 124.8 108.1 45.5 171.8 160.3 23.9 43.8 7.4 0.2 0.0 0.4 126.6 82.4 0.1 0.3 45.5 27.3 0.9 0.3 0.0 7.1 0.1 40.7 0.0 0.1 61.0 30.6 129.1 155.6 59.7 11.7 0.1 0.0 0.4 33.3 0.1 0.0 0.2 17.4 0.0 20.2 0.1 2.5 0.1 12.6 0.0 20.5 50.3 0.0 0.4 0.1 3.2 0.6 0.0 43.3 232.7 2.3 96.0 21.6 0.1 0.0 0.1 63.1 0.0 7.5 0.3 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.9 0.8 7.8 2.7 5.3 0.4 4.2 2.1 1.8 2.0 2.1 5.2 2.3 0.0 3.9 2.0 0.2 1.5 0.3 2.4 0.0 3.8 1.2 14.6 5.1 0.0 0.4 0.0 0.0 9.8 0.3 0.1 0.0 1.9 0.7 2.4 75.7 1.4 6.7 0.0 26.5 1.3 20.4 95.1 0.0 1.4 0.0 5.3 2.2 0.0 3.6 1.7 31.9 0.5 0.0 0.0 1.9 0.7 20.8 0.9 0.0 4.7 0.0 0.5 0.0 1.0 3.6 0.9 0.0 57.9 0.6 2.0 0.1 0.1 0.2 1.1 0.0 65.0 8.5 0.1 0.1 0.4 1.0 10.4 1.1 2.2 0.3 0.5 GRAMD1B "KIAA1201, LINC01059" ENSG00000023171 "GRAM domain containing 1B" Q3KR37 11 123358428-123627774 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 258.8;choroid plexus: 91.8;retina: 96.7" "Cell type enhanced" "Detected in many" "Astrocytes: 94.7;Cone photoreceptor cells: 114.7;Excitatory neurons: 120.7;Inhibitory neurons: 102.8;Oligodendrocyte precursor cells: 95.0;Rod photoreceptor cells: 92.3;Theca cells: 109.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "plasmacytoid DC: 7.0" "Lineage enriched" "Detected in many" 4 "dendritic cells: 7.0" "Group enriched" "Detected in many" 4 "A549: 62.4;HDLM-2: 168.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008557, HPA075204" Approved Supported "Endoplasmic reticulum,Vesicles,Plasma membrane" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 58: Brain - Synaptic function" "Cluster 44: HDLM-2 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Endoplasmic reticulum, Plasma membrane" Vesicles "HPA008557: AB_1079197, HPA075204: " "unprognostic (1.86e-1)" "unprognostic (7.18e-3)" "unprognostic (2.43e-2)" "unprognostic (2.74e-3)" "unprognostic (8.15e-2)" "unprognostic (4.28e-2)" "unprognostic (2.69e-3)" "unprognostic (4.12e-3)" "unprognostic (1.40e-1)" "unprognostic (2.90e-2)" "unprognostic (9.60e-2)" "unprognostic (8.06e-2)" "prognostic unfavorable (4.30e-7)" "unprognostic (1.39e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (1.69e-1)" 1.8 258.8 22.5 4.3 27.4 18.6 1.1 80.1 52.3 0.9 91.8 1.6 34.6 1.1 9.4 0.6 3.6 12.1 15.0 55.6 19.4 15.5 1.5 2.6 5.4 25.7 20.1 15.2 2.4 0.7 16.6 5.0 24.2 1.1 1.1 96.7 1.9 2.0 3.4 0.5 25.2 1.2 9.4 3.6 11.4 16.8 33.5 6.6 4.9 2.2 3.5 1.2 0.8 26.1 0.1 62.4 3.5 0.1 0.3 0.7 9.5 20.5 14.6 4.1 1.8 2.6 0.4 3.8 10.4 10.1 6.8 0.0 6.2 0.0 4.3 168.5 5.0 0.0 28.3 0.7 0.0 22.1 0.0 1.0 0.1 7.1 0.0 5.2 1.8 1.6 0.0 0.2 3.7 0.5 3.8 7.2 7.6 28.3 23.0 10.8 9.8 6.8 0.2 0.0 20.0 16.3 4.9 0.5 0.1 8.1 0.5 12.0 12.3 23.8 3.2 4.2 1.0 0.0 0.0 0.0 4.6 20.5 1.1 0.0 1.2 0.4 0.4 0.7 0.2 0.0 1.5 1.2 1.7 0.0 0.2 0.2 0.1 1.6 0.7 7.0 0.7 0.5 22.5 27.4 80.1 52.3 55.6 19.4 25.7 20.1 24.2 9.4 33.5 26.1 1.4 0.0 0.5 94.7 0.6 0.0 0.0 0.1 1.2 44.3 1.1 1.0 5.7 21.5 0.2 5.5 114.7 6.9 17.9 0.1 3.9 0.7 9.6 1.6 0.6 1.0 0.0 0.0 120.7 0.4 3.7 1.6 16.3 0.9 0.0 41.9 0.7 0.0 2.6 45.4 102.8 1.8 0.0 3.8 2.6 2.7 0.6 7.5 0.0 37.5 2.5 23.4 0.0 95.0 5.5 3.9 1.3 0.7 2.4 0.1 17.3 8.9 0.4 92.3 0.0 3.0 4.2 3.9 1.9 0.1 0.4 2.5 7.2 109.3 1.5 0.0 SCN3B HSA243396 ENSG00000166257 "Sodium voltage-gated channel beta subunit 3" Q9NY72 11 123629187-123655244 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.2;pituitary gland: 28.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 31.6;Excitatory neurons: 58.8;Horizontal cells: 20.2;Inhibitory neurons: 35.7;Late spermatids: 31.3" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Group enriched" "Detected in many" 8 "amygdala: 34.3;basal ganglia: 40.6;cerebral cortex: 49.7;hippocampal formation: 54.2;white matter: 15.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.8;GAMG: 1.8;hTCEpi: 5.8;RH-30: 2.0;SCLC-21H: 5.5;SH-SY5Y: 4.5" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "hippocampal formation: 166.1" HPA041707 Approved "Intermediate filaments,Cytosol" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Intermediate filaments" Cytosol "HPA041707: AB_2732493" "unprognostic (1.41e-1)" "unprognostic (8.72e-2)" "unprognostic (8.13e-4)" "unprognostic (3.93e-3)" "unprognostic (7.05e-2)" "unprognostic (3.29e-3)" "unprognostic (5.64e-2)" "unprognostic (3.34e-4)" "unprognostic (1.72e-1)" "unprognostic (1.13e-2)" "unprognostic (9.16e-4)" "unprognostic (4.01e-1)" "unprognostic (1.89e-4)" "unprognostic (2.01e-2)" "unprognostic (9.01e-2)" "unprognostic (8.23e-2)" "unprognostic (1.43e-2)" 1.9 8.4 34.3 0.6 40.6 0.4 1.8 0.0 49.7 1.0 0.0 1.4 0.8 1.5 0.7 0.7 1.2 0.5 1.4 54.2 2.4 1.4 0.1 1.0 0.3 0.0 4.7 1.0 1.1 4.4 28.0 0.1 0.5 0.8 0.8 10.0 0.7 0.5 14.1 1.5 1.3 1.4 0.9 0.5 0.7 2.2 0.9 0.2 4.1 3.3 0.2 0.8 1.0 15.3 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.9 0.1 1.8 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.2 0.2 0.1 0.0 0.1 0.0 5.8 0.1 0.1 0.0 0.1 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.0 0.0 0.0 0.1 5.5 4.5 0.4 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 34.3 40.6 0.0 49.7 54.2 2.4 0.0 4.7 0.5 0.9 0.9 15.3 7.7 0.0 0.5 3.9 0.0 5.7 1.1 0.0 1.2 31.6 1.3 1.0 2.1 0.0 0.0 1.8 6.2 0.1 0.0 0.3 0.0 0.3 13.9 0.2 0.3 13.0 4.2 0.0 58.8 1.0 0.1 1.5 0.0 0.2 0.0 1.4 5.3 0.0 0.2 20.2 35.7 0.0 0.0 0.0 2.3 31.3 0.0 0.4 0.0 5.6 0.0 6.3 1.0 4.5 2.5 0.3 0.0 0.4 0.0 1.0 0.1 0.5 0.0 6.0 6.6 5.7 0.8 1.0 2.0 0.4 5.5 0.0 0.1 1.4 0.1 0.5 ZNF202 "ZKSCAN10, ZSCAN42" ENSG00000166261 "Zinc finger protein 202" O95125 11 123723914-123741675 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 14.7;Spermatogonia: 14.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059229 Approved "Nucleoli rim,Nuclear bodies,Mitotic chromosome" Yes No "Cluster 32: T-cells - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoli rim, Mitotic chromosome" "Nuclear bodies" "HPA059229: " "unprognostic (3.12e-2)" "unprognostic (7.75e-2)" "unprognostic (2.20e-2)" "unprognostic (4.49e-2)" "unprognostic (2.10e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.52e-6)" "unprognostic (1.23e-1)" "unprognostic (1.74e-3)" "unprognostic (2.80e-1)" "unprognostic (9.48e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (9.93e-7)" "unprognostic (2.61e-2)" "unprognostic (2.11e-2)" "unprognostic (1.17e-1)" "unprognostic (1.35e-2)" 5.7 4.7 5.9 6.7 5.9 5.2 7.6 5.9 6.5 8.1 5.7 6.3 4.4 9.7 9.3 6.0 6.8 4.6 4.5 5.7 5.9 6.2 5.1 5.1 8.9 5.4 5.8 10.4 9.7 5.2 5.9 6.2 5.4 7.2 7.9 6.1 6.0 5.3 6.2 8.4 6.5 7.3 4.8 9.9 6.2 9.8 5.8 6.7 6.9 3.9 8.7 6.9 6.4 6.8 6.0 9.3 15.3 18.5 6.6 10.1 11.9 9.3 7.4 8.5 7.6 10.5 15.7 17.7 8.6 7.2 13.7 14.3 15.9 10.6 11.7 7.3 8.9 31.5 6.6 10.2 9.0 18.5 8.9 7.2 21.0 9.7 28.7 7.3 10.0 14.8 17.1 11.8 11.2 6.3 16.0 25.3 25.2 21.0 12.8 19.2 9.5 6.5 8.3 11.4 11.3 12.6 7.8 9.4 6.2 12.5 17.8 12.8 8.7 16.3 10.5 11.8 9.5 7.6 5.9 12.1 4.3 20.2 10.8 0.0 1.2 0.0 1.7 1.8 1.6 1.6 2.3 2.5 1.9 1.9 2.6 2.4 0.0 1.6 0.7 1.2 2.2 1.7 5.9 5.9 5.9 6.5 5.7 5.9 5.4 5.8 5.4 4.8 5.8 6.8 3.1 6.4 0.5 7.8 3.8 2.9 3.8 1.9 0.6 3.1 3.4 3.2 3.1 2.8 9.7 3.7 0.0 2.2 2.1 1.5 1.9 2.2 5.1 1.4 3.3 3.1 3.0 1.7 8.9 3.5 1.7 2.8 4.6 2.0 3.8 6.0 2.2 1.9 1.8 6.7 8.3 3.9 0.0 2.0 2.0 5.0 1.8 3.1 0.0 3.7 1.6 2.4 1.0 6.6 11.0 3.2 2.4 1.2 3.6 2.5 1.0 1.4 1.3 3.1 6.6 5.0 2.2 14.7 14.5 3.6 3.0 0.8 3.0 3.1 3.2 2.9 OR6X1 ENSG00000221931 "Olfactory receptor family 6 subfamily X member 1" Q8NH79 11 123753488-123754545 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6M1 ENSG00000196099 "Olfactory receptor family 6 subfamily M member 1" Q8NGM8 11 123805335-123806387 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048674 Uncertain NA NA "Cluster 29: Early spermatids - Spermatogenesis" "HPA048674: AB_2680489" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM225 "PMP22CD, PPP1R154, SPATA47" ENSG00000204300 "Transmembrane protein 225" Q6GV28 11 123882920-123885670 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 162 "testis: 21.9" "Cell type enhanced" "Detected in some" "Early spermatids: 113.4;Late spermatids: 28.0;Spermatocytes: 80.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (3.38e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8D4 ENSG00000181518 "Olfactory receptor family 8 subfamily D member 4" Q8NGM9 11 123902167-123909229 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "Granulosa cells: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 40: Granulosa cells - Unknown function" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 OR4D5 ENSG00000171014 "Olfactory receptor family 4 subfamily D member 5" Q8NGN0 11 123939543-123940637 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045005 Uncertain NA NA "HPA045005: AB_10959302" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6T1 ENSG00000181499 "Olfactory receptor family 6 subfamily T member 1" Q8NGN1 11 123942785-123943873 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060893 Uncertain NA NA "HPA060893: AB_2684380" "unprognostic (9.30e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10S1 ENSG00000196248 "Olfactory receptor family 10 subfamily S member 1" Q8NGN2 11 123976661-123977781 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA019038 Uncertain NA NA "HPA019038: AB_1854785" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G6 "OR10G6P, OR10G6Q" ENSG00000198674 "Olfactory receptor family 10 subfamily G member 6" Q8NH81 11 123994163-123995161 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "Distal tubular cells: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 39: Non-specific - Basic cellular processes" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G4 ENSG00000254737 "Olfactory receptor family 10 subfamily G member 4" Q8NGN3 11 124012997-124018732 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 11: Alveolar cells - Smell perception" 0.0 0.0 0.4 0.0 0.4 0.3 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.2 0.1 0.2 0.2 0.0 0.2 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 OR10G9 OR10G10P ENSG00000236981 "Olfactory receptor family 10 subfamily G member 9" Q8NGN4 11 124023013-124023948 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G8 ENSG00000234560 "Olfactory receptor family 10 subfamily G member 8" Q8NGN5 11 124026798-124030634 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G7 ENSG00000182634 "Olfactory receptor family 10 subfamily G member 7" Q8NGN6 11 124036013-124041325 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VWA5A "BCSC-1, LOH11CR2A" ENSG00000110002 "Von Willebrand factor A domain containing 5A" O00534 11 124115404-124147721 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "granulocytes: 563.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 57.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 57.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 59.7;HEL: 44.1;HHSteC: 32.1;HUVEC TERT2: 39.5;RPTEC TERT1: 43.0" "Low region specificity" "Detected in all" "HPA037813, HPA037814, HPA061500" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 45: Intestine - Brush border" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 60: Granulocytes - Receptor signaling" Nucleoplasm Nucleoli "HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: AB_2684542" "unprognostic (2.69e-1)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (6.48e-2)" "unprognostic (8.49e-3)" "unprognostic (2.48e-1)" "unprognostic (8.18e-2)" "unprognostic (4.88e-2)" "unprognostic (1.18e-1)" "unprognostic (5.15e-2)" "unprognostic (4.53e-2)" "unprognostic (2.38e-2)" "prognostic favorable (1.55e-5)" "unprognostic (4.54e-2)" "unprognostic (7.21e-2)" "unprognostic (2.16e-1)" "unprognostic (4.65e-1)" 17.2 24.9 18.7 12.8 16.1 3.1 24.2 12.8 19.4 22.4 14.3 37.9 26.5 13.9 25.3 15.0 15.0 31.1 6.8 16.9 44.0 21.7 6.4 30.8 12.2 21.3 25.6 10.2 20.7 4.4 37.4 10.2 27.9 17.8 43.3 11.9 30.0 19.2 4.3 28.5 36.6 16.0 17.0 8.3 28.2 9.6 47.1 8.0 11.5 12.3 14.6 22.8 12.6 16.2 0.0 0.6 7.6 0.5 7.9 7.4 2.8 1.1 0.6 0.6 0.3 0.4 59.7 0.0 7.2 1.3 10.3 0.4 1.5 13.6 0.0 20.9 0.2 44.1 10.5 1.4 32.1 0.6 19.8 21.8 1.5 1.3 4.4 2.9 39.5 5.8 2.4 7.3 2.4 0.2 0.9 0.7 11.9 0.0 1.5 0.0 26.2 0.3 43.0 0.5 6.7 0.7 1.1 0.4 2.1 17.3 5.4 1.9 1.0 0.2 5.5 0.3 0.0 2.7 2.5 0.0 24.1 0.9 0.4 57.8 7.9 0.9 4.7 5.5 1.1 7.1 5.0 2.7 8.0 3.8 6.3 4.1 0.6 8.1 9.3 4.3 12.7 6.1 18.7 16.1 12.8 19.4 16.9 44.0 21.3 25.6 27.9 17.0 47.1 16.2 5.0 9.6 28.3 4.6 1.3 17.2 14.6 14.9 4.6 3.8 12.6 8.8 2.6 5.7 33.2 33.1 2.1 7.9 2.0 25.0 9.8 27.8 50.6 11.5 4.8 4.3 15.0 3.4 4.0 28.1 2.5 11.4 17.3 7.6 563.0 3.8 3.9 3.2 35.7 32.0 17.1 22.3 30.5 6.6 7.2 6.0 2.8 6.7 5.4 1.9 3.6 14.3 3.1 8.0 2.6 17.7 16.8 0.4 2.5 6.5 50.6 15.1 59.1 1.4 0.0 9.5 5.7 0.7 4.1 4.8 12.5 1.9 9.4 5.9 23.7 13.6 OR10D3 "HTPCRX09, OR10D3P" ENSG00000197309 "Olfactory receptor family 10 subfamily D member 3" Q8NH80 11 124183219-124188780 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8G1 "HSTPCR25, OR8G1P, TPCR25" ENSG00000197849 "Olfactory receptor family 8 subfamily G member 1" Q15617 11 124241095-124254364 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "Early spermatids: 3.6;Late spermatids: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 31: Spermatids - Spermatogenesis" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8G5 "OR8G5P, OR8G6" ENSG00000255298 "Olfactory receptor family 8 subfamily G member 5" 11 124256376-124266218 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 16 "testis: 2.5" "Group enriched" "Detected in some" 11 "Early spermatids: 18.3;Late spermatids: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "K-562: 1.8;PC-3: 1.0;T-47d: 1.7" NA NA "Cluster 6: T47d - Mammary gland" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (1.48e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 29.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8D1 "OR8D3, OST004" ENSG00000196341 "Olfactory receptor family 8 subfamily D member 1" Q8WZ84 11 124302831-124315099 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059510 Uncertain NA NA "HPA059510: AB_2684045" 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8D2 ENSG00000279116 "Olfactory receptor family 8 subfamily D member 2" Q9GZM6 11 124319238-124320288 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B2 ENSG00000284680 "Olfactory receptor family 8 subfamily B member 2" Q96RD0 11 124382394-124384499 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.2" "Group enriched" "Detected in some" 63 "Early spermatids: 44.9;Late spermatids: 30.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 34: Spermatids - Unknown function" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B3 ENSG00000284609 "Olfactory receptor family 8 subfamily B member 3" Q8NGG8 11 124395534-124399024 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "Early spermatids: 13.6;Late spermatids: 3.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 29: Early spermatids - Spermatogenesis" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B4 OR8B4P ENSG00000280090 "Olfactory receptor family 8 subfamily B member 4" Q96RC9 11 124423904-124424893 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B8 TPCR85 ENSG00000197125 "Olfactory receptor family 8 subfamily B member 8" Q15620 11 124437445-124445696 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.9 0.1 0.5 0.1 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B12 ENSG00000170953 "Olfactory receptor family 8 subfamily B member 12" Q8NGG6 11 124539635-124545333 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8A1 OST025 ENSG00000196119 "Olfactory receptor family 8 subfamily A member 1" Q8NGG7 11 124566660-124582942 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Early spermatids: 1.7;Excitatory neurons: 1.1;granulocytes: 3.8;Late spermatids: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 60: Granulocytes - Receptor signaling" 0.1 0.0 0.5 0.2 0.4 0.9 0.3 0.9 0.8 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.3 0.6 0.1 0.8 0.1 0.2 0.3 0.3 0.2 0.2 0.2 0.0 0.1 0.4 0.2 0.1 0.5 0.2 0.0 0.0 0.6 0.2 0.1 0.0 0.2 0.2 0.3 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.2 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.5 0.1 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.9 0.8 0.3 0.6 0.3 0.3 0.4 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PANX3 Px3 ENSG00000154143 "Pannexin 3" Q96QZ0 11 124611428-124620356 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (5.80e-2)" "unprognostic (3.10e-1)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 TBRG1 "FLJ14621, NIAM, TB-5" ENSG00000154144 "Transforming growth factor beta regulator 1" Q3YBR2 11 124622836-124635926 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 21.6;HMC-1: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055645, HPA068022" Supported Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 10: Brain - Neuronal signaling" "Cluster 3: HMC-1 - Innate immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA055645: AB_2682873, HPA068022: AB_2685942" "unprognostic (1.64e-2)" "unprognostic (3.24e-2)" "unprognostic (7.81e-2)" "unprognostic (1.37e-2)" "unprognostic (9.21e-2)" "unprognostic (3.66e-1)" "unprognostic (1.03e-1)" "unprognostic (4.58e-2)" "unprognostic (1.18e-3)" "unprognostic (1.52e-1)" "unprognostic (7.40e-2)" "unprognostic (3.72e-3)" "unprognostic (1.78e-1)" "unprognostic (1.70e-1)" "unprognostic (1.22e-1)" "unprognostic (3.83e-1)" "unprognostic (7.13e-3)" 5.5 7.2 6.4 5.5 9.5 4.0 4.3 5.3 9.8 3.8 5.9 5.9 6.2 3.9 4.0 5.0 4.1 3.1 4.3 6.9 6.6 6.2 8.1 6.0 6.4 5.6 5.2 2.7 8.1 2.3 4.1 3.8 5.3 5.1 5.4 1.8 5.6 3.0 10.1 5.1 8.4 2.5 5.1 8.3 6.8 3.4 6.0 3.9 5.7 3.9 6.1 4.3 4.0 7.2 3.7 3.1 2.7 1.5 4.6 3.1 2.7 3.7 2.5 2.0 1.8 6.0 2.7 4.4 4.5 3.7 4.0 4.5 3.5 4.8 3.8 4.5 2.7 21.6 1.8 3.9 3.2 6.7 20.9 3.2 8.1 3.7 2.8 2.3 3.6 3.6 7.4 4.8 5.1 1.7 3.0 6.6 2.9 8.6 2.1 2.7 3.6 3.2 3.3 3.6 2.2 2.3 2.1 3.5 2.5 2.5 5.6 3.3 5.5 4.5 1.8 1.5 3.2 3.8 6.2 5.1 2.5 7.8 3.2 30.5 24.3 35.1 25.6 22.9 19.1 34.0 25.9 22.1 14.8 30.6 27.4 22.1 33.1 14.6 21.7 23.9 27.5 13.1 6.4 9.5 5.3 9.8 6.9 6.6 5.6 5.2 5.3 5.1 6.0 7.2 37.9 44.8 56.5 37.9 67.2 46.1 52.0 37.5 67.2 19.2 34.8 30.6 24.0 40.0 39.5 23.9 12.5 32.9 58.0 46.4 52.8 38.8 61.3 25.1 31.1 42.7 28.3 43.3 113.8 47.4 28.8 45.9 39.3 25.9 72.1 23.6 31.8 69.7 36.2 30.3 53.6 46.7 30.5 45.8 66.8 11.5 37.9 55.9 33.8 41.2 53.6 33.5 64.9 33.7 50.1 58.5 43.2 33.4 62.1 88.7 61.9 90.4 33.9 19.5 26.3 39.3 83.3 52.0 24.7 42.5 48.2 48.3 65.7 27.7 33.4 68.6 SIAE "CSE-C, LSE, MGC87009, YSG2" ENSG00000110013 "Sialic acid acetylesterase" Q9HAT2 11 124633113-124695707 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 104.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 58.0;Cardiomyocytes: 59.5;Distal enterocytes: 102.4;Paneth cells: 53.0;Proximal enterocytes: 51.6;Undifferentiated cells: 63.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 7.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 88.6;ASC TERT1: 91.3;HSkMC: 98.9;OE19: 97.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038052, HPA038053" Approved "Intracellular and membrane" NA NA 2200000 "Cluster 18: Basophils - Vesicular transport" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA038052: AB_10671518, HPA038053: AB_10673039" "unprognostic (9.97e-2)" "unprognostic (1.28e-2)" "unprognostic (2.48e-3)" "prognostic favorable (4.66e-5)" "unprognostic (3.30e-2)" "unprognostic (5.20e-2)" "unprognostic (4.90e-2)" "unprognostic (4.32e-2)" "unprognostic (1.18e-1)" "unprognostic (2.26e-1)" "unprognostic (2.45e-1)" "unprognostic (9.19e-2)" "prognostic favorable (4.42e-11)" "unprognostic (7.24e-2)" "unprognostic (3.22e-1)" "unprognostic (4.49e-2)" "unprognostic (1.92e-2)" 18.7 17.3 16.8 11.8 21.6 3.7 15.9 26.9 19.8 13.0 38.9 97.8 34.3 7.1 34.3 13.6 19.3 16.7 43.8 16.1 27.1 62.1 43.4 20.6 5.8 25.3 23.7 5.7 17.3 45.3 14.4 11.8 24.7 20.4 104.4 6.2 18.4 15.3 26.7 13.0 35.8 10.4 23.0 9.1 19.0 10.3 24.9 3.7 54.0 33.3 6.7 16.8 7.8 26.3 8.9 14.0 8.0 34.6 88.6 91.3 20.9 16.8 24.0 4.3 2.6 10.9 61.4 5.5 24.2 21.5 9.4 17.3 12.8 18.7 4.2 26.0 3.9 8.6 3.7 11.1 41.8 0.7 7.2 98.9 24.9 11.4 17.3 58.5 30.6 11.0 7.1 37.5 14.8 16.5 0.2 0.6 5.0 97.7 28.5 3.2 0.2 8.4 51.4 12.1 2.4 5.1 46.5 18.6 8.0 24.0 36.8 3.2 34.1 23.6 4.3 26.5 4.0 9.4 7.5 0.7 8.3 4.6 9.8 7.6 2.9 0.1 0.4 2.1 0.3 0.5 1.3 0.6 1.9 0.7 1.7 1.1 0.5 0.2 3.7 0.5 0.6 1.8 16.8 21.6 26.9 19.8 16.1 27.1 25.3 23.7 24.7 23.0 24.9 26.3 4.2 19.2 58.0 11.8 2.4 3.2 6.3 6.7 7.4 6.5 10.1 4.3 59.5 12.8 9.4 36.8 0.0 7.6 0.6 102.4 9.8 15.2 14.0 9.1 9.3 6.9 14.5 5.2 15.0 3.8 8.8 7.5 12.8 14.0 1.3 3.9 8.9 30.0 4.5 5.0 9.1 31.0 4.1 3.5 1.6 12.0 3.1 4.3 3.6 6.5 4.5 1.9 1.0 8.0 6.7 5.2 53.0 1.2 3.9 7.4 51.6 26.2 11.9 1.8 0.0 4.9 7.9 14.8 9.6 12.2 5.3 6.7 2.0 8.9 63.6 7.1 SPA17 "CT22, SP17" ENSG00000064199 "Sperm autoantigenic protein 17" Q15506 11 124673844-124697518 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 231.3" "Cell type enhanced" "Detected in many" "Early spermatids: 1583.7;Endometrial ciliated cells: 371.2;Late spermatids: 2667.9;Respiratory ciliated cells: 368.6;Spermatocytes: 580.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037568 Enhanced Approved Vesicles NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 6: T47d - Mammary gland" "Cluster 31: Spermatids - Spermatogenesis" Vesicles "HPA037568: AB_10672905" "unprognostic (1.41e-2)" "unprognostic (3.49e-1)" "unprognostic (2.39e-3)" "prognostic favorable (1.03e-4)" "unprognostic (2.85e-1)" "unprognostic (1.56e-1)" "unprognostic (1.01e-4)" "unprognostic (2.64e-1)" "unprognostic (3.80e-2)" "unprognostic (4.56e-2)" "unprognostic (6.47e-2)" "unprognostic (8.54e-2)" "unprognostic (1.71e-3)" "unprognostic (6.78e-2)" "unprognostic (9.78e-3)" "unprognostic (8.52e-2)" "unprognostic (2.71e-1)" 3.2 4.2 2.6 1.1 2.8 1.6 3.8 2.4 2.6 4.4 9.0 5.4 1.4 4.4 10.5 5.0 24.5 2.3 4.5 2.8 3.1 11.6 2.1 7.7 1.0 4.6 4.9 1.6 4.3 4.7 13.5 0.9 4.1 4.3 3.2 1.0 3.5 2.1 1.2 2.6 3.0 1.6 3.8 1.8 4.0 231.3 3.3 2.6 8.9 0.2 1.4 3.2 3.0 3.3 4.1 5.4 12.6 4.3 4.2 6.4 4.7 3.8 8.4 5.4 4.4 1.4 11.5 2.8 2.2 6.7 4.3 3.4 4.9 8.0 7.3 2.6 3.6 3.6 0.8 2.4 2.3 1.0 1.6 2.6 4.8 7.9 4.1 4.2 4.5 5.7 5.5 2.2 12.4 5.5 0.5 0.2 4.7 8.3 4.3 3.8 1.5 0.1 12.8 3.1 6.6 5.8 9.1 2.7 1.8 4.6 17.1 3.1 3.2 4.8 3.8 2.8 4.5 1.4 0.9 1.1 5.0 0.9 5.1 0.5 0.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.1 0.1 0.6 0.1 0.0 0.2 2.6 2.8 2.4 2.6 2.8 3.1 4.6 4.9 4.1 3.8 3.3 3.3 5.9 3.2 12.6 3.6 0.9 2.7 4.7 26.9 1.8 2.6 6.2 6.5 2.1 17.2 54.2 20.2 4.2 6.7 2.3 13.0 19.6 29.2 1583.7 371.2 13.8 7.2 7.2 3.2 5.8 15.5 10.8 5.8 8.2 19.4 0.0 7.1 1.8 1.5 11.9 0.0 2.8 9.2 32.6 3.1 1.0 2667.9 28.0 6.6 1.8 1.9 2.6 8.1 0.0 1.0 0.7 12.7 10.0 18.0 1.4 2.9 6.3 47.0 368.6 1.2 13.1 6.2 10.5 580.0 63.6 4.9 2.3 2.7 2.6 8.4 10.4 5.6 NRGN RC3 ENSG00000154146 Neurogranin Q92686 11 124739942-124747210 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 21 "brain: 1158.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 245.6;Macrophages: 214.7;Smooth muscle cells: 60.5" "Cancer enhanced" "Detected in all" "glioma: 39.8" "Region enhanced" "Detected in many" "cerebral cortex: 1158.0" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 6 "dendritic cells: 1.8;granulocytes: 2.5;monocytes: 3.6" "Cell line enhanced" "Detected in many" "HEL: 154.7;PC-3: 122.8" "Group enriched" "Detected in all" 9 "amygdala: 785.5;basal ganglia: 687.3;cerebral cortex: 1219.9;hippocampal formation: 641.9;white matter: 422.3" "Group enriched" "Detected in all" 6 "basal ganglia: 2940.0;cerebral cortex: 4703.6;hippocampal formation: 2490.2" "CAB006908, HPA038171" Enhanced NA NA 5300000 "Cluster 41: Basophils - Cellular respiration" "Cluster 10: Brain - Neuronal signaling" "Cluster 36: HEL - Hemostasis" "Cluster 51: Myeloid cells - Hemostasis" "CAB006908: , HPA038171: AB_2675878" "unprognostic (1.37e-1)" "unprognostic (8.24e-3)" "unprognostic (3.95e-2)" "unprognostic (1.45e-2)" "unprognostic (3.49e-2)" "unprognostic (5.33e-3)" "unprognostic (1.02e-2)" "unprognostic (9.16e-2)" "unprognostic (2.87e-2)" "unprognostic (3.72e-3)" "unprognostic (4.14e-3)" "unprognostic (5.20e-2)" "prognostic unfavorable (1.52e-5)" "unprognostic (8.29e-2)" "unprognostic (2.12e-1)" "unprognostic (4.06e-2)" "unprognostic (4.03e-2)" 13.8 4.4 119.9 7.8 563.0 36.3 9.1 0.0 1158.0 9.6 0.0 6.1 1.9 10.5 2.7 4.4 12.4 5.2 19.7 282.2 0.0 29.6 6.5 55.2 3.5 0.0 0.0 9.5 2.7 0.4 11.6 5.8 0.0 6.3 1.5 1.1 3.4 2.5 3.7 4.1 6.3 4.9 0.0 55.8 4.8 7.0 0.0 1.5 11.8 4.3 1.6 8.0 7.8 627.0 13.5 11.2 44.8 51.2 0.6 0.2 1.5 6.4 3.8 5.7 3.5 7.7 20.3 38.1 22.4 1.4 14.5 4.2 8.8 15.4 2.4 6.4 24.9 154.7 4.9 4.5 0.2 3.8 47.4 0.3 0.0 4.7 1.1 4.4 29.4 13.2 8.7 15.0 4.7 51.3 0.2 2.1 16.1 7.7 122.8 21.6 21.5 3.6 3.2 9.0 8.2 16.3 8.6 27.8 1.8 8.7 25.7 41.3 31.2 21.8 16.0 9.1 16.8 3.6 0.6 0.3 15.2 39.9 27.5 1.7 3.6 0.9 0.1 2.1 0.2 0.2 0.2 0.0 1.8 0.4 0.2 0.2 2.5 0.1 1.3 0.5 0.0 6.8 119.9 563.0 0.0 1158.0 282.2 0.0 0.0 0.0 0.0 0.0 0.0 627.0 12.5 0.0 41.9 35.9 4.3 3.6 0.9 0.6 0.6 5.3 2.1 2.7 2.3 1.5 0.1 0.0 0.0 1.6 4.7 2.2 3.9 0.9 3.1 1.7 1.4 20.8 6.0 5.5 245.6 0.2 2.7 3.8 1.5 1.5 1.3 0.9 15.7 1.0 13.0 0.0 14.4 1.7 0.0 43.4 15.2 7.2 0.6 214.7 5.4 42.2 45.4 0.1 25.7 29.7 33.4 0.3 0.3 0.7 3.4 0.6 0.3 0.1 0.2 1.8 19.7 1.6 60.5 3.6 6.5 1.3 1.4 0.1 4.6 0.8 2.2 1.6 VSIG2 "CTH, CTXL" ENSG00000019102 "V-set and immunoglobulin domain containing 2" Q96IQ7 11 124747474-124752255 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "stomach 1: 619.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 514.3;Gastric mucus-secreting cells: 623.4;Intestinal goblet cells: 285.6;Pancreatic endocrine cells: 260.2;Paneth cells: 509.9;Undifferentiated cells: 207.0;Urothelial cells: 285.3" "Cancer enhanced" "Detected in many" "urothelial cancer: 87.4" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "OE19: 429.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035919, HPA050147" Enhanced Approved Nucleoplasm NA NA 78000 "Cluster 39: Non-specific - mRNA processing" "Cluster 4: Stomach - Digestion" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA035919: AB_10669981, HPA050147: AB_2681032" "unprognostic (1.64e-3)" "unprognostic (1.21e-1)" "unprognostic (1.10e-2)" "unprognostic (1.90e-1)" "unprognostic (2.00e-1)" "unprognostic (2.18e-3)" "unprognostic (2.16e-1)" "unprognostic (2.22e-2)" "unprognostic (3.47e-3)" "unprognostic (2.02e-1)" "unprognostic (6.01e-2)" "unprognostic (2.78e-2)" "unprognostic (2.99e-2)" "unprognostic (2.61e-1)" "unprognostic (1.95e-1)" "unprognostic (1.87e-1)" "unprognostic (1.36e-2)" 6.5 0.8 3.1 7.0 6.4 3.4 9.5 0.8 7.1 29.7 0.2 136.2 6.2 4.9 0.4 26.4 17.5 26.5 5.3 2.8 1.5 6.3 3.0 45.7 0.9 1.7 3.6 1.1 2.0 1.9 1.7 6.0 2.0 58.2 137.8 0.6 31.8 4.3 2.3 1.5 2.8 4.7 1.1 1.6 619.2 0.9 3.1 0.2 43.7 2.5 2.5 84.5 9.3 3.6 0.4 0.1 4.8 3.4 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.9 1.5 2.4 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.3 16.6 0.0 7.9 0.7 0.5 3.0 0.1 0.0 0.0 0.0 0.3 2.8 0.3 0.3 0.6 0.0 1.6 0.1 0.1 0.6 429.0 3.7 0.4 3.6 0.1 0.1 69.2 0.3 0.9 0.1 4.6 0.0 0.7 0.4 2.4 4.1 1.8 1.1 0.3 0.8 0.3 0.0 0.0 0.6 1.7 0.9 0.0 1.2 0.0 0.0 0.1 0.5 0.0 0.5 0.1 0.4 0.0 0.6 0.4 0.1 0.3 0.2 0.0 0.7 0.9 3.1 6.4 0.8 7.1 2.8 1.5 1.7 3.6 2.0 1.1 3.1 3.6 4.6 125.0 51.6 0.0 1.5 0.8 19.2 25.3 2.8 1.5 31.5 18.4 0.7 82.9 99.3 3.7 0.0 0.0 0.6 514.3 1.9 14.6 0.0 12.1 1.8 5.0 66.8 0.0 0.2 90.9 0.1 0.9 623.4 18.3 1.3 0.1 3.9 0.2 0.1 0.0 0.1 285.6 20.3 0.3 2.7 0.0 1.5 2.4 3.6 1.0 0.0 0.0 0.0 0.0 0.1 260.2 509.9 0.0 0.7 61.6 1.3 0.1 36.7 0.0 0.0 0.3 6.2 0.2 0.7 0.7 0.4 0.0 2.2 0.3 207.0 285.3 ESAM W117m ENSG00000149564 "Endothelial cell adhesion molecule" Q96AP7 11 124752583-124762290 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 405.9;Endothelial cells: 301.0;Hepatic stellate cells: 138.1;Sertoli cells: 151.2;Smooth muscle cells: 89.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 8.2;naive B-cell: 7.5" "Group enriched" "Detected in many" 9 "B-cells: 7.5;granulocytes: 8.2;T-cells: 2.2" "Group enriched" "Detected in many" 10 "HEL: 218.8;HUVEC TERT2: 277.9;TIME: 142.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056293, HPA072563" Uncertain Approved "Cell Junctions,Cytosol" NA NA 82000000 "Cluster 34: Basophils - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Cell Junctions" Cytosol "HPA056293: AB_2683089, HPA072563: " "unprognostic (1.52e-1)" "unprognostic (2.03e-1)" "unprognostic (1.05e-2)" "unprognostic (3.56e-1)" "unprognostic (1.41e-2)" "unprognostic (4.49e-3)" "unprognostic (2.61e-1)" "unprognostic (1.10e-1)" "unprognostic (9.05e-2)" "unprognostic (2.99e-2)" "unprognostic (3.08e-1)" "unprognostic (3.60e-1)" "unprognostic (1.54e-1)" "unprognostic (1.24e-2)" "unprognostic (5.10e-2)" "unprognostic (2.29e-1)" "unprognostic (5.06e-2)" 97.5 17.7 38.4 9.0 37.7 1.9 79.4 38.8 46.9 33.3 30.1 20.0 7.0 36.2 7.8 21.8 34.2 20.0 83.0 35.2 38.7 63.6 11.5 112.5 8.7 40.9 38.9 14.4 13.6 13.2 14.8 106.9 44.0 19.8 7.8 2.5 15.6 15.6 27.1 18.2 20.9 29.4 37.3 17.3 23.4 4.3 45.4 5.4 95.9 49.8 8.3 30.8 30.2 37.8 1.2 1.6 0.4 1.2 0.0 0.3 5.1 0.1 0.1 0.0 0.1 2.7 14.1 1.2 3.2 0.0 0.2 0.0 3.7 0.0 0.0 1.8 1.3 218.8 0.1 8.0 0.6 0.4 3.6 0.0 0.0 0.0 0.0 0.2 277.9 0.1 0.2 5.9 0.5 1.8 0.0 0.0 0.6 20.8 2.1 0.0 1.0 0.9 0.0 2.4 0.2 0.8 0.1 16.1 0.0 7.5 3.3 0.8 142.0 0.4 0.4 0.5 0.0 0.2 0.2 0.2 0.1 0.5 0.4 8.2 0.6 0.0 0.1 0.3 0.0 2.1 1.5 0.1 0.4 7.5 2.2 0.8 6.5 0.0 0.0 0.4 0.4 24.8 38.4 37.7 38.8 46.9 35.2 38.7 40.9 38.9 44.0 37.3 45.4 37.8 405.9 38.5 56.0 2.0 4.5 15.2 0.5 0.2 2.8 18.5 2.5 3.2 11.2 0.0 3.0 14.7 4.2 1.8 2.5 3.5 5.9 7.6 5.0 1.1 1.5 301.0 0.0 5.3 1.5 2.4 18.7 13.8 3.6 1.4 3.8 0.1 138.1 1.7 1.1 0.0 0.4 0.4 0.0 5.3 22.1 26.3 0.9 25.7 12.4 20.6 1.2 0.7 0.0 0.5 0.4 46.5 2.1 0.4 2.8 1.8 0.1 0.1 1.9 1.3 151.2 4.6 89.4 0.1 0.9 0.8 10.9 37.1 2.0 2.4 1.6 2.3 MSANTD2 "C11orf61, FLJ23342" ENSG00000120458 "Myb/SANT DNA binding domain containing 2" Q6P1R3 11 124766498-124800706 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 33.5;Microglial cells: 31.9;Oligodendrocyte precursor cells: 33.7;Oligodendrocytes: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038694, HPA038695" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nuclear bodies" Nucleoplasm "HPA038694: AB_2676155, HPA038695: AB_10674693" "unprognostic (2.20e-1)" "unprognostic (1.86e-1)" "unprognostic (7.06e-2)" "unprognostic (2.31e-1)" "unprognostic (2.06e-1)" "unprognostic (6.19e-2)" "unprognostic (7.77e-4)" "unprognostic (4.77e-3)" "unprognostic (3.32e-2)" "unprognostic (3.91e-1)" "unprognostic (1.14e-1)" "unprognostic (2.60e-3)" "prognostic unfavorable (2.50e-4)" "unprognostic (5.67e-2)" "unprognostic (1.64e-1)" "unprognostic (1.85e-1)" "prognostic favorable (2.65e-4)" 9.8 6.3 8.0 3.8 9.0 0.7 9.9 8.2 10.8 16.2 8.5 10.2 4.0 11.5 7.5 7.5 12.8 2.8 7.2 7.4 8.6 19.1 8.3 9.3 4.5 8.4 8.6 14.1 14.2 3.2 15.3 5.1 8.6 13.5 3.8 5.9 9.3 4.0 4.7 8.4 10.1 2.8 7.8 13.7 10.5 4.7 8.4 3.4 25.3 1.9 3.9 9.4 11.4 10.9 3.0 0.9 10.5 9.9 5.2 6.7 6.1 6.4 3.6 2.3 3.0 4.3 6.2 3.5 5.9 3.3 3.4 5.5 4.5 2.1 3.6 5.8 4.0 3.3 3.9 4.5 2.6 1.9 2.7 3.4 3.8 4.0 3.3 9.1 5.3 3.0 3.9 4.7 5.8 2.6 1.4 9.4 8.0 5.5 14.4 4.2 2.6 3.3 4.4 2.6 3.3 13.0 2.9 3.7 1.9 7.7 8.6 2.1 6.8 15.4 4.3 4.5 6.4 3.0 2.2 2.1 3.2 3.4 8.0 0.0 0.2 0.6 0.6 0.4 0.3 0.3 0.5 0.9 0.3 0.8 0.5 0.4 0.0 0.2 0.5 0.2 1.1 0.2 8.0 9.0 8.2 10.8 7.4 8.6 8.4 8.6 8.6 7.8 8.4 10.9 10.9 3.2 10.3 28.7 7.7 8.8 4.4 2.5 9.6 8.7 6.7 6.7 3.3 5.7 1.8 7.3 2.1 2.9 7.7 3.4 3.9 4.6 5.2 3.2 11.1 9.4 1.2 1.3 33.5 1.0 4.4 10.1 6.6 5.6 1.3 9.0 10.4 3.0 3.0 13.5 30.6 3.1 4.1 3.8 7.3 1.5 9.6 4.1 1.8 31.9 4.4 5.6 8.2 33.7 48.4 4.6 4.0 7.2 4.3 5.0 2.2 3.6 2.9 6.2 13.1 11.3 14.0 2.4 1.6 4.4 4.1 1.9 5.8 7.3 5.0 3.2 ROBO3 "FLJ21044, HGPPS, HGPS, RBIG1" ENSG00000154134 "Roundabout guidance receptor 3" Q96MS0 11 124865432-124881471 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 6.4" "Cell type enhanced" "Detected in many" "Astrocytes: 32.3;Muller glia cells: 45.3" "Cancer enhanced" "Detected in many" "glioma: 5.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "AF22: 18.4" "Region enhanced" "Detected in single" "cerebral cortex: 2.1" "Low region specificity" "Detected in many" HPA071053 Approved "Vesicles,Plasma membrane" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" Vesicles "HPA071053: " "unprognostic (1.30e-1)" "unprognostic (2.17e-1)" "unprognostic (4.95e-3)" "unprognostic (3.42e-2)" "unprognostic (3.84e-2)" "unprognostic (6.25e-2)" "unprognostic (6.95e-3)" "unprognostic (9.65e-2)" "unprognostic (1.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (7.15e-2)" "unprognostic (3.75e-8)" "unprognostic (7.27e-3)" "unprognostic (2.21e-1)" "unprognostic (1.47e-1)" "unprognostic (4.91e-3)" 2.8 1.8 0.5 0.0 0.3 0.2 1.9 0.0 3.2 0.7 0.0 1.3 0.3 0.8 0.0 0.7 2.0 0.0 1.8 0.7 0.2 1.6 0.4 1.1 0.1 0.9 0.9 6.4 0.7 0.0 0.8 0.2 0.2 1.4 0.0 0.2 1.2 0.0 0.5 0.7 0.9 0.8 0.2 1.6 0.6 1.2 1.7 0.0 1.4 0.0 0.0 0.7 1.2 0.9 0.0 0.0 18.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.3 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 1.1 0.0 0.0 1.5 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.2 0.3 0.0 0.1 0.1 0.0 0.6 0.9 0.0 0.9 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.3 0.0 3.2 0.7 0.2 0.9 0.9 0.2 0.2 1.7 0.9 13.2 0.0 7.3 32.3 0.4 2.9 14.5 16.2 4.0 1.9 5.9 10.9 2.7 1.5 5.9 12.9 0.0 0.2 8.5 2.1 0.0 9.3 0.4 0.4 0.5 11.4 3.5 2.1 6.9 0.8 0.2 19.0 0.5 0.7 8.9 19.0 7.5 0.3 1.6 0.0 2.3 2.4 10.2 1.6 20.1 0.6 13.4 8.0 3.6 11.2 1.6 45.3 8.2 4.5 9.2 1.2 2.5 8.2 0.7 8.2 1.0 0.8 0.6 2.1 0.0 14.3 4.4 10.1 10.8 2.3 1.0 0.1 3.6 3.5 2.7 6.5 ROBO4 "ECSM4, FLJ20798, MRB" ENSG00000154133 "Roundabout guidance receptor 4" Q8WZ75 11 124883691-124898500 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation" "Developmental protein, Receptor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Adipocytes: 181.5;Endothelial cells: 119.7;Hepatic stellate cells: 148.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "HUVEC TERT2: 247.6;TIME: 224.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065212 Approved "Plasma membrane" NA NA 380000000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane" "HPA065212: AB_2685434" "unprognostic (2.86e-1)" "unprognostic (9.35e-2)" "unprognostic (2.67e-1)" "unprognostic (1.07e-1)" "unprognostic (3.82e-2)" "unprognostic (6.97e-2)" "prognostic favorable (4.85e-4)" "unprognostic (7.94e-2)" "unprognostic (2.27e-1)" "unprognostic (1.43e-1)" "unprognostic (1.73e-3)" "unprognostic (2.17e-1)" "unprognostic (1.17e-2)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.55e-1)" "unprognostic (4.63e-1)" "unprognostic (5.15e-2)" 41.4 7.2 11.4 6.6 9.6 0.2 31.8 9.0 9.4 10.0 5.8 6.5 2.9 10.9 2.1 5.5 10.3 9.7 25.8 7.9 9.2 18.5 5.3 34.8 7.8 11.3 10.7 4.1 4.3 4.7 4.6 28.6 11.2 7.0 1.7 0.2 4.1 4.6 13.9 6.9 7.3 9.9 9.5 43.5 6.3 1.4 13.2 1.8 16.7 11.9 2.0 9.4 7.0 8.6 0.4 0.0 0.4 0.0 0.0 1.1 0.1 0.2 3.1 0.7 1.5 0.0 0.0 0.0 23.6 0.1 1.0 0.0 0.0 0.4 1.2 0.0 0.0 0.9 0.0 0.1 0.6 0.0 0.0 0.1 0.0 8.9 3.0 0.4 247.6 0.0 0.0 0.0 8.6 0.0 0.0 0.2 0.0 0.0 3.4 0.0 8.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 224.8 1.2 0.6 0.3 1.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 9.6 9.0 9.4 7.9 9.2 11.3 10.7 11.2 9.5 13.2 8.6 181.5 0.0 4.2 2.3 1.6 2.2 1.0 0.2 0.6 0.2 0.6 1.0 3.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.5 0.5 0.2 0.3 119.7 0.0 4.0 0.0 0.2 0.0 5.2 0.0 0.3 2.5 0.6 148.9 1.5 0.1 0.0 0.0 0.0 0.0 8.1 3.7 1.7 4.4 2.8 1.8 20.6 0.1 1.1 0.0 0.5 0.1 0.1 0.0 1.2 2.6 0.3 0.0 0.0 0.0 5.2 0.0 4.5 2.1 0.0 0.1 0.6 1.3 0.0 0.9 2.0 0.1 0.2 HEPACAM "FLJ25530, GLIALCAM" ENSG00000165478 "Hepatic and glial cell adhesion molecule" Q14CZ8 11 124919205-124936412 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Cell cycle, Growth arrest, Growth regulation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 222.6;choroid plexus: 79.7" "Group enriched" "Detected in some" 9 "Astrocytes: 184.8;Oligodendrocyte precursor cells: 72.9;Oligodendrocytes: 163.2" "Cancer enriched" "Detected in some" 12 "glioma: 29.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 30 "Hep G2: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017613, CAB025486" Enhanced Approved Vesicles NA NA "Cluster 42: Non-specific - Transcription" "Cluster 70: Brain - Nervous system development" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 64: Astrocytes - Nervous system maintenance" Vesicles "CAB025486: , HPA017613: AB_1850595" "unprognostic (3.22e-3)" "unprognostic (1.06e-2)" "unprognostic (1.64e-1)" "unprognostic (6.41e-2)" "unprognostic (1.47e-1)" "unprognostic (9.16e-2)" "unprognostic (2.25e-1)" "unprognostic (7.58e-2)" "unprognostic (1.33e-2)" "unprognostic (1.06e-6)" "unprognostic (2.62e-1)" "unprognostic (3.21e-1)" 15.6 0.3 172.8 0.2 203.3 0.0 2.5 170.4 162.1 0.2 79.7 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.2 163.2 156.1 0.1 16.2 0.0 0.2 222.6 182.8 0.0 0.0 0.0 0.8 0.0 183.6 0.2 0.2 1.8 0.2 0.5 0.1 0.0 0.2 0.1 205.7 0.0 0.1 0.2 182.0 0.0 0.0 0.3 0.6 0.0 0.1 212.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 25.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.2 172.8 203.3 170.4 162.1 163.2 156.1 222.6 182.8 183.6 205.7 182.0 212.2 0.1 0.0 0.0 184.8 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 11.2 0.0 0.0 2.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.6 0.0 15.5 0.0 72.9 163.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 HEPN1 ENSG00000221932 "Hepatocellular carcinoma, down-regulated 1" Q6WQI6 11 124919244-124920677 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 11.4;brain: 37.3;liver: 20.9" "Group enriched" "Detected in some" 23 "Astrocytes: 94.3;Muller glia cells: 29.1;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 114.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 287 "Hep G2: 55.5" "HPA043768, HPA063054" Uncertain Approved "Golgi apparatus" Yes NA "Cluster 15: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 64: Astrocytes - Nervous system maintenance" "Golgi apparatus" "HPA043768: AB_2678662, HPA063054: AB_2684932" 11.4 0.2 6.1 0.1 23.1 0.0 8.3 0.3 9.4 0.4 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.0 0.6 5.0 6.1 0.2 20.9 0.1 0.1 37.3 10.3 0.1 0.2 0.0 2.4 0.0 13.5 0.8 0.0 2.2 0.4 0.0 0.2 0.3 0.7 0.0 5.1 0.1 0.5 0.5 19.0 0.0 0.2 0.0 0.0 0.2 0.5 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 23.1 0.3 9.4 5.0 6.1 37.3 10.3 13.5 5.1 19.0 17.9 0.2 0.0 0.0 94.3 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 3.1 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.5 0.6 0.0 0.0 1.9 0.0 29.1 0.0 49.3 114.6 0.0 0.0 1.2 0.0 0.1 0.0 2.2 0.0 1.9 0.0 0.1 0.1 1.8 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 CCDC15 FLJ13215 ENSG00000149548 "Coiled-coil domain containing 15" Q0P6D6 11 124954121-125041489 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.5" "Group enriched" "Detected in many" 5 "Early spermatids: 42.8;Erythroid cells: 26.3;Late spermatids: 25.8;Spermatocytes: 99.7;Spermatogonia: 34.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040450, HPA041738" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Plasma membrane" Cytosol "HPA040450: AB_10794031, HPA041738: AB_10794675" "unprognostic (2.38e-1)" "unprognostic (3.93e-2)" "unprognostic (8.81e-2)" "unprognostic (1.85e-1)" "unprognostic (2.50e-1)" "unprognostic (4.59e-4)" "unprognostic (2.12e-3)" "unprognostic (1.43e-1)" "unprognostic (1.46e-2)" "unprognostic (2.04e-2)" "unprognostic (9.05e-3)" "unprognostic (3.25e-2)" "unprognostic (9.38e-3)" "unprognostic (1.33e-2)" "unprognostic (3.14e-1)" "unprognostic (5.04e-2)" "unprognostic (1.66e-1)" 0.7 0.3 0.5 0.9 0.8 2.1 2.8 0.5 0.6 0.6 0.3 0.8 0.7 0.6 1.5 0.8 1.1 0.5 0.2 0.6 0.5 0.6 1.3 0.7 1.2 0.9 0.6 0.8 0.8 0.6 0.5 0.7 0.6 1.6 0.8 1.7 3.9 0.5 0.1 2.1 0.7 0.6 0.7 0.8 0.6 10.5 0.7 2.8 0.7 0.2 1.4 0.5 0.6 1.2 5.4 1.0 6.9 0.0 0.5 1.9 0.0 5.7 6.9 5.3 6.5 0.1 4.4 6.3 4.9 2.0 10.5 4.2 2.9 3.8 9.4 5.3 1.1 7.7 0.8 1.6 0.2 2.3 4.3 0.5 2.7 11.0 5.5 1.0 4.0 7.8 5.2 6.3 11.2 1.2 4.9 2.6 1.6 4.6 6.3 5.9 12.6 2.0 0.8 2.1 3.9 3.4 3.3 0.4 1.5 3.3 7.9 2.0 2.9 10.8 2.4 4.8 7.2 1.5 1.8 5.3 1.5 12.6 7.3 4.0 0.5 0.8 1.0 0.7 1.1 0.3 0.9 1.7 0.1 0.7 1.2 1.4 0.4 1.1 0.8 0.5 1.7 0.5 0.5 0.8 0.5 0.6 0.6 0.5 0.9 0.6 0.6 0.7 0.7 1.2 2.4 3.2 1.1 5.2 2.3 5.0 2.1 2.2 2.2 6.4 4.2 2.8 0.6 0.0 2.9 0.0 0.0 0.9 2.9 1.1 0.0 2.3 42.8 2.6 2.0 3.4 1.2 26.3 1.2 3.5 0.4 2.5 3.6 1.4 8.9 4.4 1.4 1.4 3.2 3.3 2.0 2.1 0.0 2.6 3.3 25.8 4.4 2.6 3.6 1.0 0.7 3.6 8.2 5.0 6.1 1.8 0.5 2.2 1.2 1.1 0.2 1.0 5.3 2.8 6.6 2.2 2.3 99.7 34.5 3.2 3.8 0.1 3.4 0.9 1.7 1.2 SLC37A2 FLJ00171 ENSG00000134955 "Solute carrier family 37 member 2" Q8TED4 11 125063302-125090516 "Predicted membrane proteins, Transporters" "Antiport, Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 78.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 13.4;Hofbauer cells: 36.5;Kupffer cells: 22.0;Macrophages: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "classical monocyte: 12.3;intermediate monocyte: 14.1;myeloid DC: 5.5;non-classical monocyte: 19.2" "Group enriched" "Detected in many" 9 "dendritic cells: 5.5;monocytes: 19.2" "Cell line enhanced" "Detected in many" "A-431: 33.8;CAPAN-2: 70.3;hTCEpi: 34.9;hTERT-HME1: 64.8;U-138 MG: 47.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014948 Uncertain NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 4: Macrophages - Innate immune response" "HPA014948: AB_2190374" "unprognostic (8.47e-2)" "unprognostic (4.85e-1)" "unprognostic (9.64e-2)" "unprognostic (2.91e-2)" "unprognostic (7.88e-2)" "unprognostic (2.84e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-1)" "unprognostic (2.06e-2)" "unprognostic (1.30e-1)" "unprognostic (2.15e-2)" "unprognostic (3.11e-1)" "unprognostic (6.61e-2)" "unprognostic (1.94e-3)" "unprognostic (1.66e-3)" "unprognostic (7.01e-2)" "unprognostic (3.24e-2)" 4.2 24.2 1.7 16.9 2.6 1.4 4.6 2.4 3.7 2.3 2.1 8.0 9.1 1.0 1.3 13.4 1.2 5.1 1.5 1.9 2.3 0.7 5.9 5.9 5.7 4.3 2.7 1.0 1.2 1.1 0.2 7.4 3.8 2.6 10.2 0.5 78.8 1.4 0.6 20.9 7.7 3.1 3.2 15.8 2.1 1.6 5.2 2.1 0.6 0.9 5.1 11.9 7.7 7.3 33.8 0.1 1.0 0.4 0.6 0.8 0.6 1.6 2.8 1.0 2.5 0.2 70.3 0.4 9.4 0.4 2.5 21.0 0.4 20.9 3.8 0.9 0.6 6.6 1.6 2.4 0.1 0.3 0.9 0.7 34.9 2.6 64.8 2.7 1.7 1.3 0.5 2.2 3.1 0.3 0.3 4.6 1.9 0.2 1.0 0.4 2.7 0.8 1.0 17.6 0.3 0.3 4.8 2.9 2.6 0.5 0.3 1.8 3.7 47.2 1.9 0.7 1.6 1.8 1.5 1.1 1.7 2.4 4.1 0.2 12.3 0.0 0.0 14.1 0.0 0.4 0.0 0.1 5.5 0.1 0.1 0.1 1.3 0.0 19.2 0.2 0.0 5.4 1.7 2.6 2.4 3.7 1.9 2.3 4.3 2.7 3.8 3.2 5.2 7.3 0.7 0.0 0.6 0.3 3.8 0.3 1.4 0.5 1.2 1.5 1.4 1.1 1.1 1.5 1.6 0.0 2.1 0.6 0.7 13.4 0.0 0.1 1.6 1.9 1.4 1.3 0.0 2.7 0.3 0.0 0.8 0.5 0.0 4.9 2.5 0.4 1.8 0.3 36.5 0.0 0.3 0.1 0.0 22.0 1.4 2.2 0.9 22.7 0.0 8.4 7.3 0.3 3.1 1.0 0.2 0.1 3.3 1.2 1.7 1.0 0.0 0.1 0.2 0.8 0.0 0.8 0.6 2.7 1.1 5.7 0.9 3.4 1.2 0.4 0.1 3.2 TMEM218 ENSG00000150433 "Transmembrane protein 218" A2RU14 11 125096545-125111763 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038489 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 4: Macrophages - Innate immune response" "Plasma membrane, Cytosol" "HPA038489: AB_10672748" "unprognostic (3.70e-2)" "unprognostic (1.16e-1)" "unprognostic (7.60e-2)" "unprognostic (2.41e-3)" "unprognostic (8.86e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.93e-5)" "unprognostic (3.63e-2)" "unprognostic (7.09e-3)" "unprognostic (2.18e-1)" "unprognostic (6.45e-2)" "unprognostic (1.09e-1)" "unprognostic (9.95e-2)" "prognostic favorable (5.50e-4)" "unprognostic (6.53e-2)" "unprognostic (1.42e-1)" "unprognostic (6.72e-2)" 17.7 18.1 4.8 9.5 5.5 5.3 14.0 5.3 6.5 15.5 5.3 13.5 8.4 16.6 6.9 11.6 14.8 7.4 10.2 4.6 5.4 12.7 12.9 12.0 10.5 6.0 5.5 15.0 14.5 10.3 15.2 5.9 5.8 13.0 6.0 6.5 10.9 6.8 9.2 8.9 11.8 8.3 5.7 16.6 13.2 5.6 5.1 8.4 10.9 5.7 7.0 13.8 13.2 6.3 12.5 24.0 14.9 18.2 13.5 18.6 9.0 12.2 9.2 9.3 12.0 2.5 35.9 15.6 29.9 7.5 14.2 14.2 9.4 11.6 12.2 22.0 13.5 35.1 6.1 10.0 13.3 11.1 12.6 14.7 15.2 16.5 19.6 14.9 13.7 19.1 14.4 19.4 16.2 6.4 2.9 23.3 12.2 34.0 22.6 16.3 18.0 12.0 8.3 12.3 12.9 19.4 16.6 6.6 9.1 8.7 31.3 15.7 17.6 11.4 10.3 13.4 13.5 11.1 10.1 12.9 9.1 22.9 20.3 43.7 40.1 17.4 21.6 31.6 18.7 29.6 20.5 20.5 47.4 23.9 17.2 20.4 15.7 32.5 30.9 41.1 20.5 27.0 4.8 5.5 5.3 6.5 4.6 5.4 6.0 5.5 5.8 5.7 5.1 6.3 21.0 19.2 13.4 7.8 17.8 12.1 19.6 34.6 19.4 7.0 22.1 24.6 8.1 15.7 16.6 14.7 0.0 28.0 18.1 5.7 27.4 20.5 3.4 23.1 22.4 15.8 10.8 14.5 4.4 16.2 18.4 21.1 8.6 10.6 3.8 22.2 18.5 15.1 42.2 23.5 7.4 11.7 20.3 21.0 17.5 1.9 10.2 21.9 17.8 14.0 26.0 26.0 18.6 9.5 11.2 13.1 3.9 16.6 15.8 9.4 8.5 19.7 29.4 12.4 26.3 16.7 18.3 16.6 13.8 18.0 14.2 9.7 14.5 27.0 13.7 16.6 PKNOX2 ENSG00000165495 "PBX/knotted 1 homeobox 2" Q96KN3 11 125164687-125433389 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 36.3" "Cell type enhanced" "Detected in many" "Astrocytes: 31.3;Early spermatids: 46.8;Excitatory neurons: 132.9;Inhibitory neurons: 137.4;Oligodendrocyte precursor cells: 85.5" "Cancer enhanced" "Detected in many" "melanoma: 8.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 39.1;AN3-CA: 9.6;hTEC/SVTERT24-B: 7.8;LHCN-M2: 11.6;SK-MEL-30: 7.8;WM-115: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028867, CAB034342, HPA055368, HPA066962" Supported Enhanced "Nucleoplasm,Cytokinetic bridge" Yes NA "Cluster 80: Striated muscle - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Cytokinetic bridge" "CAB034342: AB_2164138, HPA028867: AB_2672802, HPA055368: AB_2682796, HPA066962: AB_2685757" "unprognostic (2.91e-2)" "unprognostic (1.62e-1)" "unprognostic (2.10e-2)" "unprognostic (7.26e-2)" "unprognostic (9.46e-2)" "unprognostic (3.97e-2)" "unprognostic (2.41e-1)" "unprognostic (2.12e-2)" "unprognostic (1.56e-1)" "unprognostic (2.44e-2)" "unprognostic (7.66e-2)" "unprognostic (3.70e-1)" "unprognostic (4.10e-6)" "unprognostic (1.76e-3)" "unprognostic (7.11e-2)" "unprognostic (1.71e-2)" "unprognostic (6.48e-3)" 3.6 3.3 2.6 2.0 5.8 0.0 1.2 1.4 12.7 3.2 8.1 2.8 0.9 3.3 2.7 1.4 6.1 1.8 7.3 4.8 0.6 3.0 0.5 10.0 1.4 3.0 0.3 14.9 3.9 0.9 5.6 8.4 1.3 6.3 1.4 2.8 2.5 5.1 15.0 2.4 1.7 2.6 2.6 2.3 2.3 4.8 0.8 3.1 12.1 36.3 1.1 3.1 2.7 3.1 0.0 0.0 39.1 9.6 0.7 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 4.8 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.2 0.0 0.0 2.0 0.0 7.8 0.1 0.0 0.0 0.0 0.0 0.0 11.6 0.3 0.0 0.0 3.9 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.8 6.1 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 5.8 1.4 12.7 4.8 0.6 3.0 0.3 1.3 2.6 0.8 3.1 0.6 0.0 0.0 31.3 0.0 0.9 0.0 0.0 0.0 0.9 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 1.4 46.8 0.0 1.1 0.5 0.0 0.0 132.9 0.2 0.0 3.1 0.0 0.0 0.0 12.2 1.8 0.0 0.3 8.4 137.4 0.0 0.0 0.0 0.3 9.6 5.0 0.0 8.8 22.5 0.0 2.9 0.0 85.5 3.8 0.1 0.0 17.7 0.0 1.9 0.0 0.1 0.0 0.3 6.6 8.8 2.9 1.2 0.4 0.0 0.4 0.1 0.0 6.9 0.0 0.0 FEZ1 UNC-76 ENSG00000149557 "Fasciculation and elongation protein zeta 1" Q99689 11 125442881-125592568 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 176.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 109.8;Horizontal cells: 166.5;Oligodendrocytes: 246.6" "Cancer enriched" "Detected in all" 10 "glioma: 68.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 23.4;MAIT T-cell: 15.5" "Lineage enriched" "Detected in many" 23 "T-cells: 23.4" "Cell line enhanced" "Detected in many" "AF22: 48.3;HBEC3-KT: 66.0;NTERA-2: 68.6;SCLC-21H: 54.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038490, HPA076844" Approved Approved Microtubules,Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 70: Brain - Nervous system development" "Cluster 5: NTERA-2 - Transcription" "Cluster 62: Horizontal cells - Visual perception" "Microtubules, Cytosol" "HPA038490: AB_10672647, HPA076844: " "unprognostic (5.68e-2)" "prognostic unfavorable (9.06e-5)" "unprognostic (7.40e-2)" "unprognostic (3.73e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-2)" "unprognostic (2.72e-1)" "unprognostic (2.06e-1)" "unprognostic (8.30e-2)" "unprognostic (2.08e-1)" "unprognostic (2.81e-1)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (2.14e-2)" "unprognostic (2.68e-1)" "unprognostic (3.99e-2)" "unprognostic (1.02e-1)" 16.9 5.4 96.8 2.9 144.0 0.9 11.3 145.5 120.6 21.8 53.1 39.3 1.7 23.5 2.3 6.2 14.7 6.9 37.4 95.5 120.4 6.8 5.5 34.2 1.9 145.6 136.9 12.7 2.5 1.9 17.6 3.8 138.9 15.4 3.3 18.7 6.4 7.6 5.9 7.9 12.6 8.3 134.8 8.8 15.9 12.7 126.7 0.5 10.2 3.0 1.4 26.5 16.9 176.6 0.3 0.0 48.3 0.2 39.2 25.3 0.0 10.3 14.6 3.8 0.6 0.2 0.3 0.1 16.3 21.1 11.4 0.5 31.2 66.0 2.4 2.3 0.5 37.6 0.1 0.0 25.3 0.0 0.6 23.1 17.6 11.5 29.3 0.4 32.0 0.0 4.5 0.6 3.8 1.5 0.2 0.0 68.6 0.5 1.2 0.0 0.1 0.2 0.0 30.3 54.3 5.5 0.3 0.1 1.4 27.3 4.9 26.4 19.3 0.4 2.4 0.2 11.1 0.6 0.5 0.1 7.9 0.0 26.6 0.2 0.8 0.0 23.4 0.1 15.5 0.1 0.9 5.1 0.4 0.0 0.6 5.5 0.2 1.0 0.0 0.1 0.0 4.4 96.8 144.0 145.5 120.6 95.5 120.4 145.6 136.9 138.9 134.8 126.7 176.6 4.9 0.0 5.2 53.2 0.8 8.0 4.9 96.9 6.2 23.1 0.5 10.3 109.8 2.8 9.6 0.0 2.1 8.0 23.3 0.1 27.4 2.8 68.6 0.8 14.2 13.9 5.4 0.0 41.0 0.4 1.2 43.0 0.5 0.5 0.0 11.1 58.9 1.0 91.6 166.5 48.7 0.0 16.2 24.9 15.5 65.9 25.4 2.3 78.2 12.2 1.9 97.1 74.2 32.2 246.6 0.3 0.0 35.3 0.9 12.7 0.0 2.1 3.8 17.8 19.7 25.4 35.6 28.8 7.7 0.2 5.5 4.2 7.8 5.5 0.1 3.5 EI24 "EPG4, PIG8, TP53I8" ENSG00000149547 "EI24 autophagy associated transmembrane protein" O14681 11 125569280-125584684 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 461.9" "Cell type enhanced" "Detected in all" "Hepatocytes: 575.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 760.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047165, HPA051029" Approved Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 36: HEL - Hemostasis" "Cluster 2: Hepatocytes - Metabolism" "Endoplasmic reticulum, Cytosol" "Golgi apparatus" "HPA047165: AB_2679965, HPA051029: AB_2681317" "unprognostic (2.04e-3)" "unprognostic (2.69e-2)" "unprognostic (1.25e-2)" "unprognostic (3.43e-2)" "unprognostic (1.68e-1)" "unprognostic (2.78e-2)" "unprognostic (5.02e-2)" "unprognostic (6.38e-2)" "unprognostic (6.74e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (9.28e-4)" "unprognostic (3.50e-2)" "unprognostic (1.35e-1)" "unprognostic (4.58e-2)" "unprognostic (8.35e-2)" "unprognostic (2.07e-1)" "unprognostic (3.01e-1)" 53.4 32.6 61.1 36.2 62.5 23.2 72.6 59.7 72.4 51.3 59.8 77.8 49.6 46.2 57.4 80.8 50.8 46.3 55.7 60.2 61.5 61.0 248.4 45.0 28.4 60.2 62.5 42.4 101.8 461.9 30.6 48.5 60.2 49.6 80.4 39.4 75.3 58.0 119.5 70.2 49.3 62.5 62.4 30.5 59.7 33.1 64.4 35.3 40.5 104.6 42.3 78.9 48.4 61.0 156.6 115.6 129.5 160.5 207.7 155.9 162.4 159.6 116.8 104.3 93.4 178.9 303.4 158.0 264.0 146.5 110.8 176.1 199.0 326.8 135.2 42.0 142.6 760.9 77.2 179.9 154.1 170.9 78.4 147.5 292.7 157.4 230.2 102.8 223.9 85.1 351.1 61.1 149.4 113.8 79.0 96.4 173.6 398.3 139.5 113.9 155.4 132.8 177.0 272.4 120.1 116.9 187.1 215.5 63.4 212.3 436.4 165.7 195.2 133.8 93.3 94.7 128.7 39.7 84.8 200.5 58.5 256.1 182.2 4.3 7.0 5.9 7.2 6.7 7.2 8.4 5.7 9.0 10.9 6.3 8.1 6.7 0.8 6.5 4.9 14.5 9.1 5.3 61.1 62.5 59.7 72.4 60.2 61.5 60.2 62.5 60.2 62.4 64.4 61.0 73.5 32.1 38.3 13.4 34.8 120.6 130.3 132.6 120.1 58.9 148.8 100.6 61.9 124.4 69.5 110.3 37.5 166.9 32.4 66.4 144.8 178.6 31.1 34.4 59.3 87.1 98.4 102.7 25.1 181.8 201.2 80.1 87.7 46.5 27.3 76.2 74.6 575.0 110.5 82.4 24.0 115.3 105.8 49.8 96.1 49.7 71.4 40.9 90.7 11.2 40.9 107.1 50.4 13.0 23.0 182.1 67.6 72.2 79.1 270.0 68.5 122.7 43.9 36.9 46.0 60.8 80.1 95.9 112.3 176.3 181.4 140.1 31.0 71.3 135.7 189.4 STT3A "ITM1, MGC9042, STT3-A, TMC" ENSG00000134910 "STT3 oligosaccharyltransferase complex catalytic subunit A" P46977 11 125591712-125625215 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Glycosyltransferase, Transferase" "Cancer-related genes, Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 391.8" "Cell type enhanced" "Detected in all" "Plasma cells: 91.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030735 Approved NA NA 23000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 1: K-562 - Erythropoiesis" "Cluster 55: Plasma cells - Humoral immune response" "HPA030735: AB_10603342" "unprognostic (8.25e-3)" "unprognostic (5.45e-2)" "unprognostic (3.02e-2)" "prognostic favorable (1.32e-4)" "unprognostic (5.10e-2)" "unprognostic (1.72e-2)" "prognostic unfavorable (3.57e-4)" "unprognostic (8.40e-2)" "unprognostic (4.80e-2)" "unprognostic (1.16e-2)" "unprognostic (8.96e-3)" "unprognostic (1.31e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.60e-2)" "unprognostic (6.38e-2)" "unprognostic (1.28e-1)" "unprognostic (1.82e-2)" 38.5 39.2 14.6 44.6 17.7 31.8 55.8 17.9 16.9 84.9 29.8 54.0 42.2 60.8 140.4 30.2 56.3 39.5 38.5 15.0 20.1 45.8 69.0 39.0 32.9 19.4 18.4 68.0 69.0 391.8 29.0 63.8 19.6 56.2 59.5 40.0 80.1 77.2 18.4 31.6 42.1 58.9 17.5 34.4 51.4 44.5 17.5 34.8 83.9 24.4 48.8 50.4 33.3 23.1 113.1 99.5 123.7 173.6 230.1 176.4 133.8 198.5 238.5 158.6 196.6 304.2 294.3 143.6 236.2 297.3 222.4 202.7 173.5 176.2 208.5 114.8 90.0 341.0 63.7 215.1 254.4 208.4 153.6 138.4 125.8 219.5 424.5 186.1 182.2 63.9 147.1 210.6 205.4 82.7 84.4 65.6 78.6 221.8 106.0 98.9 107.1 221.5 173.7 170.1 77.5 66.2 142.9 229.3 72.5 144.9 267.8 148.1 164.5 227.7 82.0 97.6 159.7 66.3 82.4 109.6 87.4 206.3 184.7 96.2 46.7 36.6 56.1 45.4 77.9 42.8 53.7 52.0 65.2 32.1 37.1 44.4 15.7 52.8 41.8 158.3 44.0 47.5 14.6 17.7 17.9 16.9 15.0 20.1 19.4 18.4 19.6 17.5 17.5 23.1 17.4 28.9 25.0 6.8 20.8 16.2 14.3 40.3 12.5 11.6 15.2 9.8 23.3 27.1 29.1 16.5 20.9 45.4 21.7 16.1 1.9 30.1 10.6 22.9 51.0 17.3 15.6 19.6 7.6 27.2 73.4 33.0 26.0 57.0 17.1 29.0 32.2 38.5 30.7 1.7 8.9 37.3 20.3 23.6 31.9 5.4 21.5 17.3 24.9 9.4 12.6 13.2 11.3 11.6 10.9 28.6 12.2 18.8 91.9 19.3 15.6 13.6 23.6 15.1 19.7 23.1 32.8 33.5 13.1 21.9 14.8 45.6 14.6 22.3 26.9 13.9 CHEK1 CHK1 ENSG00000149554 "Checkpoint kinase 1" O14757 11 125625665-125676255 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.7;lymphoid tissue: 20.7;seminal vesicle: 29.8" "Cell type enhanced" "Detected in many" "Cholangiocytes: 32.9;Erythroid cells: 34.5;Extravillous trophoblasts: 35.6;Spermatocytes: 48.9;Spermatogonia: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "T-reg: 6.2" "Group enriched" "Detected in many" 5 "granulocytes: 1.7;T-cells: 6.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA044364 Supported Nucleoplasm,Vesicles NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Vesicles "HPA044364: AB_2678913" "unprognostic (6.74e-2)" "unprognostic (3.63e-1)" "prognostic favorable (3.62e-4)" "unprognostic (5.54e-2)" "unprognostic (2.17e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.70e-6)" "unprognostic (3.95e-3)" "unprognostic (1.26e-3)" "unprognostic (2.54e-2)" "prognostic unfavorable (3.10e-6)" "unprognostic (1.75e-1)" "prognostic unfavorable (1.04e-8)" "unprognostic (2.89e-2)" "unprognostic (2.64e-1)" "unprognostic (8.16e-2)" "unprognostic (1.33e-1)" 1.6 1.3 0.7 8.2 1.0 25.7 2.6 0.6 1.3 1.7 0.5 7.9 6.8 1.7 6.7 4.1 1.1 1.7 0.9 0.7 0.9 2.2 2.1 1.3 14.9 0.7 0.8 1.8 2.0 13.2 1.7 4.8 0.8 1.6 8.7 0.7 1.5 29.8 0.6 3.6 7.3 3.4 0.6 2.2 2.6 8.9 1.2 20.7 1.0 1.3 13.9 3.3 2.1 0.8 48.5 37.0 81.1 47.4 13.5 28.9 35.7 61.1 28.7 41.6 40.1 88.0 100.3 120.7 63.5 24.9 53.7 52.6 54.2 33.2 50.1 81.4 24.8 224.2 27.2 44.7 4.3 121.1 39.6 15.7 6.0 47.6 36.0 19.9 44.7 84.1 117.3 102.7 51.4 23.8 181.3 65.0 86.1 77.1 33.2 104.7 74.4 67.2 37.9 63.2 50.5 53.6 45.2 35.4 15.2 57.3 93.9 40.6 28.4 51.0 47.3 29.6 60.8 21.9 45.4 187.5 20.5 86.6 67.6 1.7 0.2 0.0 0.4 0.1 0.2 0.7 1.6 0.4 0.6 0.3 0.4 0.3 1.1 0.3 0.1 0.7 6.2 0.4 0.7 1.0 0.6 1.3 0.7 0.9 0.7 0.8 0.8 0.6 1.2 0.8 1.1 3.2 0.5 1.6 5.5 6.2 3.9 5.8 5.2 1.7 3.9 6.0 4.6 32.9 4.1 7.3 0.0 17.3 6.0 4.5 3.9 3.4 7.8 5.5 8.0 3.5 1.8 34.5 3.3 1.1 35.6 5.3 6.1 9.9 0.0 21.1 3.6 1.2 11.1 0.0 2.5 9.2 2.0 0.0 5.2 3.1 1.5 3.2 0.0 2.8 3.2 2.8 3.1 1.5 1.6 2.9 3.9 1.2 17.7 3.1 8.0 9.4 2.5 1.7 0.0 3.1 7.8 48.9 49.8 9.5 4.8 7.8 5.1 4.8 16.7 3.0 ACRV1 "D11S4365, SP-10, SPACA2" ENSG00000134940 "Acrosomal vesicle protein 1" P26436 11 125671522-125680874 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "testis: 116.7" "Group enriched" "Detected in some" 48 "Early spermatids: 904.8;Late spermatids: 278.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 5.0;HEL: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038718, HPA038719" Enhanced "Secreted in male reproductive system" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 12: NES - Nervous system development" "Cluster 29: Early spermatids - Spermatogenesis" "HPA038718: AB_2676171, HPA038719: AB_10670787" "unprognostic (3.58e-2)" "unprognostic (8.68e-3)" "unprognostic (1.46e-1)" "unprognostic (6.18e-2)" "unprognostic (4.58e-2)" "unprognostic (7.91e-3)" "unprognostic (6.73e-4)" "unprognostic (1.76e-1)" "unprognostic (2.12e-3)" "unprognostic (8.39e-2)" "unprognostic (7.09e-2)" "unprognostic (2.90e-3)" "unprognostic (1.80e-8)" "unprognostic (5.26e-3)" "unprognostic (2.52e-1)" "unprognostic (1.95e-1)" "unprognostic (3.75e-1)" 0.0 0.0 1.8 0.1 1.9 0.2 0.1 1.3 2.0 0.0 1.2 0.1 0.1 0.1 3.5 0.0 0.1 0.0 0.0 1.7 1.6 0.0 0.0 0.0 0.4 1.5 1.5 0.0 0.0 0.0 0.2 0.1 1.6 0.2 0.0 0.2 0.0 0.7 0.0 0.1 0.1 0.2 1.6 0.0 0.0 116.7 1.9 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.3 1.2 5.0 3.2 0.0 0.0 1.0 1.5 0.0 0.1 0.0 1.8 1.7 2.7 0.6 0.0 0.7 0.4 0.0 0.0 0.3 1.9 0.9 5.0 0.6 0.9 0.1 2.5 1.1 0.0 0.0 0.0 0.2 0.2 0.0 0.8 1.4 2.0 0.4 0.7 2.7 3.4 1.1 0.5 1.0 2.3 1.2 0.5 0.0 0.5 0.6 0.8 0.6 0.1 0.1 0.9 0.9 0.6 0.5 1.7 1.1 0.2 0.3 0.9 1.2 1.3 0.2 1.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 1.9 1.3 2.0 1.7 1.6 1.5 1.5 1.6 1.6 1.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 904.8 0.8 0.1 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 278.8 6.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PATE1 PATE ENSG00000171053 "Prostate and testis expressed 1" Q8WXA2 11 125746279-125749867 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "epididymis: 1868.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.3;NB-4: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA076587 Approved "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 24: NB-4 - Immune response" "Cluster 22: Epithelial cell types - Mixed function" "HPA076587: AB_2732316" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1868.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 209.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PATE2 "C11orf38, LVLF3112, PATE-M, UNQ3112" ENSG00000196844 "Prostate and testis expressed 2" Q6UY27 11 125776113-125778828 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "epididymis: 450.6" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 8.4;Early spermatids: 4.4;Excitatory neurons: 2.7;Inhibitory neurons: 3.1;Late spermatids: 13.7;Oligodendrocyte precursor cells: 3.0;Spermatocytes: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (3.28e-1)" "unprognostic (7.26e-2)" "unprognostic (2.95e-1)" "unprognostic (1.18e-2)" "unprognostic (2.63e-1)" "unprognostic (6.84e-3)" "unprognostic (1.55e-2)" "unprognostic (5.08e-1)" "unprognostic (2.55e-1)" 0.0 0.1 0.5 0.0 0.6 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 450.6 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.4 0.0 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.0 0.7 0.4 0.0 0.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.2 0.9 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.8 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PATE3 "HEL-127, PATE-DJ" ENSG00000236027 "Prostate and testis expressed 3" B3GLJ2 11 125788127-125791600 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "epididymis: 158.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 25: Spermatids - Spermatogenesis" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 158.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.4 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PATE4 "FLJ41047, PATE-B" ENSG00000237353 "Prostate and testis expressed 4" P0C8F1 11 125833316-125840072 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "seminal vesicle: 106.8" "Group enriched" "Detected in some" 70 "Early spermatids: 22.9;Late spermatids: 19.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045632 Approved "Secreted in male reproductive system" NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 34: Spermatids - Unknown function" "HPA045632: AB_10960489" "unprognostic (4.90e-1)" "unprognostic (2.93e-2)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" 0.1 0.2 0.7 0.1 0.6 0.4 0.1 1.8 1.3 0.1 0.0 0.0 0.1 0.1 14.9 0.1 0.1 0.1 0.1 0.5 0.2 0.4 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 2.9 0.1 0.7 0.1 106.8 0.2 0.4 0.1 0.0 0.0 0.1 0.1 0.4 0.4 0.0 0.4 0.0 0.0 0.1 0.0 1.2 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.7 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.4 0.2 0.3 0.5 0.2 0.3 0.1 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.6 1.8 1.3 0.5 0.2 0.0 0.0 0.1 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HYLS1 FLJ32915 ENSG00000198331 "HYLS1 centriolar and ciliogenesis associated" Q96M11 11 125883614-125900646 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 26.5" "Cell type enhanced" "Detected in many" "Early spermatids: 80.8;Late spermatids: 54.9;Spermatocytes: 92.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041210 Enhanced Supported "Plasma membrane,Cytosol" NA Yes "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 78: Testis - Spermatogenesis" "Cluster 6: T47d - Mammary gland" "Cluster 29: Early spermatids - Spermatogenesis" "Plasma membrane, Cytosol" "HPA041210: AB_10794987" "unprognostic (2.46e-1)" "unprognostic (1.60e-1)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" "unprognostic (3.53e-3)" "unprognostic (1.17e-2)" "prognostic unfavorable (1.92e-4)" "unprognostic (3.28e-1)" "unprognostic (1.04e-3)" "unprognostic (6.56e-3)" "unprognostic (7.63e-2)" "unprognostic (4.81e-3)" "unprognostic (3.00e-2)" "unprognostic (2.19e-1)" "unprognostic (2.49e-1)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" 2.9 2.4 5.7 3.0 5.3 2.4 4.3 8.0 8.5 4.2 4.9 4.7 6.0 3.8 6.7 3.7 4.2 2.6 5.0 5.4 5.3 5.5 5.8 2.5 6.2 5.0 4.7 3.9 2.2 2.7 2.3 4.4 5.0 5.0 5.0 4.3 3.1 6.1 2.7 4.8 3.3 6.4 4.5 3.6 5.4 26.5 6.0 5.2 2.5 4.3 9.0 3.8 2.3 5.2 11.2 23.9 8.4 5.9 16.5 11.6 14.8 27.3 10.9 24.8 16.9 0.3 17.2 5.0 11.3 25.4 8.4 15.8 12.2 10.0 28.7 27.1 9.2 3.5 2.3 4.9 12.9 12.4 16.9 7.2 11.0 25.2 28.3 5.1 18.4 11.0 6.1 27.3 33.6 18.6 9.1 36.2 18.4 46.2 40.8 19.0 0.1 16.5 27.3 17.9 11.6 7.2 29.6 22.2 11.0 10.5 53.6 26.9 16.7 1.8 20.9 19.4 4.6 10.1 11.4 11.4 5.1 26.7 22.2 5.7 7.6 1.5 10.6 8.7 10.2 16.1 13.8 12.6 10.0 16.1 13.2 9.7 1.1 6.8 6.3 20.4 15.5 7.1 5.7 5.3 8.0 8.5 5.4 5.3 5.0 4.7 5.0 4.5 6.0 5.2 3.9 0.0 0.5 2.6 9.3 4.2 2.8 8.0 4.6 7.1 4.1 5.3 5.5 1.5 2.2 1.8 4.2 18.6 11.5 4.0 11.7 5.5 80.8 5.8 3.4 3.7 4.9 9.1 14.3 4.2 13.0 5.9 8.6 2.1 0.0 7.1 6.8 5.4 7.6 0.0 13.8 3.2 8.2 3.2 4.0 54.9 8.4 2.5 7.2 6.5 11.9 5.8 12.3 6.0 5.8 3.6 5.8 6.0 4.2 3.3 5.2 12.1 4.8 6.5 6.6 2.3 5.7 92.1 32.3 6.2 4.3 4.4 4.9 7.5 5.5 1.5 PUS3 FKSG32 ENSG00000110060 "Pseudouridine synthase 3" Q9BZE2 11 125893485-125903221 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" Isomerase "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038040, HPA063802" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 42: Non-specific - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 1: K-562 - Erythropoiesis" "Cluster 2: Hepatocytes - Metabolism" Nucleoplasm Cytosol "HPA038040: AB_10697092, HPA063802: AB_2685126" "unprognostic (5.89e-2)" "unprognostic (7.24e-2)" "unprognostic (1.29e-1)" "unprognostic (4.37e-3)" "unprognostic (4.59e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (7.67e-2)" "unprognostic (1.77e-1)" "unprognostic (8.92e-3)" "unprognostic (4.47e-3)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (2.08e-3)" "unprognostic (9.95e-2)" "unprognostic (1.32e-1)" "unprognostic (1.13e-1)" "unprognostic (2.44e-1)" 8.3 8.4 7.1 8.2 7.8 3.3 9.4 8.4 11.6 7.7 6.7 8.5 10.9 7.8 9.7 9.0 7.4 6.5 7.1 7.1 8.7 9.0 33.2 6.1 9.2 7.8 7.8 7.3 17.8 7.0 8.5 6.7 7.3 8.7 7.9 8.4 7.7 5.4 15.0 9.5 6.8 9.7 7.0 7.6 10.1 7.2 8.5 11.0 9.3 15.2 10.5 10.1 6.3 7.6 6.5 7.9 23.2 24.9 24.3 29.7 11.0 21.1 17.0 11.6 13.2 24.0 23.2 31.4 33.3 9.2 17.1 22.5 37.6 19.7 11.5 28.2 18.2 31.2 9.5 18.6 24.6 20.5 9.2 23.1 23.4 13.7 29.8 16.2 21.0 23.5 34.0 16.1 13.0 4.0 23.7 23.6 19.8 47.0 15.8 4.8 20.5 18.4 20.3 9.5 27.1 25.7 13.1 21.4 11.7 16.5 43.2 13.8 15.3 24.0 10.1 11.9 17.3 12.4 20.1 33.6 6.7 31.9 17.1 14.2 10.5 9.9 13.4 10.8 15.3 13.3 13.1 12.8 9.2 14.8 17.0 16.0 4.2 14.9 14.0 8.0 15.0 8.3 7.1 7.8 8.4 11.6 7.1 8.7 7.8 7.8 7.3 7.0 8.5 7.6 8.5 9.6 11.5 3.6 9.5 12.9 12.2 10.6 8.0 9.3 7.3 9.4 5.4 11.5 13.6 5.5 29.2 9.7 7.4 3.6 5.9 17.8 7.7 4.4 8.9 10.5 4.8 14.5 2.9 27.2 12.7 6.1 9.2 4.4 12.7 6.1 10.4 33.0 8.2 5.0 3.4 4.6 10.2 5.0 2.9 6.3 7.8 5.5 1.8 1.9 9.9 9.8 6.2 2.5 3.8 15.0 3.9 7.9 6.7 9.1 10.2 16.9 6.2 10.9 6.6 9.9 10.1 7.8 7.2 6.7 11.8 14.0 7.9 12.8 6.5 10.9 DDX25 GRTH ENSG00000109832 "DEAD-box helicase 25" Q9UHL0 11 125903348-125943702 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, mRNA transport, Spermatogenesis, Translation regulation, Transport" "Developmental protein, Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 91.4" "Group enriched" "Detected in some" 4 "Early spermatids: 332.1;Spermatocytes: 266.3" "Cancer enhanced" "Detected in some" "glioma: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "JURKAT: 16.1;NTERA-2: 10.8;SCLC-21H: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020137 Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "HPA020137: AB_1847552" "unprognostic (5.78e-3)" "unprognostic (9.75e-3)" "unprognostic (7.93e-2)" "unprognostic (5.09e-3)" "unprognostic (1.11e-2)" "unprognostic (1.78e-2)" "unprognostic (1.54e-1)" "unprognostic (2.91e-3)" "unprognostic (6.24e-5)" "unprognostic (2.57e-1)" "unprognostic (2.44e-3)" "unprognostic (3.89e-1)" "unprognostic (3.44e-3)" "unprognostic (1.44e-1)" "unprognostic (1.76e-1)" "unprognostic (9.72e-2)" "unprognostic (1.69e-1)" 0.4 2.7 15.0 0.1 16.1 0.3 0.3 12.4 17.0 0.3 4.0 0.4 0.4 0.3 0.2 0.1 0.6 0.1 0.0 14.3 16.7 2.6 0.3 0.2 0.1 8.7 10.4 0.6 1.4 1.7 14.9 0.2 10.6 0.2 0.1 21.8 0.2 0.4 0.1 1.1 0.1 0.0 7.6 0.3 0.4 91.4 15.0 0.6 4.7 0.1 0.1 0.0 0.2 13.5 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 16.1 0.0 0.2 0.0 0.5 1.7 0.0 10.8 0.5 0.0 0.4 0.0 0.0 0.0 0.1 8.7 1.9 0.1 0.0 1.7 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.6 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 15.0 16.1 12.4 17.0 14.3 16.7 8.7 10.4 10.6 7.6 15.0 13.5 0.2 0.0 0.5 16.0 0.5 0.1 0.8 0.0 2.2 18.0 0.1 0.8 1.1 0.0 0.0 0.0 16.7 0.1 0.0 0.0 3.9 0.3 332.1 0.2 0.0 1.0 0.0 0.0 18.0 0.2 0.2 0.4 0.0 0.1 0.0 2.3 0.4 0.5 0.1 16.8 23.1 0.0 0.0 0.0 0.3 66.0 3.7 0.4 0.0 1.9 0.0 20.2 0.0 15.6 3.1 0.1 0.0 4.9 0.0 0.5 0.0 2.7 0.0 16.6 0.0 0.2 0.3 266.3 28.6 0.4 0.0 0.0 0.1 4.0 0.0 0.2 VSIG10L2 ENSG00000283703 "V-set and immunoglobulin domain containing 10 like 2" P0DP72 11 125946056-125958647 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "skin 1: 18.6" "Group enriched" "Detected in some" 4 "Breast glandular cells: 11.9;Breast myoepithelial cells: 6.7" "Region enhanced" "Detected in single" "cerebellum: 3.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 61: Skin - Cornification" "Cluster 35: Glandular cells - Unknown function" 0.2 0.0 0.1 0.0 0.2 0.0 1.8 3.2 0.8 0.8 0.0 0.0 0.0 0.3 0.0 0.8 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 18.6 0.0 0.7 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.2 0.8 0.3 0.1 0.1 0.0 0.3 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 6.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 CDON "CDO, CDON1, ORCAM" ENSG00000064309 "Cell adhesion associated, oncogene regulated" Q4KMG0 11 125955796-126063335 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Holoprosencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 58.3;Fibroblasts: 23.5;Inhibitory neurons: 49.5;Muller glia cells: 39.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 23.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 28.4;ASC diff: 32.7;RH-30: 48.9;SuSa: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB012422, HPA017377" Uncertain NA NA 15000000 "Cluster 89: Fibroblasts - ECM organization" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 50: Fibroblasts - ECM organization" "CAB012422: AB_2260246, HPA017377: AB_1846453" "prognostic favorable (1.35e-4)" "unprognostic (1.03e-1)" "unprognostic (2.86e-2)" "unprognostic (1.25e-4)" "unprognostic (1.10e-1)" "unprognostic (5.16e-2)" "unprognostic (2.49e-3)" "unprognostic (5.77e-3)" "unprognostic (2.78e-1)" "unprognostic (1.32e-1)" "unprognostic (1.81e-1)" "unprognostic (3.09e-1)" "prognostic unfavorable (1.78e-7)" "unprognostic (5.39e-2)" "unprognostic (1.51e-1)" "unprognostic (5.83e-3)" "unprognostic (1.86e-4)" 12.6 0.7 1.9 1.6 2.0 0.0 5.1 23.0 4.0 7.9 1.2 12.4 1.0 14.0 2.1 1.7 14.2 4.8 4.0 1.6 1.8 0.8 1.2 2.7 1.1 2.2 1.9 20.6 1.2 2.5 3.0 2.7 2.7 1.3 1.6 10.1 1.7 2.8 1.2 9.9 2.9 17.0 0.5 0.7 4.6 3.6 2.3 2.8 18.5 1.6 1.5 2.5 3.0 2.1 1.6 3.2 28.4 2.8 32.7 14.5 0.4 0.5 2.9 0.9 0.3 1.1 9.4 1.4 6.8 0.6 3.3 0.4 7.1 1.0 0.8 5.5 6.3 0.5 6.5 2.9 6.4 0.4 1.8 4.5 1.2 0.6 0.0 12.2 0.3 4.8 0.1 1.9 2.7 0.4 3.6 1.0 2.6 0.8 3.7 1.1 48.9 0.9 1.7 0.5 2.4 9.6 3.7 0.3 4.7 23.8 2.4 1.0 0.5 3.2 2.2 6.3 3.3 2.5 5.5 0.2 2.0 1.6 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.0 23.0 4.0 1.6 1.8 2.2 1.9 2.7 0.5 2.3 2.1 3.0 6.4 9.9 11.1 0.1 15.2 1.4 0.8 2.2 5.1 5.4 1.9 5.2 2.8 5.6 0.0 16.7 0.6 0.1 0.2 0.0 1.3 3.1 1.7 0.5 3.0 7.7 0.4 58.3 0.6 0.4 23.5 1.5 1.1 0.0 1.8 1.1 2.1 0.3 0.0 49.5 0.3 0.0 0.0 7.6 2.7 14.9 0.2 3.6 2.8 0.1 39.3 0.0 14.1 5.8 2.4 0.4 11.3 0.8 1.1 0.6 0.5 4.2 4.6 0.0 2.9 2.7 1.8 3.8 0.5 10.7 0.7 0.6 13.2 0.4 1.6 RPUSD4 FLJ14494 ENSG00000165526 "RNA pseudouridine synthase D4" Q96CM3 11 126202096-126211692 "Metabolic proteins, Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 135.5;tongue: 75.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039689 Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 54: Cardiomyocytes - Muscle contraction" Mitochondria Nucleoplasm "HPA039689: AB_10673537" "unprognostic (2.02e-2)" "unprognostic (3.65e-1)" "prognostic favorable (6.14e-4)" "unprognostic (3.16e-3)" "unprognostic (2.90e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.32e-1)" "unprognostic (7.64e-3)" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (1.20e-2)" "unprognostic (1.56e-1)" "unprognostic (7.11e-2)" "unprognostic (5.44e-2)" "unprognostic (7.33e-2)" "unprognostic (5.47e-2)" 14.8 12.7 10.2 9.8 10.4 10.6 14.0 10.5 11.2 13.8 10.7 12.1 10.4 12.6 7.7 15.1 12.9 8.1 27.2 10.5 10.4 11.8 20.5 9.4 13.8 10.2 10.2 18.3 26.8 7.8 8.8 6.8 10.5 11.5 10.1 6.1 14.4 7.0 135.5 17.1 12.1 9.2 10.6 14.4 20.0 8.8 10.5 13.2 10.1 75.2 15.5 12.4 13.4 10.5 15.6 14.0 17.0 19.7 24.5 34.3 12.5 16.2 22.7 16.6 15.1 46.4 27.3 35.7 16.8 14.1 23.7 25.1 40.3 25.8 17.3 32.4 23.9 84.1 15.0 40.5 18.3 42.5 17.1 29.8 35.0 18.4 22.9 24.8 33.4 28.8 51.8 25.1 20.2 13.5 26.6 46.3 18.4 49.3 29.1 31.0 25.2 33.3 25.7 19.8 29.3 20.5 21.5 29.7 16.7 17.0 46.2 21.9 20.9 18.6 13.3 15.4 19.9 10.1 12.4 30.7 8.8 47.2 19.7 1.6 12.7 1.4 15.9 11.7 19.6 14.4 18.0 14.3 16.3 14.5 20.4 16.8 0.9 14.3 14.0 7.0 18.1 13.3 10.2 10.4 10.5 11.2 10.5 10.4 10.2 10.2 10.5 10.6 10.5 10.5 10.0 3.2 8.4 6.8 15.3 27.5 20.4 13.2 17.1 9.9 13.1 9.1 35.4 12.8 7.4 7.3 8.4 14.0 12.3 7.2 9.8 12.3 1.8 6.7 7.1 11.9 15.5 6.7 7.0 19.6 17.1 10.2 10.7 7.4 5.7 15.2 13.6 11.3 13.3 11.8 8.4 10.7 2.0 15.9 8.7 2.3 9.6 8.6 10.6 8.4 21.0 5.3 14.4 6.6 7.8 13.5 7.4 8.6 12.4 17.4 15.6 14.5 7.0 8.2 6.6 15.6 9.9 10.3 16.7 13.2 24.0 13.3 13.1 18.3 18.8 14.7 FAM118B FLJ21103 ENSG00000197798 "Family with sequence similarity 118 member B" Q9BPY3 11 126211724-126262984 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041644, HPA042100" Approved NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA041644: AB_10794303, HPA042100: AB_10795394" "unprognostic (8.11e-2)" "unprognostic (9.87e-3)" "unprognostic (4.05e-3)" "unprognostic (3.13e-2)" "unprognostic (9.55e-3)" "unprognostic (4.04e-2)" "prognostic unfavorable (6.67e-7)" "unprognostic (1.85e-2)" "unprognostic (3.03e-3)" "unprognostic (1.43e-1)" "unprognostic (7.12e-2)" "unprognostic (1.64e-1)" "unprognostic (3.76e-2)" "unprognostic (1.15e-1)" "unprognostic (9.49e-2)" "unprognostic (3.82e-1)" "unprognostic (7.44e-2)" 9.3 10.5 15.1 10.3 19.2 4.3 7.6 15.7 20.4 10.4 20.2 24.0 18.5 10.0 12.3 7.6 6.7 10.5 18.2 15.5 16.2 10.3 8.9 16.3 12.7 15.1 15.3 6.2 5.7 7.7 9.0 11.1 15.3 7.3 23.6 9.0 8.0 9.3 22.0 5.4 13.1 14.2 16.0 10.5 14.9 21.4 15.6 14.1 10.2 16.3 14.0 13.6 6.2 16.3 11.7 14.3 31.5 23.6 43.4 28.5 14.0 18.5 33.2 20.4 21.2 29.0 18.5 13.0 19.2 23.5 42.4 15.2 33.5 19.7 24.8 21.2 14.5 41.3 6.8 19.5 33.7 20.7 13.0 23.7 19.9 25.0 23.0 20.5 46.8 24.9 25.8 17.8 29.6 10.9 27.8 16.2 25.6 63.3 26.4 24.1 25.1 11.6 34.4 18.3 14.5 15.2 21.5 14.0 26.8 36.8 27.3 12.4 29.2 20.7 15.2 17.9 16.3 9.3 11.7 22.0 8.9 31.0 26.9 33.8 43.4 21.9 14.6 58.8 18.6 15.2 14.4 18.9 48.1 15.9 12.9 16.0 9.0 18.9 59.6 21.9 18.0 25.2 15.1 19.2 15.7 20.4 15.5 16.2 15.1 15.3 15.3 16.0 15.6 16.3 8.6 3.2 16.4 14.4 5.6 4.1 4.2 21.9 1.2 3.1 3.3 3.6 10.4 4.3 9.6 12.9 4.2 9.3 5.0 21.9 5.9 16.0 7.5 5.0 6.0 12.4 3.6 8.6 19.1 17.2 12.4 8.3 21.4 4.1 10.8 9.1 9.7 5.5 24.2 1.7 17.6 11.4 12.2 16.7 9.4 9.2 7.8 11.0 3.6 12.2 16.9 13.5 13.4 16.1 12.7 14.0 12.8 21.8 9.5 4.1 11.4 12.9 6.8 5.7 6.6 3.4 10.2 46.0 20.6 3.5 3.4 13.0 5.3 11.0 16.6 5.7 SRPRA "SR-alpha, Sralpha, SRP-alpha, SRPR" ENSG00000182934 "SRP receptor subunit alpha" P08240 11 126262938-126269144 "Plasma proteins, Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 232.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 19000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 1: K-562 - Erythropoiesis" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.23e-3)" "unprognostic (6.87e-2)" "unprognostic (6.11e-2)" "prognostic favorable (8.56e-4)" "unprognostic (1.44e-2)" "unprognostic (5.21e-2)" "unprognostic (2.87e-1)" "unprognostic (3.64e-1)" "unprognostic (4.78e-1)" "unprognostic (3.96e-2)" "unprognostic (2.22e-2)" "unprognostic (2.73e-1)" "unprognostic (3.72e-1)" "unprognostic (1.33e-2)" "unprognostic (4.38e-2)" "unprognostic (1.93e-1)" "unprognostic (2.74e-2)" 64.4 78.9 24.9 71.4 25.9 82.5 58.0 27.2 32.5 85.6 51.7 54.7 53.1 64.8 144.2 55.7 57.4 64.7 62.9 26.7 29.2 54.1 164.0 65.5 67.4 28.9 26.9 55.8 254.8 71.5 88.9 49.9 28.9 81.8 61.9 36.3 236.8 87.7 91.1 53.8 52.2 68.8 25.6 66.7 96.3 32.7 30.6 61.8 90.2 69.3 86.4 82.0 48.6 27.6 65.5 63.5 59.5 90.9 160.1 124.0 79.5 183.8 168.5 87.4 102.9 117.5 163.4 122.2 186.4 182.3 109.2 126.4 91.1 105.8 87.2 134.9 71.9 223.8 49.1 117.9 223.7 198.7 139.9 106.4 132.5 134.6 245.0 105.5 120.9 47.7 76.2 284.3 124.1 87.6 95.9 78.5 39.7 193.1 135.5 62.8 82.3 128.4 86.8 132.2 85.5 80.3 125.6 150.9 95.7 48.0 198.7 117.5 115.5 153.2 68.2 88.0 132.8 123.3 85.0 73.9 85.3 177.5 202.5 72.1 61.8 95.9 91.3 67.4 79.7 48.7 62.6 74.0 59.4 41.1 56.3 65.2 64.3 62.3 82.8 78.1 53.5 94.7 24.9 25.9 27.2 32.5 26.7 29.2 28.9 26.9 28.9 25.6 30.6 27.6 52.9 44.8 69.3 0.0 69.1 0.0 53.5 0.0 44.9 30.4 37.6 24.9 0.0 32.9 46.4 22.0 8.4 38.0 81.7 12.1 1.9 64.3 9.8 33.5 53.2 36.5 12.2 24.6 0.0 90.9 42.4 42.9 35.2 67.9 49.2 25.9 32.9 77.9 25.7 60.6 0.0 14.2 0.0 27.0 0.0 8.4 36.4 43.4 0.0 0.0 56.6 28.0 52.5 0.0 0.0 67.6 9.5 46.6 232.5 60.6 25.1 19.2 21.1 28.8 46.0 42.3 30.7 18.5 34.3 36.3 0.0 81.0 64.3 38.4 9.5 66.3 FOXRED1 H17 ENSG00000110074 "FAD dependent oxidoreductase domain containing 1" Q96CU9 11 126269055-126278131 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039620, HPA046192" Uncertain Supported Mitochondria NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 39: Non-specific - Mitochondria" "Cluster 6: T47d - Mammary gland" "Cluster 12: Non-specific - Cell cycle regulation" Mitochondria "HPA039620: AB_2676602, HPA046192: AB_2679580" "prognostic unfavorable (7.36e-4)" "unprognostic (4.62e-2)" "unprognostic (2.71e-1)" "unprognostic (3.47e-3)" "unprognostic (1.76e-1)" "unprognostic (1.84e-1)" "unprognostic (9.59e-2)" "unprognostic (1.43e-1)" "unprognostic (8.14e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-2)" "unprognostic (1.59e-1)" "prognostic favorable (2.01e-6)" "unprognostic (1.57e-1)" "unprognostic (1.10e-1)" "unprognostic (2.00e-1)" "unprognostic (1.94e-1)" 8.1 13.8 13.6 5.9 14.6 12.1 7.6 15.3 16.6 5.8 17.1 12.0 10.4 6.7 6.4 9.2 7.5 5.6 21.2 15.0 14.7 14.7 37.4 5.3 10.4 15.3 14.3 4.8 7.8 9.7 8.1 7.1 15.3 6.9 12.9 3.7 7.3 6.8 17.8 7.5 8.6 7.9 14.7 11.1 10.9 8.7 15.8 11.5 6.1 29.4 10.6 7.1 6.0 14.8 23.5 26.6 19.5 24.3 14.2 6.8 26.1 11.6 14.9 22.1 22.1 40.0 24.1 38.2 32.3 9.8 28.7 38.5 51.7 31.5 13.8 20.4 14.3 79.7 16.7 48.2 18.8 19.7 16.4 6.3 12.1 14.9 26.5 6.0 24.7 40.2 46.6 20.6 18.7 32.7 23.1 35.3 16.0 61.8 45.2 37.0 34.1 45.2 20.5 11.9 25.0 21.5 23.8 35.7 13.1 12.2 85.9 33.4 9.0 13.1 10.7 23.8 19.4 12.2 19.0 31.9 16.2 66.5 18.7 1.6 10.1 5.9 6.7 13.4 7.0 7.1 5.3 8.9 12.1 6.2 7.4 6.7 2.0 9.9 9.9 16.8 7.6 8.1 13.6 14.6 15.3 16.6 15.0 14.7 15.3 14.3 15.3 14.7 15.8 14.8 6.1 9.6 11.5 19.6 13.5 3.6 6.2 14.9 8.0 24.8 7.3 7.0 21.7 10.0 10.7 3.7 27.1 27.7 12.2 12.6 7.9 13.6 4.2 7.4 8.7 7.6 13.1 14.9 24.7 13.8 24.1 9.8 17.9 7.8 9.5 17.8 10.0 28.2 20.4 13.5 27.1 12.6 8.2 7.1 5.1 7.2 5.6 8.0 8.8 4.7 7.1 18.6 9.2 14.1 16.1 10.7 5.9 11.3 24.4 4.6 8.9 21.0 6.7 32.2 6.6 8.9 9.6 24.5 24.0 11.0 5.7 21.1 8.9 25.0 14.9 4.8 TIRAP "Mal, wyatt" ENSG00000150455 "TIR domain containing adaptor protein" P58753 11 126283065-126298845 "Predicted intracellular proteins, Transporters" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054431 Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes NA "Cluster 41: Basophils - Cellular respiration" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 1: K-562 - Erythropoiesis" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA054431: AB_2682486" "unprognostic (9.30e-3)" "unprognostic (7.39e-2)" "unprognostic (1.21e-1)" "prognostic favorable (1.24e-4)" "unprognostic (2.73e-2)" "unprognostic (5.77e-2)" "unprognostic (1.27e-1)" "unprognostic (6.89e-2)" "unprognostic (2.40e-1)" "unprognostic (2.28e-1)" "unprognostic (4.65e-2)" "unprognostic (1.42e-1)" "unprognostic (3.34e-3)" "unprognostic (4.29e-3)" "unprognostic (3.62e-2)" "unprognostic (3.47e-1)" "unprognostic (2.57e-1)" 4.3 4.3 1.5 4.9 1.4 2.9 4.5 3.1 2.4 5.4 3.6 5.3 7.6 4.5 2.5 4.4 5.3 4.5 5.3 1.3 2.1 3.9 6.3 4.2 4.1 1.9 1.8 8.0 4.7 7.2 3.6 4.9 2.1 5.7 5.5 3.1 8.0 6.4 5.3 4.3 6.9 4.7 1.0 5.0 4.3 1.5 1.6 3.1 4.8 4.9 5.1 4.5 3.3 1.1 2.2 7.0 3.7 6.2 6.2 8.5 4.4 5.7 9.3 3.9 3.7 11.0 8.3 5.7 9.6 5.9 6.9 6.2 3.9 4.4 1.5 15.3 3.7 15.4 4.2 7.1 4.9 9.6 7.9 6.4 6.0 7.4 5.1 4.7 6.5 4.6 4.2 12.9 4.6 4.0 0.3 1.5 1.7 15.9 6.3 2.0 1.0 5.4 3.1 7.8 4.6 5.8 6.8 6.7 4.6 4.8 18.2 4.9 6.5 2.2 2.1 4.5 4.3 3.6 5.6 4.2 3.4 7.5 7.0 5.3 5.8 2.9 4.0 4.5 3.7 2.1 3.1 4.2 4.6 3.8 2.5 2.4 4.9 2.6 3.2 3.2 3.5 3.7 1.5 1.4 3.1 2.4 1.3 2.1 1.9 1.8 2.1 1.0 1.6 1.1 1.7 6.4 2.6 2.3 3.7 0.4 1.8 2.0 4.0 3.5 2.7 2.0 1.3 2.8 2.8 3.7 0.0 3.4 2.2 4.2 0.0 3.3 0.0 1.1 2.3 3.2 1.2 0.8 3.7 4.0 4.9 2.7 2.0 1.7 1.3 2.0 2.5 4.8 5.2 3.3 5.0 3.9 2.0 4.4 0.8 0.3 4.7 3.7 1.8 3.7 2.1 3.6 4.1 3.0 1.8 3.6 8.1 4.5 9.2 2.0 6.5 2.2 1.6 2.5 0.0 2.0 2.5 0.1 0.6 3.5 0.1 2.6 4.2 2.3 2.4 1.5 DCPS "HINT-5, HINT5, HSL1, HSPC015" ENSG00000110063 "Decapping enzyme, scavenger" Q96C86 11 126304060-126350005 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" Hydrolase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 50.7" "Cell type enhanced" "Detected in many" "Plasma cells: 101.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 46.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 79.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039632, HPA058597" Supported Supported Nucleoplasm,Cytosol NA NA 1200000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm Cytosol "HPA039632: AB_10794200, HPA058597: AB_2683770" "unprognostic (1.45e-1)" "unprognostic (5.48e-3)" "unprognostic (1.76e-1)" "unprognostic (3.55e-2)" "unprognostic (5.22e-2)" "unprognostic (1.26e-1)" "unprognostic (1.96e-1)" "unprognostic (2.90e-1)" "unprognostic (5.57e-2)" "unprognostic (1.91e-2)" "unprognostic (4.83e-2)" "unprognostic (5.00e-2)" "unprognostic (5.25e-2)" "unprognostic (2.24e-2)" "unprognostic (8.04e-2)" "unprognostic (7.67e-2)" "unprognostic (3.40e-2)" 8.3 11.4 2.8 7.4 4.0 12.1 8.5 5.0 4.5 10.9 8.1 10.1 4.7 11.0 4.1 11.3 8.6 16.0 9.9 3.9 3.2 13.5 50.7 9.0 12.1 3.3 3.4 9.2 12.1 3.5 8.2 4.0 2.9 8.1 5.9 6.3 12.0 5.3 14.6 11.3 9.4 5.5 2.7 17.3 8.7 6.1 3.6 8.9 7.5 5.8 9.6 13.3 9.2 3.4 13.9 8.5 10.2 19.8 7.9 11.2 8.9 6.5 10.3 11.5 10.8 17.5 29.1 19.5 28.0 12.2 7.5 16.2 14.4 24.4 5.9 35.8 7.1 27.1 9.9 14.7 18.8 33.3 25.4 12.5 14.0 16.0 17.6 5.9 14.1 17.0 11.6 34.8 11.2 21.6 21.1 41.5 8.0 79.8 28.7 13.7 13.8 40.6 11.4 15.1 16.1 11.0 20.3 21.1 15.8 6.3 33.8 22.1 9.3 18.7 7.3 8.9 13.7 13.4 14.6 20.0 6.0 51.0 46.7 4.2 10.5 4.3 9.3 15.2 7.8 13.0 8.5 9.7 16.6 8.6 6.4 6.7 1.3 8.9 15.3 46.6 15.4 8.9 2.8 4.0 5.0 4.5 3.9 3.2 3.3 3.4 2.9 2.7 3.6 3.4 14.2 12.8 11.2 6.2 31.2 6.9 16.4 38.7 8.0 6.7 12.2 17.1 5.0 47.1 18.8 42.3 0.0 39.9 35.3 6.4 56.7 19.7 8.1 11.1 12.1 12.4 7.3 14.5 5.8 29.2 43.8 15.9 11.2 23.2 17.1 9.8 8.6 31.4 29.2 3.3 6.0 12.0 28.5 14.1 11.7 2.2 17.1 16.8 17.8 2.8 15.3 10.1 22.6 2.5 4.6 17.1 14.9 18.4 101.1 8.7 6.1 15.0 15.7 9.4 19.7 10.8 14.6 14.8 24.9 18.3 8.9 27.1 24.3 16.2 14.4 24.0 ST3GAL4 "CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ" ENSG00000110080 "ST3 beta-galactoside alpha-2,3-sialyltransferase 4" Q11206 11 126355640-126440344 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 270.0;Paneth cells: 214.3;Syncytiotrophoblasts: 962.5" "Cancer enhanced" "Detected in all" "melanoma: 57.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 111.9;neutrophil: 71.8;plasmacytoid DC: 93.7" "Group enriched" "Detected in many" 12 "dendritic cells: 93.7;granulocytes: 111.9" "Cell line enhanced" "Detected in all" "SK-MEL-30: 234.7;WM-115: 515.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049827 Approved "Intracellular and membrane" NA NA 15000 "Cluster 38: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "HPA049827: AB_2680900" "unprognostic (8.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.92e-2)" "unprognostic (6.93e-2)" "unprognostic (8.33e-2)" "unprognostic (3.80e-2)" "unprognostic (2.71e-3)" "unprognostic (1.90e-3)" "unprognostic (2.62e-1)" "unprognostic (1.80e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (3.16e-3)" "unprognostic (2.79e-2)" "unprognostic (1.28e-1)" "unprognostic (8.36e-3)" "unprognostic (8.78e-3)" 23.4 117.1 25.2 14.4 41.2 19.0 19.5 43.5 28.9 29.2 36.5 58.1 4.2 16.3 87.6 70.7 19.2 23.9 60.0 24.3 28.7 41.0 28.4 38.2 10.0 42.3 41.3 111.3 13.7 1.7 15.7 35.3 39.5 22.6 66.4 10.8 44.2 16.0 6.1 16.7 12.3 19.0 31.9 41.5 13.3 42.2 37.6 6.3 14.7 7.7 22.7 49.3 33.8 57.2 26.4 21.4 17.0 13.6 46.8 39.4 38.5 30.2 56.6 26.5 18.2 11.4 44.5 7.0 21.9 47.0 88.0 37.1 34.0 19.2 20.0 27.7 9.7 62.8 52.7 13.4 29.9 78.8 126.1 31.5 30.7 39.9 60.9 47.7 34.6 27.5 41.4 18.8 32.2 107.3 25.7 76.5 10.2 166.2 136.6 25.8 50.3 3.3 6.0 74.1 29.5 18.4 32.8 193.5 234.7 10.6 66.3 52.2 13.2 61.7 14.2 44.1 56.2 2.0 4.3 4.0 28.5 118.7 515.8 111.9 5.3 0.7 5.2 8.7 4.8 0.4 1.7 3.3 20.6 0.1 0.6 2.6 71.8 4.7 3.8 93.7 0.3 6.4 25.2 41.2 43.5 28.9 24.3 28.7 42.3 41.3 39.5 31.9 37.6 57.2 10.3 9.6 0.6 17.0 1.9 10.6 6.6 23.0 0.6 4.0 12.8 6.7 25.9 5.7 23.1 31.3 10.4 115.9 37.5 149.2 49.0 6.1 1.5 3.2 9.8 15.0 5.3 3.4 16.3 6.6 72.3 43.2 2.0 10.2 41.9 270.0 31.8 11.9 17.8 5.0 17.5 115.7 16.2 5.9 14.9 7.2 76.1 11.2 78.2 3.7 9.5 5.4 18.6 5.0 83.3 5.3 214.3 93.6 6.7 16.5 0.0 3.9 5.5 10.0 13.1 4.3 43.1 1.5 17.4 0.7 6.7 962.5 8.4 36.8 23.2 41.1 KIRREL3 "KIAA1867, KIRRE, NEPH2" ENSG00000149571 "Kirre like nephrin family adhesion molecule 3" Q8IZU9 11 126423358-127003460 "Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 21.5" "Group enriched" "Detected in some" 16 "Excitatory neurons: 274.4;Inhibitory neurons: 482.6;Oligodendrocytes: 390.3" "Cancer enhanced" "Detected in some" "glioma: 1.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 12 "plasmacytoid DC: 8.3" "Lineage enriched" "Detected in single" 12 "dendritic cells: 8.3" "Cell line enhanced" "Detected in some" "BJ: 25.2;BJ hTERT+: 14.7;BJ hTERT+ SV40 Large T+: 9.3;BJ hTERT+ SV40 Large T+ RasG12V: 9.7;fHDF/TERT166: 18.3;U-138 MG: 11.3;U-251 MG: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053324 Enhanced "Intracellular and membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA053324: " "unprognostic (1.92e-1)" "unprognostic (5.29e-2)" "unprognostic (1.06e-1)" "unprognostic (4.72e-2)" "unprognostic (2.50e-2)" "unprognostic (1.09e-1)" "unprognostic (4.49e-3)" "unprognostic (6.23e-3)" "unprognostic (4.08e-2)" "unprognostic (1.76e-1)" "unprognostic (7.05e-3)" "unprognostic (3.81e-2)" "unprognostic (4.06e-6)" "unprognostic (9.91e-3)" "unprognostic (1.15e-1)" "unprognostic (2.76e-2)" "unprognostic (2.92e-1)" 0.2 1.4 17.3 0.5 21.5 0.3 0.1 4.9 19.9 0.6 0.0 3.8 0.4 0.1 0.0 0.4 0.1 0.2 2.1 15.5 8.5 0.2 0.1 0.0 0.6 12.2 14.6 0.5 0.2 0.0 0.1 0.3 7.6 0.3 0.4 2.5 1.4 1.1 0.0 0.1 0.8 0.5 14.0 2.5 0.6 0.2 16.0 0.0 0.1 0.2 0.4 0.6 0.3 17.8 0.4 3.0 0.2 0.0 0.0 0.1 0.2 25.2 14.7 9.3 9.7 0.0 0.1 0.0 0.1 18.3 0.1 0.1 0.0 0.0 5.7 0.1 0.0 0.1 0.4 0.0 0.0 0.3 0.7 0.0 0.0 1.8 0.0 4.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 6.1 0.2 0.4 0.5 0.0 0.0 1.3 0.0 0.1 2.8 0.2 0.1 0.2 0.0 0.0 0.1 0.4 0.0 11.3 7.8 4.5 14.1 0.0 0.0 0.0 0.1 0.0 5.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.3 0.0 0.0 17.3 21.5 4.9 19.9 15.5 8.5 12.2 14.6 7.6 14.0 16.0 17.8 0.0 0.0 0.0 9.1 0.0 0.0 0.1 0.2 0.0 17.3 0.1 0.1 2.2 1.5 0.4 0.0 0.0 0.0 5.4 0.9 0.0 0.1 5.2 0.0 0.1 0.2 0.0 0.0 274.4 0.0 0.0 0.5 0.0 0.1 1.3 0.3 0.4 0.0 0.0 0.0 482.6 0.4 2.0 0.0 0.3 12.9 0.0 0.2 1.8 18.7 0.1 0.5 0.0 23.1 390.3 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.2 0.3 0.1 0.3 0.0 0.1 0.0 0.2 0.2 0.2 0.1 ETS1 "ETS-1, EWSR2, FLJ10768" ENSG00000134954 "ETS proto-oncogene 1, transcription factor" P14921 11 128458761-128587558 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Immunity, Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 328.8" "Cell type enhanced" "Detected in many" "Adipocytes: 263.1;dendritic cells: 378.9;Endothelial cells: 190.4;Hepatic stellate cells: 213.8;NK-cells: 399.6;T-cells: 323.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 352.9;JURKAT: 362.3;U-698: 462.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002575, HPA063230" Enhanced Enhanced Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 3: T-cells - Adaptive immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "CAB002575: AB_563721, HPA063230: AB_2684965" "unprognostic (1.76e-2)" "unprognostic (2.49e-1)" "unprognostic (3.18e-3)" "unprognostic (6.22e-2)" "unprognostic (3.07e-1)" "unprognostic (2.56e-1)" "unprognostic (1.24e-2)" "unprognostic (1.57e-1)" "unprognostic (1.35e-2)" "unprognostic (7.17e-2)" "unprognostic (2.46e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.30e-5)" "unprognostic (2.02e-1)" "unprognostic (3.08e-2)" "unprognostic (1.38e-1)" "unprognostic (5.48e-3)" 101.2 19.2 11.7 145.7 10.4 35.3 65.4 9.8 14.1 35.9 8.9 31.2 26.9 36.5 9.3 21.8 20.2 62.5 43.0 8.9 11.3 30.4 47.6 76.2 277.1 13.1 14.7 27.0 20.1 28.4 7.8 56.3 13.4 17.1 31.4 1.8 16.5 20.7 25.6 18.1 49.3 38.1 11.6 185.8 46.1 8.0 15.2 328.8 39.8 42.3 250.2 67.9 19.2 11.3 87.7 15.7 72.8 0.3 30.7 49.3 0.2 65.7 140.2 80.9 77.3 5.1 91.7 312.1 65.7 109.5 184.7 29.8 7.0 190.0 169.0 66.6 1.1 352.9 6.4 0.3 82.2 36.7 4.0 97.2 15.0 69.6 252.2 46.1 67.9 362.3 0.6 63.3 98.1 0.0 185.7 27.4 27.0 7.9 55.0 50.4 118.7 24.5 64.2 95.6 0.9 5.0 34.5 0.7 73.6 48.5 0.3 17.7 126.1 180.5 57.1 35.5 109.1 46.7 8.9 462.5 32.2 68.0 162.1 51.2 0.1 6.6 20.4 0.3 28.9 12.3 27.0 25.0 0.2 9.2 32.5 26.1 1.1 27.8 1.0 6.2 33.3 9.5 11.7 10.4 9.8 14.1 8.9 11.3 13.1 14.7 13.4 11.6 15.2 11.3 263.1 25.6 26.5 2.9 125.6 114.8 41.0 12.4 1.8 0.0 8.2 7.2 9.0 4.3 24.3 11.0 0.0 0.2 378.9 13.1 0.0 31.9 6.2 26.3 51.0 190.4 15.5 13.7 2.0 22.6 0.5 45.5 17.3 66.2 19.6 1.3 213.8 5.4 7.3 0.0 25.6 15.0 10.2 18.3 48.2 1.5 14.0 12.5 69.4 65.6 16.8 0.2 399.6 55.3 9.5 99.3 6.6 15.4 129.6 26.8 2.2 4.6 5.9 0.2 105.2 55.5 76.6 0.7 1.8 1.5 63.2 0.4 323.2 40.4 5.8 32.6 FLI1 "EWSR2, SIC-1" ENSG00000151702 "Fli-1 proto-oncogene, ETS transcription factor" Q01543 11 128686535-128813267 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.8" "Cell type enhanced" "Detected in many" "B-cells: 65.7;Endothelial cells: 84.2;Hepatic stellate cells: 64.6;Kupffer cells: 86.4;Microglial cells: 231.4;monocytes: 68.4;NK-cells: 93.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 113.9;HUVEC TERT2: 60.5;REH: 49.8;TIME: 63.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065030, HPA073099" Approved Supported "Nucleoplasm,Nuclear bodies" Yes NA "Cluster 10: Basophils - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 36: HEL - Hemostasis" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Nuclear bodies" "HPA065030: , HPA073099: AB_2686572" "unprognostic (1.38e-2)" "unprognostic (7.46e-2)" "unprognostic (6.16e-2)" "unprognostic (3.74e-2)" "unprognostic (6.22e-2)" "unprognostic (4.26e-3)" "unprognostic (1.33e-1)" "unprognostic (8.32e-3)" "unprognostic (2.97e-1)" "unprognostic (9.91e-2)" "unprognostic (1.60e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (4.60e-4)" "unprognostic (4.79e-2)" "unprognostic (2.07e-2)" "unprognostic (2.62e-1)" "unprognostic (4.79e-2)" 10.2 1.9 3.7 10.9 2.3 12.2 6.0 2.1 2.8 5.7 1.2 3.7 3.2 4.6 1.1 2.8 2.7 6.1 6.2 1.8 2.9 2.1 2.8 10.8 12.3 4.7 2.7 1.2 1.7 3.5 0.7 12.5 4.3 1.9 2.9 0.5 2.2 2.2 2.8 1.7 4.0 5.9 3.5 35.8 4.3 0.9 3.9 17.2 2.9 6.6 10.4 6.7 1.9 2.8 0.2 0.0 5.6 0.0 0.8 1.0 0.1 3.3 9.2 3.8 3.1 0.0 0.0 18.5 31.7 11.1 1.1 0.1 0.8 13.5 4.1 9.0 0.2 113.9 0.5 0.0 6.0 13.7 14.6 0.8 1.1 7.7 17.3 11.1 60.5 25.6 0.0 23.3 0.8 0.0 13.3 8.1 1.8 0.0 3.1 49.8 0.1 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.0 20.4 63.0 0.7 0.0 0.2 3.5 7.3 16.4 16.6 0.1 31.8 5.2 34.5 15.5 24.5 10.1 15.3 11.9 6.8 8.9 8.2 19.1 6.0 3.7 8.2 11.8 12.3 19.1 3.3 11.1 20.1 3.7 2.3 2.1 2.8 1.8 2.9 4.7 2.7 4.3 3.5 3.9 2.8 53.4 6.4 5.3 0.3 65.7 5.1 0.3 1.7 2.2 0.0 0.7 1.3 5.5 5.7 0.1 1.8 0.0 0.4 43.1 0.0 0.0 0.0 0.5 0.4 0.6 84.2 0.0 23.4 0.3 0.0 0.4 5.9 2.0 0.3 22.8 0.0 64.6 1.3 43.2 0.0 1.5 0.1 0.0 86.4 24.7 0.5 1.8 60.3 7.2 231.4 68.4 0.1 93.7 4.0 0.7 0.0 0.0 0.7 56.9 0.3 0.0 0.4 0.8 0.4 6.6 2.1 3.1 0.2 0.1 0.6 4.1 0.3 52.8 0.9 0.2 0.4 KCNJ1 "Kir1.1, ROMK1" ENSG00000151704 "Potassium inwardly rectifying channel subfamily J member 1" P48048 11 128836315-128867373 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Bartter syndrome, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 117 "kidney: 198.0" "Cell type enriched" "Detected in some" 5 "Distal tubular cells: 195.6" "Cancer enriched" "Detected in some" 7 "renal cancer: 3.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 39 "RPTEC TERT1: 116.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA026962 Enhanced NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 39: Non-specific - Basic cellular processes" "HPA026962: AB_10601934" "unprognostic (1.75e-1)" "unprognostic (4.38e-2)" "unprognostic (1.14e-1)" "unprognostic (3.19e-1)" "unprognostic (7.55e-2)" "unprognostic (1.29e-1)" "unprognostic (3.01e-2)" "unprognostic (2.69e-1)" "unprognostic (1.46e-1)" "unprognostic (2.44e-2)" "unprognostic (6.47e-2)" "unprognostic (2.78e-1)" "unprognostic (6.05e-2)" "unprognostic (4.99e-2)" "unprognostic (1.61e-1)" "unprognostic (1.28e-1)" "unprognostic (7.81e-3)" 0.2 0.1 1.0 0.1 1.6 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.0 0.0 1.4 0.1 0.1 0.0 0.1 0.5 0.1 198.0 0.1 0.2 0.1 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 1.0 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.5 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 116.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 2.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.6 0.1 0.3 0.5 0.1 0.2 0.2 0.2 0.1 0.3 0.2 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 38.6 0.0 0.0 0.1 0.0 195.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 KCNJ5 "CIR, GIRK4, KATP1, Kir3.4, LQT13" ENSG00000120457 "Potassium inwardly rectifying channel subfamily J member 5" P48544 11 128891356-128921163 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Cancer-related genes, Disease variant, Long QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 64.3;pancreas: 20.4" "Cell type enriched" "Detected in many" 4 "Hofbauer cells: 48.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "HBEC3-KT: 13.3" "Group enriched" "Detected in many" 6 "basal ganglia: 2.9;hypothalamus: 6.8;midbrain: 1.9;thalamus: 3.6" "Low region specificity" "Detected in all" "HPA014722, HPA017353, CAB022569" Approved NA NA "Cluster 17: Basophils - Unknown function" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 30: Epithelial cell lines - Translation" "Cluster 4: Macrophages - Innate immune response" "CAB022569: , HPA014722: AB_1852133, HPA017353: AB_1852135" "unprognostic (2.01e-1)" "unprognostic (2.43e-3)" "unprognostic (2.56e-3)" "unprognostic (5.81e-2)" "unprognostic (4.24e-2)" "unprognostic (3.60e-2)" "unprognostic (2.90e-1)" "unprognostic (3.54e-2)" "unprognostic (6.83e-2)" "unprognostic (1.96e-1)" "unprognostic (3.17e-1)" "unprognostic (9.29e-2)" "unprognostic (1.81e-2)" "unprognostic (6.82e-2)" "unprognostic (9.49e-2)" "unprognostic (1.88e-2)" "unprognostic (2.23e-2)" 1.5 64.3 1.2 0.6 0.9 0.4 0.9 0.6 2.0 1.3 0.2 0.8 0.8 0.3 0.9 1.0 0.9 2.2 8.5 0.7 3.2 5.4 0.4 5.9 1.6 3.7 1.7 0.9 20.4 1.3 11.9 7.3 2.7 1.3 0.7 1.0 0.9 9.6 0.4 0.4 0.5 0.6 1.7 13.6 2.3 1.1 7.9 5.8 0.5 0.4 0.5 1.5 0.4 3.9 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.1 0.3 13.3 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 1.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 1.2 0.9 0.6 2.0 0.7 3.2 3.7 1.7 2.7 1.7 7.9 3.9 0.2 0.0 10.0 0.3 0.2 1.5 2.2 4.7 0.0 2.7 0.2 1.4 7.6 0.0 0.3 1.8 0.0 0.8 0.1 0.0 0.0 0.1 2.3 0.2 0.2 0.6 0.0 0.0 0.2 3.9 0.7 1.1 0.0 0.3 0.0 0.2 0.4 0.1 48.3 1.7 3.1 0.0 0.0 2.2 2.9 7.8 0.9 10.9 3.6 3.7 1.2 0.3 3.1 0.5 0.1 0.8 0.0 0.7 0.3 0.6 0.0 0.1 0.3 1.4 0.0 0.9 0.2 0.9 0.5 0.5 1.7 1.2 0.6 2.3 0.0 0.6 C11orf45 "FLJ43646, MGC35558" ENSG00000174370 "Chromosome 11 open reading frame 45" Q8TAV5 11 128899565-128906035 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 5.7;Hofbauer cells: 8.7;Kupffer cells: 5.9;Late spermatids: 8.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 11.2;U-937: 8.9" HPA039716 Approved Approved Cytosol "Secreted - unknown location" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 61: Skin - Cornification" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 4: Macrophages - Innate immune response" Cytosol "HPA039716: AB_10672892" "unprognostic (8.32e-2)" "unprognostic (3.93e-2)" "unprognostic (5.99e-3)" "unprognostic (1.35e-3)" "unprognostic (1.01e-1)" "unprognostic (9.93e-2)" "unprognostic (4.50e-5)" "unprognostic (1.97e-2)" "unprognostic (4.78e-2)" "unprognostic (3.10e-1)" "unprognostic (2.80e-1)" "unprognostic (9.27e-2)" "unprognostic (2.55e-9)" "unprognostic (2.37e-1)" "unprognostic (2.60e-2)" "unprognostic (6.87e-2)" "unprognostic (7.22e-2)" 0.6 3.3 1.7 0.7 4.4 0.8 0.9 0.6 2.1 1.0 0.8 0.7 1.4 0.5 0.6 2.9 1.0 2.0 4.5 1.4 1.6 2.0 0.5 2.6 0.8 1.9 1.9 0.9 2.6 3.8 2.3 2.1 1.6 1.1 0.9 0.2 1.6 2.8 0.1 6.6 0.9 0.5 1.1 1.5 1.8 1.1 2.3 2.4 1.8 0.2 0.9 1.2 1.3 2.2 2.4 4.5 0.0 0.0 0.3 0.4 1.6 0.8 4.7 1.7 4.2 6.3 5.8 0.0 3.2 0.5 4.2 2.3 2.4 11.2 0.8 0.0 1.1 0.3 2.7 0.0 0.2 0.0 0.0 0.3 1.5 1.3 0.9 3.8 1.0 3.5 0.0 0.2 2.0 1.2 2.6 2.4 1.8 1.0 3.9 1.1 4.6 0.5 3.9 1.1 0.0 0.2 1.8 5.0 0.3 1.2 0.8 4.4 0.5 0.0 6.2 0.0 0.8 0.1 0.0 0.0 0.8 8.9 0.2 0.0 0.6 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.9 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.2 1.7 4.4 0.6 2.1 1.4 1.6 1.9 1.9 1.6 1.1 2.3 2.2 0.1 0.0 0.5 0.0 0.0 2.8 1.3 0.9 5.7 0.0 0.3 0.4 1.7 0.0 0.2 0.0 0.0 2.0 0.0 0.1 1.9 1.0 2.0 0.3 0.1 0.2 0.0 0.0 0.3 0.8 2.1 0.3 0.0 0.5 1.3 0.3 0.4 0.0 8.7 0.0 0.2 0.1 0.0 5.9 0.8 8.2 0.0 2.2 0.0 2.8 0.6 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 1.5 1.7 3.0 0.9 1.2 0.2 0.1 0.2 1.1 TP53AIP1 p53AIP1 ENSG00000120471 "Tumor protein p53 regulated apoptosis inducing protein 1" Q9HCN2 11 128934731-128943399 "Predicted intracellular proteins" Apoptosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 24.5;lymphoid tissue: 29.5;skin 1: 20.4;vagina: 13.6" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 45.5;Basal respiratory cells: 42.4;Basal squamous epithelial cells: 179.2;Endometrial ciliated cells: 38.7;Respiratory ciliated cells: 27.3;Squamous epithelial cells: 72.1;Suprabasal keratinocytes: 32.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044300, HPA048797" Uncertain NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA044300: AB_2678888, HPA048797: AB_2680524" "unprognostic (4.12e-7)" "unprognostic (3.00e-2)" "unprognostic (1.48e-1)" "unprognostic (1.64e-2)" "unprognostic (1.15e-1)" "unprognostic (1.04e-2)" "unprognostic (1.18e-1)" "unprognostic (4.66e-2)" "unprognostic (1.22e-1)" "unprognostic (6.62e-2)" "unprognostic (1.03e-1)" "unprognostic (2.94e-1)" "unprognostic (6.57e-6)" "unprognostic (1.10e-2)" "unprognostic (3.71e-1)" "unprognostic (7.75e-2)" "unprognostic (1.78e-2)" 0.0 0.6 0.9 0.0 0.8 0.0 1.3 1.1 1.3 5.6 0.6 0.1 0.0 0.1 2.5 24.5 2.7 0.0 0.0 0.8 0.6 0.8 0.1 0.2 0.0 1.0 1.0 0.0 0.2 0.0 1.8 0.0 0.9 2.0 0.0 0.5 3.9 0.8 0.1 20.4 0.1 0.0 0.5 0.0 0.0 1.6 1.0 29.5 0.0 0.0 1.1 0.0 13.6 0.8 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.8 1.1 1.3 0.8 0.6 1.0 1.0 0.9 0.5 1.0 0.8 0.2 0.0 0.5 1.0 0.0 45.5 11.4 42.4 179.2 0.7 1.5 23.9 0.3 0.0 5.3 0.0 0.0 0.1 0.0 0.3 7.9 0.0 0.9 38.7 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 1.8 1.1 0.0 0.4 1.8 1.0 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.0 0.0 0.2 27.3 0.4 0.0 0.6 1.6 0.2 0.3 72.1 32.7 0.3 0.3 0.0 0.3 2.6 ARHGAP32 "GC-GAP, GRIT, KIAA0712, MGC1892, RICS" ENSG00000134909 "Rho GTPase activating protein 32" A7KAX9 11 128965060-129279324 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 240.6;Excitatory neurons: 403.4;Inhibitory neurons: 239.7;Oligodendrocyte precursor cells: 170.9" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 26.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 36.6;RT4: 39.5;SK-BR-3: 42.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038382, HPA038389, HPA061505" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA038382: AB_2675984, HPA038389: AB_10670972, HPA061505: AB_2684544" "unprognostic (1.17e-1)" "unprognostic (3.58e-2)" "unprognostic (2.54e-2)" "unprognostic (1.82e-1)" "unprognostic (3.89e-2)" "unprognostic (5.64e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-2)" "unprognostic (7.32e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (6.64e-4)" "unprognostic (1.47e-1)" "unprognostic (6.17e-3)" "unprognostic (1.17e-1)" "unprognostic (4.01e-1)" "unprognostic (5.80e-2)" "unprognostic (1.64e-2)" 4.7 7.5 2.6 3.4 8.2 2.1 10.3 0.0 26.6 11.9 0.0 14.1 21.1 8.1 9.0 26.3 13.3 7.6 4.3 15.1 0.0 7.0 5.0 5.8 1.6 0.0 0.0 10.9 15.2 10.7 6.1 8.6 0.0 6.4 15.8 33.5 15.8 4.2 7.6 20.1 20.6 5.9 0.0 3.0 12.0 10.7 0.0 10.5 3.8 4.3 6.9 9.4 17.1 5.1 12.2 6.4 19.7 0.1 6.3 6.3 14.2 4.5 6.3 2.8 3.4 14.9 24.7 0.1 6.7 8.7 14.1 27.2 9.0 11.4 5.4 0.0 3.1 0.2 3.4 5.6 3.1 0.0 0.0 6.1 14.4 2.7 16.3 6.2 3.5 10.2 0.6 0.2 4.9 9.5 10.2 0.2 5.4 36.6 6.8 24.9 5.9 2.5 3.0 39.5 19.3 7.9 6.8 42.3 8.0 7.5 21.9 3.9 6.6 9.9 5.2 5.9 8.9 0.3 0.0 0.1 4.3 27.4 6.4 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.1 0.7 0.1 0.3 0.1 0.1 2.6 8.2 0.0 26.6 15.1 0.0 0.0 0.0 0.0 0.0 0.0 5.1 5.3 6.4 16.8 240.6 3.4 18.2 12.7 29.1 16.5 31.6 36.5 17.1 4.3 14.3 46.6 11.0 123.0 23.1 4.8 48.7 1.9 8.3 19.0 27.7 10.0 5.6 40.7 2.5 403.4 27.2 4.2 14.1 35.2 25.4 1.3 9.8 5.0 16.2 6.5 18.5 239.7 61.9 20.3 4.1 4.2 12.3 6.8 5.7 16.0 103.0 2.9 113.6 0.0 170.9 95.0 24.5 44.2 13.2 1.5 22.7 52.7 9.9 61.6 37.9 19.7 19.4 9.5 8.6 9.6 55.4 31.1 28.5 2.0 4.0 54.0 59.5 BARX2 ENSG00000043039 "BARX homeobox 2" Q9UMQ3 11 129375848-129452279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 158.0;salivary gland: 131.4;vagina: 72.2" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 128.5;Breast glandular cells: 50.4;Squamous epithelial cells: 136.4;Suprabasal keratinocytes: 82.5;Urothelial cells: 84.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HDLM-2: 163.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "cerebral cortex: 2.8;hippocampal formation: 1.7" "CAB033311, HPA064966, HPA068414" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 44: HDLM-2 - Immune response" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "Golgi apparatus, Cytosol" "CAB033311: AB_781574, HPA064966: , HPA068414: AB_2685984" "unprognostic (4.25e-2)" "unprognostic (2.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.22e-5)" "unprognostic (3.85e-2)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (1.43e-3)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (4.35e-3)" "unprognostic (1.15e-1)" "unprognostic (8.39e-2)" "unprognostic (3.48e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (3.06e-4)" 0.3 0.0 0.1 1.3 0.3 0.0 14.9 1.1 0.3 24.2 5.5 7.0 17.9 0.1 0.2 158.0 16.7 4.7 0.2 0.3 0.4 5.4 0.0 0.3 0.7 3.0 1.6 0.0 10.3 0.3 1.7 3.6 3.2 4.8 4.9 0.2 131.4 0.6 2.2 34.8 13.0 0.2 1.8 0.0 6.4 2.4 0.4 0.4 0.3 39.3 8.8 0.4 72.2 2.9 23.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.3 0.0 1.0 20.9 0.0 5.1 0.0 163.7 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 7.1 0.0 3.9 0.0 6.2 0.0 0.0 0.0 20.6 0.9 0.0 0.0 39.8 0.0 0.3 0.2 0.0 0.0 19.4 0.1 0.4 3.8 0.1 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.1 0.3 0.3 0.4 3.0 1.6 3.2 1.8 0.4 2.9 0.2 0.0 1.1 0.3 0.5 43.1 128.5 8.7 3.4 0.6 50.4 16.9 0.5 4.3 8.0 0.0 0.0 13.4 0.8 29.4 7.9 23.7 7.2 11.3 0.6 1.2 1.8 0.0 1.8 0.7 5.8 2.7 6.6 4.6 0.0 0.0 0.0 0.2 1.9 0.0 0.3 13.4 0.0 0.3 2.2 1.6 0.0 0.7 10.6 0.0 0.1 0.7 0.0 0.0 0.3 6.2 29.8 0.4 0.9 25.6 34.0 3.4 11.8 0.3 0.0 0.6 1.7 0.1 5.3 136.4 82.5 4.2 1.7 0.0 19.4 84.8 TMEM45B "BC016153, FLJ40787" ENSG00000151715 "Transmembrane protein 45B" Q96B21 11 129815848-129860003 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 66.5;intestine: 136.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 325.6;Paneth cells: 221.6;Proximal enterocytes: 288.7;Respiratory ciliated cells: 133.9;Undifferentiated cells: 122.2;Urothelial cells: 162.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 3.0;naive CD4 T-cell: 3.6;neutrophil: 11.7" "Group enriched" "Detected in many" 14 "granulocytes: 11.7;T-cells: 3.6" "Group enriched" "Detected in some" 5 "OE19: 333.1;RT4: 133.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015474, HPA015878" Approved Approved Nucleoplasm NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 9: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA015474: , HPA015878: AB_2205046" "unprognostic (4.92e-3)" "unprognostic (7.94e-2)" "unprognostic (5.98e-2)" "unprognostic (1.81e-1)" "unprognostic (5.44e-3)" "unprognostic (7.11e-2)" "unprognostic (1.17e-1)" "unprognostic (6.53e-2)" "unprognostic (1.76e-1)" "unprognostic (1.02e-3)" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (1.04e-1)" "unprognostic (1.42e-2)" "unprognostic (2.24e-1)" "unprognostic (1.68e-2)" "unprognostic (1.52e-1)" 0.7 0.6 1.5 8.3 1.6 1.1 13.2 1.9 1.8 14.9 7.6 95.1 136.4 1.1 13.6 66.5 21.7 24.1 0.1 2.1 2.0 20.6 24.7 6.0 0.9 1.5 2.8 0.2 1.2 12.4 4.2 1.4 1.5 3.6 94.6 0.4 15.4 8.2 0.3 25.4 127.4 2.8 0.9 0.8 24.3 0.3 2.0 0.4 6.5 0.0 15.0 30.8 27.3 1.4 0.1 0.1 0.1 0.2 0.0 0.0 6.0 0.0 0.0 0.0 0.0 39.1 16.8 0.2 7.0 0.0 0.2 22.3 0.0 0.0 0.0 0.1 0.5 0.3 2.1 40.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.4 0.2 0.2 0.1 0.0 13.3 0.2 1.5 0.2 333.1 49.2 0.3 0.1 2.6 21.0 133.1 4.1 0.6 0.2 10.8 0.1 0.1 37.1 0.2 0.3 0.2 0.3 0.4 0.1 0.2 0.1 0.4 0.1 0.3 0.1 1.2 0.5 0.1 0.2 0.1 0.2 0.2 3.0 0.8 0.0 0.4 3.6 0.6 11.7 0.5 0.1 0.3 0.5 0.9 1.5 1.6 1.9 1.8 2.1 2.0 1.5 2.8 1.5 0.9 2.0 1.4 0.1 19.2 12.5 0.3 1.1 3.3 16.4 29.1 0.0 0.1 6.7 2.5 0.8 18.6 68.8 46.0 0.0 3.8 0.0 325.6 13.7 26.9 0.4 27.7 2.9 1.0 55.4 0.0 0.8 8.6 0.8 0.8 17.9 29.5 2.5 0.3 0.4 8.4 0.5 0.0 0.4 49.3 20.3 0.6 0.4 0.3 0.3 2.9 3.6 2.8 0.1 0.1 0.0 0.0 0.3 50.2 221.6 0.0 0.0 23.8 288.7 1.4 133.9 0.2 0.0 0.7 3.6 0.1 0.2 4.4 20.9 0.4 1.8 0.1 122.2 162.0 NFRKB "DKFZp547B2013, INO80G" ENSG00000170322 "Nuclear factor related to kappaB binding protein" Q6P4R8 11 129863636-129895590 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007082, HPA007128" Approved Enhanced Nucleoplasm Yes No "Cluster 46: Basophils - DNA binding" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 36: HEL - Hemostasis" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "HPA007082: AB_1079481, HPA007128: AB_1079482" "unprognostic (1.22e-1)" "unprognostic (3.42e-2)" "unprognostic (2.12e-1)" "unprognostic (9.41e-2)" "unprognostic (6.56e-2)" "unprognostic (2.65e-2)" "prognostic unfavorable (5.78e-4)" "unprognostic (6.36e-3)" "unprognostic (1.68e-2)" "unprognostic (1.82e-1)" "unprognostic (2.00e-1)" "unprognostic (5.31e-2)" "unprognostic (9.22e-2)" "unprognostic (4.15e-2)" "unprognostic (6.57e-2)" "unprognostic (7.14e-2)" "unprognostic (3.93e-2)" 9.8 9.0 7.2 10.8 9.9 22.7 11.0 9.7 7.3 15.0 9.1 11.8 13.1 15.6 17.5 13.2 17.9 9.9 7.5 8.3 6.5 10.6 11.8 10.8 14.5 4.9 5.5 20.6 13.9 10.5 11.7 13.1 5.5 12.4 10.1 9.8 14.3 13.3 15.4 21.9 12.4 13.5 4.5 11.2 11.2 20.3 7.2 15.0 20.0 9.7 13.4 12.6 13.8 6.7 17.9 16.8 37.4 20.3 15.6 15.4 23.5 12.2 11.0 14.2 13.9 52.6 30.1 42.6 32.5 9.4 20.8 44.8 36.5 23.8 13.2 16.9 31.9 84.2 32.8 22.2 11.4 21.7 27.3 9.9 25.9 23.3 24.3 16.3 24.9 28.1 49.9 31.5 14.4 16.2 18.6 37.1 19.1 26.2 39.1 27.2 16.3 19.6 17.7 55.6 19.0 20.0 27.4 26.7 7.3 27.5 62.3 19.9 19.7 21.1 20.6 15.6 15.4 10.0 13.3 39.0 8.8 41.9 18.5 6.6 5.1 6.3 6.0 5.8 6.3 3.3 6.1 5.1 5.1 3.9 5.0 4.2 6.0 2.4 5.2 4.5 4.4 4.5 7.2 9.9 9.7 7.3 8.3 6.5 4.9 5.5 5.5 4.5 7.2 6.7 6.2 9.6 15.0 17.0 10.0 29.3 16.8 17.5 18.8 10.2 12.1 10.0 7.6 20.0 17.0 7.3 10.4 19.2 7.8 9.5 7.9 11.9 14.8 12.9 14.4 9.5 8.5 9.4 13.1 10.0 15.6 9.7 6.1 17.8 10.8 14.1 8.9 10.9 10.4 8.4 10.7 9.7 8.2 7.7 6.2 7.1 14.6 8.4 14.2 9.4 12.4 9.7 12.3 12.1 7.7 10.9 8.0 10.5 10.5 15.4 15.6 8.1 12.9 11.1 32.9 10.8 14.2 43.0 49.0 10.7 35.2 23.3 13.1 9.4 12.2 17.9 PRDM10 "KIAA1231, MGC131802, PFM7" ENSG00000170325 "PR/SET domain 10" Q9NQV6 11 129899706-130002835 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 22.5;Excitatory neurons: 21.3;Inhibitory neurons: 21.2;Oligodendrocytes: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026997, HPA061749" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm "Nucleoli fibrillar center, Vesicles" "HPA026997: AB_1855681, HPA061749: " "unprognostic (4.40e-2)" "unprognostic (2.17e-1)" "unprognostic (5.32e-3)" "unprognostic (2.03e-1)" "unprognostic (1.50e-1)" "unprognostic (1.52e-3)" "unprognostic (2.19e-2)" "unprognostic (2.48e-1)" "unprognostic (1.87e-3)" "unprognostic (3.33e-2)" "unprognostic (4.45e-2)" "unprognostic (3.57e-2)" "unprognostic (1.87e-1)" "unprognostic (5.69e-2)" "unprognostic (4.88e-1)" "unprognostic (6.23e-2)" "unprognostic (1.51e-1)" 2.8 2.4 2.5 3.1 2.5 7.9 4.2 7.4 3.3 3.2 2.8 3.4 3.4 3.0 3.3 4.0 2.6 2.8 2.0 2.9 3.4 2.2 3.5 3.0 3.9 1.8 1.8 3.4 3.1 3.4 4.6 2.6 1.9 3.4 3.9 4.7 3.1 2.5 6.7 6.2 3.7 2.5 0.9 3.1 4.0 2.4 3.3 6.7 3.0 3.8 4.0 2.6 3.4 4.0 4.7 6.1 7.7 5.1 3.4 4.1 5.1 3.9 5.0 3.2 4.1 6.2 4.8 17.8 4.5 4.6 4.4 6.1 6.4 3.2 5.2 6.6 5.5 12.3 7.5 5.0 2.2 10.9 44.8 2.9 7.1 4.8 3.1 4.9 5.7 5.0 7.0 6.6 4.7 5.2 6.7 5.7 5.9 6.3 4.4 6.5 4.8 2.9 4.7 8.0 8.3 4.3 5.7 6.4 1.7 4.3 4.5 4.8 5.7 7.2 3.4 3.8 5.1 1.7 3.0 25.1 3.2 6.1 5.9 2.4 2.2 6.0 2.6 2.5 2.6 6.8 2.1 2.2 2.1 3.6 3.1 1.4 6.3 4.4 2.7 2.1 2.9 1.4 2.5 2.5 7.4 3.3 2.9 3.4 1.8 1.8 1.9 0.9 3.3 4.0 2.7 3.2 2.7 22.5 3.2 6.1 2.6 1.8 6.8 3.7 3.5 2.2 2.7 1.5 2.0 0.0 0.0 1.5 2.5 6.3 0.0 1.2 3.0 2.9 2.7 1.8 1.8 8.6 21.3 1.1 1.2 2.7 4.6 3.2 1.3 2.7 1.1 2.3 1.6 1.7 21.2 3.1 2.0 3.1 2.9 4.1 2.5 2.8 0.0 13.1 2.1 1.0 1.0 13.6 21.6 0.9 3.2 1.9 2.4 4.6 3.1 1.0 2.3 2.7 0.0 3.9 3.4 0.8 0.8 7.2 5.1 0.5 3.5 1.7 2.7 5.8 APLP2 "APPH, APPL2" ENSG00000084234 "Amyloid beta precursor like protein 2" Q06481 11 130068147-130144811 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "classical monocyte: 249.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039319 Approved Approved Vesicles NA NA 1500000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 1: Thyroid gland - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 56: Bipolar cells - Visual perception" Vesicles "HPA039319: AB_10673141" "unprognostic (2.83e-2)" "unprognostic (1.29e-1)" "unprognostic (2.06e-1)" "unprognostic (3.18e-2)" "unprognostic (1.24e-2)" "unprognostic (1.10e-2)" "prognostic unfavorable (3.37e-4)" "unprognostic (3.86e-2)" "unprognostic (2.33e-1)" "unprognostic (2.70e-2)" "unprognostic (3.12e-3)" "unprognostic (7.44e-2)" "prognostic favorable (1.33e-9)" "unprognostic (3.20e-3)" "unprognostic (4.95e-2)" "prognostic favorable (2.90e-4)" "unprognostic (4.42e-2)" 217.2 130.2 125.6 144.0 126.0 196.5 192.3 164.7 157.9 170.4 252.6 209.9 272.4 176.6 138.6 134.2 167.6 201.8 271.6 131.0 153.2 359.9 334.8 391.4 77.5 130.9 137.5 180.8 136.0 291.5 87.1 324.8 133.1 287.7 176.7 540.8 135.3 291.0 65.9 113.3 226.6 211.5 135.4 95.7 149.7 54.9 157.9 81.5 607.8 85.2 56.8 199.1 129.6 152.8 216.7 170.3 307.1 281.2 1259.7 847.8 393.7 598.6 741.1 294.2 251.8 1300.5 1541.3 107.9 1515.3 1422.2 322.4 540.4 229.1 567.6 168.0 165.6 206.4 180.9 116.7 502.9 191.9 556.7 363.8 566.4 367.8 244.5 469.5 1520.2 912.7 34.1 180.7 228.9 495.2 205.7 26.9 245.3 182.8 256.8 301.1 70.0 69.8 105.5 758.9 589.6 109.9 239.0 706.9 368.0 92.0 535.8 582.2 489.5 1567.6 314.1 211.7 496.8 281.9 33.8 50.6 245.5 347.0 487.7 221.0 55.1 249.3 65.3 17.9 122.2 13.5 16.3 12.7 17.0 110.1 44.8 9.4 12.6 160.8 15.6 94.6 10.5 20.0 149.5 125.6 126.0 164.7 157.9 131.0 153.2 130.9 137.5 133.1 135.4 157.9 152.8 239.6 942.3 550.3 37.9 74.4 106.7 175.4 497.0 78.6 967.9 252.9 183.1 262.0 254.5 460.6 404.6 706.8 798.1 72.0 354.2 52.8 305.5 13.6 211.0 191.3 220.3 92.8 156.3 99.0 107.1 130.3 253.5 86.6 432.8 103.5 109.6 127.1 498.2 652.4 240.6 133.5 159.8 463.9 287.6 214.3 13.8 167.4 405.5 96.0 54.4 293.1 396.1 56.7 45.8 31.6 276.5 220.7 214.4 45.5 190.1 352.0 244.9 258.3 729.0 190.7 148.9 207.7 182.8 240.4 81.6 109.4 927.3 58.8 165.9 161.5 215.4 ST14 "HAI, MT-SP1, PRSS14, SNC19, TMPRSS14" ENSG00000149418 "ST14 transmembrane serine protease matriptase" Q9Y5Y6 11 130159782-130210362 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease variant, Hypotrichosis, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 144.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 489.4;Paneth cells: 327.2;Proximal enterocytes: 251.9;Undifferentiated cells: 216.9;Urothelial cells: 286.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "thalamus: 10.0" "Immune cell enriched" "Detected in many" 4 "plasmacytoid DC: 25.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 25.0" "Cell line enhanced" "Detected in many" "CACO-2: 224.2;CAPAN-2: 443.0;HaCaT: 311.4;OE19: 240.4;RPMI-8226: 301.2;SK-BR-3: 203.1;T-47d: 308.3;U-698: 218.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA047014, HPA056258" Enhanced Approved Nucleoplasm,Vesicles NA NA 1100000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Vesicles" "HPA047014: AB_2679902, HPA056258: " "unprognostic (1.17e-1)" "unprognostic (1.15e-1)" "unprognostic (9.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.20e-1)" "unprognostic (3.97e-2)" "unprognostic (5.29e-1)" "unprognostic (3.21e-1)" "unprognostic (1.03e-3)" "unprognostic (2.25e-1)" "prognostic favorable (5.03e-11)" "unprognostic (1.92e-2)" "unprognostic (2.71e-1)" "unprognostic (1.28e-2)" "unprognostic (5.60e-2)" 4.3 3.9 0.8 26.7 1.2 4.3 17.7 1.8 2.9 18.6 1.2 124.7 130.7 5.7 21.8 104.5 37.1 32.6 0.9 0.9 1.1 43.2 6.3 18.5 11.9 1.8 1.7 0.6 59.2 36.5 19.1 15.1 3.1 23.1 60.1 0.0 58.7 23.6 0.3 50.2 144.8 5.4 1.1 9.1 64.9 1.0 10.0 10.5 28.6 0.0 20.9 34.8 42.5 2.7 167.2 0.2 0.0 0.6 0.0 0.0 86.4 0.0 0.0 0.0 0.0 224.2 443.0 163.6 16.7 0.0 0.1 311.4 0.0 99.3 0.0 0.1 0.2 0.1 0.1 0.9 0.0 22.0 0.8 0.0 49.3 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 128.5 0.3 1.1 1.7 240.4 0.9 0.2 0.0 301.2 28.8 134.2 17.8 0.4 1.5 203.1 0.4 1.6 308.3 32.0 0.1 0.4 2.7 0.7 0.7 0.2 0.3 218.5 0.3 50.4 0.5 0.0 3.6 3.4 0.0 2.2 0.1 5.0 0.0 0.0 6.2 3.6 0.0 0.0 0.5 0.0 0.3 25.0 0.0 1.2 0.8 1.2 1.8 2.9 0.9 1.1 1.8 1.7 3.1 1.1 10.0 2.7 0.2 32.1 28.6 0.0 18.2 40.9 51.5 45.2 26.2 0.0 36.5 21.5 1.2 77.2 61.6 62.5 0.0 45.6 26.1 489.4 3.9 115.8 37.8 43.9 5.7 1.7 123.4 0.8 1.0 91.8 14.6 3.2 112.1 79.6 11.4 0.2 0.4 2.1 58.1 0.0 0.4 201.0 148.5 22.7 13.2 13.9 1.8 28.0 7.2 0.0 13.6 0.0 1.0 0.0 0.1 153.4 327.2 0.7 5.9 108.7 251.9 10.0 76.4 0.0 6.6 0.0 4.9 0.2 0.3 61.3 43.9 39.7 2.9 0.0 216.9 286.8 ZBTB44 "BTBD15, HSPC063, ZNF851" ENSG00000196323 "Zinc finger and BTB domain containing 44" Q8NCP5 11 130226677-130314917 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052589 Approved Approved Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA052589: AB_2681874" "unprognostic (4.04e-2)" "unprognostic (1.33e-1)" "unprognostic (8.03e-2)" "unprognostic (7.60e-2)" "unprognostic (4.13e-2)" "unprognostic (5.63e-2)" "unprognostic (2.19e-1)" "unprognostic (2.47e-2)" "unprognostic (1.93e-2)" "unprognostic (3.56e-2)" "unprognostic (1.38e-3)" "unprognostic (3.34e-1)" "unprognostic (8.45e-3)" "unprognostic (6.39e-2)" "unprognostic (2.19e-1)" "unprognostic (1.43e-1)" "unprognostic (1.78e-2)" 13.0 11.2 14.0 10.5 16.4 12.8 15.6 21.3 13.8 12.6 9.1 11.3 8.8 12.0 17.5 11.5 14.6 8.7 11.3 13.2 12.2 25.4 14.1 11.5 15.7 10.4 13.6 15.8 11.4 16.0 8.2 12.6 10.8 10.6 9.8 16.7 14.2 11.6 36.9 14.6 10.9 9.4 11.1 14.3 10.4 36.9 15.0 25.3 13.4 31.4 16.4 12.3 12.0 16.5 14.0 9.1 13.6 12.4 18.9 18.4 14.9 8.3 14.7 7.5 9.4 15.7 42.5 44.0 42.8 14.0 18.4 14.0 19.1 18.0 12.7 37.8 11.6 65.3 10.2 9.7 11.2 34.2 47.2 12.3 19.2 12.8 27.8 15.9 11.5 26.3 18.6 63.8 8.5 11.1 33.4 24.2 12.0 21.1 13.6 21.8 12.1 15.0 21.4 14.2 28.4 12.1 24.4 16.3 6.5 12.9 29.8 26.9 12.8 15.3 13.5 6.9 9.5 12.2 19.4 40.0 4.0 42.4 14.1 0.7 0.7 0.9 2.0 0.8 1.3 1.1 1.2 1.2 0.8 1.3 1.0 1.2 2.0 1.5 0.6 1.6 1.6 0.4 14.0 16.4 21.3 13.8 13.2 12.2 10.4 13.6 10.8 11.1 15.0 16.5 32.6 25.6 39.4 33.0 42.9 72.1 33.9 33.8 46.7 44.4 56.6 41.4 49.3 40.0 28.6 77.3 58.4 34.0 61.6 18.3 19.6 26.6 56.5 47.9 38.7 33.8 19.3 55.2 50.5 20.4 18.6 40.2 16.3 85.3 10.2 56.6 38.6 43.4 14.9 20.2 48.5 26.8 24.4 42.5 29.9 58.3 73.7 30.0 23.2 39.4 33.6 23.2 104.0 64.3 125.7 21.4 16.9 79.0 27.1 51.7 27.7 69.7 30.5 37.6 39.5 64.4 26.5 103.4 61.6 39.8 82.1 26.8 40.2 42.3 33.1 40.9 ADAMTS8 "ADAM-TS8, FLJ41712, METH2" ENSG00000134917 "ADAM metallopeptidase with thrombospondin type 1 motif 8" Q9UP79 11 130404923-130428609 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Heparin-binding, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 27.6" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 14.5;Endometrial stromal cells: 30.9;Glandular and luminal cells: 37.7;Skeletal myocytes: 26.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.5;HeLa: 1.3;HMC-1: 4.4;NTERA-2: 2.2;U-2 OS: 9.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA066349 Approved "Secreted to extracellular matrix" NA NA 3600000 "Cluster 19: Lung - Lung function" "Cluster 9: U-2 OS - Unknown function" "Cluster 44: Endometrium - Transcription" "HPA066349: AB_2685662" "unprognostic (4.76e-6)" "unprognostic (3.92e-2)" "unprognostic (6.13e-2)" "prognostic favorable (1.38e-4)" "unprognostic (2.41e-1)" "unprognostic (7.81e-2)" "unprognostic (3.09e-2)" "unprognostic (9.83e-2)" "unprognostic (1.09e-4)" "unprognostic (3.05e-1)" "unprognostic (1.50e-1)" "unprognostic (2.40e-1)" "unprognostic (4.66e-3)" "unprognostic (4.03e-3)" "unprognostic (5.23e-1)" "unprognostic (1.05e-1)" "unprognostic (2.41e-1)" 1.8 0.1 1.5 10.1 2.7 0.0 0.7 0.0 3.7 2.0 0.0 7.0 1.1 3.0 1.0 3.0 2.1 1.6 2.3 3.5 0.0 0.5 0.0 27.6 0.1 0.7 0.1 0.4 0.7 0.0 0.2 2.6 0.2 2.7 0.5 0.0 0.5 4.9 0.5 0.3 2.1 4.2 0.1 0.4 5.3 0.3 1.0 0.0 0.2 0.5 0.0 4.2 0.9 1.8 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 1.3 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.7 0.0 3.7 3.5 0.0 0.7 0.1 0.2 0.1 1.0 1.8 1.3 0.0 0.6 1.0 0.0 0.4 0.4 0.1 0.0 2.4 2.3 3.9 9.1 0.0 1.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 14.5 30.9 0.6 0.0 0.0 7.4 0.0 0.0 6.6 0.0 37.7 1.3 1.3 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.7 0.5 0.0 0.1 1.8 2.8 0.0 0.1 1.0 0.5 5.9 0.0 0.0 1.5 0.0 0.5 0.0 0.1 2.6 0.2 0.0 26.9 5.7 0.1 0.3 0.1 0.1 0.0 0.6 0.1 0.0 0.0 ADAMTS15 ENSG00000166106 "ADAM metallopeptidase with thrombospondin type 1 motif 15" Q8TE58 11 130448974-130476641 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 26.4" "Cell type enhanced" "Detected in some" "Adipocytes: 8.6;Cardiomyocytes: 11.0;Endometrial stromal cells: 15.6;Fibroblasts: 9.6;Gastric mucus-secreting cells: 8.2;Glandular and luminal cells: 7.5;Granulosa cells: 6.8;Skeletal myocytes: 6.9" "Cancer enhanced" "Detected in many" "breast cancer: 13.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 72.0;ASC TERT1: 43.0;EFO-21: 36.6;hTERT-RPE1: 19.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA042867 Uncertain Approved Cytosol "Secreted to extracellular matrix" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" Cytosol "HPA042867: AB_10794535" "unprognostic (7.64e-2)" "unprognostic (1.49e-3)" "unprognostic (7.15e-2)" "unprognostic (1.34e-3)" "unprognostic (1.07e-3)" "unprognostic (7.07e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (9.72e-4)" "unprognostic (6.18e-2)" "unprognostic (4.37e-2)" "unprognostic (2.56e-1)" "unprognostic (7.40e-2)" "unprognostic (1.29e-2)" "unprognostic (5.95e-3)" "unprognostic (6.68e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.63e-5)" 26.4 1.2 0.4 1.7 0.5 0.0 15.3 0.4 0.8 3.4 1.7 3.2 0.5 4.3 1.3 3.7 9.8 2.3 14.5 0.4 0.9 11.0 0.4 7.2 1.1 4.4 0.6 2.7 1.4 0.4 1.3 16.9 1.5 1.9 1.9 0.2 1.3 1.1 1.8 5.0 3.6 4.6 1.0 2.3 5.5 0.9 1.2 1.1 7.0 1.0 0.3 8.8 2.6 1.0 0.0 2.6 1.6 0.8 72.0 43.0 0.0 2.7 5.2 1.0 0.2 0.5 1.2 0.0 36.6 0.2 2.6 7.0 0.6 0.7 0.2 0.0 1.7 0.0 3.3 0.0 0.7 0.0 0.0 14.1 0.0 0.6 0.1 19.5 0.0 0.3 0.0 0.0 0.0 0.1 0.1 8.1 1.3 0.0 5.7 0.0 4.1 0.0 0.1 0.1 0.6 0.0 12.1 0.0 0.0 5.2 3.9 0.0 0.0 0.6 8.5 7.0 3.5 0.0 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.4 0.8 0.4 0.9 4.4 0.6 1.5 1.0 1.2 1.0 8.6 0.0 0.0 0.3 0.2 0.5 0.1 3.5 0.0 1.3 5.6 2.7 11.0 0.0 0.5 1.8 0.0 0.6 0.0 1.0 0.0 0.0 0.0 4.4 15.6 1.7 0.0 0.0 0.4 0.8 0.6 9.6 8.2 7.5 0.0 6.8 0.4 0.1 0.9 0.0 1.6 0.5 2.0 0.0 0.3 0.0 5.0 0.3 3.6 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.9 0.7 0.0 0.0 0.1 1.0 0.5 0.0 0.0 6.9 3.6 0.2 0.3 0.0 0.3 0.8 0.1 0.0 1.8 0.1 SNX19 "CHET8, KIAA0254" ENSG00000120451 "Sorting nexin 19" Q92543 11 130866250-130916479 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 112.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013447 Uncertain Approved Mitochondria NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 35: Non-specific - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 46: Photoreceptor cells - Phototransduction" Mitochondria "HPA013447: AB_1857347" "unprognostic (8.79e-3)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (1.56e-1)" "unprognostic (2.97e-2)" "unprognostic (2.43e-1)" "unprognostic (4.17e-2)" "unprognostic (9.19e-2)" "unprognostic (3.43e-2)" "unprognostic (4.05e-2)" "unprognostic (2.89e-1)" "unprognostic (4.97e-2)" "prognostic favorable (3.56e-5)" "unprognostic (1.05e-1)" "unprognostic (2.77e-1)" "unprognostic (2.92e-2)" "unprognostic (1.55e-2)" 15.9 18.5 19.0 12.4 24.3 8.7 14.8 18.0 17.9 15.5 18.2 22.3 11.8 18.0 19.1 14.7 16.3 14.9 20.1 15.3 17.6 16.6 19.3 14.6 11.0 27.4 22.5 14.0 19.4 16.1 17.2 12.6 21.1 16.6 14.1 15.5 19.4 14.4 23.8 12.9 15.4 19.5 22.1 15.2 19.0 21.3 23.8 11.1 21.5 13.1 11.7 19.1 13.5 28.7 13.8 23.2 17.4 27.7 52.9 36.9 13.2 35.7 38.1 17.9 18.1 20.6 26.2 12.4 27.0 40.3 45.3 25.6 3.2 25.1 20.8 20.9 13.7 24.3 18.3 0.1 30.9 0.0 19.1 42.1 24.4 20.0 17.9 35.3 20.9 17.9 23.5 0.1 35.3 10.9 18.6 10.6 4.9 30.0 19.3 16.1 17.2 8.0 11.9 27.8 19.6 16.4 16.7 22.4 11.1 13.4 46.6 13.0 34.4 26.7 20.9 21.8 21.3 4.5 0.0 0.1 9.7 13.5 28.9 6.5 3.6 2.5 2.1 3.2 3.0 2.8 1.9 2.5 2.9 1.8 2.3 2.0 1.7 1.6 4.0 2.7 1.9 3.5 19.0 24.3 18.0 17.9 15.3 17.6 27.4 22.5 21.1 22.1 23.8 28.7 12.6 25.6 7.9 44.4 14.8 4.0 7.2 7.8 8.6 25.6 11.6 9.1 20.4 15.7 12.9 23.9 10.4 10.3 10.0 19.4 9.8 11.5 35.8 10.8 14.3 12.2 11.4 7.4 30.0 16.0 5.7 11.4 15.8 11.0 18.4 13.5 13.9 21.3 10.1 16.8 34.9 12.5 6.1 11.7 5.2 44.7 13.7 11.9 3.6 20.6 9.6 22.4 13.4 35.7 112.6 16.6 14.5 15.8 15.5 10.2 14.4 8.6 16.9 37.9 13.1 12.7 9.8 37.1 15.5 9.8 4.3 14.0 9.2 13.1 10.3 10.8 NTM "CEPU-1, HNT, IGLON2, NTRI" ENSG00000182667 Neurotrimin Q9P121 11 131370478-132336822 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 321.8;choroid plexus: 89.2;retina: 74.8" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 608.9;Astrocytes: 2164.2;Cone photoreceptor cells: 950.8;Excitatory neurons: 651.0;Inhibitory neurons: 1056.6;Oligodendrocyte precursor cells: 1930.7;Oligodendrocytes: 1257.6;Rod photoreceptor cells: 1415.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 175 "plasmacytoid DC: 17.4" "Lineage enriched" "Detected in single" 175 "dendritic cells: 17.4" "Cell line enhanced" "Detected in many" "LHCN-M2: 122.4;U-138 MG: 47.7;U-2 OS: 81.8;WM-115: 166.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB024875 Enhanced "Intracellular and membrane" NA NA 58000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 65: Brain - Ion transport" "Cluster 17: WM-115 - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" "CAB024875: " "unprognostic (1.52e-2)" "unprognostic (4.38e-3)" "unprognostic (1.61e-2)" "unprognostic (1.89e-1)" "unprognostic (4.25e-1)" "unprognostic (1.07e-1)" "unprognostic (9.99e-3)" "unprognostic (9.61e-2)" "unprognostic (1.26e-2)" "unprognostic (2.52e-2)" "unprognostic (4.29e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.10e-8)" "unprognostic (4.60e-3)" "unprognostic (1.37e-1)" "unprognostic (2.94e-1)" "unprognostic (9.31e-3)" 17.9 4.7 137.2 2.3 138.8 0.0 2.9 165.1 321.8 1.6 89.2 12.0 2.5 1.3 0.6 9.4 0.9 9.6 30.5 136.9 131.5 2.3 0.3 25.8 0.4 144.0 135.4 0.3 0.9 22.1 0.9 0.7 143.6 1.9 3.8 74.8 2.7 2.8 0.9 6.1 4.6 4.5 135.0 0.5 2.0 0.6 154.2 0.5 1.1 5.0 0.4 3.5 1.8 158.4 0.1 0.0 7.5 0.1 0.9 22.2 0.0 36.7 19.5 11.7 6.8 0.1 0.0 0.0 0.0 20.3 0.0 0.3 0.0 43.6 12.6 0.1 0.4 0.0 0.0 0.4 0.4 0.0 0.2 2.0 0.0 38.0 45.0 29.0 7.5 0.0 0.0 0.3 122.4 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 3.9 20.8 0.0 2.4 3.8 0.0 0.0 0.2 1.3 0.0 0.1 8.1 47.7 81.8 2.2 31.6 0.0 0.0 0.2 0.1 0.0 166.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 137.2 138.8 165.1 321.8 136.9 131.5 144.0 135.4 143.6 135.0 154.2 158.4 1.2 608.9 27.6 2164.2 0.0 1.8 0.0 1.5 2.2 225.3 0.9 4.4 13.7 0.0 29.7 20.2 950.8 0.0 5.4 0.4 0.0 0.6 10.9 0.0 0.5 2.9 0.0 2.7 651.0 0.0 0.0 22.2 0.5 0.0 53.0 0.1 0.7 0.0 0.1 40.4 1056.6 0.1 0.0 0.0 3.8 2.2 0.3 0.7 3.6 139.6 0.0 30.5 0.0 1930.7 1257.6 0.1 0.2 0.4 0.1 0.1 0.0 0.1 1.5 1415.0 0.0 20.6 7.5 0.4 0.9 0.5 4.8 0.0 0.8 0.0 0.8 0.1 OPCML "IGLON1, OBCAM, OPCM" ENSG00000183715 "Opioid binding protein/cell adhesion molecule like" Q14982 11 132414977-133532519 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "brain: 39.2;parathyroid gland: 10.3;retina: 11.6" "Group enriched" "Detected in some" 34 "Excitatory neurons: 2120.9;Inhibitory neurons: 1900.4;Oligodendrocyte precursor cells: 3173.2" "Cancer enriched" "Detected in some" 4 "glioma: 3.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BJ: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 7100000 "Cluster 6: Brain - Smell perception" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (1.59e-1)" "unprognostic (2.26e-2)" "unprognostic (3.70e-2)" "unprognostic (3.31e-4)" "unprognostic (8.23e-2)" "unprognostic (3.53e-2)" "unprognostic (1.19e-1)" "unprognostic (1.44e-1)" "unprognostic (8.46e-3)" "unprognostic (2.59e-2)" "unprognostic (2.80e-1)" "unprognostic (4.73e-2)" "unprognostic (1.11e-2)" "unprognostic (1.13e-2)" "unprognostic (1.76e-1)" "unprognostic (9.71e-2)" "unprognostic (2.19e-1)" 0.2 0.4 13.2 0.1 16.6 0.0 0.1 22.3 39.2 0.4 0.0 0.1 0.1 0.6 0.1 0.4 0.5 0.2 0.3 18.4 3.1 1.4 0.0 0.0 0.0 0.0 5.1 0.3 0.0 10.3 1.3 0.0 0.0 0.1 0.1 11.6 0.2 0.6 0.1 0.1 0.1 0.5 0.2 0.7 0.2 0.4 9.6 0.0 0.1 0.3 0.0 0.1 0.1 13.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 9.4 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.3 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 16.6 22.3 39.2 18.4 3.1 0.0 5.1 0.0 0.2 9.6 13.4 0.0 0.0 0.0 25.5 0.0 0.1 0.0 0.0 0.0 40.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 6.7 0.0 0.0 0.4 0.0 0.0 2120.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.7 1900.4 0.0 0.0 0.3 0.4 14.9 0.0 0.1 0.0 69.3 0.0 1.3 0.0 3173.2 30.3 0.0 0.0 1.2 0.0 0.0 0.0 0.6 0.0 4.2 6.6 0.0 1.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SPATA19 "CT132, FLJ25851, SPAS1, spergen1" ENSG00000166118 "Spermatogenesis associated 19" Q7Z5L4 11 133840631-133845538 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 321 "testis: 134.6" "Group enriched" "Detected in some" 162 "Early spermatids: 771.9;Late spermatids: 2291.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA040082 Enhanced NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 34: Spermatids - Unknown function" "HPA040082: AB_2676836" "unprognostic (9.90e-3)" "unprognostic (3.34e-2)" "unprognostic (2.66e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 134.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 771.9 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2291.2 9.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGSF9B "KIAA1030, LINC00947, LOC283174, MIR4697HG" ENSG00000080854 "Immunoglobulin superfamily member 9B" Q9UPX0 11 133896438-133956968 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.8;choroid plexus: 20.2" "Group enriched" "Detected in some" 4 "Excitatory neurons: 25.2;Inhibitory neurons: 11.6;Oligodendrocyte precursor cells: 30.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 38.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 10.0;SCLC-21H: 17.7;SH-SY5Y: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010802 Uncertain Approved "Golgi apparatus,Cell Junctions" NA NA "Cluster 6: Brain - Smell perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus, Cell Junctions" "HPA010802: AB_1079194" "unprognostic (9.04e-4)" "unprognostic (1.74e-2)" "unprognostic (7.52e-3)" "unprognostic (4.38e-4)" "unprognostic (8.35e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (6.17e-2)" "unprognostic (1.38e-1)" "unprognostic (8.10e-2)" "unprognostic (2.81e-1)" "unprognostic (2.99e-4)" "unprognostic (3.17e-1)" "unprognostic (2.19e-1)" "unprognostic (1.41e-1)" "unprognostic (9.14e-4)" "unprognostic (3.12e-3)" 1.0 1.4 9.4 1.4 3.8 0.2 0.8 38.8 30.7 2.2 20.2 4.7 0.5 4.8 3.0 2.8 4.6 1.2 6.7 8.3 0.0 0.4 0.0 0.8 0.7 0.0 0.9 1.0 0.9 0.7 2.6 0.6 1.1 2.6 1.3 9.3 0.8 4.1 4.7 2.3 1.3 4.5 0.0 0.9 1.9 3.3 0.0 0.5 2.5 3.5 0.7 2.6 1.6 0.0 0.0 0.6 1.2 0.0 0.0 0.0 4.2 0.1 0.0 0.1 0.0 0.1 2.6 1.6 0.7 0.6 0.3 3.7 3.9 0.0 0.1 2.8 3.1 0.0 0.0 0.0 0.1 1.0 5.1 0.1 0.0 0.0 0.5 0.5 0.0 4.7 0.0 0.0 0.0 1.9 0.5 0.4 2.5 10.0 0.0 0.0 0.0 0.0 0.9 0.0 17.7 11.1 0.1 0.2 0.0 3.7 1.8 0.0 0.0 1.2 1.3 1.0 0.9 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.4 3.8 38.8 30.7 8.3 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 3.4 0.1 0.2 0.0 2.9 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.9 0.0 0.4 0.0 0.0 0.9 0.0 0.0 25.2 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.5 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 30.7 0.2 0.1 0.1 0.4 0.0 0.2 0.0 0.1 0.0 0.9 0.0 0.2 0.6 0.0 0.3 0.1 4.8 0.0 0.6 0.1 0.2 0.1 JAM3 "JAM-C, JAMC" ENSG00000166086 "Junctional adhesion molecule 3" Q9BX67 11 134069071-134152001 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion, Differentiation, Spermatogenesis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 342.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 5.3" "Group enriched" "Detected in many" 7 "B-cells: 5.3;T-cells: 2.3" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 99.5;RH-30: 122.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003417, HPA050434" Approved Enhanced "Golgi apparatus" "Secreted to blood" NA NA 44000 "Cluster 43: B-cells - Humoral immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA003417: AB_1851981, HPA050434: AB_2681126" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (1.38e-2)" "unprognostic (3.24e-1)" "unprognostic (1.60e-1)" "unprognostic (3.59e-1)" "unprognostic (1.32e-1)" "unprognostic (6.59e-2)" "unprognostic (1.13e-1)" "unprognostic (1.93e-1)" "unprognostic (5.06e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (3.73e-4)" "unprognostic (3.23e-3)" "unprognostic (2.17e-1)" "unprognostic (1.06e-3)" "prognostic unfavorable (2.68e-4)" 23.6 18.7 53.4 10.1 86.3 1.3 19.2 68.7 73.4 33.4 52.9 54.6 6.6 40.8 17.5 21.5 28.7 24.5 31.0 56.5 61.3 11.4 3.2 29.6 7.8 73.5 76.8 48.7 5.1 17.7 33.3 102.7 71.0 32.5 12.9 47.3 13.3 44.5 7.0 13.0 22.5 42.8 59.7 13.5 22.4 35.7 73.3 17.6 15.8 14.6 7.5 41.7 23.4 115.2 0.0 1.0 87.9 42.5 85.3 62.7 75.4 37.0 49.1 15.1 14.8 0.3 0.6 0.0 38.7 53.3 56.2 0.5 70.0 0.7 28.2 0.2 29.6 0.3 0.0 6.9 24.9 0.4 36.2 43.2 0.0 10.7 9.6 35.8 99.5 40.8 0.3 0.2 64.5 1.0 27.5 0.2 18.9 0.6 2.9 0.5 122.8 0.0 0.9 0.2 57.5 32.2 0.0 0.2 1.0 35.3 0.2 0.2 0.6 25.1 18.4 40.3 24.7 0.1 0.1 0.4 27.6 1.2 48.0 0.0 0.0 0.1 1.3 0.0 1.6 5.3 1.6 0.9 0.0 3.1 2.3 1.7 0.5 0.0 0.0 0.0 0.0 1.8 53.4 86.3 68.7 73.4 56.5 61.3 73.5 76.8 71.0 59.7 73.3 115.2 22.2 0.0 6.0 12.7 10.9 5.1 5.6 0.9 0.0 21.7 0.3 9.3 15.7 0.0 0.7 5.5 8.4 6.0 1.2 0.1 1.9 0.4 2.1 0.8 23.3 35.5 0.0 0.4 84.3 0.2 71.2 29.6 1.5 0.5 1.3 11.7 12.5 0.0 8.6 8.4 44.2 0.0 12.2 0.6 4.2 4.9 42.9 10.9 17.8 24.4 0.2 20.2 1.0 76.4 342.8 0.3 0.0 64.3 0.9 2.2 0.0 0.2 1.5 75.6 26.3 19.0 24.3 15.5 19.2 0.2 3.8 6.2 3.5 9.7 0.0 1.0 NCAPD3 "CAP-D3, FLJ42888, hCAP-D3, hcp-6, hHCP-6, KIAA0056" ENSG00000151503 "Non-SMC condensin II complex subunit D3" P42695 11 134150113-134225454 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "prostate: 58.5" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 8 "prostate cancer: 50.8" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040286 Supported Nucleoplasm NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 72: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA040286: AB_2676918" "unprognostic (4.27e-2)" "unprognostic (6.05e-2)" "unprognostic (7.78e-3)" "unprognostic (8.22e-3)" "unprognostic (2.79e-1)" "unprognostic (4.29e-2)" "unprognostic (2.15e-3)" "unprognostic (2.56e-1)" "unprognostic (4.32e-2)" "unprognostic (4.75e-1)" "unprognostic (2.79e-3)" "unprognostic (1.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.93e-2)" "unprognostic (3.35e-2)" "unprognostic (3.94e-1)" "unprognostic (3.48e-1)" 4.7 5.5 1.9 3.1 2.0 10.0 4.9 4.0 3.8 4.2 2.3 4.4 3.5 4.0 3.3 7.1 3.8 2.6 5.0 3.1 1.6 3.6 8.8 4.9 4.2 2.0 1.1 3.4 4.5 1.9 7.0 3.1 1.1 58.5 1.5 4.5 5.7 0.9 3.7 9.0 5.4 1.3 0.9 6.2 5.1 9.5 1.6 3.1 6.0 0.9 1.7 3.7 5.2 3.0 5.5 1.9 12.3 25.3 1.8 1.3 10.6 11.5 1.9 3.5 4.0 5.6 3.4 6.1 11.1 3.5 9.8 6.1 3.5 5.2 4.4 9.2 21.7 26.6 5.1 8.5 2.3 13.1 15.4 1.7 1.1 5.1 2.0 3.6 2.6 11.6 7.1 4.7 4.2 6.0 10.9 15.1 8.6 5.5 13.8 2.9 13.7 8.5 4.1 3.2 22.1 13.4 9.1 5.9 1.7 10.0 9.7 6.9 1.7 11.8 5.7 11.8 9.9 4.5 4.5 5.5 8.3 16.4 15.2 1.6 3.3 1.6 5.7 2.7 2.2 2.3 3.7 3.8 2.5 5.2 5.5 5.8 1.6 1.7 2.2 8.0 6.5 1.9 1.9 2.0 4.0 3.8 3.1 1.6 2.0 1.1 1.1 0.9 1.6 3.0 7.7 3.2 8.1 8.5 12.1 9.2 4.4 6.0 8.0 20.2 9.9 8.6 6.7 2.8 7.0 12.9 10.4 13.0 13.2 5.4 0.0 2.7 7.2 7.8 12.8 5.6 7.8 32.8 19.7 2.6 9.9 7.5 7.7 9.0 2.5 19.6 5.7 9.7 8.8 11.8 16.7 7.2 10.2 6.4 8.7 10.4 4.7 10.9 1.8 15.0 17.1 9.0 17.5 11.1 16.0 2.8 1.6 4.1 22.9 8.8 3.2 3.6 4.9 20.9 0.0 9.5 9.2 21.5 14.4 10.7 9.1 4.5 14.2 11.3 11.6 3.4 VPS26B "MGC10485, Pep8b" ENSG00000151502 "VPS26, retromer complex component B" Q4G0F5 11 134224671-134247788 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038172 Uncertain NA NA 8800 "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 25: Spermatids - Spermatogenesis" "HPA038172: AB_10675630" "unprognostic (1.55e-2)" "unprognostic (6.56e-2)" "unprognostic (7.02e-3)" "unprognostic (2.52e-3)" "unprognostic (1.52e-1)" "unprognostic (5.76e-2)" "unprognostic (5.29e-2)" "unprognostic (1.71e-1)" "unprognostic (3.54e-1)" "unprognostic (7.77e-2)" "unprognostic (6.97e-3)" "unprognostic (1.66e-1)" "unprognostic (3.42e-3)" "unprognostic (3.15e-2)" "unprognostic (7.05e-3)" "unprognostic (2.44e-1)" "unprognostic (2.13e-1)" 17.7 21.2 37.8 13.5 40.8 30.4 16.3 33.1 42.4 18.2 28.6 23.5 20.5 20.5 31.5 19.8 20.4 15.3 23.7 42.4 36.4 14.2 29.5 15.8 14.0 31.4 33.1 19.1 25.8 17.5 21.4 13.4 33.3 21.0 17.2 24.7 21.6 18.8 17.1 35.3 21.4 20.5 30.8 18.5 20.1 16.9 35.9 30.2 17.7 16.1 12.8 18.9 16.7 35.4 25.1 27.8 22.8 70.0 50.2 44.2 19.1 26.3 31.5 23.4 17.4 46.4 43.3 15.8 52.0 46.1 27.4 35.8 30.5 43.6 17.5 37.4 21.9 69.5 16.1 30.3 36.6 41.3 42.9 42.1 28.0 22.4 41.3 32.9 41.9 60.1 34.3 27.1 33.3 30.4 89.8 47.0 13.0 78.3 45.1 20.5 18.4 22.5 29.2 39.6 38.0 38.3 30.0 53.9 17.3 24.0 99.8 31.9 34.7 29.5 16.5 37.7 18.8 34.0 20.0 6.4 19.2 64.1 22.3 3.9 3.3 8.3 5.4 4.1 4.8 0.9 4.6 5.8 3.0 0.4 2.9 5.3 4.9 5.5 3.6 3.4 5.1 2.9 37.8 40.8 33.1 42.4 42.4 36.4 31.4 33.1 33.3 30.8 35.9 35.4 14.3 12.8 6.4 14.7 9.4 17.7 12.7 7.1 25.0 30.0 21.9 22.1 29.1 17.2 6.9 20.2 8.4 18.8 36.2 31.4 21.5 8.6 26.5 12.9 16.7 14.0 28.4 24.8 24.8 14.8 27.1 19.2 29.0 11.5 1.3 22.5 14.6 34.7 23.9 30.3 18.8 30.3 10.2 32.7 16.4 67.9 18.0 27.5 12.4 11.2 21.7 23.8 48.4 13.6 19.9 11.2 32.4 30.9 26.8 11.7 63.8 22.7 7.7 22.8 6.6 14.6 19.7 13.4 21.3 24.4 24.0 12.4 26.6 20.0 25.7 12.0 THYN1 THY28 ENSG00000151500 "Thymocyte nuclear protein 1" Q9P016 11 134248279-134253370 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038732, HPA038733" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA038732: AB_10697397, HPA038733: AB_2676183" "unprognostic (5.91e-2)" "unprognostic (6.22e-3)" "unprognostic (4.54e-2)" "unprognostic (3.48e-3)" "unprognostic (2.32e-2)" "unprognostic (8.99e-2)" "unprognostic (2.12e-1)" "prognostic favorable (1.01e-5)" "unprognostic (3.32e-2)" "unprognostic (1.99e-2)" "unprognostic (1.02e-1)" "unprognostic (1.13e-1)" "unprognostic (2.37e-1)" "unprognostic (1.71e-1)" "unprognostic (6.92e-2)" "unprognostic (1.66e-2)" "unprognostic (2.61e-2)" 42.3 40.5 74.2 22.0 75.4 43.3 45.1 74.4 104.9 39.8 68.5 53.9 30.2 43.1 75.8 28.1 47.6 31.1 51.7 75.9 76.2 40.1 57.5 28.3 40.5 72.2 71.3 62.9 32.8 27.9 50.8 22.2 73.2 50.1 44.9 41.3 29.6 54.2 32.3 28.1 36.3 42.3 72.5 36.6 39.4 42.6 74.9 77.1 52.1 38.0 44.5 44.3 33.1 76.6 32.0 19.5 69.8 56.0 65.9 74.7 41.0 26.9 59.2 62.0 58.1 106.8 76.3 60.0 88.6 37.8 66.6 48.9 106.8 82.0 60.5 61.5 30.3 165.5 25.7 97.6 94.3 133.0 52.4 56.9 43.2 73.9 48.2 80.6 98.9 199.0 78.1 28.0 56.5 17.7 155.1 242.8 81.0 127.0 71.0 72.3 51.8 50.6 86.4 55.4 66.4 53.7 55.8 13.6 33.1 50.3 78.2 66.5 52.7 26.6 41.3 24.4 41.7 31.4 35.0 126.9 39.5 170.6 31.5 185.4 89.8 330.3 145.2 108.4 175.6 122.1 152.3 146.8 99.1 96.4 175.4 200.0 47.2 139.1 104.4 131.3 199.8 160.0 74.2 75.4 74.4 104.9 75.9 76.2 72.2 71.3 73.2 72.5 74.9 76.6 41.9 32.1 28.8 8.1 31.1 23.8 42.2 107.4 28.5 28.6 37.5 65.4 52.1 47.1 57.7 36.8 14.6 52.7 33.5 25.5 86.1 48.2 28.2 44.7 33.8 36.9 57.6 40.8 15.3 55.6 52.9 42.3 20.4 23.4 40.5 65.5 37.1 47.9 53.0 28.6 12.0 47.9 75.3 22.2 23.7 16.0 50.4 32.7 40.9 8.4 43.1 65.7 44.3 11.1 11.1 53.2 33.0 48.5 29.8 13.4 49.3 93.3 73.1 23.9 46.0 34.0 51.3 79.1 94.9 31.4 20.6 13.8 44.1 72.7 52.7 31.6 ACAD8 ENSG00000151498 "Acyl-CoA dehydrogenase family member 8" Q9UKU7 11 134253548-134265855 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Branched-chain amino acid catabolism, Transcription, Transcription regulation" "Activator, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 59.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040689, HPA043903" Enhanced NA NA "Cluster 11: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" "HPA040689: AB_2677080, HPA043903: AB_2678724" "unprognostic (5.00e-2)" "unprognostic (2.40e-2)" "prognostic favorable (7.62e-4)" "unprognostic (7.57e-3)" "unprognostic (9.83e-2)" "prognostic favorable (6.19e-4)" "unprognostic (2.53e-1)" "prognostic favorable (2.38e-4)" "unprognostic (4.10e-2)" "unprognostic (2.84e-1)" "unprognostic (7.81e-3)" "unprognostic (2.16e-1)" "prognostic favorable (6.42e-10)" "unprognostic (1.08e-1)" "unprognostic (1.17e-2)" "unprognostic (4.02e-2)" "unprognostic (1.03e-2)" 11.0 18.1 13.9 3.5 14.2 6.8 11.3 14.3 15.4 7.5 18.7 11.6 11.3 6.3 12.6 9.6 9.4 5.2 27.2 14.7 14.3 31.6 24.8 7.8 5.0 14.3 14.1 6.9 16.7 12.4 6.5 4.8 13.8 20.5 10.9 5.0 12.6 7.5 32.5 14.3 8.4 8.3 14.5 8.6 12.6 6.3 14.8 8.5 27.7 39.2 8.9 8.4 6.9 14.8 5.9 5.9 11.8 17.6 20.2 11.5 13.5 11.3 14.0 14.7 10.3 16.2 10.8 14.2 21.1 11.7 15.5 6.0 14.6 14.3 10.2 13.0 4.7 29.4 5.8 11.3 17.0 16.5 18.3 13.8 4.4 14.8 4.5 13.3 16.3 20.8 13.8 7.0 12.4 7.5 12.2 18.1 17.0 49.8 9.7 9.8 11.9 8.5 20.1 17.5 3.7 11.7 19.5 14.8 7.3 11.9 31.0 15.0 11.3 7.1 7.5 6.2 11.2 7.8 3.8 12.7 7.2 15.4 11.2 36.2 13.4 23.1 11.8 13.5 11.5 11.6 11.1 11.7 12.7 9.2 13.0 11.7 12.1 31.5 12.9 10.8 15.1 12.3 13.9 14.2 14.3 15.4 14.7 14.3 14.3 14.1 13.8 14.5 14.8 14.8 11.7 3.2 12.2 15.3 8.8 6.0 4.7 23.5 7.4 11.2 17.5 11.9 24.6 4.3 19.7 18.4 14.6 19.7 14.0 20.0 52.8 12.1 5.3 8.2 11.8 9.7 3.6 12.0 21.5 11.9 10.6 9.8 10.2 8.5 3.8 15.7 10.8 36.7 12.9 15.2 16.0 14.3 48.8 14.2 6.9 6.1 11.5 10.0 28.4 13.1 12.7 11.8 9.2 12.1 15.8 12.6 15.8 10.1 14.6 5.9 17.4 59.8 20.1 17.1 6.6 8.7 9.6 22.4 17.3 10.9 7.7 8.3 10.5 36.0 14.9 5.3 GLB1L3 FLJ90231 ENSG00000166105 "Galactosidase beta 1 like 3" Q8NCI6 11 134274245-134319564 "Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.0;prostate: 7.9;seminal vesicle: 4.3" "Cell type enhanced" "Detected in some" "Early spermatids: 9.8;Excitatory neurons: 39.5;Inhibitory neurons: 20.9;Oligodendrocyte precursor cells: 11.6;Spermatogonia: 7.5" "Cancer enhanced" "Detected in some" "prostate cancer: 5.0" "Region enhanced" "Detected in some" "cerebral cortex: 4.0" "Group enriched" "Detected in many" 11 "gdT-cell: 1.2;memory CD4 T-cell: 3.1;memory CD8 T-cell: 1.9;naive CD4 T-cell: 2.4;naive CD8 T-cell: 1.9;T-reg: 1.5" "Lineage enriched" "Detected in single" 31 "T-cells: 3.1" "Cell line enhanced" "Detected in some" "HEK 293: 5.5;JURKAT: 11.4;NTERA-2: 3.4;PC-3: 4.5;SCLC-21H: 6.8" "Not detected" "Not detected" HPA039916 Uncertain NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 68: Epididymis - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA039916: AB_2676746" "unprognostic (1.64e-3)" "unprognostic (7.80e-3)" "unprognostic (5.12e-2)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (1.55e-2)" "unprognostic (8.69e-3)" "prognostic favorable (1.97e-4)" "unprognostic (6.58e-3)" "unprognostic (3.81e-1)" "unprognostic (6.95e-3)" "unprognostic (9.73e-2)" "unprognostic (1.52e-5)" "unprognostic (1.39e-1)" "unprognostic (6.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.07e-1)" 0.0 1.0 0.9 0.4 1.0 0.1 0.3 2.3 4.0 0.4 0.0 0.9 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.2 7.9 0.0 1.6 2.7 4.3 0.0 3.3 0.1 0.0 0.0 0.1 0.0 1.3 0.2 0.1 1.3 0.0 0.1 0.1 0.8 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.2 0.0 2.1 5.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 2.2 0.0 3.4 0.0 4.5 0.0 0.0 0.0 0.0 0.0 6.8 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 3.1 1.9 0.0 0.0 2.4 1.9 0.0 0.0 0.0 0.0 1.5 0.6 0.9 1.0 2.3 4.0 0.4 0.1 0.5 0.0 0.2 0.0 0.2 0.8 0.0 0.0 0.0 1.3 0.1 0.5 0.1 1.3 0.0 0.5 0.4 1.3 0.7 0.0 0.1 0.0 0.0 1.3 0.3 0.0 0.0 0.0 9.8 0.1 0.3 0.3 0.0 0.0 39.5 0.0 3.4 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 20.9 0.0 0.0 0.0 0.0 1.2 0.6 0.1 0.0 1.9 0.0 0.3 0.0 11.6 0.9 0.1 0.0 0.0 0.3 0.4 0.0 0.5 0.0 0.7 0.0 0.0 0.1 4.3 7.5 0.0 0.1 1.2 0.3 0.0 0.0 0.1 GLB1L2 ENSG00000149328 "Galactosidase beta 1 like 2" Q8IW92 11 134331874-134378341 "Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 160.6" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 182.0" "Cancer enhanced" "Detected in many" "prostate cancer: 21.0" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "gdT-cell: 3.2;NK-cell: 3.1" "Group enriched" "Detected in many" 24 "NK-cells: 3.1;T-cells: 3.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 49.9;HaCaT: 52.6;OE19: 123.6;SCLC-21H: 34.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054808, HPA059955" Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 21: OE19 - Mitochondria" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm Vesicles "HPA054808: AB_2682608, HPA059955: AB_2684178" "unprognostic (2.63e-2)" "unprognostic (9.77e-3)" "unprognostic (2.32e-2)" "unprognostic (2.20e-2)" "unprognostic (8.07e-2)" "unprognostic (1.54e-1)" "unprognostic (5.98e-2)" "unprognostic (2.08e-2)" "unprognostic (1.51e-1)" "unprognostic (8.31e-2)" "unprognostic (1.67e-1)" "unprognostic (1.48e-1)" "unprognostic (4.73e-2)" "unprognostic (1.22e-2)" "unprognostic (2.64e-1)" "unprognostic (3.88e-3)" "unprognostic (1.01e-1)" 1.5 2.1 3.0 2.6 2.1 0.3 7.0 0.1 7.7 5.9 14.7 27.6 5.7 33.9 2.1 3.5 25.6 2.8 1.2 8.5 0.3 20.7 0.6 3.6 0.6 1.0 0.8 13.7 10.6 25.0 14.1 1.5 1.0 34.5 11.7 160.6 9.1 25.2 1.0 9.4 4.0 4.4 0.1 0.6 9.0 8.3 0.7 0.5 22.7 0.2 0.6 6.7 5.0 1.3 16.0 1.6 8.2 4.7 0.0 0.0 5.5 0.0 0.0 0.0 0.0 13.3 49.9 0.0 16.3 0.0 6.8 52.6 25.2 0.4 0.0 0.0 23.9 0.0 6.7 0.6 2.2 0.0 28.4 0.3 0.7 0.0 0.0 0.0 0.1 7.6 26.3 0.0 0.0 15.3 4.4 3.0 4.7 123.6 18.2 0.0 0.0 1.5 14.1 11.0 34.9 13.1 11.4 14.2 0.0 1.2 18.4 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 4.1 0.0 3.1 0.0 0.0 0.0 3.2 0.0 1.2 0.0 0.6 1.2 0.0 0.1 0.9 1.4 0.0 3.1 0.0 0.0 0.0 0.5 3.0 2.1 0.1 7.7 8.5 0.3 1.0 0.8 1.0 0.1 0.7 1.3 0.2 0.0 1.8 0.3 0.4 2.2 5.2 1.0 1.8 6.2 7.2 7.9 1.6 1.5 2.5 0.0 41.7 0.2 3.4 19.5 0.0 2.5 2.1 7.9 22.1 1.2 9.0 0.0 1.6 2.4 1.0 3.6 4.1 2.2 0.0 41.9 0.0 0.2 0.2 5.0 1.2 5.9 0.0 0.0 0.3 6.8 1.2 0.3 5.4 1.0 0.0 10.8 1.0 1.0 0.3 2.2 6.3 0.7 2.2 8.1 3.0 8.4 10.1 182.0 0.0 3.7 2.3 2.6 4.6 1.9 0.9 0.1 2.5 3.4 11.5 2.7 B3GAT1 "CD57, GlcAT-P, HNK-1, LEU7, NK-1" ENSG00000109956 "Beta-1,3-glucuronyltransferase 1" Q9P2W7 11 134378504-134412242 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 195.2" "Cell type enhanced" "Detected in some" "Astrocytes: 27.4;Bipolar cells: 37.0;Excitatory neurons: 37.2;Inhibitory neurons: 30.4;Muller glia cells: 116.2;Oligodendrocyte precursor cells: 33.2;Oligodendrocytes: 77.8" "Group enriched" "Detected in some" 11 "glioma: 10.8;prostate cancer: 3.5;thyroid cancer: 4.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 23.1;HMC-1: 25.3;NTERA-2: 22.1;SH-SY5Y: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002500, CAB010893, HPA069468, HPA074314" Enhanced Enhanced Vesicles "Secreted in brain" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 65: Brain - Ion transport" "Cluster 12: NES - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" Vesicles "CAB002500: AB_563601, CAB010893: AB_1078474, HPA069468: AB_2686138, HPA074314: " "unprognostic (6.72e-2)" "unprognostic (3.97e-4)" "unprognostic (2.13e-2)" "unprognostic (1.40e-3)" "unprognostic (5.52e-2)" "unprognostic (2.60e-3)" "unprognostic (6.30e-2)" "unprognostic (1.96e-2)" "unprognostic (8.74e-2)" "unprognostic (2.72e-1)" "unprognostic (1.57e-3)" "unprognostic (1.58e-1)" "unprognostic (9.34e-3)" "unprognostic (3.87e-3)" "unprognostic (2.42e-1)" "unprognostic (4.07e-2)" "unprognostic (2.26e-2)" 0.2 4.2 146.6 0.4 135.6 1.0 3.9 114.3 195.2 0.4 32.5 0.9 0.5 1.4 0.2 0.2 0.4 0.3 0.3 191.8 85.5 1.8 5.8 0.6 2.1 133.6 145.2 0.2 0.4 0.0 4.5 0.1 118.9 2.8 0.1 23.8 1.2 0.4 0.1 0.5 0.6 0.1 115.0 1.4 34.9 0.9 133.6 0.4 6.2 0.2 0.4 0.7 0.3 176.0 0.0 0.0 23.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.7 3.9 0.0 0.9 1.2 1.6 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.1 0.1 25.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.1 0.0 0.1 22.1 1.1 0.0 0.4 0.0 1.7 0.0 0.1 3.1 8.4 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 2.3 0.1 0.0 0.1 0.0 0.1 0.2 0.1 5.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 146.6 135.6 114.3 195.2 191.8 85.5 133.6 145.2 118.9 115.0 133.6 176.0 0.1 0.0 0.0 27.4 0.1 0.0 0.0 0.0 0.0 37.0 1.2 0.8 1.1 2.8 0.0 0.0 4.2 0.0 14.4 0.1 0.0 0.0 1.8 0.1 0.1 0.4 1.8 0.4 37.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.4 4.7 0.1 23.5 30.4 0.0 0.0 0.3 0.0 3.9 0.0 0.2 0.0 3.7 0.0 116.2 15.5 33.2 77.8 0.0 0.0 0.4 7.5 0.9 0.0 1.9 0.0 8.6 0.0 0.1 0.2 0.2 0.8 0.0 0.0 0.1 3.8 0.0 0.0 0.3